Citrus Sinensis ID: 004155
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 771 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGN2 | 1020 | Probable leucine-rich rep | yes | no | 0.985 | 0.745 | 0.566 | 0.0 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.941 | 0.761 | 0.538 | 0.0 | |
| C0LGE0 | 1014 | Probable LRR receptor-lik | no | no | 0.964 | 0.733 | 0.522 | 0.0 | |
| C0LGG9 | 1035 | Probable LRR receptor-lik | no | no | 0.963 | 0.717 | 0.516 | 0.0 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.957 | 0.710 | 0.520 | 0.0 | |
| Q9FXF2 | 1021 | Probable LRR receptor-lik | no | no | 0.945 | 0.714 | 0.482 | 0.0 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.966 | 0.731 | 0.467 | 0.0 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.927 | 0.692 | 0.405 | 1e-162 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.968 | 0.723 | 0.398 | 1e-159 | |
| Q9M0X5 | 675 | Cysteine-rich receptor-li | no | no | 0.446 | 0.509 | 0.423 | 3e-78 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 932 bits (2408), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/826 (56%), Positives = 593/826 (71%), Gaps = 66/826 (7%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L TL D RISDN FTG IP+FIQNW LEKLVIQASGLVGPIPS I L LTDLRI+DL
Sbjct: 205 LTTLTDLRISDNQFTGAIPDFIQNWKGLEKLVIQASGLVGPIPSAIGLLGTLTDLRITDL 264
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
+G E+PFPPL M MK LILR+CN++G LP YLG LK LD+SFNKL+G IP+T+ G
Sbjct: 265 SGPESPFPPLRNMTSMKYLILRNCNLTGDLPAYLGQNRKLKNLDLSFNKLSGPIPATYSG 324
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK-- 179
L DVD+IY T N+L G +P WM+ +GD +D++YN+F+ +E CQ +SVN F+S+S
Sbjct: 325 LSDVDFIYFTSNMLNGQVPSWMVDQGDTIDITYNNFSKDKTE-ECQQKSVNTFSSTSPLV 383
Query: 180 GNNSTGIVSCLRSFRCPKTYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAFRGSNNW 239
NNS+ VSCL + CPKT+Y +HINCGG ++T N D D G + N W
Sbjct: 384 ANNSSN-VSCLSKYTCPKTFYGLHINCGGNEITSNETKYDADTWDTPG----YYDSKNGW 438
Query: 240 AFSNTGHFLDDDRPADTYIQ---------TNTSI-------------------------- 264
SNTG+FLDDDR + + TN+SI
Sbjct: 439 VSSNTGNFLDDDRTNNGKSKWSNSSELKITNSSIDFRLYTQARLSAISLTYQALCLGKGN 498
Query: 265 ---------LLMNDSHSF---GRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVV 312
++ N+ + + GRR FD+Y+QGK +KDFNI DEA G+GKA+VK+FPV+V
Sbjct: 499 YTVNLHFAEIMFNEKNMYSNLGRRYFDIYVQGKREVKDFNIVDEAKGVGKAVVKKFPVMV 558
Query: 313 INSTIEIRLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSE---NGSSSSISAGTVVG 369
N +EIRL WAGKGT +PVRGVYGPLISA+S++PDFIPP E S V
Sbjct: 559 TNGKLEIRLQWAGKGTQAIPVRGVYGPLISAVSVDPDFIPPKEPGTGTGGGSSVGTVVGS 618
Query: 370 IVAATTFVIILLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKI 429
++A+T F+++L+ GILWW+GC RP+ +E++ + +D SF+LRQIK AT+NF P NKI
Sbjct: 619 VIASTVFLVLLIGGILWWRGCLRPKSQMEKDFKNLDFQISSFSLRQIKVATDNFDPANKI 678
Query: 430 GEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEG 489
GEGGFGPV+KG M DGTV+AVKQLS+KSKQGNREF+NEI MISALQHP+LVKL+GCC+EG
Sbjct: 679 GEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNREFLNEIAMISALQHPHLVKLYGCCVEG 738
Query: 490 NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRD 549
+QLLL+YEY+ENNSLARALFGP+ ++ L+WP R +ICVGIARGLAYLHEESRLKIVHRD
Sbjct: 739 DQLLLVYEYLENNSLARALFGPQETQIPLNWPMRQKICVGIARGLAYLHEESRLKIVHRD 798
Query: 550 IKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVY 609
IKATNVLLDK+LNPKISDFGLAKLDEE+NTHISTRVAGT+GYMAPEYAMRG+LTDKADVY
Sbjct: 799 IKATNVLLDKELNPKISDFGLAKLDEEENTHISTRVAGTYGYMAPEYAMRGHLTDKADVY 858
Query: 610 SFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVM 669
SFG+VALEIV G+SN+S + K D FYLLDW +L+ Q L+E+VD RLG++++K++ ++M
Sbjct: 859 SFGVVALEIVHGKSNTSSRSKADTFYLLDWVHVLREQNTLLEVVDPRLGTDYNKQEALMM 918
Query: 670 INVALLCTDVSSTSRPSMSSVVSMLEGRADVQ-DFVPDSSVVSNIDKTKSEAIRNYYEFS 728
I + +LCT + RPSMS+VVSMLEG + V + + ++SV + D+ A++ +Y
Sbjct: 919 IQIGMLCTSPAPGDRPSMSTVVSMLEGHSTVNVEKLLEASVNNEKDEESVRAMKRHYATI 978
Query: 729 EEQSMDGCQTQSMSIDGPYTGSSTSAA---DLYPINLDSDYLNSRV 771
E+ + T + + DGP+T SSTS A DLYP+ LDS Y N+R
Sbjct: 979 GEEEI----TNTTTTDGPFTSSSTSTANANDLYPVKLDSAYWNTRT 1020
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 855 bits (2209), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/801 (53%), Positives = 557/801 (69%), Gaps = 75/801 (9%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L TL+DFR+SDN +G IP+FIQ WT LE+L IQASGLVGPIP IASL +L DLRISDL
Sbjct: 181 LTTLRDFRVSDNQLSGTIPDFIQKWTKLERLFIQASGLVGPIPIAIASLVELKDLRISDL 240
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
NG E+PFP L +KKM+TLILR+CN++G LPDYLG +TS K LD+SFNKL+GAIP+T++
Sbjct: 241 NGPESPFPQLRNIKKMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLSGAIPNTYIN 300
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKGN 181
L D YIY TGN+L G++P WM+ KG ++DLSYN+F+ + C+Y +V
Sbjct: 301 LRDGGYIYFTGNMLNGSVPDWMVNKGYKIDLSYNNFSVDPTNAVCKYNNV---------- 350
Query: 182 NSTGIVSCLRSFRCPKTYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAFRGSNNWAF 241
+SC+R+++CPKT+ ++HINCGG ++++NG T +E D + S + R N W
Sbjct: 351 -----LSCMRNYQCPKTFNALHINCGGDEMSING-TIYESDKYDRLESWYESR--NGWFS 402
Query: 242 SNTGHFLDDDR-PADTYIQTNTSILLM--------------------------------- 267
+N G F+DD P I++N+S L +
Sbjct: 403 NNVGVFVDDKHVPERVTIESNSSELNVVDFGLYTQARISAISLTYYALCLENGNYNVNLH 462
Query: 268 ---------NDSHSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVINSTIE 318
N+ S GRR FD+YIQ KL +KDFNI EA +G ++K FPV + + +E
Sbjct: 463 FAEIMFNGNNNYQSLGRRFFDIYIQRKLEVKDFNIAKEAKDVGNVVIKTFPVEIKDGKLE 522
Query: 319 IRLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENGSSSSISAGTV-VGIVAATTFV 377
IRLYWAG+GTT +P VYGPLISAIS++ P NG +S GT+ +V + F+
Sbjct: 523 IRLYWAGRGTTVIPKERVYGPLISAISVDSSVNPSPRNG----MSTGTLHTLVVILSIFI 578
Query: 378 IILLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPV 437
+ L+ G LW KG R + +E++ + ++L SF+LRQIK ATNNF N+IGEGGFGPV
Sbjct: 579 VFLVFGTLWKKGYLRSKSQMEKDFKSLELMIASFSLRQIKIATNNFDSANRIGEGGFGPV 638
Query: 438 YKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497
YKG + DGT++AVKQLS+ SKQGNREF+NEIGMISAL HPNLVKL+GCC+EG QLLL+YE
Sbjct: 639 YKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVYE 698
Query: 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL 557
++ENNSLARALFGP+ +L+LDWPTR +IC+G+ARGLAYLHEESRLKIVHRDIKATNVLL
Sbjct: 699 FVENNSLARALFGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLL 758
Query: 558 DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALE 617
DK LNPKISDFGLAKLDEED+THISTR+AGTFGYMAPEYAMRG+LTDKADVYSFGIVALE
Sbjct: 759 DKQLNPKISDFGLAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALE 818
Query: 618 IVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCT 677
IV GRSN + K + FYL+DW +L+ + NL+ELVD RLGS +++E+ M MI +A++CT
Sbjct: 819 IVHGRSNKIERSKNNTFYLIDWVEVLREKNNLLELVDPRLGSEYNREEAMTMIQIAIMCT 878
Query: 678 DVSSTSRPSMSSVVSMLEGRADVQ-DFVPDSSVVSNIDKTKS-EAIRNYYEFSEEQSMDG 735
RPSMS VV MLEG+ V+ + + ++SV + ++ ++ YYE M G
Sbjct: 879 SSEPCERPSMSEVVKMLEGKKMVEVEKLEEASVHRETKRLENMNTMKKYYE------MIG 932
Query: 736 CQTQSMSIDGPYTGSSTSAAD 756
Q S S+ + S S+AD
Sbjct: 933 -QEISTSMSMIMSDRSESSAD 952
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 796 bits (2055), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/811 (52%), Positives = 562/811 (69%), Gaps = 67/811 (8%)
Query: 1 MLVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD 60
+L L D RISDN+FTG IP+FI NWT + KL + GL GPIPS I+SL+ LTDLRISD
Sbjct: 207 LLKNLTDMRISDNNFTGPIPDFISNWTRILKLQMHGCGLDGPIPSSISSLTSLTDLRISD 266
Query: 61 LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM 120
L G + FPPL ++ +KTLILR C + G +P Y+G + LK LD+SFN L+G IPS+F
Sbjct: 267 LGGKPSSFPPLKNLESIKTLILRKCKIIGPIPKYIGDLKKLKTLDLSFNLLSGEIPSSFE 326
Query: 121 GLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETS--CQYRSVNLFASSS 178
+ D+IYLTGN LTG +P + +++ VD+S+N+FT SS S C + NL S +
Sbjct: 327 NMKKADFIYLTGNKLTGGVPNYFVERNKNVDVSFNNFTDESSIPSHDCNRVTSNLVESFA 386
Query: 179 KGNNSTGIVSC-LRSFRC--PKTY--YSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAF 233
GN S +C L+ C PK Y Y ++INCGG +V V+ T++ D + G S +
Sbjct: 387 LGNKSHKGSTCFLQRMPCVHPKRYHLYKLYINCGGGEVKVDKEITYQADDEPKGASMYVL 446
Query: 234 RGSNNWAFSNTGHFLDDDRPADTYIQTNTSILLMNDS----------------------- 270
+ WA S+TG+F+D+D AD Y NTS L +N S
Sbjct: 447 GANKRWALSSTGNFMDNDDDADEYTVQNTSRLSVNASSPSFGLYRTARVSPLSLTYYGIC 506
Query: 271 -----------------------HSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQ 307
+S G+R+FD+Y+Q +LV+K+FNI++ A G GK I+K
Sbjct: 507 LGNGNYTVNLHFAEIIFTDDNTLYSLGKRLFDIYVQDQLVIKNFNIQEAARGSGKPIIKS 566
Query: 308 FPVVVINSTIEIRLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENGSSSSISAGTV 367
F V V + T++I L WAGKGTTG+P+RGVYGP+ISAIS+ P+F PP + I
Sbjct: 567 FLVNVTDHTLKIGLRWAGKGTTGIPIRGVYGPMISAISVEPNFKPPVYYDTKDIILK--- 623
Query: 368 VGI-VAATTFVIILLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPD 426
VG+ VAA T ++ ++VG+ W K R ++ +++ELRG+DL TG+FTLRQIKAAT+NF
Sbjct: 624 VGVPVAAATLLLFIIVGVFWKKR--RDKNDIDKELRGLDLQTGTFTLRQIKAATDNFDVT 681
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
KIGEGGFG VYKG +++G ++AVKQLS+KS+QGNREFVNEIGMISALQHPNLVKL+GCC
Sbjct: 682 RKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIGMISALQHPNLVKLYGCC 741
Query: 487 IEGNQLLLIYEYMENNSLARALFGP-EAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
+EGNQL+L+YEY+ENN L+RALFG E+ RLKLDW TR +I +GIA+GL +LHEESR+KI
Sbjct: 742 VEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKIFLGIAKGLTFLHEESRIKI 801
Query: 546 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDK 605
VHRDIKA+NVLLDKDLN KISDFGLAKL+++ NTHISTR+AGT GYMAPEYAMRGYLT+K
Sbjct: 802 VHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIAGTIGYMAPEYAMRGYLTEK 861
Query: 606 ADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQ 665
ADVYSFG+VALEIVSG+SN++ +P ED YLLDWA +L+ +G+L+ELVD L S++ +E+
Sbjct: 862 ADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYVLQERGSLLELVDPTLASDYSEEE 921
Query: 666 VMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQDFVPDSSVVSNIDKTKSEAIRNYY 725
M+M+NVAL+CT+ S T RP+MS VVS++EG+ +Q+ + D S + K K A+RN++
Sbjct: 922 AMLMLNVALMCTNASPTLRPTMSQVVSLIEGKTAMQELLSDPSFSTVNPKLK--ALRNHF 979
Query: 726 EFSEEQSMDGCQTQSMSIDGPYTGSSTSAAD 756
+ E S ++ S S GP T S+ S D
Sbjct: 980 -WQNELS----RSLSFSTSGPRTASANSLVD 1005
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 771 bits (1990), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/806 (51%), Positives = 539/806 (66%), Gaps = 63/806 (7%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L L +FRI N +GKIP+FI NWT L +L +Q + + GPIP+ I++L LT+LRI+DL
Sbjct: 206 LKNLTNFRIDGNSLSGKIPDFIGNWTRLVRLDLQGTSMEGPIPASISNLKNLTELRITDL 265
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGL-MTSLKVLDVSFNKLNGAIPSTFM 120
G +PFP L M M+ L+LR+C + +P+Y+G MT LK+LD+S N LNG IP TF
Sbjct: 266 RGPTSPFPDLQNMTNMERLVLRNCLIREPIPEYIGTSMTMLKLLDLSSNMLNGTIPDTFR 325
Query: 121 GLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFAS-SSK 179
L +++YL N LTG +P ++L +DLSYN+FT + SC VNL +S S
Sbjct: 326 SLNAFNFMYLNNNSLTGPVPQFILDSKQNIDLSYNNFTQPPT-LSCNQLDVNLISSYPSV 384
Query: 180 GNNSTGIVSCLRS-FRCP--KTYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAFRGS 236
NNS + CLR CP + S+ INCGG ++ V+ + + DD ++ G S F+ S
Sbjct: 385 TNNS--VQWCLRKDLPCPGDAHHSSLFINCGGNRLKVDKDE-YADDLNKRGASTFS-SVS 440
Query: 237 NNWAFSNTGHFLDDDRPADTYIQTNT---------------------------------- 262
W +S++G +L +D TY+ T+T
Sbjct: 441 ERWGYSSSGAWLGND--GATYLATDTFNLINESTPEYYKTARLASQSLKYYGLCMRRGSY 498
Query: 263 -------SILLMNDS--HSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVI 313
I+ ND S GRR+FD+Y+QG L+ +DFNI AGG+GK ++Q V +
Sbjct: 499 KVQLYFAEIMFSNDQTYSSLGRRLFDIYVQGILLERDFNIAQRAGGVGKPFLRQVDEVQV 558
Query: 314 N-STIEIRLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENGSSSSISAGTVVGIVA 372
N ST+EI L W GKGT +P RGVYGPLISAI++ P+F + S+ + AG V+
Sbjct: 559 NGSTLEIHLKWTGKGTNVIPTRGVYGPLISAITVTPNFKVDTGKPLSNGVVAGIVIAACV 618
Query: 373 ATTFVIILLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEG 432
A ++++++ + + G E +ELRG+DL TGSFTL+QIK ATNNF P+NKIGEG
Sbjct: 619 AFGLLVLVILRLTGYLGG--KEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEG 676
Query: 433 GFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQL 492
GFGPVYKG +ADG +AVKQLSSKSKQGNREFV EIGMISALQHPNLVKL+GCCIEG +L
Sbjct: 677 GFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKEL 736
Query: 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKA 552
LL+YEY+ENNSLARALFG E RL LDW TR+++C+GIA+GLAYLHEESRLKIVHRDIKA
Sbjct: 737 LLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKA 796
Query: 553 TNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFG 612
TNVLLD LN KISDFGLAKLDEE+NTHISTR+AGT GYMAPEYAMRGYLTDKADVYSFG
Sbjct: 797 TNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFG 856
Query: 613 IVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINV 672
+V LEIVSG+SN++ +PKE+ YLLDWA +L+ QG+L+ELVD LG++F K++ M M+N+
Sbjct: 857 VVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNI 916
Query: 673 ALLCTDVSSTSRPSMSSVVSMLEGRADVQ-DFVPDSSVVSNIDKTKSEAIRNYYEFSEEQ 731
ALLCT+ S T RP MSSVVSML+G+ VQ V + S + +A+ + + SE Q
Sbjct: 917 ALLCTNPSPTLRPPMSSVVSMLQGKIKVQPPLVKREADPSGSAAMRFKALEHLSQDSESQ 976
Query: 732 ----SMDGCQTQSMSIDGPYTGSSTS 753
+ + S S+DGP+ SS S
Sbjct: 977 VSTYTRNKEHKSSSSMDGPWVDSSFS 1002
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 761 bits (1964), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/812 (52%), Positives = 537/812 (66%), Gaps = 74/812 (9%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L L +FRI N +GKIP+FI NWTLLE+L +Q + + GPIP I++L+ LT+LRI+DL
Sbjct: 208 LKNLTEFRIDGNSLSGKIPDFIGNWTLLERLDLQGTSMEGPIPPSISNLTNLTELRITDL 267
Query: 62 NGTEA-PFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM 120
G A FP L + KMK L+LR+C + G +P+Y+G M+ LK LD+S N L G IP TF
Sbjct: 268 RGQAAFSFPDLRNLMKMKRLVLRNCLIRGPIPEYIGSMSELKTLDLSSNMLTGVIPDTFR 327
Query: 121 GLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFAS-SSK 179
L ++++L N LTG +P +++ + +DLS N+FT + SC VNL +S S
Sbjct: 328 NLDAFNFMFLNNNSLTGPVPQFIINSKENLDLSDNNFTQPPT-LSCNQLDVNLISSYPSV 386
Query: 180 GNNSTGIVSCLRS-FRCPK--TYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAFRGS 236
+NS + CLR CP+ S+ INCGG ++ + G T+ DD + G S F+ S
Sbjct: 387 TDNS--VQWCLREGLPCPEDAKQSSLFINCGGSRLKI-GKDTYTDDLNSRGQSTFS-SVS 442
Query: 237 NNWAFSNTG--------HFLDDDR------PADTYIQTN--------------------- 261
W +S++G +L DR Y +T
Sbjct: 443 ERWGYSSSGVWLGKEDAGYLATDRFNLINGSTPEYYKTARLSPQSLKYYGLCLRRGSYKL 502
Query: 262 ----TSILLMNDS--HSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVIN- 314
I+ ND +S GRRIFD+Y+QG L+ +DFNI + AGG+GK ++Q V +N
Sbjct: 503 QLHFAEIMFSNDQTFNSLGRRIFDIYVQGNLLERDFNIAERAGGVGKPFIRQIDGVQVNG 562
Query: 315 STIEIRLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENGSSSSISAGTVVGIVAAT 374
ST+EI L W GKGT +P RGVYGPLISAI++ P+F + + +S G V GIV A
Sbjct: 563 STLEIHLQWTGKGTNVIPTRGVYGPLISAITITPNF----KVDTGKPLSNGAVAGIVIAA 618
Query: 375 TFVIILLV-GILWWKGCFRPEHTLE-QELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEG 432
V LLV IL G + E +ELRG+DL TGSFTL+QIK ATNNF P+NKIGEG
Sbjct: 619 CAVFGLLVLVILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEG 678
Query: 433 GFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQL 492
GFGPVYKG +ADG +AVKQLSSKSKQGNREFV EIGMISALQHPNLVKL+GCCIEG +L
Sbjct: 679 GFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKEL 738
Query: 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKA 552
LL+YEY+ENNSLARALFG E RL LDW TR++IC+GIA+GLAYLHEESRLKIVHRDIKA
Sbjct: 739 LLVYEYLENNSLARALFGTEKQRLHLDWSTRNKICIGIAKGLAYLHEESRLKIVHRDIKA 798
Query: 553 TNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFG 612
TNVLLD LN KISDFGLAKL++++NTHISTR+AGT GYMAPEYAMRGYLTDKADVYSFG
Sbjct: 799 TNVLLDLSLNAKISDFGLAKLNDDENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFG 858
Query: 613 IVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINV 672
+V LEIVSG+SN++ +PKE+ YLLDWA +L+ QG+L+ELVD LG++F K++ M M+N+
Sbjct: 859 VVCLEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNI 918
Query: 673 ALLCTDVSSTSRPSMSSVVSMLEGRADVQ------DFVPDSSVVSNIDKTK-----SEAI 721
ALLCT+ S T RP MSSVVSMLEG+ VQ + P S + SE+
Sbjct: 919 ALLCTNPSPTLRPPMSSVVSMLEGKIKVQPPLVKREADPSGSAAMRFKALELLSQDSESQ 978
Query: 722 RNYYEFSEEQSMDGCQTQSMSIDGPYTGSSTS 753
+ Y + EQ + S S+DGP+ SS S
Sbjct: 979 VSTYARNREQDI-----SSSSMDGPWVDSSFS 1005
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 688 bits (1776), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/783 (48%), Positives = 489/783 (62%), Gaps = 54/783 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L + DFRI+D +G IP++IQNW LE+L + ASGL GPIPS I+ LS L +LRISD+
Sbjct: 216 LQNMTDFRINDLQLSGTIPSYIQNWKQLERLEMIASGLTGPIPSVISVLSNLVNLRISDI 275
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
G PFP L + + +IL++CN+SG++P YL + L+ LD+SFNKL G IPS F
Sbjct: 276 RGPVQPFPSLKNVTGLTKIILKNCNISGQIPTYLSHLKELETLDLSFNKLVGGIPS-FAQ 334
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSET-SCQYR---SVNLFASS 177
++ +I L GN+L G P +L+ G VDLSYN+ S E+ +C+ ++NLF S+
Sbjct: 335 AENLRFIILAGNMLEGDAPDELLRDGITVDLSYNNLKWQSPESRACRPNMNLNLNLFQST 394
Query: 178 SKGNNSTGIVSCLRSFRCPKTYYSVHINCGGKQVTVNGNTTFE----DDTDEAGPSRFAF 233
S S+ + C++ F+CP+ +H+NCGG + V T E D E G +++
Sbjct: 395 ST-KKSSKFLPCIKDFKCPRYSSCLHVNCGGSDMYVKEKKTKELYEGDGNVEGGAAKYFL 453
Query: 234 RGSNNWAFSNTGHFLDDDR----------PAD----------------TYIQTN------ 261
+ NW FS+TG F+DD+ PA TY
Sbjct: 454 KPDANWGFSSTGDFMDDNNFQNTRFTMFVPASNQSDLYKSARIAPVSLTYFHACLENGNY 513
Query: 262 ------TSILLMNDSH--SFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVI 313
I ND + GRR+FD+YIQ KLV KDFNI DEA G I+K V
Sbjct: 514 TINLDFAEIRFTNDENYNRLGRRLFDIYIQEKLVAKDFNIMDEAKGAQTPIIKPLTAYVT 573
Query: 314 NSTIEIRLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENGSSSSISAGTVVGIVAA 373
N + IRL WAGKGTT +P RGVYGP+ISAIS+ D P + S A +GI A
Sbjct: 574 NHFLTIRLSWAGKGTTRIPTRGVYGPIISAISIVSDSKPCERPKTGMSPGAYIAIGIGAP 633
Query: 374 TTFVIILLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGG 433
+II ++G LW GC ++ +L +G+FTLRQIK AT++F P NKIGEGG
Sbjct: 634 C--LIIFILGFLWICGCLPRCGRQRKDPYEEELPSGTFTLRQIKFATDDFNPTNKIGEGG 691
Query: 434 FGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLL 493
FG V+KG +ADG VVAVKQLSSKS+QGNREF+NEIG IS LQHPNLVKLHG C+E QLL
Sbjct: 692 FGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAISCLQHPNLVKLHGFCVERAQLL 751
Query: 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKAT 553
L YEYMENNSL+ ALF P+ ++ +DWPTR +IC GIA+GLA+LHEES LK VHRDIKAT
Sbjct: 752 LAYEYMENNSLSSALFSPKHKQIPMDWPTRFKICCGIAKGLAFLHEESPLKFVHRDIKAT 811
Query: 554 NVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGI 613
N+LLDKDL PKISDFGLA+LDEE+ THIST+VAGT GYMAPEYA+ GYLT KADVYSFG+
Sbjct: 812 NILLDKDLTPKISDFGLARLDEEEKTHISTKVAGTIGYMAPEYALWGYLTFKADVYSFGV 871
Query: 614 VALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVA 673
+ LEIV+G +NS+ D LL++A G+LM++VD+RL D+++ +I VA
Sbjct: 872 LVLEIVAGITNSNFMGAGDSVCLLEFANECVESGHLMQVVDERLRPEVDRKEAEAVIKVA 931
Query: 674 LLCTDVSSTSRPSMSSVVSMLEGRADVQDFVPDSSVVSNIDKTKSEAIRNYYEFSEEQSM 733
L+C+ S T RP MS VV+MLEG V + P V N + +A ++ E S
Sbjct: 932 LVCSSASPTDRPLMSEVVAMLEGLYPVPESTP--GVSRNAGDIRFKAFKDLRRGMENNSK 989
Query: 734 DGC 736
C
Sbjct: 990 TQC 992
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 647 bits (1668), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/825 (46%), Positives = 510/825 (61%), Gaps = 80/825 (9%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
LV L+ RI DN+FTG IP +I NWT L+KL + ASGL GPIP + L L +L +SD
Sbjct: 213 LVNLERVRICDNNFTGIIPAYIGNWTRLQKLHLYASGLTGPIPDAVVRLENLLELSLSDT 272
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
G ++ FP L K +K LILR+ +SG +P Y+ +T LK+LD+SFNKLNG + G
Sbjct: 273 TGIKS-FPNLSS-KGLKRLILRNVGLSGPIPSYIWNLTDLKILDLSFNKLNGIV----QG 326
Query: 122 LLDV-DYIYLTGNLLTGTIPPW-MLQKGDRVDLSYNSFTAGSSETSCQYRS-VNLFASSS 178
+ + IYLTGNLL+G I +L +DLSYN+F+ SS CQ S +N + SS
Sbjct: 327 VQNPPKNIYLTGNLLSGNIESGGLLNSQSYIDLSYNNFSWSSS---CQKGSTINTYQSSY 383
Query: 179 KGNNSTGIVSCLRSFRCPKTYYSVHINCGGKQVTVN---GNTTFEDD----TDEAGPSRF 231
NN TG+ C C K +HINCGG++V++ G T++ D T+ A +F
Sbjct: 384 SKNNLTGLPPCAVPANCKKYQRFLHINCGGEEVSIRNSLGKITYQTDNSRQTNAASNQQF 443
Query: 232 AFRGSNNWAFSNTGHFLDDDRPADTYIQTNTSILLMNDS----------------HSF-- 273
+ W SNTG F DD+ D Y T+T++ L D ++F
Sbjct: 444 DY-----WGVSNTGDFTDDNSDHDEYY-TSTNLTLSGDYPDLYKTARRSALSLVYYAFCL 497
Query: 274 -------------------------GRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQF 308
GRRIFDVY+QGKL L+DFNI EA G K ++K+
Sbjct: 498 ENGNYNVKLHFMEIQFSDKEVYSRLGRRIFDVYVQGKLFLRDFNINKEANGNMKPVIKEI 557
Query: 309 PVVVINSTIEIRLYWAGKGTTGVPVRGVYGPLISAISLNPDFIP-PSENGSSSSISAGTV 367
V N +EIRLYWAGKGTT +P RG YGPLISAISL P + I +
Sbjct: 558 NATVTNHMLEIRLYWAGKGTTLIPKRGNYGPLISAISLCHSQEPLCGVEKTKHHIKYPLI 617
Query: 368 VGIVAATTFVIILLVGILWWKGCFRPEHTLEQE-LRGVDLHTGSFTLRQIKAATNNFAPD 426
+G A +++L VGI + +G +R ++ + LR L T F+ RQ++ ATNNF
Sbjct: 618 LGASGALVTIVLLAVGI-YARGIYRRDNNRRERDLRAQGLQTVCFSWRQLQTATNNFDQA 676
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
NK+GEGGFG V+KG ++DGT++AVKQLSSKS QGNREFVNEIGMIS L HPNLVKL+GCC
Sbjct: 677 NKLGEGGFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNEIGMISGLNHPNLVKLYGCC 736
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
+E +QLLL+YEYMENNSLA ALFG + LKLDW R +ICVGIARGL +LH+ S +++V
Sbjct: 737 VERDQLLLVYEYMENNSLALALFGQNS--LKLDWAARQKICVGIARGLEFLHDGSAMRMV 794
Query: 547 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKA 606
HRDIK TNVLLD DLN KISDFGLA+L E ++THIST+VAGT GYMAPEYA+ G LT+KA
Sbjct: 795 HRDIKTTNVLLDTDLNAKISDFGLARLHEAEHTHISTKVAGTIGYMAPEYALWGQLTEKA 854
Query: 607 DVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQV 666
DVYSFG+VA+EIVSG+SN+ + D L++WAL L+ G+++E+VD+ L F++ +
Sbjct: 855 DVYSFGVVAMEIVSGKSNTKQQGNADSVSLINWALTLQQTGDILEIVDRMLEGEFNRSEA 914
Query: 667 MVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQDFVPDSSVVSNIDKTKSEAIRNYYE 726
+ MI VAL+CT+ S + RP+MS V MLEG ++ + D + + D + S+ +R+
Sbjct: 915 VRMIKVALVCTNSSPSLRPTMSEAVKMLEGEIEITQVMSDPGIYGH-DWSISK-LRDIDT 972
Query: 727 FSEEQSMDGCQTQSMSIDGPYTGSSTSAADLYPINLDSDYLNSRV 771
S S G Q+ + SS S DLYP+ +S LNS V
Sbjct: 973 HSSS-STSGVTDQTTTT----MKSSVSGCDLYPLYPESMILNSTV 1012
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 572 bits (1473), Expect = e-162, Method: Compositional matrix adjust.
Identities = 318/785 (40%), Positives = 454/785 (57%), Gaps = 70/785 (8%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
LV L+ I+D TG+IP+FI +WT L L I +GL GPIP+ ++L+ LT+LR+ D+
Sbjct: 217 LVELEQAWIADMELTGQIPDFIGDWTKLTTLRILGTGLSGPIPASFSNLTSLTELRLGDI 276
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
+ + + MK + L+LR+ N++G +P +G +SL+ LD+SFNKL+G IP++
Sbjct: 277 SNGNSSLEFIKDMKSLSILVLRNNNLTGTIPSNIGEYSSLRQLDLSFNKLHGTIPASLFN 336
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAG-----SSETSCQYRSVNLFAS 176
L + +++L N L G++P Q VD+SYN + S N F
Sbjct: 337 LRQLTHLFLGNNTLNGSLPTQKGQSLSNVDVSYNDLSGSLPSWVSLPNLNLNLVANNFTL 396
Query: 177 SSKGNNSTGIVSCL-RSFRCPK---TYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFA 232
N ++CL ++F C + Y INCGG ++ FE + ++ GP+ F
Sbjct: 397 EGLDNRVLSGLNCLQKNFPCNRGKGIYSDFSINCGGPEIRSVTEAVFEREDEDLGPASFV 456
Query: 233 FRGSNNWAFSNTGHFLDDDRPADTYIQTNTSILL-------------------------- 266
WA S+ G F + YI T+ S +
Sbjct: 457 VSAGQRWAASSVGLFAGSSN--NIYISTSQSQFVNTLDSELFQSARLSASSLRYYGLGLE 514
Query: 267 -------------------MNDSHSFGRRIFDVYIQGKLVLKDFNIEDEAG-GIGKAIVK 306
N GRR FD+Y+QG+LV KDF++ AG +A+ +
Sbjct: 515 NGGYTVTLQFAEIQILGSTSNTWRGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQR 574
Query: 307 QFPVVVINSTIEIRLYWAGKGTTGVPVRGVYGPLISAISLNPDFIP-----PSENGSSSS 361
++ V + +EI L+WAGKGT +P++G YGPLISA+ PDF P P G S +
Sbjct: 575 EYKANVSQNHLEIHLFWAGKGTCCIPIQGAYGPLISAVGATPDFTPTVGNRPPSKGKSMT 634
Query: 362 ISAGTVVGIVAATTFVIILLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATN 421
GT+VG++ + I+ +++ R +T ++E+ +D+ +FT ++K+AT
Sbjct: 635 ---GTIVGVIVGVGLLSIISGVVIFIIRKRRKRYTDDEEILSMDVKPYTFTYSELKSATQ 691
Query: 422 NFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVK 481
+F P NK+GEGGFGPVYKG + DG VAVK LS S+QG +FV EI ISA+QH NLVK
Sbjct: 692 DFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAISAVQHRNLVK 751
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
L+GCC EG LL+YEY+ N SL +ALFG + L LDW TR+ IC+G+ARGL YLHEE+
Sbjct: 752 LYGCCYEGEHRLLVYEYLPNGSLDQALFGEKT--LHLDWSTRYEICLGVARGLVYLHEEA 809
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGY 601
RL+IVHRD+KA+N+LLD L PK+SDFGLAKL ++ THISTRVAGT GY+APEYAMRG+
Sbjct: 810 RLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGH 869
Query: 602 LTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661
LT+K DVY+FG+VALE+VSGR NS +++ YLL+WA L +G +EL+D +L + F
Sbjct: 870 LTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHEKGREVELIDHQL-TEF 928
Query: 662 DKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQDFVPDSSVVSN--IDKTKSE 719
+ E+ MI +ALLCT S RP MS VV+ML G +V D +++ D T +
Sbjct: 929 NMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEVSDVTSKPGYLTDWRFDDTTAS 988
Query: 720 AIRNY 724
+I +
Sbjct: 989 SISGF 993
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 561 bits (1445), Expect = e-159, Method: Compositional matrix adjust.
Identities = 326/818 (39%), Positives = 467/818 (57%), Gaps = 71/818 (8%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
LV L+ I+D T +IP+FI +WT L L I +GL GPIPS ++L+ LT+LR+ D+
Sbjct: 218 LVQLEQAWIADLEVTDQIPDFIGDWTKLTTLRIIGTGLSGPIPSSFSNLTSLTELRLGDI 277
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
+ + + MK + L+LR+ N++G +P +G +SL+ +D+SFNKL+G IP++
Sbjct: 278 SSGSSSLDFIKDMKSLSVLVLRNNNLTGTIPSTIGEHSSLRQVDLSFNKLHGPIPASLFN 337
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAG-SSETSCQYRSVNLFASS--- 177
L + +++L N L G+ P Q VD+SYN + S S +NL A++
Sbjct: 338 LSQLTHLFLGNNTLNGSFPTQKTQSLRNVDVSYNDLSGSLPSWVSLPSLKLNLVANNFTL 397
Query: 178 -SKGNNSTGIVSCL-RSFRCPK---TYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFA 232
N ++CL ++F C + Y INCGG + FE + ++ GP+ F
Sbjct: 398 EGLDNRVLPGLNCLQKNFPCNRGKGIYSDFSINCGGPEKRSVTGALFEREDEDFGPASFF 457
Query: 233 FRGSNNWAFSNTGHFLDDDRPADTYIQTNTSILLMN-DSHSF------------------ 273
WA S+ G F + YI T+ S + DS F
Sbjct: 458 VSAGQRWAASSVGLFAGSSN--NIYIATSQSQFVNTLDSELFQSARLSASSVRYYGLGLE 515
Query: 274 --------------------------GRRIFDVYIQGKLVLKDFNIEDEAG-GIGKAIVK 306
GRR FD+Y+QG+LV KDF++ AG +A+ +
Sbjct: 516 NGGYTVTLQFAEIQILGSTSTTWKGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQR 575
Query: 307 QFPVVVINSTIEIRLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENG--SSSSISA 364
+ V + +E+ L+WAGKGT +P++G YGPLISA+S PDF P N S
Sbjct: 576 VYKANVSENHLEVHLFWAGKGTCCIPIQGAYGPLISAVSATPDFTPTVANKPPSKGKNRT 635
Query: 365 GTVVGIVAATTFVIILLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFA 424
GT+VG++ + IL +++ R +T ++EL G+D+ FT ++K+AT +F
Sbjct: 636 GTIVGVIVGVGLLSILAGVVMFTIRKRRKRYTDDEELLGMDVKPYIFTYSELKSATQDFD 695
Query: 425 PDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHG 484
P NK+GEGGFGPVYKG++ DG VVAVK LS S+QG +FV EI IS++ H NLVKL+G
Sbjct: 696 PSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISSVLHRNLVKLYG 755
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
CC EG +L+YEY+ N SL +ALFG + L LDW TR+ IC+G+ARGL YLHEE+ ++
Sbjct: 756 CCFEGEHRMLVYEYLPNGSLDQALFGDKT--LHLDWSTRYEICLGVARGLVYLHEEASVR 813
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
IVHRD+KA+N+LLD L P+ISDFGLAKL ++ THISTRVAGT GY+APEYAMRG+LT+
Sbjct: 814 IVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTE 873
Query: 605 KADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKE 664
K DVY+FG+VALE+VSGR NS +E+ YLL+WA L + +EL+D +L ++F+ E
Sbjct: 874 KTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRDIELIDDKL-TDFNME 932
Query: 665 QVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQDFVPDSSVVSN--IDKTKSEAIR 722
+ MI +ALLCT S RP MS VV+ML G ++ D VS+ D T ++
Sbjct: 933 EAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDVTSKPGYVSDWRFDDTTGSSLS 992
Query: 723 NYYEFSEEQSMDGCQTQSMSIDGPYTGSSTSAADLYPI 760
+ + SMS+ P + S +D P+
Sbjct: 993 GF-------QIKDTTGYSMSLVAPGSEISPRDSDFKPM 1023
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 293 bits (751), Expect = 3e-78, Method: Compositional matrix adjust.
Identities = 150/354 (42%), Positives = 222/354 (62%), Gaps = 10/354 (2%)
Query: 348 PDFIPPSENGSSSSISAGTVVGIVAATTFVIILLVGILWWKGCFRPEHTLEQELRGVD-- 405
P PSE G +++ +V +A V +LL+G + W R + L E +D
Sbjct: 268 PPLNIPSEKGKGKNLTV--IVTAIAVPVSVCVLLLGAMCWLLARRRNNKLSAETEDLDED 325
Query: 406 ----LHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGN 461
T F I+AATN F+ NK+G GGFG VYKG + G VA+K+LS S QG
Sbjct: 326 GITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGA 385
Query: 462 REFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWP 521
EF NE+ +++ LQH NL KL G C++G + +L+YE++ N SL LF E R+ LDW
Sbjct: 386 EEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRV-LDWQ 444
Query: 522 TRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581
R++I GIARG+ YLH +SRL I+HRD+KA+N+LLD D++PKISDFG+A++ D T
Sbjct: 445 RRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQA 504
Query: 582 ST-RVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWA 640
+T R+ GT+GYM+PEYA+ G + K+DVYSFG++ LE+++G+ NSS ++ + L+ +
Sbjct: 505 NTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGDLVTYV 564
Query: 641 LILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSML 694
L + + +ELVD+ + NF +V+ I++ALLC S+ RPSM ++ M+
Sbjct: 565 WKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVMM 618
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 771 | ||||||
| 359493983 | 1007 | PREDICTED: probable leucine-rich repeat | 0.988 | 0.756 | 0.688 | 0.0 | |
| 302142829 | 1036 | unnamed protein product [Vitis vinifera] | 0.988 | 0.735 | 0.688 | 0.0 | |
| 359493981 | 1007 | PREDICTED: probable leucine-rich repeat | 0.988 | 0.756 | 0.685 | 0.0 | |
| 359493985 | 1011 | PREDICTED: probable leucine-rich repeat | 0.989 | 0.754 | 0.677 | 0.0 | |
| 255567058 | 985 | ATP binding protein, putative [Ricinus c | 0.957 | 0.749 | 0.654 | 0.0 | |
| 255567064 | 1007 | ATP binding protein, putative [Ricinus c | 0.985 | 0.754 | 0.647 | 0.0 | |
| 357492929 | 996 | Cysteine-rich receptor-like protein kina | 0.970 | 0.751 | 0.630 | 0.0 | |
| 449456691 | 1007 | PREDICTED: probable leucine-rich repeat | 0.983 | 0.752 | 0.636 | 0.0 | |
| 449503668 | 1007 | PREDICTED: probable leucine-rich repeat | 0.983 | 0.752 | 0.636 | 0.0 | |
| 351723187 | 999 | receptor-like protein kinase 2-like prec | 0.974 | 0.751 | 0.612 | 0.0 |
| >gi|359493983|ref|XP_002283596.2| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1138 bits (2943), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 559/812 (68%), Positives = 649/812 (79%), Gaps = 50/812 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L TLKDFR+ DN FTGKIPNFIQNWT LEKLVIQ SG GPIPSGIA L+K+TDLRISDL
Sbjct: 202 LTTLKDFRVGDNQFTGKIPNFIQNWTKLEKLVIQGSGFSGPIPSGIALLTKITDLRISDL 261
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
NGTEA FPPL M+ +KTLILRSCN+ G LPDYLG MT LK LD+SFNKL G IPS+F+G
Sbjct: 262 NGTEATFPPLSDMRNLKTLILRSCNIVGPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVG 321
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKGN 181
L + DY+Y TGN+LTG +P WML++GD DLSYN+FT+ SS CQ RSVNLF SSS GN
Sbjct: 322 LSNADYMYFTGNMLTGAVPDWMLKRGDNYDLSYNNFTSESSR-GCQERSVNLFGSSSGGN 380
Query: 182 NSTGIVSCLRSFRCPKTYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAFRGSNNWAF 241
N GIVSCLRSF CPK +YS+HINCGGK+V V+GNTT+EDDTD GPS+F ++ NWAF
Sbjct: 381 N-FGIVSCLRSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDTDSGGPSKF-YQSRTNWAF 438
Query: 242 SNTGHFLDDDRPADTYIQTNTSILLMNDS------------------------------- 270
S+TGHF+DDDRP D++I TN S L M +S
Sbjct: 439 SSTGHFMDDDRPTDSFIGTNVSRLTMENSGLYTTARLSALSLTYYGFCLENGNYTVKLHF 498
Query: 271 -----------HSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVINSTIEI 319
S GRR+FDVY+Q +LVLKDF+IED+AGG+ K I+K F VV N+T+EI
Sbjct: 499 AEITFTDDKTYSSLGRRLFDVYVQDELVLKDFDIEDDAGGVSKEIIKYFTAVVTNNTLEI 558
Query: 320 RLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENGSSSSISAGTVVGIVAATTFVII 379
R YWAGKGTTG+PVRGVYGPLISAIS++PDFIPP++NGSSS S G VVG VA ++
Sbjct: 559 RFYWAGKGTTGIPVRGVYGPLISAISVDPDFIPPTKNGSSSK-SVGIVVGHVAGVILLVF 617
Query: 380 LLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYK 439
L++GILWW+GC R + TLEQEL+G+DL TG FTLRQIKAATNNF NKIGEGGFG VYK
Sbjct: 618 LVIGILWWRGCLRRKDTLEQELKGLDLQTGLFTLRQIKAATNNFDAANKIGEGGFGSVYK 677
Query: 440 GHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499
G ++DGT++AVKQLSSKSKQGNREFVNE+GMISALQHP+LVKL+GCCIEGNQLLLIYEYM
Sbjct: 678 GVLSDGTIIAVKQLSSKSKQGNREFVNELGMISALQHPHLVKLYGCCIEGNQLLLIYEYM 737
Query: 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 559
ENNSLARALFGPE +L+LDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK
Sbjct: 738 ENNSLARALFGPEECQLQLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 797
Query: 560 DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 619
DLNPKISDFGLAKLDEEDNTHISTR+AGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV
Sbjct: 798 DLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 857
Query: 620 SGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDV 679
SGRSN++ +PKE+ YLLDWAL LK +GNLM+LVD RLGS+F+KE+VM M+N+ALLCT++
Sbjct: 858 SGRSNTTYRPKEECTYLLDWALSLKEKGNLMDLVDPRLGSDFNKEEVMAMLNIALLCTNI 917
Query: 680 SSTSRPSMSSVVSMLEGRADVQDFVPDSSVVSNIDKTKSEAIRNYYEFSEEQSMDGCQTQ 739
SS RP+MSSVVSMLEG VQD V D S S D K + ++ +Y +E+SMD +++
Sbjct: 918 SSAVRPAMSSVVSMLEGITAVQDIVSDPSAPS--DDLKLKEMKEHYRHIQEKSMDVSESK 975
Query: 740 SMSI-DGPYTGSSTSAADLYPINLDSDYLNSR 770
+ S+ DGP+T SS S DLYP+ LDS+Y R
Sbjct: 976 AQSMPDGPWTASS-SITDLYPVTLDSEYWEKR 1006
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142829|emb|CBI20124.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1137 bits (2942), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 559/812 (68%), Positives = 649/812 (79%), Gaps = 50/812 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L TLKDFR+ DN FTGKIPNFIQNWT LEKLVIQ SG GPIPSGIA L+K+TDLRISDL
Sbjct: 231 LTTLKDFRVGDNQFTGKIPNFIQNWTKLEKLVIQGSGFSGPIPSGIALLTKITDLRISDL 290
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
NGTEA FPPL M+ +KTLILRSCN+ G LPDYLG MT LK LD+SFNKL G IPS+F+G
Sbjct: 291 NGTEATFPPLSDMRNLKTLILRSCNIVGPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVG 350
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKGN 181
L + DY+Y TGN+LTG +P WML++GD DLSYN+FT+ SS CQ RSVNLF SSS GN
Sbjct: 351 LSNADYMYFTGNMLTGAVPDWMLKRGDNYDLSYNNFTSESSR-GCQERSVNLFGSSSGGN 409
Query: 182 NSTGIVSCLRSFRCPKTYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAFRGSNNWAF 241
N GIVSCLRSF CPK +YS+HINCGGK+V V+GNTT+EDDTD GPS+F ++ NWAF
Sbjct: 410 N-FGIVSCLRSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDTDSGGPSKF-YQSRTNWAF 467
Query: 242 SNTGHFLDDDRPADTYIQTNTSILLMNDS------------------------------- 270
S+TGHF+DDDRP D++I TN S L M +S
Sbjct: 468 SSTGHFMDDDRPTDSFIGTNVSRLTMENSGLYTTARLSALSLTYYGFCLENGNYTVKLHF 527
Query: 271 -----------HSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVINSTIEI 319
S GRR+FDVY+Q +LVLKDF+IED+AGG+ K I+K F VV N+T+EI
Sbjct: 528 AEITFTDDKTYSSLGRRLFDVYVQDELVLKDFDIEDDAGGVSKEIIKYFTAVVTNNTLEI 587
Query: 320 RLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENGSSSSISAGTVVGIVAATTFVII 379
R YWAGKGTTG+PVRGVYGPLISAIS++PDFIPP++NGSSS S G VVG VA ++
Sbjct: 588 RFYWAGKGTTGIPVRGVYGPLISAISVDPDFIPPTKNGSSSK-SVGIVVGHVAGVILLVF 646
Query: 380 LLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYK 439
L++GILWW+GC R + TLEQEL+G+DL TG FTLRQIKAATNNF NKIGEGGFG VYK
Sbjct: 647 LVIGILWWRGCLRRKDTLEQELKGLDLQTGLFTLRQIKAATNNFDAANKIGEGGFGSVYK 706
Query: 440 GHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499
G ++DGT++AVKQLSSKSKQGNREFVNE+GMISALQHP+LVKL+GCCIEGNQLLLIYEYM
Sbjct: 707 GVLSDGTIIAVKQLSSKSKQGNREFVNELGMISALQHPHLVKLYGCCIEGNQLLLIYEYM 766
Query: 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 559
ENNSLARALFGPE +L+LDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK
Sbjct: 767 ENNSLARALFGPEECQLQLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 826
Query: 560 DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 619
DLNPKISDFGLAKLDEEDNTHISTR+AGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV
Sbjct: 827 DLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 886
Query: 620 SGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDV 679
SGRSN++ +PKE+ YLLDWAL LK +GNLM+LVD RLGS+F+KE+VM M+N+ALLCT++
Sbjct: 887 SGRSNTTYRPKEECTYLLDWALSLKEKGNLMDLVDPRLGSDFNKEEVMAMLNIALLCTNI 946
Query: 680 SSTSRPSMSSVVSMLEGRADVQDFVPDSSVVSNIDKTKSEAIRNYYEFSEEQSMDGCQTQ 739
SS RP+MSSVVSMLEG VQD V D S S D K + ++ +Y +E+SMD +++
Sbjct: 947 SSAVRPAMSSVVSMLEGITAVQDIVSDPSAPS--DDLKLKEMKEHYRHIQEKSMDVSESK 1004
Query: 740 SMSI-DGPYTGSSTSAADLYPINLDSDYLNSR 770
+ S+ DGP+T SS S DLYP+ LDS+Y R
Sbjct: 1005 AQSMPDGPWTASS-SITDLYPVTLDSEYWEKR 1035
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493981|ref|XP_003634703.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1098 bits (2840), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 557/812 (68%), Positives = 644/812 (79%), Gaps = 50/812 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L TLKDFR+ DN FTGKIPNFIQNWT LEKLVIQ SG GPIPSGIA L+K+TDLRISDL
Sbjct: 202 LTTLKDFRVGDNQFTGKIPNFIQNWTKLEKLVIQGSGFSGPIPSGIALLTKITDLRISDL 261
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
NGTEA FPPL M+ +KTLILRSCN+ LPDYLG MT LK LD+SFNKL G IPS+F+G
Sbjct: 262 NGTEATFPPLSDMRDLKTLILRSCNIVDPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVG 321
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKGN 181
L + DY+Y TGN+LTG +P WML++GD DLSYN+FT+ SS CQ RSVNLF SSS GN
Sbjct: 322 LSNADYMYFTGNMLTGAVPDWMLKRGDNYDLSYNNFTSESSR-GCQERSVNLFGSSSGGN 380
Query: 182 NSTGIVSCLRSFRCPKTYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAFRGSNNWAF 241
NS IVSCLRSF CPK +YS+HINCGGK+V V+GNTT+EDDTD GPS+F ++ NWAF
Sbjct: 381 NSG-IVSCLRSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDTDSGGPSKF-YQSRTNWAF 438
Query: 242 SNTGHFLDDDRPADTYIQTNTSILLMNDS------------------------------- 270
S+TGHF+DDDRP D++I TN S L+M +S
Sbjct: 439 SSTGHFMDDDRPTDSFIGTNVSRLIMENSGLYTTARLSALSLTYYGFCLENGNYTVKLHF 498
Query: 271 -----------HSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVINSTIEI 319
S GRR+FDVY+Q KLVLKDFNIEDEAGG+ K I+K F VV N+T+EI
Sbjct: 499 AEITFTDDKTYSSLGRRLFDVYVQDKLVLKDFNIEDEAGGVSKEILKYFTAVVTNNTLEI 558
Query: 320 RLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENGSSSSISAGTVVGIVAATTFVII 379
R YWAGKGTTG+PVRGVYGPLISAIS++PDFIPP+ENGSSS V IVA ++
Sbjct: 559 RFYWAGKGTTGIPVRGVYGPLISAISVDPDFIPPTENGSSSISVGVVVG-IVAGVILLVF 617
Query: 380 LLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYK 439
LL+GILWW+ C R + TLEQEL+G+DL TG FTLRQIKAATNNF NKIGEGGFG VYK
Sbjct: 618 LLIGILWWRDCLRRKDTLEQELKGLDLQTGLFTLRQIKAATNNFDAANKIGEGGFGSVYK 677
Query: 440 GHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499
G ++DGT++AVKQLSSKSKQGNREFVNEIGMISALQHP+LVKL+GCCIEGNQLLLIYEYM
Sbjct: 678 GVLSDGTIIAVKQLSSKSKQGNREFVNEIGMISALQHPHLVKLYGCCIEGNQLLLIYEYM 737
Query: 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 559
ENNSLARALFGPE +L+LDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK
Sbjct: 738 ENNSLARALFGPEECQLQLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 797
Query: 560 DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 619
DLNPKISDFGLAKLDEEDNTHISTR+AGT+GYMAPEYAMRGYLTDKADVYSFG+VALEIV
Sbjct: 798 DLNPKISDFGLAKLDEEDNTHISTRIAGTYGYMAPEYAMRGYLTDKADVYSFGVVALEIV 857
Query: 620 SGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDV 679
SGRSN++ +PKE+ YLLD AL LK +G+LM++VD RLGS+F+KE+VM M+N+ALLCT +
Sbjct: 858 SGRSNTTYRPKEESIYLLDRALSLKEKGSLMDIVDPRLGSDFNKEEVMAMLNIALLCTTI 917
Query: 680 SSTSRPSMSSVVSMLEGRADVQDFVPDSSVVSNIDKTKSEAIRNYYEFSEEQSMDGCQTQ 739
SS RP+MSSVVSMLEGR VQD V D S S D K E ++ +Y +E+SM +++
Sbjct: 918 SSAVRPAMSSVVSMLEGRTAVQDIVSDPSAPS--DDLKLEEMKEHYRHIQEKSMGVSESK 975
Query: 740 SMSI-DGPYTGSSTSAADLYPINLDSDYLNSR 770
+ S+ DGP+T SS S DLYP+NLDS+Y R
Sbjct: 976 AQSMPDGPWTASS-SIPDLYPVNLDSEYWEKR 1006
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493985|ref|XP_002283578.2| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1083 bits (2802), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 552/815 (67%), Positives = 640/815 (78%), Gaps = 52/815 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L TLKDFR++DN FTGKIPNFIQNWT LEKLVI SG GPIPSGIA L+K+TDLRISDL
Sbjct: 202 LTTLKDFRVADNQFTGKIPNFIQNWTKLEKLVIHGSGFSGPIPSGIALLTKITDLRISDL 261
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
NGTEA FPPL M+ +KTLILRSC++ G LPDYLG MT LK LD+SFNKL G IPS+F+G
Sbjct: 262 NGTEATFPPLSDMRNLKTLILRSCSIVGPLPDYLGEMTKLKTLDLSFNKLTGEIPSSFVG 321
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKGN 181
L DYIY TGN+LTG +P WML++GD DLSYN+FT+ SS CQ RSVNLF SSS GN
Sbjct: 322 LSKADYIYFTGNMLTGAVPDWMLKRGDNYDLSYNNFTSESSR-GCQERSVNLFGSSSGGN 380
Query: 182 NSTGIVSCLRSFRCPKTYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAFRGSNNWAF 241
NS IVSCLRSF CPK +YS+HINCGGK+V V+GNTT+EDD D GPS+F ++ NWAF
Sbjct: 381 NSG-IVSCLRSFNCPKKFYSMHINCGGKEVIVDGNTTYEDDKDSGGPSKF-YQSRTNWAF 438
Query: 242 SNTGHFLDDDRPADTYIQTNTSILLMNDS------------------------------- 270
S+TGHF+DDD P D++I TN S L M +S
Sbjct: 439 SSTGHFMDDDHPTDSFIGTNVSRLAMENSGLYTTARLSALSLTYYGFCLENGNYTVKLHF 498
Query: 271 -----------HSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVINSTIEI 319
S GRR+FDVY+Q +LVLKDFNIEDEAGG+ K I+K F +V N+T+EI
Sbjct: 499 AEITFTDDKTYSSLGRRLFDVYVQDELVLKDFNIEDEAGGVSKEILKFFTAIVTNNTLEI 558
Query: 320 RLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSEN---GSSSSISAGTVVGIVAATTF 376
R YWAGKGTTG+PVRGVYGPLISAIS++PDFIPP+EN S I G VVGIVA
Sbjct: 559 RFYWAGKGTTGIPVRGVYGPLISAISVDPDFIPPTENRSSSISVGIVVGVVVGIVAGVIL 618
Query: 377 VIILLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGP 436
++ L++GILWW+ C R + TLEQEL+G+DL TG FTLRQIKAATNNF NKIGEGGFG
Sbjct: 619 LVFLVIGILWWRVCLRRKDTLEQELKGLDLQTGLFTLRQIKAATNNFDAANKIGEGGFGS 678
Query: 437 VYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496
VYKG ++DGT++AVKQLSSKSKQGNREFV EIGMISALQHP+LVKL+GCCIEGNQLLLIY
Sbjct: 679 VYKGVLSDGTIIAVKQLSSKSKQGNREFVTEIGMISALQHPHLVKLYGCCIEGNQLLLIY 738
Query: 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVL 556
EYMENNSLARALFGPE +L+LDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVL
Sbjct: 739 EYMENNSLARALFGPEECQLQLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVL 798
Query: 557 LDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVAL 616
LDKDLNPKISDFGLAKLDEE NTHISTR+AGTFGYMAPEYAMRGYLTDKADVYSFG+VAL
Sbjct: 799 LDKDLNPKISDFGLAKLDEEYNTHISTRIAGTFGYMAPEYAMRGYLTDKADVYSFGVVAL 858
Query: 617 EIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLC 676
EIVSGRSN++ +PKE+ YLLD AL LK +G+LM++VD RLGS+F+KE+VM M+N+ALLC
Sbjct: 859 EIVSGRSNTTYRPKEESIYLLDRALSLKEKGSLMDIVDPRLGSDFNKEEVMAMLNIALLC 918
Query: 677 TDVSSTSRPSMSSVVSMLEGRADVQDFVPDSSVVSNIDKTKSEAIRNYYEFSEEQSMDGC 736
T +SS RP+MSSVVSMLEGR VQD V D S S D K E ++ +Y +E+SM
Sbjct: 919 TTISSAVRPAMSSVVSMLEGRTAVQDIVSDPSAPS--DDLKLEEMKEHYRHIQEKSMGVS 976
Query: 737 QTQSMSI-DGPYTGSSTSAADLYPINLDSDYLNSR 770
++++ S+ DGP+T SS S DLYP+NLDS+Y R
Sbjct: 977 ESKAQSMPDGPWTASS-SIPDLYPVNLDSEYWEKR 1010
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255567058|ref|XP_002524511.1| ATP binding protein, putative [Ricinus communis] gi|223536185|gb|EEF37838.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1060 bits (2740), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 533/814 (65%), Positives = 620/814 (76%), Gaps = 76/814 (9%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
+VTL+DFRI DN FTG+IPN IQNWT LEKLVIQ SGL GPIPSGI L K+TDLRISDL
Sbjct: 202 MVTLQDFRIGDNQFTGQIPNLIQNWTNLEKLVIQGSGLSGPIPSGIGLLGKMTDLRISDL 261
Query: 62 -NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM 120
NGTE PFPPL MK +KTLI R+CN+ G+LP YLG MT LKVLD+SFNKL G IPS+F
Sbjct: 262 SNGTETPFPPLSNMKNLKTLICRTCNIVGELPQYLGGMTKLKVLDLSFNKLTGEIPSSFS 321
Query: 121 GLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKG 180
GL + DYI DLSYN+ T ++SCQ S+NLF SSS
Sbjct: 322 GLANTDYI----------------------DLSYNNLTF---QSSCQQGSINLFGSSSMA 356
Query: 181 NNSTGIVSCLRSFRCPKTYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAFRGSNNWA 240
N S VSCLRS+RCPK +YS HINCGGK+ ++G T +EDD D GPS+F ++ NWA
Sbjct: 357 NVS-ATVSCLRSYRCPKNFYSFHINCGGKEAIISGKT-YEDDIDSGGPSKF-YQSRTNWA 413
Query: 241 FSNTGHFLDDDRPADTYIQTNTS------------------------------------- 263
FS+TGHFLDDDR D+YI TNT+
Sbjct: 414 FSSTGHFLDDDRQPDSYIWTNTTKLYAGTSALYMDARLSPISLTYYGFCMGNGNYTVSLH 473
Query: 264 ---ILLMNDS--HSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVINSTIE 318
I+ NDS S GRRIFD+YIQG+LV KDFNI +EAGG GKAI+K F +VIN T+E
Sbjct: 474 FAEIMFTNDSTYSSLGRRIFDIYIQGELVKKDFNIAEEAGGAGKAIIKSFAAIVINHTLE 533
Query: 319 IRLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENGSSSSISAGTVVGIVAATTFVI 378
IR YW GKGTTG+PVRGVYGPLISAIS+ DF+PPSEN + IS GTV+GIVA VI
Sbjct: 534 IRFYWNGKGTTGIPVRGVYGPLISAISVTSDFVPPSEN--NKRISIGTVIGIVATAIAVI 591
Query: 379 ILLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVY 438
++G+LWWKGC + L+Q+LRG++L TGSFTL+QIKAATNNF PDNKIGEGGFG VY
Sbjct: 592 FFILGVLWWKGCLGRKDILDQDLRGLELQTGSFTLKQIKAATNNFDPDNKIGEGGFGSVY 651
Query: 439 KGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498
KG ++DGT +AVKQLSSKSKQGNREF+ EIGMISALQHP+LVKL+GCCI+GNQL L+YEY
Sbjct: 652 KGLLSDGTAIAVKQLSSKSKQGNREFITEIGMISALQHPHLVKLYGCCIDGNQLFLLYEY 711
Query: 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD 558
MENNSLARALFGPE +L LDWPTRH+ICVGIARGLA+LHEESRLKIVHRDIKATNVLLD
Sbjct: 712 MENNSLARALFGPEECQLNLDWPTRHKICVGIARGLAFLHEESRLKIVHRDIKATNVLLD 771
Query: 559 KDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEI 618
K+L+PKISDFGLAKLDEE+NTHISTRVAGTFGYMAPEYAMRG+LTDKADVYSFGIVALEI
Sbjct: 772 KNLDPKISDFGLAKLDEEENTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEI 831
Query: 619 VSGRSNSSCKP--KEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLC 676
VSGRSN+S + KED FYLLDWAL+LK +G+L+ELVD R+G+N+DK QVM MINVAL C
Sbjct: 832 VSGRSNTSLRQNMKEDCFYLLDWALVLKEKGSLLELVDPRMGTNYDKNQVMTMINVALQC 891
Query: 677 TDVSSTSRPSMSSVVSMLEGRADVQDFVPDSSVVSNIDKTKSEAIRNYYEFSEEQSMDGC 736
VSS +RP+MSSVVS+LEG+ VQD V D S VS+ D+ K EA+R +++ + E
Sbjct: 892 ASVSSVARPAMSSVVSILEGKTTVQDLVLDDSNVSH-DEKKIEAMRKHFQHNIESQTSES 950
Query: 737 QTQSMSIDGPYTGSSTSAADLYPINLDSDYLNSR 770
QTQSMS+DGP+TGSS+SA DLYPI LDS+Y SR
Sbjct: 951 QTQSMSLDGPWTGSSSSAGDLYPITLDSNYWESR 984
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255567064|ref|XP_002524514.1| ATP binding protein, putative [Ricinus communis] gi|223536188|gb|EEF37841.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1030 bits (2663), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 527/814 (64%), Positives = 630/814 (77%), Gaps = 54/814 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L TL DFRI DN FTG+IP+ IQNWT L+KLVIQ SGL GP+PSGI+ L+ +TD+RISDL
Sbjct: 202 LTTLIDFRIGDNKFTGQIPDLIQNWTNLQKLVIQGSGLSGPVPSGISLLANITDMRISDL 261
Query: 62 -NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM 120
NGTE PFP L MK +KTLILRSCN+ G+LP YLG MT+L+ LD+SFNKL G IPS F
Sbjct: 262 SNGTETPFPALSSMKNLKTLILRSCNIVGQLPLYLGGMTNLRTLDLSFNKLTGGIPSDFS 321
Query: 121 GLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKG 180
+ DYIYLTGN L GT+P W+LQKG+ +DLSYN+F +++CQ RS+NLF SSS
Sbjct: 322 NIQKADYIYLTGNRLNGTVPDWILQKGNNIDLSYNNFI---DQSTCQQRSINLFGSSSM- 377
Query: 181 NNSTGIVSCLRSFRCPKTYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAFRGSNNWA 240
N+T IVSCLRS RCPK +YS HINCGGK+ +N NT +E+D D GPSRF ++ NWA
Sbjct: 378 ENATEIVSCLRSHRCPKNFYSFHINCGGKEAVINRNT-YEEDVDSGGPSRF-YQSRTNWA 435
Query: 241 FSNTGHFLDDDRPADTYIQTNTSIL------LMNDSH----------------------- 271
FS+TGHFLDDDRP D+Y TNT+ L L D+
Sbjct: 436 FSSTGHFLDDDRPTDSYTWTNTTKLSSGISALYTDARLSPLSLTYYGFCMGNGNYTVDLH 495
Query: 272 -------------SFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVINSTIE 318
S GRR+FD+YIQGKLV KDFNI D+AGG+GKAI+K+F +V N T+E
Sbjct: 496 FAEIIFTADNTYSSLGRRMFDIYIQGKLVGKDFNIADDAGGVGKAIIKKFTAIVTNHTLE 555
Query: 319 IRLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENGSSSSISAGTVVGIVAATTFVI 378
IR YW GKGTTG+P+RG+YGPLISAIS+ P+F+PPSEN SSS + GTV GIV V+
Sbjct: 556 IRFYWDGKGTTGIPLRGIYGPLISAISVTPNFVPPSENSSSSIST-GTVAGIVIVVVVVV 614
Query: 379 ILLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVY 438
L++G+LWWKGC + T++Q L+G+DL TGSFTL+QIKAAT+NF DNKIGEGGFG VY
Sbjct: 615 FLVLGVLWWKGCLGQKDTVDQALKGLDLQTGSFTLKQIKAATHNFNLDNKIGEGGFGSVY 674
Query: 439 KGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498
KG ++DGT++AVKQLSSKSKQGNREFVNEIGMISALQHP+LVKL+GCCIE NQLLL+YEY
Sbjct: 675 KGLLSDGTIIAVKQLSSKSKQGNREFVNEIGMISALQHPHLVKLYGCCIEENQLLLVYEY 734
Query: 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD 558
MENNSLARALFGPE +L LDWPTRH+ICVGIARGLA+LHEESRLKIVHRDIKATNVLLD
Sbjct: 735 MENNSLARALFGPEECQLDLDWPTRHKICVGIARGLAFLHEESRLKIVHRDIKATNVLLD 794
Query: 559 KDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEI 618
K+LNPKISDFGLAKLDEE+NTHISTRVAGTFGYMAPEYAMRG+LTDKADVYSFGIVALEI
Sbjct: 795 KNLNPKISDFGLAKLDEEENTHISTRVAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEI 854
Query: 619 VSGRSNSSCK--PKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLC 676
VSGRSN+S + KE+ YLLDWAL+LK +G+L+ELVD R+G+N++K +VM +INVAL C
Sbjct: 855 VSGRSNTSYRLNLKENCVYLLDWALVLKEKGSLLELVDPRMGTNYNKAEVMTVINVALQC 914
Query: 677 TDVSSTSRPSMSSVVSMLEGRADVQDFVPDSSVVSNIDKTKSEAIRNYYEFSEEQSMDGC 736
VS RP+MSSVVSMLEG+ VQDF ++S S+ D+ K EA+ +++ S E
Sbjct: 915 ASVSPGVRPAMSSVVSMLEGKTVVQDFTQETS--SSFDEMKDEAMSKHFQHSIEHKTSES 972
Query: 737 QTQSMSIDGPYTGSSTSAADLYPINLDSDYLNSR 770
Q QSMS+DGP+ SSTS DLYP+ LDS+Y +R
Sbjct: 973 QIQSMSLDGPWVASSTSEQDLYPVTLDSNYWENR 1006
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357492929|ref|XP_003616753.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355518088|gb|AES99711.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 993 bits (2567), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 513/813 (63%), Positives = 621/813 (76%), Gaps = 65/813 (7%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L TL+D RI DN F+GKIP+FIQ+WT L KL+I+ SGL GPIPSGI+ L KLTDLRISDL
Sbjct: 204 LTTLQDIRIQDNQFSGKIPDFIQSWTSLTKLIIEGSGLSGPIPSGISKLEKLTDLRISDL 263
Query: 62 NGTE-APFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM 120
+G+E +PFP L +K +KTLILR+CN++G LP+YLG MT+LK LD+SFNKL+G IPS +
Sbjct: 264 SGSEFSPFPQLKDLK-LKTLILRNCNINGTLPEYLGTMTTLKNLDLSFNKLSGPIPSNYD 322
Query: 121 GLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKG 180
L VDYIYLTGNLLTG +P W QK D +D+SYN+FT CQ +VN F SSS
Sbjct: 323 PLRKVDYIYLTGNLLTGPVPAWT-QKADNLDISYNNFTISQGSQPCQDGNVNYF-SSSLT 380
Query: 181 NNSTGIVSCLRSFRCPKTYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAFRGSNNWA 240
N +G+VSCL+SF CPKT Y++ INCGGK VTVNG +T++DD+D A P+RF G+N W
Sbjct: 381 RNESGVVSCLKSFVCPKTSYALRINCGGKSVTVNG-STYDDDSDTAAPARFHQSGTN-WG 438
Query: 241 FSNTGHFLDDDRPADTYIQTNTS------------------------------------- 263
FS TG+F+D+D D Y +N S
Sbjct: 439 FSTTGNFMDNDG-GDYYTWSNRSKLSIANAELYTNARVSPTSLTYYGFCMANGNYTVNLQ 497
Query: 264 ---ILLMNDS--HSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVINSTIE 318
I+ ND +S GRR+FD+YIQGKLV KDF+I EAGG+ K + K F VV +ST+E
Sbjct: 498 FAEIMFTNDQTFNSLGRRVFDIYIQGKLVKKDFDIAKEAGGVDKEVTKPFTAVVTDSTLE 557
Query: 319 IRLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENGSSSSISAGTVVGIVAATTFVI 378
IRLYWAGKGTTG+P R VYGPLISAIS+ DF PSENGSS IS G VVGIVAA VI
Sbjct: 558 IRLYWAGKGTTGIPFRSVYGPLISAISVQSDFPAPSENGSS--ISIGAVVGIVAAVVIVI 615
Query: 379 ILLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVY 438
ILL GILWWKGCF + +LE E++G++L F +RQIK ATNNF NKIGEGGFGPVY
Sbjct: 616 ILLFGILWWKGCFGKKSSLENEVKGLNLQMSLFNVRQIKGATNNFDISNKIGEGGFGPVY 675
Query: 439 KGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498
KG ++DGT++AVK LSSKSKQGNREF+NEIGMISALQHP+LVKL+GCC+EG+QL+LIYEY
Sbjct: 676 KGRLSDGTLIAVKLLSSKSKQGNREFLNEIGMISALQHPHLVKLYGCCVEGDQLMLIYEY 735
Query: 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD 558
+ENNSLARALFGP H+++LDWPTR++ICVGIARGLAYLHEESRLK+VHRDIKATNVLLD
Sbjct: 736 LENNSLARALFGPAEHQIRLDWPTRYKICVGIARGLAYLHEESRLKVVHRDIKATNVLLD 795
Query: 559 KDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEI 618
KDLNPKISDFGLAKLDEE+NTHISTR+AGT+GYMAPEYAM GYLTDKADVYSFGIVALEI
Sbjct: 796 KDLNPKISDFGLAKLDEEENTHISTRIAGTYGYMAPEYAMHGYLTDKADVYSFGIVALEI 855
Query: 619 VSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTD 678
+ G +N+ + KE+ F+LLDWA ILK +GN +ELVDKRLGSNF+KE+ M+MINVALLCT+
Sbjct: 856 LHGSNNTILRQKEEAFHLLDWAHILKEKGNEIELVDKRLGSNFNKEEAMLMINVALLCTN 915
Query: 679 VSSTSRPSMSSVVSMLEGRADVQDFVPDSSVVSNIDKTKSEAIRNYYEFSEEQSMDGCQT 738
V+S+ RP+MSSVVSMLEG+ +Q+ V +SS V +D+ K EA+R +Y Q
Sbjct: 916 VTSSLRPAMSSVVSMLEGKIAIQELVLESSEV--LDEKKMEAMRKHY-----------QD 962
Query: 739 QSMSIDGPYTGSSTS-AADLYPINLDSDYLNSR 770
QS+S++GP+T SS+S DLYP+NLDS YL +R
Sbjct: 963 QSISMEGPWTASSSSVTTDLYPVNLDSSYLKNR 995
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449456691|ref|XP_004146082.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 985 bits (2547), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/811 (63%), Positives = 611/811 (75%), Gaps = 53/811 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
+ TL DFRI DN+FTG IP F+QNWT L+K+ IQASGL GPIPS I L+KLTDLRISDL
Sbjct: 207 ITTLTDFRIGDNNFTGPIPTFLQNWTNLDKIAIQASGLSGPIPSEIGLLTKLTDLRISDL 266
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
NG + PPL+ + K+K LILRSC+++G LPD L + L+ LD SFNK+ G IP +F
Sbjct: 267 NGGSSQLPPLNTLTKLKHLILRSCSITGMLPDILAGFSDLRTLDFSFNKITGPIPHSFEA 326
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKGN 181
L VD I+LTGNLL G++P WML +G +DLSYN+FT S T CQ R++NLFASSS+ +
Sbjct: 327 LKKVDSIFLTGNLLNGSVPNWMLNQGKSIDLSYNTFTQ-SQNTGCQPRNLNLFASSSEDS 385
Query: 182 NSTGIVSCLRSFRCPKTYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAFRGSNNWAF 241
NS G VSCL + C KT+YSVHINCGG + +NG T F D E G S F +G NW F
Sbjct: 386 NS-GTVSCLGA--CEKTWYSVHINCGGNEEFINGTTKF-DANPETGTSSFFLQGRTNWGF 441
Query: 242 SNTGHFLDDDRPADTYIQTNTSILLM---------------------------------- 267
SNTG F+DD + +D +I N S L M
Sbjct: 442 SNTGTFMDDGQTSDDFIARNLSALSMPNPELYVRARISPISLTYYAHCLGTGNYTLSLHF 501
Query: 268 ------NDS--HSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVINSTIEI 319
ND S GRR+FDVY+QGKL LKDFNI D AGGIGK +VK+F V VIN T+EI
Sbjct: 502 AEIAFTNDETYRSLGRRVFDVYVQGKLELKDFNIADAAGGIGKPLVKKFTVSVINGTVEI 561
Query: 320 RLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENGSSSSISAGTVVGIVAATTFVII 379
RL+WAGKG+ +PVRGVYGPLISAISL+PDF PPSE G++ ISAG V GIV A FVI+
Sbjct: 562 RLFWAGKGSNAIPVRGVYGPLISAISLDPDFEPPSEGGNA--ISAGAVAGIVVAVVFVIL 619
Query: 380 LLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYK 439
L++G+LWW+GC R TLEQEL+G+DL TGSF+LRQI+ ATNNF NKIGEGGFGPV+K
Sbjct: 620 LVLGVLWWRGCLRKPSTLEQELKGLDLGTGSFSLRQIRDATNNFDAANKIGEGGFGPVFK 679
Query: 440 GHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499
G +ADGT++AVKQLSSKSKQGNREFVNEIGMISALQHP+LVKL+GCCIEGNQLLLIYEY+
Sbjct: 680 GVLADGTIIAVKQLSSKSKQGNREFVNEIGMISALQHPHLVKLYGCCIEGNQLLLIYEYL 739
Query: 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 559
ENNSLARALFGP +LKLDWPTR +ICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK
Sbjct: 740 ENNSLARALFGPGESQLKLDWPTRQKICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 799
Query: 560 DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 619
+L+ KISDFGLAKLDEE+NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV
Sbjct: 800 NLDAKISDFGLAKLDEEENTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 859
Query: 620 SGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDV 679
SGRSN+S + K+D FYLLD A LK + +L+ELVD RLGS+F+K + M MIN+ L CT+V
Sbjct: 860 SGRSNTSYRTKDDCFYLLDHANTLKEKDSLLELVDSRLGSDFNKREAMAMINIGLQCTNV 919
Query: 680 SSTSRPSMSSVVSMLEGRADVQDFVPDSSVVSNIDKTKSEAIRNYYEFSEEQSMDGCQTQ 739
S RP+MSSVVSMLEG+ V++ V D S I K A+ + + Q+ QTQ
Sbjct: 920 VSADRPAMSSVVSMLEGKIAVKEVVSDPS----ISKQDVNAMWSQIYRQKGQTTSESQTQ 975
Query: 740 SMSIDGPYTGSSTSAADLYPINLDSDYLNSR 770
S+++DGP+TGSST+A+DLYPIN+DS YL +R
Sbjct: 976 SLTMDGPWTGSSTTASDLYPINMDSKYLENR 1006
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449503668|ref|XP_004162117.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 985 bits (2546), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/811 (63%), Positives = 611/811 (75%), Gaps = 53/811 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
+ TL DFRI DN+FTG IP F+QNWT L+K+ IQASGL GPIPS I L+KLTDLRISDL
Sbjct: 207 ITTLTDFRIGDNNFTGPIPTFLQNWTNLDKIAIQASGLSGPIPSEIGLLTKLTDLRISDL 266
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
NG + PPL+ + K+K LILRSC+++G LPD L + L+ LD SFNK+ G IP +F
Sbjct: 267 NGGSSQLPPLNTLTKLKHLILRSCSITGMLPDNLAGFSDLRTLDFSFNKITGPIPHSFEA 326
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKGN 181
L VD I+LTGNLL G++P WML +G +DLSYN+FT S T CQ R++NLFASSS+ +
Sbjct: 327 LKKVDSIFLTGNLLNGSVPNWMLNQGKSIDLSYNTFTQ-SQNTGCQPRNLNLFASSSEDS 385
Query: 182 NSTGIVSCLRSFRCPKTYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAFRGSNNWAF 241
NS G VSCL + C KT+YSVHINCGG + +NG T F D E G S F +G NW F
Sbjct: 386 NS-GTVSCLGA--CEKTWYSVHINCGGNEEFINGTTKF-DANPETGTSSFFLQGRTNWGF 441
Query: 242 SNTGHFLDDDRPADTYIQTNTSILLM---------------------------------- 267
SNTG F+DD + +D +I N S L M
Sbjct: 442 SNTGTFMDDGQTSDDFIARNLSALSMPNPELYVRARISPISLTYYAHCLGTGNYTLSLHF 501
Query: 268 ------NDS--HSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVINSTIEI 319
ND S GRR+FDVY+QGKL LKDFNI D AGGIGK +VK+F V VIN T+EI
Sbjct: 502 AEIAFTNDETYRSLGRRVFDVYVQGKLELKDFNIADAAGGIGKPLVKKFTVSVINGTVEI 561
Query: 320 RLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENGSSSSISAGTVVGIVAATTFVII 379
RL+WAGKG+ +PVRGVYGPLISAISL+PDF PPSE G++ ISAG V GIV A FVI+
Sbjct: 562 RLFWAGKGSNAIPVRGVYGPLISAISLDPDFEPPSEGGNA--ISAGAVAGIVVAVVFVIL 619
Query: 380 LLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYK 439
L++G+LWW+GC R TLEQEL+G+DL TGSF+LRQI+ ATNNF NKIGEGGFGPV+K
Sbjct: 620 LVLGVLWWRGCLRKPSTLEQELKGLDLGTGSFSLRQIRDATNNFDAANKIGEGGFGPVFK 679
Query: 440 GHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499
G +ADGT++AVKQLSSKSKQGNREFVNEIGMISALQHP+LVKL+GCCIEGNQLLLIYEY+
Sbjct: 680 GVLADGTIIAVKQLSSKSKQGNREFVNEIGMISALQHPHLVKLYGCCIEGNQLLLIYEYL 739
Query: 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 559
ENNSLARALFGP +LKLDWPTR +ICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK
Sbjct: 740 ENNSLARALFGPGESQLKLDWPTRQKICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 799
Query: 560 DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 619
+L+ KISDFGLAKLDEE+NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV
Sbjct: 800 NLDAKISDFGLAKLDEEENTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 859
Query: 620 SGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDV 679
SGRSN+S + K+D FYLLD A LK + +L+ELVD RLGS+F+K + M MIN+ L CT+V
Sbjct: 860 SGRSNTSYRTKDDCFYLLDHANTLKEKDSLLELVDSRLGSDFNKREAMAMINIGLQCTNV 919
Query: 680 SSTSRPSMSSVVSMLEGRADVQDFVPDSSVVSNIDKTKSEAIRNYYEFSEEQSMDGCQTQ 739
S RP+MSSVVSMLEG+ V++ V D S I K A+ + + Q+ QTQ
Sbjct: 920 VSADRPAMSSVVSMLEGKIAVKEVVSDPS----ISKQDVNAMWSQIYRQKGQTTSESQTQ 975
Query: 740 SMSIDGPYTGSSTSAADLYPINLDSDYLNSR 770
S+++DGP+TGSST+A+DLYPIN+DS YL +R
Sbjct: 976 SLTMDGPWTGSSTTASDLYPINMDSKYLENR 1006
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351723187|ref|NP_001237014.1| receptor-like protein kinase 2-like precursor [Glycine max] gi|51847838|gb|AAU10526.1| putative receptor-like protein kinase 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 969 bits (2505), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/812 (61%), Positives = 611/812 (75%), Gaps = 61/812 (7%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L TL+D RI DN F+GKIPNFIQ+ T L+KLVIQ SGL GPIPSGI+ L LTDLRISDL
Sbjct: 205 LTTLQDIRIGDNQFSGKIPNFIQSLTSLQKLVIQGSGLSGPIPSGISFLENLTDLRISDL 264
Query: 62 NGTE-APFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM 120
NG+E + FP L++MK +K LILR+CN++G LP YLG MT+LK LD+SFNKL G IPST+
Sbjct: 265 NGSEHSLFPQLNQMKNLKYLILRNCNINGTLPPYLGNMTTLKNLDLSFNKLTGPIPSTYD 324
Query: 121 GLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKG 180
L VDYIYLTGNLL G +P W +K D VD+S+N+F+ S ++CQ +VNLFASS
Sbjct: 325 ALRKVDYIYLTGNLLNGQVPAWT-EKSDNVDISFNNFSVTSQGSTCQIGNVNLFASSMTH 383
Query: 181 NNSTGIVSCLRSFRCPKTYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAFRGSNNWA 240
N+S G V+CL S C +T YS+HINCGGK VT NG +T++DD+D GP+RF G+ NWA
Sbjct: 384 NDS-GTVACLGSSVCQETLYSLHINCGGKIVTDNG-STYDDDSDTGGPARFHRSGTKNWA 441
Query: 241 FSNTGHFLDDDRPADTYIQTNT-------------------------------------- 262
+ NTG+F+D+D A +Q T
Sbjct: 442 YINTGNFMDNDAGAYYIVQNKTLLSTDNVDLYMDARVSPISLTYYGFCLGNGNYTVNLHF 501
Query: 263 -SILLMNDS--HSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVINSTIEI 319
I+ ++D +S GRR+FD+YIQG LV KDF+I +EAGGIGKA++ F VV ++T+EI
Sbjct: 502 AEIMFIDDQTFNSLGRRVFDIYIQGALVKKDFDIVEEAGGIGKAVITSFTAVVTSNTLEI 561
Query: 320 RLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENGSSSSISAGTVVGIVAATTFVII 379
RLYWAGKGTT +P R VYGPLISAIS+ PDF PPS+N SS S+ V A +++
Sbjct: 562 RLYWAGKGTTSLPFRSVYGPLISAISVEPDFTPPSKNKSSISVGVVVGVVAAGAVVIILV 621
Query: 380 LLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYK 439
L GILWWKGCF + +LE+EL+G+DL TG FTLRQIKAATNNF NKIGEGGFGPVYK
Sbjct: 622 L--GILWWKGCFGKKSSLERELQGLDLRTGLFTLRQIKAATNNFDVANKIGEGGFGPVYK 679
Query: 440 GHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499
G +DGT++AVKQLSSKS+QGNREF+NEIGMISALQHP+LVKL+GCC+EG+QLLL+YEYM
Sbjct: 680 GCFSDGTLIAVKQLSSKSRQGNREFLNEIGMISALQHPHLVKLYGCCVEGDQLLLVYEYM 739
Query: 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 559
ENNSLARALFG E H++KLDW TR++ICVGIARGLAYLHEESRLKIVHRDIKATNVLLD+
Sbjct: 740 ENNSLARALFGAEEHQIKLDWTTRYKICVGIARGLAYLHEESRLKIVHRDIKATNVLLDQ 799
Query: 560 DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 619
DLNPKISDFGLAKLDEEDNTHISTR+AGTFGYMAPEYAM GYLTDKADVYSFGIVALEI+
Sbjct: 800 DLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAPEYAMHGYLTDKADVYSFGIVALEII 859
Query: 620 SGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDV 679
+GRSN+ + KE+ F +L+WA +L+ +G++M+LVD+RLG F+KE+ +VMI VALLCT+V
Sbjct: 860 NGRSNTIHRQKEESFSVLEWAHLLREKGDIMDLVDRRLGLEFNKEEALVMIKVALLCTNV 919
Query: 680 SSTSRPSMSSVVSMLEGRADV-QDFVPDSSVVSNIDKTKSEAIRNYYEFSEEQSMDGCQT 738
++ RP+MSSVVSMLEG+ V ++F +++ V +D+ K E +R YY Q
Sbjct: 920 TAALRPTMSSVVSMLEGKIVVDEEFSGETTEV--LDEKKMEKMRLYY-----------QE 966
Query: 739 QSMSIDGPYTGSSTSAADLYPINLDSDYLNSR 770
S S + P+T SSTS ADLYP+ LDS YL R
Sbjct: 967 LSNSKEEPWTASSTSVADLYPVGLDSSYLEKR 998
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 771 | ||||||
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.591 | 0.478 | 0.590 | 4.4e-213 | |
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.631 | 0.470 | 0.589 | 1.2e-199 | |
| TAIR|locus:2203847 | 1021 | RKF1 "receptor-like kinase in | 0.627 | 0.474 | 0.524 | 2e-175 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.433 | 0.344 | 0.586 | 1.8e-167 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.613 | 0.438 | 0.495 | 2.2e-161 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.583 | 0.429 | 0.463 | 8.5e-134 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.950 | 0.710 | 0.369 | 7.3e-114 | |
| TAIR|locus:2017923 | 390 | AT1G16670 [Arabidopsis thalian | 0.405 | 0.802 | 0.492 | 2e-79 | |
| TAIR|locus:2095334 | 393 | AT3G09010 [Arabidopsis thalian | 0.345 | 0.676 | 0.546 | 1.3e-75 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.369 | 0.338 | 0.5 | 1.2e-71 |
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1419 (504.6 bits), Expect = 4.4e-213, Sum P(2) = 4.4e-213
Identities = 272/461 (59%), Positives = 342/461 (74%)
Query: 268 NDSHSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVINSTIEIRLYWAGKG 327
N+ S GRR FD+YIQ KL +KDFNI EA +G ++K FPV + + +EIRLYWAG+G
Sbjct: 472 NNYQSLGRRFFDIYIQRKLEVKDFNIAKEAKDVGNVVIKTFPVEIKDGKLEIRLYWAGRG 531
Query: 328 TTGVPVRGVYGPLISAISLNPDFIPPSENXXXXXXXXXXXXXXXAATTFVIILLVGILWW 387
TT +P VYGPLISAIS++ P N + F++ L+ G LW
Sbjct: 532 TTVIPKERVYGPLISAISVDSSVNPSPRNGMSTGTLHTLVVIL---SIFIVFLVFGTLWK 588
Query: 388 KGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTV 447
KG R + +E++ + ++L SF+LRQIK ATNNF N+IGEGGFGPVYKG + DGT+
Sbjct: 589 KGYLRSKSQMEKDFKSLELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTI 648
Query: 448 VAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARA 507
+AVKQLS+ SKQGNREF+NEIGMISAL HPNLVKL+GCC+EG QLLL+YE++ENNSLARA
Sbjct: 649 IAVKQLSTGSKQGNREFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARA 708
Query: 508 LFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 567
LFGP+ +L+LDWPTR +IC+G+ARGLAYLHEESRLKIVHRDIKATNVLLDK LNPKISD
Sbjct: 709 LFGPQETQLRLDWPTRRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISD 768
Query: 568 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSC 627
FGLAKLDEED+THISTR+AGTFGYMAPEYAMRG+LTDKADVYSFGIVALEIV GRSN
Sbjct: 769 FGLAKLDEEDSTHISTRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIE 828
Query: 628 KPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDXXXXXXXXX 687
+ K + FYL+DW +L+ + NL+ELVD RLGS +++E+ M MI +A++CT
Sbjct: 829 RSKNNTFYLIDWVEVLREKNNLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSM 888
Query: 688 XXXXXMLEGRADVQ-DFVPDSSVVSNIDKTKS-EAIRNYYE 726
MLEG+ V+ + + ++SV + ++ ++ YYE
Sbjct: 889 SEVVKMLEGKKMVEVEKLEEASVHRETKRLENMNTMKKYYE 929
|
|
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1440 (512.0 bits), Expect = 1.2e-199, Sum P(2) = 1.2e-199
Identities = 294/499 (58%), Positives = 360/499 (72%)
Query: 264 ILLMNDS--HSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVIN-STIEIR 320
I+ ND S GRR+FD+Y+QG L+ +DFNI AGG+GK ++Q V +N ST+EI
Sbjct: 507 IMFSNDQTYSSLGRRLFDIYVQGILLERDFNIAQRAGGVGKPFLRQVDEVQVNGSTLEIH 566
Query: 321 LYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENXXXXXXXXXXXXXXXAATTFVIIL 380
L W GKGT +P RGVYGPLISAI++ P+F + A F +++
Sbjct: 567 LKWTGKGTNVIPTRGVYGPLISAITVTPNF--KVDTGKPLSNGVVAGIVIAACVAFGLLV 624
Query: 381 LVGILWWKGCFRPEHTLE-QELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYK 439
LV IL G + E +ELRG+DL TGSFTL+QIK ATNNF P+NKIGEGGFGPVYK
Sbjct: 625 LV-ILRLTGYLGGKEVDENEELRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYK 683
Query: 440 GHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499
G +ADG +AVKQLSSKSKQGNREFV EIGMISALQHPNLVKL+GCCIEG +LLL+YEY+
Sbjct: 684 GVLADGMTIAVKQLSSKSKQGNREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYL 743
Query: 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 559
ENNSLARALFG E RL LDW TR+++C+GIA+GLAYLHEESRLKIVHRDIKATNVLLD
Sbjct: 744 ENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDL 803
Query: 560 DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 619
LN KISDFGLAKLDEE+NTHISTR+AGT GYMAPEYAMRGYLTDKADVYSFG+V LEIV
Sbjct: 804 SLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIV 863
Query: 620 SGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDX 679
SG+SN++ +PKE+ YLLDWA +L+ QG+L+ELVD LG++F K++ M M+N+ALLCT+
Sbjct: 864 SGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNP 923
Query: 680 XXXXXXXXXXXXXMLEGRADVQD-FVPDSSVVSNIDKTKSEAIRNYYEFSEEQSMDGCQT 738
ML+G+ VQ V + S + +A+ + + SE Q +
Sbjct: 924 SPTLRPPMSSVVSMLQGKIKVQPPLVKREADPSGSAAMRFKALEHLSQDSESQVSTYTRN 983
Query: 739 Q----SMSIDGPYTGSSTS 753
+ S S+DGP+ SS S
Sbjct: 984 KEHKSSSSMDGPWVDSSFS 1002
|
|
| TAIR|locus:2203847 RKF1 "receptor-like kinase in flowers 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1209 (430.6 bits), Expect = 2.0e-175, Sum P(2) = 2.0e-175
Identities = 259/494 (52%), Positives = 320/494 (64%)
Query: 264 ILLMNDSH--SFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVINSTIEIRL 321
I ND + GRR+FD+YIQ KLV KDFNI DEA G I+K V N + IRL
Sbjct: 522 IRFTNDENYNRLGRRLFDIYIQEKLVAKDFNIMDEAKGAQTPIIKPLTAYVTNHFLTIRL 581
Query: 322 YWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENXXXXXXXXXXXXXXXAATTFVIILL 381
WAGKGTT +P RGVYGP+ISAIS+ D P E A +I +L
Sbjct: 582 SWAGKGTTRIPTRGVYGPIISAISIVSDS-KPCERPKTGMSPGAYIAIGIGAPCLIIFIL 640
Query: 382 VGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGH 441
G LW GC ++ +L +G+FTLRQIK AT++F P NKIGEGGFG V+KG
Sbjct: 641 -GFLWICGCLPRCGRQRKDPYEEELPSGTFTLRQIKFATDDFNPTNKIGEGGFGAVFKGV 699
Query: 442 MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMEN 501
+ADG VVAVKQLSSKS+QGNREF+NEIG IS LQHPNLVKLHG C+E QLLL YEYMEN
Sbjct: 700 LADGRVVAVKQLSSKSRQGNREFLNEIGAISCLQHPNLVKLHGFCVERAQLLLAYEYMEN 759
Query: 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 561
NSL+ ALF P+ ++ +DWPTR +IC GIA+GLA+LHEES LK VHRDIKATN+LLDKDL
Sbjct: 760 NSLSSALFSPKHKQIPMDWPTRFKICCGIAKGLAFLHEESPLKFVHRDIKATNILLDKDL 819
Query: 562 NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 621
PKISDFGLA+LDEE+ THIST+VAGT GYMAPEYA+ GYLT KADVYSFG++ LEIV+G
Sbjct: 820 TPKISDFGLARLDEEEKTHISTKVAGTIGYMAPEYALWGYLTFKADVYSFGVLVLEIVAG 879
Query: 622 RSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDXXX 681
+NS+ D LL++A G+LM++VD+RL D+++ +I VAL+C+
Sbjct: 880 ITNSNFMGAGDSVCLLEFANECVESGHLMQVVDERLRPEVDRKEAEAVIKVALVCSSASP 939
Query: 682 XXXXXXXXXXXMLEGRADVQDFVPDSSVVSNIDKTKSEAIRNYYEFSEEQSMDGCQTQSM 741
MLEG V + P V N + +A ++ E S C +S
Sbjct: 940 TDRPLMSEVVAMLEGLYPVPESTP--GVSRNAGDIRFKAFKDLRRGMENNSKTQCSVKSY 997
Query: 742 SIDGPYTGSSTSAA 755
P + S++S A
Sbjct: 998 ----PSSSSTSSGA 1007
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1019 (363.8 bits), Expect = 1.8e-167, Sum P(4) = 1.8e-167
Identities = 197/336 (58%), Positives = 253/336 (75%)
Query: 400 ELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQ 459
+L+G DL TGSF+LRQ+K ATN+F P NKIGEGGFG VYKG + DGT++AVK+LSSKS Q
Sbjct: 617 KLKGPDLRTGSFSLRQLKVATNDFDPLNKIGEGGFGSVYKGRLPDGTLIAVKKLSSKSHQ 676
Query: 460 GNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLD 519
GN+EFVNEIGMI+ LQHPNLVKL+GCC+E NQLLL+YEY+ENN L+ ALF + LKL+
Sbjct: 677 GNKEFVNEIGMIACLQHPNLVKLYGCCVEKNQLLLVYEYLENNCLSDALFAGRSC-LKLE 735
Query: 520 WPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579
W TRH+IC+GIARGLA+LHE+S +KI+HRDIK TNVLLDKDLN KISDFGLA+L E++ +
Sbjct: 736 WGTRHKICLGIARGLAFLHEDSAVKIIHRDIKGTNVLLDKDLNSKISDFGLARLHEDNQS 795
Query: 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY-LLD 638
HI+TRVAGT GYMAPEYAMRG+LT+KADVYSFG+VA+EIVSG+SN+ P ++ LLD
Sbjct: 796 HITTRVAGTIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVSGKSNAKYTPDDECCVGLLD 855
Query: 639 WALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDXXXXXXXXXXXXXXMLEGRA 698
WA +L+ +G++ E++D RL FD + MI V+LLC + MLEG
Sbjct: 856 WAFVLQKKGDIAEILDPRLEGMFDVMEAERMIKVSLLCANKSSTLRPNMSQVVKMLEGET 915
Query: 699 DVQDFVPDSSVVSNIDKTKSEAIRNYYEFSEEQSMD 734
+++ + D V S+ K ++ + Y S S +
Sbjct: 916 EIEQIISDPGVYSDNLHFKPSSLSSDYILSIPSSSE 951
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1177 (419.4 bits), Expect = 2.2e-161, Sum P(2) = 2.2e-161
Identities = 252/509 (49%), Positives = 331/509 (65%)
Query: 268 NDSHSFGR---RIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVINSTIEIRLYWA 324
+D F R R+F++Y+QGKL+ +DF+I +EA G K ++K+ V ++T+EIRLYWA
Sbjct: 519 SDEEPFSRLAKRVFNIYVQGKLIWEDFSIREEANGTHKEVIKEVNTTVTDNTLEIRLYWA 578
Query: 325 GKGTTGVPVRGVYGPLISAISLNPDF-----IP----PSENXXXXXXXXXXXXXXXAATT 375
GKGTT +P RG YG LISAIS+ P +P P A
Sbjct: 579 GKGTTIIPKRGNYGSLISAISVCPSSESECGVPVQIHPVTKQQHKQRKYHLILGIAALIV 638
Query: 376 FVIILLVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFG 435
+ L++G L+W+ C + E RG SF+LRQ+K AT++F P NKIGEGGFG
Sbjct: 639 SLSFLILGALYWRICVS---NADGEKRG------SFSLRQLKVATDDFNPLNKIGEGGFG 689
Query: 436 PVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495
VYKG + +GT++AVK+LSSKS QGN+EF+NEIG+I+ LQHPNLVKL+GCC+E QLLL+
Sbjct: 690 SVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIGIIACLQHPNLVKLYGCCVEKTQLLLV 749
Query: 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNV 555
YEY+ENN LA ALFG LKLDW TRH+IC+GIARGLA+LHE+S +KI+HRDIK TN+
Sbjct: 750 YEYLENNCLADALFGRSG--LKLDWRTRHKICLGIARGLAFLHEDSAVKIIHRDIKGTNI 807
Query: 556 LLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVA 615
LLDKDLN KISDFGLA+L E+D +HI+TRVAGT GYMAPEYAMRG+LT+KADVYSFG+VA
Sbjct: 808 LLDKDLNSKISDFGLARLHEDDQSHITTRVAGTIGYMAPEYAMRGHLTEKADVYSFGVVA 867
Query: 616 LEIVSGRSNSSCKPKEDIFY-LLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVAL 674
+EIVSG+SN++ P + LLDWA +L+ +G E++D +L FD + MI V+L
Sbjct: 868 MEIVSGKSNANYTPDNECCVGLLDWAFVLQKKGAFDEILDPKLEGVFDVMEAERMIKVSL 927
Query: 675 LCTDXXXXXXXXXXXXXXMLEGRADVQDFVPDSSVVSNIDKTKSEAIRNYYEFSEEQSMD 734
LC+ MLEG ++++ + D + + K A E S
Sbjct: 928 LCSSKSPTLRPTMSEVVKMLEGETEIEEIISDPGAYGDELRFKKTA--------EIGSSS 979
Query: 735 GCQTQSMSIDGPYTGSSTSAADLYPINLD 763
+SI T S SA DLYP++ D
Sbjct: 980 LPSDYLVSI----TSSCESAYDLYPLSPD 1004
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1041 (371.5 bits), Expect = 8.5e-134, Sum P(2) = 8.5e-134
Identities = 216/466 (46%), Positives = 300/466 (64%)
Query: 268 NDSHSFGRRIFDVYIQGKLVLKDFNIEDEAGGIG-KAIVKQFPVVVINSTIEIRLYWAGK 326
N GRR F++Y+QG+LV KDF+I AGG +A+ +++ V + +E+ L+WAGK
Sbjct: 552 NSWKGIGRRRFNIYVQGRLVEKDFDIRRTAGGSSVRAVQREYKTNVSENHLEVHLFWAGK 611
Query: 327 GTTGVPVRGVYGPLISAISLNPDFIP------PSENXXXXXXXXXXXXXXXAATTFVIIL 380
GT +P++G YGPLI+A+S PDF P PS+ + F ++
Sbjct: 612 GTCCIPIQGAYGPLIAAVSATPDFTPTVANRPPSKGKSRTGTIVGVIVGVGLLSIFAGVV 671
Query: 381 LVGILWWKGCFRPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKG 440
++ I K R +T ++E+ +D+ +FT ++K AT +F NK+GEGGFG VYKG
Sbjct: 672 ILVIR--KR--RKPYTDDEEILSMDVKPYTFTYSELKNATQDFDLSNKLGEGGFGAVYKG 727
Query: 441 HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500
++ DG VAVKQLS S+QG +FV EI IS++ H NLVKL+GCC EG+ LL+YEY+
Sbjct: 728 NLNDGREVAVKQLSIGSRQGKGQFVAEIIAISSVLHRNLVKLYGCCFEGDHRLLVYEYLP 787
Query: 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD 560
N SL +ALFG ++ L LDW TR+ IC+G+ARGL YLHEE+ ++I+HRD+KA+N+LLD +
Sbjct: 788 NGSLDQALFGDKS--LHLDWSTRYEICLGVARGLVYLHEEASVRIIHRDVKASNILLDSE 845
Query: 561 LNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
L PK+SDFGLAKL ++ THISTRVAGT GY+APEYAMRG+LT+K DVY+FG+VALE+VS
Sbjct: 846 LVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVS 905
Query: 621 GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDXX 680
GR NS +E YLL+WA L + +EL+D L S ++ E+V MI +ALLCT
Sbjct: 906 GRKNSDENLEEGKKYLLEWAWNLHEKNRDVELIDDEL-SEYNMEEVKRMIGIALLCTQSS 964
Query: 681 XXXXXXXXXXXXMLEGRADVQDFVPDSSVVSN--IDKTKSEAIRNY 724
ML G A+V D +++ D T S + N+
Sbjct: 965 YALRPPMSRVVAMLSGDAEVNDATSKPGYLTDCTFDDTTSSSFSNF 1010
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1123 (400.4 bits), Expect = 7.3e-114, P = 7.3e-114
Identities = 290/784 (36%), Positives = 424/784 (54%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L +L + R+ D +FI++ L LV++ + L G IPS I S L + +S
Sbjct: 266 LTSLTELRLGDISSGSSSLDFIKDMKSLSVLVLRNNNLTGTIPSTIGEHSSLRQVDLS-F 324
Query: 62 NGTEAPFPP-LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM 120
N P P L + ++ L L + ++G P SL+ +DVS+N L+G++PS ++
Sbjct: 325 NKLHGPIPASLFNLSQLTHLFLGNNTLNGSFPTQK--TQSLRNVDVSYNDLSGSLPS-WV 381
Query: 121 GLLDVDYIYLTGNL----LTGTIPPWM--LQKG---DRVDLSYNSFTAGSSETSCQYRSV 171
L + + N L + P + LQK +R Y+ F+ + RSV
Sbjct: 382 SLPSLKLNLVANNFTLEGLDNRVLPGLNCLQKNFPCNRGKGIYSDFSINCGGP--EKRSV 439
Query: 172 N--LFASSSKG-NNSTGIVSCLRSFRCPK------TYYSVHINCGGKQ-VTVNGNTTFED 221
LF + ++ VS + + + +++I Q V + F+
Sbjct: 440 TGALFEREDEDFGPASFFVSAGQRWAASSVGLFAGSSNNIYIATSQSQFVNTLDSELFQS 499
Query: 222 DTDEAGPSRFAFRGSNNWAFSNTGHFLDDDRPADTYIQTNTSILLMNDSHSFGRRIFDVY 281
A R+ G N ++ T F A+ I +TS GRR FD+Y
Sbjct: 500 ARLSASSVRYYGLGLENGGYTVTLQF------AEIQILGSTSTTWKG----LGRRRFDIY 549
Query: 282 IQGKLVLKDFNIEDEAG-GIGKAIVKQFPVVVINSTIEIRLYWAGKGTTGVPVRGVYGPL 340
+QG+LV KDF++ AG +A+ + + V + +E+ L+WAGKGT +P++G YGPL
Sbjct: 550 VQGRLVEKDFDVRRTAGDSTVRAVQRVYKANVSENHLEVHLFWAGKGTCCIPIQGAYGPL 609
Query: 341 ISAISLNPDFIPPSENXXXXXXXXXXXXXXXAATTFVII-LLVGILWWK-GCFRPEHTLE 398
ISA+S PDF P N ++ +L G++ + R +T +
Sbjct: 610 ISAVSATPDFTPTVANKPPSKGKNRTGTIVGVIVGVGLLSILAGVVMFTIRKRRKRYTDD 669
Query: 399 QELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSK 458
+EL G+D+ FT ++K+AT +F P NK+GEGGFGPVYKG++ DG VVAVK LS S+
Sbjct: 670 EELLGMDVKPYIFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSR 729
Query: 459 QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKL 518
QG +FV EI IS++ H NLVKL+GCC EG +L+YEY+ N SL +ALFG + L L
Sbjct: 730 QGKGQFVAEIVAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKT--LHL 787
Query: 519 DWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578
DW TR+ IC+G+ARGL YLHEE+ ++IVHRD+KA+N+LLD L P+ISDFGLAKL ++
Sbjct: 788 DWSTRYEICLGVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKK 847
Query: 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLD 638
THISTRVAGT GY+APEYAMRG+LT+K DVY+FG+VALE+VSGR NS +E+ YLL+
Sbjct: 848 THISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLE 907
Query: 639 WALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDXXXXXXXXXXXXXXMLEGRA 698
WA L + +EL+D +L ++F+ E+ MI +ALLCT ML G
Sbjct: 908 WAWNLHEKSRDIELIDDKL-TDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDV 966
Query: 699 DVQDFVPDSSVVSN--IDKTKSEAIRNYYEFSEEQSMDGCQTQSMSIDGPYTGSSTSAAD 756
++ D VS+ D T ++ + Q D SMS+ P + S +D
Sbjct: 967 EIGDVTSKPGYVSDWRFDDTTGSSLSGF------QIKD-TTGYSMSLVAPGSEISPRDSD 1019
Query: 757 LYPI 760
P+
Sbjct: 1020 FKPM 1023
|
|
| TAIR|locus:2017923 AT1G16670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 798 (286.0 bits), Expect = 2.0e-79, P = 2.0e-79
Identities = 156/317 (49%), Positives = 216/317 (68%)
Query: 387 WKGCFRPEHT-LEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADG 445
W C R E T ++ E+ +D + + R+I+ AT++F+ +NKIGEGGFG VYKG + DG
Sbjct: 5 WLSCHRREATEVDGEIAAID-NVKIYKYREIRQATDDFSAENKIGEGGFGSVYKGCLKDG 63
Query: 446 TVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLA 505
+ A+K LS++S+QG +EF+ EI +IS +QH NLVKL+GCC+EGN +L+Y ++ENNSL
Sbjct: 64 KLAAIKVLSAESRQGVKEFLTEINVISEIQHENLVKLYGCCVEGNHRILVYNFLENNSLD 123
Query: 506 RALF--GPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 563
+ L G ++ DW +R ICVG+A+GLA+LHEE R I+HRDIKA+N+LLDK L+P
Sbjct: 124 KTLLAGGYTRSGIQFDWSSRANICVGVAKGLAFLHEEVRPHIIHRDIKASNILLDKYLSP 183
Query: 564 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRS 623
KISDFGLA+L + TH+STRVAGT GY+APEYA+RG LT KAD+YSFG++ +EIVSGRS
Sbjct: 184 KISDFGLARLMPPNMTHVSTRVAGTIGYLAPEYAVRGQLTRKADIYSFGVLLMEIVSGRS 243
Query: 624 NSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDXXXXX 683
N + + + YLL+ A L + L++LVD L FD E+ + + LLCT
Sbjct: 244 NKNTRLPTEYQYLLERAWELYERNELVDLVDSGLNGVFDAEEACRYLKIGLLCTQDSPKL 303
Query: 684 XXXXXXXXXMLEGRADV 700
+L G D+
Sbjct: 304 RPSMSTVVRLLTGEKDI 320
|
|
| TAIR|locus:2095334 AT3G09010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 762 (273.3 bits), Expect = 1.3e-75, P = 1.3e-75
Identities = 146/267 (54%), Positives = 192/267 (71%)
Query: 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGM 470
F+ +++AT++F P N+IG GG+G V+KG + DGT VAVK LS++SKQG REF+ EI +
Sbjct: 34 FSYNSLRSATDSFHPTNRIGGGGYGVVFKGVLRDGTQVAVKSLSAESKQGTREFLTEINL 93
Query: 471 ISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGI 530
IS + HPNLVKL GCCIEGN +L+YEY+ENNSLA L G + + LDW R ICVG
Sbjct: 94 ISNIHHPNLVKLIGCCIEGNNRILVYEYLENNSLASVLLGSRSRYVPLDWSKRAAICVGT 153
Query: 531 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 590
A GLA+LHEE +VHRDIKA+N+LLD + +PKI DFGLAKL ++ TH+STRVAGT G
Sbjct: 154 ASGLAFLHEEVEPHVVHRDIKASNILLDSNFSPKIGDFGLAKLFPDNVTHVSTRVAGTVG 213
Query: 591 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLM 650
Y+APEYA+ G LT KADVYSFGI+ LE++SG S++ ++ L++W L+ + L+
Sbjct: 214 YLAPEYALLGQLTKKADVYSFGILVLEVISGNSSTRAAFGDEYMVLVEWVWKLREERRLL 273
Query: 651 ELVDKRLGSNFDKEQVMVMINVALLCT 677
E VD L + F ++V I VAL CT
Sbjct: 274 ECVDPEL-TKFPADEVTRFIKVALFCT 299
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 705 (253.2 bits), Expect = 1.2e-71, Sum P(2) = 1.2e-71
Identities = 144/288 (50%), Positives = 193/288 (67%)
Query: 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGM 470
F+ + +AT +FA +NK+G+GGFG VYKG+ ++G +AVK+LS KSKQG EF NEI +
Sbjct: 513 FSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILL 572
Query: 471 ISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGI 530
I+ LQH NLV+L GCCIE N+ +L+YEYM N SL R LF E+ + LDW R + GI
Sbjct: 573 IAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFD-ESKQGSLDWRKRWEVIGGI 631
Query: 531 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST-RVAGTF 589
ARGL YLH +SRLKI+HRD+KA+N+LLD ++NPKISDFG+A++ H +T RV GT+
Sbjct: 632 ARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTY 691
Query: 590 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL 649
GYMAPEYAM G ++K+DVYSFG++ LEIVSGR N S + D L+ +A L +QG
Sbjct: 692 GYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGT-DHGSLIGYAWHLWSQGKT 750
Query: 650 MELVDKRLGSNFDKEQVMVMINVALLCTDXXXXXXXXXXXXXXMLEGR 697
E++D + D + M I+V +LCT MLE +
Sbjct: 751 KEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQ 798
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGN2 | Y3148_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5665 | 0.9857 | 0.7450 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 771 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-53 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-51 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-37 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-37 | |
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 7e-37 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-36 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-36 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-35 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-34 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-32 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-31 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-31 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-30 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-29 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-29 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-27 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-27 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-27 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-27 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-26 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-26 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-26 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-24 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-24 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-22 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-19 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-19 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-15 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-15 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 1e-53
Identities = 88/276 (31%), Positives = 124/276 (44%), Gaps = 29/276 (10%)
Query: 426 DNKIGEGGFGPVYKGH-----MADGTVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNL 479
K+GEG FG VYKG VAVK L S+Q EF+ E ++ L HPN+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
VKL G C E L ++ EYME L L +R KL + IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLE- 119
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 599
+HRD+ A N L+ ++L KISDFGL++ +D+ + +MAPE
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 600 GYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658
G T K+DV+SFG++ EI + G E++ L G +
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-------NGYRLPQPP---- 226
Query: 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSML 694
N E + ++ L C RP+ S +V +L
Sbjct: 227 -NCPPE----LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 4e-53
Identities = 76/194 (39%), Positives = 107/194 (55%), Gaps = 11/194 (5%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLHGCC 486
+GEGGFG VY G VA+K + + E + EI ++ L HPN+VKL+G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
+ N L L+ EY E SL L + + KL RI + I GL YLH I+
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 547 HRDIKATNVLLDKD-LNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-YAMRGYLTD 604
HRD+K N+LLD D K++DFGL+KL D + + T V GT YMAPE +GY ++
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173
Query: 605 KADVYSFGIVALEI 618
K+D++S G++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 8e-52
Identities = 84/276 (30%), Positives = 122/276 (44%), Gaps = 28/276 (10%)
Query: 426 DNKIGEGGFGPVYKGH-----MADGTVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNL 479
K+GEG FG VYKG VAVK L S+Q EF+ E ++ L HPN+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
VKL G C E L+++ EYM L L + +L + IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLE- 120
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 599
+HRD+ A N L+ ++L KISDFGL++ +D+ + +MAPE
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 600 GYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658
G T K+DV+SFG++ EI + G ++ L +G +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-------KGYRLPKP----- 226
Query: 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSML 694
N E + + L C RP+ S +V +L
Sbjct: 227 PNCPPE----LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 2e-51
Identities = 89/284 (31%), Positives = 130/284 (45%), Gaps = 37/284 (13%)
Query: 427 NKIGEGGFGPVYKGHMADG----TVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVK 481
K+GEG FG VYKG + T VAVK L S++ ++F+ E ++ L HPN+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 482 LHGCCIEGNQLLLIYEYMENNSL-----ARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
L G C E L L+ EYME L P + L + IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAP 594
L K VHRD+ A N L+ +DL KISDFGL++ D D+ + + G +MAP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYRKKTGGKLPIRWMAP 176
Query: 595 EYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKA--QGNLME 651
E G T K+DV+SFG++ EI + G + P + +L+ +G +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGAT-----PYPGL----SNEEVLEYLRKGYRLP 227
Query: 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
E + + L C + RP+ S +V LE
Sbjct: 228 -----KPEYCPDE----LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 7e-49
Identities = 75/203 (36%), Positives = 106/203 (52%), Gaps = 17/203 (8%)
Query: 428 KIGEGGFGPVYKGHM-----ADGTVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVK 481
K+GEG FG VYKG + T VAVK L S++ EF+ E ++ L HPN+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
L G C +G L ++ EYM L L H KL ++ + IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLES-- 120
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG---YMAPEYAM 598
VHRD+ A N L+ ++L KISDFGL++ ED+ + G +MAPE
Sbjct: 121 -KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESLK 177
Query: 599 RGYLTDKADVYSFGIVALEIVSG 621
G T K+DV+SFG++ EI +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 9e-49
Identities = 73/199 (36%), Positives = 106/199 (53%), Gaps = 12/199 (6%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQL--SSKSKQGNREFVNEIGMISALQHPNLVKLHG 484
K+G G FG VYK H G +VAVK L S+ + ++ EI ++ L HPN+V+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+ + L L+ EY E L L L +I + I RGL YLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGG-PLSEDEAKKIALQILRGLEYLHSNG--- 118
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-YAMRGYLT 603
I+HRD+K N+LLD++ KI+DFGLAK + ++ ++T V GT YMAPE
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 604 DKADVYSFGIVALEIVSGR 622
K DV+S G++ E+++G+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 4e-48
Identities = 68/199 (34%), Positives = 105/199 (52%), Gaps = 11/199 (5%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLHG 484
K+GEG FG VY G +VA+K + K + +RE + EI ++ L+HPN+V+L+
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+ ++L L+ EY E L L R +L I L YLH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLHS---KG 117
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
IVHRD+K N+LLD+D + K++DFGLA+ + ++T V GT YMAPE +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGKGYGK 175
Query: 605 KADVYSFGIVALEIVSGRS 623
D++S G++ E+++G+
Sbjct: 176 AVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 77/209 (36%), Positives = 105/209 (50%), Gaps = 27/209 (12%)
Query: 427 NKIGEGGFGPVYKGHMAD-GTVVAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVKLH 483
+G G FG VY D G ++AVK LS S++ EI ++S+LQHPN+V+ +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 484 GCCI--EGNQLLLIYEYMENNSLARAL--FGPEAHRLKLDWP-----TRHRICVGIARGL 534
G E N L + EY+ SL+ L FG KL P TR I GL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQ-----ILEGL 114
Query: 535 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMA 593
AYLH IVHRDIK N+L+D D K++DFG AK L + + + V GT +MA
Sbjct: 115 AYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171
Query: 594 PEYAMRGYLTDKADVYSFGIVALEIVSGR 622
PE AD++S G +E+ +G+
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 7e-42
Identities = 70/198 (35%), Positives = 106/198 (53%), Gaps = 13/198 (6%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
KIG+GGFG VYK H G VA+K + +SK+ + +NEI ++ +HPN+VK +G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
++ ++L ++ E+ SL L ++ L +C + +GL YLH I+
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSN---GII 120
Query: 547 HRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
HRDIKA N+LL D K+ DFGL+ D + + GT +MAPE
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM----VGTPYWMAPEVINGKPYDY 176
Query: 605 KADVYSFGIVALEIVSGR 622
KAD++S GI A+E+ G+
Sbjct: 177 KADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 5e-41
Identities = 75/206 (36%), Positives = 113/206 (54%), Gaps = 25/206 (12%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLS--SKSKQGNREFVNEIGMISALQHPNLVKLH 483
+ IG G FG VYKG ++ G VA+KQ+S ++ + + EI ++ L+HPN+VK
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 484 GCCIEGNQLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHRICVGIA---RGLAYLH 538
G + L +I EY EN SL + + FGP L + V + +GLAYLH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL---------VAVYVYQVLQGLAYLH 116
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRVAGTFGYMAPE-Y 596
E+ ++HRDIKA N+L KD K++DFG+A KL++ V GT +MAPE
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVI 171
Query: 597 AMRGYLTDKADVYSFGIVALEIVSGR 622
M G + +D++S G +E+++G
Sbjct: 172 EMSG-ASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 70/198 (35%), Positives = 112/198 (56%), Gaps = 15/198 (7%)
Query: 428 KIGEGGFGPVYKGH-MADGTVVAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVKLHG 484
KIGEG G VYK A G VA+K+ L ++K+ +NEI ++ +HPN+V +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNIVDYYD 82
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+ G++L ++ EYM+ SL + + ++++ P +C + +GL YLH
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDII---TQNFVRMNEPQIAYVCREVLQGLEYLH---SQN 136
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLT 603
++HRDIK+ N+LL KD + K++DFG A+L +E + S V GT +MAPE R
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYG 194
Query: 604 DKADVYSFGIVALEIVSG 621
K D++S GI+ +E+ G
Sbjct: 195 PKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 80/201 (39%), Positives = 110/201 (54%), Gaps = 17/201 (8%)
Query: 428 KIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGN---REFVNEIGMISALQHPNLVKLHG 484
K+G G FG V+ G T VAVK L K G F+ E ++ L+H LV+L+
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
C E + ++ EYM SL L E +L+L P + IA G+AYL ESR
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYL--ESR-N 123
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGYL 602
+HRD+ A N+L+ ++L KI+DFGLA+L E+D + R F + APE A G
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDD--EYTAREGAKFPIKWTAPEAANYGRF 181
Query: 603 TDKADVYSFGIVALEIVS-GR 622
T K+DV+SFGI+ EIV+ GR
Sbjct: 182 TIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 7e-37
Identities = 68/164 (41%), Positives = 86/164 (52%), Gaps = 19/164 (11%)
Query: 200 YSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAFRGSNNWAFSNTGHFLDD-------DR 252
+ INCGG + T + T+E DT G S + N + S G +
Sbjct: 1 VVLAINCGGPEHTDSDGITYEADTYFTGGSADYYVSDTNGSSSIAGTTDPELYQTERYSP 60
Query: 253 PADTY---IQTN---TSIL----LMNDSHSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGK 302
+ +Y N T IL + GRR+FDVY+QGKLVLKDF+I EAGG GK
Sbjct: 61 SSFSYYIPCLENGNYTVILHFAEIYFGEDGLGRRVFDVYVQGKLVLKDFDIVAEAGGKGK 120
Query: 303 AIVKQF-PVVVINSTIEIRLYWAGKGTTGVPVRGVYG-PLISAI 344
K++ PV V + T+EI YWAGKGT +P RGVYG P ISAI
Sbjct: 121 TAHKEYIPVTVTDGTLEIHFYWAGKGTLLIPFRGVYGNPKISAI 164
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 84/284 (29%), Positives = 135/284 (47%), Gaps = 27/284 (9%)
Query: 427 NKIGEGGFGPVYKGH---MADGT--VVAVKQLS-SKSKQGNREFVNEIGMISALQHPNLV 480
++GEG FG V + D T VAVK L+ S +Q +F EI ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 481 KLHGCCIE--GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
K G C + G L LI EY+ + SL L + HR +++ I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG---TFGYMAPE 595
+ + +HRD+ A N+L++ + KISDFGLAK+ ED + + G F Y APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 596 YAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD- 654
+ +DV+SFG+ E+ + + S P + ++ A L+EL+
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT-YGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241
Query: 655 -KRLG--SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+RL + E +M LC + RPS + ++ +++
Sbjct: 242 GERLPRPPSCPDEVYDLMK----LCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 70/205 (34%), Positives = 107/205 (52%), Gaps = 20/205 (9%)
Query: 423 FAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKL 482
F + K+G G FG V++G + VA+K L S ++F E+ + L+H +L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVG--IARGLAYLHEE 540
C G + +I E ME SL L PE L P I + +A G+AYL E+
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVL----PVASLIDMACQVAEGMAYLEEQ 123
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED-----NTHISTRVAGTFGYMAPE 595
+HRD+ A N+L+ +DL K++DFGLA+L +ED + I + + APE
Sbjct: 124 ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK------WTAPE 174
Query: 596 YAMRGYLTDKADVYSFGIVALEIVS 620
A G + K+DV+SFGI+ E+ +
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 423 FAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVK 481
F K+GEG +G VYK H G VVA+K + + +E + EI ++ P +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
+G + L ++ EY S++ + + L I +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM---KITNKTLTEEEIAAILYQTLKGLEYLH--- 116
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-G 600
K +HRDIKA N+LL+++ K++DFG++ + +T V GT +MAPE G
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIG 175
Query: 601 YLTDKADVYSFGIVALEIVSGR 622
Y +KAD++S GI A+E+ G+
Sbjct: 176 Y-NNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 73/195 (37%), Positives = 101/195 (51%), Gaps = 12/195 (6%)
Query: 429 IGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIE 488
IG+G FG V G G VAVK L S F+ E +++ L+HPNLV+L G ++
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 489 GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHR 548
GN L ++ EYM SL L + L + + + G+ YL E+ VHR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 549 DIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADV 608
D+ A NVL+ +DL K+SDFGLAK E S ++ + APE + K+DV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFSTKSDV 182
Query: 609 YSFGIVALEIVS-GR 622
+SFGI+ EI S GR
Sbjct: 183 WSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 73/213 (34%), Positives = 107/213 (50%), Gaps = 27/213 (12%)
Query: 429 IGEGGFGPVYKGHMA------DGTVVAVKQLS-SKSKQGNREFVNEIGMISALQHPNLVK 481
+GEG FG V+ G D +VAVK L + S ++F E +++ QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTR--------HRICVGIA 531
+G C EG+ ++++EYME+ L + L GP+A LK +I V IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 532 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT--- 588
G+ YL + VHRD+ N L+ DL KI DFG+++ D + RV G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-DVYTTDYY--RVGGHTML 186
Query: 589 -FGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+M PE M T ++DV+SFG+V EI +
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 68/205 (33%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGN--REFVNEIGMISALQHPNLVKLH 483
NKIG G FG VY ++ G ++AVK++ + +E +E+ ++ L+HPNLVK +
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
G + ++ + EY +L L H LD + + GLAYLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG---YMAPEYAMRG 600
IVHRDIK N+ LD + K+ DFG A + + T + V G YMAPE G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 601 YLTDK---ADVYSFGIVALEIVSGR 622
AD++S G V LE+ +G+
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLS-SKSKQGNREFV-NEIGMISALQHPN 478
+ +IG+G FG VY +DG + +K++ S + RE NE+ ++ L HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRI---CVGIARGLA 535
++K + E +L ++ EY + L++ + + + + +I V + L
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKI---KKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 595
YLH KI+HRDIK N+ L + K+ DFG++K+ T V GT Y++PE
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE 173
Query: 596 -YAMRGYLTDKADVYSFGIVALEIVSGR 622
+ Y K+D++S G V E+ + +
Sbjct: 174 LCQNKPY-NYKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 67/202 (33%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 426 DNKIGEGGFGPVYKGHMA----DGTVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLV 480
+ IG G FG V +G + VA+K L + S R +F+ E ++ HPN++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
+L G + +++I EYMEN SL + L + K + GIA G+ YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFL---RENDGKFTVGQLVGMLRGIASGMKYL--- 122
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG--YMAPEYAM 598
S + VHRD+ A N+L++ +L K+SDFGL++ E+ +T+ G + APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIRWTAPEAIA 181
Query: 599 RGYLTDKADVYSFGIVALEIVS 620
T +DV+SFGIV E++S
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-31
Identities = 70/201 (34%), Positives = 110/201 (54%), Gaps = 13/201 (6%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVKLH 483
NKIG+G FG V+K AD V A+KQ LS +++ E ++E +++ L +++ +
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLD--WPTRHRICVGIARGLAYLHEES 541
++ +L ++ EY EN L + L L D W R + I GLA+LH +
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHLHSK- 120
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGY 601
KI+HRDIK+ N+ LD N KI D G+AKL DNT+ + + GT Y++PE
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTNFANTIVGTPYYLSPELCEDKP 177
Query: 602 LTDKADVYSFGIVALEIVSGR 622
+K+DV++ G+V E +G+
Sbjct: 178 YNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 79/288 (27%), Positives = 128/288 (44%), Gaps = 46/288 (15%)
Query: 429 IGEGGFGPVYKGHMAD------GTVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVK 481
+G+G FG VY+G T VA+K ++ + R EF+NE ++ ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 482 LHGCCIEGNQLLLIYEYMENNSLA---RALFGPEAHRLKLDWPTRHRI---CVGIARGLA 535
L G G L++ E M L R+ + L PT + IA G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAP 594
YL K VHRD+ A N ++ +DL KI DFG+ + + E D + +MAP
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 595 EYAMRGYLTDKADVYSFGIVALEIVS-------GRSNSSCKPKEDIFYLLDWALILKAQG 647
E G T K+DV+SFG+V E+ + G SN +E + +++D G
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-----EEVLKFVID--------G 237
Query: 648 NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
++L + N + + +M +C + RP+ +VS L+
Sbjct: 238 GHLDLPE-----NCPDKLLELM----RMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 76/201 (37%), Positives = 110/201 (54%), Gaps = 18/201 (8%)
Query: 428 KIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNRE---FVNEIGMISALQHPNLVKLHG 484
K+G G FG V+ G+ T VA+K L KQG+ F+ E ++ LQHP LV+L+
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+ + +I EYMEN SL L PE +L + + IA G+A++ R
Sbjct: 69 V-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTI--NKLIDMAAQIAEGMAFIE---RKN 122
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGYL 602
+HRD++A N+L+ + L KI+DFGLA+L E + + R F + APE G
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 603 TDKADVYSFGIVALEIVS-GR 622
T K+DV+SFGI+ EIV+ GR
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 7e-30
Identities = 69/198 (34%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 428 KIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI 487
K+G G FG V++G + T VAVK L + +F+ E ++ L+HP L++L+ C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 488 EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVH 547
+ ++ E M+ SL L G LKL P + +A G+AYL ++ +H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 548 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGYLTDK 605
RD+ A NVL+ ++ K++DFGLA++ +ED R F + APE A+ + K
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDI--YEAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 606 ADVYSFGIVALEIVS-GR 622
+DV+SFGI+ EIV+ GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 74/215 (34%), Positives = 114/215 (53%), Gaps = 24/215 (11%)
Query: 429 IGEGGFGPVYKGH-MADG----TVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVKL 482
+G G FG VYKG + +G VA+K L S + N+E ++E +++++ HP++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
G C+ +Q+ LI + M L + H+ + CV IA+G++YL EE R
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYV---RNHKDNIGSQYLLNWCVQIAKGMSYL-EEKR 129
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG---TFGYMAPEYAMR 599
L VHRD+ A NVL+ + KI+DFGLAKL + D G +MA E +
Sbjct: 130 L--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALESILH 185
Query: 600 GYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDI 633
T K+DV+S+G+ E+++ G KP E I
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGA-----KPYEGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 68/211 (32%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 428 KIGEGGFGPVYKGHMA------DGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVK 481
++GEG FG V+ D +VAVK L S+ ++F E +++ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARAL--FGPEAHRL---------KLDWPTRHRICVGI 530
+G C EG LL+++EYM + L R L GP+A L +L I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 531 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTF 589
A G+ YL + L VHRD+ N L+ + L KI DFG+++ + D + R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 590 GYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+M PE + T ++D++SFG+V EI +
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 67/196 (34%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 428 KIGEGGFGPVYKGHMAD-GTVVAVKQLSSKSKQGNREFVN-EIGMISALQHPNLVKLHGC 485
IG+G FG VYK VVA+K + + + E + EI +S + P + K +G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
++G++L +I EY S L KLD I + GL YLHEE
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEE---GK 119
Query: 546 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDK 605
+HRDIKA N+LL ++ + K++DFG++ + +T V GT +MAPE + +K
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEK 178
Query: 606 ADVYSFGIVALEIVSG 621
AD++S GI A+E+ G
Sbjct: 179 ADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 25/205 (12%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLHGC 485
+G+G G VYK H G + A+K++ + R + + E+ + + + P +VK +G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIAR----GLAYLHEES 541
+ ++ ++ EYM+ SLA L + P + IAR GL YLH +
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL------KKVGKIP--EPVLAYIARQILKGLDYLH--T 117
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKL----DEEDNTHISTRVAGTFGYMAPEYA 597
+ I+HRDIK +N+L++ KI+DFG++K+ ++ NT + GT YM+PE
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPERI 172
Query: 598 MRGYLTDKADVYSFGIVALEIVSGR 622
+ AD++S G+ LE G+
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (297), Expect = 6e-29
Identities = 73/215 (33%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 422 NFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHP- 477
++ K+GEG FG VY D +VA+K L+ K + F+ EI ++++L HP
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 478 NLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYL 537
N+VKL+ + L L+ EY++ SL L + L I I L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 538 HEESRLKIVHRDIKATNVLLDKDLN-PKISDFGLAKLDEEDNTHISTR-----VAGTFGY 591
H + I+HRDIK N+LLD+D K+ DFGLAKL + + S GT GY
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 592 MAPEYAM---RGYLTDKADVYSFGIVALEIVSGRS 623
MAPE + Y + +D++S GI E+++G
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 70/208 (33%), Positives = 105/208 (50%), Gaps = 30/208 (14%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLS-----SKSKQGNREFVNEIGMISALQHPNLVKL 482
+G G FG VY+G ++ DG AVK++S ++ ++ EI ++S LQHPN+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 483 HGCCIEGNQLLLIYEYMENNSLARAL--FGPEAHRLKLDWP-----TRHRICVGIARGLA 535
G E + L + E + SLA+ L +G P TR I GL
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGS------FPEPVIRLYTRQ-----ILLGLE 116
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 595
YLH+ VHRDIK N+L+D + K++DFG+AK E + S G+ +MAPE
Sbjct: 117 YLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPE 171
Query: 596 YAMR-GYLTDKADVYSFGIVALEIVSGR 622
+ G AD++S G LE+ +G+
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 17/222 (7%)
Query: 429 IGEGGFGPVYK-GHMADGTVVAVKQLSSKSKQGNREFV---NEIGMISALQHPNLVKLHG 484
+G+G FG V G + A+K L K +E E ++S + HP +VKLH
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+L L+ EY L L + + I L YLH L
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHL----SKEGRFSEERARFYAAEIVLALEYLH---SLG 113
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
I++RD+K N+LLD D + K++DFGLAK + + +T GT Y+APE +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYGK 172
Query: 605 KADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ 646
D +S G++ E+++G+ + +++I+ ILK
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIY-----EKILKDP 209
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 427 NKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFV-NEIGMISALQHPNLVKLHG 484
IG G VY + + VA+K++ + Q + + + E+ +S HPN+VK +
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLK---LDWPTRHRICVGIARGLAYLHEES 541
+ G++L L+ Y+ SL + LD + + +GL YLH
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIM----KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHIS-TRVAGTFGYMAPE--Y 596
+ +HRDIKA N+LL +D + KI+DFG++ D D T GT +MAPE
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 597 AMRGYLTDKADVYSFGIVALEIVSGR 622
+ GY KAD++SFGI A+E+ +G
Sbjct: 180 QVHGY-DFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 64/205 (31%), Positives = 107/205 (52%), Gaps = 14/205 (6%)
Query: 428 KIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI 487
+IG G FG V+ G+ + VA+K + + +F+ E ++ L HP LV+L+G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 488 EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVH 547
E + + L++E+ME+ L+ L A R K T +C+ + G+AYL + ++H
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 548 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKAD 607
RD+ A N L+ ++ K+SDFG+ + +D ST + +PE + K+D
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 608 VYSFGIVALEIVS-------GRSNS 625
V+SFG++ E+ S RSNS
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNS 208
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 21/200 (10%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGC 485
+IG G +G VYK +A G +VA+K + + EI M+ +HPN+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 486 CIEGNQLLLIYEYMENNSLA---RALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
+ ++L ++ EY SL + GP L +C +GLAYLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGP------LSELQIAYVCRETLKGLAYLHE--- 119
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVA--GTFGYMAPEYA--- 597
+HRDIK N+LL +D + K++DFG++ + T I+ R + GT +MAPE A
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSA--QLTAT-IAKRKSFIGTPYWMAPEVAAVE 176
Query: 598 MRGYLTDKADVYSFGIVALE 617
+G K D+++ GI A+E
Sbjct: 177 RKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 423 FAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREF----VNEIGMISALQHP 477
+ K+GEG +G VYK G +VA+K++ + + EI ++ L+HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHP 58
Query: 478 NLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYL 537
N+VKL +L L++EY + + L + L + L I + RGLAY
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDMD-LKKYL---DKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 538 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-- 595
H S +I+HRD+K N+L+++D K++DFGLA+ + V T Y APE
Sbjct: 115 H--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEIL 170
Query: 596 YAMRGYLTDKADVYSFGIVALEIVSGR 622
+ Y T D++S G + E+++G+
Sbjct: 171 LGSKHYST-AVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-27
Identities = 89/303 (29%), Positives = 137/303 (45%), Gaps = 48/303 (15%)
Query: 422 NFAPDNKIGEGGFGPVYKGH------MADGTVVAVKQLSSKSKQGN-REFVNEIGMISAL 474
N +GEG FG V K A T VAVK L + R+ ++E ++ +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 475 QHPNLVKLHGCCIEGNQLLLIYEYMENNSLARAL------------FGPEAHRLKLDWPT 522
HP+++KL+G C + LLLI EY + SL L + LD P
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 523 RHRICVG--------IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574
+ +G I+RG+ YL E +K+VHRD+ A NVL+ + KISDFGL++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 575 EEDNTHIS-TRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKED 632
E+++++ ++ +MA E T ++DV+SFG++ EIV+ G + E
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
Query: 633 IFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692
+F LL G ME + N +E M N+ L C RP+ + +
Sbjct: 238 LFNLLK-------TGYRMERPE-----NCSEE----MYNLMLTCWKQEPDKRPTFADISK 281
Query: 693 MLE 695
LE
Sbjct: 282 ELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 74/207 (35%), Positives = 108/207 (52%), Gaps = 17/207 (8%)
Query: 428 KIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI 487
K+G G FG V+ G+ + T VAVK L + + F+ E ++ LQH LV+L+
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 488 EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVH 547
+ + +I EYM SL L E ++ L P IA G+AY+ R +H
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 548 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGYLTDK 605
RD++A NVL+ + L KI+DFGLA++ E++ + R F + APE G T K
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDN--EYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 606 ADVYSFGIVALEIVS-------GRSNS 625
+DV+SFGI+ EIV+ G SNS
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMSNS 211
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 427 NKIGEGGFGPVYK-GHMADGTVVAVKQLS-----SKSKQGNREFVNEIGMISALQHPNLV 480
IG+G FG V K +DG ++ K++ K KQ + V+E+ ++ L+HPN+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQ---QLVSEVNILRELKHPNIV 62
Query: 481 KLHGCCI-EGNQLLLIY-EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+ + I NQ L I EY E LA+ + + R ++ RI + L H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 539 --EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 596
+ ++HRD+K N+ LD + N K+ DFGLAK+ D++ T V GT YM+PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQ 181
Query: 597 AMRGYLTDKADVYSFGIVALEIVSGR 622
+K+D++S G + E+ +
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 73/274 (26%), Positives = 131/274 (47%), Gaps = 29/274 (10%)
Query: 422 NFAPDNKIGEGGFGPVYK-GHMADGTVVAVKQ--LSSKSKQGNREFVNEIGMISALQHPN 478
+F K+G+G +G VYK ++D A+K+ L S S++ + VNEI +++++ HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
++ ++GN+L ++ EY L++A+ + R + RI + + RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED--NTHISTRVAGTFGYMAPEY 596
E KI+HRD+K+ N+LL + KI D G++K+ +++ T I GT YMAPE
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYMAPEV 172
Query: 597 AMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656
+ K+D++S G + E+ + + +D+ Y K Q
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY--------KVQRGKYP----P 220
Query: 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSV 690
+ + ++ + N V RP+ +
Sbjct: 221 IPPIYSQD----LQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 70/212 (33%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 429 IGEGGFGPVYKGH------MADGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVK 481
+GEG FG VYKG T VA+K L + +EF E ++S LQHPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARAL----------FGPEAHRLK--LDWPTRHRICVG 529
L G C + +++EY+ + L L +K LD I +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD-EEDNTHISTRVAGT 588
IA G+ YL S VHRD+ A N L+ + L KISDFGL++ D + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 589 FGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+M PE + G T ++D++SFG+V EI S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 428 KIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLHGCC 486
KIG+G FG VYKG + T VAVK S + F+ E ++ HPN+VKL G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
++ + ++ E + SL L + RL + ++ + A G+ YL ES+ +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKN-RLTVK--KLLQMSLDAAAGMEYL--ESK-NCI 115
Query: 547 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGYLTD 604
HRD+ A N L+ ++ KISDFG+++ +EE + + + APE G T
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 605 KADVYSFGIVALEIVSG 621
++DV+S+GI+ E S
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 91/290 (31%), Positives = 135/290 (46%), Gaps = 45/290 (15%)
Query: 429 IGEGGFGPV--YKGHMA-DGT--VVAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKL 482
+GEG FG V Y A DGT +VAVK L + Q N + EI ++ L H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 483 HGCCIEGNQ--LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVG--------IAR 532
GCC E L LI EY+ SL D+ +H++ + I
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSL-------------RDYLPKHKLNLAQLLLFAQQICE 118
Query: 533 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG---TF 589
G+AYLH + +HRD+ A NVLLD D KI DFGLAK E + + R G F
Sbjct: 119 GMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 175
Query: 590 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL 649
Y A E + +DV+SFG+ E+++ +S P + ++ L
Sbjct: 176 WY-AVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVVRL 233
Query: 650 MELVDK--RL--GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+EL+++ RL N +E ++M N C + + RP+ S++ +L+
Sbjct: 234 IELLERGMRLPCPKNCPQEVYILMKN----CWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 86/316 (27%), Positives = 132/316 (41%), Gaps = 74/316 (23%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSK-SKQGNREFVNEIGMISA 473
NN IG+G FG V++ T+VAVK L + S +F E +++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 474 LQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRL----------------K 517
HPN+VKL G C G + L++EYM L L
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 518 LDWPTRHRICVG--IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA---- 571
L ++C+ +A G+AYL E K VHRD+ N L+ +++ KI+DFGL+
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 572 -----KLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS------ 620
K E D I +M PE T ++DV+++G+V EI S
Sbjct: 182 SADYYKASENDAIPIR--------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233
Query: 621 -GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDV 679
G ++ +E I+Y+ D GN++ D N E + N+ LC
Sbjct: 234 YGMAH-----EEVIYYVRD--------GNVLSCPD-----NCPLE----LYNLMRLCWSK 271
Query: 680 SSTSRPSMSSVVSMLE 695
+ RPS +S+ +L+
Sbjct: 272 LPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 69/203 (33%), Positives = 107/203 (52%), Gaps = 23/203 (11%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV-NEIGMISALQH---PNLVKLH 483
IG G +G VY+G H+ G VVA+K ++ + + + E+ ++S L+ PN+ K +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIAR----GLAYLHE 539
G ++G +L +I EY E S+ R L P + I R L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-RTLMKAG--------PIAEKYISVIIREVLVALKYIHK 119
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 599
++HRDIKA N+L+ N K+ DFG+A L ++++ ST V GT +MAPE
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITE 175
Query: 600 GYLTD-KADVYSFGIVALEIVSG 621
G D KAD++S GI E+ +G
Sbjct: 176 GKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 62/200 (31%), Positives = 111/200 (55%), Gaps = 18/200 (9%)
Query: 427 NKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFV-NEIGMISALQHPNLVKLHG 484
KIGEG G V + G VAVK++ + KQ RE + NE+ ++ QHPN+V+++
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+ G++L ++ E++E +L + +++ +C+ + + L++LH +
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHAQ---G 135
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTR--VAGTFGYMAPEYAMRGY 601
++HRDIK+ ++LL D K+SDFG A++ +E + R + GT +MAPE R
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----VPRRKSLVGTPYWMAPEVISRLP 191
Query: 602 LTDKADVYSFGIVALEIVSG 621
+ D++S GI+ +E+V G
Sbjct: 192 YGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 30/208 (14%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQG--NREFVNEIGMISALQHPNLVKLHG 484
KIGEG +G VYK G +VA+K++ + + + + EI ++ L HPN++KL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 485 CCIEGNQLLLIYEYMENNSL----ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
L L++E+M+ + R PE+ + + +GLA+ H
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQ--------LLQGLAFCH-- 115
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN---TH-ISTRVAGTFGYMAPE- 595
I+HRD+K N+L++ + K++DFGLA+ TH + TR Y APE
Sbjct: 116 -SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPEL 169
Query: 596 -YAMRGYLTDKADVYSFGIVALEIVSGR 622
+GY + D++S G + E++S R
Sbjct: 170 LLGDKGY-STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 68/204 (33%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 427 NKIGEGGFGPVYKG--HMADGTV--VAVKQLS-SKSKQGNREFVNEIGMISALQHPNLVK 481
++G G FG V KG M G VAVK L G +EF+ E +++ L HP +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFG-PE--AHRLKLDWPTRHRICVGIARGLAYLH 538
L G C +G L+L+ E L + L E LK + +A G+AYL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE-LAHQ------VAMGMAYL- 111
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEY 596
E VHRD+ A NVLL KISDFG+++ + + AG + + APE
Sbjct: 112 ESKHF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC 169
Query: 597 AMRGYLTDKADVYSFGIVALEIVS 620
G + K+DV+S+G+ E S
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 429 IGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIE 488
+G G FG V+ G VA+K + + +F+ E ++ L HPNLV+L+G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 489 GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHR 548
+ ++ EYM N L L + KL +C + + YL +HR
Sbjct: 71 QRPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHR 124
Query: 549 DIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKA 606
D+ A N L+ +D K+SDFGLA+ LD++ + T+ + PE + K+
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFSSKS 182
Query: 607 DVYSFGIVALEIVSG 621
DV+SFG++ E+ S
Sbjct: 183 DVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVK--QLSSKSKQGNREFVNEIGMISALQHPNLVKLH 483
++G G G V K H G ++AVK +L ++ + E+ ++ P +V +
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI-QKQILRELDILHKCNSPYIVGFY 65
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRH--RICVGIARGLAYLHEES 541
G + + EYM+ SL + L ++ P R +I V + +GL YLHE
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKIL-----KEVQGRIPERILGKIAVAVLKGLTYLHE-- 118
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGY 601
+ KI+HRD+K +N+L++ K+ DFG++ + N+ ++ GT YMAPE
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG--QLVNS-LAKTFVGTSSYMAPERIQGND 175
Query: 602 LTDKADVYSFGIVALEIVSGR--SNSSCKPKEDIFYLLD 638
+ K+D++S G+ +E+ +GR P + IF LL
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ 214
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 70/254 (27%), Positives = 107/254 (42%), Gaps = 29/254 (11%)
Query: 429 IGEGGFGPVYK-GHMADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHG 484
IG+G FG V + A+K ++ + K R +NE ++ L HP LV L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+ + L+ + + L L + ++K I L YLH +
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKFWICEIVLALEYLHSK---G 120
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRVAGTFGYMAPEYAMRGYLT 603
I+HRDIK N+LLD+ + I+DF +A K+ + T T +GT GYMAPE R +
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQGYS 177
Query: 604 DKADVYSFGIVALEIVSGR---SNSSCKPKEDIFYLLDWALILKAQGNLMELVD------ 654
D +S G+ A E + G+ S ++ I + A +L E +D
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 655 -----KRLGSNFDK 663
KRLG N
Sbjct: 238 ERDPQKRLGDNLKD 251
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-25
Identities = 71/200 (35%), Positives = 104/200 (52%), Gaps = 12/200 (6%)
Query: 426 DNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGC 485
+ K+G G FG V+ T VAVK + S F+ E ++ LQH LVKLH
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
+ + +I E+M SL L E + L P IA G+A++ + +
Sbjct: 70 -VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---Y 123
Query: 546 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGYLT 603
+HRD++A N+L+ L KI+DFGLA++ EDN + + R F + APE G T
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTA-REGAKFPIKWTAPEAINFGSFT 181
Query: 604 DKADVYSFGIVALEIVS-GR 622
K+DV+SFGI+ +EIV+ GR
Sbjct: 182 IKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 72/203 (35%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 423 FAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGN---REFVNEIGMISALQHPN 478
F +IG G FG VY + VVA+K++S KQ N ++ + E+ + L+HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
++ GC + + L+ EY L A E H+ L IC G +GLAYLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEY----CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE--Y 596
+ +HRDIKA N+LL + K++DFG A L N+ + GT +MAPE
Sbjct: 133 S---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVIL 184
Query: 597 AM-RGYLTDKADVYSFGIVALEI 618
AM G K DV+S GI +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 72/198 (36%), Positives = 109/198 (55%), Gaps = 12/198 (6%)
Query: 428 KIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI 487
K+G+G FG V+ G T VA+K L + F+ E ++ L+H LV+L+
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 488 EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVH 547
E + ++ EYM SL L G L+L P + IA G+AY+ R+ VH
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVH 125
Query: 548 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGYLTDK 605
RD++A N+L+ ++L K++DFGLA+L EDN + + R F + APE A+ G T K
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLI-EDNEY-TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 606 ADVYSFGIVALEIVS-GR 622
+DV+SFGI+ E+ + GR
Sbjct: 184 SDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 428 KIGEGGFGPVYKG--HMADGTV--VAVKQLSSKSKQGN-REFVNEIGMISALQHPNLVKL 482
K+G+G FG V +G + G V VAVK L S +F+ E ++ +L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
+G + + L+++ E SL L + T V IA G+ YL +
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLI--STLCDYAVQIANGMRYLESK-- 116
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHIST---RVAGTFGYMAPEYAM 598
+ +HRD+ A N+LL D KI DFGL + L + ++ ++ +V F + APE
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCAPESLR 173
Query: 599 RGYLTDKADVYSFGIVALEIVS 620
+ +DV+ FG+ E+ +
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 72/213 (33%), Positives = 105/213 (49%), Gaps = 18/213 (8%)
Query: 429 IGEGGFGPVYKGH---MADGT--VVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLH 483
+G+G FG V + D T VVAVK+L + + R+F EI ++ +LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 484 GCCIEG--NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
G C L L+ EY+ SL L + HR +LD I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYL---G 125
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG---TFGYMAPEYAM 598
+ VHRD+ N+L++ + KI DFGL K+ +D + R G F Y APE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLT 184
Query: 599 RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKE 631
+ +DV+SFG+V E+ + S+ SC P
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT-YSDKSCSPPA 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 29/208 (13%)
Query: 428 KIGEGGFGPVYK-GHMADGTVVAVKQLSSKSKQGN--REFVNEIGMISALQHPNLVKLHG 484
+IGEG G V+K G VA+K+++ + +G + + EI + A QHP +VKL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 485 CCIEGNQLLLIYEYMENNSLA-------RALFGPEAHRLKLDWPTRHRICVGIARGLAYL 537
G+ +L+ EYM + L+ R L + + +G+AY+
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM----------LLKGVAYM 115
Query: 538 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL-DEEDNTHISTRVAGTFGYMAPE- 595
H I+HRD+K N+L+ D KI+DFGLA+L EE+ S +VA T Y APE
Sbjct: 116 HAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPEL 171
Query: 596 -YAMRGYLTDKADVYSFGIVALEIVSGR 622
Y R Y D+++ G + E+++G
Sbjct: 172 LYGARKY-DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 31/211 (14%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREF----VNEIGMISALQHPNLVK 481
+IGEG +G VYK + G +VA+K++ + + F + EI ++ L+HPN+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 482 LHGCCIE--GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
L + +++EYM+++ L L PE +K + GL YLH
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHD-LTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHS 118
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST-RVAGTFGYMAPE--- 595
I+HRDIK +N+L++ D K++DFGLA+ + N+ T RV T Y PE
Sbjct: 119 N---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLL 174
Query: 596 ----YAMRGYLTDKADVYSFGIVALEIVSGR 622
Y + D++S G + E+ G+
Sbjct: 175 GATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 70/211 (33%), Positives = 109/211 (51%), Gaps = 26/211 (12%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQL-----SSKSKQGNREFVN----EIGMISALQHPN 478
IG G FG VY G + + G ++AVKQ+ S+ SK R ++ EI ++ LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHRICVGIARGLAY 536
+V+ G ++ + L + EY+ S+A L +G + I +GL Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNY 121
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVA-----GTFGY 591
LH I+HRDIK N+L+D KISDFG++K E ++ T A G+ +
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 592 MAPEYAMRGYLTDKADVYSFGIVALEIVSGR 622
MAPE + T KAD++S G + +E+++G+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 73/213 (34%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGC- 485
IGEG +G VYK H G +VA+K + + E E ++ HPN+ +G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 486 -----CIEGNQLLLIYEYMENNS---LARALFGPEAHRLKLDWPTRHRICVGIARGLAYL 537
+QL L+ E S L + L + RLK +W I RGLAYL
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAY--ILRETLRGLAYL 129
Query: 538 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDEED---NTHISTRVAGTFGYMA 593
HE K++HRDIK N+LL K+ K+ DFG+ A+LD NT I GT +MA
Sbjct: 130 HEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-----GTPYWMA 181
Query: 594 PE-----YAMRGYLTDKADVYSFGIVALEIVSG 621
PE ++DV+S GI A+E+ G
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 73/198 (36%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 428 KIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI 487
K+G G FG V+ G T VAVK L + F+ E ++ L+H LV+L+
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 488 EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVH 547
E + ++ EYM SL L E LKL P + +A G+AY+ R+ +H
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 548 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGYLTDK 605
RD+++ N+L+ L KI+DFGLA+L EDN + + R F + APE A+ G T K
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLI-EDNEY-TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 606 ADVYSFGIVALEIVS-GR 622
+DV+SFGI+ E+V+ GR
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 67/202 (33%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 429 IGEGGFGPVYKGHMADGTV-VAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI 487
+G+G +G VY V +A+K++ + + + EI + S L+H N+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 488 EGNQLLLIYEYMENNSLA---RALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
E + E + SL+ R+ +GP LK + T I GL YLH+ +
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGP----LKDNEQTIIFYTKQILEGLKYLHD---NQ 128
Query: 545 IVHRDIKATNVLLDKDLNP-KISDFGLAKLDEEDNTHISTRVAGTFGYMAPE---YAMRG 600
IVHRDIK NVL++ KISDFG +K N T GT YMAPE RG
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPRG 187
Query: 601 YLTDKADVYSFGIVALEIVSGR 622
Y AD++S G +E+ +G+
Sbjct: 188 Y-GAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 70/210 (33%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 429 IGEGGFGPVYKGH----MADGT---VVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLV 480
+G G FG VY+G + G+ VAVK L + Q +EF+ E ++S HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLK---LDWPTRHRICVGIARGLAYL 537
KL G C+ +I E ME L L R L IC+ +A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 538 HEESRLKIVHRDIKATNVLL-----DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG-- 590
++ +HRD+ A N L+ D D KI DFGLA+ D + + G
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYRKEGEGLLPVR 178
Query: 591 YMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+MAPE + G T ++DV+SFG++ EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 429 IGEGGFGPVYKGHMAD-GTVVAVKQL------SSKSKQGNREFV----NEIGMISALQHP 477
IG+G +G VY G ++AVKQ+ + + ++ V +EI + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 478 NLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYL 537
N+V+ G L + EY+ S+ L + + + GLAYL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYL 124
Query: 538 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE--DNTHISTRVAGTFGYMAPE 595
H + I+HRD+KA N+L+D D KISDFG++K ++ DN + + G+ +MAPE
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ-NMSMQGSVFWMAPE 180
Query: 596 Y---AMRGYLTDKADVYSFGIVALEIVSGR 622
+GY + K D++S G V LE+ +GR
Sbjct: 181 VIHSYSQGY-SAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSKSKQGNREFVNEIGMISAL 474
+N ++GEG FG V+ D +VAVK L S ++F E +++ L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 475 QHPNLVKLHGCCIEGNQLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRH-------R 525
QH ++VK +G C+EG+ L++++EYM++ L + L GP+A +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 526 ICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTR 584
I IA G+ YL + VHRD+ N L+ ++L KI DFG+++ + D +
Sbjct: 125 IAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181
Query: 585 VAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+M PE M T ++DV+S G+V EI +
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 43/290 (14%)
Query: 429 IGEGGFGPVYKG------HMADGTVVAVKQL-SSKSKQGNREFVNEIGMISAL-QHPNLV 480
+GEG FG V K + + + VAVK L +++ + V+E+ M+ + +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 481 KLHGCCIEGNQLLLIYEYMENNSL-----AR-------ALFGPEAHRLKLDWPTRHRICV 528
L G C + L ++ EY + +L AR + P L
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 529 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT 588
+ARG+ +L S+ K +HRD+ A NVL+ +D KI+DFGLA+ D + G
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLAR-DIHHIDYYRKTTNGR 195
Query: 589 FGY--MAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKA 645
MAPE T ++DV+SFG++ EI + G S P E++F LL
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-------K 248
Query: 646 QGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+G ME N +E +M + C + RP+ +V L+
Sbjct: 249 EGYRME-----KPQNCTQELYHLMRD----CWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 73/200 (36%), Positives = 109/200 (54%), Gaps = 12/200 (6%)
Query: 426 DNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGC 485
D K+G+G FG V+ G T VA+K L + F+ E ++ L+H LV L+
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
E + ++ E+M SL L + LKL P + IA G+AY+ R+
Sbjct: 70 VSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKL--PQLVDMAAQIADGMAYIE---RMNY 123
Query: 546 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRGYLT 603
+HRD++A N+L+ +L KI+DFGLA+L EDN + + R F + APE A+ G T
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLI-EDNEY-TARQGAKFPIKWTAPEAALYGRFT 181
Query: 604 DKADVYSFGIVALEIVS-GR 622
K+DV+SFGI+ E+V+ GR
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 68/221 (30%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 428 KIGEGGFGPVYKGHM--ADG----------------TVVAVKQLSSK-SKQGNREFVNEI 468
K+GEG FG V H+ A+G +VAVK L + +K +F+ EI
Sbjct: 12 KLGEGQFGEV---HLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 469 GMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL-----ARALFGPEAHRLKLDWPTR 523
++S L++PN+++L G C+ + L +I EYMEN L R + H + +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 524 HRI---CVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNT 579
+ V IA G+ YL + L VHRD+ N L+ KI+DFG+++ L D
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
I R +MA E + G T +DV++FG+ E+ +
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI 487
+G+G FG VYK H G A K + +S++ +F+ EI ++S +HPN+V L+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 488 EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVH 547
N+L ++ E+ + +L + E L P +C + L +LH K++H
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 548 RDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD-- 604
RD+KA N+LL D + K++DFG+ AK T + GT +MAPE D
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVACETFKDNP 184
Query: 605 ---KADVYSFGIVALEIVSGR 622
KAD++S GI +E+
Sbjct: 185 YDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 429 IGEGGFGPVYKGHMA----DGTVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLH 483
IG G FG V++G + VA+K L + R +F++E ++ H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
G + ++I EYMEN +L + L + R GIA G+ YL S +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL---SDM 126
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG--YMAPEYAMRGY 601
VHRD+ A N+L++ +L K+SDFGL+++ E+D T G + APE
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 602 LTDKADVYSFGIVALEIVS 620
T +DV+SFGIV E++S
Sbjct: 187 FTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 428 KIGEGGFGPVYKGH------MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVK 481
++GEG FG V+ D +VAVK L + ++F E +++ LQH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHR----------ICVG 529
+G C +G+ L++++EYM++ L + L GP+A L P + + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGT 588
IA G+ YL + VHRD+ N L+ +L KI DFG+++ + D +
Sbjct: 132 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 589 FGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+M PE M T ++DV+SFG++ EI +
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 17/202 (8%)
Query: 429 IGEGGFGPVYKGHMA----DGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLH 483
IG G FG V +G + VA+K L S +++ R+F++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
G + +++I E+MEN +L L + + R GIA G+ YL E +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSE---M 125
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG-----YMAPEYAM 598
VHRD+ A N+L++ +L K+SDFGL++ E+D + T + G + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD-PTYTSSLGGKIPIRWTAPEAIA 184
Query: 599 RGYLTDKADVYSFGIVALEIVS 620
T +DV+S+GIV E++S
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 65/199 (32%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 429 IGEGGFGPVYKGHMA----DGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLH 483
IG G FG V G + VA+K L + +++ R+F++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
G + ++++ EYMEN SL L + + R GIA G+ YL S +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYL---SDM 125
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG--YMAPEYAMRGY 601
VHRD+ A N+L++ +L K+SDFGL+++ E+D T G + APE
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 602 LTDKADVYSFGIVALEIVS 620
T +DV+S+GIV E++S
Sbjct: 186 FTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 14/211 (6%)
Query: 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQ------LSSKSKQGNREFVNEIGMIS 472
NF + KIG+G F VYK + DG VVA+K+ + +K++Q + + EI ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57
Query: 473 ALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIAR 532
L HPN++K IE N+L ++ E + L+R + + + + T + V +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 533 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYM 592
L ++H + +I+HRDIK NV + K+ D GL + T + V GT YM
Sbjct: 118 ALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 173
Query: 593 APEYAMRGYLTDKADVYSFGIVALEIVSGRS 623
+PE K+D++S G + E+ + +S
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-23
Identities = 67/199 (33%), Positives = 104/199 (52%), Gaps = 18/199 (9%)
Query: 428 KIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI 487
IGEG FG V +G G VAVK + K + F+ E +++ L H NLV+L G I
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGV-I 68
Query: 488 EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVH 547
N L ++ E M +L F R + + + +A G+ YL ES+ K+VH
Sbjct: 69 LHNGLYIVMELMSKGNLVN--FLRTRGRALVSVIQLLQFSLDVAEGMEYL--ESK-KLVH 123
Query: 548 RDIKATNVLLDKDLNPKISDFGLAKLDEE--DNTHISTRVAGTFGYMAPEYAMRGYLTDK 605
RD+ A N+L+ +D K+SDFGLA++ DN+ + + + APE + K
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSK 177
Query: 606 ADVYSFGIVALEIVS-GRS 623
+DV+S+G++ E+ S GR+
Sbjct: 178 SDVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 67/229 (29%), Positives = 100/229 (43%), Gaps = 24/229 (10%)
Query: 427 NKIGEGGFGPVYKG---HMADGTV---VAVKQL-SSKSKQGNREFVNEIGMISALQHPNL 479
+G G FG VY+G V VAVK L S S+Q +F+ E ++S H N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHR------ICVGIARG 533
V+L G E ++ E M L L +R + + P+ +A+G
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFL---RENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 534 LAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAK-LDEEDNTHISTRVAGTF 589
YL EE+ +HRDI A N LL KI+DFG+A+ + R
Sbjct: 129 CKYL-EENHF--IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 590 GYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLL 637
+M PE + G T K DV+SFG++ EI S G + +++ +
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 6e-23
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 423 FAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSKQGN---REFVNEIGMISALQHPN 478
F +IG G FG VY VVA+K++S KQ N ++ + E+ + ++HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
++ GC + + L+ EY L A E H+ L I G +GLAYLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEY----CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 598
+ ++HRDIKA N+LL + K++DFG A + N+ + GT +MAPE +
Sbjct: 143 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVIL 194
Query: 599 ---RGYLTDKADVYSFGIVALEI 618
G K DV+S GI +E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 65/196 (33%), Positives = 105/196 (53%), Gaps = 12/196 (6%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
KIG+G G VY +A G VA+KQ++ + + +NEI ++ +HPN+V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
+ G++L ++ EY+ SL + +D +C + L +LH +++
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 547 HRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDK 605
HRDIK+ N+LL D + K++DFG A++ E + ST V GT +MAPE R K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMV-GTPYWMAPEVVTRKAYGPK 195
Query: 606 ADVYSFGIVALEIVSG 621
D++S GI+A+E+V G
Sbjct: 196 VDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 1e-22
Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 423 FAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGN---REFVNEIGMISALQHPN 478
F+ +IG G FG VY + + VVA+K++S KQ N ++ + E+ + L+HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
++ GC + + L+ EY L A E H+ L + G +GLAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEY----CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 598
+ ++HRD+KA N+LL + K+ DFG A + N + GT +MAPE +
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVIL 184
Query: 599 ---RGYLTDKADVYSFGIVALEI 618
G K DV+S GI +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 75/220 (34%), Positives = 110/220 (50%), Gaps = 18/220 (8%)
Query: 423 FAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN-EIGMISALQHPNLV 480
F +IG+G FG V+KG VVA+K + + + E + EI ++S P +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 481 KLHGCCIEGNQLLLIYEYMENNS---LARALFGPEAHRLKLDWPTRHRICVGIARGLAYL 537
K +G ++G +L +I EY+ S L RA GP D + I +GL YL
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GP------FDEFQIATMLKEILKGLDYL 117
Query: 538 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 597
H E K +HRDIKA NVLL + + K++DFG+A + +T V F +MAPE
Sbjct: 118 HSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVI 173
Query: 598 MRGYLTDKADVYSFGIVALEIVSGR-SNSSCKPKEDIFYL 636
+ KAD++S GI A+E+ G NS P +F +
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 3e-22
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 35/211 (16%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGN------REFVNEIGMISALQHPNL 479
N+IG G G VYK H G + A+K + GN R+ EI ++ + HPN+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVI-----YGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
VK H ++ ++ E+M+ SL E + R I G+AYLH
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV---ARQ-----ILSGIAYLH- 185
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY--- 596
R IVHRDIK +N+L++ N KI+DFG++++ + ++ V GT YM+PE
Sbjct: 186 --RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINT 242
Query: 597 -----AMRGYLTDKADVYSFGIVALEIVSGR 622
A GY D++S G+ LE GR
Sbjct: 243 DLNHGAYDGY---AGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 3e-22
Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 29/219 (13%)
Query: 428 KIGEGGFGPVY-----------KGHMA------DGTVVAVKQLSSKSKQGNR-EFVNEIG 469
K+GEG FG V+ + +VAVK L + + R +F+ EI
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 470 MISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALF-------GPEAHRLKLDWPT 522
++S L+ PN+++L CI + L +I EYMEN L + L +A + + + T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 523 RHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHI 581
+ IA G+ YL S L VHRD+ N L+ K+ KI+DFG+++ L D I
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
R +M+ E + G T +DV++FG+ EI++
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 66/203 (32%), Positives = 98/203 (48%), Gaps = 21/203 (10%)
Query: 429 IGEGGFGPVYKGHMAD-GTVVAVKQ-----LSSKSKQGNREFVNEIGMISALQHPNLVKL 482
+G+G FG VY + D G +AVKQ S ++K+ EI ++ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 483 HGCCIEGNQLLLIYEYMENNSLAR--ALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
+GC + L + EYM S+ +G + + TR I G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKY-TRQ-----ILEGVEYLH-- 121
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS--TRVAGTFGYMAPEYAM 598
IVHRDIK N+L D N K+ DFG +K + + + V GT +M+PE
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 599 -RGYLTDKADVYSFGIVALEIVS 620
GY KADV+S G +E+++
Sbjct: 181 GEGY-GRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 4e-22
Identities = 68/199 (34%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 427 NKIGEGGFGPVY-KGHMADGTVVAVKQLSSKSKQGN---REFVNEIGMISALQHPNLVKL 482
++IG G FG VY + VVAVK++S KQ N ++ + E+ + L+HPN ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
GC ++ + L+ EY L A E H+ L I G +GLAYLH +
Sbjct: 87 KGCYLKEHTAWLVMEY----CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN- 141
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM---R 599
++HRDIKA N+LL + K++DFG A N+ + GT +MAPE +
Sbjct: 142 --MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDE 194
Query: 600 GYLTDKADVYSFGIVALEI 618
G K DV+S GI +E+
Sbjct: 195 GQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 69/289 (23%), Positives = 123/289 (42%), Gaps = 51/289 (17%)
Query: 422 NFAPDNKIGEGGFGP--VYKGHMADGTVVAVKQ--LSSKSKQGNREFVNEIGMISALQHP 477
++ P +G+G FG +Y+ D ++V K+ L+ S++ R+ +NEI ++S LQHP
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 478 NLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICV--GIARGLA 535
N++ + ++ N LL+ EY +L + + + + I ++
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKI----VRQKGQLFEEEMVLWYLFQIVSAVS 115
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 595
Y+H+ I+HRDIK N+ L K K+ DFG++K+ + + T V GT YM+PE
Sbjct: 116 YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPE 171
Query: 596 YAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK---AQGNLMEL 652
K+D+++ G V E+ L LK N + L
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYEL----------------------LTLKRTFDATNPLNL 209
Query: 653 VDKRLGSN-------FDKEQVMVMINVALLCTDVSSTSRPSMSSVVSML 694
V K + N + E + ++ + RP+ V+
Sbjct: 210 VVKIVQGNYTPVVSVYSSELISLVHS----LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 65/224 (29%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQL---SSKSKQGNREFVN---EIGMISALQHPNLV 480
+G+G +G VY G G ++AVKQ+ +S +E+ E+ ++ +L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+ G C++ N + + E++ S++ L FGP L P + I G+AYLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGP------LPEPVFCKYTKQILDGVAYLH 119
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-----TRVAGTFGYMA 593
+VHRDIK NV+L + K+ DFG A+ H + + GT +MA
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 594 PEYAMRGYLTDKADVYSFGIVALEIVSGRSN-SSCKPKEDIFYL 636
PE K+D++S G E+ +G+ +S +FY+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI 220
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 4e-22
Identities = 68/230 (29%), Positives = 107/230 (46%), Gaps = 43/230 (18%)
Query: 428 KIGEGGFGPVY--------------------KGHMADGTVVAVKQL-SSKSKQGNREFVN 466
K+GEG FG V+ KG +VAVK L +K +F+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR---PLLVAVKILRPDANKNARNDFLK 68
Query: 467 EIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARAL---------------FGP 511
E+ ++S L+ PN+++L G C++ + L +I EYMEN L + L P
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 512 EAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571
+ + + + + IA G+ YL S L VHRD+ N L+ ++L KI+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 572 K-LDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+ L D I R +MA E + G T +DV++FG+ EI+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 429 IGEGGFGPVYKGH-MADGTVVAVKQLS----SKSKQGN--REFVNEIGMISALQHPNLVK 481
+G G F Y+ + GT++AVKQ++ + S+Q EI +++ L HP++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
+ G E + L E+M S++ L +G + + + RGL+YLHE
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII------NYTEQLLRGLSYLHE 121
Query: 540 ESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAKLDEEDNT---HISTRVAGTFGYMA 593
+I+HRD+K N+L+D + L +I+DFG A T ++ GT +MA
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 594 PEYAMRGYLTDKA-DVYSFGIVALEIVSGR 622
PE +RG ++ DV+S G V +E+ + +
Sbjct: 177 PE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 31/226 (13%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK--SKQGNREFVN-EIGMISAL-Q 475
++F IGEG F V A+K L + K+ ++V E +++ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 476 HPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLA 535
HP ++KL+ + L + EY N L + + LD I L
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLALE 116
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVA--------- 586
YLH I+HRD+K N+LLDKD++ KI+DFG AK+ + +++ S +
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 587 ----------GTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 622
GT Y++PE +D+++ G + ++++G+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 428 KIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI 487
++G G FG V G VA+K + S + EF+ E ++ L H LV+L+G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 488 EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVH 547
+ + ++ EYM N L L H + +C + G+AYL ES+ + +H
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYL--ESK-QFIH 123
Query: 548 RDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDK 605
RD+ A N L+D K+SDFGL++ LD+E + + ++ + PE + + K
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYSKFSSK 181
Query: 606 ADVYSFGIVALEIVS 620
+DV++FG++ E+ S
Sbjct: 182 SDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 7e-22
Identities = 63/195 (32%), Positives = 103/195 (52%), Gaps = 10/195 (5%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
KIG+G G V+ +A G VA+KQ++ + + +NEI ++ L++PN+V
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
+ G++L ++ EY+ SL + +D +C + L +LH +++
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 547 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKA 606
HRDIK+ NVLL D + K++DFG + + ST V GT +MAPE R K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 607 DVYSFGIVALEIVSG 621
D++S GI+A+E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 70/219 (31%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 428 KIGEGGFGPVY------------KGH----MADGTV-VAVKQL-SSKSKQGNREFVNEIG 469
K+GEG FG V+ K AD V VAVK L S +F+ E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 470 MISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHR-- 525
++S L PN+ +L G C L +I EYMEN L + L E L + +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 526 ---ICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHI 581
+ IA G+ YL L VHRD+ N L+ K+ KI+DFG+++ L D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
R +MA E + G T K+DV++FG+ EI++
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 9e-22
Identities = 67/206 (32%), Positives = 114/206 (55%), Gaps = 13/206 (6%)
Query: 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGN-REFVNEIGMISALQHPNL 479
NF K+GEG + VYKG + G +VA+K++ +++G + EI ++ L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
V+LH N+L+L++EYM+ + L + + R LD T + +G+A+ HE
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKD-LKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYAM 598
+++HRD+K N+L++K K++DFGLA+ NT + V T Y AP+ +
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLL 173
Query: 599 --RGYLTDKADVYSFGIVALEIVSGR 622
R Y T D++S G + E+++GR
Sbjct: 174 GSRTYST-SIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 13/200 (6%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQL--SSKSKQGNREFVNEIGMISALQHPNLVKLHG 484
+GEG +G V K + A G +VA+K+ S + + + E+ ++ L+H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+L L++EY+E L EA L + + +AY H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELL----EASPGGLPPDAVRSYIWQLLQAIAYCH---SHN 120
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYAMRGYLT 603
I+HRDIK N+L+ + K+ DFG A+ L + ++ VA T Y APE +
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTNY 179
Query: 604 DKA-DVYSFGIVALEIVSGR 622
K DV++ G + E++ G
Sbjct: 180 GKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 15/204 (7%)
Query: 429 IGEGGFGPVYKGHM------ADGTVVAVKQLSSKSKQG-NREFVNEIGMISALQHPNLVK 481
+G G FG V+ T+V VK L + EF E+ M L H N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWP---TRHR--ICVGIARGLAY 536
L G C E +I EY + L + L ++ KL P T+ + +C IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 596
L S + VHRD+ A N L+ K+S L+K + ++APE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 597 AMRGYLTDKADVYSFGIVALEIVS 620
+ K+DV+SFG++ E+ +
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 73/217 (33%), Positives = 109/217 (50%), Gaps = 12/217 (5%)
Query: 423 FAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN-EIGMISALQHPNLV 480
F +IG+G FG VYKG VVA+K + + + E + EI ++S P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
+ +G ++G +L +I EY+ S A L P L+ I I +GL YLH E
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS-ALDLLKPGP----LEETYIATILREILKGLDYLHSE 120
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 600
+ +HRDIKA NVLL + + K++DFG+A + +T V F +MAPE +
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQS 176
Query: 601 YLTDKADVYSFGIVALEIVSGR-SNSSCKPKEDIFYL 636
KAD++S GI A+E+ G NS P +F +
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 3e-21
Identities = 62/195 (31%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
KIG+G G VY +A G VA+KQ++ + + +NEI ++ ++PN+V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
+ G++L ++ EY+ SL + +D +C + L +LH +++
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 547 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKA 606
HRDIK+ N+LL D + K++DFG + + ST V GT +MAPE R K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 607 DVYSFGIVALEIVSG 621
D++S GI+A+E+V G
Sbjct: 197 DIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 3e-21
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 28/207 (13%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN--EIGMISALQ-HPNLVKLH 483
++G+G FG VY + G +VA+K++ K E +N E+ + L HPN+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLK 64
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHR--LKLDWPTRHRICVGIARGLAYLHEES 541
E ++L ++EYME N L+ R I I +GLA++H
Sbjct: 65 EVFRENDELYFVFEYMEGN-----LYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--- 116
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN-----THISTRVAGTFGYMAPEY 596
+ HRD+K N+L+ KI+DFGLA+ E + ++STR Y APE
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-----WYRAPEI 169
Query: 597 AMR-GYLTDKADVYSFGIVALEIVSGR 622
+R + D+++ G + E+ + R
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 4e-21
Identities = 74/293 (25%), Positives = 134/293 (45%), Gaps = 32/293 (10%)
Query: 410 SFTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIG 469
S T+ I ++ +N I G G YKG + V + + + ++G
Sbjct: 682 SITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMG 738
Query: 470 MISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVG 529
LQHPN+VKL G C LI+EY+E +L+ L L W R +I +G
Sbjct: 739 ---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIG 788
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 589
IA+ L +LH +V ++ +++D P + L L D +
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS----- 842
Query: 590 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY-----LLDWALILK 644
Y+APE +T+K+D+Y FG++ +E+++G+S + D + +++WA
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA------DAEFGVHGSIVEWARYCY 896
Query: 645 AQGNLMELVDKRLGSN--FDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ +L +D + + ++ +++ ++N+AL CT T+RP + V+ LE
Sbjct: 897 SDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-21
Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 428 KIGEGGFGPVYKGH-----MADGTVVAVKQLSS-KSKQGNREFVNEIGMISALQHPNLVK 481
++GE FG +YKGH M +VA+K L + Q EF E +++ L HPN+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAH-------------RLKLDWPTRHRICV 528
L G + + +++EY+ L L H + LD I +
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 529 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAG 587
IA G+ YL S VH+D+ A N+L+ + L+ KISD GL++ + D + +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 588 TFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+M PE M G + +D++SFG+V EI S
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 13/198 (6%)
Query: 427 NKIGEGGFGPVYKGHMAD-GTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGC 485
+K+G G +G VY+G VAVK L + + EF+ E ++ ++HPNLV+L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
C +I E+M +L L E +R +++ + I+ + YL E +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYL--EKK-NF 125
Query: 546 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT---FGYMAPEYAMRGYL 602
+HRD+ A N L+ ++ K++DFGL++L D T AG + APE
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 603 TDKADVYSFGIVALEIVS 620
+ K+DV++FG++ EI +
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 33/207 (15%)
Query: 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVN-----EIGMISALQ 475
+ K+GEG + VYK G +VA+K++ ++ ++ +N EI ++ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 476 HPNLVKLHGCCIEGNQLLLIYEYME--------NNSLARALFGPEAHRLKLDWPTRHRIC 527
HPN++ L + + L++E+ME + S+ + P A +K
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTP-AD-IK-------SYM 108
Query: 528 VGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG 587
+ RGL YLH I+HRD+K N+L+ D K++DFGLA+ N ++ +V
Sbjct: 109 LMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV- 164
Query: 588 TFGYMAPE--YAMRGYLTDKADVYSFG 612
T Y APE + R Y D++S G
Sbjct: 165 TRWYRAPELLFGARHY-GVGVDMWSVG 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 7e-21
Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 427 NKIGEGGFGPVYK-GHMADGTVVAVKQLSSKSKQG-NREFVNEIGMISALQHPNLVKLHG 484
+++GEG G V K G + A+K +++ ++ + E+ + + + P +VK +G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 485 CCIE--GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
++ + + + EY E SL + ++ +I + +GL+YLH
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-- 124
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG----YMAPEYAM 598
KI+HRDIK +N+LL + K+ DFG++ + +AGTF YMAPE
Sbjct: 125 -KIIHRDIKPSNILLTRKGQVKLCDFGVSG-------ELVNSLAGTFTGTSFYMAPERIQ 176
Query: 599 RGYLTDKADVYSFGIVALEIVSGR 622
+ +DV+S G+ LE+ R
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 12/202 (5%)
Query: 424 APDNKIGEGGFGPVYKG----HMADGTVVAVKQLSSKSKQGNRE-FVNEIGMISALQHPN 478
IGEG FG VY+G + VAVK + + RE F+ E ++ HP+
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+VKL G E N + ++ E L L + ++ LD + ++ LAYL
Sbjct: 69 IVKLIGVITE-NPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYL- 123
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 598
ES+ + VHRDI A NVL+ K+ DFGL++ E+++ + +++ +MAPE
Sbjct: 124 -ESK-RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 599 RGYLTDKADVYSFGIVALEIVS 620
T +DV+ FG+ EI+
Sbjct: 182 FRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 9e-21
Identities = 66/205 (32%), Positives = 108/205 (52%), Gaps = 29/205 (14%)
Query: 428 KIGEGGFGPVYKGHMAD-GTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
++G+G FG VYK + G + A K + +KS++ +++ EI +++ HP +VKL G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDW----PTRHRICVGIARGLAYLHEESR 542
+L ++ E+ ++ +A L+LD P IC + L YLH
Sbjct: 79 YWDGKLWIMIEFCPGGAV-------DAIMLELDRGLTEPQIQVICRQMLEALQYLHS--- 128
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLA----KLDEEDNTHISTRVAGTFGYMAPEYAM 598
+KI+HRD+KA NVLL D + K++DFG++ K + ++ I GT +MAPE M
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVM 183
Query: 599 RGYLTD-----KADVYSFGIVALEI 618
+ D KAD++S GI +E+
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 9e-21
Identities = 74/218 (33%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 423 FAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN-EIGMISALQHPNLV 480
F KIG+G FG V+KG VVA+K + + + E + EI ++S P +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
K +G ++ +L +I EY+ S A L P LD I I +GL YLH E
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGP----LDETQIATILREILKGLDYLHSE 120
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-TRVAGTFGYMAPEYAMR 599
+ +HRDIKA NVLL + K++DFG+A + +T I GT +MAPE +
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 600 GYLTDKADVYSFGIVALEIVSGR-SNSSCKPKEDIFYL 636
KAD++S GI A+E+ G +S P + +F +
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 58/196 (29%), Positives = 107/196 (54%), Gaps = 12/196 (6%)
Query: 428 KIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
KIGEG G V + + G +VAVK++ + +Q NE+ ++ QH N+V+++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
+ G++L ++ E++E +L + +++ +C+ + + L+ LH + ++
Sbjct: 87 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQG---VI 138
Query: 547 HRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDK 605
HRDIK+ ++LL D K+SDFG A++ +E S + GT +MAPE R +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPE 196
Query: 606 ADVYSFGIVALEIVSG 621
D++S GI+ +E+V G
Sbjct: 197 VDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 71/230 (30%), Positives = 105/230 (45%), Gaps = 37/230 (16%)
Query: 419 ATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQ-LSSKSKQGNREF----VNEIGMIS 472
++ K+GEG FG VYK + G VVA+K+ L K G F + EI ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62
Query: 473 ALQHPNLVKLHGCCIE-----GNQLLLIY---EYMENNSLARALFGPEAHRLKLDWPTRH 524
L+HPN+V L +E + +Y YM+++ L+ L P +KL
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHD-LSGLLENP---SVKLTESQIK 118
Query: 525 RICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED------- 577
+ + G+ YLHE I+HRDIKA N+L+D KI+DFGLA+ +
Sbjct: 119 CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 578 ---NTHISTRVAGTFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGR 622
T T + T Y PE + R Y T D++ G V E+ + R
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQ------LSSKSKQGNREFVNEIGMISAL 474
NF + KIG G F VY+ + DG VA+K+ + +K++ + + EI ++ L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 59
Query: 475 QHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGL 534
HPN++K + IE N+L ++ E + L+R + + + + T + V + L
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 535 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP 594
++H +++HRDIK NV + K+ D GL + T + V GT YM+P
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 595 EYAMRGYLTDKADVYSFGIVALEIVSGRS 623
E K+D++S G + E+ + +S
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 26/205 (12%)
Query: 429 IGEGGFGPVYKG-HMADGTV----VAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKL 482
+G G FG V+KG + +G VA+K + +S +Q +E + + + +L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 483 HGCCIEGNQLLLIYEYMENNSLA------RALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
G C G L L+ + SL R P+ L+W CV IA+G+ Y
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQ---RLLNW------CVQIAKGMYY 124
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPE 595
L E ++VHR++ A N+LL D +I+DFG+A L +D + + +MA E
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 596 YAMRGYLTDKADVYSFGIVALEIVS 620
+ G T ++DV+S+G+ E++S
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 2e-20
Identities = 59/196 (30%), Positives = 104/196 (53%), Gaps = 12/196 (6%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
KIG+G G VY +A G VA++Q++ + + +NEI ++ ++PN+V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
+ G++L ++ EY+ SL + +D +C + L +LH +++
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 547 HRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDK 605
HRDIK+ N+LL D + K++DFG A++ E + + + GT +MAPE R K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 196
Query: 606 ADVYSFGIVALEIVSG 621
D++S GI+A+E++ G
Sbjct: 197 VDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 428 KIGEGGFGPV-YKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
KIGEG G V G VAVK + + +Q NE+ ++ QH N+V+++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
+ G +L ++ E+++ +L + + +L+ +C + + L YLH + ++
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV-----SQTRLNEEQIATVCESVLQALCYLHSQG---VI 139
Query: 547 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKA 606
HRDIK+ ++LL D K+SDFG +D + V GT +MAPE R +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEV 198
Query: 607 DVYSFGIVALEIVSG 621
D++S GI+ +E+V G
Sbjct: 199 DIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 19/200 (9%)
Query: 428 KIGEGGFGPVYKGHMAD-GTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
++G+G FG VYK + G + A K + +KS++ +++ EI ++++ HPN+VKL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
N L ++ E+ ++ + E R L P +C L YLHE KI+
Sbjct: 72 YYENNLWILIEFCAGGAVDAVML--ELER-PLTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 547 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR---VAGTFGYMAPEYAMRGYLT 603
HRD+KA N+L D + K++DFG++ NT R GT +MAPE M
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 604 D-----KADVYSFGIVALEI 618
D KADV+S GI +E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 71/210 (33%), Positives = 105/210 (50%), Gaps = 28/210 (13%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCC 486
+G G +G VYKG H+ G + A+K + + E EI M+ H N+ +G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 487 IEGN------QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
I+ N QL L+ E+ S+ + + + LK +W IC I RGL++LH+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDE---EDNTHISTRVAGTFGYMAPEY 596
K++HRDIK NVLL ++ K+ DFG+ A+LD NT I GT +MAPE
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEV 182
Query: 597 AMRGYLTD-----KADVYSFGIVALEIVSG 621
D K+D++S GI A+E+ G
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 25/216 (11%)
Query: 422 NFAPDNKIGEGGFGPVYK--GHMADGTVVAVKQLS---------SKSKQGN-REFVNEIG 469
+A +G G FG VYK ++A+K+++ + + + + V+E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 470 MI-SALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARAL--FGPEAHRLKLD--WPTRH 524
+I L+HPN+V+ + +E ++L ++ + +E L + R + W
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW---- 116
Query: 525 RICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 584
I V + L YLH+E R IVHRD+ N++L +D I+DFGLAK + ++ T
Sbjct: 117 NIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTS 172
Query: 585 VAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
V GT Y PE +KADV++FG + ++ +
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 11/199 (5%)
Query: 429 IGEGGFGPVYKGHMAD-GTVVAVKQLSS---KSKQGNREFVNEIGMISALQHPNLVKLHG 484
+G+GGFG V + G + A K+L K ++G + +NE ++ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+ L L+ M L ++ I GL +LH+ +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIY--NVGEPGFPEARAIFYAAQIICGLEHLHQR---R 115
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
IV+RD+K NVLLD N +ISD GLA ++ + I R AGT GYMAPE
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKIKGR-AGTPGYMAPEVLQGEVYDF 173
Query: 605 KADVYSFGIVALEIVSGRS 623
D ++ G E+++GRS
Sbjct: 174 SVDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 5e-20
Identities = 68/202 (33%), Positives = 110/202 (54%), Gaps = 20/202 (9%)
Query: 429 IGEGGFGPVYKG-HMADGTVV----AVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKL 482
+G G FG VYKG + +G V A+K L+ + + N EF++E +++++ HP+LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPE---AHRLKLDWPTRHRICVGIARGLAYLHE 539
G C+ + L+ + M + L + + +L L+W CV IA+G+ YL E
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL-E 126
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT-FGYMAPEYAM 598
E RL VHRD+ A NVL+ + KI+DFGLA+L E D + +MA E
Sbjct: 127 ERRL--VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 599 RGYLTDKADVYSFGIVALEIVS 620
T ++DV+S+G+ E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 9e-20
Identities = 63/192 (32%), Positives = 107/192 (55%), Gaps = 5/192 (2%)
Query: 5 LKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGT 64
L+ +S+N +G+IPN I +++ L+ L + + LVG IP+ + +L+ L L ++
Sbjct: 142 LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLV 201
Query: 65 EAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLD 124
L +MK +K + L N+SG++P +G +TSL LD+ +N L G IPS+ L +
Sbjct: 202 GQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKN 261
Query: 125 VDYIYLTGNLLTGTIPP--WMLQKGDRVDLSYNSFTAGSSETSCQYRS---VNLFASSSK 179
+ Y++L N L+G IPP + LQK +DLS NS + E Q ++ ++LF+++
Sbjct: 262 LQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFT 321
Query: 180 GNNSTGIVSCLR 191
G + S R
Sbjct: 322 GKIPVALTSLPR 333
|
Length = 968 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 74/214 (34%), Positives = 109/214 (50%), Gaps = 23/214 (10%)
Query: 429 IGEGGFGPVY------KGHMADGTVVAVKQLSSKSKQGNR--EFVNEIGMISALQHPNLV 480
+GEG FG V +G G VAVK L +S GN + EI ++ L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIV 69
Query: 481 KLHGCCIE--GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
K G C E GN + LI E++ + SL L P ++ K++ + + V I +G+ YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PR-NKNKINLKQQLKYAVQICKGMDYLG 126
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---LDEEDNTHISTRVAGTFGYMAPE 595
SR + VHRD+ A NVL++ + KI DFGL K D+E T + F Y APE
Sbjct: 127 --SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APE 182
Query: 596 YAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKP 629
++ +DV+SFG+ E+++ +S P
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT-YCDSESSP 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 429 IGEGGFGPVYKGHMA--DGTV--VAVK--QLSSKSKQGNREFVNEIGMISALQHPNLVKL 482
+GEG FG V +G ++ DG+ VAVK +L + EF++E + HPN++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 483 HGCCIEGNQL------LLIYEYMENNSLARALFGPEAHRLKLDWPTRH--RICVGIARGL 534
G C E + L ++I +M++ L L L P + + V IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 535 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT-FGYMA 593
YL S +HRD+ A N +L +D+ ++DFGL+K + + R+A ++A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 594 PEYAMRGYLTDKADVYSFGIVALEIVS 620
E T K+DV++FG+ EI +
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 13/196 (6%)
Query: 429 IGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLHGCCI 487
+G+G FG V+KG + D T VAVK Q + +F++E ++ HPN+VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 488 EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRH--RICVGIARGLAYLHEESRLKI 545
+ + ++ E + L + K + T+ + + A G+AYL ES+
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL-----RKKKDELKTKQLVKFALDAAAGMAYL--ESK-NC 114
Query: 546 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT-FGYMAPEYAMRGYLTD 604
+HRD+ A N L+ ++ KISDFG+++ E+D + S+ + + APE G +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 605 KADVYSFGIVALEIVS 620
++DV+S+GI+ E S
Sbjct: 174 ESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 58/196 (29%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 428 KIGEGGFGPV-YKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
KIGEG G V G VAVK++ + +Q NE+ ++ H N+V ++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
+ G++L ++ E++E +L + +++ +C+ + R L+YLH + ++
Sbjct: 89 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQG---VI 140
Query: 547 HRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDK 605
HRDIK+ ++LL D K+SDFG A++ +E S + GT +MAPE R +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTE 198
Query: 606 ADVYSFGIVALEIVSG 621
D++S GI+ +E++ G
Sbjct: 199 VDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 81/290 (27%), Positives = 132/290 (45%), Gaps = 42/290 (14%)
Query: 429 IGEGGFGPVYKG-HMADG----TVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVKL 482
+G G FG VYKG + DG VA+K L + S + N+E ++E +++ + P + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 483 HGCCIEGNQLLLIYEYMENNSL---ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
G C+ + + L+ + M L R + L+W CV IA+G++YL E
Sbjct: 75 LGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLEE 127
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT-FGYMAPEYAM 598
+++VHRD+ A NVL+ + KI+DFGLA+L + D T +MA E +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 599 RGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657
T ++DV+S+G+ E+++ G P +I LL+ +RL
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG--------------ERL 230
Query: 658 GS--NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA-DVQDFV 704
+ M+M+ C + S RP +V A D FV
Sbjct: 231 PQPPICTIDVYMIMVK----CWMIDSECRPRFRELVDEFSRMARDPSRFV 276
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 34/208 (16%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLS-SKSKQGNREF-VNEIGM---ISALQHPNLV 480
+IGEG +G VYK + G VA+K++ S++G + EI + + + +HPN+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 481 KL----HGCCIEGN-QLLLIYEYMENNSLARAL-------FGPEAHRLKLDWPTRHRICV 528
+L HG + +L L++E+++ + LA L PE + R
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQD-LATYLSKCPKPGLPPE----TIKDLMRQ---- 115
Query: 529 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT 588
+ RG+ +LH +IVHRD+K N+L+ D KI+DFGLA++ T V T
Sbjct: 116 -LLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALTSVVVT 169
Query: 589 FGYMAPEYAMRGYLTDKADVYSFG-IVA 615
Y APE ++ D++S G I A
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFA 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 69/210 (32%), Positives = 113/210 (53%), Gaps = 24/210 (11%)
Query: 423 FAPDNKIGEGGFGPVYKG-HMADG----TVVAVKQL-SSKSKQGNREFVNEIGMISALQH 476
F +G G FG VYKG + +G VA+K+L + S + N+E ++E +++++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 477 PNLVKLHGCCIEGNQLLLIYEYMENNSL---ARALFGPEAHRLKLDWPTRHRICVGIARG 533
P++ +L G C+ + + LI + M L R + L+W CV IA+G
Sbjct: 69 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 534 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL---DEEDNTHISTRVAGTFG 590
+ YL EE RL VHRD+ A NVL+ + KI+DFGLAKL DE++ +V
Sbjct: 122 MNYL-EERRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP--IK 176
Query: 591 YMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+MA E + T ++DV+S+G+ E+++
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 71/210 (33%), Positives = 104/210 (49%), Gaps = 28/210 (13%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCC 486
+G G +G VYKG H+ G + A+K + + E EI M+ H N+ +G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 487 IE------GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
I+ +QL L+ E+ S+ + + + LK DW IC I RGLA+LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH 140
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDE---EDNTHISTRVAGTFGYMAPEY 596
K++HRDIK NVLL ++ K+ DFG+ A+LD NT I GT +MAPE
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEV 192
Query: 597 AMRGYLTD-----KADVYSFGIVALEIVSG 621
D ++D++S GI A+E+ G
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 37/212 (17%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGM---ISALQH--PNLVKL 482
IG G G VYK G V+AVKQ+ + GN+E I M + H P +VK
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 483 HGCCIEGNQLLLIYEYMEN--NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
+G I + + + E M + L + + GP + ++ V I + L YL E+
Sbjct: 80 YGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDI------LGKMTVAIVKALHYLKEK 133
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE----- 595
++HRD+K +N+LLD N K+ DFG++ + TR AG YMAPE
Sbjct: 134 H--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPP 189
Query: 596 -----YAMRGYLTDKADVYSFGIVALEIVSGR 622
Y +R ADV+S GI +E+ +G+
Sbjct: 190 DPNPKYDIR------ADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 67/196 (34%), Positives = 98/196 (50%), Gaps = 14/196 (7%)
Query: 429 IGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIE 488
IG+G FG V G G VAVK + K+ + F+ E +++ L+H NLV+L G +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 489 GN-QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVH 547
L ++ EYM SL L R L + + + + YL + VH
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125
Query: 548 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKAD 607
RD+ A NVL+ +D K+SDFGL K E +T + ++ + APE + K+D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSD 181
Query: 608 VYSFGIVALEIVS-GR 622
V+SFGI+ EI S GR
Sbjct: 182 VWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLS-SKSKQG-NREFVNEIGMISALQHPN 478
F N+IGEG +G VY+ G +VA+K++ + G + EI ++ L+HPN
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 479 LVKLHGCCIEGNQL---LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLA 535
+V+L + G L L+ EY E + LA L + + + + RGL
Sbjct: 68 IVELKE-VVVGKHLDSIFLVMEYCEQD-LASLL---DNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 595
YLHE I+HRD+K +N+LL KI+DFGLA+ ++ +V T Y APE
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPE 178
Query: 596 --YAMRGYLTDKADVYSFGIVALEIVSGR 622
Y T D+++ G + E+++ +
Sbjct: 179 LLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 67/213 (31%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 428 KIGEGGFGPVYKGHMADGT------VVAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLV 480
++GE FG VYKGH+ VA+K L K++ RE F +E M S LQHPN+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAH------------RLKLDWPTRHRICV 528
L G + L +I+ Y ++ L L H + L+ I
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 529 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAG 587
IA G+ +L S +VH+D+ NVL+ LN KISD GL + + D +
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 588 TFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+M+PE M G + +D++S+G+V E+ S
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 31/209 (14%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVKLHG 484
KIGEG +G VYK G +VA+K+ L ++ + + EI ++ L HPN+V+L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 485 CCIEGNQLLLIYEYMEN------NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
N+L L++E+++ +S P + L +++ +G+AY H
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYL-----YQLL----QGIAYCH 116
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---LDEEDNTHISTRVAGTFGYMAPE 595
S +++HRD+K N+L+D++ K++DFGLA+ + TH V T Y APE
Sbjct: 117 --SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPE 169
Query: 596 YAM--RGYLTDKADVYSFGIVALEIVSGR 622
+ R Y T D++S G + E+V+ R
Sbjct: 170 ILLGSRQYST-PVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 15/198 (7%)
Query: 429 IGEGGFGPVYK-GHMADGTVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLHGCC 486
+G G G V K H+ GTV+A K + +K R + + E+ ++ + P +V +G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 487 IEGNQLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+ N + + E+M+ SL R GP + ++ +I V + GL YL+ R
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGP----IPVE--ILGKIAVAVVEGLTYLYNVHR-- 124
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
I+HRDIK +N+L++ K+ DFG++ E N+ T V GT YM+PE G T
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVS--GELINSIADTFV-GTSTYMSPERIQGGKYTV 181
Query: 605 KADVYSFGIVALEIVSGR 622
K+DV+S GI +E+ G+
Sbjct: 182 KSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 7/193 (3%)
Query: 428 KIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI 487
++G G FG V+ G VA+K ++ + +F+ E ++ L HP LV+L+G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 488 EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVH 547
+ L ++ E+MEN L L + KL +C + G+ YL S +H
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 548 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKAD 607
RD+ A N L+ K+SDFG+ + +D S+ + PE + K+D
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 608 VYSFGIVALEIVS 620
V+SFG++ E+ +
Sbjct: 184 VWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 8e-19
Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 51/295 (17%)
Query: 429 IGEGGFGPVYKGHM-------ADGTV-VAVKQLSSKSKQGN-REFVNEIGMISAL-QHPN 478
+GEG FG V + D TV VAVK L + + + ++E+ ++ + +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSL-----AR-------ALFGPEAHRLKLDWPTRHRI 526
++ L G C + L +I EY +L AR + +L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 527 CVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVA 586
+ARG+ YL ESR + +HRD+ A NVL+ +D KI+DFGLA+ I
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDYYKK 192
Query: 587 GTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWA 640
+ G +MAPE T ++DV+SFGI+ EI + G S P E++F LL
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL--- 249
Query: 641 LILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+G+ M+ SN E M+M C T RP+ +V L+
Sbjct: 250 ----REGHRMD-----KPSNCTHELYMLMRE----CWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 8e-19
Identities = 57/205 (27%), Positives = 86/205 (41%), Gaps = 16/205 (7%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVA---VKQL-SSKSKQGNREFVNEIGMISALQHPNLVKL 482
++IG G FG V G G A VK+L +S + F+ E+ L HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAH-RLKLDWPTRHRICVGIARGLAYLHEES 541
G CIE LL+ E+ L L R+ +A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD-EEDNTHISTRVAGTFGYMAPEYA--- 597
+ +H D+ N L DL+ KI D+GLA ED A ++APE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 598 ----MRGYLTDKADVYSFGIVALEI 618
+ T K++++S G+ E+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 8e-19
Identities = 76/290 (26%), Positives = 122/290 (42%), Gaps = 40/290 (13%)
Query: 421 NNFAPDNKIGEGGFGPVYK------GHMADGTVVAVKQLSSKSKQGNRE-FVNEIGMISA 473
NN + +G G FG V + VAVK L + RE ++E+ ++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 474 L-QHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLK---LDWPTRHRICVG 529
L H N+V L G C G +L+I EY L L R + L
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-----RRKRESFLTLEDLLSFSYQ 149
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI---STRVA 586
+A+G+A+L ++ +HRD+ A NVLL KI DFGLA+ D+ ++ + R+
Sbjct: 150 VAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206
Query: 587 GTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKA 645
+MAPE T ++DV+S+GI+ EI S G + P + FY
Sbjct: 207 --VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY---------- 254
Query: 646 QGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
L++ + ++ ++ C D RP+ +V ++
Sbjct: 255 --KLIKEGYRMAQPEHAPAEIYDIMKT---CWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 64/199 (32%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 428 KIGEGGFGPVYKGHM-ADGTVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVKLHGC 485
+IG G FG V+ G + AD T VAVK + +F+ E ++ HPN+V+L G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
C + + ++ E ++ E RLK+ ++ A G+ YL ES+
Sbjct: 62 CTQKQPIYIVMELVQGGDF-LTFLRTEGPRLKVK--ELIQMVENAAAGMEYL--ESK-HC 115
Query: 546 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT----FGYMAPEYAMRGY 601
+HRD+ A N L+ + KISDFG+++ +EED + ST G + APE G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYAST--GGMKQIPVKWTAPEALNYGR 172
Query: 602 LTDKADVYSFGIVALEIVS 620
+ ++DV+SFGI+ E S
Sbjct: 173 YSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 69/205 (33%), Positives = 106/205 (51%), Gaps = 23/205 (11%)
Query: 429 IGEGGFGPVYKGHMADG----TVVAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLH 483
IG+G FG VY G + D AVK L+ + E F+ E ++ HPN++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 484 GCCI--EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPT-RHRICVG--IARGLAYLH 538
G C+ EG+ L+++ YM++ L R E H PT + I G +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVL-PYMKHGDL-RNFIRSETHN-----PTVKDLIGFGLQVAKGMEYLA 115
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEE-DNTHISTRVAGTFGYMAPE 595
+ K VHRD+ A N +LD+ K++DFGLA+ D+E + H T +MA E
Sbjct: 116 SK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 596 YAMRGYLTDKADVYSFGIVALEIVS 620
T K+DV+SFG++ E+++
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 64/209 (30%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQ--LSSKSKQGNREFVNEIGMISALQHPN 478
NF KIGEG +G VYK + G VVA+K+ L ++++ + EI ++ L HPN
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+VKL N+L L++E++ + L + + + L P + +GLA+ H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL--PLIKSYLFQLLQGLAFCH 117
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---LDEEDNTHISTRVAGTFGYMAPE 595
+++HRD+K N+L++ + K++DFGLA+ + TH V T Y APE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPE 170
Query: 596 YAM-RGYLTDKADVYSFGIVALEIVSGRS 623
+ Y + D++S G + E+V+ R+
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 87/298 (29%), Positives = 133/298 (44%), Gaps = 57/298 (19%)
Query: 429 IGEGGFGPVYKGHMADG-----------TVVAVKQLSSKSKQGN-REFVNEIGMISAL-Q 475
+GEG FG V MA+ T VAVK L S + + + + ++E+ M+ + +
Sbjct: 26 LGEGCFGQVV---MAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 476 HPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRH----------- 524
H N++ L G C + L +I EY +L L ++ +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 525 -RICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 583
+ARG+ YL + K +HRD+ A NVL+ +D KI+DFGLA+ D HI
Sbjct: 143 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDY 195
Query: 584 RVAGTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLL 637
T G +MAPE T ++DV+SFG++ EI + G S P E++F LL
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255
Query: 638 DWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+G+ M DK SN E M+M + C + RP+ +V L+
Sbjct: 256 K-------EGHRM---DKP--SNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 428 KIGEGGFGPVYKGHMADGTV-------VAVKQLSSKSKQGNR-EFVNEIGMISALQHPNL 479
++G+G FG VY+G +A G V VA+K ++ + R EF+NE ++ ++
Sbjct: 13 ELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSLA---RALFGPEAHRLKLDWPTRHRICV---GIARG 533
V+L G +G L+I E M L R+L + P+ ++ IA G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 534 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYM 592
+AYL+ K VHRD+ A N ++ +D KI DFG+ + + E D + +M
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 593 APEYAMRGYLTDKADVYSFGIVALEIVS 620
+PE G T +DV+SFG+V EI +
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 20/205 (9%)
Query: 429 IGEGGFGPVYK-GHMADGTVVAVKQL-SSKSKQGNREFVNE--IGMISALQHPNLVKLHG 484
+G G +G V K H+ GT++AVK++ ++ + Q + + + I M S P V +G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSV-DCPYTVTFYG 67
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEA--HRLKLDWPTRHRICVGIARGLAYLHEESR 542
+ + E M+ SL + F + L + +I V I + L YLH +
Sbjct: 68 ALFREGDVWICMEVMDT-SLDK--FYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--K 122
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-----YA 597
L ++HRD+K +NVL++++ K+ DFG++ ++ T AG YMAPE
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSVAKTIDAGCKPYMAPERINPELN 180
Query: 598 MRGYLTDKADVYSFGIVALEIVSGR 622
+GY K+DV+S GI +E+ +GR
Sbjct: 181 QKGYDV-KSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 7e-18
Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 429 IGEGGFGPVYKGHMA----DGTVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVKLH 483
+G G FG + +G + VA+ L + S + R F+ E + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
G GN ++++ EYM N +L L H +L + G+A G+ YL E +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYLSE---M 126
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLT 603
VH+ + A VL++ DL KIS F + D+ + + + + APE + +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 604 DKADVYSFGIVALEIVS 620
+DV+SFGIV E++S
Sbjct: 187 SASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 81/281 (28%), Positives = 131/281 (46%), Gaps = 41/281 (14%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQH-PNLVKLHGC 485
IG G FG V K H GT++AVK++ S ++ + + ++ ++ P +VK +G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 486 CI-EGNQLLLIYEYMENNSLARALFGPEAH-RLKLDWPTR--HRICVGIARGLAYLHEES 541
EG+ + ME ++ F + LK P +I V + L YL EE
Sbjct: 72 LFREGDCWIC----MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE- 126
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRVAGTFGYMAPE----Y 596
LKI+HRD+K +N+LLD++ N K+ DFG++ +L ++ TR AG YMAPE
Sbjct: 127 -LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERIDPS 182
Query: 597 AMRGYLTD-KADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD- 654
A GY D ++DV+S GI E+ +G+ F W + L ++V
Sbjct: 183 ARDGY--DVRSDVWSLGITLYEVATGK-----------FPYPKWNSVFD---QLTQVVKG 226
Query: 655 --KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693
L ++ ++E +N LC + RP ++
Sbjct: 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 9e-18
Identities = 83/292 (28%), Positives = 134/292 (45%), Gaps = 45/292 (15%)
Query: 429 IGEGGFGPVY--------KGHMADGTVVAVKQLSSKSKQGN-REFVNEIGMISAL-QHPN 478
+GEG FG V K + VAVK L + + + + V+E+ M+ + +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARAL---------FGPEAHRLKLDWPTRHRICVG 529
++ L G C + L +I EY +L L + + R+ D + V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP-DEQMTFKDLVS 141
Query: 530 ----IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTR 584
+ARG+ YL + K +HRD+ A NVL+ ++ KI+DFGLA+ ++ D +T
Sbjct: 142 CTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 585 VAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALIL 643
+MAPE T ++DV+SFG++ EI + G S P E++F LL
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK----- 253
Query: 644 KAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+G+ M DK +N E M+M + C + RP+ +V L+
Sbjct: 254 --EGHRM---DKP--ANCTNELYMMMRD----CWHAIPSHRPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 34/218 (15%)
Query: 426 DNKIGEGGFGPVYKGHMA-DGTVV--AVKQLSS-KSKQGNREFVNEIGMISAL-QHPNLV 480
++ IGEG FG V + + DG + A+K L S+ +R+F E+ ++ L HPN++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 481 KLHGCCIEGNQLLLIYEYMENNSL------ARAL-----FGPEAHRLKLDWPTRH--RIC 527
L G C L + EY +L +R L F E H ++ +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKE-HGTASTLTSQQLLQFA 125
Query: 528 VGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG 587
+A G+ YL E+ + +HRD+ A NVL+ ++L KI+DFGL++ +E V
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEE-------VYVKK 175
Query: 588 TFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
T G +MA E T K+DV+SFG++ EIVS
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 30/226 (13%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLS-SKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
+G G G VYK H+ ++AVK + + + ++ ++E+ ++ P ++ +G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
N++ + E+M+ SL PE RI V + +GL YL LKI+
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPE--------HVLGRIAVAVVKGLTYLWS---LKIL 117
Query: 547 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKA 606
HRD+K +N+L++ K+ DFG++ + I+ GT YMAPE +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 607 DVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652
DV+S GI +E+ GR + I K QG+LM L
Sbjct: 175 DVWSLGISFMELALGR--------------FPYPQIQKNQGSLMPL 206
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREF---VNEIGMISALQHPNLVKLHG 484
I +G +G V+ + G + A+K + + + E ++S Q P +VKL+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 485 CCIEGNQLLLIYEYMENNSLARAL--FG--PEAHRLKLDWPTRHRICVG-IARGLAYLHE 539
L L+ EY+ LA L G E RI + I L YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA---------RIYIAEIVLALEYLH- 110
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-------LDEEDNTHISTRVAGTFGYM 592
I+HRD+K N+L+D + + K++DFGL+K ++ D+ R+ GT Y+
Sbjct: 111 --SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 593 APEYAMRGYLTDKADVYSFGIVALEIVSG 621
APE + + D +S G + E + G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 428 KIGEGGFGPVYKGHMAD------GTVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLV 480
++G+G FG VY+G+ D T VAVK ++ + R EF+NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARAL--FGPEAH----RLKLDWPTRHRICVGIARGL 534
+L G +G L++ E M + L L PEA R ++ IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 535 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMA 593
AYL+ + K VHRD+ A N ++ D KI DFG+ + + E D + +MA
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 594 PEYAMRGYLTDKADVYSFGIVALEIVS 620
PE G T +D++SFG+V EI S
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 32/208 (15%)
Query: 428 KIGEGGFGPVY--KGHMADGTVVAVKQLS-----SKSKQGNREFVNEIGMISALQHPNLV 480
KIGEG FG +Y K +D +K++ K K+ ++ E+ +++ ++HPN+V
Sbjct: 7 KIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKMKHPNIV 62
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLAR-------ALFGPEAHRLKLDWPTRHRICVGIARG 533
E +L ++ EY + L + LF + L W V I+ G
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ---ILSW------FVQISLG 113
Query: 534 LAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLDEEDNTHISTRVAGTFGYM 592
L ++H+ KI+HRDIK+ N+ L K+ + K+ DFG+A+ D+ ++ GT Y+
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSMELAYTCVGTPYYL 169
Query: 593 APEYAMRGYLTDKADVYSFGIVALEIVS 620
+PE +K D++S G V E+ +
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVKLHG 484
KIGEG +G VYKG + G +VA+K+ L S+ + + EI ++ LQHPN+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 485 CCIEGNQLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
++ ++L LI+E++ + L + L + +D I +G+ + H
Sbjct: 67 VLMQESRLYLIFEFLSMD-LKKYLDSLPKGQY---MDAELVKSYLYQILQGILFCH---S 119
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV----AGTFGYMAPEYAM 598
+++HRD+K N+L+D K++DFGLA+ I RV T Y APE +
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLAR-----AFGIPVRVYTHEVVTLWYRAPEVLL 174
Query: 599 RG--YLTDKADVYSFGIVALEIVSGR 622
Y T D++S G + E+ + +
Sbjct: 175 GSPRYST-PVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 65/258 (25%), Positives = 105/258 (40%), Gaps = 51/258 (19%)
Query: 428 KIGEGGFGPVYKGHM---ADGTVVAVKQLSSKSKQG---NREFVNEIGMISALQHPNLVK 481
IG G +G VYK DG A+K+ +Q ++ EI ++ L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 482 LHGCCIEGNQ--LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
L +E + L+++Y E++ F +A R+ + + I G+ YLH
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 540 ESRLKIVHRDIKATNVLLDKDLNP----KISDFGLAK--------LDEEDNTHISTRVAG 587
++HRD+K N+L+ + KI D GLA+ L + D V
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD------PVVV 177
Query: 588 TFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGRSNSSCKPK-------------ED 632
T Y APE + R Y T D+++ G + E+++ + E
Sbjct: 178 TIWYRAPELLLGARHY-TKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236
Query: 633 IFYLL------DWALILK 644
IF +L DW I K
Sbjct: 237 IFEVLGTPTEKDWPDIKK 254
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 73/207 (35%), Positives = 105/207 (50%), Gaps = 35/207 (16%)
Query: 429 IGEGGFGPV----YKGHMADGTVVAVKQLSS----KSKQGNREFV-NEIGMISALQHPNL 479
+G G FG V +KG G A+K LS K KQ E V NE ++ +++HP L
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQ--VEHVLNEKRILQSIRHPFL 63
Query: 480 VKLHGCCIEGNQLLLIYEYM---ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
V L+G + + L L+ EY+ E S R + R + V +A L Y
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-----SGRFPEPVARFYAAQVVLA--LEY 116
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 596
LH L IV+RD+K N+LLD D KI+DFG AK + T+ + GT Y+APE
Sbjct: 117 LH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR-VKGRTYT---LCGTPEYLAPEI 169
Query: 597 AM-RGYLTDKA-DVYSFGIVALEIVSG 621
+ +GY KA D ++ GI+ E+++G
Sbjct: 170 ILSKGY--GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 32/208 (15%)
Query: 428 KIGEGGFGPVYK-GHMADGTVVAVKQL--SSKSKQGNREFVNEIGMISALQHPNLVKLHG 484
KIGEG +G V+K + G +VA+K+ S + + EI M+ L+HPNLV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+L L++EY ++ L E + + +I + + + H +
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNEL----EKNPRGVPEHLIKKIIWQTLQAVNFCH---KHN 120
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKL----DEEDNTHISTRVAGTFGYMAPE----- 595
+HRD+K N+L+ K K+ DFG A++ ++ +++TR Y APE
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPELLVGD 175
Query: 596 --YAMRGYLTDKADVYSFGIVALEIVSG 621
Y DV++ G V E+++G
Sbjct: 176 TQYG------PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 60/187 (32%), Positives = 89/187 (47%), Gaps = 29/187 (15%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQ-LSSKSKQGNREF----VNEIGMISALQHPNLV 480
KIG+G FG V+K H +VA+K+ L K+G F + EI ++ L+H N+V
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVV 74
Query: 481 KLHGCC----IEGN----QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIAR 532
L C N L++E+ E++ LA L +K ++ +
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLLSNK---NVKFTLSEIKKVMKMLLN 130
Query: 533 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL----DEEDNTHISTRVAGT 588
GL Y+H R KI+HRD+KA N+L+ KD K++DFGLA+ + RV T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186
Query: 589 FGYMAPE 595
Y PE
Sbjct: 187 LWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 56/206 (27%), Positives = 108/206 (52%), Gaps = 15/206 (7%)
Query: 421 NNFAPDNKIGEGGFGPVYK-GHMADGTVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPN 478
++F +++G G G V K H G ++A K + + K R + + E+ ++ P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+V +G ++ + E+M+ SL + L EA R+ + ++ + + RGLAYL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEE--ILGKVSIAVLRGLAYLR 120
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAPEY 596
E+ +I+HRD+K +N+L++ K+ DFG++ +D N+ + TR YM+PE
Sbjct: 121 EKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPER 173
Query: 597 AMRGYLTDKADVYSFGIVALEIVSGR 622
+ + ++D++S G+ +E+ GR
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ----HPNLVK 481
KIGEG F V K G A+K + K + E VN + I AL+ HPN+++
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 482 LHGCCIE--GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
L + +L L++E M+ N L + G + L + + L ++H
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMN-LYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMH- 117
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNT-HISTRVAGTFGYMAPEY 596
R I HRDIK N+L+ D+ K++DFG + + T +ISTR Y APE
Sbjct: 118 --RNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTR-----WYRAPEC 169
Query: 597 AMR-GYLTDKADVYSFGIVALEIVS 620
+ GY K D+++ G V EI+S
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQ------LSSKSKQGNREFVNEIGMISAL 474
NF + KIG G F VY+ + D VA+K+ + +K++Q + V EI ++ L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQL 59
Query: 475 QHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGL 534
HPN++K IE N+L ++ E + L++ + + + + T + V + +
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 535 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP 594
++H SR +++HRDIK NV + K+ D GL + T + V GT YM+P
Sbjct: 120 EHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 595 EYAMRGYLTDKADVYSFGIVALEIVSGRS 623
E K+D++S G + E+ + +S
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 13/197 (6%)
Query: 429 IGEGGFGPVY--KGHMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHG 484
+G G FG V+ + AD +V +KQ+ + +K NE ++ L HPN+++ +
Sbjct: 8 VGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+E L+++ EY +LA + + LD T V I L ++H +
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVHTK---L 121
Query: 545 IVHRDIKATNVLLDKDLNP-KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLT 603
I+HRD+K N+LLDK KI DFG++K + + V GT Y++PE
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 604 DKADVYSFGIVALEIVS 620
K+D+++ G V E+ S
Sbjct: 180 QKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 9e-17
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 34/215 (15%)
Query: 429 IGEGGFGPVYKGHMA-DGTVV--AVKQLSS-KSKQGNREFVNEIGMISAL-QHPNLVKLH 483
IGEG FG V K + DG + A+K++ SK +R+F E+ ++ L HPN++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 484 GCCIEGNQLLLIYEYMENNSL------ARAL-----FGPEAHRLKLDWPTRH--RICVGI 530
G C L L EY + +L +R L F + ++ +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA-NSTASTLSSQQLLHFAADV 121
Query: 531 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 590
ARG+ YL ++ + +HRD+ A N+L+ ++ KI+DFGL++ E V T G
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTMG 171
Query: 591 -----YMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+MA E T +DV+S+G++ EIVS
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 428 KIGEGGFGPVYKG--HMADGTV-VAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLH 483
++G G FG V KG M + VA+K L +++++ R E + E ++ L +P +V++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICV---GIARGLAYLHEE 540
G C E L+L+ E L + L G K D T + ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSG------KKDEITVSNVVELMHQVSMGMKYLEGK 114
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAM 598
+ VHRD+ A NVLL KISDFGL+K D+++ R AG + + APE
Sbjct: 115 N---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 599 RGYLTDKADVYSFGIVALEIVS 620
+ ++DV+S+GI E S
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 70/233 (30%), Positives = 105/233 (45%), Gaps = 27/233 (11%)
Query: 429 IGEGGFGPVY--------KGHMADGTVVAVKQLSSKSKQGN-REFVNEIGMISAL-QHPN 478
+GEG FG V K VAVK L + + + V+E+ M+ + +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFG--PEAHRLKLD---WPTRHRIC------ 527
++ L G C + L ++ EY +L L P D P
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 528 -VGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRV 585
+ARG+ YL + K +HRD+ A NVL+ +D KI+DFGLA+ + D +T
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 586 AGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLL 637
+MAPE T ++DV+SFG++ EI + G S P E++F LL
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 428 KIGEGGFG-PVYKGHMADGTVVAVKQL--SSKSKQGNREFVNEIGMISALQHPNLVKLHG 484
KIGEG FG + DG +K++ S S + E E+ ++S ++HPN+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 485 CCIEGNQLLLIYEYMENNSL------ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
E L ++ +Y E L R + PE LDW V I L ++H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPE--DQILDW------FVQICLALKHVH 118
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 598
+ KI+HRDIK+ N+ L KD K+ DFG+A++ ++ GT Y++PE
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPEICE 174
Query: 599 RGYLTDKADVYSFGIVALEIVS 620
+K+D+++ G V E+ +
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 428 KIGEGGFGPVYK-GHMADGTVVAVKQL--SSKSKQGNREFVNEIGMISALQHPNLVKLHG 484
+GEG +G V K H G +VA+K+ S K + + EI M+ L+H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+L L++E++++ L E + LD + I RG+ + H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
I+HRDIK N+L+ + K+ DFG A+ + VA T Y APE +
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-TRWYRAPELLVGDTKYG 179
Query: 605 KA-DVYSFGIVALEIVSG 621
+A D+++ G + E+++G
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 70/221 (31%), Positives = 104/221 (47%), Gaps = 17/221 (7%)
Query: 413 LRQIKAATNNFAPDNKIGEGGFGPVYK-GHMADGTVVAVKQLSSKSKQGNREFVNEIGMI 471
L + T+ + IG+G +G VYK + DG++ AVK L S + E E ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNIL 72
Query: 472 SAL-QHPNLVKLHGCCIE-----GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHR 525
+L HPN+VK +G + G QL L+ E S+ + G +LD
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 526 ICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV 585
I G GL +LH +I+HRD+K N+LL + K+ DFG++ +T V
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 586 AGTFGYMAPEY----AMRGYLTD-KADVYSFGIVALEIVSG 621
GT +MAPE Y D + DV+S GI A+E+ G
Sbjct: 190 -GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 35/232 (15%)
Query: 429 IGEGGFGPVY---KGHMAD-GTVVAVKQLSSKSKQGNREFV---NEIGMISALQHPNLVK 481
+G+G FG V+ K D G + A+K L K+ R+ V E +++ + HP +VK
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLK-KATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 482 LHGCCIEGNQLLLIYEYMENNSL-----ARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
LH +L LI +++ L +F E + L +A L +
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL---------AELALALDH 113
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAP 594
LH L I++RD+K N+LLD++ + K++DFGL+K +D E + GT YMAP
Sbjct: 114 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAP 167
Query: 595 EYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ 646
E R T AD +SFG++ E+++G K +++ +ILKA+
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM-----TMILKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 428 KIGEGGFGPVYKGHMADG---TVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVKLH 483
+IG G FG V G + G V VK+L S S Q +F+ E +LQH NL++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPE-AHRLKLDWPTRHRICVGIARGLAYLHEESR 542
G C E LL+ E+ L L A + D T R+ IA GL +LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLD-EEDNTHISTRVAGTFGYMAPEYA--MR 599
+H D+ N LL DL KI D+GL+ +ED ++ ++APE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 600 GYL-----TDKADVYSFGIVALEI 618
G L T +++V+S G+ E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 10/148 (6%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVK--QLSSKSKQGNREFVNEIGMISALQHPNLVKLHG 484
KIGEG +G V+K + +VA+K +L + + EI ++ L+H N+V+L+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+L L++EY + + L + ++ +D + +GLA+ H
Sbjct: 67 VLHSDKKLTLVFEYCDQD-LKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAK 572
++HRD+K N+L++K+ K++DFGLA+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-16
Identities = 57/206 (27%), Positives = 104/206 (50%), Gaps = 17/206 (8%)
Query: 429 IGEGGFGPVYKGHM-ADGTV--VAVK--QLSSKSKQGNREFVNEIGMISALQHPNLVKLH 483
+GEG FG V +G + D ++ VAVK +++ ++ +F++E + HPN+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 484 GCCIEGNQL------LLIYEYMENNSLARALFGPEAHRLKLDWPTRH--RICVGIARGLA 535
G C++ + ++I +M++ L L PT+ + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT-FGYMAP 594
YL S +HRD+ A N +L++++N ++DFGL+K + + R+A ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 595 EYAMRGYLTDKADVYSFGIVALEIVS 620
E T K+DV+SFG+ EI +
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 36/213 (16%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLS-SKSKQGNREF----VNEIGMISALQHPNLV 480
N+I EG +G VY+ G +VA+K+L K K+G F + EI ++ LQHPN+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIV 67
Query: 481 KLH----GCCIEGNQLLLIYEYMEN------NSLARALFGPEAHRLKLDWPTRHRICVGI 530
+ G + +++ ++ EY+E+ ++ + E L L +
Sbjct: 68 TVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQ----------L 115
Query: 531 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 590
G+A+LH+ I+HRD+K +N+LL+ KI DFGLA+ + T++ T
Sbjct: 116 LSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQLVVTLW 171
Query: 591 YMAPEYAM-RGYLTDKADVYSFGIVALEIVSGR 622
Y APE + + D++S G + E+++ +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 32/214 (14%)
Query: 429 IGEGGFGPVYKGHM-ADGTVV--AVKQLSS-KSKQGNREFVNEIGMISAL-QHPNLVKLH 483
IGEG FG V K + DG + A+K++ SK +R+F E+ ++ L HPN++ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 484 GCCIEGNQLLLIYEYMENNSL------ARAL-FGPE---AHRLKLDWPTRHRI--CVGIA 531
G C L L EY + +L +R L P A+ ++ + +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 532 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG- 590
RG+ YL S+ + +HRD+ A N+L+ ++ KI+DFGL++ E V T G
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTMGR 184
Query: 591 ----YMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+MA E T +DV+S+G++ EIVS
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 72/205 (35%), Positives = 108/205 (52%), Gaps = 23/205 (11%)
Query: 429 IGEGGFGPVYKGHMAD-GTVVAVKQL--SSKSKQGNREFVN----EIGMISALQHPNLVK 481
+G G FG VY + AD G +AVKQ+ S++ ++E VN EI ++ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68
Query: 482 LHGCC--IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
+GC E +L + EYM S+ L +A+ + TR R I +G++YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTR-RYTRQILQGVSYLHS 124
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE---DNTHISTRVAGTFGYMAPEY 596
IVHRDIK N+L D N K+ DFG +K + T I + V GT +M+PE
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEV 180
Query: 597 -AMRGYLTDKADVYSFGIVALEIVS 620
+ GY KADV+S +E+++
Sbjct: 181 ISGEGY-GRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 428 KIGEGGFGPVYKGHMADGTVVA---VKQL--SSKSKQGNREFVNEIGMISALQHPNLVKL 482
+IG G FG V + T VA VK+L ++ SK+ N EF+ + LQHPN+++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN-EFLQQGDPYRILQHPNILQC 60
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
G C+E LL++EY E L L + HR R+ IA G+ ++H +
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLD-EEDNTHISTRVAGTFGYMAPEY--AMR 599
+H D+ N L DL K+ D+G+ +ED ++APE
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 600 GYL-----TDKADVYSFGIVALEI 618
G L T ++V++ G+ E+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQG-NREFVNEIGMISALQHPNLVKLHGC 485
K+GEG + VYKG +G +VA+K +S K+++G + E ++ L+H N+V LH
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 486 CIEGNQLLLIYEYMENNSLARALF----GPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
L ++EYM + LA+ + G + ++L + RGLAY+H
Sbjct: 72 IHTKETLTFVFEYMHTD-LAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYIH--- 120
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG- 600
I+HRD+K N+L+ K++DFGLA+ + S+ V T Y P+ +
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGAT 179
Query: 601 -YLTDKADVYSFGIVALEIVSGR 622
Y + D++ G + +E++ G+
Sbjct: 180 DYSSA-LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 67/219 (30%), Positives = 104/219 (47%), Gaps = 41/219 (18%)
Query: 425 PDNKIGEGGFGPVYK-GHMADGTVVAVKQL--------SSKSKQGNREFVNEIGMISALQ 475
PD IG G FG V+ DG VA+K++ S K R F E+ M+ +
Sbjct: 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCK-----RVF-RELKMLCFFK 57
Query: 476 HPNLVKL-------HGCCIEGNQLLLIYEYMENNSLARALFGPE---AHRLKLDWPTRHR 525
H N++ H E ++ ++ E M+++ L + + P+ + +K+
Sbjct: 58 HDNVLSALDILQPPHIDPFE--EIYVVTELMQSD-LHKIIVSPQPLSSDHVKV------- 107
Query: 526 ICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV 585
I RGL YLH I+HRDIK N+L++ + KI DFGLA+++E D + T+
Sbjct: 108 FLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE 164
Query: 586 AGTFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGR 622
T Y APE M R Y T D++S G + E++ R
Sbjct: 165 VVTQYYRAPEILMGSRHY-TSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 422 NFAPDNKIGEGGFGPVY----KGHMADGTVVAVKQLSSKS---KQGNREFV-NEIGMISA 473
NF +G G +G V+ G G + A+K L + K E E ++ A
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 474 LQH-PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVG-IA 531
++ P LV LH +L LI +Y+ L L+ E + R+ + I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE-----SEVRVYIAEIV 115
Query: 532 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL---DEEDNTHISTRVAGT 588
L +LH+ L I++RDIK N+LLD + + ++DFGL+K +EE+ + GT
Sbjct: 116 LALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGT 169
Query: 589 FGYMAPEYAMRGYLT-DKA-DVYSFGIVALEIVSGRS 623
YMAPE G DKA D +S G++ E+++G S
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 68/256 (26%), Positives = 118/256 (46%), Gaps = 21/256 (8%)
Query: 427 NKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLHG 484
K+GEG + V+KG +VA+K++ + ++G + E+ ++ L+H N+V LH
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 485 CCIEGNQLLLIYEYMENNSLARALFG----PEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
L L++EY++ + L + + H +K+ I RGLAY H
Sbjct: 72 IVHTDKSLTLVFEYLDKD-LKQYMDDCGNIMSMHNVKI-------FLYQILRGLAYCH-- 121
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-R 599
R K++HRD+K N+L+++ K++DFGLA+ S V T Y P+ +
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGS 179
Query: 600 GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL--MELVDKRL 657
+ + D++ G + E+ SGR ED +L+ L + + D+
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239
Query: 658 GSNFDKEQVMVMINVA 673
NF K + +IN A
Sbjct: 240 NYNFPKYKPQPLINHA 255
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 29/211 (13%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLH 483
+ IGEG +G V H G VA+K++S Q R + EI ++ +H N++ +
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHENIIGIL 69
Query: 484 GCCIEG-----NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICV---GIARGLA 535
N + ++ E ME + L + + + L D H I I RGL
Sbjct: 70 DIIRPPSFESFNDVYIVQELMETD-LYKLI---KTQHLSND----H-IQYFLYQILRGLK 120
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD--EEDNTHISTRVAGTFGYMA 593
Y+H + ++HRD+K +N+LL+ + + KI DFGLA++ E D+T T T Y A
Sbjct: 121 YIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 594 PEYAM--RGYLTDKADVYSFGIVALEIVSGR 622
PE + +GY T D++S G + E++S R
Sbjct: 178 PEIMLNSKGY-TKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 429 IGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHG 484
+G+GGFG V + A G + A K+L K ++G +NE ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRI--CVGIARGLAYLHEESR 542
+ L L+ M L ++ H + + + I GL LH+E
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIY----HMGEAGFEEGRAVFYAAEICCGLEDLHQE-- 121
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYL 602
+IV+RD+K N+LLD + +ISD GLA E T I RV GT GYMAPE
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERY 178
Query: 603 TDKADVYSFGIVALEIVSGRS 623
T D ++ G + E+++G+S
Sbjct: 179 TFSPDWWALGCLLYEMIAGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 429 IGEGGFGPV-YKGHMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLV----K 481
+G+G +G V H DG +K+L+ + S++ + E ++S L+HPN+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLK----LDWPTRHRICVGIARGLAYL 537
G E L ++ + E L L + L ++W V IA L YL
Sbjct: 68 WEG---EDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQYL 118
Query: 538 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 597
HE+ I+HRD+K NV L + K+ D G+A++ E ST + GT YM+PE
Sbjct: 119 HEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELF 174
Query: 598 MRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY 635
K+DV++ G E+ + + + K + Y
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 428 KIGEGGFGPVYKG--HMADGT-VVAVKQLSSKSKQG--NREFVNEIGMISALQHPNLVKL 482
++G G FG V KG M VAVK L + + E + E ++ L +P +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
G C E +L+ E E L + L + K H++ +G + YL E +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKYLEETN- 115
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMRG 600
VHRD+ A NVLL KISDFGL+K D + + G + + APE
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 601 YLTDKADVYSFGIVALEIVS 620
+ K+DV+SFG++ E S
Sbjct: 174 KFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-15
Identities = 64/198 (32%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKS---KQGNREFVNEIG-MISALQHPNLVKLH 483
IG+G FG V H A+ AVK L K+ K+ + ++E ++ ++HP LV LH
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
++L + +Y+ L L + R L+ P IA L YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL---QRERCFLE-PRARFYAAEIASALGYLHS---L 115
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLT 603
IV+RD+K N+LLD + ++DFGL K + E N ST GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQPYD 174
Query: 604 DKADVYSFGIVALEIVSG 621
D + G V E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 428 KIGEGGFGPVY----KGHMADGTVVAVKQLSSKSKQGNREFVN---EIGMISALQHPNLV 480
++G+G FG VY K +A+ + +K++ N E V E ++S L HP +V
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPN-ETVQANQEAQLLSKLDHPAIV 65
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
K H +E + +I EY E L L + L + + G+ Y+H+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-YAMR 599
+I+HRD+KA N+ L +L KI DFG+++L + ++T GT YM+PE +
Sbjct: 126 ---RILHRDLKAKNIFLKNNL-LKIGDFGVSRL-LMGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 600 GYLTDKADVYSFGIVALEI 618
GY + K+D++S G + E+
Sbjct: 181 GYDS-KSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 65/200 (32%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIG----MISALQHPNLVKLH 483
IG+G FG V H ADG AVK L K+ +E + + ++ ++HP LV LH
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVG-IARGLAYLHEESR 542
++L + +Y+ L L R + R R IA L YLH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHL-----QRERSFPEPRARFYAAEIASALGYLHS--- 114
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYL 602
L I++RD+K N+LLD + ++DFGL K E + ST GT Y+APE +R
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPE-VLRKQP 172
Query: 603 TDKA-DVYSFGIVALEIVSG 621
D+ D + G V E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 69/206 (33%), Positives = 107/206 (51%), Gaps = 21/206 (10%)
Query: 429 IGEGGFGPVYKGHMAD-GTVVAVKQLS--SKSKQGNREFVN---EIGMISALQHPNLVKL 482
+G+G FG VY + D G +A KQ+ +S + ++E EI ++ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 483 HGCCIE-GNQLLLIY-EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
+GC + + L I+ EYM S+ L +A+ + TR + I G++YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTR-KYTRQILEGMSYLHSN 125
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE---DNTHISTRVAGTFGYMAPEY- 596
IVHRDIK N+L D N K+ DFG +K + T I + V GT +M+PE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPEVI 181
Query: 597 AMRGYLTDKADVYSFGIVALEIVSGR 622
+ GY KADV+S G +E+++ +
Sbjct: 182 SGEGY-GRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGN-REFVNEIGMISALQHPNLVKLHG 484
+++G+G +G VYK H G +A+K++ + + + + E+ ++ P +V +G
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+ + EYM+ SL + L+ + RI + +GL +L EE
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY------AM 598
I+HRD+K TNVL++ + K+ DFG++ ++ G YMAPE
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 599 RGYLTDKADVYSFGIVALEIVSGR 622
T ++DV+S G+ LE+ GR
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 28/208 (13%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVKLHG 484
KIGEG +G VYK +A+K+ L + + + EI ++ +QH N+V+L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRIC----VGIARGLAYLHEE 540
+L L++EY++ + P D+ R+ I RG+AY H
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSP-------DFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 541 SRLKIVHRDIKATNVLLDKDLNP-KISDFGLAK---LDEEDNTHISTRVAGTFGYMAPEY 596
+++HRD+K N+L+D+ N K++DFGLA+ + TH T Y APE
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAPEI 174
Query: 597 AM--RGYLTDKADVYSFGIVALEIVSGR 622
+ R Y T D++S G + E+V+ +
Sbjct: 175 LLGSRHYST-PVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 20/199 (10%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
++G G +G VYK ++ G + AVK + + EI M+ +H N+V G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 487 IEGNQLLLIYEYMENNSLARA--LFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+ +L + EY SL + GP + L++ + +C +GLAYLH + ++
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSE-LQIAY-----VCRETLQGLAYLHSKGKM- 128
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVA--GTFGYMAPEYAM---R 599
HRDIK N+LL + + K++DFG+A + I+ R + GT +MAPE A
Sbjct: 129 --HRDIKGANILLTDNGDVKLADFGVAA---KITATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 600 GYLTDKADVYSFGIVALEI 618
G D+++ GI A+E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 23/205 (11%)
Query: 427 NKIGEGGFGPVYKGH--MADGTVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLH 483
+K+GEG + VYKG + D +VA+K++ + ++G + E+ ++ L+H N+V LH
Sbjct: 12 DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFG----PEAHRLKLDWPTRHRICVGIARGLAYLHE 539
L L++EY++ + L + L H +KL + RGL Y H
Sbjct: 71 DIIHTEKSLTLVFEYLDKD-LKQYLDDCGNSINMHNVKL-------FLFQLLRGLNYCH- 121
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 599
R K++HRD+K N+L+++ K++DFGLA+ S V T Y P+ +
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLG 178
Query: 600 G--YLTDKADVYSFGIVALEIVSGR 622
Y T + D++ G + E+ +GR
Sbjct: 179 STDYST-QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 53/222 (23%)
Query: 429 IGEGGFGPVYKGHMAD-GTVVAVKQLSSKSKQGNREFVN---------EIGMISALQHPN 478
IG G +G V G VA+K++ + F + EI ++ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 479 LVKLHGCCI-----EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRH--RICVGIA 531
++ L + N + ++ E ME + L + + P L D H I
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETD-LHKVIKSP--QPLTDD----HIQYFLYQIL 113
Query: 532 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-------TR 584
RGL YLH ++HRD+K +N+L++ + + KI DFGLA+ + D TR
Sbjct: 114 RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 585 VAGTFGYMAPE--YAMRGYLTDKA-DVYSFG-IVALEIVSGR 622
Y APE + Y KA D++S G I A E+++ +
Sbjct: 171 W-----YRAPELLLSSSRY--TKAIDIWSVGCIFA-ELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 429 IGEGGFGPVYKGHMAD-GTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHG 484
+G+GGFG V + + G + A K+L K K G + + E ++ + P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRI---CVGIARGLAYLHEES 541
L L+ M L ++ L+++ R+ I G+ +LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME-----RVIHYSAQITCGILHLHS-- 113
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGY 601
+ IV+RD+K NVLLD N ++SD GLA ++ +D I+ R AGT GYMAPE
Sbjct: 114 -MDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTITQR-AGTNGYMAPEILKEEP 170
Query: 602 LTDKADVYSFGIVALEIVSGRS 623
+ D ++ G E+V+GR+
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRT 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 56/198 (28%), Positives = 101/198 (51%), Gaps = 15/198 (7%)
Query: 429 IGEGGFGPVYK-GHMADGTVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLHGCC 486
+G G G V K H G ++A K + + K R + + E+ ++ P +V +G
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
++ + E+M+ SL + L +A R+ +I + + RGL YL E+ KI+
Sbjct: 69 YSDGEISICMEHMDGGSLDQVL--KKAGRIP--ENILGKISIAVLRGLTYLREK--HKIM 122
Query: 547 HRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
HRD+K +N+L++ K+ DFG++ +D N+ + TR YM+PE + T
Sbjct: 123 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQGTHYTV 177
Query: 605 KADVYSFGIVALEIVSGR 622
++D++S G+ +E+ GR
Sbjct: 178 QSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 480
+F +IG G +G VYK ++ G + A+K + + + EI M+ +H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARA--LFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
G + ++L + E+ SL + GP + ++ + +R + +GL YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSE-SQIAYVSRETL-----QGLYYLH 123
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVA------GTFGYM 592
+ ++ HRDIK N+LL + + K++DFG++ I+ +A GT +M
Sbjct: 124 SKGKM---HRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWM 173
Query: 593 APEYAM---RGYLTDKADVYSFGIVALEI 618
APE A +G D+++ GI A+E+
Sbjct: 174 APEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 55/208 (26%), Positives = 109/208 (52%), Gaps = 19/208 (9%)
Query: 421 NNFAPDNKIGEGGFGPVYK-GHMADGTVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPN 478
++F +++G G G V+K H G ++A K + + K R + + E+ ++ P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTR--HRICVGIARGLAY 536
+V +G ++ + E+M+ SL + L +A R+ P + ++ + + +GL Y
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRI----PEQILGKVSIAVIKGLTY 118
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAP 594
L E+ KI+HRD+K +N+L++ K+ DFG++ +D N+ + TR YM+P
Sbjct: 119 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 171
Query: 595 EYAMRGYLTDKADVYSFGIVALEIVSGR 622
E + + ++D++S G+ +E+ GR
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 427 NKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLHG 484
+K+GEG + V+KG +VA+K++ + ++G + E+ ++ L+H N+V LH
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 485 CCIEGNQLLLIYEYMENNSLARALFG----PEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
L L++EY++++ L + L H +K+ + RGL+Y H+
Sbjct: 71 IIHTERCLTLVFEYLDSD-LKQYLDNCGNLMSMHNVKI-------FMFQLLRGLSYCHKR 122
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 600
KI+HRD+K N+L+++ K++DFGLA+ S V T Y P+ +
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGS 178
Query: 601 --YLTDKADVYSFGIVALEIVSGR 622
Y T D++ G + E+ +GR
Sbjct: 179 TEYST-PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-14
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 31/221 (14%)
Query: 428 KIGEGGFGPVYKGH-MADGTVVAVKQLS---SKSKQGNREFVNEIGMISALQHPNLVKLH 483
IG+GG G VY + VA+K++ S++ + F+ E + + L HP +V ++
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFG-------PEAHRLKLDWPTRHRICVGIARGLAY 536
C +G+ + Y+E +L L + K I I + Y
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---LDEED--------------NT 579
+H S+ ++HRD+K N+LL I D+G A L+EED +
Sbjct: 129 VH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
I ++ GT YMAPE + ++ D+Y+ G++ ++++
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 10/199 (5%)
Query: 429 IGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHG 484
+G+GGFG V M A G + A K+L+ K ++G + E +++ + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
L L+ M L ++ + P I GL +LH+ +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
I++RD+K NVLLD D N +ISD GLA ++ +D + AGT G+MAPE ++G D
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGTPGFMAPEL-LQGEEYD 175
Query: 605 KA-DVYSFGIVALEIVSGR 622
+ D ++ G+ E+++ R
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 66/257 (25%), Positives = 106/257 (41%), Gaps = 53/257 (20%)
Query: 426 DNKIGE----GGFGPVYKGHMADGTVVAVKQ--LSSKSKQGNREFVNEIGMISALQHPNL 479
IG+ + K H T+VAVK+ L S SK+ + EI LQHPN+
Sbjct: 3 LTLIGKCFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 480 VKLHGCCIEGNQLLLIYEYMENNS---LARALFG---PE---AHRLKLDWPTRHRICVGI 530
+ I ++L ++ M S L + F PE A LK +
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK-----------DV 110
Query: 531 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRVAGTF 589
L Y+H +HR +KA+++LL D +S + + + RV F
Sbjct: 111 LNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ---RVVHDF 164
Query: 590 G--------YMAPEY---AMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLD 638
+++PE ++GY +K+D+YS GI A E+ +G P +D+
Sbjct: 165 PKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANG-----HVPFKDMPATQ- 217
Query: 639 WALILKAQGNLMELVDK 655
L+ K +G + L+DK
Sbjct: 218 -MLLEKVRGTVPCLLDK 233
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 17/200 (8%)
Query: 429 IGEGGFGPVY-KGHMADGTVVAVKQLSSKS----KQGNREFVNEIGMISALQHPNLVKLH 483
IG+G FG V +DG+ AVK L K+ K+ N ++ L+HP LV LH
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
+L + +Y+ L F + R L+ P +A + YLH L
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLE-PRARFYAAEVASAIGYLHS---L 115
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAPEYAMRGY 601
I++RD+K N+LLD + ++DFGL K ++ E+ T + GT Y+APE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRKEP 172
Query: 602 LTDKADVYSFGIVALEIVSG 621
D + G V E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 29/204 (14%)
Query: 429 IGEGGFGPVYKGH-MADGTVVAVKQLS-----SKSKQGNREFVNEIGMISALQHPNLVKL 482
I +G FG VY + G A+K L +K++ N + I MI + P + KL
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQG-ESPYVAKL 62
Query: 483 HGCCIEGNQLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHRICVGIAR---GLAYL 537
+ + L L+ EY+ A + G L DW IA G+ L
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGG----LPEDW-----AKQYIAEVVLGVEDL 113
Query: 538 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 597
H+ I+HRDIK N+L+D+ + K++DFGL++ N + + GT Y+APE
Sbjct: 114 HQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETI 165
Query: 598 MRGYLTDKADVYSFGIVALEIVSG 621
+ +D +S G V E + G
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 65/208 (31%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 429 IGEGGFGPVYKGHMAD-GTVVAVKQLSSKS---KQGNREFVNE---IGMISALQHPNLVK 481
IG GGFG VY AD G + A+K L K KQG +NE + ++S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 482 LHGCCIEGNQLLLIYEYMENNSL-----ARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
+ ++L I + M L +F + R I GL +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF---------YATEIILGLEH 112
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 596
+H +V+RD+K N+LLD+ + +ISD GLA + H S GT GYMAPE
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 166
Query: 597 AMRGYLTD-KADVYSFGIVALEIVSGRS 623
+G D AD +S G + +++ G S
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 66/203 (32%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 429 IGEGGFGPVYKGHMAD-GTVVAVKQLSSKS---KQGNREFVNE---IGMISALQHPNLVK 481
IG GGFG VY AD G + A+K L K KQG +NE + ++S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
+ ++L I + M L L H + + R I GL ++H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEAEMRF-YAAEIILGLEHMHNRF 117
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGY 601
+V+RD+K N+LLD+ + +ISD GLA + H S GT GYMAPE +G
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGV 171
Query: 602 LTD-KADVYSFGIVALEIVSGRS 623
D AD +S G + +++ G S
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 27/209 (12%)
Query: 429 IGEGGFGPVYKGHMAD-GTVVAVKQL--SSKSKQGNREFVN----EIGMISALQHPNLVK 481
+G+G FG VY + AD G +AVKQ+ +S + ++E VN EI ++ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE-VNALECEIQLLKNLLHERIVQ 68
Query: 482 LHGCCIEGNQ--LLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHRICVGIARGLAYL 537
+GC + + L + E+M S+ L +G + + TR I G++YL
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKY-TRQ-----ILEGVSYL 122
Query: 538 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE---DNTHISTRVAGTFGYMAP 594
H IVHRDIK N+L D N K+ DFG +K + T + + V GT +M+P
Sbjct: 123 HSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSP 178
Query: 595 EY-AMRGYLTDKADVYSFGIVALEIVSGR 622
E + GY KAD++S G +E+++ +
Sbjct: 179 EVISGEGY-GRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 17/200 (8%)
Query: 429 IGEGGFGPVYK-GHMADGTVVAVKQLSSKSKQGNRE---FVNEIGMISALQHPNLVKLHG 484
+G GGFG V + A+K + + + +E ++ HP +VKL+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+ + ++ EY L L R D T + YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL----RDRGLFDEYTARFYIACVVLAFEYLH---NRG 113
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYAM-RGYL 602
I++RD+K N+LLD + K+ DFG AK L T T GT Y+APE + +GY
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKGY- 169
Query: 603 TDKADVYSFGIVALEIVSGR 622
D +S GI+ E+++GR
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 427 NKIGEGGFGPVYKGHMAD-GTVVAVKQLS-SKSKQGNREF----VNEIGMISALQHPNLV 480
+IGEG +G VYK D G +VA+K++ K+G F + EI ++ L H N+V
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG---FPITAIREIKILRQLNHRNIV 69
Query: 481 KLHGCCIEGNQLL----------LIYEYMENNSLARALFGPEAHRLKLDWPTRH--RICV 528
L + L L++EYM+++ L G L + + H
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGL-VHFSEDHIKSFMK 123
Query: 529 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT 588
+ GL Y H+++ L HRDIK +N+LL+ K++DFGLA+L + + T T
Sbjct: 124 QLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 589 FGYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGR 622
Y PE + DV+S G + E+ + +
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 54/197 (27%), Positives = 96/197 (48%), Gaps = 11/197 (5%)
Query: 428 KIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLHGC 485
K+GEG + VYKG +G +VA+K + + ++G + E ++ L+H N+V LH
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
L L++EY+ + L + + + H L + RGL+Y+H+ I
Sbjct: 72 IHTKETLTLVFEYVHTD-LCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 546 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGY-LTD 604
+HRD+K N+L+ K++DFGLA+ + S V T Y P+ + +
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 605 KADVYSFGIVALEIVSG 621
D++ G + +E++ G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 429 IGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLHGC- 485
IG+G +G V+K +G+ AVK L + E E ++ AL HPN+VK +G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 486 ----CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
G+QL L+ E S+ + G +++ P I GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY----- 596
K +HRD+K N+LL + K+ DFG++ +T V GT +MAPE
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQ 200
Query: 597 AMRGYLTDKADVYSFGIVALEIVSG 621
+ + DV+S GI A+E+ G
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 28/213 (13%)
Query: 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSS--KSKQGNREFVNEIGMISALQH 476
TN + +G G FG V G VA+K++ + + E+ ++ L+H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 477 PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRIC----VGIAR 532
N++ L I + L IY E L G + HRL P + I R
Sbjct: 69 ENIISL--SDIFISPLEDIYFVTE-------LLGTDLHRLLTSRPLEKQFIQYFLYQILR 119
Query: 533 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-HISTRVAGTFGY 591
GL Y+H +VHRD+K +N+L++++ + KI DFGLA++ + T ++STR Y
Sbjct: 120 GLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----Y 171
Query: 592 MAPEYAM--RGYLTDKADVYSFGIVALEIVSGR 622
APE + + Y + D++S G + E++ G+
Sbjct: 172 RAPEIMLTWQKY-DVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 429 IGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHG 484
+G+GGFG V + A G + A K+L K ++G +NE ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 485 CCIEGNQLLLIYEYMENNSLARALF-----GPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
+ L L+ M L ++ G E R I GL LH
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF-------YAAEILCGLEDLHR 120
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRVAGTFGYMAPEYAM 598
E+ V+RD+K N+LLD + +ISD GLA K+ E ++ I RV GT GYMAPE
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVLN 174
Query: 599 RGYLTDKADVYSFGIVALEIVSGRS 623
T D + G + E++ G+S
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 423 FAPDNKIGEGGFGPVYKGH--MADGTVVAVKQLSSKSKQGNREF--VNEIGMISALQ--- 475
+ +IGEG +G V+K G VA+K++ ++ + + E+ ++ L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 476 HPNLVKLHGCCI-----EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGI 530
HPN+V+L C +L L++E+++ + PE + T + +
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDMMFQL 119
Query: 531 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 590
RGL +LH ++VHRD+K N+L+ K++DFGLA++ T V T
Sbjct: 120 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTLW 174
Query: 591 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 622
Y APE ++ D++S G + E+ +
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 12/162 (7%)
Query: 475 QHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGL 534
+HP L +LH C ++L + EY+ L +F + + D P I GL
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDL---MFHIQRSG-RFDEPRARFYAAEIVLGL 109
Query: 535 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYM 592
+LHE I++RD+K NVLLD + + KI+DFG+ K + T + GT Y+
Sbjct: 110 QFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYI 163
Query: 593 APEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF 634
APE D ++ G++ E+++G+S ++++F
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-13
Identities = 54/156 (34%), Positives = 82/156 (52%), Gaps = 15/156 (9%)
Query: 4 TLKDFRISDNHFTGKIPN-FIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLN 62
+L+ +S+N+FTG IP I N LE L + + L G IP+ I S S L++ DL
Sbjct: 119 SLRYLNLSNNNFTGSIPRGSIPN---LETLDLSNNMLSGEIPNDIGSFSS---LKVLDLG 172
Query: 63 GT----EAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPST 118
G + P L + ++ L L S + G++P LG M SLK + + +N L+G IP
Sbjct: 173 GNVLVGKIP-NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE 231
Query: 119 FMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSY 154
GL ++++ L N LTG IP + G+ +L Y
Sbjct: 232 IGGLTSLNHLDLVYNNLTGPIPSSL---GNLKNLQY 264
|
Length = 968 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 422 NFAPDNKIGEGGFGPVY-----KGHMADGTVVAVKQLS-----SKSKQGNREFVNEIGMI 471
NF +G G +G V+ GH + G + A+K L K+K +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDS-GKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 472 SALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIA 531
Q P LV LH +L LI +Y+ L F + R + + +
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERF---KEQEVQIYSG 112
Query: 532 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY 591
+ L +L I++RDIK N+LLD + + ++DFGL+K ED + GT Y
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172
Query: 592 MAPEYAMRGYLT--DKA-DVYSFGIVALEIVSGRS 623
MAP+ +RG DKA D +S G++ E+++G S
Sbjct: 173 MAPD-IVRGGDGGHDKAVDWWSMGVLMYELLTGAS 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 16/208 (7%)
Query: 421 NNFAPDNKIGEGGFGPVYK-GHMADGTVVAVKQLSSKSKQGNREF----VNEIGMISALQ 475
N F +GEG +G V K H +VA+K+ K + N E + E+ M+ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58
Query: 476 HPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICV-GIARGL 534
N+V+L +L L++EY+E N L P P + R + + + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP-----PEKVRSYIYQLIKAI 113
Query: 535 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP 594
+ H+ IVHRDIK N+L+ + K+ DFG A+ E + T T Y +P
Sbjct: 114 HWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170
Query: 595 EYAMRGYLTDKADVYSFGIVALEIVSGR 622
E + D++S G + E+ G+
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 429 IGEGGFGPVYKGHMADGT----VVAVKQLSS----KSKQGNREFVNEIGMISALQHPNLV 480
+G+GG+G V++ G + A+K L ++++ E ++ A++HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
L G +L LI EY+ L L E + ++ T I+ L +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFME-DTACFYLSEISLALEHLH-- 117
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 600
+ I++RD+K N+LLD + K++DFGL K + T T GT YMAPE MR
Sbjct: 118 -QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAPEILMRS 175
Query: 601 YLTDKADVYSFGIVALEIVSG 621
D +S G + ++++G
Sbjct: 176 GHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-13
Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 24/193 (12%)
Query: 445 GTVVAVKQLSSKSKQGNRE---FVNEIGMISALQHPNLVKL--HGCCIEGNQLLLIYEYM 499
G VA+K L + + + + F E + + L HPN+V L G G L ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYV 61
Query: 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL-- 557
+L L A L R+ + + LA H + IVHRD+K N+++
Sbjct: 62 PGRTLREVL----AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQ 114
Query: 558 -DKDLNPKISDFGLAKL----DEEDNTHIS--TRVAGTFGYMAPEYAMRGY-LTDKADVY 609
+ K+ DFG+ L + D ++ T V GT Y APE +RG +T +D+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLY 173
Query: 610 SFGIVALEIVSGR 622
++G++ LE ++G+
Sbjct: 174 AWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 429 IGEGGFGPVYKGHMAD-GTVVAVKQLSSKSKQGNREFVNEIGMISALQH------PNLVK 481
IG+G FG VY+ D + A+K LS K +E + IG + L P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVG-IARGLAYLHEE 540
L + L L+ +YM L F + R + + + L +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL----FWHLQKEGRFS-EDRAKFYIAELVLALEHLHKY 115
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-- 598
IV+RD+K N+LLD + + DFGL+K + DN +T GT Y+APE +
Sbjct: 116 D---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLLDE 171
Query: 599 RGYLTDKADVYSFGIVALEIVSGRS 623
+GY T D +S G++ E+ G S
Sbjct: 172 KGY-TKHVDFWSLGVLVFEMCCGWS 195
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 17/213 (7%)
Query: 429 IGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMIS------ALQHPNLVK 481
+G+G FG V+ + A+K L + + E M+ A +HP L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFLTH 60
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
L+ L + EY+ L + H K D P I GL +LH +
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHI--QSCH--KFDLPRATFYAAEIICGLQFLHSKG 116
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGY 601
IV+RD+K N+LLD D + KI+DFG+ K + + T GT Y+APE +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQK 172
Query: 602 LTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF 634
D +SFG++ E++ G+S +E++F
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 429 IGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREF---VNEIGMIS-ALQHPNLVKLH 483
+G+G FG V + G + AVK L + + + E ++S A HP L +L+
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
C ++L + E++ L +F + R + D I L +LH++
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDL---MFHIQKSR-RFDEARARFYAAEITSALMFLHDKG-- 116
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLT 603
I++RD+K NVLLD + + K++DFG+ K + ST GT Y+APE
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEMLYG 174
Query: 604 DKADVYSFGIVALEIVSGRSNSSCKPKEDIF 634
D ++ G++ E++ G + + ++D+F
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 423 FAPDNKIGEGGFGPVYKGHMAD-GTVVAVKQLSSKSKQGNREF--VNEIGMISALQ---H 476
+ P +IG G +G VYK G VA+K + ++ + V E+ ++ L+ H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 477 PNLVKLHGCCIEGN-----QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIA 531
PN+V+L C ++ L++E+++ + L L L + T +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQD-LRTYLDKVPPPGLPAE--TIKDLMRQFL 118
Query: 532 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-TRVAGTFG 590
RGL +LH IVHRD+K N+L+ K++DFGLA++ + ++ T V T
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLW 172
Query: 591 YMAPEYAMRGYLTDKADVYSFGIVALEI 618
Y APE ++ D++S G + E+
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 26/203 (12%)
Query: 429 IGEGGFG-PVYKGHMADGTVVAVKQL----SSKSKQGNREFVNEIGMISALQHPNLVKLH 483
+GEG FG + H+ A+K++ SS + + +R+ E +++ ++HPN+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAFK 64
Query: 484 GCCIEGNQLLLIYEY------MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYL 537
L ++ EY M+ L R PE L W + +C+G+ ++
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPE--DTILQWFVQ--MCLGVQ----HI 116
Query: 538 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 597
HE+ +++HRDIK+ N+ L ++ K+ DFG A+L + T V GT Y+ PE
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW 172
Query: 598 MRGYLTDKADVYSFGIVALEIVS 620
+K+D++S G + E+ +
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 429 IGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHG 484
+G+GGFG V + A G + A K+L K ++G +NE ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 485 CCIEGNQLLLIYEYMENNSLARALF-----GPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
+ L L+ M L ++ G + R I GL LH
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-------YAAEITCGLEDLHR 120
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 599
E +IV+RD+K N+LLD + +ISD GLA ++ + I RV GT GYMAPE
Sbjct: 121 E---RIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRV-GTVGYMAPEVVKN 175
Query: 600 GYLTDKADVYSFGIVALEIVSGRS 623
T D + G + E++ G+S
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 51/165 (30%), Positives = 75/165 (45%), Gaps = 13/165 (7%)
Query: 472 SALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWP--TRHRICVG 529
++ +HP LV L C + + + EY L + H P + CV
Sbjct: 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVV 111
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 589
+ GL YLHE KIV+RD+K N+LLD + KI+DFGL K ST GT
Sbjct: 112 L--GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTP 165
Query: 590 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF 634
++APE T D + G++ E++ G S +E++F
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 12/167 (7%)
Query: 470 MISALQHPNLVKLHGCCIEGNQ-LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRI-C 527
+ A +HP L L C + + L + EY+ L + + R R R
Sbjct: 49 LALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDE---ARARFYA 102
Query: 528 VGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG 587
I GL +LH++ I++RD+K NVLLDKD + KI+DFG+ K + ST G
Sbjct: 103 AEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCG 158
Query: 588 TFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF 634
T Y+APE + D +SFG++ E++ G+S + ++++F
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 39/214 (18%)
Query: 431 EGGFGPVYKGHMADGT--------VVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKL 482
EG FG ++ G + D V VK +S+ Q + E ++ L H N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEI-QVTL-LLQESCLLYGLSHQNILPI 73
Query: 483 HGCCIEGNQL-LLIYEYMENNSLARAL----FGPEAHRLKLDWPTRHRICVG--IARGLA 535
CIE + ++Y YM +L L G + L T+ + + IA G++
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS--TQQLVHMAIQIACGMS 131
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---------LDEEDNTHISTRVA 586
YLH + ++H+DI A N ++D++L KI+D L++ L + +N +
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---- 184
Query: 587 GTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+MA E + + +DV+SFG++ E+++
Sbjct: 185 ----WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 14/155 (9%)
Query: 472 SALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRH-RICVG- 529
+A HP LV LH C ++L + E++ L +F + R KL P H R
Sbjct: 51 TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQR-KL--PEEHARFYSAE 104
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 589
I+ L +LHE I++RD+K NVLLD + + K++D+G+ K ST GT
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTP 160
Query: 590 GYMAPEYAMRGYLTD-KADVYSFGIVALEIVSGRS 623
Y+APE +RG D ++ G++ E+++GRS
Sbjct: 161 NYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 39/227 (17%)
Query: 426 DNKIGEGGFGPVYKGH-MADGTVVAVKQLS----SKSKQGNREFVNEIGM---------- 470
+GEG +G V K + G +VA+K++ S +R+ V G+
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 471 ISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGI 530
++ ++H N++ L +EG+ + L+ + M ++ L + + +++L I + I
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVV----DRKIRLTESQVKCILLQI 128
Query: 531 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-------------KLDEED 577
GL LH+ +HRD+ N+ ++ KI+DFGLA K +
Sbjct: 129 LNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 578 NTHISTRVAGTFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGR 622
T T Y APE M Y D++S G + E+++G+
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKY-HFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 52/155 (33%), Positives = 77/155 (49%), Gaps = 16/155 (10%)
Query: 473 ALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHR--ICVGI 530
A HP LV LH C ++L + EY+ L +F + R KL P H I
Sbjct: 52 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQR-KL--PEEHARFYSAEI 105
Query: 531 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGT 588
+ L YLHE I++RD+K NVLLD + + K++D+G+ K L D T + GT
Sbjct: 106 SLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGT 159
Query: 589 FGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRS 623
Y+APE D ++ G++ E+++GRS
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 59/228 (25%), Positives = 86/228 (37%), Gaps = 45/228 (19%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV------NEIGMISALQHPNLVK 481
IG G FG V+ G V A+K L KS R + +I + A P +VK
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLR-KSDMIKRNQIAHVRAERDI-LADA-DSPWIVK 65
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
L+ + L L+ EYM L L + R I A + L
Sbjct: 66 LYYSFQDEEHLYLVMEYMPGGDLMNLLI--RKDVFPEET-ARFYI----AELVLALDSVH 118
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAK----------------------------L 573
+L +HRDIK N+L+D D + K++DFGL K
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 574 DEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 621
D + + GT Y+APE + D +S G++ E++ G
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 72/256 (28%), Positives = 113/256 (44%), Gaps = 28/256 (10%)
Query: 429 IGEGGFGPVYKGHMA-DGTVVAVKQLSSKSKQGNREFVNEIG----MISALQHPNLVKLH 483
IG+G FG V DG AVK L K +E + + ++ ++HP LV LH
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
+L + +++ L F + R P IA L YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL---FFHLQRER-SFPEPRARFYAAEIASALGYLHS---I 115
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTFGYMAPEYAMRGY 601
IV+RD+K N+LLD + ++DFGL K + + D T T GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRKQP 172
Query: 602 LTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF-YLLDWALILK------AQGNLMELVD 654
+ D + G V E++ G C+ +++ +L L+L+ A L EL++
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLE 232
Query: 655 K----RLGSNFDKEQV 666
K RLG+ D ++
Sbjct: 233 KDRQRRLGAKEDFLEI 248
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 429 IGEGGFGPVYKGH--MADGTV--VAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKL 482
+G+G FG V + DG+ VAVK L + S EF+ E + HPN++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 483 HGCCIEGNQL------LLIYEYMENNSLARALF----GPEAHRLKLDWPTRHRICVGIAR 532
G + ++I +M++ L L G E L L T R + IA
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQ--TLVRFMIDIAS 124
Query: 533 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRVAGTFGY 591
G+ YL S +HRD+ A N +L++++ ++DFGL+ K+ D +
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 592 MAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+A E T +DV++FG+ EI++
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 53/159 (33%), Positives = 79/159 (49%), Gaps = 24/159 (15%)
Query: 473 ALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRH------RI 526
A +P LV LH C ++L L+ EY+ L +F + R KL P H I
Sbjct: 52 ASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQR-KL--PEEHARFYAAEI 105
Query: 527 CVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTR 584
C+ L +LHE I++RD+K NVLLD D + K++D+G+ K L D T +
Sbjct: 106 CIA----LNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---ST 155
Query: 585 VAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRS 623
GT Y+APE D ++ G++ E+++GRS
Sbjct: 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 51/215 (23%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKS----KQGNREFV-NEIGMISALQHPNLVKL 482
+G G FG V+ A+K ++ KQ + V NE ++ + HP +++L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ--EQHVHNEKRVLKEVSHPFIIRL 66
Query: 483 HGCCIEGNQLLLIYEYME--------------NNSLARALFGPEAHRLKLDWPTRHRICV 528
+ L ++ EY+ +NS + E
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL-FYASE---------------- 109
Query: 529 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT 588
I L YLH +IV+RD+K N+LLDK+ + K++DFG AK D T + GT
Sbjct: 110 -IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRTWT---LCGT 161
Query: 589 FGYMAPE-YAMRGYLTDKA-DVYSFGIVALEIVSG 621
Y+APE +G+ +KA D ++ GI+ E++ G
Sbjct: 162 PEYLAPEVIQSKGH--NKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 1e-11
Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 40/217 (18%)
Query: 427 NKIGEGGFGPVYKGHMAD---GTVVAVK------QLSSKSKQGNRE--FVNEIGMISALQ 475
K+G+G +G V+K D VVA+K + ++ +++ RE F+ E+G
Sbjct: 13 QKLGKGAYGIVWKA--IDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----D 65
Query: 476 HPNLVKLHGC--CIEGNQLLLIYEYMEN--NSLARALFGPEAHRLKLDWPTRHRICVGIA 531
HPN+VKL + L++EYME +++ RA + H+ R+ I +
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHK-------RY-IMYQLL 117
Query: 532 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK----LDEEDNTHISTRVAG 587
+ L Y+H S ++HRD+K +N+LL+ D K++DFGLA+ L+E + T
Sbjct: 118 KALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 588 TFGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 622
T Y APE Y T D++S G + E++ G+
Sbjct: 175 TRWYRAPEILLGSTRY-TKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 428 KIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLVKLHGC 485
K+GEG + VYKG G +VA+K++ + ++G + E ++ L+H N+V LH
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICV-GIARGLAYLHEESRLK 544
L L++EY++ + L + + + L R+ + + RGLAY H+ +
Sbjct: 72 IHTKKTLTLVFEYLDTD-LKQYM---DDCGGGLS-MHNVRLFLFQLLRGLAYCHQR---R 123
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM--RGYL 602
++HRD+K N+L+ + K++DFGLA+ + S V T Y P+ + Y
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLGSTEYS 182
Query: 603 TDKADVYSFGIVALEIVSGR 622
T D++ G + E+ +GR
Sbjct: 183 T-SLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 31/195 (15%)
Query: 448 VAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLH--------------GCCIEGNQLL 493
VAVK++ Q + + EI +I L H N+VK++ G E N +
Sbjct: 33 VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92
Query: 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKAT 553
++ EYME + LA L E L + + RGL Y+H + ++HRD+K
Sbjct: 93 IVQEYMETD-LANVL---EQGPLSEEHAR--LFMYQLLRGLKYIHSAN---VLHRDLKPA 143
Query: 554 NVLLD-KDLNPKISDFGLAKLDEEDNTH---ISTRVAGTFGYMAPEYAM--RGYLTDKAD 607
NV ++ +DL KI DFGLA++ + +H +S + + Y +P + Y T D
Sbjct: 144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNY-TKAID 201
Query: 608 VYSFGIVALEIVSGR 622
+++ G + E+++G+
Sbjct: 202 MWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 24/221 (10%)
Query: 412 TLRQIKAATNNFAPDNKIGEGGFGPVYKGHMAD-GTVVAVKQLSS--KSKQGNREFVNEI 468
T+ ++ N +P +G G +G V G VAVK+LS +S + E+
Sbjct: 11 TIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 67
Query: 469 GMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRL----KLDWPTRH 524
++ ++H N++ L L E + L L G + + + KL
Sbjct: 68 RLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 123
Query: 525 RICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHIST 583
+ I RGL Y+H I+HRD+K +N+ +++D KI DFGLA+ D+E +++T
Sbjct: 124 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 180
Query: 584 RVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRS 623
R Y APE + + D++S G + E+++GR+
Sbjct: 181 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 65/215 (30%), Positives = 92/215 (42%), Gaps = 23/215 (10%)
Query: 422 NFAPDNKIGEGGFGPVY---------KGHMADGTVVAVKQLSSKSKQGNREFVNEIGMIS 472
NF +G G +G V+ G + V+ L K+K +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 473 ALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVG-IA 531
Q P LV LH +L LI +Y+ + L+ + D R G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY--QRDNFSED---EVRFYSGEII 115
Query: 532 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEEDNTHISTRVAGTF 589
L +LH +L IV+RDIK N+LLD + + ++DFGL+K L EE S GT
Sbjct: 116 LALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTI 170
Query: 590 GYMAPEYAMRGYLTDKA-DVYSFGIVALEIVSGRS 623
YMAPE KA D +S GI+ E+++G S
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS 205
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 429 IGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHG 484
+G+GGFG V + A G + A K+L K ++G +NE ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 485 CCIEGNQLLLIYEYMENNSLARALF-----GPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
+ L L+ M L ++ G + R +C G L +
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF---YAAELCCG-------LED 117
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 599
R +IV+RD+K N+LLD + +ISD GLA E T + RV GT GYMAPE
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINN 175
Query: 600 GYLTDKADVYSFGIVALEIVSGRS 623
T D + G + E++ G+S
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 12/213 (5%)
Query: 429 IGEGGFGPV-YKGHMADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHG 484
+G+G FG V A G A+K L + +K + E ++ +HP L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
++L + EY+ L F R+ + TR I L YLH K
Sbjct: 63 SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRF-YGAEIVSALDYLHSG---K 115
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
IV+RD+K N++LDKD + KI+DFGL K D + T GT Y+APE
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGR 174
Query: 605 KADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL 637
D + G+V E++ GR + E +F L+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 64/214 (29%), Positives = 92/214 (42%), Gaps = 13/214 (6%)
Query: 429 IGEGGFGPV-YKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ---HPNLVKLHG 484
+G+G FG V A G A+K L + E + + LQ HP L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRIC-VGIARGLAYLHEESRL 543
++L + EY L L R ++ R R I L YLH E
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDYLHSEK-- 115
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLT 603
+V+RD+K N++LDKD + KI+DFGL K +D + T GT Y+APE
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYG 174
Query: 604 DKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL 637
D + G+V E++ GR + E +F L+
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 31/213 (14%)
Query: 428 KIGEGGFGPVYKGH-MADGTVVAVKQ--LSSKSKQGNREFVNEIGMISALQH-PNLVKLH 483
KIGEG +G VYK G +VA+K+ L + + EI ++ L +V+L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL- 66
Query: 484 GCCIEGN-------QLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHRICVGIARGL 534
+E L L++EY++++ L + + G R L T + +G+
Sbjct: 67 -LDVEHVEEKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGR-PLPAKTIKSFMYQLLKGV 123
Query: 535 AYLHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAK---LDEEDNTHISTRVAGTFG 590
A+ H + ++HRD+K N+L+DK KI+D GL + + + TH T
Sbjct: 124 AHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----TLW 176
Query: 591 YMAPEYAM--RGYLTDKADVYSFGIVALEIVSG 621
Y APE + Y T D++S G + E+
Sbjct: 177 YRAPEVLLGSTHYST-PVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 42/223 (18%)
Query: 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPN 478
+ P IG G +G V G VA+K++ + + E+ ++ +H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 479 LVKLHGCCI---------EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWP-TRHRICV 528
++ I + + ++ + ME++ L + D P T I
Sbjct: 66 II-----AIRDILRPPGADFKDVYVVMDLMESD-LHHIIHS--------DQPLTEEHIRY 111
Query: 529 ---GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL----DEEDNTHI 581
+ RGL Y+H ++HRD+K +N+L+++D +I DFG+A+ E +
Sbjct: 112 FLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 582 STRVAGTFGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 622
+ VA T Y APE ++ Y T D++S G + E++ GR
Sbjct: 169 TEYVA-TRWYRAPELLLSLPEY-TTAIDMWSVGCIFAEML-GR 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 38/108 (35%), Positives = 54/108 (50%), Gaps = 4/108 (3%)
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 589
I L YLH +V+RD+K N++LDKD + KI+DFGL K D + T GT
Sbjct: 104 IVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 159
Query: 590 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL 637
Y+APE D + G+V E++ GR + E +F L+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 8/162 (4%)
Query: 473 ALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIAR 532
A +HP L LH C ++L + EY+ L +F + R K D P +
Sbjct: 52 AAKHPFLTALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSR-KFDEPRSRFYAAEVTL 107
Query: 533 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYM 592
L +LH R +++RD+K N+LLD + + K++DFG+ K + N +T GT Y+
Sbjct: 108 ALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYI 163
Query: 593 APEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF 634
APE D ++ G++ E+++G+ ++D+F
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 39/161 (24%), Positives = 68/161 (42%), Gaps = 29/161 (18%)
Query: 470 MISALQHPNLVKLHGCCIEGNQLLLI--------YEYMENNSLARALFGPEAHRLKLDWP 521
++ + HP+++++ + G ++ Y Y+ S P P
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS------RP--------LP 155
Query: 522 TRHRICV--GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579
+ + I GL YLH + +I+HRD+K N+ ++ I D G A+
Sbjct: 156 IDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212
Query: 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+ +AGT APE R KAD++S GIV E+++
Sbjct: 213 FLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 6/165 (3%)
Query: 13 NHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPP-L 71
N+ +G+IP I T L L + + L GPIPS + +L L L + N P PP +
Sbjct: 222 NNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQ-NKLSGPIPPSI 280
Query: 72 DKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLT 131
++K+ +L L ++SG++P+ + + +L++L + N G IP L + + L
Sbjct: 281 FSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLW 340
Query: 132 GNLLTGTIPPWMLQKGDR--VDLSYNSFTAGSSETSCQYRSVNLF 174
N +G IP + + + +DLS N+ T E C S NLF
Sbjct: 341 SNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS--SGNLF 383
|
Length = 968 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 32/95 (33%), Positives = 56/95 (58%), Gaps = 10/95 (10%)
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-HISTRVAGT 588
I RGL Y+H I+HRD+K +N+ +++D KI DFGLA+ +++ T +++TR
Sbjct: 127 ILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR---- 179
Query: 589 FGYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGR 622
Y APE + + D++S G + E+++G+
Sbjct: 180 -WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 412 TLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTV--VAVKQLSS----KSKQGNREFV 465
R+ K +F +G G FG V + VA+K+ K KQ + F
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF- 79
Query: 466 NEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHR 525
+E +++ + HP V L+G + + L L+ E++ L R +P
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL------RRNKRFPNDVG 133
Query: 526 ICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV 585
C A+ + L IV+RD+K N+LLDKD K++DFG AK+ + T T +
Sbjct: 134 -CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD---TRTYT-L 188
Query: 586 AGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKP 629
GT Y+APE + AD ++ GI EI+ G C P
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG-----CPP 227
|
Length = 340 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 427 NKIGEGGFGPV-YKGHMADGTVVAVKQLSS----KSKQGNREFVNEIGMISALQHPNLVK 481
+G G FG V H G A+K L K KQ + E ++ L HP +V
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSHPFIVN 82
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
+ + N++ + E++ L L +A R D + + YLH
Sbjct: 83 MMCSFQDENRVYFLLEFVVGGELFTHL--RKAGRFPNDVAKFY--HAELVLAFEYLHS-- 136
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-RG 600
I++RD+K N+LLD + K++DFG AK D T + GT Y+APE +G
Sbjct: 137 -KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFT---LCGTPEYLAPEVIQSKG 191
Query: 601 YLTDKA-DVYSFGIVALEIVSG 621
+ KA D ++ G++ E ++G
Sbjct: 192 H--GKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 8/158 (5%)
Query: 477 PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
P L +LH C ++L + EY+ L + + R K P IA GL +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI--QQVGRFK--EPHAVFYAAEIAIGLFF 116
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 596
LH + I++RD+K NV+LD + + KI+DFG+ K + D T GT Y+APE
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCGTPDYIAPEI 172
Query: 597 AMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF 634
D ++FG++ E+++G++ + ++++F
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 19/221 (8%)
Query: 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMIS----ALQH 476
+F +G+G FG V + A+K L + + E M+ ALQ
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV--ECTMVEKRVLALQD 58
Query: 477 --PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGL 534
P L +LH C ++L + EY+ L + K P I+ GL
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISVGL 114
Query: 535 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV-AGTFGYMA 593
+LH I++RD+K NV+LD + + KI+DFG+ K D ++TR GT Y+A
Sbjct: 115 FFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIA 169
Query: 594 PEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF 634
PE D +++G++ E+++G+ + ++++F
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 64/214 (29%), Positives = 92/214 (42%), Gaps = 14/214 (6%)
Query: 429 IGEGGFGPV-YKGHMADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHG 484
+G+G FG V A G A+K L + +K V E ++ +HP L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRIC-VGIARGLAYLHEESRL 543
++L + EY L L R ++ R R I L YLH
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSRD-- 115
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLT 603
+V+RDIK N++LDKD + KI+DFGL K D + T GT Y+APE
Sbjct: 116 -VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYG 173
Query: 604 DKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL 637
D + G+V E++ GR + E +F L+
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 17/199 (8%)
Query: 428 KIGEGGFGPVYKGHMAD-GTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLH 483
++G+GG+G V+ D G +VA+K++ R + E +++ + LVKL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
+ L L EY+ R L + + R + A + L
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDF-RTLL--NNLGVLSEDHARFYM----AEMFEAVDALHEL 120
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-RGYL 602
+HRD+K N L+D + K++DFGL+K + V G+ YMAPE +GY
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKGY- 175
Query: 603 TDKADVYSFGIVALEIVSG 621
D +S G + E + G
Sbjct: 176 DFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 13/200 (6%)
Query: 429 IGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNRE----FVNEIGMISALQHPNLVKLH 483
+G+G FG V + G AVK L + + V + + A ++P L L+
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
L + E++ L + + R L T + I GL +LH +
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHI--QDKGRFDLYRATFY--AAEIVCGLQFLHSKG-- 116
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLT 603
I++RD+K NV+LD+D + KI+DFG+ K + + ST GT Y+APE T
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYT 174
Query: 604 DKADVYSFGIVALEIVSGRS 623
D +SFG++ E++ G+S
Sbjct: 175 FSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 57/223 (25%), Positives = 106/223 (47%), Gaps = 24/223 (10%)
Query: 428 KIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQG---NREFVNEIGMISALQHPNLVKLHG 484
K+G G +G VYK DG K+ + K +G + EI ++ L+HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 485 CCIEGN--QLLLIYEYMENN--SLARALFGPEAHRLKLDWPTR--HRICVGIARGLAYLH 538
+ + ++ L+++Y E++ + + +A++ + P + I G+ YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 539 EESRLKIVHRDIKATNVLLDKDLNP-----KISDFGLAKLDEEDNTHIS--TRVAGTFGY 591
++HRD+K N+L+ + P KI+D G A+L ++ V TF Y
Sbjct: 126 ANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 592 MAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDI 633
APE + + T D+++ G + E+++ C+ +EDI
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR-QEDI 223
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 18/214 (8%)
Query: 421 NNFAPDNKIGEGGFGPVY-KGHMADGTVVAVKQLSSKSKQGNRE----FVNEIGMISALQ 475
+F + +G G FG V A G + A+K + KS +E F E ++S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMK-KSVLLAQETVSFFEEERDILSISN 59
Query: 476 HPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLA 535
P + +L + + L L+ EY L L + + D + +
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIH 116
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 595
+H+ + VHRDIK NVL+D+ + K++DFG A + S GT Y+APE
Sbjct: 117 SVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 596 Y--AMRGYLTDKADV----YSFGIVALEIVSGRS 623
M G V +S G++A E++ GRS
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 7e-10
Identities = 52/161 (32%), Positives = 74/161 (45%), Gaps = 24/161 (14%)
Query: 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPS-------------GIASL 50
+LK + N GKIPN + N T LE L + ++ LVG IP G +L
Sbjct: 165 SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224
Query: 51 S--------KLTDLRISDL--NGTEAPFPP-LDKMKKMKTLILRSCNVSGKLPDYLGLMT 99
S LT L DL N P P L +K ++ L L +SG +P + +
Sbjct: 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQ 284
Query: 100 SLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIP 140
L LD+S N L+G IP + L +++ ++L N TG IP
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-10
Identities = 52/186 (27%), Positives = 73/186 (39%), Gaps = 28/186 (15%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L L +SDN +G+IP + LE L + ++ G IP + SL +L
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRL-------- 334
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
+ L L S SG++P LG +L VLD+S N L G IP
Sbjct: 335 ----------------QVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
Query: 122 LLDVDYIYLTGNLLTGTIPP--WMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179
++ + L N L G IP + RV L NSF+ + V S+
Sbjct: 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISN- 437
Query: 180 GNNSTG 185
NN G
Sbjct: 438 -NNLQG 442
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 9e-10
Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 6/182 (3%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLT--DLRIS 59
L L+ + N+FTGKIP + + L+ L + ++ G IP + + LT DL +
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
Query: 60 DLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTF 119
+L G E P K LIL S ++ G++P LG SL+ + + N +G +PS F
Sbjct: 367 NLTG-EIPEGLCSSGNLFK-LILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424
Query: 120 MGLLDVDYIYLTGNLLTGTI--PPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASS 177
L V ++ ++ N L G I W + + L+ N F G ++ R NL S
Sbjct: 425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSR 484
Query: 178 SK 179
++
Sbjct: 485 NQ 486
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 40/139 (28%), Positives = 70/139 (50%), Gaps = 3/139 (2%)
Query: 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNG 63
+L+ ++ N F G +P+ + LE L + + G +P + SLS+L L++S+ N
Sbjct: 453 SLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSE-NK 510
Query: 64 TEAPFP-PLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGL 122
P L KK+ +L L +SG++P M L LD+S N+L+G IP +
Sbjct: 511 LSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNV 570
Query: 123 LDVDYIYLTGNLLTGTIPP 141
+ + ++ N L G++P
Sbjct: 571 ESLVQVNISHNHLHGSLPS 589
|
Length = 968 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 57/223 (25%), Positives = 104/223 (46%), Gaps = 24/223 (10%)
Query: 428 KIGEGGFGPVYKGHMADG---TVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHG 484
K+G G +G VYK DG A+KQ+ + EI ++ L+HPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 65
Query: 485 CCIE--GNQLLLIYEYMENN--SLARALFGPEAHRLKLDWP--TRHRICVGIARGLAYLH 538
+ ++ L+++Y E++ + + +A++ + P + I G+ YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 539 EESRLKIVHRDIKATNVLLDKDLNP-----KISDFGLAKLDEEDNTHIS--TRVAGTFGY 591
++HRD+K N+L+ + P KI+D G A+L ++ V TF Y
Sbjct: 126 ANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 592 MAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDI 633
APE + + T D+++ G + E+++ C+ +EDI
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR-QEDI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 14/161 (8%)
Query: 477 PNLVKLHGCCIEGNQLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHRICVGIARGL 534
P L +LH C ++L + EY+ L + G K P IA GL
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGL 114
Query: 535 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV-AGTFGYMA 593
+LH + I++RD+K NV+LD + + KI+DFG+ K E +TR GT Y+A
Sbjct: 115 FFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIA 169
Query: 594 PEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF 634
PE D ++FG++ E+++G+ + ++++F
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 413 LRQIKAATNNFAPDNKIGEGGFGPV-YKGHMADGTVVAVKQLSSKS--KQGNREFVNEIG 469
+R+++ ++ IG G FG V H + V A+K LS K+ + F E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 470 MISALQH-PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICV 528
I A + P +V+L + L ++ EYM L + + + W + V
Sbjct: 95 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAEV 151
Query: 529 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRVAG 587
+A L +H + ++HRD+K N+LLDK + K++DFG K+DE T V G
Sbjct: 152 VLA--LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-G 205
Query: 588 TFGYMAPEYAMR----GYLTDKADVYSFGIVALEIVSG 621
T Y++PE GY + D +S G+ E++ G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 24/205 (11%)
Query: 429 IGEGGFGPVY-KGHMADGTVVAVKQLSSKS--KQGNREFVNEIGMISAL-QHPNLVKLHG 484
IG G FG V H + V A+K LS K+ + F E I A +V+LH
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110
Query: 485 CCIEGNQLLLIYEYMENNSLARALFG---PEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
+ L ++ EYM L + PE W + V +A L +H
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE------KWARFYTAEVVLA--LDAIH--- 159
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRVAGTFGYMAPEYAMR- 599
+ +HRD+K N+LLDK + K++DFG K+D T V GT Y++PE
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQ 218
Query: 600 ---GYLTDKADVYSFGIVALEIVSG 621
GY + D +S G+ E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 37/94 (39%), Positives = 56/94 (59%), Gaps = 8/94 (8%)
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI---STRVA 586
+ARG+ +L SR K +HRD+ A N+LL ++ KI DFGLA+ +D ++ S R+
Sbjct: 183 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 587 GTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+MAPE T ++DV+SFG++ EI S
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 429 IGEGGFGPVYKGHMAD-GTVVAVKQLSS--KSKQGNREFVNEIGMISALQHPNLVKLHGC 485
+G G +G V + VAVK+LS +S R E+ ++ ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRL----KLDWPTRHRICVGIARGLAYLHEES 541
+ E L L G + + + KL + + RGL Y+H
Sbjct: 83 FTPATSI----ENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG 138
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYAMRG 600
I+HRD+K +NV +++D +I DFGLA+ D+E +++TR Y APE +
Sbjct: 139 ---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNW 190
Query: 601 -YLTDKADVYSFGIVALEIVSGRS 623
+ D++S G + E++ G++
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 429 IGEGGFGPVYKG---HMADG-----TVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 480
+G+G F ++KG + D T V +K L + + F M+S L H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY-LHE 539
+G C+ G++ +++ EY++ SL L + + + W +A+ LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISWKLE------VAKQLAWALHF 115
Query: 540 ESRLKIVHRDIKATNVLL-----DKDLNP---KISDFGL--AKLDEEDNTHISTRVAGTF 589
+ H ++ A NVLL K NP K+SD G+ L +E + R+
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE---ILLERIP--- 169
Query: 590 GYMAPEYAMRG-YLTDKADVYSFGIVALEIVSG 621
++ PE L+ AD +SFG EI SG
Sbjct: 170 -WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 37/94 (39%), Positives = 53/94 (56%), Gaps = 8/94 (8%)
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 589
+ARG+ +L ++ VHRD+ A NVLL + KI DFGLA+ D+ ++S TF
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK--GSTF 300
Query: 590 ---GYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+MAPE T +DV+S+GI+ EI S
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 4/92 (4%)
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG-T 588
+ARG+ +L SR K +HRD+ A N+LL ++ KI DFGLA+ +D ++ A
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 589 FGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
+MAPE T ++DV+SFG++ EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 27/198 (13%)
Query: 441 HMADGTVVAVK--QLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498
H GT+V V+ L + +++ + NE+ + +HPN++ G+ L +I +
Sbjct: 21 HTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80
Query: 499 M---ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNV 555
M NSL + F PE L I G RGL YLH+ +HR+IKA+++
Sbjct: 81 MAYGSANSLLKTYF-PEGMSEAL----IGNILFGALRGLNYLHQNG---YIHRNIKASHI 132
Query: 556 LLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG--------YMAPEYA---MRGYLTD 604
L+ D +S GL+ L +V F +++PE + GY
Sbjct: 133 LISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGY-NV 189
Query: 605 KADVYSFGIVALEIVSGR 622
K+D+YS GI A E+ +GR
Sbjct: 190 KSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 8e-09
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 26/206 (12%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSS--KSKQGNREFVNEIGMISALQHPNLVKLHGC 485
+G G +G V G VA+K+LS +S+ + E+ ++ +QH N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 486 CI------EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
E L+ YM+ + + + G K+ + +C GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLC-----GLKYIHS 135
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYAM 598
I+HRD+K N+ +++D KI DFGLA+ D E ++ TR Y APE +
Sbjct: 136 AG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVIL 187
Query: 599 RG-YLTDKADVYSFGIVALEIVSGRS 623
+ D++S G + E+++G++
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKT 213
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 34/92 (36%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 529 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRVAG 587
+ LAYLH I+HRD+K N+ LD+ N + DFG A KLD +T +G
Sbjct: 193 RLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 588 TFGYMAPEY-AMRGYLTDKADVYSFGIVALEI 618
T +PE A+ Y K D++S G+V E+
Sbjct: 250 TLETNSPELLALDPYCA-KTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 51/189 (26%), Positives = 85/189 (44%), Gaps = 28/189 (14%)
Query: 445 GTVVAVKQLS------SKSKQGNREFVNEIGMISALQHPNLVKL------HGCCIEGNQL 492
G VAVK+LS + +K+ RE V ++ + H N++ L E +
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELV----LLKCVNHKNIISLLNVFTPQKSLEEFQDV 101
Query: 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKA 552
L+ E M+ N L + + ++LD + + G+ +LH I+HRD+K
Sbjct: 102 YLVMELMDAN-LCQVI------HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 151
Query: 553 TNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFG 612
+N+++ D KI DFGLA+ + T T Y APE + + D++S G
Sbjct: 152 SNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 209
Query: 613 IVALEIVSG 621
+ E+V G
Sbjct: 210 CIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 37/100 (37%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 524 HRICVG--IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581
IC +A+G+ +L SR K +HRD+ A N+LL ++ KI DFGLA+ +D ++
Sbjct: 180 DLICYSFQVAKGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 236
Query: 582 STRVAG-TFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
A +MAPE T ++DV+SFG++ EI S
Sbjct: 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 429 IGEGGFGPV-YKGHMADGTVVAVKQLSS--KSKQGNREFVNEIGMISALQHPNLVKLHGC 485
+G G +G V G VA+K+L +S+ + E+ ++ ++H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRL-KLDWPTRHRI---CVGIARGLAYLHEES 541
L +++ L G + +L K + + RI + +GL Y+H
Sbjct: 83 FTPDLSLDRFHDFY----LVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG 138
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYAMRG 600
I+HRD+K N+ +++D KI DFGLA+ D E ++ TR Y APE +
Sbjct: 139 ---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVILNW 190
Query: 601 -YLTDKADVYSFGIVALEIVSGR 622
+ T D++S G + E+++G+
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 49/221 (22%)
Query: 429 IGEGGFGPVYKG-------HMADGTVVAVKQLSSKSKQGNR---EFVNEIGMISALQHPN 478
+G+G F +YKG G V + +R F ++S L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 479 LVKLHGCCI-EGNQLLLIYEYME----NNSLARALFGPEAH-RLKLDWPTRHRICVGIAR 532
LVKL+G C+ + N ++ EY++ + L R H +L + +A
Sbjct: 63 LVKLYGVCVRDENIMVE--EYVKFGPLDVFLHREKNNVSLHWKLDVAK--------QLAS 112
Query: 533 GLAYLHEESRLKIVHRDIKATNVLLDK-DLNP------KISDFGLAK---LDEEDNTHIS 582
L YL ++ K+VH ++ N+L+ + LN K+SD G+ EE I
Sbjct: 113 ALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP 169
Query: 583 TRVAGTFGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSG 621
++APE G LT AD +SFG LEI S
Sbjct: 170 --------WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 36/99 (36%), Positives = 55/99 (55%), Gaps = 11/99 (11%)
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT- 588
+A+G+ +L ++ +HRD+ A NVLL KI DFGLA+ D+ ++ V G
Sbjct: 221 VAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNA 274
Query: 589 ---FGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRS 623
+MAPE T ++DV+S+GI+ EI S G+S
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 42/217 (19%)
Query: 429 IGEGGFGPV---YKGHMADGTVVAVKQLSS--KSKQGNREFVNEIGMISALQHPNLVKLH 483
IG+G +G V H G VA+K+++ + + EI ++ L+HP++V++
Sbjct: 8 IGKGSYGVVCSAIDTHT--GEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 484 GCCI-----EGNQLLLIYEYME---------NNSLARALFGPEAHRLKLDWPTRHRICVG 529
+ E + +++E ME N+ L PE H+ L
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLT-----PEHHQFFL---------YQ 111
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED--NTHISTRVAG 587
+ R L Y+H + + HRD+K N+L + D KI DFGLA++ D T
Sbjct: 112 LLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168
Query: 588 TFGYMAPEY--AMRGYLTDKADVYSFGIVALEIVSGR 622
T Y APE + T D++S G + E+++G+
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 6/157 (3%)
Query: 466 NEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTR-H 524
+E+ ++A H +VK ++LLLI EY L + + RLK P + +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI----KQRLKEHLPFQEY 169
Query: 525 RICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHIST 583
+ + + + L E K++HRD+K+ N+ L K+ DFG +K + + +++
Sbjct: 170 EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 584 RVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
GT Y+APE R + KAD++S G++ E+++
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 40/110 (36%), Positives = 58/110 (52%), Gaps = 9/110 (8%)
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 589
+A G+ +L ++ VHRD+ A NVL+ + KI DFGLA+ D+ +IS TF
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK--GSTF 302
Query: 590 ---GYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFY 635
+MAPE T +DV+SFGI+ EI + G + P + FY
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 458 KQGNRE-FVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRL 516
K G R E ++ A+ HP++++L G LI + + L+ A +
Sbjct: 123 KAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD-----LYCYLAAKR 177
Query: 517 KLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576
+ I + R + YLHE I+HRDIKA N+ ++ + + DFG A +
Sbjct: 178 NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234
Query: 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSN 624
N + AGT APE R D++S GIV E+ + +
Sbjct: 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282
|
Length = 391 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 43/214 (20%)
Query: 429 IGEGGFGPVYKGHMADGTV----VAVKQLS------SKSKQGNREFVNEIGMISALQHPN 478
IG G G V A TV VA+K+LS + +K+ RE V ++ + H N
Sbjct: 24 IGSGAQGIVC---AAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKN 76
Query: 479 LVKLHGCCI------EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIAR 532
++ L E + L+ E M+ N L + + ++ LD + +
Sbjct: 77 IIGLLNVFTPQKSLEEFQDVYLVMELMDAN-LCQVI------QMDLDHERMSYLLYQMLC 129
Query: 533 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT---HISTRVAGTF 589
G+ +LH I+HRD+K +N+++ D KI DFGLA+ ++ TR
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 590 GYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGR 622
Y APE + GY + D++S G + E++ G
Sbjct: 183 -YRAPEVILGMGY-KENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-08
Identities = 25/68 (36%), Positives = 44/68 (64%)
Query: 73 KMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTG 132
K++ ++++ L ++ G +P LG +TSL+VLD+S+N NG+IP + L + + L G
Sbjct: 440 KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499
Query: 133 NLLTGTIP 140
N L+G +P
Sbjct: 500 NSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 420 TNNFAPDNKIGEGGFGPVYKGHMAD-GTVVAVKQLSS--KSKQGNREFVNEIGMISALQH 476
+ P IG G +G V ++ VA+K++++ ++ + + EI ++ L H
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDH 63
Query: 477 PNLVKLHGCCI-----EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRIC---- 527
N++ + N + ++YE M+ + L + + + L D H C
Sbjct: 64 ENVIAIKDIMPPPHREAFNDVYIVYELMDTD-LHQIIRSSQT--LSDD----H--CQYFL 114
Query: 528 VGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG 587
+ RGL Y+H + ++HRD+K +N+LL+ + + KI DFGLA+ E ++ V
Sbjct: 115 YQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV- 170
Query: 588 TFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGR 622
T Y APE + Y T DV+S G + E++ GR
Sbjct: 171 TRWYRAPELLLNCSEY-TTAIDVWSVGCIFAELL-GR 205
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 49/171 (28%), Positives = 80/171 (46%), Gaps = 26/171 (15%)
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT- 588
+A+G+++L ++ +HRD+ A N+LL KI DFGLA+ D+ ++ V G
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNA 276
Query: 589 ---FGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILK 644
+MAPE T ++DV+S+GI+ EI S G S P + FY + +K
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM-----IK 331
Query: 645 AQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+G M L + M ++ C D RP+ +V ++E
Sbjct: 332 -EGYRM------LSPECAPSE---MYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 7e-08
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 34/169 (20%)
Query: 534 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG--- 590
LA H S+ ++HRDIK+ N+LL + K+ DFG +K+ T +S V TF
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKM--YAAT-VSDDVGRTFCGTP 209
Query: 591 -YMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL 649
Y+APE R + KAD++S G++ E+++ + +P + N+
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK-----RPFDGE--------------NM 250
Query: 650 MELVDKRLGSNFDK-----EQVMVMINVALLCTDVSSTSRPSMSSVVSM 693
E++ K L +D M I ALL +D RPS S +++M
Sbjct: 251 EEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSD--PKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-08
Identities = 36/115 (31%), Positives = 63/115 (54%), Gaps = 2/115 (1%)
Query: 5 LKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGT 64
L++ +S N F+G +P + + + L +L + + L G IP ++S KL L +S +
Sbjct: 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS 536
Query: 65 EAPFPPLDKMKKMKTLILRSCN-VSGKLPDYLGLMTSLKVLDVSFNKLNGAIPST 118
+M + L L S N +SG++P LG + SL +++S N L+G++PST
Sbjct: 537 GQIPASFSEMPVLSQLDL-SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 9e-08
Identities = 67/244 (27%), Positives = 100/244 (40%), Gaps = 52/244 (21%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHMAD-GTVVAVKQLSSKSKQGNREFV----NEIGMISALQ 475
++F IG G FG V D G + A+K+L KS+ +E V E +++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEAD 59
Query: 476 HPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLA 535
+P +VKL+ + N L LI EY+ + L +K D T IA +
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL-------MKKDTFTEEETRFYIAETIL 112
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL----------------------AKL 573
+ +L +HRDIK N+LLD + K+SDFGL L
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 574 DEEDNTHISTRVA---------------GTFGYMAPEYAMR-GYLTDKADVYSFGIVALE 617
D S R A GT Y+APE ++ GY + D +S G++ E
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYE 231
Query: 618 IVSG 621
++ G
Sbjct: 232 MLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 49/223 (21%)
Query: 429 IGEGGFGPVY-KGHMADGTVVAVKQLSSKS----KQGNREFVNEIGMISALQHPNLVKLH 483
I G +G VY H A+K+++ ++ Q + FV E +++ ++P +V +
Sbjct: 9 ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAENPFVVSMF 67
Query: 484 GCCIEGNQ-LLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHRICVGIAR-------- 532
C E + L ++ EY+E A L G + V +AR
Sbjct: 68 -CSFETKRHLCMVMEYVEGGDCATLLKNIGA--------------LPVDMARMYFAETVL 112
Query: 533 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--------------LDEEDN 578
L YLH IVHRD+K N+L+ + K++DFGL+K ++++
Sbjct: 113 ALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 621
+ +V GT Y+APE +R D ++ GI+ E + G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 32/87 (36%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY--AM- 598
+L VHRDIK NVLLDK+ + +++DFG D T S GT Y++PE AM
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 599 --RGYLTDKADVYSFGIVALEIVSGRS 623
+G + D +S G+ E++ G +
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 48/184 (26%), Positives = 85/184 (46%), Gaps = 28/184 (15%)
Query: 448 VAVKQLS------SKSKQGNREFVNEIGMISALQHPNLVKL------HGCCIEGNQLLLI 495
VA+K+LS + +K+ RE V ++ + H N++ L E + L+
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 100
Query: 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNV 555
E M+ N L + + +++LD + + G+ +LH I+HRD+K +N+
Sbjct: 101 MELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNI 150
Query: 556 LLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVA 615
++ D KI DFGLA+ + + T T Y APE + + D++S G +
Sbjct: 151 VVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 208
Query: 616 LEIV 619
E+V
Sbjct: 209 GEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 48/197 (24%)
Query: 448 VAVKQLS------SKSKQGNREFVNEIGMISALQHPNLVKL------HGCCIEGNQLLLI 495
VA+K+LS + +K+ RE V ++ + H N++ L E + ++
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 107
Query: 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNV 555
E M+ N L + + +++LD + + G+ +LH I+HRD+K +N+
Sbjct: 108 MELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNI 157
Query: 556 LLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGY----------LTDK 605
++ D KI DFGLA R AGT M P R Y +
Sbjct: 158 VVKSDCTLKILDFGLA------------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 606 ADVYSFGIVALEIVSGR 622
D++S G + E++ G
Sbjct: 206 VDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 29/88 (32%), Positives = 50/88 (56%), Gaps = 4/88 (4%)
Query: 534 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 593
L LH+ +++RD+K N+LLD + + DFGL KL+ +D+ +T GT Y+A
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLA 161
Query: 594 PEYAMRGYLTDKADVYSFGIVALEIVSG 621
PE + T D ++ G++ E+++G
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 27/167 (16%)
Query: 464 FVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTR 523
F ++S + H +L +HG C+ G++ +++ E++E+ L L + K P
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL-----RKEKGRVPVA 117
Query: 524 HRICVG--IARGLAYLHEESRLKIVHRDIKATNVLLDK-----DLNP--KISDFG--LAK 572
+I V +A L+YL +++ +VH ++ A N+LL + +P K+SD G
Sbjct: 118 WKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA 174
Query: 573 LDEEDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEI 618
L E+ R+ ++APE G L+ AD +SFG LEI
Sbjct: 175 LSREERVE---RIP----WIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 413 LRQIKAATNNFAPDNKIGEGGFGPV-YKGHMADGTVVAVKQLSSKS--KQGNREFVNEIG 469
+R ++ ++ IG G FG V H + V A+K LS K+ + F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 470 MISALQH-PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICV 528
I A + P +V+L + L ++ EYM L + + + W + V
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEV 151
Query: 529 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTHISTRVAG 587
+A L +H + +HRD+K N+LLDK + K++DFG K+++E T V G
Sbjct: 152 VLA--LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 205
Query: 588 TFGYMAPEYAMR----GYLTDKADVYSFGIVALEIVSG 621
T Y++PE GY + D +S G+ E++ G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 11/99 (11%)
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK----LDEEDNTHISTRV 585
I GL Y+H + ++HRD+K N+L++ D KI DFGLA+ E+ ++ V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 586 AGTFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGR 622
A T Y APE + + Y T DV+S G + E++ +
Sbjct: 171 A-TRWYRAPEIMLSFQSY-TKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 40/163 (24%), Positives = 72/163 (44%), Gaps = 19/163 (11%)
Query: 466 NEIGMISALQHPNLVKLHGCC-IEGNQLLL-------IYEYMENNSLARALFGPEAHRLK 517
NEI + L H N++K+ E N ++ +Y +M + + +
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF-------DWKDRP 264
Query: 518 LDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577
L TR I + + Y+H++ K++HRDIK N+ L+ D + DFG A E++
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
GT +PE + D++S G++ L+++S
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 62/243 (25%), Positives = 91/243 (37%), Gaps = 59/243 (24%)
Query: 423 FAPDNKIGEGGFGPVYKGHMAD-GTVVAVKQLSSKSKQGNREFVN----EIGMISALQHP 477
F +G+G G V+ + G + A+K L K R V E +++ L HP
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHP 61
Query: 478 NLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIAR----- 532
L L+ L L+ +Y G E RL L + +AR
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCP---------GGELFRL-LQRQPGKCLSEEVARFYAAE 111
Query: 533 ---GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK----------------- 572
L YLH L IV+RD+K N+LL + + +SDF L+K
Sbjct: 112 VLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 573 ------------LDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKA-DVYSFGIVALEIV 619
EE + S GT Y+APE + G A D ++ GI+ E++
Sbjct: 169 RRSSVNSIPSETFSEEPSF-RSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEML 226
Query: 620 SGR 622
G
Sbjct: 227 YGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 429 IGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNRE----FVNEIGMISALQHPNLVKLHG 484
IG G FG V + + V ++ +K + R F E ++ + + LH
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+ N L L+ +Y L L RL D + +A + + +L
Sbjct: 69 AFQDENNLYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFY-----LAEMVIAIDSVHQLH 122
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY--AM---R 599
VHRDIK N+L+D + + +++DFG ED T S+ GT Y++PE AM +
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 600 GYLTDKADVYSFGIVALEIVSGRS 623
G + D +S G+ E++ G +
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 61/232 (26%), Positives = 108/232 (46%), Gaps = 53/232 (22%)
Query: 417 KAATNNFAPDNKIGEGGFGPVYKGHMADGT-VVAVKQLSSKSKQGNREFVNEIGMISALQ 475
++ ++ N IG G FG VY+ D + VA+K++ + NRE + ++ L
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLN 117
Query: 476 HPNLVKL----HGCCIEGNQ--LLL----------IYEYME-----NNSLARALFGPEAH 514
H N++ L + C + N+ + L +++YM+ N++L L
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFL------ 171
Query: 515 RLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAK- 572
+KL +++C R LAY+H + I HRD+K N+L+D + + K+ DFG AK
Sbjct: 172 -VKL---YSYQLC----RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220
Query: 573 --LDEEDNTHISTRVAGTFGYMAPEYAMRGY-LTDKADVYSFGIVALEIVSG 621
+ ++I +R Y APE + T D++S G + E++ G
Sbjct: 221 LLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 29/87 (33%), Positives = 49/87 (56%), Gaps = 2/87 (2%)
Query: 38 GLVGPIPSGIASLSKLTDLRISDLNGTEAPFPP-LDKMKKMKTLILRSCNVSGKLPDYLG 96
GL G IP+ I+ L L + +S N PP L + ++ L L + +G +P+ LG
Sbjct: 429 GLRGFIPNDISKLRHLQSINLSG-NSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG 487
Query: 97 LMTSLKVLDVSFNKLNGAIPSTFMGLL 123
+TSL++L+++ N L+G +P+ G L
Sbjct: 488 QLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 589
IA + +H +L VHRDIK NVLLD + + +++DFG +D T S+ GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167
Query: 590 GYMAPEY--AMR---GYLTDKADVYSFGIVALEIVSGRS 623
Y++PE AM G + D +S G+ E++ G +
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 56/272 (20%), Positives = 105/272 (38%), Gaps = 43/272 (15%)
Query: 437 VYKGHMADGTVV--AVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGN---- 490
+YKG + V+ K+ K NEI + + N++K++G I+
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDI 550
+L LI EY L L + L + T+ + + +GL L++ + ++++
Sbjct: 96 RLSLILEYCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNL 149
Query: 551 KATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD------ 604
+ + L+ ++ KI GL K+ +S+ +M Y L D
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI-------LSSPPFKNVNFMV--YFSYKMLNDIFSEYT 200
Query: 605 -KADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDK 663
K D+YS G+V EI +G P E+ L I +++K
Sbjct: 201 IKDDIYSLGVVLWEIFTG-----KIPFEN----LTTKEIYDL------IINKNNSLKLPL 245
Query: 664 EQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ + + + CT S RP++ ++ L
Sbjct: 246 DCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 17/153 (11%)
Query: 429 IGEGGFGPVYKGHMA-DGTVVAVKQLSSKSKQGNREFVNEI----GMISALQHPNLVKLH 483
I G FG VY G + + AVK + K+ N+ V+++ ++ + P +V L+
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 484 GCCIEGNQLLLIYEYMENNSLAR--ALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
N + L+ EY+ + ++G D + +A L YLH
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRHG 124
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574
I+HRD+K N+L+ + + K++DFGL+K+
Sbjct: 125 ---IIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 9e-06
Identities = 19/60 (31%), Positives = 30/60 (50%)
Query: 76 KMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLL 135
+K+L L + ++ + +LKVLD+S N L P F GL + + L+GN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 1e-05
Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 46/239 (19%)
Query: 421 NNFAPDNKIGEGGFGPVY-KGHMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHP 477
N + KIG G FG V+ H K +S + ++ + V E+ ++ L+H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 478 NLVK-LHGCCIEGNQ-LLLIYEYMENNSLAR------ALFGPEAHRLKLDWPTRHRICVG 529
N+V+ + + NQ L ++ E+ + L+R +FG +D I
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD------ITRQ 126
Query: 530 IARGLAYLHE----ESRLKIVHRDIKATNVLLD-------------KDLN----PKISDF 568
+ LAY H + +++HRD+K N+ L +LN KI DF
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186
Query: 569 GLAK-LDEEDNTHISTRVAGTFGYMAPE---YAMRGYLTDKADVYSFGIVALEIVSGRS 623
GL+K + E H GT Y +PE + + Y DK+D+++ G + E+ SG++
Sbjct: 187 GLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSY-DDKSDMWALGCIIYELCSGKT 241
|
Length = 1021 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 40/178 (22%), Positives = 71/178 (39%), Gaps = 62/178 (34%)
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLA---------------------------KLD 574
++ +HRDIK N+L+D+D + K++DFGL +
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 575 EEDNTHIST---------------RVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 619
E D + + GT Y+APE +R T D +S G++ E++
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 620 SGR----SNSSCKPKEDIFYLLDW--ALILKAQGNL----MELV-------DKRLGSN 660
G+ +++ P E +++W L + +Q L +L+ + RLG N
Sbjct: 239 VGQPPFLADT---PAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKN 293
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 41/227 (18%)
Query: 407 HTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVN 466
H G T QI A N+ D++ + K V +K L + + F
Sbjct: 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIK--------VILKVLDPSHRDISLAFFE 53
Query: 467 EIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPE---AHRLK--LDWP 521
M+ + H ++V L+G C+ + +++ E++E FGP HR L P
Sbjct: 54 TASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVE--------FGPLDLFMHRKSDVLTTP 105
Query: 522 TRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL-----DKDLNP--KISDFG--LAK 572
+ ++ +A L+YL ++ +VH ++ N+LL D + P K+SD G +
Sbjct: 106 WKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV 162
Query: 573 LDEEDNTHISTRVAGTFGYMAPEYAM-RGYLTDKADVYSFGIVALEI 618
L ++ R+ ++APE L+ AD +SFG EI
Sbjct: 163 LSRQECVE---RIP----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 42/155 (27%), Positives = 68/155 (43%), Gaps = 11/155 (7%)
Query: 421 NNFAPDNKIGEGGFGPV-YKGHMADGTVVAVKQL--SSKSKQGNREFVN-EIGMISALQH 476
+F IG+G FG V G + A+K L S K+ V E +++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 477 PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
P +V L+ + L LI E++ L L +K D + +A +
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML-------IKYDTFSEDVTRFYMAECVLA 113
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571
+ +L +HRDIK N+L+D+ + K+SDFGL+
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 61/251 (24%), Positives = 96/251 (38%), Gaps = 48/251 (19%)
Query: 429 IGEGGFGPVYKGHMAD-GTVVAVKQLSSKSKQGNREFVNEI----GMISALQHPNLVKLH 483
IG G FG V D G V A+K L K+ +E V I ++ +VK+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILR-KADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
+ L LI E++ + L +K D T IA + + +L
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLL-------MKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGL--------------------------------- 570
+HRDIK N+LLD + K+SDFGL
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 571 -AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSN-SSCK 628
A+ + + ++ GT Y+APE M+ D +S G++ E++ G S
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 629 PKEDIFYLLDW 639
P+E +++W
Sbjct: 241 PQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 37/155 (23%), Positives = 64/155 (41%), Gaps = 15/155 (9%)
Query: 477 PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
PN+V LH + + + L+ ++ E L + + L + R + L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI----SKFLNIPEECVKRWAAEMVVALDA 100
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE--DNTHISTRVAGTFGYMAP 594
LH E IV RD+ N+LLD + +++ F E+ D + Y AP
Sbjct: 101 LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAP 151
Query: 595 EYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKP 629
E T+ D +S G + E+++G++ C P
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 60/259 (23%), Positives = 100/259 (38%), Gaps = 48/259 (18%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHMAD-GTVVAVKQLSSKSKQGNREFVNEI----GMISALQ 475
++F IG G FG V D G + A+K L K+ +E V I ++
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDILVEAD 59
Query: 476 HPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLA 535
+VK+ + L LI E++ + L +K D + IA +
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL-------MKKDTLSEEATQFYIAETVL 112
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL------------------------- 570
+ +L +HRDIK N+LLD + K+SDFGL
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 571 ---------AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 621
A+ +++ ++ GT Y+APE M+ D +S G++ E++ G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 622 RSN-SSCKPKEDIFYLLDW 639
S P+E +++W
Sbjct: 233 YPPFCSETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 27/161 (16%)
Query: 476 HPNLVKLHGCCIEGNQLLLIYEYMENNSLARAL----FGPEAHRLKLDWPTRHRICVGIA 531
HPN+V I N+L ++ +M S A+ L F L + + I G+
Sbjct: 58 HPNIVPYRATFIADNELWVVTSFMAYGS-AKDLICTHFMDGMSELAIAY-----ILQGVL 111
Query: 532 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG- 590
+ L Y+H + VHR +KA+++L+ D +S GL N RV F
Sbjct: 112 KALDYIHH---MGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPK 166
Query: 591 -------YMAPEYA---MRGYLTDKADVYSFGIVALEIVSG 621
+++PE ++GY K+D+YS GI A E+ +G
Sbjct: 167 YSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 3e-04
Identities = 40/152 (26%), Positives = 68/152 (44%), Gaps = 23/152 (15%)
Query: 476 HPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIAR--- 532
+PN +KL+ +LI +Y+++ L F LK + I R
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----F----DLLKKEGKLSEAEVKKIIRQLV 119
Query: 533 -GLAYLHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAKLDEEDNTHISTRVAGTFG 590
L LH + I+H DIK NVL D+ + + D+GL K + GT
Sbjct: 120 EALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLD 171
Query: 591 YMAPEYAMRGYLTDKA-DVYSFGIVALEIVSG 621
Y +PE ++G+ D + D ++ G++ E+++G
Sbjct: 172 YFSPE-KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 6/155 (3%)
Query: 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNG 63
LK+ +S N + +P + N + L L + + + +P I LS L +L +S+ +
Sbjct: 164 NLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGN-KISDLPPEIELLSALEELDLSNNSI 221
Query: 64 TEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLL 123
E L +K + L L S N LP+ +G +++L+ LD+S N+++ S+ L
Sbjct: 222 IELL-SSLSNLKNLSGLEL-SNNKLEDLPESIGNLSNLETLDLSNNQIS--SISSLGSLT 277
Query: 124 DVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
++ + L+GN L+ +P L L T
Sbjct: 278 NLRELDLSGNSLSNALPLIALLLLLLELLLNLLLT 312
|
Length = 394 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 55/262 (20%), Positives = 99/262 (37%), Gaps = 78/262 (29%)
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLA------------------KLDEEDNTH--- 580
++ +HRDIK N+L+D+D + K++DFGL + D D ++
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 581 -------------------------ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVA 615
++ + GT Y+APE +R T D +S G++
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 616 LEIVSGRSNS-SCKPKEDIFYLLDW--ALILKAQGNL----MELV-------DKRLGSNF 661
E++ G+ + P E +++W +L + Q L +L+ + RLG N
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNG 298
Query: 662 DKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQDFVP--------DSSVVSNI 713
E + + D SS R + + + D +F P D N+
Sbjct: 299 ADE---IKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFDPVDPDKLWSDDDKEGNV 355
Query: 714 DKTKSEAIRN-------YYEFS 728
+ T + +N +YEF+
Sbjct: 356 NDTLNGWYKNGKHPEHAFYEFT 377
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 28/78 (35%), Positives = 41/78 (52%), Gaps = 8/78 (10%)
Query: 429 IGEGGFGPVYK------GHMADGTVVAVKQLSSKSKQGNRE-FVNEIGMISAL-QHPNLV 480
+G G FG V + G + VAVK L + + RE ++E+ ++S L QH N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 481 KLHGCCIEGNQLLLIYEY 498
L G C G +L+I EY
Sbjct: 106 NLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 33/149 (22%), Positives = 55/149 (36%), Gaps = 16/149 (10%)
Query: 428 KIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLV-KLHGC 485
+ G VY D V +K S+ K +RE E+ ++ L + V K+
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LKINPSREKGADRE--REVAILQLLARKGLPVPKVLAS 61
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
L+ E++E +L + + I +A LA LH+ L +
Sbjct: 62 GESDGWSYLLMEWIEGETLD--------EVSEEEKE---DIAEQLAELLAKLHQLPLLVL 110
Query: 546 VHRDIKATNVLLDKDLNPKISDFGLAKLD 574
H D+ N+L+D I D+ A
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 37/153 (24%), Positives = 65/153 (42%), Gaps = 27/153 (17%)
Query: 10 ISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFP 69
+S + +GKI + I ++ + + + L GPIP I + S
Sbjct: 76 LSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSS----------------- 118
Query: 70 PLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIY 129
++ L L + N +G +P G + +L+ LD+S N L+G IP+ + +
Sbjct: 119 ------SLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD 170
Query: 130 LTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAG 160
L GN+L G IP + L + + L+ N
Sbjct: 171 LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQ 203
|
Length = 968 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 29/83 (34%), Positives = 40/83 (48%), Gaps = 4/83 (4%)
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED-NTHISTRVAGTFGYMAP 594
Y+H E I+HRDIK NVL++ + + DFG A +T +AGT AP
Sbjct: 275 YIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331
Query: 595 EYAMRGYLTDKADVYSFGIVALE 617
E T D++S G+V E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 28/97 (28%), Positives = 36/97 (37%), Gaps = 27/97 (27%)
Query: 526 ICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD-----EEDNTH 580
+C+ L LH R K+ N+LL D GL KLD +
Sbjct: 22 VCLQCLGALRELH---------RQAKSGNILLTWD--------GLLKLDGSVAFKTPEQS 64
Query: 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALE 617
+MAPE T+KAD+YS GI E
Sbjct: 65 RPDPY-----FMAPEVIQGQSYTEKADIYSLGITLYE 96
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.0 bits (84), Expect = 0.004
Identities = 21/61 (34%), Positives = 31/61 (50%), Gaps = 4/61 (6%)
Query: 100 SLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRV---DLSYNS 156
+LK LD+S N+L F GL ++ + L+GN LT +I P + DLS N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 157 F 157
Sbjct: 60 L 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 771 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.67 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.67 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.51 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.49 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.44 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.44 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.41 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.38 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.38 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.37 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.35 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.32 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.31 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.26 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.25 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.13 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.11 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.01 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.99 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.93 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.86 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.83 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.77 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.74 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.71 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.67 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.64 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.52 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.49 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.47 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.44 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.41 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.39 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.39 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.38 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.29 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-62 Score=607.03 Aligned_cols=561 Identities=25% Similarity=0.375 Sum_probs=390.5
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|++++|++++.+|..++++++|+.|+|++|++++.+|..|..+++|+.|+|++|++++..+..+..+++|+.|+
T Consensus 379 ~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 458 (968)
T PLN00113 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLS 458 (968)
T ss_pred cCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEE
Confidence 46788899999999888898888899999999999999988898898999999999999998888877788888888888
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCcccc
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~ 159 (771)
|++|++.|.+|..+ .+++|+.|+|++|++++.+|..|.++++|+.|+|++|+++|.+|..+ +++|+.|+|++|.+++
T Consensus 459 L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 537 (968)
T PLN00113 459 LARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSG 537 (968)
T ss_pred CcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccc
Confidence 88888888888765 45788888888888888888888888888888888888888888877 7888888888888888
Q ss_pred CCCcccccccccceeccCCCCCCCCCccc-cccCCcCCCceeeEEEeeCCceeeecCCeeecCCCCCCCCcceeccCCCc
Q 004155 160 GSSETSCQYRSVNLFASSSKGNNSTGIVS-CLRSFRCPKTYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAFRGSNN 238 (771)
Q Consensus 160 ~~p~~~~~l~~L~~l~~s~~~~~~~~~~~-c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (771)
.+|..+..+++|+.|+++.|.- .+..+ .... ..... .+.+.+|.. .+.
T Consensus 538 ~~p~~~~~l~~L~~L~Ls~N~l--~~~~p~~l~~-l~~L~-----------~l~ls~N~l-------~~~---------- 586 (968)
T PLN00113 538 QIPASFSEMPVLSQLDLSQNQL--SGEIPKNLGN-VESLV-----------QVNISHNHL-------HGS---------- 586 (968)
T ss_pred cCChhHhCcccCCEEECCCCcc--cccCChhHhc-CcccC-----------EEeccCCcc-------eee----------
Confidence 8888888888888888875433 32221 1111 00111 111111110 000
Q ss_pred eeeccccccccCCCCCcceeeecceeeeccCcccccceEEEEEecCeeccccCCcchhcCCcCcceeeeeeeeeecceeE
Q 004155 239 WAFSNTGHFLDDDRPADTYIQTNTSILLMNDSHSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVINSTIE 318 (771)
Q Consensus 239 ~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~ 318 (771)
.+..+.|.. |+.
T Consensus 587 --~p~~~~~~~-----------------------------------------~~~------------------------- 598 (968)
T PLN00113 587 --LPSTGAFLA-----------------------------------------INA------------------------- 598 (968)
T ss_pred --CCCcchhcc-----------------------------------------cCh-------------------------
Confidence 000000000 000
Q ss_pred EEEEEcCCcceecccCCCCCCcccccccCCCCCCCCCCCCCCccccceeehhHHHHHHHHHH-HHHhhhhcccccCC-cc
Q 004155 319 IRLYWAGKGTTGVPVRGVYGPLISAISLNPDFIPPSENGSSSSISAGTVVGIVAATTFVIIL-LVGILWWKGCFRPE-HT 396 (771)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~iv~i~~~~~~~~~~-~~~~~~~~~~~~~~-~~ 396 (771)
.-+..+.+.|+.+. ....+|+... .....++.++++++++++++++ ++++++++++++.. +.
T Consensus 599 -~~~~~n~~lc~~~~-------------~~~~~~c~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 662 (968)
T PLN00113 599 -SAVAGNIDLCGGDT-------------TSGLPPCKRV--RKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKR 662 (968)
T ss_pred -hhhcCCccccCCcc-------------ccCCCCCccc--cccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccc
Confidence 00001111111000 0000111110 1111223333333333333222 22233333222111 11
Q ss_pred hhhhh--ccccc----ccCCCCHHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHH
Q 004155 397 LEQEL--RGVDL----HTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIG 469 (771)
Q Consensus 397 ~~~~~--~~~~~----~~~~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~ 469 (771)
.+.+. ..... ....++++++ ...|...+.||+|+||.||+|.. .+|+.||||++...... ...|++
T Consensus 663 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~ 735 (968)
T PLN00113 663 VENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIA 735 (968)
T ss_pred cccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHH
Confidence 11100 00000 0112334443 45678889999999999999964 67899999998653322 234688
Q ss_pred HHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccC
Q 004155 470 MISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRD 549 (771)
Q Consensus 470 ~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~D 549 (771)
++++++|||||+++++|.+.+..++||||+++|+|.++++ .++|.++.+|+.|||+||+|||..+.++|+|||
T Consensus 736 ~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~d 808 (968)
T PLN00113 736 DMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808 (968)
T ss_pred HHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCC
Confidence 9999999999999999999999999999999999999993 489999999999999999999977667999999
Q ss_pred CCCCcEEEcCCCCeEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Q 004155 550 IKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKP 629 (771)
Q Consensus 550 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~ 629 (771)
|||+||+++.++.+++. ||.+...... ....||..|+|||++.+..++.++|||||||++|||+||+.||+...
T Consensus 809 lkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~ 882 (968)
T PLN00113 809 LSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882 (968)
T ss_pred CCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc
Confidence 99999999999988876 6665533221 12357899999999999999999999999999999999999996432
Q ss_pred ccchhhHHHHHHHHHhhCChhHHhhhhcCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 630 KEDIFYLLDWALILKAQGNLMELVDKRLGS--NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
. ......+|++...........+|+.+.. ..+.++..++.+++.+||+.||++||+|.||+++|+++..
T Consensus 883 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 883 G-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred C-CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2 2334667776655555566667776643 2345677789999999999999999999999999998644
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-56 Score=482.68 Aligned_cols=292 Identities=52% Similarity=0.866 Sum_probs=258.8
Q ss_pred ccCCCCHHHHHHHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEE
Q 004155 407 HTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486 (771)
Q Consensus 407 ~~~~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 486 (771)
....|++++++.||++|...++||+|+||.||+|.+.+|+.||||++........++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 35679999999999999999999999999999999999999999988765433156699999999999999999999999
Q ss_pred EeCC-EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEE
Q 004155 487 IEGN-QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 565 (771)
Q Consensus 487 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 565 (771)
.+.+ +.+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9988 599999999999999999876543 8999999999999999999999998889999999999999999999999
Q ss_pred EeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh
Q 004155 566 SDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA 645 (771)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 645 (771)
+|||+|+..........+...||.+|+|||++..+..+.|+|||||||+|+||+||+++.+.........+++|++....
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99999976554122211111799999999999999999999999999999999999999887655555569999999999
Q ss_pred hCChhHHhhhhcC-CCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 646 QGNLMELVDKRLG-SNFDK-EQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 646 ~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
.+.+.+++|+.+. ..++. +++.++..++.+|++.+|++||+|.||+++|+.+...
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 9999999999987 56664 6888999999999999999999999999999665443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=401.07 Aligned_cols=253 Identities=36% Similarity=0.547 Sum_probs=211.8
Q ss_pred CCccccCCceeEEEEEcCCCcEEEEEEcccCChh--cHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC-EEEEEEEeccCC
Q 004155 426 DNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLHGCCIEGN-QLLLIYEYMENN 502 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~~~~g 502 (771)
.+.||+|+||+||+|.+.....||||++...... ..+.|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4569999999999999964344999999764322 2569999999999999999999999999887 799999999999
Q ss_pred CHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCc-eeccCCCCCcEEEcCCC-CeEEEeecCccccCCCCcc
Q 004155 503 SLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK-IVHRDIKATNVLLDKDL-NPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~ 580 (771)
+|.++++.. .+..+++..+++||.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 126 sL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 126 SLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred cHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 999999764 346899999999999999999999998 5 99999999999999997 99999999998765432 2
Q ss_pred cccccccCCCccchhhhc--cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 581 ISTRVAGTFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~--~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
..+...||+.|||||++. ...++.|+||||||+++|||+||+.||........ ...++....+
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~---------------~~~v~~~~~R 264 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV---------------ASAVVVGGLR 264 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH---------------HHHHHhcCCC
Confidence 223367999999999999 56999999999999999999999999986544211 1122223333
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
...+......+..++.+||+.||++||++.+++.+|+.+..
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 44444567778999999999999999999999999997654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=373.43 Aligned_cols=253 Identities=29% Similarity=0.453 Sum_probs=211.4
Q ss_pred CCHHHHHHHhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe
Q 004155 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIE 488 (771)
Q Consensus 411 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 488 (771)
+++.|++. .+.||+|..|+|||+ +..+++.+|+|++... .....+++.+|++++++.+||+||+++|.|..
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 56666654 589999999999999 6678999999999544 34457889999999999999999999999999
Q ss_pred CC-EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEe
Q 004155 489 GN-QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 567 (771)
Q Consensus 489 ~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 567 (771)
.. ...++||||++|||++++.. ..++++...-+|+.+|++||.|||+.. +||||||||+|||++..|++||+|
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicD 222 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICD 222 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEecc
Confidence 88 59999999999999999932 256999999999999999999999742 899999999999999999999999
Q ss_pred ecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--ccchhhHHHHHHHHHh
Q 004155 568 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKP--KEDIFYLLDWALILKA 645 (771)
Q Consensus 568 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~--~~~~~~~~~~~~~~~~ 645 (771)
||.++.+.+. .....+||..|||||.+.+..|+.++||||||++++|+.+|+.|+.... ......++.
T Consensus 223 FGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~------- 292 (364)
T KOG0581|consen 223 FGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC------- 292 (364)
T ss_pred ccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH-------
Confidence 9999876554 4456789999999999999999999999999999999999999997641 222222222
Q ss_pred hCChhHHhhhhcCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 646 QGNLMELVDKRLGSNFDK-EQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 646 ~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+++... ...+. ....++..++..||++||.+||++.|+++
T Consensus 293 -----~Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 293 -----AIVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred -----HHhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2333211 22222 25567999999999999999999999986
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=390.51 Aligned_cols=247 Identities=28% Similarity=0.441 Sum_probs=211.4
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
.+|...+.||+|||+.||.+.. ..|..||+|++.+. .....+...+|+++.+.|+|||||+++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999965 88999999999764 3344677889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
|+|++++|..++. .+.++++.++..++.||+.||.|||++ +|+|||||-.|+||++++++||+|||+|.....
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999993 456899999999999999999999999 899999999999999999999999999998765
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
+... ....+||+.|+|||++.....+..+||||+|||+|-|++|++||+.....+...-+.. -+-
T Consensus 171 ~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~-------------~~Y- 235 (592)
T KOG0575|consen 171 DGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL-------------NEY- 235 (592)
T ss_pred cccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-------------cCc-
Confidence 4332 3457899999999999999999999999999999999999999986544443322210 011
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+.....+..+|+.++|+.||.+|||+++|+.
T Consensus 236 ---~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 ---SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ---ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 112233345678999999999999999999996
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=371.32 Aligned_cols=204 Identities=31% Similarity=0.554 Sum_probs=182.0
Q ss_pred hcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
..+|...+.||+|+||+||+| ...++..||||.+.+. .+...+.+..|+.+|+.++|||||.+++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888889999999999999 4556899999999776 5556677899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC------CCeEEEeecC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD------LNPKISDFGL 570 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DFGl 570 (771)
|||.||+|.+|++. ...+++.++..++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999944 34799999999999999999999999 89999999999999764 4689999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKED 632 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~ 632 (771)
||.+.... .....+|++.|||||+++..+|+.|+|+||+|+++|+|++|++||......+
T Consensus 162 AR~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 162 ARFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hhhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 99887433 3355789999999999999999999999999999999999999998655443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=361.94 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=212.1
Q ss_pred CCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEE-EEEeCCE-EEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHG-CCIEGNQ-LLLIY 496 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lV~ 496 (771)
+|.+.++||+|.||+|||+ .+.+|..||.|.+.-. .....+....|+.+|++++|||||++++ .+.++.+ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 4566789999999999999 7789999999998743 3445677899999999999999999999 4555555 89999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCC-CceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR-LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||..|+|.+.+......+..+++..+++++.|+++||.++|+.-+ .-|+||||||.||+++.+|.+||+|||+++++.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999997777777889999999999999999999999432 138999999999999999999999999999887
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
...+. ....+|||.||+||.+....|+.|+||||+||++|||+.-++||.++.. ..+.+ ....++.
T Consensus 180 s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~---~~L~~----KI~qgd~------ 245 (375)
T KOG0591|consen 180 SKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL---LSLCK----KIEQGDY------ 245 (375)
T ss_pred chhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH---HHHHH----HHHcCCC------
Confidence 65443 3457899999999999999999999999999999999999999986521 11111 1111111
Q ss_pred hcCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 656 RLGSNFD-KEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 656 ~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
...+ .-....+..++..|+..||+.||+...++..+...
T Consensus 246 ---~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 246 ---PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred ---CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 1122 34566788999999999999999966666555543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=372.43 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=202.4
Q ss_pred HhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCCh-------hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSK-------QGNREFVNEIGMISALQHPNLVKLHGCCIEGN 490 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 490 (771)
..+.|.+.+.||+|+||.|-+| ...+|+.||||++++... .......+|+++|++++|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3456788899999999999999 667899999999976421 12334679999999999999999999999999
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC---CCeEEEe
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNPKISD 567 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~D 567 (771)
..|+|||||+||.|.+.+-. +..+.+..-.-++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999943 34577777889999999999999999 99999999999999655 7899999
Q ss_pred ecCccccCCCCcccccccccCCCccchhhhccCC---CCchHhHHHHHHHHHHHHhCCCCCCCCCccc-hhhHHHHHHHH
Q 004155 568 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGY---LTDKADVYSFGIVALEIVSGRSNSSCKPKED-IFYLLDWALIL 643 (771)
Q Consensus 568 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDV~S~Gvil~elltG~~p~~~~~~~~-~~~~~~~~~~~ 643 (771)
||+|+...+. ......+||+.|.|||++.... +..|.|+||+||+||-+++|.+||.....+. ....+
T Consensus 323 FGlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI------ 394 (475)
T KOG0615|consen 323 FGLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI------ 394 (475)
T ss_pred cchhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH------
Confidence 9999987633 3345678999999999998653 3448899999999999999999997643322 11100
Q ss_pred HhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 644 KAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 644 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..++.. .......+..++.++++.+||..||++||++.|+++
T Consensus 395 -~~G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 -LKGRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -hcCccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 011000 011122345567889999999999999999999986
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=382.93 Aligned_cols=252 Identities=30% Similarity=0.466 Sum_probs=215.4
Q ss_pred CCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCH
Q 004155 425 PDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL 504 (771)
Q Consensus 425 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 504 (771)
..+.||+|-||.||.|.+.....||+|.++.. ....+.|.+|+++|.+|+|++||+++|+|..++.++||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 35899999999999999977779999999875 33457899999999999999999999999998899999999999999
Q ss_pred HHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccccc
Q 004155 505 ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 584 (771)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 584 (771)
.++|+. ..+..+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+||...++.......
T Consensus 289 l~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 289 LDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred HHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 999965 2346789999999999999999999999 89999999999999999999999999999655444433344
Q ss_pred cccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCH
Q 004155 585 VAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDK 663 (771)
Q Consensus 585 ~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 663 (771)
..-...|.|||.+..+.++.|||||||||+||||+| |+.|+......+. .+.++...+-..+.
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev----------------~~~le~GyRlp~P~ 427 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV----------------LELLERGYRLPRPE 427 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH----------------HHHHhccCcCCCCC
Confidence 445678999999999999999999999999999999 8888876544332 23344444444555
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 664 EQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 664 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
.++..+.+++..||..+|++|||+..+...|+...
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 67788999999999999999999999999888754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=356.34 Aligned_cols=243 Identities=26% Similarity=0.366 Sum_probs=201.9
Q ss_pred hcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
.++|++.++||+|+||.||.+ ...+++.+|+|++++.. ....+....|..+|.+++||+||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467899999999999999999 44568999999998752 23456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
+||+.||.|..+|. +...+++..+.-++.+|+.||.|||+. +||||||||+|||||.+|+++|+|||+++...
T Consensus 104 ld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999993 345799999999999999999999999 89999999999999999999999999999654
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.... .+...+||+.|||||++.+..++..+|.||+|+++|||++|.+||........... +...
T Consensus 177 ~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~---------------I~~~ 240 (357)
T KOG0598|consen 177 KDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDK---------------ILKG 240 (357)
T ss_pred cCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHH---------------HhcC
Confidence 4433 23447899999999999999999999999999999999999999986543322211 1111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPS 686 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 686 (771)
.+ ...+.-...+..+++...+..||++|--
T Consensus 241 k~-~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 241 KL-PLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred cC-CCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 11 1111112345678889999999999963
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=385.39 Aligned_cols=261 Identities=30% Similarity=0.494 Sum_probs=216.3
Q ss_pred cCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCChh-cHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
.+....+.||+|+||+||+|+.. +.+.||||.++..... ...+|++|++++..++|||||+++|.|.+++..|
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 44556789999999999999543 3467999999987655 7889999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcCCCc----------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCe
Q 004155 494 LIYEYMENNSLARALFGPEA----------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 563 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 563 (771)
+|+|||..|+|.++|..... .+.+++..+.+.||.|||.||+||-++ .+|||||..+|+||.++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 99999999999999954311 134589999999999999999999998 79999999999999999999
Q ss_pred EEEeecCccccCCCCccc-ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHH
Q 004155 564 KISDFGLAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWAL 641 (771)
Q Consensus 564 kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 641 (771)
||+|||++|..-..+.+. .....-.++|||||.+..+++|.+||||||||+|||+++ |+.||.....++....+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i---- 718 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI---- 718 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH----
Confidence 999999998543332221 112234579999999999999999999999999999998 99999876555443222
Q ss_pred HHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 642 ILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 642 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
..+++ -..+..++.++.+|+..||+..|++||+++||-..|+.....
T Consensus 719 ---~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 719 ---RAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ---HcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 12222 344556778899999999999999999999999999886543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=359.51 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=208.0
Q ss_pred HHHhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCE
Q 004155 417 KAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK---SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 417 ~~~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 491 (771)
+...++|...+.||+|+|++||+| ....++.||||++.+. .....+-...|-++|.+| .||.|++|+..|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 344568889999999999999999 5567999999998764 222345567788999999 89999999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
+|+|+||+++|+|.++|+ ....+++.....++.+|+.||+|||++ |||||||||+|||||+||++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~----K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIK----KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHH----HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence 999999999999999994 345799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcc----------cc--cccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHH
Q 004155 572 KLDEEDNTH----------IS--TRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDW 639 (771)
Q Consensus 572 ~~~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~ 639 (771)
+.+...... .. ..++||..|.+||++.++..++.+|+|+||||||+|+.|++||....+-..+..
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk--- 298 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK--- 298 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH---
Confidence 977542211 11 447899999999999999999999999999999999999999986543222111
Q ss_pred HHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 640 ALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 640 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+.+ ++-.+...++ +...+|+.+.|..||.+|++..++.+
T Consensus 299 ---------I~~-l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 299 ---------IQA-LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ---------HHH-hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhh
Confidence 011 1222223333 45778899999999999999988876
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=339.50 Aligned_cols=262 Identities=22% Similarity=0.349 Sum_probs=206.8
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
+.|+...++|+|+||.|||++ ..+|+.||||++..... .-.+-.++|+.+|++++|+|+|.++..|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 457788899999999999994 45699999999875432 335667899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
||+. ++.+-| ......++...+.+++.|++.|+.|+|++ ++|||||||+|||++.++.+||||||+|+.+...
T Consensus 82 ~~dh-TvL~eL---e~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDH-TVLHEL---ERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecch-HHHHHH---HhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9987 444444 23345789999999999999999999999 8999999999999999999999999999988753
Q ss_pred CcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh-
Q 004155 578 NTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK- 655 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~- 655 (771)
....+..+.|..|+|||.+.+ .+|+...||||+||++.||++|.+.|.+..+-+..+.+........+ +..+++..
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p-rhq~iF~~N 232 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP-RHQSIFSSN 232 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH-HHHHHhccC
Confidence 334566778999999999987 68999999999999999999999999876655554444322110000 01111111
Q ss_pred ---------hc------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 ---------RL------GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ---------~l------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. ...++ .....+++++..|++.||++|++-++++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 00 01111 12236789999999999999999999874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=364.33 Aligned_cols=249 Identities=29% Similarity=0.479 Sum_probs=211.4
Q ss_pred cCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
..|....+||+|+.|.||.| +..+++.||||++........+-+.+|+.+|+..+|+|||++++.|...+++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 35667789999999999999 66778999999998776666777899999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
+||+|.+.+ ....+++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvV-----t~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVV-----TKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhh-----hcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999999 345699999999999999999999999 899999999999999999999999999987776554
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
.. ...+||+.|||||+.....|++|.||||||++++||+-|.+||-...+-...+++. ..+ . +. -
T Consensus 425 KR-~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa------~ng-~-----P~--l 489 (550)
T KOG0578|consen 425 KR-STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TNG-T-----PK--L 489 (550)
T ss_pred cc-ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh------hcC-C-----CC--c
Confidence 33 44679999999999999999999999999999999999999997543322222221 111 1 11 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.........+.+++.+||+.|+++||++.|+++
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 122234456889999999999999999999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=375.83 Aligned_cols=271 Identities=28% Similarity=0.458 Sum_probs=229.1
Q ss_pred cCCCCHHHHHHHhcC---------CCCCCccccCCceeEEEEEcCC----CcEEEEEEcccC-ChhcHHHHHHHHHHHHc
Q 004155 408 TGSFTLRQIKAATNN---------FAPDNKIGEGGFGPVYKGHMAD----GTVVAVKQLSSK-SKQGNREFVNEIGMISA 473 (771)
Q Consensus 408 ~~~~~~~~l~~~~~~---------f~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~ 473 (771)
...++|+|-..|... ..+.++||.|.||.||+|.++- ...||||.++.. .+...++|+.|+.+|.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 345777765555443 3567899999999999996642 357999999875 44567899999999999
Q ss_pred CCCCcEEeEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCC
Q 004155 474 LQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKAT 553 (771)
Q Consensus 474 l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~ 553 (771)
+.||||++|.|........+||+|||+||+|+.+|+.+. ..+++.+...++++||.|++||-+. ++|||||.++
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAAR 760 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAAR 760 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhh
Confidence 999999999999999999999999999999999996655 4599999999999999999999988 8999999999
Q ss_pred cEEEcCCCCeEEEeecCccccCCCCccccccccc--CCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCc
Q 004155 554 NVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG--TFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPK 630 (771)
Q Consensus 554 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~ 630 (771)
|||++.+..+|++|||++|.+.++.....+...| ..+|.|||.+...++|.++||||||+++||.++ |.+||.....
T Consensus 761 NILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 761 NILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred heeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 9999999999999999999887665433333333 468999999999999999999999999999886 9999876544
Q ss_pred cchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 631 EDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
++ +.+.+++..+...+.+++..+.+|++.||++|-.+||++.+++..|.+....
T Consensus 841 Qd----------------VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 841 QD----------------VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HH----------------HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 33 2344555555667788899999999999999999999999999999876543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=355.05 Aligned_cols=265 Identities=24% Similarity=0.375 Sum_probs=208.7
Q ss_pred cCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC--CEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEG--NQLLLI 495 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 495 (771)
+.|+..++||+|.||.||+| +..+|+.||+|++.... .....-..+||.+|++|+||||+++.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 34666789999999999999 67789999999997654 34456678999999999999999999998876 689999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
+|||+. +|.-++.. ....++..++..++.|++.||+|+|.+ +|+|||||.+|||||.+|.+||+|||+|+++.
T Consensus 197 FeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999987 88888833 345799999999999999999999999 89999999999999999999999999999888
Q ss_pred CCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChh--HH
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLM--EL 652 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 652 (771)
.......+..+-|..|+|||.+.+. .|+.+.|+||.||||.||++|++.|.+..+-+....+-.......+..+. ++
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 7766656667789999999999875 79999999999999999999999998765443332221111001111111 01
Q ss_pred hhhh-cC--CCCCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 653 VDKR-LG--SNFDK-------EQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 653 ~d~~-l~--~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.... +. ..+.. ......++|+..+|..||.+|.|+.+++.
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0000 00 01111 11235678999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=363.91 Aligned_cols=262 Identities=31% Similarity=0.506 Sum_probs=211.0
Q ss_pred HHHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 417 KAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 417 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
+...+.+.+...||+|.||+||+|.+. -.||||++... ..+..+.|++|+.++++-+|.||+-+.|||..+.. .|
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 333344556789999999999999885 35999999765 34567899999999999999999999999998877 99
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
|+.+|+|-+|..+||..+ ..++..+.+.||+|||+|+.|||.+ +|||||||+.|||+++++.|||+|||++...
T Consensus 465 iTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeee
Confidence 999999999999998755 4789999999999999999999999 8999999999999999999999999999633
Q ss_pred CC-CCcccccccccCCCccchhhhcc---CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChh
Q 004155 575 EE-DNTHISTRVAGTFGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLM 650 (771)
Q Consensus 575 ~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (771)
.. ..........|...|||||+++. .+|++.+||||||+|+|||+||..||.....+.+...+ ..|.+.
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV-------GrG~l~ 611 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV-------GRGYLM 611 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe-------cccccC
Confidence 22 11122233457889999999974 47999999999999999999999999854444332211 111110
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 651 ELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 651 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
.|. ........+++.+|+..||..++++||.+.+++.+|+....
T Consensus 612 --pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 --PDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred --ccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 010 11123456689999999999999999999999998888766
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=355.49 Aligned_cols=266 Identities=23% Similarity=0.333 Sum_probs=209.9
Q ss_pred HhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCC-EEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSK-QGNREFVNEIGMISALQ-HPNLVKLHGCCIEGN-QLLL 494 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 494 (771)
..++|...++||.|.||.||+| ...+|..||||++++.-. .++..=++|+..|++++ ||||+++.+.+.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 3467888899999999999999 566789999999987532 22334478999999998 999999999999887 9999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
|||||+. +|.+++..+ +..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+||..
T Consensus 88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999975 999999654 46899999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCcccccccccCCCccchhhhc-cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCCh----
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL---- 649 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 649 (771)
..... .+..+.|..|+|||++. .+.|+.+.|+||+|||++|+.+-++.|.+..+-+..+.+-.+........+
T Consensus 161 ~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 161 RSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 54433 35677899999999886 568999999999999999999999999776554443322111111111111
Q ss_pred --hHHhhhhcCC----C---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 650 --MELVDKRLGS----N---FDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 650 --~~~~d~~l~~----~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
...+.-.+.. . .-.....+.++++.+|+.+||++|||+.|+++.
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111110 0 011245678899999999999999999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=350.11 Aligned_cols=254 Identities=28% Similarity=0.409 Sum_probs=201.3
Q ss_pred cCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC--EEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGN--QLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~E 497 (771)
.+|...+.||+|+||+||++... +|...|||.+........+.+.+|+.+|++++|||||+.+|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45677899999999999999554 48999999987654333667899999999999999999999855444 6999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC-CCCeEEEeecCccccCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAKLDEE 576 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~ 576 (771)
|+++|+|.+++.... ..+++..+.+.+.||++||+|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999994332 2699999999999999999999998 8999999999999999 79999999999987663
Q ss_pred --CCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 577 --DNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 577 --~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
..........||+.|||||++..+ ....++|||||||++.||+||++||... . ....+........
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~---~~~~~~~~ig~~~------ 239 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--F---EEAEALLLIGRED------ 239 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--c---chHHHHHHHhccC------
Confidence 222223457899999999999964 3445999999999999999999999753 0 1111111111111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSML 694 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 694 (771)
....++........+++..|+..+|++|||++++++.-
T Consensus 240 ---~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 240 ---SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ---CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11123333445678899999999999999999999853
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=360.89 Aligned_cols=262 Identities=26% Similarity=0.415 Sum_probs=204.7
Q ss_pred HhcCCCCCCccccCCceeEEEEEc------CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeC-
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEG- 489 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 489 (771)
..++|++.++||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788999999999999999953 235789999987543 23356789999999999 899999999998764
Q ss_pred CEEEEEEEeccCCCHHHHhcCCCcc-------------------------------------------------------
Q 004155 490 NQLLLIYEYMENNSLARALFGPEAH------------------------------------------------------- 514 (771)
Q Consensus 490 ~~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------------------------- 514 (771)
...++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999999643210
Q ss_pred ---CCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc-ccccccCCC
Q 004155 515 ---RLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI-STRVAGTFG 590 (771)
Q Consensus 515 ---~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~ 590 (771)
...+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......... .....++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 23588899999999999999999998 89999999999999999999999999998654332221 122346778
Q ss_pred ccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHH
Q 004155 591 YMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVM 669 (771)
Q Consensus 591 y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 669 (771)
|+|||++.+..++.++|||||||++|||++ |+.||......+.. . .... .+.. ...+......+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~--~---~~~~-~~~~---------~~~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF--C---QRLK-DGTR---------MRAPENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH--H---HHHh-cCCC---------CCCCCCCCHHH
Confidence 999999999999999999999999999997 99999754322111 0 0111 1100 01112233468
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 670 INVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 670 ~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
.+++.+||+.||++||++.|++++|+...
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 89999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.63 Aligned_cols=246 Identities=27% Similarity=0.404 Sum_probs=209.1
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
++|.+.+.||+|+||+||||+ ..+.+.||+|.+.+.. +.+.+.+.+|++++++++||||+.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578888999999999999994 4568899999997643 3446678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+.| +|..+| .....++++.+..|+.++..||.|||+. +|+|||+||.|||++.++.+|++|||+|+.+..
T Consensus 82 ~a~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9987 999999 3456799999999999999999999999 899999999999999999999999999997654
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
++...+.+.||+.|||||...+..|+..+|.||+||++||+++|++||... .+..+++. ++...
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv~~------------I~~d~- 216 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLVKS------------ILKDP- 216 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHHHH------------HhcCC-
Confidence 455667788999999999999999999999999999999999999999632 12222211 11110
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...+......+.+++...+.+||.+|-+-.+++.
T Consensus 217 -v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 -VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1233355667899999999999999999999875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=341.62 Aligned_cols=266 Identities=26% Similarity=0.395 Sum_probs=210.2
Q ss_pred hcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.+.|+..+.||.|..++||+| ..+.+..||||++.-.. ....+.+.+|+..++.++||||++++.+|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 356888999999999999999 66778999999997542 2335789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
||.+||+.+.+...- ...+++..+..|++++++||.|||.+ |.||||||+.||||+.+|.+||+|||.+..+...
T Consensus 105 fMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999995433 34699999999999999999999999 8999999999999999999999999998655443
Q ss_pred Ccccc---cccccCCCccchhhhcc--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 578 NTHIS---TRVAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 578 ~~~~~---~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
..... ...+||+.|||||++.. ..|+.|+||||||++..||.+|..||...++-... . +.-.+.....
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l-----~tLqn~pp~~ 252 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--L-----LTLQNDPPTL 252 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--H-----HHhcCCCCCc
Confidence 32221 44689999999999653 47999999999999999999999999865543221 1 1111111111
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGR 697 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 697 (771)
.-..+..+........+.+++..|++.||.+|||++++++ .++..
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 1000111111223346889999999999999999999986 34443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=343.45 Aligned_cols=257 Identities=21% Similarity=0.277 Sum_probs=205.0
Q ss_pred CCCHHHHHHHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhc---HHHHHHHHHHHHcCCCCcEEeEEEEE
Q 004155 410 SFTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQG---NREFVNEIGMISALQHPNLVKLHGCC 486 (771)
Q Consensus 410 ~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~ 486 (771)
.++.+++. ......||+|++|.||+|.. +|+.||||+++...... .+.|.+|+.++++++||||++++|++
T Consensus 14 ~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~ 87 (283)
T PHA02988 14 CIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87 (283)
T ss_pred ecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence 34555552 22346799999999999987 68999999997653322 46788999999999999999999998
Q ss_pred Ee----CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC
Q 004155 487 IE----GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 562 (771)
Q Consensus 487 ~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 562 (771)
.+ ....++||||+++|+|.+++.. ...+++....+++.|++.||.|||+.. +++||||||+||++++++.
T Consensus 88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 88 IDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYK 161 (283)
T ss_pred EecccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCc
Confidence 76 3578999999999999999943 246899999999999999999999742 6889999999999999999
Q ss_pred eEEEeecCccccCCCCcccccccccCCCccchhhhcc--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHH
Q 004155 563 PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWA 640 (771)
Q Consensus 563 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~ 640 (771)
+||+|||+++...... ....||..|+|||++.+ ..++.++|||||||++|||++|+.||......+....
T Consensus 162 ~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~---- 233 (283)
T PHA02988 162 LKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL---- 233 (283)
T ss_pred EEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH----
Confidence 9999999998654322 23458899999999976 6889999999999999999999999975433221110
Q ss_pred HHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 641 LILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 641 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
++........+......+.+++.+||+.||++|||+.|+++.|+..
T Consensus 234 -----------i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 234 -----------IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred -----------HHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1111111112223455688999999999999999999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=319.72 Aligned_cols=263 Identities=24% Similarity=0.325 Sum_probs=207.6
Q ss_pred cCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.+|...++||+|.||.||+| +..+|+.||||+++.... .-.....+|++.|+.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46777899999999999999 667899999999976532 225678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
||+. +|+..++. ....++..++..++.++++||+|||++ .|+||||||.|+|++++|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9976 99999944 345899999999999999999999999 8999999999999999999999999999988765
Q ss_pred CcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh--hCCh---hH
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA--QGNL---ME 651 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~---~~ 651 (771)
+..... .+-|..|+|||.+.+. .|+...|+||.|||+.||+-|.+-|.+..+-+. +..-.+.+.. ++.+ .+
T Consensus 155 ~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ--L~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 155 NRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ--LSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred Cccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH--HHHHHHHcCCCCcccCccccc
Confidence 544333 3578899999999875 799999999999999999999987765443222 2221221111 1111 11
Q ss_pred Hhh---hhc-----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 652 LVD---KRL-----GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 652 ~~d---~~l-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
+.| -.. ....-.......++++..++..||.+|++++|++++
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111 110 011112334456899999999999999999999874
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=346.34 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=203.6
Q ss_pred cCCCCCCccccCCceeEEEEEcC-----------------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-----------------DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKL 482 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-----------------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 482 (771)
++|.+.++||+|+||.||++... ++..||+|++.... .....+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 57888999999999999999643 23479999987643 3345679999999999999999999
Q ss_pred EEEEEeCCEEEEEEEeccCCCHHHHhcCCC---------------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceec
Q 004155 483 HGCCIEGNQLLLIYEYMENNSLARALFGPE---------------AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVH 547 (771)
Q Consensus 483 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH 547 (771)
++++.+.+..++||||+++|+|.+++.... .....+++..+++++.||+.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999985421 1123578899999999999999999998 8999
Q ss_pred cCCCCCcEEEcCCCCeEEEeecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh--CCCC
Q 004155 548 RDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS--GRSN 624 (771)
Q Consensus 548 ~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt--G~~p 624 (771)
|||||+|||++.++.+||+|||+++....... .......++..|+|||++..+.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543322 12223456789999999998899999999999999999997 4567
Q ss_pred CCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 625 SSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
|......+. ............. ......+...+..+.+++.+||+.||++||++.||.+.|++
T Consensus 242 ~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQV---IENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHHH---HHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 754332221 1111111111000 00001111234568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.76 Aligned_cols=247 Identities=22% Similarity=0.312 Sum_probs=203.4
Q ss_pred HHhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
...++|+.+++||+|+||.||+|+ ..+|..+|+|++++.. ..+.+..+.|-.+|....+|.||+++..|.+.+++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 345789999999999999999994 4569999999998763 344567888999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
|||||++||++..+|. ....|++..+..++.+++.|++.||+. |+|||||||+|+|||..|++||+|||++.-
T Consensus 218 LiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999993 345799999999999999999999998 999999999999999999999999999852
Q ss_pred cCC-----------------------CCc----cc-------------------ccccccCCCccchhhhccCCCCchHh
Q 004155 574 DEE-----------------------DNT----HI-------------------STRVAGTFGYMAPEYAMRGYLTDKAD 607 (771)
Q Consensus 574 ~~~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~ksD 607 (771)
+.. +.. .. ....+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 211 000 00 11257999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCccchh-hHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 004155 608 VYSFGIVALEIVSGRSNSSCKPKEDIF-YLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPS 686 (771)
Q Consensus 608 V~S~Gvil~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 686 (771)
.||+|||+|||+.|.+||....+.+.. .++.|...+..+. ......+..+++.+|+. ||++|--
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999999987766554 3444443322211 11122457788999998 9999986
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=338.76 Aligned_cols=256 Identities=25% Similarity=0.386 Sum_probs=205.0
Q ss_pred hcCCCCCCccccCCceeEEEEEc----CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM----ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
.++|++.+.||+|+||.||+|.+ ..+..||+|.++... ....+.|.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 35688899999999999999954 246789999987653 3335678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+++|+|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999999432 24689999999999999999999998 8999999999999999999999999987654
Q ss_pred CCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||......+. ... . ..+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~---~-~~~------ 224 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKA---V-EDG------ 224 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHH---H-HCC------
Confidence 3222111122345678999999999999999999999999999775 9999975433221 110 0 111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.....+...+..+.+++.+||+.+|++||++.++.+.|+..
T Consensus 225 ---~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 ---FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11111223445688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=349.04 Aligned_cols=250 Identities=22% Similarity=0.362 Sum_probs=204.8
Q ss_pred HHhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccC----Ch-hcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCC
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK----SK-QGNREFVNEIGMISALQ-HPNLVKLHGCCIEGN 490 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 490 (771)
...++|...+.||+|+||+|+.| ...+|..||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568899999999999999999 5667899999977653 11 23456678999999998 999999999999999
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC-CCeEEEeec
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFG 569 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG 569 (771)
..++||||+.+|+|.+++.. ..++.+..+.+++.|++.|++|+|++ +|+||||||+|||+|.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999943 45788999999999999999999998 89999999999999999 999999999
Q ss_pred CccccCCCCcccccccccCCCccchhhhccCC-CC-chHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC
Q 004155 570 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGY-LT-DKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG 647 (771)
Q Consensus 570 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 647 (771)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..........
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k----------- 234 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK----------- 234 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-----------
Confidence 999774 2222345578999999999999865 65 799999999999999999999986322211110
Q ss_pred ChhHHhhhhcCCCCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 648 NLMELVDKRLGSNFDKEQ-VMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 648 ~~~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+..... .++... ...+..++.+|+..||.+|+++.+++.
T Consensus 235 ----i~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 235 ----IRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ----HhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 111111 111111 456889999999999999999999993
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=320.41 Aligned_cols=236 Identities=26% Similarity=0.364 Sum_probs=198.1
Q ss_pred cCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCCh---hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|+..+.||.|+||+|.++ ...+|..+|+|++++..- .+.+...+|..+|+.+.||+++++++.|.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45677899999999999999 455689999999987532 33456778999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||++||.|..+++ ...+++++.+.-+|.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999994 345799999999999999999999998 899999999999999999999999999997654
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
. +...+||+.|+|||+++...+..++|.|||||++|||+.|.+||....+..++ .+++...
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY---------------~KI~~~~ 257 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY---------------EKILEGK 257 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH---------------HHHHhCc
Confidence 3 45578999999999999999999999999999999999999999866543222 1222222
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSR 684 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 684 (771)
+ .++.--...+.+|+...++.|-.+|
T Consensus 258 v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 V--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred c--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2 2232233346778888888888888
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=355.35 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=204.0
Q ss_pred cCCCCCCccccCCceeEEEEEc------CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 492 (771)
++|++.++||+|+||.||+|.. .++..||||+++... ....+.+.+|+.+++.+ +||||++++++|.+.+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4678889999999999999852 345689999997543 23456788999999999 899999999999999999
Q ss_pred EEEEEeccCCCHHHHhcCCCc-----------------------------------------------------------
Q 004155 493 LLIYEYMENNSLARALFGPEA----------------------------------------------------------- 513 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 513 (771)
++||||+++|+|.+++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999999854321
Q ss_pred ------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 514 ------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 514 ------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
....+++..+++++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 112578999999999999999999998 89999999999999999999999999998654332211
Q ss_pred -ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 582 -STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 582 -~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
.....++..|+|||++.+..++.++|||||||++|||++ |..||........ ... .+......
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~-------------~~~~~~~~ 336 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYK-------------MIKEGYRM 336 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHH-------------HHHhCccC
Confidence 122335678999999999999999999999999999998 8888865432211 111 11111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
..+.....++.+++.+||+.||++||++.||+++|+..
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11111234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=333.30 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=203.7
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
++|++.+.||+|+||.||++...++..+|+|.+... ......+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457788999999999999998888889999988643 2335678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+|+|.++++... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999995432 3589999999999999999999998 8999999999999999999999999999865433222
Q ss_pred cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
......++..|+|||++.+..++.++||||||+++|||++ |+.||......+. .... . .+. ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i---~-~~~---------~~ 220 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMI---S-RGF---------RL 220 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH---H-CCC---------CC
Confidence 2222345678999999988889999999999999999999 8999865432211 1111 0 010 00
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
..+......+.+++.+||+.+|++||++.|+++.|.
T Consensus 221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011112346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.83 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=200.4
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.|+..+.||+|+||.||+|. ..+|+.||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 36778999999999999995 4678999999986532 2234567899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999998884322 24689999999999999999999998 8999999999999999999999999999865432
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
.. .....||..|+|||++.+..++.++|||||||++|||++|+.||............. .. +...
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~--------~~~~-- 220 (285)
T cd05631 156 ET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RR--------VKED-- 220 (285)
T ss_pred Ce--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HH--------hhcc--
Confidence 21 233568999999999999999999999999999999999999997644322111100 00 0000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPS-----MSSVVS 692 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 692 (771)
...++......+.+++.+||+.||++||+ ++++++
T Consensus 221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01122223446788999999999999997 667665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.71 Aligned_cols=255 Identities=29% Similarity=0.445 Sum_probs=207.8
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35688899999999999999988788899999986533 34568899999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++.... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.......
T Consensus 84 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 84 AKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999995432 34688999999999999999999998 899999999999999999999999999987654332
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.......++..|+|||++....++.++|||||||++|||+| |+.||........ ..+. . .. ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~---~-~~---------~~ 222 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSAL---Q-RG---------YR 222 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHH---H-cC---------CC
Confidence 22233346778999999998899999999999999999998 9999865432221 1111 0 00 00
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
..........+.+++.+|++.+|++||+++++.++|+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01111233468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=344.68 Aligned_cols=251 Identities=27% Similarity=0.397 Sum_probs=209.9
Q ss_pred cCCCCHHHHHHHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEE
Q 004155 408 TGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI 487 (771)
Q Consensus 408 ~~~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 487 (771)
...+.+++|.. .+-||.|+.|.||.|+++ ++.||||+++... ..+++-|++|+||||+.+.|+|.
T Consensus 118 ~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCt 182 (904)
T KOG4721|consen 118 LWEIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCT 182 (904)
T ss_pred hccCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeec
Confidence 44567777654 578999999999999985 6889999885422 34788899999999999999999
Q ss_pred eCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEe
Q 004155 488 EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 567 (771)
Q Consensus 488 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 567 (771)
....+|||||||..|-|...|+ ...++.......|..+||.|+.|||.+ .|||||||+-||||..+..+||+|
T Consensus 183 qsPcyCIiMEfCa~GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsD 255 (904)
T KOG4721|consen 183 QSPCYCIIMEFCAQGQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISD 255 (904)
T ss_pred CCceeEEeeeccccccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEecc
Confidence 9999999999999999999993 345788889999999999999999999 899999999999999999999999
Q ss_pred ecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC
Q 004155 568 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG 647 (771)
Q Consensus 568 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 647 (771)
||-++...+..+ ...++||..|||||++++.+.++|+||||||||||||+||..||.......+..-+
T Consensus 256 FGTS~e~~~~ST--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV---------- 323 (904)
T KOG4721|consen 256 FGTSKELSDKST--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV---------- 323 (904)
T ss_pred ccchHhhhhhhh--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec----------
Confidence 999987655432 34578999999999999999999999999999999999999999754333222111
Q ss_pred ChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 648 NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 648 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
-...+....+..+++.+.-|+.+||+..|..||++.+++.-|+-.
T Consensus 324 -----GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 324 -----GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred -----cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 111222344556777888899999999999999999999988653
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.36 Aligned_cols=264 Identities=20% Similarity=0.336 Sum_probs=204.4
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.++|++.+.||+|+||.||++.. .+|..||+|++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 36789999999999999999954 468899999987642 3345679999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999943 346899999999999999999999863 6999999999999999999999999999755332
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh-----------
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ----------- 646 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------- 646 (771)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||......+..............
T Consensus 158 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred c---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 2 23356899999999999999999999999999999999999999654322211110000000000
Q ss_pred ----------------CChhHHhhhhc---CCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 647 ----------------GNLMELVDKRL---GSNF-DKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 647 ----------------~~~~~~~d~~l---~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
....+..+... .... .......+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00001111100 0000 1123456889999999999999999999986
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=353.23 Aligned_cols=259 Identities=28% Similarity=0.436 Sum_probs=203.4
Q ss_pred cCCCCCCccccCCceeEEEEEc------CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 492 (771)
++|++.+.||+|+||.||+|.. .++..||||+++... ......+.+|+.+++.+ +|+||++++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4678899999999999999852 234579999997543 33356788999999999 899999999999999999
Q ss_pred EEEEEeccCCCHHHHhcCCCc-----------------------------------------------------------
Q 004155 493 LLIYEYMENNSLARALFGPEA----------------------------------------------------------- 513 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 513 (771)
++||||+++|+|.++++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999999853210
Q ss_pred -------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc-ccccc
Q 004155 514 -------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH-ISTRV 585 (771)
Q Consensus 514 -------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~ 585 (771)
...++++.++++++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++........ .....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 113578899999999999999999998 8999999999999999999999999999865433221 11223
Q ss_pred ccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHH
Q 004155 586 AGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKE 664 (771)
Q Consensus 586 ~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 664 (771)
.++..|+|||++.+..++.++|||||||++|||++ |+.||......... ...+........+..
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~---------------~~~~~~~~~~~~~~~ 339 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF---------------YKMVKRGYQMSRPDF 339 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH---------------HHHHHcccCccCCCC
Confidence 35678999999998999999999999999999997 99999654322111 011111111111111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 665 QVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 665 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
....+.+++.+||+.||++||++.+|+++|+++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 235688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=339.75 Aligned_cols=265 Identities=21% Similarity=0.293 Sum_probs=202.3
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
++|++.+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4788999999999999999955 468899999987542 2335678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|++++.+..+.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999887765542 234689999999999999999999998 8999999999999999999999999999876443
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHH---------HHHHhhCC
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWA---------LILKAQGN 648 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~---------~~~~~~~~ 648 (771)
.........||..|+|||++.+..++.++|||||||++|||++|++||......+........ ........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 332233456899999999999888999999999999999999999999764332221111100 00000000
Q ss_pred hhHHhhhhcCCC------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 649 LMELVDKRLGSN------FDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 649 ~~~~~d~~l~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
......+..... ........+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000 00112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=341.14 Aligned_cols=248 Identities=29% Similarity=0.425 Sum_probs=208.5
Q ss_pred cCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
..|+..+.||+|.||.||+| ....++.||+|++.-.. +...+++++|+.+|..++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35667789999999999999 55678999999997653 34467889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
|.||++.+.+. ....+++..+.-|+++++.||.|||.+ +.+|||||+.|||+..+|.+||+|||.+.......
T Consensus 93 ~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999992 333458888889999999999999999 89999999999999999999999999998776554
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
... ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+..... ++.+...
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf----------------lIpk~~P 228 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF----------------LIPKSAP 228 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE----------------eccCCCC
Confidence 443 56789999999999998899999999999999999999999997654422211 1222222
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...+......+.+++..|++.||+.||++.++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2223334456889999999999999999999986
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=331.53 Aligned_cols=255 Identities=29% Similarity=0.451 Sum_probs=207.4
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.++|++.+.||+|+||.||+|...+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688899999999999999987778899999987543 34567899999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999995433 34689999999999999999999998 899999999999999999999999999987653322
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
........+..|+|||+..+..++.++||||||+++|||++ |+.||......... . .++....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~-------------~~~~~~~ 222 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL---Q-------------QVDQGYR 222 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---H-------------HHHcCCC
Confidence 21122223458999999998899999999999999999999 99998653322111 0 1111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
...+......+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11122334568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=334.63 Aligned_cols=257 Identities=28% Similarity=0.477 Sum_probs=206.8
Q ss_pred cCCCCCCccccCCceeEEEEEcCC------CcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMAD------GTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......|.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 367788999999999999996432 2579999987543 334567899999999999999999999999989999
Q ss_pred EEEEeccCCCHHHHhcCCCc------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC
Q 004155 494 LIYEYMENNSLARALFGPEA------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 561 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 561 (771)
++|||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999954321 114688999999999999999999998 899999999999999999
Q ss_pred CeEEEeecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHH
Q 004155 562 NPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDW 639 (771)
Q Consensus 562 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~ 639 (771)
.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||......+...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~---- 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE---- 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----
Confidence 999999999986543222 12233456789999999998899999999999999999998 999987544322211
Q ss_pred HHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 640 ALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 640 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
.+........+...+..+.+++.+||+.||++||++.||++.|+.
T Consensus 238 ------------~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 ------------MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ------------HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111112223345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=347.43 Aligned_cols=252 Identities=22% Similarity=0.284 Sum_probs=203.7
Q ss_pred cCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.++||+|+||.||+|... +|+.||||+++... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46888999999999999999654 58999999987542 223457889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999942 34689999999999999999999998 899999999999999999999999999986543
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHH-HHHHHHHhhCChhHHhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL-DWALILKAQGNLMELVDK 655 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~d~ 655 (771)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... .|. ..+..
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------~~~~~ 219 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK----------ETLQR 219 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc----------ccccC
Confidence 223456899999999999999999999999999999999999999765433322111 110 00000
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
.............+.+++.+|+..+|++||++.++++.
T Consensus 220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00000001234467889999999999999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=331.72 Aligned_cols=256 Identities=29% Similarity=0.480 Sum_probs=211.5
Q ss_pred HhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
...+|+..++||.|+||.||+|...+++.+|+|.+..........+..|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45678889999999999999998777999999999876655567899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999996543 34689999999999999999999998 89999999999999999999999999998664332
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
.. .....++..|+|||...+..++.++||||||+++|+|++ |+.||......+... . +....
T Consensus 159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~---~-------------~~~~~ 221 (261)
T cd05148 159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD---Q-------------ITAGY 221 (261)
T ss_pred cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH---H-------------HHhCC
Confidence 22 123346778999999998899999999999999999998 899986543222111 1 01111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
....+......+.+++.+|++.||++||++.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 111122334568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=340.22 Aligned_cols=263 Identities=29% Similarity=0.418 Sum_probs=212.3
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
....+.++||+|-||.|..+....+..||||+++.... ....+|.+|+++|.+++||||++++|.|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 45677899999999999999887789999999987644 44689999999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC-
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN- 578 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~- 578 (771)
++|+|.+++...... .+.-....+|+.|||.||+||.+. ++|||||.++|+|+|.++++||+|||++|-+-...
T Consensus 618 EnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred hcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999554332 245667788999999999999998 89999999999999999999999999999554333
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh--CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS--GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
.+...+.+-.++|||||.+..++++.++|||+||+++||+++ ...||.....++..+ -...+...+...
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vve---n~~~~~~~~~~~------ 763 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVE---NAGEFFRDQGRQ------ 763 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHH---hhhhhcCCCCcc------
Confidence 333444556789999999999999999999999999999876 667886544433321 111111111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.....+.-++..+.+++.+||..|-++||+++++...|++.
T Consensus 764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 01122344667788999999999999999999999988764
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.44 Aligned_cols=244 Identities=23% Similarity=0.304 Sum_probs=199.3
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4688899999999999999954 468999999986432 223456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999943 34689999999999999999999998 899999999999999999999999999986543
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+....
T Consensus 154 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~---------------~i~~~~ 214 (291)
T cd05612 154 RT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE---------------KILAGK 214 (291)
T ss_pred Cc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---------------HHHhCC
Confidence 21 23468999999999998889999999999999999999999997543222111 011111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPS-----MSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 692 (771)
..++......+.+++.+|++.||.+||+ ++|+++
T Consensus 215 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 215 --LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred --cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 1112222345789999999999999995 666663
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=331.23 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=205.9
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.+|.+.++||+|+||.||+|.. .+++.||+|++... .....++.+|++++++++|+||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 3577789999999999999954 45889999998754 334567899999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999995432 34689999999999999999999998 899999999999999999999999999986654332
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.....++.. . .+.....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~------~----------~~~~~~~ 223 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------E----------LLEKGYR 223 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH------H----------HHHCCCC
Confidence 22222334668999999998999999999999999999998 89998653322111 0 0111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
...+......+.+++.+|++.+|++||++.+++++|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 122222345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=358.31 Aligned_cols=252 Identities=20% Similarity=0.261 Sum_probs=204.6
Q ss_pred CCCCCCccccCCceeEEEEEc-CC-CcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-AD-GTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.|.+.+.||+|+||.||+|.. .+ ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 388899999999999999943 34 6789999876655555567888999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++|+|.++++.......++++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999998865433445789999999999999999999998 899999999999999999999999999986644322
Q ss_pred -ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 580 -HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 580 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+.....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~---------------~~~~~~~- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ---------------QVLYGKY- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---------------HHHhCCC-
Confidence 22334569999999999999999999999999999999999999996543221111 0000000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...+......+.+++.+||+.||++||++.+++.
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0111123346889999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=329.92 Aligned_cols=270 Identities=30% Similarity=0.411 Sum_probs=201.1
Q ss_pred CCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHc--CCCCcEEeEEEEEEeCC----EEEEEE
Q 004155 423 FAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISA--LQHPNLVKLHGCCIEGN----QLLLIY 496 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lV~ 496 (771)
....++||+|+||.||||.+. ++.||||++.. +..+.|++|-++.+. ++|+||++++++-.... +++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 345688999999999999985 59999999864 455678888888765 58999999999877555 899999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhc------CCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE------SRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
||.+.|+|.+|| ....++|....+|+..+++||+|||+. .+++|+|||||++|||+..|+++.|+|||+
T Consensus 288 ~fh~kGsL~dyL-----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 288 EFHPKGSLCDYL-----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeccCCcHHHHH-----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999 446799999999999999999999975 367899999999999999999999999999
Q ss_pred ccccCCCCcc-cccccccCCCccchhhhccC-CCC-----chHhHHHHHHHHHHHHhCCCCCCCCCccch-hhHHHHHHH
Q 004155 571 AKLDEEDNTH-ISTRVAGTFGYMAPEYAMRG-YLT-----DKADVYSFGIVALEIVSGRSNSSCKPKEDI-FYLLDWALI 642 (771)
Q Consensus 571 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~-----~ksDV~S~Gvil~elltG~~p~~~~~~~~~-~~~~~~~~~ 642 (771)
|..+...... .....+||.+|||||++.+. .+. .+.||||+|.|||||++....+......+. .-....+..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9877643322 22336799999999999754 222 368999999999999997665532111110 000000110
Q ss_pred HHhhCChhHH-hhhhcCCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCC
Q 004155 643 LKAQGNLMEL-VDKRLGSNFDK-----EQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQ 701 (771)
Q Consensus 643 ~~~~~~~~~~-~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 701 (771)
...-+++.+. +.++.+..++. ..+..+.+.+..||+.||+.|-|+.=|.+++.+.....
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 1111112221 11222222221 34567889999999999999999999988887765444
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=328.75 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=203.5
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
++|.+.+.||+|+||.||+|...++..||+|.+.... .....+.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3577889999999999999987777789999987543 335678999999999999999999999998889999999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+|+|.+++.... ..+++..+++++.||+.||+|||+. +++|+||||+||+++.++.+||+|||.++........
T Consensus 83 ~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999995422 3689999999999999999999998 8999999999999999999999999999865443322
Q ss_pred cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
......++..|+|||+..+..++.++|||||||++|||++ |+.||......+... . .. .+ ...
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~---~---~~-~~---------~~~ 220 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE---K---VS-QG---------LRL 220 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH---H---Hh-cC---------CCC
Confidence 2222345678999999998889999999999999999999 999986543322111 0 00 00 000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
.........+.+++.+||+.+|.+||++.++++.|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111122456889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=335.55 Aligned_cols=264 Identities=21% Similarity=0.323 Sum_probs=199.2
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
++|.+.++||+|+||.||+|. ..+++.||+|+++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 468889999999999999995 4568999999987543 22345678999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++ +|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 999988432 23578999999999999999999998 89999999999999999999999999997654322
Q ss_pred cccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh---------CC
Q 004155 579 THISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ---------GN 648 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------~~ 648 (771)
.. .....||+.|+|||.+.+ ..++.++||||+||++|||+||++||......+.............. ..
T Consensus 158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred cc-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 21 233468899999999875 56899999999999999999999999765433322111100000000 00
Q ss_pred hhHHhhhhcCCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 649 LMELVDKRLGSNF----DKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 649 ~~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
......+...... .........+++.+|++.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000001000000 0011235779999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=348.52 Aligned_cols=257 Identities=30% Similarity=0.460 Sum_probs=207.3
Q ss_pred CCCCccccCCceeEEEEEcC--CC---cEEEEEEccc---CChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 424 APDNKIGEGGFGPVYKGHMA--DG---TVVAVKQLSS---KSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 424 ~~~~~lG~G~~g~Vy~~~~~--~g---~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
...++||+|+||.||+|.+. ++ ..||||..+. .......+|.+|++++++++|||||+++|++.....+++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 34589999999999999553 33 2389999885 2466788999999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
||+|.||+|.++|.... ..++..++++++.+.|.||+|||+. ++|||||-++|+|++.++.+||+|||+++...
T Consensus 240 mEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 99999999999995433 2699999999999999999999999 89999999999999999999999999998543
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
...... ....-...|+|||.+..+.+++++|||||||++||+++ |..||......+.. . .++.
T Consensus 314 ~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~---~------------kI~~ 377 (474)
T KOG0194|consen 314 QYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK---A------------KIVK 377 (474)
T ss_pred ceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH---H------------HHHh
Confidence 111111 01123568999999999999999999999999999999 88898765433211 1 1111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQD 702 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 702 (771)
.......+...+..+..++.+||..+|++||+|.++.+.|+......+
T Consensus 378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 122223333556667788889999999999999999999988765543
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=332.62 Aligned_cols=257 Identities=28% Similarity=0.474 Sum_probs=206.7
Q ss_pred cCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCChh-cHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
++|.+.+.||+|+||.||+|... +++.||||.++..... ....+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45778899999999999999653 3478999998765443 4578999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcCCC----------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCe
Q 004155 494 LIYEYMENNSLARALFGPE----------AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 563 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 563 (771)
+||||+++++|.+++.... .....+++.++..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999996432 1234688999999999999999999998 89999999999999999999
Q ss_pred EEEeecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHH
Q 004155 564 KISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWAL 641 (771)
Q Consensus 564 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 641 (771)
||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+. .....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHH
Confidence 9999999975433221 11223346788999999999999999999999999999998 9999865433221 11110
Q ss_pred HHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 642 ILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 642 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
.+. ....+......+.+++.+||+.||++||++.||+++|++
T Consensus 239 ----~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 ----QGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111 111112234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.14 Aligned_cols=241 Identities=24% Similarity=0.314 Sum_probs=195.7
Q ss_pred CccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCC
Q 004155 427 NKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENN 502 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 502 (771)
+.||+|+||.||++. ..+|+.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999994 4578999999987532 233456788999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccc
Q 004155 503 SLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 582 (771)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 582 (771)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cc
Confidence 99999843 34689999999999999999999998 899999999999999999999999999975332221 12
Q ss_pred cccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCC
Q 004155 583 TRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFD 662 (771)
Q Consensus 583 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 662 (771)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... . +.... ..++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~---~------------~~~~~--~~~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---L------------ILMEE--IRFP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHH---H------------HHcCC--CCCC
Confidence 33569999999999999999999999999999999999999997543221111 0 00000 1112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 663 KEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 663 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
......+.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 22344578899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.70 Aligned_cols=256 Identities=24% Similarity=0.355 Sum_probs=203.4
Q ss_pred HHHhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCCh--------------hcHHHHHHHHHHHHcCCCCcEEe
Q 004155 417 KAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSK--------------QGNREFVNEIGMISALQHPNLVK 481 (771)
Q Consensus 417 ~~~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~ 481 (771)
....+.|++.+.||+|.||.|-+| ...+++.||||++.+... ...+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345678999999999999999999 455789999999965311 11357889999999999999999
Q ss_pred EEEEEEe--CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC
Q 004155 482 LHGCCIE--GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 559 (771)
Q Consensus 482 l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 559 (771)
|+.+..+ .+.+|||+|||..|.+...= .....+++.+++++++++..||+|||.+ +||||||||+|+||++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence 9999875 46899999999988764332 2233499999999999999999999999 8999999999999999
Q ss_pred CCCeEEEeecCccccCCC----CcccccccccCCCccchhhhccC----CCCchHhHHHHHHHHHHHHhCCCCCCCCCcc
Q 004155 560 DLNPKISDFGLAKLDEED----NTHISTRVAGTFGYMAPEYAMRG----YLTDKADVYSFGIVALEIVSGRSNSSCKPKE 631 (771)
Q Consensus 560 ~~~~kl~DFGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDV~S~Gvil~elltG~~p~~~~~~~ 631 (771)
+|++||+|||.+...... ........+||+.|+|||...++ ..+.+.||||+||+||.|+.|+.||.....-
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 999999999999866322 11122346899999999998763 3556889999999999999999999754322
Q ss_pred chhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004155 632 DIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSML 694 (771)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 694 (771)
+. ..+++...+.-....+....+.+|+.++|++||++|.+..+|....
T Consensus 326 ~l---------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 326 EL---------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HH---------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 11 1234444443333335567788999999999999999999987643
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=328.54 Aligned_cols=256 Identities=29% Similarity=0.463 Sum_probs=206.0
Q ss_pred hcCCCCCCccccCCceeEEEEEcC----CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMA----DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
.++|++.+.||+|+||.||+|.+. +...||||.++... .....+|.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357889999999999999999653 24589999987543 3345678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+++++|.+++.... ..+++..+++++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999995432 3789999999999999999999998 8999999999999999999999999999877
Q ss_pred CCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 575 EEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 575 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||........ .... ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~----~~~----- 224 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---IKAV----EDG----- 224 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---HHHH----HcC-----
Confidence 522221 2222345678999999998899999999999999999998 9999864332211 1110 000
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.....+......+.+++.+|++.+|++||++.||++.|++.
T Consensus 225 ----~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 ----YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00111122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=326.84 Aligned_cols=251 Identities=26% Similarity=0.400 Sum_probs=202.5
Q ss_pred CCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
+|++.+.||+|+||.||+|...++..+|+|.+.... .....+.+|++++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 577889999999999999987777789999986432 2345788999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 84 GCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999995432 3689999999999999999999998 89999999999999999999999999998654332222
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSN 660 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 660 (771)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+... . +.......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---~-------------~~~~~~~~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE---S-------------VSAGYRLY 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH---H-------------HHcCCcCC
Confidence 222234568999999998899999999999999999999 888986543222111 0 00111111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 661 FDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 661 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
.+......+.+++.+||..+|++||++.|+++.|.
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 11223456889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=333.18 Aligned_cols=260 Identities=27% Similarity=0.474 Sum_probs=208.3
Q ss_pred cCCCCCCccccCCceeEEEEEc------CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
++|.+.+.||+|+||.||++.. .++..+|+|.+..........+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5688899999999999999953 2356799999987666666789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCC---------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEE
Q 004155 495 IYEYMENNSLARALFGPE---------AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 565 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 565 (771)
||||+++++|.+++.... .....+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999995432 1223589999999999999999999998 8999999999999999999999
Q ss_pred EeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHH
Q 004155 566 SDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALIL 643 (771)
Q Consensus 566 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 643 (771)
+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+.. ...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~---~~i--- 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI---ECI--- 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH---
Confidence 999999865432211 1223345778999999998899999999999999999998 89998654322211 100
Q ss_pred HhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 644 KAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 644 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
..+.. ...+......+.+++.+||+.+|.+||++.||++.|+.+..
T Consensus 236 -~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 236 -TQGRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred -HcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 01110 00111123458999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=368.12 Aligned_cols=260 Identities=30% Similarity=0.466 Sum_probs=211.4
Q ss_pred cCCCCCCccccCCceeEEEEEcCC--Cc----EEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMAD--GT----VVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~--g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
.+....+.||+|.||.||.|...+ |. .||||.+++. +.+...+|.+|..+|++++|||||+++|.|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344567789999999999995543 43 4999999876 4556789999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcCCC---ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 494 LIYEYMENNSLARALFGPE---AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
+++|||++|+|..+|+..+ .+...++....+.++.|||+|+.||+++ ++|||||.++|+||+....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999997652 2245789999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 571 AKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 571 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
|+........ ......-...|||||.+.++.++.|+|||||||++||++| |..||......+....+ ...+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~------~~gg- 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV------LEGG- 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH------HhCC-
Confidence 9943332221 1112123468999999999999999999999999999999 88888765443322111 1111
Q ss_pred hhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 649 LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 649 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
+-+.+..++..+.+++.+||+.+|++||++..+++++..+..
T Consensus 922 ---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 922 ---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred ---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 223445677789999999999999999999999998877654
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.52 Aligned_cols=253 Identities=29% Similarity=0.474 Sum_probs=204.4
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46788999999999999999887888999999875432 3567999999999999999999999875 456899999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+++|.++++... ...+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+|||+++........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 84 KGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999995432 24589999999999999999999998 8999999999999999999999999999865443322
Q ss_pred cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
......++..|+|||+..+..++.++||||||+++|||++ |+.||......+. .++ +......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~-------------~~~~~~~ 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV---LEQ-------------VERGYRM 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH-------------HHcCCCC
Confidence 2222345678999999988899999999999999999999 8889865332211 111 1111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
..+......+.+++.+|++.+|++|||+.++.+.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1222334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=332.49 Aligned_cols=248 Identities=34% Similarity=0.540 Sum_probs=192.8
Q ss_pred CCccccCCceeEEEEEcC-----CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 426 DNKIGEGGFGPVYKGHMA-----DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.+.||.|.||.||+|.+. .+..|+||.++... ....+.|.+|++.+++++||||++++|++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 478999999999999665 35789999996543 334788999999999999999999999999888899999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++|+|.++|... ....+++.++++|+.||++||+|||+. +++||||+++||++++++.+||+|||+++.......
T Consensus 84 ~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999554 235789999999999999999999998 899999999999999999999999999987632221
Q ss_pred -ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 580 -HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 580 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
.......+...|+|||.+.+..++.++||||||+++|||++ |+.||......+. .. .. ....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~---~~---~~----------~~~~ 222 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI---IE---KL----------KQGQ 222 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH---HH---HH----------HTTE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc---cc----------cccc
Confidence 22223446778999999999989999999999999999999 6788764422211 11 11 1111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSML 694 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 694 (771)
....+......+.+++.+||+.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112222345688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=346.29 Aligned_cols=261 Identities=26% Similarity=0.387 Sum_probs=205.6
Q ss_pred hcCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKSK-QGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 491 (771)
.++|.+.++||+|+||.||+|... .+..||||+++.... ...+.+.+|+++++++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457888999999999999999542 234799999975433 33567899999999996 9999999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCc----------------------------------------------------------
Q 004155 492 LLLIYEYMENNSLARALFGPEA---------------------------------------------------------- 513 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 513 (771)
.++||||+++|+|.++++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999999854211
Q ss_pred ----------------------------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC
Q 004155 514 ----------------------------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 559 (771)
Q Consensus 514 ----------------------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 559 (771)
....+++..++.++.||+.||+|||+. +|+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 013578889999999999999999998 8999999999999999
Q ss_pred CCCeEEEeecCccccCCCCccc-ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHH
Q 004155 560 DLNPKISDFGLAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLL 637 (771)
Q Consensus 560 ~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~ 637 (771)
++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~-- 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY-- 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH--
Confidence 9999999999998654332221 222346788999999998899999999999999999997 989986532221110
Q ss_pred HHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 638 DWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 638 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
..+........+......+.+++.+||+.+|++||++.+|.++|+...
T Consensus 351 -------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 -------------NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -------------HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 000111111112233456889999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=332.77 Aligned_cols=260 Identities=25% Similarity=0.457 Sum_probs=209.4
Q ss_pred cCCCCCCccccCCceeEEEEEc------CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
.+|...+.||+|+||.||+|.. .++..+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 3577789999999999999953 2456799999877666666789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCc------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC
Q 004155 495 IYEYMENNSLARALFGPEA------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 562 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 562 (771)
||||+++++|.+++..... ....+++..+++++.||+.||+|||++ +++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999954321 223589999999999999999999998 8999999999999999999
Q ss_pred eEEEeecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHH
Q 004155 563 PKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWA 640 (771)
Q Consensus 563 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~ 640 (771)
++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||+| |+.||......+.. +.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI---EC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH-
Confidence 99999999975543221 11223456788999999999999999999999999999999 99998654332211 10
Q ss_pred HHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 641 LILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 641 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
...+.. .......+..+.+++.+||+.+|++||++.+|+++|+.+..
T Consensus 238 ---~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ---ITQGRV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ---HhCCCC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 011111 11112234568899999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=337.46 Aligned_cols=264 Identities=20% Similarity=0.343 Sum_probs=202.8
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.++|++.++||+|+||.||++.. .+|..+|+|++.... ......+.+|++++++++||||++++++|.++++.++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 46899999999999999999954 468899999887542 3345678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ +++||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999943 345889999999999999999999753 6999999999999999999999999999755332
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHH----------------
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL---------------- 641 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~---------------- 641 (771)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus 158 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred c---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 1 223468999999999998899999999999999999999999997543221111000000
Q ss_pred -----HH----HhhCChhHHhhhhcCC---CCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 642 -----IL----KAQGNLMELVDKRLGS---NFD-KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 642 -----~~----~~~~~~~~~~d~~l~~---~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. ........+.+..... ... .....++.+++.+||+.||++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 00 0000001111111100 000 012345889999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=329.90 Aligned_cols=259 Identities=26% Similarity=0.421 Sum_probs=204.5
Q ss_pred HhcCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 491 (771)
.+++|+..+.||+|+||.||+|... .++.||+|++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5678999999999999999998532 35679999986432 2345678999999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCcc------CCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEE
Q 004155 492 LLLIYEYMENNSLARALFGPEAH------RLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 565 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 565 (771)
.++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998543211 23468889999999999999999998 8999999999999999999999
Q ss_pred EeecCccccCCCCccc-ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHH
Q 004155 566 SDFGLAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALIL 643 (771)
Q Consensus 566 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 643 (771)
+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......... ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~---~~---- 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL---RF---- 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HH----
Confidence 9999997554322211 122345778999999998899999999999999999999 68888654332211 10
Q ss_pred HhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 644 KAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 644 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
..... . ...+......+.+++.+|++.+|++||++.|+++.|++
T Consensus 234 ~~~~~--------~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGG--------L-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCC--------c-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 00110 0 11122234568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.42 Aligned_cols=260 Identities=23% Similarity=0.360 Sum_probs=208.7
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||.||+|. ..+++.||||.+... .......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 578899999999999999995 457899999987542 2333567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++.........+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998854333345689999999999999999999998 899999999999999999999999999986644
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
.... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ...... .... ..
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~---~~~~---------~~ 224 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQ---KIEQ---------CD 224 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHH---HHhc---------CC
Confidence 3221 12345888999999999888999999999999999999999998643221 111111 1000 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
............+.+++.+||+.+|++||++.+|++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 01111123445688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=342.97 Aligned_cols=244 Identities=22% Similarity=0.329 Sum_probs=198.6
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5688889999999999999955 468999999986532 233457889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999943 34688999999999999999999998 899999999999999999999999999986543
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||......... + .+....
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~------------~i~~~~ 231 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY---E------------KILAGR 231 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH---H------------HHhcCC
Confidence 22 2346899999999999988999999999999999999999999654322111 0 011111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPS-----MSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 692 (771)
+ .++......+.+++.+||+.||.+||+ +.+++.
T Consensus 232 ~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 232 L--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred c--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1 111112345788999999999999997 466553
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=331.72 Aligned_cols=265 Identities=29% Similarity=0.402 Sum_probs=203.9
Q ss_pred CCCCccccCCceeEEEEE-----cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC--CEEEEE
Q 004155 424 APDNKIGEGGFGPVYKGH-----MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEG--NQLLLI 495 (771)
Q Consensus 424 ~~~~~lG~G~~g~Vy~~~-----~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 495 (771)
...+.||+|+||+||++. ..+++.||+|.++... ......+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 788999999999998763 2457899999987643 23456788999999999999999999998753 468999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++++|.+++.. ..+++.+++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999932 3589999999999999999999998 89999999999999999999999999998665
Q ss_pred CCCcc--cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 576 EDNTH--ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 576 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
..... ......++..|+|||.+.+..++.++||||||+++|||+||+.|+....... .....+.........+.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhh
Confidence 43221 1122345667999999998889999999999999999999999986533211 11111111001111122222
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
+.......+......+.+++.+||+.+|++||++++++++|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 22222222233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=338.11 Aligned_cols=243 Identities=20% Similarity=0.306 Sum_probs=194.8
Q ss_pred cccCCceeEEEEEc-CCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCH
Q 004155 429 IGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL 504 (771)
Q Consensus 429 lG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 504 (771)
||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999954 46889999998653 233456788899999999999999999999999999999999999999
Q ss_pred HHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccccc
Q 004155 505 ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 584 (771)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 584 (771)
.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-cccc
Confidence 999943 34689999999999999999999998 899999999999999999999999999985433222 2234
Q ss_pred cccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHH
Q 004155 585 VAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKE 664 (771)
Q Consensus 585 ~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 664 (771)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. +.... ..++..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~------~~---------~~~~~--~~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY------RK---------ILQEP--LRFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH------HH---------HHcCC--CCCCCc
Confidence 56999999999999999999999999999999999999999754322111 00 11110 111222
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 665 QVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 665 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
....+.+++.+||+.||++||++..+.+.|+.
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 33457889999999999999876555444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.58 Aligned_cols=255 Identities=28% Similarity=0.441 Sum_probs=205.3
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.++|++.++||+|+||.||+|...++..||+|+++... .....+.+|++++++++||||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35688999999999999999977676789999987532 33467899999999999999999999875 45689999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999995432 24679999999999999999999998 899999999999999999999999999986654332
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.......++..|+|||+..+..++.++|||||||++|||+| |+.||......+.... +.....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~----------------~~~~~~ 221 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----------------VERGYR 221 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH----------------HhcCCC
Confidence 22223446778999999998899999999999999999999 8888865432221110 000001
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
..........+.+++.+|++.+|++||++.+++++|+..
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 112233456688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=310.47 Aligned_cols=264 Identities=22% Similarity=0.314 Sum_probs=213.4
Q ss_pred HhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC-----CEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEG-----NQL 492 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 492 (771)
..++|++.+.||+|||+-||.+ ...+++.||+|++...+.++.+..++|++..++++|||+++++++...+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 4568999999999999999999 5678899999999888778888999999999999999999999987543 358
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
|++++|...|||.+.+......+..+++.++++|+.+|++||++||+.. ++++||||||.|||+.+++.++|.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999777767778999999999999999999999984 479999999999999999999999999997
Q ss_pred ccCCCCc--c------cccccccCCCccchhhhc---cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHH
Q 004155 573 LDEEDNT--H------ISTRVAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL 641 (771)
Q Consensus 573 ~~~~~~~--~------~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~ 641 (771)
...-.-. . .......|..|+|||.+. +...++++|||||||+||+|+.|..||+......
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G--------- 248 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG--------- 248 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC---------
Confidence 5432110 0 011234688999999885 5578999999999999999999999997422211
Q ss_pred HHHhhCCh-hHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 642 ILKAQGNL-MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 642 ~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
+.+ ..+....+.-.-.....+.+.+++..|++.||.+||++.+++..++..
T Consensus 249 -----gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 249 -----GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111 111111111111122566789999999999999999999999988753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=344.29 Aligned_cols=244 Identities=24% Similarity=0.386 Sum_probs=204.7
Q ss_pred HHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEE
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 492 (771)
...++|...++||+|.||+|+++.. .+++.+|||++++.. ..+.+..+.|..++... +||.++.++.+|.+.+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 3456889999999999999999954 468899999998863 44566777888888777 599999999999999999
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
|+||||+.||++..+. +...+++..+.-++..|+.||.|||++ +||+||||-+|||||.+|++||+|||+++
T Consensus 445 ~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999955444 335799999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 573 LDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 573 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
..-... ..+...+||+.|||||++.+..|+...|.|||||+||||+.|..||.+.++++..+-+
T Consensus 517 e~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI--------------- 580 (694)
T KOG0694|consen 517 EGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI--------------- 580 (694)
T ss_pred ccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---------------
Confidence 543222 2456689999999999999999999999999999999999999999877665543211
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSM 687 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 687 (771)
+.. ...++.....+.+.++.+.+..+|++|--+
T Consensus 581 ~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 VND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111 123444556678889999999999999877
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=323.54 Aligned_cols=260 Identities=25% Similarity=0.392 Sum_probs=210.4
Q ss_pred cCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67899999999999999999654 7899999988642 2233567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++++|.+++.........+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999865444455689999999999999999999998 899999999999999999999999999986543
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
.... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... .....+ . +...
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~---~----------~~~~ 223 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK---K----------IEKC 223 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHh---h----------hhcC
Confidence 3221 22345888999999999888999999999999999999999998643211 111110 0 0011
Q ss_pred cCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 657 LGSNFD-KEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 657 l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
.....+ ......+.+++.+||+.+|++||++.+|+++|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111111 133456889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=305.96 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=207.8
Q ss_pred hcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
.++|++.+.||+|-||.||.| ..+++..||+|++.+.. .+..+++.+|+++-+.++||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 357888999999999999999 45668899999997652 23467899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
+||..+|+|...|.... ...+++.....++.|+|.||.|+|.. +|+||||||+|+|++.++..|++|||.+...+
T Consensus 101 lEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999996433 34688899999999999999999998 89999999999999999999999999997554
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
. ......+||..|.|||...+...+.+.|+|++|++.||++.|.+||.....++.+..+. .-
T Consensus 176 ~---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~---------------k~ 237 (281)
T KOG0580|consen 176 S---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR---------------KV 237 (281)
T ss_pred C---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH---------------Hc
Confidence 2 22345789999999999999999999999999999999999999998655333322111 11
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. -.++........+++.+|+..+|.+|.+..||++
T Consensus 238 ~--~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 238 D--LKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred c--ccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1 1122233445788999999999999999999986
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=342.48 Aligned_cols=245 Identities=27% Similarity=0.377 Sum_probs=192.7
Q ss_pred CCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 423 FAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
|+..++||+|+||.||+|. ..+|+.||||++.... ......+.+|++++++++|+||+++++++...+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 4456899999999999995 4578999999986543 2335678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+|+|.+.. ..++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 156 ~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 156 GGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 99986532 356778889999999999999998 899999999999999999999999999986543221
Q ss_pred cccccccCCCccchhhhcc-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 581 ISTRVAGTFGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
......||..|+|||++.. ...+.++|||||||++|||++|+.||......+........ ..
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-------------~~ 290 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI-------------CM 290 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-------------hc
Confidence 1233568999999998743 34456999999999999999999999743322211111100 00
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.............+.+++.+||+.||++||++.|+++
T Consensus 291 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 291 SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011112233456889999999999999999999987
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=328.49 Aligned_cols=257 Identities=27% Similarity=0.458 Sum_probs=203.8
Q ss_pred cCCCCCCccccCCceeEEEEEc-----CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-----ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
++|++.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999963 356789999997543 3344678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCc-------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC
Q 004155 495 IYEYMENNSLARALFGPEA-------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 561 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 561 (771)
||||+++++|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853211 123588999999999999999999998 899999999999999999
Q ss_pred CeEEEeecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHH
Q 004155 562 NPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDW 639 (771)
Q Consensus 562 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~ 639 (771)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||......... +
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~---~- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI---E- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH---H-
Confidence 999999999986543221 11223345778999999988889999999999999999998 99898654322111 1
Q ss_pred HHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 640 ALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 640 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
.++.......+......+.+++.+|++.||++||++.++.++|+.
T Consensus 238 ------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 ------------MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111111112234568889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.76 Aligned_cols=254 Identities=31% Similarity=0.471 Sum_probs=206.0
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.++|++.++||+|+||.||+|...+++.||+|.+.... .....+.+|+.++++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 45788899999999999999988889999999987543 33567899999999999999999999874 46789999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 83 ENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999985432 34689999999999999999999988 899999999999999999999999999986653322
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.......++..|+|||++....++.++||||||+++|||++ |+.||......+... . +.....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~-------------~~~~~~ 221 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ---N-------------LERGYR 221 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH---H-------------HHcCCC
Confidence 22223346778999999998889999999999999999999 999997543222111 0 011111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
.........++.+++.+|++.+|++||+++++++.|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11112233468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=340.71 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=207.2
Q ss_pred CCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
-|+..+.||.|+.|.|-.| +..+|+.+|||++.+.. ......+.+|+-+|+-+.|||++++++.+++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4677899999999999999 67789999999997652 2335568899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++|-|.+++ -.+.++++.++.+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||+|....++
T Consensus 93 yv~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred ecCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999999 3456899999999999999999999998 8999999999999999999999999999865443
Q ss_pred CcccccccccCCCccchhhhccCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
. .-...+|.+.|.|||++++.+| +.++||||+|||||.|+||+.||++++ ...+. .+.
T Consensus 166 k--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LL----------------lKV 224 (786)
T KOG0588|consen 166 K--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLL----------------LKV 224 (786)
T ss_pred c--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHH----------------HHH
Confidence 3 2234579999999999998755 569999999999999999999998432 22222 222
Q ss_pred cCCCC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCC
Q 004155 657 LGSNF--DKEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGR 697 (771)
Q Consensus 657 l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 697 (771)
-.+.| +.....+..+|+.+|++.||++|.|+.||++ .|.+.
T Consensus 225 ~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 225 QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 22222 2344556889999999999999999999998 34443
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.18 Aligned_cols=267 Identities=28% Similarity=0.404 Sum_probs=204.0
Q ss_pred cCCCCCCccccCCceeEEEEEc-----CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe--CCEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-----ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIE--GNQLL 493 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 493 (771)
++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678899999999999999853 3578999999987666667789999999999999999999998754 34689
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999999432 23589999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCccc--ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh-hC---
Q 004155 574 DEEDNTHI--STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA-QG--- 647 (771)
Q Consensus 574 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~~--- 647 (771)
........ .....++..|+|||++.+..++.++|||||||++|||++|..++........ ........ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 233 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM----RMMGNDKQGQMIVY 233 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh----hhcccccccccchH
Confidence 65433211 1112234569999999988999999999999999999999877643221100 00000000 00
Q ss_pred ChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 648 NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 648 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.+.+.+........+......+.+++.+||+.+|++|||+.||+++|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 01111111111111222345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.96 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=197.5
Q ss_pred CccccCCceeEEEEEc-CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCH
Q 004155 427 NKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL 504 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 504 (771)
+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999955 478999999876542 34456799999999999999999999999999999999999999999
Q ss_pred HHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccc-c
Q 004155 505 ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-T 583 (771)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~ 583 (771)
.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.......... .
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9999432 24689999999999999999999998 899999999999999999999999999975443211110 1
Q ss_pred ccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCC
Q 004155 584 RVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFD 662 (771)
Q Consensus 584 ~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 662 (771)
...++..|+|||.+.++.++.++|||||||++|||++ |..||......... ..+........+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~----------------~~~~~~~~~~~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR----------------EAIEQGVRLPCP 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH----------------HHHHcCCCCCCc
Confidence 1123457999999998899999999999999999998 88888643322111 111111111222
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 663 KEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 663 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
......+.+++.+|++.+|++||++.++.++|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 233456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=338.25 Aligned_cols=241 Identities=26% Similarity=0.337 Sum_probs=194.7
Q ss_pred CccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCC
Q 004155 427 NKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENN 502 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 502 (771)
+.||+|+||.||++. ..+|+.||+|+++.. .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999995 457899999998753 2233456788999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccc
Q 004155 503 SLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 582 (771)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 582 (771)
+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 152 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cc
Confidence 99998832 34689999999999999999999998 899999999999999999999999999875322221 12
Q ss_pred cccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCC
Q 004155 583 TRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFD 662 (771)
Q Consensus 583 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 662 (771)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........... +..... .++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~---------------~~~~~~--~~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL---------------ILMEEI--RFP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---------------HhcCCC--CCC
Confidence 235689999999999999999999999999999999999999975433221110 000000 112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 663 KEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 663 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
......+.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 22334578899999999999998 7887765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=355.06 Aligned_cols=259 Identities=20% Similarity=0.308 Sum_probs=207.3
Q ss_pred HHHHhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC--
Q 004155 416 IKAATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGN-- 490 (771)
Q Consensus 416 l~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 490 (771)
.....++|.+.+.||+|+||+||+|. ..+|+.||||++... .......+.+|+.++..++|+|+++++..+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 34456799999999999999999994 567999999998654 3344567889999999999999999988775432
Q ss_pred ------EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeE
Q 004155 491 ------QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 564 (771)
Q Consensus 491 ------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 564 (771)
..++||||+++|+|.+++.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEE
Confidence 36899999999999999966544456789999999999999999999998 899999999999999999999
Q ss_pred EEeecCccccCCCC-cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHH
Q 004155 565 ISDFGLAKLDEEDN-THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALIL 643 (771)
Q Consensus 565 l~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 643 (771)
|+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . .
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~---~---~- 256 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM---H---K- 256 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH---H---H-
Confidence 99999998654322 12223457999999999999999999999999999999999999999754322111 0 0
Q ss_pred HhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 644 KAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 644 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
...... ...+......+.+++.+||+.||++||++.++++.
T Consensus 257 --------~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 --------TLAGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --------HhcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 000000 11122234568899999999999999999999863
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=338.15 Aligned_cols=251 Identities=25% Similarity=0.414 Sum_probs=212.2
Q ss_pred cCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE-EEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQ-LLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 496 (771)
++|...+++|+|+||.++.. +..+++.|++|.+.-. .....+...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999998 5557889999998654 23345578899999999999999999999998887 99999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
+||+||+|.+.+.... ...++++.+.+|+.|++.|+.|||+. .|+|||||+.|||++.+..+||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999995543 46789999999999999999999987 899999999999999999999999999998876
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
... ....+.||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+.... + .++.. .
T Consensus 159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L---i------------~ki~~-~ 221 (426)
T KOG0589|consen 159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL---I------------LKINR-G 221 (426)
T ss_pred chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH---H------------HHHhh-c
Confidence 553 33457899999999999999999999999999999999999999976543221 1 11111 1
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
.....+.....++..++..|++.+|..||++.+++.+
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1233344556678899999999999999999999986
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=320.33 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=199.6
Q ss_pred CccccCCceeEEEEEcCCCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCHH
Q 004155 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLA 505 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 505 (771)
++||+|+||.||+|...+++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46999999999999887889999999876532 33457889999999999999999999999999999999999999999
Q ss_pred HHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccccccc
Q 004155 506 RALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV 585 (771)
Q Consensus 506 ~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 585 (771)
+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 998432 23588999999999999999999988 899999999999999999999999999975443222212223
Q ss_pred ccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHH
Q 004155 586 AGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKE 664 (771)
Q Consensus 586 ~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 664 (771)
.++..|+|||++.+..++.++||||||+++||+++ |..||.......... .+........+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~----------------~~~~~~~~~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE----------------QVEKGYRMSCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH----------------HHHcCCCCCCCCC
Confidence 34678999999998899999999999999999998 999986543221110 0001111111222
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 665 QVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 665 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
....+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 3456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=340.60 Aligned_cols=263 Identities=22% Similarity=0.342 Sum_probs=196.0
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC-----CEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEG-----NQLL 493 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 493 (771)
+|++.++||+|+||.||+|. ..+|+.||||++... .......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 47788999999999999995 457899999998643 223345788999999999999999999988643 3589
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+||||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 689998832 34689999999999999999999998 899999999999999999999999999985
Q ss_pred cCCCCc--ccccccccCCCccchhhhcc--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHH--------
Q 004155 574 DEEDNT--HISTRVAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL-------- 641 (771)
Q Consensus 574 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~-------- 641 (771)
...... .......||..|+|||++.+ ..++.++|||||||++|||++|++||................
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432221 11234568999999999875 678999999999999999999999997543221111100000
Q ss_pred HHHhhCChhHHhhhh---cCCCCCH---HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 642 ILKAQGNLMELVDKR---LGSNFDK---EQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 642 ~~~~~~~~~~~~d~~---l~~~~~~---~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.........+.+... ....... .....+.+++.+||+.||++||+++|+++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000011111110 0000000 11245789999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=338.67 Aligned_cols=241 Identities=26% Similarity=0.329 Sum_probs=195.3
Q ss_pred CccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCC
Q 004155 427 NKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENN 502 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 502 (771)
+.||+|+||.||++. ..+|+.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999994 457899999998754 2234567888999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccc
Q 004155 503 SLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 582 (771)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 582 (771)
+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cc
Confidence 99998833 34689999999999999999999998 899999999999999999999999999975432221 12
Q ss_pred cccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCC
Q 004155 583 TRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFD 662 (771)
Q Consensus 583 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 662 (771)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........... .. .. +. .++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~------~~-~~------~~----~~p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL------IL-ME------DI----KFP 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH------hc-cC------Cc----cCC
Confidence 335699999999999988999999999999999999999999975432211110 00 00 01 111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 663 KEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 663 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
......+.+++.+||+.||++|| ++.|+++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 22334578899999999999997 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=327.03 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=196.1
Q ss_pred cccCCceeEEEEE-cCCCcEEEEEEcccCCh---hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCH
Q 004155 429 IGEGGFGPVYKGH-MADGTVVAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL 504 (771)
Q Consensus 429 lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 504 (771)
||+|+||+||++. ..+|+.||+|++..... ...+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 7999999999995 45789999999865322 2235678899999999999999999999999999999999999999
Q ss_pred HHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccccc
Q 004155 505 ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 584 (771)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 584 (771)
.+++.........+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 988865444456799999999999999999999998 8999999999999999999999999999765443221 233
Q ss_pred cccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHH
Q 004155 585 VAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKE 664 (771)
Q Consensus 585 ~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 664 (771)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ... ..+.... ..++..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~---------~~~~~~~--~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELK---------QRILNDS--VTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHH---------HhhcccC--CCCccc
Confidence 568999999999999999999999999999999999999997543221100 000 0011110 112223
Q ss_pred HHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 665 QVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 665 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
....+.+++.+|++.||++|| +++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 345688999999999999999 5566664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=342.39 Aligned_cols=258 Identities=22% Similarity=0.253 Sum_probs=196.9
Q ss_pred cCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
++|++.+.||+|+||.||++ ...+++.||+|.... ..+.+|++++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 57999999999999999999 456789999997532 35678999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
. ++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|+.......
T Consensus 166 ~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 166 K-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred C-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 5 689888833 34689999999999999999999998 899999999999999999999999999975433222
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc----hhhHHHHHHHHHh----------
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKED----IFYLLDWALILKA---------- 645 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~----~~~~~~~~~~~~~---------- 645 (771)
.......||+.|+|||++.+..++.++|||||||++|||++|+.|+....... .............
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 22334579999999999999999999999999999999999998875422110 0000000000000
Q ss_pred hCChhHHh---hhhcC---C-CCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 646 QGNLMELV---DKRLG---S-NFD----KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 646 ~~~~~~~~---d~~l~---~-~~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...+.+.. ..... . ... ......+.+++.+||+.||++|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00001111 00000 0 000 123456889999999999999999999985
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=329.72 Aligned_cols=263 Identities=23% Similarity=0.342 Sum_probs=197.8
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.++|++.++||+|+||.||+|.. .+|+.||||++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46899999999999999999955 4789999999875432 234567889999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+. ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 5888887432 34688999999999999999999998 8999999999999999999999999999754332
Q ss_pred CcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC---h---h
Q 004155 578 NTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN---L---M 650 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---~ 650 (771)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ............... . .
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchh
Confidence 21 1233468999999999865 46889999999999999999999999753221 111111111100000 0 0
Q ss_pred HH--hhh-hcC--CCCCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 651 EL--VDK-RLG--SNFDK-------EQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 651 ~~--~d~-~l~--~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. .++ ... ..... .....+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 000 000 00000 01235678999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=328.50 Aligned_cols=258 Identities=31% Similarity=0.455 Sum_probs=205.1
Q ss_pred CCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
+|++.+.||+|+||.||+|... ....+|+|.+..... .....+.+|+.+++.++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999542 235799998875432 335678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCC--------------------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCc
Q 004155 495 IYEYMENNSLARALFGPE--------------------AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATN 554 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~N 554 (771)
|+||+.+|+|.+++.... .....+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999985421 1123588999999999999999999988 89999999999
Q ss_pred EEEcCCCCeEEEeecCccccCCCCccc-ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccc
Q 004155 555 VLLDKDLNPKISDFGLAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKED 632 (771)
Q Consensus 555 Ill~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~ 632 (771)
|++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999998654332211 122345678999999988889999999999999999999 999986543222
Q ss_pred hhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 633 IFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
.. +.+........+......+.+++.+|++.+|++||++.|+++.|+++.
T Consensus 238 ~~----------------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 LF----------------NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HH----------------HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11 111111111122233456889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=324.19 Aligned_cols=260 Identities=23% Similarity=0.374 Sum_probs=208.8
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||.||+|. ..+|+.||||.+... ......++.+|+.+++.++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 467888999999999999995 457899999987643 2233467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++++|.+++.........+++..++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999854333345789999999999999999999998 899999999999999999999999999886543
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
.... .....|+..|+|||++.+..++.++||||||+++|||++|..||.....+ ...... . ......+
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~---~------~~~~~~~- 226 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK---K------IEQCDYP- 226 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhh---h------hhcCCCC-
Confidence 3221 12345888999999999888999999999999999999999998643221 111110 0 0000001
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
..........+.+++.+||+.+|++||||.+|++++++.
T Consensus 227 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 --PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111123445688999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.54 Aligned_cols=261 Identities=27% Similarity=0.421 Sum_probs=203.5
Q ss_pred hcCCCCCCccccCCceeEEEEEc------CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEe-CC
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIE-GN 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~ 490 (771)
.++|++.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 35788999999999999999943 235789999987543 23345678899999999 89999999998864 45
Q ss_pred EEEEEEEeccCCCHHHHhcCCCcc--------------------------------------------------------
Q 004155 491 QLLLIYEYMENNSLARALFGPEAH-------------------------------------------------------- 514 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 514 (771)
..+++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 788999999999999998532110
Q ss_pred -CCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc-ccccccCCCcc
Q 004155 515 -RLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI-STRVAGTFGYM 592 (771)
Q Consensus 515 -~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~ 592 (771)
...++|..+.+++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 13689999999999999999999998 89999999999999999999999999998654332221 22334677899
Q ss_pred chhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHH
Q 004155 593 APEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMIN 671 (771)
Q Consensus 593 aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 671 (771)
|||++.+..++.++|||||||++|||++ |+.||......+.. .. .. ..+ .....+......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~--~~---~~-~~~---------~~~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF--CR---RL-KEG---------TRMRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH--HH---HH-hcc---------CCCCCCccCCHHHHH
Confidence 9999999999999999999999999998 99998653322210 00 00 011 011111223356889
Q ss_pred HHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 672 VALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 672 l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
++.+||+.+|++||++.|+++.|+.+.
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.77 Aligned_cols=263 Identities=25% Similarity=0.373 Sum_probs=195.1
Q ss_pred cCCCCCCccccCCceeEEEEEc--CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcC---CCCcEEeEEEEEEe-----
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM--ADGTVVAVKQLSSKS--KQGNREFVNEIGMISAL---QHPNLVKLHGCCIE----- 488 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~--~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 488 (771)
++|++.+.||+|+||.||+|.. .+|+.||+|+++... ......+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4688999999999999999954 346889999986532 22234566777777765 69999999999862
Q ss_pred CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEee
Q 004155 489 GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 568 (771)
Q Consensus 489 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 568 (771)
....++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 59999985432 24589999999999999999999998 8999999999999999999999999
Q ss_pred cCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhH-HHHHHHHHhhC
Q 004155 569 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYL-LDWALILKAQG 647 (771)
Q Consensus 569 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~~ 647 (771)
|+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|++||......+.... .+... .....
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~-~~~~~ 231 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG-LPGEE 231 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC-CCChh
Confidence 999865433 222345689999999999988999999999999999999999999976543322111 11000 00000
Q ss_pred ChhH---HhhhhcC--CCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 648 NLME---LVDKRLG--SNFD-----KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 648 ~~~~---~~d~~l~--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.... .....+. .... ......+.+++.+|++.||++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 0000000 0000 112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=321.47 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=203.4
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
++|.+.+.||+|+||.||+|....+..||+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4578889999999999999987777789999886533 33567889999999999999999999875 456899999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+++|.++++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999995432 24589999999999999999999998 8999999999999999999999999999866433222
Q ss_pred cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
......++..|+|||+..+..++.++|||||||++|||+| |+.||......+.. .+. . .....
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~---~----------~~~~~ 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---EQV---E----------RGYRM 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH---H----------cCCCC
Confidence 2222346778999999998899999999999999999999 89998754322211 110 0 00011
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
..+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122344568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=314.53 Aligned_cols=262 Identities=23% Similarity=0.305 Sum_probs=202.2
Q ss_pred cCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChh--cHHHHHHHHHHHHcCCCCcEEeEEEEEEe--CCEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLHGCCIE--GNQLLLI 495 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 495 (771)
+.|+..++|++|.||.||+| +..+++.||+|+++..... -.-.-++|+.+|.+.+|||||.+..+... -+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 34667899999999999999 5567899999999865322 13456899999999999999999988763 4679999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
||||+. +|..++.... .++...++..++.|+++|++|||.+ .|+|||||++|+|+...|.+||+|||+||.+.
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999987 8999995544 5789999999999999999999998 79999999999999999999999999999887
Q ss_pred CCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh--hCChhHH
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA--QGNLMEL 652 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 652 (771)
..... .+..+-|..|+|||.+.+. .|+...|+||+|||+.||+++++.|.+..+-+..+.+ +..+.. +..+..+
T Consensus 229 sp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I--f~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 229 SPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI--FKLLGTPSEAIWPGY 305 (419)
T ss_pred CCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH--HHHhCCCccccCCCc
Confidence 65443 3455679999999999875 6999999999999999999999999776543332221 111110 0000000
Q ss_pred -----h---------hhhcCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 653 -----V---------DKRLGSNFDKE-QVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 653 -----~---------d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+ -..+...+... ..+.-.+++...+..||.+|-|++|.++
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0 00111111111 2245568889999999999999999886
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.85 Aligned_cols=251 Identities=24% Similarity=0.282 Sum_probs=197.5
Q ss_pred CCCCCCccccCCceeEEEEEc----CCCcEEEEEEcccCC----hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM----ADGTVVAVKQLSSKS----KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 492 (771)
+|++.++||+|+||.||++.. .+|+.||+|++.... ....+.+..|+.++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999854 358899999986431 22345678899999999 599999999999999999
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999843 34689999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 573 LDEEDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 573 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
..............||..|+|||++.+. .++.++|||||||++|||+||+.||............. .....
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~~------ 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRILK------ 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHhc------
Confidence 6544333333345799999999999865 47889999999999999999999997533222111110 00000
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
.++ ..+......+.+++.+|++.||++|| ++.++++
T Consensus 226 -~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 -CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 011 11222334578899999999999999 5666664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=345.75 Aligned_cols=251 Identities=22% Similarity=0.293 Sum_probs=200.7
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
..++|++.++||+|+||.||++. ..+++.||+|++... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 45688999999999999999995 456899999998643 12334557889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999832 3578888999999999999999998 8999999999999999999999999999866
Q ss_pred CCCCcccccccccCCCccchhhhccC----CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChh
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRG----YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLM 650 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (771)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||......... .
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---------------~ 257 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY---------------S 257 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH---------------H
Confidence 54332223345799999999998653 4789999999999999999999999754332111 1
Q ss_pred HHhhhh--cCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 004155 651 ELVDKR--LGSNFDKEQVMVMINVALLCTDVSSTS--RPSMSSVVS 692 (771)
Q Consensus 651 ~~~d~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~ 692 (771)
.+.+.. +.-.........+.+++.+|++.+|++ ||++.|+++
T Consensus 258 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 258 KIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred HHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 111110 100001123456788999999999988 999999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=351.88 Aligned_cols=260 Identities=21% Similarity=0.261 Sum_probs=211.2
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCC-cEEEEEEcccCChhcHHHHHHHHHHHHcCC-CCcEEeEEEE-EEe------CC
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADG-TVVAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLHGC-CIE------GN 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~ 490 (771)
..++++.+.|.+|||+.||.|....+ ..||+|++-...+...+...+|+++|++|+ |+|||.+++. ... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34556789999999999999976665 999999998878888899999999999997 9999999994 221 23
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
+++|.||||.||+|-+++..+.. ..|++.++++|+.|+++|+++||.. +++|||||||-+||||..++..||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 68999999999999999965443 4599999999999999999999987 57899999999999999999999999999
Q ss_pred ccccCCCCccc--------ccccccCCCccchhhh---ccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHH
Q 004155 571 AKLDEEDNTHI--------STRVAGTFGYMAPEYA---MRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDW 639 (771)
Q Consensus 571 a~~~~~~~~~~--------~~~~~gt~~y~aPE~~---~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~ 639 (771)
|.-........ .-...-|+.|+|||.+ .+...++|+|||||||+||-|+....||+....-.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------- 265 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------- 265 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-------
Confidence 96322211100 0112468999999987 46789999999999999999999999997543322
Q ss_pred HHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCC
Q 004155 640 ALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQ 701 (771)
Q Consensus 640 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 701 (771)
+++....-.....+...+.+||..||+.||.+||++-+|+..+..+...+
T Consensus 266 ------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 266 ------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 22332222222467788999999999999999999999999887766543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=339.61 Aligned_cols=245 Identities=24% Similarity=0.286 Sum_probs=198.8
Q ss_pred hcCCCCCCccccCCceeEEEEEcCC--CcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMAD--GTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
.++|.+.+.||+|+||.||+|...+ +..||+|++... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3468889999999999999996432 368999998643 22334578899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999943 34689999999999999999999998 8999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
.... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+..
T Consensus 182 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~---------------~i~~ 242 (340)
T PTZ00426 182 DTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ---------------KILE 242 (340)
T ss_pred CCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH---------------HHhc
Confidence 4321 23569999999999998889999999999999999999999997543221111 0111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
... .++......+.+++.+|++.||++|+ +++++++
T Consensus 243 ~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 243 GII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 110 11112234577899999999999995 7888775
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=344.34 Aligned_cols=250 Identities=23% Similarity=0.306 Sum_probs=202.8
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|.+.+.||+|+||.||+|.. .+|+.||||+++... ......+..|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4788999999999999999954 468999999987532 234567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999432 4689999999999999999999997 899999999999999999999999999986544
Q ss_pred CC----------------------------cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Q 004155 577 DN----------------------------THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCK 628 (771)
Q Consensus 577 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~ 628 (771)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 33 11223356999999999999999999999999999999999999999764
Q ss_pred CccchhhHHHHHHHHHhhCChhHHhh--hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 004155 629 PKEDIFYLLDWALILKAQGNLMELVD--KRLGSNFDKEQVMVMINVALLCTDVSSTSRPS-MSSVVSM 693 (771)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 693 (771)
....... .+.. ..+...........+.+++.+|+. ||.+||+ +.|+++.
T Consensus 234 ~~~~~~~---------------~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYN---------------KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHH---------------HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 4221110 0111 011000011124567889999997 9999999 9999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.05 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=205.3
Q ss_pred cCCCCCCccccCCceeEEEEEc------CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
++|...++||+|+||.||++.. .++..+|+|.+..........+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4567789999999999999953 2466899999887666667789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCc-----------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCe
Q 004155 495 IYEYMENNSLARALFGPEA-----------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 563 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 563 (771)
||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999954321 113589999999999999999999998 89999999999999999999
Q ss_pred EEEeecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHH
Q 004155 564 KISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWAL 641 (771)
Q Consensus 564 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 641 (771)
||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |++||......+....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----- 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC----- 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH-----
Confidence 9999999975533221 11122345778999999999999999999999999999998 8999864332221110
Q ss_pred HHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 642 ILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 642 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
+........+......+.+++.+||+.||++||++.||++.|+.
T Consensus 237 -----------~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 -----------ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -----------HHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 00000011111233457899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.46 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=202.5
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCc----EEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGT----VVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
.+|+..+.||+|+||.||+|.+ .+|. .||+|+++... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 4688999999999999999964 3343 48999987543 34467889999999999999999999999764 5789
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
|+||+++|+|.+++... ...+++..+++++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999543 23688999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCcccc-cccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 575 EEDNTHIS-TRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 575 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
........ ....++..|+|||++.+..++.++|||||||++|||++ |+.||......+... +
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~----------------~ 223 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----------------I 223 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH----------------H
Confidence 54332211 22234678999999999999999999999999999998 999987543222111 1
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
+........+......+.+++.+||+.+|++||++.+++..+.....
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 224 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred HhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 11100011111223457889999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.10 Aligned_cols=263 Identities=27% Similarity=0.422 Sum_probs=208.7
Q ss_pred HHHhcCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEe
Q 004155 417 KAATNNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSK-SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIE 488 (771)
Q Consensus 417 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 488 (771)
....++|+..+.||+|+||.||++... ....+|+|.+... ......++.+|++++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 334567888999999999999999643 2368999998754 233456788999999999 79999999999999
Q ss_pred CCEEEEEEEeccCCCHHHHhcCCC------------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEE
Q 004155 489 GNQLLLIYEYMENNSLARALFGPE------------AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVL 556 (771)
Q Consensus 489 ~~~~~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIl 556 (771)
.+..++||||+++|+|.+++.... .....+++..+++++.|++.||+|||+. +|+||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence 999999999999999999995421 2245689999999999999999999988 8999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchh
Q 004155 557 LDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIF 634 (771)
Q Consensus 557 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~ 634 (771)
++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......+..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 999999999999999866543221 1122335678999999998899999999999999999998 98898654332211
Q ss_pred hHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 635 YLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
. .+........+......+.+++.+|++.+|++|||+.|+++.|+.+.
T Consensus 245 ~----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 K----------------LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H----------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 11111111122233456889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.04 Aligned_cols=256 Identities=21% Similarity=0.305 Sum_probs=200.6
Q ss_pred HHHHHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC
Q 004155 415 QIKAATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGN 490 (771)
Q Consensus 415 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 490 (771)
++....++|++.+.||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 3444567899999999999999999954 46889999998642 2223456888999999999999999999999999
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..++||||+++|+|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence 9999999999999999993 23578899999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhccC----CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMRG----YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ 646 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 646 (771)
++..............||+.|+|||++.+. .++.++||||+||++|||++|+.||.........
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------------ 256 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------------ 256 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------------
Confidence 987654333223345799999999998753 3788999999999999999999999754322111
Q ss_pred CChhHHhhhhcCCCCC--HHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 004155 647 GNLMELVDKRLGSNFD--KEQVMVMINVALLCTDVSSTS--RPSMSSVVSM 693 (771)
Q Consensus 647 ~~~~~~~d~~l~~~~~--~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 693 (771)
..+.+......++ ......+.+++..|+..++.+ ||++.|+++.
T Consensus 257 ---~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 257 ---SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111111001111 122345677888888755543 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=320.58 Aligned_cols=256 Identities=32% Similarity=0.496 Sum_probs=207.8
Q ss_pred HhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
..++|.+.++||+|+||.||+|...+++.||||.+.... ....++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346788999999999999999987778899999987533 3456799999999999999999999999988899999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++.... ...+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999995532 24689999999999999999999998 89999999999999999999999999998665422
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
........++..|+|||.+.+..++.++|||||||++|||++ |+.||........ ... +....
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~-------------~~~~~ 221 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQ-------------VERGY 221 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH-------------HHcCC
Confidence 221222335668999999998899999999999999999999 9999864332211 110 00001
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
....+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111112224568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=324.90 Aligned_cols=251 Identities=25% Similarity=0.314 Sum_probs=200.8
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
+|+..++||+|+||.||++.. .+++.||+|++.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999954 568999999986532 1223567889999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999999885432 24689999999999999999999998 8999999999999999999999999999865432
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||............ ...+...
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~------------~~~~~~~- 220 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV------------ERRVKED- 220 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH------------HHHhhhc-
Confidence 22 12346899999999999889999999999999999999999999754332211110 0011110
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
...++......+.+++.+|++.||++|| ++.++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 1122223445688999999999999999 7777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=320.31 Aligned_cols=246 Identities=27% Similarity=0.395 Sum_probs=196.4
Q ss_pred ccccCCceeEEEEEc---CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCC
Q 004155 428 KIGEGGFGPVYKGHM---ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENN 502 (771)
Q Consensus 428 ~lG~G~~g~Vy~~~~---~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 502 (771)
.||+|+||.||+|.+ .++..||+|+++... ....+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999953 457899999986543 234567899999999999999999999885 45679999999999
Q ss_pred CHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccc
Q 004155 503 SLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 582 (771)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 582 (771)
+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999943 24689999999999999999999998 899999999999999999999999999986654332211
Q ss_pred --cccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 583 --TRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 583 --~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
....++..|+|||.+....++.++|||||||++|||++ |+.||......+. .. .+......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~-------------~i~~~~~~ 217 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQ-------------MIESGERM 217 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH-------------HHHCCCCC
Confidence 12234578999999988889999999999999999998 9999975432211 11 11111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
..+......+.+++.+||+.||++||++.+|+..|++.
T Consensus 218 ~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 218 ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 12222345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=324.57 Aligned_cols=258 Identities=26% Similarity=0.374 Sum_probs=203.7
Q ss_pred HhcCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 491 (771)
.+++|.+.+.||+|+||.||+|... .+..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567889999999999999999654 35789999886543 3345679999999999999999999999999889
Q ss_pred EEEEEEeccCCCHHHHhcCCCc---cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC---CeEE
Q 004155 492 LLLIYEYMENNSLARALFGPEA---HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NPKI 565 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 565 (771)
.++||||+++++|.+++..... ....+++..+++++.||+.||+|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999954321 123689999999999999999999998 899999999999998654 5999
Q ss_pred EeecCccccCCCCccc-ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHH
Q 004155 566 SDFGLAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALIL 643 (771)
Q Consensus 566 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 643 (771)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~-------- 232 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME-------- 232 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--------
Confidence 9999998653322111 112233568999999999999999999999999999997 999987543322111
Q ss_pred HhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 644 KAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 644 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
.+........+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 233 --------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 --------FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111111122233456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=341.92 Aligned_cols=250 Identities=20% Similarity=0.315 Sum_probs=194.8
Q ss_pred CCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.|...+.||+|+||+||+| ...+++.||||++.... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999 45678999999986532 2335678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999843 34688999999999999999999998 8999999999999999999999999997643110
Q ss_pred Cc----------------------------------------------ccccccccCCCccchhhhccCCCCchHhHHHH
Q 004155 578 NT----------------------------------------------HISTRVAGTFGYMAPEYAMRGYLTDKADVYSF 611 (771)
Q Consensus 578 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~ 611 (771)
.. .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123469999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCccchhh-HHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHH--ccCCCCCCCCCHH
Q 004155 612 GIVALEIVSGRSNSSCKPKEDIFY-LLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALL--CTDVSSTSRPSMS 688 (771)
Q Consensus 612 Gvil~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~~ 688 (771)
||++|||++|+.||......+... ...| ...+..........++.+++.+ |+..+|..||++.
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~--------------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINW--------------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHcc--------------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 999999999999997644322110 0000 0000000000112345566665 5667777799999
Q ss_pred HHHH
Q 004155 689 SVVS 692 (771)
Q Consensus 689 evl~ 692 (771)
|++.
T Consensus 301 ~~l~ 304 (381)
T cd05626 301 DIKA 304 (381)
T ss_pred HHhc
Confidence 9986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=337.71 Aligned_cols=202 Identities=25% Similarity=0.344 Sum_probs=174.7
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|+..+.||+|+||+||++. ..+++.||+|++.... ......+.+|+.++.+++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 478899999999999999994 4568999999987532 223456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999943 34689999999999999999999998 899999999999999999999999999975432
Q ss_pred CCc----------------------------------ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCC
Q 004155 577 DNT----------------------------------HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 622 (771)
Q Consensus 577 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~ 622 (771)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012346999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 004155 623 SNSSCKP 629 (771)
Q Consensus 623 ~p~~~~~ 629 (771)
.||....
T Consensus 234 ~Pf~~~~ 240 (363)
T cd05628 234 PPFCSET 240 (363)
T ss_pred CCCCCCC
Confidence 9997544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=329.58 Aligned_cols=261 Identities=26% Similarity=0.408 Sum_probs=204.4
Q ss_pred cCCCCCCccccCCceeEEEEEcC-CCc--EEEEEEcccC-ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-DGT--VVAVKQLSSK-SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 495 (771)
++|++.+.||+|+||.||+|... ++. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888999999999999999654 333 5788888743 334456789999999999 799999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCc------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCe
Q 004155 496 YEYMENNSLARALFGPEA------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 563 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 563 (771)
|||+++|+|.++++.... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999954321 123588999999999999999999998 89999999999999999999
Q ss_pred EEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHH
Q 004155 564 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALI 642 (771)
Q Consensus 564 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~ 642 (771)
||+|||++........ ......+..|+|||+.....++.++|||||||++|||++ |+.||......+...
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~------- 229 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE------- 229 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------
Confidence 9999999874322111 111223557999999998889999999999999999997 999996543322110
Q ss_pred HHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 004155 643 LKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQD 702 (771)
Q Consensus 643 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 702 (771)
.+........+......+.+++.+|++.+|.+||++.++++.|+.+.....
T Consensus 230 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 230 ---------KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred ---------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 011111111122233468899999999999999999999999988765443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=319.61 Aligned_cols=251 Identities=26% Similarity=0.342 Sum_probs=201.9
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-----hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-----KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
++|...+.||+|++|.||+|. ..+++.||+|.+.... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 578999999999999999995 4568999999886432 1224568889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
|+||+++++|.+++.. ...+++..+.+++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999843 34688999999999999999999998 8999999999999999999999999999765
Q ss_pred CCCCcccc--cccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 575 EEDNTHIS--TRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 575 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
........ ....|+..|+|||++.+..++.++||||||+++|||++|+.||......... . ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~------------~~ 219 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---F------------KI 219 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---H------------HH
Confidence 43222111 2345788999999999988999999999999999999999998643221110 0 00
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
.........+......+.+++.+||+.+|++||++.|+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 220 ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred hccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01111112222334567889999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.27 Aligned_cols=252 Identities=23% Similarity=0.278 Sum_probs=201.0
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|.+.+.||+|+||.||++. ..+|+.||+|+++... ......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 468889999999999999994 4578999999987542 234566888999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999433 24689999999999999999999998 899999999999999999999999999987654
Q ss_pred CCcccccccccCCCccchhhhc------cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAM------RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLM 650 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (771)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||.......... .......
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~~~~-- 226 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN------NIMNFQR-- 226 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH------HHHcCCC--
Confidence 4333333457899999999986 4567899999999999999999999997543322111 0000000
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 651 ELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 651 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+.-.........+.+++..|++ +|++||++.+++.
T Consensus 227 -----~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 -----FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -----ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00000011123457788899997 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=326.35 Aligned_cols=249 Identities=24% Similarity=0.423 Sum_probs=203.4
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.+|+..+.||+|+||.||+|. ..+++.||+|.+..........+.+|+.+++.++|+||+++++++..+.+.++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 578888999999999999995 4578999999987655555677899999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++.. ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999832 3578999999999999999999998 899999999999999999999999999876543222
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
. .....|++.|+|||.+.+..++.++|||||||++|||++|+.||......... .. ... ......
T Consensus 172 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~----~~~--------~~~~~~ 236 (296)
T cd06654 172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YL----IAT--------NGTPEL 236 (296)
T ss_pred c-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HH----Hhc--------CCCCCC
Confidence 1 22346889999999999888999999999999999999999999654321110 00 000 000001
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+......+.+++.+|++.+|++||++.|+++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 112233456788999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=324.08 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=199.5
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCc----EEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGT----VVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
++|++.+.||+|+||.||+|.+ .+|+ .|++|.+.... .....++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 4677789999999999999965 3444 47888875432 233467788888999999999999999885 455789
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
++||+++|+|.+++... ...+++..+..|+.||+.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999542 24689999999999999999999998 8999999999999999999999999999865
Q ss_pred CCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 575 EEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 575 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
...... ......++..|+|||++.++.++.++|||||||++|||++ |+.||........... ...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~~~--- 229 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-------LEKGER--- 229 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHCCCc---
Confidence 433221 2233457789999999998899999999999999999998 9999865432221111 111110
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
...+......+.+++.+||..+|++||++.|+++.|..+.
T Consensus 230 ------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 230 ------LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 0011112335678899999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=326.29 Aligned_cols=256 Identities=28% Similarity=0.420 Sum_probs=202.5
Q ss_pred CCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCChh-cHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
+|++.+.||+|+||.||+|... +++.||+|+++..... ..+.+.+|+.++.+++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3566789999999999999642 3578999999755332 34678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCC------------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC
Q 004155 495 IYEYMENNSLARALFGPE------------AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 562 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 562 (771)
++||+++++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999984321 1123588999999999999999999998 8999999999999999999
Q ss_pred eEEEeecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHH
Q 004155 563 PKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWA 640 (771)
Q Consensus 563 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~ 640 (771)
+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||......+.. +
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---~-- 237 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI---E-- 237 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H--
Confidence 99999999886543221 11223346789999999988889999999999999999998 88888653322111 1
Q ss_pred HHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 641 LILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 641 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
. +.+.. ....+......+.+++..||+.+|++||++.+|++.|+.
T Consensus 238 -~---------i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 -M---------IRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -H---------HHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 11111 111222344568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=342.61 Aligned_cols=251 Identities=22% Similarity=0.285 Sum_probs=197.2
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4788999999999999999954 568999999997532 233456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999943 34689999999999999999999998 899999999999999999999999999875432
Q ss_pred CCcc-------------------------------------cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHH
Q 004155 577 DNTH-------------------------------------ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 619 (771)
Q Consensus 577 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ell 619 (771)
.... ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011245999999999999999999999999999999999
Q ss_pred hCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 004155 620 SGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPS---MSSVVS 692 (771)
Q Consensus 620 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~ 692 (771)
+|+.||......+... .. ... ...+...........+.+++.+|+. +|.+|++ +.|+++
T Consensus 234 ~G~~Pf~~~~~~~~~~---~i---~~~-------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQETYR---KI---INW-------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHHHHHH---HH---HcC-------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999997543322110 00 000 0000000000122356778888886 9999998 887766
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=318.44 Aligned_cols=250 Identities=32% Similarity=0.497 Sum_probs=205.4
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.++|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356788999999999999999764 78999999976544 5678999999999999999999999999889999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 83 AKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999995432 23689999999999999999999998 899999999999999999999999999986633221
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
...++..|+|||++....++.++||||||+++|||++ |+.||......+.. .. +.....
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~-------------~~~~~~ 217 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PH-------------VEKGYR 217 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HH-------------HhcCCC
Confidence 2234668999999998899999999999999999997 99998654322211 10 001111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
...+...+..+.+++.+|+..+|++||++.|++++|+.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11122234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=333.60 Aligned_cols=239 Identities=25% Similarity=0.372 Sum_probs=190.3
Q ss_pred CCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHH---HcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 423 FAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMI---SALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
|++.+.||+|+||.||+|. ..+|+.||||+++... ....+.+.+|+.++ ++++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 5678899999999999995 4568999999987532 22334566666554 567899999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++|+|..+++ ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 99999999998883 24689999999999999999999998 89999999999999999999999999987533
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+... .+...
T Consensus 153 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~---------------~i~~~ 216 (324)
T cd05589 153 GFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD---------------SIVND 216 (324)
T ss_pred CCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH---------------HHHhC
Confidence 2222 2234569999999999999999999999999999999999999997543322111 01111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSM 687 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 687 (771)
. ..++......+.+++.+||+.||.+||++
T Consensus 217 ~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 217 E--VRYPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred C--CCCCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 0 01112233457889999999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=327.48 Aligned_cols=264 Identities=26% Similarity=0.401 Sum_probs=202.4
Q ss_pred cCCCCCCccccCCceeEEEEEcCC---------------CcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMAD---------------GTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHG 484 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~---------------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~ 484 (771)
++|++.++||+|+||.||++...+ ...||+|+++.. .......|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578899999999999999985432 235899998764 2334567999999999999999999999
Q ss_pred EEEeCCEEEEEEEeccCCCHHHHhcCCCc--------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEE
Q 004155 485 CCIEGNQLLLIYEYMENNSLARALFGPEA--------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVL 556 (771)
Q Consensus 485 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIl 556 (771)
++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 99999999999999999999999854321 112478999999999999999999998 8999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh--CCCCCCCCCccch
Q 004155 557 LDKDLNPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS--GRSNSSCKPKEDI 633 (771)
Q Consensus 557 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt--G~~p~~~~~~~~~ 633 (771)
+++++.+||+|||+++....... .......++..|+|||+..++.++.++|||||||++|||++ |..||.....++.
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999976543221 11222345778999999998899999999999999999998 5567764332221
Q ss_pred hhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 634 FYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
.. ......... ........+...+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus 242 ~~---~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 242 IE---NTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HH---HHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11 111101000 0000011111233568999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=334.05 Aligned_cols=241 Identities=26% Similarity=0.379 Sum_probs=194.0
Q ss_pred CccccCCceeEEEEEc----CCCcEEEEEEcccCC----hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 427 NKIGEGGFGPVYKGHM----ADGTVVAVKQLSSKS----KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
++||+|+||.||++.. .+++.||+|+++... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999954 357899999987531 22345678899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999832 34678889999999999999999998 89999999999999999999999999997543322
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+.....
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~---------------~~~~~~~~- 217 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI---------------DKILKGKL- 217 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH---------------HHHHcCCC-
Confidence 2 223356999999999999888999999999999999999999999754322111 01111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
..+......+.+++.+|++.+|++|| ++.++++
T Consensus 218 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 -NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11122234578999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=331.56 Aligned_cols=238 Identities=24% Similarity=0.373 Sum_probs=189.2
Q ss_pred CccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
++||+|+||.||+|.. .+++.||+|+++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999954 468899999987532 22334556677777654 899999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999999843 34689999999999999999999998 89999999999999999999999999998543322 22
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 661 (771)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +... ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~---------------i~~~--~~~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS---------------ILND--RPHF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH---------------HHcC--CCCC
Confidence 2345699999999999998999999999999999999999999975433221110 0000 0111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 004155 662 DKEQVMVMINVALLCTDVSSTSRPSMSS 689 (771)
Q Consensus 662 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 689 (771)
+......+.+++.+||+.||++||++.+
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 2223345778999999999999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=341.17 Aligned_cols=260 Identities=24% Similarity=0.335 Sum_probs=199.5
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC-----EEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGN-----QLL 493 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 493 (771)
+|++.++||+|+||.||++. ..+|+.||||++... .....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47889999999999999995 457899999998653 2234567889999999999999999999998776 789
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+||||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 588888732 34689999999999999999999998 899999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC----
Q 004155 574 DEEDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN---- 648 (771)
Q Consensus 574 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 648 (771)
.............+|..|+|||++.+. .++.++|||||||++|||++|+.||...........+.. ......
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~~g~~~~~~~ 229 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD---LLGTPSLEAM 229 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHH---HcCCCCHHHH
Confidence 544333333344678999999998774 579999999999999999999999976543322211110 000000
Q ss_pred ------hhHHhhhhcCC--------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 649 ------LMELVDKRLGS--------NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 649 ------~~~~~d~~l~~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
....+...... .........+.+++.+|++.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000000000 011112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=338.83 Aligned_cols=260 Identities=26% Similarity=0.402 Sum_probs=204.5
Q ss_pred hcCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKSK-QGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 491 (771)
.++|.+.++||+|+||.||+|.+. .++.||||+++.... ...+.+.+|+.++.++. ||||++++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 345677899999999999999642 346899999976432 23457889999999997 9999999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCc----------------------------------------------------------
Q 004155 492 LLLIYEYMENNSLARALFGPEA---------------------------------------------------------- 513 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 513 (771)
.++||||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999964321
Q ss_pred ------------------------------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE
Q 004155 514 ------------------------------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL 557 (771)
Q Consensus 514 ------------------------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 557 (771)
....+++..+++++.||+.||+|||+. +++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence 113477888999999999999999987 89999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhh
Q 004155 558 DKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFY 635 (771)
Q Consensus 558 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~ 635 (771)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+..
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~- 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF- 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH-
Confidence 99999999999999865332211 1122356789999999998889999999999999999998 88898654322211
Q ss_pred HHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 636 LLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.+.+........+......+.+++.+||+.+|.+||+++||++.|+..
T Consensus 352 --------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 352 --------------YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred --------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 011111111111222345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.45 Aligned_cols=250 Identities=27% Similarity=0.403 Sum_probs=204.5
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+|+..+.||+|+||.||+|.. .+|+.|++|.+... .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477789999999999999954 56899999998643 334567889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999996432 34689999999999999999999988 89999999999999999999999999998665432
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.. .....|+..|+|||+..+..++.++|||||||++|||++|+.||........ ..+ +... ..
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~------------~~~~-~~ 218 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---ILK------------IIRG-VF 218 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHH------------HHcC-CC
Confidence 22 2334688899999999999999999999999999999999999975432111 110 0111 11
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11222344568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.74 Aligned_cols=241 Identities=25% Similarity=0.326 Sum_probs=194.6
Q ss_pred CccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCC
Q 004155 427 NKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENN 502 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 502 (771)
+.||+|+||.||++. ..+|+.||+|+++.. .......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999994 457899999998753 2233456788999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 503 SLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE-ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
+|.+++.. ...+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~- 152 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT- 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-
Confidence 99998832 3468999999999999999999997 5 8999999999999999999999999998754322221
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 661 (771)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.....+...... .... ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i---------------~~~~--~~~ 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---------------LMEE--IRF 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH---------------hcCC--CCC
Confidence 22356999999999999999999999999999999999999999754332211110 0000 011
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 662 DKEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 662 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
+......+.+++.+|++.||++|+ ++.++++
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 112234578899999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=324.14 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=205.9
Q ss_pred hcCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 492 (771)
.++|.+.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 457888999999999999999543 24689999987543 23456788999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcCCCc------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEE
Q 004155 493 LLIYEYMENNSLARALFGPEA------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 566 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 566 (771)
++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 999999999999999964322 123578999999999999999999988 89999999999999999999999
Q ss_pred eecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHH
Q 004155 567 DFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 567 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
|||+++....... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||......... .+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~~~--- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL---KFVI--- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH---HHHh---
Confidence 9999976543321 11223456789999999998889999999999999999998 89898644332211 1110
Q ss_pred hhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 645 AQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 645 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
.+. ....+......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 236 -~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 -DGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -cCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 110 011122234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=320.40 Aligned_cols=256 Identities=27% Similarity=0.450 Sum_probs=204.4
Q ss_pred hcCCCCCCccccCCceeEEEEEcC-CC---cEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMA-DG---TVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~-~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
+++|+..+.||+|+||.||+|... ++ ..+|+|.++... ....+.+..|++++++++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457788899999999999999653 33 379999987542 3345678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+++++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999999999432 24689999999999999999999998 8999999999999999999999999999866
Q ss_pred CCCCcccc--cccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 575 EEDNTHIS--TRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 575 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
........ .....+..|+|||++....++.++|||||||++|||++ |+.||......+.. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~------~~i~------- 224 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM------KAIN------- 224 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH------HHHh-------
Confidence 43322211 11223457999999998889999999999999999998 99998654322111 1111
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
..............+.+++.+|++.+|++||++.+|++.|+++
T Consensus 225 ---~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 225 ---DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1011111122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=325.41 Aligned_cols=264 Identities=27% Similarity=0.401 Sum_probs=203.5
Q ss_pred cCCCCCCccccCCceeEEEEEcC-----------------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-----------------DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKL 482 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-----------------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 482 (771)
++|++.++||+|+||.||++... ++..||+|++.... ......+.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56889999999999999998432 24479999987543 3345689999999999999999999
Q ss_pred EEEEEeCCEEEEEEEeccCCCHHHHhcCCCc-------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcE
Q 004155 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEA-------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNV 555 (771)
Q Consensus 483 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NI 555 (771)
++++...+..++||||+++|+|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999965321 123578899999999999999999998 899999999999
Q ss_pred EEcCCCCeEEEeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh--CCCCCCCCCccc
Q 004155 556 LLDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS--GRSNSSCKPKED 632 (771)
Q Consensus 556 ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt--G~~p~~~~~~~~ 632 (771)
+++.++.++|+|||+++........ ......++..|+|||....+.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999999865433221 1122334678999999988899999999999999999998 677886543322
Q ss_pred hhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 633 IFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
... .......... .......+......+.+++.+||+.||++||++.||++.|++
T Consensus 242 ~~~---~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 VIE---NTGEFFRDQG------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHH---HHHHHHhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 211 1110000000 000001111233568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.12 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=198.5
Q ss_pred CCCCCccccCCceeEEEEEcCC-Cc--EEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC------CE
Q 004155 423 FAPDNKIGEGGFGPVYKGHMAD-GT--VVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEG------NQ 491 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~~~-g~--~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 491 (771)
|.+.++||+|+||.||+|...+ +. .||+|.++.. .....+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999996543 33 6999988653 334467789999999999999999999987532 25
Q ss_pred EEEEEEeccCCCHHHHhcCCC--ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeec
Q 004155 492 LLLIYEYMENNSLARALFGPE--AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 569 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 569 (771)
.++||||+++|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999874321 2234589999999999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCccc-ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhC
Q 004155 570 LAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQG 647 (771)
Q Consensus 570 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 647 (771)
+++......... .....+++.|+|||+..+..++.++|||||||++|||++ |+.||......+. .+ .. ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~---~~-~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI---YD---YL-RQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH---HH-HcC
Confidence 998664332211 122345678999999999999999999999999999999 7888865322211 11 01 111
Q ss_pred ChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 648 NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 648 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.. ..........+.+++.+||+.+|++||++.++++.|+.+
T Consensus 231 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NR---------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 10 011112334588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=320.90 Aligned_cols=256 Identities=26% Similarity=0.432 Sum_probs=201.5
Q ss_pred CCCCCccccCCceeEEEEEcCC----CcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE-----
Q 004155 423 FAPDNKIGEGGFGPVYKGHMAD----GTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQ----- 491 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 491 (771)
|.+.+.||+|+||.||+|.... +..||+|+++... ......+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999996532 3679999987542 3345678999999999999999999999876544
Q ss_pred -EEEEEEeccCCCHHHHhcCCC--ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEee
Q 004155 492 -LLLIYEYMENNSLARALFGPE--AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 568 (771)
Q Consensus 492 -~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 568 (771)
.++||||+++|+|..++.... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 799999999999999985432 2234689999999999999999999998 8999999999999999999999999
Q ss_pred cCccccCCCCccc-ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhh
Q 004155 569 GLAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQ 646 (771)
Q Consensus 569 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 646 (771)
|+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+. .++. . .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~---~~~~---~-~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI---YDYL---R-H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH---H-c
Confidence 9998654433221 112335678999999988899999999999999999999 8888865332211 1111 0 0
Q ss_pred CChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 647 GNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 647 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
+ .....+......+.+++.+|++.||++||++.|+++.|++.
T Consensus 231 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 G---------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C---------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01112223445688999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=332.54 Aligned_cols=241 Identities=23% Similarity=0.357 Sum_probs=193.2
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCC-CcEEeEEEEEEeCCEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQH-PNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~ 496 (771)
+|++.+.||+|+||.||+|.. .+++.||||++... .....+.+..|..++..++| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 478889999999999999954 45789999998753 22345667889999999976 56889999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999843 34689999999999999999999998 899999999999999999999999999874322
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+... .+....
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~---------------~i~~~~ 217 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ---------------SIMEHN 217 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH---------------HHHcCC
Confidence 111 1233568999999999999999999999999999999999999997543322111 011110
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSM 687 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 687 (771)
..++......+.+++.+|++.||.+||+.
T Consensus 218 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 --VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11122233457889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=318.23 Aligned_cols=252 Identities=27% Similarity=0.483 Sum_probs=202.6
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
.+|++.+.||+|+||.||+|...+++.+|+|.+.... .....|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677889999999999999987778899999986532 334678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999998532 23588999999999999999999998 8999999999999999999999999999865433222
Q ss_pred cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
......++.+|+|||++.++.++.++||||||+++|||++ |+.||......... + ... .+ ...
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---~---~~~-~~---------~~~ 220 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV---E---TIN-AG---------FRL 220 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH---H---HHh-CC---------CCC
Confidence 1222335678999999998899999999999999999998 99998653322111 1 000 00 000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
..+......+.+++.+||+.+|++||++.|++++|.
T Consensus 221 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 001112356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=328.96 Aligned_cols=260 Identities=28% Similarity=0.417 Sum_probs=205.4
Q ss_pred hcCCCCCCccccCCceeEEEEEcC--------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeC
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMA--------DGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEG 489 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 489 (771)
.++|.+.+.||+|+||.||++... ++..||+|.++... .....++..|+++++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357889999999999999999532 23579999997642 33456788899999999 799999999999999
Q ss_pred CEEEEEEEeccCCCHHHHhcCCCc------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE
Q 004155 490 NQLLLIYEYMENNSLARALFGPEA------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL 557 (771)
Q Consensus 490 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 557 (771)
+..++||||+++|+|.+++..... ....+++.++++++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999965321 123589999999999999999999988 89999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCccc-ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhh
Q 004155 558 DKDLNPKISDFGLAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFY 635 (771)
Q Consensus 558 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~ 635 (771)
+.++.+||+|||.++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.....++...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 999999999999997654322111 112234568999999998889999999999999999998 888886543222111
Q ss_pred HHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 636 LLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
. +........+......+.+++.+|+..+|++||++.+|++.|+.+.
T Consensus 254 ~----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 254 L----------------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred H----------------HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1 1111111122233456888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.59 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=196.4
Q ss_pred ccccCCceeEEEEEcC---CCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCC
Q 004155 428 KIGEGGFGPVYKGHMA---DGTVVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNS 503 (771)
Q Consensus 428 ~lG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 503 (771)
.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999543 356799999876532 33567999999999999999999999886 457899999999999
Q ss_pred HHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccc-
Q 004155 504 LARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS- 582 (771)
Q Consensus 504 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~- 582 (771)
|.+++... ...+++..+++++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99998532 34689999999999999999999998 899999999999999999999999999986544332211
Q ss_pred -cccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCC
Q 004155 583 -TRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSN 660 (771)
Q Consensus 583 -~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 660 (771)
....++..|+|||++....++.++|||||||++||+++ |+.||......+.. ..+.......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~----------------~~~~~~~~~~ 218 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM----------------SFIEQGKRLD 218 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH----------------HHHHCCCCCC
Confidence 11233578999999988889999999999999999996 99999754332211 1111111112
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 661 FDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 661 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.+.....++.+++.+||..+|++||++.+|.+.|+..
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 2233455788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=325.19 Aligned_cols=261 Identities=23% Similarity=0.354 Sum_probs=207.7
Q ss_pred HhcCCCCCCccccCCceeEEEEEcCC-----CcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe-CCE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMAD-----GTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIE-GNQ 491 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 491 (771)
..++|.+.+.||+|+||.||+|...+ +..||+|++... .......+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678899999999999999997654 688999998754 23446678899999999999999999998876 467
Q ss_pred EEEEEEeccCCCHHHHhcCCCcc----CCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEe
Q 004155 492 LLLIYEYMENNSLARALFGPEAH----RLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 567 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 567 (771)
.++++||+++++|.+++...... ...+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998553321 25689999999999999999999998 899999999999999999999999
Q ss_pred ecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHh
Q 004155 568 FGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKA 645 (771)
Q Consensus 568 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 645 (771)
||+++.+...... ......++..|+|||++.+..++.++|||||||++||+++ |+.||......+ ...+. ..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~---~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYL---KD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHH---Hc
Confidence 9999865433222 1222346778999999998889999999999999999999 999996543221 11111 11
Q ss_pred hCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 646 QGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 646 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
. ............+.+++.+||..||++||++.+++++|+...
T Consensus 235 ~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 G----------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred C----------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 000111123346889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=326.83 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=205.2
Q ss_pred hcCCCCCCccccCCceeEEEEEc------CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 491 (771)
.++|.+.+.||+|+||.||+|.. ..+..||||+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35688899999999999999953 234589999987543 33356789999999999 79999999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.++||||+++|+|.++++... ...+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999995432 23489999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCCh
Q 004155 572 KLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNL 649 (771)
Q Consensus 572 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (771)
+........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+.. .
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~------------ 254 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--Y------------ 254 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--H------------
Confidence 865433221 1122345778999999999999999999999999999998 99998654332211 0
Q ss_pred hHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 650 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
+.++.......+......+.+++.+|++.+|++||++.|+++.|++.
T Consensus 255 -~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 255 -KLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111111111112234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.84 Aligned_cols=265 Identities=26% Similarity=0.400 Sum_probs=205.6
Q ss_pred hcCCCCCCccccCCceeEEEEEcCC-----------------CcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMAD-----------------GTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVK 481 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 481 (771)
..+|++.+.||+|+||.||+|...+ +..||+|++.... ......+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999985432 2468999987643 344668899999999999999999
Q ss_pred EEEEEEeCCEEEEEEEeccCCCHHHHhcCCCc-------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCc
Q 004155 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEA-------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATN 554 (771)
Q Consensus 482 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~N 554 (771)
+++++..++..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999955331 123689999999999999999999998 89999999999
Q ss_pred EEEcCCCCeEEEeecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh--CCCCCCCCCcc
Q 004155 555 VLLDKDLNPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS--GRSNSSCKPKE 631 (771)
Q Consensus 555 Ill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt--G~~p~~~~~~~ 631 (771)
|+++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999976543221 12233456789999999998889999999999999999998 66777543322
Q ss_pred chhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 632 DIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
. ............. .......+.....++.+++.+|++.||++||++.|+++.|+.
T Consensus 241 ~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 Q---VIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred H---HHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 2 1111111111100 000011111233568999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.45 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=205.3
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.++|++.++||+|+||.||+|...++..+|+|.+... ......+.+|++++++++|+||+++.+++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3578889999999999999998777888999988753 2345678999999999999999999999887 7789999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++.... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 83 AKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999995432 34688999999999999999999988 899999999999999999999999999976543322
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.......++..|+|||++....++.++|||||||++|+++| |+.||........ ..+. .....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~-------------~~~~~ 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRAL-------------ERGYR 221 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH-------------hCCCC
Confidence 22222345678999999998889999999999999999999 8999865432211 1110 01111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
..........+.+++.+|++.+|++||++.++.++|+.
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11112334568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=320.29 Aligned_cols=255 Identities=28% Similarity=0.447 Sum_probs=203.9
Q ss_pred cCCCCCCccccCCceeEEEEEcC----CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA----DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
++|++.+.||+|+||.||+|... .+..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56888999999999999999542 23479999987543 33456889999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999543 23689999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcccc--cccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 576 EDNTHIS--TRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 576 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
....... ....++..|+|||++.+..++.++|||||||++||+++ |+.||......+. ..+. ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~----~~~----- 225 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAI----EEG----- 225 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHH----hCC-----
Confidence 4332221 11223568999999998899999999999999999886 9999865432221 1111 000
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.........+..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 ----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00111112345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=320.35 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=201.0
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35788999999999999999964 57899999998765444556788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999843 34689999999999999999999998 89999999999999999999999999998654322
Q ss_pred cccccccccCCCccchhhhc---cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 579 THISTRVAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
. ......|+..|+|||.+. ...++.++|||||||++|||++|+.||............ .... ...+
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~~~---~~~~ 229 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SKSN---FQPP 229 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ecCC---CCCC
Confidence 1 112345888999999884 345788999999999999999999998643221110000 0000 0000
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
... ........+.+++.+||+.+|++||+++++++.
T Consensus 230 ~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 230 KLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 010 011223568899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=320.95 Aligned_cols=259 Identities=27% Similarity=0.355 Sum_probs=198.5
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC-----EEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGN-----QLLLI 495 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lV 495 (771)
.|...+++|.|+||.||+|.. .++..||||+.-.+.+ .-.+|+++|+++.|||||++..+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 355678999999999999954 4578999999865433 2246899999999999999999987432 45689
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC-CCeEEEeecCcccc
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLD 574 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFGla~~~ 574 (771)
||||+. +|.+.++.....+..++...+.-+..||++||+|||+. +|+||||||.|+|+|.+ |.+||+|||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 99999965544567888899999999999999999997 99999999999999976 99999999999987
Q ss_pred CCCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh--CChh-
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ--GNLM- 650 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~- 650 (771)
....... ....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+....+. +.+....+..+ +.+.
T Consensus 177 ~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHHHHhh
Confidence 6654442 23467799999999875 799999999999999999999999977543332 22222222111 0111
Q ss_pred ------HHhhhhcCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 651 ------ELVDKRLGSN-----FDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 651 ------~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+.-.+.+... +......+.++++.+++..+|.+|.++.|++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111111111 12234456889999999999999999999986
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=331.65 Aligned_cols=243 Identities=22% Similarity=0.319 Sum_probs=190.6
Q ss_pred CccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
++||+|+||.||+|. ..+++.||+|+++... ......+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 469999999999995 4568999999997532 23345678899999988 799999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-T 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC-c
Confidence 999998832 34699999999999999999999998 899999999999999999999999999974322221 2
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc--hhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKED--IFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .....++.... +.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~-- 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV--------ILEKQI-- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH--------HHcCCC--
Confidence 234568999999999999999999999999999999999999996422111 10111111111 111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSM 687 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 687 (771)
..+......+.+++.+|++.||.+||++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1122233457889999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=331.17 Aligned_cols=237 Identities=22% Similarity=0.372 Sum_probs=190.3
Q ss_pred CccccCCceeEEEEEc-CCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
+.||+|+||.||+|.. .+++.||||++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999954 46899999998753 223345677888888876 699999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-T 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-c
Confidence 999998843 34689999999999999999999998 899999999999999999999999999875432221 2
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 661 (771)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +.... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~---------------i~~~~--~~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA---------------ILNDE--VVY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH---------------HhcCC--CCC
Confidence 2345699999999999999999999999999999999999999975433221110 00000 011
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH
Q 004155 662 DKEQVMVMINVALLCTDVSSTSRPSMS 688 (771)
Q Consensus 662 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 688 (771)
+......+.+++.+|++.||++||++.
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 112234578899999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.78 Aligned_cols=260 Identities=26% Similarity=0.421 Sum_probs=204.5
Q ss_pred HhcCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 491 (771)
.+++|++.++||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999998532 24589999986543 2334568899999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCc------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEE
Q 004155 492 LLLIYEYMENNSLARALFGPEA------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 565 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 565 (771)
.++||||+++|+|.+++..... .....++..+.+++.|++.||.|||+. +|+||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999954221 123457788999999999999999998 8999999999999999999999
Q ss_pred EeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHH
Q 004155 566 SDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALIL 643 (771)
Q Consensus 566 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 643 (771)
+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||.....++.. ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~---~~---- 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL---KF---- 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----
Confidence 999999855432221 1122345678999999998899999999999999999999 78888653322211 10
Q ss_pred HhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 644 KAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 644 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
+.+... ...+......+.+++.+|++.+|++||++.++++.|++.
T Consensus 234 --------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 --------VMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred --------HHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111100 111122345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=331.10 Aligned_cols=241 Identities=23% Similarity=0.361 Sum_probs=193.6
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 496 (771)
+|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 477889999999999999954 467899999987542 22334567788888777 5899999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999999843 34689999999999999999999998 899999999999999999999999999975432
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......... .+....
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~---------------~i~~~~ 217 (323)
T cd05616 154 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ---------------SIMEHN 217 (323)
T ss_pred CCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH---------------HHHhCC
Confidence 221 2234569999999999999999999999999999999999999997544322111 011111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSM 687 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 687 (771)
..++......+.+++.+|++.||++|++.
T Consensus 218 --~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 --VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11222234567889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=331.19 Aligned_cols=241 Identities=22% Similarity=0.373 Sum_probs=192.5
Q ss_pred CccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
++||+|+||.||+|.. .+++.||+|+++... ....+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999954 457899999987532 23345677889988866 799999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 999998843 34689999999999999999999998 899999999999999999999999999975432222 1
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 661 (771)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~---------------~i~~~~~--~~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE---------------SILHDDV--LY 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH---------------HHHcCCC--CC
Confidence 234568999999999999899999999999999999999999997554322111 0110000 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHH
Q 004155 662 DKEQVMVMINVALLCTDVSSTSRP-------SMSSVVS 692 (771)
Q Consensus 662 ~~~~~~~l~~l~~~Cl~~dP~~RP-------s~~evl~ 692 (771)
+......+.+++..|++.||++|| ++.++++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 111234578899999999999999 6666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=331.06 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=190.3
Q ss_pred CccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
+.||+|+||.||+|. ..+++.||+|+++.. .......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999995 456889999998754 223345677888888876 799999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 999988832 34689999999999999999999998 899999999999999999999999999975432221 1
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc--hhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKED--IFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....... ......+..... .... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--------~~~~--~ 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--------LEKQ--I 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--------hcCC--C
Confidence 234568999999999999999999999999999999999999996422111 001111111111 1111 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSM 687 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 687 (771)
..+......+.+++.+||+.||++||++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1222334457899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=324.77 Aligned_cols=240 Identities=24% Similarity=0.370 Sum_probs=190.9
Q ss_pred CccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
+.||+|+||.||+|.. .+++.||||+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999954 457899999987542 22345567788888764 899999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|+|.+++.. ...+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 999999942 34689999999999999999999998 899999999999999999999999999975322221 2
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 661 (771)
.....||..|+|||++.+..++.++|||||||++|||++|+.||......+.. .... .. .+ .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~---~~i~----~~------~~----~~ 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF---QSIR----MD------NP----CY 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHH---HHHH----hC------CC----CC
Confidence 23456899999999999989999999999999999999999999754332211 1100 00 01 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 004155 662 DKEQVMVMINVALLCTDVSSTSRPSMS-SVV 691 (771)
Q Consensus 662 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl 691 (771)
+......+.+++.+|++.||++||++. ++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 112234577899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.11 Aligned_cols=256 Identities=25% Similarity=0.341 Sum_probs=203.4
Q ss_pred HHHHhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 416 IKAATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 416 l~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
++.+++++.....||+|+||.||+|. ..+++.||+|.+........+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 45567778788899999999999995 45678999999877666667789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCC--ChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC-CCCeEEEeecCc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKL--DWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLA 571 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFGla 571 (771)
|+||+++++|.+++.... ..+ ++..+..++.||+.||+|||+. +|+||||||+||+++. ++.++|+|||.+
T Consensus 83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 999999999999995432 234 7888999999999999999998 8999999999999976 679999999999
Q ss_pred cccCCCCcccccccccCCCccchhhhccC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCCh
Q 004155 572 KLDEEDNTHISTRVAGTFGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL 649 (771)
Q Consensus 572 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (771)
......... .....|+..|+|||++.+. .++.++||||||+++|+|++|+.||......... .+.....
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~----- 227 (268)
T cd06624 157 KRLAGINPC-TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMF----- 227 (268)
T ss_pred eecccCCCc-cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhh-----
Confidence 765432221 2234588999999998764 3789999999999999999999998643221110 0000000
Q ss_pred hHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 650 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
......+......+.+++.+||+.+|++||++.|+++
T Consensus 228 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 ------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0011122233456888999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.10 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=198.6
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
++|+..++||+|+||.||+|. ..+++.||+|++... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 367788999999999999994 467899999998654 234456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999997653 468889999999999999999998 89999999999999999999999999997654321
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchh-hHHHHHHHHHhhCChhHHhhhhc
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF-YLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||......... ....+.. .+.+...
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---------~~~~~~~ 217 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ---------CIVDEDP 217 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH---------HHhccCC
Confidence 23356899999999999889999999999999999999999999653221111 0001000 0111110
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
...........+.+++.+|++.+|++||++.|+++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 218 PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000011123457899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=327.66 Aligned_cols=259 Identities=27% Similarity=0.420 Sum_probs=202.3
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCc--EEEEEEcccC-ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGT--VVAVKQLSSK-SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 494 (771)
.++|++.+.||+|+||.||+|.. .++. .+|+|.++.. .......+.+|++++.++ +|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 35788889999999999999964 3454 4688877643 334456788999999999 89999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCc------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC
Q 004155 495 IYEYMENNSLARALFGPEA------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 562 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 562 (771)
||||+++|+|.++++.... ....+++.+++.++.|++.||+|||+. +++||||||+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999964321 123689999999999999999999998 8999999999999999999
Q ss_pred eEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHH
Q 004155 563 PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWAL 641 (771)
Q Consensus 563 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 641 (771)
+||+|||+++....... .....++..|+|||++.+..++.++|||||||++|||+| |..||......+.. .
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~--- 234 (303)
T cd05088 163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---E--- 234 (303)
T ss_pred EEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH---H---
Confidence 99999999864321111 111234668999999988889999999999999999998 99999654332211 1
Q ss_pred HHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 642 ILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 642 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
... .......+......+.+++.+|++.+|++||++.++++.|+.+..
T Consensus 235 ~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 235 KLP----------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HHh----------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000 000011111223457899999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=339.97 Aligned_cols=252 Identities=21% Similarity=0.267 Sum_probs=195.3
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|.+.++||+|+||.||++. ..+|+.||||++.... ......+.+|++++++++||||+++++++.+.++.|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 478889999999999999994 4578999999986532 233467888999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999943 34688999999999999999999998 899999999999999999999999999963321
Q ss_pred CCc------------c----------------------------------cccccccCCCccchhhhccCCCCchHhHHH
Q 004155 577 DNT------------H----------------------------------ISTRVAGTFGYMAPEYAMRGYLTDKADVYS 610 (771)
Q Consensus 577 ~~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S 610 (771)
... . ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 000 0 001246999999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCC---CCH
Q 004155 611 FGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSR---PSM 687 (771)
Q Consensus 611 ~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~ 687 (771)
|||++|||++|+.||......+.... ..... ..+.-.........+.+++.+|+. +|.+| +++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~------i~~~~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRK------IINWR-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHH------HHccC-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 99999999999999975443221110 00000 000000000122357788889997 66665 588
Q ss_pred HHHHHH
Q 004155 688 SSVVSM 693 (771)
Q Consensus 688 ~evl~~ 693 (771)
.|++..
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 888763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=314.53 Aligned_cols=266 Identities=23% Similarity=0.329 Sum_probs=203.6
Q ss_pred cCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCc-EEeEEEEEEeCC------
Q 004155 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPN-LVKLHGCCIEGN------ 490 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 490 (771)
..|...++||+|.||+||+| ...+|+.||+|++.-... .......+|+.+|++++|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34556678999999999999 566789999999976543 23456789999999999999 999999998877
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..++|+||++. +|.+++.........++...+..++.||++||+|||++ +|+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78999999976 99999965443224677789999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh--hC
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA--QG 647 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~ 647 (771)
|+...-+... .+..++|..|+|||++.+. .|+...||||+|||+.||+++++.|.+..+.+... .-...+.. ..
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~--~If~~lGtP~e~ 243 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF--RIFRLLGTPNEK 243 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH--HHHHHcCCCCcc
Confidence 9965533222 3456789999999999886 79999999999999999999999997765432221 11111111 11
Q ss_pred ChhHH---hhhh--cCCC-----CCHHHH---HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 648 NLMEL---VDKR--LGSN-----FDKEQV---MVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 648 ~~~~~---~d~~--l~~~-----~~~~~~---~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
.+..+ .+-. .... ...... ....+++.+|++.+|.+|.+++.+++.
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11111 1111 0000 001111 257889999999999999999999875
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.76 Aligned_cols=240 Identities=23% Similarity=0.345 Sum_probs=190.5
Q ss_pred CccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
++||+|+||.||+|.. .+|+.||+|+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999954 468999999987532 22345567788888754 899999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 999999843 34689999999999999999999998 89999999999999999999999999987432211 12
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 661 (771)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... +.. . . ..+ .+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~---~~~---~-~------~~~----~~ 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF---ESI---R-V------DTP----HY 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---HHH---H-h------CCC----CC
Confidence 23456899999999999999999999999999999999999999754332111 100 0 0 001 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 004155 662 DKEQVMVMINVALLCTDVSSTSRPSMS-SVV 691 (771)
Q Consensus 662 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl 691 (771)
+......+.+++.+|++.||++||++. ++.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 112234577899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=320.18 Aligned_cols=248 Identities=25% Similarity=0.306 Sum_probs=194.2
Q ss_pred cccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCH
Q 004155 429 IGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL 504 (771)
Q Consensus 429 lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 504 (771)
||+|+||.||++.. .+|+.||+|.+.... ......+..|++++++++||||+++++++..+.+.++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999954 568999999986432 12234566799999999999999999999999999999999999999
Q ss_pred HHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccccc
Q 004155 505 ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 584 (771)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 584 (771)
.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~ 153 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQ 153 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eec
Confidence 98885432 34589999999999999999999998 899999999999999999999999999986543322 233
Q ss_pred cccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHH
Q 004155 585 VAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKE 664 (771)
Q Consensus 585 ~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 664 (771)
..||..|+|||++.+..++.++|||||||++|||++|+.||......... ...... .+...... ....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~---------~~~~~~~~-~~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRR---------TLEDEVKF-EHQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHH---------hhcccccc-cccc
Confidence 46899999999999888999999999999999999999999643221110 010000 11111100 0012
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 665 QVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 665 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
...++.+++.+||+.||++||++.|+++.+.
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 2345789999999999999999988765433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.50 Aligned_cols=262 Identities=27% Similarity=0.429 Sum_probs=207.0
Q ss_pred HhcCCCCCCccccCCceeEEEEEc--------CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEe
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM--------ADGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIE 488 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~--------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 488 (771)
..++|.+.+.||+|+||.||+|.. .++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 345778889999999999999953 134579999987542 34456789999999999 89999999999999
Q ss_pred CCEEEEEEEeccCCCHHHHhcCCCc------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEE
Q 004155 489 GNQLLLIYEYMENNSLARALFGPEA------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVL 556 (771)
Q Consensus 489 ~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIl 556 (771)
....++||||+++|+|.+++..... ....+++.+++.++.||+.||+|||+. +++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 9999999999999999999965321 124588999999999999999999998 8999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCCccc-ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchh
Q 004155 557 LDKDLNPKISDFGLAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIF 634 (771)
Q Consensus 557 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~ 634 (771)
++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 9999999999999998665433221 222345678999999998889999999999999999998 78887644322211
Q ss_pred hHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 635 YLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
. .... + .....+......+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 250 ~------~~~~-~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 250 K------LLKE-G---------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred H------HHHc-C---------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1 1111 0 0111122334568889999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=320.58 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=202.6
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCc----EEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGT----VVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
.++|+..++||+|+||.||+|.+ .+|+ .||+|+++.. ......++.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35678889999999999999953 4454 4899998754 33346678999999999999999999999975 4578
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+++||+++|+|.++++.. ...+++..++.++.||+.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999999543 24689999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCccc-ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 574 DEEDNTHI-STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 574 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
........ .....++..|+|||...+..++.++|||||||++|||++ |..||........ ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~------------ 223 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---PDL------------ 223 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH------------
Confidence 65332211 112235678999999998899999999999999999998 8999865432221 111
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
+........+......+.+++.+||+.||++||++.++++.|+....
T Consensus 224 -~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 224 -LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred -HHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11110111112234467899999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=345.06 Aligned_cols=260 Identities=23% Similarity=0.286 Sum_probs=193.4
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC--------C
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEG--------N 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 490 (771)
.++|.+.++||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 46799999999999999999954 568999999885432 2345799999999999999999987532 2
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC-CeEEEeec
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFG 569 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG 569 (771)
..++||||+++ +|.+++.........+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46799999975 78777744333445789999999999999999999998 899999999999998665 79999999
Q ss_pred CccccCCCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 570 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 570 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++|++||......+..... .... ....
T Consensus 217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i--~~~~-~~p~ 291 (440)
T PTZ00036 217 SAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI--IQVL-GTPT 291 (440)
T ss_pred cchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHHh-CCCC
Confidence 9986543322 2234689999999998764 6899999999999999999999999765432221111 1000 0000
Q ss_pred hhHH--hhh-------------hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 649 LMEL--VDK-------------RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 649 ~~~~--~d~-------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.... ..+ .+...++.....++.+++.+||+.||.+|||+.|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0000 000 0000011112346889999999999999999999985
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=322.08 Aligned_cols=258 Identities=30% Similarity=0.497 Sum_probs=204.4
Q ss_pred hcCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 492 (771)
.++|+..+.||+|+||.||+|... ++..||+|++.... .....++.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999642 46789999987543 33456799999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcCCC------------------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCc
Q 004155 493 LLIYEYMENNSLARALFGPE------------------AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATN 554 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~N 554 (771)
++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999995321 1123578999999999999999999998 89999999999
Q ss_pred EEEcCCCCeEEEeecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccc
Q 004155 555 VLLDKDLNPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKED 632 (771)
Q Consensus 555 Ill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~ 632 (771)
|+++.++.++|+|||+++....... ........+..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875433221 11122234668999999998899999999999999999998 888886443222
Q ss_pred hhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 633 IFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
.. ... ..+... ..+......+.+++.+|++.+|++||++.|+++.|++
T Consensus 241 ~~------~~~-~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VI------YYV-RDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HH------HHH-hcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 111 111110 1111234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=334.08 Aligned_cols=238 Identities=24% Similarity=0.346 Sum_probs=192.7
Q ss_pred CccccCCceeEEEEEc----CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 427 NKIGEGGFGPVYKGHM----ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~----~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
+.||+|+||.||++.. .+|+.||+|++.... ......+..|++++++++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999853 468999999987532 1234567789999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999999832 34689999999999999999999998 899999999999999999999999999986543322
Q ss_pred cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCC
Q 004155 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSN 660 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 660 (771)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.. . .+.... ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~------------~i~~~~--~~ 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM---T------------MILKAK--LG 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH---H------------HHHcCC--CC
Confidence 223456899999999999888999999999999999999999999754322111 0 011111 11
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 004155 661 FDKEQVMVMINVALLCTDVSSTSRPSMSS 689 (771)
Q Consensus 661 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 689 (771)
.+......+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 12223345788999999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=312.21 Aligned_cols=278 Identities=22% Similarity=0.302 Sum_probs=210.0
Q ss_pred HHhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcc--cCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe-----C
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLS--SKSKQGNREFVNEIGMISALQHPNLVKLHGCCIE-----G 489 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 489 (771)
.....|...+.||+|+||.|+.+ ...+|+.||||++. -......++-.+|+.+|+.++|+||+.+.+.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34556666789999999999999 56679999999987 3345556788899999999999999999999864 3
Q ss_pred CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeec
Q 004155 490 NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 569 (771)
Q Consensus 490 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 569 (771)
+..|+|+|+|+ -+|.+.++ .+..++...+.-+++|+++||.|+|+. +|+||||||+|+|++.+...||+|||
T Consensus 99 ~DvYiV~elMe-tDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ceeEEehhHHh-hHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 57899999995 49999993 334599999999999999999999998 89999999999999999999999999
Q ss_pred CccccCCC-CcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHH-----
Q 004155 570 LAKLDEED-NTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALI----- 642 (771)
Q Consensus 570 la~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~----- 642 (771)
+|+..... .....+..+.|..|+|||.+.. ..|+.+.||||.|||+.||++|++.|.+...-+...++.....
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 99977543 1122345678999999998864 5899999999999999999999999987654333332211110
Q ss_pred ---HHhhCChhHHhhhhcC-CCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCCCCCCCC
Q 004155 643 ---LKAQGNLMELVDKRLG-SNFD-----KEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGRADVQDF 703 (771)
Q Consensus 643 ---~~~~~~~~~~~d~~l~-~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~~~~ 703 (771)
..........+..... ...+ +......++++.+||..||.+|+|++|.++ .|+...+..+.
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dE 322 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDE 322 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccC
Confidence 0111111122211110 0111 112235789999999999999999999987 35554444333
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=338.13 Aligned_cols=260 Identities=20% Similarity=0.278 Sum_probs=202.0
Q ss_pred HHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe
Q 004155 413 LRQIKAATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIE 488 (771)
Q Consensus 413 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 488 (771)
.+++....++|++.+.||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 455666778999999999999999999954 46889999998642 12234567889999999999999999999999
Q ss_pred CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEee
Q 004155 489 GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 568 (771)
Q Consensus 489 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 568 (771)
++..++||||+++|+|.+++.. ..++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999832 3578889999999999999999998 8999999999999999999999999
Q ss_pred cCccccCCCCcccccccccCCCccchhhhccC----CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHH
Q 004155 569 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG----YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 569 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
|+++..............||+.|+|||++... .++.++|||||||++|||++|+.||.......... ...
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------~i~ 260 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------KIM 260 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHH------HHH
Confidence 99987654333333446799999999998753 37899999999999999999999997543321110 000
Q ss_pred hhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 004155 645 AQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTS--RPSMSSVVSM 693 (771)
Q Consensus 645 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 693 (771)
..... +.-.........+.+++..|+..++.+ ||++.|+++.
T Consensus 261 ~~~~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 261 NHKNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cCCCc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 00000 000001123345778889999844433 7788888874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.75 Aligned_cols=248 Identities=28% Similarity=0.439 Sum_probs=197.0
Q ss_pred CccccCCceeEEEEEcC--C--CcEEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGHMA--D--GTVVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~--~--g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
++||+|+||.||+|... + +..||+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999542 2 26899999876543 34567899999999999999999999876 4568999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|+|.+++... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999432 3689999999999999999999998 89999999999999999999999999998664433222
Q ss_pred cc--ccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 582 ST--RVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 582 ~~--~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.. ...++..|+|||...+..++.++|||||||++|||++ |+.||......+ ...+.. ... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~----~~~---------~ 216 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLE----SGE---------R 216 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH----cCC---------c
Confidence 11 1224568999999998899999999999999999998 999986543221 111111 110 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
...+......+.+++.+|+..+|++||++.++++.|+++.
T Consensus 217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1111223356889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.40 Aligned_cols=241 Identities=23% Similarity=0.386 Sum_probs=193.4
Q ss_pred CccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
+.||+|+||.||+|.. .+++.||||+++... ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999954 457899999987532 23345677888998887 699999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 999998833 34689999999999999999999998 899999999999999999999999999975322221 1
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 661 (771)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... . . +.... ..+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~---~---~---------i~~~~--~~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF---Q---S---------ILEDE--VRY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH---H---H---------HHcCC--CCC
Confidence 23346899999999999999999999999999999999999999754322111 0 0 00000 011
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 004155 662 DKEQVMVMINVALLCTDVSSTSRPSM-----SSVVS 692 (771)
Q Consensus 662 ~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 692 (771)
+......+.+++.+||+.||++||++ .++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 22233467899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.92 Aligned_cols=264 Identities=23% Similarity=0.343 Sum_probs=199.0
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
++|...++||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5688899999999999999954 4678999999875432 2345678899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++ +|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 888887432 23588999999999999999999998 89999999999999999999999999997543322
Q ss_pred cccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCCh------hH
Q 004155 579 THISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL------ME 651 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 651 (771)
.. .....+|..|+|||.+.+ ..++.++|||||||++|||+||++||......+................. .+
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 KT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred cc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 21 223457899999998865 46899999999999999999999999765443322211110000000000 00
Q ss_pred HhhhhcCCC-------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 652 LVDKRLGSN-------FDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 652 ~~d~~l~~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+...... ........+.+++.+|++.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 00112335779999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=340.83 Aligned_cols=252 Identities=19% Similarity=0.269 Sum_probs=194.3
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||.||+|. ..+++.||||++.... ......+.+|++++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 368899999999999999995 4568999999986532 223456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|..+..
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999943 34688899999999999999999998 899999999999999999999999999753210
Q ss_pred CC------------------------------------------cccccccccCCCccchhhhccCCCCchHhHHHHHHH
Q 004155 577 DN------------------------------------------THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIV 614 (771)
Q Consensus 577 ~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvi 614 (771)
.. ........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 000113469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCC---CHHHHH
Q 004155 615 ALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRP---SMSSVV 691 (771)
Q Consensus 615 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~evl 691 (771)
+|||++|+.||......+.... .... ...+...........+.+++.+|+ .+|.+|+ ++.|++
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~------i~~~-------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLK------VINW-------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHH------Hhcc-------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 9999999999976543221110 0000 000000000112234556666765 4999999 788887
Q ss_pred HH
Q 004155 692 SM 693 (771)
Q Consensus 692 ~~ 693 (771)
+.
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.31 Aligned_cols=249 Identities=30% Similarity=0.445 Sum_probs=200.1
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEE-eCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI-EGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~~ 499 (771)
++|.+.+.||+|+||.||++... |+.||+|.++... ..+.+.+|+.++++++|+|++++++++. .++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46788899999999999999764 7889999986532 3467899999999999999999999765 456789999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999995432 23588999999999999999999998 89999999999999999999999999987543322
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
....++..|+|||++.+..++.++|||||||++|||++ |+.||......+. ..+ . .....
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~---~~~---~----------~~~~~ 217 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPR---V----------EKGYK 217 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH---H----------hcCCC
Confidence 12334668999999998899999999999999999998 9999864322111 111 0 01111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
..........+.+++.+|++.+|++||++.++++.|+.+
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 111223345688999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=354.82 Aligned_cols=261 Identities=23% Similarity=0.318 Sum_probs=203.1
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.++||+|+||.||+|.. .+|+.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5788999999999999999954 468999999987532 233567999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCC-------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeec
Q 004155 497 EYMENNSLARALFGPE-------AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 569 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~-------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 569 (771)
||++||+|.+++.... .....+++..+++++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999985321 1123567888999999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCc-----------------ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc
Q 004155 570 LAKLDEEDNT-----------------HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKED 632 (771)
Q Consensus 570 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~ 632 (771)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 01122469999999999999999999999999999999999999996532211
Q ss_pred hhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhcCCC
Q 004155 633 IFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRP-SMSSVVSMLEGRA 698 (771)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~ 698 (771)
... . . .+.++.- .....+.+..+.+++.+|++.||++|| ++.++.+.|+...
T Consensus 239 i~~----~------~---~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 239 ISY----R------D---VILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred hhh----h------h---hccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 100 0 0 0000000 000112334578899999999999996 5677777666543
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=317.78 Aligned_cols=251 Identities=27% Similarity=0.427 Sum_probs=196.0
Q ss_pred CccccCCceeEEEEEcC-CCc--EEEEEEcccC-ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGHMA-DGT--VVAVKQLSSK-SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
+.||+|+||.||+|... ++. .+|+|.++.. .......+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999654 343 5788988753 234456788999999999 799999999999999999999999999
Q ss_pred CCHHHHhcCCCc------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeec
Q 004155 502 NSLARALFGPEA------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 569 (771)
Q Consensus 502 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 569 (771)
|+|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999964321 123588999999999999999999997 89999999999999999999999999
Q ss_pred CccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 570 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 570 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
+++....... ......+..|+|||++....++.++|||||||++|||++ |+.||......+.. . .
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~---~------ 223 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---E---K------ 223 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH---H---H------
Confidence 9863221111 111223567999999988889999999999999999997 99998653322111 0 0
Q ss_pred hhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 649 LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 649 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
+...............+.+++.+|++.+|.+||++.+++..|+++.
T Consensus 224 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 ----LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111111111123346789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=328.16 Aligned_cols=244 Identities=23% Similarity=0.309 Sum_probs=191.3
Q ss_pred CccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
+.||+|+||.||+|.. .+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999954 567899999997542 23345678899999888 699999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-T 152 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-c
Confidence 999998832 34699999999999999999999998 899999999999999999999999999975322221 1
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 661 (771)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||............++..... .... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~--~~~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--------LEKP--IRI 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH--------HhCC--CCC
Confidence 234569999999999999999999999999999999999999996532221111111111111 1111 111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH
Q 004155 662 DKEQVMVMINVALLCTDVSSTSRPSMS 688 (771)
Q Consensus 662 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 688 (771)
+......+.+++.+|++.||++||++.
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 222234577899999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=331.02 Aligned_cols=237 Identities=26% Similarity=0.398 Sum_probs=188.1
Q ss_pred CccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHH-HHHcCCCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIG-MISALQHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
+.||+|+||.||+|.. .+|+.||+|++.... .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999954 578999999986532 122344555554 56789999999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 999999843 34689999999999999999999998 89999999999999999999999999997543222 12
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 661 (771)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~---------------~i~~~~~--~~ 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD---------------NILNKPL--RL 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH---------------HHHcCCC--CC
Confidence 234569999999999999999999999999999999999999997543222110 0111111 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH
Q 004155 662 DKEQVMVMINVALLCTDVSSTSRPSMS 688 (771)
Q Consensus 662 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 688 (771)
.......+.+++.+|++.||++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 112244578899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=316.29 Aligned_cols=256 Identities=25% Similarity=0.429 Sum_probs=202.7
Q ss_pred CCCCCCccccCCceeEEEEEcCC--CcEEEEEEcccC----------ChhcHHHHHHHHHHHHc-CCCCcEEeEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMAD--GTVVAVKQLSSK----------SKQGNREFVNEIGMISA-LQHPNLVKLHGCCIE 488 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 488 (771)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999996654 688999987532 12234567788888875 799999999999999
Q ss_pred CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEee
Q 004155 489 GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 568 (771)
Q Consensus 489 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 568 (771)
++..++||||+++++|.+++.........+++..+++++.|++.||.|||+.. +++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988543334457899999999999999999999632 7999999999999999999999999
Q ss_pred cCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 569 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 569 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
|.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|++||........ ..
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~~---------- 223 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---AT---------- 223 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---HH----------
Confidence 9998655433 22345688999999999988899999999999999999999999864322111 10
Q ss_pred hhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 649 LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 649 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
.+.+..............+.+++.+||+.||++||++.||.+++++
T Consensus 224 --~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 224 --KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred --HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 0111111000111223468889999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=315.97 Aligned_cols=246 Identities=22% Similarity=0.369 Sum_probs=205.5
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
..+|++.+.||+|.||.|-+|. ...|+.||||.+++.. +++.-.+.+|+++|+.++||||+.++..|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3567888999999999999994 4679999999998753 34455678999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||..+|.|.+|+ .....+++.++..+++||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++.++.
T Consensus 132 MEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999999 3456799999999999999999999998 89999999999999999999999999998876
Q ss_pred CCCcccccccccCCCccchhhhccCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
.... .+.++|++-|.+||++.+.+| .+..|-||+||+||.|+.|..||++.+.... + ++.
T Consensus 205 ~~kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l---v---rQI----------- 265 (668)
T KOG0611|consen 205 DKKF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL---V---RQI----------- 265 (668)
T ss_pred cccH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH---H---HHh-----------
Confidence 5443 355789999999999998765 5789999999999999999999986432211 1 111
Q ss_pred hhcCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 655 KRLGSNF-DKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 655 ~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
-.+.+ ..+.+....-|+++||..+|++|.|+.+|..-
T Consensus 266 --s~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 266 --SRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred --hcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 11111 12223345668899999999999999999864
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=339.39 Aligned_cols=201 Identities=22% Similarity=0.342 Sum_probs=172.2
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
+|...++||+|+||.||+|. ..+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58889999999999999994 4568899999986532 2334578899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999843 24688899999999999999999998 8999999999999999999999999997532100
Q ss_pred C----------------------------------------------cccccccccCCCccchhhhccCCCCchHhHHHH
Q 004155 578 N----------------------------------------------THISTRVAGTFGYMAPEYAMRGYLTDKADVYSF 611 (771)
Q Consensus 578 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~ 611 (771)
. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000122469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 004155 612 GIVALEIVSGRSNSSCKP 629 (771)
Q Consensus 612 Gvil~elltG~~p~~~~~ 629 (771)
||++|||++|++||....
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (382)
T cd05625 235 GVILYEMLVGQPPFLAQT 252 (382)
T ss_pred hHHHHHHHhCCCCCCCCC
Confidence 999999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=314.22 Aligned_cols=248 Identities=28% Similarity=0.436 Sum_probs=200.0
Q ss_pred CccccCCceeEEEEEcCC--C--cEEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGHMAD--G--TVVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~--g--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
++||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999996532 3 3699999987655 556789999999999999999999999988 889999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999965432 4689999999999999999999998 89999999999999999999999999998765432211
Q ss_pred --ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 582 --STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 582 --~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||......+.... .. ... ..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---~~---~~~-------~~-- 219 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK---ID---KEG-------ER-- 219 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HH---hcC-------Cc--
Confidence 122457789999999998899999999999999999999 9999865433221111 00 000 00
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
...+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0111223456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.89 Aligned_cols=254 Identities=28% Similarity=0.469 Sum_probs=202.1
Q ss_pred CCCCCCccccCCceeEEEEEcC-CC---cEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMA-DG---TVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~-~g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
+|++.+.||+|+||.||+|... ++ ..||||.++.. ......+|..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4678899999999999999653 23 36999998764 3444678999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++++|.+++... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999543 24689999999999999999999998 899999999999999999999999999976543
Q ss_pred CCccc--ccccc--cCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 577 DNTHI--STRVA--GTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 577 ~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
..... ..... .+..|+|||++.+..++.++|||||||++|||++ |..||......+ ...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~---------- 225 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIE---------- 225 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHH----------
Confidence 22211 11111 2457999999999999999999999999999886 999986543221 111110
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.......+.+.+..+.+++.+||+.+|++||++.+++.+|+..
T Consensus 226 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 ---QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0001111123345678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=304.58 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=203.0
Q ss_pred HhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
.++.|++.+.||+|.|+.||+. +.++|+.+|+|++... +..+.+++.+|+.+-+.++||||+++.+...+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3456778889999999999998 6778999999987543 334677899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc---CCCCeEEEeecCcc
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAK 572 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFGla~ 572 (771)
+|+|.|++|..-+- .+..+++..+-..++||+.||.|+|.+ +|||||+||+|+++- ..--+||+|||+|.
T Consensus 89 Fe~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999987662 234678888999999999999999999 899999999999994 34469999999998
Q ss_pred ccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 573 LDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 573 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
... ........+||++|||||++...+++..+|||+.||+||-|+.|.+||........+.-+ . .+.
T Consensus 162 ~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I---~----~g~---- 228 (355)
T KOG0033|consen 162 EVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI---K----AGA---- 228 (355)
T ss_pred EeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH---h----ccc----
Confidence 776 333445678999999999999999999999999999999999999999864433222111 0 000
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.| ..+..-....+...+++.+|+..||.+|.|+.|.+.
T Consensus 229 yd--~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 229 YD--YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cC--CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 00 001011122345678999999999999999999875
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=321.76 Aligned_cols=250 Identities=26% Similarity=0.439 Sum_probs=204.0
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
..+|++.+.||+|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 3678899999999999999995 467999999999765555567788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++. ...+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 99999999983 23578999999999999999999998 89999999999999999999999999997654332
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.. .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||............ .......
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~--------------~~~~~~~ 234 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------------ATNGTPE 234 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee--------------ccCCCCC
Confidence 21 22346888999999999988999999999999999999999999654322110000 0000000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...+......+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111223345778999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.26 Aligned_cols=250 Identities=21% Similarity=0.330 Sum_probs=202.1
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
+|++.++||+|+||.||++. ..+++.||+|.++.. .....+.+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 47788999999999999995 446899999998643 2334567889999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++|+|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||++++++.++++|||.++.......
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999884322 24578999999999999999999998 899999999999999999999999999986643322
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......... .. ..+.. .
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~------~~-~~~~~---------~ 218 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL------KV-CQGSY---------K 218 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH------HH-hcCCC---------C
Confidence 1233568899999999998889999999999999999999999997533211100 00 01110 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
..+......+.+++.+||+.||++||++.|++..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1112233457889999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.09 Aligned_cols=255 Identities=25% Similarity=0.401 Sum_probs=215.2
Q ss_pred CCCCCCccccCCceeEEEEEcCC-CcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMAD-GTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
+....++||-|-||.||.|.|+. .-.||||.++.+. ...++|+.|+.+|+.++|||+|+++|.|..+..+|||+|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 34567899999999999997754 4679999998654 447899999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+|+|.+||+... +..++.-..+.+|.||+.|++||..+ ++|||||..+|.|+.++..+||+|||+++++..+...
T Consensus 347 yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 347 YGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred CccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 999999996543 34577778889999999999999988 8999999999999999999999999999998765443
Q ss_pred cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
......-.+.|.|||.+....++.|+|||+|||+|||+.| |..||...+... +..+++...+-
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq----------------VY~LLEkgyRM 485 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYGLLEKGYRM 485 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH----------------HHHHHhccccc
Confidence 3333334678999999999999999999999999999998 888886543322 23444454444
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
+.+..++..+.+|++.||+++|.+||++.|+.+.++.+.
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 556667888999999999999999999999999887753
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.71 Aligned_cols=253 Identities=27% Similarity=0.415 Sum_probs=199.4
Q ss_pred HHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeC------
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEG------ 489 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 489 (771)
.+++.|+..+.||+|+||.||+|.. .+++.||+|++.... .....+..|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4677888999999999999999954 568899999986543 3456788999999998 699999999998753
Q ss_pred CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeec
Q 004155 490 NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 569 (771)
Q Consensus 490 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 569 (771)
...++||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 46899999999999999995422 34689999999999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCcccccccccCCCccchhhhc-----cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHH
Q 004155 570 LAKLDEEDNTHISTRVAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 570 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
+++....... ......|+..|+|||++. +..++.++|||||||++|||++|+.||.......... . ..
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~-~~ 229 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----L-IP 229 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----H-Hh
Confidence 9986543222 223456899999999986 3467889999999999999999999996432211110 0 00
Q ss_pred hhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 645 AQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 645 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
... .... ........+.+++.+||..+|.+||++.|+++
T Consensus 230 -~~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 -RNP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -cCC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 0000 11122346789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=313.04 Aligned_cols=250 Identities=34% Similarity=0.553 Sum_probs=203.2
Q ss_pred CccccCCceeEEEEEcCC----CcEEEEEEcccCChh-cHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGHMAD----GTVVAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
+.||+|+||.||+|.... +..||+|.+...... ..+.+.+|+++++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999996543 789999999765433 367889999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCcc-----CCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 502 NSLARALFGPEAH-----RLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 502 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
++|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999654211 36799999999999999999999998 899999999999999999999999999987654
Q ss_pred CCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 577 DNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 577 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
... .......++..|+|||.+....++.++||||+||++|||++ |..||......+.. +. .. +
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~---~~---------~ 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL---EY---LR---------K 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH---HH---HH---------c
Confidence 331 12233457889999999988899999999999999999999 69999765322211 10 00 0
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
......+......+.+++.+|++.+|++||++.|+++.|+
T Consensus 223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 -GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0011122233456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=323.75 Aligned_cols=264 Identities=21% Similarity=0.326 Sum_probs=202.0
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
++|++.+.||+|+||.||++. ..+|..||+|.+.... .....++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 468899999999999999995 4568899999987542 33346688999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++.. ...+++..+..++.|++.||.|||+.. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999943 246899999999999999999999742 79999999999999999999999999987553321
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh------------
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ------------ 646 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------------ 646 (771)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||.....................
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 22346889999999998888999999999999999999999998643322111100000000000
Q ss_pred -----CChhHHhhhhcCC---CCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 647 -----GNLMELVDKRLGS---NFD-KEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 647 -----~~~~~~~d~~l~~---~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
....+..+..... ..+ ......+.+++.+|++.+|++||++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001111111100 000 1123458899999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=311.33 Aligned_cols=248 Identities=28% Similarity=0.426 Sum_probs=199.6
Q ss_pred CccccCCceeEEEEEcCCCcEEEEEEcccCChh-cHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCHH
Q 004155 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLA 505 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 505 (771)
++||+|+||.||++...+++.||+|.+...... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999997766999999998765333 4568999999999999999999999999999999999999999999
Q ss_pred HHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccc-cc
Q 004155 506 RALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS-TR 584 (771)
Q Consensus 506 ~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~~ 584 (771)
+++... ...+++..+..++.+++.||+|||++ +++||||||+||+++.++.+||+|||+++.......... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999543 23678999999999999999999998 899999999999999999999999999986542221111 11
Q ss_pred cccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCH
Q 004155 585 VAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDK 663 (771)
Q Consensus 585 ~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 663 (771)
..++..|+|||.+.++.++.++|||||||++|||+| |..||.......... .+........+.
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~----------------~~~~~~~~~~~~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE----------------RIESGYRMPAPQ 218 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH----------------HHhcCCCCCCCc
Confidence 234567999999998899999999999999999999 888886543221111 111111111222
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 664 EQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 664 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
.....+.+++.+|+..+|++||++.|+++.|+.
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 334578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.88 Aligned_cols=261 Identities=25% Similarity=0.384 Sum_probs=202.5
Q ss_pred cCCCCCCccccCCceeEEEEEc-----CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC--CEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-----ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEG--NQL 492 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 492 (771)
..|++.+.||+|+||.||.+.. .++..||+|.++... ......+.+|++++++++|||++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999863 357899999987543 33456799999999999999999999998865 578
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
++||||+++++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999998432 23589999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcc--cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---------chhhHHHHHH
Q 004155 573 LDEEDNTH--ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKE---------DIFYLLDWAL 641 (771)
Q Consensus 573 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~---------~~~~~~~~~~ 641 (771)
........ ......++..|+|||++.+..++.++|||||||++|||+|++.|....... .......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 235 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL-- 235 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH--
Confidence 65433221 112345677899999999888999999999999999999988765331110 00000000
Q ss_pred HHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 642 ILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 642 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.+.+...............+.+++.+|++.+|++||++.++++.|+.+
T Consensus 236 --------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 --------VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred --------HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 011111111111122345789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=318.09 Aligned_cols=246 Identities=24% Similarity=0.308 Sum_probs=195.1
Q ss_pred CCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 423 FAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
|+..+.||+|+||+||+|. ..+++.||+|.+.... ......+.+|++++++++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 6677899999999999994 4578999999986532 12234578899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999999885432 24699999999999999999999998 89999999999999999999999999997654322
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||............. .. +... .
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~---------~~~~--~ 221 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RR---------VLET--E 221 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hh---------hhcc--c
Confidence 1 123468999999999998899999999999999999999999997543221111110 00 0000 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMS 688 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 688 (771)
..+.......+.+++..|++.||++||++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 011122334578899999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=324.37 Aligned_cols=260 Identities=27% Similarity=0.441 Sum_probs=204.6
Q ss_pred hcCCCCCCccccCCceeEEEEEc--------CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeC
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM--------ADGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEG 489 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~--------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 489 (771)
.++|.+.++||+|+||.||+|.. .....||+|.++... ......+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 35678899999999999999953 124579999987542 33456788999999999 699999999999999
Q ss_pred CEEEEEEEeccCCCHHHHhcCCCc------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE
Q 004155 490 NQLLLIYEYMENNSLARALFGPEA------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL 557 (771)
Q Consensus 490 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 557 (771)
+..++||||+++|+|.+++..... ....+++.++.+++.|++.||+|||+. +++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 999999999999999999955321 124589999999999999999999998 89999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCccc-ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhh
Q 004155 558 DKDLNPKISDFGLAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFY 635 (771)
Q Consensus 558 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~ 635 (771)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999998654322211 112234568999999998899999999999999999999 888886543322211
Q ss_pred HHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 636 LLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
.. ..+ .....+......+.+++.+|++.+|++||++.|+++.|++..
T Consensus 248 ~~-------~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 248 LL-------REG---------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HH-------HcC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 10 011 001112223446789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.08 Aligned_cols=252 Identities=30% Similarity=0.440 Sum_probs=200.3
Q ss_pred CCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcH--HHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 423 FAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGN--REFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
|+..+.||+|+||+||++.. .+++.||+|++........ ....+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 55678999999999999954 5577999999987654332 23456999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++. ....+++..+..++.|+++||++||+. +++|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred cccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence 9999999994 346789999999999999999999998 899999999999999999999999999986422 22
Q ss_pred ccccccccCCCccchhhhc-cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 580 HISTRVAGTFGYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.......++..|+|||++. +..++.++||||+|+++|+|++|+.||......+.......... ........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~ 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK--------RPLPSSSQ 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH--------THHHHHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc--------cccccccc
Confidence 2334456899999999998 88899999999999999999999999976522222211111100 00011110
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. .......+.+++..||+.||++||++.++++
T Consensus 225 ~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 Q--SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp S--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred c--cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0011267899999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=319.96 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=198.5
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.|+..+.||+|+||.||++. ..+++.||+|.+.... ......+.+|+.++++++|++++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 36778899999999999994 4578999999986532 2223457789999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999999985432 24689999999999999999999988 8999999999999999999999999999765432
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
.. .....||..|+|||++.+..++.++|||||||++|||++|+.||............. ...+. .
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~------------~~~~~-~ 220 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------------RLVKE-V 220 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH------------hhhhh-h
Confidence 22 123468999999999999999999999999999999999999997543221111000 00000 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPS-----MSSVVS 692 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 692 (771)
...+.......+.+++.+||+.||++||+ +.|+++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00111122345788999999999999999 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=312.45 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=203.0
Q ss_pred cCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
++|+..++||+|+||.||+|... +++.||+|.+..... ..++.+|++++++++|+||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57889999999999999999665 478999999875432 678999999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999998432 34789999999999999999999998 899999999999999999999999999986654332
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||........... . .....+.+
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~-----~~~~~~~~-- 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------I-----PNKPPPTL-- 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------h-----ccCCCCCC--
Confidence 12234578899999999988999999999999999999999999975332211100 0 00000000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+......+.+++.+|++.+|++||++.|+++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 111223346889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.31 Aligned_cols=270 Identities=27% Similarity=0.392 Sum_probs=206.2
Q ss_pred cCCCCCCccccCCceeEEEEEcC-----CCcEEEEEEcccCChh-cHHHHHHHHHHHHcCCCCcEEeEEEEEEe--CCEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-----DGTVVAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLHGCCIE--GNQL 492 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 492 (771)
+.|...+.||+|+||.||+|... +++.||||++...... ....|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667799999999999999643 3689999999765443 46789999999999999999999999887 5689
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999995432 3589999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCccc--ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChh
Q 004155 573 LDEEDNTHI--STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLM 650 (771)
Q Consensus 573 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (771)
......... .....++..|+|||...+..++.++||||||+++|||++|+.|+............. .........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLL 236 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHH
Confidence 765332211 112345567999999998899999999999999999999999986533221100000 00000000011
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 651 ELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 651 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
+.+........+......+.+++.+|++.+|++||+|.||+++|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111111111223345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=315.32 Aligned_cols=247 Identities=30% Similarity=0.426 Sum_probs=202.2
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
++|+..+.||.|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 4688889999999999999954 468999999987543 33456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999942 2789999999999999999999998 89999999999999999999999999998765432
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
. ......++..|+|||++.+..++.++|||||||++|||+||+.||.......... .+.....
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~----------------~~~~~~~ 215 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF----------------LIPKNNP 215 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH----------------HhhhcCC
Confidence 2 1233468889999999998889999999999999999999999996543211100 0000011
Q ss_pred CCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 659 SNFDKE-QVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 659 ~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...... ....+.+++.+|+..+|++||+++++++
T Consensus 216 ~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 216 PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111111 3345788999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=316.95 Aligned_cols=258 Identities=27% Similarity=0.405 Sum_probs=203.8
Q ss_pred cCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCChh-cHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
++|+..+.||+|+||.||+|... +.+.||+|.+...... ...++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999643 3467999988764433 4567999999999999999999999999989999
Q ss_pred EEEEeccCCCHHHHhcCCCcc-----CCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEee
Q 004155 494 LIYEYMENNSLARALFGPEAH-----RLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 568 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 568 (771)
+||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999544321 12689999999999999999999998 8999999999999999999999999
Q ss_pred cCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhC
Q 004155 569 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQG 647 (771)
Q Consensus 569 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 647 (771)
|+++..............++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ... . ..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~~~---~-~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---LNR---L-QAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---HHH---H-HcC
Confidence 9987543322222233456778999999988889999999999999999999 7888854322211 110 0 001
Q ss_pred ChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 648 NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 648 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
. ............+.+++.+|++.+|++||++.|+++.|..
T Consensus 235 ~--------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 K--------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred C--------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 1 0001111233468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=301.81 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=202.1
Q ss_pred HHhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCC----hh----cHHHHHHHHHHHHcC-CCCcEEeEEEEEE
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKS----KQ----GNREFVNEIGMISAL-QHPNLVKLHGCCI 487 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~----~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 487 (771)
..-++|...+.||+|..+.|-++ ..++|..+|+|++.... .. -.+.-.+|+.+|+++ .||+|+++.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34467888999999999999988 66778999999985421 11 123456799999998 6999999999999
Q ss_pred eCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEe
Q 004155 488 EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 567 (771)
Q Consensus 488 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 567 (771)
.+...++|+|.|+.|.|.++| .....+++....+|+.|+..|++|||.. +||||||||+|||+|++.++||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred CcchhhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 999999999999999999999 4456799999999999999999999998 899999999999999999999999
Q ss_pred ecCccccCCCCcccccccccCCCccchhhhcc------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHH
Q 004155 568 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR------GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL 641 (771)
Q Consensus 568 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~ 641 (771)
||+|+....... -...+||++|+|||.+.- ..|+...|+||+||++|.|+.|.+||.....--+.
T Consensus 167 FGFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML------- 237 (411)
T KOG0599|consen 167 FGFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLML------- 237 (411)
T ss_pred cceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHH-------
Confidence 999997765443 245789999999998852 36888999999999999999999999642111000
Q ss_pred HHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 642 ILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 642 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+...|+. ......-.+......+++.+|++.||.+|.|++|+++
T Consensus 238 R~ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 238 RMIMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 01111110 0011111233456789999999999999999999986
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.43 Aligned_cols=255 Identities=25% Similarity=0.378 Sum_probs=203.1
Q ss_pred cCCCCCCccccCCceeEEEEEcCC----CcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMAD----GTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
++|.+.++||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999996533 2479999887654 4456789999999999999999999998875 557899
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999432 23589999999999999999999998 89999999999999999999999999998665
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
...........++..|+|||.+....++.++||||||+++||+++ |+.||......+.. .+. . .+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~---~-~~~------ 225 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRI---E-NGE------ 225 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHH---H-cCC------
Confidence 443222223345568999999988889999999999999999996 99999654332211 110 0 000
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
....+......+.+++.+|+..+|++||++.++++.|++..
T Consensus 226 ---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 226 ---RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred ---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00111223456888999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.84 Aligned_cols=247 Identities=29% Similarity=0.435 Sum_probs=203.2
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.|+..+.||.|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 467788999999999999964 468899999987542 344667899999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++|+|.+++.. .++++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999832 3588999999999999999999998 899999999999999999999999999976543322
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
......++..|+|||++.+..++.++|||||||++|||++|+.||.......... .+......
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----------------~~~~~~~~ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF----------------LIPKNNPP 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh----------------hhhcCCCC
Confidence 1223457889999999998889999999999999999999999987543221110 01111112
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
.........+.+++.+||+.+|++||++.+++..
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2333456678899999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=329.30 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=201.1
Q ss_pred hcCCCCCCccccCCceeEEEEEc------CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeC-C
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEG-N 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 490 (771)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999952 357899999997543 23346788999999999 689999999988654 5
Q ss_pred EEEEEEEeccCCCHHHHhcCCCc---------------------------------------------------------
Q 004155 491 QLLLIYEYMENNSLARALFGPEA--------------------------------------------------------- 513 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 513 (771)
..++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 68999999999999999854211
Q ss_pred ------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc-ccccc
Q 004155 514 ------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI-STRVA 586 (771)
Q Consensus 514 ------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~ 586 (771)
....+++..+.+++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 012478889999999999999999998 89999999999999999999999999998653322211 12234
Q ss_pred cCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHH
Q 004155 587 GTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQ 665 (771)
Q Consensus 587 gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 665 (771)
++..|+|||.+.+..++.++||||||+++|||++ |..||......... . .....+. ....+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~----~~~~~~~---------~~~~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--C----RRLKEGT---------RMRAPDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH--H----HHHhccC---------CCCCCCCC
Confidence 5678999999988899999999999999999997 89898653222110 0 0001110 00111112
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 666 VMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 666 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
...+.+++..||+.+|++||++.|+++.|+...
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 235789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=326.35 Aligned_cols=242 Identities=22% Similarity=0.370 Sum_probs=193.5
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 496 (771)
+|+..+.||+|+||.||+|. ..+|+.||+|++.... ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 46778999999999999995 4578999999987532 233456778889988885 578889999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999832 34689999999999999999999998 899999999999999999999999999975432
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... . .+....
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~---~------------~i~~~~ 217 (323)
T cd05615 154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF---Q------------SIMEHN 217 (323)
T ss_pred CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH---H------------HHHhCC
Confidence 221 123356899999999999989999999999999999999999999754332211 1 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMS 688 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 688 (771)
. .++......+.+++.+|++.+|.+|++..
T Consensus 218 ~--~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 218 V--SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred C--CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 1 11222334578899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=324.37 Aligned_cols=237 Identities=25% Similarity=0.396 Sum_probs=187.4
Q ss_pred CccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHH-HHHcCCCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIG-MISALQHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
++||+|+||.||+|.. .+|+.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999954 568999999986532 122344555554 57889999999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|+|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 999988832 34688899999999999999999998 89999999999999999999999999987532222 12
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 661 (771)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... + .+..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~------------~i~~~~~--~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY---D------------NILHKPL--QL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH---H------------HHhcCCC--CC
Confidence 23456899999999999889999999999999999999999999754322111 0 0111111 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH
Q 004155 662 DKEQVMVMINVALLCTDVSSTSRPSMS 688 (771)
Q Consensus 662 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 688 (771)
+......+.+++.+|++.||.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 222344678999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=316.30 Aligned_cols=239 Identities=22% Similarity=0.371 Sum_probs=188.4
Q ss_pred ccccCCceeEEEEEcC-------------------------CCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeE
Q 004155 428 KIGEGGFGPVYKGHMA-------------------------DGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKL 482 (771)
Q Consensus 428 ~lG~G~~g~Vy~~~~~-------------------------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l 482 (771)
.||+|+||.||+|... ....||+|++.........+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999998531 123589999876554455678899999999999999999
Q ss_pred EEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC-
Q 004155 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL- 561 (771)
Q Consensus 483 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~- 561 (771)
+++|.+....++||||+++|+|..++... ...+++..+.+++.||++||+|||+. +|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 99999999999999999999999998432 34689999999999999999999998 899999999999997654
Q ss_pred ------CeEEEeecCccccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHH-hCCCCCCCCCccch
Q 004155 562 ------NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIV-SGRSNSSCKPKEDI 633 (771)
Q Consensus 562 ------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~ell-tG~~p~~~~~~~~~ 633 (771)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+.
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999998643221 12347788999998875 56899999999999999994 79999865433221
Q ss_pred hhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 634 FYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
.. ...... ..+......+.+++.+||+.+|++||++.++++.|+
T Consensus 231 ~~----------------~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ER----------------FYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH----------------HHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11 001100 011111235788999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=320.69 Aligned_cols=249 Identities=27% Similarity=0.467 Sum_probs=203.1
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.+|+..+.||.|+||.||+|. ..+|+.||+|.+..........+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 468889999999999999995 4678999999987655555677899999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++. ...+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 9999999983 23589999999999999999999998 899999999999999999999999999876543322
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
. .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||........... ... ... +.+
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~------~~~-~~~-----~~~-- 235 (296)
T cd06655 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IAT-NGT-----PEL-- 235 (296)
T ss_pred c-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHh-cCC-----ccc--
Confidence 1 2234688899999999988899999999999999999999999975433211100 000 000 000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+......+.+++.+||..||++||++.+++.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 111122345778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=312.67 Aligned_cols=248 Identities=27% Similarity=0.439 Sum_probs=199.0
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChh---------cHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQ---------GNREFVNEIGMISALQHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 491 (771)
+|.+...||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999954 46889999988653221 12568889999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999933 24688999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcc-----cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh
Q 004155 572 KLDEEDNTH-----ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ 646 (771)
Q Consensus 572 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 646 (771)
+........ ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------------ 221 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI------------ 221 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH------------
Confidence 866432111 112245788999999999888999999999999999999999999753221110
Q ss_pred CChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 647 GNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 647 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+.. ......+......+.+++.+||+.||++||++.|+++
T Consensus 222 ---~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 222 ---FKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---HHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00000 0111222233456888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=328.29 Aligned_cols=255 Identities=21% Similarity=0.251 Sum_probs=194.9
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||.||++. ..+++.||+|++... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 478899999999999999995 456899999998642 2223456888999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999999432 34689999999999999999999998 899999999999999999999999999976554
Q ss_pred CCcccccccccCCCccchhhhcc-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.. ...........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~~ 228 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKEHFQ 228 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH------HHHHcCCCccc
Confidence 33333333569999999999863 45788999999999999999999999754322111 01110000000
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHH
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDV--SSTSRPSMSSVVSM 693 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~ 693 (771)
+... .......+.+++.+|+.. ++..||++.++++.
T Consensus 229 -----~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 -----FPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -----CCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0000 011233466677776654 44447888888764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=329.94 Aligned_cols=243 Identities=25% Similarity=0.381 Sum_probs=190.8
Q ss_pred CccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHH-HHHcCCCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIG-MISALQHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
+.||+|+||.||+|. ..+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999994 4578999999986531 223345556655 46778999999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|+|..++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 152 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-T 152 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-C
Confidence 99999883 234689999999999999999999998 899999999999999999999999999875322211 2
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 661 (771)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+....+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~---------------~~~~~~~--~~ 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD---------------NILHKPL--VL 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH---------------HHHcCCc--cC
Confidence 234569999999999999999999999999999999999999997543222111 0111111 01
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004155 662 DKEQVMVMINVALLCTDVSSTSRPSMSSVVSML 694 (771)
Q Consensus 662 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 694 (771)
.......+.+++.+|++.+|.+||++.+.++.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 111234577899999999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=318.29 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=203.4
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
++|++.+.||+|+||+||++. ..+|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 567788999999999999995 4568999999886543 33457889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++.. ...+++..+..++.+++.||.|||+.. +++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999999843 246899999999999999999999742 79999999999999999999999999987543221
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccch-----hhHHHHHHHHHhhCChhHHh
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDI-----FYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 653 (771)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......+. ....++. ..++
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~ 226 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL---------QQIV 226 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH---------HHHh
Confidence 1234689999999999888999999999999999999999999975433211 0111111 1111
Q ss_pred hhhcCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004155 654 DKRLGSNFD-KEQVMVMINVALLCTDVSSTSRPSMSSVVSML 694 (771)
Q Consensus 654 d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 694 (771)
.... .... .+....+.+++.+|++.||++||++.|++++.
T Consensus 227 ~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 227 QEPP-PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hccC-CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111 1111 12445688999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=313.53 Aligned_cols=254 Identities=27% Similarity=0.394 Sum_probs=192.9
Q ss_pred CccccCCceeEEEEEcC---CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCC
Q 004155 427 NKIGEGGFGPVYKGHMA---DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENN 502 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 502 (771)
+.||+|+||.||+|... .+..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999643 34579999987643 233457889999999999999999999999989999999999999
Q ss_pred CHHHHhcCCCc-cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 503 SLARALFGPEA-HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 503 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
+|.+++..... .....++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999964322 223567888899999999999999998 89999999999999999999999999997543322211
Q ss_pred -ccccccCCCccchhhhccC-------CCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 582 -STRVAGTFGYMAPEYAMRG-------YLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 582 -~~~~~gt~~y~aPE~~~~~-------~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||......+... . ...+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~----~~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---Y----TVREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---H----HhhcccCCC
Confidence 1234577889999998642 35789999999999999996 999996543322111 0 001111111
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
.++.+.. .....+.+++..|+ .+|++||+++||++.|+
T Consensus 231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1222111 12334777889998 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=313.19 Aligned_cols=250 Identities=26% Similarity=0.430 Sum_probs=200.1
Q ss_pred CCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCC------hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKS------KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
+|...+.||+|+||.||+|...+|+.+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999987789999999886432 12235688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||+++...
T Consensus 81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999943 24688999999999999999999998 89999999999999999999999999997543
Q ss_pred CCC-----cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChh
Q 004155 576 EDN-----THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLM 650 (771)
Q Consensus 576 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (771)
... ........|+..|+|||++.+..++.++|||||||++|||++|+.||.......... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-----~~~~~~~--- 225 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-----YIGAHRG--- 225 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-----HhhhccC---
Confidence 211 111223468899999999998889999999999999999999999996532211100 0000000
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 651 ELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 651 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+. .+......+.+++.+||+.+|++||++.|+++
T Consensus 226 --~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 --LMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --CCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111 11223445788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=312.09 Aligned_cols=240 Identities=20% Similarity=0.324 Sum_probs=189.5
Q ss_pred CccccCCceeEEEEEcCC-------------CcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 427 NKIGEGGFGPVYKGHMAD-------------GTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
+.||+|+||.||+|...+ ...||+|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999996432 2368999987655555667889999999999999999999999989999
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC-------eEEE
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN-------PKIS 566 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~ 566 (771)
+||||+++|+|..++... ...+++..+++++.||+.||+|||+. +|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999988432 24689999999999999999999998 8999999999999987664 8999
Q ss_pred eecCccccCCCCcccccccccCCCccchhhhc-cCCCCchHhHHHHHHHHHHHH-hCCCCCCCCCccchhhHHHHHHHHH
Q 004155 567 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-RGYLTDKADVYSFGIVALEIV-SGRSNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~S~Gvil~ell-tG~~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|+.|+......+... .
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~- 221 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------F- 221 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-------H-
Confidence 99998754322 1235788999999886 467899999999999999998 5888875432211100 0
Q ss_pred hhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 645 AQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 645 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
...... ........+.+++.+||+.||.+||++.++++.++
T Consensus 222 --------~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 --------YEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred --------HhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000000 01112345788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=327.80 Aligned_cols=245 Identities=26% Similarity=0.366 Sum_probs=190.9
Q ss_pred CccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHH-HHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEI-GMISALQHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
+.||+|+||.||+|.. .+++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999954 467899999986532 12233444444 456788999999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence 999999943 34578889999999999999999998 899999999999999999999999999975432221 2
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 661 (771)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .. +..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~------------i~~~~~--~~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY---DN------------ILNKPL--QL 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH---HH------------HHhCCc--CC
Confidence 23456999999999999999999999999999999999999999754332211 10 111111 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 662 DKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 662 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
.......+.+++.+|++.||.+||++.+.+..+.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 11223457889999999999999998865544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=317.32 Aligned_cols=247 Identities=29% Similarity=0.441 Sum_probs=200.5
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.|+..+.||+|+||.||+|. ..+++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 35566889999999999995 4568899999987543 334567899999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999999983 24689999999999999999999998 899999999999999999999999999976543322
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.|+.......... .+......
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----------------~~~~~~~~ 219 (277)
T cd06642 157 K-RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF----------------LIPKNSPP 219 (277)
T ss_pred h-hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh----------------hhhcCCCC
Confidence 1 223457889999999998899999999999999999999999986433221110 01111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
.........+.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1222344568899999999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.36 Aligned_cols=264 Identities=25% Similarity=0.349 Sum_probs=205.0
Q ss_pred CCHHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEE-
Q 004155 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCI- 487 (771)
Q Consensus 411 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~- 487 (771)
+.++.+..+.++|++.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 45566777899999999999999999999944 568899999886532 2245688899999999 6999999999884
Q ss_pred ----eCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCe
Q 004155 488 ----EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 563 (771)
Q Consensus 488 ----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 563 (771)
.++..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 34578999999999999998854333345789999999999999999999998 89999999999999999999
Q ss_pred EEEeecCccccCCCCcccccccccCCCccchhhhcc-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHH
Q 004155 564 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLD 638 (771)
Q Consensus 564 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~ 638 (771)
||+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.||......... ..
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~~ 240 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--FK 240 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--hh
Confidence 9999999986543222 1223468999999998753 45788999999999999999999998654321110 00
Q ss_pred HHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 639 WALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 639 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
. ... ..+.. ..+......+.+++.+|++.||++||++.|+++.
T Consensus 241 ----~-~~~-----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 241 ----I-PRN-----PPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ----c-ccc-----CCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 000 00000 0011123458899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=315.94 Aligned_cols=249 Identities=26% Similarity=0.414 Sum_probs=198.5
Q ss_pred CCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 423 FAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
|++.+.||+|+||.||+|.. .++..+|+|.+..........+.+|+++++.++|||++++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 56678899999999999955 45788999998766656667889999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
++|..++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....... .
T Consensus 87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 9999988432 24689999999999999999999998 899999999999999999999999999975433221 1
Q ss_pred ccccccCCCccchhhhc-----cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 582 STRVAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
.....++..|+|||++. +..++.++|||||||++|||++|++||......+.. .. ... .. .+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~----~~~-~~-----~~~ 227 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LK----IAK-SE-----PPT 227 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HH----Hhh-cC-----CCC
Confidence 23346889999999984 345788999999999999999999998653321110 00 000 00 000
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. ..+......+.+++.+||+.+|.+||++.++++
T Consensus 228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 228 L--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 111123346889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=329.22 Aligned_cols=257 Identities=24% Similarity=0.348 Sum_probs=196.5
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC------
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEG------ 489 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 489 (771)
..++|++.+.||+|+||.||++. ..+|+.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 45789999999999999999995 456899999998653 233456788999999999999999999998644
Q ss_pred CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeec
Q 004155 490 NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 569 (771)
Q Consensus 490 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 569 (771)
...++||||+++ +|.+.++ ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 357999999975 6766662 2478899999999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC--
Q 004155 570 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG-- 647 (771)
Q Consensus 570 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-- 647 (771)
+++...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||......+. |.......+
T Consensus 169 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-----~~~~~~~~~~~ 241 (359)
T cd07876 169 LARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ-----WNKVIEQLGTP 241 (359)
T ss_pred CccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHhcCCC
Confidence 997543321 22335689999999999999999999999999999999999999975432211 100000000
Q ss_pred ----------ChhHHhhhh--cC----------------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 648 ----------NLMELVDKR--LG----------------SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 648 ----------~~~~~~d~~--l~----------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
......... .. ..........+.+++.+|++.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 00 0001112345789999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=320.91 Aligned_cols=261 Identities=20% Similarity=0.350 Sum_probs=198.3
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
++|.+.++||+|+||.||+|.. .+++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 4688899999999999999954 468899999986543 23345678899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
++ ++|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 5899888432 24688999999999999999999998 89999999999999999999999999997544322
Q ss_pred cccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh---hCChhHHhh
Q 004155 579 THISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA---QGNLMELVD 654 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d 654 (771)
.. .....+++.|+|||.+.+ ..++.++|||||||++|||++|++||......+... ....... ...+..+++
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 159 KT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH---FIFRILGTPTEETWPGILS 234 (301)
T ss_pred Cc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCChhhchhhhc
Confidence 21 123357889999999875 457899999999999999999999997654322211 1111000 000111110
Q ss_pred h---------hcCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 K---------RLGSN----FDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~---------~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. ..... ........+.+++.+|++.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 00000 00112335788999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=319.07 Aligned_cols=263 Identities=27% Similarity=0.375 Sum_probs=206.4
Q ss_pred CCHHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEe
Q 004155 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIE 488 (771)
Q Consensus 411 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 488 (771)
++++++..++++|.+.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 56677778899999999999999999999954 568999999986532 2345678899999998 79999999999875
Q ss_pred C-----CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCe
Q 004155 489 G-----NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 563 (771)
Q Consensus 489 ~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 563 (771)
. +..++||||+++++|.++++........+++..++.++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 4 368999999999999999864433445789999999999999999999998 89999999999999999999
Q ss_pred EEEeecCccccCCCCcccccccccCCCccchhhhccC-----CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHH
Q 004155 564 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG-----YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLD 638 (771)
Q Consensus 564 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~ 638 (771)
||+|||+++........ .....|+..|+|||++... .++.++|||||||++|||++|+.||........ ...
T Consensus 168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~~ 244 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LFK 244 (291)
T ss_pred EEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HHH
Confidence 99999999865432211 1234588899999997643 368899999999999999999999975432111 110
Q ss_pred HHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 639 WALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 639 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+ . .... +.+ .........+.+++.+|++.+|++||++.|+++
T Consensus 245 ~----~-~~~~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 245 I----P-RNPP-----PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred H----h-cCCC-----CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 0 0000 000 011123346889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=324.35 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=209.1
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChh---cHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQ---GNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 493 (771)
....|.+.+.||+|.||.||++.. .+|+.+|+|++.+.... ....+.+|+.+|+++. |||||.+.+.|++.+..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 345688889999999999999954 45999999999775433 3468999999999998 999999999999999999
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC----CCCeEEEeec
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK----DLNPKISDFG 569 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DFG 569 (771)
+|||++.||.|.+.+... .+++..+..++.|++.|++|||+. +|+||||||+|+|+.. ++.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999443 399999999999999999999998 9999999999999953 3579999999
Q ss_pred CccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCCh
Q 004155 570 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL 649 (771)
Q Consensus 570 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (771)
++..... .......+||+.|+|||++....++..+||||+||++|.|++|.+||...........+ ..++.
T Consensus 185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i-------~~~~~ 255 (382)
T KOG0032|consen 185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI-------LRGDF 255 (382)
T ss_pred CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH-------HcCCC
Confidence 9998766 33445678999999999999999999999999999999999999999876544432211 01111
Q ss_pred hHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 650 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
......-........+++..|+..||.+|+++.++++
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1112222334556788999999999999999999998
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=314.54 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=199.7
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
++|.+.++||+|+||.||+|. ..+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 467778899999999999995 4568999999987655455567889999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++.. ...+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 99999999843 34689999999999999999999998 899999999999999999999999999876543221
Q ss_pred ccccccccCCCccchhhhc---cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 580 HISTRVAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
......|+..|+|||++. ...++.++|||||||++|||++|+.||............ . .... ..+.
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~------~-~~~~---~~~~ 230 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------T-KSNF---QPPK 230 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh------h-ccCC---CCCc
Confidence 123346899999999874 456889999999999999999999998643322111000 0 0000 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
... .......+.+++.+|++.+|++||+++++++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000 0012235788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.13 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=203.8
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+|+..+.||+|+||.||.+. ..+++.+++|.+... ......++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 57889999999999999984 456899999987643 344566789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++.... ...+++.++..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999995432 34689999999999999999999988 89999999999999999999999999998664433
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
. ......|+..|+|||+..+..++.++||||||+++|||++|+.||......+... ... .+. .
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~------~~~-~~~--------~- 218 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV------KIV-QGN--------Y- 218 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHH-cCC--------C-
Confidence 2 2233568999999999988888999999999999999999999986533221110 000 111 1
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
..........+.+++.+|++.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11112234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=311.77 Aligned_cols=249 Identities=27% Similarity=0.373 Sum_probs=192.0
Q ss_pred CccccCCceeEEEEEcC----CCcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEE-eCCEEEEEEEecc
Q 004155 427 NKIGEGGFGPVYKGHMA----DGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCI-EGNQLLLIYEYME 500 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~~~ 500 (771)
+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999642 2457999998643 3344567889999999999999999999876 4556899999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999543 23467888899999999999999998 8999999999999999999999999999755332111
Q ss_pred ---cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhC-CCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 581 ---ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG-RSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 581 ---~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
......++..|+|||++.+..++.++|||||||++|||++| .+||...... ..... ... +
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~---~~~-~--------- 218 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVY---LLQ-G--------- 218 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH---Hhc-C---------
Confidence 11233467789999999888999999999999999999995 4555432211 11111 100 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.....+...+..+.+++.+||+.+|++||++.|+++.|++.
T Consensus 219 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00011112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.64 Aligned_cols=262 Identities=24% Similarity=0.355 Sum_probs=193.2
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcC---CCCcEEeEEEEEEe-----CC
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK--QGNREFVNEIGMISAL---QHPNLVKLHGCCIE-----GN 490 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 490 (771)
+|++.+.||+|+||.||+|. ..+|+.||+|.++.... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47888999999999999994 45789999999875322 2234556777777665 69999999998864 34
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..++||||+.+ +|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 68999999975 8988885432 24589999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhh-HHHHHHHHHhhCCh
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY-LLDWALILKAQGNL 649 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 649 (771)
++....... .....||..|+|||++.+..++.++|||||||++|||++|++||......+... ....... ......
T Consensus 155 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~-~~~~~~ 231 (288)
T cd07863 155 ARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL-PPEDDW 231 (288)
T ss_pred cccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCC-CChhhC
Confidence 986543221 233568999999999998899999999999999999999999996543322111 1100000 000000
Q ss_pred hH---HhhhhcCC-------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 650 ME---LVDKRLGS-------NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 650 ~~---~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. ........ .........+.+++.+|++.||++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00000000 000122345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=314.02 Aligned_cols=251 Identities=29% Similarity=0.467 Sum_probs=197.6
Q ss_pred CccccCCceeEEEEEcCC-------CcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 427 NKIGEGGFGPVYKGHMAD-------GTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~-------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+.||+|+||.||+|...+ ++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999996532 2579999886543 23456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCc---cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC-----CeEEEeecC
Q 004155 499 MENNSLARALFGPEA---HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-----NPKISDFGL 570 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DFGl 570 (771)
+++++|.+++..... ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.+. .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999964321 234588999999999999999999988 899999999999999877 899999999
Q ss_pred ccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 571 AKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 571 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
++....... .......++..|+|||++.++.++.++|||||||++|||++ |+.||......+. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~--------- 225 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQH--------- 225 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHH---------
Confidence 975533221 11122345678999999999999999999999999999998 9999864322111 110
Q ss_pred hhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 649 LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 649 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
++.......+......+.+++.+||+.+|++||++.++++.|++
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 226 ----VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ----HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00000111122334568899999999999999999999998864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=309.55 Aligned_cols=251 Identities=21% Similarity=0.258 Sum_probs=205.3
Q ss_pred CCCCCCccccCCceeEEEEEcCC-CcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMAD-GTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
+|+..+.||+|.-|+||++++.+ +..+|+|++.+.. .....+...|-+||+.++||.++.|++.|+.++..|+|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 34456899999999999997654 5899999998753 3334567789999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC-
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE- 576 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~- 576 (771)
||+||+|..+++.+. ...+++..+.-++.+++-||+|||-. |||.|||||+||||.++|++-|+||.++.....
T Consensus 158 yCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred cCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999996544 45799999999999999999999998 999999999999999999999999998742210
Q ss_pred --------------------------------CCc----------------------ccccccccCCCccchhhhccCCC
Q 004155 577 --------------------------------DNT----------------------HISTRVAGTFGYMAPEYAMRGYL 602 (771)
Q Consensus 577 --------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 602 (771)
... ..+..++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 11223579999999999999999
Q ss_pred CchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCC
Q 004155 603 TDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSST 682 (771)
Q Consensus 603 ~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~ 682 (771)
+.++|.|+|||++|||+.|+.||.+...++.. ..++-+.+.-....+....+.+|+.+.|.+||+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 99999999999999999999999887665543 233333332222224456788999999999999
Q ss_pred CCCC----HHHHHH
Q 004155 683 SRPS----MSSVVS 692 (771)
Q Consensus 683 ~RPs----~~evl~ 692 (771)
+|-. +.||-+
T Consensus 378 kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKR 391 (459)
T ss_pred hhhccccchHHhhc
Confidence 9998 666654
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=339.91 Aligned_cols=266 Identities=17% Similarity=0.210 Sum_probs=195.2
Q ss_pred HHHHHHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCC------CcEEeEEEEE
Q 004155 414 RQIKAATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQH------PNLVKLHGCC 486 (771)
Q Consensus 414 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~ 486 (771)
+++...+++|++.++||+|+||+||+|.. ..++.||||+++... ...+++..|+.+++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 34455678999999999999999999954 568899999986532 223455667777776654 5689999988
Q ss_pred EeC-CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC----
Q 004155 487 IEG-NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL---- 561 (771)
Q Consensus 487 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---- 561 (771)
... .+.|+|||++ +++|.+++.. ...+++..+..|+.||+.||+|||++. +||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccc
Confidence 754 5789999988 6789888843 346899999999999999999999742 899999999999998765
Q ss_pred ------------CeEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Q 004155 562 ------------NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKP 629 (771)
Q Consensus 562 ------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~ 629 (771)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998864322 1234679999999999999999999999999999999999999997654
Q ss_pred ccchhhHHHHH---------HHHHhhCChhHHhhhh--cCCCC---------------CHHHHHHHHHHHHHccCCCCCC
Q 004155 630 KEDIFYLLDWA---------LILKAQGNLMELVDKR--LGSNF---------------DKEQVMVMINVALLCTDVSSTS 683 (771)
Q Consensus 630 ~~~~~~~~~~~---------~~~~~~~~~~~~~d~~--l~~~~---------------~~~~~~~l~~l~~~Cl~~dP~~ 683 (771)
..+....+... .... .....++.+.. +.... .......+.+|+.+||+.||++
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCG-TEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhcc-chhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 33222221110 0000 00000011000 00000 0011245779999999999999
Q ss_pred CCCHHHHHH
Q 004155 684 RPSMSSVVS 692 (771)
Q Consensus 684 RPs~~evl~ 692 (771)
|||+.|+++
T Consensus 429 R~ta~e~L~ 437 (467)
T PTZ00284 429 RLNARQMTT 437 (467)
T ss_pred CCCHHHHhc
Confidence 999999986
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.01 Aligned_cols=193 Identities=24% Similarity=0.317 Sum_probs=164.9
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
...+|.+.+.||+|+||.||+|.. .+++.||+|+.... ....|+.++++++||||+++++++...+..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 345799999999999999999954 45788999975432 23568999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+. ++|.+++.. ....+++..+..|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred ccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 995 588888843 234689999999999999999999998 8999999999999999999999999999754322
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCC
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSS 626 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~ 626 (771)
. ......||..|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 211 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 P--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred c--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 1 1233568999999999999999999999999999999999666553
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.41 Aligned_cols=251 Identities=27% Similarity=0.415 Sum_probs=200.7
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
++|++.++||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 5688899999999999999955 458999999998766666778999999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|..++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 999999887432 24689999999999999999999998 899999999999999999999999999875433211
Q ss_pred ccccccccCCCccchhhhc-----cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 580 HISTRVAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
......++..|+|||++. ...++.++|||||||++|||++|+.||........ .. .... .. .
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~-~~-----~ 232 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LL----KIAK-SE-----P 232 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HH----HHhc-CC-----C
Confidence 122345788999999885 34578899999999999999999999865332111 00 0000 00 0
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+.. ..+......+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 111223345788999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.10 Aligned_cols=244 Identities=30% Similarity=0.409 Sum_probs=203.0
Q ss_pred ccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCHHH
Q 004155 428 KIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLAR 506 (771)
Q Consensus 428 ~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 506 (771)
+||+|.||+||.|+. .+...+|||.+........+.+..|+...++++|.|||+++|+|.++++.-+.||.++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 699999999999954 4566799999987766667778899999999999999999999999999999999999999999
Q ss_pred HhcCCCccCCCC--ChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc-CCCCeEEEeecCccccCCCCccccc
Q 004155 507 ALFGPEAHRLKL--DWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTHIST 583 (771)
Q Consensus 507 ~l~~~~~~~~~l--~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~ 583 (771)
+|+.. ..++ .+.++--+.+||++||.|||+. .|||||||-+|||++ -.|.+||+|||-++.+..-+. .+.
T Consensus 662 LLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TE 734 (1226)
T KOG4279|consen 662 LLRSK---WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTE 734 (1226)
T ss_pred HHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc-ccc
Confidence 99543 3455 7788888999999999999999 899999999999995 678999999999987765443 344
Q ss_pred ccccCCCccchhhhccC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC
Q 004155 584 RVAGTFGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661 (771)
Q Consensus 584 ~~~gt~~y~aPE~~~~~--~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 661 (771)
.+.||..|||||++..+ .|+.++|||||||++.||.||++||......... +..-| --......
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------MFkVG------myKvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------MFKVG------MYKVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------hhhhc------ceecCCCC
Confidence 57799999999999876 5899999999999999999999999764332110 00000 00112345
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 662 DKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 662 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+.+...+...++++|+.+||.+||++++++.
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 6677778899999999999999999999986
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.28 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=204.0
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe--CCEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIE--GNQLLLIY 496 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 496 (771)
+|++.+.||.|+||.||++. ..+|+.||+|.+... .....+.+..|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 47788999999999999994 457899999998643 33445678899999999999999999998764 45689999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcC--CCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES--RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||+++++|.+++.........+++..++.++.||+.||+|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999654334567999999999999999999999331 238999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
...... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ..+. +.
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~-------------~~ 223 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASK-------------IK 223 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHH-------------Hh
Confidence 543321 223468999999999998889999999999999999999999997543211 1111 11
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
.......+......+.+++.+|++.+|++||++.+|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111112233445678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=326.67 Aligned_cols=254 Identities=20% Similarity=0.247 Sum_probs=195.2
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|.+.+.||+|+||.||++.. .+++.||+|++... .......+.+|..++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4788999999999999999954 46889999998652 1223455788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999532 24689999999999999999999998 899999999999999999999999999986654
Q ss_pred CCcccccccccCCCccchhhhcc-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
..........||+.|+|||++.+ +.++.++|||||||++|||++|+.||......+... .........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~~~- 227 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHEERF- 227 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH------HHHcCCCcc-
Confidence 43333334569999999999875 467889999999999999999999997543221110 000000000
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTS--RPSMSSVVS 692 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~ 692 (771)
.+... .......+.+++.+|+..++++ |+++.++++
T Consensus 228 ----~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 228 ----QFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred ----cCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 00000 0112345778888888765543 457777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=308.79 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=200.0
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe-CCEEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIE-GNQLLLIYE 497 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E 497 (771)
+|++.+.||+|++|.||++. ..+++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47888999999999999995 4457899999986532 3345678899999999999999999998764 446899999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++++|.+++.... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999995422 34689999999999999999999998 8999999999999999999999999999866433
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
.. ......+++.|+|||++.+..++.++||||||+++|||++|+.||......... .... .+. +
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~------~~~~-~~~--------~ 219 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV------YRII-EGK--------L 219 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHH-hcC--------C
Confidence 22 223346889999999999999999999999999999999999998643322111 0000 111 1
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...+......+.+++.+|++.+|++||++.++++
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1122234456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=324.23 Aligned_cols=261 Identities=28% Similarity=0.426 Sum_probs=205.7
Q ss_pred cCCCCCCccccCCceeEEEEEcC--------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCC
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA--------DGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGN 490 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 490 (771)
.+|.+.+.||+|+||.||+|... .+..||+|.++... ....+++.+|+.+++++ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999999531 12469999887543 33456889999999999 7999999999999999
Q ss_pred EEEEEEEeccCCCHHHHhcCCCc------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc
Q 004155 491 QLLLIYEYMENNSLARALFGPEA------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD 558 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 558 (771)
..++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 99999999999999999964321 224588999999999999999999998 899999999999999
Q ss_pred CCCCeEEEeecCccccCCCCccc-ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhH
Q 004155 559 KDLNPKISDFGLAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYL 636 (771)
Q Consensus 559 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~ 636 (771)
.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.....++...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~- 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK- 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH-
Confidence 99999999999998654322211 122234568999999999999999999999999999998 888886543222111
Q ss_pred HHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 637 LDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 637 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
... .......+......+.+++.+|++.+|++||++.|+++.|+.+...
T Consensus 248 -----~~~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 248 -----LLK----------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred -----HHH----------cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 111 1111111222345688999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.08 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=204.5
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
++|+..+.||+|+||.||+|.. .+++.+|+|.+........+.+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5788899999999999999954 467899999998765556678999999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|||.+........
T Consensus 83 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999999998432 24689999999999999999999998 899999999999999999999999999976543221
Q ss_pred ccccccccCCCccchhhhccC---CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 580 HISTRVAGTFGYMAPEYAMRG---YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~---~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
......++..|+|||.+... .++.++|||||||++|||++|+.||............ . .... ....
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~------~-~~~~---~~~~ 225 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI------S-KSNF---PPPK 225 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------H-hccC---CCcc
Confidence 12234688899999999776 8899999999999999999999999754322211100 0 0000 0000
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..........+.+++.+||..+|.+||++.+|+.
T Consensus 226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 --LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0112234456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.29 Aligned_cols=249 Identities=26% Similarity=0.347 Sum_probs=193.9
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-----hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe--CCEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-----KQGNREFVNEIGMISALQHPNLVKLHGCCIE--GNQL 492 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 492 (771)
.+|...+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4788999999999999999954 568999999886432 2234568889999999999999999999875 3678
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
++++||+++++|.+++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 999999999999999943 23588999999999999999999988 89999999999999999999999999997
Q ss_pred ccCCCCc--ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChh
Q 004155 573 LDEEDNT--HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLM 650 (771)
Q Consensus 573 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (771)
....... .......++..|+|||++.+..++.++|||||||++|||++|+.||........ .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~------ 222 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIA------ 222 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHh------
Confidence 6533211 111234588899999999988899999999999999999999999964322111 00000
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 651 ELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 651 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
........+......+.+++ .||..+|++||+++||++
T Consensus 223 ---~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 223 ---TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00001112222233445555 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.76 Aligned_cols=254 Identities=23% Similarity=0.398 Sum_probs=190.2
Q ss_pred CccccCCceeEEEEEcCCC---cEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCC
Q 004155 427 NKIGEGGFGPVYKGHMADG---TVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENN 502 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 502 (771)
+.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||++++++|.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999964333 356677765443 334678999999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC-ccc
Q 004155 503 SLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN-THI 581 (771)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~-~~~ 581 (771)
+|.+++..........++..+..++.||+.||+|||+. +++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999965433334567778899999999999999998 89999999999999999999999999986432211 111
Q ss_pred ccccccCCCccchhhhcc-------CCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 582 STRVAGTFGYMAPEYAMR-------GYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~-------~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||......+... ... .+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~------~~~-~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN------HVI-KDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHH-hhcccccC
Confidence 223467889999998753 245789999999999999997 466775433221111 111 11112223
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
++.+...+ ...+.+++..|| .+|++||++.+|++.|.
T Consensus 231 ~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33332222 235677888999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=332.09 Aligned_cols=203 Identities=24% Similarity=0.353 Sum_probs=174.6
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|+..+.||+|+||.||++.. .+++.||+|++.... ......+..|+.++..++||+|+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999954 568999999986432 233457888999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999943 34689999999999999999999998 899999999999999999999999999875432
Q ss_pred CCc----------------------------------ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCC
Q 004155 577 DNT----------------------------------HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 622 (771)
Q Consensus 577 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~ 622 (771)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0112346999999999999999999999999999999999999
Q ss_pred CCCCCCCc
Q 004155 623 SNSSCKPK 630 (771)
Q Consensus 623 ~p~~~~~~ 630 (771)
.||.....
T Consensus 234 ~Pf~~~~~ 241 (360)
T cd05627 234 PPFCSETP 241 (360)
T ss_pred CCCCCCCH
Confidence 99976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=328.61 Aligned_cols=262 Identities=22% Similarity=0.287 Sum_probs=198.1
Q ss_pred HHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC-----
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEG----- 489 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 489 (771)
...++|+..+.||+|+||.||++.. ..++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3557899999999999999999954 46889999998753 223356778899999999999999999988643
Q ss_pred -CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEee
Q 004155 490 -NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 568 (771)
Q Consensus 490 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 568 (771)
...++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 357999999975 6777762 2588999999999999999999998 8999999999999999999999999
Q ss_pred cCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh---
Q 004155 569 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA--- 645 (771)
Q Consensus 569 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--- 645 (771)
|+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+..... ......
T Consensus 164 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~ 239 (355)
T cd07874 164 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV--IEQLGTPCP 239 (355)
T ss_pred cccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhCCCCH
Confidence 9998654322 223356899999999999989999999999999999999999999754322211100 000000
Q ss_pred ------hCChhHHhhh---------------hc-C--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 646 ------QGNLMELVDK---------------RL-G--SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 646 ------~~~~~~~~d~---------------~l-~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
.......++. .+ . ..........+.+++.+|++.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000 00 0 00111123467899999999999999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=310.32 Aligned_cols=262 Identities=28% Similarity=0.403 Sum_probs=202.6
Q ss_pred HhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHc--CCCCcEEeEEEEEEeC----CEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISA--LQHPNLVKLHGCCIEG----NQL 492 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~ 492 (771)
........+.||+|.||.||+|.+. |..||||++... +++.+.+|.++.+. |+|+||+.+++.-..+ .++
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 3456677899999999999999995 899999999653 34567788888875 5999999999986544 378
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhc-----CCCceeccCCCCCcEEEcCCCCeEEEe
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE-----SRLKIVHRDIKATNVLLDKDLNPKISD 567 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~D 567 (771)
|||++|.+.|||.||| ....++....++++..+|.||+|||.. ++|.|.|||||+.|||+.+++.+.|+|
T Consensus 285 wLvTdYHe~GSL~DyL-----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYL-----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEeeecccCCcHHHHH-----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 9999999999999999 346799999999999999999999964 578999999999999999999999999
Q ss_pred ecCccccCCCCcc---cccccccCCCccchhhhccCC------CCchHhHHHHHHHHHHHHhC----------CCCCCCC
Q 004155 568 FGLAKLDEEDNTH---ISTRVAGTFGYMAPEYAMRGY------LTDKADVYSFGIVALEIVSG----------RSNSSCK 628 (771)
Q Consensus 568 FGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~ksDV~S~Gvil~elltG----------~~p~~~~ 628 (771)
+|+|......... .....+||.+|||||++...- --..+||||||.|+||+... +.||...
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999766554322 124467999999999996531 12368999999999999863 3566543
Q ss_pred CccchhhHHHHHHHHHhhCChhHHh-hhhcCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 629 PKEDIFYLLDWALILKAQGNLMELV-DKRLGSNF-----DKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~-d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
.+.+... +.+.+++ .++++... +.+.+..+.+++..||..+|..|-|+-.+-+.|.++.+.
T Consensus 440 Vp~DPs~-----------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 440 VPSDPSF-----------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCCCCH-----------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 2222110 0111111 12222222 246778899999999999999999999998888776543
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=325.42 Aligned_cols=255 Identities=20% Similarity=0.240 Sum_probs=194.8
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.++||+|+||.||++.. .+++.||+|++.+. .......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999954 45788999998642 1223445788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999532 24689999999999999999999998 899999999999999999999999999976544
Q ss_pred CCcccccccccCCCccchhhhc-----cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 577 DNTHISTRVAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||......+.. .........
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~~~-- 226 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKER-- 226 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH------HHHhCCCcc--
Confidence 3333333457999999999986 346889999999999999999999999754322111 111100000
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCC--CCCCHHHHHHH
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSST--SRPSMSSVVSM 693 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~--~RPs~~evl~~ 693 (771)
. ... .........+.+++.+|+..+++ .||++.|+++.
T Consensus 227 ~---~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 F---QFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c---cCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 000 00012234567778887755444 36888888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=315.27 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=202.3
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
.++|++.+.||+|+||.||+|.. .++..||+|.+..........+.+|++++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 45688899999999999999965 46899999999876666667899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999998432 24689999999999999999999998 89999999999999999999999999987554322
Q ss_pred cccccccccCCCccchhhhc-----cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 579 THISTRVAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
.. .....|+..|+|||.+. ...++.++||||||+++|||++|+.||......... .. .. ....
T Consensus 158 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~~----~~-~~~~---- 225 (280)
T cd06611 158 QK-RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--LK----IL-KSEP---- 225 (280)
T ss_pred cc-cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--HH----Hh-cCCC----
Confidence 21 22346889999999975 345778999999999999999999999754321110 00 00 0000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+.+ ..+......+.+++.+||+.+|++||++.++++
T Consensus 226 -~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 -PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred -CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 000 111122346788999999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=308.11 Aligned_cols=251 Identities=33% Similarity=0.540 Sum_probs=201.3
Q ss_pred CCCCCccccCCceeEEEEEcCC-----CcEEEEEEcccCChh-cHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 423 FAPDNKIGEGGFGPVYKGHMAD-----GTVVAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
|.+.+.||+|+||.||++...+ +..||+|++...... ....+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999996543 388999999765433 5678999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999954321 1289999999999999999999998 899999999999999999999999999986654
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
..........++..|+|||.+.+..++.++||||+|+++|||++ |++||......... ... . ...
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~---~~~---~-~~~------- 221 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL---EYL---K-KGY------- 221 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH---h-cCC-------
Confidence 43222222337789999999988889999999999999999998 78888653222111 110 0 000
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSML 694 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 694 (771)
...........+.+++.+|+..+|++|||+.|+++.|
T Consensus 222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 --RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111122345688899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=347.78 Aligned_cols=264 Identities=23% Similarity=0.344 Sum_probs=202.4
Q ss_pred HHHHhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe--CC
Q 004155 416 IKAATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIE--GN 490 (771)
Q Consensus 416 l~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 490 (771)
.....++|.+.++||+|+||+||+|. ..++..||+|.+... .......|..|+.++++++|||||+++++|.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 34456789999999999999999994 456788999998653 23345678999999999999999999998864 35
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCC----CceeccCCCCCcEEEcC-------
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR----LKIVHRDIKATNVLLDK------- 559 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~----~~ivH~Dlkp~NIll~~------- 559 (771)
.+|+||||+++|+|.++|.........+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 7899999999999999996543334579999999999999999999998531 25999999999999964
Q ss_pred ----------CCCeEEEeecCccccCCCCcccccccccCCCccchhhhcc--CCCCchHhHHHHHHHHHHHHhCCCCCCC
Q 004155 560 ----------DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNSSC 627 (771)
Q Consensus 560 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvil~elltG~~p~~~ 627 (771)
.+.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2348999999998654322 1234569999999999864 4589999999999999999999999964
Q ss_pred CCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCC
Q 004155 628 KPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGR 697 (771)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 697 (771)
..... .+. ..... . +.+.. ......+.+|+..||+.+|.+||++.|++. .+...
T Consensus 246 ~~~~~--qli---~~lk~-~-------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 246 ANNFS--QLI---SELKR-G-------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCcHH--HHH---HHHhc-C-------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 32211 111 11100 0 00100 112345889999999999999999999983 45433
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.91 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=199.0
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
++|.+.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999975 67889999986532 346788999999999999999999998754 4799999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 82 KGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 999999995432 24689999999999999999999988 89999999999999999999999999997543221
Q ss_pred cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
.....+..|+|||++.+..++.++|||||||++|||++ |+.||......+... . +......
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~------~----------~~~~~~~ 216 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE------C----------VEKGYRM 216 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH------H----------HhCCCCC
Confidence 12234568999999998899999999999999999998 999986543322111 0 1111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
......+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1122234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.16 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=190.1
Q ss_pred CccccCCceeEEEEEcCC---CcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCC
Q 004155 427 NKIGEGGFGPVYKGHMAD---GTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENN 502 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 502 (771)
+.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+++++.++|+||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999995433 3578899876543 333567889999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCcc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc-
Q 004155 503 SLARALFGPEAH-RLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH- 580 (771)
Q Consensus 503 sL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~- 580 (771)
+|.+++...... ....++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999654321 23456888899999999999999998 8999999999999999999999999998754332211
Q ss_pred cccccccCCCccchhhhcc-------CCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 581 ISTRVAGTFGYMAPEYAMR-------GYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~-------~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
......++..|+|||+... ..++.++|||||||++|||++ |..||......+.. . .... .....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~---~---~~~~-~~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL---K---QVVR-EQDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH---H---HHhh-ccCccC
Confidence 1122345778999998743 357889999999999999999 77788643322111 0 0000 111111
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
.++.+ +......+.+++..|+ .||++||+++||++.|.
T Consensus 231 ~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11211 2223345667888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=310.72 Aligned_cols=238 Identities=26% Similarity=0.411 Sum_probs=189.2
Q ss_pred CccccCCceeEEEEEcCC-C----------cEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 427 NKIGEGGFGPVYKGHMAD-G----------TVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~-g----------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
+.||+|+||.||+|...+ + ..|++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 469999999999996643 2 25888887654333 6788999999999999999999999988 778999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC-------CeEEEee
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-------NPKISDF 568 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~DF 568 (771)
|||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999995432 2689999999999999999999998 899999999999999888 7999999
Q ss_pred cCccccCCCCcccccccccCCCccchhhhccC--CCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHh
Q 004155 569 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG--YLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKA 645 (771)
Q Consensus 569 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 645 (771)
|+++..... ....++..|+|||++... .++.++|||||||++|||++ |..|+.......... + ..
T Consensus 153 g~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~---~~- 220 (259)
T cd05037 153 GIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---F---YQ- 220 (259)
T ss_pred Ccccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---H---Hh-
Confidence 999865431 223467789999999876 78999999999999999999 567775433211110 0 00
Q ss_pred hCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 646 QGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 646 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
... ..+......+.+++.+||+.+|.+||++.++++.|+
T Consensus 221 --------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 --------DQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --------cCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 000011156889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.34 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=197.4
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+|++.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 477889999999999999954 468999999986532 22346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
++ ++|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 689888854332 34689999999999999999999998 89999999999999999999999999997554322
Q ss_pred cccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh--------CC-
Q 004155 579 THISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ--------GN- 648 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------~~- 648 (771)
. ......+++.|+|||++.+. .++.++|||||||++|||+||++||......+.. .......... ..
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL--FRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhhhcchhh
Confidence 1 12233578899999988654 5789999999999999999999999754322111 0000000000 00
Q ss_pred --hhHHhhhhcCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 649 --LMELVDKRLGSN---FDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 649 --~~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
....++...... .......++.+++.+|++.||++|||+.+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000 00012345778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=313.05 Aligned_cols=255 Identities=29% Similarity=0.473 Sum_probs=202.6
Q ss_pred cCCCCCCccccCCceeEEEEEcC-CCc----EEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-DGT----VVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
.+|++.+.||+|+||.||+|... +|. .||+|.+.... .....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46778899999999999999643 333 68999887653 3345678999999999999999999999987 78999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999543 23589999999999999999999997 8999999999999999999999999999876
Q ss_pred CCCCcccc-cccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 575 EEDNTHIS-TRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 575 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
........ ....++..|+|||.+....++.++||||||+++||+++ |+.||.....++... ... .+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~------~~~-~~----- 227 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD------LLE-KG----- 227 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH------HHh-CC-----
Confidence 54332211 11224568999999988889999999999999999999 999997543322111 000 00
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
.....+......+.+++.+||..+|++||++.++++.|+...
T Consensus 228 ----~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 228 ----ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 001111122345788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=323.47 Aligned_cols=260 Identities=22% Similarity=0.301 Sum_probs=197.2
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC------
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEG------ 489 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 489 (771)
..++|...+.||+|+||.||++. ...++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 45789999999999999999995 456889999998753 223356788999999999999999999987543
Q ss_pred CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeec
Q 004155 490 NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 569 (771)
Q Consensus 490 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 569 (771)
...|+||||+++ +|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999975 7777772 2478899999999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh----
Q 004155 570 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA---- 645 (771)
Q Consensus 570 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---- 645 (771)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+....+ ......
T Consensus 172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~~~~~ 247 (364)
T cd07875 172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV--IEQLGTPCPE 247 (364)
T ss_pred CccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcCCCCHH
Confidence 998654322 123356899999999999999999999999999999999999999764432211110 000000
Q ss_pred -----hCChhHHhhhh--------------c----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 646 -----QGNLMELVDKR--------------L----GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 646 -----~~~~~~~~d~~--------------l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
........... . ...........+.+++.+|++.||.+|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000000 0 00001112346789999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=315.53 Aligned_cols=197 Identities=26% Similarity=0.442 Sum_probs=161.8
Q ss_pred CCccccCCceeEEEEEcC---CCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe--CCEEEEEEEecc
Q 004155 426 DNKIGEGGFGPVYKGHMA---DGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIE--GNQLLLIYEYME 500 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~~ 500 (771)
.++||+|+||.||+|... +++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999643 46789999986542 23457889999999999999999999864 457899999986
Q ss_pred CCCHHHHhcCCC-----ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE----cCCCCeEEEeecCc
Q 004155 501 NNSLARALFGPE-----AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLA 571 (771)
Q Consensus 501 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFGla 571 (771)
+ +|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4 8888874321 1223589999999999999999999998 89999999999999 46678999999999
Q ss_pred cccCCCCcc--cccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCC
Q 004155 572 KLDEEDNTH--ISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCK 628 (771)
Q Consensus 572 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~ 628 (771)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876433221 1234578999999999876 46899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=328.10 Aligned_cols=261 Identities=19% Similarity=0.200 Sum_probs=198.5
Q ss_pred hcCCCCCCccccCCceeEEEEEc---CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM---ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~---~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
..+|.+.+.||+|+||.||++.. ..++.||+|.+... ..+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 34788999999999999999854 24578999988643 23568999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
|++. ++|.+++. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.++|+|||+++....
T Consensus 166 e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9996 68888882 235799999999999999999999998 899999999999999999999999999976544
Q ss_pred CCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC-------C
Q 004155 577 DNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG-------N 648 (771)
Q Consensus 577 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-------~ 648 (771)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...................... .
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 3222 2234579999999999999999999999999999999999999997644322111111111100000 0
Q ss_pred ---hhHHhh---hhcCCCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 649 ---LMELVD---KRLGSNFD-------KEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 649 ---~~~~~d---~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
+.+.+. ......+. ......+.+++.+|+..||++||++.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 00000000 0112357789999999999999999999874
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.32 Aligned_cols=265 Identities=22% Similarity=0.356 Sum_probs=202.6
Q ss_pred cCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
++|++.+.||+|+||.||+|... +++.||+|+++.. .......+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46888999999999999999554 6889999998653 23335678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|++++.+..+.. ....+++..+..++.||+.||+|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877766652 234589999999999999999999998 8999999999999999999999999999876654
Q ss_pred CcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHH---------HHHhhC
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL---------ILKAQG 647 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~---------~~~~~~ 647 (771)
.........++..|+|||++.+. .++.++||||||+++|+|++|++||......+......... ......
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 43233445678899999999888 88999999999999999999999997543322111110000 000000
Q ss_pred Chh-----HHhhhh-cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 648 NLM-----ELVDKR-LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 648 ~~~-----~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
... +..+.. ....++......+.+++.+||+.+|++||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 000000 000111122567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=330.99 Aligned_cols=261 Identities=21% Similarity=0.257 Sum_probs=195.3
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
..+|.+.+.||+|+||.||+|.. ..++.||||.... ..+.+|++++++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45789999999999999999954 4578999996432 3457899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+. ++|.+++... ...+++.+++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 6898888432 23699999999999999999999998 89999999999999999999999999998654332
Q ss_pred c-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--------chhhHHHHHHHHHh--h-
Q 004155 579 T-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKE--------DIFYLLDWALILKA--Q- 646 (771)
Q Consensus 579 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~--------~~~~~~~~~~~~~~--~- 646 (771)
. .......||..|+|||++.+..++.++|||||||++|||++|..|+...... .....+.+...... .
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 2 1223456999999999999999999999999999999999988765432111 11111111110000 0
Q ss_pred ---CChhHHhhhh----cCCCCC----H---HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 647 ---GNLMELVDKR----LGSNFD----K---EQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 647 ---~~~~~~~d~~----l~~~~~----~---~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
..+....... ...... . .....+.+|+.+||+.||.+|||+.|+++.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000000 000000 0 111257789999999999999999999873
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=327.01 Aligned_cols=259 Identities=22% Similarity=0.318 Sum_probs=197.1
Q ss_pred HHHHhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC---
Q 004155 416 IKAATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEG--- 489 (771)
Q Consensus 416 l~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 489 (771)
.....++|.+.+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 34456889999999999999999995 4578899999987532 22345678899999999999999999987543
Q ss_pred ---CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEE
Q 004155 490 ---NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 566 (771)
Q Consensus 490 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 566 (771)
...++++|++ +++|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 4579999988 779998883 24689999999999999999999998 89999999999999999999999
Q ss_pred eecCccccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh
Q 004155 567 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA 645 (771)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 645 (771)
|||+++...... ....||..|+|||++.+ ..++.++|||||||++|||++|+.||......+... .+ .....
T Consensus 161 Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~-~~~~~ 233 (343)
T cd07878 161 DFGLARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK--RI-MEVVG 233 (343)
T ss_pred CCccceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH--HH-HHHhC
Confidence 999998654321 23468999999999876 578999999999999999999999996543221111 00 00000
Q ss_pred hC-----------ChhHHhhhhcCCCCCH--------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 646 QG-----------NLMELVDKRLGSNFDK--------EQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 646 ~~-----------~~~~~~d~~l~~~~~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. .....+. .+. ..+. .....+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 234 TPSPEVLKKISSEHARKYIQ-SLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCCHHHHHhcchhhHHHHhh-ccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0000000 000 0000 01224678999999999999999999996
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.38 Aligned_cols=255 Identities=29% Similarity=0.473 Sum_probs=199.8
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCc----EEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGT----VVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
++|+..+.||+|+||.||+|.. .+|. .||+|.+..... ....++.+|+.++++++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4677889999999999999954 3444 579998875432 3345788999999999999999999998754 4679
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
++||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 99999999999998432 23688999999999999999999998 8999999999999999999999999999866
Q ss_pred CCCCccc-ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 575 EEDNTHI-STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 575 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
....... .....++..|+|||++.+..++.++|||||||++|||++ |+.||......... ++. ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~---~~~----~~~~---- 228 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP---DLL----EKGE---- 228 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HCCC----
Confidence 4332221 122345778999999998899999999999999999997 88998654322211 111 1110
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
...........+.+++..||..+|++||++.++++.|+.+.
T Consensus 229 -----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 229 -----RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00111122346788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=306.98 Aligned_cols=247 Identities=28% Similarity=0.415 Sum_probs=199.7
Q ss_pred CCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCC-----hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKS-----KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999654 78999999986532 23456789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999943 23588999999999999999999998 89999999999999999999999999998654
Q ss_pred CCCcccccccccCCCccchhhhccCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGY-LTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
... ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||........ .. .......
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~----~~~~~~~------ 219 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VF----KIGRSKE------ 219 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HH----HHHhccc------
Confidence 333 123456888999999987766 89999999999999999999999965431111 00 0000000
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
....+......+.+++.+|++.+|++||++.+++.
T Consensus 220 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 ---LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 01112223355788999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=312.63 Aligned_cols=240 Identities=24% Similarity=0.375 Sum_probs=189.4
Q ss_pred CccccCCceeEEEEEcCC--------CcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 427 NKIGEGGFGPVYKGHMAD--------GTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999995422 235888988665555567788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC--------eEEEeecC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN--------PKISDFGL 570 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DFGl 570 (771)
+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999995432 3689999999999999999999998 8999999999999987765 59999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCC-CCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGR-SNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
+...... ....++..|+|||++.+. .++.++|||||||++|||++|. .|+..........
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~------------- 216 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ------------- 216 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-------------
Confidence 8654321 224578899999999864 5799999999999999999995 5554322211100
Q ss_pred hhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 649 LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 649 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
..... ...+......+.+++.+||+.+|++||+++++++.|+
T Consensus 217 ---~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 217 ---FYEDR--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---HHHcc--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 1111122345789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.09 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=194.8
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-hhcHHHHHHHHHH-HHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-KQGNREFVNEIGM-ISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
++|++.+.||+|+||.||+|.. .+|+.||+|+++... ......+..|+.. ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4788899999999999999954 569999999987542 2234456666665 566789999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|++ |+|.+++.........+++..++.++.||+.||+|||++. +++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6888888554333467999999999999999999999863 7999999999999999999999999999865432
Q ss_pred CcccccccccCCCccchhhhcc----CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 578 NTHISTRVAGTFGYMAPEYAMR----GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
.. .....|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||...... .... ....
T Consensus 158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~------------~~~~ 221 (283)
T cd06617 158 VA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQL------------KQVV 221 (283)
T ss_pred cc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHH------------HHHH
Confidence 21 123458889999998864 45688999999999999999999998642211 0000 0111
Q ss_pred hhhcCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 654 DKRLGSNFD-KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 654 d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.... ...+ ......+.+++.+||..+|++||++.++++
T Consensus 222 ~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 222 EEPS-PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred hcCC-CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1100 1111 123356889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=307.26 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=201.8
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+|+..++||+|+||.||++. ..+|+.||+|.+... ......++.+|+.++++++||||+++++++.+.++.++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 57888999999999999994 456899999998643 233456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++.... ...+++.++++++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999985322 23578999999999999999999998 89999999999999999999999999998654432
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||......+.. . +++....
T Consensus 156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~---------~~~~~~~- 218 (256)
T cd08218 156 EL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV------L---------KIIRGSY- 218 (256)
T ss_pred hh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH------H---------HHhcCCC-
Confidence 21 22345888999999999888999999999999999999999998643222111 0 0111000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...+......+.+++.+|++.+|++||++.+|++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1112233456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=312.41 Aligned_cols=262 Identities=24% Similarity=0.338 Sum_probs=199.9
Q ss_pred cCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++|+|++++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999654 68999999886432 2234568899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++++|..++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999988887732 23689999999999999999999998 8999999999999999999999999999866543
Q ss_pred CcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh-CChhHHhh-
Q 004155 578 NTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ-GNLMELVD- 654 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~d- 654 (771)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+...... ...... ....+..+
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIR--KTLGDLIPRHQQIFST 230 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--HHhCCCChHHhhhccc
Confidence 32 1223457889999999876 567899999999999999999999997544322211110 000000 00000000
Q ss_pred ---------hhcCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 ---------KRLGSNFD-----KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ---------~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+......+ ......+.+++.+|++.+|++||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000 012346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=316.84 Aligned_cols=252 Identities=22% Similarity=0.287 Sum_probs=201.4
Q ss_pred cCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCCh---hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+..|++++++++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888899999999999999554 589999999876432 24567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+.+++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999985332 35689999999999999999999998 899999999999999999999999999875432
Q ss_pred CCcc----------------------------cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Q 004155 577 DNTH----------------------------ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCK 628 (771)
Q Consensus 577 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~ 628 (771)
.... ......||..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 111246888999999999988999999999999999999999999754
Q ss_pred CccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 004155 629 PKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPS----MSSVVS 692 (771)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~ 692 (771)
...... .++.+..............+.+++.+|++.+|++||+ +.|++.
T Consensus 236 ~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDETF---------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHHHH---------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 332211 1111111111111124567899999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=306.96 Aligned_cols=249 Identities=24% Similarity=0.301 Sum_probs=195.6
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-----hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC--CEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-----KQGNREFVNEIGMISALQHPNLVKLHGCCIEG--NQL 492 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 492 (771)
++|++.++||+|+||.||+|.. .+|+.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5788899999999999999954 568999999875321 22345788899999999999999999998763 568
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
++||||+++++|.+++.. ...+++..+.+++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999842 23578899999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCc--ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChh
Q 004155 573 LDEEDNT--HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLM 650 (771)
Q Consensus 573 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (771)
....... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---------------~ 219 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI---------------F 219 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH---------------H
Confidence 5533211 1122345888999999998888999999999999999999999999643211110 0
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 651 ELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 651 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+..........+......+.+++.+|+. +|++||+++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 220 KIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0000001112233344567788888984 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=324.02 Aligned_cols=243 Identities=30% Similarity=0.473 Sum_probs=200.9
Q ss_pred CCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChh---cHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 423 FAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQ---GNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
|...+.||.|+||.||.| ...+...||||++....++ ...++.+|+..|++++|||++.+.|||..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 444577999999999999 4567889999999765443 346789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
|- ||-.+++. -.+.++-+.++..|+.+.+.||+|||++ +.||||||+.|||+++.|.|||+|||.|....+.+
T Consensus 108 Cl-GSAsDlle---VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 108 CL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred Hh-ccHHHHHH---HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 95 58888873 2346889999999999999999999999 89999999999999999999999999998776544
Q ss_pred cccccccccCCCccchhhhc---cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 579 THISTRVAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.++||+.|||||++. .+.|+-|+||||+|++..||...++|....+.-...+.+. .+. .|
T Consensus 181 -----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA-------QNe-----sP 243 (948)
T KOG0577|consen 181 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------QNE-----SP 243 (948)
T ss_pred -----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH-------hcC-----CC
Confidence 367999999999985 5789999999999999999999999987654332222110 100 01
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+ ...+....+.+++..||+.-|.+|||..+++.
T Consensus 244 tL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 244 TL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11 12355667899999999999999999999876
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=331.16 Aligned_cols=255 Identities=31% Similarity=0.458 Sum_probs=211.9
Q ss_pred CCCCccccCCceeEEEEE-cCCCc----EEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 424 APDNKIGEGGFGPVYKGH-MADGT----VVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 424 ~~~~~lG~G~~g~Vy~~~-~~~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
...++||+|+||+||+|. .++|+ +||+|++... ..+...++++|+.+|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 456899999999999994 44553 6899998665 3445788999999999999999999999998765 889999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
||+.|+|.++++. ++..+-....+.|..|||+||.|||++ ++|||||-++|||+.+-..+||.|||+|+....+
T Consensus 778 ~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999965 345788899999999999999999998 8999999999999999999999999999988776
Q ss_pred Cccccccc-ccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 578 NTHISTRV-AGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 578 ~~~~~~~~-~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
........ .-.+.|||-|.+....++.++|||||||++||++| |..|++....+++.++.+ .
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle----------------~ 915 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE----------------K 915 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh----------------c
Confidence 65544332 23568999999999999999999999999999998 899998776665543332 2
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCC
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQ 701 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 701 (771)
..+...++-....+..++.+||..|++.||+++++...+.+....+
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 1122333445567888999999999999999999999887765543
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.54 Aligned_cols=256 Identities=20% Similarity=0.298 Sum_probs=193.4
Q ss_pred CCCccccC--CceeEEEEE-cCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 425 PDNKIGEG--GFGPVYKGH-MADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 425 ~~~~lG~G--~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
+.++||+| +|++||++. ..+|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 789999994 4678999999987542 233456778999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999984432 23589999999999999999999998 899999999999999999999999987643321111
Q ss_pred c------cccccccCCCccchhhhcc--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 580 H------ISTRVAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 580 ~------~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... .... .+....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~-----~~~~~~ 229 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKL-----NGTVPC 229 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHh-----cCCccc
Confidence 0 1112346778999999976 46899999999999999999999999753322111 0000 000000
Q ss_pred Hhh-------------------hhc-----------------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 652 LVD-------------------KRL-----------------GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 652 ~~d-------------------~~l-----------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.++ ... ...........+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 000 00011123346889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=307.83 Aligned_cols=247 Identities=29% Similarity=0.438 Sum_probs=200.5
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
-|+..+.||+|+||.||+|. ..+++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 36678899999999999995 4568999999876432 334567889999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++. ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999983 24689999999999999999999998 899999999999999999999999999876543322
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
. .....++..|+|||++.+..++.++|||||||++|+|++|..||.......... . +......
T Consensus 157 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~------~----------~~~~~~~ 219 (277)
T cd06641 157 K-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF------L----------IPKNNPP 219 (277)
T ss_pred h-hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH------H----------HhcCCCC
Confidence 1 223457889999999988889999999999999999999999986432211110 0 0000011
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
.........+.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1222334568889999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.80 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=200.7
Q ss_pred cCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
++|++.+.||+|+||.||++... +|+.||+|.++.. .......+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999654 7899999988654 233356788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++.... ....+++..+..++.|++.||.|||+.. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999985432 1346899999999999999999999742 89999999999999999999999999997553322
Q ss_pred cccccccccCCCccchhhhccC------CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 579 THISTRVAGTFGYMAPEYAMRG------YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||........... +..+
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~------------~~~~ 222 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ------------LSAI 222 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH------------HHHH
Confidence 2234578899999998654 358899999999999999999999965332211110 0111
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+.. ....+......+.+++.+|++.+|++||++.+++.
T Consensus 223 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 223 VDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1111 11222334556789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=307.32 Aligned_cols=252 Identities=24% Similarity=0.433 Sum_probs=201.2
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC------hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS------KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
+|+..+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47788999999999999995 4678999999986532 1234678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC-CeEEEeecCccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKL 573 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFGla~~ 573 (771)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999843 34688999999999999999999998 899999999999998776 599999999976
Q ss_pred cCCCCcc---cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChh
Q 004155 574 DEEDNTH---ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLM 650 (771)
Q Consensus 574 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (771)
....... ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||.............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------ 221 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF------------ 221 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH------------
Confidence 6443211 1123468889999999988889999999999999999999999996433222111110
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 651 ELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 651 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+..........+......+.+++.+|++.+|++||++.|++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 222 KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000001112233344456889999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.03 Aligned_cols=262 Identities=24% Similarity=0.355 Sum_probs=199.4
Q ss_pred cCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
++|+..++||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999654 589999999865322 234678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++++|.++... ...+++.+++.++.||+.||+|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999999887732 23589999999999999999999998 8999999999999999999999999999865443
Q ss_pred CcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhh-HHHHHHHHHhhCChhHHhh-
Q 004155 578 NTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY-LLDWALILKAQGNLMELVD- 654 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d- 654 (771)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|++||......+... ...+..... ....+..+
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 230 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLI--PRHQEIFQK 230 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCc--hhhHHHhcc
Confidence 32 2233457889999999875 457889999999999999999999986433211111 110000000 00000000
Q ss_pred -----hhcCCCC---------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 -----KRLGSNF---------DKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 -----~~l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
....... .......+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000 0122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=324.92 Aligned_cols=261 Identities=23% Similarity=0.316 Sum_probs=202.4
Q ss_pred cCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-C-----CcEEeEEEEEEeCCEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-H-----PNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~ 493 (771)
-+|.+.+.||+|.||.|-+| +..+++.||||+++.. +.-.++-..|+.+|..++ | -|+|+++++|...++.|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 38899999999999999999 5667999999999864 334556678999999996 4 48999999999999999
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC--CeEEEeecCc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL--NPKISDFGLA 571 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DFGla 571 (771)
||+|.++. +|.++|..+.. .+++...+..|+.||+.||.+||+. +|||+||||+||||.+-. .+||+|||.|
T Consensus 265 iVfELL~~-NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhhhh-hHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 99999965 99999966543 4699999999999999999999988 899999999999996443 7999999999
Q ss_pred cccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHH------h
Q 004155 572 KLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK------A 645 (771)
Q Consensus 572 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~------~ 645 (771)
.+....-. ...-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+..+.+....+..+.... .
T Consensus 339 c~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 339 CFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 87654322 3445678999999999999999999999999999999988887765544332221110000 0
Q ss_pred hCChhHHh--------------------------------hhhcCC--------CCCHHHHHHHHHHHHHccCCCCCCCC
Q 004155 646 QGNLMELV--------------------------------DKRLGS--------NFDKEQVMVMINVALLCTDVSSTSRP 685 (771)
Q Consensus 646 ~~~~~~~~--------------------------------d~~l~~--------~~~~~~~~~l~~l~~~Cl~~dP~~RP 685 (771)
..+....+ +..... ......-..+++++.+|+++||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 00000000 100000 01113345789999999999999999
Q ss_pred CHHHHHH
Q 004155 686 SMSSVVS 692 (771)
Q Consensus 686 s~~evl~ 692 (771)
|..++++
T Consensus 495 tp~qal~ 501 (586)
T KOG0667|consen 495 TPAQALN 501 (586)
T ss_pred CHHHHhc
Confidence 9999987
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.45 Aligned_cols=246 Identities=24% Similarity=0.409 Sum_probs=198.2
Q ss_pred CCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCC
Q 004155 425 PDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNS 503 (771)
Q Consensus 425 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 503 (771)
....||+|+||.||++.. .++..||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 346799999999999954 5688999999876555556778999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccccc
Q 004155 504 LARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 583 (771)
Q Consensus 504 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 583 (771)
|.+++. ...+++.++..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++......... ..
T Consensus 106 L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~ 176 (292)
T cd06658 106 LTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RK 176 (292)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cc
Confidence 999883 23589999999999999999999998 8999999999999999999999999998755332221 22
Q ss_pred ccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCH
Q 004155 584 RVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDK 663 (771)
Q Consensus 584 ~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 663 (771)
...|+..|+|||...+..++.++|||||||++|||++|+.||........... ......+.... ..
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~------------~~~~~~~~~~~--~~ 242 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR------------IRDNLPPRVKD--SH 242 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------------HHhcCCCcccc--cc
Confidence 34688999999999888899999999999999999999999975332211110 00011111111 11
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 664 EQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 664 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
.....+.+++.+|+..||.+||++.|+++.
T Consensus 243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 223357789999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=311.87 Aligned_cols=260 Identities=27% Similarity=0.388 Sum_probs=203.7
Q ss_pred CCHHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEe
Q 004155 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIE 488 (771)
Q Consensus 411 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 488 (771)
.++.++..+.+.|++.+.||+|+||.||+|.. .+++.||+|++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 46667777889999999999999999999954 568999999986543 3345688899999998 69999999999853
Q ss_pred ------CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC
Q 004155 489 ------GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 562 (771)
Q Consensus 489 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 562 (771)
.+..++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +++||||||+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 467899999999999999985432 24578888999999999999999998 8999999999999999999
Q ss_pred eEEEeecCccccCCCCcccccccccCCCccchhhhc-----cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHH
Q 004155 563 PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL 637 (771)
Q Consensus 563 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~ 637 (771)
++|+|||++........ ......|+..|+|||.+. +..++.++|||||||++|||++|+.||..........
T Consensus 160 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-- 236 (282)
T cd06636 160 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-- 236 (282)
T ss_pred EEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh--
Confidence 99999999875533221 122356889999999875 3467889999999999999999999996432211110
Q ss_pred HHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 638 DWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 638 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+................+.+++.+||+.||.+||++.|+++
T Consensus 237 -------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 -------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000000000011123456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.82 Aligned_cols=256 Identities=28% Similarity=0.406 Sum_probs=201.9
Q ss_pred HHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCC-----
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGN----- 490 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----- 490 (771)
.++++|++.+.||+|+||.||+|.. .+++.||+|++..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 3578999999999999999999965 4678999999876443 346789999999999 6999999999997644
Q ss_pred -EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeec
Q 004155 491 -QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 569 (771)
Q Consensus 491 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 569 (771)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 58999999999999999855433346789999999999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCcccccccccCCCccchhhhcc-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHH
Q 004155 570 LAKLDEEDNTHISTRVAGTFGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 570 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
++......... .....|+..|+|||++.. ..++.++|||||||++|+|++|+.||........ ... ..
T Consensus 159 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~----~~ 231 (275)
T cd06608 159 VSAQLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFK----IP 231 (275)
T ss_pred cceecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHH----hh
Confidence 99765432221 223458899999998753 3577899999999999999999999964322111 000 00
Q ss_pred hhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 645 AQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 645 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. ..+.+ .........+.+++.+||..||++|||+.++++
T Consensus 232 -~~-----~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 -RN-----PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -cc-----CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 00011 111224457889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=312.07 Aligned_cols=261 Identities=24% Similarity=0.324 Sum_probs=200.9
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 477889999999999999964 578999999987643 23356789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+ +++|.+++.... ..+++.+++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999985432 4689999999999999999999998 89999999999999999999999999998665443
Q ss_pred cccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC---------
Q 004155 579 THISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN--------- 648 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 648 (771)
........|+..|+|||++.+. .++.++||||+||++|||++|++||........ ..+.........
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccC
Confidence 2223345689999999998654 468999999999999999999888764432211 111111000000
Q ss_pred ---hhHHhhhhcCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 649 ---LMELVDKRLGS----NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 649 ---~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...+..+.... ....+....+.+++.+|++.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 000122367889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=308.90 Aligned_cols=259 Identities=24% Similarity=0.344 Sum_probs=202.4
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC--CEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCCIEG--NQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 496 (771)
++|...+.||.|++|.||++.. .+++.||+|.+..... .....+.+|++++++++||||++++++|.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4678889999999999999965 4689999999875432 3456789999999999999999999998653 4789999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998754333445689999999999999999999998 899999999999999999999999999875433
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc--cchhhHHHHHHHHHhhCChhHHhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPK--EDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
... ....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ........+.. . .....+ .
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~-~~~~~~-~ 229 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV---N-MPNPEL-K 229 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh---c-CCchhh-c
Confidence 221 234578899999999988999999999999999999999999976432 11111221111 1 000011 1
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
... .........+.+++.+||+.+|.+|||+.|+++
T Consensus 230 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 DEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 001123456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=304.37 Aligned_cols=245 Identities=27% Similarity=0.393 Sum_probs=205.4
Q ss_pred CCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 423 FAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
|.+.++||+|+||.||+| +.+.|+.||||++... .+.+++.+|+.++++.+.|++|+++|.+.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 556789999999999999 6778999999998754 3467899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|++.+.++- .+.++++.++..|++..++||+|||.. .-||||||+.|||++.+|.+||+|||.|..+.+.-. .
T Consensus 113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-K 185 (502)
T KOG0574|consen 113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-K 185 (502)
T ss_pred CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-h
Confidence 999999944 346899999999999999999999998 789999999999999999999999999976543222 2
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCC-
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSN- 660 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~- 660 (771)
...+.||+.|||||++..-.|..++||||+|++..||..|++||..-.+-.... ++.......
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----------------MIPT~PPPTF 249 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----------------MIPTKPPPTF 249 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----------------eccCCCCCCC
Confidence 244789999999999999999999999999999999999999997533221110 000111111
Q ss_pred -CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 661 -FDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 661 -~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+.+...++.+++..|+-..|++|-|+.++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 23445567899999999999999999998876
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=308.88 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=197.2
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCCh----------hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK----------QGNREFVNEIGMISALQHPNLVKLHGCCIEGN 490 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 490 (771)
+|...+.||+|+||.||+|. ..+|+.||+|.++.... ...+.+.+|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 46778999999999999995 45689999998753211 11346788999999999999999999999999
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999433 4689999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcc-cccccccCCCccchhhhccCC--CCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC
Q 004155 571 AKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGY--LTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG 647 (771)
Q Consensus 571 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 647 (771)
++........ ......|+..|+|||.+.... ++.++||||||+++||+++|+.||........ ..+ .. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~----~~-~~ 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFK----LG-NK 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHH----hh-cc
Confidence 9765432211 123346889999999987654 88999999999999999999999864322111 000 00 00
Q ss_pred ChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 648 NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 648 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.....+.. .........+.+++.+|++.+|++||++.+|++
T Consensus 228 ~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 228 RSAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00000111 111123456888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.05 Aligned_cols=245 Identities=25% Similarity=0.399 Sum_probs=197.5
Q ss_pred CCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCH
Q 004155 426 DNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL 504 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 504 (771)
...||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 45799999999999954 46899999998765445566788999999999999999999999999999999999999999
Q ss_pred HHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccccc
Q 004155 505 ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 584 (771)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 584 (771)
.+++. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......... ...
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~ 176 (297)
T cd06659 106 TDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKS 176 (297)
T ss_pred HHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccc
Confidence 99872 24689999999999999999999998 8999999999999999999999999998755433221 223
Q ss_pred cccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHH
Q 004155 585 VAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKE 664 (771)
Q Consensus 585 ~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 664 (771)
..|+..|+|||++.+..++.++|||||||++|||++|+.||......+.. .. .. ... .... .....
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~---~~-~~~-----~~~~--~~~~~ 242 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KR---LR-DSP-----PPKL--KNAHK 242 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HH---Hh-ccC-----CCCc--cccCC
Confidence 56889999999999888999999999999999999999999754322211 10 00 000 0000 00111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 665 QVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 665 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
....+.+++.+|++.+|++||++.++++.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 23457889999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=314.15 Aligned_cols=256 Identities=21% Similarity=0.285 Sum_probs=201.6
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|+..+.||+|+||.||++. ...++.||+|.+.... ......+.+|+++++.++||||+++++.+..+++.++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468889999999999999994 4567899999987543 223457889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999943 24689999999999999999999998 899999999999999999999999999874211
Q ss_pred CC--------------cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHH
Q 004155 577 DN--------------THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALI 642 (771)
Q Consensus 577 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~ 642 (771)
.. ........|+..|+|||++.+..++.++|||||||++|||++|+.||......+... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~------~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------Q 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------H
Confidence 10 001112357889999999988889999999999999999999999997543221110 0
Q ss_pred HHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 643 LKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 643 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
... +. ...+.. .......+.+++.+|++.+|++||++.++.+.|+..
T Consensus 228 ~~~-~~---~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 228 VIS-DD---IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHh-cc---cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 000 00 000000 012334578999999999999999988888777763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=320.40 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=213.3
Q ss_pred HHHhcCCCCCCccccCCceeEEEEEcCC---C--cEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC
Q 004155 417 KAATNNFAPDNKIGEGGFGPVYKGHMAD---G--TVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGN 490 (771)
Q Consensus 417 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~---g--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 490 (771)
+...+.....++||+|-||.||+|.+.+ | -.||||..+.+ .....+.|+.|..++++++||||++++|.|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 3334444566799999999999995432 3 36999998875 44557889999999999999999999999986 4
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..|+|||.++-|.|..||+.+ ...++......++.||..||+|||+. ++|||||..+|||+...-.+||+|||+
T Consensus 464 P~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ceeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence 689999999999999999554 34788999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCCh
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNL 649 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (771)
+|....+.....+...-.+.|||||.+.-..++.++|||.|||.+||++. |..||......+..-
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------------- 603 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------------- 603 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE--------------
Confidence 99888766555555555778999999999999999999999999999987 999997644333211
Q ss_pred hHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 650 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
.++..-+...+..++..+..++.+||+++|.+||++.|+...|..+.
T Consensus 604 --~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 604 --HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred --EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 11111122345567778999999999999999999999998887653
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.29 Aligned_cols=197 Identities=26% Similarity=0.447 Sum_probs=161.3
Q ss_pred CCccccCCceeEEEEEcC---CCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe--CCEEEEEEEecc
Q 004155 426 DNKIGEGGFGPVYKGHMA---DGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIE--GNQLLLIYEYME 500 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~~ 500 (771)
..+||+|+||.||+|... ++..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999654 45789999986542 23467889999999999999999999853 567899999987
Q ss_pred CCCHHHHhcCCC-----ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE----cCCCCeEEEeecCc
Q 004155 501 NNSLARALFGPE-----AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLA 571 (771)
Q Consensus 501 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFGla 571 (771)
+ +|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 7877774221 1223588999999999999999999998 89999999999999 56779999999999
Q ss_pred cccCCCCcc--cccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCC
Q 004155 572 KLDEEDNTH--ISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCK 628 (771)
Q Consensus 572 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~ 628 (771)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 866443221 1233568999999999876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=305.58 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=204.0
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
++|++.+.||.|+||+||+|.. .++..+|+|++.... ......+.+|+++++.++|+|++++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4788999999999999999964 468899999986532 23567889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999954321 24689999999999999999999998 89999999999999999999999999997665433
Q ss_pred cc---cccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 579 TH---ISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 579 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
.. ......|+..|+|||++... .++.++|||||||++|||++|+.||......... .+.. .. ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--~~~~----~~------~~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--MLTL----QN------DP 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH--HHHh----cC------CC
Confidence 22 22334688999999998877 7899999999999999999999999754332111 0000 00 00
Q ss_pred hhcCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 KRLGSNF-DKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+.+.... .......+.+++.+|++.||++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111110 0123456889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=306.95 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=202.1
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
++|+..+.||+|+||.||++.. .+++.||+|.+.... .....++.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 3677889999999999999955 468999999987653 34456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE-ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
+++++|.+++.... ..+++..+..++.|++.||+|||+ . +++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999995432 578899999999999999999999 6 8999999999999999999999999998755332
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
... ...++..|+|||++.+..++.++||||||+++|+|++|+.||........ ...+.... ......
T Consensus 155 ~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~---------~~~~~~ 221 (265)
T cd06605 155 LAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQY---------IVNEPP 221 (265)
T ss_pred Hhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHH---------HhcCCC
Confidence 211 25688899999999998999999999999999999999999965421110 11111111 111110
Q ss_pred CCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 658 GSNFDKE-QVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 658 ~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...... ....+.+++.+|+..+|++||++.+++.
T Consensus 222 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 222 -PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 111111 3456889999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=307.85 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=199.0
Q ss_pred CCCCCccccCCceeEEEEEcC----CCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC------
Q 004155 423 FAPDNKIGEGGFGPVYKGHMA----DGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGN------ 490 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 490 (771)
|.+.+.||+|+||.||+|... +++.||||++... .....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999542 4688999998754 2334567889999999999999999999886532
Q ss_pred EEEEEEEeccCCCHHHHhcCCC--ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEee
Q 004155 491 QLLLIYEYMENNSLARALFGPE--AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 568 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 568 (771)
..++++||+.+|+|.+++.... .....+++..+++++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999998875322 1223578999999999999999999988 8999999999999999999999999
Q ss_pred cCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhh
Q 004155 569 GLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQ 646 (771)
Q Consensus 569 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 646 (771)
|+++........ ......++..|++||.+....++.++|||||||++|||++ |++||......+ ...+.. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~----~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI----K 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH----c
Confidence 999865432211 1122345678999999998889999999999999999999 888886443221 111110 0
Q ss_pred CChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 647 GNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 647 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.. .+ ..+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 231 ~~-------~~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GN-------RL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC-------cC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 00 11112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=311.96 Aligned_cols=250 Identities=26% Similarity=0.444 Sum_probs=202.9
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
++|.+.+.||+|+||.||++. ..+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 678889999999999999995 4568899999987554455677899999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999832 3578999999999999999999998 899999999999999999999999999875543322
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
. .....|++.|+|||.+.+..++.++|||||||++|++++|+.||............ .. ......
T Consensus 171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~--------~~~~~~ 235 (293)
T cd06647 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------AT--------NGTPEL 235 (293)
T ss_pred c-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hc--------CCCCCC
Confidence 2 22345888999999998888999999999999999999999999754322111000 00 000000
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
.........+.+++.+||+.+|++||++.+++..
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112233467889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=304.82 Aligned_cols=251 Identities=30% Similarity=0.454 Sum_probs=200.6
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+|...+.||+|+||.||+|.. .+++.||+|.++.... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 578889999999999999954 4789999999876543 3567899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999943 23578999999999999999999998 89999999999999999999999999998765433
Q ss_pred ccccc---ccccCCCccchhhhccCC---CCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 579 THIST---RVAGTFGYMAPEYAMRGY---LTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 579 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
..... ...++..|+|||++.+.. .+.++||||||+++||+++|+.||........ .. ..... +
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~---~~~~~-~----- 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IM---FHVGA-G----- 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HH---HHHhc-C-----
Confidence 32211 346788999999998766 88999999999999999999999964321111 00 00000 0
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+.+.. .......+.+++.+|++.+|++||++.|++.
T Consensus 223 ~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0001100 1112445778999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=323.44 Aligned_cols=236 Identities=25% Similarity=0.333 Sum_probs=182.9
Q ss_pred cccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcC---CCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 429 IGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISAL---QHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 429 lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
||+|+||+||+|. ..+|+.||||++.... ......+..|..++.+. +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999995 4568999999986432 12233455677777665 699999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 999999842 34689999999999999999999998 899999999999999999999999999975432222 2
Q ss_pred ccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCC
Q 004155 582 STRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSN 660 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 660 (771)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||......+... .. ..+. ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~------~i-~~~~------~~~~~- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR------NI-AFGK------VRFPK- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHH------HH-HcCC------CCCCC-
Confidence 2345699999999998764 57999999999999999999999997543222111 00 0000 01110
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 004155 661 FDKEQVMVMINVALLCTDVSSTSRPSMS 688 (771)
Q Consensus 661 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 688 (771)
......+.+++.+||+.||++||++.
T Consensus 219 --~~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 219 --NVLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred --ccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 11234567899999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.38 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=206.6
Q ss_pred cCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
++|++.+.||+|++|.||+|... +++.||+|++..... .....+.+|+.++.+++|+|++++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999654 589999999876543 4467899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE-ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
+++++|.+++... ..+++..++.++.|+++||+|||+ . +++||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999432 568999999999999999999999 7 8999999999999999999999999999866543
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
.... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.............+. ....
T Consensus 154 ~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~------------~~~~- 219 (264)
T cd06623 154 LDQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CDGP- 219 (264)
T ss_pred CCcc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH------------hcCC-
Confidence 3221 2345788999999999999999999999999999999999999754321211111111 1111
Q ss_pred CCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 658 GSNFDKE-QVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 658 ~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
....+.. ....+.+++.+|++.+|++||++.|+++.
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 220 PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111222 44578899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=303.86 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=199.9
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+|+..+.||+|+||.||++.. .+++.+|+|.+... .......+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 578889999999999999944 56889999998654 233456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC-CCeEEEeecCccccCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLDEED 577 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFGla~~~~~~ 577 (771)
+++++|.+++.... ...+++..+.+++.|++.||+|||++ +++||||||+||+++.+ +.+||+|||.++.....
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999995432 34589999999999999999999998 89999999999999855 46899999999866443
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
.. .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ ..+. ....
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~------------~~~~- 217 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKI------------MSGT- 217 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHH------------HhcC-
Confidence 22 2234688899999999988899999999999999999999999865432211 1100 0000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...........+.+++.+||+.+|++|||+.|+++
T Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 01111123446889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=306.96 Aligned_cols=247 Identities=28% Similarity=0.457 Sum_probs=198.9
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC-ChhcHHHHHHHHHHHHcCC---CCcEEeEEEEEEeCCEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK-SKQGNREFVNEIGMISALQ---HPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 496 (771)
.|+..+.||+|+||.||+|. ..+++.||+|.+... ......++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 47778999999999999995 467899999998654 2334567889999999986 999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++++|.+++.. ..+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999999832 3689999999999999999999998 899999999999999999999999999987654
Q ss_pred CCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.... .....|+..|+|||.+.++ .++.++|||||||++|+|++|+.||........... ......+
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~------------~~~~~~~ 220 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML------------IPKSKPP 220 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc------------cccCCCC
Confidence 3322 2334688999999998754 578999999999999999999999975432111100 0000001
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+... .....+.+++.+|++.||++||++.|++.
T Consensus 221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11111 13456889999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=310.55 Aligned_cols=262 Identities=22% Similarity=0.349 Sum_probs=195.6
Q ss_pred cCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
++|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999554 689999999865432 2234577899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+.+ +|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 985 999988433 23689999999999999999999998 89999999999999999999999999987543221
Q ss_pred cccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh---hCChhHHhh
Q 004155 579 THISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA---QGNLMELVD 654 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d 654 (771)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ .......... .........
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhh
Confidence 1 1122346789999999875 4588999999999999999999999965431111 1100000000 000000000
Q ss_pred --------------hhcCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 --------------KRLGSNF-DKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 --------------~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+.... .......+.+++.+|++.+|++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 0011246778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.07 Aligned_cols=262 Identities=23% Similarity=0.303 Sum_probs=199.1
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChh-----cHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQ-----GNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
+|+..+.||+|+||.||+|.. .+|+.||||.+...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477888999999999999964 46899999998764322 345677899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+ +|+|.+++.... ..+++..++.++.||++||+|||++ +++||||||+||+++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 899999995432 3689999999999999999999998 89999999999999999999999999998665
Q ss_pred CCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh--------h
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA--------Q 646 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--------~ 646 (771)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|.+||......+... ........ .
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG--KIFEALGTPTEENWPGV 230 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHH--HHHHHcCCCchhhhhhc
Confidence 43222 122346788999998865 467899999999999999999988876543221111 00000000 0
Q ss_pred CChhHHhhhhcCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 647 GNLMELVDKRLGSNFD-----KEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 647 ~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
...............+ ......+.+++.+||+.+|++||++.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000111 1224568899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=310.87 Aligned_cols=261 Identities=21% Similarity=0.285 Sum_probs=195.5
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+|+..+.||+|+||.||+|.. .+|+.||+|+++.... .....+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 477889999999999999954 5689999999865322 2235678899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
++ ++|.+++... ...+++..++.++.||++||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 4888887432 24689999999999999999999998 89999999999999999999999999998654322
Q ss_pred cccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC------hhH
Q 004155 579 THISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN------LME 651 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 651 (771)
.. .....++..|+|||++.+. .++.++|||||||++|||+||+.|+........ ............. ...
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhh
Confidence 21 1234578899999998764 478999999999999999999988654322111 1111100000000 000
Q ss_pred HhhhhcCCCC---------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 652 LVDKRLGSNF---------DKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 652 ~~d~~l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+....... .......+.+++.+||+.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000000 0112346788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.11 Aligned_cols=267 Identities=21% Similarity=0.284 Sum_probs=197.9
Q ss_pred CCCCCCccccCCceeEEEEEcC---CCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC--CEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMA---DGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEG--NQLL 493 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~---~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 493 (771)
+|++.++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999654 47899999987632 33346678899999999999999999999988 8899
Q ss_pred EEEEeccCCCHHHHhcCCCc-cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC----CCCeEEEee
Q 004155 494 LIYEYMENNSLARALFGPEA-HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK----DLNPKISDF 568 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DF 568 (771)
+||||+++ +|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 67776643322 223789999999999999999999998 8999999999999999 999999999
Q ss_pred cCccccCCCCc--ccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchh-------hHHH
Q 004155 569 GLAKLDEEDNT--HISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF-------YLLD 638 (771)
Q Consensus 569 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~-------~~~~ 638 (771)
|+++....... .......+|..|+|||++.+. .++.++|||||||++|||++|++||.....+... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986644322 112334678899999988764 5789999999999999999999999764433200 0000
Q ss_pred HHHHHHh-----------hCChhHHhhhhcCCCCC----H-------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 639 WALILKA-----------QGNLMELVDKRLGSNFD----K-------EQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 639 ~~~~~~~-----------~~~~~~~~d~~l~~~~~----~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
....+.. ........+......++ . .....+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 00000000000001111 0 12345889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.82 Aligned_cols=243 Identities=26% Similarity=0.362 Sum_probs=198.1
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4688899999999999999954 468999999986532 233567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999943 24689999999999999999999998 899999999999999999999999999986644
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
. .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||........ .. .+....
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~------------~~~~~~ 214 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI---YE------------KILEGK 214 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---HH------------HHhcCC
Confidence 3 2334688999999999888889999999999999999999999965432111 00 011100
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRP-----SMSSVV 691 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl 691 (771)
...+......+.+++.+||+.+|.+|| ++.|++
T Consensus 215 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 215 --VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred --ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 011122235678899999999999999 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.25 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=201.7
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 496 (771)
...|++.++||+||.+.||++...+.+.||+|++... ..+....|.+|+..|.+++ |.+|+++++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 4568889999999999999998888889999987543 4455678999999999995 999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||= ..+|..+|..... ....| .+..+..|++.|+.++|++ ||||.||||.|+|+-+ |.+||+|||+|.....
T Consensus 440 E~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred ecc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 976 4599999955432 22334 7888999999999999999 9999999999999954 6999999999998776
Q ss_pred CCcccc-cccccCCCccchhhhccC-----------CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHH
Q 004155 577 DNTHIS-TRVAGTFGYMAPEYAMRG-----------YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 577 ~~~~~~-~~~~gt~~y~aPE~~~~~-----------~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
+.+.+. ...+||+.||+||.+... +.+.++||||+|||||+|+.|++||..- .. .|
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n--~~----- 579 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----IN--QI----- 579 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HH--HH-----
Confidence 655443 345799999999998532 3678999999999999999999999521 11 11
Q ss_pred hhCChhHHhhhhcCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 645 AQGNLMELVDKRLGSNFDK-EQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 645 ~~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.++..+.|+...-+++. ....++++++..||+.||++||+..|+++
T Consensus 580 --aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 --AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 13455666644333331 11223899999999999999999999987
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.60 Aligned_cols=247 Identities=24% Similarity=0.396 Sum_probs=199.5
Q ss_pred CCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 423 FAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
|...+.||+|++|.||++. ..+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 4456799999999999995 457899999998765555566788999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
++|.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+........ .
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 999999843 4689999999999999999999998 899999999999999999999999998875543221 1
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 661 (771)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||......... ..... . ..+... .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~------~~~~~-~-----~~~~~~--~ 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------KRIRD-N-----LPPKLK--N 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH------HHHHh-c-----CCCCCc--c
Confidence 22345889999999998888999999999999999999999998653321111 11100 0 001110 0
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 662 DKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 662 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.......+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1113346889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.80 Aligned_cols=264 Identities=23% Similarity=0.301 Sum_probs=196.3
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++++|.+.+.||+|+||.||+|. ..+|+.||+|++..... .....+.+|+.+++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 45789999999999999999995 45689999999865432 22346788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+. ++|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 6777776332 23578889999999999999999998 899999999999999999999999999975433
Q ss_pred CCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh----------
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA---------- 645 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---------- 645 (771)
.... .....++..|+|||++.+. .++.++|||||||++|||++|+.||........ ..........
T Consensus 156 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 156 PSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhh
Confidence 2211 1223578899999998754 578999999999999999999999975432111 1110100000
Q ss_pred ---hCChhHHhhhhcCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 646 ---QGNLMELVDKRLGSNFD-----KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 646 ---~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
................. ......+.+++.+|++.||.+|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000000 011345778999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.16 Aligned_cols=249 Identities=27% Similarity=0.422 Sum_probs=204.6
Q ss_pred CCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+|++.++||+|+||.||++ ...+++.+|+|.+... ......++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999 4557889999998753 233456788899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++.........+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999855433345789999999999999999999998 89999999999999999999999999998765441
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||........ .. .+.....
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~-------------~~~~~~~ 218 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---RY-------------KVQRGKY 218 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH-------------HHhcCCC
Confidence 2224578899999999998999999999999999999999999975432211 10 0011111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..........+.+++.+|++.+|++||++.|+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1222344566899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=296.76 Aligned_cols=249 Identities=30% Similarity=0.482 Sum_probs=203.5
Q ss_pred CCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
+|+..+.||+|++|.||++... +++.|++|++..........+.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677899999999999999654 689999999977655566789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+++|.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999984432 4789999999999999999999997 899999999999999999999999999986654332
Q ss_pred cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCC
Q 004155 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSN 660 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 660 (771)
.....++..|+|||++.....+.++||||||+++|+|++|+.||........... .. ...... . .
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------~~-~~~~~~-----~--~ 218 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK------IA-TNGPPG-----L--R 218 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH------HH-hcCCCC-----c--C
Confidence 2345688899999999988899999999999999999999999875432111100 00 000000 0 0
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 661 FDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 661 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
........+.+++.+|++.||++||++.|+++
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01112456889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=308.80 Aligned_cols=246 Identities=29% Similarity=0.446 Sum_probs=196.2
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
+.|...+.||+|+||.||+|.. .+|+.||+|++.... .....++.+|+++++.++||||+++.++|.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4588889999999999999954 468999999986432 233457889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+. |++.+++... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 5777777322 24689999999999999999999998 899999999999999999999999999976543
Q ss_pred CCcccccccccCCCccchhhhc---cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
.. ...++..|+|||++. ...++.++||||||+++|||+||+.||........... .. ..
T Consensus 168 ~~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~------~~-~~------ 229 (307)
T cd06607 168 AN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IA-QN------ 229 (307)
T ss_pred CC-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH------Hh-cC------
Confidence 22 245788999999874 45688999999999999999999999865432211100 00 00
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
.............+.+++.+||+.+|++||++.+++..
T Consensus 230 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 --DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00001112344568899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.76 Aligned_cols=264 Identities=23% Similarity=0.342 Sum_probs=198.4
Q ss_pred cCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC--CEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEG--NQLLLI 495 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 495 (771)
++|+..+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999654 688999999875432 2234577899999999999999999999877 899999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++ +|.+++.... ..+++..++.++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999974 9999884322 3689999999999999999999998 89999999999999999999999999998665
Q ss_pred CCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHH-H---------HHHH--
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL-D---------WALI-- 642 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~-~---------~~~~-- 642 (771)
..... .....++..|+|||.+.+. .++.++||||||+++|||++|++||......+..... . |...
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 43221 2234578899999998764 4689999999999999999999999764432221111 0 0000
Q ss_pred HH--hhCChhHHhhhhcCCCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 643 LK--AQGNLMELVDKRLGSNFDKE-QVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 643 ~~--~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+. ............+...++.. ....+.+++.+|++.+|++||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 00000000001111111111 2455788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=319.26 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=202.4
Q ss_pred cCCCCCCccccCCceeEEEEEcCC-CcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMAD-GTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
+.|.++..||.|+||.||+|..++ +-..|.|++...+....++|.-|+++|....||+||++++.|...+.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 346677889999999999995543 5556788888878888899999999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
.||-++..+-. -..++.+.++.-+++|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+.......
T Consensus 112 ~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~- 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR- 184 (1187)
T ss_pred CCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH-
Confidence 99999888743 245899999999999999999999999 89999999999999999999999999986432211
Q ss_pred ccccccccCCCccchhhhc-----cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 580 HISTRVAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
.....+.||++|||||+.. ..+|+.++||||||++|.||..+.+|.+...+-. .++. ........++
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--VllK-----iaKSePPTLl- 256 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLK-----IAKSEPPTLL- 256 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HHHH-----HhhcCCCccc-
Confidence 1123468999999999874 4689999999999999999999999976433211 1111 0000001111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+......+.+++.+||..||..||++.++++
T Consensus 257 ------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 ------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 12344567889999999999999999999986
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.48 Aligned_cols=263 Identities=25% Similarity=0.368 Sum_probs=198.8
Q ss_pred CCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC--CEEEEEEE
Q 004155 423 FAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEG--NQLLLIYE 497 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~E 497 (771)
|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999654 58999999998653 33356788999999999999999999999987 89999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++ +|.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 8998884332 4789999999999999999999998 8999999999999999999999999999866554
Q ss_pred CcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChh---HH-
Q 004155 578 NTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLM---EL- 652 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~- 652 (771)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||......................... .+
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 3222333457889999998765 467899999999999999999999997644322211110000000000000 00
Q ss_pred ----h------hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 653 ----V------DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 653 ----~------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. ...+...+.......+.+++.+|++.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 000000000112456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.36 Aligned_cols=262 Identities=26% Similarity=0.377 Sum_probs=196.8
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+|+..+.||.|+||.||+|.. .+|+.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478889999999999999954 468999999986542 22345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+. ++|.+++.... ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 68999885432 34689999999999999999999998 89999999999999999999999999997654322
Q ss_pred cccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC-C----hhHH
Q 004155 579 THISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG-N----LMEL 652 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~ 652 (771)
.. .....++..|+|||++.+. .++.++|||||||++|||+||+.||......+. ..+......... . ...+
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhHH
Confidence 21 2233468899999988764 468899999999999999999999975432211 111111000000 0 0000
Q ss_pred ------hhhhcCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 653 ------VDKRLGSNF---DKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 653 ------~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
......... .......+.+++.+|++.||++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000 0011235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.72 Aligned_cols=249 Identities=23% Similarity=0.394 Sum_probs=199.5
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+|+..+.||+|+||.||+|.. .+|..||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 577889999999999999954 458899999986531 23456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC-CeEEEeecCccccCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLDEED 577 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~~ 577 (771)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999995432 24589999999999999999999998 899999999999998885 4699999999866443
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
.. ......|++.|+|||+..+..++.++||||||+++|||++|+.||....... +... ......
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~---------~~~~~~ 219 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLK---------ICQGYF 219 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHH---------HhcccC
Confidence 22 2223458899999999988889999999999999999999999986432211 1111 111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..........+.+++.+|++.+|++||++.|+++
T Consensus 220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 -APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1111122346888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=304.64 Aligned_cols=253 Identities=27% Similarity=0.457 Sum_probs=204.4
Q ss_pred HHhcCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
..++.|+..+.||+|+||.||+|... +++.||+|++..... ....+.+|++++++++|+|++++++++...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35677888899999999999999654 688999999976544 5667889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999995432 3799999999999999999999997 899999999999999999999999999875543
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
... ......++..|+|||++.+..++.++|||||||++|+|++|+.||......... . ... ......
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~---~---~~~-~~~~~~----- 235 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL---F---LIT-TKGIPP----- 235 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH---H---HHH-hcCCCC-----
Confidence 221 112345788999999998888999999999999999999999998643322111 0 000 000000
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..........+.+++.+|++.+|.+||++.++++
T Consensus 236 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 --LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred --CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0011113456889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=299.29 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=205.6
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+|+..+.||+|+||.||++.. .+++.||+|++..... .....+.+|++++++++|+|++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 577889999999999999954 4689999999876532 4567789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++.........+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999965443346799999999999999999999998 89999999999999999999999999998665443
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||........ . ... .... .
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~---~~~---------~~~~-~ 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL---A---LKI---------LKGQ-Y 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH---H---HHH---------hcCC-C
Confidence 122334688899999999988899999999999999999999999865432111 1 000 0000 1
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...+......+.+++.+||..+|++||++.|+++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1112223456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=317.14 Aligned_cols=269 Identities=24% Similarity=0.350 Sum_probs=200.7
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC-----CE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEG-----NQ 491 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 491 (771)
.+++|++.++||+|+||.||+|. ..+|+.||+|++.... ......+.+|+.++++++|+||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 35789999999999999999994 5678999999986432 23356688899999999999999999987644 35
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.++|+||+.+ +|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 8999999975 8888872 24689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcc--cccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh--
Q 004155 572 KLDEEDNTH--ISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ-- 646 (771)
Q Consensus 572 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-- 646 (771)
+........ ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~ 230 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPS 230 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCC
Confidence 765432221 1123468899999998754 5689999999999999999999999965432111 1111110000
Q ss_pred -CChhHHhhhh-------cC--CCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCCCC
Q 004155 647 -GNLMELVDKR-------LG--SNFD-----KEQVMVMINVALLCTDVSSTSRPSMSSVVSM--LEGRAD 699 (771)
Q Consensus 647 -~~~~~~~d~~-------l~--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~ 699 (771)
+.+..+.+.. .. ...+ ......+.+++.+||+.+|++||++.|+++. ++....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0011111100 00 0000 1123468899999999999999999999985 555443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.34 Aligned_cols=265 Identities=22% Similarity=0.274 Sum_probs=195.4
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCE-----
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQ----- 491 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 491 (771)
++|+..+.||+|+||.||+|.. .+|+.||+|+++.... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688899999999999999954 5689999998765422 23457888999999995 6999999999987665
Q ss_pred EEEEEEeccCCCHHHHhcCCCcc-CCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC-CCCeEEEeec
Q 004155 492 LLLIYEYMENNSLARALFGPEAH-RLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFG 569 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG 569 (771)
.++||||+++ +|.+++...... ...+++..++.++.||+.||+|||+. +++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 898888543322 35689999999999999999999998 8999999999999998 8999999999
Q ss_pred CccccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC-
Q 004155 570 LAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG- 647 (771)
Q Consensus 570 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~- 647 (771)
+++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|..||........ ............
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHhCCCCh
Confidence 99855332211 122346889999998865 4579999999999999999999999975432211 111000000000
Q ss_pred ----ChhHHhh----hhcCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 648 ----NLMELVD----KRLGS----NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 648 ----~~~~~~d----~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...+..+ +.... .........+.+++.+|++.||++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 00000 000112345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=315.88 Aligned_cols=245 Identities=26% Similarity=0.383 Sum_probs=205.6
Q ss_pred CCccccCCceeEEEEEcC--CCc--EEEEEEcccCChh-cHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 426 DNKIGEGGFGPVYKGHMA--DGT--VVAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~--~g~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
.++||+|.||.|++|.|. .|+ .||||.++..... ...+|++|+.+|.+|+|+|++++||...+ ....+|+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 478999999999999664 344 6899999876544 57899999999999999999999999987 67899999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
.|||.+.|+. ..+..+-......++.|||.||.||.++ ++|||||..+|+||-....+||+|||+.+.+......
T Consensus 194 lGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 194 LGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 9999999976 3456788888999999999999999998 8999999999999999999999999999988765544
Q ss_pred cc--cccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 581 IS--TRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 581 ~~--~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
.. ....-.+.|+|||.+....++.++|||+|||++|||+| |..||.+.....+ .+.+|..-
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI----------------L~~iD~~e 332 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI----------------LKNIDAGE 332 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH----------------HHhccccc
Confidence 32 12233568999999999999999999999999999998 6778876543322 23344333
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
....+..+.+.+.+++..||..+|++||++..+.+
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 33445667888999999999999999999999974
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=308.15 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=198.7
Q ss_pred HHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC----
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGN---- 490 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 490 (771)
...++|++.+.||+|+||.||+|.. .+|+.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4567899999999999999999965 468999999987542 223456788999999999999999999987654
Q ss_pred ------EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeE
Q 004155 491 ------QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 564 (771)
Q Consensus 491 ------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 564 (771)
..++|+||+++ ++.+.+... ...+++..+..++.||+.||+|||+. +|+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 777777432 34689999999999999999999998 899999999999999999999
Q ss_pred EEeecCccccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHH
Q 004155 565 ISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALIL 643 (771)
Q Consensus 565 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 643 (771)
|+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|++||......+....+ ...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~---~~~ 233 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI---SRL 233 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHH
Confidence 99999998665433222233346788999998865 45789999999999999999999999754322111111 111
Q ss_pred HhhC---ChhHHh--------hh------hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 644 KAQG---NLMELV--------DK------RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 644 ~~~~---~~~~~~--------d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.... ....+. ++ ...... ......+.+++.+||+.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 000000 00 000000 012356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.21 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=209.9
Q ss_pred cCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.-|...+.||+|.|+.|-+| +.-+|..||||++.+... .....+.+|+..|+.++|||||++|........+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 44667789999999999999 556899999999977533 334578889999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE-cCCCCeEEEeecCccccCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL-DKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DFGla~~~~~ 576 (771)
.-++|+|.+||.. +...+.+....+++.||..|+.|+|+. .+|||||||+||.+ .+-|-+||+|||++..+.+
T Consensus 98 LGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999954 345799999999999999999999998 69999999999876 5678999999999987665
Q ss_pred CCcccccccccCCCccchhhhccCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLT-DKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.... +..+|...|-|||++.+..|. ++.||||+|||||-|++|++||......+. +..++|-
T Consensus 172 G~kL--~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDC 234 (864)
T KOG4717|consen 172 GKKL--TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDC 234 (864)
T ss_pred cchh--hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcc
Confidence 4332 446799999999999987655 688999999999999999999987655443 2334443
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCC
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGR 697 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 697 (771)
.. ..+.....++.+|+..||..||++|.+.+|++. +|+..
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 32 334556678999999999999999999999986 45543
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=296.58 Aligned_cols=250 Identities=29% Similarity=0.392 Sum_probs=204.1
Q ss_pred CCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC--CEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEG--NQLLLIY 496 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 496 (771)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++++... +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999654 789999999876542 4567889999999999999999999999988 8999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999999432 3789999999999999999999997 899999999999999999999999999987655
Q ss_pred CCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 577 DNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 577 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.... ......++..|+|||...+...+.++||||||+++|+|++|+.||....... ... ..+...
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~------------~~~~~~ 219 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--AAL------------YKIGSS 219 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHH------------Hhcccc
Confidence 4321 1233568889999999998889999999999999999999999997544111 000 001111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
......+......+.+++.+|++.+|++||++.+++.
T Consensus 220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1111222233567889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=302.53 Aligned_cols=265 Identities=25% Similarity=0.386 Sum_probs=198.9
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
+|+..++||+|++|.||+|.. .+|+.||||+++.... .....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 578899999999999999965 4689999999876432 23456788999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++ +|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 89888854332 34689999999999999999999988 899999999999999999999999999975543221
Q ss_pred ccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh-hhc
Q 004155 580 HISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD-KRL 657 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~l 657 (771)
. .....++..|+|||++.+. .++.++|||||||++|||++|+.||......+...................+.+ +.+
T Consensus 156 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 T-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred c-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 1 1224578899999988654 578999999999999999999999976543322111100000000000000000 000
Q ss_pred CCC-----------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 658 GSN-----------FDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 658 ~~~-----------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
... ........+.+++.+|++.||.+||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 00122346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=301.85 Aligned_cols=241 Identities=25% Similarity=0.300 Sum_probs=186.2
Q ss_pred ccccCCceeEEEEEc-CCCcEEEEEEcccCCh---hcHHHHHHHHHHHH---cCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 428 KIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK---QGNREFVNEIGMIS---ALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 428 ~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
.||+|+||.||++.. .+|+.||+|.+..... .....+.+|..+++ ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999954 5689999998865321 22233445544443 3479999999999999999999999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 9999999842 34699999999999999999999998 899999999999999999999999999975533221
Q ss_pred cccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 581 ISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
....||..|+|||.+.+ ..++.++|||||||++|||++|+.||............. .. .....
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~----------~~~~~ 216 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MT----------LTVNV 216 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH----Hh----------hcCCc
Confidence 23468999999999864 568999999999999999999999997543322211110 00 00111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
..+......+.+++.+|++.||++|| +++|+++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 12223345688899999999999999 5888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=303.45 Aligned_cols=247 Identities=25% Similarity=0.325 Sum_probs=201.0
Q ss_pred CCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
+|++.++||.|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788899999999999999654 68999999987532 2345788999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999933 24789999999999999999999998 8999999999999999999999999999865443
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||............ . .... .
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~---------~~~~-~ 217 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----A---------KQET-A 217 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----H---------Hhcc-c
Confidence 2 123345888999999999888999999999999999999999999765432111111 0 0000 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSM--SSVV 691 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl 691 (771)
....+......+.+++.+||+.||.+||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 112222334678899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=298.27 Aligned_cols=242 Identities=21% Similarity=0.288 Sum_probs=194.8
Q ss_pred cccCCceeEEEEEcC-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCH
Q 004155 429 IGEGGFGPVYKGHMA-DGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL 504 (771)
Q Consensus 429 lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 504 (771)
||.|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999653 58999999986532 23356789999999999999999999999999999999999999999
Q ss_pred HHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccccc
Q 004155 505 ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 584 (771)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 584 (771)
.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||+++...... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 9999432 3589999999999999999999998 89999999999999999999999999998665432 1223
Q ss_pred cccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHH
Q 004155 585 VAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKE 664 (771)
Q Consensus 585 ~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 664 (771)
..|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.....+. .... ..+.+......++..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~------------~~~~~~~~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIY------------NDILKGNGKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHH------------HHHhccCCCCCCCcc
Confidence 468889999999988889999999999999999999999997654211 1111 111111111122222
Q ss_pred HHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 004155 665 QVMVMINVALLCTDVSSTSRPS-----MSSVVS 692 (771)
Q Consensus 665 ~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 692 (771)
....+.+++.+||+.+|++||+ +.|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 3557899999999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=305.51 Aligned_cols=248 Identities=27% Similarity=0.424 Sum_probs=196.1
Q ss_pred CCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 423 FAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
|...+.||+|+||.||+|.. .+|..||+|++.... ......+.+|++++++++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 55678899999999999954 568999999986432 22345788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+.+ +|.+.+... ...+++.++..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 974 787777432 34689999999999999999999998 8999999999999999999999999998754332
Q ss_pred cccccccccCCCccchhhhc---cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 579 THISTRVAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||.......... .+...
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~---------------~~~~~ 239 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---------------HIAQN 239 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH---------------HHHhc
Confidence 2245888999999974 4578999999999999999999999986532211110 01111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.............+.+++.+|++.+|.+||++.++++..--.
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 240 ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 110111122344688999999999999999999999865443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=304.19 Aligned_cols=261 Identities=25% Similarity=0.361 Sum_probs=196.4
Q ss_pred CCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 423 FAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
|+..+.||.|++|.||+|. ..+|+.||+|++.... ......+.+|++++++++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 5678899999999999995 4579999999987543 223457889999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
+ ++|.+++..... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 699999854322 3689999999999999999999998 899999999999999999999999999976543221
Q ss_pred ccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC--------Chh
Q 004155 580 HISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG--------NLM 650 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 650 (771)
. .....++..|+|||++.+. .++.++||||||+++|||++|++||........ ............ .+.
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhch
Confidence 1 1223468899999988664 578999999999999999999999975432211 111111000000 000
Q ss_pred HHhhhh--cC-C---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 651 ELVDKR--LG-S---NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 651 ~~~d~~--l~-~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+..... .. . .........+.+++.+|++.+|++||+++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 00 0 000112246789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=297.12 Aligned_cols=249 Identities=25% Similarity=0.320 Sum_probs=196.7
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC-----ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC--CEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK-----SKQGNREFVNEIGMISALQHPNLVKLHGCCIEG--NQL 492 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 492 (771)
.+|++.+.||+|+||.||+|. ..+|+.||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 578899999999999999995 456899999987532 123346788999999999999999999998764 468
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
++|+||+++++|.+++.. ...+++..+.+++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999842 23588999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCc--ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChh
Q 004155 573 LDEEDNT--HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLM 650 (771)
Q Consensus 573 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (771)
....... .......|+..|+|||++.+..++.++|||||||++|||++|+.||......... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~ 219 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI---------------F 219 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH---------------H
Confidence 6532111 1112345889999999999888999999999999999999999999643221110 0
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 651 ELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 651 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+..........+......+.+++.+|++ +|.+||++.+++.
T Consensus 220 ~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 220 KIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111111122233344568899999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=326.27 Aligned_cols=269 Identities=17% Similarity=0.217 Sum_probs=190.6
Q ss_pred HhcCCCCCCccccCCceeEEEEEcCC--CcEEEEE------------------EcccCChhcHHHHHHHHHHHHcCCCCc
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMAD--GTVVAVK------------------QLSSKSKQGNREFVNEIGMISALQHPN 478 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~~--g~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~h~n 478 (771)
..++|++.++||+|+||+||++..+. +..+++| .+. ........+.+|+.++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999985422 2222222 111 11223456889999999999999
Q ss_pred EEeEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCc-cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE
Q 004155 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEA-HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL 557 (771)
Q Consensus 479 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 557 (771)
|+++++++...+..++|+|++. ++|.+++..... .........+..|+.||+.||+|||+. +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999985 577777743321 122344567788999999999999998 89999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCC-CCCCCccchhhH
Q 004155 558 DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSN-SSCKPKEDIFYL 636 (771)
Q Consensus 558 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p-~~~~~~~~~~~~ 636 (771)
+.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|..+ +..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999987655443333446799999999999999999999999999999999998864 433222221222
Q ss_pred HHHHHHHH-----hhC---ChhHHhhhhcCC----CCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 637 LDWALILK-----AQG---NLMELVDKRLGS----NFDK-----EQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 637 ~~~~~~~~-----~~~---~~~~~~d~~l~~----~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+...... ... .+.+.++..... .... .....+.+++.+|++.||++||++.|+++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11111100 000 011111110000 0000 01224677889999999999999999986
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=304.46 Aligned_cols=255 Identities=27% Similarity=0.389 Sum_probs=193.7
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+|...+.||+|+||.||++. ..+|+.||+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 44556789999999999994 4568999999987543 234567889999999996 99999999999999999999999
Q ss_pred ccCCCHHHHhcC-CCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 499 MENNSLARALFG-PEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 499 ~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
+.. ++.++... .......+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 65554311 1112356899999999999999999999753 7999999999999999999999999999765432
Q ss_pred CcccccccccCCCccchhhhccC---CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRG---YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
... ....|+..|+|||++.+. .++.++|||||||++|||++|+.||..... ..+....... + ..
T Consensus 162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~-----~~ 228 (288)
T cd06616 162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-G-----DP 228 (288)
T ss_pred Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-C-----CC
Confidence 221 234588899999998766 689999999999999999999999864321 1110000000 0 01
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+.+...........+.+++.+|++.+|++||++.+|+.
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111234456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=303.21 Aligned_cols=243 Identities=24% Similarity=0.398 Sum_probs=196.5
Q ss_pred CccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCHH
Q 004155 427 NKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLA 505 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 505 (771)
.+||+|+||.||++.. .+|+.||||++..........+.+|+.++++++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999954 578999999986555555677899999999999999999999999999999999999999999
Q ss_pred HHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccccccc
Q 004155 506 RALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV 585 (771)
Q Consensus 506 ~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 585 (771)
+++. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++........ .....
T Consensus 106 ~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 106 DIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 9883 23589999999999999999999998 899999999999999999999999999875543221 12234
Q ss_pred ccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHH
Q 004155 586 AGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQ 665 (771)
Q Consensus 586 ~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 665 (771)
.|+..|+|||++.+..++.++|||||||++|||++|+.||........... .. ......+.. ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~---~~---------~~~~~~~~~--~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---IR---------DNLPPKLKN--LHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH---------hhCCcccCC--cccC
Confidence 588999999999888889999999999999999999999875332211110 00 001111100 1122
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 666 VMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 666 ~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...+.+++.+||+.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 345778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=294.46 Aligned_cols=247 Identities=29% Similarity=0.427 Sum_probs=202.2
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+|++.+.||+|++|.||++.. .+++.||+|.+..... .....+.+|++++++++|+|++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 477889999999999999954 4678999999976543 4556899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998432 4789999999999999999999998 89999999999999999999999999998765433
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.. .....++..|+|||...+..++.++||||+|+++|+|++|+.||........ .+.. . .. ..
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----~~~~--~-~~---------~~ 216 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----LFRI--V-QD---------DH 216 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHH--h-cc---------CC
Confidence 32 2334688899999999888889999999999999999999999864331111 0000 0 00 00
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...+......+.+++.+|++.+|++||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1112223456789999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=301.34 Aligned_cols=257 Identities=23% Similarity=0.281 Sum_probs=192.9
Q ss_pred CCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeC--CEEEEEEE
Q 004155 423 FAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQ-HPNLVKLHGCCIEG--NQLLLIYE 497 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~E 497 (771)
|++.++||+|+||.||+|. ..+++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 5678899999999999995 4568999999987542 222334567889999885 99999999999987 88999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|++ |+|.+++... ...+++.++..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 5888887432 24689999999999999999999998 8999999999999999 99999999999865433
Q ss_pred CcccccccccCCCccchhhhc-cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC--ChhHHhh
Q 004155 578 NTHISTRVAGTFGYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG--NLMELVD 654 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d 654 (771)
... ....++..|+|||++. +..++.++|||||||++|||++|++||......+. ..+........ .+.....
T Consensus 153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhc
Confidence 221 2345788999999765 45678999999999999999999999976443221 11111110000 0000000
Q ss_pred hhcCC--CC-----------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 KRLGS--NF-----------DKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~~l~~--~~-----------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..-.. .+ .......+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000 00 0123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=306.89 Aligned_cols=262 Identities=25% Similarity=0.351 Sum_probs=196.1
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC--CEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEG--NQLLL 494 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 494 (771)
.++|++.+.||+|+||.||+|.. .+|+.||+|+++.... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46789999999999999999954 5689999999865422 2233567899999999999999999998754 56899
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+.+ +|.+++... ...+++.++..++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 888888432 24689999999999999999999998 8999999999999999999999999999866
Q ss_pred CCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh--CChhH
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ--GNLME 651 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 651 (771)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|++||......+...... ..... .....
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~---~~~~~~~~~~~~ 234 (309)
T cd07845 159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII---QLLGTPNESIWP 234 (309)
T ss_pred CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcCCCChhhch
Confidence 543221 122345788999999865 467899999999999999999999997544322211111 00000 00000
Q ss_pred Hhh-------hhcCC-CCC------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 652 LVD-------KRLGS-NFD------KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 652 ~~d-------~~l~~-~~~------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.++ ..+.. ... ......+.+++.+|++.||++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 00000 000 012345778999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=312.44 Aligned_cols=262 Identities=22% Similarity=0.285 Sum_probs=197.8
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC------
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEG------ 489 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 489 (771)
..++|+..+.||+|+||.||+|. ..+|+.||+|++... .......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 45789999999999999999995 457899999998643 223345677899999999999999999998643
Q ss_pred CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeec
Q 004155 490 NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 569 (771)
Q Consensus 490 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 569 (771)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999996 488888721 288999999999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHH---------HHH
Q 004155 570 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL---------DWA 640 (771)
Q Consensus 570 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~---------~~~ 640 (771)
+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||............ ++.
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9986543221 22345788999999999999999999999999999999999999754321111000 000
Q ss_pred HHH-------Hh-h-----CChhHHhhhhcCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 641 LIL-------KA-Q-----GNLMELVDKRLGS----NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 641 ~~~-------~~-~-----~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
... .. . ....+........ .........+.+++.+|++.||++||++.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 00 0 0000111110000 001123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=299.43 Aligned_cols=241 Identities=25% Similarity=0.318 Sum_probs=189.8
Q ss_pred cccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCH
Q 004155 429 IGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL 504 (771)
Q Consensus 429 lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 504 (771)
||+|+||+||++. ..+|+.||+|.+.... ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6999999999994 4568999999986532 22345677899999999999999999999999999999999999999
Q ss_pred HHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccccc
Q 004155 505 ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 584 (771)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 584 (771)
.+++..... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 999954332 4689999999999999999999998 89999999999999999999999999997654321 1223
Q ss_pred cccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHH
Q 004155 585 VAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKE 664 (771)
Q Consensus 585 ~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 664 (771)
..++..|+|||++.+..++.++|||||||++|+|++|+.||............. .. ... .....+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~----~~~--~~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK-------RR----TLE--MAVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH-------hc----ccc--ccccCCcc
Confidence 457889999999988889999999999999999999999997543311111000 00 000 00111122
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHH
Q 004155 665 QVMVMINVALLCTDVSSTSRPSMSS 689 (771)
Q Consensus 665 ~~~~l~~l~~~Cl~~dP~~RPs~~e 689 (771)
....+.+++.+||+.+|++||+..|
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCc
Confidence 3446789999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=300.40 Aligned_cols=258 Identities=18% Similarity=0.216 Sum_probs=185.4
Q ss_pred hcCCCCCCccccCCceeEEEEEcCC----CcEEEEEEcccCChhc-----------HHHHHHHHHHHHcCCCCcEEeEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMAD----GTVVAVKQLSSKSKQG-----------NREFVNEIGMISALQHPNLVKLHG 484 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~ 484 (771)
.++|.+.++||+|+||.||+|...+ +..+|+|+........ ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999996543 4567777643322111 011223344556678999999999
Q ss_pred EEEeCC----EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC
Q 004155 485 CCIEGN----QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD 560 (771)
Q Consensus 485 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 560 (771)
++.... ..++++|++.. ++.+.+.. ....++..+..|+.|++.||+|||+. +|+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 876543 45788887743 66666622 12357888999999999999999998 89999999999999999
Q ss_pred CCeEEEeecCccccCCCCcc------cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccch-
Q 004155 561 LNPKISDFGLAKLDEEDNTH------ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDI- 633 (771)
Q Consensus 561 ~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~- 633 (771)
+.++|+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999865432211 11224699999999999999999999999999999999999999976532221
Q ss_pred hhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 634 FYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
....... -+..+...... .......+.+++..|++.+|++||++.++++.|+
T Consensus 243 ~~~~~~~-------~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAAKCD-------FIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHhHHH-------HHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111000 00011111110 0112456889999999999999999999998763
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.46 Aligned_cols=245 Identities=21% Similarity=0.281 Sum_probs=190.1
Q ss_pred CccccCCceeEEEEEc-CCCcEEEEEEcccCCh---hcHHHHHHHHHHH-HcCCCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK---QGNREFVNEIGMI-SALQHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
+.||+|+||.||+|.. .+|+.||+|++..... .....+..|..++ ...+|+|++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999954 4689999999865422 2223445555544 445899999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999943 24689999999999999999999998 899999999999999999999999999875433
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 661 (771)
.....|+..|+|||.+.+..++.++||||||+++|||++|..||........... .. .... ......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------~~-~~~~------~~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN------IL-SRRI------NWPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH------HH-hccc------CCCCcc
Confidence 1234578899999999888889999999999999999999999975433221110 00 0000 000111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 662 DKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 662 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
.......+.+++.+||+.+|++||++.++.+.|..
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 11234568899999999999999988777665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=298.39 Aligned_cols=244 Identities=25% Similarity=0.370 Sum_probs=196.8
Q ss_pred cccCCceeEEEEEcC-CCcEEEEEEcccCCh---hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCH
Q 004155 429 IGEGGFGPVYKGHMA-DGTVVAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL 504 (771)
Q Consensus 429 lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 504 (771)
||+|+||.||++... +|+.||+|.+..... .....+.+|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999665 489999999875433 3456788999999999999999999999999999999999999999
Q ss_pred HHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc-----
Q 004155 505 ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT----- 579 (771)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~----- 579 (771)
.+++... ..+++..+..++.||+.||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999432 3689999999999999999999998 899999999999999999999999999875433211
Q ss_pred --ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 580 --HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 580 --~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
.......++..|+|||.......+.++||||||+++|||++|+.||......+... .. .....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~------~~---------~~~~~ 218 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ------NI---------LNGKI 218 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH---------hcCCc
Confidence 12233457889999999988889999999999999999999999997544322111 00 00000
Q ss_pred CCCCCHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 658 GSNFDKE--QVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 658 ~~~~~~~--~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
..+.. ....+.+++.+|++.+|++||++.++.+.|+.
T Consensus 219 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 219 --EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred --CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 01111 24568899999999999999999777776664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=294.98 Aligned_cols=250 Identities=21% Similarity=0.259 Sum_probs=192.9
Q ss_pred HHHHHHHhcCCCCCCcc--ccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEe
Q 004155 413 LRQIKAATNNFAPDNKI--GEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIE 488 (771)
Q Consensus 413 ~~~l~~~~~~f~~~~~l--G~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 488 (771)
..+.....++|++.+.+ |+|+||.||++. ..++..+|+|.+....... .|+.....+ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34455556778887877 999999999995 4568899999986532111 122222222 79999999999999
Q ss_pred CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC-CeEEEe
Q 004155 489 GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISD 567 (771)
Q Consensus 489 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~D 567 (771)
.+..++||||+++++|.+++... ..+++.++..++.|+++||.|||+. +++||||||+||+++.++ .++|+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence 99999999999999999999432 3789999999999999999999998 899999999999999998 999999
Q ss_pred ecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC
Q 004155 568 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG 647 (771)
Q Consensus 568 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 647 (771)
||+++...... ...|+..|+|||++.+..++.++|||||||++|||++|+.||.....+. .....+....
T Consensus 154 fg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~---- 223 (267)
T PHA03390 154 YGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ---- 223 (267)
T ss_pred CccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh----
Confidence 99997654322 2358899999999998889999999999999999999999997443322 1112211111
Q ss_pred ChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 004155 648 NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPS-MSSVVS 692 (771)
Q Consensus 648 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~ 692 (771)
... ..........+.+++.+|++.+|.+||+ ++|+++
T Consensus 224 ------~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 ------QKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ------ccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000 0111123446889999999999999996 588874
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=305.72 Aligned_cols=263 Identities=23% Similarity=0.316 Sum_probs=194.4
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC------
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGN------ 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 490 (771)
-++|+..++||+|+||.||+|.. .+++.||||.+.... ......+.+|+.++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35788999999999999999954 468999999886432 222345678999999999999999999987643
Q ss_pred --EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEee
Q 004155 491 --QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 568 (771)
Q Consensus 491 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 568 (771)
..++||||+.+ +|.+++... ...+++.+++.++.||+.||+|||++ +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 45999999965 888887432 23689999999999999999999998 8999999999999999999999999
Q ss_pred cCccccCCCCcc---cccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHH
Q 004155 569 GLAKLDEEDNTH---ISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 569 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
|++......... ......++..|+|||.+.+. .++.++||||||+++|||++|++||...................
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999865432211 11234578899999988764 47889999999999999999999997644322222111111000
Q ss_pred hhC------------------ChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 645 AQG------------------NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 645 ~~~------------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
... .....+...+... .....+.+++.+||+.||++||+++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 0000000000000 01234678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=300.92 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=200.9
Q ss_pred CCCCCCccccCCceeEEEEEc----CCCcEEEEEEcccCC----hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM----ADGTVVAVKQLSSKS----KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 492 (771)
+|++.+.||+|+||.||++.. .+++.||||+++... ......+.+|+.++.++ +||||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467789999999999999853 357899999986432 22345688999999999 599999999999999999
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999843 24688999999999999999999987 89999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCccchhhhccCC--CCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChh
Q 004155 573 LDEEDNTHISTRVAGTFGYMAPEYAMRGY--LTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLM 650 (771)
Q Consensus 573 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (771)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|..||......... .+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~-------- 223 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRR-------- 223 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHH--------
Confidence 65443332223346889999999987654 788999999999999999999998643221111 111110
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 651 ELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 651 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
+.... ...+......+.+++.+|++.+|++|||+.++.+.|+..
T Consensus 224 -~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 224 -ILKSK--PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -HHccC--CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 00000 111122234578899999999999999999998887763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=311.13 Aligned_cols=266 Identities=22% Similarity=0.303 Sum_probs=198.1
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeC--CEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK--SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEG--NQL 492 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 492 (771)
..++|++.+.||+|+||.||+|.. .+|+.||+|++... .......+.+|+.+++++ +||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 456788999999999999999965 46889999988542 223345677899999999 999999999998643 468
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 599998832 2688999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCc----ccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHH----
Q 004155 573 LDEEDNT----HISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALIL---- 643 (771)
Q Consensus 573 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~---- 643 (771)
....... .......||..|+|||++.+ ..++.++||||||+++|||++|+.||......+...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 6543322 12233568999999998764 56789999999999999999999999654332221111000000
Q ss_pred ----HhhCChhHHhhhhcCCC------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 644 ----KAQGNLMELVDKRLGSN------FDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 644 ----~~~~~~~~~~d~~l~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
........+++...... ........+.+++.+|++.+|++||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000011111000000 001124568899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=302.48 Aligned_cols=243 Identities=27% Similarity=0.343 Sum_probs=200.6
Q ss_pred cCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
+.|+.-++||+||||.||.+ ...+|+.+|.|++.+. .+.+..-.++|-.+|.+++.+.||.+-..|++.+.+|+|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 56888899999999999998 4457999999988654 3345667789999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
..|.||+|.-+|++... ..+++..++-++.+|+.||++||+. +||.||+||+|||+|+.|+++|+|.|+|..+.+
T Consensus 265 tlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999966543 6799999999999999999999998 899999999999999999999999999997766
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
.... ...+||.+|||||++.++.|+...|.||+||++|||+.|+.||......... +-+|.+
T Consensus 340 g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~----------------eEvdrr 401 (591)
T KOG0986|consen 340 GKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR----------------EEVDRR 401 (591)
T ss_pred CCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH----------------HHHHHH
Confidence 5443 3347999999999999999999999999999999999999999643221111 111222
Q ss_pred cC---CCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 004155 657 LG---SNFDKEQVMVMINVALLCTDVSSTSRPS 686 (771)
Q Consensus 657 l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 686 (771)
.. ..++..-.++...+....|+.||++|--
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 11 1233333445677888889999999863
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=312.30 Aligned_cols=269 Identities=22% Similarity=0.326 Sum_probs=200.0
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC-----CE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEG-----NQ 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 491 (771)
.++|.+.+.||+|+||.||+|. ..+|+.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4678999999999999999994 457899999998653 223345677899999999999999999988644 35
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 899999996 689888832 34689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHH--------H
Q 004155 572 KLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL--------I 642 (771)
Q Consensus 572 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~--------~ 642 (771)
+....... ......++..|+|||.+.. ..++.++|||||||++|+|++|++||................ .
T Consensus 156 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 156 RTTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 86544321 2233457889999998865 468999999999999999999999997543221111110000 0
Q ss_pred HHhhCChhHHhhhhcCC-C-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCC
Q 004155 643 LKAQGNLMELVDKRLGS-N-----FDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM--LEGR 697 (771)
Q Consensus 643 ~~~~~~~~~~~d~~l~~-~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~ 697 (771)
........+.+...... . ........+.+++.+|++.+|++||++.|+++- ++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000111111100000 0 001234567899999999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=301.40 Aligned_cols=260 Identities=23% Similarity=0.329 Sum_probs=199.3
Q ss_pred CCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 423 FAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
|+..+.||+|++|.||+|.. .+|+.+|+|++..... .....+.+|++++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999955 4789999999875432 24567889999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++ +|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 888888432 24789999999999999999999998 89999999999999999999999999998665443
Q ss_pred ccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh--hCChhHHhh--
Q 004155 580 HISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA--QGNLMELVD-- 654 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~d-- 654 (771)
.......++..|+|||.+.+. .++.++||||||+++|+|+||+.||......+...... ..... ........+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF--RTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HHcCCCchHhcccchhhh
Confidence 112234578899999998876 78999999999999999999999996544322211110 00000 000000000
Q ss_pred ----hhcC-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 ----KRLG-------SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ----~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.... ..........+.+++.+||+.||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0011123457889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=310.84 Aligned_cols=267 Identities=20% Similarity=0.317 Sum_probs=197.3
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC------C
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEG------N 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 490 (771)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 37899999999999999999964 578999999986532 22345688999999999999999999998754 3
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 56999999964 787766 13589999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHH-------
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALI------- 642 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~------- 642 (771)
++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.................
T Consensus 164 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 164 ARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98543321 23457889999999876 4689999999999999999999999975432221111000000
Q ss_pred -HHhhCChhHHhhh--hc-CCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCCCCC
Q 004155 643 -LKAQGNLMELVDK--RL-GSNFD---KEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGRADV 700 (771)
Q Consensus 643 -~~~~~~~~~~~d~--~l-~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~ 700 (771)
............. .. ..... ......+.+++.+||+.||++||++.|++. .++...+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 0000000000000 00 00000 012245789999999999999999999985 36665443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=312.03 Aligned_cols=265 Identities=19% Similarity=0.297 Sum_probs=198.8
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe----CCEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIE----GNQL 492 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 492 (771)
.++|++.+.||+|+||.||+|. ..+|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 4789999999999999999995 4568999999987542 2335667889999999999999999998763 3578
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
++||||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 589998843 34589999999999999999999998 89999999999999999999999999997
Q ss_pred ccCCCCcc---cccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHH-------
Q 004155 573 LDEEDNTH---ISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL------- 641 (771)
Q Consensus 573 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~------- 641 (771)
........ ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 65432221 1123468899999999865 468999999999999999999999997543322111100000
Q ss_pred -HHHhhCChhHHhhhhc-CCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 642 -ILKAQGNLMELVDKRL-GSNFD-----KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 642 -~~~~~~~~~~~~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.......+.+.++..- ..... ......+.+++.+|++.+|++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000011111111100 00111 123456899999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.27 Aligned_cols=263 Identities=22% Similarity=0.347 Sum_probs=194.9
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
++|+..+.||+|++|.||+|.. .+|+.||+|.+..... .....+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 5788899999999999999955 4689999999865322 234578899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC-CCCeEEEeecCccccCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAKLDEE 576 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~ 576 (771)
|++ ++|.+++.... ...+++..+..++.||+.||+|||+. +++||||+|+||+++. ++.+||+|||+++....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 58888874322 23467888899999999999999998 8999999999999985 56799999999976543
Q ss_pred CCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh-C-------
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ-G------- 647 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~------- 647 (771)
... ......+++.|+|||++.+ ..++.++|||||||++|+|+||++||......+..... ....... .
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI--FRILGTPNEETWPGVT 232 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhCCCChhhccccc
Confidence 221 1223457889999998876 45789999999999999999999999754332211100 0000000 0
Q ss_pred ChhHHhh--hhcCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 648 NLMELVD--KRLGSN----FDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 648 ~~~~~~d--~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+..... +..... ........+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 000000 00112345788999999999999999999986
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.15 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=195.5
Q ss_pred CCCCCCccccCCceeEEEEEc----CCCcEEEEEEcccCC----hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM----ADGTVVAVKQLSSKS----KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 492 (771)
+|++.+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999964 468999999987532 12346788899999999 599999999999999999
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999943 34688999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCccchhhhccC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChh
Q 004155 573 LDEEDNTHISTRVAGTFGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLM 650 (771)
Q Consensus 573 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (771)
..............|+..|+|||.+... .++.++||||||+++|+|++|+.||......... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~----- 226 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILK----- 226 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHHHhhc-----
Confidence 6544332222345688999999998753 4688999999999999999999998643221111 111110000
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 651 ELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 651 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
. ...++......+.+++.+|++.+|++|| ++.+++.
T Consensus 227 ----~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 227 ----S--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----c--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 0112222344678999999999999998 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=304.78 Aligned_cols=259 Identities=24% Similarity=0.317 Sum_probs=191.6
Q ss_pred CccccC--CceeEEEEEc-CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEG--GFGPVYKGHM-ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G--~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
..||+| +||+||++.. .+|+.||+|++.... ....+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 9999999954 579999999987532 23346788999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999985432 23589999999999999999999988 89999999999999999999999998654322111110
Q ss_pred ------ccccccCCCccchhhhccC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHH-----------
Q 004155 582 ------STRVAGTFGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALI----------- 642 (771)
Q Consensus 582 ------~~~~~gt~~y~aPE~~~~~--~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~----------- 642 (771)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||......... ......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCcccccc
Confidence 0112356679999999764 5789999999999999999999999754321110 000000
Q ss_pred -----HHhh----------------CChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 643 -----LKAQ----------------GNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 643 -----~~~~----------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.... .......+..+...........+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000 0000001111111112334567899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.71 Aligned_cols=243 Identities=26% Similarity=0.411 Sum_probs=191.4
Q ss_pred CCCccccCCceeEEEE-EcCCCcEEEEEEccc----CChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE--EEEEEE
Q 004155 425 PDNKIGEGGFGPVYKG-HMADGTVVAVKQLSS----KSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQ--LLLIYE 497 (771)
Q Consensus 425 ~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV~E 497 (771)
...+||+|+|-+||+| +..+|..||--.++. .+....++|..|+.+|+.|+||||++++.++.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3568999999999999 445677787433322 134445889999999999999999999999986654 788999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc-CCCCeEEEeecCccccCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFGla~~~~~ 576 (771)
.|..|+|..|+. ....++...+..|++||++||.|||++ .|+|||||||.+||||+ ..|.+||+|.|+|.....
T Consensus 124 L~TSGtLr~Y~k----k~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRK----KHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHH----HhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 999999999993 345688899999999999999999998 46999999999999997 458999999999987654
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCC-CCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSC-KPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
... ..+.|||.|||||... ..|.+..||||||+.++||+|+..||.. ..+..++. .+ ..|.-...+.+
T Consensus 199 s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYK---KV----~SGiKP~sl~k 267 (632)
T KOG0584|consen 199 SHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYK---KV----TSGIKPAALSK 267 (632)
T ss_pred ccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHH---HH----HcCCCHHHhhc
Confidence 332 3478999999999876 7889999999999999999999999964 22222211 11 11111111111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
-.-.++.+++.+|+.. ..+|||+.|++.
T Consensus 268 --------V~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 --------VKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred --------cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1122478899999999 999999999987
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.19 Aligned_cols=271 Identities=25% Similarity=0.367 Sum_probs=206.5
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC------CEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEG------NQLL 493 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 493 (771)
.|...+.||+|+||.||+|+ ...|+.||||.++... ....+...+|+++|++++|+|||++++.-++. +...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 34556789999999999996 7789999999998753 34466788999999999999999999886543 4678
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc--CCC--CeEEEeec
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD--KDL--NPKISDFG 569 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DFG 569 (771)
+|||||.+|||...|..... ..++++.+.+.++.+++.||.|||++ +|+||||||.||++- .+| .-||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 99999999999999977654 46899999999999999999999988 999999999999993 333 57999999
Q ss_pred CccccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 570 LAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 570 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
.|+-.+++. ....++||..|.+||.+.+ +.++..+|.|||||++||.+||..||...........+.|......+..
T Consensus 170 ~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 170 AARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred ccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 999876654 4456789999999999984 8999999999999999999999999976433322222333332222221
Q ss_pred hhHHhhhhcC------------CCCCHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHhcCCC
Q 004155 649 LMELVDKRLG------------SNFDKEQVMVMINVALLCTDVSSTSRP--SMSSVVSMLEGRA 698 (771)
Q Consensus 649 ~~~~~d~~l~------------~~~~~~~~~~l~~l~~~Cl~~dP~~RP--s~~evl~~L~~~~ 698 (771)
+.-..++... ..........+-+.+..++..+|++|- ...+....+..+.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 1111111111 112233445677777888888999998 5555555554443
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=302.36 Aligned_cols=274 Identities=22% Similarity=0.343 Sum_probs=202.2
Q ss_pred HHHHhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC--
Q 004155 416 IKAATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGN-- 490 (771)
Q Consensus 416 l~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 490 (771)
+....++|++.+.||+|+||.||+|. ..+|+.||||++... .......+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 34457789999999999999999994 567899999998643 2223456889999999999999999999987543
Q ss_pred ----EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEE
Q 004155 491 ----QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 566 (771)
Q Consensus 491 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 566 (771)
..++||||+ +++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 469999999 679998883 24689999999999999999999998 89999999999999999999999
Q ss_pred eecCccccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhh-HH-------
Q 004155 567 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY-LL------- 637 (771)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~-~~------- 637 (771)
|||+++...... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......... ..
T Consensus 161 dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 161 DFGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred ecccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999998654321 23457889999999876 468899999999999999999999997543211110 00
Q ss_pred -HHHHHHHhhCChhHHhhhh--cCC-C---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCCCCCCCC
Q 004155 638 -DWALILKAQGNLMELVDKR--LGS-N---FDKEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGRADVQDF 703 (771)
Q Consensus 638 -~~~~~~~~~~~~~~~~d~~--l~~-~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~~~~ 703 (771)
.+..... .......+... ... . ........+.+++.+|++.||++||++.+++. .++........
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~ 310 (343)
T cd07880 237 KEFVQKLQ-SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDE 310 (343)
T ss_pred HHHHHhhc-chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccc
Confidence 0000000 00000000000 000 0 00112235789999999999999999999984 45555444333
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=300.85 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=193.2
Q ss_pred cCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 497 (771)
++|++.+.||+|+||.||+|... +++.||||+++... .....++..|+.++.+.. |+||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 56788899999999999999765 48999999987543 233456777887777775 9999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+.+ ++.+++... ...+++..+..++.|++.||+|||+.. +|+||||+|+||++++++.+||+|||++......
T Consensus 95 ~~~~-~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMST-CLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccCc-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9854 777776332 237899999999999999999999742 8999999999999999999999999999765433
Q ss_pred CcccccccccCCCccchhhhccCC----CCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGY----LTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
... ....++..|+|||++.+.. ++.++||||||+++|||++|+.||...... ..... .++
T Consensus 169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~------------~~~ 232 (296)
T cd06618 169 KAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLT------------KIL 232 (296)
T ss_pred Ccc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHH------------HHh
Confidence 222 2335788999999987543 788999999999999999999999642211 11110 111
Q ss_pred hhhcCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 654 DKRLGS-NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 654 d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
+..... .........+.+++.+|++.||++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 233 QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred cCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111000 0011234468899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=295.17 Aligned_cols=241 Identities=25% Similarity=0.296 Sum_probs=185.9
Q ss_pred ccccCCceeEEEEEc-CCCcEEEEEEcccCCh---hcHHHHHHHHH---HHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 428 KIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK---QGNREFVNEIG---MISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 428 ~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
.||+|+||.||+|.. .+++.||+|.+..... .....+..|.. .++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999954 5689999999865321 12223444443 3444579999999999999999999999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 9999998832 34699999999999999999999998 899999999999999999999999999975533221
Q ss_pred cccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 581 ISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
....|+..|+|||.+.++ .++.++||||+||++|||++|+.||............. . .......
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~---------~~~~~~~--- 217 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-M---------TLTMAVE--- 217 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-H---------hhccCCC---
Confidence 234689999999998754 68999999999999999999999997543222111000 0 0000111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
.+......+.+++.+|+..+|.+|| ++.++++
T Consensus 218 -~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 -LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1112245688899999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.68 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=201.3
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 495 (771)
++|...+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4788899999999999999954 47899999998653 2233567889999999998 99999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++++|.+++.. ...+++..+..|+.|++.||+|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999943 23799999999999999999999998 89999999999999999999999999998654
Q ss_pred CCCc-------------------ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhH
Q 004155 576 EDNT-------------------HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYL 636 (771)
Q Consensus 576 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~ 636 (771)
.... .......++..|+|||......++.++||||||++++++++|+.||........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--- 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--- 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---
Confidence 4321 112234578899999999888899999999999999999999999975432111
Q ss_pred HHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 004155 637 LDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSM----SSVVS 692 (771)
Q Consensus 637 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~ 692 (771)
.. ...+ .....+......+.+++.+|++.+|++||++ .++++
T Consensus 231 ~~------------~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQ------------KILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH------------HHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00 0111 1112222334568899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=300.07 Aligned_cols=245 Identities=27% Similarity=0.424 Sum_probs=193.7
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.|...+.||+|+||.||+|.. .++..||+|.+... ......++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 466678899999999999954 46889999998642 22334568889999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+. |++.+++... ...+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 5888877432 24589999999999999999999998 8999999999999999999999999998765432
Q ss_pred CcccccccccCCCccchhhhc---cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 578 NTHISTRVAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
....|+..|+|||.+. ...++.++|||||||++|||++|+.||.......... . +..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~-------------~~~ 228 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--H-------------IAQ 228 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--H-------------Hhh
Confidence 2345788999999975 3567889999999999999999999986432211110 0 000
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
..............+.+++.+||+.+|++||++.+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 000000111234557899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=298.03 Aligned_cols=243 Identities=28% Similarity=0.428 Sum_probs=192.1
Q ss_pred CCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh---hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 423 FAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
|...++||+|+||.||+|.. .+|+.||+|++..... .....+.+|++++++++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55677899999999999954 5689999999865322 2345688899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+. |++.+++... ...+++.++..++.||+.||.|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~- 174 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA- 174 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence 96 5788777432 34689999999999999999999998 8999999999999999999999999998643221
Q ss_pred cccccccccCCCccchhhhc---cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 579 THISTRVAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
....|+..|+|||++. ...++.++|||||||++|||++|++||......... .+ .... .
T Consensus 175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~~---~~~~-~------- 236 (313)
T cd06633 175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YH---IAQN-D------- 236 (313)
T ss_pred ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HH---HHhc-C-------
Confidence 2346888999999984 456889999999999999999999998654321111 10 0000 0
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
............+.+++.+|++.+|.+||++.+++.
T Consensus 237 -~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 237 -SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000111122345788999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=308.55 Aligned_cols=269 Identities=22% Similarity=0.277 Sum_probs=204.0
Q ss_pred CCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC-----EEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGN-----QLL 493 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 493 (771)
+|.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999654 58999999987643 344567899999999999999999999988765 789
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+||||++ ++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 489998843 23799999999999999999999998 899999999999999999999999999986
Q ss_pred cCCCCc--ccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHH-------
Q 004155 574 DEEDNT--HISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALIL------- 643 (771)
Q Consensus 574 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~------- 643 (771)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|++||......+....+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 654331 112334578899999999887 8999999999999999999999999765433221111000000
Q ss_pred -HhhCChhHHhhhhc-CCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCCC
Q 004155 644 -KAQGNLMELVDKRL-GSNF-----DKEQVMVMINVALLCTDVSSTSRPSMSSVVSM--LEGRA 698 (771)
Q Consensus 644 -~~~~~~~~~~d~~l-~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 698 (771)
.......+.+...- .... .......+.+++.+||+.+|++||++.+++.. +++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00000111111000 0000 01123567899999999999999999999973 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.48 Aligned_cols=270 Identities=23% Similarity=0.317 Sum_probs=201.4
Q ss_pred CCHHHHHHHhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEE
Q 004155 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCI 487 (771)
Q Consensus 411 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 487 (771)
...+++..++++|.+.+.||+|+||.||+|. ..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 3556778889999999999999999999995 4678999999987532 233466888999999999999999999886
Q ss_pred eC------CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC
Q 004155 488 EG------NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 561 (771)
Q Consensus 488 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 561 (771)
.. ...+++++++ +++|.+++. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 43 3468888877 779998883 23589999999999999999999998 899999999999999999
Q ss_pred CeEEEeecCccccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHH-HH
Q 004155 562 NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL-DW 639 (771)
Q Consensus 562 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~-~~ 639 (771)
.+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............ ..
T Consensus 158 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 158 ELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred CEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999999999854332 123467889999998866 56889999999999999999999999654322211110 00
Q ss_pred H-------HHHHhhCChhHH---hhhhcCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 640 A-------LILKAQGNLMEL---VDKRLGSNFD---KEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 640 ~-------~~~~~~~~~~~~---~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
. ............ ++......+. ......+.+++.+|++.||.+||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 000000000000 0000000000 0123457899999999999999999998863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=303.87 Aligned_cols=262 Identities=21% Similarity=0.299 Sum_probs=194.5
Q ss_pred hcCCCC-CCccccCCceeEEEEE-cCCCcEEEEEEcccCChhc--------------HHHHHHHHHHHHcCCCCcEEeEE
Q 004155 420 TNNFAP-DNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQG--------------NREFVNEIGMISALQHPNLVKLH 483 (771)
Q Consensus 420 ~~~f~~-~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~ 483 (771)
.++|.. .+.||+|+||.||+|. ..+++.||||+++...... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 345654 4679999999999995 4468999999986532211 12577899999999999999999
Q ss_pred EEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCe
Q 004155 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 563 (771)
Q Consensus 484 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 563 (771)
+++...+..++||||+. |+|.+++. ....+++.....++.|++.||+|||+. +++||||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCE
Confidence 99999999999999997 58999883 234689999999999999999999998 89999999999999999999
Q ss_pred EEEeecCccccCCCC-------------cccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCC
Q 004155 564 KISDFGLAKLDEEDN-------------THISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKP 629 (771)
Q Consensus 564 kl~DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~ 629 (771)
+|+|||+++...... ........++..|+|||.+.+. .++.++|||||||++|||++|++||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999997654111 1111223467899999998764 47899999999999999999999997654
Q ss_pred ccchhhHHHHHHHHHhhCC---hhHHhh--------hhcCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 630 KEDIFYLLDWALILKAQGN---LMELVD--------KRLGSN---FDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~---~~~~~d--------~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+.. ........... +....+ ...... ........+.+++.+|++.+|++||++.|++.
T Consensus 239 ~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 EIDQL---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHH---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 32211 11111100000 000000 000000 00112345789999999999999999999986
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=301.51 Aligned_cols=265 Identities=23% Similarity=0.338 Sum_probs=199.5
Q ss_pred HHHHHhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe-CC
Q 004155 415 QIKAATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIE-GN 490 (771)
Q Consensus 415 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 490 (771)
++..++++|++.+.||+|+||.||+|. ..+|+.||+|++... .....+.+..|++++++++||||+++.+++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 344578899999999999999999995 557899999987542 22335678889999999999999999999875 56
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..++|+||+ +++|.+++. ...+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccc
Confidence 789999998 568998883 23578888999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHH-HH--------H
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL-DW--------A 640 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~-~~--------~ 640 (771)
++...... ....++..|+|||++.+ ..++.++|||||||++|||++|++||............ ++ .
T Consensus 155 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 155 ARIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred ccccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 97543221 22357889999998765 57899999999999999999999999654322111110 00 0
Q ss_pred HHHHhhCChhHHhhhh-cCCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 641 LILKAQGNLMELVDKR-LGSNFDK-----EQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 641 ~~~~~~~~~~~~~d~~-l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
.... .+...+.+... .....+. .....+.+++.+|++.+|++||++.+++..
T Consensus 231 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 231 NTIC-SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred Hhcc-chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00011111110 0011111 123568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.06 Aligned_cols=250 Identities=23% Similarity=0.344 Sum_probs=195.9
Q ss_pred CCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccC-----ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSK-----SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
+|.+.+.||+|+||.||++... .+..+++|+++.. .......+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5788899999999999999543 3455666665432 222344677899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||+++. +.++|+|||.++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999865433446799999999999999999999998 8999999999999975 569999999998664
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.... ......|+..|+|||...+..++.++||||||+++|+|++|+.||...... ... .. ....
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~---~~---------~~~~ 220 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---SVV---LR---------IVEG 220 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHH---HH---------HHcC
Confidence 3322 222345788999999998888899999999999999999999998643211 111 00 0010
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.....+......+.+++.+|++.+|++||++.|+++
T Consensus 221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 -PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111223344557889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=295.85 Aligned_cols=262 Identities=24% Similarity=0.347 Sum_probs=196.4
Q ss_pred CCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEEEEEEec
Q 004155 423 FAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSK-QGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
|++.+.||+|+||.||+|... +++.||||++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999764 578999999865422 22334567999999999 999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
+|+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.++.......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 789999885433 24689999999999999999999998 899999999999999999999999999986544322
Q ss_pred ccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHH-H---------HHHHHHhhCC
Q 004155 580 HISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL-D---------WALILKAQGN 648 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~-~---------~~~~~~~~~~ 648 (771)
.....++..|+|||++.+ ..++.++||||||+++|||++|++||......+..... . |.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 123457889999998754 46789999999999999999999999654332221100 0 1000000000
Q ss_pred hhHHhhhhcCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 649 LMELVDKRLGS---NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 649 ~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
....+...... .........+.+++.+|++.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000000 000011356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=296.48 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=194.3
Q ss_pred CCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCCh--hcHHHHHHHHHHHHcC---CCCcEEeEEEEEEeCCE-----
Q 004155 423 FAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSK--QGNREFVNEIGMISAL---QHPNLVKLHGCCIEGNQ----- 491 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 491 (771)
|++.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999765 489999999874322 2234566788777665 59999999999988776
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.+++|||+.+ +|.+++.... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 9999999975 8998884432 23689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCCh--
Q 004155 572 KLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL-- 649 (771)
Q Consensus 572 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 649 (771)
......... ....++..|+|||++.+..++.++|||||||++|||++|++||......+.. .............
T Consensus 155 ~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 230 (287)
T cd07838 155 RIYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKIFDVIGLPSEEEW 230 (287)
T ss_pred eeccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHHHHHcCCCChHhc
Confidence 866433221 2234788999999999999999999999999999999999998754332211 1111100000000
Q ss_pred -------hHHhhhhcCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 650 -------MELVDKRLGSN---FDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 650 -------~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
........... ........+.+++.+||+.||++||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000000 01123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=299.99 Aligned_cols=260 Identities=21% Similarity=0.245 Sum_probs=192.7
Q ss_pred CCCccccCCceeEEEEEcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCC
Q 004155 425 PDNKIGEGGFGPVYKGHMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENN 502 (771)
Q Consensus 425 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 502 (771)
+.+.+|.|+++.||++.. +|+.||||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344556666666666655 7899999998754 3445678999999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc---
Q 004155 503 SLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT--- 579 (771)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~--- 579 (771)
+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999995432 24588999999999999999999998 899999999999999999999999999875432211
Q ss_pred ---ccccccccCCCccchhhhcc--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHH----h-----
Q 004155 580 ---HISTRVAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK----A----- 645 (771)
Q Consensus 580 ---~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~----~----- 645 (771)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||........ ..+...... .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchh
Confidence 11123457788999999876 3588999999999999999999999975432211 111100000 0
Q ss_pred --hCChhH----Hhhhh----cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 646 --QGNLME----LVDKR----LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 646 --~~~~~~----~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...... ..+.. ............+.+++.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000000 00000 000111223356888999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=278.73 Aligned_cols=245 Identities=25% Similarity=0.395 Sum_probs=194.1
Q ss_pred CCCCccccCCceeEEEEE-cCCCcEEEEEEcccC-ChhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 424 APDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK-SKQGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 424 ~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
+....||.|..|.||++. ...|...|||.+.+. .++..++++..++++.+-+ +|+||+.+|||..+...++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 445789999999999994 456899999999765 4555677888888887765 8999999999999999999999985
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
. .++.++.. -..++++.-+-++...+..||.||.+++ +|+|||+||+|||+|+.|++|++|||++-++-+...+
T Consensus 175 ~-C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 175 T-CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred H-HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 4 45555522 2346888888899999999999999886 9999999999999999999999999999776554333
Q ss_pred cccccccCCCccchhhhc---cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh---
Q 004155 581 ISTRVAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD--- 654 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--- 654 (771)
++.+|-+.|||||.+. ...|+-++||||||+.++||.||+.||..-..+- .. +..+++
T Consensus 249 --trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~------------ltkvln~eP 312 (391)
T KOG0983|consen 249 --TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EV------------LTKVLNEEP 312 (391)
T ss_pred --ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HH------------HHHHHhcCC
Confidence 5567999999999986 3478889999999999999999999997633221 11 111222
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+.+... ......+.+++..||+.|+.+||...++++
T Consensus 313 P~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 313 PLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 122111 113446889999999999999999999886
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=302.02 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=194.5
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC---------
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEG--------- 489 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 489 (771)
..+|...+.||+|+||.||+|. ..+|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 3678899999999999999994 456899999998766555667789999999999999999999776543
Q ss_pred -----CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc-CCCCe
Q 004155 490 -----NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNP 563 (771)
Q Consensus 490 -----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~ 563 (771)
...++||||++ ++|.+++. ...+++..+..++.||+.||.|||+. +++||||||+||+++ .++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 35799999997 58988883 23689999999999999999999998 899999999999997 45678
Q ss_pred EEEeecCccccCCCCcc--cccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHH
Q 004155 564 KISDFGLAKLDEEDNTH--ISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWA 640 (771)
Q Consensus 564 kl~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~ 640 (771)
||+|||.++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999765432211 1122357889999998754 56888999999999999999999999754332211110000
Q ss_pred HHHH---hhCC----hhHHhh-hhcCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 641 LILK---AQGN----LMELVD-KRLGSNFD-----KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 641 ~~~~---~~~~----~~~~~d-~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.... .... ...... .......+ ......+.+++.+|++.||++||++.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000 0000 000000 00000000 012245789999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=335.79 Aligned_cols=252 Identities=30% Similarity=0.431 Sum_probs=201.9
Q ss_pred HHhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
..+-+|....+||.|.||.||.| ...+|...|+|-++... ........+|+.++..++|||+|+++|+-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 34557888899999999999999 56779999999886532 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
.||||++|+|.+.+ ......++.....+..|++.|++|||++ |||||||||.||+|+.+|.+|++|||.|...
T Consensus 1312 FMEyC~~GsLa~ll----~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLL----EHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHhccCcHHHHH----HhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence 99999999999999 3334566777778899999999999999 8999999999999999999999999999877
Q ss_pred CCCCcc---cccccccCCCccchhhhccC---CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHH-hhC
Q 004155 575 EEDNTH---ISTRVAGTFGYMAPEYAMRG---YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK-AQG 647 (771)
Q Consensus 575 ~~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~~ 647 (771)
...... .....+||+.|||||++.+. ....++||||+|||+.||+||++||...+.+ |+.... ..+
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~g 1457 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAAG 1457 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhcc
Confidence 554211 12346899999999999753 4567899999999999999999999754322 222111 111
Q ss_pred ChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 648 NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 648 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. ...++.....+-.+++.+|++.||++|-++.|+++
T Consensus 1458 h---------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1458 H---------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred C---------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1 12333344455678999999999999988887765
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=285.62 Aligned_cols=240 Identities=26% Similarity=0.324 Sum_probs=196.7
Q ss_pred cCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|...++||+|.||.|-++ ....|+.+|+|++++.. +.....-..|-.+|+..+||.+..+...|...+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 56788899999999999999 55679999999998763 333445567899999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+.||.|.-+|. ....+++....-+-..|..||.|||++ +||.||||.+|.++|++|++||+|||+++.--.
T Consensus 248 eyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 248 EYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999998883 345788888889999999999999998 899999999999999999999999999984333
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
.. ......+||+.|+|||++....|..+.|.|.+||++|||++|+.||.....+..+.++- -..
T Consensus 321 ~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl---------------~ed 384 (516)
T KOG0690|consen 321 YG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL---------------MED 384 (516)
T ss_pred cc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH---------------hhh
Confidence 22 23456889999999999999999999999999999999999999998655443332221 011
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRP 685 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 685 (771)
-.++.....+...++...+..||.+|-
T Consensus 385 --~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 385 --LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 122222233455677788889999997
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=299.67 Aligned_cols=266 Identities=26% Similarity=0.351 Sum_probs=194.1
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC-------
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEG------- 489 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 489 (771)
.++|++.++||+|+||.||+|. ..+++.||+|++..... .....+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 5789999999999999999995 45689999999865322 2234677899999999999999999987543
Q ss_pred -CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEee
Q 004155 490 -NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 568 (771)
Q Consensus 490 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 568 (771)
...++||||+.+ +|...+... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 357999999975 777777432 34699999999999999999999998 8999999999999999999999999
Q ss_pred cCccccCCCCcc----------cccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHH
Q 004155 569 GLAKLDEEDNTH----------ISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL 637 (771)
Q Consensus 569 Gla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~ 637 (771)
|+++........ ..+...++..|+|||.+.+. .++.++|||||||++|||++|++||............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999765432211 11234578889999987654 5889999999999999999999999754432221111
Q ss_pred HHHHHHHhhC------ChhHHhhhhcCCCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 638 DWALILKAQG------NLMELVDKRLGSNFD-------KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 638 ~~~~~~~~~~------~~~~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.......... .+....+.......+ ......+.+++.+|++.||++|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1000000000 000000000000000 011246789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=292.16 Aligned_cols=259 Identities=25% Similarity=0.340 Sum_probs=197.7
Q ss_pred CCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 423 FAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
|+..+.||+|+||.||+|... +++.||+|++.... ......+..|+.++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999554 58999999987653 333467788999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
+ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||.++.......
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 59999994322 4689999999999999999999998 899999999999999999999999999986644332
Q ss_pred ccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh---CChhHH---
Q 004155 580 HISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ---GNLMEL--- 652 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--- 652 (771)
. .....++..|+|||.+.+. .++.++|||||||++|||++|++||......+.. ......... ......
T Consensus 154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL---FKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH---HHHHHHhCCCcHHHHHhhccc
Confidence 1 1223457789999998776 8899999999999999999999999654322211 111000000 000000
Q ss_pred --hhhhcC---CC-C---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 653 --VDKRLG---SN-F---DKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 653 --~d~~l~---~~-~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+.... .. . .......+.+++.+|++.+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000 00 0 0012356899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=299.45 Aligned_cols=262 Identities=23% Similarity=0.278 Sum_probs=191.5
Q ss_pred CCCCCCccccCCceeEEEEEcC-C--CcEEEEEEcccC--ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeC----CE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMA-D--GTVVAVKQLSSK--SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEG----NQ 491 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~-~--g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 491 (771)
+|++.+.||+|+||.||++... . +..||+|++... .....+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999643 3 779999998643 222345778899999999 599999999976432 45
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.++++||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999886 689998832 34689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcc---cccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHH--------
Q 004155 572 KLDEEDNTH---ISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDW-------- 639 (771)
Q Consensus 572 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~-------- 639 (771)
+........ ......||..|+|||++.+ ..++.++|||||||++|+|++|++||..............
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432211 1223468999999998765 4689999999999999999999999975432211110000
Q ss_pred -HHHHHhhCChhHHhhh---hcCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 640 -ALILKAQGNLMELVDK---RLGSNF---DKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 640 -~~~~~~~~~~~~~~d~---~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...... ......... .....+ .......+.+++.+|++.||++||++.|++.
T Consensus 233 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGS-PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhh-hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000 000000000 000000 0012346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=300.83 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=203.6
Q ss_pred HhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
....|.+...||+|.|+.|..| +..+|..||||.+.+..- ...+.+.+|++++..++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467889999999999999999 555799999999987532 2335588999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+.+|.+.+++.. ...+....+..++.|+.+|++|||++ .|+|||||++||||+.++++||+|||++.++.
T Consensus 134 ~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999943 34566688899999999999999999 89999999999999999999999999999886
Q ss_pred CCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
... .....+|++.|.|||++.+. ..++++|+||+|+++|-|+.|..||+...-.+ +-+
T Consensus 207 ~~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~ 265 (596)
T KOG0586|consen 207 YGL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRP 265 (596)
T ss_pred ccc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccc
Confidence 433 33457899999999999876 46789999999999999999999998543221 111
Q ss_pred hhcCCCC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 KRLGSNF--DKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+.+.+.+ +.-...++.+++++++-.+|.+|++++++.+
T Consensus 266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 2222221 1112235778899999999999999999876
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=305.94 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=197.1
Q ss_pred HHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE---
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQ--- 491 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 491 (771)
...++|.+.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++|+|++++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3567899999999999999999955 46889999998653 22334567889999999999999999998766554
Q ss_pred ---EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEee
Q 004155 492 ---LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 568 (771)
Q Consensus 492 ---~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 568 (771)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 5699999832 4689999999999999999999998 8999999999999999999999999
Q ss_pred cCccccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh--
Q 004155 569 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA-- 645 (771)
Q Consensus 569 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~-- 645 (771)
|++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+... .......
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~---~i~~~~~~~ 235 (343)
T cd07851 163 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLK---RIMNLVGTP 235 (343)
T ss_pred ccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHhcCCC
Confidence 999865432 123457889999999865 467899999999999999999999997543322111 0000000
Q ss_pred ---------hCChhHHhhhhcC---CCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 646 ---------QGNLMELVDKRLG---SNFD---KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 646 ---------~~~~~~~~d~~l~---~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.......+..... ..+. ......+.+++.+|++.+|++|||+.||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000001110000 0000 012456889999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=323.17 Aligned_cols=257 Identities=23% Similarity=0.285 Sum_probs=208.2
Q ss_pred HHHHHHHhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe
Q 004155 413 LRQIKAATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIE 488 (771)
Q Consensus 413 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 488 (771)
.++++...++|.+.++||+|+||.|..++ ..+++.||+|++.+. ......-|..|-++|..-+.+=|+.++..|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 45666667899999999999999999994 456899999999873 23445678899999999899999999999999
Q ss_pred CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEee
Q 004155 489 GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 568 (771)
Q Consensus 489 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 568 (771)
++++|+|||||+||+|-.++.. ..++++..+.-++..|.-||.-||+. |+|||||||+|||+|..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 9999999999999999999922 22689999999999999999999998 8999999999999999999999999
Q ss_pred cCccccCCCCcccccccccCCCccchhhhc----c-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHH
Q 004155 569 GLAKLDEEDNTHISTRVAGTFGYMAPEYAM----R-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALIL 643 (771)
Q Consensus 569 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 643 (771)
|.+-.+..++.-.+...+|||.|++||++. + +.|++.+|.||+||++|||+.|..||.....-+.+
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY--------- 290 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY--------- 290 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH---------
Confidence 999888877777777788999999999985 3 67999999999999999999999999754322221
Q ss_pred HhhCChhHHhhhhcCCCCC--HHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 004155 644 KAQGNLMELVDKRLGSNFD--KEQVMVMINVALLCTDVSSTSRPS---MSSVVS 692 (771)
Q Consensus 644 ~~~~~~~~~~d~~l~~~~~--~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~ 692 (771)
.++++..-.-.++ .+......+|+.+.+. +|+.|-. +.++-.
T Consensus 291 ------~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 291 ------GKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred ------HHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 1122221111222 2234456667776664 7788887 777654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=318.97 Aligned_cols=261 Identities=30% Similarity=0.452 Sum_probs=207.3
Q ss_pred HhcCCCCCCccccCCceeEEEEEcC--------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEe
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMA--------DGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIE 488 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 488 (771)
..++..+.+.||+|.||.|++|... ....||||.++... ..+.+.+..|+++++.+ +|+||+.++|+|..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3445556679999999999999532 14579999998653 34567899999999998 69999999999999
Q ss_pred CCEEEEEEEeccCCCHHHHhcCCC---c-------cC--CCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEE
Q 004155 489 GNQLLLIYEYMENNSLARALFGPE---A-------HR--LKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVL 556 (771)
Q Consensus 489 ~~~~~lV~E~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIl 556 (771)
.+..++|+||++.|+|.++|+..+ . .. ..++....+.++.|||.|++||++. ++|||||-.+|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEE
Confidence 999999999999999999996654 0 01 2388999999999999999999998 8999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCCccccccccc--CCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccch
Q 004155 557 LDKDLNPKISDFGLAKLDEEDNTHISTRVAG--TFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDI 633 (771)
Q Consensus 557 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~ 633 (771)
+.++..+||+|||+|+..............| ...|||||.+....++.|+|||||||+||||+| |..|+.......
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~- 529 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE- 529 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH-
Confidence 9999999999999999655444333222233 346999999999999999999999999999999 777886422111
Q ss_pred hhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 634 FYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.+. +.+.+.-+...+..+..++.+++..||+.+|++||++.++++.++..
T Consensus 530 -~l~-------------~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 530 -ELL-------------EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred -HHH-------------HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 111 11222222233334466788999999999999999999999999884
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=283.50 Aligned_cols=236 Identities=25% Similarity=0.359 Sum_probs=192.0
Q ss_pred cccCCceeEEEEEcC-CCcEEEEEEcccCCh---hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCH
Q 004155 429 IGEGGFGPVYKGHMA-DGTVVAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL 504 (771)
Q Consensus 429 lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 504 (771)
||+|+||.||++... +++.||+|++..... .....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999554 589999999875432 2456789999999999999999999999999999999999999999
Q ss_pred HHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccccc
Q 004155 505 ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 584 (771)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 584 (771)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNT 152 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccC
Confidence 999943 23689999999999999999999997 899999999999999999999999999986544321 2234
Q ss_pred cccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHH
Q 004155 585 VAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKE 664 (771)
Q Consensus 585 ~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 664 (771)
..++..|+|||...+...+.++|+||||+++||+++|+.||........ ... +.... ...+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~~------------~~~~~--~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI---YEK------------ILKDP--LRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHH------------HhcCC--CCCCCC
Confidence 5688899999999988899999999999999999999999965432111 110 11111 112222
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHH
Q 004155 665 QVMVMINVALLCTDVSSTSRPSMSS 689 (771)
Q Consensus 665 ~~~~l~~l~~~Cl~~dP~~RPs~~e 689 (771)
....+.+++.+|+..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2456789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=277.17 Aligned_cols=267 Identities=21% Similarity=0.284 Sum_probs=201.1
Q ss_pred CHHHHHHHhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeC
Q 004155 412 TLRQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEG 489 (771)
Q Consensus 412 ~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 489 (771)
+++|+-+.| .+.||+|+|+.|-.+ ...+|..||||++.+.....+.+..+|++++... .|+||++++++|+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 356666655 468999999999988 6778999999999888777788899999999988 499999999999999
Q ss_pred CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC---CeEEE
Q 004155 490 NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NPKIS 566 (771)
Q Consensus 490 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 566 (771)
...|||||-|.||+|..+|+. +..+++.++.++..+|+.||.|||.+ +|.||||||+|||-.+.. -+||+
T Consensus 149 ~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeee
Confidence 999999999999999999943 45789999999999999999999998 899999999999996543 48999
Q ss_pred eecCccccCC--C----CcccccccccCCCccchhhhc-----cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhh
Q 004155 567 DFGLAKLDEE--D----NTHISTRVAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY 635 (771)
Q Consensus 567 DFGla~~~~~--~----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~ 635 (771)
||.+..-... + .+......+|+..|||||+.. ...|+.++|.||+|||||-|++|.+||.+.-.++..+
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 9988753221 1 111223457889999999873 3468899999999999999999999998654333211
Q ss_pred HHHHHHHHHhhCChhHHhhhhcCCCCCHH----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 636 LLDWALILKAQGNLMELVDKRLGSNFDKE----QVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
-...+...- ++.+.+-+...- -+++.. ...+..+++...+-.|+.+|-++.+++.
T Consensus 302 drGe~Cr~C-Q~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 302 DRGEVCRVC-QNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCCccHHH-HHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 000000000 001111111110 122222 2234566777778899999999999887
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=276.73 Aligned_cols=264 Identities=20% Similarity=0.265 Sum_probs=210.8
Q ss_pred HHHHHHhcCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEE
Q 004155 414 RQIKAATNNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCC 486 (771)
Q Consensus 414 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 486 (771)
+++.....+++....+-+|.||.||.|.+. +.+.|-+|.++.. +.-+...+..|.-.+..+.|||+..+.+.+
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 355556678888889999999999999543 3456778887765 344567788999999999999999999998
Q ss_pred EeC-CEEEEEEEeccCCCHHHHhcC----CCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC
Q 004155 487 IEG-NQLLLIYEYMENNSLARALFG----PEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 561 (771)
Q Consensus 487 ~~~-~~~~lV~E~~~~gsL~~~l~~----~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 561 (771)
.++ ...+.+|.++.-|+|..+|.. .......++..+...++.|++.|++|||++ +|||.||..+|.++|+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhe
Confidence 754 577899999999999999962 122345678888999999999999999999 899999999999999999
Q ss_pred CeEEEeecCccccCCCCccc-ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHH
Q 004155 562 NPKISDFGLAKLDEEDNTHI-STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDW 639 (771)
Q Consensus 562 ~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~ 639 (771)
++||+|=.++|.+-+.+.+. .........||+||.+.+..++.++|||||||++|||+| |+.|+..-++.+....
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y--- 510 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY--- 510 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH---
Confidence 99999999998654433322 222234668999999999999999999999999999998 8899876554443221
Q ss_pred HHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 640 ALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 640 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
+....+-..+..++.++..++.-||..+|++||++++++.-|.+
T Consensus 511 -------------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 511 -------------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -------------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 11111223344677789999999999999999999999988765
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=275.13 Aligned_cols=205 Identities=26% Similarity=0.389 Sum_probs=171.7
Q ss_pred hcCCCCCCccccCCceeEEEEEcCC-----CcEEEEEEcccCChh--cHHHHHHHHHHHHcCCCCcEEeEEEEEEe-CCE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMAD-----GTVVAVKQLSSKSKQ--GNREFVNEIGMISALQHPNLVKLHGCCIE-GNQ 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 491 (771)
...|+....||+|.||.||+|...+ .+.+|+|+++..... -.....+|+..++.++||||+.+...+.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568889999999999999994322 237999999865332 24567899999999999999999998877 788
Q ss_pred EEEEEEeccCCCHHHHhcCCC-ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC----CCeEEE
Q 004155 492 LLLIYEYMENNSLARALFGPE-AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD----LNPKIS 566 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~ 566 (771)
+++++||.+. +|.+.++-.+ .....++...+..|+.||+.|+.|||++ =|+||||||.|||+..+ |++||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 8988885432 2235788899999999999999999999 69999999999999877 899999
Q ss_pred eecCccccCCCCccc--ccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCC
Q 004155 567 DFGLAKLDEEDNTHI--STRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCK 628 (771)
Q Consensus 567 DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~ 628 (771)
|||++|.+...-... ...++-|+.|+|||.+.+. .||.+.||||.|||+.||+|-.+.|.+.
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999887644332 3456679999999999875 7999999999999999999999888764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=316.81 Aligned_cols=254 Identities=28% Similarity=0.405 Sum_probs=189.6
Q ss_pred HHHHhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe-----
Q 004155 416 IKAATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIE----- 488 (771)
Q Consensus 416 l~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----- 488 (771)
.-+..++|+..+.||+||||.|||++ .-||+.||||++.-.. ......+.+|+..|++|+|||||+++..+.+
T Consensus 474 ~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 474 FSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 34567789999999999999999994 4589999999997653 3345678899999999999999998654321
Q ss_pred --------------------------------------------------C-----------------------------
Q 004155 489 --------------------------------------------------G----------------------------- 489 (771)
Q Consensus 489 --------------------------------------------------~----------------------------- 489 (771)
.
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0
Q ss_pred -----------------------------------CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHH
Q 004155 490 -----------------------------------NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGL 534 (771)
Q Consensus 490 -----------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL 534 (771)
-.+||-||||+..+|.++++.+.-. -.....++++++|+.||
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGL 710 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHH
Confidence 1247889999987777777432211 04667899999999999
Q ss_pred HHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC-----------------CCCcccccccccCCCccchhhh
Q 004155 535 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE-----------------EDNTHISTRVAGTFGYMAPEYA 597 (771)
Q Consensus 535 ~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~ 597 (771)
.|+|++ +||||||||.|||+|++..+||+|||+|+... ..+....+..+||.-|+|||++
T Consensus 711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999999 89999999999999999999999999998621 0111133557899999999999
Q ss_pred ccC---CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC--CCCCHHHHHHHHHH
Q 004155 598 MRG---YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG--SNFDKEQVMVMINV 672 (771)
Q Consensus 598 ~~~---~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~l 672 (771)
.+. .|+.|+|+||+|||++||+. ||.... +.+..+ ..+-+..+. ..+.......=.++
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--------ERa~iL------~~LR~g~iP~~~~f~~~~~~~e~sl 850 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--------ERASIL------TNLRKGSIPEPADFFDPEHPEEASL 850 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchH--------HHHHHH------HhcccCCCCCCcccccccchHHHHH
Confidence 764 59999999999999999995 453211 111111 111112221 12223333445679
Q ss_pred HHHccCCCCCCCCCHHHHHH
Q 004155 673 ALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 673 ~~~Cl~~dP~~RPs~~evl~ 692 (771)
+.++++.||.+|||+.|++.
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhh
Confidence 99999999999999999986
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=316.96 Aligned_cols=145 Identities=28% Similarity=0.408 Sum_probs=129.8
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|.+.++||+|+||.||+|.. .+++.||||+++... ......+..|+.++..++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 5788999999999999999955 468999999987532 233467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
||+.+++|.+++.. ...+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999943 23588999999999999999999998 89999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=277.07 Aligned_cols=221 Identities=22% Similarity=0.228 Sum_probs=175.5
Q ss_pred CCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCHHHHhcC
Q 004155 432 GGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFG 510 (771)
Q Consensus 432 G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 510 (771)
|.||.||++ ...+|+.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999 45678999999987643 233455555566799999999999999999999999999999999843
Q ss_pred CCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccccccccCCC
Q 004155 511 PEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 590 (771)
Q Consensus 511 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~ 590 (771)
...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+....... ....++..
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~ 147 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENM 147 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcc
Confidence 23589999999999999999999998 89999999999999999999999999886554321 22345678
Q ss_pred ccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHH
Q 004155 591 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMI 670 (771)
Q Consensus 591 y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 670 (771)
|+|||...+..++.++||||+|+++|||++|+.|+....... ........+......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------------NTHTTLNIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------------ccccccCCcccCCHHHH
Confidence 999999988889999999999999999999998875321100 00000011112234578
Q ss_pred HHHHHccCCCCCCCCCHHH
Q 004155 671 NVALLCTDVSSTSRPSMSS 689 (771)
Q Consensus 671 ~l~~~Cl~~dP~~RPs~~e 689 (771)
+++.+|++.||++||++.+
T Consensus 207 ~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 207 SLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHccCCHHHhcCCCc
Confidence 8999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-33 Score=289.47 Aligned_cols=244 Identities=27% Similarity=0.366 Sum_probs=194.0
Q ss_pred CCccccCCceeEEEE-EcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCC
Q 004155 426 DNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENN 502 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 502 (771)
.++||+|-||+||-| +.++|+.||||++.+. ...+...+.+|+.+|++++||.||.+.-.|++.+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 578999999999999 6678999999999764 3445678999999999999999999999999999999999999664
Q ss_pred CHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC---CCeEEEeecCccccCCCCc
Q 004155 503 SLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFGla~~~~~~~~ 579 (771)
-|+..| .. ...++++....-++.||+.||.|||.+ +|+|+||||+|||+.+. -.+||+|||+||+..+...
T Consensus 649 MLEMIL-Ss--EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 649 MLEMIL-SS--EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred HHHHHH-Hh--hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 455555 32 345799999999999999999999998 99999999999999543 4699999999999877554
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
. ..++||+.|+|||++++..|...-|+||.|||+|--++|..||..+. ++-+.++-+..+....
T Consensus 723 R--rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~------------ 786 (888)
T KOG4236|consen 723 R--RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPN------------ 786 (888)
T ss_pred h--hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCC------------
Confidence 3 45789999999999999999999999999999999999999997532 2222222111111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.-.+.....++++...++..-.+|-+....+.
T Consensus 787 -PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 787 -PWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred -chhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 11233334567777777777778888776654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=294.25 Aligned_cols=240 Identities=23% Similarity=0.328 Sum_probs=192.9
Q ss_pred HhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 496 (771)
.++.|.....+|.|+|+.|-.+ ...+++..+||++.+.. .+-.+|+.++... +||||+++.+.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3566777888999999999888 56678999999997652 2234567666655 6999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE-cCCCCeEEEeecCccccC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL-DKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DFGla~~~~ 575 (771)
|.+.++-+.+.+... +....++..|+.+|+.|+.|||++ ++|||||||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999888777332 222267788999999999999998 89999999999999 699999999999998765
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.. ....+-|..|.|||++....+++++|+||||++||+|++|+.||...+.+. . +...
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--e----------------i~~~ 525 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--E----------------IHTR 525 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--H----------------HHHh
Confidence 54 222345789999999999999999999999999999999999998655431 1 1111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...+.+.........+|+.+||+.||.+||+|.++..
T Consensus 526 i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 526 IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred hcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1122233344456788999999999999999999976
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=279.80 Aligned_cols=242 Identities=24% Similarity=0.362 Sum_probs=194.0
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh---hcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK---QGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 494 (771)
..+|....+||+|+||.|-+|.. .+.+.+|||+++++.. .+.+--..|-.+|... +-|.+++++.+|.+-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 34788899999999999999944 4467899999987632 2222234466666555 57899999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+.||+|--++++ -..+.++.+.-+|.+||-||-+||++ +||.||||.+||++|.+|++||+|||+++.-
T Consensus 428 VMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999988843 34677888999999999999999999 8999999999999999999999999999832
Q ss_pred CCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
--+ ...+...+||+.|+|||++...+|+..+|.|||||+||||+.|++||+..++++.+ ..+.+
T Consensus 501 i~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF---------------~aI~e 564 (683)
T KOG0696|consen 501 IFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---------------QAIME 564 (683)
T ss_pred ccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---------------HHHHH
Confidence 222 22345578999999999999999999999999999999999999999876655432 22333
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPS 686 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 686 (771)
... .++.....+...+....+...|.+|--
T Consensus 565 hnv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 565 HNV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 322 445455556667777888889998863
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-33 Score=274.10 Aligned_cols=263 Identities=25% Similarity=0.338 Sum_probs=198.1
Q ss_pred cCCCCHHHHHHHhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCCh-hcHHHHHHHHHHHHcC-CCCcEEeEEE
Q 004155 408 TGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKLHG 484 (771)
Q Consensus 408 ~~~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~ 484 (771)
...|+-++++. ...||.|+||+|+|- +.+.|+..|||+++.... ....+++.|.+...+- +.||||+++|
T Consensus 58 ~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 44566666654 468999999999998 677899999999987644 4567888888876555 6899999999
Q ss_pred EEEeCCEEEEEEEeccCCCHHHHhcC-CCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCe
Q 004155 485 CCIEGNQLLLIYEYMENNSLARALFG-PEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 563 (771)
Q Consensus 485 ~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 563 (771)
.+..++..|+.||.|.- ||+.+-.. ...++..+++.-.-+|...+..||.||.+.. .|||||+||+|||+|..|.+
T Consensus 131 a~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCE
Confidence 99999999999999964 76654311 1123457888888899999999999998874 89999999999999999999
Q ss_pred EEEeecCccccCCCCcccccccccCCCccchhhhcc--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHH
Q 004155 564 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL 641 (771)
Q Consensus 564 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~ 641 (771)
||+|||++..+.+. ...+.-+|-..|||||.+.. ..+.-++||||+|++|||+.||+.|+..- ....+...
T Consensus 208 KLCDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w-----~svfeql~ 280 (361)
T KOG1006|consen 208 KLCDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW-----DSVFEQLC 280 (361)
T ss_pred eeecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH-----HHHHHHHH
Confidence 99999999755432 22244568889999999863 35889999999999999999999998521 11111111
Q ss_pred HHHhhCChhHHhhhhcCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 642 ILKAQGNLMELVDKRLGSNF-DKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 642 ~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
+... +.. +.+..+. ..+....+..++..|+.+|-.+||...++.++
T Consensus 281 ~Vv~-gdp-----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 281 QVVI-GDP-----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHc-CCC-----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1111 111 1111111 12345578899999999999999999998763
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=303.09 Aligned_cols=260 Identities=23% Similarity=0.290 Sum_probs=170.3
Q ss_pred HhcCCCCCCccccCCceeEEEEEcC-C----CcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEE------EE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMA-D----GTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGC------CI 487 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 487 (771)
..++|...++||+|+||.||+|... + +..||||++...... +.+..| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999654 4 689999987643221 111111 1112222222222111 24
Q ss_pred eCCEEEEEEEeccCCCHHHHhcCCCcc----------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCC
Q 004155 488 EGNQLLLIYEYMENNSLARALFGPEAH----------------RLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIK 551 (771)
Q Consensus 488 ~~~~~~lV~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlk 551 (771)
.+...++||||+.+++|.+++...... ........+..++.||+.||+|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 567899999999999999998543210 01112344668999999999999998 89999999
Q ss_pred CCcEEEcC-CCCeEEEeecCccccCCCCcccccccccCCCccchhhhccC----------------------CCCchHhH
Q 004155 552 ATNVLLDK-DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG----------------------YLTDKADV 608 (771)
Q Consensus 552 p~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ksDV 608 (771)
|+|||++. ++.+||+|||+|+..............+|+.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 68999999999986654443444556789999999965322 23456799
Q ss_pred HHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC-hh---HHhhhhcCCC----CC--HHHHHHHHHHHHHccC
Q 004155 609 YSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN-LM---ELVDKRLGSN----FD--KEQVMVMINVALLCTD 678 (771)
Q Consensus 609 ~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~d~~l~~~----~~--~~~~~~l~~l~~~Cl~ 678 (771)
|||||++|||+++..++... .......+...+. .. ..+.+....+ +. ........+|+.+|++
T Consensus 363 wSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999999977664321 1111111111110 00 1111110000 00 0011235589999999
Q ss_pred CCCCCCCCHHHHHH
Q 004155 679 VSSTSRPSMSSVVS 692 (771)
Q Consensus 679 ~dP~~RPs~~evl~ 692 (771)
.||++|||+.|+++
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999999997
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=280.51 Aligned_cols=273 Identities=19% Similarity=0.277 Sum_probs=205.4
Q ss_pred CCCCHHHHHHHhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-C-C----cEEe
Q 004155 409 GSFTLRQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-H-P----NLVK 481 (771)
Q Consensus 409 ~~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~ 481 (771)
+.+-++.-...+++|.+...+|+|.||.|-.+ +.+.+..||||+++.-. .-.+..+-|+++|+++. + | -+|.
T Consensus 77 GH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 77 GHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred ceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 33334444445889999999999999999998 34457899999997643 23445677999999994 2 3 3788
Q ss_pred EEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC--
Q 004155 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK-- 559 (771)
Q Consensus 482 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-- 559 (771)
+.++|.-.++.|+|+|.+ |-|+.++|..+ ...+++..++..|+.|++++++|||+. +++|-||||+|||+.+
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSE 229 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccc
Confidence 899999999999999988 56999999443 345788999999999999999999998 8999999999999931
Q ss_pred ------------------CCCeEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhC
Q 004155 560 ------------------DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG 621 (771)
Q Consensus 560 ------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG 621 (771)
+..+||+|||.|++..+.. ..++.|..|+|||++.+-.++.++||||+||||+|+.||
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence 2358999999999765544 345678899999999999999999999999999999999
Q ss_pred CCCCCCCCccchhhHHHHHHH--------------HHhhCCh-----------hHHhhhhc----CCCCCHHHHHHHHHH
Q 004155 622 RSNSSCKPKEDIFYLLDWALI--------------LKAQGNL-----------MELVDKRL----GSNFDKEQVMVMINV 672 (771)
Q Consensus 622 ~~p~~~~~~~~~~~~~~~~~~--------------~~~~~~~-----------~~~~d~~l----~~~~~~~~~~~l~~l 672 (771)
...|..-+..+....++.+.. ....+.+ ..+.+... .......+..++.+|
T Consensus 306 ~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL 385 (415)
T KOG0671|consen 306 ETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL 385 (415)
T ss_pred ceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence 998876443332222221111 0001100 00111000 001123456679999
Q ss_pred HHHccCCCCCCCCCHHHHHH
Q 004155 673 ALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 673 ~~~Cl~~dP~~RPs~~evl~ 692 (771)
+..++..||.+|+|+.|++.
T Consensus 386 l~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 386 LRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHccCccccccHHHHhc
Confidence 99999999999999999985
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=247.54 Aligned_cols=263 Identities=22% Similarity=0.331 Sum_probs=196.6
Q ss_pred CCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+|...++||+|.||+||+| ...+++.||+|+++-.. +.-.....+|+.+|+.++|.|||++++....++..-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566789999999999999 45568899999987543 23356788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
|.. +|..+... -+..++.+.+..++.|+++||.++|++ ++.|||+||.|.|++.+|+.|++|||+++.+.-.-
T Consensus 83 cdq-dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 965 88888732 345789999999999999999999999 89999999999999999999999999999776544
Q ss_pred cccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCCh---hHHh
Q 004155 579 THISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNL---MELV 653 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 653 (771)
...+. .+-|..|++|.++.+. -|+...|+||-||++.|+.. |++.|...+.++....+-|......++.+ ..+.
T Consensus 156 rcysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 156 RCYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred Eeeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 33333 3468899999999875 58889999999999999987 55556554444433222222211222221 2222
Q ss_pred hhhcCCCCCH-----HHHH----HHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 654 DKRLGSNFDK-----EQVM----VMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 654 d~~l~~~~~~-----~~~~----~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
|-.....++. +.+. .=.+++...+.-+|.+|.++++.++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 3222222221 1111 2245666666778999999988765
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=296.33 Aligned_cols=260 Identities=27% Similarity=0.411 Sum_probs=211.2
Q ss_pred CHHHHHHHhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEe-
Q 004155 412 TLRQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIE- 488 (771)
Q Consensus 412 ~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 488 (771)
.++.+..-++.|++.+.||.|.+|.||++ ..++|+.+|+|++.... ...++...|.++|+.. .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 44455556778999999999999999999 56789999999987653 3456778899999888 69999999999873
Q ss_pred ----CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeE
Q 004155 489 ----GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 564 (771)
Q Consensus 489 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 564 (771)
++++|||||||.+||..+++.+.. ...+.|+.+.-|++.+++||.+||.. .++|||||-.|||++.++.+|
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence 578999999999999999997655 56899999999999999999999998 799999999999999999999
Q ss_pred EEeecCccccCCCCcccccccccCCCccchhhhcc-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHH
Q 004155 565 ISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDW 639 (771)
Q Consensus 565 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~ 639 (771)
|.|||.+......... .....||+.|||||++.. ..|+..+|+||+|++..||--|.+|+....+......+
T Consensus 164 LvDFGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I-- 240 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-- 240 (953)
T ss_pred Eeeeeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC--
Confidence 9999999866543332 234679999999999863 35777999999999999999999998754432211100
Q ss_pred HHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 640 ALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 640 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. .+......+....+++.+++..|+..|-++||++.++++
T Consensus 241 -----pR-------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 -----PR-------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -----CC-------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 00 111112234456678999999999999999999999886
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=267.86 Aligned_cols=236 Identities=26% Similarity=0.382 Sum_probs=192.2
Q ss_pred CceeEEEEEcC-CCcEEEEEEcccCChhc-HHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCHHHHhcC
Q 004155 433 GFGPVYKGHMA-DGTVVAVKQLSSKSKQG-NREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFG 510 (771)
Q Consensus 433 ~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 510 (771)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999665 58999999997665444 67899999999999999999999999999999999999999999999843
Q ss_pred CCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccccccccCCC
Q 004155 511 PEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 590 (771)
Q Consensus 511 ~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~ 590 (771)
. ..+++..++.++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 2 2389999999999999999999998 89999999999999999999999999998765432 2234567889
Q ss_pred ccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCH--HHHHH
Q 004155 591 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDK--EQVMV 668 (771)
Q Consensus 591 y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~--~~~~~ 668 (771)
|+|||......++.++||||||+++|+|++|..||...... ....++ +.......... .....
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~-------------~~~~~~~~~~~~~~~~~~ 216 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKK-------------IGKPKPPFPPPEWKISPE 216 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHH-------------HhccCCCCccccccCCHH
Confidence 99999999888999999999999999999999998653111 111111 11000000000 03456
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHH
Q 004155 669 MINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 669 l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=281.27 Aligned_cols=256 Identities=24% Similarity=0.376 Sum_probs=196.1
Q ss_pred hcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccC--Chhc-----HHHHHHHHHHHHcCCCCcEEeEEEEEE-eCC
Q 004155 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK--SKQG-----NREFVNEIGMISALQHPNLVKLHGCCI-EGN 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~--~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~ 490 (771)
.++|-..+.||+|||+.||+| ++...+.||||+-.-. .+.. .+...+|..+.+.+.||.||+++++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 356778899999999999999 6667889999985432 1111 345678999999999999999999997 557
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc---CCCCeEEEe
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISD 567 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~D 567 (771)
.+|-|+|||+|.+|+-||. ...-+++.++..|+.||+.||.||.+. .++|||-||||.|||+. .-|.+||+|
T Consensus 542 sFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 7899999999999999993 345689999999999999999999987 56899999999999994 557899999
Q ss_pred ecCccccCCCCc------ccccccccCCCccchhhhcc----CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHH
Q 004155 568 FGLAKLDEEDNT------HISTRVAGTFGYMAPEYAMR----GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL 637 (771)
Q Consensus 568 FGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~----~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~ 637 (771)
||+++.++.+.. ..+...+||..|++||.+.- .+.+.|+||||.|||+|..+.|+.||....... .++
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dIL 694 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DIL 694 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HHH
Confidence 999998876432 23455789999999998753 368889999999999999999999997543221 111
Q ss_pred HHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 004155 638 DWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVV 691 (771)
Q Consensus 638 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 691 (771)
+. ..+...-+-.+.. .+....+...++++||++.-++|....++.
T Consensus 695 qe-------NTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 695 QE-------NTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hh-------hchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11 1111111111100 012223467889999999999997766554
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=264.61 Aligned_cols=258 Identities=21% Similarity=0.256 Sum_probs=196.3
Q ss_pred HhcCCCCC-CccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEe----CCE
Q 004155 419 ATNNFAPD-NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIE----GNQ 491 (771)
Q Consensus 419 ~~~~f~~~-~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 491 (771)
.|++|++. ++||-|-.|.|-.+ +..+|+.+|+|++... ....+|++..-.. .|||||.+++.|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45556553 57999999999988 6678999999998653 2345677765444 69999999999864 356
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC---CCCeEEEee
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDF 568 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DF 568 (771)
+.+|||.|+||.|...+.+.. ...+++.++-.|+.||+.|+.|||+. +|.||||||+|+|... |-.+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 789999999999999996544 35799999999999999999999998 8999999999999964 457999999
Q ss_pred cCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 569 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 569 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
|+|+.......- ...+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.......+-- +
T Consensus 209 GFAK~t~~~~~L--~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp-----------g- 274 (400)
T KOG0604|consen 209 GFAKETQEPGDL--MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----------G- 274 (400)
T ss_pred ccccccCCCccc--cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh-----------h-
Confidence 999966543322 33567999999999999999999999999999999999999997643211100 0
Q ss_pred hhHHhhhhcCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCCCCCC
Q 004155 649 LMELVDKRLGSNFDK----EQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGRADVQ 701 (771)
Q Consensus 649 ~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~~ 701 (771)
+..-+... .-.++. ...+...++++..|..+|.+|-|+.|+++ .+.+...++
T Consensus 275 Mk~rI~~g-qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp 332 (400)
T KOG0604|consen 275 MKRRIRTG-QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP 332 (400)
T ss_pred HHhHhhcc-CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence 00000000 012222 23456778999999999999999999987 344444433
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=292.47 Aligned_cols=261 Identities=20% Similarity=0.240 Sum_probs=181.1
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-----------------CCCcEEEEEEcccCChhcHHHH--------------HHH
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-----------------ADGTVVAVKQLSSKSKQGNREF--------------VNE 467 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~~--------------~~E 467 (771)
..++|++.++||+|+||.||+|.. ..++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999953 2456899999875433323333 346
Q ss_pred HHHHHcCCCCcE-----EeEEEEEEe--------CCEEEEEEEeccCCCHHHHhcCCCc--------------------c
Q 004155 468 IGMISALQHPNL-----VKLHGCCIE--------GNQLLLIYEYMENNSLARALFGPEA--------------------H 514 (771)
Q Consensus 468 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~ 514 (771)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677787753 3568999999999999999964311 1
Q ss_pred CCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccccccccCCCccch
Q 004155 515 RLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP 594 (771)
Q Consensus 515 ~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aP 594 (771)
...++|..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12457888999999999999999998 899999999999999999999999999975543222212223457899999
Q ss_pred hhhccCC----------------------CCchHhHHHHHHHHHHHHhCCC-CCCCCCccch------hhHHHHHHHHHh
Q 004155 595 EYAMRGY----------------------LTDKADVYSFGIVALEIVSGRS-NSSCKPKEDI------FYLLDWALILKA 645 (771)
Q Consensus 595 E~~~~~~----------------------~~~ksDV~S~Gvil~elltG~~-p~~~~~~~~~------~~~~~~~~~~~~ 645 (771)
|.+.... ...+.||||+||++|||++|.. |+........ .....|... .
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--K 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--c
Confidence 9875432 1235799999999999999975 6643111000 001111110 0
Q ss_pred hCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHH
Q 004155 646 QGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSS---TSRPSMSSVVS 692 (771)
Q Consensus 646 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~ 692 (771)
. ....-...........+++.+++..+| .+|+|++|+++
T Consensus 458 ~--------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 G--------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred c--------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0 000000011223457788888998765 68999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=265.87 Aligned_cols=264 Identities=23% Similarity=0.355 Sum_probs=195.6
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe--------CC
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIE--------GN 490 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~ 490 (771)
.|....+||+|.||.||+|+ ..+|+.||+|++-.. ...-.....+|+.+|..++|+|++.++..|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 45556789999999999994 445788999876432 22224567899999999999999999988853 23
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..|+|+++|+. +|.-+|.. ...+++..++.+++.++..||.|+|.. .|+|||+||.|+|++.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 58999999987 88888832 335799999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCC---cccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh
Q 004155 571 AKLDEEDN---THISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ 646 (771)
Q Consensus 571 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 646 (771)
|+.+.... ....+..+-|..|++||.+.+ ..++++.|||+-|||+.||+||.+-+....+.....++.........
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 97654322 122334456899999999886 47999999999999999999999988776555444433322211111
Q ss_pred CC--------hhHHhhhh-cC-CCCC--HHHH------HHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 647 GN--------LMELVDKR-LG-SNFD--KEQV------MVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 647 ~~--------~~~~~d~~-l~-~~~~--~~~~------~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+- +.+.+.-. +. +.+. .+.. ....+++..++..||.+|+.+++++.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11 11111000 10 0000 0111 14668889999999999999999876
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=276.86 Aligned_cols=206 Identities=22% Similarity=0.348 Sum_probs=173.2
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
.-|..++.||-|+||.|.++. ..+...||+|.+++.. +......+.|-+||.....+=||+|+..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 347778899999999999994 4456789999997653 334456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc--
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD-- 574 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~-- 574 (771)
||++||++-.+|- ....+.+..+.-++.++..|+++.|.. |+|||||||+|||||.+|++||+|||++.-+
T Consensus 709 dYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred eccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence 9999999999883 234577888888899999999999998 9999999999999999999999999998522
Q ss_pred -------CCCC-----------------cc---------------cccccccCCCccchhhhccCCCCchHhHHHHHHHH
Q 004155 575 -------EEDN-----------------TH---------------ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVA 615 (771)
Q Consensus 575 -------~~~~-----------------~~---------------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil 615 (771)
.+.+ .. .....+||+.|+|||++....++.-+|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 1100 00 01124799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCccch
Q 004155 616 LEIVSGRSNSSCKPKEDI 633 (771)
Q Consensus 616 ~elltG~~p~~~~~~~~~ 633 (771)
|||+.|++||....+.+.
T Consensus 862 ~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHHhhCCCCccCCCCCcc
Confidence 999999999987665544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=246.08 Aligned_cols=202 Identities=27% Similarity=0.418 Sum_probs=168.8
Q ss_pred cCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccC-ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK-SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 497 (771)
+.......||+|+||.|-+- +..+|+..|+|.+... ..+..++.++|+.+..+- .+|.+|.++|...+....++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 33344678999999999887 5568999999999765 344567788898887664 69999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
.|.- ||+.+-..--..+..+++.-.-+||..+.+||.|||++ ..++|||+||+|||++.+|++|++|||.+-.+.+.
T Consensus 126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 9965 88877654445567899999999999999999999998 48999999999999999999999999999876543
Q ss_pred CcccccccccCCCccchhhhcc----CCCCchHhHHHHHHHHHHHHhCCCCCCC
Q 004155 578 NTHISTRVAGTFGYMAPEYAMR----GYLTDKADVYSFGIVALEIVSGRSNSSC 627 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDV~S~Gvil~elltG~~p~~~ 627 (771)
-.. +.-.|...|||||.+.. ..|+-|+||||+|+.+.||.+++.|++.
T Consensus 203 iAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 203 IAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 221 22457789999998853 3789999999999999999999999864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=258.89 Aligned_cols=248 Identities=22% Similarity=0.317 Sum_probs=194.2
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 494 (771)
.++|...++||+|+|+.|..+.+ ++.+.+|+|++++. ..+.....+.|-.+..+. +||.+|.+..+|.++..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46789999999999999999954 56789999999864 334455667777777766 79999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
|.||++||+|--+++ .+..++++.+.-+..+|.-||.|||++ |||.||||.+|||+|..|++||+|||+++.-
T Consensus 329 vieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999977763 345799999999999999999999999 8999999999999999999999999999854
Q ss_pred CCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchh-hHHHHHHHHHhhCChhHHh
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF-YLLDWALILKAQGNLMELV 653 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 653 (771)
-.+. ..+..++||+.|+|||++++..|....|.|++||+++||+.|+.||+....+... .-.++. ..-++
T Consensus 402 l~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl--------fqvil 472 (593)
T KOG0695|consen 402 LGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL--------FQVIL 472 (593)
T ss_pred CCCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH--------HHHHh
Confidence 3332 2345688999999999999999999999999999999999999999753221110 000110 11122
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRP 685 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 685 (771)
++.++ .+.....+...++..-+++||.+|-
T Consensus 473 ekqir--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 473 EKQIR--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hhccc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 22221 1222223345677788899999885
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=277.18 Aligned_cols=241 Identities=22% Similarity=0.286 Sum_probs=197.4
Q ss_pred CCCCCCccccCCceeEEEEEcCCC-cEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMADG-TVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~~g-~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
++.....||-||||.|=++..... ..+|+|++++. ...+.+....|-.+|...+.|.||++|-.|.+..+.|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 445567899999999999866443 34899988764 23345667789999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
-|-||.|...|+ .+..++..+..-++..+.+|++|||.+ +||.|||||+|.++|.+|-+||.|||+|+.....
T Consensus 501 aClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 501 ACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999994 345788899999999999999999998 8999999999999999999999999999987654
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
.. +..++||+.|.|||++.+...+.++|.||+|+++|||++|++||...++-..+.++- +-+|.
T Consensus 574 ~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL------------kGid~-- 637 (732)
T KOG0614|consen 574 RK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL------------KGIDK-- 637 (732)
T ss_pred Cc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH------------hhhhh--
Confidence 43 456789999999999999999999999999999999999999998765544333221 11111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPS 686 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 686 (771)
-.++....+...+++.+.+..+|.+|--
T Consensus 638 -i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 -IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 1233344455677888888889999865
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=286.65 Aligned_cols=246 Identities=27% Similarity=0.337 Sum_probs=187.3
Q ss_pred CCCCCccccCCcee-EEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 423 FAPDNKIGEGGFGP-VYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 423 f~~~~~lG~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
|...+++|.|+-|+ ||+|.. +|+.||||++-. +......+|+..|+.- +|||||++++.-.+..+.||+.|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 45556889999876 699988 589999999854 3334567899999887 59999999999889999999999996
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC-----CCCeEEEeecCccccC
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK-----DLNPKISDFGLAKLDE 575 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFGla~~~~ 575 (771)
. +|.+++...........-...+.+..|++.||++||+. +||||||||.||||+. ..+++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 99999966311111112245678899999999999997 8999999999999965 3579999999999887
Q ss_pred CCCccc--ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhC-CCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 576 EDNTHI--STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG-RSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 576 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
.+.... .....||-+|+|||++....-+.++||||+||++|..++| ..||......+. ..+.....+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-------NIl~~~~~L~~- 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-------NILTGNYTLVH- 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-------hhhcCccceee-
Confidence 654433 3456799999999999998888899999999999999997 889974322211 01111111100
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+ ....++ +..+|+.+|++.+|..||++.+|+.
T Consensus 735 ----L--~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 ----L--EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ----e--ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 001111 5678999999999999999999974
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=256.27 Aligned_cols=132 Identities=25% Similarity=0.437 Sum_probs=112.8
Q ss_pred hcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-----C---CcEEeEEEEEEe--
Q 004155 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-----H---PNLVKLHGCCIE-- 488 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 488 (771)
..+|.+.++||-|-|++||++ +..+.+.||+|+.+.. ..-.+..+.|+.+|++++ | ..||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 368899999999999999999 5667789999998753 334566788999999884 3 369999999974
Q ss_pred --CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE
Q 004155 489 --GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL 557 (771)
Q Consensus 489 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 557 (771)
+.++|+|+|++ |.+|..+|.... ...++...+.+|++||+.||.|||..| +|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56999999999 668999985443 357899999999999999999999998 99999999999999
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-27 Score=238.10 Aligned_cols=210 Identities=36% Similarity=0.589 Sum_probs=182.5
Q ss_pred cccCCceeEEEEEcCC-CcEEEEEEcccCChh-cHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCHHH
Q 004155 429 IGEGGFGPVYKGHMAD-GTVVAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLAR 506 (771)
Q Consensus 429 lG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 506 (771)
||+|++|.||++...+ |+.+++|++...... ....+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999996644 899999998765432 34679999999999999999999999999999999999999999999
Q ss_pred HhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC-CCCeEEEeecCccccCCCCccccccc
Q 004155 507 ALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAKLDEEDNTHISTRV 585 (771)
Q Consensus 507 ~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~ 585 (771)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 994321 3689999999999999999999998 8999999999999999 89999999999986654331 12234
Q ss_pred ccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHH
Q 004155 586 AGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKE 664 (771)
Q Consensus 586 ~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 664 (771)
.+...|++||..... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577899999999877 888999999999999999
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 665 QVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 665 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
..+.+++..|++.+|++||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 347789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-30 Score=248.33 Aligned_cols=263 Identities=24% Similarity=0.327 Sum_probs=195.5
Q ss_pred CCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC-----CEEEEE
Q 004155 424 APDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEG-----NQLLLI 495 (771)
Q Consensus 424 ~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lV 495 (771)
+..+.||.|+||.||.+. -++|+.||+|++... +-...+.+.+|+.+|.-++|.|++..++...-. .+.|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 456889999999999994 457999999998653 223456788999999999999999988876533 256888
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
+|.|.. +|...+ -....++-..+.-+++||++||+|||+. +|.||||||.|.|++.+...||+|||+|+..+
T Consensus 136 TELmQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELMQS-DLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHh-hhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 898854 787777 3456789999999999999999999998 89999999999999999999999999999776
Q ss_pred CCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHH--------HHHhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL--------ILKAQ 646 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~ 646 (771)
.+.....+..+-|..|+|||++.+. .|+.+.||||.|||+.|++..+-.|....+-+..+++.-.. ...-+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 6554444445568899999999875 79999999999999999999888887655433332221100 00001
Q ss_pred CChhHHhhhhcCC-CC--------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004155 647 GNLMELVDKRLGS-NF--------DKEQVMVMINVALLCTDVSSTSRPSMSSVVSML 694 (771)
Q Consensus 647 ~~~~~~~d~~l~~-~~--------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 694 (771)
+.-..++....+. +. +...-.+...+...++..||++|.+..+.+..+
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111122111110 00 011223455677888999999999999988754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=230.16 Aligned_cols=257 Identities=18% Similarity=0.291 Sum_probs=194.6
Q ss_pred hcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeC--CEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLHGCCIEG--NQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV 495 (771)
.++|++.+++|+|.|+.||.| ...+.+.++||+++.- ..+.+.+|+.+|+.++ ||||+++++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 467888999999999999999 5567889999999763 3467889999999997 99999999998765 457899
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC-CCeEEEeecCcccc
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLD 574 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFGla~~~ 574 (771)
+||+.+-+...+- +.++...+...+.+++.||.|+|+. ||.|||+||.|+++|.. -..+|+|+|+|.++
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999998877665 4688889999999999999999999 99999999999999865 46999999999988
Q ss_pred CCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh-------
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ------- 646 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------- 646 (771)
...... ...+.+..|.-||.+.. ..++..-|+|||||++..|+..+.||..... ...+++.-+..+...
T Consensus 184 Hp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHHH
Confidence 765432 22345668899998865 4678899999999999999999999875332 122233222221111
Q ss_pred -------CChhHHhhhhcCC-------CCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 647 -------GNLMELVDKRLGS-------NFDK-EQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 647 -------~~~~~~~d~~l~~-------~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+...++....+. .... -...+.++++...+..|-++|||++|.+.
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1111111111100 0001 11246788999999999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=238.36 Aligned_cols=199 Identities=35% Similarity=0.507 Sum_probs=172.2
Q ss_pred CCCCCccccCCceeEEEEEcCC-CcEEEEEEcccCChh-cHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 423 FAPDNKIGEGGFGPVYKGHMAD-GTVVAVKQLSSKSKQ-GNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
|+..+.||+|++|.||++...+ ++.+|+|.+...... ....+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999996654 899999999865544 56789999999999999999999999999899999999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+++|.+++..... .+++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999943221 188999999999999999999998 8999999999999999999999999999876554311
Q ss_pred cccccccCCCccchhhh-ccCCCCchHhHHHHHHHHHHHHhCCCCCCC
Q 004155 581 ISTRVAGTFGYMAPEYA-MRGYLTDKADVYSFGIVALEIVSGRSNSSC 627 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~-~~~~~~~ksDV~S~Gvil~elltG~~p~~~ 627 (771)
......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334578899999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=258.81 Aligned_cols=196 Identities=26% Similarity=0.371 Sum_probs=167.0
Q ss_pred cCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhc--------HHHHHHHHHHHHcCC---CCcEEeEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQG--------NREFVNEIGMISALQ---HPNLVKLHGCCIE 488 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~--------~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 488 (771)
.+|...+.+|+|+||.|+.+ +.++...|+||.+.+..--. .-..-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35888999999999999999 45567789999987642110 112456999999997 9999999999999
Q ss_pred CCEEEEEEEec-cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEe
Q 004155 489 GNQLLLIYEYM-ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 567 (771)
Q Consensus 489 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 567 (771)
++++||+||-. ++-+|.+++ ..+..+++.++.-|+.||+.|+++||++ +|||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999975 456899999 4456899999999999999999999999 899999999999999999999999
Q ss_pred ecCccccCCCCcccccccccCCCccchhhhccCCC-CchHhHHHHHHHHHHHHhCCCCCC
Q 004155 568 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNSS 626 (771)
Q Consensus 568 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvil~elltG~~p~~ 626 (771)
||.|........ ..++||.+|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus 714 fgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999987654433 34679999999999998754 556799999999999999888875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=235.17 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=193.6
Q ss_pred hcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC------C
Q 004155 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEG------N 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 490 (771)
..+|.-...+|.|.- .|-.+ +.-.+++||+|++... .....++..+|..++..+.|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777888999988 55555 4446899999987543 223356778899999999999999999998643 3
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..|+|||||.. +|...++ ..++-.++..|..|++.|++|||+. +|+||||||+||++..+..+||.|||+
T Consensus 95 e~y~v~e~m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 68999999965 8988884 4677889999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCCh-
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL- 649 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 649 (771)
|+..... ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+..|.+.. .+-+|......-+..
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPD 237 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCC
Confidence 9865433 34456778899999999999889999999999999999999998886432 122222221111110
Q ss_pred --------------------------hHH-hhhhcCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 650 --------------------------MEL-VDKRLGS--NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 650 --------------------------~~~-~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+. .|..... +.+.-......+++.+||-.+|++|-++.++++
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 000 0000000 111122345678999999999999999999987
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=230.37 Aligned_cols=253 Identities=19% Similarity=0.310 Sum_probs=185.9
Q ss_pred hcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEE-EEeCCEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGC-CIEGNQLLLIY 496 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lV~ 496 (771)
.+.|.+.+.+|+|.||.+-++ +....+.+++|.+... ....++|.+|...--.| .|.||+.-++. |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 356888999999999999999 4556788999988753 34568899998765556 48999987764 67788999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE-c-CCCCeEEEeecCcccc
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL-D-KDLNPKISDFGLAKLD 574 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll-~-~~~~~kl~DFGla~~~ 574 (771)
||++.|+|..-+ ....+.+....+++.|++.|+.|||+. ++||||||.+|||+ + +..++||+|||+++..
T Consensus 102 E~aP~gdL~snv-----~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNV-----EAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhc-----CcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999888 235788899999999999999999999 89999999999999 3 3448999999999854
Q ss_pred CCCCcccccccccCCCccchhhhccC-----CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCCh
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRG-----YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL 649 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (771)
+..- ....-+..|.|||..... ...+.+|||.||+++|.++||+.||......+. ...+|.....+ ..
T Consensus 174 g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~Y~~~~~w~~r--k~ 246 (378)
T KOG1345|consen 174 GTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-PYWEWEQWLKR--KN 246 (378)
T ss_pred Ccee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-hHHHHHHHhcc--cC
Confidence 3221 223345689999987532 467789999999999999999999984332222 22233222221 11
Q ss_pred hHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 004155 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSML 694 (771)
Q Consensus 650 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 694 (771)
.. +...+. .......++..+-+..+|++|-...++.++-
T Consensus 247 ~~-----~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 PA-----LPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cc-----Cchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 11 111111 1123455667788899999996666655543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=251.26 Aligned_cols=275 Identities=18% Similarity=0.229 Sum_probs=208.4
Q ss_pred CCCCHHHHHHHhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC------CCcEEe
Q 004155 409 GSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ------HPNLVK 481 (771)
Q Consensus 409 ~~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~ 481 (771)
+.|.+.--+....+|.+....|+|-|++|..|. ..-|..||||++.... ...+.=+.|+++|.+|+ --|+++
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 445555566677899999999999999999994 4457899999997643 23344567999999995 247899
Q ss_pred EEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC
Q 004155 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 561 (771)
Q Consensus 482 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 561 (771)
++-.|...+++|||+|-+.- +|.+.|.... .+..|....+..++.|+.-||..|-.. +|+|.||||.|||+++..
T Consensus 499 l~r~F~hknHLClVFE~Lsl-NLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPLSL-NLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHhhhcceeEEEehhhhc-hHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCc
Confidence 99999999999999998854 8999995543 356799999999999999999999987 999999999999998654
Q ss_pred -CeEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHH
Q 004155 562 -NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWA 640 (771)
Q Consensus 562 -~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~ 640 (771)
.+||||||.|.+..+.... ...-+..|.|||++.+..|+...|+||.||+||||.||+..|.+.....+..+..-.
T Consensus 574 ~iLKLCDfGSA~~~~eneit---PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~ 650 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEIT---PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL 650 (752)
T ss_pred ceeeeccCcccccccccccc---HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence 6899999999876654322 122234799999999999999999999999999999999999876665554333211
Q ss_pred H-----HHHhhCChh---------------------------HHhhh------hcCC--CCC---HHHHHHHHHHHHHcc
Q 004155 641 L-----ILKAQGNLM---------------------------ELVDK------RLGS--NFD---KEQVMVMINVALLCT 677 (771)
Q Consensus 641 ~-----~~~~~~~~~---------------------------~~~d~------~l~~--~~~---~~~~~~l~~l~~~Cl 677 (771)
. .+...+.+. ..+.| .+.. .++ ...+..+.+|+..|+
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml 730 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML 730 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence 1 011111000 00111 1111 122 334567889999999
Q ss_pred CCCCCCCCCHHHHHH
Q 004155 678 DVSSTSRPSMSSVVS 692 (771)
Q Consensus 678 ~~dP~~RPs~~evl~ 692 (771)
..||++|.|..+.+.
T Consensus 731 ~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 731 ILDPEKRITVNQALK 745 (752)
T ss_pred ccChhhcCCHHHHhc
Confidence 999999999998875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-28 Score=260.31 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=201.2
Q ss_pred hcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
.++|....++|.|.||.|||+ +...++..|+|+++-.......-.++|+-+++..+|||||.++|.+...+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 457888999999999999999 4567899999999887777777788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
|.+|+|++.-|. ..++++.++..+++..++||+|||+. +-+|||||-.||++++.|.+|++|||.+..+...-
T Consensus 94 cgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh
Confidence 999999988743 35799999999999999999999998 78999999999999999999999999986543221
Q ss_pred cccccccccCCCccchhhh---ccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 579 THISTRVAGTFGYMAPEYA---MRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~---~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
. ....+.||+.|||||+. +.+.|..++|||+.|+...|+-.-++|.....+.....+. .. ...++
T Consensus 167 ~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm-------Tk----S~~qp 234 (829)
T KOG0576|consen 167 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM-------TK----SGFQP 234 (829)
T ss_pred h-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh-------hc----cCCCC
Confidence 1 22446799999999987 4678999999999999999998888775433222111111 00 01111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.- .+-.......+-+++..|+..+|++||+++.+++
T Consensus 235 p~-lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PT-LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred Cc-ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 10 0111123345778999999999999999876653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=236.01 Aligned_cols=265 Identities=26% Similarity=0.390 Sum_probs=196.4
Q ss_pred HHHHhcCCCCCCccccCCceeEEEEEcC----CCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCC
Q 004155 416 IKAATNNFAPDNKIGEGGFGPVYKGHMA----DGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGN 490 (771)
Q Consensus 416 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 490 (771)
+....+.|...++||+|.|++||++.+. .++.||+|.+...+. .....+|+++|..+ .+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4445677899999999999999999443 467899999876533 35688999999999 4999999999999999
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc-CCCCeEEEeec
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFG 569 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG 569 (771)
..++|+||++.....++. ..++...+...+..++.||+++|.. |||||||||+|+|.+ ..++-.|.|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence 999999999999988888 3577899999999999999999999 999999999999997 45678999999
Q ss_pred CccccCCC------------------C---------------c----------ccccccccCCCccchhhhcc-CCCCch
Q 004155 570 LAKLDEED------------------N---------------T----------HISTRVAGTFGYMAPEYAMR-GYLTDK 605 (771)
Q Consensus 570 la~~~~~~------------------~---------------~----------~~~~~~~gt~~y~aPE~~~~-~~~~~k 605 (771)
+|...+.. . . ......+||++|+|||++.. ...+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 99621100 0 0 00112469999999999875 467899
Q ss_pred HhHHHHHHHHHHHHhCCCCCCCCCccc--hhh---HHHHHHH---HHhhCC-----------hhHH------hh-hhcCC
Q 004155 606 ADVYSFGIVALEIVSGRSNSSCKPKED--IFY---LLDWALI---LKAQGN-----------LMEL------VD-KRLGS 659 (771)
Q Consensus 606 sDV~S~Gvil~elltG~~p~~~~~~~~--~~~---~~~~~~~---~~~~~~-----------~~~~------~d-~~l~~ 659 (771)
.||||.|||++-+++++.||.....+- ... +..+... ....+. +.+. ++ ..+..
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 999999999999999999997543221 111 1111110 000111 0011 00 00000
Q ss_pred -CC--------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 660 -NF--------DKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 660 -~~--------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. .......+.+++.+|++.||.+|.|++|.+.
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 00 0112236789999999999999999999886
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=271.18 Aligned_cols=194 Identities=18% Similarity=0.221 Sum_probs=137.3
Q ss_pred CCC-CcEEeEEEEE-------EeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCce
Q 004155 474 LQH-PNLVKLHGCC-------IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545 (771)
Q Consensus 474 l~h-~niv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i 545 (771)
++| +||++++++| .+.+..+.++||+ +++|.++|... ...+++.+++.++.||++||+|||++ +|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 345 5777788877 2334577888987 55999999532 34699999999999999999999998 89
Q ss_pred eccCCCCCcEEEcC-------------------CCCeEEEeecCccccCCCCc---------------ccccccccCCCc
Q 004155 546 VHRDIKATNVLLDK-------------------DLNPKISDFGLAKLDEEDNT---------------HISTRVAGTFGY 591 (771)
Q Consensus 546 vH~Dlkp~NIll~~-------------------~~~~kl~DFGla~~~~~~~~---------------~~~~~~~gt~~y 591 (771)
+||||||+||||+. ++.+|++|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965 44556666666653211000 001123578899
Q ss_pred cchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHH
Q 004155 592 MAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMIN 671 (771)
Q Consensus 592 ~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 671 (771)
||||++.+..++.++|||||||+||||++|.+|+.... .. ... .. .....+.. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~--~~~----~~-----~~~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RT--MSS----LR-----HRVLPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HH--HHH----HH-----HhhcChhh-----hhcCHHHHH
Confidence 99999999999999999999999999999988764211 00 000 00 00011110 111233567
Q ss_pred HHHHccCCCCCCCCCHHHHHH
Q 004155 672 VALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 672 l~~~Cl~~dP~~RPs~~evl~ 692 (771)
++.+||+.+|.+||+|.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 888999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=210.40 Aligned_cols=166 Identities=21% Similarity=0.176 Sum_probs=123.9
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|+|.+++... ...+++.+++.|+.||+.||+|||++ + ||+||+++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6899999432 34699999999999999999999998 4 999999999999999 99998664422
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 661 (771)
..||+.|+|||++.+..++.++|||||||++|||+||+.||........ ....+..... .. ++. ....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~-~~------~~~-~~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMP-AD------DPR-DRSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhc-cC------Ccc-cccc
Confidence 2588999999999999999999999999999999999999864322111 0111000000 00 000 0001
Q ss_pred CHHHH--HHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 662 DKEQV--MVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 662 ~~~~~--~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
..... ..+.+++.+||+.+|++||++.|+++.+..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11122 258999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=222.36 Aligned_cols=260 Identities=20% Similarity=0.222 Sum_probs=194.0
Q ss_pred CCCCCCccccCCceeEEEEEcCC--CcEEEEEEcccCChhcHHHHHHHHHHHHcCCC----CcEEeEEEEE-EeCCEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMAD--GTVVAVKQLSSKSKQGNREFVNEIGMISALQH----PNLVKLHGCC-IEGNQLLL 494 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 494 (771)
+|.+.++||+|+||.||++.... ...+|+|............+..|+.++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999996544 35799998766533333378889999988862 6889999998 57788999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC-----CCeEEEeec
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-----LNPKISDFG 569 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DFG 569 (771)
||+.+ |.+|.++..... ...++..++++|+.|++.+|++||+. |++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99977 779999874443 46899999999999999999999998 89999999999999754 469999999
Q ss_pred Ccc--ccCCCCc----cc---ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHH
Q 004155 570 LAK--LDEEDNT----HI---STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWA 640 (771)
Q Consensus 570 la~--~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~ 640 (771)
+++ .+..... .. .....||..|+++....+...+.+.|+||++.++.|++.|..||..............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~- 251 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK- 251 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH-
Confidence 998 3222111 11 1235599999999999999999999999999999999999999965433222111100
Q ss_pred HHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 641 LILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 641 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
... ...... .....+..+.++...+-..+...+|....+...++....
T Consensus 252 --~~~----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 252 --DPR----KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred --Hhh----hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 000 000000 111123345555566666899999999999988766543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=224.45 Aligned_cols=178 Identities=21% Similarity=0.212 Sum_probs=136.5
Q ss_pred HHHHHHhcCCCCCCccccCCceeEEEEEcC--CCcEEEEEEcccC-----ChhcHHHHHHHHHHHHcCCCCcEEe-EEEE
Q 004155 414 RQIKAATNNFAPDNKIGEGGFGPVYKGHMA--DGTVVAVKQLSSK-----SKQGNREFVNEIGMISALQHPNLVK-LHGC 485 (771)
Q Consensus 414 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~ 485 (771)
.+.....++|...+.||+|+||+||+|... +++.||||++... .....+.|.+|+++|++++|+|+++ +++
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~- 89 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA- 89 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence 344556788999999999999999999543 5788899986533 1223567899999999999999985 443
Q ss_pred EEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCC-CCCcEEEcCCCCeE
Q 004155 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDI-KATNVLLDKDLNPK 564 (771)
Q Consensus 486 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~k 564 (771)
.+..++||||++|++|.... . .. ...++.|+++||+|||+. +|+|||| ||+|||++.++.+|
T Consensus 90 ---~~~~~LVmE~~~G~~L~~~~----~----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 90 ---TGKDGLVRGWTEGVPLHLAR----P----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred ---cCCcEEEEEccCCCCHHHhC----c----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEE
Confidence 24579999999999997321 0 00 146789999999999998 8999999 99999999999999
Q ss_pred EEeecCccccCCCCccc-------ccccccCCCccchhhhccC------CCCchHhHH
Q 004155 565 ISDFGLAKLDEEDNTHI-------STRVAGTFGYMAPEYAMRG------YLTDKADVY 609 (771)
Q Consensus 565 l~DFGla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~------~~~~ksDV~ 609 (771)
|+|||+|+......... .....+++.|+|||++... ..+..+|-|
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99999998765433211 1345688999999998643 233446666
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.8e-23 Score=196.28 Aligned_cols=272 Identities=20% Similarity=0.209 Sum_probs=204.6
Q ss_pred hcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCC-CcEEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQH-PNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 497 (771)
.++|...++||.|+||.+|.| ...+|..||||+-+..... ..+..|..+.+.+++ ..|..+..+..+.++-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 468899999999999999999 6778999999987654333 457778889888875 788888888999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC---CCCeEEEeecCcccc
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGLAKLD 574 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFGla~~~ 574 (771)
.+ |.||+++..- ....++..+++-++-|++.-++|+|.+ ++|||||||+|+|+.- ...+.++|||+|+.+
T Consensus 92 LL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 88 7899998832 234789999999999999999999999 7999999999999953 346899999999876
Q ss_pred CCCCcc------cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 575 EEDNTH------ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 575 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
.+..+. ......||.+|.+--...+...+.+.|+-|+|.+|..+.-|..||............+.....+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK---- 240 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK---- 240 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh----
Confidence 543322 1234679999999888888888999999999999999999999998754433222111111100
Q ss_pred hhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCCCCCCCCcc
Q 004155 649 LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQDFVPDSSV 709 (771)
Q Consensus 649 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~ 709 (771)
....-..+...++ .++...+.-|-..--++-|...-+.+.+.-.........+..+
T Consensus 241 -~s~~ie~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iy 296 (341)
T KOG1163|consen 241 -MSTPIEVLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIY 296 (341)
T ss_pred -cCCCHHHHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEe
Confidence 0011111222333 3466677788888888999888777776655544444444444
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-23 Score=202.73 Aligned_cols=248 Identities=24% Similarity=0.364 Sum_probs=191.9
Q ss_pred CCCccccCCceeEEEEEcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCC
Q 004155 425 PDNKIGEGGFGPVYKGHMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENN 502 (771)
Q Consensus 425 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 502 (771)
...+|.+...|..|+|++. |..+++|++.-. .....++|..|.-.|+-+.||||++++|.|....+..++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3457889999999999995 566777877543 2233568999999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccc
Q 004155 503 SLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS 582 (771)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 582 (771)
||...||+... ..++-.++.+++.+||+|++|||+.. +-|.---|.+..|++|++.+++|+ .+-+++.-..
T Consensus 273 slynvlhe~t~--vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris-mad~kfsfqe----- 343 (448)
T KOG0195|consen 273 SLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQE----- 343 (448)
T ss_pred HHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee-cccceeeeec-----
Confidence 99999977543 56788899999999999999999985 234445689999999999988874 1222211111
Q ss_pred cccccCCCccchhhhccCCC---CchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 583 TRVAGTFGYMAPEYAMRGYL---TDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 583 ~~~~gt~~y~aPE~~~~~~~---~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
....-.+.||+||.++..+- -.++|+|||++++||+.|...||..-.+-+.. +++.-+.++.
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialeglrv 408 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEGLRV 408 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhccccc
Confidence 11234578999999987643 35899999999999999999999765443321 1222233444
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
..++.....+.+++.-|+..||.+||.+..|+-.|+..
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 55555666788999999999999999999999888864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-20 Score=201.94 Aligned_cols=260 Identities=31% Similarity=0.417 Sum_probs=197.1
Q ss_pred CCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChh---cHHHHHHHHHHHHcCCCC-cEEeEEEEEEeCCEEEEEEEe
Q 004155 423 FAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQ---GNREFVNEIGMISALQHP-NLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~E~ 498 (771)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567788999999999999765 78999998765332 367899999999999988 799999999877778999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC-CeEEEeecCccccCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLDEED 577 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~~ 577 (771)
+.++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++... .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777332211 3688999999999999999999998 799999999999999988 7999999999865544
Q ss_pred Ccc-----cccccccCCCccchhhhcc---CCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-chhhHHHHHHHHHhhCC
Q 004155 578 NTH-----ISTRVAGTFGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGRSNSSCKPKE-DIFYLLDWALILKAQGN 648 (771)
Q Consensus 578 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 648 (771)
... ......||..|+|||.+.+ ...+...|+||+|++++++++|..||...... .............. .
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~ 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT--P 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC--c
Confidence 322 2355679999999999987 68899999999999999999999997654321 01111111110000 0
Q ss_pred hhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 649 LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 649 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001123467788999999999999999887764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=195.82 Aligned_cols=201 Identities=23% Similarity=0.335 Sum_probs=170.1
Q ss_pred CCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
+|++.++||+|.||.++.| .+-+++.||||.-...++ ..++..|....+.| ..++|..++.+..++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 6788999999999999999 566899999998765443 34567788887777 4699999999989999999999988
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC-----CCeEEEeecCcccc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-----LNPKISDFGLAKLD 574 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DFGla~~~ 574 (771)
|.||+++. .-....++..++..||.|++.-++|+|++ .+|.|||||+|+||... ..+.|+|||+|+.+
T Consensus 107 -GPSLEDLF---D~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLF---DLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHH---HHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 77998887 23356899999999999999999999999 79999999999999533 35899999999977
Q ss_pred CCCCccc------ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc
Q 004155 575 EEDNTHI------STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKE 631 (771)
Q Consensus 575 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~ 631 (771)
.+..+.. .....||.+||+-....+...+.+.|.-|+|-+++..+-|..||......
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 6544321 23467999999999999999999999999999999999999999875443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-22 Score=227.94 Aligned_cols=253 Identities=23% Similarity=0.277 Sum_probs=185.7
Q ss_pred CCCCccccCCceeEEEEE-cCCCcEEEEEEcc----c-CChhc-HHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 424 APDNKIGEGGFGPVYKGH-MADGTVVAVKQLS----S-KSKQG-NREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 424 ~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~----~-~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
...+++|.|++|.|+... ......++.|... . ..... ...+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 356789999999888773 3334444444432 1 11111 122566777778899999988877777666666669
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
|||++ +|...+.. ...++..++..++.|+..|++|||+. ||.|||+|++|++++.+|.+||+|||.+..+.-
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 99999832 24688899999999999999999999 899999999999999999999999999976543
Q ss_pred CCc---ccccccccCCCccchhhhccCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 577 DNT---HISTRVAGTFGYMAPEYAMRGYLTD-KADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 577 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
+.. .......|+..|+|||++.+..|.+ ..||||.|+++..|++|+.||.....++.... ........ .+
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-----~~~~~~~~-~~ 546 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-----TNNYSDQR-NI 546 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-----hhcccccc-cc
Confidence 332 4556678999999999999887776 67999999999999999999986544432210 00000000 00
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..-........+.+...++.++++.||.+|.|+.+|++
T Consensus 547 --~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 --FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred --ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000112234556788999999999999999999986
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-21 Score=238.04 Aligned_cols=178 Identities=33% Similarity=0.493 Sum_probs=123.9
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+|..|+++++|++|+|++|++++..|..++++++|+.|+
T Consensus 139 l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 218 (968)
T PLN00113 139 IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIY 218 (968)
T ss_pred cCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEE
Confidence 45666666666666666676677777777777777777777777777777777777777777766666677777777777
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCcccc
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~ 159 (771)
|++|++++.+|..++++++|++|+|++|++++.+|..++++++|+.|+|++|+++|.+|..+ +++|+.|+|++|.+++
T Consensus 219 L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~ 298 (968)
T PLN00113 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSG 298 (968)
T ss_pred CcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeecc
Confidence 77777777777777777777777777777776777777777777777777777766666655 5666666777666666
Q ss_pred CCCcccccccccceeccCCC
Q 004155 160 GSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 160 ~~p~~~~~l~~L~~l~~s~~ 179 (771)
.+|..+.++++|+.|+++.+
T Consensus 299 ~~p~~~~~l~~L~~L~l~~n 318 (968)
T PLN00113 299 EIPELVIQLQNLEILHLFSN 318 (968)
T ss_pred CCChhHcCCCCCcEEECCCC
Confidence 66666666666666665443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-21 Score=192.42 Aligned_cols=171 Identities=16% Similarity=0.165 Sum_probs=134.2
Q ss_pred HhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHH---H------HHHHHHHHHcCCCCcEEeEEEEEEeC
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNR---E------FVNEIGMISALQHPNLVKLHGCCIEG 489 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~---~------~~~E~~~l~~l~h~niv~l~~~~~~~ 489 (771)
..++|+..+++|.|+||.||.+.. ++..+|||.+........+ . +.+|+..+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468999999999999999999866 5778999999754322222 2 67899999999999999999886643
Q ss_pred --------CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC
Q 004155 490 --------NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 561 (771)
Q Consensus 490 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 561 (771)
...++||||++|.+|.++. .++. ....+++.+|..+|+. +++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 3589999999999998874 1222 3466999999999998 899999999999999988
Q ss_pred CeEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHH
Q 004155 562 NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 619 (771)
Q Consensus 562 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ell 619 (771)
++|+|||..+........ ..+.....+..++|+|+||+.+.-+.
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988755322111 11334445667999999999877654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=186.71 Aligned_cols=141 Identities=16% Similarity=0.211 Sum_probs=108.3
Q ss_pred CCccccCCceeEEEEEcCCCcEEEEEEcccCChh--c-------H-----------------HHHHHHHHHHHcCCCCcE
Q 004155 426 DNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQ--G-------N-----------------REFVNEIGMISALQHPNL 479 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni 479 (771)
...||+|+||.||+|...+|+.||||+++..... . . .....|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999998778999999999754211 1 0 122349999999987766
Q ss_pred EeEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHh-hhcCCCceeccCCCCCcEEEc
Q 004155 480 VKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYL-HEESRLKIVHRDIKATNVLLD 558 (771)
Q Consensus 480 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~ivH~Dlkp~NIll~ 558 (771)
.....+.. ...++||||++++++..... ....+++.+...++.|++.+|.|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 43332222 22389999999887765431 224688999999999999999999 576 899999999999998
Q ss_pred CCCCeEEEeecCccccCC
Q 004155 559 KDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 559 ~~~~~kl~DFGla~~~~~ 576 (771)
++.++|+|||+|.....
T Consensus 153 -~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 -DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred -CCcEEEEEccccccCCC
Confidence 47899999999975433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.6e-21 Score=215.64 Aligned_cols=251 Identities=22% Similarity=0.263 Sum_probs=182.5
Q ss_pred CCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCC-hhcHHHHHHHHHH--HHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKS-KQGNREFVNEIGM--ISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+|...+.||++.|=+|.+|..++|. |+||++-+.. .-..+.|.++++- ...++|||.+++.-.-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999888887 8899886543 3334555554443 3445899999988777777788999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc--ccCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK--LDEE 576 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~--~~~~ 576 (771)
+.. +|.|.| ..++-+...+.+.|+.|++.||..+|.. +|+|||||.+|||++.-.-+.|+||..-+ ++.+
T Consensus 103 vkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 976 899888 3445678888999999999999999998 89999999999999999999999998765 2333
Q ss_pred CCcccccccc----cCCCccchhhhccC-----------CCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHH
Q 004155 577 DNTHISTRVA----GTFGYMAPEYAMRG-----------YLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWA 640 (771)
Q Consensus 577 ~~~~~~~~~~----gt~~y~aPE~~~~~-----------~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~ 640 (771)
++....+-+. .-.+|+|||.+... ..+++-||||+||++.||++ |++||.. -.+..+.
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr 248 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYR 248 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHh
Confidence 3332221111 22379999977431 26789999999999999998 6778752 1122111
Q ss_pred HHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 641 LILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 641 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.. ........+.+ +. -..+.+++..|++.||.+|-++++.++.-.+.
T Consensus 249 ~~--~~~~~e~~Le~-Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 249 SG--NADDPEQLLEK-IE-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred cc--CccCHHHHHHh-Cc-------CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 10 00011111111 10 01477899999999999999999999986664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=179.68 Aligned_cols=140 Identities=19% Similarity=0.240 Sum_probs=110.9
Q ss_pred CCccccCCceeEEEEEcCCCcEEEEEEcccCChh---------------------c-----HHHHHHHHHHHHcCCCCcE
Q 004155 426 DNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQ---------------------G-----NREFVNEIGMISALQHPNL 479 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~ni 479 (771)
...||+|+||.||+|...+|+.||||+++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999998778999999998754211 0 1224578999999999887
Q ss_pred EeEEEEEEeCCEEEEEEEeccCCCHHHH-hcCCCccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceeccCCCCCcEEE
Q 004155 480 VKLHGCCIEGNQLLLIYEYMENNSLARA-LFGPEAHRLKLDWPTRHRICVGIARGLAYLHE-ESRLKIVHRDIKATNVLL 557 (771)
Q Consensus 480 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dlkp~NIll 557 (771)
.....+... ..++||||++++++... + ....++.....+++.|++.++.++|+ . +|+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l-----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL-----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh-----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 544433332 24899999998855433 3 12357788999999999999999999 7 89999999999999
Q ss_pred cCCCCeEEEeecCccccCC
Q 004155 558 DKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 558 ~~~~~~kl~DFGla~~~~~ 576 (771)
+ ++.++|+|||+++....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 88999999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.2e-19 Score=174.96 Aligned_cols=187 Identities=17% Similarity=0.098 Sum_probs=143.2
Q ss_pred CCCCccccCCceeEEEEEcCCCcEEEEEEcccCChh----cHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEEEEEEe
Q 004155 424 APDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQ----GNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 424 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
.+...|++|+||+||.+.. .+.+++.+.+...... ....+.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999998866 6788887777654321 1235889999999995 5889999886 346999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCC-CCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDI-KATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
+.|.+|.+.+. . ....++.|++.+|+++|++ ||+|||| ||+|||++.++.++|+|||+|......
T Consensus 80 I~G~~L~~~~~-----~------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPP-----R------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhh-----h------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 99999876541 0 1135788999999999998 8999999 799999999999999999999865543
Q ss_pred Ccc----c--------ccccccCCCccchhhhccC-CCC-chHhHHHHHHHHHHHHhCCCCCCCCC
Q 004155 578 NTH----I--------STRVAGTFGYMAPEYAMRG-YLT-DKADVYSFGIVALEIVSGRSNSSCKP 629 (771)
Q Consensus 578 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~ksDV~S~Gvil~elltG~~p~~~~~ 629 (771)
... . ......++.|++|+...-. ..+ ...+.++-|+-+|.++|++.+...+.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 310 0 1112367889999865432 233 67899999999999999998876543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.5e-19 Score=194.99 Aligned_cols=218 Identities=27% Similarity=0.359 Sum_probs=163.5
Q ss_pred HHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCC
Q 004155 471 ISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDI 550 (771)
Q Consensus 471 l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dl 550 (771)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....++|.-...++++|+.||+|||+.. --.|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeee
Confidence 3567899999999999999999999999999999999954 3467999999999999999999999872 2399999
Q ss_pred CCCcEEEcCCCCeEEEeecCccccCCCC-cccccccccCCCccchhhhccC-------CCCchHhHHHHHHHHHHHHhCC
Q 004155 551 KATNVLLDKDLNPKISDFGLAKLDEEDN-THISTRVAGTFGYMAPEYAMRG-------YLTDKADVYSFGIVALEIVSGR 622 (771)
Q Consensus 551 kp~NIll~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDV~S~Gvil~elltG~ 622 (771)
+++|.++|..+.+||+|||+..+..... ........-..-|.|||.+... ..+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999998764311 0111111234579999998763 2577899999999999999999
Q ss_pred CCCCCCCccch-hhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 623 SNSSCKPKEDI-FYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 623 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
.||........ ..++.++.. .+ ...+.+.+... .+....+..++.+||..+|.+||++.+|-..++.+...
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~---~~--~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK---GG--SNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCChHHHHHHHHh---cC--CCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99986432221 122222111 01 11111111100 13333688999999999999999999999998886554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=180.04 Aligned_cols=232 Identities=19% Similarity=0.190 Sum_probs=147.9
Q ss_pred CCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCC----------CcEEeEEEEE---
Q 004155 424 APDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQH----------PNLVKLHGCC--- 486 (771)
Q Consensus 424 ~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~--- 486 (771)
.....||.|+++.||.+. -.+|+.+|||+..... ....+.+++|.-....+.+ -.++--++..
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 346789999999999995 4568999999875432 2335666666655544322 1121111111
Q ss_pred ------EeC---C-----EEEEEEEeccCCCHHHHhc---CCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccC
Q 004155 487 ------IEG---N-----QLLLIYEYMENNSLARALF---GPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRD 549 (771)
Q Consensus 487 ------~~~---~-----~~~lV~E~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~D 549 (771)
... . ..+++|+-+. ++|.+++. ........+....++.+..|+++.+++||+. |++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 111 1 2467888774 58887752 2111122345566778889999999999999 899999
Q ss_pred CCCCcEEEcCCCCeEEEeecCccccCCCCcccccccccCCCccchhhhcc--------CCCCchHhHHHHHHHHHHHHhC
Q 004155 550 IKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR--------GYLTDKADVYSFGIVALEIVSG 621 (771)
Q Consensus 550 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDV~S~Gvil~elltG 621 (771)
|||+|++++.+|.++|+||+.....+.... . ...+..|.+||.... -.++.+.|.|++|+++|.|++|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEE---G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceee---c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999988875443221 1 234578999997743 2578899999999999999999
Q ss_pred CCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 004155 622 RSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSR 684 (771)
Q Consensus 622 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 684 (771)
+.||.....+..... .+ .... +.++.+..|+..+|+.+|.+|
T Consensus 247 ~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999986533222110 11 1223 566778899999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.2e-18 Score=170.37 Aligned_cols=136 Identities=17% Similarity=0.264 Sum_probs=107.0
Q ss_pred CCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-----CCCcEEeEEEEEEeCC---E-EEE
Q 004155 424 APDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-----QHPNLVKLHGCCIEGN---Q-LLL 494 (771)
Q Consensus 424 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l 494 (771)
...+.||+|+||.||. +..++.. +||++........+.+.+|+.+++.+ .||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4567899999999996 4445444 79988765444567899999999999 5799999999998863 4 347
Q ss_pred EEEe--ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHH-HHhhhcCCCceeccCCCCCcEEEcC----CCCeEEEe
Q 004155 495 IYEY--MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGL-AYLHEESRLKIVHRDIKATNVLLDK----DLNPKISD 567 (771)
Q Consensus 495 V~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~D 567 (771)
|+|| +.+|+|.+++.. ..+++. ..++.+++.++ +|||++ +|+||||||+|||++. +..++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 557999999933 235544 35678888777 999998 8999999999999974 34799999
Q ss_pred ecCc
Q 004155 568 FGLA 571 (771)
Q Consensus 568 FGla 571 (771)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-19 Score=197.05 Aligned_cols=186 Identities=28% Similarity=0.383 Sum_probs=155.8
Q ss_pred ccccCCceeEEEEE----cCCCcEEEEEEcccCChhc--HHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 428 KIGEGGFGPVYKGH----MADGTVVAVKQLSSKSKQG--NREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 428 ~lG~G~~g~Vy~~~----~~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
.+|+|.||.|+.+. ...|..+|+|++++..... ......|..++...+ ||.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999863 2347789999887643211 124556788888886 9999999999999999999999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+|.|...+. ....+++.........++-|++++|+. +++|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 999998883 334567777788888999999999998 8999999999999999999999999999865443222
Q ss_pred cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCC
Q 004155 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSC 627 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~ 627 (771)
+||..|||||++. .....+|.||||++++||+||..||..
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7999999999998 557789999999999999999999975
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-20 Score=170.76 Aligned_cols=160 Identities=21% Similarity=0.276 Sum_probs=147.1
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++++.|-||+|+++ .+|+.+..|.+|+.|++++|+|+ .+|.+++.|++|+.|+++-|++... |..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~l-prgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNIL-PRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcC-ccccCCCchhhhhh
Confidence 467888999999999 99999999999999999999999 8999999999999999999998865 58899999999999
Q ss_pred ccCCcCc-ccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccc
Q 004155 82 LRSCNVS-GKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFT 158 (771)
Q Consensus 82 Ls~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~ 158 (771)
|..|+++ ..+|..|..|+.|+.|+|+.|.+. .+|..+++|++|+.|.+.+|.+- .+|..+ +..|+.|.+.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 9999986 358999999999999999999999 99999999999999999999999 899998 999999999999999
Q ss_pred cCCCccccc
Q 004155 159 AGSSETSCQ 167 (771)
Q Consensus 159 ~~~p~~~~~ 167 (771)
-.+| .+++
T Consensus 187 vlpp-el~~ 194 (264)
T KOG0617|consen 187 VLPP-ELAN 194 (264)
T ss_pred ecCh-hhhh
Confidence 5544 4443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.1e-18 Score=201.31 Aligned_cols=199 Identities=21% Similarity=0.238 Sum_probs=158.7
Q ss_pred HHHHHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC---CCcEEeEEEEEEeCCE
Q 004155 415 QIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ---HPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 415 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~ 491 (771)
+.+...+.|.+.+.||+|+||+||.|...+|+.||+|+-+...... |.--.+++.+|+ -+-|..+..++.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 4555667899999999999999999987789999999977655432 222233444444 2345555555556677
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc-------CCCCeE
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD-------KDLNPK 564 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~~k 564 (771)
-+||+||.+.|+|.+++. ....++|.-++.++.|+++-+++||.. +||||||||+|++|. .+.-++
T Consensus 769 S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence 899999999999999994 456799999999999999999999998 899999999999993 234589
Q ss_pred EEeecCccccCCC-CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCC
Q 004155 565 ISDFGLAKLDEED-NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRS 623 (771)
Q Consensus 565 l~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~ 623 (771)
|+|||.+-.+.-- +.......++|-.+-.+|...+..++...|-|.++-+++-|+.|+.
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999999533211 1123345678999999999999999999999999999999999974
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-19 Score=192.98 Aligned_cols=181 Identities=21% Similarity=0.313 Sum_probs=134.0
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchh-hcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSG-IASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 80 (771)
|..|+.||||+|+++ +.|..+...+++-.|+||+|+|. .||.. |.+|+.|-+||||+|++...| +-+..|..|++|
T Consensus 102 l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LP-PQ~RRL~~LqtL 178 (1255)
T KOG0444|consen 102 LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLP-PQIRRLSMLQTL 178 (1255)
T ss_pred cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcC-HHHHHHhhhhhh
Confidence 456777777777777 77777777777777777777777 55554 556777777777777776654 445566666666
Q ss_pred EccCCcCc-------------------------ccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcc
Q 004155 81 ILRSCNVS-------------------------GKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLL 135 (771)
Q Consensus 81 ~Ls~N~l~-------------------------g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l 135 (771)
+|++|.+. ..+|.++..|.+|..+|||.|+|. .+|+.+.++.+|+.|+||+|+|
T Consensus 179 ~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~i 257 (1255)
T KOG0444|consen 179 KLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKI 257 (1255)
T ss_pred hcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCce
Confidence 66666442 125666777778888888888888 8888888888888888888888
Q ss_pred cccCchhh--hhcCCeecccCCccccCCCcccccccccceeccCCCCCCCCCccc
Q 004155 136 TGTIPPWM--LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKGNNSTGIVS 188 (771)
Q Consensus 136 ~g~iP~~~--~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~~ 188 (771)
+ .+.... ..+|+.|+||.|+|+ .+|.++|.++.|+.|....|.-+..|+++
T Consensus 258 t-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPS 310 (1255)
T KOG0444|consen 258 T-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPS 310 (1255)
T ss_pred e-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCcc
Confidence 8 555444 778888999999988 68999999999998887766655555543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=169.73 Aligned_cols=142 Identities=18% Similarity=0.163 Sum_probs=111.1
Q ss_pred CCCCCCccccCCceeEEEEE--cCCCcEEEEEEcccCChh------------------------cHHHHHHHHHHHHcCC
Q 004155 422 NFAPDNKIGEGGFGPVYKGH--MADGTVVAVKQLSSKSKQ------------------------GNREFVNEIGMISALQ 475 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 475 (771)
.|++.+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36778999999999999997 678999999998753210 1123568999999997
Q ss_pred CC--cEEeEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCc-eeccCCCC
Q 004155 476 HP--NLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK-IVHRDIKA 552 (771)
Q Consensus 476 h~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~-ivH~Dlkp 552 (771)
+. .+.+++++ ...++||||+++++|..... ....+...+...++.||+.++++||+. + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 53 34455543 23589999999988876542 123455667789999999999999998 8 99999999
Q ss_pred CcEEEcCCCCeEEEeecCccccC
Q 004155 553 TNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 553 ~NIll~~~~~~kl~DFGla~~~~ 575 (771)
+||+++ ++.++|+|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999987543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.9e-19 Score=188.38 Aligned_cols=174 Identities=20% Similarity=0.222 Sum_probs=155.6
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
|.++++|+|+.|+++..--.++.+|+.|+.|+||+|.|...-++++...++|++|+|++|+++...+..|..|..|++|.
T Consensus 268 l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~Ln 347 (873)
T KOG4194|consen 268 LEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELN 347 (873)
T ss_pred ecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhc
Confidence 46789999999999955566899999999999999999988899999999999999999999999999999999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCc---cccCCCCCcEEEcCCCcccccCchhh---hhcCCeecccCC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPS---TFMGLLDVDYIYLTGNLLTGTIPPWM---LQKGDRVDLSYN 155 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~---~~~~l~~L~~L~Ls~N~l~g~iP~~~---~~~L~~l~ls~N 155 (771)
|++|+++..-...|..+++|+.|||++|.|++.|-+ .|..|++|+.|+|.+|+|. .||+-. +..|+.|||.+|
T Consensus 348 Ls~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~N 426 (873)
T KOG4194|consen 348 LSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDN 426 (873)
T ss_pred ccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccceecCCCC
Confidence 999999966666789999999999999999977755 4788999999999999999 788644 889999999999
Q ss_pred ccccCCCcccccccccceeccC
Q 004155 156 SFTAGSSETSCQYRSVNLFASS 177 (771)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~l~~s 177 (771)
.+..+-|++|..+ .|+.|.++
T Consensus 427 aiaSIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 427 AIASIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred cceeecccccccc-hhhhhhhc
Confidence 9999999999998 88887754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.2e-17 Score=163.25 Aligned_cols=134 Identities=20% Similarity=0.306 Sum_probs=113.3
Q ss_pred CccccCCceeEEEEEcCCCcEEEEEEcccCCh--------hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSK--------QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+.||+|++|.||+|.. +|..|++|+...... .....+.+|+.++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999977 678899998654321 1124678899999999999988777777777888999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
++|++|.+++... .+ .+..++.+++.+|.+||+. +++|||++|+||+++ ++.++|+|||.++.
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998321 12 8889999999999999998 899999999999999 78999999999874
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-19 Score=165.54 Aligned_cols=159 Identities=23% Similarity=0.332 Sum_probs=144.1
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCC-CCCCCccCCCCCcEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTE-APFPPLDKMKKMKTL 80 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L 80 (771)
|.+|+.|++++|+|+ .+|..+++|++|+.|+++-|++. .+|..|+.++.|+.|||..|++.. ..|..|..|..|+.|
T Consensus 55 l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlral 132 (264)
T KOG0617|consen 55 LKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRAL 132 (264)
T ss_pred hhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHH
Confidence 678999999999999 99999999999999999999998 999999999999999999999986 467788899999999
Q ss_pred EccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-----hhcCCeecccCC
Q 004155 81 ILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-----LQKGDRVDLSYN 155 (771)
Q Consensus 81 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-----~~~L~~l~ls~N 155 (771)
+|++|.|. .+|..++++++|+.|.+..|.|- .+|.+++.|+.|++|++.+|+++ .+|+.+ ..+-+.+.+.+|
T Consensus 133 yl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~N 209 (264)
T KOG0617|consen 133 YLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEEN 209 (264)
T ss_pred HhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhC
Confidence 99999999 99999999999999999999999 89999999999999999999999 888876 223356778888
Q ss_pred ccccCCCccc
Q 004155 156 SFTAGSSETS 165 (771)
Q Consensus 156 ~l~~~~p~~~ 165 (771)
++...+.+.+
T Consensus 210 Pwv~pIaeQf 219 (264)
T KOG0617|consen 210 PWVNPIAEQF 219 (264)
T ss_pred CCCChHHHHH
Confidence 8876555543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.3e-17 Score=161.16 Aligned_cols=144 Identities=21% Similarity=0.206 Sum_probs=112.4
Q ss_pred HHHHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCCh----------------------hcHHHHHHHHHHHHc
Q 004155 416 IKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSK----------------------QGNREFVNEIGMISA 473 (771)
Q Consensus 416 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~ 473 (771)
+......|...+.||+|+||.||++...+|+.||||++..... .....+..|..++.+
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3333344778899999999999999888899999998654320 011236778889988
Q ss_pred CCCC--cEEeEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCC
Q 004155 474 LQHP--NLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIK 551 (771)
Q Consensus 474 l~h~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlk 551 (771)
+.|+ .+++.++. ...++||||+++++|..... ......++.+++.++.++|+. +++|||||
T Consensus 90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHcCCCCCceeec----CCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 8777 44555442 34589999999999876541 034567899999999999997 89999999
Q ss_pred CCcEEEcCCCCeEEEeecCccccCC
Q 004155 552 ATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 552 p~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
|+||++++++.++|+|||.+.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999975443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.1e-17 Score=185.52 Aligned_cols=145 Identities=19% Similarity=0.281 Sum_probs=116.2
Q ss_pred HHHHHHHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEc-ccC-C------hhcHHHHHHHHHHHHcCCCCcEEeEEE
Q 004155 413 LRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQL-SSK-S------KQGNREFVNEIGMISALQHPNLVKLHG 484 (771)
Q Consensus 413 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l-~~~-~------~~~~~~~~~E~~~l~~l~h~niv~l~~ 484 (771)
..........|...++||+|+||.||+|.+... .+++|+. .+. . .....++.+|++++++++|++++....
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 333344455667789999999999999977544 3444432 211 1 112356889999999999999988888
Q ss_pred EEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeE
Q 004155 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 564 (771)
Q Consensus 485 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 564 (771)
++......++||||+++++|.+++. ....++.+++++|.|||+. +++||||||+||++ +++.++
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~ 467 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLY 467 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEE
Confidence 8877778899999999999999882 4578999999999999998 89999999999999 678999
Q ss_pred EEeecCcccc
Q 004155 565 ISDFGLAKLD 574 (771)
Q Consensus 565 l~DFGla~~~ 574 (771)
|+|||+++..
T Consensus 468 liDFGla~~~ 477 (535)
T PRK09605 468 LIDFGLGKYS 477 (535)
T ss_pred EEeCcccccC
Confidence 9999999854
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.8e-17 Score=161.08 Aligned_cols=131 Identities=23% Similarity=0.318 Sum_probs=106.9
Q ss_pred ccccCCceeEEEEEcCCCcEEEEEEcccCCh--------hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 428 KIGEGGFGPVYKGHMADGTVVAVKQLSSKSK--------QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 428 ~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.||+|+||.||+|.+ +|..|++|+...... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 678899998654221 11356778999999999887655555556667789999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
+|++|.+++.... . .++.+++.+|.+||+. +++|||++|.||+++ ++.++++|||+++..
T Consensus 80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999999883211 0 7899999999999998 899999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.7e-17 Score=165.89 Aligned_cols=197 Identities=22% Similarity=0.306 Sum_probs=139.0
Q ss_pred CCCcEEeEEEEEEe---------------------------CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHH
Q 004155 475 QHPNLVKLHGCCIE---------------------------GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRIC 527 (771)
Q Consensus 475 ~h~niv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 527 (771)
+|||||++.++|.+ ....|+||..++. +|.+++.. ...+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence 59999999988753 2357999998865 99999933 345667788899
Q ss_pred HHHHHHHHHhhhcCCCceeccCCCCCcEEE--cCCC--CeEEEeecCccccCCCC-----cccccccccCCCccchhhhc
Q 004155 528 VGIARGLAYLHEESRLKIVHRDIKATNVLL--DKDL--NPKISDFGLAKLDEEDN-----THISTRVAGTFGYMAPEYAM 598 (771)
Q Consensus 528 ~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~DFGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~ 598 (771)
.|+++|+.|||.+ +|.|||+|++|||+ |+|. ...|+|||++--.+... ........|...-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 89999999999999 4444 46899999985332211 11112245777899999986
Q ss_pred cCC------CCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHH
Q 004155 599 RGY------LTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINV 672 (771)
Q Consensus 599 ~~~------~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 672 (771)
..+ --.|+|.|+.|.+.||+++...||....+... +... .++..+ ...+...+..+.++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~r~-----Yqe~qL---------Palp~~vpp~~rql 489 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DTRT-----YQESQL---------PALPSRVPPVARQL 489 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-chhh-----hhhhhC---------CCCcccCChHHHHH
Confidence 432 23599999999999999999999976322110 0000 111111 12223344457788
Q ss_pred HHHccCCCCCCCCCHHHHHHHhc
Q 004155 673 ALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 673 ~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
+...++.||.+||+..-....|.
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHH
Confidence 89999999999999876555543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.4e-17 Score=177.02 Aligned_cols=174 Identities=23% Similarity=0.328 Sum_probs=129.3
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
+.++.|++|...+|.+||..+.. ....++...+.++.|++.|++| + +.+|+|+||.||++..+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 57899999999999999965443 3467889999999999999999 4 799999999999999999999999999
Q ss_pred ccccCCCC-----cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHH
Q 004155 571 AKLDEEDN-----THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 571 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
........ ....+...||..||+||.+.+..|+.|+||||||++|+|+++ =..+++... ...-.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~ 472 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDI 472 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhh
Confidence 97665444 222345679999999999999999999999999999999997 222221100 00001
Q ss_pred hhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 004155 645 AQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSV 690 (771)
Q Consensus 645 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 690 (771)
+++. +++....+++. =..++.+++.+.|.+||++.++
T Consensus 473 r~g~----ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 473 RDGI----IPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hcCC----CChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence 1111 11111112221 2468899999999999955544
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.7e-17 Score=177.94 Aligned_cols=177 Identities=18% Similarity=0.182 Sum_probs=100.5
Q ss_pred CCCcEEEccCCcccccCCc-cccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 3 VTLKDFRISDNHFTGKIPN-FIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+.|+.||||.|.|+ .||. .|..-.+|++|+|++|+|+..--..|.+|.+|..|.|++|+++..++..|.+|++|+.|+
T Consensus 149 ~alrslDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~Ld 227 (873)
T KOG4194|consen 149 PALRSLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLD 227 (873)
T ss_pred hhhhhhhhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhh
Confidence 34556666666665 5553 344445566666666666544455555566666666666666665555555566666655
Q ss_pred ccCCcCc------------------------ccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccc
Q 004155 82 LRSCNVS------------------------GKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTG 137 (771)
Q Consensus 82 Ls~N~l~------------------------g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g 137 (771)
|..|+|. ..-...|..|.++++|+|+.|+++..--.++.+|+.|+.|+||+|.|..
T Consensus 228 LnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~r 307 (873)
T KOG4194|consen 228 LNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQR 307 (873)
T ss_pred ccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhhe
Confidence 5555554 2222234445555556666666654444455566666666666666653
Q ss_pred cCchhh--hhcCCeecccCCccccCCCcccccccccceeccCCCC
Q 004155 138 TIPPWM--LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 138 ~iP~~~--~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
.-++.. .++|.+|+|++|+++...++.+..|..|+.|.++.|.
T Consensus 308 ih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Ns 352 (873)
T KOG4194|consen 308 IHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNS 352 (873)
T ss_pred eecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccc
Confidence 333322 5666666666666666666666666666666665553
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.9e-18 Score=181.50 Aligned_cols=174 Identities=23% Similarity=0.282 Sum_probs=120.5
Q ss_pred CCCCcEEEccCCccc-ccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEE
Q 004155 2 LVTLKDFRISDNHFT-GKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~-~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 80 (771)
|+.|+.+++.+|++. .-||+.+..|..|+.||||+|+|+ ..|..+..-+++-.|+||+|++.++|-+-|.+|+.|-.|
T Consensus 77 Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfL 155 (1255)
T KOG0444|consen 77 LPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFL 155 (1255)
T ss_pred chhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhh
Confidence 456666777777764 347777888888888888888887 778888888888888888888888777777788888888
Q ss_pred EccCCcCcccCChhhhcCCCCcEEEccCCCCCC-------------------------CCCccccCCCCCcEEEcCCCcc
Q 004155 81 ILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNG-------------------------AIPSTFMGLLDVDYIYLTGNLL 135 (771)
Q Consensus 81 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-------------------------~ip~~~~~l~~L~~L~Ls~N~l 135 (771)
|||+|++. .+|+.+..|..|+.|+|++|.|.. .+|.++..|.+|..++||.|+|
T Consensus 156 DLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~L 234 (1255)
T KOG0444|consen 156 DLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNL 234 (1255)
T ss_pred ccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCC
Confidence 88888887 777777777888888888876531 2455555556666666666666
Q ss_pred cccCchhh--hhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 136 TGTIPPWM--LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 136 ~g~iP~~~--~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
. .+|..+ +.+|+.|+||+|.++ .+........+|+.|++|.|
T Consensus 235 p-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrN 278 (1255)
T KOG0444|consen 235 P-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRN 278 (1255)
T ss_pred C-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccc
Confidence 6 566555 556666666666665 23334444455555555543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.66 E-value=9e-19 Score=180.20 Aligned_cols=170 Identities=25% Similarity=0.339 Sum_probs=144.7
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+.+|..|+.++|.+. ++|+.++.+..|+.|+..+|+++ .+|.+++++.+|..|++.+|+++..+|..+. ++.|+.||
T Consensus 113 ~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld 189 (565)
T KOG0472|consen 113 LISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLD 189 (565)
T ss_pred hhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcc
Confidence 346777888888888 78888888888888888888888 7888888888888888888888887766665 88999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh---hhcCCeecccCCccc
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM---LQKGDRVDLSYNSFT 158 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~---~~~L~~l~ls~N~l~ 158 (771)
..+|-+. .+|+.++.|.+|.-|+|.+|++. .+| +|.+++.|++|+++.|++. .+|.+. ++++..|||.+|+++
T Consensus 190 ~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk 265 (565)
T KOG0472|consen 190 CNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK 265 (565)
T ss_pred cchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc
Confidence 9999888 89999999999999999999998 788 7889999999999999998 888887 667788999999998
Q ss_pred cCCCcccccccccceeccCCC
Q 004155 159 AGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 159 ~~~p~~~~~l~~L~~l~~s~~ 179 (771)
..|+.+|.+++|+.||+|.|
T Consensus 266 -e~Pde~clLrsL~rLDlSNN 285 (565)
T KOG0472|consen 266 -EVPDEICLLRSLERLDLSNN 285 (565)
T ss_pred -cCchHHHHhhhhhhhcccCC
Confidence 68889999999999998743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.6e-17 Score=183.89 Aligned_cols=213 Identities=23% Similarity=0.275 Sum_probs=143.2
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.+|..++.|..|+||.||.+.. ...+.+|+|+ .+.. .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee-------------------
Confidence 5678889999999999999944 4567888854 2211 11110 22222334333
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC-
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN- 578 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~- 578 (771)
|+-...+... ..++. +++.+++|||+. +|+|||+||+|.+++.-|++|++|||+.+..-...
T Consensus 136 --gDc~tllk~~----g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 --GDCATLLKNI----GPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred --chhhhhcccC----CCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 3444444211 22322 227899999998 89999999999999999999999999986432110
Q ss_pred -------------cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh
Q 004155 579 -------------THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA 645 (771)
Q Consensus 579 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 645 (771)
......++||+.|+|||++....|...+|.|++|+|+||.+.|+.||..+.+++.+..+- .
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi------s 272 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI------S 272 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh------h
Confidence 112244689999999999999999999999999999999999999999876665432110 0
Q ss_pred hCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 004155 646 QGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVV 691 (771)
Q Consensus 646 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 691 (771)
|.....+-+.....+..+++.+.++.+|..|--....+
T Consensus 273 --------d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 273 --------DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred --------hhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 00000111222334567788888889999886444333
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.2e-17 Score=171.95 Aligned_cols=170 Identities=23% Similarity=0.336 Sum_probs=151.8
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
-.|+.|+..+|+++ ++|+.+.++.+|..|++.+|.+. .+|...-+++.|+.||..+|-+... |+.++.|.+|..|||
T Consensus 137 ~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~tl-P~~lg~l~~L~~LyL 213 (565)
T KOG0472|consen 137 LDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLETL-PPELGGLESLELLYL 213 (565)
T ss_pred hhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhhcC-ChhhcchhhhHHHHh
Confidence 35778899999999 99999999999999999999999 5666655699999999999877775 578999999999999
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCcccc-CCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCcccc
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM-GLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~ 159 (771)
.+|+|. .+| +|+.|..|++|+++.|+++ .+|.+.+ ++++|..|||.+|+++ .+|..+ +.+|.+||||+|.+++
T Consensus 214 ~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~ 289 (565)
T KOG0472|consen 214 RRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS 289 (565)
T ss_pred hhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc
Confidence 999999 899 8999999999999999999 8998876 8999999999999999 899888 8889999999999995
Q ss_pred CCCcccccccccceeccCCCCCCC
Q 004155 160 GSSETSCQYRSVNLFASSSKGNNS 183 (771)
Q Consensus 160 ~~p~~~~~l~~L~~l~~s~~~~~~ 183 (771)
.|..++++ .|++|.+- ||..
T Consensus 290 -Lp~sLgnl-hL~~L~le--GNPl 309 (565)
T KOG0472|consen 290 -LPYSLGNL-HLKFLALE--GNPL 309 (565)
T ss_pred -CCcccccc-eeeehhhc--CCch
Confidence 67788888 88887754 5554
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.9e-15 Score=141.21 Aligned_cols=135 Identities=21% Similarity=0.226 Sum_probs=114.8
Q ss_pred CCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCC--CcEEeEEEEEEeCCEEEEEEEeccCC
Q 004155 425 PDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQH--PNLVKLHGCCIEGNQLLLIYEYMENN 502 (771)
Q Consensus 425 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~g 502 (771)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .+++++++++...+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999998744 7899999865433 4678899999999976 58999999888888899999999887
Q ss_pred CHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 503 SLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||.++.
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 65432 5567788999999999999987545799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.3e-15 Score=147.20 Aligned_cols=138 Identities=22% Similarity=0.244 Sum_probs=98.6
Q ss_pred CCccccCCceeEEEEEcCCCcEEEEEEcccCChh--cHHH----------------------HHHHHHHHHcCCCC--cE
Q 004155 426 DNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQ--GNRE----------------------FVNEIGMISALQHP--NL 479 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~h~--ni 479 (771)
.+.||+|+||.||+|...+|+.||||++...... .... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999998878999999998653211 1111 13456666666433 24
Q ss_pred EeEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceeccCCCCCcEEEc
Q 004155 480 VKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE-ESRLKIVHRDIKATNVLLD 558 (771)
Q Consensus 480 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dlkp~NIll~ 558 (771)
.+.+++ ...++||||++++.+....... .... .....++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~----~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD----VRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhh----hhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444443 2468999999995432111000 0011 6678999999999999998 6 899999999999999
Q ss_pred CCCCeEEEeecCccccCC
Q 004155 559 KDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 559 ~~~~~kl~DFGla~~~~~ 576 (771)
++.++++|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 89999999999975443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-14 Score=147.26 Aligned_cols=136 Identities=19% Similarity=0.242 Sum_probs=105.7
Q ss_pred CCccc-cCCceeEEEEEcCCCcEEEEEEcccCC-------------hhcHHHHHHHHHHHHcCCCCcE--EeEEEEEEeC
Q 004155 426 DNKIG-EGGFGPVYKGHMADGTVVAVKQLSSKS-------------KQGNREFVNEIGMISALQHPNL--VKLHGCCIEG 489 (771)
Q Consensus 426 ~~~lG-~G~~g~Vy~~~~~~g~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 489 (771)
...|| .||.|+||.+... +..++||.+.... ......+.+|++++.+++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 8999999999774 6789999875321 1223567889999999998774 6777765432
Q ss_pred -C---EEEEEEEeccC-CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeE
Q 004155 490 -N---QLLLIYEYMEN-NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 564 (771)
Q Consensus 490 -~---~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 564 (771)
. ..++||||+++ .+|.+++.. ..++.. .+.+|+.+|.+||+. ||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 699998832 234433 367899999999998 899999999999999999999
Q ss_pred EEeecCcccc
Q 004155 565 ISDFGLAKLD 574 (771)
Q Consensus 565 l~DFGla~~~ 574 (771)
|+|||.++..
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999998753
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.5e-14 Score=164.43 Aligned_cols=142 Identities=24% Similarity=0.285 Sum_probs=73.6
Q ss_pred CCCCcEEEccCCcccccCCccccCC-----------------CcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCC
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNW-----------------TLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGT 64 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l-----------------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~ 64 (771)
+++|++|+|++|+|+ .+|..+.+| ++|+.|+|++|+|+ .+|.. +++|+.|+|++|+++
T Consensus 241 p~~Lk~LdLs~N~Lt-sLP~lp~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~ 315 (788)
T PRK15387 241 PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLA 315 (788)
T ss_pred CCCCcEEEecCCccC-cccCcccccceeeccCCchhhhhhchhhcCEEECcCCccc-ccccc---ccccceeECCCCccc
Confidence 456777777777777 555432221 23455566666665 44532 355666666666666
Q ss_pred CCCC--CCccC--------------CCCCcEEEccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEE
Q 004155 65 EAPF--PPLDK--------------MKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYI 128 (771)
Q Consensus 65 ~~~~--~~~~~--------------l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L 128 (771)
+++. ..+.. ..+|+.|+|++|+|+ .+|... .+|+.|++++|+|+ .+|... .+|+.|
T Consensus 316 ~Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~-~LP~l~---~~L~~L 387 (788)
T PRK15387 316 SLPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLT-SLPALP---SGLKEL 387 (788)
T ss_pred cCCCCcccccccccccCccccccccccccceEecCCCccC-CCCCCC---cccceehhhccccc-cCcccc---cccceE
Confidence 5432 11110 136777777777777 455422 34455555555555 344321 345555
Q ss_pred EcCCCcccccCchhhhhcCCeecccCCccc
Q 004155 129 YLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158 (771)
Q Consensus 129 ~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~ 158 (771)
+|++|+|+ .+|.. ..+|+.|++++|+|+
T Consensus 388 dLs~N~Lt-~LP~l-~s~L~~LdLS~N~Ls 415 (788)
T PRK15387 388 IVSGNRLT-SLPVL-PSELKELMVSGNRLT 415 (788)
T ss_pred EecCCccc-CCCCc-ccCCCEEEccCCcCC
Confidence 55555555 34422 234555555555554
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.8e-14 Score=166.04 Aligned_cols=156 Identities=21% Similarity=0.361 Sum_probs=94.9
Q ss_pred CCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEcc
Q 004155 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILR 83 (771)
Q Consensus 4 ~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 83 (771)
+...|+|++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+++.++ ..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP-~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIP-ATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCC-hhhh--ccccEEECc
Confidence 4566777777777 6666553 46777777777776 5665543 46777777777766543 2222 356777777
Q ss_pred CCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhcCCeecccCCccccCCCc
Q 004155 84 SCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSE 163 (771)
Q Consensus 84 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~p~ 163 (771)
+|++. .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+..+|+.|++++|+++. +|.
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp~sL~~L~Ls~N~Lt~-LP~ 321 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLPSGITHLNVQSNSLTA-LPE 321 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccchhhHHHHHhcCCcccc-CCc
Confidence 77776 6666554 46777777777776 5665543 36677777777776 4555555556666666666664 333
Q ss_pred ccccccccceeccCC
Q 004155 164 TSCQYRSVNLFASSS 178 (771)
Q Consensus 164 ~~~~l~~L~~l~~s~ 178 (771)
.+. ++|+.|+++.
T Consensus 322 ~l~--~sL~~L~Ls~ 334 (754)
T PRK15370 322 TLP--PGLKTLEAGE 334 (754)
T ss_pred ccc--ccceeccccC
Confidence 221 3455555443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.2e-15 Score=173.15 Aligned_cols=254 Identities=23% Similarity=0.281 Sum_probs=185.2
Q ss_pred CCCCCCccccCCceeEEEEEcC--CCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMA--DGTVVAVKQLSSKS--KQGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 496 (771)
.|...+.||+|+|+.|-..... ....+|+|.+.... .........|..+-..+. |+|++.+++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4566777999999999887543 34456777665443 222334445777777776 999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhh-hcCCCceeccCCCCCcEEEcCCC-CeEEEeecCcccc
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH-EESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLD 574 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFGla~~~ 574 (771)
||..++++.+.+.. ......+....-....|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|..+
T Consensus 101 ~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred Cccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999998887731 11125667778889999999999999 66 899999999999999999 9999999999866
Q ss_pred CC--CCccccccccc-CCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChh
Q 004155 575 EE--DNTHISTRVAG-TFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLM 650 (771)
Q Consensus 575 ~~--~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (771)
.. ..........| ++.|+|||...+ ....+..|+||.|+++.-+++|..||......... ...|... .+...
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~---~~~~~ 251 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSN---KGRFT 251 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeeccc---ccccc
Confidence 55 22333344567 999999999887 46778899999999999999999999865443321 1111110 00000
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 651 ELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 651 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
............++..+++..+|..|.+.+++..
T Consensus 252 --------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 252 --------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --------cCccccCChhhhhcccccccCCchhccccccccc
Confidence 0011112233567778888899999999887754
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.2e-14 Score=166.66 Aligned_cols=158 Identities=21% Similarity=0.339 Sum_probs=130.1
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
.+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+++..+ ..+. ++|+.|+|
T Consensus 241 ~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP-~~lp--~sL~~L~L 311 (754)
T PRK15370 241 DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTLP-AHLP--SGITHLNV 311 (754)
T ss_pred ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccccCc-ccch--hhHHHHHh
Confidence 46899999999999 8998775 58999999999999 6888764 58999999999999865 3332 57899999
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhcCCeecccCCccccCCC
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSS 162 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~p 162 (771)
++|+++ .+|..+. ++|+.|++++|.|+ .+|..+. ++|+.|+|++|+|+ .+|..+.+.|+.|+|++|+|+. +|
T Consensus 312 s~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp~~L~~LdLs~N~Lt~-LP 383 (754)
T PRK15370 312 QSNSLT-ALPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT-VLPETLPPTITTLDVSRNALTN-LP 383 (754)
T ss_pred cCCccc-cCCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCC-cCChhhcCCcCEEECCCCcCCC-CC
Confidence 999999 6776654 78999999999999 5887664 68999999999998 7888778899999999999985 55
Q ss_pred cccccccccceeccCCC
Q 004155 163 ETSCQYRSVNLFASSSK 179 (771)
Q Consensus 163 ~~~~~l~~L~~l~~s~~ 179 (771)
..+. ..|+.|++++|
T Consensus 384 ~~l~--~sL~~LdLs~N 398 (754)
T PRK15370 384 ENLP--AALQIMQASRN 398 (754)
T ss_pred HhHH--HHHHHHhhccC
Confidence 5443 35777777764
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.9e-15 Score=152.91 Aligned_cols=84 Identities=17% Similarity=0.301 Sum_probs=69.3
Q ss_pred CCcEEEccCCcccccCCc-cccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCC-CCCCCCCCCCccCCCCCcEEE
Q 004155 4 TLKDFRISDNHFTGKIPN-FIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD-LNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 4 ~L~~L~Ls~N~l~~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~ 81 (771)
.-+.++|..|+|+ .||+ .|+.+++|+.|||++|+|+.+-|++|.+|++|..|-+.+ |+|+.++-..|.+|..|+.|.
T Consensus 68 ~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 68 ETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred cceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 4678999999999 6665 789999999999999999988899999999999888876 899888877787776666555
Q ss_pred ccCCcCc
Q 004155 82 LRSCNVS 88 (771)
Q Consensus 82 Ls~N~l~ 88 (771)
+.-|++.
T Consensus 147 lNan~i~ 153 (498)
T KOG4237|consen 147 LNANHIN 153 (498)
T ss_pred cChhhhc
Confidence 5544444
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.9e-15 Score=160.99 Aligned_cols=168 Identities=24% Similarity=0.326 Sum_probs=144.7
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
+.-...||+.|++. ++|..++.+..|+.|.|..|.+. .+|..+.+|..|++|||+.|+++..+. .+..|+ |+.|.+
T Consensus 75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~lp~-~lC~lp-Lkvli~ 150 (722)
T KOG0532|consen 75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHLPD-GLCDLP-LKVLIV 150 (722)
T ss_pred cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhcCCh-hhhcCc-ceeEEE
Confidence 34466789999998 99999999999999999999998 899999999999999999999988764 444444 889999
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCccccCC
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTAGS 161 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~~~ 161 (771)
++|+++ .+|..++.+..|..||.+.|++. .+|..++.+.+|+.|++..|++. .+|.++ --.|..||+|.|+++ .+
T Consensus 151 sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNkis-~i 226 (722)
T KOG0532|consen 151 SNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNKIS-YL 226 (722)
T ss_pred ecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCcee-ec
Confidence 999998 89999998899999999999998 88888999999999999999998 788777 446788999999998 68
Q ss_pred CcccccccccceeccCC
Q 004155 162 SETSCQYRSVNLFASSS 178 (771)
Q Consensus 162 p~~~~~l~~L~~l~~s~ 178 (771)
|-.|+.++.|+.+-+..
T Consensus 227 Pv~fr~m~~Lq~l~Len 243 (722)
T KOG0532|consen 227 PVDFRKMRHLQVLQLEN 243 (722)
T ss_pred chhhhhhhhheeeeecc
Confidence 88999999999888753
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.1e-14 Score=164.48 Aligned_cols=104 Identities=28% Similarity=0.386 Sum_probs=51.3
Q ss_pred CCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCCh-hhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcC
Q 004155 53 LTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPD-YLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLT 131 (771)
Q Consensus 53 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls 131 (771)
|+.|+|.+|.++....+.+.+.++|+.|+|++|+|. .+|+ .+.++..|+.|+||+|+|+ .+|..+..+..|+.|...
T Consensus 361 Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ah 438 (1081)
T KOG0618|consen 361 LQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAH 438 (1081)
T ss_pred HHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhc
Confidence 444455555555444444555555555555555554 4443 2444555555555555555 455555555555555555
Q ss_pred CCcccccCchhh-hhcCCeecccCCcccc
Q 004155 132 GNLLTGTIPPWM-LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 132 ~N~l~g~iP~~~-~~~L~~l~ls~N~l~~ 159 (771)
+|+|. ..|... ++.|+.+|||.|+|+.
T Consensus 439 sN~l~-~fPe~~~l~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 439 SNQLL-SFPELAQLPQLKVLDLSCNNLSE 466 (1081)
T ss_pred CCcee-echhhhhcCcceEEecccchhhh
Confidence 55554 444222 4445555555555543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.6e-15 Score=165.80 Aligned_cols=148 Identities=21% Similarity=0.231 Sum_probs=79.9
Q ss_pred CCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccC
Q 004155 29 LEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSF 108 (771)
Q Consensus 29 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 108 (771)
|+.|+|.+|.|+...-..|.+.++|+.|+|++|++...+...+.++..|+.|+||+|+++ .+|+.+.++..|++|...+
T Consensus 361 Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahs 439 (1081)
T KOG0618|consen 361 LQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHS 439 (1081)
T ss_pred HHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcC
Confidence 344555555555444334555556666666666665555555556666666666666665 5566666666666666666
Q ss_pred CCCCCCCCccccCCCCCcEEEcCCCccc-ccCchhhh-hcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 109 NKLNGAIPSTFMGLLDVDYIYLTGNLLT-GTIPPWML-QKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 109 N~l~g~ip~~~~~l~~L~~L~Ls~N~l~-g~iP~~~~-~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
|+|. .+| .+..++.|+.+|||.|+|+ +.+|.... ++|++|||++|...-..-..+..++++..++.+-+
T Consensus 440 N~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 440 NQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred Ccee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 6665 555 4555666666666666655 23333332 55666666666543333344444444444444333
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.3e-13 Score=148.93 Aligned_cols=142 Identities=21% Similarity=0.249 Sum_probs=100.8
Q ss_pred CCccccCCceeEEEEEcCCCcEEEEEEcccCChhc----------------------------------------HHHHH
Q 004155 426 DNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQG----------------------------------------NREFV 465 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~----------------------------------------~~~~~ 465 (771)
.+.||.|++|.||+|++.+|+.||||+.+...... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 46799999999999999999999999986532110 01245
Q ss_pred HHHHHHHcCC----CCcEEeEEEEE-EeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHH-HHHHhhh
Q 004155 466 NEIGMISALQ----HPNLVKLHGCC-IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIAR-GLAYLHE 539 (771)
Q Consensus 466 ~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-aL~~LH~ 539 (771)
+|+..+.+++ |.+-+.+-..+ ......+|||||++|++|.++..... ... .+.+++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHh
Confidence 5666555542 32223322222 22345799999999999988763211 112 34567777766 4778888
Q ss_pred cCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 540 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
. |++|+|+||.||+++.+++++++|||++.....
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7 899999999999999999999999999976543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.9e-13 Score=157.73 Aligned_cols=156 Identities=23% Similarity=0.282 Sum_probs=117.3
Q ss_pred CCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCch---hhcC-------------C-cCCCEEEcCCCCCCCC
Q 004155 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPS---GIAS-------------L-SKLTDLRISDLNGTEA 66 (771)
Q Consensus 4 ~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~---~~~~-------------l-~~L~~L~L~~n~l~~~ 66 (771)
+|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++ +|. .+.. + .+|+.|+|++|+++++
T Consensus 283 ~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~L 357 (788)
T PRK15387 283 GLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLASL 357 (788)
T ss_pred hcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCCCccCCC
Confidence 4555556666655 45542 3567777777777763 332 1111 1 3799999999999986
Q ss_pred CCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhc
Q 004155 67 PFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQK 146 (771)
Q Consensus 67 ~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~ 146 (771)
++ . ..+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|+ .+|.. .++|+.|+|++|+|+ .+|. +..+
T Consensus 358 P~-l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~-l~~~ 423 (788)
T PRK15387 358 PT-L---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPM-LPSG 423 (788)
T ss_pred CC-C---Ccccceehhhccccc-cCccc---ccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCc-chhh
Confidence 53 2 367889999999999 68864 367999999999999 57754 367999999999999 5886 3567
Q ss_pred CCeecccCCccccCCCcccccccccceeccCCC
Q 004155 147 GDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 147 L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
|+.|+|++|+|+ .+|..++++.+|..++++.|
T Consensus 424 L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N 455 (788)
T PRK15387 424 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 455 (788)
T ss_pred hhhhhhccCccc-ccChHHhhccCCCeEECCCC
Confidence 889999999998 68999999999999988744
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.9e-14 Score=154.79 Aligned_cols=160 Identities=24% Similarity=0.370 Sum_probs=145.7
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
..|+.|.|.+|.|. .||..+++|..|++|||+.|+++ .+|..+..|+ |+.|-+++|+++.++ +.++.+..|..||.
T Consensus 98 ~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~~lp-~~ig~~~tl~~ld~ 173 (722)
T KOG0532|consen 98 VSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLTSLP-EEIGLLPTLAHLDV 173 (722)
T ss_pred HHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccccCC-cccccchhHHHhhh
Confidence 35778899999999 99999999999999999999999 8999988876 999999999999875 66778999999999
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccccC
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~~ 160 (771)
+.|++. .+|..++.+.+|+.|.+..|++. .+|.+++.| .|..||+|.|+++ .||..| +..|++|-|.+|+|+ .
T Consensus 174 s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-S 248 (722)
T KOG0532|consen 174 SKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-S 248 (722)
T ss_pred hhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-C
Confidence 999999 99999999999999999999999 889999866 7999999999999 899999 999999999999999 5
Q ss_pred CCccccccccc
Q 004155 161 SSETSCQYRSV 171 (771)
Q Consensus 161 ~p~~~~~l~~L 171 (771)
+|..+|..-.+
T Consensus 249 PPAqIC~kGkV 259 (722)
T KOG0532|consen 249 PPAQICEKGKV 259 (722)
T ss_pred ChHHHHhccce
Confidence 78888765554
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.38 E-value=9e-14 Score=149.92 Aligned_cols=177 Identities=18% Similarity=0.182 Sum_probs=97.3
Q ss_pred CCCcEEEccCCcccc------cCCccccCCCcCCEEEcccCCccccCchhhcCCcC---CCEEEcCCCCCCCCC----CC
Q 004155 3 VTLKDFRISDNHFTG------KIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSK---LTDLRISDLNGTEAP----FP 69 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~------~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~n~l~~~~----~~ 69 (771)
++|+.|++++|.+.+ .++..+..+++|+.|+|++|.+.+..+..+..+.+ |+.|++++|+++... ..
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence 456666776666651 23344555666777777777766555555555554 777777766665311 11
Q ss_pred CccCC-CCCcEEEccCCcCccc----CChhhhcCCCCcEEEccCCCCCCC----CCccccCCCCCcEEEcCCCcccccCc
Q 004155 70 PLDKM-KKMKTLILRSCNVSGK----LPDYLGLMTSLKVLDVSFNKLNGA----IPSTFMGLLDVDYIYLTGNLLTGTIP 140 (771)
Q Consensus 70 ~~~~l-~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~iP 140 (771)
.+..+ ++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++.-.
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 210 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA 210 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH
Confidence 23344 6667777777766632 233445556667777777666632 23334445566777777666653322
Q ss_pred hhh------hhcCCeecccCCccccCCCccccc-----ccccceeccCCC
Q 004155 141 PWM------LQKGDRVDLSYNSFTAGSSETSCQ-----YRSVNLFASSSK 179 (771)
Q Consensus 141 ~~~------~~~L~~l~ls~N~l~~~~p~~~~~-----l~~L~~l~~s~~ 179 (771)
..+ +++|+.|++++|+++......++. ...|+.++++.+
T Consensus 211 ~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n 260 (319)
T cd00116 211 SALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCN 260 (319)
T ss_pred HHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCC
Confidence 211 345666677766666432222222 145566655543
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.2e-12 Score=159.74 Aligned_cols=159 Identities=24% Similarity=0.261 Sum_probs=97.0
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEE-
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTL- 80 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L- 80 (771)
|++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|..+++|++|+.|+|++|...+..|..+ ++++|+.|
T Consensus 633 l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~ 710 (1153)
T PLN03210 633 LTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLN 710 (1153)
T ss_pred CCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEe
Confidence 56777777777654446664 6777777777777766555777777777777777777764433333322 34444444
Q ss_pred --------------------EccCCcCcccCChhh------------------------------hcCCCCcEEEccCCC
Q 004155 81 --------------------ILRSCNVSGKLPDYL------------------------------GLMTSLKVLDVSFNK 110 (771)
Q Consensus 81 --------------------~Ls~N~l~g~~p~~~------------------------------~~l~~L~~L~Ls~N~ 110 (771)
+|++|.+. .+|..+ ..+++|+.|+|++|.
T Consensus 711 Lsgc~~L~~~p~~~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~ 789 (1153)
T PLN03210 711 LSGCSRLKSFPDISTNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIP 789 (1153)
T ss_pred CCCCCCccccccccCCcCeeecCCCccc-cccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCC
Confidence 44444443 333321 012356777777776
Q ss_pred CCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCccccCCCc
Q 004155 111 LNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTAGSSE 163 (771)
Q Consensus 111 l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~~~p~ 163 (771)
..+.+|.++++|++|+.|+|++|..-+.+|... +++|+.|+|++|.....+|.
T Consensus 790 ~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p~ 843 (1153)
T PLN03210 790 SLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFPD 843 (1153)
T ss_pred CccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCccccccc
Confidence 666778888888888888887765444666655 55666666666544434443
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.3e-12 Score=159.63 Aligned_cols=170 Identities=15% Similarity=0.182 Sum_probs=88.4
Q ss_pred CCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEcc
Q 004155 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILR 83 (771)
Q Consensus 4 ~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 83 (771)
+|+.|+|++|+|. .+|..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|......|..+.++++|+.|+|+
T Consensus 612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~ 689 (1153)
T PLN03210 612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689 (1153)
T ss_pred CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence 3444444444444 4444444444444444444332223332 4444444444444444333334444444444444444
Q ss_pred CCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--------------------
Q 004155 84 SCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-------------------- 143 (771)
Q Consensus 84 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-------------------- 143 (771)
+|..-+.+|..+ ++++|+.|+|++|...+.+|.. ..+|+.|+|++|.+. .+|..+
T Consensus 690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~ 764 (1153)
T PLN03210 690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWE 764 (1153)
T ss_pred CCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccccccccccccccccchhhccc
Confidence 433222444333 3444444444444333333321 234555666666655 455321
Q ss_pred ------------hhcCCeecccCCccccCCCcccccccccceeccCCCC
Q 004155 144 ------------LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 144 ------------~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
.++|+.|+|++|+..+.+|..+.++++|+.|+++.+.
T Consensus 765 ~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~ 813 (1153)
T PLN03210 765 RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCI 813 (1153)
T ss_pred cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCC
Confidence 2467788888888888899999999999999987643
|
syringae 6; Provisional |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.5e-13 Score=134.40 Aligned_cols=203 Identities=21% Similarity=0.311 Sum_probs=141.7
Q ss_pred HHHHcCCCCcEEeEEEEEEeC-----CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCC
Q 004155 469 GMISALQHPNLVKLHGCCIEG-----NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543 (771)
Q Consensus 469 ~~l~~l~h~niv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~ 543 (771)
.-|-.+-|.|||+++.|+.+. ....++.|||+-|++..+|+........+......+|+.||..||.|||+. .|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 345556799999999987644 357899999999999999987776677888999999999999999999996 67
Q ss_pred ceeccCCCCCcEEEcCCCCeEEEeecCccccCC----CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHH
Q 004155 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE----DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIV 619 (771)
Q Consensus 544 ~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ell 619 (771)
+|+|+++..+-|++..++-+|+.-- ....... ..........+-++|.|||+-.....+.++|||+||+..+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 9999999999999999988887421 1111100 0011112234678999999887778888999999999999998
Q ss_pred hCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 620 SGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 620 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.|..--......-. . +......+- .+.... =..++..|++..|..||+|.+++.
T Consensus 277 ilEiq~tnseS~~~---~--------ee~ia~~i~-~len~l-------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVE---V--------EENIANVII-GLENGL-------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceee---h--------hhhhhhhee-eccCcc-------ccCcCcccccCCCCCCcchhhhhc
Confidence 87643211110000 0 000000000 000000 124667899999999999998765
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.5e-13 Score=146.42 Aligned_cols=179 Identities=18% Similarity=0.224 Sum_probs=139.8
Q ss_pred CCCCcEEEccCCcccc----cCCccccCCCcCCEEEcccCCcc------ccCchhhcCCcCCCEEEcCCCCCCCCCCCCc
Q 004155 2 LVTLKDFRISDNHFTG----KIPNFIQNWTLLEKLVIQASGLV------GPIPSGIASLSKLTDLRISDLNGTEAPFPPL 71 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~----~ip~~~~~l~~L~~L~L~~N~l~------~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~ 71 (771)
+.+|+.|+|++|.++. .++..+...++|+.|++++|.+. ..++..+..+++|+.|+|++|.+....+..+
T Consensus 22 l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~ 101 (319)
T cd00116 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVL 101 (319)
T ss_pred HhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHH
Confidence 4569999999999953 36667778888999999999887 2345678889999999999999987665666
Q ss_pred cCCCC---CcEEEccCCcCcc----cCChhhhcC-CCCcEEEccCCCCCCC----CCccccCCCCCcEEEcCCCcccccC
Q 004155 72 DKMKK---MKTLILRSCNVSG----KLPDYLGLM-TSLKVLDVSFNKLNGA----IPSTFMGLLDVDYIYLTGNLLTGTI 139 (771)
Q Consensus 72 ~~l~~---L~~L~Ls~N~l~g----~~p~~~~~l-~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~i 139 (771)
..+.+ |+.|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+..+.+|++|+|++|.+++..
T Consensus 102 ~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 181 (319)
T cd00116 102 ESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAG 181 (319)
T ss_pred HHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHH
Confidence 65555 9999999999983 344456677 8999999999999953 3445677889999999999998532
Q ss_pred ----chhh--hhcCCeecccCCccccCC----CcccccccccceeccCCCC
Q 004155 140 ----PPWM--LQKGDRVDLSYNSFTAGS----SETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 140 ----P~~~--~~~L~~l~ls~N~l~~~~----p~~~~~l~~L~~l~~s~~~ 180 (771)
+..+ .++|+.|+|++|.+++.. +..+..+++|+.|+++.+.
T Consensus 182 ~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~ 232 (319)
T cd00116 182 IRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNN 232 (319)
T ss_pred HHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCc
Confidence 2222 348999999999987543 3456677889999988653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.31 E-value=3e-12 Score=149.38 Aligned_cols=91 Identities=21% Similarity=0.338 Sum_probs=69.0
Q ss_pred CcEEEccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccC
Q 004155 77 MKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSY 154 (771)
Q Consensus 77 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~ 154 (771)
++.|+|++|.++|.+|..++.|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..+ +++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 6677777777777777777777777777777777777777777777777777777777777777766 67777777777
Q ss_pred CccccCCCccccc
Q 004155 155 NSFTAGSSETSCQ 167 (771)
Q Consensus 155 N~l~~~~p~~~~~ 167 (771)
|+++|.+|..+..
T Consensus 500 N~l~g~iP~~l~~ 512 (623)
T PLN03150 500 NSLSGRVPAALGG 512 (623)
T ss_pred CcccccCChHHhh
Confidence 7777777776654
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.5e-12 Score=148.88 Aligned_cols=111 Identities=26% Similarity=0.452 Sum_probs=100.9
Q ss_pred CCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcC
Q 004155 52 KLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLT 131 (771)
Q Consensus 52 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls 131 (771)
.++.|+|++|.+.+..|..+.+|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..+++|++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCchhh---hhcCCeecccCCccccCCC
Q 004155 132 GNLLTGTIPPWM---LQKGDRVDLSYNSFTAGSS 162 (771)
Q Consensus 132 ~N~l~g~iP~~~---~~~L~~l~ls~N~l~~~~p 162 (771)
+|+|+|.+|..+ ..++..+++++|...+..|
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 999999999887 3456789999998766554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.8e-12 Score=140.03 Aligned_cols=247 Identities=23% Similarity=0.240 Sum_probs=177.5
Q ss_pred CCCCCCcccc--CCceeEEEEEc---CCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEE
Q 004155 422 NFAPDNKIGE--GGFGPVYKGHM---ADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 422 ~f~~~~~lG~--G~~g~Vy~~~~---~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 493 (771)
.|.+.+.+|. |.+|.||.+.. .++..+|+|.-+.. .......=.+|+....+++ |++.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566788999 99999999954 56888999984332 2233334456777777774 999999888889999999
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHH----HHHHhhhcCCCceeccCCCCCcEEEcCC-CCeEEEee
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIAR----GLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDF 568 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DF 568 (771)
+-+|++. .+|..+.+... ..++....+.+..+... ||.++|.. +++|-|+||.||+...+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 9999885 68888885433 23566677777777777 99999998 89999999999999999 88999999
Q ss_pred cCccccCCCCcc----cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHH
Q 004155 569 GLAKLDEEDNTH----ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 569 Gla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
|+...+...... ...+..|...|++||... +-++.++|+|++|.+..+..+|..+........ |.. .
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~~--~ 338 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS------WSQ--L 338 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC------ccc--c
Confidence 999877654422 123335778899999765 456899999999999999999887654331111 110 0
Q ss_pred hhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 645 AQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 645 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+. .. +-+... ..-..++...+.++++.+|..|++...+..
T Consensus 339 r~--~~-ip~e~~-----~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQ--GY-IPLEFC-----EGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cc--cc-Cchhhh-----cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00 00 111111 011123344778899999999998887765
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.5e-11 Score=138.74 Aligned_cols=145 Identities=14% Similarity=0.188 Sum_probs=93.8
Q ss_pred cCCCCCCccccCCceeEEEEEcCC-CcEEEEEEcccCChh----------------------------------cH----
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMAD-GTVVAVKQLSSKSKQ----------------------------------GN---- 461 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~----------------------------------~~---- 461 (771)
..|+. +.||+|++|.||+|.+++ |+.||||+.+..-.. -.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 789999999999998877 999999998754110 01
Q ss_pred --HHHHHHHHHHHcCC----CCcEEeEEEEEEe-CCEEEEEEEeccCCCHHHHh--cCCCccCCCCChHHHHHHHHHHHH
Q 004155 462 --REFVNEIGMISALQ----HPNLVKLHGCCIE-GNQLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHRICVGIAR 532 (771)
Q Consensus 462 --~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~ia~ 532 (771)
-+|.+|+..+.+++ +...+.+-..+.+ ....+|||||++|+.+.+.- .........+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 12444555554442 3333333333322 34678999999999998742 1110000112222222333333
Q ss_pred HHHHhhhcCCCceeccCCCCCcEEEcCCC----CeEEEeecCccccCC
Q 004155 533 GLAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISDFGLAKLDEE 576 (771)
Q Consensus 533 aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFGla~~~~~ 576 (771)
+.. |++|+|+||.||+++.++ ++++.|||++.....
T Consensus 277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 334 899999999999999888 999999999986654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.4e-11 Score=119.86 Aligned_cols=131 Identities=21% Similarity=0.137 Sum_probs=97.0
Q ss_pred CCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcE-EeEEEEEEeCCEEEEEEEeccCCCH
Q 004155 426 DNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNL-VKLHGCCIEGNQLLLIYEYMENNSL 504 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~gsL 504 (771)
.+.|+.|.++.||++... |..|++|+...... ....+..|+.+++.+.+.++ .+++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467899999999999864 78899998765432 22356789999988865444 3455443 2345899999999876
Q ss_pred HHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcC--CCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 505 ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES--RLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
.+.- .....++.+++++|+.||+.. +.+++|||++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5320 112346789999999999873 23469999999999999 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.4e-11 Score=133.55 Aligned_cols=167 Identities=19% Similarity=0.214 Sum_probs=129.2
Q ss_pred EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCCh
Q 004155 441 HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDW 520 (771)
Q Consensus 441 ~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~ 520 (771)
...++.+|.|...+...........+-++.|+.++||||++++..++.++..|+|+|-+. .|..++. .+..
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk-------~l~~ 103 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK-------ELGK 103 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH-------HhHH
Confidence 455788999998877655444556777889999999999999999999999999999984 6777772 2345
Q ss_pred HHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccccccccCCCccchhhhccC
Q 004155 521 PTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 600 (771)
Q Consensus 521 ~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 600 (771)
....-.+.||+.||.|||+.| +++|++|.-+.|+++..|+.||++|.++........ ......--..|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 666778899999999999886 899999999999999999999999998864433221 00111112246677754332
Q ss_pred CCCchHhHHHHHHHHHHHHhC
Q 004155 601 YLTDKADVYSFGIVALEIVSG 621 (771)
Q Consensus 601 ~~~~ksDV~S~Gvil~elltG 621 (771)
. -..|.|.|||+++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 356999999999999999
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.5e-12 Score=141.91 Aligned_cols=169 Identities=24% Similarity=0.360 Sum_probs=141.9
Q ss_pred CCCcEEEccCCcccccCCccccCCC-cCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWT-LLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+.++.|++.+|.++ .+|+....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++..+ ...+.+++|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~l~-~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLP-KLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhhhhh-hhhhhhhhhhhee
Confidence 56889999999999 8888888885 9999999999998 78888899999999999999999876 3334789999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCcccc
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~ 159 (771)
+++|+++ .+|.....+..|+.|.+++|++. .++..+.++.++..|.+.+|++. .+|..+ +..++.|++++|.++.
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~ 269 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS 269 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceeccccccccc
Confidence 9999999 88887777777999999999765 57778889999999999999988 445444 7779999999999986
Q ss_pred CCCcccccccccceeccCCC
Q 004155 160 GSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 160 ~~p~~~~~l~~L~~l~~s~~ 179 (771)
..+ +..+.+++.++++.+
T Consensus 270 i~~--~~~~~~l~~L~~s~n 287 (394)
T COG4886 270 ISS--LGSLTNLRELDLSGN 287 (394)
T ss_pred ccc--ccccCccCEEeccCc
Confidence 544 778888888887643
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.3e-11 Score=119.12 Aligned_cols=120 Identities=24% Similarity=0.328 Sum_probs=41.3
Q ss_pred EccCCcccccCCccccCCCcCCEEEcccCCccccCchhhc-CCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcC
Q 004155 9 RISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIA-SLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNV 87 (771)
Q Consensus 9 ~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 87 (771)
.|..+.|. .+|. +.+..++++|+|.+|+|+ .+. .++ .|.+|+.|+|++|.++.+. .+..+++|++|+|++|+|
T Consensus 3 ~lt~~~i~-~~~~-~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I 76 (175)
T PF14580_consen 3 RLTANMIE-QIAQ-YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRI 76 (175)
T ss_dssp -------------------------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS--
T ss_pred cccccccc-cccc-cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCC
Confidence 45666666 6666 555667899999999998 453 465 5889999999999999864 577889999999999999
Q ss_pred cccCChhh-hcCCCCcEEEccCCCCCCCCC--ccccCCCCCcEEEcCCCccc
Q 004155 88 SGKLPDYL-GLMTSLKVLDVSFNKLNGAIP--STFMGLLDVDYIYLTGNLLT 136 (771)
Q Consensus 88 ~g~~p~~~-~~l~~L~~L~Ls~N~l~g~ip--~~~~~l~~L~~L~Ls~N~l~ 136 (771)
+ .++..+ ..+++|+.|+|++|+|.. +- ..+..+++|+.|+|.+|.++
T Consensus 77 ~-~i~~~l~~~lp~L~~L~L~~N~I~~-l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 77 S-SISEGLDKNLPNLQELYLSNNKISD-LNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --S-CHHHHHH-TT--EEE-TTS---S-CCCCGGGGG-TT--EEE-TT-GGG
T ss_pred C-ccccchHHhCCcCCEEECcCCcCCC-hHHhHHHHcCCCcceeeccCCccc
Confidence 9 676555 468999999999999973 22 34677888999999999887
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.9e-10 Score=111.89 Aligned_cols=138 Identities=15% Similarity=0.155 Sum_probs=99.1
Q ss_pred CCccccCCceeEEEEEcCC-------CcEEEEEEcccCC----------------------hhcHHHH----HHHHHHHH
Q 004155 426 DNKIGEGGFGPVYKGHMAD-------GTVVAVKQLSSKS----------------------KQGNREF----VNEIGMIS 472 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~-------g~~vavK~l~~~~----------------------~~~~~~~----~~E~~~l~ 472 (771)
...||.|-=+.||.|...+ +..+|||+.+... ....+.+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999996543 5799999874210 0012223 37999999
Q ss_pred cCCC--CcEEeEEEEEEeCCEEEEEEEeccCCCHHH-HhcCCCccCCCCChHHHHHHHHHHHHHHHHh-hhcCCCceecc
Q 004155 473 ALQH--PNLVKLHGCCIEGNQLLLIYEYMENNSLAR-ALFGPEAHRLKLDWPTRHRICVGIARGLAYL-HEESRLKIVHR 548 (771)
Q Consensus 473 ~l~h--~niv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~ivH~ 548 (771)
++.. -++.+++++ ...++||||+.+..+.. .+ ....++..+...+..+++.+|..| |+. +++||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L-----kd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL-----KDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh-----hccccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 8853 456666654 45789999997653321 22 112345556778889999999999 676 89999
Q ss_pred CCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 549 DIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 549 Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||++.||+++ ++.++|+|||.+.....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999999997 46899999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.2e-11 Score=119.32 Aligned_cols=121 Identities=18% Similarity=0.275 Sum_probs=51.6
Q ss_pred CCCcEEEccCCcccccCCcccc-CCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQ-NWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
.++++|+|++|+|+ .|. .++ .+.+|+.|+|++|+|+ .++ .+..|++|+.|++++|+++.+.+.....+++|+.|+
T Consensus 19 ~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 19 VKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELY 94 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEE
Confidence 46899999999999 675 466 5899999999999999 555 588899999999999999987532224689999999
Q ss_pred ccCCcCcccCC--hhhhcCCCCcEEEccCCCCCCCCCc----cccCCCCCcEEE
Q 004155 82 LRSCNVSGKLP--DYLGLMTSLKVLDVSFNKLNGAIPS----TFMGLLDVDYIY 129 (771)
Q Consensus 82 Ls~N~l~g~~p--~~~~~l~~L~~L~Ls~N~l~g~ip~----~~~~l~~L~~L~ 129 (771)
|++|+|. .+- ..+..+++|+.|+|.+|.++ ..+. .+..+++|+.||
T Consensus 95 L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv~-~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 95 LSNNKIS-DLNELEPLSSLPKLRVLSLEGNPVC-EKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp -TTS----SCCCCGGGGG-TT--EEE-TT-GGG-GSTTHHHHHHHH-TT-SEET
T ss_pred CcCCcCC-ChHHhHHHHcCCCcceeeccCCccc-chhhHHHHHHHHcChhheeC
Confidence 9999997 333 46788999999999999998 3333 355677777776
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.4e-10 Score=116.18 Aligned_cols=142 Identities=20% Similarity=0.278 Sum_probs=111.0
Q ss_pred CccccCCceeEEEEEcCCCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCCC--CcEEeEEEEEEeC---CEEEEEEEecc
Q 004155 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSK-QGNREFVNEIGMISALQH--PNLVKLHGCCIEG---NQLLLIYEYME 500 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lV~E~~~ 500 (771)
+.|+.|.++.||++...+|+.+++|+...... .....+..|+++++.+++ ..+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999877778999999765322 134578899999999975 3457777776653 25689999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES--------------------------------------- 541 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~--------------------------------------- 541 (771)
|.++.+.+.. ..++...+..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9887765521 35677788888999999999998531
Q ss_pred --------------CCceeccCCCCCcEEEcC--CCCeEEEeecCccc
Q 004155 542 --------------RLKIVHRDIKATNVLLDK--DLNPKISDFGLAKL 573 (771)
Q Consensus 542 --------------~~~ivH~Dlkp~NIll~~--~~~~kl~DFGla~~ 573 (771)
+..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.2e-11 Score=135.49 Aligned_cols=156 Identities=24% Similarity=0.367 Sum_probs=138.2
Q ss_pred CCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEcc
Q 004155 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILR 83 (771)
Q Consensus 4 ~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 83 (771)
+|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|++++|++..+++ ....+..|++|+++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~-~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPP-EIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccccCch-hhhhhhhhhhhhhc
Confidence 8999999999999 89888999999999999999999 888887789999999999999998763 33456679999999
Q ss_pred CCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCccccCCC
Q 004155 84 SCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTAGSS 162 (771)
Q Consensus 84 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~~~p 162 (771)
+|++. .++..+.++.++..|.+++|++. .++..++.+++|+.|++++|+++ .++... +.+++.|++++|.++..+|
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc-ccccccccCccCEEeccCccccccch
Confidence 99766 67888999999999999999998 66788999999999999999999 676633 7899999999999998777
Q ss_pred ccc
Q 004155 163 ETS 165 (771)
Q Consensus 163 ~~~ 165 (771)
...
T Consensus 295 ~~~ 297 (394)
T COG4886 295 LIA 297 (394)
T ss_pred hhh
Confidence 544
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.2e-12 Score=125.13 Aligned_cols=131 Identities=17% Similarity=0.222 Sum_probs=69.1
Q ss_pred cccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCC
Q 004155 22 FIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSL 101 (771)
Q Consensus 22 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 101 (771)
.+..++.|+.|||++|.|+ .+..+..-+++++.|++|.|.+.... .+..|++|+.||||+|.++ .+-.+=..|.+.
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 3444455555666666555 45555555555566666665555442 3555556666666666555 444444445555
Q ss_pred cEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchh--h--hhcCCeecccCCcccc
Q 004155 102 KVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPW--M--LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 102 ~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~--~--~~~L~~l~ls~N~l~~ 159 (771)
+.|.|+.|.|. .+ ..+.+|-+|.+||+++|++. .+..- + ++-|+.+.|.+|++.+
T Consensus 355 KtL~La~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 355 KTLKLAQNKIE-TL-SGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred eeeehhhhhHh-hh-hhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCCccc
Confidence 56666666555 22 23455555566666666554 22110 1 4445555556666553
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.3e-11 Score=126.05 Aligned_cols=174 Identities=21% Similarity=0.196 Sum_probs=131.7
Q ss_pred CCCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEE
Q 004155 1 MLVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 1 ~L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 80 (771)
.|++|+.|+|++|+|+..-+.+|..+..|++|+|..|+|...-...|.+|..|+.|+|++|+++...|.+|..+.+|.+|
T Consensus 272 ~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l 351 (498)
T KOG4237|consen 272 KLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTL 351 (498)
T ss_pred hcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeee
Confidence 37899999999999997778899999999999999999986667789999999999999999999999999999999999
Q ss_pred EccCCcCcc-----------------cCChhhhcCCCCcEEEccCCCCC---C---------------------------
Q 004155 81 ILRSCNVSG-----------------KLPDYLGLMTSLKVLDVSFNKLN---G--------------------------- 113 (771)
Q Consensus 81 ~Ls~N~l~g-----------------~~p~~~~~l~~L~~L~Ls~N~l~---g--------------------------- 113 (771)
+|-.|.+.= ..|. -+.-..++.++++.+-+. -
T Consensus 352 ~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~-Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRc 430 (498)
T KOG4237|consen 352 NLLSNPFNCNCRLAWLGEWLRKKSVVGNPR-CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRC 430 (498)
T ss_pred ehccCcccCccchHHHHHHHhhCCCCCCCC-CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhh
Confidence 998886630 0111 011123444444444332 0
Q ss_pred ------CCCccccCCCCCcEEEcCCCcccccCchhhhhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 114 ------AIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 114 ------~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
.+|..+. ..-.+|+|.+|.++ .+|...+.+| .+|+++|+++......|.++.+|..|-+|++
T Consensus 431 Snk~lk~lp~~iP--~d~telyl~gn~~~-~vp~~~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 431 SNKLLKLLPRGIP--VDVTELYLDGNAIT-SVPDELLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred cccchhhcCCCCC--chhHHHhcccchhc-ccCHHHHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 2222211 13467889999998 8998888888 8999999998777778888888888877764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=7.3e-11 Score=130.01 Aligned_cols=248 Identities=20% Similarity=0.196 Sum_probs=174.2
Q ss_pred HHHhcCCCCCCccccCCceeEEEEEc--CCCcEEEEEEcccCChhc--HHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCE
Q 004155 417 KAATNNFAPDNKIGEGGFGPVYKGHM--ADGTVVAVKQLSSKSKQG--NREFVNEIGMISAL-QHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 417 ~~~~~~f~~~~~lG~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 491 (771)
...+.+|..+..||.|.|+.|++... .++..|++|.+....... ...-..|+.+...+ .|.++++....+...+.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 33456788899999999999999843 467899999887643222 22234566666665 48888888777777778
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC-CCeEEEeecC
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGL 570 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFGl 570 (771)
.++--|||+++++...+ .-...++...++++..|++.++.++|+. .++|+|+||+||++..+ +..+++|||.
T Consensus 341 ~~ip~e~~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccCchhhhcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence 88999999999887766 2234678888999999999999999987 89999999999999876 7889999999
Q ss_pred ccccCCCCcccccccccCCCcc--chhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 571 AKLDEEDNTHISTRVAGTFGYM--APEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
+..+.-.. ....++-++. +|+......+..+.|+||||.-+.|.++|..--.... .|
T Consensus 414 ~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~--------- 472 (524)
T KOG0601|consen 414 WTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QS--------- 472 (524)
T ss_pred ccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cc---------
Confidence 86422111 1112223344 5555566788899999999999999999875322110 00
Q ss_pred hhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 649 LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 649 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
..+....+ ...+. ....+..++..+...++..||.+.+.....+
T Consensus 473 -~~i~~~~~-p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 473 -LTIRSGDT-PNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -eeeecccc-cCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 00000000 11111 1145666777888899999999888766544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2e-09 Score=102.27 Aligned_cols=132 Identities=23% Similarity=0.315 Sum_probs=100.9
Q ss_pred CccccCCceeEEEEEcCCCcEEEEEEcccCC--------hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKS--------KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
..+++|+=+.+|.+.+. |..+++|.-.++. +-...+-.+|+.++.+++--.|.-.+-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999774 4456666533221 11234567799999988765555555566677888999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
++|-.|.+.+... ...++..+-.-+.-||.. +|+||||.++||.+..+. +.++|||++.+.
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888322 356778888888999998 899999999999997764 999999999843
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.9e-11 Score=119.96 Aligned_cols=125 Identities=26% Similarity=0.285 Sum_probs=65.5
Q ss_pred CcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccC
Q 004155 5 LKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRS 84 (771)
Q Consensus 5 L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 84 (771)
|++||||+|.|+ .|.+++.-++.++.|+|++|+|. .+. .++.|.+|+.||||+|.++... .+-.+|.+.+.|.|+.
T Consensus 286 LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~~~-Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 286 LTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAECV-GWHLKLGNIKTLKLAQ 361 (490)
T ss_pred hhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHhhh-hhHhhhcCEeeeehhh
Confidence 455555555555 55555555555555555555555 222 2555555555555555555433 2233455555555555
Q ss_pred CcCcccCChhhhcCCCCcEEEccCCCCCCCCC--ccccCCCCCcEEEcCCCccc
Q 004155 85 CNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIP--STFMGLLDVDYIYLTGNLLT 136 (771)
Q Consensus 85 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip--~~~~~l~~L~~L~Ls~N~l~ 136 (771)
|.|. .+ ..++.|-+|..||+++|++. .+. ..+++|+.|+.|.|.+|.|.
T Consensus 362 N~iE-~L-SGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 362 NKIE-TL-SGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hhHh-hh-hhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCCcc
Confidence 5554 22 13445555555555555555 221 23555555555555555555
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.5e-09 Score=99.96 Aligned_cols=143 Identities=19% Similarity=0.279 Sum_probs=105.6
Q ss_pred CCCccccCCceeEEEEEcCCCcEEEEEEcccC--------ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 425 PDNKIGEGGFGPVYKGHMADGTVVAVKQLSSK--------SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 425 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~--------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
....|-+|+-+.|+++.+ .|+...||.-... .+-..++-.+|+..|.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467899999999999988 4787777753221 1223456788999999886555544444566667778999
Q ss_pred EeccC-CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC---CeEEEeecCcc
Q 004155 497 EYMEN-NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NPKISDFGLAK 572 (771)
Q Consensus 497 E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFGla~ 572 (771)
||++| .++.+++..... .....+.....+.+|-+.+.-||.. .|+||||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99977 478888754322 1222333378899999999999998 899999999999996554 45899999986
Q ss_pred c
Q 004155 573 L 573 (771)
Q Consensus 573 ~ 573 (771)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.4e-08 Score=107.83 Aligned_cols=170 Identities=19% Similarity=0.312 Sum_probs=131.3
Q ss_pred ceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEE----eCCEEEEEEEeccC-CCHHHH
Q 004155 434 FGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI----EGNQLLLIYEYMEN-NSLARA 507 (771)
Q Consensus 434 ~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lV~E~~~~-gsL~~~ 507 (771)
-.+.||+ ...||..|++|+++....+....-..-+++++++.|+|+|++...+. .+..+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3678999 55689999999996543333323345688899999999999999886 34578999999986 477776
Q ss_pred hcCCC-----------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 508 LFGPE-----------AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 508 l~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
-+... ..+...++...|.++.|+..||.++|+. |+..+-|.+.+|+++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 64432 2234678899999999999999999998 899999999999999999999998887766554
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCC
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSN 624 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p 624 (771)
+.... +. --.+-|.=.||.+++.|.||...
T Consensus 446 d~~~~---------------le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTEP---------------LE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCcc---------------hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 43110 10 12367999999999999999754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=8.5e-09 Score=101.15 Aligned_cols=126 Identities=24% Similarity=0.261 Sum_probs=84.8
Q ss_pred eEEEEEcCCCcEEEEEEcccCC--------------h------------hcHHHHHHHHHHHHcCCCC--cEEeEEEEEE
Q 004155 436 PVYKGHMADGTVVAVKQLSSKS--------------K------------QGNREFVNEIGMISALQHP--NLVKLHGCCI 487 (771)
Q Consensus 436 ~Vy~~~~~~g~~vavK~l~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 487 (771)
.||.|...+|..+|||+.+... . .......+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899988899999999864310 0 1123567899999999765 466666542
Q ss_pred eCCEEEEEEEecc--CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHh-hhcCCCceeccCCCCCcEEEcCCCCeE
Q 004155 488 EGNQLLLIYEYME--NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYL-HEESRLKIVHRDIKATNVLLDKDLNPK 564 (771)
Q Consensus 488 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~L-H~~~~~~ivH~Dlkp~NIll~~~~~~k 564 (771)
..++||||++ |..+..+.. ..++......++.+++..+..+ |.. +++||||.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~------~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD------VDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH------CGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHh------ccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 3479999998 555544331 1222456677888888866665 566 99999999999999988 999
Q ss_pred EEeecCccccC
Q 004155 565 ISDFGLAKLDE 575 (771)
Q Consensus 565 l~DFGla~~~~ 575 (771)
++|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999987544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=6.3e-10 Score=128.54 Aligned_cols=249 Identities=17% Similarity=0.205 Sum_probs=166.7
Q ss_pred HHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
...+.|.+.+-+-+|.++.++.+.- ..|...+.|...... ....+....+-.++-..+||.++.....+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 3456777888899999999998733 234444444433221 111222223323332334576666555544566789
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
||++|..+++|...|+... ..+.+........+..+++|||.. .+.|+|++|.|++...++..+++|||....
T Consensus 881 L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence 9999999999999996543 355555556667788899999987 689999999999999999999999984431
Q ss_pred cCCC------------------------------CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCC
Q 004155 574 DEED------------------------------NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRS 623 (771)
Q Consensus 574 ~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~ 623 (771)
.... .........||+.|.+||...+......+|.|+.|++++|.++|.+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 1100 0011223568999999999999999999999999999999999999
Q ss_pred CCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc-CCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 004155 624 NSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL-GSNFDKEQVMVMINVALLCTDVSSTSRPSMS 688 (771)
Q Consensus 624 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 688 (771)
||.....+..+.- ++.... ....+.+......+++...+..+|.+|-.|.
T Consensus 1034 p~na~tpq~~f~n---------------i~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQIFEN---------------ILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhhhhhc---------------cccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9986655443211 111100 0111222233455666777788888888776
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.3e-10 Score=102.12 Aligned_cols=136 Identities=24% Similarity=0.261 Sum_probs=107.7
Q ss_pred CcCCEEEcccCCccccCchhhcCCc---CCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcE
Q 004155 27 TLLEKLVIQASGLVGPIPSGIASLS---KLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKV 103 (771)
Q Consensus 27 ~~L~~L~L~~N~l~~~~p~~~~~l~---~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 103 (771)
..+..|+|++++|. .+++....+. .|+..+|++|.+...++..-.+.+.++.|+|++|+|+ .+|.++..++.|+.
T Consensus 27 kE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 27 KELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred HHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 34667888888886 5666655544 4666689999888887666667788999999999999 99999999999999
Q ss_pred EEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hh-cCCeecccCCccccCCCcccc
Q 004155 104 LDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQ-KGDRVDLSYNSFTAGSSETSC 166 (771)
Q Consensus 104 L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~-~L~~l~ls~N~l~~~~p~~~~ 166 (771)
|++++|.|. ..|..+..|.+|..|+..+|.+. .||..+ .+ .....++.+|++.+.-+..+.
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klq 167 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQ 167 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccc
Confidence 999999999 88888888999999999999998 888665 33 334457777888776554433
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.5e-08 Score=101.20 Aligned_cols=141 Identities=16% Similarity=0.040 Sum_probs=100.8
Q ss_pred CccccCCceeEEEEEcCCCcEEEEEEcccCChh-----------cHHHHHHHHHHHHcCCCCc--EEeEEEEEEe-----
Q 004155 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQ-----------GNREFVNEIGMISALQHPN--LVKLHGCCIE----- 488 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~----- 488 (771)
+.+-......|+++.. +|+.|.||+....... ....+.+|...+.++...+ .++++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445777766 6788999977443211 1124778998888874333 3445555543
Q ss_pred CCEEEEEEEeccCC-CHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC-------C
Q 004155 489 GNQLLLIYEYMENN-SLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK-------D 560 (771)
Q Consensus 489 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-------~ 560 (771)
...-++|||++++- +|.+++.... ....+...+..++.+++..+.-||.. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23578999999886 8999883221 12445667789999999999999999 9999999999999975 4
Q ss_pred CCeEEEeecCccc
Q 004155 561 LNPKISDFGLAKL 573 (771)
Q Consensus 561 ~~~kl~DFGla~~ 573 (771)
+.+.++||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998863
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.1e-09 Score=83.62 Aligned_cols=39 Identities=23% Similarity=0.324 Sum_probs=14.4
Q ss_pred hcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCC
Q 004155 47 IASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSC 85 (771)
Q Consensus 47 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 85 (771)
|.++++|++|+|++|+++.+++..|.++++|++|+|++|
T Consensus 21 f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 21 FSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp TTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred HcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 333333333333333333333333333333333333333
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=4e-09 Score=83.66 Aligned_cols=59 Identities=29% Similarity=0.399 Sum_probs=28.1
Q ss_pred CCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccCCC
Q 004155 52 KLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNK 110 (771)
Q Consensus 52 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 110 (771)
+|+.|+|++|+++.+++..|.++++|++|+|++|+++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444444444444445555555555555543333444445555555554444
|
... |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.3e-09 Score=121.94 Aligned_cols=173 Identities=24% Similarity=0.249 Sum_probs=115.0
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+..++.|++..|.|. .+-..+..+++|+.|+|.+|+|. .+...+..+++|++|+|++|+|+.+. .+..++.|+.|+
T Consensus 71 l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhhe
Confidence 456677778888887 54455777888888888888887 44444677888888888888888764 466677788888
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCcc-ccCCCCCcEEEcCCCcccccCch-hhhhcCCeecccCCcccc
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPST-FMGLLDVDYIYLTGNLLTGTIPP-WMLQKGDRVDLSYNSFTA 159 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~-~~~l~~L~~L~Ls~N~l~g~iP~-~~~~~L~~l~ls~N~l~~ 159 (771)
+++|.|+ .+. .+..+++|+.+++++|.+. .+... ...+.+|+.+++.+|.+. .+.. ..+..+..+++..|.++.
T Consensus 147 l~~N~i~-~~~-~~~~l~~L~~l~l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~-~i~~~~~~~~l~~~~l~~n~i~~ 222 (414)
T KOG0531|consen 147 LSGNLIS-DIS-GLESLKSLKLLDLSYNRIV-DIENDELSELISLEELDLGGNSIR-EIEGLDLLKKLVLLSLLDNKISK 222 (414)
T ss_pred eccCcch-hcc-CCccchhhhcccCCcchhh-hhhhhhhhhccchHHHhccCCchh-cccchHHHHHHHHhhccccccee
Confidence 8888887 444 4555788888888888888 44432 467778888888888877 3332 224555555667776664
Q ss_pred CCCcccccccccceeccCCCCCC
Q 004155 160 GSSETSCQYRSVNLFASSSKGNN 182 (771)
Q Consensus 160 ~~p~~~~~l~~L~~l~~s~~~~~ 182 (771)
.-+-.......|+.++++.++..
T Consensus 223 ~~~l~~~~~~~L~~l~l~~n~i~ 245 (414)
T KOG0531|consen 223 LEGLNELVMLHLRELYLSGNRIS 245 (414)
T ss_pred ccCcccchhHHHHHHhcccCccc
Confidence 33211111112455555554443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.5e-09 Score=121.34 Aligned_cols=167 Identities=21% Similarity=0.206 Sum_probs=98.7
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|+|.+|+|. .+...+..+++|++|+|++|.|+...+ +..|+.|+.|++++|.++.+. .+..+++|+.|+
T Consensus 94 ~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~~--~~~~l~~L~~l~ 168 (414)
T KOG0531|consen 94 LKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISDIS--GLESLKSLKLLD 168 (414)
T ss_pred ccceeeeeccccchh-hcccchhhhhcchheeccccccccccc--hhhccchhhheeccCcchhcc--CCccchhhhccc
Confidence 456777777777777 454446667777777777777763333 445666777777777776643 444567777777
Q ss_pred ccCCcCcccCChh-hhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhc--CCeecccCCccc
Q 004155 82 LRSCNVSGKLPDY-LGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQK--GDRVDLSYNSFT 158 (771)
Q Consensus 82 Ls~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~--L~~l~ls~N~l~ 158 (771)
+++|++. .+... ...+.+|+.+++++|.+. .+ ..+..+..+..+++..|.++-.-+...+.. |+.+++++|++.
T Consensus 169 l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~-~i-~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~ 245 (414)
T KOG0531|consen 169 LSYNRIV-DIENDELSELISLEELDLGGNSIR-EI-EGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRIS 245 (414)
T ss_pred CCcchhh-hhhhhhhhhccchHHHhccCCchh-cc-cchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCccc
Confidence 7777776 44332 456677777777777776 22 234445555555777777662222211222 667777777766
Q ss_pred cCCCcccccccccceeccC
Q 004155 159 AGSSETSCQYRSVNLFASS 177 (771)
Q Consensus 159 ~~~p~~~~~l~~L~~l~~s 177 (771)
. .++.+..+..+..++.+
T Consensus 246 ~-~~~~~~~~~~l~~l~~~ 263 (414)
T KOG0531|consen 246 R-SPEGLENLKNLPVLDLS 263 (414)
T ss_pred c-ccccccccccccccchh
Confidence 3 22334444455555544
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.1e-09 Score=111.10 Aligned_cols=156 Identities=20% Similarity=0.219 Sum_probs=118.5
Q ss_pred CCCCcEEEccCCcccccCC--ccccCCCcCCEEEcccCCccccCchh-hcCCcCCCEEEcCCCCCCCCCCC-CccCCCCC
Q 004155 2 LVTLKDFRISDNHFTGKIP--NFIQNWTLLEKLVIQASGLVGPIPSG-IASLSKLTDLRISDLNGTEAPFP-PLDKMKKM 77 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip--~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L 77 (771)
|++++.||||.|-|+.-.| .-...|++|+.|+|+.|++.-..... -..++.|+.|.|+.|.++.-... ....+++|
T Consensus 145 ~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl 224 (505)
T KOG3207|consen 145 LPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSL 224 (505)
T ss_pred CCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcH
Confidence 7899999999998883222 33566999999999999997433322 23578999999999999853222 34568999
Q ss_pred cEEEccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCC--ccccCCCCCcEEEcCCCccccc-Cchh------h-hhcC
Q 004155 78 KTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIP--STFMGLLDVDYIYLTGNLLTGT-IPPW------M-LQKG 147 (771)
Q Consensus 78 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip--~~~~~l~~L~~L~Ls~N~l~g~-iP~~------~-~~~L 147 (771)
+.|+|..|..-+.-.....-+..|+.|||++|++- ..+ ...+.++.|+.|+++.+.+... +|+. . +++|
T Consensus 225 ~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL 303 (505)
T KOG3207|consen 225 EVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKL 303 (505)
T ss_pred HHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccc
Confidence 99999999643344445556788999999999998 555 3578899999999999988731 2332 1 7899
Q ss_pred CeecccCCccc
Q 004155 148 DRVDLSYNSFT 158 (771)
Q Consensus 148 ~~l~ls~N~l~ 158 (771)
++|+++.|++.
T Consensus 304 ~~L~i~~N~I~ 314 (505)
T KOG3207|consen 304 EYLNISENNIR 314 (505)
T ss_pred eeeecccCccc
Confidence 99999999986
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=5.8e-07 Score=94.86 Aligned_cols=259 Identities=17% Similarity=0.195 Sum_probs=157.3
Q ss_pred CCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEE------E-eCCEEEEEE
Q 004155 425 PDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCC------I-EGNQLLLIY 496 (771)
Q Consensus 425 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~-~~~~~~lV~ 496 (771)
....||+|+-+.+|..-.- +. -+.|++..-......+ .+..|.+. .||-+-.-+.+= - ......+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4578999999999975221 12 3347665543322222 23334444 455433312211 1 122367788
Q ss_pred EeccCCCHHHHhcC---CCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 497 EYMENNSLARALFG---PEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 497 E~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+.+.+.-=-..+.. ++.+.....|.-.+++++.+|.+.+-||+. |.+-||+.++|+|+.+++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 88776422222222 223345689999999999999999999998 889999999999999999999998544332
Q ss_pred cCCCCcccccccccCCCccchhhhc-----cCCCCchHhHHHHHHHHHHHHhC-CCCCCCCCccc---hhhHHHHHHHHH
Q 004155 574 DEEDNTHISTRVAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSG-RSNSSCKPKED---IFYLLDWALILK 644 (771)
Q Consensus 574 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvil~elltG-~~p~~~~~~~~---~~~~~~~~~~~~ 644 (771)
. .+.......+|...|.+||... +-.-+...|-|.+||++++++.| ++||..-.... .-...+-
T Consensus 167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I----- 239 (637)
T COG4248 167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI----- 239 (637)
T ss_pred c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh-----
Confidence 2 2222334457889999999765 33567789999999999999987 89997632110 0000000
Q ss_pred hhCChhHHhhhhcC-----CCCCH-HHHHHHHHHHHHccCC--CCCCCCCHHHHHHHhcCCC
Q 004155 645 AQGNLMELVDKRLG-----SNFDK-EQVMVMINVALLCTDV--SSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 645 ~~~~~~~~~d~~l~-----~~~~~-~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~L~~~~ 698 (771)
..+.....-|.... ...+- -....+..+..+|+.. .+.-||+++..+..|....
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 01111111111110 11111 1223566677888864 3668999998888776543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.7e-09 Score=110.69 Aligned_cols=176 Identities=16% Similarity=0.149 Sum_probs=118.1
Q ss_pred CCCCcEEEccCCcccccCC--ccccCCCcCCEEEcccCCccccC--chhhcCCcCCCEEEcCCCCCCCCCCC-CccCCCC
Q 004155 2 LVTLKDFRISDNHFTGKIP--NFIQNWTLLEKLVIQASGLVGPI--PSGIASLSKLTDLRISDLNGTEAPFP-PLDKMKK 76 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip--~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~ 76 (771)
+..|+...|.+..+. ..+ .....+++++.|||+.|-|..-. -.-...|++|+.|+|+.|++.-.... .-..+++
T Consensus 120 ~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 120 LKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred HHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 566788888888776 444 24566888888999988887322 23345688888899988888754432 2235788
Q ss_pred CcEEEccCCcCccc-CChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh----hhcCCeec
Q 004155 77 MKTLILRSCNVSGK-LPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM----LQKGDRVD 151 (771)
Q Consensus 77 L~~L~Ls~N~l~g~-~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~----~~~L~~l~ 151 (771)
|+.|.|+.|.|+-. +-..+..+++|+.|+|..|..-+.--....-+..|+.|+|++|++. ..+..- ++.|..|+
T Consensus 199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhh
Confidence 88888888888722 1123456788888888888533333344555678888888888887 344211 77788888
Q ss_pred ccCCccccC-CCcc-----cccccccceeccCCC
Q 004155 152 LSYNSFTAG-SSET-----SCQYRSVNLFASSSK 179 (771)
Q Consensus 152 ls~N~l~~~-~p~~-----~~~l~~L~~l~~s~~ 179 (771)
++.+.+... .|+. ...+.+|+.|+.+.|
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N 311 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISEN 311 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccC
Confidence 888877654 3333 345566777766544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.8e-07 Score=94.22 Aligned_cols=134 Identities=25% Similarity=0.231 Sum_probs=98.1
Q ss_pred CCCCccccCCceeEEEEEcCCCcEEEEEEcccCC----------------------hhcHHHHHHHHHHHHcCCCC--cE
Q 004155 424 APDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKS----------------------KQGNREFVNEIGMISALQHP--NL 479 (771)
Q Consensus 424 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~----------------------~~~~~~~~~E~~~l~~l~h~--ni 479 (771)
.+.++||.|-=+.||.|..++|.++|||.-+... .......++|.++|.++.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4568999999999999999999999999643110 01234567899999998644 66
Q ss_pred EeEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC
Q 004155 480 VKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 559 (771)
Q Consensus 480 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 559 (771)
.+.+++ +..++||||++|-.|... +++....-.|+..|+.-+..+-.. ||||||+.+-||++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCcccc----ccceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 666654 557899999998555432 223444445555555555555444 8999999999999999
Q ss_pred CCCeEEEeecCccc
Q 004155 560 DLNPKISDFGLAKL 573 (771)
Q Consensus 560 ~~~~kl~DFGla~~ 573 (771)
+|.+.++||=-+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999976653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.5e-08 Score=111.64 Aligned_cols=150 Identities=19% Similarity=0.298 Sum_probs=102.7
Q ss_pred HHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc--------ccccccccCCCccchhhhcc
Q 004155 528 VGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT--------HISTRVAGTFGYMAPEYAMR 599 (771)
Q Consensus 528 ~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~ 599 (771)
.+++.||.|+|... ++||++|.|++|.++.++.+||+.|+.+........ .......-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34559999999874 899999999999999999999999999865443211 11111234568999999999
Q ss_pred CCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccC
Q 004155 600 GYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTD 678 (771)
Q Consensus 600 ~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~ 678 (771)
...+.++|+||+||++|.+.. |+.-+............ ...+..-...+..+.+.++.+=+.+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHHHHHHHHHhc
Confidence 889999999999999999994 54444332211111100 0001100112223445567777788899
Q ss_pred CCCCCCCCHHHHHH
Q 004155 679 VSSTSRPSMSSVVS 692 (771)
Q Consensus 679 ~dP~~RPs~~evl~ 692 (771)
.++.-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998877765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=1e-06 Score=88.69 Aligned_cols=107 Identities=22% Similarity=0.215 Sum_probs=83.9
Q ss_pred HHHHHHHHHHHHcCCC--CcEEeEEEEEEeC----CEEEEEEEeccCC-CHHHHhcCCCccCCCCChHHHHHHHHHHHHH
Q 004155 461 NREFVNEIGMISALQH--PNLVKLHGCCIEG----NQLLLIYEYMENN-SLARALFGPEAHRLKLDWPTRHRICVGIARG 533 (771)
Q Consensus 461 ~~~~~~E~~~l~~l~h--~niv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~a 533 (771)
.....+|...+..+.. =..++.+++.... ...++|+|++++. +|.+++.... ..+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 4467788888877743 3345666666542 2458999999874 7999984321 25667788999999999
Q ss_pred HHHhhhcCCCceeccCCCCCcEEEcCCC---CeEEEeecCcccc
Q 004155 534 LAYLHEESRLKIVHRDIKATNVLLDKDL---NPKISDFGLAKLD 574 (771)
Q Consensus 534 L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFGla~~~ 574 (771)
++-||+. ||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 899999999999998887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.2e-08 Score=103.08 Aligned_cols=177 Identities=17% Similarity=0.140 Sum_probs=129.8
Q ss_pred CCCcEEEccCCcccccCCcc----ccCCCcCCEEEcccCCcccc----C---------chhhcCCcCCCEEEcCCCCCCC
Q 004155 3 VTLKDFRISDNHFTGKIPNF----IQNWTLLEKLVIQASGLVGP----I---------PSGIASLSKLTDLRISDLNGTE 65 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~----~~~l~~L~~L~L~~N~l~~~----~---------p~~~~~l~~L~~L~L~~n~l~~ 65 (771)
+.|+.||||+|-|.-.-++. +.+...|++|+|.||.+... + ..-.+.-++|+++...+|++..
T Consensus 92 ~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen 171 (382)
T KOG1909|consen 92 PKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLEN 171 (382)
T ss_pred CceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccccc
Confidence 47999999999998444443 46678899999999998621 1 1122345689999999999887
Q ss_pred CCCC----CccCCCCCcEEEccCCcCccc----CChhhhcCCCCcEEEccCCCCCCC----CCccccCCCCCcEEEcCCC
Q 004155 66 APFP----PLDKMKKMKTLILRSCNVSGK----LPDYLGLMTSLKVLDVSFNKLNGA----IPSTFMGLLDVDYIYLTGN 133 (771)
Q Consensus 66 ~~~~----~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~Ls~N 133 (771)
.... .|...+.|+.+.++.|.|... +-..|..+++|+.|||..|-|+-. +...++.++.|+.|+++++
T Consensus 172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dc 251 (382)
T KOG1909|consen 172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDC 251 (382)
T ss_pred ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccc
Confidence 5533 366778999999999998621 223577899999999999999832 3446778889999999999
Q ss_pred cccccCchhh-------hhcCCeecccCCccccC----CCcccccccccceeccCCC
Q 004155 134 LLTGTIPPWM-------LQKGDRVDLSYNSFTAG----SSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 134 ~l~g~iP~~~-------~~~L~~l~ls~N~l~~~----~p~~~~~l~~L~~l~~s~~ 179 (771)
.+...--..+ .++|+.|.|.+|.++.. +-......+.|..|+++.|
T Consensus 252 ll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN 308 (382)
T KOG1909|consen 252 LLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGN 308 (382)
T ss_pred ccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcc
Confidence 9984433332 66899999999998743 2233445667777776533
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.2e-06 Score=83.59 Aligned_cols=138 Identities=17% Similarity=0.128 Sum_probs=103.2
Q ss_pred cccCCceeEEEEEcCCCcEEEEEEcccC---C---hhcHHHHHHHHHHHHcCCC--CcEEeEEEEEEe----CCEEEEEE
Q 004155 429 IGEGGFGPVYKGHMADGTVVAVKQLSSK---S---KQGNREFVNEIGMISALQH--PNLVKLHGCCIE----GNQLLLIY 496 (771)
Q Consensus 429 lG~G~~g~Vy~~~~~~g~~vavK~l~~~---~---~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~----~~~~~lV~ 496 (771)
-|+||-+.|+..... |..+=+|+-... + +.+...|.+|...|.++.. -.+.++..+... ...-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 477999999998774 557888876421 1 3456789999999998853 235555522222 12468999
Q ss_pred EeccC-CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC--eEEEeecCcc
Q 004155 497 EYMEN-NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN--PKISDFGLAK 572 (771)
Q Consensus 497 E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFGla~ 572 (771)
|-+++ -+|.+++.... ..+.+...+..+..+++..++-||+. ++.|+|+.+.||+++.++. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98763 48999884322 23567778889999999999999998 8999999999999986667 9999998775
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=7.6e-09 Score=92.61 Aligned_cols=132 Identities=18% Similarity=0.208 Sum_probs=104.5
Q ss_pred CcEEEccCCcccccCCccc---cCCCcCCEEEcccCCccccCchhhcC-CcCCCEEEcCCCCCCCCCCCCccCCCCCcEE
Q 004155 5 LKDFRISDNHFTGKIPNFI---QNWTLLEKLVIQASGLVGPIPSGIAS-LSKLTDLRISDLNGTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 5 L~~L~Ls~N~l~~~ip~~~---~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 80 (771)
+..|+|+++.|- .+++.. .....|+..+|++|.+. .+|..|.. .+.++.|+|++|.++..|. .+..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPe-E~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPE-ELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchH-HHhhhHHhhhc
Confidence 556889999886 677654 44556777899999998 77777765 4589999999999999764 49999999999
Q ss_pred EccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCch
Q 004155 81 ILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPP 141 (771)
Q Consensus 81 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~ 141 (771)
+++.|.|. ..|..+..|.+|-+||..+|.+. .||-.+---+.+-...+.+|.+.+.-|.
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 99999999 88999999999999999999998 7876633222333445577888776664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.41 E-value=3e-06 Score=86.38 Aligned_cols=138 Identities=17% Similarity=0.211 Sum_probs=85.9
Q ss_pred CccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCc--EEeEEEEEEeCCEEEEEEEeccCCC-
Q 004155 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPN--LVKLHGCCIEGNQLLLIYEYMENNS- 503 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~E~~~~gs- 503 (771)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+++++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 24567889876533 3345688999998886433 4677888877778899999999863
Q ss_pred HHHHh---------------------cCCCccCCCCChHHHHH-HHH----------HHHH-HHHHhhhc-CCCceeccC
Q 004155 504 LARAL---------------------FGPEAHRLKLDWPTRHR-ICV----------GIAR-GLAYLHEE-SRLKIVHRD 549 (771)
Q Consensus 504 L~~~l---------------------~~~~~~~~~l~~~~~~~-i~~----------~ia~-aL~~LH~~-~~~~ivH~D 549 (771)
+...+ |.-... ......... +-. .+.. ...+|... ..+.++|+|
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~--~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD--TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC--CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 22111 211100 111111100 000 0011 11222211 134678999
Q ss_pred CCCCcEEEcCCCCeEEEeecCcc
Q 004155 550 IKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 550 lkp~NIll~~~~~~kl~DFGla~ 572 (771)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999876
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.1e-06 Score=85.66 Aligned_cols=73 Identities=53% Similarity=0.957 Sum_probs=57.3
Q ss_pred ccccceEEEEEecCeeccccCCcchhcCCcCcceeeee-eeeeecceeEEEEEEcCCcceecccCCCCC-Ccccc
Q 004155 271 HSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQF-PVVVINSTIEIRLYWAGKGTTGVPVRGVYG-PLISA 343 (771)
Q Consensus 271 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~-p~~~~ 343 (771)
...|+|+|||+++|+.++++|||..++|+..+++.+.| .+.|.++.+.|++.|++++.+++|..+..+ |.|++
T Consensus 99 ~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~~~~~i~~~~~~~~p~Isa 173 (174)
T PF11721_consen 99 SGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGKGTLCIPFIGSYGNPLISA 173 (174)
T ss_dssp --SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--SEEEEEEESSSSSSSEEE
T ss_pred cCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCCCcEEeeccccCCCcEEee
Confidence 44899999999999999999999999999997877777 999999999999999999999988766555 66654
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.6e-06 Score=82.76 Aligned_cols=137 Identities=18% Similarity=0.181 Sum_probs=92.7
Q ss_pred HhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHH---------HHHHHHHHcCC---CCcEEeEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREF---------VNEIGMISALQ---HPNLVKLHGCC 486 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~---h~niv~l~~~~ 486 (771)
..++|...+++-......|.+-.. +|+.+++|..+.......+.| .+++..+.+++ ....+.++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 456788888888888888887776 578899998766433322222 23333333332 23333333332
Q ss_pred E-----eCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC
Q 004155 487 I-----EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 561 (771)
Q Consensus 487 ~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 561 (771)
. -....++||||++|..|.+.. .++. .++..++.++.-||+. |++|||.+|+|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE--------DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch--------hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc
Confidence 2 223567999999998776654 1222 3556778889999998 999999999999998654
Q ss_pred CeEEEeecCcc
Q 004155 562 NPKISDFGLAK 572 (771)
Q Consensus 562 ~~kl~DFGla~ 572 (771)
++++||+..+
T Consensus 173 -i~iID~~~k~ 182 (229)
T PF06176_consen 173 -IRIIDTQGKR 182 (229)
T ss_pred -EEEEECcccc
Confidence 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.8e-06 Score=97.31 Aligned_cols=140 Identities=17% Similarity=0.242 Sum_probs=92.5
Q ss_pred CccccCCceeEEEEEcCCCcEEEEEEcccCCh----------------------h------------------cHHHHHH
Q 004155 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSK----------------------Q------------------GNREFVN 466 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~----------------------~------------------~~~~~~~ 466 (771)
+.|+.++-|.||+|++++|+.||||+.+..-. . .+-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 68999999999999999999999999754210 0 0112345
Q ss_pred HHHHHHcCC-----CCcEEeEEEEE-EeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHH-HHHhhh
Q 004155 467 EIGMISALQ-----HPNLVKLHGCC-IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARG-LAYLHE 539 (771)
Q Consensus 467 E~~~l~~l~-----h~niv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~a-L~~LH~ 539 (771)
|...+.+++ .+++ ++=..+ +-.....|+|||++|-.+.+...-.. ..++ +..++..++++ +..+=.
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d---~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGID---RKELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHh
Confidence 555555542 2332 222222 23456799999999988887742111 2344 33344444433 222222
Q ss_pred cCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 540 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
. ++.|+|.+|.||+++.++++.+.|||+.....+
T Consensus 284 d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 D---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred c---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 3 899999999999999999999999999876554
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=6.5e-06 Score=82.46 Aligned_cols=157 Identities=19% Similarity=0.232 Sum_probs=106.5
Q ss_pred CCCCHHHHHHHhcCCCCCCccc---cCCceeEEEEEcCCCcEEEEEEcccCChh-------------------c-----H
Q 004155 409 GSFTLRQIKAATNNFAPDNKIG---EGGFGPVYKGHMADGTVVAVKQLSSKSKQ-------------------G-----N 461 (771)
Q Consensus 409 ~~~~~~~l~~~~~~f~~~~~lG---~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-------------------~-----~ 461 (771)
...+++.+....++..+....| .|--+.||+|...++..||||+++..... . .
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~ 112 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF 112 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence 3456777777777777766655 55567899998888999999998642110 1 1
Q ss_pred HHHHHHHHHHHcCC--CCcEEeEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhh
Q 004155 462 REFVNEIGMISALQ--HPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539 (771)
Q Consensus 462 ~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~ 539 (771)
....+|+..|.++. +-.+.+.+++. .-.|||||+.... .-...-...++...+...+..++++.+.-|-.
T Consensus 113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g----~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDG----LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCC----CCCCCcccCCcCchhHHHHHHHHHHHHHHHHH
Confidence 12346777777763 34455555544 3579999996531 10111112233333677788888888888876
Q ss_pred cCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 540 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
.+ ++||+||+.-|||+. ++.+.|+|||-|.....
T Consensus 185 ~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 185 EA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred hc--CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 43 899999999999999 88999999999875543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.4e-08 Score=112.73 Aligned_cols=123 Identities=23% Similarity=0.236 Sum_probs=55.2
Q ss_pred CCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCCh-hhhcCCCCcEEEcc
Q 004155 29 LEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPD-YLGLMTSLKVLDVS 107 (771)
Q Consensus 29 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~Ls 107 (771)
|...+.+.|+|. .+..++.-++.|+.|+|++|+++... .+..|++|+.|||+.|++. .+|. ....+. |+.|.|+
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeec
Confidence 444444445544 44444444445555555555544432 3444455555555555554 3332 111222 4555555
Q ss_pred CCCCCCCCCccccCCCCCcEEEcCCCccccc---CchhhhhcCCeecccCCccc
Q 004155 108 FNKLNGAIPSTFMGLLDVDYIYLTGNLLTGT---IPPWMLQKGDRVDLSYNSFT 158 (771)
Q Consensus 108 ~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~---iP~~~~~~L~~l~ls~N~l~ 158 (771)
+|.++ .+- .+.+|.+|..|||++|-|.+. .|-|.+..|..|+|.+|++-
T Consensus 241 nN~l~-tL~-gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALT-TLR-GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHH-hhh-hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 55554 221 244444555555555544432 22233444455555555543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 771 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-62 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-60 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-54 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-53 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-37 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-25 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-23 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-22 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-20 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-20 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-20 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-18 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-17 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-16 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-16 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-13 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-13 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 8e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 551 bits (1422), Expect = 0.0
Identities = 135/309 (43%), Positives = 188/309 (60%), Gaps = 4/309 (1%)
Query: 398 EQELRGVDL-HTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSK 456
+E V L F+LR+++ A++NF+ N +G GGFG VYKG +ADGT+VAVK+L +
Sbjct: 6 AEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE 65
Query: 457 SKQGN-REFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHR 515
QG +F E+ MIS H NL++L G C+ + LL+Y YM N S+A L +
Sbjct: 66 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 516 LKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575
LDWP R RI +G ARGLAYLH+ KI+HRD+KA N+LLD++ + DFGLAKL +
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSN--SSCKPKEDI 633
+TH++T V GT G++APEY G ++K DV+ +G++ LE+++G+ + +D
Sbjct: 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 634 FYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693
LLDW L + L LVD L N+ E+V +I VALLCT S RP MS VV M
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 694 LEGRADVQD 702
LEG +
Sbjct: 306 LEGDGLAER 314
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 495 bits (1277), Expect = e-172
Identities = 125/293 (42%), Positives = 177/293 (60%), Gaps = 4/293 (1%)
Query: 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGM 470
L ++ ATNNF IG G FG VYKG + DG VA+K+ + +S QG EF EI
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 471 ISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGI 530
+S +HP+LV L G C E N+++LIY+YMEN +L R L+G + + + W R IC+G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 531 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL-DEEDNTHISTRVAGTF 589
ARGL YLH + I+HRD+K+ N+LLD++ PKI+DFG++K E D TH+ST V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 590 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL 649
GY+ PEY ++G LT+K+DVYSFG+V E++ RS ++ L +WA+ G L
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQD 702
++VD L E + + A+ C +SS RPSM V+ LE +Q+
Sbjct: 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 485 bits (1252), Expect = e-168
Identities = 113/311 (36%), Positives = 170/311 (54%), Gaps = 21/311 (6%)
Query: 398 EQELRGVDLHTGSFTLRQIKAATNNFAP------DNKIGEGGFGPVYKGHMADGTVVAVK 451
+ L D SF+ ++K TNNF NK+GEGGFG VYKG++ + T VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK 60
Query: 452 QLSS----KSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARA 507
+L++ +++ ++F EI +++ QH NLV+L G +G+ L L+Y YM N SL
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 508 LFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 567
L + L W R +I G A G+ +LHE +HRDIK+ N+LLD+ KISD
Sbjct: 121 LSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 568 FGLAKL-DEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSS 626
FGLA+ ++ T +++R+ GT YMAPE +RG +T K+D+YSFG+V LEI++G
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 627 CKPKEDIFYLLDWAL-ILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRP 685
+ LLD I + + + +DK++ + D V M +VA C RP
Sbjct: 236 EHREPQ--LLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 686 SMSSVVSMLEG 696
+ V +L+
Sbjct: 293 DIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 1e-91
Identities = 76/308 (24%), Positives = 120/308 (38%), Gaps = 30/308 (9%)
Query: 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGM 470
+ + G FG V+K + VAVK + KQ + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 471 ISALQHPNLVKLHGCCIEGN----QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRI 526
+ ++H N+++ G G L LI + E SL+ L + W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHI 126
Query: 527 CVGIARGLAYLHEE-------SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579
+ARGLAYLHE+ + I HRDIK+ NVLL +L I+DFGLA E +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 580 HI-STRVAGTFGYMAPEYAMRGYLTD-----KADVYSFGIVALEIVSGRSNSSCKPKEDI 633
+ GT YMAPE + D+Y+ G+V E+ S + + E +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 634 FYLLDWALILKAQGNLMELVDKR-----LGSNFDKEQVM-VMINVALLCTDVSSTSRPSM 687
+ + ++ E+V + L + K M ++ C D + +R S
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 688 SSVVSMLE 695
V +
Sbjct: 307 GCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 7e-74
Identities = 74/315 (23%), Positives = 120/315 (38%), Gaps = 49/315 (15%)
Query: 419 ATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNE--IGMISALQH 476
+N IG G +G VYKG + D VAVK S ++Q F+NE I + ++H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEH 66
Query: 477 PNLVKLHGCCIEGN-----QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIA 531
N+ + + LL+ EY N SL + L DW + R+ +
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVT 121
Query: 532 RGLAYLHEE------SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL-------DEEDN 578
RGLAYLH E + I HRD+ + NVL+ D ISDFGL+ +
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 579 THISTRVAGTFGYMAPEYAM-------RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKE 631
+ + GT YMAPE + D+Y+ G++ EI ++ P E
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF--PGE 239
Query: 632 DIF-YLLDWALILKAQGNLMEL----VDKRL------GSNFDKEQVMVMINVALLCTDVS 680
+ Y + + + ++ ++ + V + C D
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 681 STSRPSMSSVVSMLE 695
+ +R + +
Sbjct: 300 AEARLTAQXAEERMA 314
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-63
Identities = 87/318 (27%), Positives = 137/318 (43%), Gaps = 35/318 (11%)
Query: 426 DNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGC 485
+ +G G FG V K VA+KQ+ +S+ + F+ E+ +S + HPN+VKL+G
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
C+ N + L+ EY E SL L G E C+ ++G+AYLH +
Sbjct: 70 CL--NPVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 546 VHRDIKATNVLLDKDLN-PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
+HRD+K N+LL KI DFG A D T G+ +MAPE ++
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 605 KADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG--SNFD 662
K DV+S+GI+ E+++ R KP ++I + ++ R N
Sbjct: 183 KCDVFSWGIILWEVITRR-----KPFDEIGGPA-FRIMWAVHNGT------RPPLIKNLP 230
Query: 663 KEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE------GRADVQDFVPDSSVVSNIDKT 716
K +M C + RPSM +V ++ AD P + +
Sbjct: 231 KPIESLMTR----CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDG 286
Query: 717 KSEAIRNYYEFSEEQSMD 734
+ E ++ EF S+D
Sbjct: 287 RVEPYVDFAEFYRLWSVD 304
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 5e-63
Identities = 83/274 (30%), Positives = 134/274 (48%), Gaps = 27/274 (9%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGN--REFVNEIGMISALQHPNLVKLHG 484
KIG G FG V++ G+ VAVK L + EF+ E+ ++ L+HPN+V G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+ L ++ EY+ SL R L A +LD R + +A+G+ YLH +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLSMAYDVAKGMNYLHNRNP-P 159
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-YAMRGYLT 603
IVHR++K+ N+L+DK K+ DFGL++L + S AGT +MAPE
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPS-N 217
Query: 604 DKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG--SNF 661
+K+DVYSFG++ E+ + + +P + L+ A ++ A G KRL N
Sbjct: 218 EKSDVYSFGVILWELATLQ-----QPWGN----LNPAQVVAAVGFK----CKRLEIPRNL 264
Query: 662 DKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ + ++ C RPS ++++ +L
Sbjct: 265 NPQVAAIIEG----CWTNEPWKRPSFATIMDLLR 294
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-60
Identities = 79/315 (25%), Positives = 130/315 (41%), Gaps = 43/315 (13%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGC 485
+G+G FG K H G V+ +K+L ++ R F+ E+ ++ L+HPN++K G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
+ +L I EY++ +L + ++ + W R IA G+AYLH + I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 546 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH-------------ISTRVAGTFGYM 592
+HRD+ + N L+ ++ N ++DFGLA+L ++ T V G +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 593 APEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652
APE +K DV+SFGIV EI+ D L +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRV-----NADPD---------YLPRTMDFGLN 235
Query: 653 VDKRLGSNFDKEQVM----VMINVALLCTDVSSTSRPSMSSVVSMLEG-RADVQDFVPDS 707
V D+ + + C D+ RPS + LE R + +P
Sbjct: 236 VRG----FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
Query: 708 SVVSNIDKTKSEAIR 722
+ +D+ E R
Sbjct: 292 PQLEQLDRGFWETYR 306
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-60
Identities = 79/283 (27%), Positives = 125/283 (44%), Gaps = 40/283 (14%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQL----SSKSKQGNREFVNEIGMISALQHPNLVKL 482
IG GGFG VY+ G VAVK Q E + + L+HPN++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
G C++ L L+ E+ L R L ++ V IARG+ YLH+E+
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 543 LKIVHRDIKATNVLLDKDLNP--------KISDFGLAKLDEEDNTHISTRVAGTFGYMAP 594
+ I+HRD+K++N+L+ + + KI+DFGLA+ E T + AG + +MAP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSA-AGAYAWMAP 183
Query: 595 EYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654
E + +DV+S+G++ E+++G P I L A L
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE-----VPFRGIDGLA--VAYGVAMNKL----- 231
Query: 655 KRLG--SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
L S + +M + C + SRPS ++++ L
Sbjct: 232 -ALPIPSTCPEPFAKLMED----CWNPDPHSRPSFTNILDQLT 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-60
Identities = 79/286 (27%), Positives = 130/286 (45%), Gaps = 42/286 (14%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGN-------REFVNEIGMISALQHPN 478
+IG+GGFG V+KG + D +VVA+K L +G +EF E+ ++S L HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+VKL+G N ++ E++ L L + W + R+ + IA G+ Y+
Sbjct: 85 IVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 539 EESRLKIVHRDIKATNVLLDK-----DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 593
++ IVHRD+++ N+ L + K++DFGL++ + H + + G F +MA
Sbjct: 140 NQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMA 194
Query: 594 PE-YAMRGYL-TDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651
PE T+KAD YSF ++ I++G P ++ Y + + + L
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGE-----GPFDEYSYGKIKFINMIREEGL-- 247
Query: 652 LVDKRLG--SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
R + + NV LC RP S +V L
Sbjct: 248 ----RPTIPEDCPPR----LRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 4e-59
Identities = 69/299 (23%), Positives = 115/299 (38%), Gaps = 42/299 (14%)
Query: 426 DNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNE--IGMISALQHPNLVKLH 483
+IG+G +G V+ G G VAVK + + E I ++H N++
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 484 GCCIEGN----QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
I+G QL LI +Y EN SL L LD + ++ GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 540 E-----SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI---STRVAGTFGY 591
E + I HRD+K+ N+L+ K+ I+D GLA D + GT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 592 MAPE------YAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA 645
M PE AD+YSFG++ E+ + + Y L + ++ +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE----YQLPYHDLVPS 268
Query: 646 QGNLMELVDK--------RLGSNFDKEQVM-VMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ ++ + + + ++ + M + C + SR + V L
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-58
Identities = 67/298 (22%), Positives = 120/298 (40%), Gaps = 42/298 (14%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNE--IGMISALQHPNLVKLHG 484
+G+G +G V++G G VAVK SS + + + E + L+H N++
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 485 CCIEGN----QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
+ QL LI Y E SL L LD + RI + IA GLA+LH E
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 541 -----SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI---STRVAGTFGYM 592
+ I HRD+K+ N+L+ K+ I+D GLA + + + + GT YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 593 APE------YAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ 646
APE + D+++FG+V E+ ++ Y + ++
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED----YKPPFYDVVPND 240
Query: 647 GNLMELVD------KRLG--SNFDKEQVM-VMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ ++ +R + + + + + + C + ++R + + L
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 3e-58
Identities = 80/277 (28%), Positives = 131/277 (47%), Gaps = 30/277 (10%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGN--REFVNEIGMISALQHPNLVKLHG 484
+IG G FG VYKG G V AVK L+ + + F NE+G++ +H N++ G
Sbjct: 30 QRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
L ++ ++ E +SL L E K + I ARG+ YLH
Sbjct: 88 YSTAPQ-LAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKL-DEEDNTHISTRVAGTFGYMAPEYAMRGYL- 602
I+HRD+K+ N+ L +D KI DFGLA +H +++G+ +MAPE +R
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDS 199
Query: 603 ---TDKADVYSFGIVALEIVSGRS-NSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658
+ ++DVY+FGIV E+++G+ S+ ++ I ++ +G+L ++
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV-------GRGSLS-PDLSKVR 251
Query: 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
SN K +M C RPS +++ +E
Sbjct: 252 SNCPKRMKRLM----AECLKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 4e-58
Identities = 61/280 (21%), Positives = 110/280 (39%), Gaps = 40/280 (14%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHG 484
K+ E G ++KG G + VK L + S + +R+F E + HPN++ + G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 485 CCIE--GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
C LI +M SL L E +D + + +ARG+A+LH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLHTLEP 132
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG-- 600
I + + +V++D+D+ +IS + + S ++APE A++
Sbjct: 133 -LIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE-ALQKKP 184
Query: 601 --YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK-AQGNLMELVDKRL 657
AD++SF ++ E+V+ P D+ + + +K A L R
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE-----VPFADLSNM---EIGMKVALEGL------RP 230
Query: 658 G--SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ + +C + RP +V +LE
Sbjct: 231 TIPPGISPH----VSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-57
Identities = 76/300 (25%), Positives = 124/300 (41%), Gaps = 44/300 (14%)
Query: 426 DNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNE--IGMISALQHPNLVKLH 483
IG+G FG V++G G VAVK SS + R + E I L+H N++
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102
Query: 484 GCCIEGN----QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
+ N QL L+ +Y E+ SL L +R + ++ + A GLA+LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 540 E-----SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI---STRVAGTFGY 591
E + I HRD+K+ N+L+ K+ I+D GLA + I GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 592 MAPEYAMRGYL-------TDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK 644
MAPE + + +AD+Y+ G+V EI S Y L + ++
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED----YQLPYYDLVP 272
Query: 645 AQGNLMEL----VDKRL-----GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ ++ E+ +++L E + VM + C + +R + + L
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 5e-55
Identities = 61/284 (21%), Positives = 109/284 (38%), Gaps = 39/284 (13%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGN--REFVNEIGMISALQHPNLVKLHG 484
IG+G FG VY G G V A++ + + + + F E+ +H N+V G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
C+ L +I + +L + ++ LD +I I +G+ YLH +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---G 150
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKL----DEEDNTHISTRVAGTFGYMAPE----- 595
I+H+D+K+ NV D I+DFGL + G ++APE
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 596 ----YAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651
+ + +DV++ G + E+ + +P E I + + G
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM-------GTGMKPN 262
Query: 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
L +G +++ C RP+ + ++ MLE
Sbjct: 263 LSQIGMGKEI--SDILLF------CWAFEQEERPTFTKLMDMLE 298
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-47
Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 428 KIGEGGFGPVYKGHM-ADGTVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVKLHGC 485
+IG G FG V+ G + AD T+VAVK + +F+ E ++ HPN+V+L G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
C + + ++ E ++ L +L T ++ A G+ YL +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESK---CC 234
Query: 546 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMRGYLT 603
+HRD+ A N L+ + KISDFG+++ +E D + ++ APE G +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 604 DKADVYSFGIVALEIVS 620
++DV+SFGI+ E S
Sbjct: 294 SESDVWSFGILLWETFS 310
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 18/219 (8%)
Query: 426 DNKIGEGGFGPVYKG-HMADGTVVAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVKL 482
D +IG G F VYKG VA + +K + F E M+ LQHPN+V+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 483 HGCCI----EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+ ++L+ E M + +L L + + + C I +GL +LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFK-VMKIKVLRSWCRQILKGLQFLH 146
Query: 539 EESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 597
+ I+HRD+K N+ + + KI D GLA L V GT +MAPE
Sbjct: 147 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMY 202
Query: 598 MRGYLTDKADVYSFGIVALEIVSGRS-NSSCKPKEDIFY 635
Y + DVY+FG+ LE+ + S C+ I+
Sbjct: 203 EEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 240
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-46
Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 23/282 (8%)
Query: 427 NKIGEGGFGPVYKG-----HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVK 481
++G+G FG V G VVAVK+L +++ R+F EI ++ +LQH N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 482 LHGCCIEGNQ--LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
G C + L LI EY+ SL L + H+ ++D + I +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYA 597
++ + +HRD+ N+L++ + KI DFGL K+ +D + G + APE
Sbjct: 131 GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 598 MRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK-- 655
+ +DV+SFG+V E+ + S P E + + + +L+EL+
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 249
Query: 656 RLG--SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
RL E M+M C + + RPS + ++
Sbjct: 250 RLPRPDGCPDEIYMIM----TECWNNNVNQRPSFRDLALRVD 287
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 4e-46
Identities = 85/283 (30%), Positives = 131/283 (46%), Gaps = 26/283 (9%)
Query: 427 NKIGEGGFGPVYKG-----HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVK 481
+++G+G FG V G +VAVKQL R+F EI ++ AL +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 482 LHGCCIEGNQ--LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
G + L L+ EY+ + L L + HR +LD I +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYL-- 143
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYA 597
SR + VHRD+ A N+L++ + + KI+DFGLAKL D + R G + APE
Sbjct: 144 GSR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 598 MRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK- 655
+ ++DV+SFG+V E+ + SC P + ++ + A L+EL+++
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCD--KSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260
Query: 656 -RLG--SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
RL E +M LC S RPS S++ L+
Sbjct: 261 QRLPAPPACPAEVHELM----KLCWAPSPQDRPSFSALGPQLD 299
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-46
Identities = 77/282 (27%), Positives = 130/282 (46%), Gaps = 23/282 (8%)
Query: 427 NKIGEGGFGPVYKG-----HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVK 481
++G+G FG V G VVAVK+L +++ R+F EI ++ +LQH N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 482 LHGCCIEGNQ--LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
G C + L LI EY+ SL L + H+ ++D + I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL-- 161
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYA 597
++ + +HRD+ N+L++ + KI DFGL K+ +D + + G + APE
Sbjct: 162 GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 598 MRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK-- 655
+ +DV+SFG+V E+ + S P E + + + +L+EL+
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280
Query: 656 RLG--SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
RL E M+M C + + RPS + ++
Sbjct: 281 RLPRPDGCPDEIYMIM----TECWNNNVNQRPSFRDLALRVD 318
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI 487
+G+G +G VY G +++ +A+K++ + + ++ EI + L+H N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 488 EGNQLLLIYEYMENNSLA---RALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
E + + E + SL+ R+ +GP LK + T I GL YLH+ +
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGP----LKDNEQTIGFYTKQILEGLKYLHDN---Q 142
Query: 545 IVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE---YAMRG 600
IVHRDIK NVL++ KISDFG +K N T GT YMAPE RG
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRG 201
Query: 601 YLTDKADVYSFGIVALEIVSGR 622
Y AD++S G +E+ +G+
Sbjct: 202 Y-GKAADIWSLGCTIIEMATGK 222
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-45
Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 25/283 (8%)
Query: 427 NKIGEGGFGPVYKGHMA-----DGTVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNLV 480
+GEG FG V G VAVK L + EI ++ L H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 481 KLHGCCIE--GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
K G C E GN + LI E++ + SL L ++ K++ + + V I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEY 596
+ VHRD+ A NVL++ + KI DFGL K E D + + + + APE
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200
Query: 597 AMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK- 655
M+ +DV+SFG+ E+++ + S + + + L+ + +
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT-RLVNTLKEG 259
Query: 656 -RLG--SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
RL N E +M C + ++R S +++ E
Sbjct: 260 KRLPCPPNCPDEVYQLM----RKCWEFQPSNRTSFQNLIEGFE 298
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-44
Identities = 80/284 (28%), Positives = 123/284 (43%), Gaps = 29/284 (10%)
Query: 427 NKIGEGGFGPVYKG-----HMADGTVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNLV 480
+GEG FG V + G +VAVK L + Q + EI ++ L H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 481 KLHGCCIE--GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
K GCC + L L+ EY+ SL L H + L I G+AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGL--AQLLLFAQQICEGMAYLH 151
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEY 596
+HRD+ A NVLLD D KI DFGLAK E + + R G + APE
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208
Query: 597 AMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655
+DV+SFG+ E+++ S+ S K + + + L EL+++
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR--LTELLER 266
Query: 656 --RLG--SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
RL E +M C + ++ RP+ +++ +L+
Sbjct: 267 GERLPRPDKCPAEVYHLM----KNCWETEASFRPTFENLIPILK 306
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-44
Identities = 72/302 (23%), Positives = 123/302 (40%), Gaps = 65/302 (21%)
Query: 427 NKIGEGGFGPVYKGH------MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 480
++GEG FG V+ D +VAVK L + ++F E +++ LQH ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 481 KLHGCCIEGNQLLLIYEYMENNSL------------ARALFGPEAHRLKLDWPTRHRICV 528
K +G C +G+ L++++EYM++ L P + +L I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 529 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT 588
IA G+ YL + VHRD+ N L+ +L KI DFG+++ + + G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGG 193
Query: 589 FG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GRSNSSCKPKEDIFYL 636
+M PE M T ++DV+SFG++ EI + SN ++
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------TEVIEC 247
Query: 637 LDWALILKAQGNLME---LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693
+ QG ++E + K + VM L C R ++ + +
Sbjct: 248 IT-------QGRVLERPRVCPKEV------YDVM------LGCWQREPQQRLNIKEIYKI 288
Query: 694 LE 695
L
Sbjct: 289 LH 290
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-44
Identities = 73/301 (24%), Positives = 118/301 (39%), Gaps = 64/301 (21%)
Query: 427 NKIGEGGFGPVYKGHMADG------TVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 480
++GEG FG V+ + +VAVK L S+ ++F E +++ LQH ++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 481 KLHGCCIEGNQLLLIYEYMENNSL-----------ARALFGPEAHRLKLDWPTRHRICVG 529
+ G C EG LL+++EYM + L G + L +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 589
+A G+ YL + L VHRD+ N L+ + L KI DFG+++ + RV G
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGR- 219
Query: 590 G-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GRSNSSCKPKEDIFYLL 637
+M PE + T ++DV+SFG+V EI + SN + +
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------TEAIDCI 273
Query: 638 DWALILKAQGNLME---LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSML 694
QG +E + +M C R S+ V + L
Sbjct: 274 T-------QGRELERPRACPPEV------YAIM------RGCWQREPQQRHSIKDVHARL 314
Query: 695 E 695
+
Sbjct: 315 Q 315
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 62/197 (31%), Positives = 95/197 (48%), Gaps = 15/197 (7%)
Query: 428 KIGEGGFGPVYKGHMADGTVVAVKQL--SSKSKQGNREFVNEIGMISALQHPNLVKLHGC 485
++G G FG V G VAVK + S S+ EF E + L HP LVK +G
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
C + + ++ EY+ N L L +H L+ +C + G+A+L +
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQF 125
Query: 546 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMRGYLT 603
+HRD+ A N L+D+DL K+SDFG+ + +D + V F APE +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 604 DKADVYSFGIVALEIVS 620
K+DV++FGI+ E+ S
Sbjct: 184 SKSDVWAFGILMWEVFS 200
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQL--SSKSKQGNREFVNEIGMISALQHPNLVKLHG 484
++G G FG V G VA+K + S S+ EF+ E ++ L H LV+L+G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYG 86
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
C + + +I EYM N L L R + +C + + YL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQ 140
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT---FGYMAPEYAMRGY 601
+HRD+ A N L++ K+SDFGL++ +D T G+ + PE M
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSK 197
Query: 602 LTDKADVYSFGIVALEIVS 620
+ K+D+++FG++ EI S
Sbjct: 198 FSSKSDIWAFGVLMWEIYS 216
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 426 DNKIGEGGFGPVYKG--HMADGTV-VAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVK 481
D ++G G FG V +G M + VA+K L K E + E ++ L +P +V+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
L G C + L+L+ E L + L R ++ + ++ G+ YL
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAMR 599
VHRD+ A NVLL KISDFGL+K D+++ + R AG + + APE
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 600 GYLTDKADVYSFGIVALEIVS 620
+ ++DV+S+G+ E +S
Sbjct: 188 RKFSSRSDVWSYGVTMWEALS 208
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 73/289 (25%), Positives = 115/289 (39%), Gaps = 50/289 (17%)
Query: 426 DNKIGEGGFGPVYKGHMADG----TVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLV 480
+ IG G FG VY G + D AVK L+ + G +F+ E ++ HPN++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 481 KLHGCCIEG-NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
L G C+ L++ YM++ L + + +A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG------YMA 593
K VHRD+ A N +LD+ K++DFGLA+ + + V G +MA
Sbjct: 147 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMA 200
Query: 594 PEYAMRGYLTDKADVYSFGIVALEIVS-------GRSNSSCKPKEDIFYLLDWALILKAQ 646
E T K+DV+SFG++ E+++ + DI L Q
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLL-------Q 247
Query: 647 GNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
G + + VM L C + RPS S +VS +
Sbjct: 248 GRRLLQPE-----YCPDPLYEVM----LKCWHPKAEMRPSFSELVSRIS 287
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 66/286 (23%), Positives = 113/286 (39%), Gaps = 44/286 (15%)
Query: 426 DNKIGEGGFGPVYKGHMADG----TVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNLV 480
D IG+G FG VY G D A+K LS ++ F+ E ++ L HPN++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 481 KLHGCCIEGN-QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
L G + ++ YM + L + + + + + +ARG+ YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYL-- 140
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTF--GYMAPEY 596
+ K VHRD+ A N +LD+ K++DFGLA+ + + + + + A E
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 597 AMRGYLTDKADVYSFGIVALEIVS-------GRSNSSCKPKEDIFYLLDWALILKAQGNL 649
T K+DV+SFG++ E+++ D+ + L QG
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP------FDLTHFLA-------QGRR 246
Query: 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ + VM C + RP+ +V +E
Sbjct: 247 LPQPE-----YCPDSLYQVM----QQCWEADPAVRPTFRVLVGEVE 283
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-43
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 426 DNKIGEGGFGPVYKG----HMADGTVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNLV 480
D +G G FG V G VA+K L +++ R+F+ E ++ HPN++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
+L G + ++++ EYMEN SL L H + + GIA G+ YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAM 598
S + VHRD+ A N+L++ +L K+SDFGL ++ E+D T G +PE
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 599 RGYLTDKADVYSFGIVALEIVS 620
T +DV+S+GIV E++S
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 74/300 (24%), Positives = 118/300 (39%), Gaps = 60/300 (20%)
Query: 427 NKIGEGGFGPVYKGHMADG------TVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNL 479
++GE FG VYKGH+ VA+K L K EF +E + + LQHPN+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSL------------ARALFGPEAHRLKLDWPTRHRIC 527
V L G + L +I+ Y + L + + L+ P +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 528 VGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG 587
IA G+ YL S +VH+D+ NVL+ LN KISD GL + + +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY----KLL 187
Query: 588 TFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GRSNSSCKPKEDIFY 635
+MAPE M G + +D++S+G+V E+ S G SN +D+
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVVE 241
Query: 636 LLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
++ ++ D + +M + C + + RP + S L
Sbjct: 242 MIR-------NRQVLPCPD-----DCPAWVYALM----IECWNEFPSRRPRFKDIHSRLR 285
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-43
Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 428 KIGEGGFGPVYKG-----HMADGTVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVK 481
IG G FG VYKG VA+K L + +++ +F+ E G++ H N+++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
L G + +++I EYMEN +L + L + + GIA G+ YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYL---A 164
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMR 599
+ VHRD+ A N+L++ +L K+SDFGL+++ E+D T G APE
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 600 GYLTDKADVYSFGIVALEIVS 620
T +DV+SFGIV E+++
Sbjct: 225 RKFTSASDVWSFGIVMWEVMT 245
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-43
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 426 DNKIGEGGFGPVYKG----HMADGTVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNLV 480
+ IG G G V G VA+K L + +++ R+F++E ++ HPN++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
+L G G +++ EYMEN SL L H + + G+ G+ YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYL--- 167
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAM 598
S L VHRD+ A NVL+D +L K+SDFGL+++ E+D T G APE
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 599 RGYLTDKADVYSFGIVALEIVS 620
+ +DV+SFG+V E+++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-43
Identities = 58/198 (29%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQL--SSKSKQGNREFVNEIGMISALQHPNLVKLHG 484
+IG G FG V+ G+ + VA+K + + S++ +F+ E ++ L HP LV+L+G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYG 70
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
C+E + L+ E+ME+ L+ L R T +C+ + G+AYL
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYL---EEAC 124
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMRGYL 602
++HRD+ A N L+ ++ K+SDFG+ + +D ++ F +PE
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRY 182
Query: 603 TDKADVYSFGIVALEIVS 620
+ K+DV+SFG++ E+ S
Sbjct: 183 SSKSDVWSFGVLMWEVFS 200
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-43
Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 426 DNKIGEGGFGPVYKGHMADG-----TVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNL 479
+G G FG VYKG VA+K+L + S + N+E ++E +++++ +P++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
+L G C+ + + LI + M L + H+ + CV IA+G+ YL
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT-FGYMAPEYAM 598
E R ++VHRD+ A NVL+ + KI+DFGLAKL + +MA E +
Sbjct: 134 EDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 599 RGYLTDKADVYSFGIVALEIVS 620
T ++DV+S+G+ E+++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMT 214
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-43
Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 427 NKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGN---REFVNEIGMISALQHPNLVKL 482
+K+G G +G VY+G VAVK L K+ EF+ E ++ ++HPNLV+L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQL 281
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
G C +I E+M +L L + + I+ + YL E +
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYL--EKK 337
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYL 602
+HR++ A N L+ ++ K++DFGL++L D + APE
Sbjct: 338 -NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 603 TDKADVYSFGIVALEIVS 620
+ K+DV++FG++ EI +
Sbjct: 397 SIKSDVWAFGVLLWEIAT 414
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 9e-43
Identities = 73/203 (35%), Positives = 107/203 (52%), Gaps = 18/203 (8%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGN---REFVNEIGMISALQHPNLVKLH 483
++G G FG V+ G+ T VAVK L KQG+ F+ E ++ LQH LV+L+
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
+ + +I EYMEN SL L P +L + + IA G+A++
Sbjct: 75 AVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTI--NKLLDMAAQIAEGMAFI---EER 128
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMRGY 601
+HRD++A N+L+ L+ KI+DFGLA+L E++ + R F APE G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGT 186
Query: 602 LTDKADVYSFGIVALEIVS-GRS 623
T K+DV+SFGI+ EIV+ GR
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI 209
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 28/207 (13%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVKLH 483
++G G FG V++ G AVK+ L + E+ + L P +V L+
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLY 116
Query: 484 GCCIEGNQLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
G EG + + E +E SL + + G L GL YLH
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGC------LPEDRALYYLGQALEGLEYLHTR- 169
Query: 542 RLKIVHRDIKATNVLLDKDLNP-KISDFGLAKLDEEDNTHISTR----VAGTFGYMAPEY 596
+I+H D+KA NVLL D + + DFG A + D S + GT +MAPE
Sbjct: 170 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 597 AM-RGYLTDKADVYSFGIVALEIVSGR 622
M + K D++S + L +++G
Sbjct: 228 VMGKPC-DAKVDIWSSCCMMLHMLNGC 253
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 427 NKIGEGGFGPVYKGHMADGTV-VAVKQLSSKSKQGN---REFVNEIGMISALQHPNLVKL 482
+K+G G +G VY+G ++ VAVK L K+ EF+ E ++ ++HPNLV+L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
G C +I E+M +L L + + I+ + YL E +
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA--VVLLYMATQISSAMEYL--EKK 130
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMRG 600
+HRD+ A N L+ ++ K++DFGL++L D + F APE
Sbjct: 131 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYN 187
Query: 601 YLTDKADVYSFGIVALEIVS-GRS 623
+ K+DV++FG++ EI + G S
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMS 211
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 54/294 (18%)
Query: 427 NKIGEGGFGPVYKGHMADG------TVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNL 479
++G+G FG VY+G T VA+K ++ + R EF+NE ++ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSLA---RALFGPEAHRLKLDWPTRHR---ICVGIARG 533
V+L G +G L+I E M L R+L A+ L P+ + + IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 534 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY-- 591
+AYL+ K VHRD+ A N ++ +D KI DFG+ + E + + G G
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLP 203
Query: 592 ---MAPEYAMRGYLTDKADVYSFGIVALEIVS-------GRSNSSCKPKEDIFYLLDWAL 641
M+PE G T +DV+SFG+V EI + G SN E + +
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRFVM--- 254
Query: 642 ILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+G L++ D N +M +C + RPS ++S ++
Sbjct: 255 ----EGGLLDKPD-----NCPDMLFELM----RMCWQYNPKMRPSFLEIISSIK 295
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-42
Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 15/232 (6%)
Query: 395 HTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQ- 452
H GVDL T + + + + KIGEG FG DG +K+
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSM----EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI 57
Query: 453 -LSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGP 511
+S S + E E+ +++ ++HPN+V+ E L ++ +Y E L + +
Sbjct: 58 NISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI--N 115
Query: 512 EAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571
+ V I L ++H+ KI+HRDIK+ N+ L KD ++ DFG+A
Sbjct: 116 AQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIA 172
Query: 572 KLDEEDNTHISTRVAGTFGYMAPE-YAMRGYLTDKADVYSFGIVALEIVSGR 622
++ + GT Y++PE + Y +K+D+++ G V E+ + +
Sbjct: 173 RVLNSTVELARACI-GTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLK 222
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 4e-42
Identities = 67/201 (33%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
IG+G FG V G G VAVK + K+ + F+ E +++ L+H NLV+L G
Sbjct: 27 QTIGKGEFGDVMLG-DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 487 IEGN-QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
+E L ++ EYM SL L L + + + + YL E
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLKFSLDVCEAMEYL--EGN-NF 138
Query: 546 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMRGYLT 603
VHRD+ A NVL+ +D K+SDFGL K T+ G APE +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASS------TQDTGKLPVKWTAPEALREKKFS 192
Query: 604 DKADVYSFGIVALEIVS-GRS 623
K+DV+SFGI+ EI S GR
Sbjct: 193 TKSDVWSFGILLWEIYSFGRV 213
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 6e-42
Identities = 59/197 (29%), Positives = 104/197 (52%), Gaps = 12/197 (6%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGC 485
KIG+G G VY +A G VA++Q++ + + +NEI ++ ++PN+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
+ G++L ++ EY+ SL + +D +C + L +LH ++
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 546 VHRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
+HRDIK+ N+LL D + K++DFG A++ E + + + GT +MAPE R
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGP 195
Query: 605 KADVYSFGIVALEIVSG 621
K D++S GI+A+E++ G
Sbjct: 196 KVDIWSLGIMAIEMIEG 212
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 7e-42
Identities = 70/327 (21%), Positives = 120/327 (36%), Gaps = 60/327 (18%)
Query: 427 NKIGEGGFGPVYKGHMADG----TVVAVKQL--SSKSKQGNREFVNEIGMISALQHPNLV 480
+G+G FG V + + VAVK L + EF+ E + HP++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 481 KLHGCCIEG------NQLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHRICVGIAR 532
KL G + ++I +M++ L L + L T R V IA
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 533 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG-- 590
G+ YL SR +HRD+ A N +L +D+ ++DFGL++ + + G
Sbjct: 149 GMEYL--SSR-NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASKL 201
Query: 591 ---YMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GRSNSSCKPKEDIFYLLDWA 640
++A E T +DV++FG+ EI++ G N +I+ L
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN------AEIYNYLI-- 253
Query: 641 LILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG--RA 698
GN ++ +E +M C RPS + + LE
Sbjct: 254 -----GGNRLKQPP-----ECMEEVYDLM----YQCWSADPKQRPSFTCLRMELENILGH 299
Query: 699 DVQDFVPDSSVVSNIDKTKSEAIRNYY 725
+ NI++ +++
Sbjct: 300 LSVLSTSQDPLYINIERAHHH---HHH 323
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 8e-42
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 426 DNKIGEGGFGPVYKG--HMADGTV-VAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVK 481
D ++G G FG V +G M + VA+K L K E + E ++ L +P +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
L G C + L+L+ E L + L R ++ + ++ G+ YL
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMR 599
VHR++ A NVLL KISDFGL+K D+++ + R AG + APE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 600 GYLTDKADVYSFGIVALEIVS 620
+ ++DV+S+G+ E +S
Sbjct: 514 RKFSSRSDVWSYGVTMWEALS 534
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-42
Identities = 59/197 (29%), Positives = 104/197 (52%), Gaps = 12/197 (6%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGC 485
KIGEG G V G VAVK + + +Q NE+ ++ QH N+V+++
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
+ G +L ++ E+++ +L + +++L+ +C + + LAYLH + +
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEAVLQALAYLHAQ---GV 162
Query: 546 VHRDIKATNVLLDKDLNPKISDFGL-AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
+HRDIK+ ++LL D K+SDFG A++ ++ S + GT +MAPE R
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYAT 220
Query: 605 KADVYSFGIVALEIVSG 621
+ D++S GI+ +E+V G
Sbjct: 221 EVDIWSLGIMVIEMVDG 237
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-42
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 426 DNKIGEGGFGPVYKGHMADG-----TVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNL 479
+G G FG V+KG V +K + +Q + + + I +L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
V+L G C + L L+ +Y+ SL + HR L V IA+G+ YL
Sbjct: 78 VRLLGLCPG-SSLQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWGVQIAKGMYYL-- 131
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT-FGYMAPEYAM 598
E +VHR++ A NVLL +++DFG+A L D+ + A T +MA E
Sbjct: 132 EEH-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 599 RGYLTDKADVYSFGIVALEIVS 620
G T ++DV+S+G+ E+++
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 9e-42
Identities = 69/286 (24%), Positives = 115/286 (40%), Gaps = 44/286 (15%)
Query: 426 DNKIGEGGFGPVYKGHMADG----TVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNLV 480
+ IG G FG VY G + D AVK L +F+ E ++ HPN++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 481 KLHGCCIEG-NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
L G C+ L++ YM++ L + + +A+G+ +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL-- 208
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTF--GYMAPEY 596
+ K VHRD+ A N +LD+ K++DFGLA+ + +++ + + +MA E
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 597 AMRGYLTDKADVYSFGIVALEIVS-------GRSNSSCKPKEDIFYLLDWALILKAQGNL 649
T K+DV+SFG++ E+++ + DI L QG
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLL-------QGRR 314
Query: 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ + VM L C + RPS S +VS +
Sbjct: 315 LLQPE-----YCPDPLYEVM----LKCWHPKAEMRPSFSELVSRIS 351
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 9e-42
Identities = 67/201 (33%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGN--REFVNEIGMISALQHPNLVKLHG 484
IG+G FG V G G VAVK + K + F+ E +++ L+H NLV+L G
Sbjct: 199 QTIGKGEFGDVMLG-DYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 485 CCIEGN-QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
+E L ++ EYM SL L L + + + + YL E
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--DCLLKFSLDVCEAMEYL--EGN- 308
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLT 603
VHRD+ A NVL+ +D K+SDFGL K E +T + ++ + APE +
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFS 364
Query: 604 DKADVYSFGIVALEIVS-GRS 623
K+DV+SFGI+ EI S GR
Sbjct: 365 TKSDVWSFGILLWEIYSFGRV 385
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-41
Identities = 71/294 (24%), Positives = 121/294 (41%), Gaps = 54/294 (18%)
Query: 427 NKIGEGGFGPVYKGHMADG----TVVAVKQL--SSKSKQGNREFVNEIGMISALQHPNLV 480
+GEG FG V +G++ VAVK + + S++ EF++E + HPN++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 481 KLHGCCIEGN-----QLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHRICVGIARG 533
+L G CIE + + ++I +M+ L L E + T + V IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 534 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG--- 590
+ YL S +HRD+ A N +L D+ ++DFGL+K + + G
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMP 212
Query: 591 --YMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GRSNSSCKPKEDIFYLLDWAL 641
++A E T K+DV++FG+ EI + G N +++ L
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN------HEMYDYLL--- 263
Query: 642 ILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
G+ ++ + + E +M C RP+ S + LE
Sbjct: 264 ----HGHRLKQPE-----DCLDELYEIM----YSCWRTDPLDRPTFSVLRLQLE 304
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-41
Identities = 68/197 (34%), Positives = 103/197 (52%), Gaps = 13/197 (6%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGN---REFVNEIGMISALQHPNLVKLH 483
K+G+G FG V+ G T VA+K L K G F+ E ++ L+H LV+L+
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
E + ++ EYM SL L G L+L P + IA G+AY+ E
Sbjct: 246 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYV--ERM- 299
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLT 603
VHRD++A N+L+ ++L K++DFGLA+L E++ + APE A+ G T
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 604 DKADVYSFGIVALEIVS 620
K+DV+SFGI+ E+ +
Sbjct: 360 IKSDVWSFGILLTELTT 376
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQL---SSKSKQGNREFVNEIGMISALQH 476
NF + KIG G F VY+ + DG VA+K++ + + + EI ++ L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 477 PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
PN++K + IE N+L ++ E + L+R + + + + T + V + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE- 595
+H +++HRDIK NV + K+ D GL + T + V GT YM+PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 596 YAMRGYLTDKADVYSFGIVALEIVSGR 622
GY K+D++S G + E+ + +
Sbjct: 208 IHENGY-NFKSDIWSLGCLLYEMAALQ 233
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 58/198 (29%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 428 KIGEGGFGPVYKG----HMADGTVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVKL 482
IGEG FG V++G VA+K + S +F+ E + HP++VKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
G E N + +I E L L + + LD + ++ LAYL
Sbjct: 82 IGVITE-NPVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYL---ES 134
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYL 602
+ VHRDI A NVL+ + K+ DFGL++ E+ + +++ +MAPE
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 603 TDKADVYSFGIVALEIVS 620
T +DV+ FG+ EI+
Sbjct: 195 TSASDVWMFGVCMWEILM 212
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 55/231 (23%), Positives = 105/231 (45%), Gaps = 37/231 (16%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPN 478
++F +G+G FG V K + D A+K++ +++ ++E+ ++++L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 479 LVKLHGCCIEGNQLLL----------IY---EYMENNSLARALFGPEAHRLKLDWPTRHR 525
+V+ + +E + ++ EY EN +L + + L R
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWR 120
Query: 526 ICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED-------- 577
+ I L+Y+H + I+HRD+K N+ +D+ N KI DFGLAK
Sbjct: 121 LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 578 ------NTHISTRVAGTFGYMAPE-YAMRGYLTDKADVYSFGIVALEIVSG 621
+ ++++ + GT Y+A E G+ +K D+YS GI+ E++
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 84/329 (25%), Positives = 132/329 (40%), Gaps = 66/329 (20%)
Query: 426 DNKIGEGGFGPVYKGHMADG---TVVAVKQL-SSKSKQGNREFVNEIGMISAL-QHPNLV 480
+ IGEG FG V K + A+K++ SK +R+F E+ ++ L HPN++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 481 KLHGCCIEGNQLLLIYEYMENNSL------------ARALFGPEAHRLKLDWPTRHRICV 528
L G C L L EY + +L A + L
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 529 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT 588
+ARG+ YL S+ + +HRD+ A N+L+ ++ KI+DFGL++ E V T
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKT 199
Query: 589 FG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GRSNSSCKPKEDIFYL 636
G +MA E T +DV+S+G++ EIVS G + +++
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEK 253
Query: 637 LDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS---- 692
L QG +E N D E +M C RPS + ++
Sbjct: 254 LP-------QGYRLEKPL-----NCDDEVYDLM----RQCWREKPYERPSFAQILVSLNR 297
Query: 693 MLEGRADVQDF-VPDSSVVSNIDKTKSEA 720
MLE R + + + + ID + EA
Sbjct: 298 MLEERKTYVNTTLYEKFTYAGIDCSAEEA 326
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 69/297 (23%), Positives = 105/297 (35%), Gaps = 60/297 (20%)
Query: 427 NKIGEGGFGPVYKGH------MADGTVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNL 479
+G G FG VY+G VAVK L + + +F+ E +IS H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSLA---RALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
V+ G ++ ++ E M L R + L + IA G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 537 LHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGLAKLDEEDNTHISTRVAGTFGY-- 591
L +HRDI A N LL KI DFG+A+ + R G
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY---YRKGGC-AMLP 208
Query: 592 ---MAPEYAMRGYLTDKADVYSFGIVALEIVS-------GRSNSSCKPKEDIFYLLDWAL 641
M PE M G T K D +SFG++ EI S +SN +++ +
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFVT--- 259
Query: 642 ILKAQGNLME---LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
G M+ + ++M C RP+ + ++ +E
Sbjct: 260 ----SGGRMDPPKNCPGPV------YRIM------TQCWQHQPEDRPNFAIILERIE 300
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-41
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 428 KIGEGGFGPVYKG----HMADGTVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNLVKL 482
+GEG FG VY+G H + VAVK + +F++E ++ L HP++VKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
G E +I E L L E ++ L T + I + +AYL
Sbjct: 79 IGII-EEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYL---ES 131
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT---FGYMAPEYAMR 599
+ VHRDI N+L+ K+ DFGL++ E+++ + + T +M+PE
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESINF 188
Query: 600 GYLTDKADVYSFGIVALEIVS 620
T +DV+ F + EI+S
Sbjct: 189 RRFTTASDVWMFAVCMWEILS 209
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 16/204 (7%)
Query: 426 DNKIGEGGFGPVYKG----HMADGTVVAVKQL---SSKSKQGNREFVNEIGMISALQHPN 478
K+G+G FG V +G VAVK L + +F+ E+ + +L H N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
L++L+G + + ++ E SL L H+ T R V +A G+ YL
Sbjct: 83 LIRLYGVVLT-PPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYL- 137
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEY 596
E R +HRD+ A N+LL KI DFGL + +++ H + + APE
Sbjct: 138 ESKRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 597 AMRGYLTDKADVYSFGIVALEIVS 620
+ +D + FG+ E+ +
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFT 219
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-41
Identities = 68/197 (34%), Positives = 103/197 (52%), Gaps = 13/197 (6%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGN---REFVNEIGMISALQHPNLVKLH 483
K+G+G FG V+ G T VA+K L K G F+ E ++ L+H LV+L+
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 328
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
E + ++ EYM SL L G L+L P + IA G+AY+ E
Sbjct: 329 AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYV--ERM- 382
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLT 603
VHRD++A N+L+ ++L K++DFGLA+L E++ + APE A+ G T
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 604 DKADVYSFGIVALEIVS 620
K+DV+SFGI+ E+ +
Sbjct: 443 IKSDVWSFGILLTELTT 459
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-41
Identities = 68/199 (34%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGN---REFVNEIGMISALQHPNLVKLH 483
K+G G FG V+ T VAVK + K G+ F+ E ++ LQH LVKLH
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKLH 249
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
+ + +I E+M SL L E + L P IA G+A++ +
Sbjct: 250 AVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFI---EQR 303
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY--MAPEYAMRGY 601
+HRD++A N+L+ L KI+DFGLA++ E++ + R F APE G
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGS 361
Query: 602 LTDKADVYSFGIVALEIVS 620
T K+DV+SFGI+ +EIV+
Sbjct: 362 FTIKSDVWSFGILLMEIVT 380
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-41
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGC 485
++G+G FG VYK + G + A K + +KS++ +++ EI +++ HP +VKL G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
+L ++ E+ ++ + L P +C + L +LH + +I
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLHSK---RI 138
Query: 546 VHRDIKATNVLLDKDLNPKISDFGL-AKLDEED---NTHISTRVAGTFGYMAPEYAMRGY 601
+HRD+KA NVL+ + + +++DFG+ AK + ++ I GT +MAPE M
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCET 193
Query: 602 LTD-----KADVYSFGIVALEIVSG 621
+ D KAD++S GI +E+
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-41
Identities = 60/202 (29%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 426 DNKIGEGGFGPVYKGHMADG-----TVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNL 479
+G G FG VYKG VA+K+L + S + N+E ++E +++++ +P++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
+L G C+ + + LI + M L + H+ + CV IA+G+ YL
Sbjct: 80 CRLLGICLT-STVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYL-- 133
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT-FGYMAPEYAM 598
E R ++VHRD+ A NVL+ + KI+DFGLAKL + +MA E +
Sbjct: 134 EDR-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 599 RGYLTDKADVYSFGIVALEIVS 620
T ++DV+S+G+ E+++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMT 214
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 9e-41
Identities = 60/202 (29%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 426 DNKIGEGGFGPVYKG--HMADGTV-VAVKQL--SSKSKQGNREFVNEIGMISALQHPNLV 480
D ++G G FG V KG M VAVK L + E + E ++ L +P +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
++ G C E +L+ E E L + L + + ++ G+ YL
Sbjct: 82 RMIGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL--- 133
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF--GYMAPEYAM 598
VHRD+ A NVLL KISDFGL+K D + + G + + APE
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 599 RGYLTDKADVYSFGIVALEIVS 620
+ K+DV+SFG++ E S
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFS 215
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 47/223 (21%), Positives = 92/223 (41%), Gaps = 37/223 (16%)
Query: 428 KIGEGGFGPVYKG--------HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNL 479
+G+G F ++KG T V +K L + + F M+S L H +L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
V +G C+ G++ +L+ E+++ SL L + ++ ++ + + +A + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMHFL-- 129
Query: 540 ESRLKIVHRDIKATNVLLDKDLNP--------KISDFGLAK-LDEEDNTHISTRVAGTFG 590
E ++H ++ A N+LL ++ + K+SD G++ + +D
Sbjct: 130 EEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP------ 182
Query: 591 YMAPE-YAMRGYLTDKADVYSFGIVALEIVS-------GRSNS 625
++ PE L D +SFG EI S +
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ 225
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-40
Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 51/298 (17%)
Query: 426 DNKIGEGGFGPVYKG--------HMADGTVVAVKQLSSKSKQGNR-EFVNEIGMISAL-Q 475
+GEG FG V + VAVK L + + + + V+E+ M+ + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 476 HPNLVKLHGCCIEGNQLLLIYEYMENNSL------------ARALFGPEAHRLKLDWPTR 523
H N++ L G C + L +I EY +L + ++ +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 524 HRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 583
+ARG+ YL S+ K +HRD+ A NVL+ ++ KI+DFGLA+ + +
Sbjct: 206 VSCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY--- 259
Query: 584 RVAGTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLL 637
T G +MAPE T ++DV+SFG++ EI + G S P E++F LL
Sbjct: 260 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318
Query: 638 DWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+G+ M+ N E M+M C + RP+ +V L+
Sbjct: 319 K-------EGHRMDKPA-----NCTNELYMMM----RDCWHAVPSQRPTFKQLVEDLD 360
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 51/298 (17%)
Query: 426 DNKIGEGGFGPVYKG--------HMADGTVVAVKQLSSKSKQGNR-EFVNEIGMISAL-Q 475
+GEG FG V + VAVK L + + + + V+E+ M+ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 476 HPNLVKLHGCCIEGNQLLLIYEYMENNSL------------ARALFGPEAHRLKLDWPTR 523
H N++ L G C + L +I EY +L + ++ +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 524 HRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 583
+ARG+ YL S+ K +HRD+ A NVL+ ++ KI+DFGLA+ + +
Sbjct: 160 VSCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY--- 213
Query: 584 RVAGTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLL 637
T G +MAPE T ++DV+SFG++ EI + G S P E++F LL
Sbjct: 214 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
Query: 638 DWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+G+ M+ N E M+M C + RP+ +V L+
Sbjct: 273 K-------EGHRMDKPA-----NCTNELYMMM----RDCWHAVPSQRPTFKQLVEDLD 314
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 18/200 (9%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGC 485
K+GEG +G VYK H G +VA+KQ+ +S +E + EI ++ P++VK +G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
+ L ++ EY S++ + L I +GL YLH +
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHFM---RK 146
Query: 546 VHRDIKATNVLLDKDLNPKISDFGL-AKLDEED---NTHISTRVAGTFGYMAPEYAMRGY 601
+HRDIKA N+LL+ + + K++DFG+ +L + NT I GT +MAPE
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFWMAPEVIQEIG 201
Query: 602 LTDKADVYSFGIVALEIVSG 621
AD++S GI A+E+ G
Sbjct: 202 YNCVADIWSLGITAIEMAEG 221
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-40
Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 426 DNKIGEGGFGPVYKG----HMADGTVVAVKQL-SSKSKQGNREFVNEIGMISALQHPNLV 480
IGEG FG V++G VA+K + S +F+ E + HP++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
KL G E N + +I E L L + + LD + ++ LAYL
Sbjct: 455 KLIGVITE-NPVWIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYL--- 507
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 600
+ VHRDI A NVL+ + K+ DFGL++ E+ + +++ +MAPE
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 601 YLTDKADVYSFGIVALEIVS 620
T +DV+ FG+ EI+
Sbjct: 568 RFTSASDVWMFGVCMWEILM 587
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-40
Identities = 68/297 (22%), Positives = 104/297 (35%), Gaps = 60/297 (20%)
Query: 427 NKIGEGGFGPVYKGH------MADGTVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPNL 479
+G G FG VY+G VAVK L + + +F+ E +IS H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSLA---RALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
V+ G ++ ++ E M L R + L + IA G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 537 LHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGLAKLDEEDNTHISTRVAGTFGY-- 591
L +HRDI A N LL KI DFG+A+ + G
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAMLP 249
Query: 592 ---MAPEYAMRGYLTDKADVYSFGIVALEIVS-------GRSNSSCKPKEDIFYLLDWAL 641
M PE M G T K D +SFG++ EI S +SN +++ +
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFVT--- 300
Query: 642 ILKAQGNLME---LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
G M+ + ++M C RP+ + ++ +E
Sbjct: 301 ----SGGRMDPPKNCPGPV------YRIM------TQCWQHQPEDRPNFAIILERIE 341
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 78/309 (25%), Positives = 124/309 (40%), Gaps = 68/309 (22%)
Query: 426 DNKIGEGGFGPVYKGHMADG------TVVAVKQLSSKSKQGNR-EFVNEIGMISALQHPN 478
+GEG FG V K T VAVK L + + ++E ++ + HP+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSL--------------------ARALFGPEAHRLKL 518
++KL+G C + LLLI EY + SL + L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 519 DWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578
I++G+ YL K+VHRD+ A N+L+ + KISDFGL++ E++
Sbjct: 148 TMGDLISFAWQISQGMQYL--AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 579 THISTRVAGTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS-------GRSNSS 626
++ V + G +MA E T ++DV+SFG++ EIV+ G
Sbjct: 205 SY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-- 258
Query: 627 CKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPS 686
E +F LL G+ ME + + + ++M L C RP
Sbjct: 259 ----ERLFNLLK-------TGHRME---RPDNCSEEMYRLM------LQCWKQEPDKRPV 298
Query: 687 MSSVVSMLE 695
+ + LE
Sbjct: 299 FADISKDLE 307
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-40
Identities = 76/312 (24%), Positives = 118/312 (37%), Gaps = 76/312 (24%)
Query: 427 NKIGEGGFGPVYKGHMADG------TVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNL 479
IGEG FG V++ T+VAVK L + S +F E +++ +PN+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSL--------------------ARALFGPEAHRLKLD 519
VKL G C G + L++EYM L + L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 520 WPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDN 578
+ I +A G+AYL S K VHRD+ N L+ +++ KI+DFGL+ + D
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 579 THISTRVAGTFGY-----MAPEYAMRGYLTDKADVYSFGIVALEIVS-------GRSNSS 626
M PE T ++DV+++G+V EI S G ++
Sbjct: 230 YKADGN-----DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-- 282
Query: 627 CKPKEDIFYLLDWALILKAQGNLME---LVDKRLGSNFDKEQVMVMINVALLCTDVSSTS 683
E++ Y + GN++ L +M LC
Sbjct: 283 ----EEVIYYVR-------DGNILACPENCPLEL------YNLM------RLCWSKLPAD 319
Query: 684 RPSMSSVVSMLE 695
RPS S+ +L+
Sbjct: 320 RPSFCSIHRILQ 331
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 50/228 (21%), Positives = 82/228 (35%), Gaps = 34/228 (14%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQ--LSSKSKQGNREFVNEIGMISAL-Q 475
T F KIG G FG V+K DG + A+K+ + + E+ + L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 476 HPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLA 535
H ++V+ E + +L+ EY SLA A+ + + + RGL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNP-------------------KISDFGLAKLDEE 576
Y+H +VH DIK +N+ + + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 577 DNTHISTRVAGTFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGR 622
G ++A E +L KAD+++ + +
Sbjct: 187 PQVEE-----GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAE 228
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 60/208 (28%), Positives = 86/208 (41%), Gaps = 18/208 (8%)
Query: 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE---FVNEIGMISAL-QH 476
+F +++G G +G V+K DG + AVK+ S +G ++ + E+G + QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 477 PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
P V+L EG L L E SL + EA L LA+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGP-SLQQHC---EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPE 595
LH + +VH D+K N+ L K+ DFGL L + G YMAPE
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE--VQE-GDPRYMAPE 226
Query: 596 YAMRGYLTDKADVYSFGIVALEIVSGRS 623
Y ADV+S G+ LE+
Sbjct: 227 LLQGSY-GTAADVFSLGLTILEVACNME 253
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 30/219 (13%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNL 479
+F IG GGFG V+K H DG +K++ K N + E+ ++ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66
Query: 480 VKLHGCCIE----------------GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTR 523
V +GC L + E+ + +L + + + KLD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLA 124
Query: 524 HRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 583
+ I +G+ Y+H + K+++RD+K +N+ L KI DFGL + D T
Sbjct: 125 LELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--T 179
Query: 584 RVAGTFGYMAPE-YAMRGYLTDKADVYSFGIVALEIVSG 621
R GT YM+PE + + Y + D+Y+ G++ E++
Sbjct: 180 RSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHV 217
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 75/296 (25%), Positives = 111/296 (37%), Gaps = 50/296 (16%)
Query: 426 DNKIGEGGFGPVYKGHMADG-------TVVAVKQL-SSKSKQGNREFVNEIGMISAL-QH 476
+G G FG V + A G VAVK L S+ ++E+ ++S L QH
Sbjct: 51 GKTLGAGAFGKVVEA-TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 477 PNLVKLHGCCIEGNQLLLIYEYMENNSL----------ARALFGPEAHRLKLDWPTRHRI 526
N+V L G C G +L+I EY L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 527 CVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVA 586
+A+G+A+L S+ +HRD+ A NVLL KI DFGLA+ D+ + +
Sbjct: 170 SSQVAQGMAFL--ASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY----IV 222
Query: 587 GTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSN-SSCKPKEDIFYLLDW 639
+MAPE T ++DV+S+GI+ EI S G + + L+
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK- 281
Query: 640 ALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
G M K +M C + T RP+ + S L+
Sbjct: 282 ------DGYQMAQPA-----FAPKNIYSIM----QACWALEPTHRPTFQQICSFLQ 322
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-39
Identities = 85/348 (24%), Positives = 136/348 (39%), Gaps = 67/348 (19%)
Query: 426 DNKIGEGGFGPVYKG--------HMADGTVVAVKQLSSKSKQGNR-EFVNEIGMISAL-Q 475
+GEG FG V T VAVK L S + + + + ++E+ M+ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 476 HPNLVKLHGCCIEGNQLLLIYEYMENNSL------------ARALFGPEAHRLKLDWPTR 523
H N++ L G C + L +I EY +L + +L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 524 HRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 583
+ARG+ YL S+ K +HRD+ A NVL+ +D KI+DFGLA+ + +
Sbjct: 194 VSCAYQVARGMEYL--ASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY--- 247
Query: 584 RVAGTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLL 637
T G +MAPE T ++DV+SFG++ EI + G S P E++F LL
Sbjct: 248 -KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306
Query: 638 DWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697
+G+ M+ N E M+M C + RP+ +V L+
Sbjct: 307 K-------EGHRMDKPS-----NCTNELYMMM----RDCWHAVPSQRPTFKQLVEDLDRI 350
Query: 698 ADVQDFVPDSSVVSNIDKTKSEAIRNYYEFSEEQSMDGCQTQSMSIDG 745
+ YY D T+++ +G
Sbjct: 351 VALTSNQEMG----------------YYHHHHHHDYDIPTTENLYFNG 382
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 52/204 (25%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQL-SSKSKQGNREFVNEIGMI-SALQHPNLVKLH 483
++G G +G V K H+ G ++AVK++ ++ + Q + + ++ + + P V +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
G + + E M + SL + + +I V I + L +LH + L
Sbjct: 73 GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--L 129
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-----YAM 598
++HRD+K +NVL++ K+ DFG++ + AG YMAPE
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 599 RGYLTDKADVYSFGIVALEIVSGR 622
+GY + K+D++S GI +E+ R
Sbjct: 188 KGY-SVKSDIWSLGITMIELAILR 210
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 62/222 (27%), Positives = 91/222 (40%), Gaps = 34/222 (15%)
Query: 426 DNKIGEGGFGPVYKG------HMADGTVVAVKQLSSKSKQGNR-EFVNEIGMISAL-QHP 477
+G G FG V + VAVK L + R ++E+ ++S L H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 478 NLVKLHGCCIEGNQLLLIYEYMENNSL--------------ARALFGPEAHRLKLDWPTR 523
N+V L G C G L+I EY L + E L LD
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 524 HRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 583
+A+G+A+L + +HRD+ A N+LL KI DFGLA+ + D+ +
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY--- 201
Query: 584 RVAGTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
V +MAPE T ++DV+S+GI E+ S
Sbjct: 202 -VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 19/212 (8%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
K+GEGGF V + DG A+K++ +Q E E M HPN+++L C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 487 IE----GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
+ ++ L+ + + +L + + L + +GI RGL +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-- 153
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVA--------GTFGYMAP 594
HRD+K TN+LL + P + D G + T Y AP
Sbjct: 154 -GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 595 E-YAMRGY--LTDKADVYSFGIVALEIVSGRS 623
E ++++ + + ++ DV+S G V ++ G
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-39
Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 33/221 (14%)
Query: 426 DNKIGEGGFGPVYKG------HMADGTVVAVKQLSSKSKQGNR-EFVNEIGMISAL-QHP 477
+G G FG V + A VAVK L + ++E+ ++ + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 478 NLVKLHGCC-IEGNQLLLIYEYMENNSL------------ARALFGPEAHRLKLDWPTRH 524
N+V L G C G L++I E+ + +L + + ++ L
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 525 RICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 584
+A+G+ +L + K +HRD+ A N+LL + KI DFGLA+ +D +
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---- 204
Query: 585 VAGTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
V +MAPE T ++DV+SFG++ EI S
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 69/200 (34%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLHGC 485
KIG+G FG V+KG VVA+K + + + E EI ++S P + K +G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
++ +L +I EY+ S L LD I I +GL YLH E K
Sbjct: 89 YLKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHSE---KK 140
Query: 546 VHRDIKATNVLLDKDLNPKISDFGL-AKLDEED---NTHISTRVAGTFGYMAPEYAMRGY 601
+HRDIKA NVLL + K++DFG+ +L + NT + GT +MAPE +
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEVIKQSA 195
Query: 602 LTDKADVYSFGIVALEIVSG 621
KAD++S GI A+E+ G
Sbjct: 196 YDSKADIWSLGITAIELARG 215
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 15/211 (7%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSK-QGNREFVNEIGMI-SALQHP 477
+ +IG G +G V K H G ++AVK++ S + ++ + ++ ++ + P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 478 NLVKLHGCCIEGNQLLLIYEYMENNSLARAL-FGPEAHRLKLDWPTRHRICVGIARGLAY 536
+V+ +G + E M + S + + + +I + + L +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE- 595
L E LKI+HRDIK +N+LLD+ N K+ DFG++ + ++ TR AG YMAPE
Sbjct: 141 LKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTRDAGCRPYMAPER 196
Query: 596 ----YAMRGYLTDKADVYSFGIVALEIVSGR 622
+ +GY ++DV+S GI E+ +GR
Sbjct: 197 IDPSASRQGY-DVRSDVWSLGITLYELATGR 226
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-38
Identities = 51/200 (25%), Positives = 103/200 (51%), Gaps = 15/200 (7%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQG-NREFVNEIGMISALQHPNLVKLHG 484
+++G G G V+K H G V+A K + + K + + E+ ++ P +V +G
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRH--RICVGIARGLAYLHEESR 542
++ + E+M+ SL + L + P + ++ + + +GL YL E+
Sbjct: 99 AFYSDGEISICMEHMDGGSLDQVL------KKAGRIPEQILGKVSIAVIKGLTYLREK-- 150
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYL 602
KI+HRD+K +N+L++ K+ DFG++ + ++ ++ V GT YM+PE +
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFV-GTRSYMSPERLQGTHY 207
Query: 603 TDKADVYSFGIVALEIVSGR 622
+ ++D++S G+ +E+ GR
Sbjct: 208 SVQSDIWSMGLSLVEMAVGR 227
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 423 FAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREF---VNEIGMISALQHPN 478
F+ +IG G FG VY + + VVA+K++S KQ N ++ + E+ + L+HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
++ GC + + L+ EY S + L E H+ L + G +GLAYLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLG-SASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 598
++HRD+KA N+LL + K+ DFG A + N+ + GT +MAPE +
Sbjct: 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVIL 223
Query: 599 R----GYLTDKADVYSFGIVALEIVSG 621
Y K DV+S GI +E+
Sbjct: 224 AMDEGQY-DGKVDVWSLGITCIELAER 249
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLHGC 485
IG G V VA+K+++ + Q + + + EI +S HPN+V +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 486 CIEGNQLLLIYEYMENNSLA----RALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
+ ++L L+ + + S+ + E LD T I + GL YLH+
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN- 140
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGL-AKL-DEEDNTHISTR--VAGTFGYMAPEYA 597
+HRD+KA N+LL +D + +I+DFG+ A L D T R GT +MAPE
Sbjct: 141 --GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 598 MR--GYLTDKADVYSFGIVALEIVSGR 622
+ GY KAD++SFGI A+E+ +G
Sbjct: 199 EQVRGY-DFKADIWSFGITAIELATGA 224
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 6e-38
Identities = 76/304 (25%), Positives = 112/304 (36%), Gaps = 57/304 (18%)
Query: 426 DNKIGEGGFGPVYKG------HMADGTVVAVKQLSSKSKQGNR-EFVNEIGMISAL-QHP 477
+G G FG V VAVK L K+ R ++E+ M++ L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 478 NLVKLHGCCIEGNQLLLIYEYMENNSL-------------------ARALFGPEAHRLKL 518
N+V L G C + LI+EY L + E L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 519 DWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578
+ +A+G+ +L VHRD+ A NVL+ KI DFGLA+ D+
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 579 THISTRVAGTFG-----YMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSN-SSCKPKE 631
+ V +MAPE G T K+DV+S+GI+ EI S G +
Sbjct: 227 NY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 632 DIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVV 691
+ + L+ G M+ +E ++M C S RPS ++
Sbjct: 283 NFYKLIQ-------NGFKMDQPF-----YATEEIYIIM----QSCWAFDSRKRPSFPNLT 326
Query: 692 SMLE 695
S L
Sbjct: 327 SFLG 330
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-38
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 10/210 (4%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQ--LSSKSKQGNREFVNEIGMISALQHP 477
++ IG G +G K +DG ++ K+ S ++ + V+E+ ++ L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 478 NLVKLHGCCIE--GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLA 535
N+V+ + I+ L ++ EY E LA + R LD R+ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 536 YLHE--ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 593
H + ++HRD+K NV LD N K+ DFGLA++ D + T V GT YM+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 594 PE-YAMRGYLTDKADVYSFGIVALEIVSGR 622
PE Y +K+D++S G + E+ +
Sbjct: 185 PEQMNRMSY-NEKSDIWSLGCLLYELCALM 213
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 55/244 (22%), Positives = 95/244 (38%), Gaps = 25/244 (10%)
Query: 395 HTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQ-- 452
H GVDL T + + + ++ +IG GG V++ + A+K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 61
Query: 453 LSSKSKQGNREFVNEIGMISALQHPNL--VKLHGCCIEGNQLLLIYEYMENNSLARALFG 510
L Q + NEI ++ LQ + ++L+ I + ++ E N L L
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-- 118
Query: 511 PEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570
+ +D R + + +H+ IVH D+K N L+ K+ DFG+
Sbjct: 119 --KKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGI 172
Query: 571 AKLDEEDNTHISTR-VAGTFGYMAPE-----------YAMRGYLTDKADVYSFGIVALEI 618
A + D T + GT YM PE + ++ K+DV+S G + +
Sbjct: 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232
Query: 619 VSGR 622
G+
Sbjct: 233 TYGK 236
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-37
Identities = 45/216 (20%), Positives = 79/216 (36%), Gaps = 32/216 (14%)
Query: 427 NKIGEG--GFGPVYKG-HMADGTVVAVKQ--LSSKSKQGNREFVNEIGMISALQHPNLVK 481
IG+G V + G V V++ L + S + E+ + HPN+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHR------ICVGIARGLA 535
I N+L ++ +M S + + I G+ + L
Sbjct: 91 YRATFIADNELWVVTSFMAYGSA--------KDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG-LAKLDEEDN-----THISTRVAGTF 589
Y+H VHR +KA+++L+ D +S +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 590 GYMAPE---YAMRGYLTDKADVYSFGIVALEIVSGR 622
+++PE ++GY K+D+YS GI A E+ +G
Sbjct: 200 PWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGH 234
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 31/224 (13%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE-FVNEIGMISALQHPN 478
+F P +G GGFG V++ + D A+K++ +++ RE + E+ ++ L+HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 479 LVKLHGCCIEGNQ------------LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRI 526
+V+ +E N L + + +L + G + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RCTIEERERSVCLHI 123
Query: 527 CVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVA 586
+ IA + +LH + ++HRD+K +N+ D K+ DFGL ++D +
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 587 -----------GTFGYMAPE-YAMRGYLTDKADVYSFGIVALEI 618
GT YM+PE Y + K D++S G++ E+
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFEL 223
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 49/212 (23%), Positives = 84/212 (39%), Gaps = 25/212 (11%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQ--LSSKSKQGNREFVNEIGMISALQHPNL--VKL 482
+IG GG V++ + A+K L Q + NEI ++ LQ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
+ I + ++ E N L L + +D R + + +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR-VAGTFGYMAPE------ 595
IVH D+K N L+ K+ DFG+A + D T + GT YM PE
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 596 -----YAMRGYLTDKADVYSFGIVALEIVSGR 622
+ ++ K+DV+S G + + G+
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-36
Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 21/211 (9%)
Query: 422 NFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIG-MISALQHPNLV 480
+F P + +G G G + M D VAVK++ + E+ + + +HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVI 81
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
+ + + E +L + E + GLA+LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 541 SRLKIVHRDIKATNVLL-----DKDLNPKISDFGLAKLDEEDNTHISTR--VAGTFGYMA 593
L IVHRD+K N+L+ + ISDFGL K S R V GT G++A
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 594 PEY---AMRGYLTDKADVYSFGIVALEIVSG 621
PE + T D++S G V ++S
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 69/216 (31%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 423 FAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLV 480
F +G G +G VYKG H+ G + A+K + E EI M+ H N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 481 KLHGC------CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGL 534
+G +QL L+ E+ S+ + + + LK +W IC I RGL
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 142
Query: 535 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL-AKLDEED---NTHISTRVAGTFG 590
++LH+ K++HRDIK NVLL ++ K+ DFG+ A+LD NT GT
Sbjct: 143 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-----FIGTPY 194
Query: 591 YMAPEYAMRGYLTD-----KADVYSFGIVALEIVSG 621
+MAPE D K+D++S GI A+E+ G
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-36
Identities = 48/212 (22%), Positives = 83/212 (39%), Gaps = 25/212 (11%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVKQ--LSSKSKQGNREFVNEIGMISALQHPNL--VKL 482
+IG GG V++ + A+K L Q + NEI ++ LQ + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
+ I + ++ E N L L + +D R + + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR-VAGTFGYMAPE------ 595
IVH D+K N L+ K+ DFG+A + D T + G YM PE
Sbjct: 175 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 596 -----YAMRGYLTDKADVYSFGIVALEIVSGR 622
+ ++ K+DV+S G + + G+
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQL-SSKSKQGNREFVNEIG-MISALQHPNLVKLHG 484
++G G G V+K G V+AVKQ+ S +K+ N+ + ++ ++ + P +V+ G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
I + + E M + + ++ V I + L YL E+
Sbjct: 92 TFITNTDVFIAMELMGTCAEKLKKRMQG----PIPERILGKMTVAIVKALYYLKEK--HG 145
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE------YAM 598
++HRD+K +N+LLD+ K+ DFG++ + R AG YMAPE
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISG--RLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 599 RGYLTDKADVYSFGIVALEIVSGR 622
Y +ADV+S GI +E+ +G+
Sbjct: 204 PDY-DIRADVWSLGISLVELATGQ 226
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 9e-34
Identities = 50/213 (23%), Positives = 86/213 (40%), Gaps = 22/213 (10%)
Query: 426 DNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLH 483
+ +G+G V++G H G + A+K ++ S + + E ++ L H N+VKL
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 484 GC--CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
+LI E+ SL L P + L + + G+ +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 542 RLKIVHRDIKATNVLL----DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-- 595
IVHR+IK N++ D K++DFG A+ ED+ + GT Y+ P+
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLHPDMY 187
Query: 596 ------YAMRGYLTDKADVYSFGIVALEIVSGR 622
+ D++S G+ +G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 428 KIGEGGFGPVYKGHMAD---GTVVAVKQLSSKSKQGNREFV----NEIGMISALQHPNLV 480
K+G GG VY D VA+K + + E + E+ S L H N+V
Sbjct: 18 KLGGGGMSTVYLAE--DTILNIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
+ E + L+ EY+E +L+ + L T I G+ + H
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAH-- 128
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYAMR 599
++IVHRDIK N+L+D + KI DFG+AK L E T + V GT Y +PE A
Sbjct: 129 -DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKG 186
Query: 600 GYLTDKADVYSFGIVALEIVSGR 622
+ D+YS GIV E++ G
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGE 209
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-33
Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 38/230 (16%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIG-MISALQHPNL 479
N + +G G G V G VAVK++ + EI + + HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNV 71
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSL-----ARALFGPEAHRLKLDWPTRHRICVGIARGL 534
++ + L + E +L ++ + K P + IA G+
Sbjct: 72 IRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPI--SLLRQIASGV 128
Query: 535 AYLHEESRLKIVHRDIKATNVLLD-------------KDLNPKISDFGLAKLDEEDNTHI 581
A+LH LKI+HRD+K N+L+ ++L ISDFGL K + +
Sbjct: 129 AHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 582 STR---VAGTFGYMAPE-------YAMRGYLTDKADVYSFGIVALEIVSG 621
T +GT G+ APE + LT D++S G V I+S
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 4e-33
Identities = 67/210 (31%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 426 DNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV-NEIGMISALQHPNLVKLH 483
++G GGFG V + H G VA+KQ + NRE EI ++ L HPN+V
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 484 GCCIE-------GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
+ + LL EY E L + L E + L + I+ L Y
Sbjct: 79 -EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRY 136
Query: 537 LHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 593
LHE +I+HRD+K N++L + L KI D G AK + + + V GT Y+A
Sbjct: 137 LHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQGELCTEFV-GTLQYLA 191
Query: 594 PE-YAMRGYLTDKADVYSFGIVALEIVSGR 622
PE + Y T D +SFG +A E ++G
Sbjct: 192 PELLEQKKY-TVTVDYWSFGTLAFECITGF 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKS--KQGNRE-FVNEIGMISALQHPNLVKLHG 484
+G+GGF ++ V A K + K RE EI + +L H ++V HG
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+ + + ++ E SL R L P I G YLH R +
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLH---RNR 135
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
++HRD+K N+ L++DL KI DFGLA E D + GT Y+APE + +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 194
Query: 605 KADVYSFGIVALEIVSGR 622
+ DV+S G + ++ G+
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-33
Identities = 44/203 (21%), Positives = 77/203 (37%), Gaps = 24/203 (11%)
Query: 428 KIGEGGFGPVYKGH--MADGTVVAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLH- 483
I GG G +Y +G V +K L + + E ++ + HP++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 484 -GCCIEGNQLLLIY---EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
+ + + Y EY+ SL R+ L + I L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPALSYLH- 199
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 599
+ +V+ D+K N++L ++ K+ D G + GT G+ APE R
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-----LYGTPGFQAPEIV-R 250
Query: 600 GYLTDKADVYSFGIVALEIVSGR 622
T D+Y+ G +
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDL 273
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 12/198 (6%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKS--KQGNRE-FVNEIGMISALQHPNLVKLHG 484
+G+GGF ++ V A K + K RE EI + +L H ++V HG
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+ + + ++ E SL R L P I G YLH R +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLH---RNR 161
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
++HRD+K N+ L++DL KI DFGLA E D + GT Y+APE + +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 220
Query: 605 KADVYSFGIVALEIVSGR 622
+ DV+S G + ++ G+
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 57/203 (28%), Positives = 82/203 (40%), Gaps = 19/203 (9%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV----NEIGMISALQHPNLVKL 482
+G GG G VY+ +VA+K +S + + F E LQ P++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 483 HGCCIEGNQLLLIYEYMENNSLARAL--FGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
H QL + + LA L GP L P I I L H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGP------LAPPRAVAIVRQIGSALDAAH-- 151
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYAMR 599
HRD+K N+L+ D + DFG+A +E T + GT YMAPE
Sbjct: 152 -AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSE 209
Query: 600 GYLTDKADVYSFGIVALEIVSGR 622
+ T +AD+Y+ V E ++G
Sbjct: 210 SHATYRADIYALTCVLYECLTGS 232
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 50/213 (23%), Positives = 86/213 (40%), Gaps = 22/213 (10%)
Query: 426 DNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKLH 483
+ +G+G V++G H G + A+K ++ S + + E ++ L H N+VKL
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 484 GC--CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
+LI E+ SL L P + L + + G+ +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 542 RLKIVHRDIKATNVLL----DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-- 595
IVHR+IK N++ D K++DFG A+ ED+ + GT Y+ P+
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLHPDMY 187
Query: 596 ------YAMRGYLTDKADVYSFGIVALEIVSGR 622
+ D++S G+ +G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKS--KQGNRE-FVNEIGMISALQHPNLVKLHG 484
+G+G F VY+ + G VA+K + K+ K G + NE+ + L+HP++++L+
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK 544
+ N + L+ E N + R L + I G+ YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLH---SHG 132
Query: 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
I+HRD+ +N+LL +++N KI+DFGLA + + T + GT Y++PE A R
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGL 191
Query: 605 KADVYSFGIVALEIVSGR 622
++DV+S G + ++ GR
Sbjct: 192 ESDVWSLGCMFYTLLIGR 209
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLS----SKSKQGNREFVNEIGMISALQHPNLVK 481
+G+G FG VY ++A+K L K+ ++ E+ + S L+HPN+++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
L+G + ++ LI EY ++ R L K D +A L+Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCH--- 126
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-RG 600
+++HRDIK N+LL KI+DFG + + GT Y+ PE R
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPEMIEGRM 183
Query: 601 YLTDKADVYSFGIVALEIVSGR 622
+ +K D++S G++ E + G+
Sbjct: 184 H-DEKVDLWSLGVLCYEFLVGK 204
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 25/209 (11%)
Query: 428 KIGEGGFGPVYKGHMAD---GTVVAVKQLSSKSKQGNREFV----NEIGMISALQHPNLV 480
+G GG V+ D VAVK L + + F E +AL HP +V
Sbjct: 19 ILGFGGMSEVHLAR--DLRDHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 481 KLH--GCCIEGNQLLLIY---EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLA 535
++ G E L Y EY++ +L + + + + L
Sbjct: 76 AVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALN 130
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI--STRVAGTFGYMA 593
+ H + I+HRD+K N+++ K+ DFG+A+ + + + V GT Y++
Sbjct: 131 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 594 PEYAMRGYLTDKADVYSFGIVALEIVSGR 622
PE A + ++DVYS G V E+++G
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 53/249 (21%), Positives = 90/249 (36%), Gaps = 35/249 (14%)
Query: 398 EQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK 456
+ + G + G LR + + EGGF VY+ + G A+K+L S
Sbjct: 15 QSDFVGQTVELGELRLRVRR----------VLAEGGFAFVYEAQDVGSGREYALKRLLSN 64
Query: 457 SKQGNREFVNEIG-MISALQHPNLVKLHGCCI-------EGNQLLLIYEYMENNSLARAL 508
++ NR + E+ M HPN+V+ G L+ + L L
Sbjct: 65 EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL 124
Query: 509 FGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 568
E+ L T +I R + ++H + I+HRD+K N+LL K+ DF
Sbjct: 125 KKMESRG-PLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDF 182
Query: 569 GLAKLDEEDNTHISTRVA-----------GTFGYMAPE---YAMRGYLTDKADVYSFGIV 614
G A + + T Y PE + +K D+++ G +
Sbjct: 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242
Query: 615 ALEIVSGRS 623
+ +
Sbjct: 243 LYLLCFRQH 251
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 35/238 (14%), Positives = 74/238 (31%), Gaps = 52/238 (21%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGN------REFVNEIGMISALQHPNLVK 481
+G+ + G V + + +E V + ++ +++ K
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 482 LHGCCIEGNQLL------------------------LIYEYMENN--SLARALFGPEAHR 515
+H I L+ +Y M++N + L +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 516 LKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575
L R ++ + + R LA LH +VH ++ +++LD+ ++ F D
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 576 EDNTHISTRVAGTFGYMAPEY-----------AMRGYLTDKADVYSFGIVALEIVSGR 622
+ + G+ PE R +T D ++ G+V I
Sbjct: 258 ARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 26/233 (11%), Positives = 58/233 (24%), Gaps = 41/233 (17%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE------------------------ 463
+G+ + G V + +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 464 ----FVNEIGMISALQHPNLVKLHGC----CIEGNQLLLIYEYMENNSLARALFGPEAHR 515
F+ ++ Q ++++ + L + L +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 516 LKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575
L R ++ + + R LA LH +VH ++ +++LD+ ++ F D
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 576 EDNTHISTRVAGTFGYMAPE-----YAMRGYLTDKADVYSFGIVALEIVSGRS 623
R A +T D ++ G+ I
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-30
Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 28/226 (12%)
Query: 409 GSFTLRQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE---F 464
G F + + + K+G G +G V A+K + K+
Sbjct: 25 GMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR-KTSVSTSSNSKL 83
Query: 465 VNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL-----ARALFGPEAHRLKLD 519
+ E+ ++ L HPN++KL+ + L+ E + L R F
Sbjct: 84 LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA---- 139
Query: 520 WPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEE 576
I + G+ YLH+ IVHRD+K N+LL +KD KI DFGL+ + E
Sbjct: 140 -----VIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191
Query: 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 622
GT Y+APE + Y +K DV+S G++ +++G
Sbjct: 192 QKKM--KERLGTAYYIAPEVLRKKY-DEKCDVWSIGVILFILLAGY 234
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 5e-30
Identities = 33/246 (13%), Positives = 71/246 (28%), Gaps = 30/246 (12%)
Query: 414 RQIKAATNNFAPDNKIGEGGFGPVYKG------HMADGTVVAVKQLSSKSKQGNREFVNE 467
+ + + + +GEG F VY+ + +K +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 468 IGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL-ARALFGPEAHRLKLDWPTRHRI 526
+ + +K + + N +L+ E +L +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 527 CVGIARGLAYLHEESRLKIVHRDIKATNVLL-----------DKDLNPKISDFGLAK-LD 574
+ + + +H+ +I+H DIK N +L D + D G + +
Sbjct: 178 AMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 575 EEDNTHISTRVAGTFGYMAPE-YAMRGYLTDKADVYSFGIVALEIVSGR------SNSSC 627
I T T G+ E + + + + D + ++ G C
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293
Query: 628 KPKEDI 633
KP+
Sbjct: 294 KPEGLF 299
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 48/226 (21%), Positives = 90/226 (39%), Gaps = 31/226 (13%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV-------------- 465
N++ + +G F + D A+K+ + R+F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 466 ---NEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMEN----NSLARALFGPEAHRLKL 518
NE+ +I+ +++ + G +++ +IYEYMEN + + +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 519 DWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578
I + +Y+H + I HRD+K +N+L+DK+ K+SDFG ++ +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 579 THISTRVAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGR 622
S GT+ +M PE+ Y K D++S GI +
Sbjct: 207 IKGS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 49/204 (24%), Positives = 83/204 (40%), Gaps = 40/204 (19%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV-NEIGMISALQHPNLVKLHGC 485
+G G F V+ G + A+K + KS + NEI ++ ++H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 486 CIEGNQLLLIYEYM---ENNSLARALFGPEAHRLKLDWPTRH---------RICVGIARG 533
L+ + + E LF D + +
Sbjct: 75 YESTTHYYLVMQLVSGGE-------LF---------DRILERGVYTEKDASLVIQQVLSA 118
Query: 534 LAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 590
+ YLHE IVHRD+K N+L +++ I+DFGL+K+++ + GT G
Sbjct: 119 VKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPG 172
Query: 591 YMAPEYAMRGYLTDKADVYSFGIV 614
Y+APE + + D +S G++
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVI 196
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV----NEIGMISALQHPNLVKLH 483
+G+G FG VY + ++A+K L KS+ EI + S L+HPN+++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLF-KSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
+ ++ L+ E+ L + L + D +A L Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHYCH---ER 133
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-RGYL 602
K++HRDIK N+L+ KI+DFG + T + GT Y+ PE + +
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPEMIEGKTH- 189
Query: 603 TDKADVYSFGIVALEIVSGR 622
+K D++ G++ E + G
Sbjct: 190 DEKVDLWCAGVLCYEFLVGM 209
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 24/228 (10%), Positives = 48/228 (21%), Gaps = 41/228 (17%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE---FVNEIGMISALQHPNLVKLHG 484
+ G V+ + A+K + ++ E + L + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 485 CC--------------------------IEGNQLLLIYEYMENN--SLARALFGPEAHRL 516
LL+ + L L R
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 517 KLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576
H + + R A L +VH N+ + D + D
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 577 DNTHISTRVAGTFGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGR 622
+ Y E+ T + + G+ +
Sbjct: 247 ----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 63/227 (27%), Positives = 95/227 (41%), Gaps = 29/227 (12%)
Query: 409 GSFTLRQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV-- 465
G F ++ + +G+G FG V G AVK +S K + +
Sbjct: 14 GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS-KRQVKQKTDKES 72
Query: 466 --NEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL-----ARALFGPEAHRLKL 518
E+ ++ L HPN++KL+ + L+ E L +R F
Sbjct: 73 LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA--- 129
Query: 519 DWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDE 575
RI + G+ Y+H+ KIVHRD+K N+LL KD N +I DFGL+ E
Sbjct: 130 ------RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180
Query: 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 622
GT Y+APE Y +K DV+S G++ ++SG
Sbjct: 181 ASKKM--KDKIGTAYYIAPEVLHGTY-DEKCDVWSTGVILYILLSGC 224
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-29
Identities = 50/163 (30%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD- 60
V L+ +S N+F+ IP F+ + + L+ L I + L G I++ ++L L IS
Sbjct: 199 CVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 257
Query: 61 -LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYL-GLMTSLKVLDVSFNKLNGAIPST 118
G P PP +K ++ L L +G++PD+L G +L LD+S N GA+P
Sbjct: 258 QFVG---PIPP-LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF 313
Query: 119 FMGLLDVDYIYLTGNLLTGTIPPWMLQKG---DRVDLSYNSFT 158
F ++ + L+ N +G +P L K +DLS+N F+
Sbjct: 314 FGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-27
Identities = 41/190 (21%), Positives = 76/190 (40%), Gaps = 8/190 (4%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD- 60
L +S N+ +G IP+ + + + L L + + L G IP + + L L +
Sbjct: 417 CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476
Query: 61 -LNGTEAPFPP-LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPST 118
L G P L + + L + ++G++P ++G + +L +L +S N +G IP+
Sbjct: 477 DLTG---EIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE 533
Query: 119 FMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSS 178
+ ++ L NL GTIP M ++ ++ N +
Sbjct: 534 LGDCRSLIWLDLNTNLFNGTIPAAMFKQ--SGKIAANFIAGKRYVYIKNDGMKKECHGAG 591
Query: 179 KGNNSTGIVS 188
GI S
Sbjct: 592 NLLEFQGIRS 601
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-27
Identities = 51/165 (30%), Positives = 86/165 (52%), Gaps = 10/165 (6%)
Query: 1 MLVTLKDFRISDNHFTGKIPNFIQNWTL--LEKLVIQASGLVGPIPSGIASLSKLTDLRI 58
+ +L +S N+F+G I + L++L +Q +G G IP +++ S+L L +
Sbjct: 366 LSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHL 425
Query: 59 SD--LNGTEAPFPP-LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAI 115
S L+G P L + K++ L L + G++P L + +L+ L + FN L G I
Sbjct: 426 SFNYLSG---TIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEI 482
Query: 116 PSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFT 158
PS ++++I L+ N LTG IP W+ L+ + LS NSF+
Sbjct: 483 PSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 527
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-25
Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 14/164 (8%)
Query: 1 MLVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD 60
LK IS N +G + + LE L + ++ IP + S L L IS
Sbjct: 176 GCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISG 232
Query: 61 --LNGTEAPFPP-LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPS 117
L+G F + ++K L + S G +P + SL+ L ++ NK G IP
Sbjct: 233 NKLSG---DFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPD 287
Query: 118 TFMGLLD-VDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFT 158
G D + + L+GN G +PP+ + + LS N+F+
Sbjct: 288 FLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS 331
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-25
Identities = 40/163 (24%), Positives = 67/163 (41%), Gaps = 11/163 (6%)
Query: 2 LVTLKDFRISDNHFTGKIP-NFIQNWTLLEKLVIQASGLVGPIPSGIA---SLSKLTDLR 57
LK +S N + LE L + A+ + G G +L L
Sbjct: 125 CSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLA 184
Query: 58 ISD--LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAI 115
IS ++G + + ++ L + S N S +P LG ++L+ LD+S NKL+G
Sbjct: 185 ISGNKISGD----VDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDF 239
Query: 116 PSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
++ + ++ N G IPP L+ + L+ N FT
Sbjct: 240 SRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFT 282
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-24
Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 12/166 (7%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIP-SGIASLSKLTDLRISD 60
TL +S NHF G +P F + +LLE L + ++ G +P + + L L +S
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 352
Query: 61 --LNGTEAPFPP-LDKMK-KMKTLILRSCNVSGKLPDYLG--LMTSLKVLDVSFNKLNGA 114
+G P L + + TL L S N SG + L +L+ L + N G
Sbjct: 353 NEFSG---ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409
Query: 115 IPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFT 158
IP T ++ ++L+ N L+GTIP + L K + L N
Sbjct: 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-22
Identities = 35/165 (21%), Positives = 70/165 (42%), Gaps = 12/165 (7%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSG--IASLSKLTDLRIS 59
L L+ +S++H G + F + L L + + L GP+ + + S S L L +S
Sbjct: 76 LTGLESLFLSNSHINGSVSGF-KCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVS 134
Query: 60 D--LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYL---GLMTSLKVLDVSFNKLNGA 114
L+ K+ ++ L L + ++SG LK L +S NK++G
Sbjct: 135 SNTLDFPG-KVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGD 193
Query: 115 IPSTFMGLLDVDYIYLTGNLLTGTIPP-WMLQKGDRVDLSYNSFT 158
+ ++++++ ++ N + IP +D+S N +
Sbjct: 194 VD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLS 236
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-20
Identities = 31/159 (19%), Positives = 65/159 (40%), Gaps = 4/159 (2%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L L ++S+N F+G IP + + L L + + G IP+ + S + + +
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG--KIAANFI 570
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
G + D MKK G + L +++ +++ G TF
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 630
Query: 122 LLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFT 158
+ ++ ++ N+L+G IP + + ++L +N +
Sbjct: 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 7e-20
Identities = 40/155 (25%), Positives = 66/155 (42%), Gaps = 8/155 (5%)
Query: 10 ISDNHFTGKIPNFIQNWTLLEKLVIQASG--LVGPIPSGIASLSKLTDLRISDLNGTEAP 67
I+ N GK +I+N + ++ + G + LS I+
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITS-RVYGGH 623
Query: 68 FPP-LDKMKKMKTLILRSCN-VSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDV 125
P D M L + S N +SG +P +G M L +L++ N ++G+IP L +
Sbjct: 624 TSPTFDNNGSMMFLDM-SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 682
Query: 126 DYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFT 158
+ + L+ N L G IP M L +DLS N+ +
Sbjct: 683 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-18
Identities = 26/130 (20%), Positives = 52/130 (40%), Gaps = 9/130 (6%)
Query: 37 SGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDY-- 94
+ + S + SL+ L L +S+ + + +L L ++SG +
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSN-SHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTS 121
Query: 95 LGLMTSLKVLDVSFNKLNGAIP-STFMGLLDVDYIYLTGNLLTGTIPPWMLQKGD----- 148
LG + LK L+VS N L+ S + L ++ + L+ N ++G +
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELK 181
Query: 149 RVDLSYNSFT 158
+ +S N +
Sbjct: 182 HLAISGNKIS 191
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-15
Identities = 32/121 (26%), Positives = 52/121 (42%), Gaps = 8/121 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRIS-- 59
L T I+ + G N + L + + L G IP I S+ L L +
Sbjct: 607 LSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666
Query: 60 DLNGTEAPFPP-LDKMKKMKTLILRSCNV-SGKLPDYLGLMTSLKVLDVSFNKLNGAIPS 117
D++G P + ++ + L L S N G++P + +T L +D+S N L+G IP
Sbjct: 667 DISG---SIPDEVGDLRGLNILDL-SSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 722
Query: 118 T 118
Sbjct: 723 M 723
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-15
Identities = 36/134 (26%), Positives = 55/134 (41%), Gaps = 8/134 (5%)
Query: 11 SDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD--LNGTEAPF 68
+ F G + + I + G + + L +S L+G
Sbjct: 592 NLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSG---YI 648
Query: 69 PP-LDKMKKMKTLILRSCNV-SGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVD 126
P + M + L L N SG +PD +G + L +LD+S NKL+G IP L +
Sbjct: 649 PKEIGSMPYLFILNL-GHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707
Query: 127 YIYLTGNLLTGTIP 140
I L+ N L+G IP
Sbjct: 708 EIDLSNNNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 3e-09
Identities = 18/102 (17%), Positives = 42/102 (41%), Gaps = 9/102 (8%)
Query: 79 TLILRSCNVS---GKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLL 135
++ L S ++ + L +T L+ L +S + +NG++ F + + L+ N L
Sbjct: 54 SIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSL 112
Query: 136 TGTIPPWM----LQKGDRVDLSYNSFTAGSSETSCQYRSVNL 173
+G + +++S N+ + S + +L
Sbjct: 113 SGPVTTLTSLGSCSGLKFLNVSSNTLD-FPGKVSGGLKLNSL 153
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-04
Identities = 13/61 (21%), Positives = 29/61 (47%), Gaps = 1/61 (1%)
Query: 99 TSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPP-WMLQKGDRVDLSYNSF 157
TS+ + N A+ S+ + L ++ ++L+ + + G++ +DLS NS
Sbjct: 53 TSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSL 112
Query: 158 T 158
+
Sbjct: 113 S 113
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 56/200 (28%), Positives = 86/200 (43%), Gaps = 27/200 (13%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV-NEIGMISALQHPNLVKLHGC 485
K+G G FG V+ + G +K ++ Q E + EI ++ +L HPN++K+
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHR--------ICVGIARGLAYL 537
+ + + ++ E E L R+ + + LAY
Sbjct: 89 FEDYHNMYIVMETCEGGEL----L----ERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 538 HEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP 594
H +VH+D+K N+L KI DFGLA+L + D T AGT YMAP
Sbjct: 141 HS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAP 195
Query: 595 EYAMRGYLTDKADVYSFGIV 614
E R T K D++S G+V
Sbjct: 196 EVFKRDV-TFKCDIWSAGVV 214
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 36/203 (17%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE---FVNEIGMISALQHPNLVKLH 483
+G+G FG V K AVK ++ K+ N++ + E+ ++ L HPN++KL
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRH---------RICVGIARGL 534
+ + ++ E L D + RI + G+
Sbjct: 88 EILEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 535 AYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY 591
Y+H+ IVHRD+K N+LL +KD + KI DFGL+ +++ GT Y
Sbjct: 135 TYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYY 189
Query: 592 MAPEYAMRGYLTDKADVYSFGIV 614
+APE Y +K DV+S G++
Sbjct: 190 IAPEVLRGTY-DEKCDVWSAGVI 211
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 46/197 (23%), Positives = 77/197 (39%), Gaps = 26/197 (13%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV-NEIGMISALQHPNLVKLHGC 485
IG G +G V A K++ K + + EI ++ +L HPN+++L+
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIP-KYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 486 CIEGNQLLLIYEYMENNSL-----ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
+ + L+ E L + +F RI + +AY H+
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA---------RIMKDVLSAVAYCHK- 124
Query: 541 SRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 597
L + HRD+K N L D K+ DFGLA + GT Y++P+
Sbjct: 125 --LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQVL 180
Query: 598 MRGYLTDKADVYSFGIV 614
Y + D +S G++
Sbjct: 181 EGLY-GPECDEWSAGVM 196
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-29
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE---FVNEIGMISALQHPNLVKL 482
+G+G FG V K AVK ++ K+ N++ + E+ ++ L HPN++KL
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRH---------RICVGIARG 533
+ + ++ E L D + RI + G
Sbjct: 87 FEILEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 534 LAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 590
+ Y+H+ IVHRD+K N+LL +KD + KI DFGL+ +++ GT
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAY 188
Query: 591 YMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 622
Y+APE Y +K DV+S G++ ++SG
Sbjct: 189 YIAPEVLRGTY-DEKCDVWSAGVILYILLSGT 219
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 65/191 (34%), Positives = 87/191 (45%), Gaps = 13/191 (6%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN-EIGMISALQHPNLVKLHGCC 486
+GEG +G V + VAVK + K E + EI + L H N+VK +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
EGN L EY L F + + P R + G+ YLH + I
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 547 HRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRVAGTFGYMAPE-YAMRGYLT 603
HRDIK N+LLD+ N KISDFGLA + ++ GT Y+APE R +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFHA 186
Query: 604 DKADVYSFGIV 614
+ DV+S GIV
Sbjct: 187 EPVDVWSCGIV 197
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 52/205 (25%), Positives = 80/205 (39%), Gaps = 20/205 (9%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN---------EIGMISALQHPN 478
+G G FG V+ V VK + K K ++ EI ++S ++H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
++K+ E ME + LF +LD P I + + YL
Sbjct: 91 IIKVLDI-FENQGF--FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-YA 597
I+HRDIK N+++ +D K+ DFG A E T GT Y APE
Sbjct: 148 ---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYT-FCGTIEYCAPEVLM 202
Query: 598 MRGYLTDKADVYSFGIVALEIVSGR 622
Y + +++S G+ +V
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 49/246 (19%), Positives = 83/246 (33%), Gaps = 56/246 (22%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVK-----QLSSKSKQGNREFVNEIGMISALQHPNLVK 481
IG+G +G V + A+K ++ + + E+ ++ L HPN+ +
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 482 LHGCCIEGNQLLLIYEYMENNSL-----ARALFGPEAHRLKLDWPTRH------------ 524
L+ + + L+ E L + +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 525 -------------------RICVGIARGLAYLHEESRLKIVHRDIKATNVLL--DKDLNP 563
I I L YLH I HRDIK N L +K
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEI 209
Query: 564 KISDFGLAKL----DEEDNTHISTRVAGTFGYMAPE---YAMRGYLTDKADVYSFGIVAL 616
K+ DFGL+K + + ++T+ GT ++APE Y K D +S G++
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESY-GPKCDAWSAGVLLH 267
Query: 617 EIVSGR 622
++ G
Sbjct: 268 LLLMGA 273
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-28
Identities = 54/204 (26%), Positives = 83/204 (40%), Gaps = 29/204 (14%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV---------NEIGMISALQHP 477
+G G G V VA++ +S K K EI ++ L HP
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 478 NLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYL 537
++K+ + ++ E ME L F +L T + + YL
Sbjct: 201 CIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYL 255
Query: 538 HEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP 594
HE I+HRD+K NVLL ++D KI+DFG +K+ + + + T GT Y+AP
Sbjct: 256 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLC-GTPTYLAP 310
Query: 595 E----YAMRGYLTDKADVYSFGIV 614
E GY D +S G++
Sbjct: 311 EVLVSVGTAGY-NRAVDCWSLGVI 333
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 61/228 (26%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN--------------------- 466
IG+G +G V + D T A+K L SK K +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVL-SKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 467 ------EIGMISALQHPNLVKLHGCCIEG---NQLLLIYEYMENNSLARALFGPEAHRLK 517
EI ++ L HPN+VKL ++ + L +++E + +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV------------- 125
Query: 518 LDWPTRHRICVGIAR--------GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 569
++ PT + AR G+ YLH KI+HRDIK +N+L+ +D + KI+DFG
Sbjct: 126 MEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 570 LAKLDEEDNTHISTRVAGTFGYMAPE---YAMRGYLTDKADVYSFGIV 614
++ + + +S GT +MAPE + + DV++ G+
Sbjct: 183 VSNEFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 37/242 (15%)
Query: 403 GVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLS------- 454
G+ ++ G + ++ ++ K+G G +G V + A+K +
Sbjct: 18 GIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKG 77
Query: 455 -----SKSKQGNREFV-NEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL---- 504
+K+ + E + NEI ++ +L HPN++KL + L+ E+ E L
Sbjct: 78 RYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI 137
Query: 505 -ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL---DKD 560
R F I I G+ YLH+ IVHRDIK N+LL +
Sbjct: 138 INRHKFDECDAA---------NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSL 185
Query: 561 LNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS 620
LN KI DFGL+ +D GT Y+APE + Y +K DV+S G++ ++
Sbjct: 186 LNIKIVDFGLSSFFSKDYKL--RDRLGTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLC 242
Query: 621 GR 622
G
Sbjct: 243 GY 244
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 53/249 (21%), Positives = 97/249 (38%), Gaps = 45/249 (18%)
Query: 392 RPEHTLEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAV 450
+P+ T + + K + P + IG G V + H A G AV
Sbjct: 65 QPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAV 124
Query: 451 KQLSSKSKQGNREFV--------NEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYEYMEN 501
K + +++ + E + E ++ + HP+++ L + + L+++ M
Sbjct: 125 KIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK 184
Query: 502 NSLARALFGPEAHRLKLDWPTRH---------RICVGIARGLAYLHEESRLKIVHRDIKA 552
L D+ T I + +++LH IVHRD+K
Sbjct: 185 GEL-------------FDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKP 228
Query: 553 TNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-------YAMRGYLTDK 605
N+LLD ++ ++SDFG + E + GT GY+APE GY +
Sbjct: 229 ENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYLAPEILKCSMDETHPGY-GKE 285
Query: 606 ADVYSFGIV 614
D+++ G++
Sbjct: 286 VDLWACGVI 294
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 55/212 (25%), Positives = 85/212 (40%), Gaps = 29/212 (13%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV---------NEIG 469
+ + +G G G V VA+K +S K K EI
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIE 67
Query: 470 MISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVG 529
++ L HP ++K+ + ++ E ME LF +L T
Sbjct: 68 ILKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQ 122
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVA 586
+ + YLHE I+HRD+K NVLL ++D KI+DFG +K+ + + + T
Sbjct: 123 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLC- 177
Query: 587 GTFGYMAPE----YAMRGYLTDKADVYSFGIV 614
GT Y+APE GY D +S G++
Sbjct: 178 GTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVI 208
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 65/191 (34%), Positives = 87/191 (45%), Gaps = 13/191 (6%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN-EIGMISALQHPNLVKLHGCC 486
+GEG +G V + VAVK + K E + EI + L H N+VK +G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
EGN L EY L F + + P R + G+ YLH + I
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 547 HRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRVAGTFGYMAPE-YAMRGYLT 603
HRDIK N+LLD+ N KISDFGLA + ++ GT Y+APE R +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFHA 186
Query: 604 DKADVYSFGIV 614
+ DV+S GIV
Sbjct: 187 EPVDVWSCGIV 197
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 58/198 (29%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLS-SKSKQGNREFVN-EIGMISALQHPNLVKLHGC 485
IG+G F V H+ G VA+K + ++ + + + E+ ++ L HPN+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
L LI EY + F ++ I + Y H + +I
Sbjct: 83 IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKRI 135
Query: 546 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-YAMRGYLTD 604
VHRD+KA N+LLD D+N KI+DFG + + G Y APE + + Y
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNE-FTVGGKLDAFC-GAPPYAAPELFQGKKYDGP 193
Query: 605 KADVYSFGIVALEIVSGR 622
+ DV+S G++ +VSG
Sbjct: 194 EVDVWSLGVILYTLVSGS 211
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 6/154 (3%)
Query: 11 SDNHFTGKIPNFIQNWTLLEKLVIQASGLVG--PIPSGIASLSKLTDLRISDLNGTEAPF 68
+ + G + + + L + L PIPS +A+L L L I +N P
Sbjct: 34 CNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPI 93
Query: 69 PP-LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDY 127
PP + K+ ++ L + NVSG +PD+L + +L LD S+N L+G +P + L ++
Sbjct: 94 PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153
Query: 128 IYLTGNLLTGTIPPWM--LQKGDRV-DLSYNSFT 158
I GN ++G IP K +S N T
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 39/162 (24%), Positives = 65/162 (40%), Gaps = 9/162 (5%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD- 60
L L I+ + +G IP+F+ L L + L G +P I+SL L +
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159
Query: 61 -LNGTEAPFPP-LDKMKKMKT-LILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPS 117
++G P K+ T + + ++GK+P + +L +D+S N L G
Sbjct: 160 RISG---AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASV 215
Query: 118 TFMGLLDVDYIYLTGNLLTGTIPPWMLQKG-DRVDLSYNSFT 158
F + I+L N L + L K + +DL N
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY 257
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 35/163 (21%), Positives = 66/163 (40%), Gaps = 11/163 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKL-TDLRISD 60
+ TL S N +G +P I + L + + + G IP S SKL T + IS
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 61 --LNGTEAPFPP-LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPS 117
L G PP + + + L + G G + + + ++ N L +
Sbjct: 184 NRLTG---KIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 118 TFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFT 158
+++ + L N + GT+P + L+ +++S+N+
Sbjct: 240 -VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 38/140 (27%), Positives = 51/140 (36%), Gaps = 8/140 (5%)
Query: 5 LKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD--LN 62
IS N TGKIP N L + + + L G S + ++ L
Sbjct: 176 FTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 63 GTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGL 122
+ K + L LR+ + G LP L + L L+VSFN L G IP L
Sbjct: 235 F---DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN-L 290
Query: 123 LDVDYIYLTGN-LLTGTIPP 141
D N L G+ P
Sbjct: 291 QRFDVSAYANNKCLCGSPLP 310
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 42.1 bits (100), Expect = 4e-04
Identities = 12/58 (20%), Positives = 21/58 (36%), Gaps = 1/58 (1%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRIS 59
L + +N G +P + L L + + L G IP G +L + +
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYA 299
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 54/200 (27%), Positives = 86/200 (43%), Gaps = 30/200 (15%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGC 485
IG G + + H A AVK + + E EI ++ QHPN++ L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEI-LLRYGQHPNIITLKDV 84
Query: 486 CIEGNQLLLIYEYMENNSL-----ARALFG-PEAHRLKLDWPTRHRICVGIARGLAYLHE 539
+G + ++ E M+ L + F EA + I + + YLH
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----LFT-----ITKTVEYLHA 134
Query: 540 ESRLKIVHRDIKATNVLL-DKDLNP---KISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 595
+VHRD+K +N+L D+ NP +I DFG AK +N + T T ++APE
Sbjct: 135 ---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPE 190
Query: 596 -YAMRGYLTDKADVYSFGIV 614
+GY D++S G++
Sbjct: 191 VLERQGY-DAACDIWSLGVL 209
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 54/206 (26%), Positives = 80/206 (38%), Gaps = 33/206 (16%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVK-----QLSSKSKQGNREFVNEIGMISALQHPNLVK 481
IG+G F V + + G AVK + +S + E + L+HP++V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 482 LHGCCIEGNQLLLIYEYMENNSL-----ARALFGP-----EAHRLKLDWPTRHRICVGIA 531
L L +++E+M+ L RA G A R I
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY-----MRQ-----IL 140
Query: 532 RGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGT 588
L Y H+ I+HRD+K VLL + K+ FG+A E RV GT
Sbjct: 141 EALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GT 196
Query: 589 FGYMAPEYAMRGYLTDKADVYSFGIV 614
+MAPE R DV+ G++
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 54/228 (23%), Positives = 89/228 (39%), Gaps = 46/228 (20%)
Query: 414 RQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVK--------QLSSKSKQGNREF 464
N+ P +G G V + H AVK S++ Q RE
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 465 V-NEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPT 522
E+ ++ + HPN+++L L+++ M+ L D+ T
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLT 116
Query: 523 RH---------RICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573
+I + + LH+ L IVHRD+K N+LLD D+N K++DFG +
Sbjct: 117 EKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173
Query: 574 DEEDNTHISTRVAGTFGYMAPE-------YAMRGYLTDKADVYSFGIV 614
+ + GT Y+APE GY + D++S G++
Sbjct: 174 LDPGEK-LREVC-GTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVI 218
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 480
+ +G G FG V+K A G +A K + ++ + E NEI +++ L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 481 KLHGCCIEGNQLLLIYEYM---ENNSLARALFG---PEAHRLKLDWPTRHRICVGIAR-- 532
+L+ N ++L+ EY+ E LF E++ L + +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE-------LFDRIIDESYNLT------ELDTILFMKQI 196
Query: 533 --GLAYLHEESRLKIVHRDIKATNVLL-DKDLNP-KISDFGLAKLDEEDNTHISTRVAGT 588
G+ ++H+ + I+H D+K N+L ++D KI DFGLA+ + + GT
Sbjct: 197 CEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARR-YKPREKLKVNF-GT 251
Query: 589 FGYMAPEYAMRGYLTDKADVYSFGIVA 615
++APE +++ D++S G++A
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-27
Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 26/199 (13%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLS-SKSKQGNREFV-NEIGMISALQHPNLVKLHG 484
++G+G F V + + G A ++ K + + + E + L+HPN+V+LH
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 485 CCIEGNQLLLIYEYMENNSL-----ARALFG-PEAHRLKLDWPTRHRICVGIARGLAYLH 538
E LI++ + L AR + +A I + + H
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH----------CIQQILEAVLHCH 127
Query: 539 EESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 595
+ + +VHR++K N+LL K K++DFGLA E + GT GY++PE
Sbjct: 128 Q---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPE 183
Query: 596 YAMRGYLTDKADVYSFGIV 614
+ D+++ G++
Sbjct: 184 VLRKDPYGKPVDLWACGVI 202
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE---FVNEIGMISALQ 475
++N+ ++G+G F V + H G A K ++ K R+ E + LQ
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQ 63
Query: 476 HPNLVKLHGCCIEGNQLLLIYEYMENNSL-----ARALFG-PEAHRLKLDWPTRHRICVG 529
HPN+V+LH E + L+++ + L AR + +A +
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQ----- 113
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVA 586
I +AY H IVHR++K N+LL K K++DFGLA + A
Sbjct: 114 ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFA 168
Query: 587 GTFGYMAPEYAMRGYLTDKADVYSFGIV 614
GT GY++PE + + D+++ G++
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVI 196
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 24/208 (11%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMI-----------SALQH 476
+G+GGFG V+ G + D VA+K + +++ +++ + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 477 PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
P +++L +L+ E A+ LF + L + + +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLP---AQDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 595
H +VHRDIK N+L+D K+ DFG L ++ GT Y PE
Sbjct: 155 CH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVYSPPE 208
Query: 596 Y-AMRGYLTDKADVYSFGIVALEIVSGR 622
+ + Y A V+S GI+ ++V G
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN-------EIGMISALQH--PN 478
+G GGFG VY G ++D VA+K + K + + + E+ ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+++L + +LI E E + LF R L + + + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 539 EESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY- 596
++HRDIK N+L+D + K+ DFG L ++ GT Y PE+
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWI 220
Query: 597 AMRGYLTDKADVYSFGIVALEIVSGR 622
Y A V+S GI+ ++V G
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 51/206 (24%), Positives = 81/206 (39%), Gaps = 20/206 (9%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN-----EIGMISALQHPNLVKL 482
+GEG +G V + AVK L K K EI ++ L+H N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILK-KKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 483 HG--CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
E ++ ++ EY + + + + H + GL YLH
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEK-RFPVCQAHGYFCQLIDGLEYLH-- 126
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE--DNTHISTRVAGTFGYMAPEYAM 598
IVH+DIK N+LL KIS G+A+ + T G+ + PE A
Sbjct: 127 -SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPPEIAN 184
Query: 599 --RGYLTDKADVYSFGIVALEIVSGR 622
+ K D++S G+ I +G
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 31/201 (15%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
++G G FG V++ A G V K +++ NEI +++ L HP L+ LH
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 487 IEGNQLLLIYEYM---ENNSLARALF---GPEAHRLKLDWPTRHRICVGIAR----GLAY 536
+ +++LI E++ E LF E +++ + R GL +
Sbjct: 118 EDKYEMVLILEFLSGGE-------LFDRIAAEDYKMS------EAEVINYMRQACEGLKH 164
Query: 537 LHEESRLKIVHRDIKATNVLL-DKDLNP-KISDFGLAKLDEEDNTHISTRVAGTFGYMAP 594
+HE IVH DIK N++ K + KI DFGLA D T + AP
Sbjct: 165 MHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAP 219
Query: 595 EYAMRGYLTDKADVYSFGIVA 615
E R + D+++ G++
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 409 GSFTLRQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE---F 464
F + ++N+ ++G+G F V + H G A K ++ K R+
Sbjct: 17 SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKL 75
Query: 465 VNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL-----ARALFG-PEAHRLKL 518
E + LQHPN+V+LH E + L+++ + L AR + +A
Sbjct: 76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--- 132
Query: 519 DWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDE 575
I +AY H IVHR++K N+LL K K++DFGLA E
Sbjct: 133 -------CIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI--E 180
Query: 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIV 614
+++ AGT GY++PE + + D+++ G++
Sbjct: 181 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQG-NREFVNEIGMISALQHPN 478
+ +K+GEG + VYKG +VA+K++ + ++G + E+ ++ L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+V LH L L++EY++ + L + L + ++ + RGLAY H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKD-LKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE--Y 596
+ K++HRD+K N+L+++ K++DFGLA+ V T Y P+
Sbjct: 118 RQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILL 173
Query: 597 AMRGYLTDKADVYSFGIVALEIVSGR 622
Y T + D++ G + E+ +GR
Sbjct: 174 GSTDYST-QIDMWGVGCIFYEMATGR 198
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 28/202 (13%)
Query: 424 APDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVK 481
D +GEG F K H AVK +S K + N + EI + + HPN+VK
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQ--KEITALKLCEGHPNIVK 70
Query: 482 LHGCCIEGNQLLLIYEYMENNSL-----ARALFG-PEAHRLKLDWPTRHRICVGIARGLA 535
LH + L+ E + L + F EA + R + ++
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRK-----LVSAVS 120
Query: 536 YLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYM 592
++H+ + +VHRD+K N+L + +L KI DFG A+L DN + T T Y
Sbjct: 121 HMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYA 176
Query: 593 APEYAMRGYLTDKADVYSFGIV 614
APE + + D++S G++
Sbjct: 177 APELLNQNGYDESCDLWSLGVI 198
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN----EIGMISALQHPNLVKLH 483
+G G FG V G H G VAVK L+ + K + + V EI + +HP+++KL+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
++ EY+ L F +++ R+ I + Y H R
Sbjct: 78 QVISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVDYCH---RH 130
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-YAMRGYL 602
+VHRD+K NVLLD +N KI+DFGL+ + D + T G+ Y APE + R Y
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRT-SCGSPNYAAPEVISGRLYA 188
Query: 603 TDKADVYSFGIVALEIVSGR 622
+ D++S G++ ++ G
Sbjct: 189 GPEVDIWSCGVILYALLCGT 208
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPN 478
+ F + G+G FG V G + G VA+K++ + NRE + + ++ L HPN
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 479 LVKLHGCCIEGNQ-------LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICV--- 528
+V+L + L ++ EY+ + L R ++ P I V
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAP--PPIL-IKVFLF 136
Query: 529 GIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGLAKL--DEEDNTH-IS 582
+ R + LH S + + HRDIK NVL+++ L K+ DFG AK E N I
Sbjct: 137 QLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSEPNVAYIC 193
Query: 583 TRVAGTFGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 622
+R Y APE + + Y T D++S G + E++ G
Sbjct: 194 SRY-----YRAPELIFGNQHY-TTAVDIWSVGCIFAEMMLGE 229
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 417 KAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGN-REFVN-----EIGM 470
+ + K+GEG +G VYK + G +VA+K + + E + EI +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALK----RIRLDAEDEGIPSTAIREISL 72
Query: 471 ISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGI 530
+ L HPN+V L L L++E+ME + L + L + ++ L +
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL---DENKTGLQDSQIKIYLYQL 128
Query: 531 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 590
RG+A+ H+ +I+HRD+K N+L++ D K++DFGLA+ + V T
Sbjct: 129 LRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLW 184
Query: 591 YMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 622
Y AP+ + Y T D++S G + E+++G+
Sbjct: 185 YRAPDVLMGSKKYST-SVDIWSIGCIFAEMITGK 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 57/198 (28%), Positives = 85/198 (42%), Gaps = 29/198 (14%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV-NEIGMISALQHPNLVKLHGC 485
++G G VY+ A+K L K +++ V EIG++ L HPN++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 486 CIEGNQLLLIYEYMENNSL-----ARALFG-PEAHRLKLDWPTRHRICVGIARGLAYLHE 539
++ L+ E + L + + +A I +AYLHE
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD----------AVKQILEAVAYLHE 166
Query: 540 ESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 596
IVHRD+K N+L D KI+DFGL+K+ E V GT GY APE
Sbjct: 167 ---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEI 221
Query: 597 AMRGYLTDKADVYSFGIV 614
+ D++S GI+
Sbjct: 222 LRGCAYGPEVDMWSVGII 239
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 49/182 (26%), Positives = 82/182 (45%), Gaps = 19/182 (10%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGN-REFVN-----EIGMISA 473
+ KIGEG +G V+K + G +VA+K K + + EI M+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQ 58
Query: 474 LQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARG 533
L+HPNLV L +L L++EY ++ + L + ++ + I +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHEL---DRYQRGVPEHLVKSITWQTLQA 114
Query: 534 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 593
+ + H+ +HRD+K N+L+ K K+ DFG A+L + + VA T Y +
Sbjct: 115 VNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRS 170
Query: 594 PE 595
PE
Sbjct: 171 PE 172
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 416 IKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN-----EIG 469
+K+ + + +GEG F VYK +VA+K++ + ++ +N EI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 470 MISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVG 529
++ L HPN++ L + + L++++ME + L + + + L L +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVII---KDNSLVLTPSHIKAYMLM 120
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572
+GL YLH+ I+HRD+K N+LLD++ K++DFGLAK
Sbjct: 121 TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGN-REFVN-----EIGMISAL 474
+ KIGEG +G VYK G A+K K + E + EI ++ L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALK----KIRLEKEDEGIPSTTIREISILKEL 57
Query: 475 QHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGL 534
+H N+VKL+ +L+L++E+++ + L + L + L+ T + + G+
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL---DVCEGGLESVTAKSFLLQLLNGI 113
Query: 535 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP 594
AY H+ +++HRD+K N+L++++ KI+DFGLA+ + + T Y AP
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAP 169
Query: 595 E--YAMRGYLTDKADVYSFGIVALEIVSGR 622
+ + Y T D++S G + E+V+G
Sbjct: 170 DVLMGSKKYST-TIDIWSVGCIFAEMVNGT 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 19/182 (10%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGN-REFVN-----EIGMISA 473
+ +GEG +G V K + G +VA+K K + + + V EI ++
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK----KFLESDDDKMVKKIAMREIKLLKQ 80
Query: 474 LQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARG 533
L+H NLV L C + + L++E++++ + L E LD+ + I G
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDL---ELFPNGLDYQVVQKYLFQIING 136
Query: 534 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 593
+ + H I+HRDIK N+L+ + K+ DFG A+ VA T Y A
Sbjct: 137 IGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRA 192
Query: 594 PE 595
PE
Sbjct: 193 PE 194
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV-NEIGMISALQHPNLVKLHGC 485
++G G FG V++ A G A K + + ++E V EI +S L+HP LV LH
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPE------AHRLKLDWPTRHRICVGIARGLAYLHE 539
+ N++++IYE+M G E K+ + +GL ++HE
Sbjct: 223 FEDDNEMVMIYEFMS---------GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 540 ESRLKIVHRDIKATNVLL-DKDLNP-KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 597
VH D+K N++ K N K+ DFGL + + GT + APE A
Sbjct: 274 ---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVA 328
Query: 598 MRGYLTDKADVYSFGIVALEIVSGRS 623
+ D++S G+++ ++SG S
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLS 354
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 37/178 (20%), Positives = 63/178 (35%), Gaps = 21/178 (11%)
Query: 454 SSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEA 513
S +I + N V L + + +L +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM----N 153
Query: 514 HRLKLDWPTRH---RICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570
R L+ I + IA + +LH + ++HRD+K +N+ D K+ DFGL
Sbjct: 154 RRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGL 210
Query: 571 AKLDEEDNTHIS-----------TRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALE 617
++D + T GT YM+PE + K D++S G++ E
Sbjct: 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 418 AATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN-----EIGMI 471
++++ F K+G G + VYKG + G VA+K + K + E EI ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK----EVKLDSEEGTPSTAIREISLM 57
Query: 472 SALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRH--RICVG 529
L+H N+V+L+ N+L L++E+M+N+ L + +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 589
+ +GLA+ HE KI+HRD+K N+L++K K+ DFGLA+ S+ V T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TL 172
Query: 590 GYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 622
Y AP+ R Y T D++S G + E+++G+
Sbjct: 173 WYRAPDVLMGSRTYST-SIDIWSCGCILAEMITGK 206
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 52/211 (24%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGN-REFVN-----EIGMISA 473
+ KIGEG +G V+K + +VA+K + + + E V EI ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALK----RVRLDDDDEGVPSSALREICLLKE 57
Query: 474 LQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARG 533
L+H N+V+LH +L L++E+ + + L + ++ LD + +G
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQD-LKKYF---DSCNGDLDPEIVKSFLFQLLKG 113
Query: 534 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 593
L + H ++HRD+K N+L++++ K+++FGLA+ S V T Y
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRP 169
Query: 594 PE--YAMRGYLTDKADVYSFGIVALEIVSGR 622
P+ + + Y T D++S G + E+ +
Sbjct: 170 PDVLFGAKLYST-SIDMWSAGCIFAELANAG 199
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 32/205 (15%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVK-----QLSSKSKQGNREFV-NEIGMISALQHPNLV 480
++G G F V K G A K +LSS + +RE + E+ ++ ++HPN++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 481 KLHGCCIEGNQLLLIYEYMENNSL-----ARALFG-PEAHRLKLDWPTRHRICVGIARGL 534
LH ++LI E + L + EA + + I G+
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQ-----ILDGV 121
Query: 535 AYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 590
YLH +I H D+K N++L + K+ DFG+A E N + GT
Sbjct: 122 HYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPE 176
Query: 591 YMAPEYAMRGYLTDKADVYSFGIVA 615
++APE L +AD++S G++
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN----EIGMISALQHPNLVKLH 483
+GEG FG V H VA+K +S + + EI + L+HP+++KL+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 484 GCCIEGNQLLLIYEYM--ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
++++ EY E LF + ++ R I + Y H
Sbjct: 76 DVITTPTDIVMVIEYAGGE-------LFDYIVEKKRMTEDEGRRFFQQIICAIEYCH--- 125
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-YAMRG 600
R KIVHRD+K N+LLD +LN KI+DFGL+ + D + T G+ Y APE +
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI-MTDGNFLKT-SCGSPNYAAPEVINGKL 183
Query: 601 YLTDKADVYSFGIVALEIVSGR 622
Y + DV+S GIV ++ GR
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGR 205
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 52/211 (24%), Positives = 81/211 (38%), Gaps = 41/211 (19%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV-NEIGMISALQ-HPNLVKLHGC 485
+GEG V ++ AVK + K R V E+ M+ Q H N+++L
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 486 CIEGNQLLLIYEYMENNSL-----ARALFG-PEAHRLKLDWPTRHRICVGIARGLAYLHE 539
E ++ L++E M S+ R F EA + + +A L +LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV-----VQD-----VASALDFLHN 129
Query: 540 ESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAK-------LDEEDNTHISTRVAGTF 589
I HRD+K N+L ++ KI DF L + T G+
Sbjct: 130 ---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSA 185
Query: 590 GYMAPE------YAMRGYLTDKADVYSFGIV 614
YMAPE Y + D++S G++
Sbjct: 186 EYMAPEVVEAFSEEASIY-DKRCDLWSLGVI 215
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 32/205 (15%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVK-----QLSSKSKQGNREFV-NEIGMISALQHPNLV 480
++G G F V K + G A K + S + +RE + E+ ++ +QHPN++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 481 KLHGCCIEGNQLLLIYEYMENNSL-----ARALFG-PEAHRLKLDWPTRHRICVGIARGL 534
LH ++LI E + L + EA + I G+
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQ-----ILNGV 127
Query: 535 AYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 590
YLH L+I H D+K N++L KI DFGLA + N + GT
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPE 182
Query: 591 YMAPEYAMRGYLTDKADVYSFGIVA 615
++APE L +AD++S G++
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 33/238 (13%)
Query: 395 HTLEQELRGVDLHTGSFTLRQIKAATNNFA-PDNKIGEGGFGPVYKG-HMADGTVVAVKQ 452
H GVDL T + + ++ N + ++G G F V + + G A K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKF 61
Query: 453 LS-SKSKQGNREFV-NEIGMISALQH-PNLVKLHGCCIEGNQLLLIYEYM---ENNSLAR 506
L + Q R + +EI ++ + P ++ LH ++++LI EY E
Sbjct: 62 LKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE------ 115
Query: 507 ALFGPEAHRLKLDWPTRH--RICVGIAR----GLAYLHEESRLKIVHRDIKATNVLL--- 557
+F + + + + G+ YLH+ IVH D+K N+LL
Sbjct: 116 -IF----SLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSI 167
Query: 558 DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVA 615
+ KI DFG+++ + + GT Y+APE +T D+++ GI+A
Sbjct: 168 YPLGDIKIVDFGMSRK-IGHACELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 39/200 (19%), Positives = 72/200 (36%), Gaps = 30/200 (15%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
+G G FG V++ + K + EI +++ +H N++ LH
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 487 IEGNQLLLIYEYMENNSL-----ARALFGPEAHRLKLDWPTRHRICVGIAR----GLAYL 537
+L++I+E++ + A E R V L +L
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNE------------REIVSYVHQVCEALQFL 118
Query: 538 HEESRLKIVHRDIKATNVLL--DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 595
H I H DI+ N++ + KI +FG A+ + + + Y APE
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPE 173
Query: 596 YAMRGYLTDKADVYSFGIVA 615
++ D++S G +
Sbjct: 174 VHQHDVVSTATDMWSLGTLV 193
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 53/190 (27%), Positives = 79/190 (41%), Gaps = 14/190 (7%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI 487
IG G FG +VAVK + + + EI +L+HPN+V+ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 488 EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVH 547
L +I EY L + + + + G++Y H ++I H
Sbjct: 87 TPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVSYCH---SMQICH 139
Query: 548 RDIKATNVLLDKDLNP--KISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-YAMRGYLTD 604
RD+K N LLD P KI DFG +K + + V GT Y+APE + Y
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV-GTPAYIAPEVLLRQEYDGK 197
Query: 605 KADVYSFGIV 614
ADV+S G+
Sbjct: 198 IADVWSCGVT 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 32/205 (15%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVK-----QLSSKSKQGNREFV-NEIGMISALQHPNLV 480
++G G F V K + G A K Q + + +RE + E+ ++ + H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 481 KLHGCCIEGNQLLLIYEYMENNSL-----ARALFG-PEAHRLKLDWPTRHRICVGIARGL 534
LH ++LI E + L + EA + I G+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQ-----ILDGV 128
Query: 535 AYLHEESRLKIVHRDIKATNVLL-DKDLNP---KISDFGLAKLDEEDNTHISTRVAGTFG 590
YLH KI H D+K N++L DK++ K+ DFGLA E+ + GT
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPE 183
Query: 591 YMAPEYAMRGYLTDKADVYSFGIVA 615
++APE L +AD++S G++
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-24
Identities = 64/219 (29%), Positives = 97/219 (44%), Gaps = 33/219 (15%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPN 478
++ IG G FG VY+ G +VA+K++ + NRE + ++ L H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCN 108
Query: 479 LVKLHGCCIEGNQ------LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICV---G 529
+V+L + L L+ +Y+ + R + L P + + +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTL--PVIY-VKLYMYQ 164
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAK--LDEEDNTH-ISTRV 585
+ R LAY+H I HRDIK N+LLD D K+ DFG AK + E N I +R
Sbjct: 165 LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 586 AGTFGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 622
Y APE + Y T DV+S G V E++ G+
Sbjct: 222 -----YRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 254
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-24
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNL 479
+ IG G FG V++ + + VA+K++ + NR E+ ++ ++HPN+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNV 94
Query: 480 VKLHGCCIEGNQ------LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARG 533
V L L L+ EY+ + RA + + + R
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 534 LAYLHEESRLKIVHRDIKATNVLLDKDLNP-KISDFGLAK--LDEEDNTH-ISTRVAGTF 589
LAY+H + I HRDIK N+LLD K+ DFG AK + E N I +R
Sbjct: 154 LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY---- 206
Query: 590 GYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 622
Y APE + Y T D++S G V E++ G+
Sbjct: 207 -YRAPELIFGATNY-TTNIDIWSTGCVMAELMQGQ 239
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-24
Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN----EIGMISALQHPNLVKLH 483
+G G FG V G H G VAVK L+ + K + + V EI + +HP+++KL+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
+ + ++ EY+ L F +LD R+ I G+ Y H R
Sbjct: 83 QVISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVDYCH---RH 135
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE-YAMRGYL 602
+VHRD+K NVLLD +N KI+DFGL+ + D + T G+ Y APE + R Y
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTSC-GSPNYAAPEVISGRLYA 193
Query: 603 TDKADVYSFGIVALEIVSGR 622
+ D++S G++ ++ G
Sbjct: 194 GPEVDIWSSGVILYALLCGT 213
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 32/205 (15%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVK-----QLSSKSKQGNREFV-NEIGMISALQHPNLV 480
++G G F V K + G A K Q + + RE + E+ ++ + HPN++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 481 KLHGCCIEGNQLLLIYEYMENNSL-----ARALFG-PEAHRLKLDWPTRHRICVGIARGL 534
LH ++LI E + L + EA + I G+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQ-----ILDGV 128
Query: 535 AYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 590
YLH KI H D+K N++L + K+ DFGLA E+ + GT
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPE 183
Query: 591 YMAPEYAMRGYLTDKADVYSFGIVA 615
++APE L +AD++S G++
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 53/204 (25%), Positives = 79/204 (38%), Gaps = 38/204 (18%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
+G G G V + H G A+K L S + +E + A P++V +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEV--DH-HWQASGGPHIVCILDVY 91
Query: 487 ----IEGNQLLLIYEYMENNSL-----ARALFG---PEAHRLKLDWPTRHRICVGIARGL 534
LL+I E ME L R EA + R I +
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI-----MRD-----IGTAI 141
Query: 535 AYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY 591
+LH I HRD+K N+L +KD K++DFG AK ++ + T T Y
Sbjct: 142 QFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYY 195
Query: 592 MAPE-YAMRGYLTDKADVYSFGIV 614
+APE Y D++S G++
Sbjct: 196 VAPEVLGPEKY-DKSCDMWSLGVI 218
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-23
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 20/219 (9%)
Query: 414 RQIKAATNNFAPDNKIGEGGFGPVYKGHMAD-GTVVAVKQLSSK---SKQGNREFVNE-- 467
I N+F+ IG GGFG VY AD G + A+K L K KQG +NE
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 468 -IGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRI 526
+ ++S P +V + ++L I + M L L + + R
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEADMRF 296
Query: 527 CVG-IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRV 585
I GL ++H +V+RD+K N+LLD+ + +ISD GLA + H V
Sbjct: 297 YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV 351
Query: 586 AGTFGYMAPEYAMRGYLTDKA-DVYSFGIVALEIVSGRS 623
GT GYMAPE +G D + D +S G + +++ G S
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 12/201 (5%)
Query: 429 IGEGGFGPVYKGHMAD-GTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHG 484
+G GGFG V+ M G + A K+L+ K ++G + + E +++ + +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVG-IARGLAYLHEESRL 543
L L+ M + ++ + P R I GL +LH+
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-RAIFYTAQIVSGLEHLHQ---R 308
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYL 602
I++RD+K NVLLD D N +ISD GLA + T GT G+MAPE + Y
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEY- 366
Query: 603 TDKADVYSFGIVALEIVSGRS 623
D ++ G+ E+++ R
Sbjct: 367 DFSVDYFALGVTLYEMIAARG 387
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 59/196 (30%), Positives = 90/196 (45%), Gaps = 35/196 (17%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLS-SKSKQGNREF----VNEIGMISAL 474
+ + KIG+G FG V+K H G VA+K++ K+G F + EI ++ L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73
Query: 475 QHPNLVKLHGCCIE--------GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRI 526
+H N+V L C + L++++ E++ LA L +K R+
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLL---SNVLVKFTLSEIKRV 129
Query: 527 CVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-------KLDEEDNT 579
+ GL Y+H KI+HRD+KA NVL+ +D K++DFGLA T
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 580 HISTRVAGTFGYMAPE 595
+ RV T Y PE
Sbjct: 187 N---RVV-TLWYRPPE 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 2e-22
Identities = 49/188 (26%), Positives = 82/188 (43%), Gaps = 30/188 (15%)
Query: 428 KIGEGGFGPVYKG---HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHG 484
K+G G +G VYK D A+KQ+ + EI ++ L+HPN++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 85
Query: 485 CCIE--GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVG--------IARGL 534
+ ++ L+++Y E++ L + + HR ++ G I G+
Sbjct: 86 VFLSHADRKVWLLFDYAEHD-LWHII---KFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 535 AYLHEESRLKIVHRDIKATNVLLDKDLNP----KISDFGLAKL---DEEDNTHISTRVAG 587
YLH ++HRD+K N+L+ + KI+D G A+L + + V
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 197
Query: 588 TFGYMAPE 595
TF Y APE
Sbjct: 198 TFWYRAPE 205
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 28/216 (12%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGN-REFVN-----EIGMISA 473
+ + K+GEG +G VYK VA+K + + + E V E+ ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIK----RIRLEHEEEGVPGTAIREVSLLKE 89
Query: 474 LQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARG 533
LQH N+++L ++L LI+EY EN+ L + + + + + + G
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYM---DKNP-DVSMRVIKSFLYQLING 144
Query: 534 LAYLHEESRLKIVHRDIKATNVLLDKDLNP-----KISDFGLAKLDEEDNTHISTRVAGT 588
+ + H + +HRD+K N+LL KI DFGLA+ + + T
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-T 200
Query: 589 FGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGR 622
Y PE + R Y T D++S + E++
Sbjct: 201 LWYRPPEILLGSRHYST-SVDIWSIACIWAEMLMKT 235
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 3e-22
Identities = 28/164 (17%), Positives = 54/164 (32%), Gaps = 26/164 (15%)
Query: 204 INCGGKQVTVNGNTTFEDDTDEAGPSRFA-FRGSNNWAFSNTGHFLDDDRPADTYIQTNT 262
+N GG+ + D E R + + SN +D T
Sbjct: 10 VNAGGESHVDVHGIHYRKDPLEGRVGRASDYGMKLPILRSNP----EDQVLYQTERYNED 65
Query: 263 S---------------ILLMNDSH--SFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIV 305
S +L + + +++FDV + G V+KD +I D G A
Sbjct: 66 SFGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHD 124
Query: 306 KQFPVVVINSTIEIRL---YWAGKGTTGVPVRGVYGPLISAISL 346
+ P+ + + ++ + GK + P + A+ +
Sbjct: 125 EIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFI 168
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 23/201 (11%), Positives = 47/201 (23%), Gaps = 45/201 (22%)
Query: 428 KIGEGGFGPVYKGHMAD---GTVVAVKQL---SSKSKQGNREFVNEIGMISALQHPNLVK 481
G ++ D VA+ + +E ++ +S + P + +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
+ L++ E++ SL R +A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAH--- 146
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGY 601
R + + V + D G L M
Sbjct: 147 RAGVALSIDHPSRVRVSID--------GDVVL-------------AYPATMPDA------ 179
Query: 602 LTDKADVYSFGIVALEIVSGR 622
+ D+ G ++ R
Sbjct: 180 -NPQDDIRGIGASLYALLVNR 199
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 48/203 (23%), Positives = 79/203 (38%), Gaps = 35/203 (17%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHG-- 484
+G G G V + + A+K L + RE E+ A Q P++V++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVY 124
Query: 485 --CCIEGNQLLLIYEYMENNSL-----ARALFG---PEAHRLKLDWPTRHRICVGIARGL 534
LL++ E ++ L R EA + + I +
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI-----MKS-----IGEAI 174
Query: 535 AYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY 591
YLH + I HRD+K N+L + K++DFG AK N+ ++T T Y
Sbjct: 175 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYY 229
Query: 592 MAPEYAMRGYLTDKADVYSFGIV 614
+APE D++S G++
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVI 252
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 22/169 (13%)
Query: 419 ATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLS-SKSKQGNREF----VNEIG--- 469
AT+ + P +IG G +G VYK G VA+K + G V E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 470 MISALQHPNLVKLHGCCI-----EGNQLLLIYEYMENNSLARALFGPEAHRLK-LDWPTR 523
+ A +HPN+V+L C ++ L++E+++ + L L + L T
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYL---DKAPPPGLPAETI 122
Query: 524 HRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572
+ RGL +LH IVHRD+K N+L+ K++DFGLA+
Sbjct: 123 KDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 30/209 (14%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV----NEIGMISALQHPNLVKLH 483
IG+G FG V + A+K ++ K K R V E+ ++ L+HP LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMN-KQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 484 GCCIEGNQLLLIYEYMEN----NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
+ + ++ + + L + + E + IC + L YL
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-------VKLFIC-ELVMALDYLQN 133
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE---- 595
+I+HRD+K N+LLD+ + I+DF +A + + + +AGT YMAPE
Sbjct: 134 ---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSS 188
Query: 596 YAMRGYLTDKA-DVYSFGIVALEIVSGRS 623
GY A D +S G+ A E++ GR
Sbjct: 189 RKGAGY--SFAVDWWSLGVTAYELLRGRR 215
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 5e-21
Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 429 IGEGGFGPVYKGHMAD-GTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHG 484
+G+GGFG V + G + A K+L K ++G +NE ++ + +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVG-IARGLAYLHEESRL 543
+ L L+ M L ++ R I GL LH E
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCGLEDLHRE--- 305
Query: 544 KIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYL 602
+IV+RD+K N+LLD + +ISD GLA + I RV GT GYMAPE Y
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQTIKGRV-GTVGYMAPEVVKNERY- 362
Query: 603 TDKADVYSFGIVALEIVSGRS 623
T D ++ G + E+++G+S
Sbjct: 363 TFSPDWWALGCLLYEMIAGQS 383
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 55/214 (25%), Positives = 90/214 (42%), Gaps = 42/214 (19%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKS--KQGNREFVN-EIGMISALQHPNLVKLHG 484
+GEG F V +A A+K L + K+ +V E ++S L HP VKL+
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 485 CCIEGNQLLLIYEYMENNSL------------ARALF-GPEAHRLKLDWPTRHRICVGIA 531
+ +L Y +N L F E I
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-----------------IV 140
Query: 532 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR-VAGTFG 590
L YLH I+HRD+K N+LL++D++ +I+DFG AK+ ++ GT
Sbjct: 141 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 591 YMAPEYAM-RGYLTDKA-DVYSFGIVALEIVSGR 622
Y++PE + K+ D+++ G + ++V+G
Sbjct: 198 YVSPELLTEKSA--CKSSDLWALGCIIYQLVAGL 229
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 51/247 (20%), Positives = 87/247 (35%), Gaps = 57/247 (23%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPN 478
+ ++ +G G FG V + + G A+K++ + NRE + ++ L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTR--------------- 523
++KL ++ +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 524 ---HRICVG-------------------IARGLAYLHEESRLKIVHRDIKATNVLLD-KD 560
H++ + R + ++H L I HRDIK N+L++ KD
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKD 178
Query: 561 LNPKISDFGLAK--LDEEDNTH-ISTRVAGTFGYMAPE--YAMRGYLTDKADVYSFGIVA 615
K+ DFG AK + E + I +R Y APE Y T D++S G V
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEY-TPSIDLWSIGCVF 232
Query: 616 LEIVSGR 622
E++ G+
Sbjct: 233 GELILGK 239
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-19
Identities = 27/163 (16%), Positives = 56/163 (34%), Gaps = 7/163 (4%)
Query: 2 LVTLKDFRISDNHFTGKIP-NFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD 60
L L+ ++ + + L L I + LS L L+++
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 61 LNGTEAPFPP--LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPST 118
N + F P +++ + L L C + P ++SL+VL++S N
Sbjct: 455 -NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513
Query: 119 FMGLLDVDYIYLTGNLLTGTIPPW---MLQKGDRVDLSYNSFT 158
+ L + + + N + + ++L+ N F
Sbjct: 514 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-19
Identities = 36/173 (20%), Positives = 66/173 (38%), Gaps = 8/173 (4%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L+ +S Q+ + L L++ + + + LS L L +
Sbjct: 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCN-VSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM 120
N P+ +K +K L + S KLP+Y +T+L+ LD+S NK+ +
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 121 GL----LDVDYIYLTGNLLTGTIPPWMLQ--KGDRVDLSYNSFTAGSSETSCQ 167
L L + L+ N + I P + + ++ L N + +T Q
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-18
Identities = 27/162 (16%), Positives = 62/162 (38%), Gaps = 7/162 (4%)
Query: 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNG 63
+ K+ +S N ++ L+ L + + SLS L+ L ++
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 64 TEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGA-IPSTFMGL 122
+ ++ L+ N++ +G + +LK L+V+ N + +P F L
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 123 LDVDYIYLTGNLLTGTIPPWM-----LQKGD-RVDLSYNSFT 158
+++++ L+ N + + + + +DLS N
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 29/165 (17%), Positives = 53/165 (32%), Gaps = 9/165 (5%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L L ++ N + L+KLV + L I L L +L ++
Sbjct: 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134
Query: 62 NGTEAPFPP-LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKV----LDVSFNKLNGAIP 116
P + ++ L L S + L ++ + + LD+S N +N P
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194
Query: 117 STFMGLLDVDYIYLTGNLLTGTIPP---WMLQKGDRVDLSYNSFT 158
F + + + L N + + L + L F
Sbjct: 195 GAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-11
Identities = 31/162 (19%), Positives = 56/162 (34%), Gaps = 13/162 (8%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L + F + + +F N + L + G P+ L L L +
Sbjct: 281 LTNVSSFSLVSVTIER-VKDFSYN-FGWQHLELVNCKF-GQFPTL--KLKSLKRLTFTSN 335
Query: 62 NGTEAPFPPLDKMKKMKTLILR--SCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTF 119
G A + ++ L L + G TSLK LD+SFN + + S F
Sbjct: 336 KGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF 392
Query: 120 MGLLDVDYIYLTGNLLTGTIPPWMLQKGD---RVDLSYNSFT 158
+GL ++++ + L + +D+S+
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 16/124 (12%), Positives = 39/124 (31%), Gaps = 10/124 (8%)
Query: 43 IPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLK 102
IP + +L +S +++ L L C + ++ L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 103 VLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-----LQKGDRVDLSYNSF 157
L ++ N + F GL + + L + L++ +++++N
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE---LNVAHNLI 136
Query: 158 TAGS 161
+
Sbjct: 137 QSFK 140
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 25/148 (16%), Positives = 48/148 (32%), Gaps = 8/148 (5%)
Query: 2 LVTLKDFRISDNHFTGKI-PNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD 60
L +L+ +++ N F P+ L L + L P+ SLS L L +S
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 503
Query: 61 --LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLG-LMTSLKVLDVSFNKLNGAIPS 117
P + ++ L ++ L +SL L+++ N
Sbjct: 504 NNFFSL--DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 561
Query: 118 T-FMG-LLDVDYIYLTGNLLTGTIPPWM 143
F+ + D + + + P
Sbjct: 562 QSFLQWIKDQRQLLVEVERMECATPSDK 589
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 21/169 (12%), Positives = 47/169 (27%), Gaps = 18/169 (10%)
Query: 10 ISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL-------- 61
+S N P + L KL ++ + + + L L + L
Sbjct: 184 LSLNPMNFIQPGAFKEIRL-HKLTLRNNFDSLNVMKT--CIQGLAGLEVHRLVLGEFRNE 240
Query: 62 -NGTEAPFPPLDKMKKMKTLILRSCNVS---GKLPDYLGLMTSLKVLDVSFNKLNGAIPS 117
N + L+ + + R + + D +T++ + +
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF 300
Query: 118 TFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSC 166
++ ++ L P L+ R+ + N SE
Sbjct: 301 SYNFGW--QHLELVNCKFGQ-FPTLKLKSLKRLTFTSNKGGNAFSEVDL 346
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 9e-09
Identities = 25/164 (15%), Positives = 49/164 (29%), Gaps = 15/164 (9%)
Query: 5 LKDFRISDNHFTGKIP-NFIQNWTLLEKLVIQ------ASGLVGPIPSGIASLSKLT--D 55
L + +N + + IQ LE + L S + L LT +
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261
Query: 56 LRISDLNGTEAPFPPL-DKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGA 114
R++ L+ L + + + + L S + + L++ K
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQF 319
Query: 115 IPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
L + + G + L+ +DLS N +
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLE---FLDLSRNGLS 360
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 56/229 (24%), Positives = 90/229 (39%), Gaps = 33/229 (14%)
Query: 413 LRQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKS--KQGNREFVN-EI 468
++Q++ +F IG G FG V V A+K L+ K+ E
Sbjct: 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER 125
Query: 469 GMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICV 528
++ + LH + N L L+ +Y L L E RL +
Sbjct: 126 DVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEM-------- 176
Query: 529 GIAR--------GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580
AR + +H+ L VHRDIK N+L+D + + +++DFG ED T
Sbjct: 177 --ARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231
Query: 581 ISTRVAGTFGYMAPE------YAMRGYLTDKADVYSFGIVALEIVSGRS 623
S+ GT Y++PE Y + D +S G+ E++ G +
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGET 279
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 34/172 (19%)
Query: 421 NNFAPDNKIGEGGFGPVYKG--HMADGTVVAVKQLS-SKSKQGN-----REFVNEIGMIS 472
+ +IGEG +G V+K G VA+K++ ++G RE ++
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-------VA 63
Query: 473 ALQ------HPNLVKLHGCCI-----EGNQLLLIYEYMENNSLARALFGPEAHR-LKLDW 520
L+ HPN+V+L C +L L++E+++ + L L + +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYL---DKVPEPGVPT 119
Query: 521 PTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572
T + + RGL +LH ++VHRD+K N+L+ K++DFGLA+
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 58/244 (23%), Positives = 101/244 (41%), Gaps = 44/244 (18%)
Query: 407 HTGSFTLRQIKAAT----NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLS--SKSKQG 460
G +R + A + + I G +G V G ++G VA+K++ +
Sbjct: 4 AKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRT 63
Query: 461 NREFVN---------EIGMISALQHPNLVKLHGCCI-----EGNQLLLIYEYMENNSLAR 506
+ EI +++ HPN++ L + ++L L+ E M + LA+
Sbjct: 64 VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQ 122
Query: 507 ALFGPEAHRLKLDWPTRHRICV---GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 563
+ R+ + + I I GL LHE +VHRD+ N+LL + +
Sbjct: 123 VI---HDQRIVI---SPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDI 173
Query: 564 KISDFGLAKLDEEDNT---HISTRVAGTFGYMAPE--YAMRGYLTDKADVYSFGIVALEI 618
I DF LA+ D D +++ R Y APE +G+ T D++S G V E+
Sbjct: 174 TICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGF-TKLVDMWSAGCVMAEM 227
Query: 619 VSGR 622
+ +
Sbjct: 228 FNRK 231
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 42/222 (18%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN---------EIG 469
+ +G G +G V G VA+K+LS R F + E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75
Query: 470 MISALQHPNLVKLH------GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTR 523
++ +QH N++ L L+ +M+ + L + + LK
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-LQKIM------GLKFSEEKI 128
Query: 524 HRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH-IS 582
+ + +GL Y+H +VHRD+K N+ +++D KI DFGLA+ + + T +
Sbjct: 129 QYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV 185
Query: 583 TRVAGTFGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 622
TR Y APE + Y D++S G + E+++G+
Sbjct: 186 TRW-----YRAPEVILSWMHY-NQTVDIWSVGCIMAEMLTGK 221
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 35/219 (15%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN---------EIG 469
+ IG G G V VA+K+LS R F N E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 470 MISALQHPNLVKLH------GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTR 523
++ + H N++ L E + ++ E M+ N L + + +++LD
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI------QMELDHERM 129
Query: 524 HRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 583
+ + G+ +LH I+HRD+K +N+++ D KI DFGLA+ + + T
Sbjct: 130 SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT 184
Query: 584 RVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 622
T Y APE + + D++S G + E++ G
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 8e-18
Identities = 63/249 (25%), Positives = 107/249 (42%), Gaps = 47/249 (18%)
Query: 397 LEQELRGVDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVY----KGHMADGTVVAVKQ 452
+E ++ + + T KA + F +G+G FG V+ + A+K
Sbjct: 1 MEGSIKEIAI-THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV 59
Query: 453 LSSKSKQGNREFVN---EIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL----- 504
L K+ R+ V E ++ + HP +VKLH +L LI +++ L
Sbjct: 60 LK-KATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS 118
Query: 505 -------ARALF-GPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVL 556
F E +A L +LH L I++RD+K N+L
Sbjct: 119 KEVMFTEEDVKFYLAE-----------------LALALDHLHS---LGIIYRDLKPENIL 158
Query: 557 LDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKA-DVYSFGIV 614
LD++ + K++DFGL+K + + GT YMAPE R G+ ++ D +SFG++
Sbjct: 159 LDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRGH--TQSADWWSFGVL 215
Query: 615 ALEIVSGRS 623
E+++G
Sbjct: 216 MFEMLTGTL 224
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 9e-18
Identities = 53/185 (28%), Positives = 78/185 (42%), Gaps = 22/185 (11%)
Query: 514 HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573
++ L +A+G+ +L SR K +HRD+ A N+LL + KI DFGLA+
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 574 DEEDNTHISTRVAGT-FGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRS-NSSCKPK 630
+D ++ A +MAPE T ++DV+SFG++ EI S G S K
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 302
Query: 631 EDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSV 690
E+ L +G M D E M L C + RP+ S +
Sbjct: 303 EEFCRRLK-------EGTRMRAPD-----YTTPEMYQTM----LDCWHGEPSQRPTFSEL 346
Query: 691 VSMLE 695
V L
Sbjct: 347 VEHLG 351
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 33/156 (21%), Positives = 57/156 (36%), Gaps = 20/156 (12%)
Query: 426 DNKIGEGGFGPVYKG------HMADGTVVAVKQL-SSKSKQGNREFVNEIG-MISALQHP 477
+G G FG V + A VAVK L + +R ++E+ +I H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 478 NLVKLHGCCI-EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
N+V L G C G L++I E+ + +L+ L R+ +G +
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----------RSKRNEFVPYKTKGARF 135
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572
+ + + D+K + + S F K
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 37/210 (17%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV----NEIGMISALQHPNLVKLH 483
+G G FG V H G A+K L K K + + NE ++ A+ P LVKL
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 484 GCCIEGNQLLLIYEYMENNSLARALFGPE-------AHRLKLDWPTRHRICVG-IARGLA 535
+ + L ++ EY+ G E R R I
Sbjct: 108 FSFKDNSNLYMVMEYVA---------GGEMFSHLRRIGRFSEP---HARFYAAQIVLTFE 155
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 595
YLH L +++RD+K N+L+D+ +++DFG AK + T T + GT +APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW--T-LCGTPEALAPE 208
Query: 596 YAM-RGYLTDKA-DVYSFGIVALEIVSGRS 623
+ +GY +KA D ++ G++ E+ +G
Sbjct: 209 IILSKGY--NKAVDWWALGVLIYEMAAGYP 236
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 83.4 bits (205), Expect = 2e-17
Identities = 43/260 (16%), Positives = 75/260 (28%), Gaps = 67/260 (25%)
Query: 419 ATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQL--------SSKSKQGNREFVNEIGM 470
T KIGEG FG V++ +AD T VA+K + + ++ E + EI +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 471 ISALQ---------HPNLVKLHGCCI------------------------------EGNQ 491
L + L+ + +Q
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIK 551
L ++ E+ + T I + LA L+ HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLH 189
Query: 552 ATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP--EYAMRGYLTDKADVY 609
NVLL K K+ K + + G +Y + D V+
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK----------SSTIPSCGLQVSIIDYTLSRLERDGIVVF 239
Query: 610 SFGIVALEIVSGRSNSSCKP 629
+ ++ +G +
Sbjct: 240 CDVSMDEDLFTGDGDYQFDI 259
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 62/213 (29%), Positives = 87/213 (40%), Gaps = 39/213 (18%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREF---VNEIGMISALQHPNLVKLHG 484
+G+G FG V A G A+K L + E + E ++ +HP L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 485 CCIEGNQLLLIYEYMENNSL------------ARALF-GPEAHRLKLDWPTRHRICVGIA 531
++L + EY L RA F G E I
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE-----------------IV 258
Query: 532 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY 591
L YLH S +V+RD+K N++LDKD + KI+DFGL K +D + T GT Y
Sbjct: 259 SALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEY 315
Query: 592 MAPEYAMR-GYLTDKADVYSFGIVALEIVSGRS 623
+APE Y D + G+V E++ GR
Sbjct: 316 LAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRL 347
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 34/228 (14%)
Query: 413 LRQIKAATNNFAPDNKIGEGGFGPVYK-GHMADGTVVAVKQLSSKSKQGNRE----FVNE 467
+R ++ ++ IG G FG V H + V A+K LS K + R F E
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSDSAFFWEE 119
Query: 468 IGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRIC 527
+++ P +V+L + L ++ EYM L + + + +
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-------------SNYDVP 166
Query: 528 VGIAR--------GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579
AR L +H + +HRD+K N+LLDK + K++DFG ++
Sbjct: 167 EKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223
Query: 580 HISTRVAGTFGYMAPE----YAMRGYLTDKADVYSFGIVALEIVSGRS 623
GT Y++PE GY + D +S G+ E++ G +
Sbjct: 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 55/231 (23%), Positives = 87/231 (37%), Gaps = 35/231 (15%)
Query: 413 LRQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE----FVNE 467
L++++ ++F IG G F V G V A+K ++ K R F E
Sbjct: 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN-KWDMLKRGEVSCFREE 111
Query: 468 IGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRIC 527
++ + +LH + N L L+ EY L L R+ +
Sbjct: 112 RDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEM------- 163
Query: 528 VGIAR--------GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579
AR + +H L VHRDIK N+LLD+ + +++DFG D T
Sbjct: 164 ---ARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217
Query: 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVY-------SFGIVALEIVSGRS 623
S GT Y++PE Y + G+ A E+ G++
Sbjct: 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 41/222 (18%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN---------EIG 469
+ +G G +G V G VA+K+L R F + E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76
Query: 470 MISALQHPNLVKLH------GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTR 523
++ ++H N++ L + L+ +M + L + + KL
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD-LGKLM-----KHEKLGEDRI 130
Query: 524 HRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-HIS 582
+ + +GL Y+H I+HRD+K N+ +++D KI DFGLA+ + + T ++
Sbjct: 131 QFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 187
Query: 583 TRVAGTFGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 622
TR Y APE Y T D++S G + E+++G+
Sbjct: 188 TRW-----YRAPEVILNWMRY-TQTVDIWSVGCIMAEMITGK 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 5e-17
Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 44/217 (20%)
Query: 429 IGEGGFGPVY----KGHMADGTVVAVKQLSSKSKQGNREFV----NEIGMISALQHPNLV 480
+G+GG+G V+ G + A+K L N + E ++ ++HP +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 481 KLHGCCIEGNQLLLIYEYM---ENNSLARALFGPEAHRLKLDWPTRHRI---------CV 528
L G +L LI EY+ E LF +L+ R I
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGE-------LF----MQLE-----REGIFMEDTACFYLA 128
Query: 529 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT 588
I+ L +LH+ I++RD+K N++L+ + K++DFGL K D T T GT
Sbjct: 129 EISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGT 184
Query: 589 FGYMAPEYAMR-GYLTDKA-DVYSFGIVALEIVSGRS 623
YMAPE MR G+ ++A D +S G + ++++G
Sbjct: 185 IEYMAPEILMRSGH--NRAVDWWSLGALMYDMLTGAP 219
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 5e-17
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 49/216 (22%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFV----NEIGMISALQHPNLVKLH 483
+G G FG V+ +G A+K L K + V +E M+S + HP ++++
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 484 GCCIEGNQLLLIYEYME--------------NNSLARALFGPEAHRLKLDWPTRHRICVG 529
G + Q+ +I +Y+E N +A+ + E
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK-FYAAE----------------- 114
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 589
+ L YLH I++RD+K N+LLDK+ + KI+DFG AK D T+ T + GT
Sbjct: 115 VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTY--T-LCGTP 167
Query: 590 GYMAPEYAMR-GYLTDKA-DVYSFGIVALEIVSGRS 623
Y+APE Y +K+ D +SFGI+ E+++G +
Sbjct: 168 DYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYT 201
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-17
Identities = 33/170 (19%), Positives = 58/170 (34%), Gaps = 15/170 (8%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKL--------VIQASGLVGPIPSGIASLSKL 53
L L D + + K+P F++ ++ + + + K+
Sbjct: 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI 307
Query: 54 TDLRISDLNGTEAPFPP-LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLN 112
+ I N P L KMKK+ L + GKLP G L L++++N++
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQIT 366
Query: 113 GAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM----LQKGDRVDLSYNSFT 158
+ V+ + N L IP + +D SYN
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIG 415
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 9e-17
Identities = 23/190 (12%), Positives = 59/190 (31%), Gaps = 37/190 (19%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD- 60
L I+ + I + ++ ++ + + + L+KL + +
Sbjct: 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNS 216
Query: 61 ------------------LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLK 102
+ D +K + + + +C KLP +L + ++
Sbjct: 217 PFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQ 276
Query: 103 VLDVSFNKL--------NGAIPSTFMGLLDVDYIYLTGN-LLTGTIPPWM-----LQKGD 148
+++V+ N+ + + + IY+ N L T + + L
Sbjct: 277 LINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGM-- 334
Query: 149 RVDLSYNSFT 158
++ YN
Sbjct: 335 -LECLYNQLE 343
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-13
Identities = 23/174 (13%), Positives = 49/174 (28%), Gaps = 28/174 (16%)
Query: 2 LVTLKDFRISDNHFTG-------KIPNFIQNWTLLEKLVIQASGLVGPIPSGIA--SLSK 52
L + N T +N LL + ++ + L + +L
Sbjct: 456 GSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPY 514
Query: 53 LTDLRISD--LNGTEAPFPP-LDKMKKMKTLILR------SCNVSGKLPDYLGLMTSLKV 103
L + +S + FP +K +R + P+ + L SL
Sbjct: 515 LVGIDLSYNSFSK----FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQ 570
Query: 104 LDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYN 155
L + N + + + + + N ++ + L Y+
Sbjct: 571 LQIGSNDIRK-VNEKITPNI--SVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-13
Identities = 16/171 (9%), Positives = 49/171 (28%), Gaps = 16/171 (9%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTL--LEKLVIQASGLVGPIPSGIASLSKLTDLRIS 59
++ + + H+ ++ L K I + I K T +
Sbjct: 132 NMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQL 191
Query: 60 DLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTF 119
N T + ++ K++ + + + + + + +
Sbjct: 192 SNNITFVS-KAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKW 245
Query: 120 MGLLDVDYIYLTGNLLTGTIPPWM-----LQKGDRVDLSYNSFTAGSSETS 165
L D+ + + +P ++ +Q ++++ N +G
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL---INVACNRGISGEQLKD 293
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-12
Identities = 28/170 (16%), Positives = 51/170 (30%), Gaps = 33/170 (19%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQA---SGLVGPIPSGIASLSKLTDLRI 58
+ L ++ N T NF +E L + P S+S ++ +
Sbjct: 352 EIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYI--PNIFDAKSVSVMSAIDF 409
Query: 59 SDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPST 118
S L ++ +++S N+++
Sbjct: 410 SYNEIGSVD-----------------GKNFDPLDPTPFKGINVSSINLSNNQISKFPKEL 452
Query: 119 FMGLLDVDYIYLTGNLLTGTIPPWMLQKGD----------RVDLSYNSFT 158
F + I L GN+LT IP L+ + +DL +N T
Sbjct: 453 FSTGSPLSSINLMGNMLTE-IPKNSLKDENENFKNTYLLTSIDLRFNKLT 501
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-12
Identities = 22/186 (11%), Positives = 53/186 (28%), Gaps = 35/186 (18%)
Query: 2 LVTLKDFRISDNHFTGKIPN--FIQNWTLLEKLVIQ-------ASGLVGPIPSGIASLSK 52
+++ + N IPN ++ +++ + P+
Sbjct: 376 TEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434
Query: 53 LTDLRISD--LNGTEAPFPP--LDKMKKMKTLILRSCNVSG-------KLPDYLGLMTSL 101
++ + +S+ ++ FP + ++ L ++ + L
Sbjct: 435 VSSINLSNNQISK----FPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490
Query: 102 KVLDVSFNKLNGAIPSTFMG-LLDVDYIYLTGNLLTGTIPPWM--------LQKGDRVDL 152
+D+ FNKL L + I L+ N + P ++ D
Sbjct: 491 TSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDA 549
Query: 153 SYNSFT 158
N
Sbjct: 550 QGNRTL 555
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 9e-11
Identities = 17/182 (9%), Positives = 45/182 (24%), Gaps = 34/182 (18%)
Query: 7 DFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRIS------- 59
+F + + + + + + L ++ G G +P I L++L L +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 60 -----------------------DLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLG 96
T + P + + + S +
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
Query: 97 LMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNS 156
+ + N + + M L + Y+ + + + + Y
Sbjct: 181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENIC---EAWENENSEYAQ 236
Query: 157 FT 158
Sbjct: 237 QY 238
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 21/123 (17%), Positives = 40/123 (32%), Gaps = 8/123 (6%)
Query: 71 LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNG----AIPSTFMGLLDVD 126
L+ ++ L L SG++PD +G +T L+VL + + P + +
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 127 YIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETS---CQYRSVNLFASSSKGNNS 183
T + D DL + + + S ++ NN
Sbjct: 137 QKQKMRMHYQKTFVD-YDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 184 TGI 186
T +
Sbjct: 196 TFV 198
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 65/246 (26%), Positives = 99/246 (40%), Gaps = 50/246 (20%)
Query: 405 DLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVY---KGHMAD-GTVVAVKQLSSKSKQG 460
+L T + T K NF +G G +G V+ K D G + A+K L +
Sbjct: 38 ELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ 97
Query: 461 NREFV------NEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL---------- 504
+ ++ + Q P LV LH +L LI +Y+ L
Sbjct: 98 KAKTTEHTRTERQV-LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF 156
Query: 505 --ARALF-GPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 561
E I L +LH+ L I++RDIK N+LLD +
Sbjct: 157 TEHEVQIYVGE-----------------IVLALEHLHK---LGIIYRDIKLENILLDSNG 196
Query: 562 NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE---YAMRGYLTDKA-DVYSFGIVALE 617
+ ++DFGL+K D T + GT YMAP+ G+ DKA D +S G++ E
Sbjct: 197 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYE 254
Query: 618 IVSGRS 623
+++G S
Sbjct: 255 LLTGAS 260
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 7e-17
Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 35/219 (15%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN---------EIG 469
+ IG G G V VA+K+LS R F N E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 470 MISALQHPNLVKLH------GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTR 523
++ + H N++ L E + L+ E M+ N L + + +++LD
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI------QMELDHERM 166
Query: 524 HRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 583
+ + G+ +LH I+HRD+K +N+++ D KI DFGLA+ + + T
Sbjct: 167 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT 221
Query: 584 RVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 622
T Y APE + + D++S G + E+V +
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-16
Identities = 76/274 (27%), Positives = 115/274 (41%), Gaps = 62/274 (22%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIG----MISALQHPNLVKLH 483
IG+G FG V H A+ AVK L K+ +E + + ++ ++HP LV LH
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 484 GCCIEGNQLLLIYEYM---ENNSLARALFGPEAHRLKLDWPTRHRI---------CVGIA 531
++L + +Y+ E LF + L+ R R IA
Sbjct: 106 FSFQTADKLYFVLDYINGGE-------LF----YHLQ-----RERCFLEPRARFYAAEIA 149
Query: 532 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGY 591
L YLH L IV+RD+K N+LLD + ++DFGL K + E N+ ST GT Y
Sbjct: 150 SALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEY 205
Query: 592 MAPEYAMR-GYLTDKA-DVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK----- 644
+APE + Y D+ D + G V E++ G + +++ IL
Sbjct: 206 LAPEVLHKQPY--DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY-----DNILNKPLQL 258
Query: 645 -------AQGNLMEL----VDKRLGSNFDKEQVM 667
A+ L L KRLG+ D ++
Sbjct: 259 KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-16
Identities = 29/170 (17%), Positives = 54/170 (31%), Gaps = 13/170 (7%)
Query: 2 LVTLKDFRISDNHFTG--KIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRIS 59
+ +L+ + P+ Q L L + + + + L KL L +
Sbjct: 453 VPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQ 512
Query: 60 D--------LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKL 111
P L + + L L S + + LK++D+ N L
Sbjct: 513 HNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNL 572
Query: 112 NGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM---LQKGDRVDLSYNSFT 158
N S F + + + L NL+T + +D+ +N F
Sbjct: 573 NTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-16
Identities = 28/161 (17%), Positives = 54/161 (33%), Gaps = 4/161 (2%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L + N + P Q +L+ L +Q + L A + LT+L +
Sbjct: 48 YSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSN 107
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTF-- 119
+ + P K K + TL L +S + +L+ L +S NK+
Sbjct: 108 SIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDI 167
Query: 120 MGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFT 158
+ + L+ N + P + + + L+
Sbjct: 168 FANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLG 208
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-15
Identities = 30/174 (17%), Positives = 54/174 (31%), Gaps = 18/174 (10%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
+LK +S N P L L + L + + T +R L
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229
Query: 62 NGT------EAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAI 115
+ + F L K + L L N++ D + L+ + +N +
Sbjct: 230 SNSQLSTTSNTTFLGL-KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288
Query: 116 PSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGD-----------RVDLSYNSFT 158
+ GL +V Y+ L + +I L K D +++ N
Sbjct: 289 SHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP 342
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-15
Identities = 27/173 (15%), Positives = 56/173 (32%), Gaps = 16/173 (9%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKL---------VIQASGLVGPIPSGIASLSK 52
L L+ F + N+ + + + L I + L L
Sbjct: 271 LPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKC 330
Query: 53 LTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGL----MTSLKVLDVSF 108
L L + D + + +K L L + S + + L +L+++
Sbjct: 331 LEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTK 390
Query: 109 NKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDR---VDLSYNSFT 158
NK++ F L ++ + L N + + + + + LSYN +
Sbjct: 391 NKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYL 443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-13
Identities = 31/158 (19%), Positives = 59/158 (37%), Gaps = 9/158 (5%)
Query: 11 SDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD--LNGTEAPF 68
S T ++P+ + + L + + L + S+LT L + ++ E
Sbjct: 12 SHLKLT-QVPDDLPTN--ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68
Query: 69 PPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYI 128
K+ +K L L+ +S T+L L + N + + F+ ++ +
Sbjct: 69 --CQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITL 126
Query: 129 YLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAGSSET 164
L+ N L+ T L+ + LS N A SE
Sbjct: 127 DLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 8e-11
Identities = 27/169 (15%), Positives = 57/169 (33%), Gaps = 15/169 (8%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGL-VGPIPSGIASLSKLTDLRISD 60
L L+ + DN G N L+ L + S + + + + L I +
Sbjct: 328 LKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILN 387
Query: 61 LNG---TEAPFPPLDKMKKMKTLILRSCNVSGKLPDY-LGLMTSLKVLDVSFNKLNGAIP 116
L ++ + ++ L L + +L + ++ + +S+NK
Sbjct: 388 LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR 447
Query: 117 STFMGLLDVDYIYLTGNLLTG--TIPPW-----MLQKGDRVDLSYNSFT 158
++F + + + L L + P L +DLS N+
Sbjct: 448 NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI---LDLSNNNIA 493
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 30/207 (14%), Positives = 58/207 (28%), Gaps = 44/207 (21%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKL--------VIQASGLVGPIPSGIASLSKL 53
L L +S+N+ + ++ LE L + G + LS L
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL 538
Query: 54 TDLRIS---------------------DLNG---TEAPFPPLDKMKKMKTLILRSCNVSG 89
L + DL P + +K+L L+ ++
Sbjct: 539 HILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS 598
Query: 90 KLPDYLG-LMTSLKVLDVSFNKLNGAIPS-----TFMGLLDVDYIYLTGNLLTGTIPPWM 143
G +L LD+ FN + S ++ + L+ + L T P
Sbjct: 599 VEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPH-- 656
Query: 144 LQKGDRVDLSYNSFTAGSSETSCQYRS 170
T+ +++ +
Sbjct: 657 YHGFPVRLFD----TSSCKDSAHHHHH 679
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 39/161 (24%), Positives = 60/161 (37%), Gaps = 33/161 (20%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
+G G G V + + A+K L + RE E+ A Q P++V++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVY 80
Query: 487 ----IEGNQLLLIYEYMENNSL-----ARALFG---PEAHRLKLDWPTRHRICVGIARGL 534
LL++ E ++ L R EA I I +
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE----------IMKSIGEAI 130
Query: 535 AYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAK 572
YLH + I HRD+K N+L + K++DFG AK
Sbjct: 131 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 64/215 (29%), Positives = 88/215 (40%), Gaps = 44/215 (20%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN----EIGMISALQHPNLVKLH 483
+G+G FG V A G A+K L K ++ V E ++ +HP L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 484 GCCIEGNQLLLIYEYMENNSL------------ARALF-GPEAHRLKLDWPTRHRICVGI 530
++L + EY L RA F G E I
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE-----------------I 114
Query: 531 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 590
L YLH +V+RDIK N++LDKD + KI+DFGL K D + T GT
Sbjct: 115 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPE 170
Query: 591 YMAPEYAMR-GYLTDKA-DVYSFGIVALEIVSGRS 623
Y+APE Y +A D + G+V E++ GR
Sbjct: 171 YLAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRL 203
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLS--SKSKQGNREFVNEIGMISALQH 476
+ + IGEG +G V + VA+K++S R EI ++ +H
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 84
Query: 477 PNLVKLHGCCI-----EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHR--ICVG 529
N++ ++ + + ++ + ME + L + L + L D H
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMETD-LYKLL---KTQHLSND----HICYFLYQ 136
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRVAG 587
I RGL Y+H + ++HRD+K +N+LL+ + KI DFGLA++ + D+T T
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 588 TFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGR 622
T Y APE + +GY T D++S G + E++S R
Sbjct: 194 TRWYRAPEIMLNSKGY-TKSIDIWSVGCILAEMLSNR 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 47/222 (21%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSS-KSKQGNREFVNEIGMISALQ-- 475
+++ K+G G + V++ ++ + V VK L K K+ RE I L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-------IKILENL 87
Query: 476 --HPNLVKLHGCCI--EGNQLLLIYEYMENNSLARALFGPEAHRL--KLDWPTRHRICV- 528
PN++ L L++E++ N +L L T + I
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDF---------KQLYQTL---TDYDIRFY 135
Query: 529 --GIARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAKLDEEDNTHIST 583
I + L Y H S I+HRD+K NV++D + L ++ D+GLA+ + +
Sbjct: 136 MYEILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKL--RLIDWGLAEFYHPGQEY-NV 189
Query: 584 RVAGTFGYMAPE--YAMRGYLTDKA-DVYSFGIVALEIVSGR 622
RVA + + PE + Y D + D++S G + ++ +
Sbjct: 190 RVA-SRYFKGPELLVDYQMY--DYSLDMWSLGCMLASMIFRK 228
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIG-----MISALQHPNLVKL 482
IG G + V + A+K + K + E ++ + A HP LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVG-IARGLAYLHEES 541
H C ++L + EY+ L + +L + R I+ L YLHE
Sbjct: 76 HSCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEE---HARFYSAEISLALNYLHE-- 128
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-G 600
I++RD+K NVLLD + + K++D+G+ K ST GT Y+APE
Sbjct: 129 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRGED 186
Query: 601 YLTDKA-DVYSFGIVALEIVSGRS 623
Y + D ++ G++ E+++GRS
Sbjct: 187 Y--GFSVDWWALGVLMFEMMAGRS 208
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 44/230 (19%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPN 478
+ + +G GG G V+ VA+K++ Q + + EI +I L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 479 LVKLH--------------GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRH 524
+VK+ G E N + ++ EYME + LA L E L + H
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVL---EQGPLLEE----H 121
Query: 525 R--ICVGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTH- 580
+ RGL Y+H + ++HRD+K N+ ++ +DL KI DFGLA++ + +H
Sbjct: 122 ARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 581 ------ISTRVAGTFGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 622
+ T+ Y +P + Y T D+++ G + E+++G+
Sbjct: 179 GHLSEGLVTK-----WYRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGK 222
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 45/224 (20%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN---------EIG 469
+ + +G G +G V G VAVK+LS R F + E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80
Query: 470 MISALQHPNLVKLH------GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTR 523
++ ++H N++ L E N + L+ M + L + + +L D
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIV---KCQKLTDD---- 132
Query: 524 HR--ICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-H 580
H + I RGL Y+H I+HRD+K +N+ +++D KI DFGLA+ ++ T +
Sbjct: 133 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 581 ISTRVAGTFGYMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 622
++TR Y APE Y D++S G + E+++GR
Sbjct: 190 VATRW-----YRAPEIMLNWMHY-NQTVDIWSVGCIMAELLTGR 227
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIG-----MISALQHPNLVKL 482
IG G + V + A++ + K + E ++ + A HP LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVG-IARGLAYLHEES 541
H C ++L + EY+ L + +L + R I+ L YLHE
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEE---HARFYSAEISLALNYLHE-- 171
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-G 600
I++RD+K NVLLD + + K++D+G+ K ST GT Y+APE
Sbjct: 172 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEILRGED 229
Query: 601 YLTDKA-DVYSFGIVALEIVSGRS 623
Y + D ++ G++ E+++GRS
Sbjct: 230 Y--GFSVDWWALGVLMFEMMAGRS 251
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-15
Identities = 23/162 (14%), Positives = 49/162 (30%), Gaps = 6/162 (3%)
Query: 2 LVTLKDFRISDNHFTGKIP-NFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD 60
L L+ + + + L L I + L+ L L+++
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAG 457
Query: 61 LNGTEAPFPP-LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTF 119
+ + + L L C + + L++L++S N L S +
Sbjct: 458 NSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHY 517
Query: 120 MGLLDVDYIYLTGNLLTGTIPPWMLQKGDR---VDLSYNSFT 158
L + + + N + T + +L+ NS
Sbjct: 518 NQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-14
Identities = 31/193 (16%), Positives = 63/193 (32%), Gaps = 12/193 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L+ +S L L++ + + P + L+ L +L +
Sbjct: 55 FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET 114
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSG-KLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM 120
P+ ++ +K L + + KLP Y +T+L +D+S+N + +
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174
Query: 121 GL----LDVDYIYLTGNLLTGTIPPWMLQ--KGDRVDLSYNSFTAGSSETSCQY----RS 170
L + ++ N + I Q K + L N ++ +T Q
Sbjct: 175 FLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHV 233
Query: 171 VNLFASSSKGNNS 183
L K +
Sbjct: 234 HRLILGEFKDERN 246
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 28/151 (18%), Positives = 50/151 (33%), Gaps = 6/151 (3%)
Query: 11 SDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPP 70
D + K+P+ I + + + + + L ++ S+L L +S
Sbjct: 19 MDQKLS-KVPDDIPSS--TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKA 75
Query: 71 LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYL 130
+ + LIL + P +TSL+ L KL L+ + + +
Sbjct: 76 WHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135
Query: 131 TGNLLTGTIPPWMLQKGDR---VDLSYNSFT 158
N + P VDLSYN
Sbjct: 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 24/163 (14%), Positives = 50/163 (30%), Gaps = 13/163 (7%)
Query: 5 LKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD--LN 62
+ I P + L+ L + + G I +L L+ L +S L+
Sbjct: 309 WQSLSIIRCQLKQ-FPT--LDLPFLKSLTL--TMNKGSISFKKVALPSLSYLDLSRNALS 363
Query: 63 GTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIP-STFMG 121
+ ++ L L + + L+ LD + L S F+
Sbjct: 364 FSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLS 422
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDR---VDLSYNSFTAGS 161
L + Y+ ++ + + ++ NSF +
Sbjct: 423 LEKLLYLDISYTNTK-IDFDGIFLGLTSLNTLKMAGNSFKDNT 464
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 25/166 (15%), Positives = 54/166 (32%), Gaps = 14/166 (8%)
Query: 2 LVTLKDFRISDNHFTGKIP-NFIQNWTLLEKLVIQASGLVG------PIPSGIASLSKLT 54
+ L + + N + I +QN L + PS + L +T
Sbjct: 203 GIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVT 262
Query: 55 --DLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLN 112
+ R++ N + + + L ++ + + + L + +L
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK 320
Query: 113 GAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
P+ + L + LT N + + L +DLS N+ +
Sbjct: 321 Q-FPTLDLPFL--KSLTLTMNKGSISFKKVALPSLSYLDLSRNALS 363
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 25/195 (12%), Positives = 55/195 (28%), Gaps = 39/195 (20%)
Query: 2 LVTLKDFRISDNHFTG-KIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRIS- 59
L+TLK ++ N K+P + N T L + + + + + + L + + +S
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSL 186
Query: 60 DLNG---TEAPFPPLDKMKKMKTLILRSCNVSGKLPD----------YLGLM-------- 98
D++ +K + L LR S + L+
Sbjct: 187 DMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER 245
Query: 99 ---------------TSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM 143
++ +++ F L +V + L G +
Sbjct: 246 NLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPK 305
Query: 144 LQKGDRVDLSYNSFT 158
K + +
Sbjct: 306 HFKWQSLSIIRCQLK 320
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.5 bits (193), Expect = 4e-15
Identities = 55/214 (25%), Positives = 87/214 (40%), Gaps = 41/214 (19%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGM-----ISALQHPNLVKL 482
+G+G FG V + AVK L K + V + + P L +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILK-KDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 483 HGCCIEGNQLLLIYEYMENNSL------------ARALFGPEAHRLKLDWPTRHRICVGI 530
H C ++L + EY+ L A+F I
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF----------------YAAEI 451
Query: 531 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 590
A GL +L I++RD+K NV+LD + + KI+DFG+ K + D T GT
Sbjct: 452 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPD 507
Query: 591 YMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRS 623
Y+APE Y D ++FG++ E+++G++
Sbjct: 508 YIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQA 540
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 47/204 (23%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN---------EIG 469
+N+ + IG G +G VY VA+K+++ R F + EI
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREIT 77
Query: 470 MISALQHPNLVKLHGCCI-----EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRH 524
+++ L+ +++L+ I + ++L ++ E +++ L + P L T
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD-LKKLFKTPI----FL---TEE 129
Query: 525 RICV---GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA-KLDEEDNTH 580
I + G ++HE I+HRD+K N LL++D + K+ DFGLA ++ E +T+
Sbjct: 130 HIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 581 ISTRVAGTFGYMAPEYAMRGYLTD 604
I + ++ LT
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTS 210
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 8e-15
Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 34/224 (15%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLS--SKSKQGNREFVNEIGMISALQH 476
+++F + +GEG +G V H G +VA+K++ K R EI ++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKH 68
Query: 477 PNLVKLH-----GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHR--ICVG 529
N++ + N++ +I E M+ + L R + L D H
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTD-LHRVI---STQMLSDD----HIQYFIYQ 120
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 589
R + LH + ++HRD+K +N+L++ + + K+ DFGLA++ +E S
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 590 G---------YMAPE--YAMRGYLTDKADVYSFGIVALEIVSGR 622
G Y APE Y + DV+S G + E+ R
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKY-SRAMDVWSCGCILAELFLRR 220
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 9e-15
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 429 IGEGGFGPVY----KGHMADGTVVAVKQLSSKSKQGNREFVNEIGM-----ISALQHPNL 479
+G+G FG V K G + AVK L K + V A HP L
Sbjct: 31 LGKGSFGKVMLARVKE---TGDLYAVKVLK-KDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVG-IARGLAYLH 538
+L C ++L + E++ L + ++ R R R I L +LH
Sbjct: 87 TQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEA---RARFYAAEIISALMFLH 141
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 598
+ I++RD+K NVLLD + + K++DFG+ K + +T GT Y+APE
Sbjct: 142 D---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPEILQ 197
Query: 599 R-GYLTDKA-DVYSFGIVALEIVSGRS 623
Y A D ++ G++ E++ G +
Sbjct: 198 EMLY--GPAVDWWAMGVLLYEMLCGHA 222
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 49/218 (22%)
Query: 429 IGEGGFGPV----YKGHMADGTVVAVKQLSSKSKQGNREFVNEIGM-----ISALQHPNL 479
+G+G FG V +K A+K L K + V + A +HP L
Sbjct: 25 LGKGSFGKVFLAEFKK---TNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSL------------ARALFGPEAHRLKLDWPTRHRIC 527
+ L + EY+ L +RA F
Sbjct: 81 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF----------------YA 124
Query: 528 VGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAG 587
I GL +LH IV+RD+K N+LLDKD + KI+DFG+ K + + +T G
Sbjct: 125 AEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCG 180
Query: 588 TFGYMAPEYAMR-GYLTDKA-DVYSFGIVALEIVSGRS 623
T Y+APE + Y + + D +SFG++ E++ G+S
Sbjct: 181 TPDYIAPEILLGQKY--NHSVDWWSFGVLLYEMLIGQS 216
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 42/208 (20%), Positives = 81/208 (38%), Gaps = 40/208 (19%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN---------EIG 469
+ + + IG G +G V + + VVA+K++ R F + EI
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 470 MISALQHPNLVKLHGCCI-----EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRH 524
+++ L H ++VK+ I + ++L ++ E +++ + P L H
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD-FKKLFRTPV--YLTEL----H 157
Query: 525 R--ICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA------KLDEE 576
+ + G+ Y+H I+HRD+K N L+++D + K+ DFGLA +
Sbjct: 158 IKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 577 DNTHISTRVAGTFGYMAPEYAMRGYLTD 604
++ LT
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 35/186 (18%), Positives = 57/186 (30%), Gaps = 17/186 (9%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKL---------VIQASGLVGPIPSGIASLSK 52
L L D + + ++P+F+ + L+ L Q + + K
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
Query: 53 LTDLRISDLNGTEAPFPP-LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKL 111
+ + N E P L KM K+ L V L G L L + +N++
Sbjct: 550 IQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQI 607
Query: 112 NGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM----LQKGDRVDLSYNSFTAGSSETSCQ 167
V+ + + N L IP + VD SYN + SC
Sbjct: 608 EEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCS 666
Query: 168 YRSVNL 173
Sbjct: 667 MDDYKG 672
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 4e-13
Identities = 28/167 (16%), Positives = 49/167 (29%), Gaps = 18/167 (10%)
Query: 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNG 63
N T I IQ T L+ + S + D
Sbjct: 426 KDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYAKQ 479
Query: 64 TEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNG---------A 114
E +K + + L +C +LPD+L + L+ L+++ N+
Sbjct: 480 YENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539
Query: 115 IPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDR---VDLSYNSFT 158
+ + Y+ N L LQK + +D +N
Sbjct: 540 LADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR 586
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 25/206 (12%), Positives = 60/206 (29%), Gaps = 50/206 (24%)
Query: 2 LVTLKDFRISDNHFT-------GKIPNFIQNWTLLEKLVIQASGLVGPIPSGIA--SLSK 52
+ +S+N T +N LL + ++ + L + +L
Sbjct: 696 GSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPY 754
Query: 53 LTDLRISD--LNGTEAPFPP-LDKMKKMKTLILR------SCNVSGKLPDYLGLMTSLKV 103
L+++ +S + FP ++K +R + + P + SL
Sbjct: 755 LSNMDVSYNCFSS----FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQ 810
Query: 104 LDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSE 163
L + N + + + + +D++ N +
Sbjct: 811 LQIGSNDIR-------------------------KVDEKLTPQLYILDIADNPNISIDVT 845
Query: 164 TSCQYRSVNLFASSSKGNNSTGIVSC 189
+ C Y ++ + + I C
Sbjct: 846 SVCPYIEAGMYVLL--YDKTQDIRGC 869
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 5e-09
Identities = 31/178 (17%), Positives = 56/178 (31%), Gaps = 29/178 (16%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRISD 60
+V L N + F L L + + + IP A ++ L S
Sbjct: 572 MVKLGLLDCVHNKVR-HLEAF-GTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSH 628
Query: 61 --LNGTEAPFPP---LDKMKKMKTLILRSCNVSGKLPDYLGLM-----TSLKVLDVSFNK 110
L P + M ++ + + + M + + +S+N+
Sbjct: 629 NKLKY----IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE 684
Query: 111 LNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRV----------DLSYNSFT 158
+ F + I L+ NL+T +IP L+ D DL +N T
Sbjct: 685 IQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT 741
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 20/204 (9%), Positives = 54/204 (26%), Gaps = 26/204 (12%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSG-IASLSKLTDLRISD 60
L LK + T F + + + + +L +
Sbjct: 346 LTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQ 405
Query: 61 LNGTE----APFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNG--- 113
P ++ T I N + + +T L+++ + +
Sbjct: 406 DAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI 465
Query: 114 ----------------AIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYN 155
++ L D+ + L +P ++ L + ++++ N
Sbjct: 466 AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525
Query: 156 SFTAGSSETSCQYRSVNLFASSSK 179
+ + + R + + K
Sbjct: 526 RGISAAQLKADWTRLADDEDTGPK 549
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 24/174 (13%), Positives = 53/174 (30%), Gaps = 21/174 (12%)
Query: 5 LKDFRISDNHFTGKIPN--FIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRIS--D 60
++ S N IPN ++ ++ + + + + S+ + S
Sbjct: 621 VEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVT 679
Query: 61 LNG---TEAPFPPLDKMKKMKTLILRSC-------NVSGKLPDYLGLMTSLKVLDVSFNK 110
L+ + P + T+IL + N L +D+ FNK
Sbjct: 680 LSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNK 739
Query: 111 LNGAIPSTFM--GLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAG 160
L + F L + + ++ N + + P + + + G
Sbjct: 740 LTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEG 791
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 22/121 (18%), Positives = 39/121 (32%), Gaps = 3/121 (2%)
Query: 71 LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYL 130
LD ++ L L G++PD +G +T LKVL + + L D
Sbjct: 319 LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378
Query: 131 TGNLLTGTIPP---WMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKGNNSTGIV 187
+ + Q+ + DL ++ + S + GN + I
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT 438
Query: 188 S 188
Sbjct: 439 F 439
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-14
Identities = 19/160 (11%), Positives = 41/160 (25%), Gaps = 6/160 (3%)
Query: 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNG 63
+ + S N L L + + S +L L ++
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 64 TEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLL 123
L K +K L +S L +L+ L + N ++
Sbjct: 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153
Query: 124 DVDYIYLTGNLLTGTIPPWMLQ-----KGDRVDLSYNSFT 158
+ + N + + + ++L+ N
Sbjct: 154 KLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGNDIA 192
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 7e-13
Identities = 30/163 (18%), Positives = 59/163 (36%), Gaps = 7/163 (4%)
Query: 2 LVTLKDFRISDNHFTGKIP-NFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD 60
L+ ++ K + QN LL+ L + S L L L L +
Sbjct: 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQG 458
Query: 61 ---LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPS 117
G L + +++ L+L C++S + + +D+S N+L +
Sbjct: 459 NHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE 518
Query: 118 TFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFT 158
L + Y+ L N ++ +P + L + ++L N
Sbjct: 519 ALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 28/164 (17%), Positives = 63/164 (38%), Gaps = 9/164 (5%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L++ ++ H + ++P+ + + L+KLV+ A+ ++ LT L I
Sbjct: 277 FSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKG- 334
Query: 62 NGTEAPFPP--LDKMKKMKTLILRSCN--VSGKLPDYLGLMTSLKVLDVSFNKLNGAIPS 117
N L+ ++ ++ L L + S L ++ L+ L++S+N+
Sbjct: 335 NTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTE 394
Query: 118 TFMGLLDVDYIYLTGNLLTGTIPPW---MLQKGDRVDLSYNSFT 158
F ++ + L L L ++LS++
Sbjct: 395 AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD 438
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-11
Identities = 24/164 (14%), Positives = 55/164 (33%), Gaps = 8/164 (4%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTL--LEKLVIQASGLVGPIPSGIASLSK--LTDLR 57
+ I ++N T+ L + P+ L + + +
Sbjct: 201 SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESIN 260
Query: 58 ISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPS 117
+ ++ L L + ++S +LP L +++LK L +S NK
Sbjct: 261 LQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQI 319
Query: 118 TFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDR---VDLSYNSFT 158
+ + ++ + GN + L+ + +DLS++
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-10
Identities = 28/162 (17%), Positives = 54/162 (33%), Gaps = 9/162 (5%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L LK +S + L+ L +Q + SL L L I L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
Query: 62 NG---TEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPST 118
+ + +K M + L ++ + L + + L+++ N ++ +PS
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSL 542
Query: 119 FMGLLDVDYIYLTGNLLTGTI-----PPWMLQKGDRVDLSYN 155
L I L N L T W + +++ + +
Sbjct: 543 LPILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQKLEDTED 584
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 26/203 (12%), Positives = 57/203 (28%), Gaps = 15/203 (7%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L ++ N + L+ L +G+ + + L L +
Sbjct: 80 QHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKV--LDVSFNKLNGAIPSTF 119
+ + P +K+K L ++ + + + + L+++ N + G I
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGA 198
Query: 120 MGLLDVDYIYLTGNLLTGTIPP-------WMLQKGDRVDLSYNSFTAGSSETSCQYRSVN 172
+ G I L G D+ + E C+ +
Sbjct: 199 FDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVES 258
Query: 173 LFASSSKGNNSTGIVSCLRSFRC 195
+ + I S +F C
Sbjct: 259 INLQ---KHYFFNISS--NTFHC 276
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 43/215 (20%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIG----MISALQHPNLVKLH 483
+G+G FG V + AVK L + + + + + P L +LH
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 484 GCCIEGNQLLLIYEYMENNSL------------ARALF-GPEAHRLKLDWPTRHRICVGI 530
C ++L + EY+ L A+F E I
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-----------------I 130
Query: 531 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 590
A GL +L I++RD+K NV+LD + + KI+DFG+ K + D T GT
Sbjct: 131 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPD 186
Query: 591 YMAPEYAMR-GYLTDKA-DVYSFGIVALEIVSGRS 623
Y+APE Y K+ D ++FG++ E+++G++
Sbjct: 187 YIAPEIIAYQPY--GKSVDWWAFGVLLYEMLAGQA 219
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 40/154 (25%), Positives = 64/154 (41%), Gaps = 8/154 (5%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L +L F N T P + N T L L I + + P +A+LS+LT L I
Sbjct: 198 LTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGT- 252
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
N + + K+K L + S +S L ++ L L ++ N+L G
Sbjct: 253 NQISDI-NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGG 309
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYN 155
L ++ ++L+ N +T P L K D D +
Sbjct: 310 LTNLTTLFLSQNHITDIRPLASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 1e-11
Identities = 24/157 (15%), Positives = 65/157 (41%), Gaps = 9/157 (5%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L L++ +++++ + P + N T + L + A+ + S +++++ L L +++
Sbjct: 109 LTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTES 165
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
+ P+ + + +L L + L +TSL N++ P
Sbjct: 166 KVKD--VTPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VAN 219
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
+ ++ + + N +T P L + +++ N +
Sbjct: 220 MTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQIS 256
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 7e-11
Identities = 28/140 (20%), Positives = 57/140 (40%), Gaps = 18/140 (12%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDL----- 56
+ L +I +N T P + N + L L I + + + + L+KL L
Sbjct: 220 MTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSN 275
Query: 57 RISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIP 116
+ISD+ L+ + ++ +L L + + + + +G +T+L L +S N + P
Sbjct: 276 QISDI-------SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
Query: 117 STFMGLLDVDYIYLTGNLLT 136
L +D ++
Sbjct: 329 --LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 37/157 (23%), Positives = 61/157 (38%), Gaps = 9/157 (5%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L L+ ++ N T P + N L L I + + S + +L+ L +L +++
Sbjct: 65 LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNED 120
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
N ++ PL + KM +L L N + L MT L L V+ +K+ P
Sbjct: 121 NISD--ISPLANLTKMYSLNL-GANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IAN 175
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
L D+ + L N + P L N T
Sbjct: 176 LTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQIT 212
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 1e-06
Identities = 16/114 (14%), Positives = 49/114 (42%), Gaps = 6/114 (5%)
Query: 45 SGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVL 104
A L++ + + T+ ++++ + L++ V+ + + +T+L+ L
Sbjct: 16 FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYL 71
Query: 105 DVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
+++ N++ P L+ + +Y+ N +T L + L+ ++ +
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQNLTNLRELYLNEDNIS 123
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 48/185 (25%), Positives = 74/185 (40%), Gaps = 22/185 (11%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQH-PN 478
NF KIG G FG + G ++ VA+K KS+ E L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+ +++ G ++ E + SL LF L T I + + + Y+H
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRTFSL--KTVLMIAIQLISRMEYVH 122
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPK-----ISDFGLAK--LDEEDNTHISTR----VAG 587
++ +++RD+K N L+ + N I DF LAK +D E HI R + G
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
Query: 588 TFGYM 592
T YM
Sbjct: 180 TARYM 184
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 35/136 (25%), Positives = 54/136 (39%), Gaps = 4/136 (2%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
LV L+ R+ +P I N L+ L I+ S L + I L KL +L +
Sbjct: 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGC 239
Query: 62 NGTEAPFPP-LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM 120
+PP +K LIL+ C+ LP + +T L+ LD+ +PS
Sbjct: 240 TALRN-YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298
Query: 121 GLLDVDYIYLTGNLLT 136
L I + +L
Sbjct: 299 QLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 32/166 (19%), Positives = 65/166 (39%), Gaps = 15/166 (9%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTL---------LEKLVIQASGLVGPIPSGIASLSK 52
L L++ I ++P + + L+ L ++ +G+ +P+ IA+L
Sbjct: 149 LNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQN 207
Query: 53 LTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVS-FNKL 111
L L+I + + P + + K++ L LR C P G LK L + + L
Sbjct: 208 LKSLKIRNSPLSALG-PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL 266
Query: 112 NGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYN 155
+P L ++ + L G + +P + L + + +
Sbjct: 267 -LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 9e-08
Identities = 21/142 (14%), Positives = 43/142 (30%), Gaps = 11/142 (7%)
Query: 22 FIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81
+ + E L Q S + P ++ + + D N + + + +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNA---DRNRWHSAWRQANSNN--PQIE 61
Query: 82 LRSCNVSGKLPDYLGLMTS--LKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTI 139
R+ D L T L++ L P L + ++ + L +
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 140 PPWM--LQKGDRVDLSYNSFTA 159
P M + + L+ N A
Sbjct: 120 PDTMQQFAGLETLTLARNPLRA 141
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 20/170 (11%), Positives = 51/170 (30%), Gaps = 16/170 (9%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVG-PIPSGIASLSKLTDLRISD 60
L + +D + N + L A+ L +
Sbjct: 32 LSQWQRHYNADRNRWHSAWRQ-ANSNNPQIETRTGRALKATADLLEDATQPGRVALELRS 90
Query: 61 LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM 120
+ + P ++ ++ + + + + +LPD + L+ L ++ N L A+P++
Sbjct: 91 VPLPQFP-DQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIA 147
Query: 121 GLLDVDYIYLTGNLLTGTIPP-----------WMLQKGDRVDLSYNSFTA 159
L + + + +P L + L + +
Sbjct: 148 SLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS 197
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 50/183 (27%), Positives = 77/183 (42%), Gaps = 20/183 (10%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQH-PN 478
N + KIG G FG +Y G +A G VA+K K+K E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+ + C EG+ +++ E + SL LF + + L T + + + Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFCSRKFSL--KTVLLLADQMISRIEYIH 122
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPK---ISDFGLAK--LDEEDNTHISTR----VAGTF 589
++ +HRD+K N L+ I DFGLAK D + HI R + GT
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 590 GYM 592
Y
Sbjct: 180 RYA 182
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 48/200 (24%), Positives = 86/200 (43%), Gaps = 33/200 (16%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVN---------EIG 469
+ K+G+G +G V+K G VVAVK++ F N EI
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 470 MISALQ-HPNLVKLHGCCI--EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHR- 525
+++ L H N+V L + L+++YME + L + A+ L+ H+
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD-LHAVI---RANILEPV----HKQ 112
Query: 526 -ICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR 584
+ + + + YLH S ++HRD+K +N+LL+ + + K++DFGL++ +
Sbjct: 113 YVVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 585 VAGTFGYMAPEYAMRGYLTD 604
+ LTD
Sbjct: 170 PLSINENTENFDDDQPILTD 189
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 43/191 (22%), Positives = 77/191 (40%), Gaps = 34/191 (17%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQH-PN 478
++ +IGEG FG +++G ++ + VA+K +S + +E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTG 67
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGP------EAHRLKLDWPTRHRICVGIAR 532
+ ++ EG +L+ ++ L GP + K T +
Sbjct: 68 IPNVYYFGQEGLHNVLV---ID-------LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLA 117
Query: 533 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPK-----ISDFGLAK--LDEEDNTHISTR- 584
+ +HE+S +V+RDIK N L+ + + + DFG+ K D HI R
Sbjct: 118 RVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174
Query: 585 ---VAGTFGYM 592
++GT YM
Sbjct: 175 KKNLSGTARYM 185
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 51/189 (26%), Positives = 78/189 (41%), Gaps = 32/189 (16%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-HPN 478
N F KIG G FG +Y G ++ VA+K + K+K + + + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTG 64
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGP------EAHRLKLDWPTRHRICVGIAR 532
+ + +EG+ +L+ M+ L GP KL T + +
Sbjct: 65 IPNVRWFGVEGDYNVLV---MD-------LLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
Query: 533 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPK---ISDFGLAKL--DEEDNTHISTR--- 584
+ ++H +S +HRDIK N L+ I DFGLAK D + HI R
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
Query: 585 -VAGTFGYM 592
+ GT Y
Sbjct: 172 NLTGTARYA 180
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 34/161 (21%), Positives = 60/161 (37%), Gaps = 7/161 (4%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRISD 60
+LK +S N + + LE L Q S L + SL L L IS
Sbjct: 372 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 61 LNGTEAPFPPLDKMKKMKTLILRSCNVSGKL-PDYLGLMTSLKVLDVSFNKLNGAIPSTF 119
+ A + + ++ L + + PD + +L LD+S +L P+ F
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490
Query: 120 MGLLDVDYIYLTGNLLTGTIPPWM---LQKGDRVDLSYNSF 157
L + + + N L ++P + L ++ L N +
Sbjct: 491 NSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 38/193 (19%), Positives = 70/193 (36%), Gaps = 14/193 (7%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L+ +S Q+ + L L++ + + + LS L L +
Sbjct: 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCN--VSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTF 119
N P+ +K +K L + + N S KLP+Y +T+L+ LD+S NK+ +
Sbjct: 111 NLASLENFPIGHLKTLKELNV-AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169
Query: 120 MGL----LDVDYIYLTGNLLTGTIPPWMLQ--KGDRVDLSYNSFTAGSSETSCQY----R 169
L L + L+ N + I P + + ++ L N + +T Q
Sbjct: 170 RVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLE 228
Query: 170 SVNLFASSSKGNN 182
L +
Sbjct: 229 VHRLVLGEFRNEG 241
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 29/164 (17%), Positives = 59/164 (35%), Gaps = 11/164 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGL--VGPIPSGIASLSKLTDLRIS 59
L +LK + N + + + LE L + +GL G + L L +S
Sbjct: 324 LKSLKRLTFTSNKGG-NAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 60 DLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDY--LGLMTSLKVLDVSFNKLNGAIPS 117
+++++ L + N+ ++ ++ + +L LD+S A
Sbjct: 382 FNGVITMS-SNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 118 TFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRV---DLSYNSFT 158
F GL ++ + + GN P + + + DLS
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 28/142 (19%), Positives = 53/142 (37%), Gaps = 4/142 (2%)
Query: 2 LVTLKDFRISDNHFTGKIP-NFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD 60
L L+ ++ + + L L I + LS L L+++
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 61 LNGTEAPFPP--LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPST 118
N + F P +++ + L L C + P ++SL+VL+++ N+L
Sbjct: 455 -NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGI 513
Query: 119 FMGLLDVDYIYLTGNLLTGTIP 140
F L + I+L N + P
Sbjct: 514 FDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 26/151 (17%), Positives = 46/151 (30%), Gaps = 6/151 (3%)
Query: 11 SDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPP 70
+ +F KIP+ + + L + + L S +L L +S
Sbjct: 15 MELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71
Query: 71 LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYL 130
+ + TLIL + ++SL+ L L L + + +
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 131 TGNLLTGTIPPWMLQKGDR---VDLSYNSFT 158
NL+ P +DLS N
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-11
Identities = 38/157 (24%), Positives = 67/157 (42%), Gaps = 11/157 (7%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L L + +N T P ++N T L +L + ++ + S I++LS LT L+
Sbjct: 111 LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTI-----SDISALSGLTSLQQLSF 163
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
PL + ++ L + S VS L +T+L+ L + N+++ P
Sbjct: 164 GNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGI 219
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
L ++D + L GN L L +DL+ N +
Sbjct: 220 LTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQIS 256
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 9e-11
Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 10/157 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L L+ ++N + P + T L++L + + L +ASL+ LTDL +++
Sbjct: 198 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLAN- 252
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
N PL + K+ L L + +S P L +T+L L+++ N+L P
Sbjct: 253 NQISN-LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISN 307
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
L ++ Y+ L N ++ P L K R+ N +
Sbjct: 308 LKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVS 344
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-10
Identities = 25/155 (16%), Positives = 58/155 (37%), Gaps = 9/155 (5%)
Query: 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNG 63
L I+ + +I K V+ + + + L ++T L+ L
Sbjct: 2 PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 64 TEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLL 123
++ + + + + ++ P L +T L + ++ N++ P L
Sbjct: 59 KS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLT 112
Query: 124 DVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
++ + L N +T P L +R++LS N+ +
Sbjct: 113 NLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTIS 147
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 9e-10
Identities = 30/186 (16%), Positives = 61/186 (32%), Gaps = 11/186 (5%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L L + +++N P I N L L + + + P ++SL+KL L +
Sbjct: 286 LTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN- 340
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
N L + + L +S P L +T + L ++ A +
Sbjct: 341 NKVSDV-SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKAN 397
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKGN 181
+ + + L D+++N + ++E S + +
Sbjct: 398 VSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGT--T 454
Query: 182 NSTGIV 187
+G V
Sbjct: 455 TFSGTV 460
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-09
Identities = 35/177 (19%), Positives = 65/177 (36%), Gaps = 29/177 (16%)
Query: 2 LVTLKDFRISDNHFTGKIPNF--------------------IQNWTLLEKLVIQASGLVG 41
L L +S N + I + N T LE+L I ++ +
Sbjct: 133 LTNLNRLELSSNTISD-ISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD 191
Query: 42 PIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSL 101
S +A L+ L L ++ ++ PL + + L L + L +T+L
Sbjct: 192 I--SVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD--IGTLASLTNL 245
Query: 102 KVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
LD++ N+++ P GL + + L N ++ P L ++L+ N
Sbjct: 246 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE 300
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 48/229 (20%), Positives = 79/229 (34%), Gaps = 56/229 (24%)
Query: 428 KIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK---QGNRE-----FVNE----------- 467
K+G G F V+ M + T VA+K + E VN+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 468 ---IGMISALQHPNLVKLHGC-CIEGNQLLL---IYEYMENNSLARALFGPEAHRLKLDW 520
+ ++ H +H E +L + ++ +
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFE----VLGENLLALIKKYE-----HRG------IPL 130
Query: 521 PTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD------KDLNPKISDFGLA-KL 573
+I + GL Y+H I+H DIK NVL++ + KI+D G A
Sbjct: 131 IYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 574 DEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 622
DE I TR Y +PE + AD++S + E+++G
Sbjct: 189 DEHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 34/175 (19%), Positives = 58/175 (33%), Gaps = 13/175 (7%)
Query: 5 LKDFRISDNHFTGKIPNF--IQNWTL--LEKLVIQASGLVGPIPSGIASLSKLTDLRISD 60
L + + + + +Q W L+ L I + + + L+ L +SD
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182
Query: 61 -LNGTEAPFPP---LDKMKKMKTLILRSCN---VSGKLPDYLGLMTSLKVLDVSFNKLNG 113
E K ++ L LR+ SG L+ LD+S N L
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242
Query: 114 AIP-STFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQ 167
A + ++ + L+ L +P + K +DLSYN S
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYNRLDRNPSPDELP 296
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 28/164 (17%), Positives = 48/164 (29%), Gaps = 15/164 (9%)
Query: 5 LKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIA----SLSKLTDLRISD 60
LK I+ H ++ + L L + + +G A L L + +
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210
Query: 61 LNGTEAPFPP---LDKMKKMKTLILRSCNVSGKLPDYLGL-MTSLKVLDVSFNKLNGAIP 116
+++ L L ++ + L L++SF L
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK 270
Query: 117 STFMGL--LDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
L LD L+ N L P L + + L N F
Sbjct: 271 GLPAKLSVLD-----LSYNRLDRNPSPDELPQVGNLSLKGNPFL 309
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 26/152 (17%), Positives = 48/152 (31%), Gaps = 15/152 (9%)
Query: 29 LEKLVIQASGLVGPIPSGIA---SLSKLTDLRISD--LNGTEAPFPPLDKMKKMKTLILR 83
L++L ++A+ + I G +S L +L + + + GT P + L LR
Sbjct: 70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129
Query: 84 SCNVSGKLPDYLGL----MTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTI 139
+ + + + L LKVL ++ + + L+ N G
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189
Query: 140 P-PWMLQKGD-----RVDLSYNSFTAGSSETS 165
L + L S S
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCS 221
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 25/136 (18%), Positives = 53/136 (38%), Gaps = 5/136 (3%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
+KD I++ H T I + LE+L I + ++ L+ LT L IS
Sbjct: 65 AHNIKDLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
++ ++ + K+ ++ L + L + LK L++ F+ ++
Sbjct: 123 AHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IED 179
Query: 122 LLDVDYIYLTGNLLTG 137
++ +Y + G
Sbjct: 180 FPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 24/97 (24%), Positives = 47/97 (48%), Gaps = 2/97 (2%)
Query: 45 SGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVL 104
+GI + DL I++++ T + P+ + ++ L + +V+ L +TSL +L
Sbjct: 60 TGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 105 DVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPP 141
D+S + + +I + L V+ I L+ N I P
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 50/218 (22%)
Query: 429 IGEGGFGPVYKGH-MADGTVVAVKQLSSKSK---QGNREFVNEIGMISALQH------PN 478
IG+G FG V K + VA+K + ++ + Q EI ++ L+ N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTMN 160
Query: 479 LVKLHGC-------CI--EGNQLLLI--YEYMENNSLARALFGPEAHRLKLDWPTRHRIC 527
++ + C+ E LL + YE ++ N F P +
Sbjct: 161 VIHMLENFTFRNHICMTFE---LLSMNLYELIKKNK-----FQG------FSLPLVRKFA 206
Query: 528 VGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP--KISDFGLA-KLDEEDNTHISTR 584
I + L LH + +I+H D+K N+LL + K+ DFG + + T+I +R
Sbjct: 207 HSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR 263
Query: 585 VAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 622
F Y APE + D++S G + E+++G
Sbjct: 264 ----F-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 38/204 (18%), Positives = 67/204 (32%), Gaps = 42/204 (20%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSKSKQ-----------GNRE 463
+ IG+GGFG +Y M VK S + E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 464 FVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTR 523
+ + L++ + K G + + FG + ++ + +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKN------GKSYRFMIMDRFGSDLQKI-YEANAK 147
Query: 524 H-------RICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI--SDFGLAK-- 572
++ + I L Y+HE VH DIKA+N+LL+ ++ D+GLA
Sbjct: 148 RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
Query: 573 LDEEDNTHISTR----VAGTFGYM 592
E + + GT +
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFT 228
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 24/156 (15%), Positives = 51/156 (32%), Gaps = 6/156 (3%)
Query: 5 LKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVG-PIPSGIASLSKLTDLRISDLNG 63
K+ +++N T + ++ L ++ + + AS L L +
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 64 TEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLL 123
+ K+KTL L S ++ + + + + NKL I
Sbjct: 182 YD--VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237
Query: 124 DVDYIYLTGNLLTGTIPPWMLQKGDRV-DLSYNSFT 158
++++ L GN K RV ++ +
Sbjct: 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 19/122 (15%), Positives = 42/122 (34%), Gaps = 5/122 (4%)
Query: 43 IPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLK 102
I + ++ +++D + +A +K L L +S L T L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 103 VLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSS 162
+L++S N L L + + L N + + + + + N+ + S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLV--GPSIETLHAANNNISRVSC 116
Query: 163 ET 164
Sbjct: 117 SR 118
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 30/169 (17%), Positives = 61/169 (36%), Gaps = 13/169 (7%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
+K+ +S N + + +T LE L + ++ L + + SLS L L +++
Sbjct: 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN- 89
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
N + L ++TL + N+S ++ K + ++ NK+
Sbjct: 90 NYVQE----LLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGC 142
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRV---DLSYNSFTAGSSETSCQ 167
V Y+ L N + + D + +L YN +
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFA 191
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 25/140 (17%), Positives = 54/140 (38%), Gaps = 8/140 (5%)
Query: 19 IPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMK 78
I QN + + S L + S S + +L +S ++ L K++
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 79 TLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGT 138
L L S + + D L +++L+ LD++ N + + ++ ++ N ++
Sbjct: 62 LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113
Query: 139 IPPWMLQKGDRVDLSYNSFT 158
+ Q + L+ N T
Sbjct: 114 VSCSRGQGKKNIYLANNKIT 133
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 19/131 (14%), Positives = 41/131 (31%), Gaps = 6/131 (4%)
Query: 2 LVTLKDFRISDNHFTG-KIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD 60
++ + N + LE L +Q + + + + +KL L +S
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSS 200
Query: 61 LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLN-GAIPSTF 119
P + + LR+ + + L +L+ D+ N + G + F
Sbjct: 201 NKLAFMG-PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258
Query: 120 MGLLDVDYIYL 130
V +
Sbjct: 259 SKNQRVQTVAK 269
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 26/183 (14%), Positives = 56/183 (30%), Gaps = 28/183 (15%)
Query: 421 NNFAPDNKIGEGGFGPVYKG---------HMADGTVVAVKQLSSKSKQGNREFVNEIGMI 471
+ + G +Y+ ++K L +K + E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 472 SALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARAL----FGP-------EAHRLKLDW 520
LQ KL+ + + + + R L G + + L
Sbjct: 101 KPLQVNKWKKLYSTPLLA--IPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSE 158
Query: 521 PTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI--SDFGLAKLDEEDN 578
+ ++ + L +LHE VH ++ A N+ +D + ++ + +G A
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 579 THI 581
H+
Sbjct: 216 KHV 218
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 27/161 (16%), Positives = 59/161 (36%), Gaps = 10/161 (6%)
Query: 4 TLKDFRISDNHFTG-KIPNFIQNWTLLEKLVIQASGLVGPIPSGIAS-LSKLTDL----- 56
T +S+N I F+ L+ L++ + S L L
Sbjct: 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461
Query: 57 RISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIP 116
+ TE + + + ++ L L ++ P +T+L+ L ++ N+L
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSH 521
Query: 117 STFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSF 157
+ L++ + ++ N L P + +D+++N F
Sbjct: 522 NDLPANLEI--LDISRNQLL-APNPDVFVSLSVLDITHNKF 559
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 36/199 (18%), Positives = 65/199 (32%), Gaps = 14/199 (7%)
Query: 2 LVTLKDFRISDNHFTGKI-PNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD 60
L L+ + + I +N L L + +S + P L L +LR+
Sbjct: 47 LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYF 106
Query: 61 LNGTEAPFPP--LDKMKKMKTLILRSCN-VSGKLPDYLGLMTSLKVLDVSFNKLNGAIPS 117
++A +K + L L S L G + SLK +D S N++
Sbjct: 107 CGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEH 166
Query: 118 TFMGL--LDVDYIYLTGNLLTGTIPPWMLQKGDR--------VDLSYNSFTAGSSETSCQ 167
L + + L N L + + + +D+S N +T +
Sbjct: 167 ELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSN 226
Query: 168 YRSVNLFASSSKGNNSTGI 186
S + S ++ G
Sbjct: 227 AISKSQAFSLILAHHIMGA 245
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 28/181 (15%), Positives = 60/181 (33%), Gaps = 13/181 (7%)
Query: 1 MLVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVG-PIPSGIASLSKLTDLRIS 59
+ ++ D +S N + + + + L I + + L L ++
Sbjct: 379 FIPSIPDIFLSGNKLV----TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILN 434
Query: 60 DLNGTEAPFPPL-DKMKKMKTLILRSCN-----VSGKLPDYLGLMTSLKVLDVSFNKLNG 113
+ + ++ L L + D ++ L+VL ++ N LN
Sbjct: 435 QNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNS 494
Query: 114 AIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRV-DLSYNSFTAGSSETSCQYRSVN 172
P F L + + L N LT + L + D+S N A + + ++
Sbjct: 495 LPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLD 553
Query: 173 L 173
+
Sbjct: 554 I 554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 22/160 (13%), Positives = 47/160 (29%), Gaps = 7/160 (4%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTL--LEKLVIQASGLVGPIPSGI-ASLSKLTDLRI 58
+ ++ N + L + + + S + +L L L +
Sbjct: 239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS-LNSRVFETLKDLKVLNL 297
Query: 59 SDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPST 118
+ + + ++ L L + + + +D+ N + T
Sbjct: 298 AYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQT 357
Query: 119 FMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
F L + + L N LT TI + + LS N
Sbjct: 358 FKFLEKLQTLDLRDNALT-TIH--FIPSIPDIFLSGNKLV 394
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 25/124 (20%), Positives = 50/124 (40%), Gaps = 14/124 (11%)
Query: 43 IPSGIASLSKLTDL---RISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKL-PDYLGLM 98
+P + + +L L I + T + FP L ++++ L L S + + +
Sbjct: 19 VPQVLNTTERL-LLSFNYIRTV--TASSFPFL---EQLQLLELGSQYTPLTIDKEAFRNL 72
Query: 99 TSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLT-GTIPPWMLQKGDR---VDLSY 154
+L++LD+ +K+ P F GL + + L L+ + + +DLS
Sbjct: 73 PNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSK 132
Query: 155 NSFT 158
N
Sbjct: 133 NQIR 136
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 17/86 (19%), Positives = 31/86 (36%), Gaps = 11/86 (12%)
Query: 84 SCNVSGKLPD--YLGL------MTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLL 135
SC+ G++ + L + + + L +SFN + S+F L + + L
Sbjct: 1 SCSFDGRIAFYRFCNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60
Query: 136 TGTIPP---WMLQKGDRVDLSYNSFT 158
TI L +DL +
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSKIY 86
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 26/184 (14%), Positives = 54/184 (29%), Gaps = 29/184 (15%)
Query: 2 LVTLKDFRISDNHFTG-KIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD 60
L L +S N + L+ + ++ + + L T L
Sbjct: 122 LKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT-LSFFS 180
Query: 61 LNG----TEAPFPPLDKMKKMKTLILRSCNVSGKL-----------------PDYLGLMT 99
L + M + ++L +VSG L L
Sbjct: 181 LAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAH 240
Query: 100 SLKVLDVSFNKLNGAIPSTFMGL--LDVDYIYLTGNLLTGTIPPWMLQKGDRV---DLSY 154
+ F+ + +TF GL V ++ L+ + ++ + + + +L+Y
Sbjct: 241 HIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAY 299
Query: 155 NSFT 158
N
Sbjct: 300 NKIN 303
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 31/163 (19%), Positives = 55/163 (33%), Gaps = 7/163 (4%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRISD 60
+LK +S N + + LE L Q S L + SL L L IS
Sbjct: 77 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 135
Query: 61 LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDY-LGLMTSLKVLDVSFNKLNGAIPSTF 119
+ A + + ++ L + + + +L LD+S +L P+ F
Sbjct: 136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 195
Query: 120 MGLLDVDYIYLTGNLLTGTIPP---WMLQKGDRVDLSYNSFTA 159
L + + ++ N ++ L +D S N
Sbjct: 196 NSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMT 237
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 27/167 (16%), Positives = 53/167 (31%), Gaps = 19/167 (11%)
Query: 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGL-VGPIPSGI-ASLSKLTDL----- 56
+ + N T L KL + ++GL S + L L
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFN 88
Query: 57 RISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDY--LGLMTSLKVLDVSFNKLNGA 114
+ ++ L + L + N+ ++ ++ + +L LD+S A
Sbjct: 89 GVITMSSNFLGLEQL------EHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVA 141
Query: 115 IPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRV---DLSYNSFT 158
F GL ++ + + GN P + + + DLS
Sbjct: 142 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 29/137 (21%), Positives = 47/137 (34%), Gaps = 8/137 (5%)
Query: 2 LVTLKDFRISDNHFTGKIPNFI-QNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRIS 59
L L IS H N I + LE L + + I L LT L +S
Sbjct: 125 LRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 60 DLNG-TEAPFPPLDKMKKMKTLILRSCNVSGKLPDY-LGLMTSLKVLDVSFNKLNGAIPS 117
+ + + ++ L + N L + + SL+VLD S N + +
Sbjct: 184 Q-CQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 241
Query: 118 TFMGLLD-VDYIYLTGN 133
+ ++ LT N
Sbjct: 242 ELQHFPSSLAFLNLTQN 258
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 49/222 (22%), Positives = 87/222 (39%), Gaps = 52/222 (23%)
Query: 427 NKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK---QGNREFVNEIGMISALQHP----- 477
+ IG+G FG V K + + VA+K + +K Q E+ ++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMK 115
Query: 478 -NLVKLHGC-------CI--EGNQLLL---IYEYMENNSLARALFGPEAHRLKLDWPTRH 524
+V L C+ E +L +Y+ + N + F +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFE----MLSYNLYDLLRNTN-----FRG------VSLNLTR 160
Query: 525 RICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP--KISDFGLA-KLDEEDNTHI 581
+ + L +L L I+H D+K N+LL KI DFG + +L + +I
Sbjct: 161 KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 219
Query: 582 STRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGR 622
+R F Y +PE + Y D++S G + +E+ +G
Sbjct: 220 QSR----F-YRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGE 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 50/263 (19%), Positives = 90/263 (34%), Gaps = 82/263 (31%)
Query: 428 KIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-----HPNLVK 481
K+G G F V+ + VA+K + S ++EI ++ +++ PN
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPN--- 99
Query: 482 LHGCCI-----------EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGI 530
+ G + +++E + + L + + L L P +I +
Sbjct: 100 -REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPL--PCVKKIIQQV 155
Query: 531 ARGLAYLHEESRLKIVHRDIKATNVLL--------------------------------- 557
+GL YLH ++ +I+H DIK N+LL
Sbjct: 156 LQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 558 ----------------DKDLNPKISDFGLA-KLDEEDNTHISTRVAGTFGYMAPEYAMRG 600
+ L KI+D G A + + I TR Y + E +
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGS 268
Query: 601 YLTDKADVYSFGIVALEIVSGRS 623
AD++S +A E+ +G
Sbjct: 269 GYNTPADIWSTACMAFELATGDY 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 27/169 (15%), Positives = 57/169 (33%), Gaps = 5/169 (2%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRISD 60
L K ++ + ++ +E L + + I + A + L +
Sbjct: 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 108
Query: 61 LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYL-GLMTSLKVLDVSFNKLNGAIPSTF 119
P + + L+L ++S LP + L L +S N L TF
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 167
Query: 120 MGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQY 168
+ + L+ N LT + ++ ++SYN + + + +
Sbjct: 168 QATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEE 215
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 25/161 (15%), Positives = 48/161 (29%), Gaps = 6/161 (3%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRISD 60
D I + + + S + +P+ + S ++ L ++D
Sbjct: 26 DCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLND 84
Query: 61 LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM 120
L E ++ L + + P + L VL + N L+ F
Sbjct: 85 LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFH 144
Query: 121 GLLDVDYIYLTGNLLTGTIPPWMLQKGD---RVDLSYNSFT 158
+ + ++ N L I Q + LS N T
Sbjct: 145 NTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 184
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 15/119 (12%), Positives = 38/119 (31%), Gaps = 4/119 (3%)
Query: 43 IPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLK 102
I S + D+ I + K + ++ + L ++
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 103 VLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDR---VDLSYNSFT 158
+L+++ ++ F + +Y+ N + +PP + Q + L N +
Sbjct: 79 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 136
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 19/114 (16%), Positives = 46/114 (40%), Gaps = 5/114 (4%)
Query: 47 IASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDV 106
+++L+ + D + ++ L L+ N++ L L +D+
Sbjct: 204 LSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLT-DTAWLLNY-PGLVEVDL 261
Query: 107 SFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPP--WMLQKGDRVDLSYNSFT 158
S+N+L + F+ + ++ +Y++ N L + + +DLS+N
Sbjct: 262 SYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 26/158 (16%), Positives = 50/158 (31%), Gaps = 13/158 (8%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRISD 60
V L ++ N+ T N+ L ++ + + L I + +L L IS+
Sbjct: 231 NVELTILKLQHNNLT-DTAWL-LNYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISN 287
Query: 61 --LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPST 118
L P+ +K L L ++ + L+ L + N + ST
Sbjct: 288 NRLVALNLYGQPI---PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLST 343
Query: 119 FMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNS 156
L + L+ N + + R +
Sbjct: 344 HHTLK---NLTLSHNDWDCNSLRALFRNVARPAVDDAD 378
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 27/169 (15%), Positives = 57/169 (33%), Gaps = 5/169 (2%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRISD 60
L K ++ + ++ +E L + + I + A + L +
Sbjct: 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 102
Query: 61 LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYL-GLMTSLKVLDVSFNKLNGAIPSTF 119
P + + L+L ++S LP + L L +S N L TF
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 161
Query: 120 MGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQY 168
+ + L+ N LT + ++ ++SYN + + + +
Sbjct: 162 QATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEE 209
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 29/157 (18%), Positives = 62/157 (39%), Gaps = 8/157 (5%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
+ +++ S N L L +Q + L + + + L ++ +S
Sbjct: 204 PIAVEELDASHNSINVVRGPVNVE---LTILKLQHNNLTDT--AWLLNYPGLVEVDLSYN 258
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
+ + P KM++++ L + + + L Y + +LKVLD+S N L +
Sbjct: 259 ELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
++ +YL N + T+ + LS+N +
Sbjct: 317 FDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 25/161 (15%), Positives = 48/161 (29%), Gaps = 6/161 (3%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRISD 60
D I + + + S + +P+ + S ++ L ++D
Sbjct: 20 DCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLND 78
Query: 61 LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM 120
L E ++ L + + P + L VL + N L+ F
Sbjct: 79 LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFH 138
Query: 121 GLLDVDYIYLTGNLLTGTIPPWMLQKGD---RVDLSYNSFT 158
+ + ++ N L I Q + LS N T
Sbjct: 139 NTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 15/119 (12%), Positives = 38/119 (31%), Gaps = 4/119 (3%)
Query: 43 IPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLK 102
I S + D+ I + K + ++ + L ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 103 VLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDR---VDLSYNSFT 158
+L+++ ++ F + +Y+ N + +PP + Q + L N +
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 25/136 (18%), Positives = 47/136 (34%), Gaps = 13/136 (9%)
Query: 1 MLVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRIS 59
+ V L ++ N+ T N+ L ++ + + L I + +L L IS
Sbjct: 224 VNVELTILKLQHNNLT-DTAWL-LNYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYIS 280
Query: 60 D--LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPS 117
+ L P+ +K L L ++ + L+ L + N + S
Sbjct: 281 NNRLVALNLYGQPI---PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLS 336
Query: 118 TFMGLLDVDYIYLTGN 133
T L + L+ N
Sbjct: 337 THHTL---KNLTLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 27/179 (15%), Positives = 62/179 (34%), Gaps = 32/179 (17%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L +S+N+ + Q T L+ L + ++ L + + + L +S
Sbjct: 140 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANVSYN 196
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPD-------YLGL-------------MTSL 101
+ L ++ L +++ + L L L
Sbjct: 197 LLST-----LAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLTDTAWLLNYPGL 250
Query: 102 KVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPP--WMLQKGDRVDLSYNSFT 158
+D+S+N+L + F+ + ++ +Y++ N L + + +DLS+N
Sbjct: 251 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 32/159 (20%), Positives = 53/159 (33%), Gaps = 26/159 (16%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L L +N +P+ + L + L LT L +S+
Sbjct: 236 LPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDL-------PELPQSLTFLDVSEN 287
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
+ P + L S + L D L SL+ L+VS NKL +P+
Sbjct: 288 IFSGLSELP----PNLYYLNASSNEIR-SLCD---LPPSLEELNVSNNKLI-ELPALPPR 338
Query: 122 LLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFT 158
L + + N L +P L++ + + YN
Sbjct: 339 LE---RLIASFNHLA-EVPELPQNLKQ---LHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 30/169 (17%), Positives = 60/169 (35%), Gaps = 24/169 (14%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L++ ++ T ++P +N + S P G ++ R+ D
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 62 NGTEA-----------PFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNK 110
+A P L +++L+ SCN +LP+ + SL V + +
Sbjct: 69 LDRQAHELELNNLGLSSLPEL--PPHLESLVA-SCNSLTELPELPQSLKSLLVDNNNLKA 125
Query: 111 LNGAIPSTFMGLLDVDYIYLTGNLLTGTIPP-WMLQKGDRVDLSYNSFT 158
L+ P ++Y+ ++ N L +P +D+ NS
Sbjct: 126 LSDLPPL-------LEYLGVSNNQLE-KLPELQNSSFLKIIDVDNNSLK 166
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 31/159 (19%), Positives = 64/159 (40%), Gaps = 22/159 (13%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
LK + +N K+P+ + LE + + L +P + +L LT + +
Sbjct: 152 SSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLEE-LPE-LQNLPFLTAIYADNN 205
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
+ + P D +++++ + + +LP+ L + L + N L +P
Sbjct: 206 SLKKLP----DLPLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLPPS 258
Query: 122 LLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFT 158
L + + + N LT +P L +D+S N F+
Sbjct: 259 L---EALNVRDNYLT-DLPELPQSLTF---LDVSENIFS 290
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 22/135 (16%), Positives = 48/135 (35%), Gaps = 17/135 (12%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L+ S NH ++P QN L++L ++ + L P S+ L +
Sbjct: 336 PPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FPDIPESVEDLR----MNS 386
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
+ E P + + +K L + N + PD + S++ L ++ ++
Sbjct: 387 HLAEVP----ELPQNLKQLHV-ETNPLREFPD---IPESVEDLRMNSERVVDPYEFAHET 438
Query: 122 LLDVDYIYLTGNLLT 136
++ +
Sbjct: 439 TDKLEDDVFEHHHHH 453
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 33/171 (19%), Positives = 63/171 (36%), Gaps = 21/171 (12%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
KIG GGFG +Y A + + ++ F +E+ + + +K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF-SELKFYQRVAKKDCIKKWIER 102
Query: 487 IEGNQL---------LLIYEYMENNSLARALFGPEAHRL-----KLDWPTRHRICVGIAR 532
+ + L L ++ + G + ++ T ++ + +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLD 162
Query: 533 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI--SDFGLAKLDEEDNTHI 581
L Y+HE VH DIKA N+LL ++ +D+GL+ + H
Sbjct: 163 VLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 32/163 (19%), Positives = 68/163 (41%), Gaps = 9/163 (5%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRISD 60
L +L + DN T + + L +L ++ + + IPS + L L + +
Sbjct: 122 LASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGE 180
Query: 61 LNG-TEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTF 119
L + + +K L L CN+ +P+ L L+ L++S N P +F
Sbjct: 181 LKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPL-VGLEELEMSGNHFPEIRPGSF 238
Query: 120 MGLLDVDYIYLTGNLLTGTIPPWM---LQKGDRVDLSYNSFTA 159
GL + +++ + ++ I L ++L++N+ ++
Sbjct: 239 HGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSS 280
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 2e-08
Identities = 83/584 (14%), Positives = 159/584 (27%), Gaps = 167/584 (28%)
Query: 119 FMG-LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASS 177
F+ +L ++Y +L + T P M+ + Y + Y +F
Sbjct: 82 FVEEVLRINYKFLMSPIKTEQRQPSMMTR------MYIE------QRDRLYNDNQVF--- 126
Query: 178 SKGNNS-----TGIVSCLRSFRCPKTYYSVHINCG----GKQVTVNGNTTFEDDTDEAGP 228
+K N S + L R P + G GK +
Sbjct: 127 AKYNVSRLQPYLKLRQALLELR-PAKNVLID---GVLGSGKTWVAL--DVCLSYKVQ--- 177
Query: 229 SRFAFRGSNNWAFSNTGHFLDDDRPADTYIQTNT------SILLMNDSHSFG-------- 274
+ F+ W N + + P HS
Sbjct: 178 CKMDFKIF--WL--NLKN---CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 275 ----RRIFD--VYIQGKLVLKDFNIEDEAGGIGKAIVKQF----PVVVINSTIEIRLYWA 324
RR+ Y LVL + +++ F +++ ++ + +
Sbjct: 231 QAELRRLLKSKPYENCLLVLLN--VQN------AKAWNAFNLSCKILLTTRFKQVTDFLS 282
Query: 325 GKGTTGVPVRGVYGP---------LISAISLNPDFIPPSENGSSSSISAGTVVGIVAATT 375
TT + + L+ + P +P ++ + I+A
Sbjct: 283 AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP-----RRLSIIAE-- 335
Query: 376 FVIILLVGI-LW--WK--GCFRPEHTLEQELRGVDLHTGSFTLRQ------IKAATNNFA 424
+ G+ W WK C + +E L ++ R+ + F
Sbjct: 336 ---SIRDGLATWDNWKHVNCDKLTTIIESSLNVLE----PAEYRKMFDRLSV------FP 382
Query: 425 PDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKS--KQGNREFVNEIGMI---SALQHPNL 479
P I ++ + +V V +L S ++ +E I I ++ N
Sbjct: 383 PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENE 442
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLD----WPTRHRICVGIARGLA 535
LH ++ Y ++ + + LD H +
Sbjct: 443 YALHRSIVD--------HY----NIPKTFDSDDLIPPYLDQYFYS---H---------IG 478
Query: 536 YLHEESRLKIVHRDIKAT---NVLLDKD-LNPKISDFGLAKLDEEDNTHISTRVAGTFGY 591
+ H LK + + T V LD L KI A + ++
Sbjct: 479 H-H----LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLK----- 528
Query: 592 MAPEYAMRGYLTDKADVYSFGIVALE--IVSGRSNSSCKPKEDI 633
Y + Y+ D Y + A+ + N C D+
Sbjct: 529 ---FY--KPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDL 567
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 1e-06
Identities = 73/523 (13%), Positives = 133/523 (25%), Gaps = 196/523 (37%)
Query: 267 MNDSHSFGRRIFDVYIQGKLVLKDFN---IEDEAGGI-GKAIVKQFPVVVINSTIE--IR 320
+ + I V+ + +F+ ++D I K + +++ + +R
Sbjct: 11 TGEHQYQYKDILSVFEDA--FVDNFDCKDVQDMPKSILSKEEIDH--IIMSKDAVSGTLR 66
Query: 321 LYWA--GKGTTGVP--VRGV----YGPLISAISLNPDFIPPSEN------------GSSS 360
L+W K V V V Y L+S I PS +
Sbjct: 67 LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQ--RQPSMMTRMYIEQRDRLYNDNQ 124
Query: 361 SISAGTVVGIVAATTFVIILLVGILWWKGCFRPEHTLE-----QELR---GVDLHTGSFT 412
+ V R + L+ ELR V +
Sbjct: 125 VFAKYNVS-----------------------RLQPYLKLRQALLELRPAKNVLID----- 156
Query: 413 LRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREF-------- 464
G G G K T VA+ S Q +F
Sbjct: 157 -----------------GVLGSG---K------TWVALDVCLSYKVQCKMDFKIFWLNLK 190
Query: 465 -VNE----IGMISALQH---PNLVKL--HGCCIEGNQLLLIYE---YMENNSLARALFGP 511
N + M+ L + PN H I+ + E +++ L
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL--- 247
Query: 512 EAHRLKLD--WPTRH--------RICV-----GIARGLAYLHEESRLKIVHRD------- 549
L L + +I + + L+ + + + H
Sbjct: 248 ----LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT-THISLDHHSMTLTPDE 302
Query: 550 -----IKATNVLLDKDL-------NP-KISDFGLAKLDEEDNT-----HI-----STRVA 586
+K + DL NP ++S + + T H+ +T +
Sbjct: 303 VKSLLLKYLDCRPQ-DLPREVLTTNPRRLSIIA-ESIRDGLATWDNWKHVNCDKLTTIIE 360
Query: 587 GTFGYMAPEYAMRGYLTDKA----DV------------YSFGIVALEIVSGRSNSS---C 627
+ + P R + + +V+ S
Sbjct: 361 SSLNVLEPAE-YRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEK 419
Query: 628 KPKEDIFYLLDWALILKAQGNLM-----ELVDK-RLGSNFDKE 664
+PKE + L LK + +VD + FD +
Sbjct: 420 QPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD 462
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 3e-04
Identities = 64/484 (13%), Positives = 129/484 (26%), Gaps = 140/484 (28%)
Query: 385 LWWKGCFRPEHTLEQ-------------------ELRGVDLHTGSF-------------- 411
L+W + E +++ E R + T +
Sbjct: 67 LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVF 126
Query: 412 ---------TLRQIKAATNNFAPDNKI---GEGGFGPVYKGHMADGTVVAVKQLSSKSKQ 459
+++ A P + G G G K T VA+ S Q
Sbjct: 127 AKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---K------TWVALDVCLSYKVQ 177
Query: 460 GNREF---------VNE----IGMISALQH---PNLVKL--HGCCIEGNQLLLIYE---Y 498
+F N + M+ L + PN H I+ + E
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237
Query: 499 MENNSLARALFGPEAHRLKLD--WPTRH--------RICV-----GIARGLAYLHEESRL 543
+++ L L L + +I + + L+ + +
Sbjct: 238 LKSKPYENCL-------LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAAT-TTHI 289
Query: 544 KIVHRDI----KATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 599
+ H + LL K L+ + D L E T + R +
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQD-----LPREVLT-TNPRRLSIIAESIRDGLAT 343
Query: 600 --GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657
+ D L + S + +P E + + ++ ++ +
Sbjct: 344 WDNWKHVNCD-------KLTTIIESSLNVLEPAEYRKMFDRLS-VFPPSAHIPTILLSLI 395
Query: 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQDFVPDSSVVSNIDKTK 717
+ K VMV++N S + S +S+ + + V +
Sbjct: 396 WFDVIKSDVMVVVN---KLHKYSLVEKQPKESTISIP----SIYL---ELKVKLENEYAL 445
Query: 718 SEAIRNYYEFSEEQSMDGCQTQSMSIDG---PYTG------SSTSAADLYP-INLDSDYL 767
+I ++Y + D +D + G L+ + LD +L
Sbjct: 446 HRSIVDHYNIPKTFDSDDLIPP--YLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFL 503
Query: 768 NSRV 771
++
Sbjct: 504 EQKI 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 28/151 (18%), Positives = 47/151 (31%), Gaps = 22/151 (14%)
Query: 2 LVTLKDFRISDNHFT--GKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRIS 59
+L+ +S NH K + L L I + P+P K+ L +S
Sbjct: 360 WPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLS 418
Query: 60 DLNGTEAPFPPLDK-----------------MKKMKTLILRSCNVSGKLPDYLGLMTSLK 102
+ +++ L + + LPD L L
Sbjct: 419 STGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDA-SLFPVLL 476
Query: 103 VLDVSFNKLNGAIPSTFMGLLDVDYIYLTGN 133
V+ +S N+L F L + I+L N
Sbjct: 477 VMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 16/119 (13%), Positives = 38/119 (31%), Gaps = 4/119 (3%)
Query: 44 PSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKV 103
+ + + L L + + ++ L L ++S + G ++SLK
Sbjct: 43 HGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKY 102
Query: 104 LDVSFNKLNG-AIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDR---VDLSYNSFT 158
L++ N + S F L ++ + + I +++ S
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 23/138 (16%), Positives = 53/138 (38%), Gaps = 2/138 (1%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVG-PIPSGIASLSKLTDLRISD 60
L +L+ +SDNH + ++ + L+ L + + + S +L+ L LRI +
Sbjct: 73 LGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGN 132
Query: 61 LNG-TEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTF 119
+ +E + + L +++ ++ L + + L + ++ +
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA 192
Query: 120 MGLLDVDYIYLTGNLLTG 137
L V Y+ L L
Sbjct: 193 DILSSVRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 24/137 (17%), Positives = 47/137 (34%), Gaps = 2/137 (1%)
Query: 2 LVTLKDFRISDNHFTG-KIPNFIQNWTLLEKLVIQASGLVGPIPSG-IASLSKLTDLRIS 59
L +LK + N + + + N T L+ L I I A L+ L +L I
Sbjct: 97 LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156
Query: 60 DLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTF 119
L+ L ++ + L L + L + +++S++ L++ L S
Sbjct: 157 ALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPL 216
Query: 120 MGLLDVDYIYLTGNLLT 136
+ +
Sbjct: 217 PVDEVSSPMKKLAFRGS 233
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 27/164 (16%), Positives = 55/164 (33%), Gaps = 23/164 (14%)
Query: 2 LVTLKDFRISDNHFTG--KIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRIS 59
+ + ++D F K+ +I + +E +GL PS +S+L +
Sbjct: 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV 286
Query: 60 DLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTF 119
+ + L + + L L+ +K + V +K+ S
Sbjct: 287 TI----------------RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFS 330
Query: 120 MGLLDVDYIYLTGNLLTGTIPPWMLQKGD-----RVDLSYNSFT 158
L ++++ L+ NL+ KG + LS N
Sbjct: 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 15/84 (17%), Positives = 35/84 (41%), Gaps = 4/84 (4%)
Query: 78 KTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTG 137
K+L L ++ L +L+VL + +++N F L ++++ L+ N L+
Sbjct: 29 KSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS- 87
Query: 138 TIPPWMLQKGD---RVDLSYNSFT 158
++ ++L N +
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQ 111
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 31/163 (19%), Positives = 63/163 (38%), Gaps = 7/163 (4%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIAS-LSKLTDLRISD 60
L L ++ + F + ++ + SG + S +S L S+
Sbjct: 275 LKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGT-RMVHMLCPSKISPFLHLDFSN 333
Query: 61 LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGL---MTSLKVLDVSFNKLNGAIPS 117
T+ F + +++TLIL+ + +L + M SL+ LD+S N ++
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
Query: 118 -TFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTA 159
+ + ++ N+LT TI + + +DL N +
Sbjct: 393 GDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKS 435
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 27/173 (15%), Positives = 59/173 (34%), Gaps = 12/173 (6%)
Query: 2 LVTLKDFRISDNHFTGKIP--NFIQNWTLLEKLVIQ--ASGLVGPIPSGI-ASLSKLTDL 56
T+ F IS+ G++ +F + T L+ L I S + G S I S +
Sbjct: 246 HTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIK 305
Query: 57 RISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIP 116
+ K+ L + ++ + + G +T L+ L + N+L +
Sbjct: 306 NFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELS 364
Query: 117 ST---FMGLLDVDYIYLTGNLLTGTIPPWM---LQKGDRVDLSYNSFTAGSSE 163
+ + + ++ N ++ + +++S N T
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR 417
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 32/157 (20%), Positives = 53/157 (33%), Gaps = 26/157 (16%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGL--VGPIPSGIASLSKLTDLRIS 59
+ S+N T + + T LE L++Q + L + I + L L IS
Sbjct: 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDIS 382
Query: 60 DLNGTEAPFPP--LDKMKKMKTLILRSC----NVSGKLPD---YLGL------------- 97
N K + +L + S + LP L L
Sbjct: 383 Q-NSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVV 441
Query: 98 -MTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGN 133
+ +L+ L+V+ N+L F L + I+L N
Sbjct: 442 KLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 37/218 (16%), Positives = 67/218 (30%), Gaps = 10/218 (4%)
Query: 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRISDLN 62
IS N+ + + I + + L L+I + + + + +L L +S
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSHNK 80
Query: 63 GTEAPFPPLDKMKKMKTLILRSCN--VSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM 120
+ +K L L S N + + G M+ LK L +S L +
Sbjct: 81 LVKISC---HPTVNLKHLDL-SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 121 GLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKG 180
L + + G P LQ + L T SV A+
Sbjct: 137 HLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEF-HFILDVSVKTVANLE-L 194
Query: 181 NNSTGIVSCLRSFRCPKTYYSVHINCGGKQVTVNGNTT 218
+N ++ + + N +T+N T
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIET 232
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 30/160 (18%), Positives = 59/160 (36%), Gaps = 13/160 (8%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
+K+ +S N + + +T LE L + ++ L + + SLS L L +++
Sbjct: 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
E L ++TL + N+S ++ K + ++ NK+
Sbjct: 91 YVQE-----LLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGC 142
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRV---DLSYNSFT 158
V Y+ L N + + D + +L YN
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 17/113 (15%), Positives = 41/113 (36%), Gaps = 7/113 (6%)
Query: 47 IASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDV 106
+ ++ +++D + +A +K L L +S L T L++L++
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 107 SFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPP-WMLQKGDRVDLSYNSFT 158
S N L L + + L N + + ++ + + N+ +
Sbjct: 66 SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVGPSIET---LHAANNNIS 112
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 25/140 (17%), Positives = 53/140 (37%), Gaps = 8/140 (5%)
Query: 19 IPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMK 78
I QN + + S L + S S + +L +S ++ L K++
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 79 TLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGT 138
L L S + D L +++L+ LD++ N + + ++ ++ N ++
Sbjct: 62 LLNLSSNVLYE-TLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113
Query: 139 IPPWMLQKGDRVDLSYNSFT 158
+ Q + L+ N T
Sbjct: 114 VSCSRGQGKKNIYLANNKIT 133
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 19/159 (11%), Positives = 41/159 (25%), Gaps = 6/159 (3%)
Query: 2 LVTLKDFRISDNHFTG-KIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD 60
++ + N + LE L +Q + + + + +KL L +S
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSS 200
Query: 61 LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLN-GAIPSTF 119
P + + LR+ + + L +L+ D+ N + G + F
Sbjct: 201 NKLAFMG-PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258
Query: 120 MGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
V +
Sbjct: 259 SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 53/238 (22%), Positives = 85/238 (35%), Gaps = 72/238 (30%)
Query: 428 KIGEGGFGPVYKG--HMADGTVVAVKQLSSKSK---QGNREFVNEIGMISALQHP----- 477
+GEG FG V + H + VA+K + + K EI ++ ++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENK 81
Query: 478 -NLVKLHGC-------CI--EGNQLLL---IYEYMENNSLARALFGPEAHRLKLDWPTRH 524
V + CI E LL +E+++ N+ F P RH
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFE----LLGKNTFEFLKENN-----FQPYPLPH-----VRH 127
Query: 525 RICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP-------------------KI 565
+ + L +LHE ++ H D+K N+L ++
Sbjct: 128 -MAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 566 SDFGLAKLDEED-NTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSG 621
+DFG A D E T ++TR Y PE + G+ DV+S G + E G
Sbjct: 184 ADFGSATFDHEHHTTIVATRH-----YRPPEVILELGWAQ-PCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 57/245 (23%), Positives = 90/245 (36%), Gaps = 86/245 (35%)
Query: 428 KIGEGGFGPVYKG--HMADGTVVAVKQLSSKSK---QGNREFVNEIGMISALQHP----- 477
+GEG FG V + H A G VAVK + + + +EI ++ L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76
Query: 478 -NLVKLHGC-------CI--EGNQLLL---IYEYMENNSLARALFGPEAHRLKLDWPTRH 524
V++ CI E LL Y++++ N F P + H
Sbjct: 77 FRCVQMLEWFEHHGHICIVFE----LLGLSTYDFIKENG-----FLP--------FRLDH 119
Query: 525 --RICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP------------------- 563
++ I + + +LH K+ H D+K N+L +
Sbjct: 120 IRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 564 KISDFGLAKLDEED-NTHISTRVAGTFGYMAPE------YAMRGYLTDKADVYSFGIVAL 616
K+ DFG A D+E +T +STR Y APE ++ DV+S G + +
Sbjct: 177 KVVDFGSATYDDEHHSTLVSTRH-----YRAPEVILALGWSQ------PCDVWSIGCILI 225
Query: 617 EIVSG 621
E G
Sbjct: 226 EYYLG 230
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 33/164 (20%), Positives = 59/164 (35%), Gaps = 10/164 (6%)
Query: 2 LVTLKDFRISDNHFTGKIP-NFIQNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRIS 59
L LK + DN I LE+L ++ L IP+ + L L LR+
Sbjct: 127 LYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLR 184
Query: 60 DLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPS-T 118
LN ++ ++K L + + +L L ++ L A+P
Sbjct: 185 HLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLA 243
Query: 119 FMGLLDVDYIYLTGNLLTGTIPPWM---LQKGDRVDLSYNSFTA 159
L+ + ++ L+ N ++ TI M L + + L
Sbjct: 244 VRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAV 286
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 30/159 (18%), Positives = 57/159 (35%), Gaps = 4/159 (2%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L L R+ + + L+ L I + + LT L I+
Sbjct: 175 LHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
N T P+ + + ++ L L +S L + L+ + + +L P F G
Sbjct: 235 NLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRG 294
Query: 122 LLDVDYIYLTGNLLTGTIPPWM---LQKGDRVDLSYNSF 157
L + + ++GN LT T+ + + + + L N
Sbjct: 295 LNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 28/151 (18%), Positives = 56/151 (37%), Gaps = 7/151 (4%)
Query: 11 SDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPP 70
F +P I T L + + + AS L +L +++ +
Sbjct: 19 HRKRFV-AVPEGIPTET--RLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGA 75
Query: 71 LDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYL 130
+ + ++TL LRS + +++L LD+S NK+ + F L ++ + +
Sbjct: 76 FNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135
Query: 131 TGNLLTGTIPP---WMLQKGDRVDLSYNSFT 158
N L I L +++ L + T
Sbjct: 136 GDNDLV-YISHRAFSGLNSLEQLTLEKCNLT 165
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 36/161 (22%), Positives = 63/161 (39%), Gaps = 9/161 (5%)
Query: 2 LVTLKDFRISDNHFTGKIPNFI-QNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRIS 59
L LK+ + +N IP++ L +L + + I G LS L L ++
Sbjct: 135 LSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193
Query: 60 DLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTF 119
N E P L + K+ L L ++S P + L+ L + +++ + F
Sbjct: 194 MCNLRE--IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAF 251
Query: 120 MGLLDVDYIYLTGNLLTGTIPPWMLQKGD---RVDLSYNSF 157
L + I L N LT +P + R+ L +N +
Sbjct: 252 DNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 29/158 (18%), Positives = 62/158 (39%), Gaps = 12/158 (7%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L L + DN T + +N T + +L + + L +++++ L ++ DL
Sbjct: 62 LNNLIGLELKDNQIT-DLAPL-KNLTKITELELSGNPL-----KNVSAIAGLQSIKTLDL 114
Query: 62 NGTEAP-FPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM 120
T+ PL + ++ L L ++ + L +T+L+ L + +++ P
Sbjct: 115 TSTQITDVTPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP--LA 170
Query: 121 GLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
L + + N ++ P L V L N +
Sbjct: 171 NLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 30/157 (19%), Positives = 59/157 (37%), Gaps = 10/157 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L + + +S N + ++ L + ++ + P +A LS L L +
Sbjct: 84 LTKITELELSGNPLK-NVSAI-AGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLN 139
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
T PL + ++ L + + VS L L ++ L L NK++ I
Sbjct: 140 QITN--ISPLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISD-ISP-LAS 193
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
L ++ ++L N ++ P V L+ + T
Sbjct: 194 LPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 20/114 (17%), Positives = 40/114 (35%), Gaps = 6/114 (5%)
Query: 45 SGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVL 104
+L+ + N T+ + + TL V+ + + + +L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGL 68
Query: 105 DVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
++ N++ P L + + L+GN L LQ +DL+ T
Sbjct: 69 ELKDNQITDLAP--LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT 120
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 27/130 (20%), Positives = 47/130 (36%), Gaps = 9/130 (6%)
Query: 29 LEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVS 88
V A + L+ LT L + + T+ ++K+ + LI S N++
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT 77
Query: 89 GKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGD 148
L L T+L L NKL + L + Y+ N LT +
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVSQNPLLT 130
Query: 149 RVDLSYNSFT 158
++ + N+ T
Sbjct: 131 YLNCARNTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 35/157 (22%), Positives = 54/157 (34%), Gaps = 15/157 (9%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L + N T +I + + T L +L + + + + ++LT L S
Sbjct: 126 NPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFN 180
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
TE K + L + N++ KL L L LD S NKL I T
Sbjct: 181 KITELDVSQN---KLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EIDVT--P 231
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158
L + Y + N LT + L K +
Sbjct: 232 LTQLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 17/158 (10%), Positives = 45/158 (28%), Gaps = 16/158 (10%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L L F S N T ++ + + L L + L+ I + ++L +
Sbjct: 232 LTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLE-ID--LTHNTQLIYFQAEGC 285
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
+ ++ L ++ ++ +L L L L ++ +L +
Sbjct: 286 RKI--KELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSH 337
Query: 122 LLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFT 158
+ + + + + +
Sbjct: 338 NTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTI 374
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 39/208 (18%), Positives = 70/208 (33%), Gaps = 55/208 (26%)
Query: 5 LKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLT--DLRISDLN 62
L I N T +P L++L + + L +P+ + L KL + +++ L
Sbjct: 123 LCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSL- 176
Query: 63 GTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLG-----------------LMTSLKVLD 105
P L ++ L + ++ LP L + LK L
Sbjct: 177 ------PML--PSGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELI 227
Query: 106 VSFNKLNGAIPSTFMGL--LDVDY---------------IYLTGNLLTGTIPPWM--LQK 146
VS N+L ++P L L V + + N LT +P + L
Sbjct: 228 VSGNRLT-SLPVLPSELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSS 285
Query: 147 GDRVDLSYNSFTAGSSETSCQYRSVNLF 174
V+L N + + + + S +
Sbjct: 286 ETTVNLEGNPLSERTLQALREITSAPGY 313
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 27/119 (22%), Positives = 48/119 (40%), Gaps = 20/119 (16%)
Query: 43 IPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLK 102
+P + + +T L I D N T P +++TL + ++ LP + L
Sbjct: 55 LPDCL--PAHITTLVIPDNNLTSLP----ALPPELRTLEVSGNQLT-SLPVLPPGLLELS 107
Query: 103 VLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTA 159
+ L A+PS L ++ GN LT ++P LQ+ + +S N +
Sbjct: 108 IFSNPLTHLP-ALPSGLCKL------WIFGNQLT-SLPVLPPGLQE---LSVSDNQLAS 155
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 30/164 (18%), Positives = 56/164 (34%), Gaps = 9/164 (5%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRISD 60
L + N LLE+L + + + + L +L L +
Sbjct: 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR 114
Query: 61 LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYL--GLMTSLKVLDVSFNKLNGAIPST 118
E + ++ L L+ + LPD L +L L + N+++
Sbjct: 115 CGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDL-GNLTHLFLHGNRISSVPERA 172
Query: 119 FMGLLDVDYIYLTGNLLTGTIPP---WMLQKGDRVDLSYNSFTA 159
F GL +D + L N + + P L + + L N+ +A
Sbjct: 173 FRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSA 215
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 54/249 (21%), Positives = 89/249 (35%), Gaps = 90/249 (36%)
Query: 428 KIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK---QGNREFVNEIGMISALQH-----PN 478
K+G+G FG V + + AVK + + K E ++ +Q+ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97
Query: 479 LVKLHGC-------CI--EGNQLLL---IYEYMENNSLARALFGPEAHRLKLDWPTRH-- 524
+VK HG C+ E L +YE + N+ + +
Sbjct: 98 IVKYHGKFMYYDHMCLIFE----PLGPSLYEIITRNN-----YNG--------FHIEDIK 140
Query: 525 RICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP--------------------- 563
C+ I + L YL + + + H D+K N+LLD
Sbjct: 141 LYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 564 ----KISDFGLAKLDEED-NTHISTRVAGTFGYMAPE------YAMRGYLTDKADVYSFG 612
K+ DFG A + + I+TR Y APE + + +D++SFG
Sbjct: 198 STGIKLIDFGCATFKSDYHGSIINTR----Q-YRAPEVILNLGWDV------SSDMWSFG 246
Query: 613 IVALEIVSG 621
V E+ +G
Sbjct: 247 CVLAELYTG 255
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 54/327 (16%), Positives = 106/327 (32%), Gaps = 27/327 (8%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDL----- 56
L + ++ N T I + N L L + + + + S + L KL L
Sbjct: 64 LPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKD-L-SSLKDLKKLKSLSLEHN 119
Query: 57 RISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIP 116
ISD+N L + ++++L L + ++ L +T L L + N+++
Sbjct: 120 GISDIN-------GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-- 168
Query: 117 STFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFAS 176
GL + +YL+ N ++ L+ D ++L NL
Sbjct: 169 VPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECL-----NKPINHQSNLVVP 223
Query: 177 SS-KGNNSTGIVSCLRSFRCPKTYYSVHINCGGKQVTVNGNTTFEDDTDEAGPSRFAFRG 235
++ K + + + + S +V + V+ ++ T +RF R
Sbjct: 224 NTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVS-FIFYQPVTIGKAKARFHGRV 282
Query: 236 SNNWAFSNTGHFLDDDRPADTYIQTNTSILLMNDSHSFGRRIFDVYIQGKLVLKDFNIED 295
+ T + D T ++ T I G Y + + D
Sbjct: 283 TQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTD 342
Query: 296 EAGGIGKAIVKQFPVVVINSTIEIRLY 322
G + F T+ + Y
Sbjct: 343 YMSGNDFTLYAVFKAETTEKTVNLTRY 369
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 29/160 (18%), Positives = 64/160 (40%), Gaps = 25/160 (15%)
Query: 1 MLVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISD 60
++ + +++ + + +P+ + + L I + L+ +P ASL L D
Sbjct: 57 LINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPASL---EYLDACD 109
Query: 61 LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM 120
+ P + +K L + + ++ LP+ L L+ ++ N+L +P
Sbjct: 110 NRLSTLP----ELPASLKHLDVDNNQLT-MLPE---LPALLEYINADNNQLT-MLPELPT 160
Query: 121 GLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFT 158
L + + + N LT +P L+ +D+S N
Sbjct: 161 SL---EVLSVRNNQLT-FLPELPESLEA---LDVSTNLLE 193
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 20/188 (10%), Positives = 47/188 (25%), Gaps = 38/188 (20%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
+LK + +N T +P LE + + L +P + L L + +
Sbjct: 119 PASLKHLDVDNNQLT-MLPELPAL---LEYINADNNQLTM-LP---ELPTSLEVLSVRNN 170
Query: 62 NGTEAPFPPLDKMKKMKTLILRSC----------------------NVSG----KLPDYL 95
T P + + ++ L + + +P+ +
Sbjct: 171 QLTFLP----ELPESLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRITHIPENI 226
Query: 96 GLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYN 155
+ + + N L+ I + + + + D
Sbjct: 227 LSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTA 286
Query: 156 SFTAGSSE 163
F
Sbjct: 287 WFPENKQS 294
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 29/165 (17%), Positives = 50/165 (30%), Gaps = 10/165 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFI-QNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRIS 59
L+ IS N I + N L ++ I+ + + I +L L L IS
Sbjct: 53 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS 112
Query: 60 DLNG-TEAPFPPLDKMKKMKTLILRSCNVSGKLPDYL--GLMTSLKVLDVSFNKLNGAIP 116
+ G P + L ++ + GL +L ++ N +
Sbjct: 113 N-TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHN 171
Query: 117 STFMGLLDVDYIYLTGNLLTGTIPP---WMLQKGDRVDLSYNSFT 158
S F G + N L +P +D+S
Sbjct: 172 SAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH 215
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 2e-05
Identities = 23/139 (16%), Positives = 45/139 (32%), Gaps = 10/139 (7%)
Query: 54 TDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDY-LGLMTSLKVLDVSFNKLN 112
+ LR + ++ L + + L + + L L + L+ L + + L
Sbjct: 11 SGLRCTRDGALDSL-HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 113 GAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQ--KGDRVDLSYNSFTAGSSETSCQYRS 170
P F + + L+ N L ++ +Q + LS N SC R
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHC-----SCALRW 123
Query: 171 VNLFASSSKGNNSTGIVSC 189
+ + G + C
Sbjct: 124 LQRWEEEGLGGVPEQKLQC 142
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 36/206 (17%), Positives = 67/206 (32%), Gaps = 20/206 (9%)
Query: 2 LVTLKDFRISDNHFTGKIPN--FIQNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRI 58
L L+ ++ I N F + + L L + + + + +G L+ L L +
Sbjct: 53 LQDLQFLKVEQQTPGLVIRNNTF-RGLSSLIILKLDYNQFLQ-LETGAFNGLANLEVLTL 110
Query: 59 SD--LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYL-GLMTSLKVLDVSFNKLNGAI 115
+ L+G + ++ L+LR N+ P M VLD++FNK+
Sbjct: 111 TQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSIC 170
Query: 116 PSTFMGL--LDVDYIYLTGNLLTGTIP----------PWMLQKGDRVDLSYNSFTAGSSE 163
+ + L+ L P+ +DLS N F ++
Sbjct: 171 EEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAK 230
Query: 164 TSCQYRSVNLFASSSKGNNSTGIVSC 189
+ S N+ S
Sbjct: 231 RFFDAIAGTKIQSLILSNSYNMGSSF 256
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 32/121 (26%), Positives = 52/121 (42%), Gaps = 8/121 (6%)
Query: 43 IPSGI-ASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSL 101
++LT L + T+ + + TL L + LP + +L
Sbjct: 46 FSLATLMPYTRLTQLNLDRAELTK--LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPAL 102
Query: 102 KVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM---LQKGDRVDLSYNSFT 158
VLDVSFN+L GL ++ +YL GN L T+PP + K +++ L+ N+ T
Sbjct: 103 TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT 161
Query: 159 A 159
Sbjct: 162 E 162
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 25/172 (14%), Positives = 56/172 (32%), Gaps = 17/172 (9%)
Query: 2 LVTLKDFRISDNHFTGKIPN-FIQNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRIS 59
L +L + N + + T L+ L + I A L+ L +L I
Sbjct: 123 LSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182
Query: 60 DLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNG----AI 115
+ L ++ + LIL L ++ + +S++ L++ L+ +
Sbjct: 183 ASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSEL 242
Query: 116 PS----TFMGLLDVDYIYLTGNLLTGTIPPWM----LQKGDRVDLSYNSFTA 159
+ + + + +T L + L ++ S N +
Sbjct: 243 STGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLL---ELEFSRNQLKS 291
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 24/167 (14%), Positives = 53/167 (31%), Gaps = 17/167 (10%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRISD 60
L L++ I + P +++ + L++ + + S + L + D
Sbjct: 173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLELRD 231
Query: 61 LNGTEAP--------FPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLN 112
+ L K + + + + ++ L ++ L L+ S N+L
Sbjct: 232 TDLDTFHFSELSTGETNSLIKKFTFRNVKI-TDESLFQVMKLLNQISGLLELEFSRNQLK 290
Query: 113 GAIPSTFMGLLDVDYIYLTGNLLT---GTIPP---WMLQKGDRVDLS 153
F L + I+L N I W+ + + S
Sbjct: 291 SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGS 337
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 35/162 (21%), Positives = 59/162 (36%), Gaps = 17/162 (10%)
Query: 5 LKDFRISDNHFTGKIPNFI-QNWTLLEKLVIQASGL-VGPIPSGIASLSKLTDLRISDLN 62
L + RI DN K+P + + + + + L G KL LRIS+
Sbjct: 125 LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183
Query: 63 GTEAPFPPLDKMKKMKTLILRSCNVSGKLPDY-LGLMTSLKVLDVSFNKLNGAIPSTFMG 121
T P D + + L L + + L + L L + N++ +
Sbjct: 184 LTG---IPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSF 239
Query: 122 LLDVDYIYLTGNLLTGTIPPW-----MLQKGDRVDLSYNSFT 158
L + ++L N L+ +P +LQ V L N+ T
Sbjct: 240 LPTLRELHLDNNKLS-RVPAGLPDLKLLQV---VYLHTNNIT 277
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 8e-05
Identities = 20/108 (18%), Positives = 46/108 (42%), Gaps = 8/108 (7%)
Query: 6 KDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTE 65
+ ++ T + + ++ L+ L + + L +P +A+L L L+ SD N E
Sbjct: 444 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASD-NALE 499
Query: 66 APFPPLDKMKKMKTLILRSCNVSGKLPD--YLGLMTSLKVLDVSFNKL 111
+ + +++ L+L + + + L L +L++ N L
Sbjct: 500 N-VDGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 29/188 (15%), Positives = 67/188 (35%), Gaps = 41/188 (21%)
Query: 2 LVTLKDFRISDNHFTGKIPNFI-QNWTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRIS 59
LV L+ +S N ++P + + L++L + + + + + L+++ + +
Sbjct: 99 LVKLERLYLSKNQLK-ELPEKMPKT---LQELRVHENEITK-VRKSVFNGLNQMIVVELG 153
Query: 60 DLNGTEAPFPP--LDKMKKMKTLILRSCNVSGKLPDYL--GL------------------ 97
+ MKK+ + + N++ +P L L
Sbjct: 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASL 212
Query: 98 --MTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPW-----MLQKGDRV 150
+ +L L +SFN ++ + + ++L N L +P +Q V
Sbjct: 213 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV---V 268
Query: 151 DLSYNSFT 158
L N+ +
Sbjct: 269 YLHNNNIS 276
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 21/126 (16%), Positives = 51/126 (40%), Gaps = 19/126 (15%)
Query: 43 IPSGI-ASLSKLTDL---RISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYL--G 96
+P + + + L DL +S L ++ + +L+L +++ +
Sbjct: 33 VPQSLPSYTALL-DLSHNNLSRLRAEWT----PTRLTNLHSLLLSHNHLN-FISSEAFVP 86
Query: 97 LMTSLKVLDVSFNKLNGAIPS-TFMGLLDVDYIYLTGNLLTGTIPPWM---LQKGDRVDL 152
+ +L+ LD+S N L+ + F L ++ + L N + + + + ++ L
Sbjct: 87 V-PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYL 143
Query: 153 SYNSFT 158
S N +
Sbjct: 144 SQNQIS 149
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 28/140 (20%), Positives = 55/140 (39%), Gaps = 18/140 (12%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDL----- 56
L LK + N + I + + LE L + + + + ++ L+KL L
Sbjct: 111 LKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDN 166
Query: 57 RISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIP 116
+ISD+ PL + K++ L L ++S L + +L VL++ +
Sbjct: 167 QISDI-------VPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPI 217
Query: 117 STFMGLLDVDYIYLTGNLLT 136
+ L+ + + T L
Sbjct: 218 NHQSNLVVPNTVKNTDGSLV 237
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 8e-04
Identities = 21/107 (19%), Positives = 37/107 (34%), Gaps = 4/107 (3%)
Query: 29 LEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTE-APFPPLDKMKKMKTLILRSCNV 87
+++LV+ S + +L L K+ K+K L L V
Sbjct: 19 VKELVLDNSRS--NEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRV 76
Query: 88 SGKLPDYLGLMTSLKVLDVSFNKLNG-AIPSTFMGLLDVDYIYLTGN 133
SG L +L L++S NK+ + L ++ + L
Sbjct: 77 SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 771 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.91 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.9 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.9 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.9 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.89 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.89 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.88 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.88 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.86 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.86 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.85 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.85 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.85 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.85 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.85 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.84 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.84 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.84 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.84 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.84 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.84 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.84 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.84 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.84 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.84 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.84 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.83 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.83 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.82 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.82 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.82 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.82 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.81 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.81 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.81 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.81 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.81 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.81 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.81 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.81 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.81 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.81 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.8 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.8 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.8 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.8 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.8 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.79 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.79 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.79 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.79 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.78 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.78 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.78 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.78 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.78 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.78 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.77 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.76 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.76 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.76 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.75 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.75 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.75 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.75 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.75 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.74 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.73 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.72 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.72 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.72 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.72 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.71 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.71 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.71 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.71 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.7 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.7 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.7 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.7 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.68 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.68 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.67 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.66 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.66 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.64 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.63 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.62 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.6 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.58 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.55 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.54 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.54 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.54 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.53 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.52 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.5 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.41 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.4 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.35 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.29 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.08 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.06 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.06 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.01 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.96 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.96 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.95 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.83 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.78 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.73 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.67 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.52 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.5 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.49 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.47 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.43 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.4 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.38 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.37 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.15 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.9 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.9 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.8 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.78 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.74 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 97.72 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.62 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.52 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.48 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.44 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.42 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.41 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.39 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.39 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.33 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.24 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.17 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.13 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.96 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.9 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.85 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.74 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.71 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.68 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.62 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.62 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.4 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.28 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.78 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.32 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 87.76 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.24 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.72 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-54 Score=455.22 Aligned_cols=259 Identities=27% Similarity=0.457 Sum_probs=214.2
Q ss_pred cCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
++|.+.++||+|+||+||+|.+. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46778899999999999999653 478899999988777778899999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCC---------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEE
Q 004155 495 IYEYMENNSLARALFGPE---------AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 565 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 565 (771)
|||||++|+|.++|+... .....++|.++++|+.|||.||+|||++ +||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999996432 2345799999999999999999999998 8999999999999999999999
Q ss_pred EeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHH
Q 004155 566 SDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALIL 643 (771)
Q Consensus 566 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 643 (771)
+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||......+... ..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~---~i--- 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE---CI--- 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH---HH---
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HH---
Confidence 999999866543322 2334569999999999999999999999999999999999 899997654332211 11
Q ss_pred HhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 644 KAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 644 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
..+. ....+...+.++.+++.+||+.||++||||+||+++|+++.
T Consensus 244 -~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 244 -TQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp -HHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111 11223334556889999999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=457.09 Aligned_cols=261 Identities=27% Similarity=0.422 Sum_probs=209.3
Q ss_pred cCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
++|.+.++||+|+||.||+|.+. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35667789999999999999753 478999999988777778899999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCc-----------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCe
Q 004155 495 IYEYMENNSLARALFGPEA-----------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 563 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 563 (771)
|||||++|+|.++++.... ...+++|.++++|+.|||.||+|||+. +||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999965432 234699999999999999999999998 89999999999999999999
Q ss_pred EEEeecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHH
Q 004155 564 KISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWAL 641 (771)
Q Consensus 564 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 641 (771)
||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||......+... .+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~---~i- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID---CI- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH---HH-
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH---HH-
Confidence 9999999986654332 23345679999999999999999999999999999999999 899997654322211 11
Q ss_pred HHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 642 ILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 642 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
..+ .....+...+.++.+++.+||+.||++||||+||+++|+.+.+.
T Consensus 274 ---~~g---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 ---TQG---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ---HHT---------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---HcC---------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111 11122333445688999999999999999999999999886544
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-53 Score=450.53 Aligned_cols=258 Identities=28% Similarity=0.417 Sum_probs=211.8
Q ss_pred CCCCCCccccCCceeEEEEEc------CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
++++.++||+|+||+||+|.+ .+++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 345678999999999999975 356899999997643 3346789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCc------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC
Q 004155 495 IYEYMENNSLARALFGPEA------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 562 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 562 (771)
|||||++|+|.++|+.... ....++|.++++|+.|||+||+|||++ +||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 9999999999999965321 134699999999999999999999998 8999999999999999999
Q ss_pred eEEEeecCccccCCCC-cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHH
Q 004155 563 PKISDFGLAKLDEEDN-THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWA 640 (771)
Q Consensus 563 ~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~ 640 (771)
+||+|||+|+...... ........||+.|||||++.++.++.++|||||||++|||+| |+.||......+.. ..
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~---~~- 259 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV---EM- 259 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH---HH-
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH---HH-
Confidence 9999999998664432 223345679999999999999999999999999999999999 89999765433221 11
Q ss_pred HHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 641 LILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 641 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
+........+...+..+.+++.+||+.||++||||+||++.|+...
T Consensus 260 ------------i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 260 ------------IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp ------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ------------HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1111112223344567889999999999999999999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=440.27 Aligned_cols=257 Identities=28% Similarity=0.444 Sum_probs=202.1
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
+++.+.++||+|+||+||+|.+. ..||||+++.. .....+.|.+|+.++++++|||||+++|+|.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 45677899999999999999875 36999998753 34456789999999999999999999998864 568999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
|++|+|.++|+.. ...++|.++++|+.|||.||+|||++ +||||||||+||||++++.+||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 113 CEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred CCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999543 24699999999999999999999998 89999999999999999999999999998765432
Q ss_pred -cccccccccCCCccchhhhcc---CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 579 -THISTRVAGTFGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 579 -~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
........||+.|||||++.+ +.++.++|||||||++|||+||+.||.......... .....+. ..
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~------~~~~~~~----~~ 256 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII------FMVGRGY----AS 256 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHTTC----CC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH------HHHhcCC----CC
Confidence 223345689999999999964 468999999999999999999999997544322111 0111110 01
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
+.+ ...+...+..+.+++.+||+.||++||||.||++.|+.+
T Consensus 257 p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 257 PDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp CCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred CCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 112233455688999999999999999999999988764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=440.29 Aligned_cols=250 Identities=22% Similarity=0.387 Sum_probs=202.4
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
++|++.++||+|+||+||+|. ..+|+.||||++... .....+.+.+|+.++++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 689999999999999999994 567999999999754 33446789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
||+||+|.++|.... ...+++.+++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999995322 34678999999999999999999998 8999999999999999999999999999876432
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
. ......+||+.|||||++.+..++.++|||||||++|||+||++||......+... .+.....
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~---------------~i~~~~~ 242 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL---------------KIISGSF 242 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---------------HHHHTCC
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---------------HHHcCCC
Confidence 2 12334679999999999999999999999999999999999999997654322211 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...+......+.+|+.+||+.||++|||+.|+++
T Consensus 243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112223346889999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=438.17 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=208.2
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
+.|+..++||+|+||.||+|. ..+|+.||||++........+.+.+|+.+|++++|||||+++++|.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 468889999999999999994 5679999999997655555567899999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++|+|.+++. ...+++.++..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.......
T Consensus 154 ~gg~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 9999999993 24699999999999999999999998 899999999999999999999999999997755433
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
. ....+||+.|||||++.+..|+.++|||||||++|||++|++||......+....+ . .+ ..+.+
T Consensus 226 ~-~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i------~-~~-----~~~~~-- 290 (346)
T 4fih_A 226 R-RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI------R-DN-----LPPRL-- 290 (346)
T ss_dssp C-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------H-HS-----SCCCC--
T ss_pred c-ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH------H-cC-----CCCCC--
Confidence 2 34568999999999999999999999999999999999999999764432221111 0 00 00111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.........+.+|+.+||+.||++|||+.|+++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111123346889999999999999999999976
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=435.76 Aligned_cols=263 Identities=28% Similarity=0.370 Sum_probs=200.3
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC----EEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGN----QLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 496 (771)
++|.+.++||+|+||+||+|.+ +|+.||||+++.... ....+..|+..+.+++|||||+++++|.+++ ..||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4567788999999999999987 589999999965322 1223344566667889999999999998654 689999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhc-----CCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE-----SRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
|||++|+|.++|+ ..+++|..+.+|+.|++.||+|||++ +.++|+||||||+|||++.++++||+|||+|
T Consensus 81 Ey~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999994 34689999999999999999999986 2458999999999999999999999999999
Q ss_pred cccCCCCccc---ccccccCCCccchhhhccC------CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhh-------
Q 004155 572 KLDEEDNTHI---STRVAGTFGYMAPEYAMRG------YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY------- 635 (771)
Q Consensus 572 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~------- 635 (771)
+......... .....||+.|||||++.+. .++.++|||||||++|||+||++|+..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 8765443321 2345799999999999754 46789999999999999999988775432211000
Q ss_pred -HHHHHHHHHhhCChhHHhhhhcCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 636 -LLDWALILKAQGNLMELVDKRLGSNF-----DKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 636 -~~~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
....... .+.+..+.... +.+....+.+++.+||+.||++||||.||+++|+++.
T Consensus 236 ~~~~~~~~--------~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 236 PSVEEMRK--------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCHHHHHH--------HHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred chHHHHHH--------HHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 0000000 11122222222 2345678899999999999999999999999998754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=428.36 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=207.1
Q ss_pred cCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||+||+| +..+|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46899999999999999999 4567999999999753 2234578999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
|||+||+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999993 335799999999999999999999998 899999999999999999999999999997754
Q ss_pred CCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 577 DNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 577 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
... ......+||+.|||||++.+..++.++||||+||++|||+||++||......+... .+...
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~---------------~i~~~ 249 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA---------------KIIKL 249 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------HHHHT
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---------------HHHcC
Confidence 332 23445789999999999999999999999999999999999999997644322211 11111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVV 691 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 691 (771)
.. .++.....++.+++.+||+.||++|||+.|++
T Consensus 250 ~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 250 EY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11 11222234578999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=422.31 Aligned_cols=246 Identities=27% Similarity=0.406 Sum_probs=195.8
Q ss_pred CCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe----CCEEEEEE
Q 004155 424 APDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIE----GNQLLLIY 496 (771)
Q Consensus 424 ~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 496 (771)
+..++||+|+||+||+|. ..+++.||+|++... .....+.|.+|++++++++|||||+++++|.+ .+.+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 456789999999999994 557899999998653 34446789999999999999999999999875 34689999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc-CCCCeEEEeecCccccC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDE 575 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFGla~~~~ 575 (771)
|||++|+|.+++. ....+++..+..|+.||+.||+|||++. ++|+||||||+|||++ .++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999994 3457999999999999999999999982 2499999999999997 47999999999998644
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.. .....+||+.|||||++.+ .++.++|||||||++|||+||+.||........ +.. . ...+.....+
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~---~-i~~~~~~~~~-- 251 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR---R-VTSGVKPASF-- 251 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH---H-HTTTCCCGGG--
T ss_pred CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHH---H-HHcCCCCCCC--
Confidence 32 2345679999999998865 689999999999999999999999965332211 111 0 1111100011
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+.....++.+++.+||+.||++|||+.|+++
T Consensus 252 ------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 252 ------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112235788999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=431.29 Aligned_cols=251 Identities=23% Similarity=0.258 Sum_probs=203.7
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
+.|...++||+|+||.||+|. ..+|+.||||+++.... ..+|+.++++++|||||++++++.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 467788899999999999995 56799999999975422 246999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC-CeEEEeecCccccCCCC
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLDEEDN 578 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFGla~~~~~~~ 578 (771)
+||+|.++|. ....+++..+..++.||+.||+|||++ +||||||||+||||+.++ ++||+|||+|+......
T Consensus 133 ~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIK----QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999994 335799999999999999999999998 899999999999999987 69999999999765432
Q ss_pred cc----cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 579 TH----ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 579 ~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
.. .....+||+.|||||++.+..++.++|||||||++|||+||++||...........+. ......
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~-----~~~~~~----- 275 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA-----SEPPPI----- 275 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH-----HSCCGG-----
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH-----cCCCCc-----
Confidence 21 1233579999999999999999999999999999999999999998655443321110 000000
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
..+ +......+.+++.+||+.||++|||+.|+++.|...
T Consensus 276 ~~~----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 276 REI----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp GGS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhc----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 011 222334588899999999999999999999887653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=439.63 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=208.9
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
+.|+..++||+|+||.||+|. ..+|+.||||++........+.+.+|+.+|++++|||||+++++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 568999999999999999994 5679999999997665555667899999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
+||+|.+++. ...+++.++..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.......
T Consensus 231 ~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 9999999993 34699999999999999999999998 899999999999999999999999999987654433
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
. ....+||+.|||||++.+..|+.++|||||||++|||++|++||......+....+ . .+ ..+.+
T Consensus 303 ~-~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i------~-~~-----~~~~~-- 367 (423)
T 4fie_A 303 R-RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI------R-DN-----LPPRL-- 367 (423)
T ss_dssp C-BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------H-HS-----CCCCC--
T ss_pred c-ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH------H-cC-----CCCCC--
Confidence 2 34568999999999999999999999999999999999999999754432221111 0 00 00111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.........+.+|+.+||+.||++|||+.|+++
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111122345789999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=414.41 Aligned_cols=245 Identities=26% Similarity=0.382 Sum_probs=190.4
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||+||+|. ..+|+.||||++.+.. ......+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 689999999999999999995 4579999999997542 233567999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+ +|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 679999984 345799999999999999999999998 899999999999999999999999999986654
Q ss_pred CCcccccccccCCCccchhhhccCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
... .....||+.|||||++.+..+ +.++||||+||++|||+||+.||......... . . +...
T Consensus 165 ~~~--~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~---~---~---------i~~~ 227 (275)
T 3hyh_A 165 GNF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF---K---N---------ISNG 227 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---H---------HHHT
T ss_pred CCc--cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH---H---H---------HHcC
Confidence 322 234679999999999988765 68999999999999999999999754322211 1 0 1111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. ..++......+.+++.+||+.||++|||+.|+++
T Consensus 228 ~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 228 V--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 1112222345788999999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=434.61 Aligned_cols=266 Identities=25% Similarity=0.354 Sum_probs=214.2
Q ss_pred HHHHHHhcCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCC-CcEEeEEEE
Q 004155 414 RQIKAATNNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQH-PNLVKLHGC 485 (771)
Q Consensus 414 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~ 485 (771)
++.+...++|++.++||+|+||.||+|.+. .++.||||+++... ....+.|.+|+.+|.+++| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 333444578999999999999999999642 24689999997653 3446789999999999965 899999999
Q ss_pred EEeC-CEEEEEEEeccCCCHHHHhcCCCc------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCC
Q 004155 486 CIEG-NQLLLIYEYMENNSLARALFGPEA------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKA 552 (771)
Q Consensus 486 ~~~~-~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp 552 (771)
|.+. +..++|||||++|+|.++|+.... ....++|.+++.|+.|||+||+|||++ +||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCc
Confidence 9764 568999999999999999965322 134689999999999999999999998 899999999
Q ss_pred CcEEEcCCCCeEEEeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCc
Q 004155 553 TNVLLDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPK 630 (771)
Q Consensus 553 ~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~ 630 (771)
+|||+++++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999976544332 2345679999999999999999999999999999999998 9999976443
Q ss_pred cchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 631 EDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.+.. . ..+........+.....++.+++.+||+.||++|||++||++.|+.+
T Consensus 294 ~~~~--~-------------~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 294 DEEF--C-------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp SHHH--H-------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH--H-------------HHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 3211 1 11111111222233345688999999999999999999999998764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=419.75 Aligned_cols=242 Identities=24% Similarity=0.349 Sum_probs=193.4
Q ss_pred cCCCCCCccccCCceeEEEEEc----CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM----ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
++|++.+.||+|+||+||+|.. .+++.||||+++... ......+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5789999999999999999953 347899999997542 2234468899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
|||||+||+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999993 345799999999999999999999998 8999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
..... ......||+.|||||++.+..++.++||||+||++|||+||++||......+.... +..
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~---------------i~~ 240 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM---------------ILK 240 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---------------HHH
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHH---------------HHc
Confidence 43332 23346799999999999999999999999999999999999999976543322111 111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSM 687 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 687 (771)
... .++.....++.+++.+||+.||++|||+
T Consensus 241 ~~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 241 AKL--GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred CCC--CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 111 1222233457899999999999999995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=404.24 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=187.9
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC--------
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGN-------- 490 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 490 (771)
++|++.+.||+|+||.||+|. ..+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 468899999999999999995 5679999999997543 334567999999999999999999999987543
Q ss_pred ----EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEE
Q 004155 491 ----QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 566 (771)
Q Consensus 491 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 566 (771)
+.|+|||||++|+|.+++..... ....++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 47999999999999999965432 22456777899999999999999998 89999999999999999999999
Q ss_pred eecCccccCCCCcc-----------cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhh
Q 004155 567 DFGLAKLDEEDNTH-----------ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY 635 (771)
Q Consensus 567 DFGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~ 635 (771)
|||+|+........ ..+..+||+.|||||++.+..++.++|||||||++|||++ ||... .+...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHH
Confidence 99999876543221 1233579999999999999999999999999999999996 66421 11100
Q ss_pred HHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 636 LLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. . ........... ........+++.+||+.||++|||+.|+++
T Consensus 236 ~~---~-~~~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TL---T-DVRNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH---H-HHHTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH---H-HHhcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0 00111111111 122334678999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=404.64 Aligned_cols=293 Identities=45% Similarity=0.767 Sum_probs=251.9
Q ss_pred cCCCCHHHHHHHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEE
Q 004155 408 TGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCC 486 (771)
Q Consensus 408 ~~~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~ 486 (771)
...|+++++..++++|++.+.||+|+||.||+|...+|+.||||++..... .....+.+|+.++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456899999999999999999999999999999888899999999976432 2234689999999999999999999999
Q ss_pred EeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEE
Q 004155 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 566 (771)
Q Consensus 487 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 566 (771)
.+.+..++||||+++|+|.+++.........+++..+..|+.|++.||+|||+.+.++|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998766666679999999999999999999999866689999999999999999999999
Q ss_pred eecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCC--CccchhhHHHHHHHHH
Q 004155 567 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCK--PKEDIFYLLDWALILK 644 (771)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~--~~~~~~~~~~~~~~~~ 644 (771)
|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||... .........+|.....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 99999977655555555567999999999999889999999999999999999999999631 1122233455555555
Q ss_pred hhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 645 AQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 645 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
.......+.+..+......+....+.+++.+||+.||++|||+.||+++|++....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 56666677777777778888999999999999999999999999999999985433
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=405.00 Aligned_cols=287 Identities=43% Similarity=0.738 Sum_probs=249.9
Q ss_pred CCHHHHHHHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC
Q 004155 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGN 490 (771)
Q Consensus 411 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 490 (771)
+++.++..++++|+..+.||+|+||.||+|...+|+.||||++........+.+.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44555666889999999999999999999998889999999988766666788999999999999999999999999999
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..++||||+++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999976554455799999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCC-cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCCh
Q 004155 571 AKLDEEDN-THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL 649 (771)
Q Consensus 571 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (771)
++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+......|.......+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98654322 22234456899999999999999999999999999999999999999876666666667776666666667
Q ss_pred hHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 650 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
...+++.+......+....+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 777777776677788899999999999999999999999999999876543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=403.93 Aligned_cols=271 Identities=19% Similarity=0.268 Sum_probs=205.0
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe------CC
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIE------GN 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 490 (771)
.++|++.+.||+|+||+||+|. ..+|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 3679999999999999999994 5679999999997542 3345678899999999999999999999764 36
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..|+|||||+ |+|.+++.. ...+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 7899999996 689999943 35799999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCC---cccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh-
Q 004155 571 AKLDEEDN---THISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA- 645 (771)
Q Consensus 571 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~- 645 (771)
|+...... .......+||+.|||||++.+. .++.++||||+||++|||++|++||......+....+........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98664322 2223456899999999998875 679999999999999999999999976544333222111000000
Q ss_pred -------hCChhHHhhhhcC-CCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCCC
Q 004155 646 -------QGNLMELVDKRLG-SNFDK-----EQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGRA 698 (771)
Q Consensus 646 -------~~~~~~~~d~~l~-~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~ 698 (771)
.......+..... ...+. .....+.+|+.+||+.||++|||+.|+++ .+++..
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 0000111110000 00010 11245789999999999999999999987 455543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=394.73 Aligned_cols=202 Identities=26% Similarity=0.416 Sum_probs=173.1
Q ss_pred HHHHhcCCCCCCccccCCceeEEEEEc----CCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCC
Q 004155 416 IKAATNNFAPDNKIGEGGFGPVYKGHM----ADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGN 490 (771)
Q Consensus 416 l~~~~~~f~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 490 (771)
+....++|++.++||+|+||+||+|.. ..++.||||++.... ...++.+|+++|+.+ +||||+++++++.+.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 334568899999999999999999953 346889999986543 345688999999998 6999999999999999
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC-CCeEEEeec
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFG 569 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG 569 (771)
+.|+||||+++|+|.+++ ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 94 ~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp EEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 999999999999999999 2589999999999999999999998 89999999999999877 799999999
Q ss_pred CccccCCCCcc---------------------------cccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhC
Q 004155 570 LAKLDEEDNTH---------------------------ISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSG 621 (771)
Q Consensus 570 la~~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG 621 (771)
+|+........ .....+||+.|+|||++.+. .++.++||||+||++|||+||
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99865432211 11235799999999999875 589999999999999999999
Q ss_pred CCCCCCCC
Q 004155 622 RSNSSCKP 629 (771)
Q Consensus 622 ~~p~~~~~ 629 (771)
+.||....
T Consensus 244 ~~Pf~~~~ 251 (361)
T 4f9c_A 244 RYPFYKAS 251 (361)
T ss_dssp CSSSSCCS
T ss_pred CCCCCCCC
Confidence 99996543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=414.08 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=209.0
Q ss_pred hcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
.++|++.+.||+|+||.||+| ...+|+.||+|++........+.+.+|+.+|+.++|||||+++++|.+.+..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999 4567999999999876666677899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC--CCeEEEeecCccccCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD--LNPKISDFGLAKLDEE 576 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFGla~~~~~ 576 (771)
|+||+|.++|... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 236 ~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 9999999999432 34699999999999999999999998 89999999999999854 8999999999997755
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
... ....+||+.|||||++.+..++.++||||+||++|||++|++||......+....+ ....... ...
T Consensus 310 ~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i-----~~~~~~~----~~~ 378 (573)
T 3uto_A 310 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-----KSCDWNM----DDS 378 (573)
T ss_dssp TSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-----HTTCCCC----CSG
T ss_pred CCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-----HhCCCCC----Ccc
Confidence 432 23457999999999999999999999999999999999999999765433221111 0000000 000
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.... ....+.+|+.+||+.||++||++.|+++
T Consensus 379 ~~~~----~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 AFSG----ISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111 2345788999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=409.68 Aligned_cols=248 Identities=25% Similarity=0.299 Sum_probs=199.1
Q ss_pred cCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCC---hhcHHHH---HHHHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKS---KQGNREF---VNEIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
++|++.++||+|+||.||+| ...+|+.||||++.+.. ......+ ..++.+++.++|||||+++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57999999999999999999 45679999999996431 1222233 34466777889999999999999999999
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+|||||+||+|.++|. ....+++..+..++.||+.||+|||++ +||||||||+||||+.+|++||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999993 345799999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 574 DEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 574 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
...... ...+||+.|||||++.+ ..++.++||||+||++|||++|++||......+...+... +
T Consensus 342 ~~~~~~---~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~------------i 406 (689)
T 3v5w_A 342 FSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM------------T 406 (689)
T ss_dssp CSSCCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH------------H
T ss_pred cCCCCC---CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh------------h
Confidence 654332 34679999999999975 5799999999999999999999999975433332211110 1
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPS-----MSSVVS 692 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 692 (771)
.... ..++......+.+|+.+||+.||.+|++ +.||++
T Consensus 407 ~~~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 407 LTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHCC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred cCCC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1111 1122223345789999999999999998 577754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=369.31 Aligned_cols=250 Identities=25% Similarity=0.449 Sum_probs=208.8
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
.++|++.++||+|+||.||+|. ..+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 4689999999999999999995 467899999999766555677899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++|+|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999993 23689999999999999999999998 89999999999999999999999999998765443
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........... ..... ...
T Consensus 171 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------~~~~~--------~~~ 235 (297)
T 3fxz_A 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATNG--------TPE 235 (297)
T ss_dssp CC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHHHC--------SCC
T ss_pred cc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCC--------CCC
Confidence 32 2345799999999999999999999999999999999999999975433221111 00000 000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...+......+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1112223446889999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=374.05 Aligned_cols=259 Identities=28% Similarity=0.466 Sum_probs=212.9
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
.++|.+.++||+|+||.||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35688899999999999999954 56899999999777777788899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++|+|.+++... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999532 34699999999999999999999998 89999999999999999999999999998764432
Q ss_pred ccc-------------ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh
Q 004155 579 THI-------------STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA 645 (771)
Q Consensus 579 ~~~-------------~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 645 (771)
... .....||+.|+|||++.+..++.++|||||||++|||++|..|+..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~---------- 232 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF---------- 232 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----------
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----------
Confidence 211 114579999999999999999999999999999999999999987543322110
Q ss_pred hCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 646 QGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 646 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
........+....... ...+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 233 GLNVRGFLDRYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp SBCHHHHHHHTCCTTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhhhccccccCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0011122222222222 234788999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=365.06 Aligned_cols=282 Identities=38% Similarity=0.628 Sum_probs=232.1
Q ss_pred cCCCCHHHHHHHhcCCCCC------CccccCCceeEEEEEcCCCcEEEEEEcccC----ChhcHHHHHHHHHHHHcCCCC
Q 004155 408 TGSFTLRQIKAATNNFAPD------NKIGEGGFGPVYKGHMADGTVVAVKQLSSK----SKQGNREFVNEIGMISALQHP 477 (771)
Q Consensus 408 ~~~~~~~~l~~~~~~f~~~------~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~h~ 477 (771)
...|++.++..++++|... ++||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4579999999999999888 8999999999999987 6889999998653 233467899999999999999
Q ss_pred cEEeEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE
Q 004155 478 NLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL 557 (771)
Q Consensus 478 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 557 (771)
||+++++++.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+. +|+||||||+||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 99999999999999999999999999999996432 234699999999999999999999998 89999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhH
Q 004155 558 DKDLNPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYL 636 (771)
Q Consensus 558 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~ 636 (771)
+.++.+||+|||+++....... .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||..........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~- 244 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL- 244 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT-
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH-
Confidence 9999999999999986654322 22334579999999998865 57899999999999999999999997654332211
Q ss_pred HHHHHHHH-hhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 637 LDWALILK-AQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 637 ~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
.+..... ....+.+.+++.+ ..........+.+++.+||+.||.+||++.+|++.|+++.
T Consensus 245 -~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 245 -DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp -HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred -HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1111111 2233445555544 3456677888999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=368.00 Aligned_cols=263 Identities=26% Similarity=0.407 Sum_probs=215.5
Q ss_pred ccCCCCHHHHHHHhcC----------CCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCChhcHHHHHHHHHHHHcCC
Q 004155 407 HTGSFTLRQIKAATNN----------FAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSKQGNREFVNEIGMISALQ 475 (771)
Q Consensus 407 ~~~~~~~~~l~~~~~~----------f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~ 475 (771)
..+.+++++++.+++. |...++||+|+||.||+|... +|+.||||++........+.+.+|+.++++++
T Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 100 (321)
T 2c30_A 21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100 (321)
T ss_dssp ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence 3456899999998875 667789999999999999654 79999999998766666778999999999999
Q ss_pred CCcEEeEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcE
Q 004155 476 HPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNV 555 (771)
Q Consensus 476 h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NI 555 (771)
||||+++++++...+..++||||+++++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI 172 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI 172 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence 9999999999999999999999999999999983 24699999999999999999999998 899999999999
Q ss_pred EEcCCCCeEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhh
Q 004155 556 LLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY 635 (771)
Q Consensus 556 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~ 635 (771)
+++.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~-- 249 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-- 249 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--
T ss_pred EECCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 9999999999999999876543322 2345799999999999999999999999999999999999999975432211
Q ss_pred HHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 636 LLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
... ... . ..+.+ .........+.+++.+||+.||++||++.|+++
T Consensus 250 -~~~---~~~-~-----~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 250 -MKR---LRD-S-----PPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp -HHH---HHH-S-----SCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHH---Hhc-C-----CCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 000 0 00011 011122345788999999999999999999987
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=374.42 Aligned_cols=266 Identities=29% Similarity=0.440 Sum_probs=206.0
Q ss_pred HHHHHHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE
Q 004155 414 RQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 414 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 491 (771)
.++....++|++.+.||+|+||.||+|.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 33444567889999999999999999976 68999999987643 3445678999999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCc--eeccCCCCCcEEEcCCCCeEEEeec
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK--IVHRDIKATNVLLDKDLNPKISDFG 569 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DFG 569 (771)
.++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg 184 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFG 184 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred eEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCC
Confidence 9999999999999999954321 12489999999999999999999998 6 9999999999999999999999999
Q ss_pred CccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCCh
Q 004155 570 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL 649 (771)
Q Consensus 570 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (771)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... .
T Consensus 185 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~------~----- 252 (309)
T 3p86_A 185 LSRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV------G----- 252 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH------H-----
T ss_pred CCcccccccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------H-----
Confidence 9986543321 223457999999999999999999999999999999999999999754432221100 0
Q ss_pred hHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 650 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
........+......+.+++.+||+.||++||++.|+++.|+.....
T Consensus 253 ----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 253 ----FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ----HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ----hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00011122223345688999999999999999999999999886543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=361.91 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=211.4
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5788899999999999999988788999999997643 345679999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 89 HGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999543 34689999999999999999999998 8999999999999999999999999999876544333
Q ss_pred cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.... +......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~----------------~~~~~~~ 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----------------ISTGFRL 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----------------HHTTCCC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH----------------HhcCccC
Confidence 3334557788999999999999999999999999999999 9999975443221110 1111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
..+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 11222344688999999999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=376.33 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=212.4
Q ss_pred hcCCCCCCccccCCceeEEEEEc--------CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeC
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM--------ADGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEG 489 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~--------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 489 (771)
.++|.+.+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+.+++++ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 36788899999999999999954 245689999997653 33456899999999999 899999999999999
Q ss_pred CEEEEEEEeccCCCHHHHhcCCCc------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE
Q 004155 490 NQLLLIYEYMENNSLARALFGPEA------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL 557 (771)
Q Consensus 490 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 557 (771)
+..++||||+++|+|.+++..... ....+++.+++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999964321 124589999999999999999999998 89999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhh
Q 004155 558 DKDLNPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFY 635 (771)
Q Consensus 558 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~ 635 (771)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986654332 12233457889999999999999999999999999999999 999997654433221
Q ss_pred HHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 636 LLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
.+........+......+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 317 ----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 317 ----------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp ----------------HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111111222334456889999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=360.77 Aligned_cols=263 Identities=26% Similarity=0.350 Sum_probs=207.8
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
.++|++.+.||+|+||.||+|. ..+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 4678999999999999999995 457899999998543 233456789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++++|.+++. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999993 234699999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
...........||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .... ....... ..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~-~~~~~~~-~~ 234 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHI-QDSVPNV-TT 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHH-SSCCCCH-HH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHh-hccCCCc-ch
Confidence 54433344567999999999999999999999999999999999999999754322110 0000 1111110 11
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhcCCCCCC
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRP-SMSSVVSMLEGRADVQ 701 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~~~ 701 (771)
..... .+..+.+++.+|++.||++|| ++.++.+.|+......
T Consensus 235 ~~~~~----~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 235 DVRKD----IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp HSCTT----SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred hcccC----CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 11122 234688999999999999999 9999999999876544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=361.01 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=213.4
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.++|++.+.||+|+||.||+|...++..||+|+++... ...+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 46788899999999999999988888899999997643 34567999999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999432 34699999999999999999999998 899999999999999999999999999987665544
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......... .. .....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~----------~~~~~ 223 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL------KV----------SQGHR 223 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------HH----------HTTCC
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH------HH----------HcCCC
Confidence 33344557778999999998889999999999999999999 999997543322111 00 00001
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
...+......+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 111112234688999999999999999999999999987554
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=372.79 Aligned_cols=258 Identities=28% Similarity=0.433 Sum_probs=209.3
Q ss_pred cCCCCCCccccCCceeEEEEEcC----CCcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA----DGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
++|++.+.||+|+||.||+|... .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56788899999999999999653 4557999999765 344567899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++|+|.+++... ...+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 129 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 129 TEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999543 24699999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcc--cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 576 EDNTH--ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 576 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+... .
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~----------------~ 266 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS----------------S 266 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH----------------H
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHH----------------H
Confidence 43322 2223346778999999999999999999999999999999 999997543322211 1
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
+........+......+.+++.+||+.||++||++.||+++|+.+...
T Consensus 267 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 267 VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 111111122233445688999999999999999999999999986543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=367.78 Aligned_cols=247 Identities=24% Similarity=0.353 Sum_probs=205.5
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
.++|++.+.||+|+||.||+|. ..+|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 4679999999999999999995 468999999998654 3344567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999932 35699999999999999999999998 899999999999999999999999999986654
Q ss_pred CCcccccccccCCCccchhhhccCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLT-DKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
... .....||+.|+|||++.+..+. .++|||||||++|||++|+.||......+... .+...
T Consensus 167 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---------------~i~~~ 229 (328)
T 3fe3_A 167 GGK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE---------------RVLRG 229 (328)
T ss_dssp SCG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------HHHHC
T ss_pred CCc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH---------------HHHhC
Confidence 332 3446799999999999887765 89999999999999999999997644322111 01111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. ..+......+.+++.+||+.||.+|||+.|+++
T Consensus 230 ~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 230 KY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11 112223345788999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=372.20 Aligned_cols=269 Identities=26% Similarity=0.362 Sum_probs=207.7
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC----EEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGN----QLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV 495 (771)
.++|++.++||+|+||.||+|... ++.||||++.... .....+..|+.++++++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467889999999999999999774 7999999997543 33445667899999999999999999998743 47999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhc-------CCCceeccCCCCCcEEEcCCCCeEEEee
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE-------SRLKIVHRDIKATNVLLDKDLNPKISDF 568 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-------~~~~ivH~Dlkp~NIll~~~~~~kl~DF 568 (771)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+. +.++|+||||||+|||++.++.+||+||
T Consensus 101 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 999999999999932 4589999999999999999999986 1237999999999999999999999999
Q ss_pred cCccccCCCCcc-cccccccCCCccchhhhccC-----CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHH
Q 004155 569 GLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRG-----YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALI 642 (771)
Q Consensus 569 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~ 642 (771)
|+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||+.||..............
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~--- 252 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE--- 252 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH---
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh---
Confidence 999876543322 22335799999999999863 556789999999999999999999976443322111110
Q ss_pred HHhhCChhHHhh----hhcCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 643 LKAQGNLMELVD----KRLGSNF-----DKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 643 ~~~~~~~~~~~d----~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
.........+.+ ....... .......+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000111111111 1111111 1245567999999999999999999999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=376.20 Aligned_cols=258 Identities=28% Similarity=0.468 Sum_probs=200.5
Q ss_pred hcCCCCCCccccCCceeEEEEEcC----CCcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMA----DGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
.++|.+.+.||+|+||.||+|... ++..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999654 5778999999764 33456789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+++|+|.+++... ...+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999543 34689999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCccc--ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 575 EEDNTHI--STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 575 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
....... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. .
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~----------------~ 261 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----------------K 261 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH----------------H
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------------H
Confidence 5433221 122345778999999999999999999999999999998 99999754332211 1
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
.++.......+......+.+++.+||+.||++||++.||+++|+.+..
T Consensus 262 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp HHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 111111122223345568899999999999999999999999987643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=369.12 Aligned_cols=265 Identities=26% Similarity=0.411 Sum_probs=207.3
Q ss_pred hcCCCCCCccccCCceeEEEEEc-----CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe--CCEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-----ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIE--GNQL 492 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 492 (771)
.++|++.++||+|+||.||+|.+ .+++.||||++........+.+.+|+.++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36788899999999999999963 4689999999987776667889999999999999999999999864 3568
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999999443 23589999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcc--cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC---
Q 004155 573 LDEEDNTH--ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG--- 647 (771)
Q Consensus 573 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 647 (771)
........ ......+|..|+|||.+.+..++.++||||||+++|||+||..|+.....+. ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-------~~~~~~~~~~~ 235 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF-------MRMIGNDKQGQ 235 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH-------HHHHCTTCCTH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH-------HhhhcCccccc
Confidence 76543321 2223457778999999999999999999999999999999999986421110 00000000
Q ss_pred ----ChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 648 ----NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 648 ----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
...+.+........+......+.+++.+||+.||++|||+.|++++|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11111222222222334456788999999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=360.24 Aligned_cols=255 Identities=24% Similarity=0.380 Sum_probs=208.8
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.++|++.+.||+|+||.||+|...++..||||++.... ...+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 45788899999999999999988888899999997643 33567999999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 102 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp TTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 999999999542 34699999999999999999999998 899999999999999999999999999987654333
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.......... .+.....
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~----------------~~~~~~~ 239 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----------------HIAQGLR 239 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH----------------HHHTTCC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH----------------HHhcccC
Confidence 33334457788999999999999999999999999999998 999997544322111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
...+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 111222234688999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=386.19 Aligned_cols=264 Identities=20% Similarity=0.243 Sum_probs=211.7
Q ss_pred CCHHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh---hcHHHHHHHHHHHHcCCCCcEEeEEEEE
Q 004155 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLHGCC 486 (771)
Q Consensus 411 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~ 486 (771)
+.+++++..+++|++.++||+|+||+||+|.. .+++.||+|++..... .....+.+|..++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34566777789999999999999999999965 4588999999865321 1223488999999999999999999999
Q ss_pred EeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEE
Q 004155 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 566 (771)
Q Consensus 487 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 566 (771)
.+.+..++|||||++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEc
Confidence 9999999999999999999999542 34699999999999999999999998 89999999999999999999999
Q ss_pred eecCccccCCCCcccccccccCCCccchhhhc-----cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHH
Q 004155 567 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL 641 (771)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~ 641 (771)
|||+|+..............||+.|+|||++. ...++.++|||||||++|||++|++||......+....+ .
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i---~ 294 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI---M 294 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---H
T ss_pred chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh---h
Confidence 99999876655544445568999999999987 567899999999999999999999999765433222111 0
Q ss_pred HHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 004155 642 ILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTS--RPSMSSVVS 692 (771)
Q Consensus 642 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~ 692 (771)
.... ...+... .......+.+++.+|+..+|++ ||++.|+++
T Consensus 295 ~~~~--------~~~~p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 295 NHKE--------RFQFPTQ-VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp THHH--------HCCCCSS-CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hccc--------cccCCcc-cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0000 0001000 0112345788999999888888 999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=385.01 Aligned_cols=260 Identities=28% Similarity=0.435 Sum_probs=213.5
Q ss_pred HHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
...++|.+.+.||+|+||.||+|...+++.||||+++... ...+.|.+|+.++++++||||+++++++. .+..++|||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 3456788899999999999999988888999999997643 35678999999999999999999999986 567899999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 263 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred ecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 999999999995432 23688999999999999999999998 8999999999999999999999999999876543
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
.........+|..|+|||++....++.++|||||||++|||+| |+.||......+... .+...
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~----------------~i~~~ 401 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR----------------ALERG 401 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH----------------HHHHT
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHH----------------HHHcC
Confidence 2222233456788999999999999999999999999999999 999997543322211 11111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
.....+......+.+++.+||+.||++|||+.+|+++|+.....
T Consensus 402 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 402 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 11122223445688999999999999999999999999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=373.07 Aligned_cols=269 Identities=25% Similarity=0.368 Sum_probs=215.6
Q ss_pred CCHHHHHHHhcCCCCCCccccCCceeEEEEE------cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeE
Q 004155 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGH------MADGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKL 482 (771)
Q Consensus 411 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~------~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l 482 (771)
+...+.+...++|.+.+.||+|+||.||+|. ..+++.||||+++... ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 4556666678899999999999999999995 3456899999997643 34456799999999999 79999999
Q ss_pred EEEEEeCC-EEEEEEEeccCCCHHHHhcCCCcc-----------------------------------------------
Q 004155 483 HGCCIEGN-QLLLIYEYMENNSLARALFGPEAH----------------------------------------------- 514 (771)
Q Consensus 483 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~----------------------------------------------- 514 (771)
++++.+.+ ..++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998754 489999999999999999654321
Q ss_pred ---------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 515 ---------------RLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 515 ---------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 12289999999999999999999998 899999999999999999999999999986644332
Q ss_pred -ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 580 -HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 580 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+... ..+....
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~---------------~~~~~~~ 313 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC---------------RRLKEGT 313 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH---------------HHHHHTC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH---------------HHHHcCC
Confidence 22344568999999999999999999999999999999998 999997654332211 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
....+......+.+++.+||+.||++||++.|+++.|+.+
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1112222334688999999999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=363.79 Aligned_cols=248 Identities=26% Similarity=0.335 Sum_probs=205.0
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
.++|++.+.||+|+||.||+|.. .+|+.||+|+++.. .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 35788999999999999999954 57999999999753 233456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999993 235789999999999999999999998 89999999999999999999999999998643
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... +...
T Consensus 157 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---------------i~~~ 220 (337)
T 1o6l_A 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL---------------ILME 220 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---------------HHHC
T ss_pred cCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH---------------HHcC
Confidence 3222 23446799999999999999999999999999999999999999975433221110 1111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
.. .++......+.+++.+||+.||++|| ++.|+++
T Consensus 221 ~~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 221 EI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CC--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11 12222334578999999999999999 8998876
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=364.70 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=205.2
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChh------cHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQ------GNREFVNEIGMISALQHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 491 (771)
..++|.+.+.||+|+||.||+|. ..+|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 35678999999999999999995 457999999999764321 35789999999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC----CeEEEe
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISD 567 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~D 567 (771)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999943 34799999999999999999999998 899999999999998777 799999
Q ss_pred ecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC
Q 004155 568 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG 647 (771)
Q Consensus 568 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 647 (771)
||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....
T Consensus 163 FG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~----------- 229 (361)
T 2yab_A 163 FGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN----------- 229 (361)
T ss_dssp CSSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-----------
T ss_pred cCCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----------
Confidence 999987654322 2345799999999999999999999999999999999999999976443222110
Q ss_pred ChhHHhhhhcCCCCCHH----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 648 NLMELVDKRLGSNFDKE----QVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 648 ~~~~~~d~~l~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+.... ..++.+ ....+.+++.+||..||++|||+.|+++
T Consensus 230 ----i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 230 ----ITAVS--YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ----HHTTC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----HHhcC--CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 011111 1245789999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=367.84 Aligned_cols=263 Identities=30% Similarity=0.477 Sum_probs=212.2
Q ss_pred HhcCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 491 (771)
..++|.+.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578899999999999999999653 45899999997653 3446789999999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCcc--------------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCC
Q 004155 492 LLLIYEYMENNSLARALFGPEAH--------------------RLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIK 551 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlk 551 (771)
.++||||+++|+|.+++...... ...+++.+++.++.||+.||+|||++ +|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 99999999999999999543211 25799999999999999999999998 89999999
Q ss_pred CCcEEEcCCCCeEEEeecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCC
Q 004155 552 ATNVLLDKDLNPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKP 629 (771)
Q Consensus 552 p~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~ 629 (771)
|+||+++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999986543321 12234568899999999999999999999999999999999 999997543
Q ss_pred ccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 630 KEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
..+... . ...+.. ...+......+.+++.+||+.||++||++.++++.|+++...
T Consensus 282 ~~~~~~------~-~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 282 HEEVIY------Y-VRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp HHHHHH------H-HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred hHHHHH------H-HhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 322111 0 011111 112223345688999999999999999999999999987543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=376.82 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=208.4
Q ss_pred hcCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.++|.+.+.||+|+||.||+|... +++.||||+++... ......|.+|+.++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457888899999999999999664 78999999987543 3334578899999999999999999999999899999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++|+|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999943 234689999999999999999999998 8999999999999999999999999999865432
Q ss_pred Ccccc-cccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 578 NTHIS-TRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 578 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
..... ....+++.|+|||.+.++.++.++|||||||++|||+| |+.||......... +.+..
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~----------------~~~~~ 330 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR----------------EFVEK 330 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH----------------HHHHT
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------------HHHHc
Confidence 21111 12235778999999998999999999999999999998 99999754332211 11111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
......+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 331 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 331 GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111122223345688999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=352.99 Aligned_cols=263 Identities=19% Similarity=0.220 Sum_probs=212.0
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.++|++.+.||+|+||.||+|. ..+|+.||||++.... ....+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 4678999999999999999995 4679999999986543 234578899999999 79999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC-----eEEEeecCcc
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN-----PKISDFGLAK 572 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DFGla~ 572 (771)
|+ +++|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++. +||+|||+++
T Consensus 87 ~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 99999999432 34699999999999999999999998 8999999999999987776 9999999998
Q ss_pred ccCCCCcc------cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh
Q 004155 573 LDEEDNTH------ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ 646 (771)
Q Consensus 573 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 646 (771)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 76543321 123457999999999999999999999999999999999999999875443332222222211111
Q ss_pred CChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 647 GNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 647 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
....+ +.... ...+.+++.+||+.||++||++.+|++.|+++...
T Consensus 240 ~~~~~-----~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 240 TPLRE-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp SCHHH-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccHHH-----HHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 11111 11122 34588999999999999999999999999886543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=385.96 Aligned_cols=258 Identities=25% Similarity=0.409 Sum_probs=214.7
Q ss_pred hcCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
.++|.+.++||+|+||.||+|... ++..||||+++... ...++|.+|+.++++++||||++++++|.+.+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 456788899999999999999664 48899999997643 3467899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++|+|.+++.... ...+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 298 MTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred cCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999995432 34689999999999999999999998 89999999999999999999999999998765443
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
........+|+.|+|||++.+..++.++|||||||++|||+| |+.||......... +.+....
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~----------------~~~~~~~ 436 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY----------------ELLEKDY 436 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH----------------HHHHTTC
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH----------------HHHHcCC
Confidence 333333456789999999999999999999999999999999 99999765433221 1122222
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
....+......+.+++.+||+.||++||++.+|+++|+.+..
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 222233344568899999999999999999999999998653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=359.77 Aligned_cols=261 Identities=19% Similarity=0.197 Sum_probs=210.8
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.++|++.+.||+|+||.||+|. ..+|+.||||++..... ...+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4678899999999999999995 46799999999875432 24688999999999 89999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC-----eEEEeecCcc
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN-----PKISDFGLAK 572 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DFGla~ 572 (771)
|+ +++|.+++... ...+++..++.|+.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 99999999432 35799999999999999999999998 8999999999999998887 9999999998
Q ss_pred ccCCCCcc------cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh
Q 004155 573 LDEEDNTH------ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ 646 (771)
Q Consensus 573 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 646 (771)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 76443321 123467999999999999999999999999999999999999999875544433322222111111
Q ss_pred CChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 647 GNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 647 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
... ..+... .+ .+.+++..||+.||.+||++.+|++.|+....
T Consensus 239 ~~~-----~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 239 TPI-----EVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp SCH-----HHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCH-----HHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 111 111111 12 68899999999999999999999999986543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=357.97 Aligned_cols=261 Identities=26% Similarity=0.375 Sum_probs=201.5
Q ss_pred HhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHc--CCCCcEEeEEEEEEeC----CEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISA--LQHPNLVKLHGCCIEG----NQL 492 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~ 492 (771)
..++|++.+.||+|+||.||+|.. +|+.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 356889999999999999999977 6899999998653 34556667777666 7999999999997642 468
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhh--------hcCCCceeccCCCCCcEEEcCCCCeE
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH--------EESRLKIVHRDIKATNVLLDKDLNPK 564 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~k 564 (771)
++||||+++|+|.+++. ...+++..+++++.||+.||+||| +. +|+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence 99999999999999993 346899999999999999999999 65 899999999999999999999
Q ss_pred EEeecCccccCCCCccc---ccccccCCCccchhhhccC------CCCchHhHHHHHHHHHHHHhC----------CCCC
Q 004155 565 ISDFGLAKLDEEDNTHI---STRVAGTFGYMAPEYAMRG------YLTDKADVYSFGIVALEIVSG----------RSNS 625 (771)
Q Consensus 565 l~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~ksDV~S~Gvil~elltG----------~~p~ 625 (771)
|+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||+|| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999998655433221 2234799999999999876 455799999999999999999 8888
Q ss_pred CCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 626 SCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS-NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.......... ............ .+.+.. .........+.+++.+||+.||++|||+.||++.|+++
T Consensus 234 ~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSF-EDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCH-HHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcch-hhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 6533222111 000000000000 000000 01234667899999999999999999999999999753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=352.77 Aligned_cols=253 Identities=28% Similarity=0.475 Sum_probs=196.9
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCCh----hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSK----QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
.++|+..+.||+|+||.||+|... |+.||||+++.... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888999999999999999864 89999999875422 2356789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC--------CCCeEEEe
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK--------DLNPKISD 567 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~D 567 (771)
|||+++++|.+++. ...+++..++.++.|++.||+|||+.+..+|+||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999993 347899999999999999999999983233999999999999986 77899999
Q ss_pred ecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC
Q 004155 568 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG 647 (771)
Q Consensus 568 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 647 (771)
||+++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------------ 224 (271)
T 3dtc_A 160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------------ 224 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------------
T ss_pred CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------------
Confidence 999986544322 23468999999999999999999999999999999999999997543221110
Q ss_pred ChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 648 NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 648 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
...........+......+.+++.+||+.||++||++.|+++.|+.
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 225 ---GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ---HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ---hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111111122223334568899999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=373.15 Aligned_cols=262 Identities=27% Similarity=0.420 Sum_probs=213.0
Q ss_pred hcCCCCCCccccCCceeEEEEEc--------CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeC
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM--------ADGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEG 489 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~--------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 489 (771)
.++|.+.++||+|+||.||+|.. ..++.||||+++... ....+.+.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 46788899999999999999964 234689999997653 34457899999999999 899999999999999
Q ss_pred CEEEEEEEeccCCCHHHHhcCCCc------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE
Q 004155 490 NQLLLIYEYMENNSLARALFGPEA------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL 557 (771)
Q Consensus 490 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 557 (771)
+..++||||+++|+|.+++..... ....+++..++.|+.||+.||+|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 999999999999999999954331 124699999999999999999999998 89999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhh
Q 004155 558 DKDLNPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFY 635 (771)
Q Consensus 558 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~ 635 (771)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~- 303 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF- 303 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 9999999999999986654332 22233457889999999999999999999999999999999 99999754432211
Q ss_pred HHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 636 LLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
+.+........+......+.+++.+||+.||++||++.||++.|+.+...
T Consensus 304 ---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 304 ---------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp ---------------HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111122223345688999999999999999999999999887543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=380.80 Aligned_cols=259 Identities=28% Similarity=0.439 Sum_probs=206.9
Q ss_pred HhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
..++|.+.++||+|+||.||+|...++..||||+++... ...+.|.+|+.++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 346788889999999999999988778889999997643 345789999999999999999999999876 678999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 260 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 260 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 9999999999432 224689999999999999999999998 89999999999999999999999999998765433
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
........+|..|+|||.+.+..++.++|||||||++|||++ |+.||......+... .+....
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~----------------~i~~~~ 398 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD----------------QVERGY 398 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----------------HHHTTC
T ss_pred eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH----------------HHHcCC
Confidence 222233457889999999999999999999999999999999 999997543322111 111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
....+......+.+++.+||+.||++|||+.+++++|+.....
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 1122233445688999999999999999999999999987644
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=372.16 Aligned_cols=263 Identities=27% Similarity=0.367 Sum_probs=210.4
Q ss_pred hcCCCCCCccccCCceeEEEEEc------CCCcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 492 (771)
.++|.+.++||+|+||.||+|.. .+++.||||+++.. .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35788899999999999999974 24678999999754 344566789999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcCCC---ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC---CeEEE
Q 004155 493 LLIYEYMENNSLARALFGPE---AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NPKIS 566 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 566 (771)
++||||+++|+|.+++.... .....+++.+++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999995432 2234689999999999999999999998 899999999999999555 59999
Q ss_pred eecCccccCCCC-cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHH
Q 004155 567 DFGLAKLDEEDN-THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 567 DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~--------- 297 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE--------- 297 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH---------
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---------
Confidence 999997543222 112233567899999999999999999999999999999998 999997544322111
Q ss_pred hhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCC
Q 004155 645 AQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQ 701 (771)
Q Consensus 645 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 701 (771)
.+........+......+.+++.+||+.||++||++.||++.|+......
T Consensus 298 -------~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 298 -------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp -------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -------HHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 11111111222233456889999999999999999999999998765443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=361.22 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=204.4
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh------hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK------QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 492 (771)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45688999999999999999954 5689999999875422 1367899999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC----CeEEEee
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISDF 568 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DF 568 (771)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999943 34699999999999999999999998 899999999999998887 8999999
Q ss_pred cCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 569 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 569 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... ......
T Consensus 163 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-----~~~~~~ 235 (326)
T 2y0a_A 163 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-----SAVNYE 235 (326)
T ss_dssp TTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-----HHTCCC
T ss_pred CCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH-----HhcCCC
Confidence 99987654322 23456999999999999999999999999999999999999999754332211100 000000
Q ss_pred hhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 649 LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 649 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
... . ... .....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~---~-~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 236 FED---E-YFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCH---H-HHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCc---c-ccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 0 001 11245789999999999999999999987
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=363.61 Aligned_cols=252 Identities=28% Similarity=0.368 Sum_probs=201.6
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 46899999999999999999954 4789999999865432 234678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999999843 34699999999999999999999998 8999999999999999999999999999865432
Q ss_pred Cc-ccccccccCCCccchhhhccCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 578 NT-HISTRVAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 578 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.. .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ...|. ..
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~----~~--------- 224 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK----EK--------- 224 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHH----TT---------
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHh----cc---------
Confidence 22 22334679999999999987765 78999999999999999999999764432211 11110 00
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.............+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 225 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0000111122345778999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=356.29 Aligned_cols=266 Identities=23% Similarity=0.318 Sum_probs=203.3
Q ss_pred HhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
..++|++.++||+|+||+||+|...+|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3467899999999999999999888899999999875432 23467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 99 e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99985 888888443 34689999999999999999999998 899999999999999999999999999987654
Q ss_pred CCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH----
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME---- 651 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 651 (771)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+...................
T Consensus 172 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 172 PVRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred Cccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 3222 233568999999999876 5689999999999999999999999986554433221110000000000000
Q ss_pred --HhhhhcC--CCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 652 --LVDKRLG--SNFD-----KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 652 --~~d~~l~--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+.... .... .....++.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000 0000 011245789999999999999999999987
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=358.79 Aligned_cols=258 Identities=25% Similarity=0.405 Sum_probs=215.8
Q ss_pred HHhcCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
...++|++.+.||+|+||.||+|... ++..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 35678889999999999999999554 58899999997543 34678999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 89 e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp ECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999995432 34689999999999999999999998 899999999999999999999999999987765
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
..........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.......... .+..
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~----------------~~~~ 227 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE----------------LLEK 227 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH----------------HHHT
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----------------HHhc
Confidence 54444445567889999999999999999999999999999999 999997654333211 1111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
......+......+.+++.+|++.||++||++.|+++.|+..
T Consensus 228 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 228 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 222222233345688999999999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=359.36 Aligned_cols=247 Identities=19% Similarity=0.298 Sum_probs=205.4
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
.++|.+.+.||+|+||.||+|. ..+|+.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4688999999999999999995 4568999999987543 3456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC--CCCeEEEeecCccccCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK--DLNPKISDFGLAKLDEE 576 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFGla~~~~~ 576 (771)
+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999432 34699999999999999999999998 8999999999999987 78999999999987654
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+....
T Consensus 157 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---------------~i~~~~ 219 (321)
T 1tki_A 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE---------------NIMNAE 219 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---------------HHHHTC
T ss_pred CCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHH---------------HHHcCC
Confidence 332 234568999999999999889999999999999999999999997644322111 011111
Q ss_pred cCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 657 LGSNFDK----EQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 657 l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. .++. .....+.+++.+||+.||++|||+.|+++
T Consensus 220 ~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 220 Y--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp C--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 1111 12346889999999999999999999997
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=354.37 Aligned_cols=256 Identities=25% Similarity=0.340 Sum_probs=196.7
Q ss_pred HhcCCCCCCccccCCceeEEEEEcC----CCcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMA----DGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
..++|++.+.||+|+||.||+|... .+..||+|++... .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 3467888999999999999999653 2567999998764 3344667999999999999999999999984 56789
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 92 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 999999999999999432 34689999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 574 DEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 574 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
.............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+....+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i--------------- 230 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------------- 230 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---------------
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH---------------
Confidence 65543333334457889999999999999999999999999999997 99999765443321111
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
........+......+.+++.+||+.||++||++.|+++.|+.+
T Consensus 231 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 231 -ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00001112223345688999999999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=363.28 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=202.8
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCc----EEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGT----VVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
++|+..++||+|+||.||+|.. .+|+ +||+|.+... .....+.+.+|+.++++++||||++++++|.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 5688899999999999999964 3444 3688887643 3345678999999999999999999999998755 789
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
|+||+++|+|.+++... ...+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999542 34699999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 575 EEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 575 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
...... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......... ..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----------------~~ 231 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----------------SI 231 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----------------HH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH----------------HH
Confidence 543322 2233457889999999999999999999999999999999 99999765443321 11
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
+........+......+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 22221122233344568899999999999999999999999987543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=359.63 Aligned_cols=259 Identities=30% Similarity=0.437 Sum_probs=211.8
Q ss_pred hcCCCCCCccccCCceeEEEEEc------CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 492 (771)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 56788899999999999999954 345899999997643 34457889999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcCCCc--------------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCC
Q 004155 493 LLIYEYMENNSLARALFGPEA--------------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKA 552 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp 552 (771)
++||||+++|+|.+++..... ....+++.+++.++.||+.||+|||++ +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999964332 123489999999999999999999998 899999999
Q ss_pred CcEEEcCCCCeEEEeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCc
Q 004155 553 TNVLLDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPK 630 (771)
Q Consensus 553 ~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~ 630 (771)
+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876543322 2233457889999999999999999999999999999999 9999976554
Q ss_pred cchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 631 EDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
...... +........+......+.+++.+||+.||++||++.|+++.|+.+
T Consensus 259 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 259 ERLFNL----------------LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GGHHHH----------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHH----------------hhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 332211 111111122223345688999999999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.61 Aligned_cols=253 Identities=30% Similarity=0.521 Sum_probs=203.6
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhc-------HHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQG-------NREFVNEIGMISALQHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 491 (771)
.++|++.+.||+|+||.||+|.. .+++.||+|++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46788899999999999999954 578999999986543221 167899999999999999999999987655
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCc--eeccCCCCCcEEEcCCCC-----eE
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK--IVHRDIKATNVLLDKDLN-----PK 564 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~k 564 (771)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ + |+||||||+||+++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 6999999999999988543 34799999999999999999999998 6 999999999999988776 99
Q ss_pred EEeecCccccCCCCcccccccccCCCccchhhhc--cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHH
Q 004155 565 ISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM--RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALI 642 (771)
Q Consensus 565 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~ 642 (771)
|+|||+++..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||.......... .. .
T Consensus 170 l~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~---~ 241 (287)
T 4f0f_A 170 VADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-IN---M 241 (287)
T ss_dssp ECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-HH---H
T ss_pred eCCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-HH---H
Confidence 9999999854332 23456999999999984 4567899999999999999999999997654332211 11 1
Q ss_pred HHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 643 LKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 643 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
..........+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 242 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 ---------IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ---------HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ---------HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111112222333445688999999999999999999999999863
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=376.62 Aligned_cols=257 Identities=20% Similarity=0.277 Sum_probs=209.0
Q ss_pred HHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe
Q 004155 413 LRQIKAATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIE 488 (771)
Q Consensus 413 ~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 488 (771)
+++++...++|.+.++||+|+||.||+|.. .+++.||+|++++.. ......+.+|+.+++.++||||++++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 455666778999999999999999999954 568999999986521 1223457889999999999999999999999
Q ss_pred CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEee
Q 004155 489 GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 568 (771)
Q Consensus 489 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 568 (771)
.+..|+||||+++|+|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~-----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 999999999999999999993 24689999999999999999999998 8999999999999999999999999
Q ss_pred cCccccCCCCcccccccccCCCccchhhhccCC----CCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHH
Q 004155 569 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGY----LTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 569 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
|+|+..............||+.|+|||++.+.. ++.++|||||||++|||++|++||......+....
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~-------- 284 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK-------- 284 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--------
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHH--------
Confidence 999877655443444567999999999998654 78999999999999999999999976543322111
Q ss_pred hhCChhHHhhhh--cCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 004155 645 AQGNLMELVDKR--LGSNFDKEQVMVMINVALLCTDVSSTS--RPSMSSVVS 692 (771)
Q Consensus 645 ~~~~~~~~~d~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~ 692 (771)
++... +.-.........+.+++.+||+.+|++ ||++.||++
T Consensus 285 -------i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 285 -------IMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp -------HHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred -------HHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 11110 000000112345788999999999988 999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=351.84 Aligned_cols=255 Identities=26% Similarity=0.421 Sum_probs=210.3
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 5688889999999999999988788999999997643 335689999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 87 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 87 HGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999432 24689999999999999999999998 8999999999999999999999999999866543222
Q ss_pred cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+... ... .....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~i~----------~~~~~ 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE------DIS----------TGFRL 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHH----------TTCCC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH------HHh----------cCCcC
Confidence 2334457789999999998999999999999999999999 899997543322111 000 01111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
..+......+.+++.+||+.||++||++.|+++.|+++.
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 112223346889999999999999999999999998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=355.18 Aligned_cols=272 Identities=19% Similarity=0.248 Sum_probs=212.6
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC--EEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGN--QLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 495 (771)
.++|.+.++||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 35788999999999999999954 458999999997543 234677889999999999999999999998765 78999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE----cCCCCeEEEeecCc
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLA 571 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFGla 571 (771)
|||+++++|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999965432 23499999999999999999999998 89999999999999 78888999999999
Q ss_pred cccCCCCcccccccccCCCccchhhhc--------cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccch-hhHHHHHHH
Q 004155 572 KLDEEDNTHISTRVAGTFGYMAPEYAM--------RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDI-FYLLDWALI 642 (771)
Q Consensus 572 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~-~~~~~~~~~ 642 (771)
+........ ....||+.|+|||++. +..++.++|||||||++|||++|+.||........ .........
T Consensus 164 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 164 RELEDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp EECCTTCCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred eecCCCCce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 876544322 3456999999999986 57889999999999999999999999975433221 111111111
Q ss_pred HHhhCChhHH---------hhhhc--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 643 LKAQGNLMEL---------VDKRL--GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 643 ~~~~~~~~~~---------~d~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
......+..+ ....+ ...........+.+++.+||+.||++||++.|+++...+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1110000000 00011 1234567777899999999999999999999999987764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=366.49 Aligned_cols=249 Identities=22% Similarity=0.359 Sum_probs=200.2
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 493 (771)
..++|++.++||+|+||.||+|. ..+|+.||||+++.. .....+.+.+|..+++.+ +||||+++++++.+.+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 34789999999999999999995 456899999999753 223456788999999988 6999999999999999999
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+||||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 101 lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 9999999999999993 235699999999999999999999998 899999999999999999999999999985
Q ss_pred cCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 574 DEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 574 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+.
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~---------------~i~ 237 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE---------------AIL 237 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------HHH
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHH---------------HHH
Confidence 43322 22344679999999999998889999999999999999999999997654332211 111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSM------SSVVS 692 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~ 692 (771)
.... .++......+.+++.+||+.||++||++ .|+++
T Consensus 238 ~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 238 NDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred cCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111 1222233457889999999999999998 66665
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=355.12 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=196.1
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCCh--------------------------hcHHHHHHHHHHHH
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK--------------------------QGNREFVNEIGMIS 472 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~ 472 (771)
.++|++.+.||+|+||.||+|. ..+|+.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 3678899999999999999995 45789999999865421 11356889999999
Q ss_pred cCCCCcEEeEEEEEEe--CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCC
Q 004155 473 ALQHPNLVKLHGCCIE--GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDI 550 (771)
Q Consensus 473 ~l~h~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dl 550 (771)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++..+..++.||+.||+|||+. +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 57899999999999998765 234799999999999999999999998 8999999
Q ss_pred CCCcEEEcCCCCeEEEeecCccccCCCCcccccccccCCCccchhhhccCC---CCchHhHHHHHHHHHHHHhCCCCCCC
Q 004155 551 KATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGY---LTDKADVYSFGIVALEIVSGRSNSSC 627 (771)
Q Consensus 551 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDV~S~Gvil~elltG~~p~~~ 627 (771)
||+||+++.++.+||+|||+++........ .....||+.|+|||.+.+.. .+.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999876543322 23457999999999997654 47899999999999999999999975
Q ss_pred CCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 628 KPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...... . .... ...............+.+++.+||+.||++||++.|+++
T Consensus 243 ~~~~~~---~---~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIMCL---H---SKIK---------SQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHHHH---H---HHHH---------HCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHHHH---H---HHHh---------cccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 432111 1 1111 111100111122345889999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=364.21 Aligned_cols=271 Identities=19% Similarity=0.229 Sum_probs=210.3
Q ss_pred HhcCCCCCCccccCCceeEEEEEcCC------CcEEEEEEcccCChhc-----------HHHHHHHHHHHHcCCCCcEEe
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMAD------GTVVAVKQLSSKSKQG-----------NREFVNEIGMISALQHPNLVK 481 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 481 (771)
..++|.+.++||+|+||.||+|...+ ++.||||++....... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35678999999999999999996644 4789999987654211 123445666777889999999
Q ss_pred EEEEEEeC----CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE
Q 004155 482 LHGCCIEG----NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL 557 (771)
Q Consensus 482 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 557 (771)
+++++... ...++||||+ +++|.+++.. ....+++..++.|+.||+.||+|||+. +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998764 4689999999 9999999943 235799999999999999999999998 89999999999999
Q ss_pred c--CCCCeEEEeecCccccCCCCccc------ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Q 004155 558 D--KDLNPKISDFGLAKLDEEDNTHI------STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKP 629 (771)
Q Consensus 558 ~--~~~~~kl~DFGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~ 629 (771)
+ .++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 88999999999998765432211 123459999999999999999999999999999999999999997533
Q ss_pred ccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 004155 630 KEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQD 702 (771)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 702 (771)
.... ...+.. ......+.+++++.+... ..+..+.+++..||+.||++||++.++++.|+.+.....
T Consensus 266 ~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 266 KDPK--YVRDSK-IRYRENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp TCHH--HHHHHH-HHHHHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCHH--HHHHHH-HHhhhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 2221 111111 112234556666665321 123458889999999999999999999999987654433
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=365.50 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=206.8
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
.++|++.+.||+|+||.||+|. ..+|+.||+|++..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 4679999999999999999995 457899999999876666667899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC--CCCeEEEeecCccccCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK--DLNPKISDFGLAKLDEE 576 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFGla~~~~~ 576 (771)
+++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 9999999999432 24689999999999999999999998 8999999999999974 57899999999987654
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. . ...... ..
T Consensus 204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~---~i~~~~-------~~ 268 (387)
T 1kob_A 204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---Q---NVKRCD-------WE 268 (387)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---H---HHHHCC-------CC
T ss_pred Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH---H---HHHhCC-------CC
Confidence 332 23346999999999999999999999999999999999999999754322211 1 000000 00
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
............+.+++.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 011111122346889999999999999999999987
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=363.31 Aligned_cols=255 Identities=21% Similarity=0.302 Sum_probs=203.8
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-----hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-----KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
.++|++.+.||+|+||.||+|. ..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3578899999999999999994 4579999999986421 124678999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC---eEEEeecC
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN---PKISDFGL 570 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFGl 570 (771)
+||||+++|+|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999988854333344689999999999999999999998 8999999999999986654 99999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChh
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLM 650 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (771)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .... ... .+...
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~---~i~-~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE---GII-KGKYK 250 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH---HHH-HTCCC
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH---HHH-cCCCC
Confidence 987654332 22345799999999999999999999999999999999999999975321 1111 000 00000
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 651 ELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 651 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+..... ....+.+++.+||+.||++||++.|+++
T Consensus 251 --~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 --MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000011 1346789999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=365.32 Aligned_cols=274 Identities=27% Similarity=0.376 Sum_probs=213.9
Q ss_pred cCCCCCCccccCCceeEEEEE-----cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEE--eCCEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-----MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI--EGNQLL 493 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-----~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 493 (771)
++|++.+.||+|+||.||+|. ..+++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 578889999999999999997 3468899999998777667788999999999999999999999987 456799
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+||||+++++|.+++... ...+++..++.|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 103 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence 999999999999999432 23699999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCcc--cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 574 DEEDNTH--ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 574 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
....... ......||..|+|||++.+..++.++|||||||++|||++|+.||.....+.. ....+.........+.+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-RMMGCERDVPALSRLLE 255 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHCC----CCHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-hhcccccccccHHHHHH
Confidence 6543322 22334688889999999999999999999999999999999999864221100 00000000000001122
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCC
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQ 701 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 701 (771)
.+........+......+.+++.+||+.||++||++.|+++.|+.+....
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 22222222333444567899999999999999999999999999875543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=362.87 Aligned_cols=253 Identities=22% Similarity=0.331 Sum_probs=204.7
Q ss_pred HHhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
...++|.+.+.||+|+||.||+|. ..+|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 345789999999999999999995 457899999999754 23345678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC---CCeEEEeecCc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNPKISDFGLA 571 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFGla 571 (771)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 106 v~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 9999999999999943 34689999999999999999999998 89999999999999765 45999999999
Q ss_pred cccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 572 KLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 572 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|++||......... .. .. .+..
T Consensus 179 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---~~---i~-~~~~-- 247 (362)
T 2bdw_A 179 IEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY---AQ---IK-AGAY-- 247 (362)
T ss_dssp BCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HH---HH-HTCC--
T ss_pred eEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH---HH---HH-hCCC--
Confidence 86654322 23457999999999999999999999999999999999999999754322211 10 00 0100
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.............+.+++.+||+.||++||++.|+++
T Consensus 248 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 248 ----DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp ----CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000122345789999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=359.63 Aligned_cols=265 Identities=23% Similarity=0.392 Sum_probs=197.7
Q ss_pred HHhcCCCCCCccccCCceeEEEEEcCC-C---cEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKGHMAD-G---TVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~-g---~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 491 (771)
...++|++.+.||+|+||.||+|.... + ..||||+++.. .....+.+.+|++++++++||||+++++++...+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345689999999999999999996543 2 27999999764 33446789999999999999999999999987765
Q ss_pred E------EEEEEeccCCCHHHHhcCCC--ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCe
Q 004155 492 L------LLIYEYMENNSLARALFGPE--AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 563 (771)
Q Consensus 492 ~------~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 563 (771)
. ++||||+++|+|.+++.... .....+++..++.|+.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 5 99999999999999984322 2223689999999999999999999998 89999999999999999999
Q ss_pred EEEeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHH
Q 004155 564 KISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWAL 641 (771)
Q Consensus 564 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~ 641 (771)
||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+....
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~----- 251 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY----- 251 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH-----
Confidence 99999999866443321 2233457789999999999999999999999999999999 9999976544332111
Q ss_pred HHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCC
Q 004155 642 ILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQ 701 (771)
Q Consensus 642 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 701 (771)
+.. ......+......+.+++.+||+.||++||++.++++.|+++...+
T Consensus 252 ----------~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 252 ----------LIG-GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp ----------HHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ----------Hhc-CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 010 1111222233456889999999999999999999999999875543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=350.54 Aligned_cols=256 Identities=30% Similarity=0.450 Sum_probs=209.8
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.++|++.+.||+|+||.||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 46788899999999999999988888899999987543 34678999999999999999999999986 45689999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++++|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 90 ENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp TTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999999432 123689999999999999999999998 899999999999999999999999999987765443
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+... . +.....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~------~----------~~~~~~ 228 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ------N----------LERGYR 228 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH------H----------HHTTCC
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHH------H----------HhcccC
Confidence 33344557889999999998899999999999999999999 999997543322111 0 011111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
...+......+.+++.+|++.||++||++.++++.|+...
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 1112223456889999999999999999999999998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.50 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=204.5
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC--CEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEG--NQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 496 (771)
++|.+.+.||+|+||.||+|... |+.||||+++... ....+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 56888999999999999999874 8999999987642 34456799999999999999999999999876 7889999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCc--eeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK--IVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||+++|+|.+++.... ...+++..++.++.||+.||+|||+. + |+||||||+||+++.++.++|+|||++...
T Consensus 89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp ECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999996432 23689999999999999999999997 6 999999999999999999999999987643
Q ss_pred CCCCcccccccccCCCccchhhhccCCCC---chHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRGYLT---DKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
.. ....||+.|+|||.+.+...+ .++|||||||++|||++|+.||......... ..
T Consensus 164 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---------------~~ 222 (271)
T 3kmu_A 164 QS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG---------------MK 222 (271)
T ss_dssp SC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH---------------HH
T ss_pred cc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH---------------HH
Confidence 22 224589999999999875444 4899999999999999999999754332211 01
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
..........+......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 223 VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11111112222233456889999999999999999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=356.31 Aligned_cols=261 Identities=28% Similarity=0.450 Sum_probs=212.3
Q ss_pred HhcCCCCCCccccCCceeEEEEEc------CCCcEEEEEEcccCCh-hcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCC
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKLHGCCIEGN 490 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 490 (771)
..++|.+.+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346788899999999999999963 3578999999976533 3457899999999999 9999999999999999
Q ss_pred EEEEEEEeccCCCHHHHhcCCCc--------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEE
Q 004155 491 QLLLIYEYMENNSLARALFGPEA--------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVL 556 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIl 556 (771)
..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+. +|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence 99999999999999999954321 123589999999999999999999998 8999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchh
Q 004155 557 LDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIF 634 (771)
Q Consensus 557 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~ 634 (771)
++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 999999999999999876544332 2233457889999999999999999999999999999999 99999765433221
Q ss_pred hHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 635 YLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
. ..+........+......+.+++.+||+.||.+||++.|+++.|++.
T Consensus 258 ~---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 258 Y---------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp H---------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---------------HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1 11111111111222345688999999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=373.17 Aligned_cols=251 Identities=29% Similarity=0.428 Sum_probs=206.5
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC-EEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGN-QLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~ 498 (771)
.++|++.++||+|+||.||+|... |+.||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 456888899999999999999874 7899999997643 4568999999999999999999999988765 79999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 9999999999532 223479999999999999999999998 89999999999999999999999999998543221
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
....+|..|+|||++.+..++.++|||||||++|||+| |+.||......+... .+....
T Consensus 344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~----------------~i~~~~ 403 (450)
T 1k9a_A 344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP----------------RVEKGY 403 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH----------------HHHTTC
T ss_pred ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----------------HHHcCC
Confidence 22357889999999999999999999999999999998 999997654433211 111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
....+......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 12223334456889999999999999999999999998753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=363.53 Aligned_cols=264 Identities=28% Similarity=0.408 Sum_probs=210.4
Q ss_pred HhcCCCCCCccccCCceeEEEEEc------CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCC
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGN 490 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 490 (771)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346788999999999999999964 346789999997542 23456789999999999 8999999999999999
Q ss_pred EEEEEEEeccCCCHHHHhcCCCcc-------------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAH-------------------RLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIK 551 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlk 551 (771)
..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||+. +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 999999999999999999654321 13489999999999999999999998 89999999
Q ss_pred CCcEEEcCCCCeEEEeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCC
Q 004155 552 ATNVLLDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKP 629 (771)
Q Consensus 552 p~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~ 629 (771)
|+||+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999866443322 2234567889999999999999999999999999999998 999997654
Q ss_pred ccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 630 KEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
...... ..+........+......+.+++.+||+.||.+||++.|+++.|+.....
T Consensus 280 ~~~~~~---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 280 VDANFY---------------KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CSHHHH---------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cHHHHH---------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 332211 11111111222223345688999999999999999999999999886543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=361.67 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=198.5
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCC--CcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQH--PNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV 495 (771)
.++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| |||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568899999999999999998888999999998654 33445788999999999976 9999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|| +.+++|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 567899999943 35789999999999999999999998 899999999999997 5789999999998765
Q ss_pred CCCcc-cccccccCCCccchhhhcc-----------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHH
Q 004155 576 EDNTH-ISTRVAGTFGYMAPEYAMR-----------GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALIL 643 (771)
Q Consensus 576 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 643 (771)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---------- 228 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---------- 228 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH----------
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH----------
Confidence 43322 2334579999999999865 6789999999999999999999999964322110
Q ss_pred HhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 644 KAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 644 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+..++++.....++......+.+++.+||+.||++|||+.|+++
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 229 ----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp ----HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 112223333222333233346889999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=359.28 Aligned_cols=266 Identities=28% Similarity=0.404 Sum_probs=208.6
Q ss_pred CCCCCccccCCceeEEEEEc-----CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe--CCEEEE
Q 004155 423 FAPDNKIGEGGFGPVYKGHM-----ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIE--GNQLLL 494 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 494 (771)
|++.++||+|+||.||++.+ .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 37889999999999988853 368899999997653 3446779999999999999999999999987 468899
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+++|+|.+++. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 999999999999993 23599999999999999999999998 8999999999999999999999999999877
Q ss_pred CCCCcc--cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 575 EEDNTH--ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 575 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
...... ......||..|+|||++.+..++.++||||||+++|||++|+.||....... .....+.........+.+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHH
Confidence 554322 2234567888999999999899999999999999999999999986421110 0000000000011112233
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
++.......+......+.+++.+||+.||++||++.|+++.|+.+
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 333333333344456789999999999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=355.52 Aligned_cols=244 Identities=25% Similarity=0.362 Sum_probs=203.3
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||.||+|.. .+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 5788999999999999999954 579999999987532 234567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999943 34689999999999999999999998 899999999999999999999999999986543
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..++...
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---------------~~i~~~~ 219 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY---------------EKILNAE 219 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---------------HHHHHCC
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---------------HHHHhCC
Confidence 2 23457999999999999999999999999999999999999999754322211 1111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
. .++......+.+++.+|++.||++|| ++.|+++
T Consensus 220 ~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 L--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp C--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1 11222234578999999999999999 8888874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=370.76 Aligned_cols=253 Identities=21% Similarity=0.307 Sum_probs=204.5
Q ss_pred HhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
..++|++.+.||+|+||.||+| ...+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4578999999999999999999 45679999999987643 23456789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc---CCCCeEEEeecCcc
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAK 572 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFGla~ 572 (771)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++
T Consensus 89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999843 35699999999999999999999998 899999999999998 56789999999998
Q ss_pred ccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 573 LDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 573 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|++||......+....+ . .+..
T Consensus 162 ~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i------~-~~~~--- 230 (444)
T 3soa_A 162 EVEGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI------K-AGAY--- 230 (444)
T ss_dssp CCCTTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------H-HTCC---
T ss_pred EecCCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH------H-hCCC---
Confidence 66543322 23467999999999999999999999999999999999999999754332221110 0 0000
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.............+.+++.+||+.||++|||+.|+++
T Consensus 231 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 231 ---DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ---CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000122345889999999999999999999987
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=350.90 Aligned_cols=262 Identities=20% Similarity=0.289 Sum_probs=200.4
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
++|++.++||+|+||+||+|.. .+|+.||||++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5788999999999999999954 568999999987543 2335778899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++ ++.+.+.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 56555532 235799999999999999999999998 8999999999999999999999999999876543
Q ss_pred CcccccccccCCCccchhhhccCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh---CChhHHh
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGY-LTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ---GNLMELV 653 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 653 (771)
.. ......||+.|+|||++.+.. ++.++|||||||++|||++|+.|+....... ............ .......
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGG
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhc
Confidence 22 223456899999999998765 8999999999999999999988865432211 111111111110 0000000
Q ss_pred ---hhhc---------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 654 ---DKRL---------GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 654 ---d~~l---------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+... ...........+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 00011123346789999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=373.94 Aligned_cols=263 Identities=21% Similarity=0.253 Sum_probs=209.3
Q ss_pred CCHHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEE
Q 004155 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCC 486 (771)
Q Consensus 411 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 486 (771)
+.+++++...++|++.++||+|+||.||+|.. .+|+.||||++++.. ......+.+|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 44566666788999999999999999999954 579999999996532 12234578899999999999999999999
Q ss_pred EeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEE
Q 004155 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 566 (771)
Q Consensus 487 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 566 (771)
.+.+..|+||||+++|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence 9999999999999999999999432 24799999999999999999999998 89999999999999999999999
Q ss_pred eecCccccCCCCcccccccccCCCccchhhhc-------cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHH
Q 004155 567 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-------RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDW 639 (771)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~ 639 (771)
|||+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i-- 282 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI-- 282 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH--
Confidence 99999877654443344567999999999987 357899999999999999999999999765433221111
Q ss_pred HHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHH
Q 004155 640 ALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSR---PSMSSVVS 692 (771)
Q Consensus 640 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~ 692 (771)
......- .+ ..........+.+++.+||. +|++| |+++|+++
T Consensus 283 -~~~~~~~--------~~-p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 283 -VHYKEHL--------SL-PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp -HTHHHHC--------CC-C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred -HhcccCc--------CC-CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0000000 00 00111223457889999999 99998 58999876
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=353.47 Aligned_cols=261 Identities=24% Similarity=0.373 Sum_probs=191.2
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.++|++.+.||+|+||.||+|.. .+|+.||+|+++.... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46789999999999999999954 4689999999875432 234678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCC--ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 498 YMENNSLARALFGPE--AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|++ |+|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999884321 1224689999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh--------
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ-------- 646 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-------- 646 (771)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+ ......
T Consensus 160 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI---FDIMGTPNESLWPS 235 (317)
T ss_dssp SCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCTTTCGG
T ss_pred CCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCChhHhhh
Confidence 33222 233568999999999976 46899999999999999999999999765443322111 111000
Q ss_pred ----------------CChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 647 ----------------GNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 647 ----------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+.+.+.+...... ...+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPL----DGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCC----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccC----CHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 001111111111122 235889999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=363.77 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=204.1
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|.+.+.||+|+||.||+|. ..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 578899999999999999995 4568999999986532 234567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+.+|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999943 34699999999999999999999998 899999999999999999999999999987654
Q ss_pred CCcccccccccCCCccchhhhcc---CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...............
T Consensus 168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~------------- 232 (384)
T 4fr4_A 168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF------------- 232 (384)
T ss_dssp TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH-------------
T ss_pred CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH-------------
Confidence 32 2244679999999999874 45899999999999999999999999764433322221110
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPS-MSSVVS 692 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~ 692 (771)
... ...++......+.+++.+||+.||++||+ +.++.+
T Consensus 233 ~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 233 ETT-VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHC-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hhc-ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 000 11222233456889999999999999998 677664
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=349.38 Aligned_cols=262 Identities=25% Similarity=0.352 Sum_probs=200.1
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
++|++.+.||+|+||.||+|...+|+.||+|++..... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57889999999999999999877899999999865432 2346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++ +|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 986 999998542 24689999999999999999999998 89999999999999999999999999998654322
Q ss_pred cccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh--CChhHH---
Q 004155 579 THISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ--GNLMEL--- 652 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--- 652 (771)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+... ......... ......
T Consensus 155 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 RK-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM--RIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCTTTSTTGGGS
T ss_pred cc-cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHHCCCChhhchhhhcc
Confidence 21 2334689999999999764 58999999999999999999999997644322211 111110000 000000
Q ss_pred --hhhhcCC-------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 653 --VDKRLGS-------NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 653 --~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.++.... .........+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 000112345789999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=360.87 Aligned_cols=245 Identities=25% Similarity=0.310 Sum_probs=192.5
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS--KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 495 (771)
.++|++.++||+|+||+||+|.. .+|+.||||++.... ......+..|+..+.++ +||||++++++|.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 36799999999999999999965 479999999986532 23344556666666555 899999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+ +++|.+++... ...+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 136 ~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 67999988432 34699999999999999999999998 89999999999999999999999999998664
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.... .....||+.|+|||++.+ .++.++|||||||++|||++|..|+.... . |. ....+....
T Consensus 209 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~-----~~--~~~~~~~~~---- 271 (311)
T 3p1a_A 209 TAGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---G-----WQ--QLRQGYLPP---- 271 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---H-----HH--HHTTTCCCH----
T ss_pred cCCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---H-----HH--HHhccCCCc----
Confidence 4322 234569999999998876 78999999999999999999977664211 0 00 001111111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+... ....+.+++.+||+.||++|||+.|+++
T Consensus 272 ~~~~~----~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 EFTAG----LSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccC----CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11111 2346889999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=364.69 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=198.0
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 494 (771)
.++|++.++||+|+||.||+|.. .+++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 35788999999999999999954 568899999997642 22234578899999887 89999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 131 V~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999994 235799999999999999999999998 8999999999999999999999999999853
Q ss_pred CCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchh--hHHHHHHHHHhhCChhHH
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF--YLLDWALILKAQGNLMEL 652 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 652 (771)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ....... ..+
T Consensus 204 ~~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~--------~~i 274 (396)
T 4dc2_A 204 LRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF--------QVI 274 (396)
T ss_dssp CCTTC-CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH--------HHH
T ss_pred ccCCC-ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH--------HHH
Confidence 32222 234567999999999999999999999999999999999999999653221110 0000000 011
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSM 687 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 687 (771)
.... ..++......+.+++.+||+.||++||++
T Consensus 275 ~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 275 LEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred hccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1111 12222234467899999999999999996
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=356.48 Aligned_cols=251 Identities=21% Similarity=0.346 Sum_probs=197.8
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC-------
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGN------- 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 490 (771)
.++|++.+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 46788999999999999999965 479999999997543 334678999999999999999999999986543
Q ss_pred --------------------------------------------------EEEEEEEeccCCCHHHHhcCCCccCCCCCh
Q 004155 491 --------------------------------------------------QLLLIYEYMENNSLARALFGPEAHRLKLDW 520 (771)
Q Consensus 491 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~ 520 (771)
..++||||+++|+|.+++..... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 38999999999999999965443 234577
Q ss_pred HHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc-----------ccccccccCC
Q 004155 521 PTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-----------HISTRVAGTF 589 (771)
Q Consensus 521 ~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~ 589 (771)
..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 78999999999999999998 899999999999999999999999999987655421 1123356999
Q ss_pred CccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHH
Q 004155 590 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVM 669 (771)
Q Consensus 590 ~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 669 (771)
.|+|||++.+..++.++|||||||++|||++|..|+. +..... .......... ........+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~----~~~~~~~~~~---------~~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRII----TDVRNLKFPL---------LFTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHH----HHHHTTCCCH---------HHHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHH----HHhhccCCCc---------ccccCChhH
Confidence 9999999999999999999999999999999876642 111000 0000111100 012233467
Q ss_pred HHHHHHccCCCCCCCCCHHHHHH
Q 004155 670 INVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 670 ~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+++.+||+.||++||++.|+++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCCCcCCCHHHHhh
Confidence 88999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=360.49 Aligned_cols=252 Identities=22% Similarity=0.284 Sum_probs=192.7
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
.++|.+.+.||+|+||.||++.. .+|+.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 46789999999999999999954 4789999999976432 346688999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC--eEEEeecCccccCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN--PKISDFGLAKLDEE 576 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFGla~~~~~ 576 (771)
+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERIC----NAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999983 234699999999999999999999998 8999999999999987765 99999999974332
Q ss_pred CCcccccccccCCCccchhhhccCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDK-ADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.. ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........... .. ..+...
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--~~---------~~~~~~ 237 (361)
T 3uc3_A 171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK--TI---------QRILSV 237 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH--HH---------HHHHTT
T ss_pred cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH--HH---------HHHhcC
Confidence 22 1233569999999999988877665 8999999999999999999976433222110 00 011111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.............+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 1111111112345789999999999999999999987
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=358.61 Aligned_cols=267 Identities=26% Similarity=0.373 Sum_probs=206.5
Q ss_pred cCCCCCCccccCCceeEEEEE-----cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC--CEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-----MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEG--NQL 492 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-----~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 492 (771)
++|++.+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 457788999999999999997 3468999999997543 33457899999999999999999999999876 678
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 101 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 999999999999999943 234699999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcc--cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh---hC
Q 004155 573 LDEEDNTH--ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA---QG 647 (771)
Q Consensus 573 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~ 647 (771)
........ ......||..|+|||.+.+..++.++||||||+++|||++|+.|+..... ........... ..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTVT 250 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccCHH
Confidence 76554322 22345688889999999999999999999999999999999988642110 00000000000 00
Q ss_pred ChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 648 NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 648 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.+...+........+......+.+++.+||+.||.+|||+.|++++|+.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 11111112112222333445688999999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=361.41 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=203.1
Q ss_pred HHHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCE
Q 004155 417 KAATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 417 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 491 (771)
....++|.+.+.||+|+||.||+|.. .+|+.||||+++... ......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 44567899999999999999999954 568999999997532 23456778899999876 89999999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999932 34689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 572 KLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 572 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+
T Consensus 166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i-------------- 230 (345)
T 1xjd_A 166 KENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-------------- 230 (345)
T ss_dssp BCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--------------
T ss_pred hhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH--------------
Confidence 85433222 234567999999999999999999999999999999999999999764432221110
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMS-SVV 691 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl 691 (771)
.... ..++......+.+++.+||+.||++||++. |++
T Consensus 231 -~~~~--~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 231 -RMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -HHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -HhCC--CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0000 111222334578999999999999999997 554
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=354.63 Aligned_cols=256 Identities=29% Similarity=0.467 Sum_probs=199.1
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
++|++.+.||+|+||.||+|... ++.||||++... ...+.|.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 46788899999999999999874 789999998653 34578999999999999999999999886 34799999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC-eEEEeecCccccCCCCc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN-PKISDFGLAKLDEEDNT 579 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DFGla~~~~~~~~ 579 (771)
+|+|.+++..... ...+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+++......
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~- 160 (307)
T 2eva_A 83 GGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM- 160 (307)
T ss_dssp TCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-
Confidence 9999999965432 235789999999999999999999943338999999999999998887 7999999997554321
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..|. .. .+ ...
T Consensus 161 ---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~-~~~~--~~-~~---------~~~ 223 (307)
T 2eva_A 161 ---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-R-IMWA--VH-NG---------TRP 223 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-H-HHHH--HH-TT---------CCC
T ss_pred ---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-H-HHHH--Hh-cC---------CCC
Confidence 234589999999999999999999999999999999999999975433211 1 1111 00 01 011
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
.........+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11122334588999999999999999999999999876543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=359.34 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=189.0
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
..++|++.+.||+|+||.||+|.. .+++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 457789999999999999999965 468899999997543 34678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC---CCCeEEEeecCcccc
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGLAKLD 574 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFGla~~~ 574 (771)
|+++|+|.+++.. ...+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999943 34689999999999999999999998 8999999999999975 889999999999865
Q ss_pred CCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... .+..
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~------------~i~~ 265 (349)
T 2w4o_A 202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFR------------RILN 265 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHH------------HHHT
T ss_pred Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHH------------HHHh
Confidence 4322 22345689999999999999999999999999999999999999975433221 110 0111
Q ss_pred hhc--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 KRL--GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
... ...........+.+++.+||+.||++||++.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 266 CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 110 00111123346889999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=356.99 Aligned_cols=261 Identities=26% Similarity=0.420 Sum_probs=210.3
Q ss_pred hcCCCCCCccccCCceeEEEEEc--------CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeC
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM--------ADGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEG 489 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~--------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 489 (771)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 46788999999999999999964 356789999997653 34457789999999999 899999999999999
Q ss_pred CEEEEEEEeccCCCHHHHhcCCCcc------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE
Q 004155 490 NQLLLIYEYMENNSLARALFGPEAH------------RLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL 557 (771)
Q Consensus 490 ~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 557 (771)
+..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 9999999999999999999654321 23589999999999999999999998 89999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhh
Q 004155 558 DKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFY 635 (771)
Q Consensus 558 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~ 635 (771)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 99999999999999876543321 2233457889999999998899999999999999999999 999997544322211
Q ss_pred HHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 636 LLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
.+........+......+.+++.+||+.||.+||++.|+++.|+.+..
T Consensus 271 ----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 271 ----------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp ----------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------------HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111111111222334568899999999999999999999999988643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=348.24 Aligned_cols=256 Identities=26% Similarity=0.365 Sum_probs=204.0
Q ss_pred HhcCCCCCCccccCCceeEEEEEcCC----CcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMAD----GTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
..++|.+.+.||+|+||.||+|...+ +..||+|++... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35678899999999999999996432 346999999765 33456789999999999999999999999865 4568
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 89 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 99999999999999943 234689999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 574 DEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 574 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~--------------- 227 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL--------------- 227 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH---------------
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH---------------
Confidence 65543333344567889999999998999999999999999999998 99999754443321111
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
........+......+.+++.+||+.||++||++.|+++.|+.+
T Consensus 228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 228 -EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -hcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 11001111122334588999999999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=354.81 Aligned_cols=264 Identities=22% Similarity=0.307 Sum_probs=207.3
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe----CCEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIE----GNQLLL 494 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 494 (771)
.++|++.+.||+|+||.||++.. .+|+.||||++........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46788999999999999999954 6799999999977666677889999999999999999999999873 347899
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+++|+|.+++.........+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999955333446799999999999999999999998 8999999999999999999999999998765
Q ss_pred CCCCcc--------cccccccCCCccchhhhccCC---CCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHH
Q 004155 575 EEDNTH--------ISTRVAGTFGYMAPEYAMRGY---LTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALIL 643 (771)
Q Consensus 575 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 643 (771)
...... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------ 252 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK------------ 252 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT------------
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc------------
Confidence 321111 012245799999999987543 689999999999999999999998531100
Q ss_pred HhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 644 KAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 644 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
.......+...............+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 253 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 253 --GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp --TSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred --cchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 0011111111111111122345688999999999999999999999999986543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=358.16 Aligned_cols=244 Identities=22% Similarity=0.322 Sum_probs=203.3
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 5788999999999999999954 579999999986532 234567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999942 34689999999999999999999998 899999999999999999999999999986643
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+....
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~---------------~i~~~~ 254 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE---------------KIVSGK 254 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------HHHHCC
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHH---------------HHHcCC
Confidence 2 234579999999999999999999999999999999999999997543322111 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPS-----MSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 692 (771)
. .++......+.+++.+||+.||++||+ +.|+++
T Consensus 255 ~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 255 V--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1 112223345889999999999999998 777765
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.39 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=201.5
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
.++|.+.+.||+|+||.||+|. ..+|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3578899999999999999995 4678999999986531 12245788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+ +|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~E~~-~g~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIV----EKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 679999883 235699999999999999999999999 89999999999999999999999999998665
Q ss_pred CCCcccccccccCCCccchhhhccCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
.... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......... .+.
T Consensus 160 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~i~ 221 (336)
T 3h4j_B 160 DGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------KVN 221 (336)
T ss_dssp TSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------CCC
T ss_pred CCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------HHH
Confidence 4332 234569999999999987765 789999999999999999999997543222110 000
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. ....+......+.+++.+||+.||.+|||+.|+++
T Consensus 222 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 222 SC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00 01112223345789999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=365.52 Aligned_cols=275 Identities=23% Similarity=0.307 Sum_probs=212.0
Q ss_pred ccCCCCHHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-----CCcEE
Q 004155 407 HTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-----HPNLV 480 (771)
Q Consensus 407 ~~~~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv 480 (771)
....+++++.....++|.+.++||+|+||.||+|.. .+++.||||+++. .....+.+..|+.++++++ ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 344567777777889999999999999999999954 5789999999975 3344567788999999986 99999
Q ss_pred eEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC-
Q 004155 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK- 559 (771)
Q Consensus 481 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~- 559 (771)
++++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDP 173 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccc
Confidence 9999999999999999999 899999995432 23589999999999999999999998 8999999999999975
Q ss_pred ------------------------CCCeEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHH
Q 004155 560 ------------------------DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVA 615 (771)
Q Consensus 560 ------------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil 615 (771)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 7899999999998654322 345689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCccchhhHHHHHHHH--------HhhCChhHHhhhh-----cCCCC-CH---------------HHH
Q 004155 616 LEIVSGRSNSSCKPKEDIFYLLDWALIL--------KAQGNLMELVDKR-----LGSNF-DK---------------EQV 666 (771)
Q Consensus 616 ~elltG~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d~~-----l~~~~-~~---------------~~~ 666 (771)
|||++|+.||......+........... .........++.. ..... .. ...
T Consensus 250 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 329 (360)
T 3llt_A 250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329 (360)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred HHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence 9999999999765433222211110000 0000000000000 00000 00 011
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 667 MVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 667 ~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+.+++.+||+.||++|||+.|+++
T Consensus 330 ~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 330 ELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 45779999999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=354.12 Aligned_cols=263 Identities=24% Similarity=0.365 Sum_probs=199.9
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||.||+|. ..+|+.||||++... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 468889999999999999995 467999999998753 2344677899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++++|.+++.........+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999954333345789999999999999999999998 899999999999999999999999999986544
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .... .... .. .
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~---~~~~-~~--------~ 254 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLC---KKIE-QC--------D 254 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHH---HHHH-TT--------C
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHH---HHhh-cc--------c
Confidence 322 2233568999999999999999999999999999999999999997533221 1111 1111 11 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
............+.+++.+||+.||++||++.+|++.|+.+.+.
T Consensus 255 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 10001112234688999999999999999999999999886544
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=361.71 Aligned_cols=246 Identities=24% Similarity=0.314 Sum_probs=196.8
Q ss_pred CCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCCH
Q 004155 426 DNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSL 504 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 504 (771)
.+.||+|+||.||+|. ..+|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 5689999999999995 467999999999877666678899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE--cCCCCeEEEeecCccccCCCCcccc
Q 004155 505 ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL--DKDLNPKISDFGLAKLDEEDNTHIS 582 (771)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DFGla~~~~~~~~~~~ 582 (771)
.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 174 FDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp HHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 9988432 34689999999999999999999998 89999999999999 6778999999999987654332 2
Q ss_pred cccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCC
Q 004155 583 TRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFD 662 (771)
Q Consensus 583 ~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 662 (771)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ...... . ...... ..
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~------~i~~~~-~-~~~~~~-~~--- 313 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN------NILACR-W-DLEDEE-FQ--- 313 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHTC-C-CSCSGG-GT---
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhcc-C-CCChhh-hc---
Confidence 33469999999999999999999999999999999999999997654322111 000000 0 000000 01
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 663 KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 663 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.....+.+++.+||+.||++||++.|+++
T Consensus 314 -~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 -DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 12346889999999999999999999987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=364.29 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=198.2
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCC--CCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQ--HPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|.+.+.||+|+||.||+|...+++.||||++... .....+.+.+|+.++++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999998878999999998654 3344678999999999996 599999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
| +.+++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 568899999943 34689999999999999999999998 899999999999995 58999999999987654
Q ss_pred CCcc-cccccccCCCccchhhhcc-----------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHH
Q 004155 577 DNTH-ISTRVAGTFGYMAPEYAMR-----------GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 577 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~--------- 275 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--S--------- 275 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--H---------
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--H---------
Confidence 3322 2334579999999999865 468999999999999999999999996532211 0
Q ss_pred hhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 645 AQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 645 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+..++++.....++......+.+++.+||+.||++||++.|+++
T Consensus 276 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 276 ---KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp ---HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 112223332222222222346889999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=351.51 Aligned_cols=264 Identities=23% Similarity=0.321 Sum_probs=199.5
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
++|++.++||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 6788999999999999999955 4689999999865432 335678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999998833 34689999999999999999999998 8999999999999999999999999999876543
Q ss_pred CcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHH--------HHHhhCC
Q 004155 578 NTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL--------ILKAQGN 648 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 648 (771)
... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||......+......... .......
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 SDY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred ccc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 322 234568999999999976 678999999999999999999999997654433322211100 0000000
Q ss_pred hhHHhh-hhcCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 649 LMELVD-KRLGSNFD-----KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 649 ~~~~~d-~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...... +....... ......+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 00000000 112345889999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=383.01 Aligned_cols=259 Identities=28% Similarity=0.439 Sum_probs=211.8
Q ss_pred HhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
..++|++.++||+|+||.||+|...++..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 456788899999999999999988778889999997643 345789999999999999999999999876 678999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++|+|.+++... ....+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 343 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 343 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 9999999999432 224689999999999999999999998 89999999999999999999999999998665432
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
........++..|+|||++.+..++.++|||||||++|||++ |+.||......+... .+....
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~----------------~i~~~~ 481 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD----------------QVERGY 481 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH----------------HHHTTC
T ss_pred eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----------------HHHcCC
Confidence 222233456789999999999999999999999999999999 999997543322111 111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
....+......+.+++.+||+.||++||++.+|+++|+.....
T Consensus 482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 1122223445688999999999999999999999999987543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=353.50 Aligned_cols=265 Identities=18% Similarity=0.229 Sum_probs=200.2
Q ss_pred hcCCCCCCccccCCceeEEEEEcC----CCcEEEEEEcccCChh-----------cHHHHHHHHHHHHcCCCCcEEeEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMA----DGTVVAVKQLSSKSKQ-----------GNREFVNEIGMISALQHPNLVKLHG 484 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 484 (771)
.++|.+.+.||+|+||.||+|... ++..||||++...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357888999999999999999654 5788999998764321 1234677889999999999999999
Q ss_pred EEEe----CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC
Q 004155 485 CCIE----GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD 560 (771)
Q Consensus 485 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~ 560 (771)
++.. ....++||||+ +++|.+++.. ...+++..++.|+.||+.||+|||+. +|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9988 77899999999 9999999943 23799999999999999999999998 89999999999999888
Q ss_pred C--CeEEEeecCccccCCCCcc------cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc
Q 004155 561 L--NPKISDFGLAKLDEEDNTH------ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKED 632 (771)
Q Consensus 561 ~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~ 632 (771)
+ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 9999999999876433211 1234579999999999999999999999999999999999999996432221
Q ss_pred hhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 633 IFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
.. ... ....... .+...+...... ......+.+++.+||+.||++||++.+|++.|+...
T Consensus 268 ~~-~~~-~~~~~~~-~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 VA-VQT-AKTNLLD-ELPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HH-HHH-HHHHHHH-TTTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HH-HHH-HHHhhcc-cccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 11 111 1111111 111112111110 012345889999999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=346.38 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=207.2
Q ss_pred cCCCCCC-ccccCCceeEEEEEc---CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 421 NNFAPDN-KIGEGGFGPVYKGHM---ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 421 ~~f~~~~-~lG~G~~g~Vy~~~~---~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
++|.+.+ .||+|+||.||+|.. .++..||||+++... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555555 899999999999964 357889999997643 34567899999999999999999999999 55679999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999532 34699999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCccc--ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 576 EDNTHI--STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 576 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
...... .....||+.|+|||++.+..++.++||||||+++|||++ |+.||......+... .
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----------------~ 225 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----------------F 225 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH----------------H
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH----------------H
Confidence 433221 223456889999999998889999999999999999998 999997654332211 1
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
+........+......+.+++.+||+.||++||++.++++.|+.+.
T Consensus 226 i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 226 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111111222334456889999999999999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=348.50 Aligned_cols=260 Identities=30% Similarity=0.485 Sum_probs=196.4
Q ss_pred HhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
..++|++.++||+|+||.||+|... ..||||+++.. .....+.+.+|+.++++++||||+++++++ ..+..++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3467889999999999999999764 35999998754 334457899999999999999999999965 456689999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 99 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 99 QWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999999543 34699999999999999999999998 899999999999999999999999999986543
Q ss_pred CC-cccccccccCCCccchhhhc---cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 577 DN-THISTRVAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 577 ~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
.. ........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+. .... ...+...
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~----~~~~~~~-- 244 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEM----VGRGSLS-- 244 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHH----HHHTSCC--
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHH----hcccccC--
Confidence 22 22223456999999999986 56789999999999999999999999976443221 1111 1111110
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
+.+ ..........+.+++.+||+.||++||++.|++++|+.+.
T Consensus 245 --~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 --PDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp --CCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --cch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 000 1111233456889999999999999999999999998864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=360.17 Aligned_cols=256 Identities=27% Similarity=0.394 Sum_probs=203.0
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcE----EEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTV----VAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
++|++.++||+|+||.||+|.. .+++. ||+|.+.... ......+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 5688899999999999999954 44543 8888875432 233456788999999999999999999986 456899
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999543 24689999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 575 EEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 575 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
...... ......||..|+|||++.+..++.++|||||||++|||+| |+.||............
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--------------- 230 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL--------------- 230 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH---------------
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH---------------
Confidence 544322 2344568889999999999999999999999999999999 99999765433322111
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
........+......+.+++.+||+.||++||++.|+++.|+....
T Consensus 231 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 231 -EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -HTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -HcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111111223347789999999999999999999999987654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=354.88 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=199.1
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 495 (771)
++|++.+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5688899999999999999954 56899999999754 233456788999999988 899999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999993 234699999999999999999999998 89999999999999999999999999998543
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchh--hHHHHHHHHHhhCChhHHh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF--YLLDWALILKAQGNLMELV 653 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 653 (771)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........ .+.
T Consensus 162 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------~i~ 232 (345)
T 3a8x_A 162 RPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--------VIL 232 (345)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH--------HHH
T ss_pred CCCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH--------HHH
Confidence 3222 234467999999999999999999999999999999999999999753221110 00000000 111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSM 687 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 687 (771)
... ..++......+.+++.+||+.||++||++
T Consensus 233 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 233 EKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred cCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111 11222234468899999999999999996
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=358.73 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=202.9
Q ss_pred HhcCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCC---hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKS---KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 493 (771)
..++|++.+.||+|+||.||+|... +|+.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3568999999999999999999654 58899999987542 23456788999999988 7999999999999999999
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+||||+++|+|.+++. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999993 234699999999999999999999998 899999999999999999999999999985
Q ss_pred cCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 574 DEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 574 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+.
T Consensus 171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~---------------~i~ 234 (353)
T 2i0e_A 171 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ---------------SIM 234 (353)
T ss_dssp CCCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------HHH
T ss_pred cccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHH---------------HHH
Confidence 432222 2344679999999999999999999999999999999999999997543322111 111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPS-----MSSVVS 692 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 692 (771)
.... .++......+.+++.+||+.||++||+ +.|+++
T Consensus 235 ~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 235 EHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred hCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111 122223346889999999999999996 466654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=347.94 Aligned_cols=260 Identities=24% Similarity=0.373 Sum_probs=205.4
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe--CCEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIE--GNQLLL 494 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 494 (771)
.++|++.+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46788999999999999999954 57899999999754 33446779999999999999999999998864 578999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcC--CCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES--RLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
||||+++++|.+++.........+++..++.++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999654333456999999999999999999999982 0129999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 573 LDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 573 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. .. .. ..+.
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~---~i-~~~~---- 232 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AG---KI-REGK---- 232 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HH-HHTC----
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HH---HH-hhcc----
Confidence 7654322 12335689999999999999999999999999999999999999975432211 11 00 1111
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
....+......+.+++.+||+.||++||++.|+++.+..
T Consensus 233 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 233 -----FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 111222234568899999999999999999999986654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=354.77 Aligned_cols=248 Identities=24% Similarity=0.357 Sum_probs=194.1
Q ss_pred hcCCCCCCccccCCceeEEEEEc----CCCcEEEEEEcccCC----hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM----ADGTVVAVKQLSSKS----KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 491 (771)
.++|++.+.||+|+||.||++.. .+|+.||+|+++... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46788999999999999999965 478999999997642 2234567889999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.++||||+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLE----REGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999993 234689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 572 KLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 572 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .
T Consensus 169 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---------------~ 232 (327)
T 3a62_A 169 KESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID---------------K 232 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---------------H
T ss_pred cccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHH---------------H
Confidence 85433222 2234579999999999999999999999999999999999999997543322111 1
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
+..... ..+......+.+++.+||+.||++|| ++.|+++
T Consensus 233 i~~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 233 ILKCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHhCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 111111 11222334688999999999999999 6777765
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=348.71 Aligned_cols=253 Identities=25% Similarity=0.351 Sum_probs=199.3
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.++|.+.++||+|+||.||+|. ..+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 4578899999999999999995 4568999999987643 3346789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE---cCCCCeEEEeecCcccc
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLD 574 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFGla~~~ 574 (771)
|+++|+|.+++.........+++..++.|+.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999854433346799999999999999999999998 89999999999999 55688999999999865
Q ss_pred CCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
..... .....||+.|+|||.+. ..++.++|||||||++|||++|+.||......+..... ... .
T Consensus 178 ~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~------~~~-------~ 241 (285)
T 3is5_A 178 KSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA------TYK-------E 241 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHC-------C
T ss_pred CCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh------ccC-------C
Confidence 44322 23456899999999886 56899999999999999999999999754432211100 000 0
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...... .......+.+++.+||+.||++||++.|+++
T Consensus 242 ~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 PNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 0012345788999999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.06 Aligned_cols=247 Identities=21% Similarity=0.309 Sum_probs=204.2
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
..++|++.+.||+|+||.||+|.. .++..||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 356789999999999999999954 4578999999987655667889999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE---cCCCCeEEEeecCcccc
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLD 574 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFGla~~~ 574 (771)
|+++++|.+++. ....+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVV----HKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999999983 234689999999999999999999998 89999999999999 88899999999999876
Q ss_pred CCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
..... .....||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+.... .. .+
T Consensus 160 ~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~-~~------- 222 (277)
T 3f3z_A 160 KPGKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK------IR-EG------- 222 (277)
T ss_dssp CTTSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HH-HC-------
T ss_pred cCccc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH------HH-hC-------
Confidence 54332 2345699999999988654 89999999999999999999999976433221110 00 00
Q ss_pred hhcCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 KRLGSNFDK----EQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. ...+. .....+.+++.+|++.||++||++.|+++
T Consensus 223 -~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 223 -T--FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -C--CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -C--CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 01111 12346889999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.70 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=203.3
Q ss_pred hcCCCCCCccccCCceeEEEEEcC-CC-------cEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMA-DG-------TVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~-~g-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 491 (771)
.++|.+.+.||+|+||.||+|... ++ +.||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 357888999999999999999543 23 5799999987666677889999999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC--------e
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN--------P 563 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~ 563 (771)
.++||||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999532 23489999999999999999999998 8999999999999998887 9
Q ss_pred EEEeecCccccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHH
Q 004155 564 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALI 642 (771)
Q Consensus 564 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~ 642 (771)
||+|||+++..... ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+........ .. ..
T Consensus 161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--~~---~~ 230 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--KL---QF 230 (289)
T ss_dssp EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HH---HH
T ss_pred eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--HH---HH
Confidence 99999999754332 22458899999999987 7799999999999999999996555433222111 00 00
Q ss_pred HHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 643 LKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 643 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
.... ..+.. .....+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 231 ~~~~--------~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 231 YEDR--------HQLPA----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHTT--------CCCCC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred hhcc--------CCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 0000 01111 1123478899999999999999999999999997653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=358.09 Aligned_cols=260 Identities=21% Similarity=0.233 Sum_probs=202.4
Q ss_pred HHHHHhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC-----ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe
Q 004155 415 QIKAATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK-----SKQGNREFVNEIGMISALQHPNLVKLHGCCIE 488 (771)
Q Consensus 415 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 488 (771)
++....++|.+.+.||+|+||.||+|. ..+++.||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 345677889999999999999999995 467889999998643 23445789999999999999999999999999
Q ss_pred CCEEEEEEEeccCCCHHHHhcCCCc------------------------------------cCCCCChHHHHHHHHHHHH
Q 004155 489 GNQLLLIYEYMENNSLARALFGPEA------------------------------------HRLKLDWPTRHRICVGIAR 532 (771)
Q Consensus 489 ~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~~ia~ 532 (771)
.+..++||||+++|+|.+++..... ....+++..++.|+.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999999842100 0122467788899999999
Q ss_pred HHHHhhhcCCCceeccCCCCCcEEEcCCC--CeEEEeecCccccCCCCc---ccccccccCCCccchhhhcc--CCCCch
Q 004155 533 GLAYLHEESRLKIVHRDIKATNVLLDKDL--NPKISDFGLAKLDEEDNT---HISTRVAGTFGYMAPEYAMR--GYLTDK 605 (771)
Q Consensus 533 aL~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~k 605 (771)
||+|||+. +|+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999998 899999999999998776 899999999986543221 12234569999999999975 678999
Q ss_pred HhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC--CHHHHHHHHHHHHHccCCCCCC
Q 004155 606 ADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF--DKEQVMVMINVALLCTDVSSTS 683 (771)
Q Consensus 606 sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~ 683 (771)
+|||||||++|||++|+.||......+... .+......... .......+.+++.+||+.||++
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTIS---------------QVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------HHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHH---------------HHHhcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence 999999999999999999997544322111 11111110000 0112346889999999999999
Q ss_pred CCCHHHHHH
Q 004155 684 RPSMSSVVS 692 (771)
Q Consensus 684 RPs~~evl~ 692 (771)
||++.|+++
T Consensus 322 Rps~~~~l~ 330 (345)
T 3hko_A 322 RFDAMRALQ 330 (345)
T ss_dssp SCCHHHHHH
T ss_pred CCCHHHHhc
Confidence 999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.91 Aligned_cols=252 Identities=22% Similarity=0.304 Sum_probs=204.9
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh------hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK------QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 491 (771)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 346788999999999999999954 5689999999875432 136789999999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC----CeEEEe
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISD 567 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~D 567 (771)
.++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999999943 34689999999999999999999998 899999999999999888 799999
Q ss_pred ecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC
Q 004155 568 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG 647 (771)
Q Consensus 568 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 647 (771)
||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..... .....
T Consensus 163 fg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i-----~~~~~ 235 (321)
T 2a2a_A 163 FGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-----TSVSY 235 (321)
T ss_dssp CTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-----HTTCC
T ss_pred CccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----Hhccc
Confidence 999987654322 23456899999999999999999999999999999999999999754332211100 00000
Q ss_pred ChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 648 NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 648 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. ++..... ....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~----~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 DF----DEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CC----CHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cc----Chhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0000011 1245789999999999999999999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=352.02 Aligned_cols=272 Identities=28% Similarity=0.369 Sum_probs=206.9
Q ss_pred CCHHHHHHHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC--CCCcEEeEEEEEEe
Q 004155 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL--QHPNLVKLHGCCIE 488 (771)
Q Consensus 411 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~ 488 (771)
.....-....++|++.++||+|+||.||+|... |+.||||++... ....+..|.+++... +||||+++++++..
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 344444556678999999999999999999874 899999998643 234555666666655 89999999999998
Q ss_pred C----CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcC-----CCceeccCCCCCcEEEcC
Q 004155 489 G----NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES-----RLKIVHRDIKATNVLLDK 559 (771)
Q Consensus 489 ~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-----~~~ivH~Dlkp~NIll~~ 559 (771)
. ...++||||+++|+|.+++. ...+++..++.++.|++.||+|||+.+ .++|+||||||+|||++.
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred CCCCCCceEEEEeccCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence 7 78999999999999999993 246899999999999999999999862 347999999999999999
Q ss_pred CCCeEEEeecCccccCCCCccc---ccccccCCCccchhhhccCCCCch------HhHHHHHHHHHHHHhC---------
Q 004155 560 DLNPKISDFGLAKLDEEDNTHI---STRVAGTFGYMAPEYAMRGYLTDK------ADVYSFGIVALEIVSG--------- 621 (771)
Q Consensus 560 ~~~~kl~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------sDV~S~Gvil~elltG--------- 621 (771)
++.+||+|||+++......... .....||+.|+|||++.+...+.+ +|||||||++|||+||
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 9999999999997665433221 123579999999999987766554 9999999999999999
Q ss_pred -CCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 622 -RSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFD-----KEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 622 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
+.||.......... .. .... ..........+ ......+.+++.+||+.||++||++.||++.|+
T Consensus 258 ~~~p~~~~~~~~~~~-~~-~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 258 YQLPYHDLVPSDPSY-ED-MREI--------VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327 (337)
T ss_dssp CCCTTTTTSCSSCCH-HH-HHHH--------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ccccHhhhcCCCCch-hh-hHHH--------HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence 56665432221110 00 0000 01111112222 256778999999999999999999999999998
Q ss_pred CCCCCC
Q 004155 696 GRADVQ 701 (771)
Q Consensus 696 ~~~~~~ 701 (771)
.+.+..
T Consensus 328 ~l~~~~ 333 (337)
T 3mdy_A 328 KMSESQ 333 (337)
T ss_dssp HHHHTT
T ss_pred HHHhhc
Confidence 865443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=343.30 Aligned_cols=264 Identities=22% Similarity=0.269 Sum_probs=203.7
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEE-EeCCEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC-IEGNQLLLIY 496 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~ 496 (771)
..++|++.+.||+|+||.||+|. ..+++.||||++..... ...+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 45789999999999999999995 46789999998755332 23578899999999887766665554 6778899999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE---cCCCCeEEEeecCccc
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKL 573 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFGla~~ 573 (771)
||+ +++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 99999999422 34699999999999999999999998 89999999999999 7899999999999987
Q ss_pred cCCCCcc------cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC
Q 004155 574 DEEDNTH------ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG 647 (771)
Q Consensus 574 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 647 (771)
....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 6543321 1234579999999999999999999999999999999999999998644333222222111111111
Q ss_pred ChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 648 NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 648 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
.. +.....+ ...+.+++.+||+.||++||++.++++.|+.+...
T Consensus 238 ~~-----~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 238 PI-----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp CH-----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hh-----hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 10 1111122 24588999999999999999999999999886543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=352.65 Aligned_cols=264 Identities=20% Similarity=0.263 Sum_probs=198.2
Q ss_pred hcCCCCC-CccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEE
Q 004155 420 TNNFAPD-NKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 420 ~~~f~~~-~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 496 (771)
.+.|.+. +.||+|+||.||+|. ..+++.||||++..........+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567764 789999999999995 457899999999876656678899999999985 7999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC---eEEEeecCccc
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN---PKISDFGLAKL 573 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFGla~~ 573 (771)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||+++.
T Consensus 91 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999943 34689999999999999999999998 8999999999999988776 99999999976
Q ss_pred cCCCCc------ccccccccCCCccchhhhcc-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHH
Q 004155 574 DEEDNT------HISTRVAGTFGYMAPEYAMR-----GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALI 642 (771)
Q Consensus 574 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~ 642 (771)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 542211 11123459999999999875 5688999999999999999999999976543221100000000
Q ss_pred HHhhCChhHHhhhhcCCCCCHH----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 643 LKAQGNLMELVDKRLGSNFDKE----QVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 643 ~~~~~~~~~~~d~~l~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. ...+.+.+... ...++.. ....+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~-~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 AC-QNMLFESIQEG-KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HH-HHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hH-HHHHHHHHhcc-CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00 00000001100 0111111 2346889999999999999999999987
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=365.57 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=206.1
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5788899999999999999954 579999999986532 123567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 96 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999943 34699999999999999999999998 899999999999999999999999999987654
Q ss_pred CCcccccccccCCCccchhhhccCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......... .+.+.
T Consensus 169 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~---------------~i~~~ 231 (476)
T 2y94_A 169 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK---------------KICDG 231 (476)
T ss_dssp TCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH---------------HHHTT
T ss_pred ccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH---------------HHhcC
Confidence 322 234579999999999988764 789999999999999999999997543322111 11111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCC
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGR 697 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 697 (771)
.. ..+......+.+++.+||+.||++|||+.|+++ .++..
T Consensus 232 ~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 232 IF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp CC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred Cc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 11 111112345788999999999999999999997 55554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=360.40 Aligned_cols=269 Identities=19% Similarity=0.266 Sum_probs=203.8
Q ss_pred HhcCCCCCCccccC--CceeEEEEEc-CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 419 ATNNFAPDNKIGEG--GFGPVYKGHM-ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 419 ~~~~f~~~~~lG~G--~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
..++|++.++||+| +||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34678999999999 9999999954 479999999997542 344567889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+||||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+..
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999995432 24689999999999999999999998 899999999999999999999999999865
Q ss_pred cCCCCc------ccccccccCCCccchhhhcc--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHH-HHHHH-H
Q 004155 574 DEEDNT------HISTRVAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL-DWALI-L 643 (771)
Q Consensus 574 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~-~~~~~-~ 643 (771)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ ..... .
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 432211 11123468999999999987 57899999999999999999999999765433321100 00000 0
Q ss_pred Hh-----hC-------------ChhHHhhh---h------cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 644 KA-----QG-------------NLMELVDK---R------LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 644 ~~-----~~-------------~~~~~~d~---~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. .. ...+.+.. . ............+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 00 00000000 0 000011222346889999999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=355.80 Aligned_cols=270 Identities=24% Similarity=0.397 Sum_probs=215.8
Q ss_pred CCHHHHHHHhcCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEE
Q 004155 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLH 483 (771)
Q Consensus 411 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~ 483 (771)
+..++.+...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344455566788999999999999999999543 36889999997543 33456789999999999999999999
Q ss_pred EEEEeCCEEEEEEEeccCCCHHHHhcCCCc------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE
Q 004155 484 GCCIEGNQLLLIYEYMENNSLARALFGPEA------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL 557 (771)
Q Consensus 484 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 557 (771)
+++.+.+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 999999999999999999999999953211 124679999999999999999999998 89999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhh
Q 004155 558 DKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFY 635 (771)
Q Consensus 558 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~ 635 (771)
+.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 251 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence 99999999999999865433221 2233457889999999999999999999999999999999 888987543322111
Q ss_pred HHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 636 LLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
.. ..... ...+......+.+++.+||+.||++||++.|+++.|++...
T Consensus 252 ------~~---------~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 ------FV---------MEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ------HH---------HTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------HH---------HcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 00 11111 11122334568899999999999999999999999998654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=353.51 Aligned_cols=244 Identities=24% Similarity=0.341 Sum_probs=178.5
Q ss_pred CCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEEEEEEeccCCC
Q 004155 426 DNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLLLIYEYMENNS 503 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gs 503 (771)
.+.||+|+||.||+|.. .+|+.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999954 56899999998643 3467788999999997 9999999999999999999999999999
Q ss_pred HHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC---CeEEEeecCccccCCCCcc
Q 004155 504 LARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL---NPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 504 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFGla~~~~~~~~~ 580 (771)
|.+++.. ...+++.++..|+.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++........
T Consensus 93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 9999943 35799999999999999999999998 899999999999997665 8999999999866543322
Q ss_pred cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCC
Q 004155 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSN 660 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 660 (771)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ...+++.......
T Consensus 166 -~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------------~~~~~~~~i~~~~ 232 (325)
T 3kn6_A 166 -LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT------------SAVEIMKKIKKGD 232 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC------------CHHHHHHHHTTTC
T ss_pred -ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc------------cHHHHHHHHHcCC
Confidence 234568999999999999999999999999999999999999997543221100 1111111111111
Q ss_pred --CC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 661 --FD----KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 661 --~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. ......+.+++.+||+.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 233 FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 11 112456889999999999999999999984
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=353.81 Aligned_cols=269 Identities=25% Similarity=0.365 Sum_probs=214.3
Q ss_pred CCHHHHHHHhcCCCCCCccccCCceeEEEEEc------CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeE
Q 004155 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKL 482 (771)
Q Consensus 411 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l 482 (771)
+...+.....++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44455555678999999999999999999952 457899999997653 33456789999999999 79999999
Q ss_pred EEEEEeCC-EEEEEEEeccCCCHHHHhcCCCcc------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccC
Q 004155 483 HGCCIEGN-QLLLIYEYMENNSLARALFGPEAH------------RLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRD 549 (771)
Q Consensus 483 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~D 549 (771)
++++...+ ..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99988654 589999999999999999654321 12388999999999999999999998 899999
Q ss_pred CCCCcEEEcCCCCeEEEeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCC
Q 004155 550 IKATNVLLDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSC 627 (771)
Q Consensus 550 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~ 627 (771)
|||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999866543322 2234568899999999999999999999999999999998 9999976
Q ss_pred CCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 628 KPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
....... .. .+........+......+.+++.+||+.||.+||++.|+++.|+.+
T Consensus 254 ~~~~~~~--~~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKIDEEF--CR-------------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCSHHH--HH-------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhHHH--HH-------------HhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 4433211 00 0111111111222334688999999999999999999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.96 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=203.9
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
.++|++.+.||+|+||.||+|. ..+|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 5789999999999999999995 456899999998654 3344567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC---eEEEeecCccc
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN---PKISDFGLAKL 573 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFGla~~ 573 (771)
||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999883 235689999999999999999999998 8999999999999976655 99999999986
Q ss_pred cCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 574 DEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 574 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........... .. .+..
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~------~~-~~~~---- 224 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ------IK-AGAY---- 224 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HH-HTCC----
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHH------HH-hccc----
Confidence 654332 2345689999999999999999999999999999999999999975433221110 00 0000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.............+.+++.+||+.||++||++.|+++
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 225 --DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp --CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000122345889999999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=343.17 Aligned_cols=264 Identities=22% Similarity=0.272 Sum_probs=207.0
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEE-EeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC-IEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~E 497 (771)
.++|++.+.||+|+||.||+|. ..+|+.||||++..... ...+.+|+.+++.++|++++..+.++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 5789999999999999999995 46799999999865433 24688999999999987766555554 67788999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE---cCCCCeEEEeecCcccc
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLD 574 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFGla~~~ 574 (771)
|+ +++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||++ +.++.+||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 89999999422 34699999999999999999999998 89999999999999 58899999999999876
Q ss_pred CCCCcc------cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 575 EEDNTH------ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 575 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 544321 12345799999999999999999999999999999999999999986443222221111111111111
Q ss_pred hhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCC
Q 004155 649 LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQ 701 (771)
Q Consensus 649 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~ 701 (771)
. +.+...+ ...+.+++.+||+.||++||++.++++.|+.+....
T Consensus 239 ~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 239 I-----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp H-----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred h-----HHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 0 1111222 245889999999999999999999999998865443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=356.69 Aligned_cols=245 Identities=27% Similarity=0.435 Sum_probs=199.2
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
+.|...+.||+|+||.||+|. ..+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 458888999999999999995 4679999999987542 233467899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+. |+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 588888732 235799999999999999999999998 899999999999999999999999999986543
Q ss_pred CCcccccccccCCCccchhhhc---cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
. ....||+.|+|||++. ...++.++|||||||++|||++|+.||......... .......
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~------ 269 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNE------ 269 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSC------
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcC------
Confidence 2 2356899999999985 567899999999999999999999999754322111 1111110
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+.. ........+.+++.+||+.||++|||+.++++
T Consensus 270 ~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 270 SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 0111 11122345788999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=344.94 Aligned_cols=247 Identities=24% Similarity=0.407 Sum_probs=201.1
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
+.++|++.+.||+|+||.||+|. ..+++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 34678899999999999999994 5567899999986532 2235678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~l~~~l~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999983 234689999999999999999999998 8999999999999999999999999998654
Q ss_pred CCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
.... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+..... ..
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---------------~~ 221 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI---------------SR 221 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---------------HH
T ss_pred Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH---------------Hh
Confidence 3322 23456899999999999999999999999999999999999999754332211100 00
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.....+......+.+++.+||+.||++||++.|+++
T Consensus 222 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 222 --VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp --TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 011122223345789999999999999999999997
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.89 Aligned_cols=263 Identities=25% Similarity=0.341 Sum_probs=198.9
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-----hhcHHHHHHHHHHHHcC---CCCcEEeEEEEEEeC
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-----KQGNREFVNEIGMISAL---QHPNLVKLHGCCIEG 489 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~ 489 (771)
.+++|++.++||+|+||+||+|.. .+|+.||||++.... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999964 578999999986432 11234567787777766 499999999999876
Q ss_pred C-----EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeE
Q 004155 490 N-----QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 564 (771)
Q Consensus 490 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 564 (771)
. ..++||||+. |+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 5 5899999997 59999995433 23499999999999999999999998 899999999999999999999
Q ss_pred EEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHH
Q 004155 565 ISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 565 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
|+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|++||......+.... .....
T Consensus 161 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~ 235 (308)
T 3g33_A 161 LADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK---IFDLI 235 (308)
T ss_dssp ECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH---HHHHH
T ss_pred EeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHh
Confidence 999999986643322 2445789999999999999999999999999999999999999976543322111 11110
Q ss_pred h---hCChhH---HhhhhcCC--CCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 645 A---QGNLME---LVDKRLGS--NFD-----KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 645 ~---~~~~~~---~~d~~l~~--~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. ...+.. ........ ... .+....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0 000000 00000000 000 112346789999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=371.49 Aligned_cols=248 Identities=25% Similarity=0.321 Sum_probs=195.0
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
.++|++.++||+|+||.||+|. ..+|+.||||++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 3578899999999999999994 567899999998753 233446678899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE-ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
|||+++|+|.+++. ....+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+|+..
T Consensus 227 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999993 23579999999999999999999998 6 8999999999999999999999999999864
Q ss_pred CCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........... +..
T Consensus 300 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---------------i~~ 363 (446)
T 4ejn_A 300 IKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---------------ILM 363 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---------------HHH
T ss_pred cCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH---------------HHh
Confidence 33322 23346799999999999999999999999999999999999999975443222111 011
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
.. ..++......+.+++.+||+.||++|| ++.|+++
T Consensus 364 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 364 EE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11 112222334688999999999999999 9999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=353.59 Aligned_cols=257 Identities=20% Similarity=0.284 Sum_probs=195.4
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC----E
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGN----Q 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 491 (771)
.++|++.+.||+|+||.||+|. ..+++.||||++.... ......+.+|+.++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4678999999999999999995 5678999999997642 233467899999999999999999999987543 3
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.++||||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 5999999999999999942 34699999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcc--cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCCh
Q 004155 572 KLDEEDNTH--ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL 649 (771)
Q Consensus 572 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (771)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCCCC
Confidence 866543222 223356899999999999999999999999999999999999999754332211 111111110
Q ss_pred hHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH-HhcC
Q 004155 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS-MLEG 696 (771)
Q Consensus 650 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~-~L~~ 696 (771)
.. ...... ....+.+++.+||+.||++||++.+++. .+..
T Consensus 238 ~~---~~~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 238 PP---SARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp CH---HHHSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred Cc---ccccCC----CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 00 000111 2345889999999999999997766553 4443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.97 Aligned_cols=257 Identities=27% Similarity=0.445 Sum_probs=201.3
Q ss_pred cCCCCCCccccCCceeEEEEEcCC-----CcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMAD-----GTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
++|...+.||+|+||.||+|.... +..||||+++... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456778999999999999995432 3469999997643 3445678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 124 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999432 34689999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCcc--cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 575 EEDNTH--ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 575 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
...... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~---------------- 261 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK---------------- 261 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----------------
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH----------------
Confidence 543221 1222346788999999999999999999999999999999 999997543322111
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
.+........+......+.+++.+||+.||++||++.++++.|+.+..
T Consensus 262 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 262 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111111111222334568899999999999999999999999987543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=354.01 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=202.2
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcE----EEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTV----VAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~----vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
.++|++.++||+|+||.||+|.. .+++. ||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 35788999999999999999954 44543 577777543 3345678999999999999999999999998765 88
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+|+||+.+|+|.+++... ...+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 999999999999999542 34689999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 574 DEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 574 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
....... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..........
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~---------------- 230 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS---------------- 230 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----------------
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----------------
Confidence 6443322 2233456889999999999999999999999999999999 999997654443221
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
.+........+......+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 231 ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111111222223445688999999999999999999999999986543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=361.20 Aligned_cols=264 Identities=22% Similarity=0.322 Sum_probs=193.5
Q ss_pred HHhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCC--E
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQ-HPNLVKLHGCCIEGN--Q 491 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 491 (771)
...++|++.+.||+|+||.||+|. ..+|+.||||++... .......+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 456789999999999999999994 567999999998643 3344667889999999997 999999999998554 7
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.|+|||||+ ++|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 86 ~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIR-----ANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHH-----HTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999997 58999983 24689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCC--------------------cccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Q 004155 572 KLDEEDN--------------------THISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPK 630 (771)
Q Consensus 572 ~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~ 630 (771)
+...... ....+...||+.|+|||++.+ ..++.++|||||||++|||++|++||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 8653311 112234579999999999986 6789999999999999999999999976543
Q ss_pred cchhhHHHHHHHHHhhCC-----------hhHHhhh----------hcCCCC------------CHHHHHHHHHHHHHcc
Q 004155 631 EDIFYLLDWALILKAQGN-----------LMELVDK----------RLGSNF------------DKEQVMVMINVALLCT 677 (771)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~-----------~~~~~d~----------~l~~~~------------~~~~~~~l~~l~~~Cl 677 (771)
.+....+. ....... ....++. .....+ .......+.+++.+||
T Consensus 237 ~~~~~~i~---~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 237 MNQLERII---GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp HHHHHHHH---HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred HHHHHHHH---HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 32221110 0000000 0000000 000000 0011345789999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 004155 678 DVSSTSRPSMSSVVSM 693 (771)
Q Consensus 678 ~~dP~~RPs~~evl~~ 693 (771)
+.||++|||+.|+++-
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 9999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=353.83 Aligned_cols=259 Identities=27% Similarity=0.420 Sum_probs=205.5
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcE--EEEEEcccC-ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTV--VAVKQLSSK-SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~--vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 495 (771)
++|.+.+.||+|+||.||+|.. .+|.. ||+|.+... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 5788899999999999999954 45664 499998753 233456789999999999 899999999999999999999
Q ss_pred EEeccCCCHHHHhcCCC------------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCe
Q 004155 496 YEYMENNSLARALFGPE------------AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 563 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 563 (771)
|||+++|+|.+++.... .....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999996543 2235799999999999999999999998 89999999999999999999
Q ss_pred EEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHH
Q 004155 564 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALI 642 (771)
Q Consensus 564 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~ 642 (771)
||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+..
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~-------- 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-------- 251 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--------
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH--------
Confidence 999999997433211 1223457889999999998889999999999999999998 99999754332211
Q ss_pred HHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 643 LKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 643 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
+.+........+......+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 252 --------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 252 --------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp --------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --------HHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11111111122223345688999999999999999999999998876443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=379.87 Aligned_cols=247 Identities=25% Similarity=0.394 Sum_probs=199.5
Q ss_pred ccccCCceeEEEEEcC---CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccCCC
Q 004155 428 KIGEGGFGPVYKGHMA---DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNS 503 (771)
Q Consensus 428 ~lG~G~~g~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 503 (771)
.||+|+||.||+|... ++..||||+++... ....++|.+|+.++++++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999553 46789999997653 3456789999999999999999999999976 56999999999999
Q ss_pred HHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccc-
Q 004155 504 LARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS- 582 (771)
Q Consensus 504 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~- 582 (771)
|.+++... ...+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 422 L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99999543 34699999999999999999999998 899999999999999999999999999987654332222
Q ss_pred -cccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCC
Q 004155 583 -TRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSN 660 (771)
Q Consensus 583 -~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 660 (771)
....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+... .+.......
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~----------------~i~~~~~~~ 559 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----------------FIEQGKRME 559 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH----------------HHHTTCCCC
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----------------HHHcCCCCC
Confidence 22345689999999999999999999999999999998 999997654433211 111111122
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 661 FDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 661 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.+......+.+++.+||+.||++||++.+|++.|+..
T Consensus 560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2333456788999999999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=350.88 Aligned_cols=261 Identities=21% Similarity=0.228 Sum_probs=199.1
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 47899999999999999999964 478999999987542 22347789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 113 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999942 34689999999999999999999998 89999999999999999999999999998665
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
...........||+.|+|||.+.+..++.++||||||+++|||++|+.||........ . .......... .
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~---~~~~~~~~~~----~ 255 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM---G---AHINQAIPRP----S 255 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH---H---HHHHSCCCCG----G
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH---H---HHhccCCCCc----c
Confidence 4433333445689999999999999999999999999999999999999975322110 0 0011000000 0
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhcCCCCCC
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRP-SMSSVVSMLEGRADVQ 701 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~~~ 701 (771)
.. .......+.+++.+||+.||++|| ++.++++.|+......
T Consensus 256 ~~----~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 256 TV----RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp GT----STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred cc----CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 11 112233588899999999999999 9999999999875543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.21 Aligned_cols=265 Identities=26% Similarity=0.413 Sum_probs=209.4
Q ss_pred hcCCCCCCccccCCceeEEEEE-----cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC--EE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-----MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGN--QL 492 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-----~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 492 (771)
.++|++.+.||+|+||.||+|. ..+|+.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 3567888999999999999997 3468999999998766666788999999999999999999999987543 68
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999999432 24689999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCccc--ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC---
Q 004155 573 LDEEDNTHI--STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG--- 647 (771)
Q Consensus 573 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--- 647 (771)
......... .....+|..|+|||.+.+..++.++||||||+++|||+||+.|+.....+ +........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~-------~~~~~~~~~~~~ 266 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-------FMRMIGNDKQGQ 266 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-------HHHHHCTTCCTH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH-------HHHhhccccchh
Confidence 765543221 22345777899999999888999999999999999999999987532100 000000000
Q ss_pred ----ChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 648 ----NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 648 ----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.+.+.+........+......+.+++.+||+.||++||++.|+++.|+.+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11122222211222233445688999999999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=360.30 Aligned_cols=250 Identities=25% Similarity=0.362 Sum_probs=193.9
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHH-HHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGM-ISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
++|++.+.||+|+||.||+|.. .+++.||||+++... ......+.+|..+ ++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 5688899999999999999954 568899999997642 2234456677776 4678999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 118 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999932 34689999999999999999999998 89999999999999999999999999998643
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .++..
T Consensus 191 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~---------------~i~~~ 254 (373)
T 2r5t_A 191 EHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD---------------NILNK 254 (373)
T ss_dssp CCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH---------------HHHHS
T ss_pred cCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------HHHhc
Confidence 3222 2344679999999999999999999999999999999999999997543322111 11111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
.+ .++......+.+++.+||+.||++||++.+.++.+.
T Consensus 255 ~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 255 PL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp CC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred cc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 11 111222345788999999999999999865444433
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=356.53 Aligned_cols=263 Identities=29% Similarity=0.409 Sum_probs=210.5
Q ss_pred HHHhcCCCCCCccccCCceeEEEEEcC-CC-----cEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEe
Q 004155 417 KAATNNFAPDNKIGEGGFGPVYKGHMA-DG-----TVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIE 488 (771)
Q Consensus 417 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~g-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 488 (771)
+...++|.+.+.||+|+||.||+|... ++ ..||+|++.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 334578899999999999999999642 22 489999997653 34457799999999999 89999999999999
Q ss_pred CCEEEEEEEeccCCCHHHHhcCCCc----------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc
Q 004155 489 GNQLLLIYEYMENNSLARALFGPEA----------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD 558 (771)
Q Consensus 489 ~~~~~lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 558 (771)
.+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+. +|+||||||+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence 9999999999999999999953211 134689999999999999999999998 899999999999999
Q ss_pred CCCCeEEEeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhH
Q 004155 559 KDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYL 636 (771)
Q Consensus 559 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~ 636 (771)
.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |..||..........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~- 277 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY- 277 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH-
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH-
Confidence 9999999999999865433222 2233457889999999999999999999999999999999 999997644332211
Q ss_pred HHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 637 LDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 637 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
..+........+......+.+++.+||+.||.+||++.|+++.|+..
T Consensus 278 --------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 278 --------------KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp --------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------------HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11111111111222345688999999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=345.96 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=204.4
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe---------
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIE--------- 488 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 488 (771)
..++|++.+.||+|+||.||+|.. .+|+.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 456789999999999999999965 479999999997643 346789999999999999999999864
Q ss_pred -------CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC
Q 004155 489 -------GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 561 (771)
Q Consensus 489 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 561 (771)
....++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 345899999999999999995422 35789999999999999999999998 899999999999999999
Q ss_pred CeEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHH
Q 004155 562 NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL 641 (771)
Q Consensus 562 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~ 641 (771)
.+||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.. . ....
T Consensus 160 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~---~~~~- 228 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----T---SKFF- 228 (284)
T ss_dssp EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----H---HHHH-
T ss_pred CEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----H---HHHH-
Confidence 999999999987654332 2335689999999999999999999999999999999999988631 0 0000
Q ss_pred HHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 004155 642 ILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQD 702 (771)
Q Consensus 642 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 702 (771)
..+.+..+...++ ..+.+++.+||+.||++||++.|+++.|+......+
T Consensus 229 --------~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 229 --------TDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp --------HHHHTTCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred --------HHhhcccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 0111111222222 347789999999999999999999999988655443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=354.10 Aligned_cols=243 Identities=21% Similarity=0.285 Sum_probs=201.7
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCCh--------hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK--------QGNREFVNEIGMISALQHPNLVKLHGCCIEG 489 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 489 (771)
..++|++.+.||+|+||.||+|. ..+|+.||||++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 45689999999999999999995 56789999999876421 1234577899999999999999999999999
Q ss_pred CEEEEEEEeccCC-CHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEee
Q 004155 490 NQLLLIYEYMENN-SLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 568 (771)
Q Consensus 490 ~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 568 (771)
+..++||||+.+| +|.+++.. ...+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 99999943 34699999999999999999999998 8999999999999999999999999
Q ss_pred cCccccCCCCcccccccccCCCccchhhhccCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC
Q 004155 569 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG 647 (771)
Q Consensus 569 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 647 (771)
|+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------- 235 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------- 235 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------
Confidence 99987654332 233569999999999988776 8899999999999999999999964211
Q ss_pred ChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 648 NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 648 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
....... .+......+.+++.+||+.||++||++.|+++.
T Consensus 236 ----~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ----TVEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----GTTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----HHhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 111123458899999999999999999999983
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.09 Aligned_cols=264 Identities=25% Similarity=0.394 Sum_probs=200.5
Q ss_pred HHHHhcCCCCCCccccCCceeEEEEEcC----CCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC
Q 004155 416 IKAATNNFAPDNKIGEGGFGPVYKGHMA----DGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEG 489 (771)
Q Consensus 416 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 489 (771)
+....++|.+.+.||+|+||.||+|... +++.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3345677889999999999999999543 3458999998754 334456799999999999999999999999865
Q ss_pred C-----EEEEEEEeccCCCHHHHhcCCC--ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC
Q 004155 490 N-----QLLLIYEYMENNSLARALFGPE--AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 562 (771)
Q Consensus 490 ~-----~~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 562 (771)
+ ..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+. +|+||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCc
Confidence 4 3599999999999999984322 2345799999999999999999999998 8999999999999999999
Q ss_pred eEEEeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHH
Q 004155 563 PKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWA 640 (771)
Q Consensus 563 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~ 640 (771)
+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||............
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~--- 262 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL--- 262 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH---
Confidence 999999999866443221 2233457889999999999999999999999999999999 88898765443321110
Q ss_pred HHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 641 LILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 641 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
. .......+......+.+++.+||+.||++||++.++++.|+.+.
T Consensus 263 ------------~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 263 ------------L-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp ------------H-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------------H-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 01111122233456889999999999999999999999998753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=352.24 Aligned_cols=270 Identities=21% Similarity=0.320 Sum_probs=210.4
Q ss_pred ccccccCCCCHHHHHHHhcCCCCC-CccccCCceeEEEEE-cCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCC-CC
Q 004155 403 GVDLHTGSFTLRQIKAATNNFAPD-NKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQ-HP 477 (771)
Q Consensus 403 ~~~~~~~~~~~~~l~~~~~~f~~~-~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~ 477 (771)
+++...+...++..+...++|.+. +.||+|+||.||+|. ..+|+.||+|++.... ......+.+|+.++.+++ ||
T Consensus 10 ~~~~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 89 (327)
T 3lm5_A 10 GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP 89 (327)
T ss_dssp ------CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCT
T ss_pred cccccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCC
Confidence 445556667777778888889887 889999999999995 4568999999987542 334678999999999994 69
Q ss_pred cEEeEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE
Q 004155 478 NLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL 557 (771)
Q Consensus 478 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 557 (771)
||+++++++.+.+..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 90 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~ 164 (327)
T 3lm5_A 90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILL 164 (327)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEE
Confidence 9999999999999999999999999999998443 235699999999999999999999998 89999999999999
Q ss_pred cC---CCCeEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchh
Q 004155 558 DK---DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF 634 (771)
Q Consensus 558 ~~---~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~ 634 (771)
+. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..
T Consensus 165 ~~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 242 (327)
T 3lm5_A 165 SSIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY 242 (327)
T ss_dssp SCBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ecCCCCCcEEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence 87 78999999999987654322 23356999999999999999999999999999999999999999754432221
Q ss_pred hHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 635 YLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
... ... ...............+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~i------~~~-------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 243 LNI------SQV-------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHH------HHT-------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHH------Hhc-------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 100 000 000111111223445889999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.20 Aligned_cols=247 Identities=23% Similarity=0.342 Sum_probs=199.9
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK--SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 494 (771)
..++|++.+.||+|+||.||+|.. .+++.||||++... .......+.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 456789999999999999999955 47999999998754 234466788999999999 89999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC---------------
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK--------------- 559 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--------------- 559 (771)
||||+++++|.+++.........+++..++.|+.||+.||+|||++ +|+||||||+||+++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999954333335799999999999999999999998 8999999999999984
Q ss_pred ----CCCeEEEeecCccccCCCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchh
Q 004155 560 ----DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF 634 (771)
Q Consensus 560 ----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~ 634 (771)
...+||+|||.++...... ...||+.|+|||.+.+. .++.++|||||||++|||++|.+++.... .
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---Q- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---H-
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---H-
Confidence 4479999999998765432 23589999999999876 66789999999999999999998764221 0
Q ss_pred hHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 635 YLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+. .+..... ...+......+.+++.+||+.||++||++.|+++
T Consensus 237 ----~~----------~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 ----WH----------EIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ----HH----------HHHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HH----------HHHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 00 0111111 1112223345889999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.16 Aligned_cols=252 Identities=28% Similarity=0.365 Sum_probs=203.6
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 46788999999999999999954 478999999986542 3345788999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999843 34689999999999999999999998 8999999999999999999999999999865432
Q ss_pred Cc-ccccccccCCCccchhhhccCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 578 NT-HISTRVAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 578 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.. .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....|. ....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~~------- 226 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKT------- 226 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH----TTCT-------
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh----hccc-------
Confidence 21 22334568999999999987664 7899999999999999999999976443221 111111 0000
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...........+.+++.+||+.||++|||+.|+++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 --YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00001122345788999999999999999999976
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=345.96 Aligned_cols=254 Identities=27% Similarity=0.380 Sum_probs=203.9
Q ss_pred hcCCCCCC-ccccCCceeEEEEEc---CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 420 TNNFAPDN-KIGEGGFGPVYKGHM---ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 420 ~~~f~~~~-~lG~G~~g~Vy~~~~---~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
.++|.+.+ .||+|+||.||+|.. .+++.||||+++... ....+++.+|+.++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 999999999999943 346889999997643 23357899999999999999999999999 567789
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 94 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999943 34689999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCccc--ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChh
Q 004155 574 DEEDNTHI--STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLM 650 (771)
Q Consensus 574 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (771)
........ .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--------------- 231 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA--------------- 231 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---------------
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH---------------
Confidence 65443322 122346788999999998889999999999999999999 999997644322111
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 651 ELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 651 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.+........+......+.+++.+||+.||++||++.++++.|++.
T Consensus 232 -~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 232 -MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp -HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111111122223345688999999999999999999999999875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=353.19 Aligned_cols=271 Identities=21% Similarity=0.335 Sum_probs=197.9
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhc-HHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQG-NREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
++|.+.++||+|+||.||+|.. .+++.||||++....... ...+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5788999999999999999954 478999999987543221 22456799999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
++ |+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 5899988432 34689999999999999999999998 89999999999999999999999999998654332
Q ss_pred cccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh--
Q 004155 579 THISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK-- 655 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-- 655 (771)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...........+......
T Consensus 155 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 KT-YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cc-cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 22 233468999999999876 57899999999999999999999999765443322211110000000011111000
Q ss_pred ----hcCC--CC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCCCC
Q 004155 656 ----RLGS--NF-----DKEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGRAD 699 (771)
Q Consensus 656 ----~l~~--~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~ 699 (771)
.... .. .......+.+++.+||+.||++|||+.|+++ .+.+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 0000 00 0012245789999999999999999999987 4554433
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=344.31 Aligned_cols=248 Identities=29% Similarity=0.437 Sum_probs=205.4
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.+.|...+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 3568889999999999999995 4578999999987543 3446789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++++|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 101 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999993 24689999999999999999999998 8999999999999999999999999999866543
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .. ... .
T Consensus 173 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~-~~~---------~ 235 (303)
T 3a7i_A 173 QIK-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF------LI-PKN---------N 235 (303)
T ss_dssp BCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HH-HHS---------C
T ss_pred ccc-cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH------Hh-hcC---------C
Confidence 322 234568999999999999999999999999999999999999997543221111 00 001 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...........+.+++.+||+.||++||++.|+++
T Consensus 236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111122345889999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=357.03 Aligned_cols=254 Identities=23% Similarity=0.304 Sum_probs=203.2
Q ss_pred hcCCCCCCccccCCceeEEEEEc----CCCcEEEEEEcccCC----hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCC
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM----ADGTVVAVKQLSSKS----KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGN 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 490 (771)
.++|.+.++||+|+||.||+|.. .+|+.||||+++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788999999999999999965 478999999987532 12345677899999999 6999999999999999
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999942 34689999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhcc--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
++..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ ....
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~----- 278 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRI----- 278 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHH-----
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHH-----
Confidence 98765444444445679999999999985 35789999999999999999999999754432221111 1110
Q ss_pred hhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 004155 649 LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRP-----SMSSVVSM 693 (771)
Q Consensus 649 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 693 (771)
... ...++......+.+++.+||+.||++|| ++.|+++.
T Consensus 279 ----~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 279 ----LKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ----HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----hcc--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 010 1122223345678999999999999999 88888863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=355.70 Aligned_cols=264 Identities=20% Similarity=0.345 Sum_probs=205.1
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.++|++.+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 35788999999999999999954 47899999999765 33446789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999932 346899999999999999999999852 7999999999999999999999999999754322
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHH------------------
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDW------------------ 639 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~------------------ 639 (771)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 12335689999999999999999999999999999999999999976443322111100
Q ss_pred -----HHHHHhhCChhHHhhhhcC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 640 -----ALILKAQGNLMELVDKRLG----SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 640 -----~~~~~~~~~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...........+.++.... ..........+.+++.+||+.||++|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000111122221110 1111122346889999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=341.31 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=199.0
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
+|.....||+|+||.||+|. ..+++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 34555699999999999995 56789999999987665566789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC-CCCeEEEeecCccccCCCCc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~~~~ 579 (771)
+++|.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+++.......
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999995432 223567889999999999999999998 8999999999999987 89999999999986654322
Q ss_pred ccccccccCCCccchhhhccCC--CCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 580 HISTRVAGTFGYMAPEYAMRGY--LTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
......||+.|+|||++.+.. ++.++||||||+++|||++|+.||......... . +.. .....
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~-~~~-----------~~~~~ 243 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA--M-FKV-----------GMFKV 243 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH--H-HHH-----------HHHCC
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH--H-Hhh-----------ccccc
Confidence 123456899999999997653 889999999999999999999999643221110 0 000 00011
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
....+......+.+++.+||+.||++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11222233456889999999999999999999985
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.60 Aligned_cols=256 Identities=27% Similarity=0.365 Sum_probs=201.6
Q ss_pred cCCCCCCccccCCceeEEEEEcCC----CcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEE-eCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMAD----GTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCI-EGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~l 494 (771)
.+|++.++||+|+||.||+|...+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457788999999999999996432 2368999987643 344578999999999999999999999865 4567899
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999542 34689999999999999999999998 8999999999999999999999999999866
Q ss_pred CCCCc---ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChh
Q 004155 575 EEDNT---HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLM 650 (771)
Q Consensus 575 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (771)
..... .......||+.|+|||.+.+..++.++||||||+++|||++ |.+||......+....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~-------------- 244 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-------------- 244 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH--------------
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH--------------
Confidence 44322 11233457889999999999999999999999999999999 5556654333222110
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 651 ELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 651 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
+........+......+.+++.+||+.||++||++.|++++|+.+.
T Consensus 245 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 245 --LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp --HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0001111111222346889999999999999999999999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=368.66 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=205.2
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
.++|...+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 36788899999999999999965 569999999996532 23356788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++|+|.+++.........+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999976554456799999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccch-hhHHHHHHHHHhhCChhHHhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDI-FYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d 654 (771)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+.. .+..
T Consensus 341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~------------~i~~ 407 (543)
T 3c4z_A 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------------RVLE 407 (543)
T ss_dssp TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH------------HHHH
T ss_pred CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH------------HHhh
Confidence 43322 2345799999999999999999999999999999999999999976432211 11111 1111
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSM 687 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 687 (771)
.. ..++......+.+++.+||+.||++||++
T Consensus 408 ~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 408 QA--VTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred cc--cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 11 11222334567889999999999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=358.37 Aligned_cols=255 Identities=28% Similarity=0.390 Sum_probs=194.3
Q ss_pred CCCCCCccccCCceeEEEEEcC--CC--cEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe-CCEEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMA--DG--TVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIE-GNQLLLI 495 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~--~g--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV 495 (771)
.|...++||+|+||.||+|... ++ ..||||.++... ....+.|.+|+.++++++||||+++++++.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4566789999999999999642 22 468999987543 3456789999999999999999999998754 4578999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999543 34688999999999999999999998 89999999999999999999999999998654
Q ss_pred CCCcc---cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 576 EDNTH---ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 576 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
..... ......+|+.|+|||++.+..++.++|||||||++|||+| |.+||......+..... . .+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~------~-~~~--- 313 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL------L-QGR--- 313 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH------H-TTC---
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH------H-cCC---
Confidence 33211 1233457889999999999999999999999999999999 67777654433321110 0 110
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
....+......+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01111223446889999999999999999999999998764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=342.91 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=202.1
Q ss_pred CCCCCCccccCCceeEEEEEcC-C---CcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEE-EEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMA-D---GTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQL-LLI 495 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~-~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lV 495 (771)
.|...++||+|+||.||+|... + +..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3556689999999999999542 2 3379999987643 34467889999999999999999999999876655 999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+.+|+|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999542 34689999999999999999999998 89999999999999999999999999998654
Q ss_pred CCCc---ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCC-CCccchhhHHHHHHHHHhhCChhH
Q 004155 576 EDNT---HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSC-KPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 576 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+.. ....+.. .
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~----------------~ 239 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT----------------H 239 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH----------------H
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH----------------H
Confidence 3221 122335678899999999999999999999999999999996655433 3222211 1
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
.+........+......+.+++.+||+.||.+|||+.+++++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 240 FLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111111122223456889999999999999999999999998754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=363.52 Aligned_cols=259 Identities=21% Similarity=0.274 Sum_probs=196.5
Q ss_pred hcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC------C
Q 004155 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEG------N 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 490 (771)
.++|++.++||+|+||.||+| ...+|+.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999 4567899999999754 334467788999999999999999999999654 4
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..|+||||+++ +|.+.+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 68999999976 5777762 2489999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh----
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ---- 646 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---- 646 (771)
|+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .......
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i--~~~lg~p~~~~ 286 (464)
T 3ttj_A 211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV--IEQLGTPCPEF 286 (464)
T ss_dssp C-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCSCCHHH
T ss_pred eeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcCCCCHHH
Confidence 98664432 234467999999999999999999999999999999999999999765432221111 0000000
Q ss_pred -C-------------------ChhHHhhhhcCCCCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 647 -G-------------------NLMELVDKRLGSNFD---KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 647 -~-------------------~~~~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. .........+..... ......+.+|+.+||+.||++|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 000111111000000 112457899999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=361.47 Aligned_cols=275 Identities=20% Similarity=0.242 Sum_probs=212.9
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC--EEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGN--QLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 495 (771)
.++|.+.++||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 35788999999999999999954 458999999997543 234577889999999999999999999998755 78999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE----cCCCCeEEEeecCc
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKISDFGLA 571 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFGla 571 (771)
|||+++|+|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999954332 23499999999999999999999998 89999999999999 77888999999999
Q ss_pred cccCCCCcccccccccCCCccchhhhcc--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc-hhhHHHHHHH
Q 004155 572 KLDEEDNTHISTRVAGTFGYMAPEYAMR--------GYLTDKADVYSFGIVALEIVSGRSNSSCKPKED-IFYLLDWALI 642 (771)
Q Consensus 572 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~-~~~~~~~~~~ 642 (771)
+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..........
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp EECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred eEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 87654332 234569999999999865 567889999999999999999999997533221 1111111110
Q ss_pred HHhhCChhHH---------hhhhc--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 643 LKAQGNLMEL---------VDKRL--GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 643 ~~~~~~~~~~---------~d~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
......+..+ ....+ ...........+.+++.+||+.||++||++.|+++.++.+...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 0000000000 00001 1233466777899999999999999999999999998886554
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=339.08 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=200.7
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh------hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK------QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 492 (771)
.++|++.+.||+|+||.||+|.. .+|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 35688999999999999999955 4689999999875421 2367899999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC----CeEEEee
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISDF 568 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DF 568 (771)
++||||+++++|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLA----EKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 99999999999999993 235689999999999999999999998 899999999999998877 8999999
Q ss_pred cCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 569 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 569 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
|+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+..... ......
T Consensus 157 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~ 229 (283)
T 3bhy_A 157 GIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI-----SAVNYD 229 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-----HTTCCC
T ss_pred ccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh-----HhcccC
Confidence 99986644322 23356899999999999999999999999999999999999999754332211100 000000
Q ss_pred hhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 649 LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 649 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. +...... ....+.+++.+||+.||++||++.|+++
T Consensus 230 ~----~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 F----DEEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C----CHHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C----cchhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 0000011 1345789999999999999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=348.21 Aligned_cols=267 Identities=27% Similarity=0.385 Sum_probs=211.0
Q ss_pred CCCHHHHHHHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHc--CCCCcEEeEEEEEE
Q 004155 410 SFTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISA--LQHPNLVKLHGCCI 487 (771)
Q Consensus 410 ~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~ 487 (771)
......-....++|.+.+.||+|+||.||+|.. +|+.||||++... ....+.+|++++.. ++||||+++++++.
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 344444556678999999999999999999987 5899999998643 34677889998887 78999999999998
Q ss_pred eCC----EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhh--------hcCCCceeccCCCCCcE
Q 004155 488 EGN----QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH--------EESRLKIVHRDIKATNV 555 (771)
Q Consensus 488 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH--------~~~~~~ivH~Dlkp~NI 555 (771)
..+ ..++||||+++|+|.+++. ...+++..++.++.|++.||+||| +. +|+||||||+||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NI 178 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNI 178 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHE
Confidence 776 8999999999999999993 246899999999999999999999 55 899999999999
Q ss_pred EEcCCCCeEEEeecCccccCCCCcc---cccccccCCCccchhhhccCC------CCchHhHHHHHHHHHHHHhC-----
Q 004155 556 LLDKDLNPKISDFGLAKLDEEDNTH---ISTRVAGTFGYMAPEYAMRGY------LTDKADVYSFGIVALEIVSG----- 621 (771)
Q Consensus 556 ll~~~~~~kl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~ksDV~S~Gvil~elltG----- 621 (771)
+++.++.+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||+||
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 9999999999999999866543322 123457999999999998652 34789999999999999999
Q ss_pred -----CCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 004155 622 -----RSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF-----DKEQVMVMINVALLCTDVSSTSRPSMSSVV 691 (771)
Q Consensus 622 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 691 (771)
+.||......... ...+... +....+.... ..+....+.+++.+||+.||++||++.||+
T Consensus 259 ~~~~~~~p~~~~~~~~~~-~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~ 328 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDPS-VEEMRKV---------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328 (342)
T ss_dssp BCCCCCCTTTTTSCSSCC-HHHHHHH---------HTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred cccccccCccccCcCccc-HHHHHHH---------HHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence 6777653322110 1111111 1111111222 235667899999999999999999999999
Q ss_pred HHhcCCC
Q 004155 692 SMLEGRA 698 (771)
Q Consensus 692 ~~L~~~~ 698 (771)
+.|+.+.
T Consensus 329 ~~L~~i~ 335 (342)
T 1b6c_B 329 KTLSQLS 335 (342)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=352.49 Aligned_cols=263 Identities=20% Similarity=0.286 Sum_probs=193.1
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
..++|++.++||+|+||.||+|. ..+|+.||||+++.... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 34678999999999999999994 56789999999975432 2245678999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE-----cCCCCeEEEeecC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL-----DKDLNPKISDFGL 570 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~DFGl 570 (771)
|||+++ +|.+++.. ...+++..+..|+.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 112 ~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999985 99999943 34689999999999999999999998 89999999999999 4555699999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh--C
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ--G 647 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~ 647 (771)
++........ .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+... ......... .
T Consensus 184 a~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~~ 260 (329)
T 3gbz_A 184 ARAFGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF--KIFEVLGLPDDT 260 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCTT
T ss_pred ccccCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH--HHHHHhCCCchh
Confidence 9866533222 2335689999999999874 58999999999999999999999997644322211 111110000 0
Q ss_pred ChhHHhh-hhcCCC------CCH------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 648 NLMELVD-KRLGSN------FDK------EQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 648 ~~~~~~d-~~l~~~------~~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
....... +..... ... .....+.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000 000000 000 02246789999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=360.77 Aligned_cols=260 Identities=22% Similarity=0.288 Sum_probs=209.2
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCC-CcEEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQH-PNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 497 (771)
.++|.+.++||+|+||.||+|. ..+++.||||++...... ..+..|+++++.++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4689999999999999999995 467999999987654332 357889999999976 667777777788899999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE---cCCCCeEEEeecCcccc
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLD 574 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFGla~~~ 574 (771)
|+ +++|.+++... ...+++.+++.|+.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 89999999432 34699999999999999999999998 89999999999999 68899999999999876
Q ss_pred CCCCcc------cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 575 EEDNTH------ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 575 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 544322 12246799999999999999999999999999999999999999987554443333332222221222
Q ss_pred hhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 649 LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 649 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
...+. ..+ ..++.+++..||+.+|++||++.+|+++|+.+
T Consensus 237 ~~~l~-----~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 237 IEALC-----RGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHH-----TTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHh-----cCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11111 122 34688999999999999999999999998775
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=341.83 Aligned_cols=248 Identities=23% Similarity=0.375 Sum_probs=204.7
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
.++|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 35788899999999999999954 46889999998654 234466789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++++|.+++. ....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 94 ~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999983 234789999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+... . +...
T Consensus 167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~---------~~~~ 230 (294)
T 2rku_A 167 YDGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------R---------IKKN 230 (294)
T ss_dssp STTCC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------H---------HHTT
T ss_pred cCccc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------H---------Hhhc
Confidence 33222 234568999999999999899999999999999999999999997543322110 0 0011
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. ..+......+.+++.+||+.||++||++.|+++
T Consensus 231 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 231 EY--SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cC--CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 00 111122345788999999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.34 Aligned_cols=250 Identities=30% Similarity=0.427 Sum_probs=198.3
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC-CEEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEG-NQLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~E~ 498 (771)
.++|++.+.||+|+||.||+|.. +|+.||||+++... ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46788899999999999999976 48999999997543 456789999999999999999999997654 478999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999999994321 12488999999999999999999998 89999999999999999999999999998554322
Q ss_pred cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
....+++.|+|||.+.+..++.++||||||+++|||+| |+.||......+... .+....
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~----------------~~~~~~ 231 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP----------------RVEKGY 231 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH----------------HHTTTC
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----------------HHhcCC
Confidence 22357889999999999999999999999999999998 999997654332211 111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
....+......+.+++.+||+.||++||++.|+++.|+.+
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 1122223345688999999999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.48 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=187.7
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhc-HHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQG-NREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
.++|++.+.||+|+||.||+|. ..+|+.||||++.... ... .+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 4678899999999999999995 4679999999997642 222 333445555678889999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++ +|.+++.........+++..++.++.|++.||+|||++. +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99974 888887543334467999999999999999999999863 799999999999999999999999999986654
Q ss_pred CCcccccccccCCCccchhhh----ccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 577 DNTHISTRVAGTFGYMAPEYA----MRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||........ .. ...
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~-------------~~~ 226 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QL-------------KQV 226 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HH-------------HHH
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HH-------------HHH
Confidence 322 2234689999999996 566789999999999999999999999975322111 00 111
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+...............+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 227 VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111111111123446889999999999999999999976
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.31 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=183.6
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35788999999999999999954 679999999986532 12346789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999999543 24689999999999999999999998 89999999999999999999999999998665
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .+...
T Consensus 164 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~ 227 (278)
T 3cok_A 164 MPHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---------------KVVLA 227 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS
T ss_pred CCCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---------------HHhhc
Confidence 33221 223568999999999998899999999999999999999999997644322110 00000
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. ..+......+.+++.+||+.||++||++.++++
T Consensus 228 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 DY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00 111222346789999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=340.94 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=196.6
Q ss_pred CCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe----CCEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIE----GNQLLL 494 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 494 (771)
.|.+.+.||+|+||.||+|. ..++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 46777899999999999994 456889999998653 34456788999999999999999999999875 456899
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc-CCCCeEEEeecCccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKL 573 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFGla~~ 573 (771)
||||+++|+|.+++. ....+++..++.++.||+.||+|||+.+ .+|+||||||+||+++ .++.+||+|||++..
T Consensus 107 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 107 VTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEecCCCCHHHHHH----HccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999993 2356899999999999999999999981 1399999999999997 889999999999975
Q ss_pred cCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 574 DEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 574 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
..... .....||+.|+|||++. +.++.++|||||||++|+|++|+.||......... . ... ..+.....
T Consensus 182 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~---~~~-~~~~~~~~- 250 (290)
T 1t4h_A 182 KRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--Y---RRV-TSGVKPAS- 250 (290)
T ss_dssp CCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--H---HHH-TTTCCCGG-
T ss_pred ccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--H---HHH-hccCCccc-
Confidence 54332 23456899999999876 45899999999999999999999999753322111 1 001 11100000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+......+.+++.+||+.||++||++.|+++
T Consensus 251 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 -------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11112245889999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=352.96 Aligned_cols=252 Identities=21% Similarity=0.340 Sum_probs=199.8
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 496 (771)
..++|++.+.||+|+||.||+|. ..+|+.||||++..... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 45679999999999999999995 45789999999976433 235688888887 7999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC----CCeEEEeecCcc
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD----LNPKISDFGLAK 572 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFGla~ 572 (771)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+.++ +.+||+|||+++
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999999943 34689999999999999999999998 89999999999998433 359999999998
Q ss_pred ccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 573 LDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 573 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+.... ..+..
T Consensus 169 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i----~~~~~--- 240 (342)
T 2qr7_A 169 QLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI----GSGKF--- 240 (342)
T ss_dssp ECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH----HHCCC---
T ss_pred cCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH----ccCCc---
Confidence 7654332 223457899999999998888899999999999999999999999754332222221111 01110
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+...........+.+++.+||+.||++||++.|+++
T Consensus 241 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 ---SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0111111223346789999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=349.76 Aligned_cols=262 Identities=27% Similarity=0.380 Sum_probs=205.7
Q ss_pred hcCCCCCCccccCCceeEEEEEc------CCCcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 492 (771)
.++|.+.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46788899999999999999963 35778999999754 344567899999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcCCCc---cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC---CCCeEEE
Q 004155 493 LLIYEYMENNSLARALFGPEA---HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKIS 566 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 566 (771)
++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+. +|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999964432 224589999999999999999999998 8999999999999984 4569999
Q ss_pred eecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHH
Q 004155 567 DFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 567 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+.. ..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~----- 257 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---EF----- 257 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HH-----
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH---HH-----
Confidence 9999975433221 12233467899999999999999999999999999999998 99999754332211 10
Q ss_pred hhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 645 AQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 645 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
+........+......+.+++.+||+.||.+||++.|+++.|+.....
T Consensus 258 --------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 258 --------VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp --------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 111111112222345688999999999999999999999999876543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=369.85 Aligned_cols=253 Identities=26% Similarity=0.334 Sum_probs=206.4
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
.++|...++||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 46789999999999999999954 579999999986532 23456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 263 mEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999995432 24599999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ..+..
T Consensus 338 ~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~------------~~i~~ 403 (576)
T 2acx_A 338 EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------------RLVKE 403 (576)
T ss_dssp TTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH------------HHHHH
T ss_pred cCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH------------HHhhc
Confidence 4332 233579999999999999899999999999999999999999997644322111110 00000
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
....++......+.+++.+||+.||++|| ++.|+++
T Consensus 404 -~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 404 -VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 01122222334688999999999999999 7788875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=344.57 Aligned_cols=255 Identities=22% Similarity=0.362 Sum_probs=204.2
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++..........+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 346788999999999999999954 5789999999986555455678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE---cCCCCeEEEeecCcccc
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLD 574 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFGla~~~ 574 (771)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++..
T Consensus 87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999999832 34689999999999999999999998 89999999999999 78899999999999764
Q ss_pred CCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
.... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ... .+..
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~i~-~~~~----- 224 (304)
T 2jam_A 160 QNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE------KIK-EGYY----- 224 (304)
T ss_dssp CCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHH-HCCC-----
T ss_pred CCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHH-cCCC-----
Confidence 4321 233468999999999999999999999999999999999999997543322111 000 1100
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcC
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEG 696 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 696 (771)
.............+.+++.+||+.||++||++.|+++ .+++
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 225 -EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred -CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 0001111123356889999999999999999999986 4554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=346.63 Aligned_cols=265 Identities=23% Similarity=0.360 Sum_probs=199.2
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 35788899999999999999954 458999999986543 233566889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999988732 34699999999999999999999998 899999999999999999999999999986544
Q ss_pred CCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHH--------HHHHhhC
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWA--------LILKAQG 647 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 647 (771)
... ......||..|+|||++.+. .++.++|||||||++|||++|+.||......+........ .......
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 322 22335689999999999875 7899999999999999999999999765433221111000 0000000
Q ss_pred -ChhHHhhhhcCCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 648 -NLMELVDKRLGSNFDK-----EQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 648 -~~~~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.......+.+...... .....+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000001111111 12356889999999999999999999886
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=378.48 Aligned_cols=247 Identities=27% Similarity=0.384 Sum_probs=198.7
Q ss_pred CccccCCceeEEEEEc---CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGHM---ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~---~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
++||+|+||.||+|.+ ..++.||||+++... ....+++.+|+.++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999944 346789999997643 3346789999999999999999999999964 568999999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc-
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH- 580 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~- 580 (771)
|+|.+++. ....+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999994 335689999999999999999999998 8999999999999999999999999999876543322
Q ss_pred -cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 581 -ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 581 -~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+.. +.+.....
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~----------------~~i~~~~~ 590 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT----------------AMLEKGER 590 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----------------HHHHTTCC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------------HHHHcCCC
Confidence 2233456789999999999999999999999999999998 99999765433221 11111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
...+......+.+++..||+.||++||++.+|+++|+..
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 222333446688999999999999999999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=356.90 Aligned_cols=250 Identities=20% Similarity=0.228 Sum_probs=189.8
Q ss_pred cCCCCC-CccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHH-cCCCCcEEeEEEEEEe----CCEEE
Q 004155 421 NNFAPD-NKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMIS-ALQHPNLVKLHGCCIE----GNQLL 493 (771)
Q Consensus 421 ~~f~~~-~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~~ 493 (771)
++|.+. ++||+|+||.||+|. ..+|+.||||++... ..+.+|++++. ..+||||+++++++.. .+..|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 689999999999994 457899999998642 35678888874 4589999999999875 56789
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC---CCCeEEEeecC
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGL 570 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFGl 570 (771)
+||||+++|+|.+++.... ...+++..+..|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999996532 24699999999999999999999998 8999999999999987 78999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhh-HHHHHHHHHhhCCh
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY-LLDWALILKAQGNL 649 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 649 (771)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ...... .+..
T Consensus 211 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~ 284 (400)
T 1nxk_A 211 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQY 284 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCC
T ss_pred ccccCCCCc--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcc
Confidence 986543322 234578999999999999999999999999999999999999997644322110 000000 0000
Q ss_pred hHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 650 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.............+.+++.+||+.||++|||+.|+++
T Consensus 285 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 285 ------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp ------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000122345889999999999999999999997
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=357.93 Aligned_cols=266 Identities=14% Similarity=0.141 Sum_probs=205.1
Q ss_pred hcCCCCCCccccCCceeEEEEEcC---------CCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEe---------
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMA---------DGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVK--------- 481 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~---------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 481 (771)
.++|.+.+.||+|+||.||+|... +++.||||++... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 367889999999999999999654 3789999998754 35788999999999999887
Q ss_pred ------EEEEEEe-CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCc
Q 004155 482 ------LHGCCIE-GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATN 554 (771)
Q Consensus 482 ------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~N 554 (771)
+++++.. ++..++||||+ +++|.+++.... ...+++..++.|+.||+.||+|||+. +|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 6788876 78899999999 999999995331 25799999999999999999999998 89999999999
Q ss_pred EEEcCCC--CeEEEeecCccccCCCCcc------cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCC
Q 004155 555 VLLDKDL--NPKISDFGLAKLDEEDNTH------ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSS 626 (771)
Q Consensus 555 Ill~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~ 626 (771)
||++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 9999999999866543221 1133479999999999999999999999999999999999999997
Q ss_pred CCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCCC
Q 004155 627 CKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQD 702 (771)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~ 702 (771)
....... ............ ...+.+.... .......+.+++.+||+.||++||++.+++++|+++.....
T Consensus 270 ~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 270 NCLPNTE-DIMKQKQKFVDK--PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGTTCHH-HHHHHHHHHHHS--CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCCcCHH-HHHHHHHhccCC--hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 5432211 111111111100 0001110000 00123458899999999999999999999999988654443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=348.39 Aligned_cols=248 Identities=24% Similarity=0.382 Sum_probs=204.5
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
.++|.+.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 35688899999999999999954 46889999998654 234467789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++++|.+++. ....+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999983 235789999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
..... .....||..|+|||++.+..++.++|||||||++|||++|+.||......+... ... ..
T Consensus 193 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~---------~~ 256 (335)
T 2owb_A 193 YDGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RIK---------KN 256 (335)
T ss_dssp STTCC-BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHH---------HT
T ss_pred cCccc-ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HHh---------cC
Confidence 33222 234569999999999999999999999999999999999999997543222110 000 00
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. ..+......+.+++.+||+.||++||++.|+++
T Consensus 257 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 257 EY--SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CC--CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 111122345788999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=354.41 Aligned_cols=262 Identities=24% Similarity=0.314 Sum_probs=192.2
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEe--------
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLHGCCIE-------- 488 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-------- 488 (771)
...+|++.++||+|+||.||+|. ..+|+.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 34578899999999999999995 4578999999997766666788999999999996 9999999999953
Q ss_pred CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCc--eeccCCCCCcEEEcCCCCeEEE
Q 004155 489 GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLK--IVHRDIKATNVLLDKDLNPKIS 566 (771)
Q Consensus 489 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~ 566 (771)
....++||||+. |+|.+++.... ....+++..++.|+.||+.||+|||+. + |+||||||+|||++.++.+||+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence 345899999996 69999884321 234699999999999999999999998 6 9999999999999999999999
Q ss_pred eecCccccCCCCccc-----------ccccccCCCccchhhh---ccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc
Q 004155 567 DFGLAKLDEEDNTHI-----------STRVAGTFGYMAPEYA---MRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKED 632 (771)
Q Consensus 567 DFGla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~ 632 (771)
|||+++......... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 999998765432211 1134589999999998 56678999999999999999999999996432211
Q ss_pred hhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCCCCC
Q 004155 633 IFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQDFV 704 (771)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 704 (771)
++...............+.+++.+||+.||++||++.|+++.|+.+.......
T Consensus 261 -------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 261 -------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp ------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred -------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 11111111111112234778999999999999999999999998875544333
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=357.78 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=191.6
Q ss_pred HHhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCC--------hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKS--------KQGNREFVNEIGMISALQHPNLVKLHGCCIE 488 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 488 (771)
...++|.+.++||+|+||.||+| ...+++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45688999999999999999999 45668999999986532 112235889999999999999999999975
Q ss_pred CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC---CCeEE
Q 004155 489 GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNPKI 565 (771)
Q Consensus 489 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl 565 (771)
.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred cCceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 4568999999999999998843 35799999999999999999999998 89999999999999654 45999
Q ss_pred EeecCccccCCCCcccccccccCCCccchhhhcc---CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHH
Q 004155 566 SDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALI 642 (771)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~ 642 (771)
+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .
T Consensus 284 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~----- 354 (419)
T 3i6u_A 284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--K----- 354 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--H-----
T ss_pred eecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--H-----
Confidence 9999998765432 2234679999999999853 67889999999999999999999999754332211 0
Q ss_pred HHhhCChhHHhhhhcCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 643 LKAQGNLMELVDKRLGSNFDK----EQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 643 ~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+.+.... ..... .....+.+++.+||+.||++||++.|+++
T Consensus 355 --------~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 355 --------DQITSGK-YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp --------HHHHTTC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --------HHHhcCC-CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0011000 01111 12346889999999999999999999987
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=339.16 Aligned_cols=245 Identities=22% Similarity=0.355 Sum_probs=202.9
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5788899999999999999954 468899999986532 223567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999942 34689999999999999999999998 899999999999999999999999999976543
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+... .+....
T Consensus 167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---------------~~~~~~ 228 (284)
T 2vgo_A 167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR---------------RIVNVD 228 (284)
T ss_dssp SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---------------HHHTTC
T ss_pred cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH---------------HHhccc
Confidence 22 233568999999999999999999999999999999999999997543222110 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..++......+.+++.+|++.||.+||++.|+++
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 --LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1122223346789999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=342.83 Aligned_cols=255 Identities=18% Similarity=0.273 Sum_probs=200.4
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEe--CCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLHGCCIE--GNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV~ 496 (771)
++|++.++||+|+||.||+|. ..+++.||||+++.. ..+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 678899999999999999994 567899999998753 3467899999999997 9999999999987 67889999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC-CeEEEeecCccccC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLDE 575 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFGla~~~~ 575 (771)
||+++++|.+++ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++...
T Consensus 113 e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999998 2489999999999999999999998 899999999999999776 89999999998765
Q ss_pred CCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
.... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+...... .......+.++
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~~-~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAKV-LGTEDLYDYID 258 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHHH-HCHHHHHHHHH
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHHh-cCCchhhhHHH
Confidence 4332 233568999999999987 678999999999999999999999996533221 111111111 11111111111
Q ss_pred hh-----------------------cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 KR-----------------------LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~~-----------------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. ............+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 10 000111113456889999999999999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=350.73 Aligned_cols=267 Identities=24% Similarity=0.300 Sum_probs=197.6
Q ss_pred HHHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChh-----cHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC
Q 004155 417 KAATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQ-----GNREFVNEIGMISALQHPNLVKLHGCCIEGN 490 (771)
Q Consensus 417 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 490 (771)
....++|.+.+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 34567899999999999999999965 46899999998753221 1246889999999999999999999999999
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..++||||+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred ceEEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 99999999986 899988432 34689999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh--C
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ--G 647 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~ 647 (771)
++....... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||......+... ......... .
T Consensus 159 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~--~i~~~~~~~~~~ 235 (346)
T 1ua2_A 159 AKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT--RIFETLGTPTEE 235 (346)
T ss_dssp GSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCTT
T ss_pred ceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHHcCCCChh
Confidence 987654332 22345689999999999764 58999999999999999999999987654322211 111100000 0
Q ss_pred ChhH---Hhhhhc---CCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 004155 648 NLME---LVDKRL---GSNFD-----KEQVMVMINVALLCTDVSSTSRPSMSSVVSM 693 (771)
Q Consensus 648 ~~~~---~~d~~l---~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 693 (771)
.... ..+... ....+ ......+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 000000 00001 1123568899999999999999999999973
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=349.51 Aligned_cols=266 Identities=23% Similarity=0.320 Sum_probs=200.6
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcCCCCcEEeEEEEEEe--------
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK--QGNREFVNEIGMISALQHPNLVKLHGCCIE-------- 488 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 488 (771)
.++|++.++||+|+||.||+|.. .+|+.||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36788999999999999999954 6799999999865432 234578899999999999999999999987
Q ss_pred CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEee
Q 004155 489 GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 568 (771)
Q Consensus 489 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 568 (771)
.+..++||||+++ +|.+.+... ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 4568999999985 777777433 24699999999999999999999998 8999999999999999999999999
Q ss_pred cCccccCCCC---cccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHH
Q 004155 569 GLAKLDEEDN---THISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 569 Gla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
|+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||...................
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9998664322 122234568999999999876 468999999999999999999999998654433222111110000
Q ss_pred hhCChhHHhhhhc--------CCCCC-HHH------HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 645 AQGNLMELVDKRL--------GSNFD-KEQ------VMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 645 ~~~~~~~~~d~~l--------~~~~~-~~~------~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
........-.... ..... .+. ...+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000000000000 00000 111 234789999999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=335.15 Aligned_cols=247 Identities=22% Similarity=0.372 Sum_probs=194.8
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 36788999999999999999965 479999999986532 23356789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999932 34689999999999999999999998 89999999999999999999999999998665
Q ss_pred CCCcccccccccCCCccchhhhccCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
.... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......... . ... .+
T Consensus 163 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~---~~~-~~------- 226 (276)
T 2h6d_A 163 DGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF---K---KIR-GG------- 226 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---HHH-HC-------
T ss_pred CCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH---H---Hhh-cC-------
Confidence 4322 233468999999999987765 68999999999999999999999754322111 1 000 00
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. ...+......+.+++.+||+.||++||++.|+++
T Consensus 227 -~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 227 -V--FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -c--ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0 0111122345788999999999999999999997
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=347.26 Aligned_cols=259 Identities=20% Similarity=0.343 Sum_probs=206.3
Q ss_pred CHHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh--------hcHHHHHHHHHHHHcC-CCCcEEe
Q 004155 412 TLRQIKAATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK--------QGNREFVNEIGMISAL-QHPNLVK 481 (771)
Q Consensus 412 ~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~ 481 (771)
.........++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.+++++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3444556678899999999999999999965 4799999999865431 1245678999999999 7999999
Q ss_pred EEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC
Q 004155 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL 561 (771)
Q Consensus 482 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 561 (771)
+++++......++||||+++++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+||+++.++
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNM 237 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence 9999999999999999999999999994 235799999999999999999999998 899999999999999999
Q ss_pred CeEEEeecCccccCCCCcccccccccCCCccchhhhcc------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhh
Q 004155 562 NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR------GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY 635 (771)
Q Consensus 562 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~ 635 (771)
.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........
T Consensus 238 ~ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~- 314 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML- 314 (365)
T ss_dssp CEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-
T ss_pred CEEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH-
Confidence 999999999987654322 234579999999999863 35889999999999999999999999754322111
Q ss_pred HHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 636 LLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. .. .+... ...+.. .. ....+.+++.+||+.||++||++.|+++
T Consensus 315 --~~---i~-~~~~~-~~~~~~-~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 315 --RM---IM-EGQYQ-FSSPEW-DD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp --HH---HH-HTCCC-CCHHHH-SS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HH---HH-hCCCC-CCCccc-cc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10 00 00000 000000 01 1245889999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=358.62 Aligned_cols=194 Identities=25% Similarity=0.404 Sum_probs=154.4
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC-----CE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEG-----NQ 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 491 (771)
.++|++.++||+|+||.||+|. ..+|+.||||++... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4689999999999999999994 457899999998653 334457889999999999999999999998533 57
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 132 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 999999984 699999843 35699999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCc--------------------------ccccccccCCCccchhhh-ccCCCCchHhHHHHHHHHHHHHhC
Q 004155 572 KLDEEDNT--------------------------HISTRVAGTFGYMAPEYA-MRGYLTDKADVYSFGIVALEIVSG 621 (771)
Q Consensus 572 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~ksDV~S~Gvil~elltG 621 (771)
+....... ...+...||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 87643211 112345789999999986 466799999999999999999993
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=348.37 Aligned_cols=270 Identities=26% Similarity=0.371 Sum_probs=197.4
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHH--HHcCCCCcEEeEEEEEEe-----CCEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGM--ISALQHPNLVKLHGCCIE-----GNQL 492 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~ 492 (771)
.++|++.+.||+|+||.||+|.. +++.||||++.... ...+..|.++ +..++||||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36788999999999999999976 68999999986532 3344555555 445899999999987653 2367
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcC------CCceeccCCCCCcEEEcCCCCeEEE
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES------RLKIVHRDIKATNVLLDKDLNPKIS 566 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~ 566 (771)
++||||+++|+|.+++. ....++..++.++.||+.||+|||+.. .++|+||||||+|||++.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLS-----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHh-----hcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 99999999999999993 234589999999999999999999872 2379999999999999999999999
Q ss_pred eecCccccCCCCc-------ccccccccCCCccchhhhcc-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc
Q 004155 567 DFGLAKLDEEDNT-------HISTRVAGTFGYMAPEYAMR-------GYLTDKADVYSFGIVALEIVSGRSNSSCKPKED 632 (771)
Q Consensus 567 DFGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~ 632 (771)
|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987653221 11223569999999999976 456779999999999999999987765432211
Q ss_pred hhhHHHHHHHHHhhCChh---HHh-hhhcCCC------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 633 IFYLLDWALILKAQGNLM---ELV-DKRLGSN------FDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~---~~~-d~~l~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
..... +........... ..+ ....... ........+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 243 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 243 EYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCT-THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHh-hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 10000 000000000000 000 0111111 122456679999999999999999999999999988653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=352.40 Aligned_cols=252 Identities=14% Similarity=0.133 Sum_probs=202.2
Q ss_pred HhcCCCCCCccccCCceeEEEE------EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC---CCcEEeEEEEEEeC
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKG------HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ---HPNLVKLHGCCIEG 489 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~------~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 489 (771)
..++|.+.++||+|+||.||+| ...+++.||||+++... ..++..|++++.+++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 4577889999999999999999 35568999999997643 456788888888886 99999999999999
Q ss_pred CEEEEEEEeccCCCHHHHhcCCCc-cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC---------
Q 004155 490 NQLLLIYEYMENNSLARALFGPEA-HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK--------- 559 (771)
Q Consensus 490 ~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--------- 559 (771)
+..++||||+++|+|.+++..... ....+++..++.|+.||+.||+|||+. +|+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccc
Confidence 999999999999999999953211 235699999999999999999999998 8999999999999998
Q ss_pred --CCCeEEEeecCccccCCC-CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhH
Q 004155 560 --DLNPKISDFGLAKLDEED-NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYL 636 (771)
Q Consensus 560 --~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~ 636 (771)
++.+||+|||+|+..... .........||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 899999999999755322 22233456799999999999999999999999999999999999999853221110
Q ss_pred HHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHhcCC
Q 004155 637 LDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSR-PSMSSVVSMLEGR 697 (771)
Q Consensus 637 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~~ 697 (771)
.++..+.... ....+.+++..|++.+|.+| |++.++.+.|+..
T Consensus 294 ---------------~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 294 ---------------KPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ---------------EECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ---------------eechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0111111111 13356678889999999988 5788888888764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.40 Aligned_cols=257 Identities=24% Similarity=0.383 Sum_probs=197.3
Q ss_pred hcCCCCCCccccCCceeEEEEEc--CCCc--EEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM--ADGT--VVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~--~~g~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 492 (771)
.++|++.+.||+|+||.||+|.. .+++ .||||+++.. .....+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 35788899999999999999964 2333 6999998754 2344678899999999999999999999998765 8
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999999432 24689999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcc--cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCCh
Q 004155 573 LDEEDNTH--ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNL 649 (771)
Q Consensus 573 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (771)
........ ......+|..|+|||++.+..++.++||||||+++|||++ |+.||......+... ...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~~----- 238 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH------KID----- 238 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHH-----
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH------HHH-----
Confidence 76544322 1233457889999999998889999999999999999999 999997544322111 111
Q ss_pred hHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 650 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
...............+.+++.+||+.||++||++.++++.|++..
T Consensus 239 ----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 239 ----KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ----TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ----ccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 110111112233456889999999999999999999999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=353.11 Aligned_cols=263 Identities=21% Similarity=0.281 Sum_probs=197.5
Q ss_pred HHHhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe-------
Q 004155 417 KAATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIE------- 488 (771)
Q Consensus 417 ~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 488 (771)
+...++|.+.+.||+|+||.||+|. ..+|+.||||++...... ..+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 4567789999999999999999994 567999999998654322 3469999999999999999999854
Q ss_pred -------------------------------CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHh
Q 004155 489 -------------------------------GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYL 537 (771)
Q Consensus 489 -------------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~L 537 (771)
....++||||++ |+|.+.+.........+++..+..++.||+.||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334899999998 488887754333446799999999999999999999
Q ss_pred hhcCCCceeccCCCCCcEEEc-CCCCeEEEeecCccccCCCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHH
Q 004155 538 HEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVA 615 (771)
Q Consensus 538 H~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil 615 (771)
|+. +|+||||||+||+++ .++.+||+|||+|+........ ....||..|+|||.+.+. .++.++||||+||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC--CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC--cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 899999999999998 6889999999999876543322 345689999999998765 589999999999999
Q ss_pred HHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh--h--------hcCCC-----CCHHHHHHHHHHHHHccCCC
Q 004155 616 LEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD--K--------RLGSN-----FDKEQVMVMINVALLCTDVS 680 (771)
Q Consensus 616 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~--------~l~~~-----~~~~~~~~l~~l~~~Cl~~d 680 (771)
|||++|+.||......+.. ...... ........+.. + ..... ++......+.+++.+||+.|
T Consensus 233 ~ell~g~~pf~~~~~~~~~--~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQL--VRIIQI-MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHH--HHHHHH-HCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCChHHHH--HHHHHH-hCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 9999999999765433221 111111 11111111100 0 00000 11112345889999999999
Q ss_pred CCCCCCHHHHHH
Q 004155 681 STSRPSMSSVVS 692 (771)
Q Consensus 681 P~~RPs~~evl~ 692 (771)
|++|||+.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=343.99 Aligned_cols=262 Identities=26% Similarity=0.399 Sum_probs=187.0
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 457899999999999999999964 468999999986543 334567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCC----CccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 497 EYMENNSLARALFGP----EAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 497 E~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
||+++++|.+++... ......+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998431 11234689999999999999999999998 89999999999999999999999999997
Q ss_pred ccCCCCc----ccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh-
Q 004155 573 LDEEDNT----HISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ- 646 (771)
Q Consensus 573 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~- 646 (771)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... .....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~~~~~ 244 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-----TLQNDP 244 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-----HHTSSC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-----HhccCC
Confidence 6543221 11233568999999999876 5689999999999999999999999976543322110 00000
Q ss_pred CCh-hHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 647 GNL-MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 647 ~~~-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
... ....+......+ ...+.+++.+||+.||++||++.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000 001111111222 345788999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=342.74 Aligned_cols=253 Identities=23% Similarity=0.402 Sum_probs=198.6
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
..++|++.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 356889999999999999999965 4689999999987666667889999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++++|.+++.. ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999843 234699999999999999999999998 8999999999999999999999999997633211
Q ss_pred CcccccccccCCCccchhhhc-----cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 578 NTHISTRVAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
. .......||+.|+|||++. ...++.++||||||+++|||++|+.||......... ....... .
T Consensus 171 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~-~--- 239 (302)
T 2j7t_A 171 L-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAKSD-P--- 239 (302)
T ss_dssp H-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSC-C---
T ss_pred c-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH------HHHhccC-C---
Confidence 1 1112346899999999983 667899999999999999999999999754322111 0011100 0
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+. ...+......+.+++.+||+.||++|||+.++++
T Consensus 240 --~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 --PT--LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --CC--CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --cc--cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 0111222346889999999999999999999876
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=362.97 Aligned_cols=250 Identities=24% Similarity=0.392 Sum_probs=197.3
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
.++|++.++||+|+||.||+|.. .++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45788999999999999999954 578999999987542 233567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC---CCCeEEEeecCccc
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFGLAKL 573 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFGla~~ 573 (771)
||+++|+|.+++. ....+++..+..|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 116 e~~~~g~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999883 335689999999999999999999998 8999999999999976 45599999999987
Q ss_pred cCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 574 DEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 574 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
...... .....||+.|+|||++. ..++.++|||||||++|+|++|++||......+....+ . .+... ..
T Consensus 189 ~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~-~~~~~-~~ 257 (494)
T 3lij_A 189 FENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV------E-KGKYT-FD 257 (494)
T ss_dssp CBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H-HTCCC-CC
T ss_pred CCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------H-hCCCC-CC
Confidence 654322 23456999999999886 56899999999999999999999999765433221111 0 00000 00
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+.. . .....+.+++.+||+.||.+|||+.|+++
T Consensus 258 ~~~~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 SPEW-K----NVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SGGG-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhc-c----cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0000 1 12345789999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.42 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=199.5
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
..++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 456899999999999999999954 468999999987543 34678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+++++|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 105 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999842 235789999999999999999999998 8999999999999999999999999999866543
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ...... .+..
T Consensus 179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~------~~~~ 245 (314)
T 3com_A 179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF------MIPTNP------PPTF 245 (314)
T ss_dssp BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHSC------CCCC
T ss_pred cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhcCC------Cccc
Confidence 22 2234568999999999999999999999999999999999999997543221110 000000 0000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+......+.+++.+||+.||.+||++.++++
T Consensus 246 --~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 --RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111122346889999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=362.25 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=201.2
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
..++|++.++||+|+||+||+|.. .+|+.||||++... .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 346799999999999999999954 57899999998643 223467889999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc---CCCCeEEEeecCcc
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAK 572 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFGla~ 572 (771)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999998832 35699999999999999999999998 899999999999995 55679999999998
Q ss_pred ccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 573 LDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 573 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|++||......+....+ . .+...
T Consensus 173 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~-~~~~~-- 240 (486)
T 3mwu_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV------E-TGKYA-- 240 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H-HTCCC--
T ss_pred ECCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------H-hCCCC--
Confidence 6654322 234569999999999875 5899999999999999999999999765432221110 0 01000
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
............+.+++.+||+.||++|||+.|+++
T Consensus 241 ----~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 241 ----FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp ----SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000112345789999999999999999999997
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=349.48 Aligned_cols=261 Identities=21% Similarity=0.310 Sum_probs=202.6
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC--------CCcEEeEEEEEE---
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ--------HPNLVKLHGCCI--- 487 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 487 (771)
.++|++.++||+|+||.||+|. ..+++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 4678999999999999999994 567899999999753 344567889999999885 788999999987
Q ss_pred -eCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC-----
Q 004155 488 -EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL----- 561 (771)
Q Consensus 488 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----- 561 (771)
.....++||||+ +++|.+++... ....+++..++.|+.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence 456899999999 55666666332 2246999999999999999999999864 799999999999998775
Q ss_pred --------------------------------------------CeEEEeecCccccCCCCcccccccccCCCccchhhh
Q 004155 562 --------------------------------------------NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 597 (771)
Q Consensus 562 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 597 (771)
.+||+|||+++..... .....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 8999999999876533 2335689999999999
Q ss_pred ccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHH-HHhhCChh--------------------------
Q 004155 598 MRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALI-LKAQGNLM-------------------------- 650 (771)
Q Consensus 598 ~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~-------------------------- 650 (771)
.+..++.++|||||||++|||++|+.||................. ....+...
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 999999999999999999999999999976543322111111110 00001100
Q ss_pred ------HHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 651 ------ELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 651 ------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+.+.. ....+......+.+++.+||+.||++|||+.|+++
T Consensus 346 ~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00111 01235667778999999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=336.12 Aligned_cols=252 Identities=21% Similarity=0.344 Sum_probs=202.9
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---------hhcHHHHHHHHHHHHcCC-CCcEEeEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---------KQGNREFVNEIGMISALQ-HPNLVKLHGCCI 487 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 487 (771)
..++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 457899999999999999999954 578999999986542 122456889999999995 999999999999
Q ss_pred eCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEe
Q 004155 488 EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 567 (771)
Q Consensus 488 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 567 (771)
..+..++||||+++++|.+++.. ...+++..++.++.||+.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999942 35789999999999999999999998 899999999999999999999999
Q ss_pred ecCccccCCCCcccccccccCCCccchhhhc------cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHH
Q 004155 568 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAM------RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL 641 (771)
Q Consensus 568 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~ 641 (771)
||+++....... .....||+.|+|||++. ...++.++||||||+++|||++|+.||..........
T Consensus 168 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------ 239 (298)
T 1phk_A 168 FGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR------ 239 (298)
T ss_dssp CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------
T ss_pred ccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH------
Confidence 999987654322 23456899999999985 4568899999999999999999999997543221110
Q ss_pred HHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 642 ILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 642 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.... +.. .............+.+++.+||+.||++||++.|+++
T Consensus 240 ~~~~-~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMS-GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHH-TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhc-CCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0000 000 0000111123456889999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=345.61 Aligned_cols=264 Identities=21% Similarity=0.321 Sum_probs=198.1
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC------C
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEG------N 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 490 (771)
.++|...+.||+|+||.||+|. ..+|+.||||++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4678899999999999999995 467999999998653 333456789999999999999999999999765 3
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 7899999932 4689999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC--
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG-- 647 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-- 647 (771)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+ .......
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i---~~~~g~~~~ 247 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI---MKVTGTPPA 247 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCCH
Confidence 9875432 234568999999999887 68999999999999999999999999765432221111 0000000
Q ss_pred ---------ChhHHhhhh--c-CC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCCCC
Q 004155 648 ---------NLMELVDKR--L-GS---NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGRAD 699 (771)
Q Consensus 648 ---------~~~~~~d~~--l-~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~ 699 (771)
.....+... . .. .........+.+++.+||+.||++|||+.|+++ .++....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 000000000 0 00 001122346889999999999999999999998 4665443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=345.20 Aligned_cols=260 Identities=21% Similarity=0.309 Sum_probs=201.2
Q ss_pred CCCHHHHHHHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCC--CCcEEeEEEE
Q 004155 410 SFTLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQ--HPNLVKLHGC 485 (771)
Q Consensus 410 ~~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~ 485 (771)
.+.++.+....++|++.+.||+|+||.||++...+++.||||++... .......+.+|+.++.+++ ||||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 34445555567789999999999999999998888999999998654 3344678899999999997 5999999999
Q ss_pred EEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEE
Q 004155 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 565 (771)
Q Consensus 486 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 565 (771)
+.+.+..++||| +.+++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||++++ +.+||
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEE
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEE
Confidence 999999999999 567899999943 34689999999999999999999998 8999999999999965 89999
Q ss_pred EeecCccccCCCCcc-cccccccCCCccchhhhcc-----------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccch
Q 004155 566 SDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMR-----------GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDI 633 (771)
Q Consensus 566 ~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~ 633 (771)
+|||+++........ ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence 999999866543322 2234568999999999875 4788999999999999999999999965332111
Q ss_pred hhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 634 FYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+...+++.....++......+.+++.+||+.||++||++.|+++
T Consensus 248 --------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 248 --------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp --------------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --------------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 011222222222222222356889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.26 Aligned_cols=274 Identities=22% Similarity=0.309 Sum_probs=203.6
Q ss_pred CHHHHHHHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCCh-----------hcHHHHHHHHHHHHcCCCCcEE
Q 004155 412 TLRQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSK-----------QGNREFVNEIGMISALQHPNLV 480 (771)
Q Consensus 412 ~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~h~niv 480 (771)
...++....++|.+.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 45678889999999999999999999999888899999999864321 1237899999999999999999
Q ss_pred eEEEEEEeC-----CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcE
Q 004155 481 KLHGCCIEG-----NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNV 555 (771)
Q Consensus 481 ~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NI 555 (771)
++++++... ...++||||++ |+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 999998643 36899999998 5888888532 34799999999999999999999998 899999999999
Q ss_pred EEcCCCCeEEEeecCccccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchh
Q 004155 556 LLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF 634 (771)
Q Consensus 556 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~ 634 (771)
+++.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEcCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999999985443222 234568999999999877 67999999999999999999999999765432221
Q ss_pred hHHHHHHHHHhhCChh-----------HHhhhhcCCCC-------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--Hh
Q 004155 635 YLLDWALILKAQGNLM-----------ELVDKRLGSNF-------DKEQVMVMINVALLCTDVSSTSRPSMSSVVS--ML 694 (771)
Q Consensus 635 ~~~~~~~~~~~~~~~~-----------~~~d~~l~~~~-------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L 694 (771)
. ............ +.+........ .......+.+++.+||+.||++|||+.|+++ .+
T Consensus 244 ~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 320 (362)
T 3pg1_A 244 N---KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320 (362)
T ss_dssp H---HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred H---HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchh
Confidence 1 111111111111 11111110000 0112345889999999999999999999987 34
Q ss_pred cCC
Q 004155 695 EGR 697 (771)
Q Consensus 695 ~~~ 697 (771)
+..
T Consensus 321 ~~~ 323 (362)
T 3pg1_A 321 ESL 323 (362)
T ss_dssp TTT
T ss_pred hhc
Confidence 444
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=353.74 Aligned_cols=199 Identities=25% Similarity=0.387 Sum_probs=167.2
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC-----CE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEG-----NQ 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 491 (771)
.++|.+.+.||+|+||.||+|. ..+|+.||||++... .....+.+.+|+.++++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4689999999999999999994 556899999999753 334457889999999999999999999999765 57
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.|+||||++ |+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 999999996 599999943 34699999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcc---------------------cccccccCCCccchhhh-ccCCCCchHhHHHHHHHHHHHHhCCCCCC
Q 004155 572 KLDEEDNTH---------------------ISTRVAGTFGYMAPEYA-MRGYLTDKADVYSFGIVALEIVSGRSNSS 626 (771)
Q Consensus 572 ~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~ksDV~S~Gvil~elltG~~p~~ 626 (771)
+........ ..+...||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876543211 12456799999999986 55679999999999999999998655543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=360.74 Aligned_cols=247 Identities=27% Similarity=0.406 Sum_probs=200.1
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCCh-------------hcHHHHHHHHHHHHcCCCCcEEeEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK-------------QGNREFVNEIGMISALQHPNLVKLHG 484 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 484 (771)
..++|.+.++||+|+||+||+|. ..+++.||||++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999995 45689999999875421 23567899999999999999999999
Q ss_pred EEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC---
Q 004155 485 CCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL--- 561 (771)
Q Consensus 485 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 561 (771)
++.+....++||||+++|+|.+++. ....+++..+..|+.||+.||+|||+. +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQII----NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999983 235699999999999999999999998 899999999999998776
Q ss_pred CeEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHH
Q 004155 562 NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL 641 (771)
Q Consensus 562 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~ 641 (771)
.+||+|||+++....... .....||+.|+|||++. +.++.++||||+||++|+|++|++||......+....+
T Consensus 187 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---- 259 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV---- 259 (504)
T ss_dssp SEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----
T ss_pred cEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----
Confidence 699999999987654322 23456999999999987 46899999999999999999999999765433221111
Q ss_pred HHHhhCChhHHhhhhcCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 642 ILKAQGNLMELVDKRLGSNFDK----EQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 642 ~~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. .+. . .++. .....+.+++.+||+.||.+|||+.|+++
T Consensus 260 --~-~~~--------~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 260 --E-KGK--------Y--YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp --H-HCC--------C--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --H-cCC--------C--CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 110 0 1111 11245889999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.79 Aligned_cols=264 Identities=22% Similarity=0.289 Sum_probs=195.1
Q ss_pred hcCCCCCCccccCCceeEEEEEcC-CCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEE-----------
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI----------- 487 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 487 (771)
.++|.+.+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467889999999999999999554 58999999998766666788999999999999999999999873
Q ss_pred ---eCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc-CCCCe
Q 004155 488 ---EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNP 563 (771)
Q Consensus 488 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~ 563 (771)
+....++||||++ |+|.+++. ...+++..++.++.|++.||+|||+. +|+||||||+||+++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence 3468899999998 59999993 24689999999999999999999998 899999999999997 56799
Q ss_pred EEEeecCccccCCCCc--ccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHH
Q 004155 564 KISDFGLAKLDEEDNT--HISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWA 640 (771)
Q Consensus 564 kl~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~ 640 (771)
||+|||+++....... .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||......+........
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999987643221 11233457999999998875 68899999999999999999999999765432221111000
Q ss_pred H-------HHHhhCChhHHhhhhcCC-CCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 641 L-------ILKAQGNLMELVDKRLGS-NFD-----KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 641 ~-------~~~~~~~~~~~~d~~l~~-~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. .......+...+...... ..+ ......+.+++.+||+.||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0 000000001111111110 001 112346889999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=345.94 Aligned_cols=265 Identities=20% Similarity=0.254 Sum_probs=195.0
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC------
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGN------ 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 490 (771)
.++|.+.+.||+|+||.||+|. ..+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4678999999999999999994 557899999998753 3344567889999999999999999999997654
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..++||||+++ +|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999975 7888883 3589999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHH------------
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLD------------ 638 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~------------ 638 (771)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+......
T Consensus 174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred cccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 98654322 2234578999999999999999999999999999999999999997644322111000
Q ss_pred ----HHHHHHhh------CChhHHhhhhcCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcC
Q 004155 639 ----WALILKAQ------GNLMELVDKRLGSNF---DKEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEG 696 (771)
Q Consensus 639 ----~~~~~~~~------~~~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 696 (771)
........ ..+............ .......+.+++.+||+.||++|||+.|+++ .++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 00000000 000001101000000 1123567899999999999999999999987 4444
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=346.84 Aligned_cols=260 Identities=26% Similarity=0.414 Sum_probs=199.8
Q ss_pred CCHHHHHHHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEe
Q 004155 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIE 488 (771)
Q Consensus 411 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 488 (771)
+++.++....++|++.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 44445556778999999999999999999954 578999999987543 3356788999999998 79999999999987
Q ss_pred ------CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC
Q 004155 489 ------GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN 562 (771)
Q Consensus 489 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 562 (771)
.+..++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCC
Confidence 568999999999999999995432 24689999999999999999999998 8999999999999999999
Q ss_pred eEEEeecCccccCCCCcccccccccCCCccchhhhc-----cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHH
Q 004155 563 PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL 637 (771)
Q Consensus 563 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~ 637 (771)
+||+|||++........ ......||+.|+|||++. +..++.++|||||||++|||++|+.||..........
T Consensus 168 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-- 244 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-- 244 (326)
T ss_dssp EEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--
T ss_pred EEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH--
Confidence 99999999986543222 123356899999999987 5678999999999999999999999996543221110
Q ss_pred HHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 638 DWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 638 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.... .. .+.. ........+.+++.+||+.||++||++.++++
T Consensus 245 ----~~~~-~~-----~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 245 ----LIPR-NP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ----HHHH-SC-----CCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ----Hhhc-Cc-----cccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000 00 0011 11112346889999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=360.55 Aligned_cols=243 Identities=14% Similarity=0.119 Sum_probs=189.4
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC---ChhcHHHHHHHHH---HHHcCCCCcEEeEE-------EE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIG---MISALQHPNLVKLH-------GC 485 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~ 485 (771)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+. ++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999965 56999999998743 3344678899994 55556899999998 66
Q ss_pred EEeCC-----------------EEEEEEEeccCCCHHHHhcCCCc---cCCCCChHHHHHHHHHHHHHHHHhhhcCCCce
Q 004155 486 CIEGN-----------------QLLLIYEYMENNSLARALFGPEA---HRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545 (771)
Q Consensus 486 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i 545 (771)
+.+.+ ..++||||+ +|+|.+++..... ....+++..++.|+.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 66553 289999999 6799999953211 112344688899999999999999998 89
Q ss_pred eccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccccccccCCCccchhhhccC-----------CCCchHhHHHHHHH
Q 004155 546 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG-----------YLTDKADVYSFGIV 614 (771)
Q Consensus 546 vH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDV~S~Gvi 614 (771)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985432 2234567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 615 ALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 615 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+|||++|+.||......... ..+.. . ....+ ..+.+++.+||+.||++||++.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~~---------------~~~~~-~-~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGS---------------EWIFR-S-CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CCS---------------GGGGS-S-CCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccch---------------hhhhh-h-ccCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999653322211 11111 0 12222 45788999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=344.03 Aligned_cols=267 Identities=22% Similarity=0.296 Sum_probs=204.7
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC-----CE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEG-----NQ 491 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 491 (771)
..++|++.+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 35689999999999999999995 4578999999997543 33457789999999999999999999999754 46
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.++||||++ |+|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 899999997 59999983 34699999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCccc--ccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 572 KLDEEDNTHI--STRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 572 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
+......... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+...... .......
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~ 252 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPS 252 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH---HHHCSCC
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---HHhCCCC
Confidence 8765432221 234579999999998764 458999999999999999999999997655443322111 1000000
Q ss_pred hh-----------HHhhhhc-CCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCC
Q 004155 649 LM-----------ELVDKRL-GSNFD-----KEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGR 697 (771)
Q Consensus 649 ~~-----------~~~d~~l-~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 697 (771)
.. ....... ....+ ......+.+++.+||+.||++|||+.|+++ .+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 00 0000000 00011 112345889999999999999999999997 35443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=363.66 Aligned_cols=251 Identities=26% Similarity=0.371 Sum_probs=203.7
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
..++|++.++||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 346788999999999999999954 578999999986542 3456789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE---cCCCCeEEEeecCc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLA 571 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFGla 571 (771)
||||+.+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999999843 34699999999999999999999998 89999999999999 56789999999999
Q ss_pred cccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 572 KLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 572 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
+....... .....||+.|+|||++.+ .++.++||||+||++|+|++|++||......+.... . ..+...
T Consensus 177 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i----~~~~~~- 245 (484)
T 3nyv_A 177 THFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKK---V----EKGKYT- 245 (484)
T ss_dssp HHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---H----HHCCCC-
T ss_pred EEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHH---H----HcCCCC-
Confidence 87654332 233569999999999876 689999999999999999999999976543222111 0 011000
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
............+.+++.+||+.||++|||+.|+++
T Consensus 246 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 -----FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -----CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 000000122345789999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=353.03 Aligned_cols=201 Identities=22% Similarity=0.315 Sum_probs=173.1
Q ss_pred HhcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC------CCCcEEeEEEEEEeCCE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL------QHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~ 491 (771)
...+|++.++||+|+||.||+| ...+++.||||++... ....+.+.+|+.+++.+ +|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3467899999999999999999 4556899999999753 33456777888888776 57799999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC--eEEEeec
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN--PKISDFG 569 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFG 569 (771)
.++||||+. ++|.+++.... ...+++..+..|+.||+.||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999996 69999985432 23589999999999999999999998 8999999999999999987 9999999
Q ss_pred CccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Q 004155 570 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPK 630 (771)
Q Consensus 570 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~ 630 (771)
+++...... ....||+.|+|||++.+..++.++|||||||++|||++|++||.....
T Consensus 248 ~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 248 SSCYEHQRV----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp TCEETTCCC----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cceecCCcc----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 997654322 235689999999999999999999999999999999999999976544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=374.48 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=204.6
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 493 (771)
..++|++.++||+|+||.||+|. ..+++.||||+++.. .....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 45789999999999999999995 456889999998753 223346788899999988 7999999999999999999
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++++||+|||+|+.
T Consensus 419 lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999942 34699999999999999999999998 899999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 574 DEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 574 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .++
T Consensus 492 ~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~---------------~i~ 555 (674)
T 3pfq_A 492 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ---------------SIM 555 (674)
T ss_dssp CCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------HHH
T ss_pred cccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH---------------HHH
Confidence 433322 2345679999999999999999999999999999999999999997644322211 111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSM-----SSVVS 692 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 692 (771)
... ..++......+.+++.+||+.||++||++ .||++
T Consensus 556 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 556 EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred hCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111 12222334568899999999999999998 66654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=338.90 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=195.8
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCCh--------hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK--------QGNREFVNEIGMISALQHPNLVKLHGCCIEG 489 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 489 (771)
..++|.+.+.||+|+||.||+|. ..+++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 45679999999999999999995 45689999999865321 1234588999999999999999999998765
Q ss_pred CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC---eEEE
Q 004155 490 NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN---PKIS 566 (771)
Q Consensus 490 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~ 566 (771)
+ .++||||+++++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 8999999999999999943 34689999999999999999999998 8999999999999987664 9999
Q ss_pred eecCccccCCCCcccccccccCCCccchhhhc---cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHH
Q 004155 567 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALIL 643 (771)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 643 (771)
|||+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||......... ....
T Consensus 160 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~--- 232 (322)
T 2ycf_A 160 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQI--- 232 (322)
T ss_dssp CCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHH---
T ss_pred cCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHH---
Confidence 999998764332 223356899999999974 567899999999999999999999999754332211 1100
Q ss_pred HhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 644 KAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 644 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+... . .+..... ....+.+++.+||+.||++||++.|+++
T Consensus 233 -~~~~~~-~-~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 -TSGKYN-F-IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HHTCCC-C-CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HhCccc-c-Cchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 011000 0 0000011 2346889999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.31 Aligned_cols=275 Identities=19% Similarity=0.265 Sum_probs=194.8
Q ss_pred HHHHHHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE-
Q 004155 414 RQIKAATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQ- 491 (771)
Q Consensus 414 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 491 (771)
.+.....++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+..++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 45667788999999999999999999954 568999999986543 223456778888899999999999999975433
Q ss_pred ------EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhh--hcCCCceeccCCCCCcEEEcC-CCC
Q 004155 492 ------LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH--EESRLKIVHRDIKATNVLLDK-DLN 562 (771)
Q Consensus 492 ------~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~ 562 (771)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 8999999986 555554322223457899999999999999999999 66 8999999999999996 899
Q ss_pred eEEEeecCccccCCCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHH
Q 004155 563 PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL 641 (771)
Q Consensus 563 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~ 641 (771)
+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||............ ..
T Consensus 171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~--~~ 246 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI--VR 246 (360)
T ss_dssp EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HH
T ss_pred EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH--HH
Confidence 99999999987654332 2345689999999998765 4899999999999999999999999765433222111 11
Q ss_pred HHHhhC-ChhHHhhh----------------hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCC
Q 004155 642 ILKAQG-NLMELVDK----------------RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGR 697 (771)
Q Consensus 642 ~~~~~~-~~~~~~d~----------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 697 (771)
...... .....+++ .............+.+++.+||+.||++|||+.|+++ .+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 100000 00000000 0001111123567899999999999999999999986 35544
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=345.07 Aligned_cols=262 Identities=23% Similarity=0.396 Sum_probs=199.6
Q ss_pred HhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
..++|++.+.||+|+||.||+|...+ .||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 45788899999999999999997643 49999987542 223456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++++|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+||+++ ++.+||+|||+++....
T Consensus 109 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp BCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 999999999999432 34689999999999999999999998 899999999999998 67999999999875532
Q ss_pred CC----cccccccccCCCccchhhhcc---------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHH
Q 004155 577 DN----THISTRVAGTFGYMAPEYAMR---------GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALIL 643 (771)
Q Consensus 577 ~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 643 (771)
.. ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ..
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~ 255 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW------QM 255 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH------HH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------Hh
Confidence 11 112233458999999999874 457899999999999999999999997544322111 01
Q ss_pred HhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCCCCCC
Q 004155 644 KAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQDFV 704 (771)
Q Consensus 644 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 704 (771)
. .+ ..+... .......+.+++.+||+.||++||++.+++++|+.+.......
T Consensus 256 ~-~~-----~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 256 G-TG-----MKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp H-TT-----CCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred c-cC-----CCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 0 11 001110 0112235789999999999999999999999999987654433
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=334.73 Aligned_cols=256 Identities=21% Similarity=0.269 Sum_probs=199.9
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC----hhcHHHHHHHHHHHHcCCCCcEEeEEEEEE--eCCE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS----KQGNREFVNEIGMISALQHPNLVKLHGCCI--EGNQ 491 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 491 (771)
..++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++. +.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 347899999999999999999965 568999999987542 234578999999999999999999999985 4567
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.++||||++++ |.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccc
Confidence 89999999876 777774322 34689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCC-cccccccccCCCccchhhhccCC--CCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 572 KLDEEDN-THISTRVAGTFGYMAPEYAMRGY--LTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 572 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
+...... ........||+.|+|||++.+.. .+.++||||||+++|||++|+.||.......... ... .+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~i~-~~- 228 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE------NIG-KG- 228 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHH-HC-
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH------HHh-cC-
Confidence 8664322 22223456899999999997643 4789999999999999999999997543221111 000 11
Q ss_pred hhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCC
Q 004155 649 LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGR 697 (771)
Q Consensus 649 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 697 (771)
. ...+......+.+++.+||+.||++||++.|+++ .+++.
T Consensus 229 -------~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 229 -------S--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp -------C--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred -------C--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 0 0111223345789999999999999999999996 45543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.65 Aligned_cols=258 Identities=21% Similarity=0.300 Sum_probs=203.1
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhc-----------------HHHHHHHHHHHHcCCCCcEEeE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQG-----------------NREFVNEIGMISALQHPNLVKL 482 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l 482 (771)
.++|.+.+.||+|+||.||+|.. +|+.||||++....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999999987 89999999986532111 1789999999999999999999
Q ss_pred EEEEEeCCEEEEEEEeccCCCHHHH------hcCCCccCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceeccCCCCCcE
Q 004155 483 HGCCIEGNQLLLIYEYMENNSLARA------LFGPEAHRLKLDWPTRHRICVGIARGLAYLHE-ESRLKIVHRDIKATNV 555 (771)
Q Consensus 483 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dlkp~NI 555 (771)
++++.+.+..++||||+++|+|.++ +.. .....+++..++.++.||+.||+|||+ . +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 522 124679999999999999999999998 7 899999999999
Q ss_pred EEcCCCCeEEEeecCccccCCCCcccccccccCCCccchhhhccC-CCCc-hHhHHHHHHHHHHHHhCCCCCCCCCccch
Q 004155 556 LLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG-YLTD-KADVYSFGIVALEIVSGRSNSSCKPKEDI 633 (771)
Q Consensus 556 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDV~S~Gvil~elltG~~p~~~~~~~~~ 633 (771)
+++.++.+||+|||+++..... ......||..|+|||.+.+. .++. ++|||||||++|||++|+.||........
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9999999999999999876443 22345689999999999877 6666 99999999999999999999976443111
Q ss_pred hhHHHHHHHHHhhCChhH------HhhhhcC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 634 FYLLDWALILKAQGNLME------LVDKRLG---SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~------~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.... . ..+...- ...+... ..........+.+++.+||+.||.+||++.|+++
T Consensus 261 --~~~~---i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 --LFNN---I-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HHHH---H-TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHH---H-hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1110 0 0110000 0000000 0000223356889999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=371.73 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=205.3
Q ss_pred HHHHhcCCCCCCccccCCceeEEEEEcC----CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC
Q 004155 416 IKAATNNFAPDNKIGEGGFGPVYKGHMA----DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGN 490 (771)
Q Consensus 416 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 490 (771)
.....++|.+.+.||+|+||.||+|... .+..||||+++... ....+.+.+|+.++++++||||+++++++. ++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 3344567888999999999999999653 25689999987643 344578999999999999999999999985 46
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCC
Confidence 689999999999999999432 34689999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCCh
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNL 649 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (771)
++..............+|+.|+|||++.+..++.++|||||||++|||++ |..||......+.. .. ..
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~---~~---i~----- 606 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GR---IE----- 606 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HH---HH-----
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HH---HH-----
Confidence 98765544333344567889999999999999999999999999999997 99999754432211 11 00
Q ss_pred hHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 650 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.......+......+.+++.+||+.||++||++.|+++.|+.+
T Consensus 607 -----~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 607 -----NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp -----HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----cCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0111112223345688999999999999999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=349.50 Aligned_cols=266 Identities=22% Similarity=0.308 Sum_probs=196.8
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC------EEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGN------QLL 493 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 493 (771)
..+|.+.++||+|+||.||+|...++..||+|++...... ..+|+++++.++||||+++++++.... ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3468889999999999999998767777999988654322 236999999999999999999996543 388
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc-CCCCeEEEeecCcc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAK 572 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFGla~ 572 (771)
+||||++++ +.+.+.........+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+|+
T Consensus 115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 999999874 4444322122345799999999999999999999998 899999999999999 79999999999998
Q ss_pred ccCCCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 573 LDEEDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 573 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
........ ....||+.|+|||++.+. .++.++|||||||++|||++|++||......+.. ....... .......
T Consensus 191 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l--~~i~~~~-g~p~~~~ 265 (394)
T 4e7w_A 191 ILIAGEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL--VEIIKVL-GTPSREQ 265 (394)
T ss_dssp ECCTTCCC--CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHH-CCCCHHH
T ss_pred cccCCCCC--cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHh-CCCCHHH
Confidence 76443322 345689999999998765 5899999999999999999999999765433221 1111111 0000000
Q ss_pred H--hhhhc-----CC--C------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCCC
Q 004155 652 L--VDKRL-----GS--N------FDKEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGRA 698 (771)
Q Consensus 652 ~--~d~~l-----~~--~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~ 698 (771)
+ .++.. .. . +.......+.+++.+||+.||++|||+.|+++ .+++..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 0 00000 00 0 01112346889999999999999999999987 355543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=340.17 Aligned_cols=262 Identities=19% Similarity=0.267 Sum_probs=203.1
Q ss_pred hcCCCCCCccccCCceeEEEEEc--CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCC------cEEeEEEEEEeCCE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM--ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHP------NLVKLHGCCIEGNQ 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~ 491 (771)
.++|++.+.||+|+||.||+|.. .+|+.||||+++.. ....+.+.+|+.+++.++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46889999999999999999954 46899999999753 34456788999999888655 59999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC------------
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK------------ 559 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~------------ 559 (771)
.++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 889999995432 24689999999999999999999998 8999999999999987
Q ss_pred -------CCCeEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc
Q 004155 560 -------DLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKED 632 (771)
Q Consensus 560 -------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~ 632 (771)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 6789999999998654322 33568999999999999999999999999999999999999997654433
Q ss_pred hhhHHHHHHH-----HHhhCCh-----------------hHHhhhhc-----CCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 004155 633 IFYLLDWALI-----LKAQGNL-----------------MELVDKRL-----GSNFDKEQVMVMINVALLCTDVSSTSRP 685 (771)
Q Consensus 633 ~~~~~~~~~~-----~~~~~~~-----------------~~~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 685 (771)
.......... ....... ...+.... ...........+.+++.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 2221111100 0000000 00000000 0011234567789999999999999999
Q ss_pred CHHHHHH
Q 004155 686 SMSSVVS 692 (771)
Q Consensus 686 s~~evl~ 692 (771)
|+.|+++
T Consensus 322 t~~ell~ 328 (339)
T 1z57_A 322 TLREALK 328 (339)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=345.41 Aligned_cols=263 Identities=23% Similarity=0.336 Sum_probs=187.0
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC------C
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEG------N 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 490 (771)
.++|.+.+.||+|+||.||+|. ..+|+.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4688999999999999999994 567999999998653 334467788999999999999999999998754 5
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
..++|+||+ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 689999999 6799988832 4699999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC--
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG-- 647 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-- 647 (771)
++..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+ .......
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i---~~~~g~p~~ 251 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGA 251 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCH
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCH
Confidence 9865432 234578999999999887 68899999999999999999999999765432221111 1110000
Q ss_pred ---------ChhHHhhhhcC-CCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCCC
Q 004155 648 ---------NLMELVDKRLG-SNFDK-----EQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGRA 698 (771)
Q Consensus 648 ---------~~~~~~d~~l~-~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~ 698 (771)
.....+..... ..... .....+.+|+.+||+.||++|||+.|+++ .++...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 00011110000 00111 11245789999999999999999999987 354443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=343.36 Aligned_cols=211 Identities=23% Similarity=0.299 Sum_probs=176.4
Q ss_pred CCHHHHHHHhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-CC-----cEEeEE
Q 004155 411 FTLRQIKAATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-HP-----NLVKLH 483 (771)
Q Consensus 411 ~~~~~l~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~ 483 (771)
+..+......++|.+.++||+|+||.||+|. ..+++.||||+++.. .....++..|+.+++.++ |+ +|++++
T Consensus 44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 3344445567899999999999999999995 457899999999753 334567788998888874 44 499999
Q ss_pred EEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc--CCC
Q 004155 484 GCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD--KDL 561 (771)
Q Consensus 484 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~ 561 (771)
+++...+..++||||++ |+|.+++.... ...+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSC
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCC
Confidence 99999999999999996 59999995432 24589999999999999999999953 23899999999999994 578
Q ss_pred CeEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Q 004155 562 NPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPK 630 (771)
Q Consensus 562 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~ 630 (771)
.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||++||.....
T Consensus 199 ~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 8999999999876432 2335689999999999999999999999999999999999999986543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=354.97 Aligned_cols=259 Identities=24% Similarity=0.316 Sum_probs=193.9
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC------CEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEG------NQLL 493 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 493 (771)
.+|...+.||+|+||.||+|.. .+|+.||||++..... .+.+|++++++++||||++++++|... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 3578889999999999999965 5689999999865432 234699999999999999999998642 2467
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC-CCeEEEeecCcc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAK 572 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFGla~ 572 (771)
+||||+++ +|.+.+.........+++..+..++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 67666643223345799999999999999999999998 89999999999999965 568999999998
Q ss_pred ccCCCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 573 LDEEDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 573 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|++||......+. +.+...... ......
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg-~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLG-TPTREQ 280 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHC-SCCHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhC-CCCHHH
Confidence 7644332 2335689999999999765 799999999999999999999999976443222 111111110 000000
Q ss_pred H--hhhhc--------CCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 652 L--VDKRL--------GSN-----FDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 652 ~--~d~~l--------~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+ .++.. ... +.......+.+|+.+||+.||++||++.|+++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0 00000 000 01122356889999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=335.02 Aligned_cols=252 Identities=26% Similarity=0.423 Sum_probs=193.4
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe---------
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIE--------- 488 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 488 (771)
..++|++.+.||+|+||.||+|. ..+|+.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 35678999999999999999995 45799999999865 33445778999999999999999999999865
Q ss_pred ----CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeE
Q 004155 489 ----GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPK 564 (771)
Q Consensus 489 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 564 (771)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 35689999999999999999532 34578899999999999999999998 899999999999999999999
Q ss_pred EEeecCccccCCCC-------------cccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Q 004155 565 ISDFGLAKLDEEDN-------------THISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPK 630 (771)
Q Consensus 565 l~DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~ 630 (771)
|+|||+++...... ........||+.|+|||++.+. .++.++|||||||++|||++ ||...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-- 231 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-- 231 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--
Confidence 99999998654321 1112345689999999999864 78999999999999999998 44321
Q ss_pred cchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 631 EDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+ .......... ....+....+......+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~---~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 ME---RVNILKKLRS-------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HH---HHHHHHHHHS-------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hh---HHHHHHhccc-------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 01 1111111110 0111122233344556889999999999999999999997
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=351.01 Aligned_cols=253 Identities=9% Similarity=0.011 Sum_probs=181.2
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCCh---hcHHHHHHHH---HHHHcCCCCcEEeEE-------EE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK---QGNREFVNEI---GMISALQHPNLVKLH-------GC 485 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 485 (771)
..+|...+.||+|+||.||+|. ..+|+.||||++..... ...+.+.+|+ ..|+. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 3458889999999999999996 45789999999987542 3345677785 45555 799988755 45
Q ss_pred EEeC-----------------CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHH------HHHHHHHHHHHHHhhhcCC
Q 004155 486 CIEG-----------------NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTR------HRICVGIARGLAYLHEESR 542 (771)
Q Consensus 486 ~~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~aL~~LH~~~~ 542 (771)
+... ...++||||++ |+|.+++... ...+.+..+ +.++.||+.||+|||++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-- 213 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK-- 213 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC--
Confidence 5433 34899999998 8999999432 224566667 78889999999999998
Q ss_pred CceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccccccccCCCccchhhhcc--CCCCchHhHHHHHHHHHHHHh
Q 004155 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVS 620 (771)
Q Consensus 543 ~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvil~ellt 620 (771)
+|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 214 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 214 -GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp -TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 89999999999999999999999999998654321 13457799999999987 679999999999999999999
Q ss_pred CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 621 GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 621 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
|+.||........... ........................+.+++.+||+.||++|||+.|+++
T Consensus 289 g~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999976532211000 000000000001100111123456889999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=336.73 Aligned_cols=263 Identities=24% Similarity=0.367 Sum_probs=199.4
Q ss_pred HhcCCCCCCccccCCceeEEEEEc--CCCcEEEEEEcccCCh--hcHHHHHHHHHHHHcC---CCCcEEeEEEEEE----
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM--ADGTVVAVKQLSSKSK--QGNREFVNEIGMISAL---QHPNLVKLHGCCI---- 487 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~--~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 487 (771)
+.++|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 567899999999999999999965 4688999999864321 1223566777777665 8999999999987
Q ss_pred -eCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEE
Q 004155 488 -EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 566 (771)
Q Consensus 488 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 566 (771)
.....++||||++ |+|.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 69999985432 23589999999999999999999998 89999999999999999999999
Q ss_pred eecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh
Q 004155 567 DFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ 646 (771)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 646 (771)
|||+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+.. .........
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~ 237 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGL 237 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCC
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCC
Confidence 999998654322 223456899999999999999999999999999999999999999765432221 111111000
Q ss_pred CChhHH------hhhhcC-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 647 GNLMEL------VDKRLG-------SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 647 ~~~~~~------~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...... ...... ..........+.+++.+||+.||++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 000000 0011122345789999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.62 Aligned_cols=267 Identities=20% Similarity=0.284 Sum_probs=202.1
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC-----CE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEG-----NQ 491 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 491 (771)
..++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 356899999999999999999954 578999999997543 33456788999999999999999999998754 67
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.++||||+. |+|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIS-----TQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999997 59999983 24689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcc---------cccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHH
Q 004155 572 KLDEEDNTH---------ISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL 641 (771)
Q Consensus 572 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~ 641 (771)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~ 236 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI---F 236 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---H
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---H
Confidence 876532211 1123468999999998765 68899999999999999999999999765432221111 0
Q ss_pred HHHhhCC------------hhHHhhhhcC-CCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCC
Q 004155 642 ILKAQGN------------LMELVDKRLG-SNFD-----KEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGR 697 (771)
Q Consensus 642 ~~~~~~~------------~~~~~d~~l~-~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 697 (771)
....... ..+.+..... .... ......+.+++.+||+.||++|||+.|+++ .++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0000000 0011100000 0000 112346789999999999999999999987 45544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=344.81 Aligned_cols=266 Identities=21% Similarity=0.321 Sum_probs=182.6
Q ss_pred cCCCC-CCccccCCceeEEEEEcC---CCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe--CCEEEE
Q 004155 421 NNFAP-DNKIGEGGFGPVYKGHMA---DGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIE--GNQLLL 494 (771)
Q Consensus 421 ~~f~~-~~~lG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 494 (771)
+.|.+ .++||+|+||.||+|... +++.||||++.... ....+.+|+.++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34555 558999999999999754 57899999997543 23568899999999999999999999965 678999
Q ss_pred EEEeccCCCHHHHhcCCC-----ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE----cCCCCeEE
Q 004155 495 IYEYMENNSLARALFGPE-----AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL----DKDLNPKI 565 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl 565 (771)
||||+++ +|.+++.... .....+++..++.|+.||+.||+|||+. +|+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 8888774211 1223599999999999999999999998 89999999999999 77899999
Q ss_pred EeecCccccCCCCc--ccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccc-------hhh
Q 004155 566 SDFGLAKLDEEDNT--HISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKED-------IFY 635 (771)
Q Consensus 566 ~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~-------~~~ 635 (771)
+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|++||.....+. ...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987654322 122346799999999999874 58999999999999999999999997643321 001
Q ss_pred HHHHHHHHHhh--CChhH---------Hhhh---hcCCCCCH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 636 LLDWALILKAQ--GNLME---------LVDK---RLGSNFDK---------EQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 636 ~~~~~~~~~~~--~~~~~---------~~d~---~l~~~~~~---------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+......+... ..+.. .... ........ .....+.+|+.+||+.||++|||+.|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111100000 00000 0000 00000000 01235789999999999999999999997
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=338.86 Aligned_cols=266 Identities=21% Similarity=0.295 Sum_probs=202.4
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-----------CCcEEeEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-----------HPNLVKLHGCCI 487 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 487 (771)
.++|.+.+.||+|+||.||+|. ..+|+.||||++... ......+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 3578899999999999999995 467899999999753 344567889999998886 899999999998
Q ss_pred eCC----EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc-----
Q 004155 488 EGN----QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD----- 558 (771)
Q Consensus 488 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~----- 558 (771)
..+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 654 789999999 889999995432 245899999999999999999999863 799999999999994
Q ss_pred -CCCCeEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchh---
Q 004155 559 -KDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF--- 634 (771)
Q Consensus 559 -~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~--- 634 (771)
..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 44589999999998665422 2346899999999999999999999999999999999999999764322111
Q ss_pred -hHHHHHHHHH-------hhCC----------------------hhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 004155 635 -YLLDWALILK-------AQGN----------------------LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSR 684 (771)
Q Consensus 635 -~~~~~~~~~~-------~~~~----------------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 684 (771)
.+........ ..+. +...+.. ...++......+.+++.+||+.||++|
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCcccc
Confidence 1111000000 0000 0111111 123456677889999999999999999
Q ss_pred CCHHHHHH--HhcCC
Q 004155 685 PSMSSVVS--MLEGR 697 (771)
Q Consensus 685 Ps~~evl~--~L~~~ 697 (771)
||+.|+++ .+.+.
T Consensus 326 pt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDT 340 (373)
T ss_dssp BCHHHHHTCGGGTTC
T ss_pred CCHHHHhhChhhhcc
Confidence 99999987 44443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.36 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=201.4
Q ss_pred HHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 418 AATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 418 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
...++|++.+.||+|+||.||+|.. .+++.||||++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 3457899999999999999999955 47899999998653 23446789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC---CCeEEEeecCc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD---LNPKISDFGLA 571 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFGla 571 (771)
||||+++++|.+++.. ...+++..++.++.||+.||+|||+. +++||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999998832 34689999999999999999999998 89999999999999754 47999999999
Q ss_pred cccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 572 KLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 572 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
+....... .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||......+.. . ... .+....
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~---~~~-~~~~~~ 241 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---K---RVE-TGKYAF 241 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---HHH-HCCCCC
T ss_pred eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH---H---HHH-cCCCCC
Confidence 86644322 123458899999998875 4899999999999999999999999764332211 1 010 111000
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. +. .. .....+.+++.+||+.||++||++.|+++
T Consensus 242 ~~-~~-~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 DL-PQ-WR----TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CS-GG-GT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cc-hh-hh----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 00 01 12345889999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=340.29 Aligned_cols=257 Identities=21% Similarity=0.336 Sum_probs=196.1
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEE----
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQL---- 492 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 492 (771)
.++|...+.||+|+||.||+|. ..+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4678889999999999999994 557999999999764 233457788999999999999999999999876654
Q ss_pred --EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 493 --LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 493 --~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
++||||+. ++|.+++ ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 5898888 23489999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh---
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ--- 646 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--- 646 (771)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..... .......
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--~~~~~~~~~~ 264 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI--LKVTGVPGTE 264 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCCCCHH
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHHhCCCcHH
Confidence 9865432 233568999999999987 68999999999999999999999999764432221111 0000000
Q ss_pred ------CC-hhHHhhhhcCC-CCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 647 ------GN-LMELVDKRLGS-NFD-----KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 647 ------~~-~~~~~d~~l~~-~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. ........... ... ......+.+++.+||+.||++|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00 00000000000 000 112356889999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=347.59 Aligned_cols=252 Identities=24% Similarity=0.291 Sum_probs=188.0
Q ss_pred CCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+.+..++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 44556889999999998776668999999998653 245678899999876 89999999999999999999999996
Q ss_pred CCCHHHHhcCCCccCCC---CChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCC-------------CCeE
Q 004155 501 NNSLARALFGPEAHRLK---LDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKD-------------LNPK 564 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~k 564 (771)
|+|.+++......... .++..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 6999999654322211 24456788999999999999998 89999999999999754 4899
Q ss_pred EEeecCccccCCCCcc---cccccccCCCccchhhhcc-------CCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccch
Q 004155 565 ISDFGLAKLDEEDNTH---ISTRVAGTFGYMAPEYAMR-------GYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDI 633 (771)
Q Consensus 565 l~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~ 633 (771)
|+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||........
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 9999999876553322 1234579999999999975 678999999999999999999 9999965332211
Q ss_pred hhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 634 FYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. ....... +......+......+.+++.+||+.||++||++.||++
T Consensus 249 -~i------~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 -NI------IRGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -HH------HHTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HH------hcCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 00 0000000 01111123455678899999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=334.71 Aligned_cols=244 Identities=24% Similarity=0.365 Sum_probs=190.6
Q ss_pred HHHHhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChh------cHHHHHHHHHHHHcC----CCCcEEeEEE
Q 004155 416 IKAATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQ------GNREFVNEIGMISAL----QHPNLVKLHG 484 (771)
Q Consensus 416 l~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~ 484 (771)
.....++|++.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999954 57899999999754321 223456789999888 8999999999
Q ss_pred EEEeCCEEEEEEEe-ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc-CCCC
Q 004155 485 CCIEGNQLLLIYEY-MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLN 562 (771)
Q Consensus 485 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~ 562 (771)
++...+..++|||| +.+++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+||+++ .++.
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 99999999999999 789999999943 34699999999999999999999998 899999999999999 8899
Q ss_pred eEEEeecCccccCCCCcccccccccCCCccchhhhccCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHH
Q 004155 563 PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL 641 (771)
Q Consensus 563 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~ 641 (771)
+||+|||+++...... .....||..|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------ 243 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------ 243 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------
Confidence 9999999998765432 234568999999999987665 459999999999999999999996310
Q ss_pred HHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 642 ILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 642 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
++.+... ..+......+.+++.+||+.||++||++.|+++
T Consensus 244 ---------~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 ---------EILEAEL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ---------HHHHTCC--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------HHhhhcc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111111 111223345788999999999999999999997
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=332.58 Aligned_cols=258 Identities=18% Similarity=0.275 Sum_probs=199.9
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCC-cEEEEEEcccCChhcHHHHHHHHHHHHcCCCCc------EEeEEEEEEeCCE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADG-TVVAVKQLSSKSKQGNREFVNEIGMISALQHPN------LVKLHGCCIEGNQ 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 491 (771)
.++|++.+.||+|+||.||+|.. .++ +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 46899999999999999999954 344 78999999753 344567888999999987655 9999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE--------------
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL-------------- 557 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll-------------- 557 (771)
.++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence 99999999 567777774322 24689999999999999999999998 89999999999999
Q ss_pred -----cCCCCeEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc
Q 004155 558 -----DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKED 632 (771)
Q Consensus 558 -----~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~ 632 (771)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 678899999999998654322 33568999999999999999999999999999999999999997654333
Q ss_pred hhhHHHHHHHHHhhCChhHH--------------------------hhhhc-----CCCCCHHHHHHHHHHHHHccCCCC
Q 004155 633 IFYLLDWALILKAQGNLMEL--------------------------VDKRL-----GSNFDKEQVMVMINVALLCTDVSS 681 (771)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~--------------------------~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dP 681 (771)
........ ... ..... +.... ...........+.+++.+||+.||
T Consensus 247 ~~~~~~~~---~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 247 HLVMMEKI---LGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp HHHHHHHH---HCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HHHHHHHH---cCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 22111111 000 00000 00000 001122345678899999999999
Q ss_pred CCCCCHHHHHH
Q 004155 682 TSRPSMSSVVS 692 (771)
Q Consensus 682 ~~RPs~~evl~ 692 (771)
++|||+.|+++
T Consensus 323 ~~Rpt~~e~l~ 333 (355)
T 2eu9_A 323 AQRITLAEALL 333 (355)
T ss_dssp TTSCCHHHHTT
T ss_pred hhCcCHHHHhc
Confidence 99999999974
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.31 Aligned_cols=257 Identities=25% Similarity=0.347 Sum_probs=178.3
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC-hhcHHHHHHHHH-HHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS-KQGNREFVNEIG-MISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
.++|...+.||+|+||.||+|.. .+|+.||||++.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 36788899999999999999955 578999999997643 333455666666 677789999999999999999999999
Q ss_pred EeccCCCHHHHhcCC-CccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 497 EYMENNSLARALFGP-EAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 497 E~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
||+++ +|.+++... ......+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 888877321 112357899999999999999999999862 79999999999999999999999999998664
Q ss_pred CCCcccccccccCCCccchhhh----ccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 576 EDNTHISTRVAGTFGYMAPEYA----MRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
.... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||......... ......
T Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----------~~~~~~ 244 (327)
T 3aln_A 178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----------LTQVVK 244 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCCC
T ss_pred cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----------HHHHhc
Confidence 3322 2234689999999998 4567899999999999999999999999753211000 000000
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...+.+...........+.+++.+||+.||++||++.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00011111111123346889999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=339.92 Aligned_cols=256 Identities=21% Similarity=0.330 Sum_probs=195.8
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE-----
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQ----- 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 491 (771)
.++|...+.||+|+||.||+|. ..+|+.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 4678889999999999999995 457999999998653 23345678999999999999999999999986643
Q ss_pred -EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 492 -LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 492 -~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
.++||||+. ++|.+++. ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 599999997 58888772 3589999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC-
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN- 648 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~- 648 (771)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.... .........
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~~~~~ 245 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ---ILKVTGVPGT 245 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHH---HHHHHCBCCH
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCCH
Confidence 9865432 233568999999999887 6789999999999999999999999976543222111 110000000
Q ss_pred ----------hhHHhhh---hcCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 649 ----------LMELVDK---RLGS---NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 649 ----------~~~~~d~---~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
....+.. .... .........+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000 0000 111223456889999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=334.84 Aligned_cols=258 Identities=20% Similarity=0.218 Sum_probs=174.6
Q ss_pred HhcCCCCCC-ccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe----CCEE
Q 004155 419 ATNNFAPDN-KIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIE----GNQL 492 (771)
Q Consensus 419 ~~~~f~~~~-~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 492 (771)
..++|.+.+ .||+|+||.||+|.. .+|+.||||++.... . ........++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 356788854 699999999999954 479999999986532 1 12222334566799999999999876 4568
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC---CCCeEEEeec
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFG 569 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG 569 (771)
++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 99999999999999996432 24699999999999999999999998 8999999999999976 4559999999
Q ss_pred CccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCCh
Q 004155 570 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL 649 (771)
Q Consensus 570 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (771)
+++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||............. ..
T Consensus 177 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~------- 244 (336)
T 3fhr_A 177 FAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK--RR------- 244 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred cceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH--Hh-------
Confidence 998654322 233568999999999988889999999999999999999999997543322110000 00
Q ss_pred hHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCC
Q 004155 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGR 697 (771)
Q Consensus 650 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 697 (771)
...................+.+++.+||+.||++|||+.|+++ .+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 245 IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred hhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 0000000001111123446889999999999999999999998 55554
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=335.64 Aligned_cols=243 Identities=22% Similarity=0.347 Sum_probs=197.9
Q ss_pred HHHhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChh------cHHHHHHHHHHHHcCC--CCcEEeEEEEEE
Q 004155 417 KAATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQ------GNREFVNEIGMISALQ--HPNLVKLHGCCI 487 (771)
Q Consensus 417 ~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~ 487 (771)
....++|++.+.||+|+||.||+|. ..+|+.||||++...... ....+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3456789999999999999999995 567899999998654211 2245678999999996 599999999999
Q ss_pred eCCEEEEEEEeccC-CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc-CCCCeEE
Q 004155 488 EGNQLLLIYEYMEN-NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKI 565 (771)
Q Consensus 488 ~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl 565 (771)
..+..++||||+.+ ++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++ +++.+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999976 899999932 35789999999999999999999998 899999999999999 7899999
Q ss_pred EeecCccccCCCCcccccccccCCCccchhhhccCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHH
Q 004155 566 SDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 192 ~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------------- 253 (320)
T 3a99_A 192 IDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------- 253 (320)
T ss_dssp CCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------------
T ss_pred eeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------------
Confidence 9999998765432 233568999999999987665 788999999999999999999995321
Q ss_pred hhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 645 AQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 645 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+...... .........+.+++.+||+.||++||++.|+++
T Consensus 254 ------~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 ------EIIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ------HHHHCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------hhhcccc--cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 011112345789999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=342.17 Aligned_cols=249 Identities=24% Similarity=0.298 Sum_probs=187.4
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
..+|...++||+|+||+||.....+|+.||||++...... .+.+|+.+++++ +||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3467888999999999976665567999999998654322 356799999999 799999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC-----CCCeEEEeecCccc
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK-----DLNPKISDFGLAKL 573 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFGla~~ 573 (771)
+. |+|.+++.... ....+..++.++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++.
T Consensus 100 ~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 100 CA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 96 59999995433 3455667889999999999999998 8999999999999943 34688999999987
Q ss_pred cCCCCc--ccccccccCCCccchhhhc---cCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhC
Q 004155 574 DEEDNT--HISTRVAGTFGYMAPEYAM---RGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQG 647 (771)
Q Consensus 574 ~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 647 (771)
...... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||......... ......
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-------~~~~~~ 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------ILLGAC 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-------HHTTCC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-------HHhccC
Confidence 654322 1223467999999999997 4577889999999999999999 89998543221110 000000
Q ss_pred ChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 648 NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 648 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. .. ..........+.+++.+||+.||++||++.||++
T Consensus 246 ~~-----~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SL-----DC--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CC-----TT--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Cc-----cc--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 00 0111234455789999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=326.59 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=178.5
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCCh-hc-HHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSK-QG-NREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
.++|+..+.||+|+||.||+|.. .+|+.||||++..... .. .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 45688889999999999999955 4789999999976432 22 233445556788889999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+ ++.+..+... ....+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 104 e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 5566655521 2357899999999999999999999842 799999999999999999999999999976544
Q ss_pred CCcccccccccCCCccchhhhc-----cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 577 DNTHISTRVAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||........ ... ......
T Consensus 178 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~---~~~~~~---- 246 (318)
T 2dyl_A 178 DKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLT---KVLQEE---- 246 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHH---HHHHSC----
T ss_pred Ccc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHH---HHhccC----
Confidence 322 23356899999999994 45788999999999999999999999975332111 110 011100
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+.+.. .......+.+++.+||+.||.+||++.|+++
T Consensus 247 --~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 --PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --CCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000100 0112345889999999999999999999976
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=352.33 Aligned_cols=259 Identities=25% Similarity=0.341 Sum_probs=197.7
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe------CCE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIE------GNQ 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 491 (771)
.++|++.++||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999954 56899999998764 34456779999999999999999999998765 667
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC---eEEEee
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN---PKISDF 568 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DF 568 (771)
.++||||+++|+|.+++..... ...+++..++.|+.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 8999999999999999965432 23689999999999999999999998 8999999999999997765 999999
Q ss_pred cCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 569 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 569 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..|.........
T Consensus 169 G~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~ 241 (676)
T 3qa8_A 169 GYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSN 241 (676)
T ss_dssp CCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC----
T ss_pred ccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccc
Confidence 99987654332 23457999999999999999999999999999999999999999653211 111000000000
Q ss_pred ----hhHHhhh------hc--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 004155 649 ----LMELVDK------RL--GSNFDKEQVMVMINVALLCTDVSSTSRPSMSS 689 (771)
Q Consensus 649 ----~~~~~d~------~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 689 (771)
..+.... .+ ...........+.+++..||+.||++|||+.|
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000000 00 11233446678999999999999999999977
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=314.88 Aligned_cols=233 Identities=12% Similarity=0.062 Sum_probs=183.2
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 35788899999999999999955 458999999997653 23357899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||+++++|.+++.. .....++.+|+.|++.||+|||++ +|+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999999999932 235567899999999999999998 89999999999999999999997443
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
|++| ++.++|||||||++|||+||+.||............. ....+.... ..
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~--~~ 226 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----RDTAGQPIE--PA 226 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----BCTTSCBCC--HH
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----HHhccCCCC--hh
Confidence 4443 6899999999999999999999998654322110000 000000000 00
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
..... ....+.+++.+||+.||++| |+.|+++.|+.....
T Consensus 227 ~~~~~----~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 227 DIDRD----IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp HHCTT----SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred hcccC----CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 11112 23458899999999999999 999999999886544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=353.36 Aligned_cols=238 Identities=20% Similarity=0.274 Sum_probs=191.6
Q ss_pred hcCCCCCCccccCCceeEEEEEcC--CCcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCE-----
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMA--DGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQ----- 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 491 (771)
.++|++.++||+|+||.||+|... +|+.||||++... .......+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999654 6899999998654 33445678999999999999999999999987655
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.|+||||+++++|.+++. ..+++.+++.|+.||+.||+|||++ +|+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 799999999999988772 2699999999999999999999998 89999999999999886 9999999999
Q ss_pred cccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhH
Q 004155 572 KLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLME 651 (771)
Q Consensus 572 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (771)
+..... ....||+.|+|||++.+.. +.++|||||||++|||++|.+|+.........
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------------- 285 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------------- 285 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-----------------
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc-----------------
Confidence 876543 3356999999999987765 89999999999999999999887642111100
Q ss_pred HhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHhcC
Q 004155 652 LVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPS-MSSVVSMLEG 696 (771)
Q Consensus 652 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~~ 696 (771)
...........+.+++.+||+.||++||+ +.++...|.+
T Consensus 286 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 ------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00000112346789999999999999995 5556555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.39 Aligned_cols=233 Identities=18% Similarity=0.248 Sum_probs=179.6
Q ss_pred hcCCCCC-CccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHH-HcCCCCcEEeEEEEEEe----CCEE
Q 004155 420 TNNFAPD-NKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMI-SALQHPNLVKLHGCCIE----GNQL 492 (771)
Q Consensus 420 ~~~f~~~-~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 492 (771)
.++|.+. +.||+|+||.||+|. ..+++.||+|++... ..+.+|+.++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3556666 779999999999995 467899999998642 4567888888 55689999999999987 6788
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC---CCCeEEEeec
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFG 569 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG 569 (771)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 99999999999999995432 24699999999999999999999998 8999999999999998 7899999999
Q ss_pred CccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCCh
Q 004155 570 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL 649 (771)
Q Consensus 570 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (771)
+++.... ..++.++|||||||++|||++|+.||......... . ..
T Consensus 166 ~a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~-~~ 210 (299)
T 3m2w_A 166 FAKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------P-GM 210 (299)
T ss_dssp TCEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------C-CS
T ss_pred ccccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------H-HH
Confidence 9874321 34578999999999999999999999653321110 0 00
Q ss_pred hHHhhhhcCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCCC
Q 004155 650 MELVDKRLGSNFDK----EQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGRA 698 (771)
Q Consensus 650 ~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~ 698 (771)
...+... ....+. .....+.+++.+||+.||++||++.|+++ .+.+..
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 211 KTRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CCSSCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HHHHhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 0000000 001111 12346889999999999999999999997 455543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.91 Aligned_cols=243 Identities=14% Similarity=0.125 Sum_probs=181.3
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCCh---hcHHHHHHHHHHHHcCCC-Cc---------------E
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK---QGNREFVNEIGMISALQH-PN---------------L 479 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h-~n---------------i 479 (771)
+.+|...++||+|+||.||+|. ..+|+.||||++..... ...+.+.+|+.+++.++| +| +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3456778899999999999996 66799999999874322 235678999999999977 21 1
Q ss_pred Ee------EEEEEEe-----CCEEEEEEEeccCCCHHHHhcCC---CccCCCCChHHHHHHHHHHHHHHHHhhhcCCCce
Q 004155 480 VK------LHGCCIE-----GNQLLLIYEYMENNSLARALFGP---EAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545 (771)
Q Consensus 480 v~------l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~i 545 (771)
+. +..++.. ....+++|+++ +++|.+++... ......+++..++.|+.||+.||+|||++ +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 11 1111111 22467777766 67999888311 11234688999999999999999999998 89
Q ss_pred eccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccccccccCCCccchhhh----------ccCCCCchHhHHHHHHHH
Q 004155 546 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA----------MRGYLTDKADVYSFGIVA 615 (771)
Q Consensus 546 vH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDV~S~Gvil 615 (771)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999999865432 234567 999999999 555688999999999999
Q ss_pred HHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 616 LEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 616 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
|||++|+.||......... ..++.. ....+ ..+.+++.+||+.||++||++.|+++
T Consensus 308 ~elltg~~Pf~~~~~~~~~---------------~~~~~~--~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGS---------------EWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCS---------------GGGGSS--CCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhhH---------------HHHHhh--cccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999754322211 111111 01222 45889999999999999999988864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.10 Aligned_cols=237 Identities=20% Similarity=0.211 Sum_probs=183.5
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCC--------hhcHHHHHHHHHHHHcCC---------CCcEEeE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKS--------KQGNREFVNEIGMISALQ---------HPNLVKL 482 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l 482 (771)
.++|++.++||+|+||.||+|.. +|+.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688899999999999999977 68999999997542 223477889999988885 8888888
Q ss_pred EEEEE------------------------------eCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHH
Q 004155 483 HGCCI------------------------------EGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIAR 532 (771)
Q Consensus 483 ~~~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~ 532 (771)
.+.+. ..+..++||||+++|++.+.+. ...+++..+..|+.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHH
Confidence 77653 2678999999999997666662 246899999999999999
Q ss_pred HHHHhh-hcCCCceeccCCCCCcEEEcCCC--------------------CeEEEeecCccccCCCCcccccccccCCCc
Q 004155 533 GLAYLH-EESRLKIVHRDIKATNVLLDKDL--------------------NPKISDFGLAKLDEEDNTHISTRVAGTFGY 591 (771)
Q Consensus 533 aL~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y 591 (771)
||+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 77 899999999999999887 8999999999866432 24699999
Q ss_pred cchhhhccCCCCchHhHHHHHHH-HHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc-CCC----CCHHH
Q 004155 592 MAPEYAMRGYLTDKADVYSFGIV-ALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL-GSN----FDKEQ 665 (771)
Q Consensus 592 ~aPE~~~~~~~~~ksDV~S~Gvi-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l-~~~----~~~~~ 665 (771)
+|||++.+.. +.++||||+|++ .+++++|..||.. ..|..... ..+..... ... .....
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 308 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLT-----DKMLKQMTFKTKCNTPAMKQI 308 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHH-----HHHHHTCCCSSCCCSHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHH-----HhhhhhhccCcccchhhhhhc
Confidence 9999998766 899999998777 7888999988731 11111100 01111100 011 12245
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHH
Q 004155 666 VMVMINVALLCTDVSSTSRPSMSSVV 691 (771)
Q Consensus 666 ~~~l~~l~~~Cl~~dP~~RPs~~evl 691 (771)
...+.+++.+||+.| |+.|++
T Consensus 309 s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 309 KRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHGGGSS-----SHHHHH
T ss_pred CHHHHHHHHHHhccC-----CHHHHH
Confidence 668999999999976 898887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-29 Score=287.74 Aligned_cols=185 Identities=17% Similarity=0.139 Sum_probs=129.7
Q ss_pred ccccCCceeEEEE-EcCCCcEEEEEEcccCC----------hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEE
Q 004155 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKS----------KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 428 ~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 495 (771)
..+.|+.|.+..+ +.-.|+.||+|++.... ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3556666666554 33358889999986541 22346799999999999 699999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
|||++|++|.++|.. ..+++.. +|+.||+.||+|+|++ |||||||||+|||+++++++||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999943 2345543 5899999999999999 89999999999999999999999999998765
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCC
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSN 624 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p 624 (771)
..... .....||++|+|||++.+ .+..++|+||+|++++++.+|..+
T Consensus 391 ~~~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCcc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 44332 234679999999999875 467789999999998887666443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=262.53 Aligned_cols=186 Identities=17% Similarity=0.198 Sum_probs=147.1
Q ss_pred CCCCCccccCCceeEEEEEcCCCcEEEEEEcccCCh--------hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 423 FAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSK--------QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
+...++||+|+||.||+|.. .++.+|+|+...... ...+.+.+|++++++++||||+++..++...+..++
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ----------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34567999999999999955 578899998644321 113458999999999999999977777777788899
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+++++|.+++.. +..++.|++.||+|||++ +|+||||||+|||++. ++||+|||+++..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999933 568999999999999998 8999999999999998 9999999999977
Q ss_pred CCCCccc------ccccccCCCccchhhhcc--CCCCchHhHHHHHHHHHHHHhCCCCCC
Q 004155 575 EEDNTHI------STRVAGTFGYMAPEYAMR--GYLTDKADVYSFGIVALEIVSGRSNSS 626 (771)
Q Consensus 575 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~ksDV~S~Gvil~elltG~~p~~ 626 (771)
....... .....||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 5532221 234679999999999986 567888999999999999888877663
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-24 Score=258.01 Aligned_cols=178 Identities=26% Similarity=0.382 Sum_probs=124.0
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|+|++|++++.+|..+..+++|++|+|++|++++.+|..+.++++|++|+|++|++++..|..++++++|++|+
T Consensus 441 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 520 (768)
T 3rgz_A 441 LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520 (768)
T ss_dssp CTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEE
T ss_pred CCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEE
Confidence 46677777777777777777777777777777777777777777777777777777777777776666777777777777
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCcccc-----------------------------------------
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM----------------------------------------- 120 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~----------------------------------------- 120 (771)
|++|+++|.+|..++.+++|+.|+|++|+++|.+|..+.
T Consensus 521 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (768)
T 3rgz_A 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIR 600 (768)
T ss_dssp CCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCC
T ss_pred CCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccccccccccc
Confidence 777777777777777777777777777766666664332
Q ss_pred -----------------------------CCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccccCCCccccccc
Q 004155 121 -----------------------------GLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAGSSETSCQYR 169 (771)
Q Consensus 121 -----------------------------~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~~~p~~~~~l~ 169 (771)
.+++|+.|+|++|+|+|.+|..+ ++.|+.|+|++|+++|.+|+.+++++
T Consensus 601 ~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~ 680 (768)
T 3rgz_A 601 SEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLR 680 (768)
T ss_dssp GGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT
T ss_pred chhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCC
Confidence 23456667777777776676666 66666777777777777777777777
Q ss_pred ccceeccCCC
Q 004155 170 SVNLFASSSK 179 (771)
Q Consensus 170 ~L~~l~~s~~ 179 (771)
+|+.|++++|
T Consensus 681 ~L~~LdLs~N 690 (768)
T 3rgz_A 681 GLNILDLSSN 690 (768)
T ss_dssp TCCEEECCSS
T ss_pred CCCEEECCCC
Confidence 7777666644
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.7e-24 Score=229.94 Aligned_cols=177 Identities=23% Similarity=0.360 Sum_probs=153.0
Q ss_pred CCCCcEEEccC-CcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEE
Q 004155 2 LVTLKDFRISD-NHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 2 L~~L~~L~Ls~-N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 80 (771)
|++|++|+|++ |++++.+|..|+++++|++|+|++|++++.+|..|.++++|++|+|++|++++..|..|.++++|++|
T Consensus 75 l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 154 (313)
T 1ogq_A 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154 (313)
T ss_dssp CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred CCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeE
Confidence 67899999995 89998999999999999999999999998899999999999999999999998888889999999999
Q ss_pred EccCCcCcccCChhhhcCC-CCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCcc
Q 004155 81 ILRSCNVSGKLPDYLGLMT-SLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSF 157 (771)
Q Consensus 81 ~Ls~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l 157 (771)
+|++|+++|.+|..++.++ +|+.|+|++|++++.+|..+..++ |+.|+|++|++++.+|..+ +++|+.|+|++|.+
T Consensus 155 ~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 233 (313)
T 1ogq_A 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233 (313)
T ss_dssp ECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEE
T ss_pred ECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCce
Confidence 9999999989999999888 899999999999888888888886 8888888888887777766 77888888888888
Q ss_pred ccCCCcccccccccceeccCCCC
Q 004155 158 TAGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 158 ~~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
++.+|. +..+++|+.|+++.|.
T Consensus 234 ~~~~~~-~~~l~~L~~L~Ls~N~ 255 (313)
T 1ogq_A 234 AFDLGK-VGLSKNLNGLDLRNNR 255 (313)
T ss_dssp CCBGGG-CCCCTTCCEEECCSSC
T ss_pred eeecCc-ccccCCCCEEECcCCc
Confidence 876665 6777888888877553
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.90 E-value=5e-24 Score=227.90 Aligned_cols=178 Identities=27% Similarity=0.344 Sum_probs=169.1
Q ss_pred CCCcEEEccCCcccc--cCCccccCCCcCCEEEccc-CCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcE
Q 004155 3 VTLKDFRISDNHFTG--KIPNFIQNWTLLEKLVIQA-SGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKT 79 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~--~ip~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 79 (771)
.+++.|+|++|+++| .+|..|+++++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++..|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 579999999999999 8999999999999999995 9999999999999999999999999999888899999999999
Q ss_pred EEccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCC-CCcEEEcCCCcccccCchhh-hhcCCeecccCCcc
Q 004155 80 LILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLL-DVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSF 157 (771)
Q Consensus 80 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~-~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l 157 (771)
|+|++|++++.+|..+..+++|++|+|++|+++|.+|..+..++ +|++|+|++|+++|.+|..+ ...|+.|+|++|.+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l 209 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNML 209 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcc
Confidence 99999999999999999999999999999999999999999998 99999999999999999888 33499999999999
Q ss_pred ccCCCcccccccccceeccCCCC
Q 004155 158 TAGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 158 ~~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
++.+|..+..+++|+.|+++.+.
T Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~ 232 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQKIHLAKNS 232 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSE
T ss_pred cCcCCHHHhcCCCCCEEECCCCc
Confidence 99999999999999999987653
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-23 Score=249.15 Aligned_cols=179 Identities=22% Similarity=0.309 Sum_probs=164.9
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|+|++|++++.+|..++++++|++|+|++|++++.+|..+..+++|+.|+|++|++++..|..+.++++|++|+
T Consensus 417 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 496 (768)
T 3rgz_A 417 CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWIS 496 (768)
T ss_dssp CTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEE
T ss_pred CCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEE
Confidence 67899999999999999999999999999999999999999999999999999999999999998888999999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh------------------
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM------------------ 143 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~------------------ 143 (771)
|++|++++.+|..++.+++|++|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..+
T Consensus 497 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~ 576 (768)
T 3rgz_A 497 LSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYV 576 (768)
T ss_dssp CCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEE
T ss_pred ccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccc
Confidence 99999999999999999999999999999999999999999999999999999999888754
Q ss_pred ------------------------------------------------------hhcCCeecccCCccccCCCccccccc
Q 004155 144 ------------------------------------------------------LQKGDRVDLSYNSFTAGSSETSCQYR 169 (771)
Q Consensus 144 ------------------------------------------------------~~~L~~l~ls~N~l~~~~p~~~~~l~ 169 (771)
++.|+.|||++|+++|.+|..+.+++
T Consensus 577 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~ 656 (768)
T 3rgz_A 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMP 656 (768)
T ss_dssp EEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCT
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccc
Confidence 14577899999999999999999999
Q ss_pred ccceeccCCCC
Q 004155 170 SVNLFASSSKG 180 (771)
Q Consensus 170 ~L~~l~~s~~~ 180 (771)
.|+.|+++.|.
T Consensus 657 ~L~~L~Ls~N~ 667 (768)
T 3rgz_A 657 YLFILNLGHND 667 (768)
T ss_dssp TCCEEECCSSC
T ss_pred cCCEEeCcCCc
Confidence 99999988653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=223.90 Aligned_cols=172 Identities=15% Similarity=0.272 Sum_probs=109.9
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
++|+.|+|++|+|+ .+|..++++++|++|+|++|.|+ .+|..++.+++|++|+|++|+++. .|..+.++++|++|+|
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~-lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCC-CCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCcccc-CcHHHhcCcCCCEEEC
Confidence 45666666666666 66666666666666666666666 666666666666666666666663 3455666666666666
Q ss_pred cCCcCcccCChhhhc---------CCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeec
Q 004155 83 RSCNVSGKLPDYLGL---------MTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVD 151 (771)
Q Consensus 83 s~N~l~g~~p~~~~~---------l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ 151 (771)
++|++.+.+|..++. +++|++|+|++|+|+ .+|..++.+++|++|+|++|+++ .+|..+ +++|+.|+
T Consensus 158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~ 235 (328)
T 4fcg_A 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELD 235 (328)
T ss_dssp EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEE
T ss_pred CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEE
Confidence 666666666665543 666666666666666 66666666666666666666666 344444 55666666
Q ss_pred ccCCccccCCCcccccccccceeccCCC
Q 004155 152 LSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 152 ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
|++|++.+.+|..+..+++|+.|+++.+
T Consensus 236 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n 263 (328)
T 4fcg_A 236 LRGCTALRNYPPIFGGRAPLKRLILKDC 263 (328)
T ss_dssp CTTCTTCCBCCCCTTCCCCCCEEECTTC
T ss_pred CcCCcchhhhHHHhcCCCCCCEEECCCC
Confidence 6666666666666666666666666543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.89 E-value=4e-23 Score=222.29 Aligned_cols=175 Identities=21% Similarity=0.260 Sum_probs=163.8
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccC--------
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDK-------- 73 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-------- 73 (771)
|++|++|+|++|+|+ .+|..++++++|++|+|++|+|+ .+|..|++|++|++|+|++|++.+..|..+..
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~ 180 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence 678999999999999 99999999999999999999999 89999999999999999999998888877664
Q ss_pred -CCCCcEEEccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCee
Q 004155 74 -MKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRV 150 (771)
Q Consensus 74 -l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l 150 (771)
+++|++|+|++|+|+ .+|..++.+++|++|+|++|+++ .+|..+..+++|++|+|++|++.+.+|..+ +++|+.|
T Consensus 181 ~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L 258 (328)
T 4fcg_A 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258 (328)
T ss_dssp ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEE
T ss_pred cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEE
Confidence 999999999999999 99999999999999999999999 577789999999999999999999999887 8899999
Q ss_pred cccCCccccCCCcccccccccceeccCCCC
Q 004155 151 DLSYNSFTAGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 151 ~ls~N~l~~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
+|++|++.+.+|..+..+++|+.|+++.+.
T Consensus 259 ~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~ 288 (328)
T 4fcg_A 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288 (328)
T ss_dssp ECTTCTTCCBCCTTGGGCTTCCEEECTTCT
T ss_pred ECCCCCchhhcchhhhcCCCCCEEeCCCCC
Confidence 999999999999999999999999988653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.5e-22 Score=211.54 Aligned_cols=178 Identities=16% Similarity=0.151 Sum_probs=157.9
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCC-CCCCCCCCccCCCCCcEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLN-GTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L 80 (771)
.++|+.|+|++|+|++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|. +....+..|..+++|++|
T Consensus 31 ~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 4679999999999996666789999999999999999998889999999999999999997 888778889999999999
Q ss_pred EccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccc
Q 004155 81 ILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFT 158 (771)
Q Consensus 81 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~ 158 (771)
+|++|++++..|..+..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..+..+ +++|+.|+|++|.++
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 190 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccc
Confidence 999999997778889999999999999999996666678999999999999999995444445 789999999999999
Q ss_pred cCCCcccccccccceeccCCC
Q 004155 159 AGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 159 ~~~p~~~~~l~~L~~l~~s~~ 179 (771)
+..|..+..+++|+.|+++.+
T Consensus 191 ~~~~~~~~~l~~L~~L~l~~n 211 (285)
T 1ozn_A 191 HVHPHAFRDLGRLMTLYLFAN 211 (285)
T ss_dssp EECTTTTTTCTTCCEEECCSS
T ss_pred ccCHhHccCcccccEeeCCCC
Confidence 998999999999999998765
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.8e-22 Score=208.74 Aligned_cols=176 Identities=18% Similarity=0.171 Sum_probs=99.4
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCC-ccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASG-LVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 80 (771)
+++|++|+|++|+|++..|..|.++++|++|+|++|+ ++...|..|..+++|++|+|++|++++.++..|.++++|++|
T Consensus 55 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 134 (285)
T 1ozn_A 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134 (285)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEE
Confidence 3455666666666654445555556666666666664 443335555556666666666666655555555556666666
Q ss_pred EccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccc
Q 004155 81 ILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFT 158 (771)
Q Consensus 81 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~ 158 (771)
+|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..+ +++|+.|+|++|+++
T Consensus 135 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 214 (285)
T 1ozn_A 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214 (285)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred ECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCC
Confidence 666666654333445555666666666666653333345555666666666666655445444 455566666666665
Q ss_pred cCCCcccccccccceeccC
Q 004155 159 AGSSETSCQYRSVNLFASS 177 (771)
Q Consensus 159 ~~~p~~~~~l~~L~~l~~s 177 (771)
+..+..+..+++|+.++++
T Consensus 215 ~~~~~~~~~l~~L~~L~l~ 233 (285)
T 1ozn_A 215 ALPTEALAPLRALQYLRLN 233 (285)
T ss_dssp CCCHHHHTTCTTCCEEECC
T ss_pred cCCHHHcccCcccCEEecc
Confidence 5544555555555555554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-21 Score=205.11 Aligned_cols=176 Identities=16% Similarity=0.184 Sum_probs=124.4
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
++|+.|+|++|+|++..+..|.++++|++|+|++|+|+...+..|..+++|++|+|++|+++..++..|.++++|++|+|
T Consensus 37 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 45777777777777444446777777777777777777444445667777777777777777777667777777777777
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccccC
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~~ 160 (771)
++|++++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..|..+ +++|+.|+|++|++++.
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 196 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRV 196 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcC
Confidence 7777776556667777777777777777775444457777777777777777774333334 56777777777777766
Q ss_pred CCcccccccccceeccCC
Q 004155 161 SSETSCQYRSVNLFASSS 178 (771)
Q Consensus 161 ~p~~~~~l~~L~~l~~s~ 178 (771)
.+..+..+++|+.++++.
T Consensus 197 ~~~~~~~l~~L~~L~l~~ 214 (270)
T 2o6q_A 197 PEGAFDSLEKLKMLQLQE 214 (270)
T ss_dssp CTTTTTTCTTCCEEECCS
T ss_pred CHHHhccccCCCEEEecC
Confidence 666677777777777653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.3e-23 Score=216.92 Aligned_cols=151 Identities=19% Similarity=0.094 Sum_probs=121.2
Q ss_pred HHHHHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCCh------------------hcHHHHHHHHHHHHcCCC
Q 004155 415 QIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSK------------------QGNREFVNEIGMISALQH 476 (771)
Q Consensus 415 ~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~h 476 (771)
.+......|.+.+.||+|+||.||+|...+|+.||||+++.... .....+.+|+.++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 33444456667799999999999999777899999999864321 13457899999999998
Q ss_pred CcEEeEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEE
Q 004155 477 PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVL 556 (771)
Q Consensus 477 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIl 556 (771)
| +++.+++.. +..++||||+++|+|.+ +. ......++.|++.||+|||+. +|+||||||+|||
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 4 666665544 45699999999999988 51 123557999999999999998 8999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCCcccccccccCCCccchhhhc
Q 004155 557 LDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 598 (771)
Q Consensus 557 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 598 (771)
++ ++.+||+|||+|+. +..|+|||++.
T Consensus 226 l~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99 99999999999973 33578999874
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-21 Score=201.91 Aligned_cols=173 Identities=18% Similarity=0.149 Sum_probs=154.8
Q ss_pred CCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEcc
Q 004155 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILR 83 (771)
Q Consensus 4 ~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 83 (771)
+.+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|++++.++..|.++++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4678999999999 8998776 689999999999998888899999999999999999999988889999999999999
Q ss_pred CCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccccCC
Q 004155 84 SCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAGS 161 (771)
Q Consensus 84 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~~~ 161 (771)
+|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..|..+ +++|+.|+|++|++++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 999997667788999999999999999996666668999999999999999995544455 789999999999999888
Q ss_pred CcccccccccceeccCCC
Q 004155 162 SETSCQYRSVNLFASSSK 179 (771)
Q Consensus 162 p~~~~~l~~L~~l~~s~~ 179 (771)
+..+..+++|+.++++.|
T Consensus 172 ~~~~~~l~~L~~L~l~~N 189 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGN 189 (251)
T ss_dssp TTTTTTCTTCCEEECCSC
T ss_pred HHHHhCCCCCCEEEeeCC
Confidence 888999999999988644
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3.2e-21 Score=199.23 Aligned_cols=160 Identities=17% Similarity=0.185 Sum_probs=145.7
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++.++..|..+++|++|+|
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 57999999999999777788999999999999999999888888999999999999999999999889999999999999
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccccC
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~~ 160 (771)
++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..+ +++|+.|+|++|++++.
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9999996666668999999999999999997666689999999999999999996555555 78999999999999976
Q ss_pred CC
Q 004155 161 SS 162 (771)
Q Consensus 161 ~p 162 (771)
..
T Consensus 195 ~~ 196 (251)
T 3m19_A 195 RC 196 (251)
T ss_dssp ST
T ss_pred cc
Confidence 33
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3.2e-21 Score=201.74 Aligned_cols=174 Identities=18% Similarity=0.200 Sum_probs=156.4
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|++++|.++ .++. +..+++|++|+|++|++++ + ..+..+++|++|+|++|++++.++..|.++++|++|+
T Consensus 40 l~~L~~L~l~~~~i~-~~~~-l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 115 (272)
T 3rfs_A 40 LNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELV 115 (272)
T ss_dssp HTTCCEEECTTSCCC-CCTT-GGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccceeeeeeCCCCcc-cccc-cccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEE
Confidence 468999999999998 6654 8899999999999999985 4 4789999999999999999999888899999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCcccc
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~ 159 (771)
|++|++++..|..|+.+++|++|+|++|++++..|..|..+++|+.|+|++|++++..|..+ +++|+.|+|++|++++
T Consensus 116 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 195 (272)
T 3rfs_A 116 LVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS 195 (272)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCc
Confidence 99999997777778999999999999999997777778999999999999999996555544 7899999999999999
Q ss_pred CCCcccccccccceeccCCC
Q 004155 160 GSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 160 ~~p~~~~~l~~L~~l~~s~~ 179 (771)
..|..+..+++|+.++++.|
T Consensus 196 ~~~~~~~~l~~L~~L~l~~N 215 (272)
T 3rfs_A 196 VPDGVFDRLTSLQYIWLHDN 215 (272)
T ss_dssp CCTTTTTTCTTCCEEECCSS
T ss_pred cCHHHHhCCcCCCEEEccCC
Confidence 88888999999999998754
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-21 Score=207.91 Aligned_cols=177 Identities=18% Similarity=0.211 Sum_probs=132.7
Q ss_pred CCCCcEEEccCCccc--ccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCC-CCccCCCCCc
Q 004155 2 LVTLKDFRISDNHFT--GKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPF-PPLDKMKKMK 78 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~--~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~ 78 (771)
+++|+.|+|++|+++ +.+|..+..+++|++|+|++|.++ .+|..+..+++|+.|+|++|++++.++ ..+..+++|+
T Consensus 51 l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 129 (306)
T 2z66_A 51 LTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 129 (306)
T ss_dssp CTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCC
T ss_pred cccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCC
Confidence 567888888888877 223566667778888888888877 567777778888888888887777665 5677778888
Q ss_pred EEEccCCcCcccCChhhhcCCCCcEEEccCCCCCC-CCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCC
Q 004155 79 TLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNG-AIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYN 155 (771)
Q Consensus 79 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N 155 (771)
+|+|++|++.+..|..+..+++|+.|+|++|.+++ .+|..+..+++|++|+|++|++++..|..+ +++|+.|+|++|
T Consensus 130 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N 209 (306)
T 2z66_A 130 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 209 (306)
T ss_dssp EEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred EEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCC
Confidence 88888888777777777777888888888887775 467777777788888888888776556555 677778888888
Q ss_pred ccccCCCcccccccccceeccCCC
Q 004155 156 SFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
++++..+..+..+++|+.|+++.|
T Consensus 210 ~l~~~~~~~~~~l~~L~~L~L~~N 233 (306)
T 2z66_A 210 NFFSLDTFPYKCLNSLQVLDYSLN 233 (306)
T ss_dssp CCSBCCSGGGTTCTTCCEEECTTS
T ss_pred ccCccChhhccCcccCCEeECCCC
Confidence 877776667777777777777655
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.8e-21 Score=204.05 Aligned_cols=177 Identities=16% Similarity=0.174 Sum_probs=152.2
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++.++..|.++++|++|+|
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 46999999999999666668999999999999999999777778999999999999999999998889999999999999
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCC-CCCccccCCCCCcEEEcCCCcccccCchhh--hhcCC----eecccCC
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNG-AIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGD----RVDLSYN 155 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~----~l~ls~N 155 (771)
++|++.+..+..++.+++|++|+|++|++++ .+|..|..+++|+.|+|++|++++..+..+ +.+|+ .|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 9999996666689999999999999999986 368999999999999999999996655555 66666 7899999
Q ss_pred ccccCCCcccccccccceeccCCCC
Q 004155 156 SFTAGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
++++..+..+.. .+|+.|+++.+.
T Consensus 188 ~l~~~~~~~~~~-~~L~~L~L~~n~ 211 (276)
T 2z62_A 188 PMNFIQPGAFKE-IRLKELALDTNQ 211 (276)
T ss_dssp CCCEECTTSSCS-CCEEEEECCSSC
T ss_pred cccccCccccCC-CcccEEECCCCc
Confidence 998766665544 378888877553
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.85 E-value=8.3e-22 Score=231.19 Aligned_cols=163 Identities=18% Similarity=0.290 Sum_probs=152.8
Q ss_pred cccccCCccccCCCcCCEEEcccCCcccc-----------------Cchhhc--CCcCCCEEEcCCCCCCCCCCCCccCC
Q 004155 14 HFTGKIPNFIQNWTLLEKLVIQASGLVGP-----------------IPSGIA--SLSKLTDLRISDLNGTEAPFPPLDKM 74 (771)
Q Consensus 14 ~l~~~ip~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l 74 (771)
+|+| ||..|+++++|++|+|++|+|+|. +|..++ +|++|++|+|++|++.+..|..|+++
T Consensus 194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 272 (636)
T 4eco_A 194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272 (636)
T ss_dssp EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence 5555 899999999999999999999986 999999 99999999999999999999999999
Q ss_pred CCCcEEEccCCc-Ccc-cCChhhhcC------CCCcEEEccCCCCCCCCCc--cccCCCCCcEEEcCCCcccccCchhh-
Q 004155 75 KKMKTLILRSCN-VSG-KLPDYLGLM------TSLKVLDVSFNKLNGAIPS--TFMGLLDVDYIYLTGNLLTGTIPPWM- 143 (771)
Q Consensus 75 ~~L~~L~Ls~N~-l~g-~~p~~~~~l------~~L~~L~Ls~N~l~g~ip~--~~~~l~~L~~L~Ls~N~l~g~iP~~~- 143 (771)
++|++|+|++|+ ++| .+|..++.+ ++|++|+|++|+++ .+|. .++.+++|+.|+|++|+++|.+| .+
T Consensus 273 ~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~ 350 (636)
T 4eco_A 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFG 350 (636)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCE
T ss_pred CCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhC
Confidence 999999999999 998 899999887 99999999999999 8998 89999999999999999999999 66
Q ss_pred -hhcCCeecccCCccccCCCcccccccc-cceeccCCCC
Q 004155 144 -LQKGDRVDLSYNSFTAGSSETSCQYRS-VNLFASSSKG 180 (771)
Q Consensus 144 -~~~L~~l~ls~N~l~~~~p~~~~~l~~-L~~l~~s~~~ 180 (771)
+++|+.|+|++|+++ .+|..+..+++ |+.|+++.|.
T Consensus 351 ~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~ 388 (636)
T 4eco_A 351 SEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNK 388 (636)
T ss_dssp EEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSC
T ss_pred CCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCc
Confidence 889999999999999 78888999999 9999998664
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.85 E-value=8.1e-21 Score=200.59 Aligned_cols=172 Identities=20% Similarity=0.239 Sum_probs=149.0
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|..+++|+.|+|++|++++.++. ..+++|++|+
T Consensus 9 l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~ 83 (290)
T 1p9a_G 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLD 83 (290)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEE
T ss_pred cCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEE
Confidence 678999999999999 8888775 6899999999999987788899999999999999999886543 7889999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCcccc
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~ 159 (771)
|++|+|+ .+|..+..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..+ +++|+.|+|++|+|+.
T Consensus 84 Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 162 (290)
T 1p9a_G 84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162 (290)
T ss_dssp CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred CCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCc
Confidence 9999998 888888999999999999999997667789999999999999999995444444 6789999999999997
Q ss_pred CCCcccccccccceeccCCC
Q 004155 160 GSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 160 ~~p~~~~~l~~L~~l~~s~~ 179 (771)
..+..+..+++|+.|+++.|
T Consensus 163 l~~~~~~~l~~L~~L~L~~N 182 (290)
T 1p9a_G 163 LPAGLLNGLENLDTLLLQEN 182 (290)
T ss_dssp CCTTTTTTCTTCCEEECCSS
T ss_pred cCHHHhcCcCCCCEEECCCC
Confidence 77777888999999988754
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=6.3e-21 Score=191.02 Aligned_cols=163 Identities=19% Similarity=0.181 Sum_probs=113.5
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
.++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|++++.++..|.++++|++|+
T Consensus 27 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 106 (208)
T 2o6s_A 27 PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELA 106 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEE
Confidence 34677777777777744444566777777777777777754455567777777777777777776666677777777777
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhcCCeecccCCccccCC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGS 161 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~ 161 (771)
|++|+|++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+.+..| .|+.|+++.|+++|.+
T Consensus 107 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~-----~l~~L~~~~n~~~g~i 181 (208)
T 2o6s_A 107 LNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP-----GIRYLSEWINKHSGVV 181 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT-----TTHHHHHHHHHCTTTB
T ss_pred cCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC-----CHHHHHHHHHhCCcee
Confidence 77777775555556777777777777777775555556777777777777777775543 5667777777777777
Q ss_pred Cccccccc
Q 004155 162 SETSCQYR 169 (771)
Q Consensus 162 p~~~~~l~ 169 (771)
|+.++.+.
T Consensus 182 p~~~~~l~ 189 (208)
T 2o6s_A 182 RNSAGSVA 189 (208)
T ss_dssp BCTTSSBC
T ss_pred eccCcccc
Confidence 76665543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-20 Score=197.31 Aligned_cols=159 Identities=19% Similarity=0.214 Sum_probs=144.7
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|+|++|++++ ++ .+.++++|++|+|++|+|++..|..|..+++|++|+|++|++++.++..|.++++|++|+
T Consensus 62 l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHD-IS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCC-CG-GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCC-ch-hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 6899999999999995 44 799999999999999999977777899999999999999999999888899999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCcccc
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~ 159 (771)
|++|++++..|..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..+ +++|+.|+|++|++.+
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 99999997667778999999999999999997777778999999999999999997666555 8899999999999987
Q ss_pred CCC
Q 004155 160 GSS 162 (771)
Q Consensus 160 ~~p 162 (771)
..|
T Consensus 220 ~~~ 222 (272)
T 3rfs_A 220 TCP 222 (272)
T ss_dssp CTT
T ss_pred cCc
Confidence 655
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=9e-21 Score=198.62 Aligned_cols=163 Identities=17% Similarity=0.151 Sum_probs=115.0
Q ss_pred EEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCc
Q 004155 7 DFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCN 86 (771)
Q Consensus 7 ~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 86 (771)
.++.++.+++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|++++.++..|.++++|++|+|++|+
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 4555666666 6776554 467777777777775555577777777777777777777766677777777777777777
Q ss_pred CcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccc-cCchhh--hhcCCeecccCCccccCCCc
Q 004155 87 VSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTG-TIPPWM--LQKGDRVDLSYNSFTAGSSE 163 (771)
Q Consensus 87 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~iP~~~--~~~L~~l~ls~N~l~~~~p~ 163 (771)
+++..|..|.++++|++|++++|++++..+..+..+++|++|+|++|++++ .+|..+ +++|+.|+|++|++++..+.
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~ 167 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence 776666677777777777777777775555567777777777777777764 256655 66777777777777776666
Q ss_pred ccccccccc
Q 004155 164 TSCQYRSVN 172 (771)
Q Consensus 164 ~~~~l~~L~ 172 (771)
.+..+.+|+
T Consensus 168 ~~~~l~~L~ 176 (276)
T 2z62_A 168 DLRVLHQMP 176 (276)
T ss_dssp GGHHHHTCT
T ss_pred Hhhhhhhcc
Confidence 666666666
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.5e-21 Score=208.53 Aligned_cols=174 Identities=15% Similarity=0.145 Sum_probs=146.3
Q ss_pred CCCCcEEEccCCcccccCCccc--cCCCcCCEEEcccCCccccCchhhcCC-----cCCCEEEcCCCCCCCCCCCCccCC
Q 004155 2 LVTLKDFRISDNHFTGKIPNFI--QNWTLLEKLVIQASGLVGPIPSGIASL-----SKLTDLRISDLNGTEAPFPPLDKM 74 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~n~l~~~~~~~~~~l 74 (771)
+++|++|+|++|+|++.+|..+ ..+++|++|+|++|+|++. |..++.+ ++|++|+|++|++++.++..|+++
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 6789999999999999999876 8899999999999999976 8888887 899999999999999988899999
Q ss_pred CCCcEEEccCCcCccc--CChhh--hcCCCCcEEEccCCCCCC--CCC-ccccCCCCCcEEEcCCCcccccCchh-h--h
Q 004155 75 KKMKTLILRSCNVSGK--LPDYL--GLMTSLKVLDVSFNKLNG--AIP-STFMGLLDVDYIYLTGNLLTGTIPPW-M--L 144 (771)
Q Consensus 75 ~~L~~L~Ls~N~l~g~--~p~~~--~~l~~L~~L~Ls~N~l~g--~ip-~~~~~l~~L~~L~Ls~N~l~g~iP~~-~--~ 144 (771)
++|++|+|++|++.|. +|..+ ..+++|++|+|++|+|++ .++ ..+..+++|++|+|++|++++.+|.. + +
T Consensus 173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 252 (312)
T 1wwl_A 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252 (312)
T ss_dssp SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCC
T ss_pred CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhc
Confidence 9999999999998866 34454 889999999999999983 222 33467889999999999999766532 2 6
Q ss_pred hcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 145 QKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 145 ~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
++|+.|+|++|+++ .+|..+. ++|+.|+++.|
T Consensus 253 ~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N 284 (312)
T 1wwl_A 253 SQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYN 284 (312)
T ss_dssp TTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSS
T ss_pred CCCCEEECCCCccC-hhhhhcc--CCceEEECCCC
Confidence 88999999999998 6677665 78888888755
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.4e-21 Score=206.14 Aligned_cols=177 Identities=18% Similarity=0.216 Sum_probs=156.7
Q ss_pred CCCCcEEEccCCcccccCCcc-ccCCCcCCEEEcccCCcc--ccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCc
Q 004155 2 LVTLKDFRISDNHFTGKIPNF-IQNWTLLEKLVIQASGLV--GPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMK 78 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~-~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 78 (771)
.++|++|+|++|+++ .+|.. |.++++|++|+|++|+++ +..|..+..+++|++|+|++|.++..+ ..+..+++|+
T Consensus 27 ~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~l~-~~~~~l~~L~ 104 (306)
T 2z66_A 27 PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMS-SNFLGLEQLE 104 (306)
T ss_dssp CTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEEEE-EEEETCTTCC
T ss_pred CCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccccCh-hhcCCCCCCC
Confidence 358999999999999 67764 789999999999999998 334788889999999999999998754 5688999999
Q ss_pred EEEccCCcCcccCC-hhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccc-cCchhh--hhcCCeecccC
Q 004155 79 TLILRSCNVSGKLP-DYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTG-TIPPWM--LQKGDRVDLSY 154 (771)
Q Consensus 79 ~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~iP~~~--~~~L~~l~ls~ 154 (771)
+|+|++|++++..+ ..+..+++|++|+|++|.+++..|..+..+++|++|+|++|.+++ .+|..+ +++|+.|+|++
T Consensus 105 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~ 184 (306)
T 2z66_A 105 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184 (306)
T ss_dssp EEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred EEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCC
Confidence 99999999995544 579999999999999999998888889999999999999999986 567766 88999999999
Q ss_pred CccccCCCcccccccccceeccCCCC
Q 004155 155 NSFTAGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
|.+++..|..+..+++|+.|+++.|.
T Consensus 185 n~l~~~~~~~~~~l~~L~~L~L~~N~ 210 (306)
T 2z66_A 185 CQLEQLSPTAFNSLSSLQVLNMSHNN 210 (306)
T ss_dssp SCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred CCcCCcCHHHhcCCCCCCEEECCCCc
Confidence 99999989999999999999988654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.8e-20 Score=194.31 Aligned_cols=173 Identities=18% Similarity=0.186 Sum_probs=156.1
Q ss_pred CCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEcc
Q 004155 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILR 83 (771)
Q Consensus 4 ~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 83 (771)
+++.+++++|+++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+++..++..|.++++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 5789999999999 8998776 689999999999997667789999999999999999999888889999999999999
Q ss_pred CCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccccCC
Q 004155 84 SCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAGS 161 (771)
Q Consensus 84 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~~~ 161 (771)
+|++++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..+ +++|+.|+|++|.+++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 999996666678999999999999999998777889999999999999999995444334 789999999999999988
Q ss_pred CcccccccccceeccCCC
Q 004155 162 SETSCQYRSVNLFASSSK 179 (771)
Q Consensus 162 p~~~~~l~~L~~l~~s~~ 179 (771)
+..+..+++|+.|+++.+
T Consensus 174 ~~~~~~l~~L~~L~L~~N 191 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNN 191 (270)
T ss_dssp TTTTTTCTTCCEEECCSS
T ss_pred hhHhccCCCcCEEECCCC
Confidence 888999999999998865
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.84 E-value=1e-21 Score=230.45 Aligned_cols=173 Identities=17% Similarity=0.312 Sum_probs=158.6
Q ss_pred CCcEEEccCCcccccCCccccCCCcCCEEEcccC----------------------------------------------
Q 004155 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQAS---------------------------------------------- 37 (771)
Q Consensus 4 ~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N---------------------------------------------- 37 (771)
+++.|+|++|+++|.+|+.|++|++|++|+|++|
T Consensus 82 ~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~ 161 (636)
T 4eco_A 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDL 161 (636)
T ss_dssp CEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHH
T ss_pred CEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHH
Confidence 6889999999999999999999999999999998
Q ss_pred --------------------------------CccccCchhhcCCcCCCEEEcCCCCCCCC-----------------CC
Q 004155 38 --------------------------------GLVGPIPSGIASLSKLTDLRISDLNGTEA-----------------PF 68 (771)
Q Consensus 38 --------------------------------~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-----------------~~ 68 (771)
+|+| +|.+|++|++|++|+|++|++++. .|
T Consensus 162 ~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip 240 (636)
T 4eco_A 162 IKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT 240 (636)
T ss_dssp HHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTT
T ss_pred HHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCc
Confidence 4445 889999999999999999999984 67
Q ss_pred CCcc--CCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccCCC-CCC-CCCccccCC------CCCcEEEcCCCccccc
Q 004155 69 PPLD--KMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNK-LNG-AIPSTFMGL------LDVDYIYLTGNLLTGT 138 (771)
Q Consensus 69 ~~~~--~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~g-~ip~~~~~l------~~L~~L~Ls~N~l~g~ 138 (771)
..++ ++++|++|+|++|++.|.+|..|+++++|++|+|++|+ ++| .+|..++.+ ++|++|+|++|+++ .
T Consensus 241 ~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ 319 (636)
T 4eco_A 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-T 319 (636)
T ss_dssp SCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-S
T ss_pred hhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-c
Confidence 8888 99999999999999999999999999999999999998 998 899988876 89999999999999 8
Q ss_pred Cch--hh--hhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 139 IPP--WM--LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 139 iP~--~~--~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
+|. .+ +++|+.|++++|.++|.+| .+..+++|+.|+++.+
T Consensus 320 ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N 363 (636)
T 4eco_A 320 FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYN 363 (636)
T ss_dssp CCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSS
T ss_pred cCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCC
Confidence 998 66 8899999999999998899 8999999999998765
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.7e-20 Score=211.10 Aligned_cols=176 Identities=18% Similarity=0.175 Sum_probs=128.9
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+++..++..|.++++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 57888999999988777788888889999999999888777788888889999999998888888778888888888888
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCc-cccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCccccC
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPS-TFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~~ 160 (771)
++|+|+...+..|.++++|+.|+|++|+..+.+|. .|..+++|++|+|++|+++ .+|... +++|+.|+|++|++++.
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~l~~~ 233 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFPEI 233 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-SCCCCTTCTTCCEEECTTSCCSEE
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc-ccccccccccccEEECcCCcCccc
Confidence 88888855455677777777777776433334443 4666666666666666666 344322 55666666666666666
Q ss_pred CCcccccccccceeccCCC
Q 004155 161 SSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 161 ~p~~~~~l~~L~~l~~s~~ 179 (771)
.|..+..+++|+.|+++.+
T Consensus 234 ~~~~~~~l~~L~~L~L~~n 252 (452)
T 3zyi_A 234 RPGSFHGLSSLKKLWVMNS 252 (452)
T ss_dssp CGGGGTTCTTCCEEECTTS
T ss_pred CcccccCccCCCEEEeCCC
Confidence 6666666666666665543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.84 E-value=2.3e-20 Score=197.08 Aligned_cols=172 Identities=16% Similarity=0.081 Sum_probs=152.0
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
.++|+.|+|++|+|++..|..|.++++|++|+|++|+|++ +|.. +.+++|+.|+|++|+++.. |..+..+++|++|+
T Consensus 30 ~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~ 106 (290)
T 1p9a_G 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLD 106 (290)
T ss_dssp CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCCEEECCSSCCSSC-CCCTTTCTTCCEEE
T ss_pred CCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCCEEECCCCcCCcC-chhhccCCCCCEEE
Confidence 3679999999999997778899999999999999999995 4543 7899999999999999965 46789999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh---hhcCCeecccCCccc
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM---LQKGDRVDLSYNSFT 158 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~---~~~L~~l~ls~N~l~ 158 (771)
|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|... +++|+.|+|++|+++
T Consensus 107 l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185 (290)
T ss_dssp CCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC-ccCHHHhcCcCCCCEEECCCCcCC
Confidence 9999999666688999999999999999999777777899999999999999999 566543 789999999999999
Q ss_pred cCCCcccccccccceeccCC
Q 004155 159 AGSSETSCQYRSVNLFASSS 178 (771)
Q Consensus 159 ~~~p~~~~~l~~L~~l~~s~ 178 (771)
.+|..+..+.+|+.++++.
T Consensus 186 -~ip~~~~~~~~L~~l~L~~ 204 (290)
T 1p9a_G 186 -TIPKGFFGSHLLPFAFLHG 204 (290)
T ss_dssp -CCCTTTTTTCCCSEEECCS
T ss_pred -ccChhhcccccCCeEEeCC
Confidence 5777788888898888763
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.4e-20 Score=210.97 Aligned_cols=176 Identities=17% Similarity=0.201 Sum_probs=146.7
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
|++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+++..++..|.++++|+.|+
T Consensus 87 l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 166 (440)
T 3zyj_A 87 LRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLD 166 (440)
T ss_dssp CSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeC
Confidence 67899999999999966667899999999999999999966566799999999999999999988888888899999999
Q ss_pred ccCCcCcccCCh-hhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccc
Q 004155 82 LRSCNVSGKLPD-YLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFT 158 (771)
Q Consensus 82 Ls~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~ 158 (771)
|++|+..+.++. .|.++++|+.|+|++|+|+ .+|. +..+++|+.|+|++|+|++..|..+ +++|+.|+|++|+++
T Consensus 167 l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 244 (440)
T 3zyj_A 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ 244 (440)
T ss_dssp CCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCC-CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred CCCCCCcceeCcchhhcccccCeecCCCCcCc-cccc-cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCcee
Confidence 988544435554 6888888888888888888 6664 7888888888888888886666666 778888888888888
Q ss_pred cCCCcccccccccceeccCCC
Q 004155 159 AGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 159 ~~~p~~~~~l~~L~~l~~s~~ 179 (771)
+..+..+..+++|+.|+++.|
T Consensus 245 ~~~~~~~~~l~~L~~L~L~~N 265 (440)
T 3zyj_A 245 VIERNAFDNLQSLVEINLAHN 265 (440)
T ss_dssp EECTTSSTTCTTCCEEECTTS
T ss_pred EEChhhhcCCCCCCEEECCCC
Confidence 888888888888888888765
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-20 Score=211.36 Aligned_cols=177 Identities=14% Similarity=0.132 Sum_probs=160.0
Q ss_pred CCCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEE
Q 004155 1 MLVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 1 ~L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 80 (771)
.|++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+++..++..|.++++|+.|
T Consensus 97 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 176 (452)
T 3zyi_A 97 HLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRL 176 (452)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEE
Confidence 36899999999999997777899999999999999999997667779999999999999999999988899999999999
Q ss_pred EccCCcCcccCCh-hhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCcc
Q 004155 81 ILRSCNVSGKLPD-YLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSF 157 (771)
Q Consensus 81 ~Ls~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l 157 (771)
+|++|+..+.+|. .|.++++|++|+|++|+|+ .+| .+..+++|+.|+|++|+|++..|..+ +++|+.|+|++|++
T Consensus 177 ~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l 254 (452)
T 3zyi_A 177 DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV 254 (452)
T ss_dssp ECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCC
T ss_pred eCCCCCCccccChhhccCCCCCCEEECCCCccc-ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcC
Confidence 9999554446654 6899999999999999999 566 48899999999999999998778777 88999999999999
Q ss_pred ccCCCcccccccccceeccCCC
Q 004155 158 TAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 158 ~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
++..|..+..+++|+.|+++.|
T Consensus 255 ~~~~~~~~~~l~~L~~L~L~~N 276 (452)
T 3zyi_A 255 SLIERNAFDGLASLVELNLAHN 276 (452)
T ss_dssp CEECTTTTTTCTTCCEEECCSS
T ss_pred ceECHHHhcCCCCCCEEECCCC
Confidence 9999999999999999999866
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.4e-20 Score=211.67 Aligned_cols=178 Identities=20% Similarity=0.226 Sum_probs=139.4
Q ss_pred CCCCcEEEccCCcccccCCcc--ccCCCcCCEEEcccCCccccCchh-hcCCcCCCEEEcCCCCCCCCCCCCccCC----
Q 004155 2 LVTLKDFRISDNHFTGKIPNF--IQNWTLLEKLVIQASGLVGPIPSG-IASLSKLTDLRISDLNGTEAPFPPLDKM---- 74 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l---- 74 (771)
|++|++|+|++|++++.+|.. |.++++|++|+|++|++++..|.. +.++++|++|+|++|++++..+..+..+
T Consensus 102 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~ 181 (455)
T 3v47_A 102 LANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKH 181 (455)
T ss_dssp CTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCE
T ss_pred cccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccc
Confidence 567777777777777655544 777777777777777777666665 6777777777777777776655444322
Q ss_pred --------------------------------------------------------------------------------
Q 004155 75 -------------------------------------------------------------------------------- 74 (771)
Q Consensus 75 -------------------------------------------------------------------------------- 74 (771)
T Consensus 182 L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~ 261 (455)
T 3v47_A 182 FTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNF 261 (455)
T ss_dssp EEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSS
T ss_pred ccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhh
Confidence
Q ss_pred -------------CCCcEEEccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCch
Q 004155 75 -------------KKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPP 141 (771)
Q Consensus 75 -------------~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~ 141 (771)
++|+.|+|++|++++.+|..++.+++|+.|+|++|++++..|..|..+++|++|+|++|++++..|.
T Consensus 262 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 341 (455)
T 3v47_A 262 KDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSR 341 (455)
T ss_dssp CCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGG
T ss_pred ccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChh
Confidence 3566677777777777888899999999999999999988888899999999999999999876676
Q ss_pred hh--hhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 142 WM--LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 142 ~~--~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
.+ +++|+.|+|++|++++..|..+..+++|+.|+++.|
T Consensus 342 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 381 (455)
T 3v47_A 342 MFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTN 381 (455)
T ss_dssp GGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred HhcCcccCCEEECCCCcccccChhhccccccccEEECCCC
Confidence 66 788999999999999888999999999999998764
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-20 Score=213.49 Aligned_cols=179 Identities=15% Similarity=0.093 Sum_probs=165.4
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
.++|+.|+|++|+|++..|..|.++++|++|+|++|.|++..|..|.+|++|++|+|++|+++..++..|.++++|++|+
T Consensus 31 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 110 (477)
T 2id5_A 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLD 110 (477)
T ss_dssp CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEE
T ss_pred CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEE
Confidence 35799999999999977788999999999999999999988899999999999999999999999888899999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCcccc
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~ 159 (771)
|++|++.+..|..|..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..+ +++|+.|+|++|.+++
T Consensus 111 Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~ 190 (477)
T 2id5_A 111 ISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINA 190 (477)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCE
T ss_pred CCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcE
Confidence 99999998889999999999999999999998888899999999999999999995444445 8899999999999999
Q ss_pred CCCcccccccccceeccCCCC
Q 004155 160 GSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 160 ~~p~~~~~l~~L~~l~~s~~~ 180 (771)
..+..+..+++|+.|+++.+.
T Consensus 191 ~~~~~~~~l~~L~~L~l~~~~ 211 (477)
T 2id5_A 191 IRDYSFKRLYRLKVLEISHWP 211 (477)
T ss_dssp ECTTCSCSCTTCCEEEEECCT
T ss_pred eChhhcccCcccceeeCCCCc
Confidence 988899999999999988653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.3e-21 Score=207.01 Aligned_cols=174 Identities=17% Similarity=0.158 Sum_probs=151.2
Q ss_pred CCCCcEEEccCCcccccCCccccCC-----CcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCC--CCCC--cc
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNW-----TLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEA--PFPP--LD 72 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~--~~~~--~~ 72 (771)
+++|++|+|++|+|++. |..++.+ ++|++|+|++|+|++..|..|+.+++|+.|+|++|++.+. .+.. +.
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 68899999999999966 8888887 9999999999999988889999999999999999998764 2223 48
Q ss_pred CCCCCcEEEccCCcCcc--cCC-hhhhcCCCCcEEEccCCCCCCCCC-ccccCCCCCcEEEcCCCcccccCchhhhhcCC
Q 004155 73 KMKKMKTLILRSCNVSG--KLP-DYLGLMTSLKVLDVSFNKLNGAIP-STFMGLLDVDYIYLTGNLLTGTIPPWMLQKGD 148 (771)
Q Consensus 73 ~l~~L~~L~Ls~N~l~g--~~p-~~~~~l~~L~~L~Ls~N~l~g~ip-~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~ 148 (771)
++++|++|+|++|+|++ .++ ..+..+++|+.|+|++|++++.+| ..+..+++|++|+|++|+|+ .+|..+.++|+
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~~~L~ 277 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLS 277 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCCSEEE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhccCCce
Confidence 89999999999999983 233 335678999999999999998775 45677899999999999999 89987778999
Q ss_pred eecccCCccccCCCcccccccccceeccCCC
Q 004155 149 RVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 149 ~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
.|+|++|++++. |. +..+++|+.++++.|
T Consensus 278 ~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N 306 (312)
T 1wwl_A 278 VLDLSYNRLDRN-PS-PDELPQVGNLSLKGN 306 (312)
T ss_dssp EEECCSSCCCSC-CC-TTTSCEEEEEECTTC
T ss_pred EEECCCCCCCCC-hh-HhhCCCCCEEeccCC
Confidence 999999999987 66 889999999998755
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-20 Score=212.26 Aligned_cols=178 Identities=16% Similarity=0.185 Sum_probs=109.5
Q ss_pred CCCCcEEEccCCcccccCC-ccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCC--CccCCCCCc
Q 004155 2 LVTLKDFRISDNHFTGKIP-NFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFP--PLDKMKKMK 78 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~--~~~~l~~L~ 78 (771)
+++|++|+|++|.+.+.+| ..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..+. .|.++++|+
T Consensus 53 l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~ 132 (455)
T 3v47_A 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLE 132 (455)
T ss_dssp CTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCC
T ss_pred CccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCC
Confidence 4556666666666654443 3456666666666666666655566666666666666666666553222 255566666
Q ss_pred EEEccCCcCcccCChh-hhcCCCCcEEEccCCCCCCCCCccccCC-----------------------------------
Q 004155 79 TLILRSCNVSGKLPDY-LGLMTSLKVLDVSFNKLNGAIPSTFMGL----------------------------------- 122 (771)
Q Consensus 79 ~L~Ls~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~g~ip~~~~~l----------------------------------- 122 (771)
+|+|++|++++..|.. +.++++|++|+|++|++++..|..+..+
T Consensus 133 ~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~ 212 (455)
T 3v47_A 133 MLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212 (455)
T ss_dssp EEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTC
T ss_pred EEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccc
Confidence 6666666666554544 5556666666666666555444333221
Q ss_pred --------------------------------------------------------------CCCcEEEcCCCcccccCc
Q 004155 123 --------------------------------------------------------------LDVDYIYLTGNLLTGTIP 140 (771)
Q Consensus 123 --------------------------------------------------------------~~L~~L~Ls~N~l~g~iP 140 (771)
++|+.|+|++|++++.+|
T Consensus 213 ~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 292 (455)
T 3v47_A 213 SITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLK 292 (455)
T ss_dssp EEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECT
T ss_pred eeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccch
Confidence 355666666666665566
Q ss_pred hhh--hhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 141 PWM--LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 141 ~~~--~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
..+ +++|+.|+|++|++++..|..+..+++|+.|+++.|
T Consensus 293 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 333 (455)
T 3v47_A 293 SVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQN 333 (455)
T ss_dssp TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred hhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCC
Confidence 655 677888888888888777777888888888877755
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.7e-20 Score=208.65 Aligned_cols=178 Identities=21% Similarity=0.176 Sum_probs=161.4
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
.++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+++..++..|..+++|++|+
T Consensus 63 ~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 142 (440)
T 3zyj_A 63 STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELW 142 (440)
T ss_dssp CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEE
T ss_pred CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceee
Confidence 35799999999999977778999999999999999999988889999999999999999999999888999999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCc-cccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCcccc
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPS-TFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~ 159 (771)
|++|+|+...+..|..+++|+.|+|++|+..+.++. .|.++++|++|+|++|+|+ .+|... +++|+.|+|++|++++
T Consensus 143 L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~l~~ 221 (440)
T 3zyj_A 143 LRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSA 221 (440)
T ss_dssp CCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCCCTTCSSCCEEECTTSCCCE
T ss_pred CCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccccCCCcccCEEECCCCccCc
Confidence 999999966667899999999999999555446655 6999999999999999999 778644 8899999999999999
Q ss_pred CCCcccccccccceeccCCCC
Q 004155 160 GSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 160 ~~p~~~~~l~~L~~l~~s~~~ 180 (771)
..|..+..+++|+.|+++.+.
T Consensus 222 ~~~~~~~~l~~L~~L~L~~n~ 242 (440)
T 3zyj_A 222 IRPGSFQGLMHLQKLWMIQSQ 242 (440)
T ss_dssp ECTTTTTTCTTCCEEECTTCC
T ss_pred cChhhhccCccCCEEECCCCc
Confidence 999999999999999988653
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.8e-20 Score=188.17 Aligned_cols=154 Identities=19% Similarity=0.236 Sum_probs=139.8
Q ss_pred cEEEccCCcccccCCccccCCCcCCEEEcccCCccccCc-hhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccC
Q 004155 6 KDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIP-SGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRS 84 (771)
Q Consensus 6 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 84 (771)
+.|++++|+++ .+|..+. ..+++|+|++|+|++..| ..|..+++|+.|+|++|++++.++..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 58999999999 7998775 467999999999997655 4589999999999999999999988999999999999999
Q ss_pred CcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccccCCC
Q 004155 85 CNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAGSS 162 (771)
Q Consensus 85 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~~~p 162 (771)
|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+ +++|+.|+|++|++++..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 99997777789999999999999999998889999999999999999999997778777 8899999999999997543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=193.41 Aligned_cols=174 Identities=19% Similarity=0.197 Sum_probs=155.5
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCC-ccccCchhhcCCcCCCEEEcCC-CCCCCCCCCCccCCCCCcEE
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASG-LVGPIPSGIASLSKLTDLRISD-LNGTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L 80 (771)
.+|+.|+|++|+|++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |+++..++..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 579999999999995555589999999999999997 8866667899999999999998 99999988899999999999
Q ss_pred EccCCcCcccCChhhhcCCCCc---EEEccCC-CCCCCCCccccCCCCCc-EEEcCCCcccccCchhh--hhcCCeeccc
Q 004155 81 ILRSCNVSGKLPDYLGLMTSLK---VLDVSFN-KLNGAIPSTFMGLLDVD-YIYLTGNLLTGTIPPWM--LQKGDRVDLS 153 (771)
Q Consensus 81 ~Ls~N~l~g~~p~~~~~l~~L~---~L~Ls~N-~l~g~ip~~~~~l~~L~-~L~Ls~N~l~g~iP~~~--~~~L~~l~ls 153 (771)
+|++|++++ +|. +..+++|+ .|+|++| ++++..+..|..+++|+ .|+|++|+++ .+|... ..+|+.|+|+
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~ 187 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcC
Confidence 999999994 887 88899998 9999999 99966666799999999 9999999999 777654 5679999999
Q ss_pred CCc-cccCCCcccccc-cccceeccCCC
Q 004155 154 YNS-FTAGSSETSCQY-RSVNLFASSSK 179 (771)
Q Consensus 154 ~N~-l~~~~p~~~~~l-~~L~~l~~s~~ 179 (771)
+|+ ++...+..+..+ ++|+.++++.+
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N 215 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQT 215 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCC
Confidence 995 998888889999 99999998864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.5e-21 Score=229.08 Aligned_cols=158 Identities=16% Similarity=0.236 Sum_probs=141.7
Q ss_pred CCccccCCCcCCEEEcccCCccc-----------------cCchhhc--CCcCCCEEEcCCCCCCCCCCCCccCCCCCcE
Q 004155 19 IPNFIQNWTLLEKLVIQASGLVG-----------------PIPSGIA--SLSKLTDLRISDLNGTEAPFPPLDKMKKMKT 79 (771)
Q Consensus 19 ip~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 79 (771)
||..|++|++|+.|+|++|+|+| .+|..++ +|++|+.|+|++|++.+..|..|++|++|+.
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 88889999999999999999998 3899887 9999999999999999988888999999999
Q ss_pred EEccCCc-Ccc-cCChhhhcCC-------CCcEEEccCCCCCCCCCc--cccCCCCCcEEEcCCCcccccCchhh--hhc
Q 004155 80 LILRSCN-VSG-KLPDYLGLMT-------SLKVLDVSFNKLNGAIPS--TFMGLLDVDYIYLTGNLLTGTIPPWM--LQK 146 (771)
Q Consensus 80 L~Ls~N~-l~g-~~p~~~~~l~-------~L~~L~Ls~N~l~g~ip~--~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~ 146 (771)
|+|++|+ |+| .+|..+++++ +|+.|+|++|+|+ .+|. .|+++++|+.|+|++|+++ .+| .+ +++
T Consensus 520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~ 596 (876)
T 4ecn_A 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVK 596 (876)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSE
T ss_pred EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCc
Confidence 9999998 998 8998887766 9999999999999 8998 8999999999999999999 888 55 788
Q ss_pred CCeecccCCccccCCCcccccccc-cceeccCCCC
Q 004155 147 GDRVDLSYNSFTAGSSETSCQYRS-VNLFASSSKG 180 (771)
Q Consensus 147 L~~l~ls~N~l~~~~p~~~~~l~~-L~~l~~s~~~ 180 (771)
|+.|+|++|+++ .+|..+..+++ |+.|+++.|.
T Consensus 597 L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~ 630 (876)
T 4ecn_A 597 LTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNK 630 (876)
T ss_dssp ESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSC
T ss_pred ceEEECcCCccc-cchHHHhhccccCCEEECcCCC
Confidence 999999999999 78888999988 9999988664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.82 E-value=4e-21 Score=230.23 Aligned_cols=176 Identities=19% Similarity=0.236 Sum_probs=155.8
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEc-ccCCcccc---------------------------------------
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVI-QASGLVGP--------------------------------------- 42 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L-~~N~l~~~--------------------------------------- 42 (771)
.+++.|+|++|+|+|.+|+.|++|++|+.|+| ++|.++|.
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 36889999999999999999999999999999 77766554
Q ss_pred -------------------------------------CchhhcCCcCCCEEEcCCCCCCC-----------------CCC
Q 004155 43 -------------------------------------IPSGIASLSKLTDLRISDLNGTE-----------------APF 68 (771)
Q Consensus 43 -------------------------------------~p~~~~~l~~L~~L~L~~n~l~~-----------------~~~ 68 (771)
+|..|++|++|+.|+|++|++++ ..|
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP 482 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCC
Confidence 88889999999999999999998 266
Q ss_pred CCcc--CCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccCCC-CCC-CCCccccCCC-------CCcEEEcCCCcccc
Q 004155 69 PPLD--KMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNK-LNG-AIPSTFMGLL-------DVDYIYLTGNLLTG 137 (771)
Q Consensus 69 ~~~~--~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~g-~ip~~~~~l~-------~L~~L~Ls~N~l~g 137 (771)
+.++ ++++|++|+|++|++.|.+|..|+++++|+.|+|++|+ |+| .+|..++.++ +|+.|+|++|+|+
T Consensus 483 ~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~- 561 (876)
T 4ecn_A 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE- 561 (876)
T ss_dssp SCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-
T ss_pred hhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-
Confidence 7776 99999999999999999999999999999999999998 998 8888776655 9999999999999
Q ss_pred cCch--hh--hhcCCeecccCCccccCCCcccccccccceeccCCCCC
Q 004155 138 TIPP--WM--LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKGN 181 (771)
Q Consensus 138 ~iP~--~~--~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~ 181 (771)
.+|. .+ +++|+.|+|++|+++ .+| .+..+++|+.|+++.|.-
T Consensus 562 ~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l 607 (876)
T 4ecn_A 562 EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQI 607 (876)
T ss_dssp BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCC
T ss_pred ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCcc
Confidence 8888 66 889999999999999 777 889999999999876543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=7.8e-20 Score=196.69 Aligned_cols=174 Identities=18% Similarity=0.207 Sum_probs=152.5
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
++|+.|+|++|+|++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|+++..+...+ ++|++|+|
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~---~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMP---KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCC---TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCccChhhc---ccccEEEC
Confidence 578999999999996656689999999999999999998889999999999999999999987654333 78999999
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCC--CCCCccccCCCCCcEEEcCCCcccccCchhhhhcCCeecccCCccccC
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLN--GAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~--g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~ 160 (771)
++|++++..+..+.++++|+.|+|++|.+. +..+..+..+++|++|++++|+++ .+|..+.++|+.|++++|.+++.
T Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~L~~L~l~~n~l~~~ 207 (330)
T 1xku_A 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKV 207 (330)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCCTTCSEEECTTSCCCEE
T ss_pred CCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCccccccCCEEECCCCcCCcc
Confidence 999999666677899999999999999996 367788999999999999999998 68877778999999999999998
Q ss_pred CCcccccccccceeccCCCC
Q 004155 161 SSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 161 ~p~~~~~l~~L~~l~~s~~~ 180 (771)
.|..+..+++|+.|+++.+.
T Consensus 208 ~~~~~~~l~~L~~L~Ls~n~ 227 (330)
T 1xku_A 208 DAASLKGLNNLAKLGLSFNS 227 (330)
T ss_dssp CTGGGTTCTTCCEEECCSSC
T ss_pred CHHHhcCCCCCCEEECCCCc
Confidence 88999999999999987653
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.2e-20 Score=201.19 Aligned_cols=174 Identities=14% Similarity=0.124 Sum_probs=143.8
Q ss_pred CCCcEEEccCCcccccCCccc--cCCCcCCEEEcccCCccccCc----hhhcCCcCCCEEEcCCCCCCCCCCCCccCCCC
Q 004155 3 VTLKDFRISDNHFTGKIPNFI--QNWTLLEKLVIQASGLVGPIP----SGIASLSKLTDLRISDLNGTEAPFPPLDKMKK 76 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 76 (771)
++|++|+|++|++++.+|..+ ..+++|++|+|++|++++..| ..+..+++|++|+|++|++++.++..|.++++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 579999999999999999888 889999999999999997665 45567999999999999999988889999999
Q ss_pred CcEEEccCCcCccc--C--ChhhhcCCCCcEEEccCCCCCCCCCc----cccCCCCCcEEEcCCCcccccCchhh--h--
Q 004155 77 MKTLILRSCNVSGK--L--PDYLGLMTSLKVLDVSFNKLNGAIPS----TFMGLLDVDYIYLTGNLLTGTIPPWM--L-- 144 (771)
Q Consensus 77 L~~L~Ls~N~l~g~--~--p~~~~~l~~L~~L~Ls~N~l~g~ip~----~~~~l~~L~~L~Ls~N~l~g~iP~~~--~-- 144 (771)
|++|+|++|++.+. + +..++.+++|++|+|++|+|+ .+|. .+..+++|++|+|++|+|++.+|..+ +
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~ 249 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMW 249 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccC
Confidence 99999999998753 2 233478889999999999997 4444 25678899999999999997767655 3
Q ss_pred -hcCCeecccCCccccCCCcccccccccceeccCCCC
Q 004155 145 -QKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 145 -~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
++|+.|+|++|+++ .+|..+. ++|+.|++++|.
T Consensus 250 ~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~ 283 (310)
T 4glp_A 250 SSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNR 283 (310)
T ss_dssp CTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCC
T ss_pred cCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCc
Confidence 68999999999998 5666664 688888887653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=8.1e-20 Score=184.74 Aligned_cols=152 Identities=16% Similarity=0.227 Sum_probs=136.2
Q ss_pred cEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCC
Q 004155 6 KDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSC 85 (771)
Q Consensus 6 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 85 (771)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 57899999999 8998776 78999999999999777778999999999999999999998999999999999999999
Q ss_pred cCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccccC
Q 004155 86 NVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 86 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~~ 160 (771)
+|+...+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+ +++|+.|+|++|++.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 9994444557899999999999999998888999999999999999999996555555 78899999999999863
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.2e-19 Score=184.56 Aligned_cols=154 Identities=18% Similarity=0.158 Sum_probs=137.8
Q ss_pred CcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccC
Q 004155 5 LKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRS 84 (771)
Q Consensus 5 L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 84 (771)
.+.++.++++++ .+|..+. ++|++|+|++|+|++..|..|..+++|+.|+|++|++...++..|.++++|++|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 467899999998 9998775 8999999999999988899999999999999999999998888899999999999999
Q ss_pred CcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccccCCC
Q 004155 85 CNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAGSS 162 (771)
Q Consensus 85 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~~~p 162 (771)
|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+ +++|+.|+|++|++.+..+
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 9999666667899999999999999999 899999999999999999999995444444 7899999999999987543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=6.2e-20 Score=214.22 Aligned_cols=177 Identities=15% Similarity=0.145 Sum_probs=130.3
Q ss_pred CCCCcEEEccCCcccccC--CccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCC-ccCCCCCc
Q 004155 2 LVTLKDFRISDNHFTGKI--PNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPP-LDKMKKMK 78 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~i--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~ 78 (771)
+++|+.|+|++|++++.. |..+.++++|++|+|++|++++..|..|..+++|+.|+|++|++++..++. +.++++|+
T Consensus 349 l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 428 (606)
T 3t6q_A 349 LENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLK 428 (606)
T ss_dssp CTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCC
T ss_pred cCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCC
Confidence 567788888888877544 667777778888888888877777777777778888888877777665443 77777777
Q ss_pred EEEccCCcCcccCChhhhcCCCCcEEEccCCCCCCC---CCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeeccc
Q 004155 79 TLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGA---IPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLS 153 (771)
Q Consensus 79 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~---ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls 153 (771)
.|+|++|++++..|..+..+++|+.|+|++|++++. .+..+..+++|+.|+|++|++++..|..+ +++|+.|+|+
T Consensus 429 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 508 (606)
T 3t6q_A 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLS 508 (606)
T ss_dssp EEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred EEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECC
Confidence 888877777777777777777777777777777752 23457777777777777777776666655 6777777777
Q ss_pred CCccccCCCcccccccccceeccCCC
Q 004155 154 YNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
+|++++..|+.+..++.| .++++.|
T Consensus 509 ~N~l~~~~~~~l~~l~~L-~L~L~~N 533 (606)
T 3t6q_A 509 HNRLTSSSIEALSHLKGI-YLNLASN 533 (606)
T ss_dssp SSCCCGGGGGGGTTCCSC-EEECCSS
T ss_pred CCccCcCChhHhCccccc-EEECcCC
Confidence 777777777777777777 6666544
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.5e-20 Score=204.36 Aligned_cols=174 Identities=17% Similarity=0.138 Sum_probs=91.3
Q ss_pred CCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEcc
Q 004155 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILR 83 (771)
Q Consensus 4 ~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 83 (771)
+|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++.++..|.++++|++|+|+
T Consensus 53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 132 (353)
T 2z80_A 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLL 132 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECT
T ss_pred cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECC
Confidence 45556666666553333355555566666666665555445555555556666666555555444445555555556665
Q ss_pred CCcCcccCCh--hhhcCCCCcEEEccCC-CCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccc
Q 004155 84 SCNVSGKLPD--YLGLMTSLKVLDVSFN-KLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFT 158 (771)
Q Consensus 84 ~N~l~g~~p~--~~~~l~~L~~L~Ls~N-~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~ 158 (771)
+|+++ .+|. .+..+++|++|++++| .+.+..|..|..+++|++|+|++|++++..|..+ +++|+.|++++|.++
T Consensus 133 ~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 211 (353)
T 2z80_A 133 GNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211 (353)
T ss_dssp TCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred CCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence 55555 3443 4555555555555555 2443334445555555555555555554444444 445555555555554
Q ss_pred cCCCcccccccccceeccCC
Q 004155 159 AGSSETSCQYRSVNLFASSS 178 (771)
Q Consensus 159 ~~~p~~~~~l~~L~~l~~s~ 178 (771)
...+..+..+++|+.|+++.
T Consensus 212 ~~~~~~~~~~~~L~~L~L~~ 231 (353)
T 2z80_A 212 LLLEIFVDVTSSVECLELRD 231 (353)
T ss_dssp THHHHHHHHTTTEEEEEEES
T ss_pred cchhhhhhhcccccEEECCC
Confidence 32222233344445444443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.2e-19 Score=211.33 Aligned_cols=112 Identities=18% Similarity=0.136 Sum_probs=78.6
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
|++|+.|+|++|.|++..|..|+++++|++|+|++|.|++..|..|+++++|++|+|++|.+++.++..|+++++|++|+
T Consensus 74 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 74 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 45677777777777755555677777777777777777766666667777777777777777766666667777777777
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNG 113 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 113 (771)
|++|.|++..|..|+.+++|+.|+|++|.|++
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 77777776666667777777777777777764
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.2e-20 Score=214.10 Aligned_cols=173 Identities=17% Similarity=0.145 Sum_probs=114.8
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCC-------------
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFP------------- 69 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~------------- 69 (771)
++|+.|+|++|+|++..|..|+.+++|++|+|++|.|++..| |..+++|++|+|++|.+++.++.
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l 111 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI 111 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCC
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcC
Confidence 489999999999997777899999999999999999997666 88999999999999888765422
Q ss_pred ---CccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCcccc-CCCCCcEEEcCCCcccccCchhhhh
Q 004155 70 ---PLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM-GLLDVDYIYLTGNLLTGTIPPWMLQ 145 (771)
Q Consensus 70 ---~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~~~~ 145 (771)
....+++|+.|+|++|+|++..|..++.+++|+.|+|++|.|++.+|..+. .+++|+.|+|++|.|++..+...++
T Consensus 112 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~ 191 (487)
T 3oja_A 112 SRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFA 191 (487)
T ss_dssp CCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCT
T ss_pred CCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCC
Confidence 011234555566666666555555555566666666666666655555554 4556666666666665432222255
Q ss_pred cCCeecccCCccccCCCcccccccccceeccCC
Q 004155 146 KGDRVDLSYNSFTAGSSETSCQYRSVNLFASSS 178 (771)
Q Consensus 146 ~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~ 178 (771)
+|+.|+|++|.+++.+|. +..+++|+.|+++.
T Consensus 192 ~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~ 223 (487)
T 3oja_A 192 KLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRN 223 (487)
T ss_dssp TCCEEECCSSCCCEECGG-GGGGTTCSEEECTT
T ss_pred CCCEEECCCCCCCCCCHh-HcCCCCccEEEecC
Confidence 566666666666653333 55556666665554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=4.6e-20 Score=215.29 Aligned_cols=178 Identities=16% Similarity=0.126 Sum_probs=148.5
Q ss_pred CCCCcEEEccCCccccc--CCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCC-CCccCCCCCc
Q 004155 2 LVTLKDFRISDNHFTGK--IPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPF-PPLDKMKKMK 78 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~--ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~ 78 (771)
+++|+.|+|++|++++. +|..+..+++|++|+|++|.++ .+|..|..+++|+.|+|++|++.+.++ ..+.++++|+
T Consensus 349 l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 427 (606)
T 3vq2_A 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427 (606)
T ss_dssp CTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCC
T ss_pred CCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCC
Confidence 67888889998888855 4778888888888888888888 467788888888888888888888776 5788888888
Q ss_pred EEEccCCcCcccCChhhhcCCCCcEEEccCCCCCC-CCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCC
Q 004155 79 TLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNG-AIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYN 155 (771)
Q Consensus 79 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N 155 (771)
+|+|++|++.+..|..+..+++|+.|+|++|++++ .+|..|..+++|+.|+|++|++++..|..+ +++|+.|+|++|
T Consensus 428 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 507 (606)
T 3vq2_A 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507 (606)
T ss_dssp EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCC
Confidence 88888888888888888888888888888888886 367788888888888888888887777666 788888888888
Q ss_pred ccccCCCcccccccccceeccCCCC
Q 004155 156 SFTAGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
++++..|..++.+++|+.|+++.|.
T Consensus 508 ~l~~~~~~~~~~l~~L~~L~l~~N~ 532 (606)
T 3vq2_A 508 NLLFLDSSHYNQLYSLSTLDCSFNR 532 (606)
T ss_dssp CCSCEEGGGTTTCTTCCEEECTTSC
T ss_pred cCCCcCHHHccCCCcCCEEECCCCc
Confidence 8888888888888888888887553
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=195.44 Aligned_cols=173 Identities=17% Similarity=0.241 Sum_probs=153.5
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+|..+. ++|+.|++++|++++.++..|.++++|+.|+
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 151 (330)
T 1xku_A 75 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVE 151 (330)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEE
Confidence 688999999999999777999999999999999999998 7887664 7999999999999998877899999999999
Q ss_pred ccCCcCc--ccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCcc
Q 004155 82 LRSCNVS--GKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSF 157 (771)
Q Consensus 82 Ls~N~l~--g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l 157 (771)
|++|++. +..+..+..+++|+.|++++|.++ .+|..+. ++|+.|+|++|++++..|..+ +++|+.|+|++|.+
T Consensus 152 l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 228 (330)
T 1xku_A 152 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 228 (330)
T ss_dssp CCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCC
T ss_pred CCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcC
Confidence 9999996 367788999999999999999998 6776654 789999999999997767766 78899999999999
Q ss_pred ccCCCcccccccccceeccCCCC
Q 004155 158 TAGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 158 ~~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
++..+..+..+++|+.|+++.+.
T Consensus 229 ~~~~~~~~~~l~~L~~L~L~~N~ 251 (330)
T 1xku_A 229 SAVDNGSLANTPHLRELHLNNNK 251 (330)
T ss_dssp CEECTTTGGGSTTCCEEECCSSC
T ss_pred ceeChhhccCCCCCCEEECCCCc
Confidence 98888889999999999988653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.81 E-value=9.6e-20 Score=196.19 Aligned_cols=175 Identities=15% Similarity=0.123 Sum_probs=131.6
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|+++++|++|+|++|+++..++..+ ++|++|+|
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~---~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLP---SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCCSCCSSCC---TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCCccCcccc---ccCCEEEC
Confidence 578888888888886656678888888888888888887778888888888888888888876554332 67777777
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCC--CCCCccccCC--------------------CCCcEEEcCCCcccccCc
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLN--GAIPSTFMGL--------------------LDVDYIYLTGNLLTGTIP 140 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~--g~ip~~~~~l--------------------~~L~~L~Ls~N~l~g~iP 140 (771)
++|++++..+..|..+++|+.|+|++|.++ +..|..+..+ ++|+.|+|++|++++..|
T Consensus 131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~ 210 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIEL 210 (332)
T ss_dssp CSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCT
T ss_pred CCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCCccCH
Confidence 777777444455777777777777777774 2344444332 477788888888886555
Q ss_pred hhh--hhcCCeecccCCccccCCCcccccccccceeccCCCC
Q 004155 141 PWM--LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 141 ~~~--~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
..+ +++|+.|+|++|++++..+..+..+++|+.|+++.|.
T Consensus 211 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 252 (332)
T 2ft3_A 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNK 252 (332)
T ss_dssp TSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSC
T ss_pred HHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCc
Confidence 555 7788999999999998888888888899998887653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-19 Score=195.19 Aligned_cols=166 Identities=19% Similarity=0.214 Sum_probs=136.7
Q ss_pred CCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEcc
Q 004155 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILR 83 (771)
Q Consensus 4 ~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 83 (771)
+|+.+++++|+++ .+|..+. ++|+.|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 5899999999999 8998775 799999999999997778899999999999999999999988999999999999999
Q ss_pred CCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCccc--ccCchhh-hhcCCeecccCCccccC
Q 004155 84 SCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLT--GTIPPWM-LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 84 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~--g~iP~~~-~~~L~~l~ls~N~l~~~ 160 (771)
+|+++ .+|..+. ++|++|+|++|++++..+..|..+++|+.|++++|.++ +..|..+ ..+|+.|++++|.+++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~- 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG- 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSS-
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCc-
Confidence 99999 8887766 89999999999999666667999999999999999996 3445444 1156666666666664
Q ss_pred CCcccccccccceeccCC
Q 004155 161 SSETSCQYRSVNLFASSS 178 (771)
Q Consensus 161 ~p~~~~~l~~L~~l~~s~ 178 (771)
+|..+. ++|+.|+++.
T Consensus 187 l~~~~~--~~L~~L~l~~ 202 (332)
T 2ft3_A 187 IPKDLP--ETLNELHLDH 202 (332)
T ss_dssp CCSSSC--SSCSCCBCCS
T ss_pred cCcccc--CCCCEEECCC
Confidence 333222 3455555543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=211.71 Aligned_cols=175 Identities=18% Similarity=0.163 Sum_probs=125.2
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|+|++|.|++..|..|+++++|++|+|++|.|++..+..|+++++|++|+|++|.+++.+|..|.++++|++|+
T Consensus 98 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 177 (597)
T 3oja_B 98 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 177 (597)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEE
Confidence 67899999999999977777889999999999999999955455578999999999999999999888999999999999
Q ss_pred ccCCcCcccCChhhhcC-------------------------------------CCCcEEEccCCCCCCCCCccccCCCC
Q 004155 82 LRSCNVSGKLPDYLGLM-------------------------------------TSLKVLDVSFNKLNGAIPSTFMGLLD 124 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l-------------------------------------~~L~~L~Ls~N~l~g~ip~~~~~l~~ 124 (771)
|++|+|++.-+..+.++ ++|+.|+|++|.+++ +..+..+++
T Consensus 178 L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~--~~~l~~l~~ 255 (597)
T 3oja_B 178 LSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPG 255 (597)
T ss_dssp CTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCC--CGGGGGCTT
T ss_pred CcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCC--ChhhccCCC
Confidence 99999985322222111 124444444444443 234566666
Q ss_pred CcEEEcCCCcccccCchhh--hhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 125 VDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 125 L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
|+.|+|++|.+++.+|..+ +++|+.|+|++|.+++ +|..+..+++|+.|+++.|
T Consensus 256 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N 311 (597)
T 3oja_B 256 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHN 311 (597)
T ss_dssp CSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSS
T ss_pred CCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCC
Confidence 6666666666666555555 5666666666666665 3444455666666666544
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.5e-19 Score=197.40 Aligned_cols=111 Identities=18% Similarity=0.141 Sum_probs=64.9
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|+++++|++|+|++|+++..++..|.++++|++|+
T Consensus 68 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 68 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEE
Confidence 35566666666666544444556666666666666666655555556666666666666666655544455566666666
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLN 112 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 112 (771)
|++|++++..|..+..+++|+.|+|++|+++
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 178 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCS
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCC
Confidence 6666665444555556666666666666655
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.2e-19 Score=211.94 Aligned_cols=177 Identities=14% Similarity=0.132 Sum_probs=151.2
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 57899999999999777778999999999999999999877888999999999999999999988889999999999999
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCC-CCCccccCCCCCcEEEcCCCcccccCchhh--hhcCC----eecccCC
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNG-AIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGD----RVDLSYN 155 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~----~l~ls~N 155 (771)
++|++++..|..++++++|++|+|++|.+++ .+|..|+++++|++|+|++|++++..|..+ +.+|+ .|++++|
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 9999986666789999999999999999985 678899999999999999999997666655 55544 7999999
Q ss_pred ccccCCCcccccccccceeccCCCC
Q 004155 156 SFTAGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
++++..+..+... +|+.++++.+.
T Consensus 192 ~l~~~~~~~~~~~-~L~~L~L~~n~ 215 (606)
T 3vq2_A 192 PIDFIQDQAFQGI-KLHELTLRGNF 215 (606)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCC
T ss_pred CcceeCcccccCc-eeeeeeccCCc
Confidence 9987766666554 78888887653
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.4e-20 Score=199.02 Aligned_cols=172 Identities=17% Similarity=0.112 Sum_probs=81.9
Q ss_pred CCCCcEEEccCCcccccCC----ccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCC---CCC-CCccC
Q 004155 2 LVTLKDFRISDNHFTGKIP----NFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTE---APF-PPLDK 73 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~-~~~~~ 73 (771)
+++|++|+|++|++++..| ..+..+++|++|+|++|+|++..|..|+.+++|++|+|++|++.+ .++ ..+..
T Consensus 116 ~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 195 (310)
T 4glp_A 116 GLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHK 195 (310)
T ss_dssp CBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTS
T ss_pred CCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhc
Confidence 3445555555555554333 223345555555555555554444555555555555555555443 111 12244
Q ss_pred CCCCcEEEccCCcCcccCCh----hhhcCCCCcEEEccCCCCCCCCCccccCC---CCCcEEEcCCCcccccCchhhhhc
Q 004155 74 MKKMKTLILRSCNVSGKLPD----YLGLMTSLKVLDVSFNKLNGAIPSTFMGL---LDVDYIYLTGNLLTGTIPPWMLQK 146 (771)
Q Consensus 74 l~~L~~L~Ls~N~l~g~~p~----~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l---~~L~~L~Ls~N~l~g~iP~~~~~~ 146 (771)
+++|++|+|++|+++ .+|. .+..+++|++|+|++|+|++.+|..+..+ ++|++|+|++|+|+ .+|..+.++
T Consensus 196 l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~ 273 (310)
T 4glp_A 196 FPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAK 273 (310)
T ss_dssp SCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSC
T ss_pred CCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCC
Confidence 555555555555554 2222 13444555555555555554444444444 35555555555555 445444445
Q ss_pred CCeecccCCccccCCCcccccccccceeccC
Q 004155 147 GDRVDLSYNSFTAGSSETSCQYRSVNLFASS 177 (771)
Q Consensus 147 L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s 177 (771)
|+.|+|++|++++. |. +..+++|+.|+++
T Consensus 274 L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~ 302 (310)
T 4glp_A 274 LRVLDLSSNRLNRA-PQ-PDELPEVDNLTLD 302 (310)
T ss_dssp CSCEECCSCCCCSC-CC-TTSCCCCSCEECS
T ss_pred CCEEECCCCcCCCC-ch-hhhCCCccEEECc
Confidence 55555555555542 21 3344444444443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=9.1e-20 Score=206.47 Aligned_cols=177 Identities=14% Similarity=0.062 Sum_probs=135.5
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|+.|+
T Consensus 55 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 134 (477)
T 2id5_A 55 FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134 (477)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence 67889999999999877788888999999999999998855555678889999999999998888888888888899999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCcccc
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~ 159 (771)
|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..+ +++|+.|++++|++.+
T Consensus 135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~ 214 (477)
T 2id5_A 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD 214 (477)
T ss_dssp ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCC
T ss_pred CCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCcccc
Confidence 98888887777788888888888888888886555567788888888888888775444444 5556666666665555
Q ss_pred CCCcccccccccceeccCC
Q 004155 160 GSSETSCQYRSVNLFASSS 178 (771)
Q Consensus 160 ~~p~~~~~l~~L~~l~~s~ 178 (771)
.+|.......+|+.|+++.
T Consensus 215 ~~~~~~~~~~~L~~L~l~~ 233 (477)
T 2id5_A 215 TMTPNCLYGLNLTSLSITH 233 (477)
T ss_dssp EECTTTTTTCCCSEEEEES
T ss_pred ccCcccccCccccEEECcC
Confidence 5554444444555555543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.9e-20 Score=203.49 Aligned_cols=171 Identities=12% Similarity=0.099 Sum_probs=151.2
Q ss_pred CcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccC
Q 004155 5 LKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRS 84 (771)
Q Consensus 5 L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 84 (771)
....++++|+++ .+|..+. ++|++|+|++|+|++..+..|.++++|+.|+|++|++++..+..|.++++|++|+|++
T Consensus 33 ~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (353)
T 2z80_A 33 NGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109 (353)
T ss_dssp TSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCC
Confidence 456889999999 8998776 5999999999999976666899999999999999999999888999999999999999
Q ss_pred CcCcccCCh-hhhcCCCCcEEEccCCCCCCCCCc--cccCCCCCcEEEcCCCc-ccccCchhh--hhcCCeecccCCccc
Q 004155 85 CNVSGKLPD-YLGLMTSLKVLDVSFNKLNGAIPS--TFMGLLDVDYIYLTGNL-LTGTIPPWM--LQKGDRVDLSYNSFT 158 (771)
Q Consensus 85 N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~ip~--~~~~l~~L~~L~Ls~N~-l~g~iP~~~--~~~L~~l~ls~N~l~ 158 (771)
|+++ .+|. .+.++++|++|+|++|+++ .+|. .|..+++|++|++++|+ +++..|..+ +++|+.|++++|.++
T Consensus 110 n~l~-~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~ 187 (353)
T 2z80_A 110 NYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187 (353)
T ss_dssp SCCS-SCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CcCC-cCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcC
Confidence 9999 4555 4899999999999999999 5665 78999999999999995 664445555 788999999999999
Q ss_pred cCCCcccccccccceeccCCCC
Q 004155 159 AGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 159 ~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
+..|..+..+++|+.|+++.+.
T Consensus 188 ~~~~~~l~~l~~L~~L~l~~n~ 209 (353)
T 2z80_A 188 SYEPKSLKSIQNVSHLILHMKQ 209 (353)
T ss_dssp EECTTTTTTCSEEEEEEEECSC
T ss_pred ccCHHHHhccccCCeecCCCCc
Confidence 9999999999999999998664
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-19 Score=212.67 Aligned_cols=176 Identities=14% Similarity=0.080 Sum_probs=159.6
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
++|++|+|++|+|++..|..|.++++|++|+|++|.+++..|..|++|++|++|+|++|+++..++..|.++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 57999999999999666667999999999999999999888999999999999999999999988888999999999999
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh----hhcCCeecccCCccc
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM----LQKGDRVDLSYNSFT 158 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~----~~~L~~l~ls~N~l~ 158 (771)
++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|+|++|++++..|..+ .++|+.|++++|+++
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~ 184 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCccc
Confidence 9999997667889999999999999999999889999999999999999999997666654 378999999999999
Q ss_pred cCCCcccccccccceeccCC
Q 004155 159 AGSSETSCQYRSVNLFASSS 178 (771)
Q Consensus 159 ~~~p~~~~~l~~L~~l~~s~ 178 (771)
+..|..+..+.+|+.++++.
T Consensus 185 ~~~~~~~~~l~~L~~L~l~~ 204 (680)
T 1ziw_A 185 EFSPGCFHAIGRLFGLFLNN 204 (680)
T ss_dssp CBCTTGGGGSSEECEEECTT
T ss_pred ccChhhhhhhhhhhhhhccc
Confidence 99999888887777766543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.5e-19 Score=197.36 Aligned_cols=174 Identities=19% Similarity=0.195 Sum_probs=127.7
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCch-hhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPS-GIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 80 (771)
+++|++|+|++|++++..|..|.++++|++|+|++|+|+ .+|. .|.++++|++|+|++|++++.++..|.++++|++|
T Consensus 92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 170 (390)
T 3o6n_A 92 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 170 (390)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEE
T ss_pred CCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEE
Confidence 678999999999999777778899999999999999999 5555 46899999999999999999888889999999999
Q ss_pred EccCCcCcccCChhhhcC-------------------------------------CCCcEEEccCCCCCCCCCccccCCC
Q 004155 81 ILRSCNVSGKLPDYLGLM-------------------------------------TSLKVLDVSFNKLNGAIPSTFMGLL 123 (771)
Q Consensus 81 ~Ls~N~l~g~~p~~~~~l-------------------------------------~~L~~L~Ls~N~l~g~ip~~~~~l~ 123 (771)
+|++|++++.-...+.++ ++|+.|+|++|++++. ..+..++
T Consensus 171 ~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~~--~~l~~l~ 248 (390)
T 3o6n_A 171 QLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDT--AWLLNYP 248 (390)
T ss_dssp ECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCCC--GGGGGCT
T ss_pred ECCCCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeeccccccccccEEECCCCCCccc--HHHcCCC
Confidence 999999884321222111 2344555555555532 3466667
Q ss_pred CCcEEEcCCCcccccCchhh--hhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 124 DVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 124 ~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
+|+.|+|++|.+++..|..+ +++|+.|+|++|++++ +|..+..+++|+.|+++.+
T Consensus 249 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n 305 (390)
T 3o6n_A 249 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHN 305 (390)
T ss_dssp TCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSS
T ss_pred CccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCC
Confidence 77777777777776556655 6677777777777765 3444556667777776654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2e-19 Score=209.98 Aligned_cols=179 Identities=18% Similarity=0.165 Sum_probs=162.7
Q ss_pred CCCCcEEEccCCcccccCCcc-ccCCCcCCEEEcccCCccccC--chhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCc
Q 004155 2 LVTLKDFRISDNHFTGKIPNF-IQNWTLLEKLVIQASGLVGPI--PSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMK 78 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~-~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 78 (771)
+++|+.|+|++|.+++.+|.. +.++++|++|+|++|++++.. |..+..+++|+.|+|++|++.+..+..|.++++|+
T Consensus 324 l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 403 (606)
T 3t6q_A 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE 403 (606)
T ss_dssp CTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCS
T ss_pred cCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCC
Confidence 688999999999999888875 899999999999999999765 78899999999999999999999889999999999
Q ss_pred EEEccCCcCcccCChh-hhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCccccc-Cc--hhh--hhcCCeecc
Q 004155 79 TLILRSCNVSGKLPDY-LGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGT-IP--PWM--LQKGDRVDL 152 (771)
Q Consensus 79 ~L~Ls~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~-iP--~~~--~~~L~~l~l 152 (771)
.|+|++|++.+..|.. +..+++|+.|+|++|.+++..|..+..+++|++|+|++|++++. +| ..+ +++|+.|++
T Consensus 404 ~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~L 483 (606)
T 3t6q_A 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483 (606)
T ss_dssp EEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEEC
T ss_pred eEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEEC
Confidence 9999999999777654 89999999999999999988899999999999999999999863 22 334 789999999
Q ss_pred cCCccccCCCcccccccccceeccCCCC
Q 004155 153 SYNSFTAGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 153 s~N~l~~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
++|++++..|..+..+++|+.|+++.|.
T Consensus 484 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 511 (606)
T 3t6q_A 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNR 511 (606)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCccCccChhhhccccCCCEEECCCCc
Confidence 9999999999999999999999998663
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.5e-19 Score=217.17 Aligned_cols=178 Identities=16% Similarity=0.086 Sum_probs=162.2
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccC-chhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPI-PSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 80 (771)
+++|+.|+|++|+|++..|..|.++++|++|+|++|.+.+.+ |..|.+|++|++|+|++|++++..|..|.++++|++|
T Consensus 23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 102 (844)
T 3j0a_A 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102 (844)
T ss_dssp CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence 578999999999999888999999999999999999777676 8889999999999999999999999999999999999
Q ss_pred EccCCcCcccCChh--hhcCCCCcEEEccCCCCCCCCC-ccccCCCCCcEEEcCCCcccccCchhh--h--hcCCeeccc
Q 004155 81 ILRSCNVSGKLPDY--LGLMTSLKVLDVSFNKLNGAIP-STFMGLLDVDYIYLTGNLLTGTIPPWM--L--QKGDRVDLS 153 (771)
Q Consensus 81 ~Ls~N~l~g~~p~~--~~~l~~L~~L~Ls~N~l~g~ip-~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~--~~L~~l~ls 153 (771)
+|++|++++.+|.. |.++++|++|+|++|.+++..| ..|+++++|++|+|++|++++..|..+ + ++|+.|+|+
T Consensus 103 ~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~ 182 (844)
T 3j0a_A 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182 (844)
T ss_dssp ECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEEC
T ss_pred eCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECC
Confidence 99999999877765 9999999999999999997655 579999999999999999998888877 4 789999999
Q ss_pred CCccccCCCcccccccc------cceeccCCC
Q 004155 154 YNSFTAGSSETSCQYRS------VNLFASSSK 179 (771)
Q Consensus 154 ~N~l~~~~p~~~~~l~~------L~~l~~s~~ 179 (771)
+|.+++..|..+..+.+ |+.|+++.+
T Consensus 183 ~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n 214 (844)
T 3j0a_A 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214 (844)
T ss_dssp CSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSC
T ss_pred CCccccccccchhhcCCccccCceeEEecCCC
Confidence 99999998887776665 888988866
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.9e-19 Score=196.35 Aligned_cols=168 Identities=16% Similarity=0.114 Sum_probs=136.7
Q ss_pred cEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhc-CCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccC
Q 004155 6 KDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIA-SLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRS 84 (771)
Q Consensus 6 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 84 (771)
+.+++++|+|+ .+|..+. +.|+.|+|++|+|++..+..|. ++++|+.|+|++|+++++++..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 57888889888 7887665 4688899999999876677777 888999999999999888888888899999999999
Q ss_pred CcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh------hhcCCeecccCCccc
Q 004155 85 CNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM------LQKGDRVDLSYNSFT 158 (771)
Q Consensus 85 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~------~~~L~~l~ls~N~l~ 158 (771)
|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+ .+|..+ +++|+.|+|++|+|+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 9998666667888899999999999998777888888999999999999998 466543 678888999999998
Q ss_pred cCCCccccccccc--ceeccC
Q 004155 159 AGSSETSCQYRSV--NLFASS 177 (771)
Q Consensus 159 ~~~p~~~~~l~~L--~~l~~s 177 (771)
...+..+..++.+ +.++++
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~ 197 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLH 197 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECC
T ss_pred ccCHHHhhhccHhhcceEEec
Confidence 7666777777664 445443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.5e-19 Score=181.15 Aligned_cols=139 Identities=16% Similarity=0.203 Sum_probs=129.3
Q ss_pred CCCcEEEccCCcccccCCc-cccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 3 VTLKDFRISDNHFTGKIPN-FIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
..++.|+|++|+|++..|. .|.++++|++|+|++|+|++..|..|.++++|+.|+|++|++++.++..|.++++|++|+
T Consensus 32 ~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 111 (220)
T 2v70_A 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLM 111 (220)
T ss_dssp TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEE
T ss_pred CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEE
Confidence 4689999999999966554 588999999999999999988788999999999999999999999988899999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCch
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPP 141 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~ 141 (771)
|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|.+++..+.
T Consensus 112 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 112 LRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp CTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred CCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence 999999988899999999999999999999988899999999999999999999987763
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.79 E-value=4.5e-19 Score=188.89 Aligned_cols=165 Identities=18% Similarity=0.263 Sum_probs=131.0
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
|++|+.|++++|+++ .+| .+..+++|++|+|++|++++ ++. +..+++|+.|+|++|++++. +.+..+++|++|+
T Consensus 40 l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~ 113 (308)
T 1h6u_A 40 LDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLD 113 (308)
T ss_dssp HHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEE
T ss_pred cCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEE
Confidence 457888889888888 666 58888889999999888884 554 88888899999988888875 3688888888899
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCccccC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~~ 160 (771)
|++|++++ +|. +..+++|+.|+|++|++++. +. +..+++|+.|+|++|++++ +|... +++|+.|++++|++++.
T Consensus 114 l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l~~n~l~~~ 188 (308)
T 1h6u_A 114 LTSTQITD-VTP-LAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKISDI 188 (308)
T ss_dssp CTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCCC-chh-hcCCCCCCEEECCCCccCcC-cc-ccCCCCccEEEccCCcCCC-ChhhcCCCCCCEEECCCCccCcC
Confidence 98888884 543 88888888888888888844 43 7888888888888888884 44422 77888888888888865
Q ss_pred CCcccccccccceeccCCC
Q 004155 161 SSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 161 ~p~~~~~l~~L~~l~~s~~ 179 (771)
.+ +..+++|+.|+++.|
T Consensus 189 ~~--l~~l~~L~~L~L~~N 205 (308)
T 1h6u_A 189 SP--LASLPNLIEVHLKNN 205 (308)
T ss_dssp GG--GGGCTTCCEEECTTS
T ss_pred hh--hcCCCCCCEEEccCC
Confidence 54 777888888888755
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.79 E-value=3.5e-19 Score=176.02 Aligned_cols=158 Identities=14% Similarity=0.116 Sum_probs=136.8
Q ss_pred cEEEccCCcccccCCccccCCCcCCEEEcccCCccccCch-hhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccC
Q 004155 6 KDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPS-GIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRS 84 (771)
Q Consensus 6 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 84 (771)
+.|++++|+|+ .+|..+.. +|++|+|++|+|++..+. .|+.+++|+.|+|++|++++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 68999999998 99987764 999999999999966664 489999999999999999999999999999999999999
Q ss_pred CcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCccccCCCc
Q 004155 85 CNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTAGSSE 163 (771)
Q Consensus 85 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~~~p~ 163 (771)
|+|++..|..|..+++|++|+|++|+|++.+|..|..+++|++|+|++|.+++..+... ...++...+..+...+..|.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~ 167 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence 99998888889999999999999999999999999999999999999999998877433 33344445566666666665
Q ss_pred ccc
Q 004155 164 TSC 166 (771)
Q Consensus 164 ~~~ 166 (771)
.+.
T Consensus 168 ~l~ 170 (192)
T 1w8a_A 168 KVR 170 (192)
T ss_dssp TTT
T ss_pred HHc
Confidence 543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=5.8e-19 Score=178.42 Aligned_cols=138 Identities=18% Similarity=0.230 Sum_probs=128.3
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+++.+++..|.++++|++|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 57999999999999666668999999999999999999888999999999999999999999998888999999999999
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCc
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIP 140 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP 140 (771)
++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+...-+
T Consensus 112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 9999998888999999999999999999997777789999999999999999985443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.5e-18 Score=173.69 Aligned_cols=154 Identities=18% Similarity=0.143 Sum_probs=135.6
Q ss_pred cEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCC
Q 004155 6 KDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSC 85 (771)
Q Consensus 6 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 85 (771)
+.++.++++++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|++++.++..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCCC--CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 57889999999 8887664 69999999999999766777899999999999999999988888999999999999999
Q ss_pred cCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccccCCC
Q 004155 86 NVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAGSS 162 (771)
Q Consensus 86 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~~~p 162 (771)
+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+..+ +++|+.|+|++|++.+..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 165 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 165 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC
Confidence 9996666668999999999999999997767678999999999999999995444434 7899999999999986544
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.8e-19 Score=176.53 Aligned_cols=151 Identities=15% Similarity=0.175 Sum_probs=118.0
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|+|++|+|+ .+| .+..+++|++|+|++|.++ . +..+..+++|++|+|++|++++..+..+..+++|++|+
T Consensus 43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 457888888888888 777 5888888888888888765 3 34788888888888888888876677888888888888
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCC-CCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCcccc
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNK-LNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~ 159 (771)
|++|++++..|..++.+++|+.|+|++|. ++ .+| .+..+++|+.|+|++|++++ ++... +++|+.|++++|++.+
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CTTGGGCSSCCEEEECBC----
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hHHhccCCCCCEEEeeCcccCC
Confidence 88888887778888888888888888887 54 666 58888888888888888884 54222 7788888888888753
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.7e-19 Score=182.16 Aligned_cols=171 Identities=16% Similarity=0.116 Sum_probs=143.6
Q ss_pred CCCCcEEEccCCc-ccccCCccccCCCcCCEEEccc-CCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCc-
Q 004155 2 LVTLKDFRISDNH-FTGKIPNFIQNWTLLEKLVIQA-SGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMK- 78 (771)
Q Consensus 2 L~~L~~L~Ls~N~-l~~~ip~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~- 78 (771)
+++|+.|+|++|+ +++..+..|.++++|++|+|++ |+|++..+..|.++++|+.|+|++|++++.+ . |..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~lp-~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFP-D-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCSCC-C-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcccc-c-ccccccccc
Confidence 6889999999997 8844455899999999999999 9999766788999999999999999999854 3 88888888
Q ss_pred --EEEccCC-cCcccCChhhhcCCCCc-EEEccCCCCCCCCCccccCCCCCcEEEcCCCc-ccccCchhh--h-hcCCee
Q 004155 79 --TLILRSC-NVSGKLPDYLGLMTSLK-VLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNL-LTGTIPPWM--L-QKGDRV 150 (771)
Q Consensus 79 --~L~Ls~N-~l~g~~p~~~~~l~~L~-~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~-l~g~iP~~~--~-~~L~~l 150 (771)
+|+|++| ++++..+..|..+++|+ .|+|++|+++ .+|......++|+.|+|++|+ +++..+..+ + ++|+.|
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L 210 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEE
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEE
Confidence 9999999 99966666799999999 9999999999 777665455899999999995 994434445 5 899999
Q ss_pred cccCCccccCCCcccccccccceeccCC
Q 004155 151 DLSYNSFTAGSSETSCQYRSVNLFASSS 178 (771)
Q Consensus 151 ~ls~N~l~~~~p~~~~~l~~L~~l~~s~ 178 (771)
++++|++++..+. .+++|+.|.++.
T Consensus 211 ~l~~N~l~~l~~~---~~~~L~~L~l~~ 235 (239)
T 2xwt_C 211 DVSQTSVTALPSK---GLEHLKELIARN 235 (239)
T ss_dssp ECTTCCCCCCCCT---TCTTCSEEECTT
T ss_pred ECCCCccccCChh---HhccCceeeccC
Confidence 9999999975555 456666666553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=6e-19 Score=204.09 Aligned_cols=177 Identities=16% Similarity=0.159 Sum_probs=156.2
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
++|+.|+|++|+|++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|+++..++..|.++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 57899999999999777778999999999999999999877888999999999999999999998889999999999999
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCC-CCCccccCCCCCcEEEcCCCcccccCchhh--hhcC----CeecccCC
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNG-AIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKG----DRVDLSYN 155 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L----~~l~ls~N 155 (771)
++|++++..+..++++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..|..+ +.+| ..|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 9999995444479999999999999999986 479999999999999999999997666666 7777 78999999
Q ss_pred ccccCCCcccccccccceeccCCCC
Q 004155 156 SFTAGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
.+++..|..+..+ +|+.++++.+.
T Consensus 188 ~l~~~~~~~~~~~-~L~~L~l~~n~ 211 (570)
T 2z63_A 188 PMNFIQPGAFKEI-RLHKLTLRNNF 211 (570)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCC
T ss_pred CceecCHHHhccC-cceeEeccccc
Confidence 9999888877766 78888887653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=6.7e-19 Score=191.94 Aligned_cols=157 Identities=16% Similarity=0.139 Sum_probs=137.2
Q ss_pred CCCCcEEEccCCcccccCCcccc-CCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQ-NWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 80 (771)
...|+.|+|++|+|++..+..+. ++++|+.|+|++|+|++..|..|.++++|+.|+|++|+++..++..|.++++|++|
T Consensus 38 ~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 117 (361)
T 2xot_A 38 PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVL 117 (361)
T ss_dssp CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEE
Confidence 35689999999999966666677 89999999999999998778889999999999999999999988899999999999
Q ss_pred EccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCcc-c---cCCCCCcEEEcCCCcccccCchhh---hhc--CCeec
Q 004155 81 ILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPST-F---MGLLDVDYIYLTGNLLTGTIPPWM---LQK--GDRVD 151 (771)
Q Consensus 81 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~-~---~~l~~L~~L~Ls~N~l~g~iP~~~---~~~--L~~l~ 151 (771)
+|++|+|++..|..|..+++|+.|+|++|+|+ .+|.. | ..+++|+.|+|++|+|+ .+|... ++. ++.|+
T Consensus 118 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~~~l~~l~ 195 (361)
T 2xot_A 118 LLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLY 195 (361)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCCEEECCSSCCC-CCCHHHHHHSCHHHHTTEE
T ss_pred ECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCCEEECCCCCCC-ccCHHHhhhccHhhcceEE
Confidence 99999999888899999999999999999999 46655 4 67999999999999999 566443 333 47899
Q ss_pred ccCCccccC
Q 004155 152 LSYNSFTAG 160 (771)
Q Consensus 152 ls~N~l~~~ 160 (771)
|++|++.+.
T Consensus 196 l~~N~~~C~ 204 (361)
T 2xot_A 196 LHNNPLECD 204 (361)
T ss_dssp CCSSCEECC
T ss_pred ecCCCccCC
Confidence 999999863
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.1e-19 Score=208.02 Aligned_cols=176 Identities=16% Similarity=0.171 Sum_probs=113.3
Q ss_pred CCCCcEEEccCCcccccC--CccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCC-CCccCCCCCc
Q 004155 2 LVTLKDFRISDNHFTGKI--PNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPF-PPLDKMKKMK 78 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~i--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~ 78 (771)
+++|+.|+|++|++++.. |..+.++++|++|+|++|.+++ +|..+..+++|+.|+|++|++.+.++ ..+.++++|+
T Consensus 346 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 424 (570)
T 2z63_A 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424 (570)
T ss_dssp CTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCC
T ss_pred CCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccc-ccccccccCCCCEEEccCCccccccchhhhhcCCCCC
Confidence 455666666666666332 4556666666666666666663 33336666666666666666666544 3466666777
Q ss_pred EEEccCCcCcccCChhhhcCCCCcEEEccCCCCC-CCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCC
Q 004155 79 TLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLN-GAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYN 155 (771)
Q Consensus 79 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~-g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N 155 (771)
+|+|++|++.+..|..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+|++|++++..|..+ +++|+.|++++|
T Consensus 425 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 504 (570)
T 2z63_A 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504 (570)
T ss_dssp EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCC
Confidence 7777777766666666666677777777777665 4566666666777777777777765556555 566677777777
Q ss_pred ccccCCCcccccccccceeccCC
Q 004155 156 SFTAGSSETSCQYRSVNLFASSS 178 (771)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~l~~s~ 178 (771)
++++.+|..+..+++|+.++++.
T Consensus 505 ~l~~~~~~~~~~l~~L~~L~l~~ 527 (570)
T 2z63_A 505 QLKSVPDGIFDRLTSLQKIWLHT 527 (570)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCS
T ss_pred cCCCCCHHHhhcccCCcEEEecC
Confidence 77666666666666666666653
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=5.1e-19 Score=204.66 Aligned_cols=172 Identities=21% Similarity=0.219 Sum_probs=83.3
Q ss_pred CCCcEEEccCCcccccCCccc-----cCCCc--------------------------CCEEEcccCCccccCchhhcCCc
Q 004155 3 VTLKDFRISDNHFTGKIPNFI-----QNWTL--------------------------LEKLVIQASGLVGPIPSGIASLS 51 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~-----~~l~~--------------------------L~~L~L~~N~l~~~~p~~~~~l~ 51 (771)
++|++|++++|+++|.+|..+ .+++. |+.|++++|++.. ++ ....++
T Consensus 276 ~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~-~~-~~~~l~ 353 (562)
T 3a79_B 276 RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIH-MV-CPPSPS 353 (562)
T ss_dssp SSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCC-CC-CCSSCC
T ss_pred ccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccc-cc-CccCCC
Confidence 478888899998888888766 22222 2222222222221 00 003444
Q ss_pred CCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcc--cCChhhhcCCCCcEEEccCCCCCCCCCcc-ccCCCCCcEE
Q 004155 52 KLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSG--KLPDYLGLMTSLKVLDVSFNKLNGAIPST-FMGLLDVDYI 128 (771)
Q Consensus 52 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~-~~~l~~L~~L 128 (771)
+|++|+|++|++++..|..+.++++|++|+|++|++++ .+|..+.++++|+.|+|++|++++.+|.. +..+++|+.|
T Consensus 354 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L 433 (562)
T 3a79_B 354 SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL 433 (562)
T ss_dssp CCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEE
T ss_pred CceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEE
Confidence 55555555555555444445555555555555555542 12233445555555555555555433332 4444555555
Q ss_pred EcCCCcccccCchhhhhcCCeecccCCccccCCCcccccccccceeccC
Q 004155 129 YLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASS 177 (771)
Q Consensus 129 ~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s 177 (771)
+|++|++++.+|..+.++|+.|+|++|+++ .+|..+..+++|+.|+++
T Consensus 434 ~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~ 481 (562)
T 3a79_B 434 NLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVA 481 (562)
T ss_dssp ECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECC
T ss_pred ECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECC
Confidence 555555544444333344555555555554 233333344455555444
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.5e-18 Score=176.53 Aligned_cols=138 Identities=22% Similarity=0.242 Sum_probs=127.9
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
.++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++++.++..|..+++|++|+
T Consensus 39 ~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 118 (229)
T 3e6j_A 39 PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELF 118 (229)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEe
Confidence 46899999999999988888999999999999999999855566789999999999999999999888899999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCc
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIP 140 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP 140 (771)
|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.+..+
T Consensus 119 Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 119 MCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp CCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred ccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 9999999 899999999999999999999996666779999999999999999997665
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.2e-19 Score=203.70 Aligned_cols=172 Identities=11% Similarity=0.073 Sum_probs=142.3
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCch----------------hhcCCcCCCEEEcCCCCCCC
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPS----------------GIASLSKLTDLRISDLNGTE 65 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~----------------~~~~l~~L~~L~L~~n~l~~ 65 (771)
|++|+.|+|++|.|++..| ++.+++|++|+|++|.|++..+. ....+++|+.|+|++|++++
T Consensus 57 l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~ 134 (487)
T 3oja_A 57 FTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITM 134 (487)
T ss_dssp CTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCS
T ss_pred CCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCC
Confidence 6788888888888886554 77888888888877777632211 01236788999999999999
Q ss_pred CCCCCccCCCCCcEEEccCCcCcccCChhhh-cCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-
Q 004155 66 APFPPLDKMKKMKTLILRSCNVSGKLPDYLG-LMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM- 143 (771)
Q Consensus 66 ~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~- 143 (771)
.+|..|+++++|+.|+|++|+|++..|..+. .+++|+.|+|++|.|++. |. +..+++|+.|+|++|+|++ +|+.+
T Consensus 135 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~ 211 (487)
T 3oja_A 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQ 211 (487)
T ss_dssp GGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGG
T ss_pred CCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCC-CCHhHc
Confidence 8888999999999999999999998898886 799999999999999965 33 4569999999999999996 44445
Q ss_pred -hhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 144 -LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 144 -~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
+++|+.|+|++|.+++ +|..+..+++|+.++++.|
T Consensus 212 ~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N 247 (487)
T 3oja_A 212 SAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGN 247 (487)
T ss_dssp GGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTC
T ss_pred CCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCC
Confidence 8899999999999996 6777888999999988644
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.5e-19 Score=206.76 Aligned_cols=162 Identities=17% Similarity=0.182 Sum_probs=104.0
Q ss_pred CCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEcc
Q 004155 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILR 83 (771)
Q Consensus 4 ~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 83 (771)
++++|||++|+|++..|..|.++++|++|+|++|+|++..|.+|.+|++|++|+|++|++++.++..|.++++|++|+|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 56677777777764444566777777777777777765555666777777777777777766666666777777777777
Q ss_pred CCcCcccCChhhhcCCCCcEEEccCCCCCC-CCCccccCCCCCcEEEcCCCcccccCchhh--hhcC----CeecccCCc
Q 004155 84 SCNVSGKLPDYLGLMTSLKVLDVSFNKLNG-AIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKG----DRVDLSYNS 156 (771)
Q Consensus 84 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L----~~l~ls~N~ 156 (771)
+|+|++..+..|+++++|++|+|++|.+++ .+|..++.+++|++|+|++|+|++..|..+ +.++ ..++++.|.
T Consensus 133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~ 212 (635)
T 4g8a_A 133 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 212 (635)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred CCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCc
Confidence 777764444456677777777777777653 345666667777777777777765555444 3332 346666666
Q ss_pred cccCCCccc
Q 004155 157 FTAGSSETS 165 (771)
Q Consensus 157 l~~~~p~~~ 165 (771)
++...+..+
T Consensus 213 l~~i~~~~~ 221 (635)
T 4g8a_A 213 MNFIQPGAF 221 (635)
T ss_dssp CCEECTTTT
T ss_pred ccccCcccc
Confidence 665544433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=6.2e-19 Score=201.83 Aligned_cols=174 Identities=20% Similarity=0.209 Sum_probs=148.6
Q ss_pred CCCcEEEccCCcccccCCccc-----cCCCcCCEEEcccCCccccCc-hhh-------------------------cCCc
Q 004155 3 VTLKDFRISDNHFTGKIPNFI-----QNWTLLEKLVIQASGLVGPIP-SGI-------------------------ASLS 51 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~-------------------------~~l~ 51 (771)
++|+.|+|++|+++|.+|..+ +++++|+.|++++|.+ .+| ..+ ..++
T Consensus 247 ~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~ 324 (520)
T 2z7x_B 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324 (520)
T ss_dssp SSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCC
T ss_pred CcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCC
Confidence 489999999999999999988 8888888888888887 455 221 6788
Q ss_pred CCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcc--cCChhhhcCCCCcEEEccCCCCCCCCCcc-ccCCCCCcEE
Q 004155 52 KLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSG--KLPDYLGLMTSLKVLDVSFNKLNGAIPST-FMGLLDVDYI 128 (771)
Q Consensus 52 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~-~~~l~~L~~L 128 (771)
+|++|+|++|++++..|..+.++++|++|+|++|++++ .+|..+..+++|++|+|++|++++.+|.. +..+++|+.|
T Consensus 325 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L 404 (520)
T 2z7x_B 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL 404 (520)
T ss_dssp CCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEE
T ss_pred cccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEE
Confidence 99999999999999888889999999999999999986 56678899999999999999999767765 7888999999
Q ss_pred EcCCCcccccCchhhhhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 129 YLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 129 ~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
+|++|++++.+|..+.++|+.|+|++|+++ .+|..+..+++|+.|+++.|
T Consensus 405 ~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N 454 (520)
T 2z7x_B 405 NMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASN 454 (520)
T ss_dssp ECCSSCCCGGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSS
T ss_pred ECcCCCCCcchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCC
Confidence 999999988888776678999999999998 67777778999999988765
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-19 Score=194.08 Aligned_cols=174 Identities=16% Similarity=0.146 Sum_probs=110.2
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCC------------
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFP------------ 69 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~------------ 69 (771)
+++|++|+|++|+|++..|..|.++++|++|+|++|++++..| |..+++|++|+|++|++++.++.
T Consensus 33 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~ 110 (317)
T 3o53_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNN 110 (317)
T ss_dssp GGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSC
T ss_pred CCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCCCCcCEEECCCCc
Confidence 4589999999999997666789999999999999999986555 88899999999999888764321
Q ss_pred ----CccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCcccc-CCCCCcEEEcCCCcccccCchhh-
Q 004155 70 ----PLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFM-GLLDVDYIYLTGNLLTGTIPPWM- 143 (771)
Q Consensus 70 ----~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~l~~L~~L~Ls~N~l~g~iP~~~- 143 (771)
....+++|++|+|++|++++..|..++.+++|++|+|++|.+++..|..+. .+++|++|+|++|++++ +|...
T Consensus 111 l~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~ 189 (317)
T 3o53_A 111 ISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV 189 (317)
T ss_dssp CSEEEECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EECCCC
T ss_pred cCCcCccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-cccccc
Confidence 011234455555555555544444555555555666666555544444442 45555666666665553 23222
Q ss_pred hhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 144 LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 144 ~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
+++|+.|+|++|++++..+ .+..+++|+.|+++.|
T Consensus 190 l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N 224 (317)
T 3o53_A 190 FAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNN 224 (317)
T ss_dssp CTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTS
T ss_pred cccCCEEECCCCcCCcchh-hhcccCcccEEECcCC
Confidence 5555666666666554332 3555555555555543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.1e-19 Score=209.62 Aligned_cols=169 Identities=14% Similarity=0.128 Sum_probs=95.3
Q ss_pred EEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcC
Q 004155 8 FRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNV 87 (771)
Q Consensus 8 L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 87 (771)
.++++|+++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++.++..|.++++|++|+|++|++
T Consensus 10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 86 (549)
T 2z81_A 10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86 (549)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence 455555555 5555443 4566666666666555555566666666666666666655555556666666666666666
Q ss_pred cccCChhhhcCCCCcEEEccCCCCCC-CCCccccCCCCCcEEEcCCCcccccCch-hh--hhcCCeecccCCccccCCCc
Q 004155 88 SGKLPDYLGLMTSLKVLDVSFNKLNG-AIPSTFMGLLDVDYIYLTGNLLTGTIPP-WM--LQKGDRVDLSYNSFTAGSSE 163 (771)
Q Consensus 88 ~g~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~Ls~N~l~g~iP~-~~--~~~L~~l~ls~N~l~~~~p~ 163 (771)
++..|..|+++++|++|+|++|++++ .+|..++++++|++|+|++|++.+.+|. .+ +++|+.|++++|.+++..|.
T Consensus 87 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 166 (549)
T 2z81_A 87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ 166 (549)
T ss_dssp CSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred CccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChh
Confidence 54444445566666666666666553 2344555566666666666654334442 22 45555566666666655555
Q ss_pred ccccccccceeccCCC
Q 004155 164 TSCQYRSVNLFASSSK 179 (771)
Q Consensus 164 ~~~~l~~L~~l~~s~~ 179 (771)
.+..+++|+.|+++.+
T Consensus 167 ~l~~l~~L~~L~l~~n 182 (549)
T 2z81_A 167 SLKSIRDIHHLTLHLS 182 (549)
T ss_dssp TTTTCSEEEEEEEECS
T ss_pred hhhccccCceEecccC
Confidence 5555555555555443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.5e-18 Score=184.78 Aligned_cols=166 Identities=18% Similarity=0.287 Sum_probs=144.7
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|+|++|+++ .++. +..+++|++|+|++|++++ +| .+..+++|+.|+|++|++++.+ .+..+++|++|+
T Consensus 62 l~~L~~L~L~~n~i~-~~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~ 135 (308)
T 1h6u_A 62 LNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLY 135 (308)
T ss_dssp CTTCCEEECCSSCCC-CCGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCC-CChh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCCch--hhcCCCCCCEEE
Confidence 689999999999999 5666 9999999999999999985 55 6999999999999999999864 389999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhcCCeecccCCccccCC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGS 161 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~ 161 (771)
|++|++++ ++. +..+++|+.|+|++|++++ ++. +..+++|+.|+|++|++++..|-.-+++|+.|+|++|++++..
T Consensus 136 l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~ 211 (308)
T 1h6u_A 136 LDLNQITN-ISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVS 211 (308)
T ss_dssp CCSSCCCC-CGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCG
T ss_pred CCCCccCc-Ccc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCccc
Confidence 99999994 444 8999999999999999995 554 9999999999999999995433222889999999999999766
Q ss_pred CcccccccccceeccCCC
Q 004155 162 SETSCQYRSVNLFASSSK 179 (771)
Q Consensus 162 p~~~~~l~~L~~l~~s~~ 179 (771)
| +..+++|+.|+++.|
T Consensus 212 ~--l~~l~~L~~L~l~~N 227 (308)
T 1h6u_A 212 P--LANTSNLFIVTLTNQ 227 (308)
T ss_dssp G--GTTCTTCCEEEEEEE
T ss_pred c--ccCCCCCCEEEccCC
Confidence 4 788999999988644
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.5e-18 Score=183.20 Aligned_cols=166 Identities=20% Similarity=0.274 Sum_probs=143.7
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
|++|+.|++++|.++ .+|. +..+++|++|+|++|++++ ++. +..+++|+.|+|++|++++. +.+..+++|++|+
T Consensus 45 l~~L~~L~l~~~~i~-~~~~-~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 118 (291)
T 1h6t_A 45 LNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLS 118 (291)
T ss_dssp HHTCCEEECTTSCCC-CCTT-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCG--GGGTTCTTCCEEE
T ss_pred cCcccEEEccCCCcc-cChh-HhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCCC--hhhccCCCCCEEE
Confidence 467999999999998 6665 8999999999999999995 444 99999999999999999885 3599999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhcCCeecccCCccccCC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGS 161 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~ 161 (771)
|++|++++ + ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++..|-.-+++|+.|+|++|.++..
T Consensus 119 L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~l- 193 (291)
T 1h6t_A 119 LEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL- 193 (291)
T ss_dssp CTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBC-
T ss_pred CCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCCC-
Confidence 99999995 4 5789999999999999999954 57999999999999999999654522288999999999999974
Q ss_pred CcccccccccceeccCCC
Q 004155 162 SETSCQYRSVNLFASSSK 179 (771)
Q Consensus 162 p~~~~~l~~L~~l~~s~~ 179 (771)
| .+..+++|+.|+++.|
T Consensus 194 ~-~l~~l~~L~~L~l~~n 210 (291)
T 1h6t_A 194 R-ALAGLKNLDVLELFSQ 210 (291)
T ss_dssp G-GGTTCTTCSEEEEEEE
T ss_pred h-hhccCCCCCEEECcCC
Confidence 4 3888999999988754
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.2e-18 Score=203.92 Aligned_cols=177 Identities=16% Similarity=0.201 Sum_probs=125.1
Q ss_pred CCCCcEEEccCCcccccCC-ccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCC--CCCCCCccCCCCCc
Q 004155 2 LVTLKDFRISDNHFTGKIP-NFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGT--EAPFPPLDKMKKMK 78 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~ 78 (771)
+++|+.|+|++|++++.+| ..|.++++|++|+|++|++++..+..|..+++|+.|++++|.+. +..|..|.++++|+
T Consensus 404 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~ 483 (680)
T 1ziw_A 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483 (680)
T ss_dssp CTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCC
T ss_pred CCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCC
Confidence 5788899999999887777 57888888888888888887766777777777777777777665 34556677777777
Q ss_pred EEEccCCcCcccCChhhhcCCCCcEEEccCCCCCCCC----C----ccccCCCCCcEEEcCCCcccccCchh-h--hhcC
Q 004155 79 TLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAI----P----STFMGLLDVDYIYLTGNLLTGTIPPW-M--LQKG 147 (771)
Q Consensus 79 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i----p----~~~~~l~~L~~L~Ls~N~l~g~iP~~-~--~~~L 147 (771)
.|+|++|+|++..|..|..+++|++|+|++|++++.. | ..|..+++|+.|+|++|+|+ .+|.. + +++|
T Consensus 484 ~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L 562 (680)
T 1ziw_A 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKDLFEL 562 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTC
T ss_pred EEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHcccccCc
Confidence 7777777777555556777777777777777776321 1 12566777777777777777 55543 3 5667
Q ss_pred CeecccCCccccCCCcccccccccceeccCCC
Q 004155 148 DRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 148 ~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
+.|+|++|++++..+..+..+++|+.|+++.|
T Consensus 563 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N 594 (680)
T 1ziw_A 563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594 (680)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred ceeECCCCCCCcCCHhHhCCCCCCCEEECCCC
Confidence 77777777777666666667777777776654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.2e-19 Score=184.93 Aligned_cols=136 Identities=18% Similarity=0.142 Sum_probs=106.9
Q ss_pred CCCCCccccCCceeEEEEEc-CCCcE--EEEEEcccCChh------------------------cHHHHHHHHHHHHcCC
Q 004155 423 FAPDNKIGEGGFGPVYKGHM-ADGTV--VAVKQLSSKSKQ------------------------GNREFVNEIGMISALQ 475 (771)
Q Consensus 423 f~~~~~lG~G~~g~Vy~~~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 475 (771)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999976 68899 999987543111 1236889999999998
Q ss_pred CCcE--EeEEEEEEeCCEEEEEEEeccC-C----CHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhh-hcCCCceec
Q 004155 476 HPNL--VKLHGCCIEGNQLLLIYEYMEN-N----SLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH-EESRLKIVH 547 (771)
Q Consensus 476 h~ni--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH-~~~~~~ivH 547 (771)
|+++ +.++++ +..++||||+.+ | +|.++.. ..++..+..++.|++.||.||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 7753 344432 246899999942 4 7777652 1245678899999999999999 77 8999
Q ss_pred cCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 548 RDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 548 ~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=186.82 Aligned_cols=172 Identities=11% Similarity=0.078 Sum_probs=139.2
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCch----------------hhcCCcCCCEEEcCCCCCCC
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPS----------------GIASLSKLTDLRISDLNGTE 65 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~----------------~~~~l~~L~~L~L~~n~l~~ 65 (771)
+++|+.|+|++|++++..| +..+++|++|+|++|+|++..+. ....+++|+.|+|++|++++
T Consensus 57 l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~N~l~~ 134 (317)
T 3o53_A 57 FTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITM 134 (317)
T ss_dssp CTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEECCCSSCEEEECCSSCCCS
T ss_pred CCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCccccCCCCEEECCCCCCCC
Confidence 5678888888888875443 77778888888887777632110 01235778899999999999
Q ss_pred CCCCCccCCCCCcEEEccCCcCcccCChhhh-cCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-
Q 004155 66 APFPPLDKMKKMKTLILRSCNVSGKLPDYLG-LMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM- 143 (771)
Q Consensus 66 ~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~- 143 (771)
..+..+..+++|++|+|++|++++..|..+. .+++|++|+|++|.+++ +|. ...+++|+.|+|++|++++ +|..+
T Consensus 135 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~ 211 (317)
T 3o53_A 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLAF-MGPEFQ 211 (317)
T ss_dssp GGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEEECCSSCCCE-ECGGGG
T ss_pred ccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccc-ccccccCCEEECCCCcCCc-chhhhc
Confidence 8888899999999999999999977777764 79999999999999994 443 4458999999999999995 55556
Q ss_pred -hhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 144 -LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 144 -~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
+++|+.|+|++|+++. +|..+..+++|+.++++.|
T Consensus 212 ~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N 247 (317)
T 3o53_A 212 SAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGN 247 (317)
T ss_dssp GGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTC
T ss_pred ccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCC
Confidence 8899999999999995 6778899999999998754
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.1e-18 Score=209.00 Aligned_cols=118 Identities=19% Similarity=0.180 Sum_probs=72.1
Q ss_pred CCCCcEEEccCCcccccC-CccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCC--ccCCCCCc
Q 004155 2 LVTLKDFRISDNHFTGKI-PNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPP--LDKMKKMK 78 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~i-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~--~~~l~~L~ 78 (771)
|++|++|+|++|.+.+.+ |..|.++++|++|+|++|.|++..|..|++|++|++|+|++|.+++..+.. |.++++|+
T Consensus 47 l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~ 126 (844)
T 3j0a_A 47 LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126 (844)
T ss_dssp CCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCC
T ss_pred cccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCC
Confidence 456666666666555455 455666666666666666666656666666666666666666666543332 66666666
Q ss_pred EEEccCCcCcccCC-hhhhcCCCCcEEEccCCCCCCCCCccc
Q 004155 79 TLILRSCNVSGKLP-DYLGLMTSLKVLDVSFNKLNGAIPSTF 119 (771)
Q Consensus 79 ~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~ip~~~ 119 (771)
+|+|++|.+++..| ..|+++++|++|+|++|.+++..|..+
T Consensus 127 ~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l 168 (844)
T 3j0a_A 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHEL 168 (844)
T ss_dssp EEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGG
T ss_pred EEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHc
Confidence 66666666664433 356666666666666666655544443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=2.8e-18 Score=200.75 Aligned_cols=164 Identities=17% Similarity=0.158 Sum_probs=145.5
Q ss_pred EEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCc
Q 004155 7 DFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCN 86 (771)
Q Consensus 7 ~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 86 (771)
+.+-++.+|+ .+|..+. +++++|+|++|+|++..|.+|.+|++|++|+|++|+++++++..|.+|++|++|+|++|+
T Consensus 35 ~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~ 111 (635)
T 4g8a_A 35 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 111 (635)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCc
Confidence 4556677888 8998775 589999999999997777899999999999999999999999999999999999999999
Q ss_pred CcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccc-cCchhh--hhcCCeecccCCccccCCCc
Q 004155 87 VSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTG-TIPPWM--LQKGDRVDLSYNSFTAGSSE 163 (771)
Q Consensus 87 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g-~iP~~~--~~~L~~l~ls~N~l~~~~p~ 163 (771)
|++..+..|.++++|++|+|++|+|++..+..|+++++|++|+|++|++++ .+|..+ ++.|+.|+|++|++++..|.
T Consensus 112 l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 191 (635)
T 4g8a_A 112 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 191 (635)
T ss_dssp CCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred CCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccc
Confidence 996556779999999999999999997666779999999999999999985 356666 78999999999999999998
Q ss_pred ccccccccce
Q 004155 164 TSCQYRSVNL 173 (771)
Q Consensus 164 ~~~~l~~L~~ 173 (771)
.+..+.++..
T Consensus 192 ~l~~L~~l~~ 201 (635)
T 4g8a_A 192 DLRVLHQMPL 201 (635)
T ss_dssp GGHHHHTCTT
T ss_pred cccchhhhhh
Confidence 8887776653
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.7e-18 Score=196.54 Aligned_cols=172 Identities=16% Similarity=0.140 Sum_probs=148.5
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCC--CCCCccCCCCCcEE
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEA--PFPPLDKMKKMKTL 80 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~--~~~~~~~l~~L~~L 80 (771)
.+|+.|++++|++. .++- +..+++|++|+|++|++++.+|..++.+++|+.|+|++|++++. .|..+.++++|++|
T Consensus 302 ~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L 379 (520)
T 2z7x_B 302 MNIKNFTVSGTRMV-HMLC-PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQL 379 (520)
T ss_dssp CCCSEEEEESSCCC-CCCC-CSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEE
T ss_pred CceeEEEcCCCccc-cccc-hhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEE
Confidence 46999999999988 3331 26789999999999999988999999999999999999999973 34568899999999
Q ss_pred EccCCcCcccCChh-hhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCcc
Q 004155 81 ILRSCNVSGKLPDY-LGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSF 157 (771)
Q Consensus 81 ~Ls~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l 157 (771)
+|++|++++.+|.. +..+++|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+ +++|+.|+|++|++
T Consensus 380 ~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l 456 (520)
T 2z7x_B 380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456 (520)
T ss_dssp ECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCC
T ss_pred ECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcC
Confidence 99999999768765 88899999999999999988887765 79999999999999 888876 88999999999999
Q ss_pred ccCCCcccccccccceeccCCC
Q 004155 158 TAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 158 ~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
+...+..+..+++|+.++++.|
T Consensus 457 ~~l~~~~~~~l~~L~~L~l~~N 478 (520)
T 2z7x_B 457 KSVPDGIFDRLTSLQKIWLHTN 478 (520)
T ss_dssp CCCCTTTTTTCTTCCEEECCSS
T ss_pred CccCHHHhccCCcccEEECcCC
Confidence 9644445888999999988744
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.8e-18 Score=199.37 Aligned_cols=179 Identities=15% Similarity=0.099 Sum_probs=159.9
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
.++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++.++..|+++++|++|+
T Consensus 25 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 104 (549)
T 2z81_A 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104 (549)
T ss_dssp CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEE
T ss_pred CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEE
Confidence 35899999999999987788999999999999999999988889999999999999999999999887899999999999
Q ss_pred ccCCcCcc-cCChhhhcCCCCcEEEccCCCCCCCCC-ccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCcc
Q 004155 82 LRSCNVSG-KLPDYLGLMTSLKVLDVSFNKLNGAIP-STFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSF 157 (771)
Q Consensus 82 Ls~N~l~g-~~p~~~~~l~~L~~L~Ls~N~l~g~ip-~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l 157 (771)
|++|++++ .+|..++++++|++|+|++|++.+.+| ..|..+++|++|+|++|++++.+|..+ +++|+.|++++|.+
T Consensus 105 Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~ 184 (549)
T 2z81_A 105 LMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184 (549)
T ss_dssp CTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBS
T ss_pred CCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcc
Confidence 99999986 467889999999999999999666776 579999999999999999999899887 78899999999998
Q ss_pred ccCCCcccccccccceeccCCCC
Q 004155 158 TAGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 158 ~~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
.......+..+++|+.|+++.+.
T Consensus 185 ~~~~~~~~~~l~~L~~L~L~~n~ 207 (549)
T 2z81_A 185 AFLLEIFADILSSVRYLELRDTN 207 (549)
T ss_dssp TTHHHHHHHSTTTBSEEEEESCB
T ss_pred cccchhhHhhcccccEEEccCCc
Confidence 75433334568899999987653
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.2e-18 Score=197.94 Aligned_cols=172 Identities=17% Similarity=0.163 Sum_probs=145.2
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCC--CCCccCCCCCcEE
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAP--FPPLDKMKKMKTL 80 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L 80 (771)
.+|+.|++++|.+. .++- ...+++|++|+|++|++++.+|..++++++|+.|+|++|++++.+ |..+.++++|++|
T Consensus 331 ~~L~~L~l~~n~~~-~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L 408 (562)
T 3a79_B 331 MNIKMLSISDTPFI-HMVC-PPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETL 408 (562)
T ss_dssp CCCSEEEEESSCCC-CCCC-CSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEE
T ss_pred CcceEEEccCCCcc-cccC-ccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEE
Confidence 46899999999987 3321 267899999999999999889999999999999999999999865 3568899999999
Q ss_pred EccCCcCcccCCh-hhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCcc
Q 004155 81 ILRSCNVSGKLPD-YLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSF 157 (771)
Q Consensus 81 ~Ls~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l 157 (771)
+|++|++++.+|. .+..+++|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+ +++|+.|+|++|++
T Consensus 409 ~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l 485 (562)
T 3a79_B 409 DVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485 (562)
T ss_dssp ECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCC
T ss_pred ECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCC
Confidence 9999999976776 478899999999999999988777654 68999999999999 788766 78899999999999
Q ss_pred ccCCCcccccccccceeccCCC
Q 004155 158 TAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 158 ~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
+...+..+..+++|+.++++.|
T Consensus 486 ~~l~~~~~~~l~~L~~L~l~~N 507 (562)
T 3a79_B 486 KSVPDGVFDRLTSLQYIWLHDN 507 (562)
T ss_dssp CCCCTTSTTTCTTCCCEECCSC
T ss_pred CCCCHHHHhcCCCCCEEEecCC
Confidence 9644444888999999888744
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.75 E-value=4.8e-18 Score=196.79 Aligned_cols=166 Identities=20% Similarity=0.256 Sum_probs=144.5
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
|++|+.|+|++|.|+ .+| .+..+++|+.|+|++|+|++..| +..|++|+.|+|++|++.+. +.+..|++|+.|+
T Consensus 42 L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~ 115 (605)
T 1m9s_A 42 LNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLS 115 (605)
T ss_dssp HTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC--TTSTTCTTCCEEE
T ss_pred CCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC--hhhccCCCCCEEE
Confidence 578999999999998 676 48999999999999999995444 89999999999999999885 3789999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhcCCeecccCCccccCC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGS 161 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~ 161 (771)
|++|+|++ + +.+..|++|+.|+|++|+|++. ..++.|++|+.|+|++|+|++..|-.-+++|+.|+|++|+|++.
T Consensus 116 Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~l- 190 (605)
T 1m9s_A 116 LEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL- 190 (605)
T ss_dssp CTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBC-
T ss_pred ecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCCC-
Confidence 99999994 4 4689999999999999999954 57999999999999999999766622289999999999999975
Q ss_pred CcccccccccceeccCCC
Q 004155 162 SETSCQYRSVNLFASSSK 179 (771)
Q Consensus 162 p~~~~~l~~L~~l~~s~~ 179 (771)
..+..+++|+.|+++.+
T Consensus 191 -~~l~~l~~L~~L~L~~N 207 (605)
T 1m9s_A 191 -RALAGLKNLDVLELFSQ 207 (605)
T ss_dssp -GGGTTCTTCSEEECCSE
T ss_pred -hHHccCCCCCEEEccCC
Confidence 35888999999998754
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-17 Score=181.16 Aligned_cols=168 Identities=17% Similarity=0.228 Sum_probs=135.9
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|++++|+++ .++. +..+++|+.|+|++|+++ .++. +..+++|+.|++++|.+....+ +..+++|+.|+
T Consensus 154 l~~L~~L~l~~~~~~-~~~~-~~~l~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~ 227 (347)
T 4fmz_A 154 MTGLNYLTVTESKVK-DVTP-IANLTDLYSLSLNYNQIE-DISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227 (347)
T ss_dssp CTTCCEEECCSSCCC-CCGG-GGGCTTCSEEECTTSCCC-CCGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEE
T ss_pred CCCCcEEEecCCCcC-Cchh-hccCCCCCEEEccCCccc-cccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEE
Confidence 678899999999988 4444 888899999999999988 4444 7888889999999888887654 78888899999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCccccC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~~ 160 (771)
|++|+++ .+|. +..+++|+.|+|++|.+++ + ..+..+++|+.|++++|++++ +|... +++|+.|++++|++++.
T Consensus 228 l~~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~~~~~l~~L~~L~L~~n~l~~~ 302 (347)
T 4fmz_A 228 IGNNKIT-DLSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNE 302 (347)
T ss_dssp CCSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCGG
T ss_pred ccCCccC-CCcc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-ChhhcCCCCCCEEECcCCcCCCc
Confidence 9999888 4444 8888889999999998884 4 458888889999999998884 45422 78888899999988888
Q ss_pred CCcccccccccceeccCCCC
Q 004155 161 SSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 161 ~p~~~~~l~~L~~l~~s~~~ 180 (771)
.|..+..+++|+.|+++.|.
T Consensus 303 ~~~~l~~l~~L~~L~L~~n~ 322 (347)
T 4fmz_A 303 DMEVIGGLTNLTTLFLSQNH 322 (347)
T ss_dssp GHHHHHTCTTCSEEECCSSS
T ss_pred ChhHhhccccCCEEEccCCc
Confidence 88888888888888887553
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.74 E-value=9.6e-18 Score=192.27 Aligned_cols=138 Identities=19% Similarity=0.309 Sum_probs=89.1
Q ss_pred CCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEcc
Q 004155 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILR 83 (771)
Q Consensus 4 ~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 83 (771)
+|+.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|+.|+|++|++++++ . +.+ +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~ip-~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLSTLP-E-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCCC-C-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCCcc-h-hhc--CCCEEECC
Confidence 56777777777773 666553 66777777777776 566 34667777777777777643 3 443 67777777
Q ss_pred CCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhcCCeecccCCccccCCCc
Q 004155 84 SCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSE 163 (771)
Q Consensus 84 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~p~ 163 (771)
+|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. +.++|+.|+|++|+|+ .+|.
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~~~L~~L~Ls~N~L~-~lp~ 197 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LPESLEALDVSTNLLE-SLPA 197 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECCSSCCS-SCCC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hhCCCCEEECcCCCCC-chhh
Confidence 777764 555 46667777777777763 554 45666667777776664 555 4466666666666666 3444
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.74 E-value=7.3e-18 Score=177.98 Aligned_cols=150 Identities=19% Similarity=0.323 Sum_probs=132.9
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|+|++|+|+ .++. +.++++|++|+|++|++++ +| .+..+++|+.|+|++|++++. +.+..+++|+.|+
T Consensus 67 l~~L~~L~L~~n~l~-~~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~ 140 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLY 140 (291)
T ss_dssp CTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEE
T ss_pred CCCCCEEEccCCccC-CCcc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEE
Confidence 689999999999999 4555 9999999999999999985 44 499999999999999999986 5789999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCccccC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~~ 160 (771)
|++|++++ + ..+..+++|+.|+|++|++++..| +..+++|+.|+|++|+|+ .+|... +++|+.|++++|+++..
T Consensus 141 l~~n~l~~-~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~-~l~~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 141 LGNNKITD-I-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-BCGGGTTCTTCSEEEEEEEEEECC
T ss_pred ccCCcCCc-c-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC-CChhhccCCCCCEEECcCCcccCC
Confidence 99999995 4 689999999999999999996544 999999999999999999 466533 88999999999999864
Q ss_pred CC
Q 004155 161 SS 162 (771)
Q Consensus 161 ~p 162 (771)
..
T Consensus 216 ~~ 217 (291)
T 1h6t_A 216 PI 217 (291)
T ss_dssp CE
T ss_pred cc
Confidence 43
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-17 Score=173.73 Aligned_cols=146 Identities=19% Similarity=0.248 Sum_probs=74.6
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++ +|. +..+++|+.|+|++|++++.++ +.. ++|+.|+|
T Consensus 41 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~l~~--~~~-~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKNLNG--IPS-ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSCCTT--CCC-SSCCEEEC
T ss_pred CcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCCcCc--ccc-CcccEEEc
Confidence 45555555555555 444 35555555555555555553 332 5555555555555555555332 112 55555555
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCccccC
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~~ 160 (771)
++|+|++ +| .+..+++|+.|+|++|+|++ +| .+..+++|+.|+|++|++++. +... +++|+.|++++|++++.
T Consensus 114 ~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 114 DNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred cCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 5555552 22 35555555555555555552 33 355555555555555555533 1111 45555555555555543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.5e-18 Score=178.80 Aligned_cols=163 Identities=16% Similarity=0.199 Sum_probs=141.3
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
.++..|+|++|.++ .++ .+..+++|+.|+|++|+|+ .+| .+..+++|+.|+|++|++++.++ +.++++|+.|+|
T Consensus 19 ~~l~~l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L 92 (263)
T 1xeu_A 19 ANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred HHHHHHHhcCCCcc-ccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence 45667889999999 555 5889999999999999998 677 79999999999999999999875 999999999999
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCccccCC
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTAGS 161 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~~~ 161 (771)
++|+++ .+|... . ++|+.|+|++|+|++ +| .+..+++|+.|+|++|+|++ +|... +++|+.|+|++|++++.
T Consensus 93 ~~N~l~-~l~~~~-~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~~l~~l~~L~~L~L~~N~i~~~- 165 (263)
T 1xeu_A 93 NRNRLK-NLNGIP-S-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IVMLGFLSKLEVLDLHGNEITNT- 165 (263)
T ss_dssp CSSCCS-CCTTCC-C-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CGGGGGCTTCCEEECTTSCCCBC-
T ss_pred CCCccC-CcCccc-c-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-ChHHccCCCCCEEECCCCcCcch-
Confidence 999999 466533 3 999999999999995 54 59999999999999999995 55322 89999999999999987
Q ss_pred CcccccccccceeccCCC
Q 004155 162 SETSCQYRSVNLFASSSK 179 (771)
Q Consensus 162 p~~~~~l~~L~~l~~s~~ 179 (771)
..+..+++|+.|+++.|
T Consensus 166 -~~l~~l~~L~~L~l~~N 182 (263)
T 1xeu_A 166 -GGLTRLKKVNWIDLTGQ 182 (263)
T ss_dssp -TTSTTCCCCCEEEEEEE
T ss_pred -HHhccCCCCCEEeCCCC
Confidence 67888999999988644
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.6e-17 Score=162.69 Aligned_cols=131 Identities=18% Similarity=0.215 Sum_probs=119.0
Q ss_pred cEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCC
Q 004155 6 KDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSC 85 (771)
Q Consensus 6 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 85 (771)
+.+++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..|.++++|+.|+|++|++++.++..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 57899999999 8998765 68999999999998 88999999999999999999999999889999999999999999
Q ss_pred cCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCc
Q 004155 86 NVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIP 140 (771)
Q Consensus 86 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP 140 (771)
+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.....
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 9997777889999999999999999995555568999999999999999985443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.9e-17 Score=191.77 Aligned_cols=157 Identities=18% Similarity=0.299 Sum_probs=137.2
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
|++|+.|+|++|+|++ +|. +..+++|+.|+|++|+|++ +| .+..|++|+.|+|++|++... +.+..|++|+.|+
T Consensus 64 l~~L~~L~Ls~N~l~~-~~~-l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~ 137 (605)
T 1m9s_A 64 LPNVTKLFLNGNKLTD-IKP-LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLY 137 (605)
T ss_dssp CTTCCEEECTTSCCCC-CGG-GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEE
T ss_pred CCCCCEEEeeCCCCCC-Chh-hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEE
Confidence 7899999999999995 555 9999999999999999984 55 799999999999999999985 4699999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCccccC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~~ 160 (771)
|++|+|++. ..+..|++|+.|+|++|.|++..| +..+++|+.|+|++|+|++ +|... +++|+.|+|++|++++.
T Consensus 138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEECCSEEEECC
T ss_pred CCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-ChHHccCCCCCEEEccCCcCcCC
Confidence 999999954 689999999999999999997666 9999999999999999995 55433 89999999999999976
Q ss_pred CCccccccc
Q 004155 161 SSETSCQYR 169 (771)
Q Consensus 161 ~p~~~~~l~ 169 (771)
....+..+.
T Consensus 213 p~~~~~~l~ 221 (605)
T 1m9s_A 213 PINHQSNLV 221 (605)
T ss_dssp CCCCCSSCE
T ss_pred cccccccEE
Confidence 554444433
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.72 E-value=7.5e-18 Score=162.47 Aligned_cols=131 Identities=21% Similarity=0.141 Sum_probs=106.3
Q ss_pred CCcCCEEEcccCCcc-ccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEE
Q 004155 26 WTLLEKLVIQASGLV-GPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVL 104 (771)
Q Consensus 26 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 104 (771)
.++|+.|+|++|+++ +.+|..+..+++|+.|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 477888888888887 77888888888888888888888876 678888888888888888887788888788889999
Q ss_pred EccCCCCCCCCC--ccccCCCCCcEEEcCCCcccccCc---hhh--hhcCCeecccCCcccc
Q 004155 105 DVSFNKLNGAIP--STFMGLLDVDYIYLTGNLLTGTIP---PWM--LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 105 ~Ls~N~l~g~ip--~~~~~l~~L~~L~Ls~N~l~g~iP---~~~--~~~L~~l~ls~N~l~~ 159 (771)
+|++|++++ +| ..+..+++|+.|+|++|++++..+ ..+ +++|+.|++++|.+..
T Consensus 101 ~Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~ 161 (168)
T 2ell_A 101 NLSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQE 161 (168)
T ss_dssp ECBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCB
T ss_pred eccCCccCc-chhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhh
Confidence 999998884 33 678888889999999998884433 234 7788888988888774
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.72 E-value=3.4e-18 Score=202.82 Aligned_cols=158 Identities=18% Similarity=0.149 Sum_probs=124.1
Q ss_pred CcEEEccCCcccc---------cCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCC
Q 004155 5 LKDFRISDNHFTG---------KIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMK 75 (771)
Q Consensus 5 L~~L~Ls~N~l~~---------~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 75 (771)
|+.|+|+.|.|++ ..|..+..+++|+.|+|++|.|. .+|..+..|++|++|+|++|+++ ..|..|++|+
T Consensus 193 l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 270 (727)
T 4b8c_D 193 LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLS 270 (727)
T ss_dssp -----------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGT
T ss_pred hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCC
Confidence 3445555555443 45778899999999999999998 89988889999999999999999 4567899999
Q ss_pred CCcEEEccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--h-hcCCeecc
Q 004155 76 KMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--L-QKGDRVDL 152 (771)
Q Consensus 76 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~-~~L~~l~l 152 (771)
+|++|+|++|+|+ .+|..|++|++|++|+|++|.|+ .+|..|+.|++|+.|+|++|.|+|.+|..+ + ..+..++|
T Consensus 271 ~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l 348 (727)
T 4b8c_D 271 NLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYL 348 (727)
T ss_dssp TCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhh
Confidence 9999999999999 89999999999999999999998 889999999999999999999999888877 2 22345889
Q ss_pred cCCccccCCCcccc
Q 004155 153 SYNSFTAGSSETSC 166 (771)
Q Consensus 153 s~N~l~~~~p~~~~ 166 (771)
++|.+++.+|..+.
T Consensus 349 ~~N~l~~~~p~~l~ 362 (727)
T 4b8c_D 349 RDNRPEIPLPHERR 362 (727)
T ss_dssp HHCCCCCCCCCC--
T ss_pred ccCcccCcCccccc
Confidence 99999999887543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.9e-19 Score=205.76 Aligned_cols=168 Identities=17% Similarity=0.099 Sum_probs=118.4
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCC-------------ccccCchhhcCCcC----------------
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASG-------------LVGPIPSGIASLSK---------------- 52 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~---------------- 52 (771)
+++|+.|+|++|+|+ .+|..++++++|+.|++++|. +.+.+|..++.|++
T Consensus 348 ~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L~ 426 (567)
T 1dce_A 348 DEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLR 426 (567)
T ss_dssp TTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHHH
T ss_pred CccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchhh
Confidence 567899999999998 999999999999999998775 55566666554433
Q ss_pred ----------------CCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCC
Q 004155 53 ----------------LTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIP 116 (771)
Q Consensus 53 ----------------L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip 116 (771)
|+.|+|++|++++++ . |+++++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|++ +|
T Consensus 427 ~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~lp-~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp 502 (567)
T 1dce_A 427 SKFLLENSVLKMEYADVRVLHLAHKDLTVLC-H-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD 502 (567)
T ss_dssp HHHHHHHHHHHHHHTTCSEEECTTSCCSSCC-C-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG
T ss_pred hhhhhcccccccCccCceEEEecCCCCCCCc-C-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc
Confidence 456677777777643 2 777777777777777777 677777777777777777777774 56
Q ss_pred ccccCCCCCcEEEcCCCcccccC-chhh--hhcCCeecccCCccccCCCcc---cccccccceec
Q 004155 117 STFMGLLDVDYIYLTGNLLTGTI-PPWM--LQKGDRVDLSYNSFTAGSSET---SCQYRSVNLFA 175 (771)
Q Consensus 117 ~~~~~l~~L~~L~Ls~N~l~g~i-P~~~--~~~L~~l~ls~N~l~~~~p~~---~~~l~~L~~l~ 175 (771)
.++.+++|+.|+|++|+|++.. |..+ +++|+.|+|++|++++.+|.. +..+++|+.|+
T Consensus 503 -~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 503 -GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp -GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred -ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 6777777777777777777554 6655 667777777777777655432 22345555553
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.71 E-value=3.8e-17 Score=184.41 Aligned_cols=166 Identities=23% Similarity=0.315 Sum_probs=140.2
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|+|++|++++..| ++.+++|+.|+|++|++++ ++ .+..+++|+.|+|++|++++.++ +..+++|+.|+
T Consensus 198 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 271 (466)
T 1o6v_A 198 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 271 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred CCCCCEEEecCCccccccc--ccccCCCCEEECCCCCccc-ch-hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEE
Confidence 6789999999999995544 7888999999999999984 44 68889999999999999988764 88899999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhcCCeecccCCccccCC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGS 161 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~ 161 (771)
|++|++++ +|. +..+++|+.|+|++|++++..| +..+++|+.|+|++|++++..|-..+++|+.|++++|++++.
T Consensus 272 l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~- 346 (466)
T 1o6v_A 272 LGANQISN-ISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV- 346 (466)
T ss_dssp CCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC-
T ss_pred CCCCccCc-ccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc-
Confidence 99999985 443 8889999999999999996544 788999999999999999766644488999999999999875
Q ss_pred CcccccccccceeccCCC
Q 004155 162 SETSCQYRSVNLFASSSK 179 (771)
Q Consensus 162 p~~~~~l~~L~~l~~s~~ 179 (771)
..+..+++|+.|+++.+
T Consensus 347 -~~l~~l~~L~~L~l~~n 363 (466)
T 1o6v_A 347 -SSLANLTNINWLSAGHN 363 (466)
T ss_dssp -GGGTTCTTCCEEECCSS
T ss_pred -hhhccCCCCCEEeCCCC
Confidence 46888899999988755
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.71 E-value=5e-17 Score=175.79 Aligned_cols=167 Identities=17% Similarity=0.229 Sum_probs=139.9
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|++++|.....++ .+..+++|++|++++|.+.+ ++. +..+++|+.|++++|.+.+..+ +..+++|+.|+
T Consensus 131 l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~-~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 205 (347)
T 4fmz_A 131 LTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKD-VTP-IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFT 205 (347)
T ss_dssp CTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred CCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCC-chh-hccCCCCCEEEccCCccccccc--ccCCCccceee
Confidence 6789999999997764544 48999999999999999984 443 8899999999999999988654 88899999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCccccC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~~ 160 (771)
+++|++.+..+ +..+++|+.|+|++|++++ +|. +..+++|+.|+|++|++++ ++... +++|+.|++++|++++.
T Consensus 206 l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~~~~~~l~~L~~L~l~~n~l~~~ 280 (347)
T 4fmz_A 206 AYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQISDI 280 (347)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCCC
T ss_pred cccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-ChhHhcCCCcCEEEccCCccCCC
Confidence 99999985443 8889999999999999994 444 8899999999999999984 55333 88999999999999875
Q ss_pred CCcccccccccceeccCCCC
Q 004155 161 SSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 161 ~p~~~~~l~~L~~l~~s~~~ 180 (771)
..+..+++|+.|+++.+.
T Consensus 281 --~~~~~l~~L~~L~L~~n~ 298 (347)
T 4fmz_A 281 --SVLNNLSQLNSLFLNNNQ 298 (347)
T ss_dssp --GGGGGCTTCSEEECCSSC
T ss_pred --hhhcCCCCCCEEECcCCc
Confidence 457888999999988664
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.5e-17 Score=190.62 Aligned_cols=155 Identities=20% Similarity=0.219 Sum_probs=135.3
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|+.|+|++|+++++++ .+++|+.|+
T Consensus 79 ~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~lp~----~l~~L~~L~ 146 (571)
T 3cvr_A 79 PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTMLPE----LPALLEYIN 146 (571)
T ss_dssp CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSCCCC----CCTTCCEEE
T ss_pred cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCCCCC----cCccccEEe
Confidence 467999999999999 899 457999999999999996 887 765 99999999999999654 689999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhcC-------CeecccC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKG-------DRVDLSY 154 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L-------~~l~ls~ 154 (771)
|++|+|++ +|. .+++|+.|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+|. +..+| +.|+|++
T Consensus 147 Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~~L~~~~~~L~~L~Ls~ 216 (571)
T 3cvr_A 147 ADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPVRNHHSEETEIFFRCRE 216 (571)
T ss_dssp CCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC--------CCEEEECCS
T ss_pred CCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHHhhhcccccceEEecCC
Confidence 99999995 886 57899999999999996 887 66 89999999999999 7888 65577 9999999
Q ss_pred CccccCCCcccccccccceeccCCC
Q 004155 155 NSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 155 N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
|+|+ .+|..+..+++|+.|+++.|
T Consensus 217 N~l~-~lp~~l~~l~~L~~L~L~~N 240 (571)
T 3cvr_A 217 NRIT-HIPENILSLDPTCTIILEDN 240 (571)
T ss_dssp SCCC-CCCGGGGGSCTTEEEECCSS
T ss_pred Ccce-ecCHHHhcCCCCCEEEeeCC
Confidence 9999 47888888999999998754
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=6.2e-17 Score=181.90 Aligned_cols=161 Identities=17% Similarity=0.150 Sum_probs=134.6
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
|++|++|+|++|+|++ +| .++.+++|++|+|++|+|++ +| ++.+++|++|+|++|++++.+ ++++++|++|+
T Consensus 41 l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~~---~~~l~~L~~L~ 112 (457)
T 3bz5_A 41 LATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNLD---VTPLTKLTYLN 112 (457)
T ss_dssp HTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEE
T ss_pred cCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCceee---cCCCCcCCEEE
Confidence 5789999999999994 56 68999999999999999996 45 889999999999999998863 88899999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhcCCeecccCCccccCC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGS 161 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~ 161 (771)
|++|++++ +| ++.+++|++|++++|+|++ ++ ++.+++|++|++++|+..+.++-.-+++|+.|++++|++++.
T Consensus 113 L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~l- 185 (457)
T 3bz5_A 113 CDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITEL- 185 (457)
T ss_dssp CCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCCC-
T ss_pred CCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCcccccccccCCcCCEEECCCCcccee-
Confidence 99999995 55 8899999999999999996 44 788888999999988766677544478888888888888873
Q ss_pred CcccccccccceeccCCC
Q 004155 162 SETSCQYRSVNLFASSSK 179 (771)
Q Consensus 162 p~~~~~l~~L~~l~~s~~ 179 (771)
| +..+++|+.|+++.+
T Consensus 186 ~--l~~l~~L~~L~l~~N 201 (457)
T 3bz5_A 186 D--VSQNKLLNRLNCDTN 201 (457)
T ss_dssp C--CTTCTTCCEEECCSS
T ss_pred c--cccCCCCCEEECcCC
Confidence 4 677778888877654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.71 E-value=5.7e-17 Score=182.92 Aligned_cols=166 Identities=22% Similarity=0.297 Sum_probs=145.4
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|+|++|+++ .++ .+..+++|++|+|++|++++..| ++.+++|+.|+|++|++++. +.+..+++|+.|+
T Consensus 176 l~~L~~L~l~~n~l~-~~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~ 249 (466)
T 1o6v_A 176 LTTLERLDISSNKVS-DIS-VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLD 249 (466)
T ss_dssp CTTCCEEECCSSCCC-CCG-GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEE
T ss_pred CCCCCEEECcCCcCC-CCh-hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEE
Confidence 688999999999998 454 48999999999999999996655 78899999999999999885 4688999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhcCCeecccCCccccCC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGS 161 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~ 161 (771)
|++|++++..| +..+++|+.|+|++|.+++..| +..+++|+.|+|++|++++..|-.-+++|+.|+|++|++++..
T Consensus 250 l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~ 325 (466)
T 1o6v_A 250 LANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS 325 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCG
T ss_pred CCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCCch
Confidence 99999996544 8899999999999999996444 8899999999999999996555333899999999999999877
Q ss_pred CcccccccccceeccCCC
Q 004155 162 SETSCQYRSVNLFASSSK 179 (771)
Q Consensus 162 p~~~~~l~~L~~l~~s~~ 179 (771)
| +..+++|+.|+++.+
T Consensus 326 ~--~~~l~~L~~L~l~~n 341 (466)
T 1o6v_A 326 P--VSSLTKLQRLFFYNN 341 (466)
T ss_dssp G--GGGCTTCCEEECCSS
T ss_pred h--hccCccCCEeECCCC
Confidence 6 778999999998765
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.2e-17 Score=163.79 Aligned_cols=150 Identities=19% Similarity=0.272 Sum_probs=133.6
Q ss_pred ccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCc
Q 004155 23 IQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLK 102 (771)
Q Consensus 23 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 102 (771)
...+++|+.|+|++|+++ .+| .+..+++|+.|+|++|.++.. +.+..+++|++|+|++|++++..|..++.+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCC--GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcc--hhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 467889999999999999 778 799999999999999977654 4789999999999999999988899999999999
Q ss_pred EEEccCCCCCCCCCccccCCCCCcEEEcCCCc-ccccCchhh-hhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 103 VLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNL-LTGTIPPWM-LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 103 ~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~-l~g~iP~~~-~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
+|+|++|++++..|..++.+++|++|+|++|+ ++ .+|... +++|+.|++++|+++.. + .+..+++|+.|+++.|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCGGGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccHhhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCc
Confidence 99999999998889999999999999999998 55 777433 88999999999999974 3 7888999999988754
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-16 Score=179.85 Aligned_cols=160 Identities=18% Similarity=0.142 Sum_probs=116.1
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|++|+|++|+|++ +| ++.+++|++|+|++|+|++ +| ++++++|++|+|++|++++.+ ++.+++|++|+
T Consensus 63 l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~l~---~~~l~~L~~L~ 133 (457)
T 3bz5_A 63 LTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTKLD---VSQNPLLTYLN 133 (457)
T ss_dssp CTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSCCC---CTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCeec---CCCCCcCCEEE
Confidence 5788888888888884 55 7888888888888888885 44 788888888888888888752 77888888888
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhcCCeecccCCccccCC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGS 161 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~ 161 (771)
|++|+|++ ++ ++.+++|++|++++|+..+.+ .+..+++|+.|+|++|++++ +|-.-+++|+.|++++|++++.
T Consensus 134 l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~l~~l~~L~~L~l~~N~l~~~- 206 (457)
T 3bz5_A 134 CARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LDVSQNKLLNRLNCDTNNITKL- 206 (457)
T ss_dssp CTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CCCTTCTTCCEEECCSSCCSCC-
T ss_pred CCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-eccccCCCCCEEECcCCcCCee-
Confidence 88888885 43 667777777777777655555 36667777777777777774 5522266667777777776654
Q ss_pred CcccccccccceeccCCC
Q 004155 162 SETSCQYRSVNLFASSSK 179 (771)
Q Consensus 162 p~~~~~l~~L~~l~~s~~ 179 (771)
.+..+++|+.|+++.+
T Consensus 207 --~l~~l~~L~~L~Ls~N 222 (457)
T 3bz5_A 207 --DLNQNIQLTFLDCSSN 222 (457)
T ss_dssp --CCTTCTTCSEEECCSS
T ss_pred --ccccCCCCCEEECcCC
Confidence 2556666666666544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=3.7e-17 Score=161.48 Aligned_cols=130 Identities=19% Similarity=0.291 Sum_probs=119.5
Q ss_pred CEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCC-CccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccC
Q 004155 30 EKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFP-PLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSF 108 (771)
Q Consensus 30 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 108 (771)
+.|++++|+|+ .+|..+.. +|+.|+|++|++++.++. .|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 78999999997 88987654 999999999999998875 589999999999999999988899999999999999999
Q ss_pred CCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccccCCC
Q 004155 109 NKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAGSS 162 (771)
Q Consensus 109 N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~~~p 162 (771)
|+|++..|..|..+++|++|+|++|+|++.+|..+ +++|+.|+|++|++++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99998888889999999999999999998888777 8899999999999997654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=9.5e-17 Score=156.15 Aligned_cols=133 Identities=22% Similarity=0.263 Sum_probs=114.3
Q ss_pred CcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccC
Q 004155 5 LKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRS 84 (771)
Q Consensus 5 L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 84 (771)
.+.+++++|+++ .+|..+. ++|+.|+|++|++++..+..|..+++|++|+|++|++++.++..|.++++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 467899999998 7886554 7899999999999966666788999999999999999988877889999999999999
Q ss_pred CcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCc
Q 004155 85 CNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIP 140 (771)
Q Consensus 85 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP 140 (771)
|+|++..+..+..+++|+.|+|++|+|++..+..+..+++|++|+|++|.+++..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99996666678889999999999999996555557889999999999999997766
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.8e-18 Score=205.20 Aligned_cols=146 Identities=20% Similarity=0.210 Sum_probs=125.7
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|+|++|+|+ .+|..++++++|++|+|++|.|+ .+|..|++|++|+.|+|++|+++.+ |..|++|++|++|+
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~l-p~~~~~l~~L~~L~ 299 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSL-PAELGSCFQLKYFY 299 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSC-CSSGGGGTTCSEEE
T ss_pred CCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCcc-ChhhcCCCCCCEEE
Confidence 578999999999999 99999999999999999999999 8999999999999999999999954 78899999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCC-CcEEEcCCCcccccCchhhhhcCCeecccCC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLD-VDYIYLTGNLLTGTIPPWMLQKGDRVDLSYN 155 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~-L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N 155 (771)
|++|.|+ .+|..|+.|++|+.|+|++|.|+|.+|..+..+.. +..|+|++|.++|.+|. .|..|+++.|
T Consensus 300 L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~----~l~~l~l~~n 369 (727)
T 4b8c_D 300 FFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH----ERRFIEINTD 369 (727)
T ss_dssp CCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC----C---------
T ss_pred CCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc----ccceeEeecc
Confidence 9999998 89999999999999999999999999988866532 23588999999999885 5667777777
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.70 E-value=3.8e-18 Score=183.67 Aligned_cols=177 Identities=15% Similarity=0.160 Sum_probs=155.1
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCcccc-CchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGP-IPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
++|+.|++++|.+++..|. +.++++|++|+|++|.+++. +|..+..+++|+.|+|++|++++..+..++.+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 6799999999999966555 67899999999999999866 888999999999999999998877777888999999999
Q ss_pred ccCC-cCccc-CChhhhcCCCCcEEEccCC-CCCCC-CCccccCCC-CCcEEEcCCC--ccc-ccCchhh--hhcCCeec
Q 004155 82 LRSC-NVSGK-LPDYLGLMTSLKVLDVSFN-KLNGA-IPSTFMGLL-DVDYIYLTGN--LLT-GTIPPWM--LQKGDRVD 151 (771)
Q Consensus 82 Ls~N-~l~g~-~p~~~~~l~~L~~L~Ls~N-~l~g~-ip~~~~~l~-~L~~L~Ls~N--~l~-g~iP~~~--~~~L~~l~ 151 (771)
|++| .+++. +|..+..+++|+.|+|++| .+++. ++..+..++ +|++|+|++| .++ +.+|..+ +++|+.|+
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~ 228 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence 9999 68763 7777899999999999999 99854 677788999 9999999999 555 4667665 88999999
Q ss_pred ccCCc-cccCCCcccccccccceeccCCCC
Q 004155 152 LSYNS-FTAGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 152 ls~N~-l~~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
+++|. +++..+..+..+++|+.|+++.+.
T Consensus 229 l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred CCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 99999 787888899999999999998775
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.6e-18 Score=185.01 Aligned_cols=178 Identities=14% Similarity=0.151 Sum_probs=152.8
Q ss_pred CCCCcEEEccCCccccc-CCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCC-CCCCC-CCCCccCCCCCc
Q 004155 2 LVTLKDFRISDNHFTGK-IPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL-NGTEA-PFPPLDKMKKMK 78 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~-ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~ 78 (771)
+++|+.|+|++|.+++. +|..+..+++|++|+|++|++++..|..++.+++|+.|+|++| .+++. .+..+.++++|+
T Consensus 92 ~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~ 171 (336)
T 2ast_B 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 171 (336)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence 68899999999999866 8888999999999999999999889999999999999999999 67652 445578899999
Q ss_pred EEEccCC-cCccc-CChhhhcCC-CCcEEEccCC--CCC-CCCCccccCCCCCcEEEcCCCc-ccccCchhh--hhcCCe
Q 004155 79 TLILRSC-NVSGK-LPDYLGLMT-SLKVLDVSFN--KLN-GAIPSTFMGLLDVDYIYLTGNL-LTGTIPPWM--LQKGDR 149 (771)
Q Consensus 79 ~L~Ls~N-~l~g~-~p~~~~~l~-~L~~L~Ls~N--~l~-g~ip~~~~~l~~L~~L~Ls~N~-l~g~iP~~~--~~~L~~ 149 (771)
+|+|++| ++++. ++..+..++ +|+.|+|++| .++ +.+|..+..+++|+.|+|++|. +++..+..+ +++|+.
T Consensus 172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~ 251 (336)
T 2ast_B 172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 251 (336)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCE
Confidence 9999999 99865 678899999 9999999999 565 5678888899999999999999 776677666 789999
Q ss_pred ecccCCc-cccCCCcccccccccceeccCCC
Q 004155 150 VDLSYNS-FTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 150 l~ls~N~-l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
|++++|. ++......+..+++|+.|+++.+
T Consensus 252 L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 252 LSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp EECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred eeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 9999996 33222236788999999998855
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=8.9e-19 Score=192.75 Aligned_cols=178 Identities=11% Similarity=0.121 Sum_probs=127.4
Q ss_pred CCCCcEEEccCC---cccccCCccc-------cCCCcCCEEEcccCCccc----cCchhhcCCcCCCEEEcCCCCCCCCC
Q 004155 2 LVTLKDFRISDN---HFTGKIPNFI-------QNWTLLEKLVIQASGLVG----PIPSGIASLSKLTDLRISDLNGTEAP 67 (771)
Q Consensus 2 L~~L~~L~Ls~N---~l~~~ip~~~-------~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~ 67 (771)
+++|+.|+|++| ++++.+|..+ .++++|++|+|++|.|++ .+|..+..+++|+.|+|++|.++...
T Consensus 59 ~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~ 138 (386)
T 2ca6_A 59 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQA 138 (386)
T ss_dssp CTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHH
T ss_pred CCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHH
Confidence 577888888884 5556667655 678888888888888886 47778888888888888888876433
Q ss_pred CCCcc----CC---------CCCcEEEccCCcCc-ccCC---hhhhcCCCCcEEEccCCCCC--C---CCCccccCCCCC
Q 004155 68 FPPLD----KM---------KKMKTLILRSCNVS-GKLP---DYLGLMTSLKVLDVSFNKLN--G---AIPSTFMGLLDV 125 (771)
Q Consensus 68 ~~~~~----~l---------~~L~~L~Ls~N~l~-g~~p---~~~~~l~~L~~L~Ls~N~l~--g---~ip~~~~~l~~L 125 (771)
+..+. .+ ++|++|+|++|+++ +.+| ..+..+++|+.|+|++|+|+ | .+|..+..+++|
T Consensus 139 ~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L 218 (386)
T 2ca6_A 139 GAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 218 (386)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTC
T ss_pred HHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCc
Confidence 33333 23 78888888888886 4455 45667788888888888877 2 344467778888
Q ss_pred cEEEcCCCccc----ccCchhh--hhcCCeecccCCccccC----CCcccc--cccccceeccCCC
Q 004155 126 DYIYLTGNLLT----GTIPPWM--LQKGDRVDLSYNSFTAG----SSETSC--QYRSVNLFASSSK 179 (771)
Q Consensus 126 ~~L~Ls~N~l~----g~iP~~~--~~~L~~l~ls~N~l~~~----~p~~~~--~l~~L~~l~~s~~ 179 (771)
+.|+|++|.++ +.+|..+ +++|+.|+|++|.+++. +|..+. .+++|+.|+++.|
T Consensus 219 ~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n 284 (386)
T 2ca6_A 219 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYN 284 (386)
T ss_dssp CEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSS
T ss_pred cEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCC
Confidence 88888888875 4566655 67788888888887765 445552 3677777777654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.1e-16 Score=154.14 Aligned_cols=136 Identities=20% Similarity=0.229 Sum_probs=121.8
Q ss_pred CCCCcEEEccCCccc-ccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEE
Q 004155 2 LVTLKDFRISDNHFT-GKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~-~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 80 (771)
.++|+.|+|++|+|+ +.+|..+..+++|++|+|++|.|++. ..+..+++|++|+|++|++++.+|..+.++++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 468999999999998 88999899999999999999999965 789999999999999999999877777789999999
Q ss_pred EccCCcCcccCC--hhhhcCCCCcEEEccCCCCCCCCC---ccccCCCCCcEEEcCCCcccccCch
Q 004155 81 ILRSCNVSGKLP--DYLGLMTSLKVLDVSFNKLNGAIP---STFMGLLDVDYIYLTGNLLTGTIPP 141 (771)
Q Consensus 81 ~Ls~N~l~g~~p--~~~~~l~~L~~L~Ls~N~l~g~ip---~~~~~l~~L~~L~Ls~N~l~g~iP~ 141 (771)
+|++|+|+ .+| ..+..+++|+.|+|++|.+++..+ ..+..+++|++|++++|.+. .+|.
T Consensus 101 ~Ls~N~l~-~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 101 NLSGNKLK-DISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp ECBSSSCC-SSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred eccCCccC-cchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 99999999 444 789999999999999999995544 37999999999999999998 6664
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.8e-17 Score=186.03 Aligned_cols=166 Identities=14% Similarity=0.148 Sum_probs=97.7
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCC-------------CEEEcCCCCCCCCCC
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKL-------------TDLRISDLNGTEAPF 68 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-------------~~L~L~~n~l~~~~~ 68 (771)
.++|++|++++|+| |.+|..|++|++|++|+|++|+++|.+|.+++++.+| +.|++++|.+++.+.
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~ 88 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE 88 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCS
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCC
Confidence 46789999999999 6999999999999999999999999999988887764 777777777776442
Q ss_pred CCccCCCCCcEEEccCCcCcccCChhhh----------------cC-CCCcEEEccCCCCCCCCCccccCCCCCcEEEcC
Q 004155 69 PPLDKMKKMKTLILRSCNVSGKLPDYLG----------------LM-TSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLT 131 (771)
Q Consensus 69 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~----------------~l-~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls 131 (771)
. .++|++|+|++|++++ +|..+. .+ ++|++|+|++|++++ +| .|+.+++|++|+++
T Consensus 89 -~---~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~ 161 (454)
T 1jl5_A 89 -L---PPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVD 161 (454)
T ss_dssp -C---CTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred -C---cCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECC
Confidence 1 2455666666666553 443221 11 467777777777774 66 47777777777777
Q ss_pred CCcccccCchhhhhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 132 GNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 132 ~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
+|++++ +|.. ..+|+.|++++|++++ +| .+..+++|+.|+++.+
T Consensus 162 ~N~l~~-lp~~-~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N 205 (454)
T 1jl5_A 162 NNSLKK-LPDL-PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNN 205 (454)
T ss_dssp SSCCSC-CCCC-CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSS
T ss_pred CCcCcc-cCCC-cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCC
Confidence 777774 5543 3577777777777776 44 4777777777776644
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.8e-18 Score=188.80 Aligned_cols=180 Identities=17% Similarity=0.157 Sum_probs=148.8
Q ss_pred CCCCcEEEccCCcccccC----CccccCCCcCCEEEcccC---CccccCchhh-------cCCcCCCEEEcCCCCCCC--
Q 004155 2 LVTLKDFRISDNHFTGKI----PNFIQNWTLLEKLVIQAS---GLVGPIPSGI-------ASLSKLTDLRISDLNGTE-- 65 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~i----p~~~~~l~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~L~L~~n~l~~-- 65 (771)
+++|+.|+|++|+|++.. +..+.++++|++|+|++| ++++.+|..+ ..+++|++|+|++|+++.
T Consensus 31 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 110 (386)
T 2ca6_A 31 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 110 (386)
T ss_dssp CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred CCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHH
Confidence 578999999999999663 445778999999999995 5666777766 789999999999999988
Q ss_pred --CCCCCccCCCCCcEEEccCCcCcccCChhhh----cC---------CCCcEEEccCCCCC-CCCC---ccccCCCCCc
Q 004155 66 --APFPPLDKMKKMKTLILRSCNVSGKLPDYLG----LM---------TSLKVLDVSFNKLN-GAIP---STFMGLLDVD 126 (771)
Q Consensus 66 --~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~----~l---------~~L~~L~Ls~N~l~-g~ip---~~~~~l~~L~ 126 (771)
..+..+..+++|++|+|++|+|++..+..+. .+ ++|++|+|++|+++ +.+| ..+..+++|+
T Consensus 111 ~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~ 190 (386)
T 2ca6_A 111 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH 190 (386)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCC
T ss_pred HHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcC
Confidence 3455788899999999999999755444444 34 89999999999998 5566 4677899999
Q ss_pred EEEcCCCccc--c---cCchhh--hhcCCeecccCCccc----cCCCcccccccccceeccCCCCC
Q 004155 127 YIYLTGNLLT--G---TIPPWM--LQKGDRVDLSYNSFT----AGSSETSCQYRSVNLFASSSKGN 181 (771)
Q Consensus 127 ~L~Ls~N~l~--g---~iP~~~--~~~L~~l~ls~N~l~----~~~p~~~~~l~~L~~l~~s~~~~ 181 (771)
.|+|++|+++ | .+|..+ +++|+.|+|++|.++ ..+|..+..+++|+.|+++.|.-
T Consensus 191 ~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i 256 (386)
T 2ca6_A 191 TVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 256 (386)
T ss_dssp EEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred EEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCC
Confidence 9999999998 3 344244 789999999999997 66888899999999999986653
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.4e-17 Score=155.56 Aligned_cols=127 Identities=21% Similarity=0.143 Sum_probs=104.9
Q ss_pred CCcCCEEEcccCCcc-ccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEE
Q 004155 26 WTLLEKLVIQASGLV-GPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVL 104 (771)
Q Consensus 26 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 104 (771)
.++|+.|+|++|.++ +.+|..+..+++|+.|+|++|++++. ..+..+++|++|+|++|++++.+|..+..+++|+.|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 477888888888888 78888888888899999988888877 678888999999999999987788888889999999
Q ss_pred EccCCCCCCC-CCccccCCCCCcEEEcCCCcccccCc---hhh--hhcCCeecccC
Q 004155 105 DVSFNKLNGA-IPSTFMGLLDVDYIYLTGNLLTGTIP---PWM--LQKGDRVDLSY 154 (771)
Q Consensus 105 ~Ls~N~l~g~-ip~~~~~l~~L~~L~Ls~N~l~g~iP---~~~--~~~L~~l~ls~ 154 (771)
+|++|++++. .|..+..+++|++|++++|++++..+ ..+ +++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999853 34778889999999999999985444 234 78888888864
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-16 Score=150.33 Aligned_cols=128 Identities=20% Similarity=0.222 Sum_probs=96.5
Q ss_pred CCCcEEEccCCccc-ccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 3 VTLKDFRISDNHFT-GKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~-~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
++|+.|++++|+++ +.+|..+..+++|++|+|++|.|++. ..++.+++|++|+|++|++++..|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 56788888888887 67777777888888888888888754 6677788888888888888776666666788888888
Q ss_pred ccCCcCccc-CChhhhcCCCCcEEEccCCCCCCCCC---ccccCCCCCcEEEcCC
Q 004155 82 LRSCNVSGK-LPDYLGLMTSLKVLDVSFNKLNGAIP---STFMGLLDVDYIYLTG 132 (771)
Q Consensus 82 Ls~N~l~g~-~p~~~~~l~~L~~L~Ls~N~l~g~ip---~~~~~l~~L~~L~Ls~ 132 (771)
|++|++++. .|..+..+++|++|++++|.+++..+ ..+..+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 888888742 33677788888888888888875444 3677788888887753
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-16 Score=173.54 Aligned_cols=176 Identities=14% Similarity=0.101 Sum_probs=131.6
Q ss_pred CCCCcEEEccCCcccccCCc-cccCCCcCCEEEcccCCccccCch-hhcCCcCCCE-EEcCCCCCCCCCCCCccCCCCCc
Q 004155 2 LVTLKDFRISDNHFTGKIPN-FIQNWTLLEKLVIQASGLVGPIPS-GIASLSKLTD-LRISDLNGTEAPFPPLDKMKKMK 78 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~-L~L~~n~l~~~~~~~~~~l~~L~ 78 (771)
.++|++|+|++|+|+ .||. .|.++++|++|+|++|++.+.+|. .|.+|++|.. +.+++|+++.+++..|..+++|+
T Consensus 29 ~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~ 107 (350)
T 4ay9_X 29 PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQ 107 (350)
T ss_dssp CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCC
T ss_pred CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccc
Confidence 357999999999999 6665 689999999999999998777764 6788988775 66677999999888999999999
Q ss_pred EEEccCCcCcccCChhhhcCCCCcEEEccC-CCCCCCCCccccCCC-CCcEEEcCCCcccccCchhh--hhcCCeecccC
Q 004155 79 TLILRSCNVSGKLPDYLGLMTSLKVLDVSF-NKLNGAIPSTFMGLL-DVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSY 154 (771)
Q Consensus 79 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~l~-~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~ 154 (771)
+|++++|+|.+..+..+....++..|++++ |++....+..|..+. .|+.|+|++|+|+ .+|... ..+|..|++++
T Consensus 108 ~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~ 186 (350)
T 4ay9_X 108 YLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSD 186 (350)
T ss_dssp EEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTT
T ss_pred cccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhcc
Confidence 999999999855555666666777777754 556533334555554 5777888888887 455443 55677777764
Q ss_pred -CccccCCCcccccccccceeccCCC
Q 004155 155 -NSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 155 -N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
|.++...++.+..+++|+.|+++.|
T Consensus 187 ~n~l~~i~~~~f~~l~~L~~LdLs~N 212 (350)
T 4ay9_X 187 NNNLEELPNDVFHGASGPVILDISRT 212 (350)
T ss_dssp CTTCCCCCTTTTTTEECCSEEECTTS
T ss_pred CCcccCCCHHHhccCcccchhhcCCC
Confidence 4555444456777777888877755
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.66 E-value=5.9e-16 Score=179.57 Aligned_cols=158 Identities=22% Similarity=0.206 Sum_probs=77.3
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++|+.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|+.|+|++|+++.++. .+++|++|+
T Consensus 80 l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~---~l~~L~~L~L~~N~l~~lp~----~l~~L~~L~ 147 (622)
T 3g06_A 80 PPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA---LPSGLCKLWIFGNQLTSLPV----LPPGLQELS 147 (622)
T ss_dssp CTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC---CCTTCCEEECCSSCCSCCCC----CCTTCCEEE
T ss_pred CCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC---CCCCcCEEECCCCCCCcCCC----CCCCCCEEE
Confidence 456667777777666 5555 4456666666666665 2343 23444444444444444321 123344444
Q ss_pred ccCCcCcccCChhh---hc--------------CCCCcEEEccCCCCCCCCCccccC-----------------CCCCcE
Q 004155 82 LRSCNVSGKLPDYL---GL--------------MTSLKVLDVSFNKLNGAIPSTFMG-----------------LLDVDY 127 (771)
Q Consensus 82 Ls~N~l~g~~p~~~---~~--------------l~~L~~L~Ls~N~l~g~ip~~~~~-----------------l~~L~~ 127 (771)
|++|+|++ +|..+ .. +++|+.|+|++|+|++ +|..+.+ +++|+.
T Consensus 148 Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~ 225 (622)
T 3g06_A 148 VSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLKE 225 (622)
T ss_dssp CCSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSSCCCCCTTCCE
T ss_pred CcCCcCCC-cCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC-CCCccchhhEEECcCCcccccCCCCCCCCE
Confidence 44444331 22111 11 1444445555554442 2221111 245666
Q ss_pred EEcCCCcccccCchhhhhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 128 IYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 128 L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
|+|++|+|+ .+| ..+++|+.|+|++|+|+. +|. .+++|+.|+++.|
T Consensus 226 L~Ls~N~L~-~lp-~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N 271 (622)
T 3g06_A 226 LIVSGNRLT-SLP-VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRN 271 (622)
T ss_dssp EECCSSCCS-CCC-CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSS
T ss_pred EEccCCccC-cCC-CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCC
Confidence 666666666 355 234566666666666663 333 3455666665543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.8e-17 Score=179.12 Aligned_cols=177 Identities=15% Similarity=0.069 Sum_probs=109.7
Q ss_pred CCCcEEEccCCcccccCC----ccccCCC-cCCEEEcccCCccccCchhhcCC-----cCCCEEEcCCCCCCCCCCCCc-
Q 004155 3 VTLKDFRISDNHFTGKIP----NFIQNWT-LLEKLVIQASGLVGPIPSGIASL-----SKLTDLRISDLNGTEAPFPPL- 71 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~n~l~~~~~~~~- 71 (771)
++|++|+|++|+|++..+ ..+.+++ +|++|+|++|+|++..+..|..+ ++|+.|+|++|+++...+..+
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 447777777777774444 5566666 67777777777776666666654 677777777777766554433
Q ss_pred ---cCC-CCCcEEEccCCcCcccCChhhhc-----CCCCcEEEccCCCCCCCC----CccccCCC-CCcEEEcCCCcccc
Q 004155 72 ---DKM-KKMKTLILRSCNVSGKLPDYLGL-----MTSLKVLDVSFNKLNGAI----PSTFMGLL-DVDYIYLTGNLLTG 137 (771)
Q Consensus 72 ---~~l-~~L~~L~Ls~N~l~g~~p~~~~~-----l~~L~~L~Ls~N~l~g~i----p~~~~~l~-~L~~L~Ls~N~l~g 137 (771)
..+ ++|++|+|++|+|++..+..+.. .++|++|+|++|.|++.. +..+..++ +|++|+|++|++++
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~ 181 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCch
Confidence 333 67777777777776544444332 257777777777776432 23334444 77777777777775
Q ss_pred cCchhh------h-hcCCeecccCCccccC----CCccccc-ccccceeccCCC
Q 004155 138 TIPPWM------L-QKGDRVDLSYNSFTAG----SSETSCQ-YRSVNLFASSSK 179 (771)
Q Consensus 138 ~iP~~~------~-~~L~~l~ls~N~l~~~----~p~~~~~-l~~L~~l~~s~~ 179 (771)
..+..+ . ++|+.|+|++|.++.. ++..+.. .++|+.|+++.|
T Consensus 182 ~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N 235 (362)
T 3goz_A 182 KNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLN 235 (362)
T ss_dssp SCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSS
T ss_pred hhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCC
Confidence 555433 1 4677777777777653 3333433 246777776654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.5e-15 Score=170.40 Aligned_cols=120 Identities=19% Similarity=0.224 Sum_probs=67.4
Q ss_pred CcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEc
Q 004155 27 TLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDV 106 (771)
Q Consensus 27 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 106 (771)
++|++|+|++|++++ +| +|+++++|++|++++|++++.+ .. ..+|++|+|++|++++ +| .++++++|+.|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp-~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLP-DL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCC-CC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccC-CC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 456666666666663 55 4666666666666666666532 22 2356666666666663 45 4566666666666
Q ss_pred cCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCcccc
Q 004155 107 SFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 107 s~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~ 159 (771)
++|++++ +|... ++|++|++++|+++ .+|... +++|+.|++++|++++
T Consensus 203 ~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~~~~l~~L~~L~l~~N~l~~ 251 (454)
T 1jl5_A 203 DNNSLKK-LPDLP---LSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLKT 251 (454)
T ss_dssp CSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCSS
T ss_pred CCCcCCc-CCCCc---CcccEEECcCCcCC-cccccCCCCCCCEEECCCCcCCc
Confidence 6666653 44322 35555555555555 455311 4555555555555554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.63 E-value=6.5e-17 Score=176.26 Aligned_cols=174 Identities=17% Similarity=0.165 Sum_probs=145.1
Q ss_pred EEEccCCcccccCCccccCCCcCCEEEcccCCccccCc----hhhcCCc-CCCEEEcCCCCCCCCCCCCccCC-----CC
Q 004155 7 DFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIP----SGIASLS-KLTDLRISDLNGTEAPFPPLDKM-----KK 76 (771)
Q Consensus 7 ~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l-----~~ 76 (771)
.++|+.|+++|.+|..+...++|++|+|++|.|++..+ ..|..++ +|+.|+|++|+++...+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 57899999999999987777889999999999997666 7888999 99999999999999877777765 99
Q ss_pred CcEEEccCCcCcccCChhhhc----C-CCCcEEEccCCCCCCCCCcccc----C-CCCCcEEEcCCCcccccCchhh---
Q 004155 77 MKTLILRSCNVSGKLPDYLGL----M-TSLKVLDVSFNKLNGAIPSTFM----G-LLDVDYIYLTGNLLTGTIPPWM--- 143 (771)
Q Consensus 77 L~~L~Ls~N~l~g~~p~~~~~----l-~~L~~L~Ls~N~l~g~ip~~~~----~-l~~L~~L~Ls~N~l~g~iP~~~--- 143 (771)
|++|+|++|++++..+..++. + ++|+.|+|++|+|++..+..+. . .++|++|+|++|++++..+..+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 999999999999777765554 4 8999999999999966655443 3 3699999999999996444333
Q ss_pred ---h-hcCCeecccCCccccCCCcccccc-----cccceeccCCCC
Q 004155 144 ---L-QKGDRVDLSYNSFTAGSSETSCQY-----RSVNLFASSSKG 180 (771)
Q Consensus 144 ---~-~~L~~l~ls~N~l~~~~p~~~~~l-----~~L~~l~~s~~~ 180 (771)
. .+|+.|+|++|++++..+..++.. ++|+.|+++.|.
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 207 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANL 207 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCC
Confidence 2 489999999999998887666554 689999998664
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.63 E-value=6.5e-16 Score=167.52 Aligned_cols=173 Identities=17% Similarity=0.113 Sum_probs=143.2
Q ss_pred CCCCcEEEccCCcccccCCc-cccCCCcCCE-EEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcE
Q 004155 2 LVTLKDFRISDNHFTGKIPN-FIQNWTLLEK-LVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKT 79 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~-~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 79 (771)
|++|++|+|++|++.+.+|. .|.++++|.. +.++.|+|+...|..|..|++|++|++++|++...++..+....++..
T Consensus 53 l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~ 132 (350)
T 4ay9_X 53 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 132 (350)
T ss_dssp CTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEE
T ss_pred CCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhh
Confidence 78999999999999877875 6788988765 777889999777889999999999999999999998888888888999
Q ss_pred EEccC-CcCcccCChhhhcCC-CCcEEEccCCCCCCCCCccccCCCCCcEEEcCC-CcccccCchhh---hhcCCeeccc
Q 004155 80 LILRS-CNVSGKLPDYLGLMT-SLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTG-NLLTGTIPPWM---LQKGDRVDLS 153 (771)
Q Consensus 80 L~Ls~-N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~-N~l~g~iP~~~---~~~L~~l~ls 153 (771)
|++.+ |++....+..|..+. .|+.|+|++|+|+ .+|.......+|+.|++++ |.++ .+|... +++|+.|||+
T Consensus 133 l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs 210 (350)
T 4ay9_X 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDIS 210 (350)
T ss_dssp EEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECT
T ss_pred hhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcC
Confidence 99966 567744445666664 6899999999999 6777666778999999986 5565 788643 8899999999
Q ss_pred CCccccCCCcccccccccceecc
Q 004155 154 YNSFTAGSSETSCQYRSVNLFAS 176 (771)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~~ 176 (771)
+|+|+...+..+.++++|+.+++
T Consensus 211 ~N~l~~lp~~~~~~L~~L~~l~~ 233 (350)
T 4ay9_X 211 RTRIHSLPSYGLENLKKLRARST 233 (350)
T ss_dssp TSCCCCCCSSSCTTCCEEECTTC
T ss_pred CCCcCccChhhhccchHhhhccC
Confidence 99999877777777777776654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.5e-15 Score=147.73 Aligned_cols=131 Identities=21% Similarity=0.284 Sum_probs=114.9
Q ss_pred cCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEcc
Q 004155 28 LLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVS 107 (771)
Q Consensus 28 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 107 (771)
..+.+++++|+++ .+|..+ .++|+.|+|++|++++.++..|.++++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 8 ~~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp ETTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence 3578999999998 678655 4799999999999999888889999999999999999996666678999999999999
Q ss_pred CCCCCCCCCccccCCCCCcEEEcCCCcccccCchh-h--hhcCCeecccCCccccCCC
Q 004155 108 FNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPW-M--LQKGDRVDLSYNSFTAGSS 162 (771)
Q Consensus 108 ~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~-~--~~~L~~l~ls~N~l~~~~p 162 (771)
+|+|++..+..|..+++|++|+|++|+|++ +|.. + +++|+.|+|++|++++..|
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceE-eCHHHhcCCcccCEEEecCCCeeccCc
Confidence 999997777778999999999999999994 5554 3 7889999999999997655
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-15 Score=150.86 Aligned_cols=127 Identities=24% Similarity=0.323 Sum_probs=113.0
Q ss_pred CCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccC
Q 004155 29 LEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSF 108 (771)
Q Consensus 29 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 108 (771)
-+.+++++|+|+ .+|..+. ++|+.|+|++|+++.++ ..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++
T Consensus 12 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip-~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 12 DTVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVP-KELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCC-GGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhH-HHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 368999999998 7887664 68999999999999765 7899999999999999999977778899999999999999
Q ss_pred CCCCCCCCccccCCCCCcEEEcCCCcccccCch-hh--hhcCCeecccCCccccC
Q 004155 109 NKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPP-WM--LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 109 N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~-~~--~~~L~~l~ls~N~l~~~ 160 (771)
|+|++..|..|..+++|+.|+|++|+|+ .+|. .+ +++|+.|+|++|++.+.
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCeecC
Confidence 9999877888999999999999999999 4555 44 78999999999999863
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.62 E-value=2.7e-16 Score=152.86 Aligned_cols=132 Identities=13% Similarity=0.156 Sum_probs=110.9
Q ss_pred cccCCCcCCEEEcccCCccccCchhhcCCc-CCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCC
Q 004155 22 FIQNWTLLEKLVIQASGLVGPIPSGIASLS-KLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTS 100 (771)
Q Consensus 22 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 100 (771)
.+.++.+|+.|+|++|+++ .+|. +..+. +|++|+|++|++++. +.|..+++|++|+|++|+|++..|..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 3677889999999999998 5665 55554 999999999999886 67889999999999999999544455689999
Q ss_pred CcEEEccCCCCCCCCCc--cccCCCCCcEEEcCCCcccccCchh----h--hhcCCeecccCCcccc
Q 004155 101 LKVLDVSFNKLNGAIPS--TFMGLLDVDYIYLTGNLLTGTIPPW----M--LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 101 L~~L~Ls~N~l~g~ip~--~~~~l~~L~~L~Ls~N~l~g~iP~~----~--~~~L~~l~ls~N~l~~ 159 (771)
|++|+|++|+|+ .+|. .+..+++|+.|+|++|.++ .+|.. + +++|+.||+++|.+..
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 999999999997 6776 7889999999999999998 67764 4 7889999999998764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=4.5e-16 Score=167.96 Aligned_cols=138 Identities=12% Similarity=0.165 Sum_probs=101.3
Q ss_pred CCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCCh--------------hcH--------HHHHHHHHHHHcCCCCcE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSK--------------QGN--------REFVNEIGMISALQHPNL 479 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------------~~~--------~~~~~E~~~l~~l~h~ni 479 (771)
-|++.++||+|+||.||+|...+|+.||||+++.... ... ....+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3888999999999999999888999999998753200 001 112456777777755443
Q ss_pred EeEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC
Q 004155 480 VKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK 559 (771)
Q Consensus 480 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~ 559 (771)
.-..-+... ..+|||||++|++|.++. ..+....++.|++.+|.|||+. +||||||||.|||+++
T Consensus 176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~----------~~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQS--RHTIVMSLVDALPMRQVS----------SVPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEEE--TTEEEEECCSCEEGGGCC----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCeeeecc--CceEEEEecCCccHhhhc----------ccHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 221111122 237999999998876554 1224567899999999999998 8999999999999987
Q ss_pred CC----------CeEEEeecCcccc
Q 004155 560 DL----------NPKISDFGLAKLD 574 (771)
Q Consensus 560 ~~----------~~kl~DFGla~~~ 574 (771)
++ .+.|+||+-+...
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCcccccccccceEEEEeCCcccC
Confidence 76 3899999987643
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.62 E-value=4e-15 Score=172.60 Aligned_cols=155 Identities=21% Similarity=0.210 Sum_probs=124.2
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
++|+.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|++|++++.+. .+++|+.|+|
T Consensus 61 ~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~l~~----~l~~L~~L~L 128 (622)
T 3g06_A 61 AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTHLPA----LPSGLCKLWI 128 (622)
T ss_dssp TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCCCCC----CCTTCCEEEC
T ss_pred CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCCCCC----CCCCcCEEEC
Confidence 68999999999999 7887 5789999999999998 6776 78999999999999998764 5789999999
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCC-----------------CCCcEEEcCCCcccccCchhh--
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGL-----------------LDVDYIYLTGNLLTGTIPPWM-- 143 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l-----------------~~L~~L~Ls~N~l~g~iP~~~-- 143 (771)
++|+|+ .+|.. +++|++|+|++|+|++ +|..+.+| ++|+.|+|++|+|++ +|..+
T Consensus 129 ~~N~l~-~lp~~---l~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~-l~~~~~~ 202 (622)
T 3g06_A 129 FGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPTLPSE 202 (622)
T ss_dssp CSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCCCCTT
T ss_pred CCCCCC-cCCCC---CCCCCEEECcCCcCCC-cCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC-CCCccch
Confidence 999999 57764 4889999999999984 44433332 788899999998884 44321
Q ss_pred -----------------hhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 144 -----------------LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 144 -----------------~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
+++|+.|+|++|.|++ +| ..+++|+.|+++.|
T Consensus 203 L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N 251 (622)
T 3g06_A 203 LYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGN 251 (622)
T ss_dssp CCEEECCSSCCSSCCCCCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSS
T ss_pred hhEEECcCCcccccCCCCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCC
Confidence 2567788888888876 44 34577888888765
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=2.1e-15 Score=146.46 Aligned_cols=129 Identities=15% Similarity=0.134 Sum_probs=108.2
Q ss_pred CCCCcEEEccCCcccccCCccccCCC-cCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWT-LLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 80 (771)
+.+|+.|+|++|+|+ .+|. +..+. +|++|+|++|+|++. ..|..+++|++|+|++|++++.++..|..+++|++|
T Consensus 18 ~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 18 AVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp TTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred cCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 567899999999998 6665 55554 899999999999864 678889999999999999988765556889999999
Q ss_pred EccCCcCcccCCh--hhhcCCCCcEEEccCCCCCCCCCcc----ccCCCCCcEEEcCCCccc
Q 004155 81 ILRSCNVSGKLPD--YLGLMTSLKVLDVSFNKLNGAIPST----FMGLLDVDYIYLTGNLLT 136 (771)
Q Consensus 81 ~Ls~N~l~g~~p~--~~~~l~~L~~L~Ls~N~l~g~ip~~----~~~l~~L~~L~Ls~N~l~ 136 (771)
+|++|+|+ .+|. .+..+++|+.|+|++|.++ .+|.. +..+++|+.|++++|.+.
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 99999996 6776 7888999999999999998 66764 888999999999998876
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.5e-17 Score=165.03 Aligned_cols=132 Identities=15% Similarity=0.187 Sum_probs=82.5
Q ss_pred CCCcEEEccCCcccccCCc------cccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCC
Q 004155 3 VTLKDFRISDNHFTGKIPN------FIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKK 76 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 76 (771)
.+++.++|+.|.++|.+|. .++.+++|++|+|++|+|++ +| .+..+++|+.|+|++|+++.. |..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l-~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKI-ENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSC-SSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccc-cchhhcCCc
Confidence 3455666666666666665 66666666777776666664 55 666666666666666666643 344555566
Q ss_pred CcEEEccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCC--ccccCCCCCcEEEcCCCcccccCc
Q 004155 77 MKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIP--STFMGLLDVDYIYLTGNLLTGTIP 140 (771)
Q Consensus 77 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip--~~~~~l~~L~~L~Ls~N~l~g~iP 140 (771)
|++|+|++|+|++ +| .+..+++|+.|+|++|++++ +| ..+..+++|++|++++|.+++.+|
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 157 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc-hhHHHHHhcCCCCCEEEecCCccccccc
Confidence 6666666666663 44 46666666666666666663 32 246666666666666666665544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.55 E-value=1.8e-14 Score=139.03 Aligned_cols=109 Identities=18% Similarity=0.200 Sum_probs=85.6
Q ss_pred CCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccC
Q 004155 29 LEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSF 108 (771)
Q Consensus 29 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 108 (771)
.+.|++++|+|+ .+|..+. ++|+.|+|++|++++.++..|.++++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 467777777777 5776553 6788888888888887777788888888888888888855555678888888888888
Q ss_pred CCCCCCCCccccCCCCCcEEEcCCCcccccCc
Q 004155 109 NKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIP 140 (771)
Q Consensus 109 N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP 140 (771)
|+|++..+..|..+++|+.|+|++|.+++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 88886656668888899999999998886544
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.54 E-value=2.9e-16 Score=176.65 Aligned_cols=178 Identities=16% Similarity=0.184 Sum_probs=100.4
Q ss_pred CCCCcEEEccCCcccccCCcccc-----CCCcCCEEEcccCCcccc----CchhhcCCcCCCEEEcCCCCCCCCC-----
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQ-----NWTLLEKLVIQASGLVGP----IPSGIASLSKLTDLRISDLNGTEAP----- 67 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~----- 67 (771)
+++|++|+|++|.++...+..+. .+++|++|+|++|.+++. ++..+..+++|+.|+|++|.+....
T Consensus 169 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~ 248 (461)
T 1z7x_W 169 KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELC 248 (461)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHH
T ss_pred CCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHH
Confidence 45677777777776643333332 245677777777777642 4666666777777777777665421
Q ss_pred CCCccCCCCCcEEEccCCcCccc----CChhhhcCCCCcEEEccCCCCCCCCCccccC-----CCCCcEEEcCCCccccc
Q 004155 68 FPPLDKMKKMKTLILRSCNVSGK----LPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG-----LLDVDYIYLTGNLLTGT 138 (771)
Q Consensus 68 ~~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~-----l~~L~~L~Ls~N~l~g~ 138 (771)
+..+..+++|++|+|++|+++.. ++..+..+++|+.|+|++|.+++..+..+.. .++|+.|+|++|.+++.
T Consensus 249 ~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~ 328 (461)
T 1z7x_W 249 PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAA 328 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGG
T ss_pred HHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchH
Confidence 11222466677777777766643 5555666666777777776665332222221 24666666666666543
Q ss_pred ----Cchhh--hhcCCeecccCCccccCCCccccc-----ccccceeccCCC
Q 004155 139 ----IPPWM--LQKGDRVDLSYNSFTAGSSETSCQ-----YRSVNLFASSSK 179 (771)
Q Consensus 139 ----iP~~~--~~~L~~l~ls~N~l~~~~p~~~~~-----l~~L~~l~~s~~ 179 (771)
+|..+ .++|+.|+|++|.++...+..++. .++|+.|+++.+
T Consensus 329 ~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n 380 (461)
T 1z7x_W 329 CCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380 (461)
T ss_dssp GHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred HHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCC
Confidence 23322 355666666666665544443332 345566655543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.54 E-value=3.2e-14 Score=137.85 Aligned_cols=107 Identities=21% Similarity=0.241 Sum_probs=84.2
Q ss_pred CCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccC
Q 004155 29 LEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSF 108 (771)
Q Consensus 29 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 108 (771)
-+.+++++|+|+ .+|..+. ++|+.|+|++|++++.+|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 367788888886 6777664 7788888888888888777888888888888888888854444567888888888888
Q ss_pred CCCCCCCCccccCCCCCcEEEcCCCccccc
Q 004155 109 NKLNGAIPSTFMGLLDVDYIYLTGNLLTGT 138 (771)
Q Consensus 109 N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ 138 (771)
|+|++..+..|..+++|+.|+|++|.+...
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 888855555588888999999999988843
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.6e-14 Score=166.09 Aligned_cols=136 Identities=15% Similarity=0.119 Sum_probs=111.1
Q ss_pred cEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCC
Q 004155 6 KDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSC 85 (771)
Q Consensus 6 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 85 (771)
..+++++|.|+ .+|. ..|+.|+|++|+|++ +|. |+.|++|+.|+|++|+++.+ |..|+++++|+.|+|++|
T Consensus 426 ~~l~l~~n~i~-~l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~l-p~~~~~l~~L~~L~Ls~N 496 (567)
T 1dce_A 426 RSKFLLENSVL-KMEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDN 496 (567)
T ss_dssp HHHHHHHHHHH-HHHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCC-CGGGGGCTTCCEEECCSS
T ss_pred hhhhhhccccc-ccCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccccc-chhhhcCCCCCEEECCCC
Confidence 33445555565 3333 258999999999995 786 99999999999999999954 578999999999999999
Q ss_pred cCcccCChhhhcCCCCcEEEccCCCCCCCC-CccccCCCCCcEEEcCCCcccccCchh--h---hhcCCeecc
Q 004155 86 NVSGKLPDYLGLMTSLKVLDVSFNKLNGAI-PSTFMGLLDVDYIYLTGNLLTGTIPPW--M---LQKGDRVDL 152 (771)
Q Consensus 86 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~i-p~~~~~l~~L~~L~Ls~N~l~g~iP~~--~---~~~L~~l~l 152 (771)
+|++ +| .++.+++|+.|+|++|+|++.+ |..|+.+++|+.|+|++|+|++..|.. + +++|+.||+
T Consensus 497 ~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 497 ALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp CCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 9995 77 8999999999999999999776 899999999999999999999665532 1 677888764
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.53 E-value=6.3e-17 Score=160.56 Aligned_cols=147 Identities=18% Similarity=0.250 Sum_probs=129.3
Q ss_pred ccCCCcCCEEEcccCCccccCch------hhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhh
Q 004155 23 IQNWTLLEKLVIQASGLVGPIPS------GIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLG 96 (771)
Q Consensus 23 ~~~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 96 (771)
+.....++.++|+.|.++|.+|. .|..+++|++|+|++|++++.+ .+.++++|++|+|++|+|+ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l~--~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS--SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCCC--CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcccc--ccccCCCCCEEECCCCCcc-cccchhh
Confidence 45567888889999999888887 9999999999999999999954 8999999999999999999 8999888
Q ss_pred cCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCch--hh--hhcCCeecccCCccccCCCcc--------
Q 004155 97 LMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPP--WM--LQKGDRVDLSYNSFTAGSSET-------- 164 (771)
Q Consensus 97 ~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~--~~--~~~L~~l~ls~N~l~~~~p~~-------- 164 (771)
.+++|+.|+|++|++++ +| .+..+++|+.|+|++|+++ .+|. .+ +++|+.|++++|++++.+|..
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~ 167 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRI 167 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCC-chhHHHHHhcCCCCCEEEecCCccccccccccchHHHHH
Confidence 89999999999999995 66 6889999999999999999 4443 34 889999999999999887653
Q ss_pred --cccccccceec
Q 004155 165 --SCQYRSVNLFA 175 (771)
Q Consensus 165 --~~~l~~L~~l~ 175 (771)
+..+++|+.|+
T Consensus 168 ~~~~~l~~L~~Ld 180 (198)
T 1ds9_A 168 EVVKRLPNLKKLD 180 (198)
T ss_dssp HHHHHCSSCSEEC
T ss_pred HHHHhCCCcEEEC
Confidence 77888888886
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.53 E-value=3.7e-14 Score=136.88 Aligned_cols=106 Identities=18% Similarity=0.170 Sum_probs=78.9
Q ss_pred CcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccC
Q 004155 5 LKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRS 84 (771)
Q Consensus 5 L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 84 (771)
.+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|++++.++..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 467777777777 6776653 6777778888877766677777777778888877777777766777777788888887
Q ss_pred CcCcccCChhhhcCCCCcEEEccCCCCCC
Q 004155 85 CNVSGKLPDYLGLMTSLKVLDVSFNKLNG 113 (771)
Q Consensus 85 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 113 (771)
|+|++..+..|..+++|+.|+|++|.++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 77775445557777777788887777774
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.52 E-value=4.4e-16 Score=175.13 Aligned_cols=179 Identities=15% Similarity=0.049 Sum_probs=146.2
Q ss_pred CCCCcEEEccCCccccc----CCccccCCCcCCEEEcccCCccccC-----chhhcCCcCCCEEEcCCCCCCCC----CC
Q 004155 2 LVTLKDFRISDNHFTGK----IPNFIQNWTLLEKLVIQASGLVGPI-----PSGIASLSKLTDLRISDLNGTEA----PF 68 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~----ip~~~~~l~~L~~L~L~~N~l~~~~-----p~~~~~l~~L~~L~L~~n~l~~~----~~ 68 (771)
+++|+.|+|++|++++. ++..+..+++|++|+|++|+++..- +..+..+++|+.|+|++|+++.. .+
T Consensus 198 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~ 277 (461)
T 1z7x_W 198 PCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC 277 (461)
T ss_dssp CCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHH
T ss_pred CCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHH
Confidence 46899999999999953 6778888999999999999998532 23334689999999999998874 34
Q ss_pred CCccCCCCCcEEEccCCcCcccCChhhhcC-----CCCcEEEccCCCCCCC----CCccccCCCCCcEEEcCCCcccccC
Q 004155 69 PPLDKMKKMKTLILRSCNVSGKLPDYLGLM-----TSLKVLDVSFNKLNGA----IPSTFMGLLDVDYIYLTGNLLTGTI 139 (771)
Q Consensus 69 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l-----~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~i 139 (771)
..+.++++|++|+|++|.+++..+..+... ++|+.|+|++|.+++. +|..+..+++|++|+|++|++++..
T Consensus 278 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~ 357 (461)
T 1z7x_W 278 RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAG 357 (461)
T ss_dssp HHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHH
T ss_pred HHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCcccccc
Confidence 557779999999999999986555555443 6999999999999865 5667788899999999999998665
Q ss_pred chhh-------hhcCCeecccCCcccc----CCCcccccccccceeccCCCC
Q 004155 140 PPWM-------LQKGDRVDLSYNSFTA----GSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 140 P~~~-------~~~L~~l~ls~N~l~~----~~p~~~~~l~~L~~l~~s~~~ 180 (771)
+..+ .++|+.|+|++|.++. .+|..+..+++|+.|+++.|.
T Consensus 358 ~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~ 409 (461)
T 1z7x_W 358 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 409 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSS
T ss_pred HHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCC
Confidence 5544 2389999999999996 678888889999999988663
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.1e-13 Score=134.21 Aligned_cols=104 Identities=16% Similarity=0.160 Sum_probs=77.3
Q ss_pred cEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCC
Q 004155 6 KDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSC 85 (771)
Q Consensus 6 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 85 (771)
+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+++++++..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 56777777776 7777664 67777777777777666777777777777777777777776666777777777777777
Q ss_pred cCcccCChhhhcCCCCcEEEccCCCCC
Q 004155 86 NVSGKLPDYLGLMTSLKVLDVSFNKLN 112 (771)
Q Consensus 86 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 112 (771)
+|++..+..|..+++|+.|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 777444444777777777777777777
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.41 E-value=6.5e-13 Score=143.48 Aligned_cols=130 Identities=18% Similarity=0.262 Sum_probs=92.4
Q ss_pred EEEcccC-CccccCchhhcCCcCCCEEEcCC-CCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccC
Q 004155 31 KLVIQAS-GLVGPIPSGIASLSKLTDLRISD-LNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSF 108 (771)
Q Consensus 31 ~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~ 108 (771)
.++++++ +|+ .+|. |..+++|+.|+|++ |+++++++..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4577776 777 5777 77777888888875 777777777788888888888888888877777888888888888888
Q ss_pred CCCCCCCCccccCCCCCcEEEcCCCcccccCc-hhh--hhcCCeecccCCccccCCCc
Q 004155 109 NKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIP-PWM--LQKGDRVDLSYNSFTAGSSE 163 (771)
Q Consensus 109 N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP-~~~--~~~L~~l~ls~N~l~~~~p~ 163 (771)
|+|++..+..|..++ |+.|+|++|.|...-. .++ +.......+..+++++..|.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 888855444555554 8888888888874433 122 22233444555666666555
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.40 E-value=5.8e-13 Score=142.88 Aligned_cols=173 Identities=20% Similarity=0.160 Sum_probs=123.8
Q ss_pred CCCCcEEEccCCccc--c-----------------cCC-ccccC--------CCcCCEEEcccCCccccCchhhcCCcCC
Q 004155 2 LVTLKDFRISDNHFT--G-----------------KIP-NFIQN--------WTLLEKLVIQASGLVGPIPSGIASLSKL 53 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~--~-----------------~ip-~~~~~--------l~~L~~L~L~~N~l~~~~p~~~~~l~~L 53 (771)
+++|+.|||++|+|+ . .|| ..|.+ +++|+.|+|.+ .++..-+.+|.+|++|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L 126 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL 126 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence 688999999999998 1 233 25667 89999999998 8885556779999999
Q ss_pred CEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcC----c----------------------ccCChhh------------
Q 004155 54 TDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNV----S----------------------GKLPDYL------------ 95 (771)
Q Consensus 54 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l----~----------------------g~~p~~~------------ 95 (771)
+.|+|++|.+..+.+..|.++.++..|.+..+.. . +.++..+
T Consensus 127 ~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~ 206 (329)
T 3sb4_A 127 KICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINF 206 (329)
T ss_dssp CEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSE
T ss_pred ceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccce
Confidence 9999999988877777777777777666655221 0 0000000
Q ss_pred ----------------hcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh---hhcCC-eecccCC
Q 004155 96 ----------------GLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM---LQKGD-RVDLSYN 155 (771)
Q Consensus 96 ----------------~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~---~~~L~-~l~ls~N 155 (771)
..+++|+.|+|++|+++..-+..|.+|++|+.|+|.+| ++ .|+... +.+|+ .+++.+
T Consensus 207 l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~- 283 (329)
T 3sb4_A 207 LTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA- 283 (329)
T ss_dssp EEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-
T ss_pred EEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-
Confidence 12678888888888888333345888888888888887 66 555543 66777 888877
Q ss_pred ccccCCCcccccccccceeccCC
Q 004155 156 SFTAGSSETSCQYRSVNLFASSS 178 (771)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~l~~s~ 178 (771)
.++.+.+.+|..+.+|+.++++.
T Consensus 284 ~l~~I~~~aF~~c~~L~~l~l~~ 306 (329)
T 3sb4_A 284 SVTAIEFGAFMGCDNLRYVLATG 306 (329)
T ss_dssp TCCEECTTTTTTCTTEEEEEECS
T ss_pred cceEEchhhhhCCccCCEEEeCC
Confidence 77777778888888888887643
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.4e-12 Score=140.84 Aligned_cols=105 Identities=15% Similarity=0.094 Sum_probs=94.2
Q ss_pred cEEEccCC-cccccCCccccCCCcCCEEEccc-CCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEcc
Q 004155 6 KDFRISDN-HFTGKIPNFIQNWTLLEKLVIQA-SGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILR 83 (771)
Q Consensus 6 ~~L~Ls~N-~l~~~ip~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 83 (771)
..++++++ +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++.++..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35789998 999 7999 99999999999996 99998888899999999999999999999999999999999999999
Q ss_pred CCcCcccCChhhhcCCCCcEEEccCCCCCC
Q 004155 84 SCNVSGKLPDYLGLMTSLKVLDVSFNKLNG 113 (771)
Q Consensus 84 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 113 (771)
+|+|++..+..|..++ |+.|+|++|.|..
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 9999954444555555 9999999999983
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=5.4e-12 Score=130.54 Aligned_cols=147 Identities=15% Similarity=0.091 Sum_probs=116.1
Q ss_pred HHHHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEEE
Q 004155 416 IKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 416 l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 494 (771)
+......|.....++.|+.+.||++... |+.+++|+...........+.+|+.+++.+. +..+.++++++.+.+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3445567888888899999999999764 6889999986532222346888999999884 6778899999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhc----------------------------------
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE---------------------------------- 540 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~---------------------------------- 540 (771)
||||++|.+|.+.+. +......++.+++++|+.||+.
T Consensus 88 v~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 999999999987641 1233457889999999999981
Q ss_pred ----------------------CCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 541 ----------------------SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 541 ----------------------~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
.+..++|||++|.||+++++..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01468999999999999876666799999875
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=4.7e-14 Score=153.81 Aligned_cols=166 Identities=12% Similarity=0.079 Sum_probs=123.0
Q ss_pred CCCCcEEEccCCcccccCCccccC-----CCcCCEEEcccCCccccCchhh-cCCcCCCEEEcCCCCCCCCCCCCc----
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQN-----WTLLEKLVIQASGLVGPIPSGI-ASLSKLTDLRISDLNGTEAPFPPL---- 71 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~-----l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~n~l~~~~~~~~---- 71 (771)
+++|+.|+|++|+|+..-...+.. .++|+.|+|++|.|+..-...+ ..+++|+.|+|++|+++......+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 367999999999998543333333 2789999999999974333333 346789999999999876443333
Q ss_pred -cCCCCCcEEEccCCcCcc----cCChhhhcCCCCcEEEccCCCCCCC----CCccccCCCCCcEEEcCCCcccccCchh
Q 004155 72 -DKMKKMKTLILRSCNVSG----KLPDYLGLMTSLKVLDVSFNKLNGA----IPSTFMGLLDVDYIYLTGNLLTGTIPPW 142 (771)
Q Consensus 72 -~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~iP~~ 142 (771)
...++|+.|+|++|.|+. .++..+..+++|++|+|++|.|+.. ++..+..+++|+.|+|++|.|+..-...
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence 346889999999999974 2455567889999999999999742 3556777889999999999998432222
Q ss_pred h------hhcCCeecccCCccccCCCccccc
Q 004155 143 M------LQKGDRVDLSYNSFTAGSSETSCQ 167 (771)
Q Consensus 143 ~------~~~L~~l~ls~N~l~~~~p~~~~~ 167 (771)
+ .++|+.|+|++|.|+......++.
T Consensus 231 l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 231 LARAAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp HHHHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred HHHHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 2 478999999999998655444443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.18 E-value=2.7e-12 Score=148.88 Aligned_cols=172 Identities=8% Similarity=0.068 Sum_probs=122.3
Q ss_pred CCcEEEccCCc-ccc-cCCccccCCCcCCEEEcccCCcccc----CchhhcCCcCCCEEEcCCCCCCCCC----CCCccC
Q 004155 4 TLKDFRISDNH-FTG-KIPNFIQNWTLLEKLVIQASGLVGP----IPSGIASLSKLTDLRISDLNGTEAP----FPPLDK 73 (771)
Q Consensus 4 ~L~~L~Ls~N~-l~~-~ip~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~ 73 (771)
+|++|+|++|. ++. .++..+.++++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++.. +..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 38999998886 321 2233334678999999999988765 4555667889999999999887433 223567
Q ss_pred CCCCcEEEccCCcCcccCChhhhcCCCCcEEEccCCCCC---CCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCC
Q 004155 74 MKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLN---GAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGD 148 (771)
Q Consensus 74 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~---g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~ 148 (771)
+++|+.|+|++|.+. .+|..+..+++|+.|+++++... +..+..+..+++|+.|+++++... .+|..+ +++|+
T Consensus 219 ~~~L~~L~L~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~ 296 (592)
T 3ogk_B 219 CRSLVSVKVGDFEIL-ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIR 296 (592)
T ss_dssp CTTCCEEECSSCBGG-GGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCC
T ss_pred CCCCcEEeccCccHH-HHHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCc
Confidence 889999999999888 47788888899999998854333 334456677778888888776443 566555 67788
Q ss_pred eecccCCccccCCC-cccccccccceeccC
Q 004155 149 RVDLSYNSFTAGSS-ETSCQYRSVNLFASS 177 (771)
Q Consensus 149 ~l~ls~N~l~~~~p-~~~~~l~~L~~l~~s 177 (771)
.|+|++|.+++... ..+..+++|+.|+++
T Consensus 297 ~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~ 326 (592)
T 3ogk_B 297 KLDLLYALLETEDHCTLIQKCPNLEVLETR 326 (592)
T ss_dssp EEEETTCCCCHHHHHHHHTTCTTCCEEEEE
T ss_pred EEecCCCcCCHHHHHHHHHhCcCCCEEecc
Confidence 88888888665433 335667777777765
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=2.4e-11 Score=125.07 Aligned_cols=136 Identities=16% Similarity=0.120 Sum_probs=100.7
Q ss_pred CCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCc--EEeEEEEEEeCCEEEEEEEec
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPN--LVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~E~~ 499 (771)
++.+....+.|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34433333455669999998777888999997653 2245778999998885444 566888888878899999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcC--------------------------------------
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES-------------------------------------- 541 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~-------------------------------------- 541 (771)
+|.+|. .. .. ....++.++++.|..||+..
T Consensus 98 ~G~~l~--~~-------~~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 98 PGQDLL--SS-------HL---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp SSEETT--TS-------CC---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred CCcccC--cC-------cC---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 998773 21 11 12367788888888888742
Q ss_pred -----------------CCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 542 -----------------RLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 542 -----------------~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
+..++|||++|.||+++++..+.|+|||.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887667799999876
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.08 E-value=2.4e-11 Score=140.81 Aligned_cols=174 Identities=14% Similarity=0.066 Sum_probs=122.4
Q ss_pred CCCCcEEEccCCccccc----CCccccCCCcCCEEEcccCCcc----ccCchhhcCCcCCCEEEcCCCCCCCCCCCCccC
Q 004155 2 LVTLKDFRISDNHFTGK----IPNFIQNWTLLEKLVIQASGLV----GPIPSGIASLSKLTDLRISDLNGTEAPFPPLDK 73 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~----ip~~~~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 73 (771)
+++|++|+|++|.+++. ++..+.++++|+.|+|++|.++ +.++..+.++++|+.|+|++|.+.+.+ ..+.+
T Consensus 163 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~-~~~~~ 241 (592)
T 3ogk_B 163 CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV-GFFKA 241 (592)
T ss_dssp CTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGH-HHHHH
T ss_pred CCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHH-HHHhh
Confidence 67899999999998765 4445567889999999999997 345666678899999999998887743 66777
Q ss_pred CCCCcEEEccCCcCc---ccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh---hhcC
Q 004155 74 MKKMKTLILRSCNVS---GKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM---LQKG 147 (771)
Q Consensus 74 l~~L~~L~Ls~N~l~---g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~---~~~L 147 (771)
+++|+.|+++++... +..+..+..+++|+.|+++++... .+|..+..+++|++|+|++|.+++.....+ +++|
T Consensus 242 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L 320 (592)
T 3ogk_B 242 AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNL 320 (592)
T ss_dssp CTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTC
T ss_pred hhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCC
Confidence 888888888754332 234455667777888887776443 677777777788888888877664443222 6677
Q ss_pred CeecccCCccccCCCcccccccccceeccC
Q 004155 148 DRVDLSYNSFTAGSSETSCQYRSVNLFASS 177 (771)
Q Consensus 148 ~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s 177 (771)
+.|++++|-..+.++.....+++|+.|+++
T Consensus 321 ~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~ 350 (592)
T 3ogk_B 321 EVLETRNVIGDRGLEVLAQYCKQLKRLRIE 350 (592)
T ss_dssp CEEEEEGGGHHHHHHHHHHHCTTCCEEEEE
T ss_pred CEEeccCccCHHHHHHHHHhCCCCCEEEee
Confidence 777777333233334444556777777776
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.06 E-value=5e-12 Score=137.75 Aligned_cols=139 Identities=17% Similarity=0.131 Sum_probs=107.4
Q ss_pred CCCcEEEccCCcccccCCcccc-CCCcCCEEEcccCCccccCchhh-----cCCcCCCEEEcCCCCCCCCC----CCCcc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQ-NWTLLEKLVIQASGLVGPIPSGI-----ASLSKLTDLRISDLNGTEAP----FPPLD 72 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~-~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~n~l~~~~----~~~~~ 72 (771)
++|+.|+|++|.|+..-...+. .+++|+.|+|++|+|+..-...+ ...++|+.|+|++|.++... ...+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 5899999999999854333343 46789999999999985434444 34688999999999987532 23346
Q ss_pred CCCCCcEEEccCCcCccc----CChhhhcCCCCcEEEccCCCCCCC----CCccccCCCCCcEEEcCCCcccccCch
Q 004155 73 KMKKMKTLILRSCNVSGK----LPDYLGLMTSLKVLDVSFNKLNGA----IPSTFMGLLDVDYIYLTGNLLTGTIPP 141 (771)
Q Consensus 73 ~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~~L~Ls~N~l~g~iP~ 141 (771)
.+++|++|+|++|+|+.. ++..+..+++|+.|+|++|.|+.. ++..+..+++|++|+|++|.|+..-..
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~ 257 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQ 257 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHH
Confidence 789999999999999743 355677889999999999999842 444566678999999999999854333
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.06 E-value=4e-10 Score=120.61 Aligned_cols=168 Identities=14% Similarity=0.085 Sum_probs=135.0
Q ss_pred CCCCcEEEccCCcccccCC-ccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCC----CCCCCCCc-----
Q 004155 2 LVTLKDFRISDNHFTGKIP-NFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNG----TEAPFPPL----- 71 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l----~~~~~~~~----- 71 (771)
+++|+.|+|.+ +++ .|+ ..|.++++|+.|+|++|.+...-+.+|.++.++..|.+..+.. ..+....|
T Consensus 100 ~~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~ 177 (329)
T 3sb4_A 100 KQTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEP 177 (329)
T ss_dssp CTTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCC
T ss_pred cCCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccc
Confidence 68999999999 898 555 5799999999999999999866677898888888887766211 11111111
Q ss_pred ---------------------------------------------cCCCCCcEEEccCCcCcccCC-hhhhcCCCCcEEE
Q 004155 72 ---------------------------------------------DKMKKMKTLILRSCNVSGKLP-DYLGLMTSLKVLD 105 (771)
Q Consensus 72 ---------------------------------------------~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~ 105 (771)
..+++|+.|+|++|+++ .+| ..|.+|++|+.|+
T Consensus 178 L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~ 256 (329)
T 3sb4_A 178 LETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIK 256 (329)
T ss_dssp CEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCC-EECTTTTTTCTTCCEEE
T ss_pred cceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcc-eecHhhhhCCCCCCEEE
Confidence 02789999999999999 555 5799999999999
Q ss_pred ccCCCCCCCCCccccCCCCCc-EEEcCCCcccccCc-hhh--hhcCCeecccCCccccCCCcccccccccceec
Q 004155 106 VSFNKLNGAIPSTFMGLLDVD-YIYLTGNLLTGTIP-PWM--LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFA 175 (771)
Q Consensus 106 Ls~N~l~g~ip~~~~~l~~L~-~L~Ls~N~l~g~iP-~~~--~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~ 175 (771)
|.+| ++..-+..|.++.+|+ .|+|.+ +++ .|+ ..| +.+|+.+++++|+++...+.+|.++++|+.+.
T Consensus 257 l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 257 LPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 9998 7744456799999999 999998 777 555 445 78899999999999998899999999998875
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.01 E-value=4.2e-11 Score=138.87 Aligned_cols=62 Identities=16% Similarity=0.285 Sum_probs=26.4
Q ss_pred CCcEEEccCCcccccCCcccc-CCCcCCEEEcccC-Ccccc-CchhhcCCcCCCEEEcCCCCCCC
Q 004155 4 TLKDFRISDNHFTGKIPNFIQ-NWTLLEKLVIQAS-GLVGP-IPSGIASLSKLTDLRISDLNGTE 65 (771)
Q Consensus 4 ~L~~L~Ls~N~l~~~ip~~~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~n~l~~ 65 (771)
+|+.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+.++++|++|+|++|.+++
T Consensus 106 ~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~ 170 (594)
T 2p1m_B 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDD 170 (594)
T ss_dssp TCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEEC
T ss_pred CCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCC
Confidence 444444444444433333332 3444455555444 23211 22333344445555555444433
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.98 E-value=3.3e-11 Score=139.74 Aligned_cols=178 Identities=10% Similarity=0.010 Sum_probs=120.1
Q ss_pred CCCCcEEEccCCccccc-CCccccCCCcCCEEEcc---------cCCccccCchhhc-CCcCCCEEEcCCCCCCCCCCCC
Q 004155 2 LVTLKDFRISDNHFTGK-IPNFIQNWTLLEKLVIQ---------ASGLVGPIPSGIA-SLSKLTDLRISDLNGTEAPFPP 70 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~-ip~~~~~l~~L~~L~L~---------~N~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~ 70 (771)
+++|+.|+|++| ++.. ++.-...+++|+.|+|+ .|.+++.....+. .+++|+.|.++.|+++......
T Consensus 313 ~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~ 391 (594)
T 2p1m_B 313 CPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALIT 391 (594)
T ss_dssp CTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHH
T ss_pred CCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHH
Confidence 578999999988 5422 22223357888888883 3555543333333 4788888888888877654444
Q ss_pred cc-CCCCCcEEEcc--C----CcCccc-----CChhhhcCCCCcEEEccCCCCCCCCCccccC-CCCCcEEEcCCCcccc
Q 004155 71 LD-KMKKMKTLILR--S----CNVSGK-----LPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG-LLDVDYIYLTGNLLTG 137 (771)
Q Consensus 71 ~~-~l~~L~~L~Ls--~----N~l~g~-----~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~-l~~L~~L~Ls~N~l~g 137 (771)
+. .+++|+.|+|+ + |+++.. ++..+..+++|+.|+|++ .+++..+..++. +++|+.|+|++|.+++
T Consensus 392 l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~ 470 (594)
T 2p1m_B 392 IARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSD 470 (594)
T ss_dssp HHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSH
T ss_pred HHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcH
Confidence 44 57888899888 4 556521 122266788889999876 666555555555 7888999998888876
Q ss_pred cCchhh---hhcCCeecccCCccccCCCc-ccccccccceeccCCCCC
Q 004155 138 TIPPWM---LQKGDRVDLSYNSFTAGSSE-TSCQYRSVNLFASSSKGN 181 (771)
Q Consensus 138 ~iP~~~---~~~L~~l~ls~N~l~~~~p~-~~~~l~~L~~l~~s~~~~ 181 (771)
..+..+ +++|+.|+|++|+++..... ....+++|+.|+++.+..
T Consensus 471 ~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 471 LGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 555444 67888899998888654443 344578888888876644
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.96 E-value=2.2e-10 Score=121.23 Aligned_cols=183 Identities=17% Similarity=0.201 Sum_probs=123.6
Q ss_pred CCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-CCc--EEeEEEEEEeCC---EEEEEEEec
Q 004155 426 DNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-HPN--LVKLHGCCIEGN---QLLLIYEYM 499 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~E~~ 499 (771)
.+.++.|....||+.. ..+++|+... ......+.+|+.+++.+. +.. +.+++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999874 4588898643 234567889999998873 322 445555443333 348899999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhc---------------------------------------
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE--------------------------------------- 540 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~--------------------------------------- 540 (771)
+|.+|.+... ..++..++..++.++++.|+.||+.
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988765331 3467778888899999999998861
Q ss_pred ----------------CCCceeccCCCCCcEEEcC--CCCeEEEeecCccccCCCCcccccccccCCCc---cchhhhcc
Q 004155 541 ----------------SRLKIVHRDIKATNVLLDK--DLNPKISDFGLAKLDEEDNTHISTRVAGTFGY---MAPEYAMR 599 (771)
Q Consensus 541 ----------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~ 599 (771)
.++.++|+|++|.||++++ ...+.|+||+.+...+....- .....+ ..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-----~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-----ISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-----HTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-----HHHHhhccccCHHHHHH
Confidence 1245899999999999988 556889999998754321110 001111 22332210
Q ss_pred -----CCC---------CchHhHHHHHHHHHHHHhCCCCC
Q 004155 600 -----GYL---------TDKADVYSFGIVALEIVSGRSNS 625 (771)
Q Consensus 600 -----~~~---------~~ksDV~S~Gvil~elltG~~p~ 625 (771)
+.. ....+.|++|.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 12368999999999999998665
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.96 E-value=9.7e-10 Score=119.15 Aligned_cols=142 Identities=17% Similarity=0.230 Sum_probs=107.1
Q ss_pred CCccccCCceeEEEEEcCCCcEEEEEEcc--cCC-hhcHHHHHHHHHHHHcCC--CCcEEeEEEEEEeC---CEEEEEEE
Q 004155 426 DNKIGEGGFGPVYKGHMADGTVVAVKQLS--SKS-KQGNREFVNEIGMISALQ--HPNLVKLHGCCIEG---NQLLLIYE 497 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~g~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~E 497 (771)
.+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..++++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 5678999999999998754 678888775 322 122456788999999886 45688899888766 45899999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcC------------------------------------
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES------------------------------------ 541 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~------------------------------------ 541 (771)
|++|..+.+.. ...++..++..++.+++++|+.||+..
T Consensus 122 ~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 122 FVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred ecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99987764321 134778889999999999999999731
Q ss_pred -------------------CCceeccCCCCCcEEEcCCCC--eEEEeecCcccc
Q 004155 542 -------------------RLKIVHRDIKATNVLLDKDLN--PKISDFGLAKLD 574 (771)
Q Consensus 542 -------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DFGla~~~ 574 (771)
+..++|||+++.||+++.++. +.|+||+.+..-
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999987753 689999998743
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.95 E-value=2.5e-09 Score=117.53 Aligned_cols=167 Identities=12% Similarity=0.155 Sum_probs=119.9
Q ss_pred CCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEcc
Q 004155 4 TLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILR 83 (771)
Q Consensus 4 ~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 83 (771)
+|+.+.|.+ .++..-+..|.++++|+.++|++|+++ .+|.....+.+|+.+.|.+ +++.+....|.++++|+.|+|.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~ 234 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIP 234 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCT-TCCEECTTTTTTCTTCCCEECC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCC-chheehhhHhhCCCCCCEEecC
Confidence 578888876 676333457888899999999988888 4554433468899998884 4777777888888899999988
Q ss_pred CCcCcccCC-hhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCccc----ccCchh-h--hhcCCeecccCC
Q 004155 84 SCNVSGKLP-DYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLT----GTIPPW-M--LQKGDRVDLSYN 155 (771)
Q Consensus 84 ~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~----g~iP~~-~--~~~L~~l~ls~N 155 (771)
+| ++ .++ ..|.+ .+|+.+.| .|.++..-+..|.+|++|+.+.+.+|.+. ..++.. | +.+|+.++|. |
T Consensus 235 ~~-l~-~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~ 309 (401)
T 4fdw_A 235 EN-VS-TIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-E 309 (401)
T ss_dssp TT-CC-EECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-T
T ss_pred CC-cc-Ccccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-C
Confidence 75 55 444 45555 78888888 45566344556888888888888887664 124433 3 6678888888 4
Q ss_pred ccccCCCcccccccccceeccCC
Q 004155 156 SFTAGSSETSCQYRSVNLFASSS 178 (771)
Q Consensus 156 ~l~~~~p~~~~~l~~L~~l~~s~ 178 (771)
.++.+...+|..+.+|+.+.+..
T Consensus 310 ~i~~I~~~aF~~c~~L~~l~lp~ 332 (401)
T 4fdw_A 310 SIRILGQGLLGGNRKVTQLTIPA 332 (401)
T ss_dssp TCCEECTTTTTTCCSCCEEEECT
T ss_pred ceEEEhhhhhcCCCCccEEEECc
Confidence 57767777888888888887743
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.83 E-value=2.2e-09 Score=116.00 Aligned_cols=174 Identities=12% Similarity=0.146 Sum_probs=121.4
Q ss_pred CCCcEEEccCCcccc-c-------CCccccCCCcCCEEEcccCCcc---------ccCchhhcCCcCCCEEEcCCCCCCC
Q 004155 3 VTLKDFRISDNHFTG-K-------IPNFIQNWTLLEKLVIQASGLV---------GPIPSGIASLSKLTDLRISDLNGTE 65 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~-~-------ip~~~~~l~~L~~L~L~~N~l~---------~~~p~~~~~l~~L~~L~L~~n~l~~ 65 (771)
.+++.|.+....+.| . +...+..+++|+.|.+.++... +.++..+..+++|+.|+|++|....
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~ 186 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS 186 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce
Confidence 457788887666542 2 1233556889999999776431 2466777889999999999874233
Q ss_pred CCCCCccCCCCCcEEEccCCcCcccCChhhh--cCCCCcEEEccC--CCCCCC-----CCccc--cCCCCCcEEEcCCCc
Q 004155 66 APFPPLDKMKKMKTLILRSCNVSGKLPDYLG--LMTSLKVLDVSF--NKLNGA-----IPSTF--MGLLDVDYIYLTGNL 134 (771)
Q Consensus 66 ~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~l~~L~~L~Ls~--N~l~g~-----ip~~~--~~l~~L~~L~Ls~N~ 134 (771)
.+ + +. +++|+.|+|..|.+.......++ .+++|+.|+|+. |...|. +...+ ..+++|+.|+|++|.
T Consensus 187 l~-~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~ 263 (362)
T 2ra8_A 187 IG-K-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263 (362)
T ss_dssp CC-S-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCT
T ss_pred ec-c-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCC
Confidence 32 2 43 89999999999988744334454 789999999864 332222 11122 357899999999999
Q ss_pred ccccCchhh-----hhcCCeecccCCccccC----CCcccccccccceeccCCC
Q 004155 135 LTGTIPPWM-----LQKGDRVDLSYNSFTAG----SSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 135 l~g~iP~~~-----~~~L~~l~ls~N~l~~~----~p~~~~~l~~L~~l~~s~~ 179 (771)
+.+..+..+ +++|+.|+|+.|.++.. ++..+..+++|+.|+++.+
T Consensus 264 i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n 317 (362)
T 2ra8_A 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317 (362)
T ss_dssp THHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSB
T ss_pred CchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCC
Confidence 985544333 67899999999999874 3444466788999998755
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.78 E-value=2.5e-08 Score=109.48 Aligned_cols=164 Identities=12% Similarity=0.083 Sum_probs=129.7
Q ss_pred CCcEEEccCCcccccCCc-cccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 4 TLKDFRISDNHFTGKIPN-FIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 4 ~L~~L~Ls~N~l~~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
+|+.+.|.+| ++ .|+. .|.+ .+|+.+.|.+ .++..-+.+|.+|.+|+.++|++|+++.++...|. +.+|+.+.|
T Consensus 136 ~L~~i~l~~~-i~-~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~l 210 (401)
T 4fdw_A 136 QIAKVVLNEG-LK-SIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLL 210 (401)
T ss_dssp CCSEEECCTT-CC-EECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEEC
T ss_pred CccEEEeCCC-cc-EECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEe
Confidence 6888999877 77 5554 5666 5799999986 77755677899999999999999999998888887 589999999
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCch-hh--hhcCCeecccCCccc-
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPP-WM--LQKGDRVDLSYNSFT- 158 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~-~~--~~~L~~l~ls~N~l~- 158 (771)
.+| +...-...|.++++|+.|+|..| ++..-...|.+ .+|+.+.| .|.++ .|+. .| +.+|+.+++.+|.+.
T Consensus 211 p~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~-~I~~~aF~~c~~L~~l~l~~~~~~~ 285 (401)
T 4fdw_A 211 PVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVT-NIASRAFYYCPELAEVTTYGSTFND 285 (401)
T ss_dssp CTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCC-EECTTTTTTCTTCCEEEEESSCCCC
T ss_pred CCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCcc-EEChhHhhCCCCCCEEEeCCccccC
Confidence 855 76344567999999999999876 55233445766 78999999 45566 5554 44 778999999988776
Q ss_pred ----cCCCcccccccccceeccC
Q 004155 159 ----AGSSETSCQYRSVNLFASS 177 (771)
Q Consensus 159 ----~~~p~~~~~l~~L~~l~~s 177 (771)
...+..|..+.+|+.+.+.
T Consensus 286 ~~~~~I~~~aF~~c~~L~~l~l~ 308 (401)
T 4fdw_A 286 DPEAMIHPYCLEGCPKLARFEIP 308 (401)
T ss_dssp CTTCEECTTTTTTCTTCCEECCC
T ss_pred CcccEECHHHhhCCccCCeEEeC
Confidence 4667889999999998876
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.73 E-value=4.2e-09 Score=113.76 Aligned_cols=157 Identities=13% Similarity=0.205 Sum_probs=108.6
Q ss_pred CCCCcEEEccCCccc---------ccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCcc
Q 004155 2 LVTLKDFRISDNHFT---------GKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLD 72 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~---------~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 72 (771)
|++|+.|.+.++... +.++..+..+++|+.|+|++|.-. .++. + .+++|+.|+|..|.+.......+.
T Consensus 138 l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~ 214 (362)
T 2ra8_A 138 FAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDIL 214 (362)
T ss_dssp HTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHH
T ss_pred cchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHH
Confidence 578999999766432 234455677899999999988411 3444 4 388999999998877543323333
Q ss_pred --CCCCCcEEEccC--CcCccc-----CChhh--hcCCCCcEEEccCCCCCCCCCcccc---CCCCCcEEEcCCCccccc
Q 004155 73 --KMKKMKTLILRS--CNVSGK-----LPDYL--GLMTSLKVLDVSFNKLNGAIPSTFM---GLLDVDYIYLTGNLLTGT 138 (771)
Q Consensus 73 --~l~~L~~L~Ls~--N~l~g~-----~p~~~--~~l~~L~~L~Ls~N~l~g~ip~~~~---~l~~L~~L~Ls~N~l~g~ 138 (771)
.+++|+.|+|+. |...|. +...+ ..+++|+.|+|++|.+.+..+..+. .+++|+.|+|+.|.|++.
T Consensus 215 ~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 215 GSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp HSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred HccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence 789999999863 332211 11122 3578999999999998754433332 578999999999999864
Q ss_pred ----Cchhh--hhcCCeecccCCccccCC
Q 004155 139 ----IPPWM--LQKGDRVDLSYNSFTAGS 161 (771)
Q Consensus 139 ----iP~~~--~~~L~~l~ls~N~l~~~~ 161 (771)
++..+ +++|+.|+|++|.++...
T Consensus 295 G~~~L~~~L~~l~~L~~L~L~~n~i~d~~ 323 (362)
T 2ra8_A 295 GARLLLDHVDKIKHLKFINMKYNYLSDEM 323 (362)
T ss_dssp HHHHHHTTHHHHTTCSEEECCSBBCCHHH
T ss_pred HHHHHHhhcccCCcceEEECCCCcCCHHH
Confidence 33332 688999999999887543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.52 E-value=2.1e-08 Score=103.04 Aligned_cols=104 Identities=13% Similarity=0.033 Sum_probs=72.5
Q ss_pred ccCCCcCCE--EEcccCCccccCch----hhcCCcCCCEEEcCCCCCCCCC--CCCccCCCCCcEEEccCCcCcccCChh
Q 004155 23 IQNWTLLEK--LVIQASGLVGPIPS----GIASLSKLTDLRISDLNGTEAP--FPPLDKMKKMKTLILRSCNVSGKLPDY 94 (771)
Q Consensus 23 ~~~l~~L~~--L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~Ls~N~l~g~~p~~ 94 (771)
|...+.|.. ++++.|+.. .++. ...++++|+.|+|++|+++++. +..+..+++|+.|+|++|+|++. ..
T Consensus 137 l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~ 213 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RE 213 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GG
T ss_pred cCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hh
Confidence 444455555 677777544 3333 2246788888888888888743 34566788888888888888854 34
Q ss_pred hhcCC--CCcEEEccCCCCCCCCCc-------cccCCCCCcEEE
Q 004155 95 LGLMT--SLKVLDVSFNKLNGAIPS-------TFMGLLDVDYIY 129 (771)
Q Consensus 95 ~~~l~--~L~~L~Ls~N~l~g~ip~-------~~~~l~~L~~L~ 129 (771)
+..+. +|+.|+|++|.+++.+|+ .+..+++|+.||
T Consensus 214 l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 214 LDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 45555 888888888888877763 366788888876
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.49 E-value=1.3e-08 Score=104.49 Aligned_cols=118 Identities=17% Similarity=0.188 Sum_probs=83.0
Q ss_pred EEcccCCccccCch-hhcCCcCCCE--EEcCCCCCCCCC---CCCccCCCCCcEEEccCCcCcc--cCChhhhcCCCCcE
Q 004155 32 LVIQASGLVGPIPS-GIASLSKLTD--LRISDLNGTEAP---FPPLDKMKKMKTLILRSCNVSG--KLPDYLGLMTSLKV 103 (771)
Q Consensus 32 L~L~~N~l~~~~p~-~~~~l~~L~~--L~L~~n~l~~~~---~~~~~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~ 103 (771)
|....|..++.++- .|...+.|.. ++++.|+..... .....++++|+.|+|++|+|++ .+|..+..+++|+.
T Consensus 121 l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~ 200 (267)
T 3rw6_A 121 MSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI 200 (267)
T ss_dssp HHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCE
T ss_pred HHhccchhccccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCE
Confidence 33444444444432 2555566665 677777443221 1112468999999999999997 56778889999999
Q ss_pred EEccCCCCCCCCCccccCCC--CCcEEEcCCCcccccCchh-------h--hhcCCeec
Q 004155 104 LDVSFNKLNGAIPSTFMGLL--DVDYIYLTGNLLTGTIPPW-------M--LQKGDRVD 151 (771)
Q Consensus 104 L~Ls~N~l~g~ip~~~~~l~--~L~~L~Ls~N~l~g~iP~~-------~--~~~L~~l~ 151 (771)
|+|++|+|++. ..+..+. +|++|+|++|.+++.+|.. + +++|+.||
T Consensus 201 L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 201 LNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp EECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred EECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 99999999954 3355555 9999999999999888731 1 77787776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=8.5e-07 Score=93.59 Aligned_cols=138 Identities=18% Similarity=0.178 Sum_probs=98.3
Q ss_pred CCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCC---cEEeEEEEEE-eCCEEEEEEEeccC
Q 004155 426 DNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHP---NLVKLHGCCI-EGNQLLLIYEYMEN 501 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~E~~~~ 501 (771)
.+.++.|....||+. |..+++|+-. .......+.+|+++|+.+.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888999999998 4668888843 233456789999999998642 3566777764 34567899999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhc-----------------------------------------
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE----------------------------------------- 540 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~----------------------------------------- 540 (771)
.++.+... ..++..++..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88776321 1345555666666666666666642
Q ss_pred ----------------CCCceeccCCCCCcEEEcC---CCC-eEEEeecCccccC
Q 004155 541 ----------------SRLKIVHRDIKATNVLLDK---DLN-PKISDFGLAKLDE 575 (771)
Q Consensus 541 ----------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DFGla~~~~ 575 (771)
.++.++|+|+++.||+++. ++. +.|+||+.+...+
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2235699999999999987 455 4899999887543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1e-06 Score=90.99 Aligned_cols=135 Identities=15% Similarity=0.113 Sum_probs=98.3
Q ss_pred ccccCCce-eEEEEEcC-CCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEEEEEEeccCCCH
Q 004155 428 KIGEGGFG-PVYKGHMA-DGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLLLIYEYMENNSL 504 (771)
Q Consensus 428 ~lG~G~~g-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gsL 504 (771)
.+..|..| .||+.... ++..+++|+-.. .....+.+|..+|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68988654 467789998643 23456888999998874 33477889999999999999999999888
Q ss_pred HHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhc--------------------------------------------
Q 004155 505 ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE-------------------------------------------- 540 (771)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-------------------------------------------- 540 (771)
.+... ........++.+++..|..||..
T Consensus 108 ~~~~~--------~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLE--------EYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHH--------HCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccc--------CCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 77651 12233445666777777777742
Q ss_pred -----------CCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 541 -----------SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 541 -----------~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
.++.++|+|+++.||+++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112379999999999999877777999998863
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.38 E-value=6e-08 Score=94.44 Aligned_cols=116 Identities=16% Similarity=0.076 Sum_probs=88.3
Q ss_pred ccccCCCcCCEEEcccC-Cccc----cCchhhcCCcCCCEEEcCCCCCCCCC----CCCccCCCCCcEEEccCCcCccc-
Q 004155 21 NFIQNWTLLEKLVIQAS-GLVG----PIPSGIASLSKLTDLRISDLNGTEAP----FPPLDKMKKMKTLILRSCNVSGK- 90 (771)
Q Consensus 21 ~~~~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~Ls~N~l~g~- 90 (771)
..+...++|++|+|++| .|.. .+...+...++|++|+|++|++.... ...+...++|++|+|++|+|...
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 34566788999999998 8863 24566677788999999999886522 22345568899999999999843
Q ss_pred ---CChhhhcCCCCcEEEc--cCCCCCCC----CCccccCCCCCcEEEcCCCccc
Q 004155 91 ---LPDYLGLMTSLKVLDV--SFNKLNGA----IPSTFMGLLDVDYIYLTGNLLT 136 (771)
Q Consensus 91 ---~p~~~~~l~~L~~L~L--s~N~l~g~----ip~~~~~l~~L~~L~Ls~N~l~ 136 (771)
+...+...++|++|+| ++|.|... +...+...++|++|+|++|.+.
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4556777889999999 88999843 3345566789999999999986
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.37 E-value=3.5e-08 Score=96.15 Aligned_cols=118 Identities=11% Similarity=0.120 Sum_probs=90.6
Q ss_pred cCchhhcCCcCCCEEEcCCC-CCCCCC----CCCccCCCCCcEEEccCCcCccc----CChhhhcCCCCcEEEccCCCCC
Q 004155 42 PIPSGIASLSKLTDLRISDL-NGTEAP----FPPLDKMKKMKTLILRSCNVSGK----LPDYLGLMTSLKVLDVSFNKLN 112 (771)
Q Consensus 42 ~~p~~~~~l~~L~~L~L~~n-~l~~~~----~~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~ 112 (771)
.+...+...++|+.|+|++| .+.... ...+...++|++|+|++|+|... +...+...++|++|+|++|.|.
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 45566778899999999999 876421 23456678999999999999742 3445666789999999999998
Q ss_pred CC----CCccccCCCCCcEEEc--CCCcccccCchhh------hhcCCeecccCCcccc
Q 004155 113 GA----IPSTFMGLLDVDYIYL--TGNLLTGTIPPWM------LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 113 g~----ip~~~~~l~~L~~L~L--s~N~l~g~iP~~~------~~~L~~l~ls~N~l~~ 159 (771)
.. +...+...++|++|+| ++|.|...--..+ .+.|+.|+|++|.+..
T Consensus 107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~~ 165 (185)
T 1io0_A 107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGP 165 (185)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHHH
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCCh
Confidence 43 4556778889999999 8899985432222 3689999999999863
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=1.1e-06 Score=94.84 Aligned_cols=80 Identities=6% Similarity=0.037 Sum_probs=55.2
Q ss_pred CCcc-ccCCceeEEEEEcC-------CCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCC-C--CcEEeEEEEEEeC--
Q 004155 426 DNKI-GEGGFGPVYKGHMA-------DGTVVAVKQLSSKS---KQGNREFVNEIGMISALQ-H--PNLVKLHGCCIEG-- 489 (771)
Q Consensus 426 ~~~l-G~G~~g~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 489 (771)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998654 26789999865422 001245678888888774 2 3567788877654
Q ss_pred -CEEEEEEEeccCCCHH
Q 004155 490 -NQLLLIYEYMENNSLA 505 (771)
Q Consensus 490 -~~~~lV~E~~~~gsL~ 505 (771)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999986654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.90 E-value=2.8e-05 Score=82.83 Aligned_cols=141 Identities=17% Similarity=0.239 Sum_probs=80.4
Q ss_pred CccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC--CCcEEeEEE------EEEeCCEEEEEEEe
Q 004155 427 NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ--HPNLVKLHG------CCIEGNQLLLIYEY 498 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lV~E~ 498 (771)
+.|+.|..+.||+....+| .+++|+.... ...+..|+.+++.+. .-.+++++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999977555 4899988752 233344555555442 112333332 12346778999999
Q ss_pred ccCCCHH--------------HHhcCCCc----c------CCCCChHHH-------------------------------
Q 004155 499 MENNSLA--------------RALFGPEA----H------RLKLDWPTR------------------------------- 523 (771)
Q Consensus 499 ~~~gsL~--------------~~l~~~~~----~------~~~l~~~~~------------------------------- 523 (771)
++|.++. ..+|.... . ...-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986432 11121000 0 001123211
Q ss_pred HHHHHHHHHHHHHhhh----------cCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 524 HRICVGIARGLAYLHE----------ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 524 ~~i~~~ia~aL~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
..+..++..++++|++ ..+..++|||+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111224446677763 124589999999999999888899999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=2.8e-05 Score=85.08 Aligned_cols=75 Identities=13% Similarity=0.119 Sum_probs=49.3
Q ss_pred CCccccCCceeEEEEEcC-CCcEEEEEEcccCCh-------hcHHHHHHHHHHHHcCCC--C-cEEeEEEEEEeCCEEEE
Q 004155 426 DNKIGEGGFGPVYKGHMA-DGTVVAVKQLSSKSK-------QGNREFVNEIGMISALQH--P-NLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l 494 (771)
.+.||.|.++.||++... +++.|+||....... .....+..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999654 468899998653221 123456778888887632 3 34455543 3455689
Q ss_pred EEEeccCC
Q 004155 495 IYEYMENN 502 (771)
Q Consensus 495 V~E~~~~g 502 (771)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.80 E-value=9.4e-05 Score=77.83 Aligned_cols=139 Identities=16% Similarity=0.156 Sum_probs=92.5
Q ss_pred CCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC---CCcEEeEEEEEEeCCEEEEEEEeccCC
Q 004155 426 DNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ---HPNLVKLHGCCIEGNQLLLIYEYMENN 502 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~E~~~~g 502 (771)
.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...++++++++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999986 4678889986532 3567888999888873 356888998888888899999999987
Q ss_pred CHH--------H---HhcCCCc-cCC-----------------CCChHHHH---HHHH----------------HHHHH-
Q 004155 503 SLA--------R---ALFGPEA-HRL-----------------KLDWPTRH---RICV----------------GIARG- 533 (771)
Q Consensus 503 sL~--------~---~l~~~~~-~~~-----------------~l~~~~~~---~i~~----------------~ia~a- 533 (771)
.+. + .||.... ... .-+|.... ++.. .+...
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 542 1 1222111 000 11444321 1111 11111
Q ss_pred HHHhhh-cCCCceeccCCCCCcEEEcCCCCeEEEeec
Q 004155 534 LAYLHE-ESRLKIVHRDIKATNVLLDKDLNPKISDFG 569 (771)
Q Consensus 534 L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 569 (771)
...|.. ..++.++|+|+.+.|++++.++ +.|.||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123321 2356899999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.78 E-value=1.8e-05 Score=87.38 Aligned_cols=80 Identities=10% Similarity=0.030 Sum_probs=50.4
Q ss_pred CCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcccccccccCCCccchhhhccC---CCCchHhHHHHHHHHHHH
Q 004155 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG---YLTDKADVYSFGIVALEI 618 (771)
Q Consensus 542 ~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDV~S~Gvil~el 618 (771)
+..++|||+++.||+++.++ ++|+||+.+..-.....-......-...|.+|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 45899999999999998876 99999999875432111000000001246666655321 122346667888888888
Q ss_pred HhCC
Q 004155 619 VSGR 622 (771)
Q Consensus 619 ltG~ 622 (771)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.74 E-value=4.2e-05 Score=79.65 Aligned_cols=78 Identities=21% Similarity=0.236 Sum_probs=56.8
Q ss_pred CCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-C--CcEEeEEEEEEeCCEEEEEEEe
Q 004155 422 NFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-H--PNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lV~E~ 498 (771)
.....+.+|.|..+.||+.+..||+.|.+|+-..........|..|+..|+.+. . --+++++++ .. -++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEe
Confidence 344567899999999999999999999999876544333456788999988874 2 234455544 22 3789999
Q ss_pred ccCCC
Q 004155 499 MENNS 503 (771)
Q Consensus 499 ~~~gs 503 (771)
++++.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 98764
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00012 Score=70.04 Aligned_cols=76 Identities=21% Similarity=0.300 Sum_probs=58.1
Q ss_pred cccccceEEEEEecCeeccccCCcchhcCCcCcceeeeeeeeeecceeEEEEEEc-CCcceecccC--CCCCCccccccc
Q 004155 270 SHSFGRRIFDVYIQGKLVLKDFNIEDEAGGIGKAIVKQFPVVVINSTIEIRLYWA-GKGTTGVPVR--GVYGPLISAISL 346 (771)
Q Consensus 270 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~-~~~~~~~~~~--~~~~p~~~~~~~ 346 (771)
+...|+|+|+||+||..++++|||..++|+ ..++.+.|.+.|.++.+.++..|+ ..|...+... ..+.|++.++.+
T Consensus 90 ~~~~~~rvFdV~ing~~~l~~fdi~~~ag~-~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~~a~inaIEI 168 (174)
T 2jwp_A 90 FAQSQQKVFDVRVNGHTVVKDLDIFDRVGH-STAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFI 168 (174)
T ss_dssp CCCSSSSCEEEEETTEEEEEEECHHHHHSS-SSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSCSSSEEEEEE
T ss_pred cCCCCCeEeEEEECCEEeecCcCHHHhhCC-CeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccCCCCcEEEEEEE
Confidence 456899999999999999999999999987 678889999999999888887775 4444433321 134566665543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00017 Score=78.71 Aligned_cols=167 Identities=12% Similarity=0.018 Sum_probs=85.3
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCC-------------------
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLN------------------- 62 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~------------------- 62 (771)
+++|+.+.|.++-.+ .-...|.++.+|+.+.+..| ++..-...|.++..|+.+.+.++.
T Consensus 161 c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~~~~~~~~~l~~i~ip 238 (394)
T 4fs7_A 161 CESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLGDFALSKTGVKNIIIP 238 (394)
T ss_dssp CTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECTTTTTTCCCCEEEEC
T ss_pred cCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEeehhhcccCCCceEEEC
Confidence 345666666544222 22334555666666666554 332233445555555544443321
Q ss_pred --CCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCc
Q 004155 63 --GTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIP 140 (771)
Q Consensus 63 --l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP 140 (771)
++.+....|..+.+|+.+.+..+... .-...|..+..|+.+.+..+.+. ...|..+.+|+.+.+.++ ++ .|+
T Consensus 239 ~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~-~I~ 312 (394)
T 4fs7_A 239 DSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VK-FIG 312 (394)
T ss_dssp TTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CC-EEC
T ss_pred CCceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cc-eec
Confidence 11112223444555555555544332 22333444444444444433221 124666777887777655 55 444
Q ss_pred hh-h--hhcCCeecccCCccccCCCcccccccccceeccC
Q 004155 141 PW-M--LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASS 177 (771)
Q Consensus 141 ~~-~--~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s 177 (771)
.. + ..+|+.++|.++ ++.+...+|.++.+|+.+.+.
T Consensus 313 ~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp 351 (394)
T 4fs7_A 313 EEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFP 351 (394)
T ss_dssp TTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCC
T ss_pred hhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEEC
Confidence 33 3 467777777643 665566777777777777654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00066 Score=73.39 Aligned_cols=126 Identities=15% Similarity=0.112 Sum_probs=63.8
Q ss_pred ccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCc
Q 004155 23 IQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLK 102 (771)
Q Consensus 23 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 102 (771)
+....+|+.+.+..+ +...-...|.++.+|+.+.+..+ ++.+....|.++.+|+.+.+..+ +...-...|.++++|+
T Consensus 213 f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~ 289 (379)
T 4h09_A 213 FSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLT 289 (379)
T ss_dssp TTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCC
T ss_pred cccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccc
Confidence 444455555555443 22233445555666666666543 44444455666666666666433 3312223455666666
Q ss_pred EEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchh-h--hhcCCeeccc
Q 004155 103 VLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPW-M--LQKGDRVDLS 153 (771)
Q Consensus 103 ~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~-~--~~~L~~l~ls 153 (771)
.+.+.+|.++..-...|.++.+|+.+.|.++ ++ .|+.. | ..+|+.+.+.
T Consensus 290 ~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 290 KVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp EEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCCC
T ss_pred cccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEEC
Confidence 6666666655222334666666666666543 44 33332 2 3445555543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00023 Score=77.65 Aligned_cols=131 Identities=13% Similarity=0.091 Sum_probs=93.8
Q ss_pred CccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCC
Q 004155 20 PNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMT 99 (771)
Q Consensus 20 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 99 (771)
...|.+..+|+.+.+.++-.+ .-...|.++.+|+.+.+. +.++.+....|.++.+|+.++|..+ ++..-...|.+|+
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~ 334 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE 334 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence 456888899999999876654 556788999999999996 4677777788999999999999865 6623345799999
Q ss_pred CCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCcc
Q 004155 100 SLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSF 157 (771)
Q Consensus 100 ~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l 157 (771)
+|+.+.|..+ ++..-...|.+|++|+.+++.+|.... ..+ ...|+.+.+..|.+
T Consensus 335 ~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 335 QLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred CCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 9999999755 662334579999999999999886541 122 55677777766654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0005 Score=74.93 Aligned_cols=164 Identities=11% Similarity=0.030 Sum_probs=104.6
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
..|+.+.+.++.. .+.+......+|+.+.+.++- +..-...|..+.+|+.+.+..+ ...+....|..+..|+.+.+
T Consensus 208 ~~L~~i~~~~~~~--~i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~-~~~i~~~~F~~~~~l~~~~~ 283 (394)
T 4fs7_A 208 ILLENMEFPNSLY--YLGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNN-KLRIGGSLFYNCSGLKKVIY 283 (394)
T ss_dssp TTCCBCCCCTTCC--EECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCT-TCEECSCTTTTCTTCCEEEE
T ss_pred cccceeecCCCce--EeehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCC-cceeeccccccccccceecc
Confidence 3455555555432 233334445678888776543 3234556777888888888765 33444566777888888877
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCch-hh--hhcCCeecccCCcccc
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPP-WM--LQKGDRVDLSYNSFTA 159 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~-~~--~~~L~~l~ls~N~l~~ 159 (771)
..+.+. ...|..+.+|+.+.+.++ ++..-...|.++.+|+.++|.++ ++ .|+. .| ..+|+.+++..| ++.
T Consensus 284 ~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~~ 356 (394)
T 4fs7_A 284 GSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LRK 356 (394)
T ss_dssp CSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CCE
T ss_pred Cceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-ccE
Confidence 766543 235677788888888655 55233445777888888888644 55 4543 33 567788888766 666
Q ss_pred CCCcccccccccceeccC
Q 004155 160 GSSETSCQYRSVNLFASS 177 (771)
Q Consensus 160 ~~p~~~~~l~~L~~l~~s 177 (771)
+...+|.++.+|+.+.+.
T Consensus 357 I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 357 IGANAFQGCINLKKVELP 374 (394)
T ss_dssp ECTTTBTTCTTCCEEEEE
T ss_pred ehHHHhhCCCCCCEEEEC
Confidence 666778788888777654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00066 Score=71.53 Aligned_cols=160 Identities=16% Similarity=0.177 Sum_probs=89.8
Q ss_pred CCCHHHHHHHhcCCCCC-----CccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCc--EEeE
Q 004155 410 SFTLRQIKAATNNFAPD-----NKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPN--LVKL 482 (771)
Q Consensus 410 ~~~~~~l~~~~~~f~~~-----~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l 482 (771)
.++.+++......|... +.|+.|....+|+....+| .+++|+..... ....+..|+.+++.+...+ +.++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 35667777777777652 3466788899999977666 58899876521 1234556777776653211 2333
Q ss_pred EEE------EEeCCEEEEEEEeccCCCHHH--------------HhcCC----CccC-CCC---ChHHHHH---------
Q 004155 483 HGC------CIEGNQLLLIYEYMENNSLAR--------------ALFGP----EAHR-LKL---DWPTRHR--------- 525 (771)
Q Consensus 483 ~~~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~----~~~~-~~l---~~~~~~~--------- 525 (771)
+.. ....+..+++|+|++|..+.. .+|.. .... ... .|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 223467799999998864310 01110 0000 001 1222110
Q ss_pred ---HHHHHHHHHHHhhhc----CCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 526 ---ICVGIARGLAYLHEE----SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 526 ---i~~~ia~aL~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
+...+...++++++. .+.+++|+|+++.||+++.+..+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455555532 23579999999999999987666899999875
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00056 Score=74.53 Aligned_cols=142 Identities=11% Similarity=0.121 Sum_probs=97.9
Q ss_pred CcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEc
Q 004155 27 TLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDV 106 (771)
Q Consensus 27 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 106 (771)
..+..+.+.+ .++..-..+|.++.+|+.+.+.++ +..+....|.++++|+.+.+. +.+...-...|.++.+|+.++|
T Consensus 242 ~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~-~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~l 318 (394)
T 4gt6_A 242 REDPAFKIPN-GVARIETHAFDSCAYLASVKMPDS-VVSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDI 318 (394)
T ss_dssp CCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTT-CCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEEC
T ss_pred cccceEEcCC-cceEcccceeeecccccEEecccc-cceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEe
Confidence 3445555543 344344667899999999999765 445556789999999999996 5566233457889999999999
Q ss_pred cCCCCCCCCCccccCCCCCcEEEcCCCcccccCchh-h--hhcCCeecccCCccccCCCcccccccccceeccC
Q 004155 107 SFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPW-M--LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASS 177 (771)
Q Consensus 107 s~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~-~--~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s 177 (771)
..| ++..-...|.+|.+|+.+.|..+ ++ .|... | ..+|+.+++.+|.... ..+....+|+.+.+.
T Consensus 319 p~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~ 386 (394)
T 4gt6_A 319 PEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVA 386 (394)
T ss_dssp CTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC------
T ss_pred CCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeC
Confidence 865 66333557999999999999765 66 56654 4 6789999999886542 345555566655543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.41 E-value=2.8e-05 Score=74.05 Aligned_cols=95 Identities=17% Similarity=0.135 Sum_probs=66.8
Q ss_pred cCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCC-CCCCCCCCccCC----CCCcEEEccCCc-CcccC
Q 004155 18 KIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLN-GTEAPFPPLDKM----KKMKTLILRSCN-VSGKL 91 (771)
Q Consensus 18 ~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~g~~ 91 (771)
.+|.....--+|+.|||+++.|+..--..+..+++|+.|+|++|. ++......++.+ ++|++|+|++|. |+..-
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~G 131 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKG 131 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHH
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHH
Confidence 345433223479999999999875434557789999999999985 554333345554 479999999985 76332
Q ss_pred ChhhhcCCCCcEEEccCCC-CC
Q 004155 92 PDYLGLMTSLKVLDVSFNK-LN 112 (771)
Q Consensus 92 p~~~~~l~~L~~L~Ls~N~-l~ 112 (771)
=..+..+++|+.|+|+++. ++
T Consensus 132 l~~L~~~~~L~~L~L~~c~~It 153 (176)
T 3e4g_A 132 IIALHHFRNLKYLFLSDLPGVK 153 (176)
T ss_dssp HHHGGGCTTCCEEEEESCTTCC
T ss_pred HHHHhcCCCCCEEECCCCCCCC
Confidence 3357789999999999875 44
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0017 Score=68.51 Aligned_cols=160 Identities=13% Similarity=0.096 Sum_probs=90.6
Q ss_pred CCCHHHHHHHhcCCCC-----CCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCC--cEEeE
Q 004155 410 SFTLRQIKAATNNFAP-----DNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHP--NLVKL 482 (771)
Q Consensus 410 ~~~~~~l~~~~~~f~~-----~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l 482 (771)
..+.+++..+...|.. ...++ |....||+....+|+.+++|+..... .....+..|..+++.+... .++++
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~ 87 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAP 87 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecce
Confidence 3455556555544432 23466 88889999987778789999986321 2345666788877776321 23444
Q ss_pred EEE-----EEeCCEEEEEEEeccCCCHH-----H------H---hcC----CC-ccCCCCChHHH----HH---------
Q 004155 483 HGC-----CIEGNQLLLIYEYMENNSLA-----R------A---LFG----PE-AHRLKLDWPTR----HR--------- 525 (771)
Q Consensus 483 ~~~-----~~~~~~~~lV~E~~~~gsL~-----~------~---l~~----~~-~~~~~l~~~~~----~~--------- 525 (771)
+.. ....+..++||||++|..+. . . +|. .. .....+++... ..
T Consensus 88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 167 (328)
T 1zyl_A 88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP 167 (328)
T ss_dssp CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence 432 22356778999999875321 1 1 111 00 00111222211 00
Q ss_pred ------HHHHHHHHHHHhhhc----CCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 526 ------ICVGIARGLAYLHEE----SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 526 ------i~~~ia~aL~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+...+...++.+.+. .+..++|||+++.||+++ + .+.|+||+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 011111222333221 234689999999999999 4 899999998764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.39 E-value=3.8e-05 Score=73.16 Aligned_cols=94 Identities=12% Similarity=0.235 Sum_probs=69.6
Q ss_pred CchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCc-CcccCChhhhcC----CCCcEEEccCCC-CCCCCC
Q 004155 43 IPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCN-VSGKLPDYLGLM----TSLKVLDVSFNK-LNGAIP 116 (771)
Q Consensus 43 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l----~~L~~L~Ls~N~-l~g~ip 116 (771)
+|.....--+|+.|||+++.++..-...+.++++|+.|+|++|. |+..-=..++.+ ++|++|+|++|. ++..--
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl 132 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI 132 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH
Confidence 45443333479999999999887655678899999999999996 663322345554 479999999974 774333
Q ss_pred ccccCCCCCcEEEcCCCc-cc
Q 004155 117 STFMGLLDVDYIYLTGNL-LT 136 (771)
Q Consensus 117 ~~~~~l~~L~~L~Ls~N~-l~ 136 (771)
..+..+++|++|+|+++. ++
T Consensus 133 ~~L~~~~~L~~L~L~~c~~It 153 (176)
T 3e4g_A 133 IALHHFRNLKYLFLSDLPGVK 153 (176)
T ss_dssp HHGGGCTTCCEEEEESCTTCC
T ss_pred HHHhcCCCCCEEECCCCCCCC
Confidence 457789999999999985 44
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00065 Score=73.48 Aligned_cols=129 Identities=12% Similarity=0.109 Sum_probs=100.0
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
.+|+.+.+..+ ++..-...|.+..+|+.+.+..+ ++..-...|.++.+|+.+.+.. ++..+....|.++.+|+.+.+
T Consensus 217 ~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~-~i~~i~~~aF~~c~~L~~i~l 293 (379)
T 4h09_A 217 KNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYA-KVKTVPYLLCSGCSNLTKVVM 293 (379)
T ss_dssp SSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECC-CCSEECTTTTTTCTTCCEEEE
T ss_pred cccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccccc-cceeccccccccccccccccc
Confidence 45677777654 44233456788899999999876 6645567889999999999975 477777778999999999999
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCccc
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLT 136 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~ 136 (771)
.++.++..-...|.++.+|+.+.|..+ ++-.-...|.++++|+.+.+..+ ++
T Consensus 294 ~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~ 345 (379)
T 4h09_A 294 DNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-IT 345 (379)
T ss_dssp CCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CC
T ss_pred cccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cC
Confidence 999998334467999999999999765 66233457999999999988654 44
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0011 Score=70.37 Aligned_cols=143 Identities=16% Similarity=0.139 Sum_probs=73.8
Q ss_pred CccccCCcee-EEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCC--CcEEeEEEEEEeCCEEEEEEEeccCCC
Q 004155 427 NKIGEGGFGP-VYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQH--PNLVKLHGCCIEGNQLLLIYEYMENNS 503 (771)
Q Consensus 427 ~~lG~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~gs 503 (771)
+.|+.|+... +|+....+|..+++|....... ..+..|+.+++.+.. -.+.+++.+..+.+ ++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4566665554 6777664467788886543221 233456666665532 23556666543333 78999998767
Q ss_pred HHHHhcCCC---------------------cc-CCCCChHHHH-------H-------------HHHHHHHHHHHhhh--
Q 004155 504 LARALFGPE---------------------AH-RLKLDWPTRH-------R-------------ICVGIARGLAYLHE-- 539 (771)
Q Consensus 504 L~~~l~~~~---------------------~~-~~~l~~~~~~-------~-------------i~~~ia~aL~~LH~-- 539 (771)
+.+++.... .. -..++..... . ....+...++.+.+
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 655442110 00 0111111100 0 00111122222211
Q ss_pred -cCCCceeccCCCCCcEEEcCC----CCeEEEeecCcccc
Q 004155 540 -ESRLKIVHRDIKATNVLLDKD----LNPKISDFGLAKLD 574 (771)
Q Consensus 540 -~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFGla~~~ 574 (771)
..+..++|||+.+.||+++.+ ..+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 124579999999999999874 67999999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00064 Score=74.95 Aligned_cols=72 Identities=15% Similarity=0.163 Sum_probs=48.7
Q ss_pred CCccccCCceeEEEEEcCC--------CcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCc-EEeEEEEEEeCCEEEEEE
Q 004155 426 DNKIGEGGFGPVYKGHMAD--------GTVVAVKQLSSKSKQGNREFVNEIGMISALQHPN-LVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~ 496 (771)
.+.|+.|....||+....+ +..+++|+.... .....+.+|..+++.+...+ .+++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 3568888899999997653 578999988432 11245567988888774323 356666553 2 3899
Q ss_pred EeccCCC
Q 004155 497 EYMENNS 503 (771)
Q Consensus 497 E~~~~gs 503 (771)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00068 Score=70.86 Aligned_cols=140 Identities=13% Similarity=0.141 Sum_probs=74.8
Q ss_pred CCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcE-EeEEEEEEeCCEEEEEEEec-cCCC
Q 004155 426 DNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNL-VKLHGCCIEGNQLLLIYEYM-ENNS 503 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~-~~gs 503 (771)
.+.|+.|....+|+. ..+++|+........ ....+|+.+++.+...++ .+++++ +.+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678999999999998 458888876432111 123457777766632222 455544 333457899999 5543
Q ss_pred HHH------------------HhcCCCcc-CCCCC-hHHHHHHHH--------------HHHHHHH----Hhhh-cCCCc
Q 004155 504 LAR------------------ALFGPEAH-RLKLD-WPTRHRICV--------------GIARGLA----YLHE-ESRLK 544 (771)
Q Consensus 504 L~~------------------~l~~~~~~-~~~l~-~~~~~~i~~--------------~ia~aL~----~LH~-~~~~~ 544 (771)
+.. .+|..... ....+ +.....+.. .+...+. .+.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 321 11221100 00011 111111100 0111111 1111 12346
Q ss_pred eeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 545 IVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 545 ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
++|+|+.+.||+ ..++.+.++||..+..-
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 56678899999988643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0016 Score=70.21 Aligned_cols=142 Identities=20% Similarity=0.210 Sum_probs=83.8
Q ss_pred CCccccCCceeEEEEEcC--------CCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEEEEE
Q 004155 426 DNKIGEGGFGPVYKGHMA--------DGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 496 (771)
.+.|..|-...+|+.... +++.|++|+.... ......+.+|..+++.+. +.-..++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 356777888999999764 3578999986432 223456678999888774 2223566666543 2999
Q ss_pred EeccCCCHHH-----------------HhcCCCcc-CCCC--ChHHHHHHHHHHHH-------------------HHHHh
Q 004155 497 EYMENNSLAR-----------------ALFGPEAH-RLKL--DWPTRHRICVGIAR-------------------GLAYL 537 (771)
Q Consensus 497 E~~~~gsL~~-----------------~l~~~~~~-~~~l--~~~~~~~i~~~ia~-------------------aL~~L 537 (771)
||++|.+|.. .||..... .... -|.++.++..++.. .++.|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9999765431 11222110 1112 24455555544322 22333
Q ss_pred hh----c-CCCceeccCCCCCcEEEcCC----CCeEEEeecCcc
Q 004155 538 HE----E-SRLKIVHRDIKATNVLLDKD----LNPKISDFGLAK 572 (771)
Q Consensus 538 H~----~-~~~~ivH~Dlkp~NIll~~~----~~~kl~DFGla~ 572 (771)
.+ . .+..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22 1 23478999999999999876 789999999886
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0038 Score=69.19 Aligned_cols=74 Identities=18% Similarity=0.071 Sum_probs=47.2
Q ss_pred CCccccCCceeEEEEEcCC-CcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcE-EeEEEEEEeCCEEEEEEEeccCCC
Q 004155 426 DNKIGEGGFGPVYKGHMAD-GTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNL-VKLHGCCIEGNQLLLIYEYMENNS 503 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~gs 503 (771)
.+.|+.|-...+|+....+ +..+++|+........ ....+|..+++.+...++ .++++++. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4578888899999997754 4788899875432111 112578888888864444 56777662 2 25999998744
Q ss_pred H
Q 004155 504 L 504 (771)
Q Consensus 504 L 504 (771)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0016 Score=58.84 Aligned_cols=37 Identities=19% Similarity=0.324 Sum_probs=20.7
Q ss_pred CCcEEEccCCcCcccCChhhhcCCCCcEEEccCCCCC
Q 004155 76 KMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLN 112 (771)
Q Consensus 76 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 112 (771)
+|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4556666666665222334555666666666666554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0019 Score=58.35 Aligned_cols=56 Identities=16% Similarity=0.100 Sum_probs=40.5
Q ss_pred EEEccCCcCc-ccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCccc
Q 004155 79 TLILRSCNVS-GKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLT 136 (771)
Q Consensus 79 ~L~Ls~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~ 136 (771)
.++.++++|+ ..+|..+. ++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 6677777775 35665543 56888888888888444455778888888888888775
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0042 Score=66.04 Aligned_cols=33 Identities=30% Similarity=0.411 Sum_probs=28.8
Q ss_pred CCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 542 ~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
+..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 457999999999999998888999999887643
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.68 E-value=0.00044 Score=67.06 Aligned_cols=113 Identities=6% Similarity=0.028 Sum_probs=76.2
Q ss_pred cCCCcCCEEEcccC-Cccc----cCchhhcCCcCCCEEEcCCCCCCCCCCCC----ccCCCCCcEEEccCCcCccc----
Q 004155 24 QNWTLLEKLVIQAS-GLVG----PIPSGIASLSKLTDLRISDLNGTEAPFPP----LDKMKKMKTLILRSCNVSGK---- 90 (771)
Q Consensus 24 ~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~~~~----~~~l~~L~~L~Ls~N~l~g~---- 90 (771)
.+-+.|+.|+|++| +|.. .+-..+..-+.|+.|+|++|++....-.. +..-+.|+.|+|++|+|...
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 44567888888885 7652 24455666678888888888887433223 33457899999999999733
Q ss_pred CChhhhcCCCCcEEEccCCCC---CC----CCCccccCCCCCcEEEcCCCccc
Q 004155 91 LPDYLGLMTSLKVLDVSFNKL---NG----AIPSTFMGLLDVDYIYLTGNLLT 136 (771)
Q Consensus 91 ~p~~~~~l~~L~~L~Ls~N~l---~g----~ip~~~~~l~~L~~L~Ls~N~l~ 136 (771)
+-..+..-+.|+.|+|++|.. .. .+-..+..-+.|+.|+|+.|.+.
T Consensus 118 la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 223355567799999987643 31 13344556678999999988754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0021 Score=69.22 Aligned_cols=72 Identities=11% Similarity=0.124 Sum_probs=42.7
Q ss_pred CccccCCceeEEEEEcCC---------CcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCc-EEeEEEEEEeCCEEEEEE
Q 004155 427 NKIGEGGFGPVYKGHMAD---------GTVVAVKQLSSKSKQGNREFVNEIGMISALQHPN-LVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~ 496 (771)
+.|+.|....+|+....+ +..+++|+....... ......|..+++.+...+ ..++++.. .+ ++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 567888889999997654 268899987543221 112356777777764223 34566543 22 6899
Q ss_pred EeccCCC
Q 004155 497 EYMENNS 503 (771)
Q Consensus 497 E~~~~gs 503 (771)
||++|.+
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.62 E-value=0.00048 Score=66.78 Aligned_cols=116 Identities=16% Similarity=0.154 Sum_probs=78.7
Q ss_pred CchhhcCCcCCCEEEcCCC-CCCCC----CCCCccCCCCCcEEEccCCcCccc----CChhhhcCCCCcEEEccCCCCCC
Q 004155 43 IPSGIASLSKLTDLRISDL-NGTEA----PFPPLDKMKKMKTLILRSCNVSGK----LPDYLGLMTSLKVLDVSFNKLNG 113 (771)
Q Consensus 43 ~p~~~~~l~~L~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g 113 (771)
+-..+.+-+.|+.|+|++| ++... .-..+..-+.|+.|+|++|+|... +...+..-+.|+.|+|++|.|..
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 3344555678999999986 66431 112355568899999999999733 23345567889999999999983
Q ss_pred C----CCccccCCCCCcEEEcCCCc---ccccC----chhh--hhcCCeecccCCccc
Q 004155 114 A----IPSTFMGLLDVDYIYLTGNL---LTGTI----PPWM--LQKGDRVDLSYNSFT 158 (771)
Q Consensus 114 ~----ip~~~~~l~~L~~L~Ls~N~---l~g~i----P~~~--~~~L~~l~ls~N~l~ 158 (771)
. +-..+..-+.|+.|+|++|. +.... -..+ -+.|..|+++.|.+.
T Consensus 113 ~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 113 ELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 3 23345566789999998763 33221 1222 457889999988754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.28 E-value=0.017 Score=56.32 Aligned_cols=103 Identities=15% Similarity=0.094 Sum_probs=66.7
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
-||.+.|.. .+.+++++++|.++.|.+.+|.-+-.... + ..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence 378999843 34689999999999999999877621100 1 1233457999999999988764 1111
Q ss_pred ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCC
Q 004155 582 STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSN 624 (771)
Q Consensus 582 ~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p 624 (771)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122567888763 4557899999999999999864433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.78 E-value=0.026 Score=61.68 Aligned_cols=142 Identities=12% Similarity=0.107 Sum_probs=83.6
Q ss_pred CCccccCCceeEEEEEcCC--------CcEEEEEEcccCChhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEEEEE
Q 004155 426 DNKIGEGGFGPVYKGHMAD--------GTVVAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 496 (771)
.+.+..|-...+|+....+ +..|++|+....... .....+|..+++.+. +.-..++++.+ .+ ++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 3567778889999997653 578999986543211 112356777777764 22234555533 22 7899
Q ss_pred EeccCCCHHH--------------H---hcCCCc---------cCCCCChHHHHHHHHHH-------------------H
Q 004155 497 EYMENNSLAR--------------A---LFGPEA---------HRLKLDWPTRHRICVGI-------------------A 531 (771)
Q Consensus 497 E~~~~gsL~~--------------~---l~~~~~---------~~~~l~~~~~~~i~~~i-------------------a 531 (771)
||++|.+|.. . +|.... ...+.-|.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865321 0 111111 11122244444443322 1
Q ss_pred HHHHHhhh---------------------cCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 532 RGLAYLHE---------------------ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 532 ~aL~~LH~---------------------~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
..+.+|.+ ..+..++|+|+.+.||+ +.++.+.++||..|..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 12346899999999999 8888999999998863
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.32 E-value=0.47 Score=51.28 Aligned_cols=30 Identities=23% Similarity=0.393 Sum_probs=25.2
Q ss_pred ceeccCCCCCcEEE------cCCCCeEEEeecCccc
Q 004155 544 KIVHRDIKATNVLL------DKDLNPKISDFGLAKL 573 (771)
Q Consensus 544 ~ivH~Dlkp~NIll------~~~~~~kl~DFGla~~ 573 (771)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999998863
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=87.76 E-value=0.31 Score=33.13 Aligned_cols=18 Identities=11% Similarity=0.353 Sum_probs=12.1
Q ss_pred CccccceeehhHHHHHHH
Q 004155 360 SSISAGTVVGIVAATTFV 377 (771)
Q Consensus 360 ~~~~~~~iv~i~~~~~~~ 377 (771)
+..+.+.++|++++.++.
T Consensus 6 ~~ls~GaIAGiVvG~v~g 23 (38)
T 2k1k_A 6 RGLTGGEIVAVIFGLLLG 23 (38)
T ss_dssp TTCCHHHHHHHHHHHHHH
T ss_pred CCCCCCceeeeehHHHHH
Confidence 445677788887776544
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.24 E-value=1.6 Score=42.38 Aligned_cols=115 Identities=9% Similarity=0.125 Sum_probs=80.0
Q ss_pred CCCcEEeEEEEEEeCCEEEEEEEeccCC-CHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCC
Q 004155 475 QHPNLVKLHGCCIEGNQLLLIYEYMENN-SLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKAT 553 (771)
Q Consensus 475 ~h~niv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~ 553 (771)
.||++++. .+-.+.+.+.+.|+.-+.+ ++.. + ..++...+++++.+|+....+++.. +|--|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence 68888866 4566667777766654322 2222 2 3578899999999999988777644 68889999
Q ss_pred cEEEcCCCCeEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCC
Q 004155 554 NVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSS 626 (771)
Q Consensus 554 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~ 626 (771)
||+++.++.+++.-.|+...+ +|. ..++..=.-.+=+++..+++++..|+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999877764322 121 11233334467788899999987774
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.72 E-value=1.9 Score=41.98 Aligned_cols=113 Identities=12% Similarity=0.199 Sum_probs=78.2
Q ss_pred CCCcEEeEEEEEEeCCEEEEEEEeccCC-CHHHHhcCCCccCCCCChHHHHHHHHHHHHHHH-HhhhcCCCceeccCCCC
Q 004155 475 QHPNLVKLHGCCIEGNQLLLIYEYMENN-SLARALFGPEAHRLKLDWPTRHRICVGIARGLA-YLHEESRLKIVHRDIKA 552 (771)
Q Consensus 475 ~h~niv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~-~LH~~~~~~ivH~Dlkp 552 (771)
.||++ -...-.+++.+.+.|+.-+++ +.. .+ ..++...+++++.+|+.... +++. -+|--|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 57887 334446778888888865443 333 33 35788999999999999888 6664 36778999
Q ss_pred CcEEEcCCCCeEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCC
Q 004155 553 TNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNS 625 (771)
Q Consensus 553 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~ 625 (771)
+||++|.++.+++.-.|+-.. ++|.- .++..=.-.+=+++..++.++..|
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~------------------lpP~e-----~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKES------------------LPPDE-----WDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp GGEEECTTCCEEESCCEETTT------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred ceEEEeCCCcEEEEEcCCccc------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence 999999999999987776432 22221 122222345667888888887665
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 771 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-72 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-70 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-67 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-63 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 9e-72
Identities = 74/279 (26%), Positives = 127/279 (45%), Gaps = 22/279 (7%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 480
+IG G FG VYKG V + +++ + Q + F NE+G++ +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
G QL ++ ++ E +SL L E K + I A+G+ YLH +
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK 123
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL-DEEDNTHISTRVAGTFGYMAPEYAM- 598
I+HRD+K+ N+ L +DL KI DFGLA + +H +++G+ +MAPE
Sbjct: 124 ---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 599 --RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656
+ + ++DVY+FGIV E+++G+ P +I +I + +
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQ-----LPYSNIN--NRDQIIFMVGRGYLSPDLSK 233
Query: 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ SN K M + C RP +++ +E
Sbjct: 234 VRSNCPKA----MKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 8e-70
Identities = 80/276 (28%), Positives = 122/276 (44%), Gaps = 24/276 (8%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 480
++G G FG V+ G+ T VAVK L + F+ E ++ LQH LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
+L+ + + +I EYMEN SL L P +KL + IA G+A++ E
Sbjct: 72 RLYAVVTQEP-IYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 600
+HRD++A N+L+ L+ KI+DFGLA+L E++ + APE G
Sbjct: 129 ---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 601 YLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659
T K+DV+SFGI+ EIV+ GR ++ L+ + N E
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE-------- 237
Query: 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ + LC RP+ + S+LE
Sbjct: 238 --------ELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 2e-67
Identities = 68/276 (24%), Positives = 121/276 (43%), Gaps = 24/276 (8%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 480
+ +IG G FG V+ G+ + VA+K + + +F+ E ++ L HP LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
+L+G C+E + L++E+ME+ L+ R T +C+ + G+AYL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 600
++HRD+ A N L+ ++ K+SDFG+ + +D ST + +PE
Sbjct: 121 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 601 YLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659
+ K+DV+SFG++ E+ S G+ + ++ + L RL S
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------RLYKPRLAS 228
Query: 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ + C RP+ S ++ L
Sbjct: 229 TH-------VYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 6e-67
Identities = 62/275 (22%), Positives = 106/275 (38%), Gaps = 22/275 (8%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 480
+ ++G G FG V G VA+K + + EF+ E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
+L+G C + + +I EYM N L L R + +C + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLE-- 117
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 600
+ +HRD+ A N L++ K+SDFGL++ +D S + PE M
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 601 YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSN 660
+ K+D+++FG++ EI S P E E + + L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK----MPYER-----------FTNSETAEHIAQGLRLY 221
Query: 661 FDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ + C + RP+ ++S +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 2e-66
Identities = 73/291 (25%), Positives = 120/291 (41%), Gaps = 30/291 (10%)
Query: 428 KIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCI 487
IG+G FG V++G G VAVK SS+ ++ + EI L+H N++
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 488 EGN----QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE--- 540
+ N QL L+ +Y E+ SL L +R + ++ + A GLA+LH E
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 541 --SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIS---TRVAGTFGYMAPE 595
+ I HRD+K+ N+L+ K+ I+D GLA + I GT YMAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 596 Y------AMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY----LLDWALILKA 645
+AD+Y+ G+V EI S + Y D ++
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 646 QGNLMELVDKRLGSNFD-KEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ + + + + + E + VM + C + +R + + L
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (552), Expect = 3e-65
Identities = 68/296 (22%), Positives = 123/296 (41%), Gaps = 28/296 (9%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNL 479
+ +K+G G +G VY+G VAVK L + + EF+ E ++ ++HPNL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
V+L G C +I E+M +L L E +R ++ + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE- 132
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 599
+ +HRD+ A N L+ ++ K++DFGL++L D + APE
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 600 GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659
+ K+DV++FG++ EI + + P + EL++K
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS----PYPG-----------IDLSQVYELLEKDYRM 235
Query: 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQDFVPDSSVVSNIDK 715
+ + + C + + RPS + + E +SS+ ++K
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE------TMFQESSISDEVEK 285
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 7e-65
Identities = 50/206 (24%), Positives = 99/206 (48%), Gaps = 11/206 (5%)
Query: 419 ATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE-FVNEIGMISALQH 476
++F +++G G G V+K H G V+A K + + K R + E+ ++
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 477 PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
P +V +G ++ + E+M+ SL + L ++ ++ + + +GL Y
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTY 119
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 596
L + KI+HRD+K +N+L++ K+ DFG++ + GT YM+PE
Sbjct: 120 LR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPER 174
Query: 597 AMRGYLTDKADVYSFGIVALEIVSGR 622
+ + ++D++S G+ +E+ GR
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (550), Expect = 7e-65
Identities = 77/303 (25%), Positives = 130/303 (42%), Gaps = 39/303 (12%)
Query: 411 FTLRQIKAATNNFAP---------DNKIGEGGFGPVYKGHMA----DGTVVAVKQL-SSK 456
FT A FA + IG G FG V GH+ VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 457 SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRL 516
+++ R+F++E ++ HPN++ L G + +++I E+MEN SL L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 517 KLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576
+ GIA G+ YL + VHRD+ A N+L++ +L K+SDFGL++ E+
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 577 DNTHISTRVA----GTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKED 632
D + + A + APE T +DV+S+GIV E++S +P D
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE----RPYWD 236
Query: 633 IFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692
+ +++ +++ + + + L C RP +V+
Sbjct: 237 M-----------TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 693 MLE 695
L+
Sbjct: 286 TLD 288
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 1e-64
Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 24/276 (8%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 480
+ + K+G+G FG V+ G T VA+K L F+ E ++ L+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
+L+ + ++ EYM SL L G L P + IA G+AY+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL--RLPQLVDMAAQIASGMAYVE-- 130
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 600
R+ VHRD++A N+L+ ++L K++DFGLA+L E++ + APE A+ G
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 601 YLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659
T K+DV+SFGI+ E+ + GR ++ ++ V++
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----------------LDQVERGYRM 233
Query: 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
E + ++ C RP+ + + LE
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 211 bits (538), Expect = 4e-63
Identities = 82/312 (26%), Positives = 130/312 (41%), Gaps = 48/312 (15%)
Query: 413 LRQIKAATNNFAPDNKIGEGGFGPVYKG------HMADGTVVAVKQLSSKSKQGNR-EFV 465
L ++ NN IGEG FG V++ T+VAVK L ++ + +F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 466 NEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRL--------- 516
E +++ +PN+VKL G C G + L++EYM L L H +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 517 -----------KLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 565
L + I +A G+AYL E K VHRD+ N L+ +++ KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181
Query: 566 SDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRS 623
+DFGL++ + D A +M PE T ++DV+++G+V EI S G
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 624 NSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTS 683
E++ Y + GN++ + N E + N+ LC
Sbjct: 242 PYYGMAHEEVIYYV-------RDGNILACPE-----NCPLE----LYNLMRLCWSKLPAD 285
Query: 684 RPSMSSVVSMLE 695
RPS S+ +L+
Sbjct: 286 RPSFCSIHRILQ 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 8e-63
Identities = 76/300 (25%), Positives = 117/300 (39%), Gaps = 42/300 (14%)
Query: 421 NNFAPDNKIGEGGFGPVYKG------HMADGTVVAVKQLSSKSKQGNRE-FVNEIGMISA 473
N + +G G FG V + VAVK L + RE ++E+ ++S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 474 L-QHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFG--------------PEAHRLKL 518
L H N+V L G C G L+I EY L L E L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 519 DWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEED 577
D +A+G+A+L + +HRD+ A N+LL KI DFGLA+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYL 636
N + +MAPE T ++DV+S+GI E+ S G S P + FY
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY- 258
Query: 637 LDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696
+++ + + M ++ C D RP+ +V ++E
Sbjct: 259 --------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 2e-62
Identities = 67/277 (24%), Positives = 114/277 (41%), Gaps = 30/277 (10%)
Query: 426 DNKIGEGGFGPVYKGHMA---DGTVVAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVK 481
D ++G G FG V +G VA+K L +++ + E + E ++ L +P +V+
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 482 LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES 541
L G C + L+L+ E L + L G R ++ + ++ G+ YL
Sbjct: 74 LIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE--- 126
Query: 542 RLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR--VAGTFGYMAPEYAMR 599
VHRD+ A NVLL KISDFGL+K D+++ + R + APE
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186
Query: 600 GYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658
+ ++DV+S+G+ E +S G+ ++ ++ QG ME
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKRMECPP---- 235
Query: 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
E + + C RP +V +
Sbjct: 236 -ECPPE----LYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 9e-62
Identities = 69/278 (24%), Positives = 113/278 (40%), Gaps = 32/278 (11%)
Query: 426 DNKIGEGGFGPVYKGHMAD---GTVVAVKQLSSKSKQGN--REFVNEIGMISALQHPNLV 480
D ++G G FG V KG+ VAVK L +++ E + E ++ L +P +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
++ G C E +L+ E E L + L + + ++ G+ YL E
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTR--VAGTFGYMAPEYAM 598
VHRD+ A NVLL KISDFGL+K D + + + APE
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 599 RGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657
+ K+DV+SFG++ E S G+ ++ +L+ +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG------------C 231
Query: 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ +E M ++ LC +RP ++V L
Sbjct: 232 PAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-61
Identities = 76/277 (27%), Positives = 113/277 (40%), Gaps = 30/277 (10%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 480
IG+G FG V G G VAVK + + + + F+ E +++ L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 481 KLHGCCIEG-NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
+L G +E L ++ EYM SL L R L + + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 540 ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR 599
VHRD+ A NVL+ +D K+SDFGL K + APE
Sbjct: 122 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALRE 174
Query: 600 GYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658
+ K+DV+SFGI+ EI S GR P +D+ ++ +G M+ D
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPD---- 223
Query: 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ V C + + RPS + LE
Sbjct: 224 -GCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 3e-61
Identities = 65/277 (23%), Positives = 121/277 (43%), Gaps = 24/277 (8%)
Query: 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQL--SSKSKQGNREFVNEIGMISALQHPN 478
++ IG G +G K +DG ++ K+L S ++ + V+E+ ++ L+HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 479 LVKLHGCCIE--GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
+V+ + I+ L ++ EY E LA + R LD R+ + L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 537 LHEESR--LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAP 594
H S ++HRD+K NV LD N K+ DFGLA++ D + + GT YM+P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMSP 183
Query: 595 EYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654
E R +K+D++S G + E+ + + ++++ + E
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG------------KIREGKF 231
Query: 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVV 691
+R+ + E + + ++ RPS+ ++
Sbjct: 232 RRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 7e-61
Identities = 70/284 (24%), Positives = 126/284 (44%), Gaps = 29/284 (10%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHMADGT-----VVAVKQLSSKSKQGNR-EFVNEIGMISAL 474
+ IG G FG VYKG + + VA+K L + + R +F+ E G++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 475 QHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGL 534
H N+++L G + +++I EYMEN +L + L + + GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGM 123
Query: 535 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRVAGTFGYM 592
YL + VHRD+ A N+L++ +L K+SDFGL+++ D+ + T+ ++ +
Sbjct: 124 KYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 593 APEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652
APE T +DV+SFGIV E+++ + +M+
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---------------EVMKA 225
Query: 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696
++ + + + + C RP + +VS+L+
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 5e-60
Identities = 76/303 (25%), Positives = 111/303 (36%), Gaps = 45/303 (14%)
Query: 421 NNFAPDNKIGEGGFGPVYKG------HMADGTVVAVKQLSSKSKQGNRE-FVNEIGMISA 473
N +G G FG V VAVK L K+ RE ++E+ M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 474 L-QHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFG-------------------PEA 513
L H N+V L G C + LI+EY L L E
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 514 HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK- 572
L + +A+G+ +L + VHRD+ A NVL+ KI DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 573 LDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKED 632
+ + N + +MAPE G T K+DV+S+GI+ EI S N P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN----PYPG 269
Query: 633 IFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692
+ N +L+ + + + C S RPS ++ S
Sbjct: 270 ----------IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 693 MLE 695
L
Sbjct: 320 FLG 322
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (514), Expect = 1e-59
Identities = 72/277 (25%), Positives = 114/277 (41%), Gaps = 34/277 (12%)
Query: 423 FAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGN---REFVNEIGMISALQHPN 478
F+ +IG G FG VY + + VVA+K++S KQ N ++ + E+ + L+HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
++ GC + + L+ EY ++ H+ L + G +GLAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 598
++HRD+KA N+LL + K+ DFG A + N+ + GT +MAPE +
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVIL 184
Query: 599 ---RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655
G K DV+S GI +E+ + Y + AQ L
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------AQNESPALQSG 237
Query: 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692
F N C RP+ ++
Sbjct: 238 HWSEYF--------RNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-59
Identities = 73/283 (25%), Positives = 115/283 (40%), Gaps = 32/283 (11%)
Query: 422 NFAPDNKIGEGGFGPVYKGHMAD----GTVVAVKQLSSKSKQGN-REFVNEIGMISALQH 476
+F + IG G FG VY G + D AVK L+ + G +F+ E ++ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 477 PNLVKLHGCCIEG-NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLA 535
PN++ L G C+ L++ YM++ L + +A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF---IRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL---DEEDNTHISTRVAGTFGYM 592
+L K VHRD+ A N +LD+ K++DFGLA+ E D+ H T +M
Sbjct: 145 FLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 593 APEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652
A E T K+DV+SFG++ E+++ P D + L L+
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRG-----APPYPDVNTFDITVYLLQGRRLL-- 254
Query: 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ V L C + RPS S +VS +
Sbjct: 255 ----QPEYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 5e-59
Identities = 69/275 (25%), Positives = 109/275 (39%), Gaps = 31/275 (11%)
Query: 426 DNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKL 482
D +IG G F VYKG VA +L + +K + F E M+ LQHPN+V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 483 HGCCIE----GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+ ++L+ E M + +L L + C I +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 539 EESRLKIVHRDIKATNVLL-DKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 597
+ I+HRD+K N+ + + KI D GLA L V GT +MAPE
Sbjct: 130 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMY 185
Query: 598 MRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657
Y + DVY+FG+ LE+ + S Y +
Sbjct: 186 EEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIY--------------RRVTSGVK 230
Query: 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692
++FDK + + + C + R S+ +++
Sbjct: 231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-58
Identities = 69/276 (25%), Positives = 107/276 (38%), Gaps = 25/276 (9%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE-FVNEIGMISALQHPN 478
++ +GEG +G V + VAVK + K E EI + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+VK +G EGN L EY L + + + P R + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVAGTFGYMAPEYA 597
+ I HRDIK N+LLD+ N KISDFGLA + + ++ GT Y+APE
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 598 MRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656
R + + DV+S GIV +++G Y K + +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-----SDWKEKKTYLNPWK-- 230
Query: 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692
D + + + ++R ++ +
Sbjct: 231 ---KIDSA----PLALLHKILVENPSARITIPDIKK 259
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-58
Identities = 78/329 (23%), Positives = 141/329 (42%), Gaps = 31/329 (9%)
Query: 413 LRQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTV----VAVKQLS-SKSKQGNREFVN 466
LR +K F +G G FG VYKG + +G VA+K+L + S + N+E ++
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 467 EIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRI 526
E +++++ +P++ +L G C+ + LI + M L L H+ +
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCL---LDYVREHKDNIGSQYLLNW 116
Query: 527 CVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRV 585
CV IA+G+ YL + ++VHRD+ A NVL+ + KI+DFGLAK L E+ + +
Sbjct: 117 CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 586 AGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA 645
+MA E + T ++DV+S+G+ E+++ S KP +
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS----KPYDG-----------IP 218
Query: 646 QGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQDFVP 705
+ +++K + + + + C + + SRP ++ A
Sbjct: 219 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 278
Query: 706 DSSVVSNIDKTKSEAIRNYYEFSEEQSMD 734
+ Y +E+ MD
Sbjct: 279 VIQGDERMHLPSPTDSNFYRALMDEEDMD 307
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 4e-58
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 13/215 (6%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGC 485
++G+G FG VYK + + A K + +KS++ +++ EI ++++ HPN+VKL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKI 545
N L ++ E+ ++ + L +C L YLH+ KI
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHD---NKI 131
Query: 546 VHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM-----RG 600
+HRD+KA N+L D + K++DFG++ + + + GT +MAPE M
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 190
Query: 601 YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY 635
KADV+S GI +E+ +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL 225
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-57
Identities = 59/276 (21%), Positives = 108/276 (39%), Gaps = 31/276 (11%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQH 476
+F +G+G FG VY ++A+K L + E+ + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 477 PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
PN+++L+G + ++ LI EY ++ R L K D +A L+Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSY 121
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 596
H +++HRDIK N+LL KI+DFG + + GT Y+ PE
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEM 175
Query: 597 AMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656
+K D++S G++ E + G+ ++ + I + + + V +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-----RISRVEFTFPDFVTEG 230
Query: 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692
++ + + RP + V+
Sbjct: 231 A------------RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 1e-56
Identities = 64/285 (22%), Positives = 115/285 (40%), Gaps = 32/285 (11%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHM----ADGTVVAVKQLSSK---SKQGNREFVNEIGMISA 473
+ K+G+G FG V +G VAVK L + +F+ E+ + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 474 LQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARG 533
L H NL++L+G + + ++ E SL L H+ T R V +A G
Sbjct: 68 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 534 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH--ISTRVAGTFGY 591
+ YL + + +HRD+ A N+LL KI DFGL + +++ H + F +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 592 MAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLM 650
APE + +D + FG+ E+ + G+ I + +D +G +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGERL 234
Query: 651 ELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ + ++ + NV + C RP+ ++ L
Sbjct: 235 PRPE-----DCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-56
Identities = 69/292 (23%), Positives = 112/292 (38%), Gaps = 37/292 (12%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHMADG---TVVAVKQLS-SKSKQGNREFVNEIGMISAL-Q 475
N+ + IGEG FG V K + A+K++ SK +R+F E+ ++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 476 HPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFG------------PEAHRLKLDWPTR 523
HPN++ L G C L L EY + +L L + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 524 HRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 583
+ARG+ YL + + +HRD+ A N+L+ ++ KI+DFGL++ E T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 584 RVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALIL 643
+MA E T +DV+S+G++ EIVS C
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----------- 233
Query: 644 KAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
L E + + + ++ C RPS + ++ L
Sbjct: 234 ----ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 2e-56
Identities = 65/229 (28%), Positives = 111/229 (48%), Gaps = 13/229 (5%)
Query: 413 LRQIKAA---TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEI 468
LR I + + KIG+G G VY +A G VA++Q++ + + +NEI
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 469 GMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICV 528
++ ++PN+V + G++L ++ EY+ SL + +D +C
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCR 123
Query: 529 GIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGT 588
+ L +LH +++HRDIK+ N+LL D + K++DFG + + ST V GT
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 179
Query: 589 FGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL 637
+MAPE R K D++S GI+A+E++ G + YL+
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 3e-56
Identities = 66/274 (24%), Positives = 109/274 (39%), Gaps = 29/274 (10%)
Query: 428 KIGEGGFGPVYKGHMAD----GTVVAVKQLSSKSKQGNRE-FVNEIGMISALQHPNLVKL 482
IGEG FG V++G VA+K + + RE F+ E + HP++VKL
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 483 HGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESR 542
G E N + +I E L + + LD + ++ LAYL
Sbjct: 74 IGVITE-NPVWIIMELCTLGEL---RSFLQVRKYSLDLASLILYAYQLSTALAYLES--- 126
Query: 543 LKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYL 602
+ VHRDI A NVL+ + K+ DFGL++ E+ + +++ +MAPE
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 603 TDKADVYSFGIVALEI-VSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNF 661
T +DV+ FG+ EI + G D+ ++ L + N
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP------------MPPNC 234
Query: 662 DKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ ++ C + RP + + + L
Sbjct: 235 PPT----LYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-55
Identities = 72/292 (24%), Positives = 121/292 (41%), Gaps = 36/292 (12%)
Query: 421 NNFAPDNKIGEGGFGPVYKG------HMADGTVVAVKQLS-SKSKQGNREFVNEIGMISA 473
++G+G FG VY+G T VA+K ++ + S + EF+NE ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 474 LQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALF------GPEAHRLKLDWPTRHRIC 527
++V+L G +G L+I E M L L ++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 528 VGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDNTHISTRVA 586
IA G+AYL+ K VHRD+ A N ++ +D KI DFG+ + + E D +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 587 GTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA- 645
+M+PE G T +DV+SFG+V EI + E + L +L+
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA--------EQPYQGLSNEQVLRFV 248
Query: 646 -QGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696
+G L++ D N + + +C + RPS ++S ++
Sbjct: 249 MEGGLLDKPD-----NCPDM----LFELMRMCWQYNPKMRPSFLEIISSIKE 291
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-54
Identities = 69/297 (23%), Positives = 115/297 (38%), Gaps = 39/297 (13%)
Query: 421 NNFAPDNKIGEGGFGPVYKG------HMADGTVVAVKQLSSKSKQG-NREFVNEIGMISA 473
+ +G G FG V + A VAVK L + +R ++E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 474 -LQHPNLVKLHGCCIE-GNQLLLIYEYMENNSLARALFG------------PEAHRLKLD 519
H N+V L G C + G L++I E+ + +L+ L + ++ L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 520 WPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK-LDEEDN 578
+A+G+ +L K +HRD+ A N+LL + KI DFGLA+ + ++ +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 579 THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLD 638
+MAPE T ++DV+SFG++ EI S + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL-----GASPYPGVKIDE 244
Query: 639 WALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+G M D E M L C + RP+ S +V L
Sbjct: 245 EFCRRLKEGTRMRAPD-----YTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 188 bits (479), Expect = 4e-54
Identities = 69/346 (19%), Positives = 131/346 (37%), Gaps = 34/346 (9%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNL 479
+++ ++G G FG V++ A G A K + + + EI +S L+HP L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 480 VKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE 539
V LH + N++++IYE+M L + K+ + +GL ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 540 ESRLKIVHRDIKATNVLLDKDLNP--KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 597
VH D+K N++ + K+ DFGL + + T GT + APE A
Sbjct: 143 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVA 197
Query: 598 MRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657
+ D++S G+++ ++SG S + ++ + N+ + +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR-----NVKSCDWNMDDSAFSGI 252
Query: 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS---MLEGRADVQD-FVPDSSVVSNI 713
+ + +R ++ + + G A +D +P S
Sbjct: 253 SEDG--------KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIR 304
Query: 714 DKTKS------EAIRNYYEFSEEQSMDGCQTQSMSIDGPYTGSSTS 753
D K+ E + S S+ + Q SI + S +
Sbjct: 305 DSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFWDRSEA 350
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-52
Identities = 77/299 (25%), Positives = 122/299 (40%), Gaps = 43/299 (14%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHM--------ADGTVVAVKQLSSKSKQGN-REFVNEIGMI 471
+ +GEG FG V T VAVK L S + + + + ++E+ M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 472 SAL-QHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRL------------KL 518
+ +H N++ L G C + L +I EY +L L L +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 519 DWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578
+ARG+ YL + K +HRD+ A NVL+ +D KI+DFGLA+ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 579 THISTRV-AGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYL 636
+ T +MAPE T ++DV+SFG++ EI + G S P E++F L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 637 LDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
L + SN E + + C + RP+ +V L+
Sbjct: 250 LKEGHRMD------------KPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 181 bits (461), Expect = 1e-51
Identities = 56/266 (21%), Positives = 98/266 (36%), Gaps = 24/266 (9%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
++G G FG V++ A G V K +++ NEI +++ L HP L+ LH
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
+ +++LI E++ L + A K+ GL ++HE IV
Sbjct: 96 EDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIV 149
Query: 547 HRDIKATNVLLDKDLNP--KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
H DIK N++ + KI DFGLA D T T + APE R +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGF 207
Query: 605 KADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKE 664
D+++ G++ ++SG S + + + + + E +
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ-----NVKRCDWEFDEDAFSSVSPEA--- 259
Query: 665 QVMVMINVALLCTDVSSTSRPSMSSV 690
+ R ++
Sbjct: 260 -----KDFIKNLLQKEPRKRLTVHDA 280
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 3e-51
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 12/211 (5%)
Query: 417 KAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK---SKQGNREFVNEIGMIS 472
K +F +GEG F V +A A+K L + + E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 473 ALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIAR 532
L HP VKL+ + +L Y +N L + + D I
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVS 119
Query: 533 GLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL-DEEDNTHISTRVAGTFGY 591
L YLH I+HRD+K N+LL++D++ +I+DFG AK+ E + GT Y
Sbjct: 120 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 592 MAPEYAMRGYLTDKADVYSFGIVALEIVSGR 622
++PE +D+++ G + ++V+G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 172 bits (438), Expect = 2e-48
Identities = 66/229 (28%), Positives = 96/229 (41%), Gaps = 18/229 (7%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQ- 475
N+F+ IG GGFG VY G + A+K L K KQG +NE M+S +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 476 --HPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARG 533
P +V + ++L I + M L L I G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYAAEIILG 119
Query: 534 LAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 593
L ++H +V+RD+K N+LLD+ + +ISD GLA + H S GT GYMA
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 173
Query: 594 PEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWAL 641
PE +G AD +S G + +++ G S +D + L
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 222
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (429), Expect = 1e-47
Identities = 70/317 (22%), Positives = 126/317 (39%), Gaps = 34/317 (10%)
Query: 414 RQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE-FVNEIGMI 471
+Q + + + + +G G F V +VA+K ++ K+ +G NEI ++
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 472 SALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIA 531
++HPN+V L G L LI + + L + + R+ +
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVL 117
Query: 532 RGLAYLHEESRLKIVHRDIKATNVLL---DKDLNPKISDFGLAKLDEEDNTHISTRVAGT 588
+ YLH+ IVHRD+K N+L D+D ISDFGL+K+ ED + + GT
Sbjct: 118 DAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGT 172
Query: 589 FGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN 648
GY+APE + + D +S G++A ++ G + +F ILKA+
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE-----QILKAEYE 227
Query: 649 LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQDFVPDSS 708
+ + + + R + + D++
Sbjct: 228 FDSPYWDDISDSA--------KDFIRHLMEKDPEKRFTCEQALQH-------PWIAGDTA 272
Query: 709 VVSNIDKTKSEAIRNYY 725
+ NI ++ SE I+ +
Sbjct: 273 LDKNIHQSVSEQIKKNF 289
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-47
Identities = 47/266 (17%), Positives = 94/266 (35%), Gaps = 25/266 (9%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
+G G FG V++ + K + K EI +++ +H N++ LH
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 487 IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546
+L++I+E++ + + +L+ + L +LH I
Sbjct: 71 ESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHS---HNIG 124
Query: 547 HRDIKATNVLLDKDLNP--KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTD 604
H DI+ N++ + KI +FG A+ + + Y APE ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVST 182
Query: 605 KADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKE 664
D++S G + ++SG + + + I I+ A+ E K +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIE-----NIMNAEYTFDEEAFKEISIEA--- 234
Query: 665 QVMVMINVALLCTDVSSTSRPSMSSV 690
++ SR + S
Sbjct: 235 -----MDFVDRLLVKERKSRMTASEA 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (424), Expect = 3e-47
Identities = 59/297 (19%), Positives = 97/297 (32%), Gaps = 29/297 (9%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNL 479
N + KIG G FG +Y G +A G VA+K K+K + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 480 VK-LHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+ + C EG+ +++ E + + K T + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLE----DLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 539 EESRLKIVHRDIKATNVL---LDKDLNPKISDFGLAKLDEEDNTHI------STRVAGTF 589
+HRD+K N L K I DFGLAK + TH + + GT
Sbjct: 121 S---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 590 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL 649
Y + + + + D+ S G V + G +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-----KYERISEKK 232
Query: 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADVQDFVPD 706
M + L + E C + +P S + + Q F D
Sbjct: 233 MSTPIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 4e-47
Identities = 59/267 (22%), Positives = 109/267 (40%), Gaps = 9/267 (3%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE-FVNEIGMISALQHP 477
+ + IGEG +G V + VA+K++S Q + + EI ++ +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 478 NLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYL 537
N++ ++ + Y+ + + L+ + L I RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125
Query: 538 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRVAGTFGYMAPE 595
H ++HRD+K +N+LL+ + KI DFGLA++ + D+T T T Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 596 YAMRGYLTD-KADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654
+ D++S G + E++S R K D + L +Q +L +++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 655 KRLGSNFDKEQVMVMINVALLCTDVSS 681
+ + + L + S
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADS 269
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-46
Identities = 66/277 (23%), Positives = 117/277 (42%), Gaps = 14/277 (5%)
Query: 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQL--SSKSKQGNREFVNEIGMISALQHPN 478
NF KIGEG +G VYK + G VVA+K++ ++++ + EI ++ L HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+VKL N+L L++E++ + F + + P + +GLA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLK---KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 598
+++HRD+K N+L++ + K++DFGLA+ + V +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 599 RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658
Y + D++S G + E+V+ R+ + D + I + G E+V +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-----RIFRTLGTPDEVVWPGVT 231
Query: 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
S D + V S + ML
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLH 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 163 bits (414), Expect = 5e-46
Identities = 53/286 (18%), Positives = 102/286 (35%), Gaps = 39/286 (13%)
Query: 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLS---------SKSKQGNREFVNEIGMI 471
N+ P +G G V + H AVK + + ++ + E+ ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 472 SALQ-HPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGI 530
+ HPN+++L L+++ M+ L L ++ L +I +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRAL 119
Query: 531 ARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFG 590
+ LH+ L IVHRD+K N+LLD D+N K++DFG + + V GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPS 174
Query: 591 YMAPEYAM------RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK 644
Y+APE + D++S G++ +++G + + + +I+
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR-----MIMS 229
Query: 645 AQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSV 690
++ V R +
Sbjct: 230 GNYQFGSPEWDDYSDTV--------KDLVSRFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-45
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 13/220 (5%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE---FVNEIGMIS-ALQ 475
+F +G+G FG V+ A+K L + + + E ++S A +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 476 HPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLA 535
HP L + L + EY+ L + K D I GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQ 117
Query: 536 YLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 595
+LH IV+RD+K N+LLDKD + KI+DFG+ K + + +T GT Y+APE
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173
Query: 596 YAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY 635
+ D +SFG++ E++ G+S + +E++F+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 162 bits (411), Expect = 3e-45
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQH 476
+F +G G FG V+ +G A+K L + + +E M+S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 477 PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
P ++++ G + Q+ +I +Y+E L L + P + L Y
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEY 119
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 596
LH I++RD+K N+LLDK+ + KI+DFG AK + + GT Y+APE
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEV 172
Query: 597 AMRGYLTDKADVYSFGIVALEIVSGRS 623
D +SFGI+ E+++G +
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (407), Expect = 6e-45
Identities = 47/288 (16%), Positives = 98/288 (34%), Gaps = 31/288 (10%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQH-PN 478
++ +IGEG FG +++G ++ + VA+K +S + +E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+ ++ EG +L+ + + + + K T + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLL----DLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 539 EESRLKIVHRDIKATNVLLDKDLNP-----KISDFGLAKLDEEDNTHI------STRVAG 587
E +V+RDIK N L+ + + + DFG+ K + T ++G
Sbjct: 119 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 588 TFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG 647
T YM+ + + + D+ + G V + + G + K
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 648 NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
L EL F +E +++ + P + +
Sbjct: 236 PLRELCA-----GFPEE----FYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 160 bits (406), Expect = 7e-45
Identities = 48/204 (23%), Positives = 94/204 (46%), Gaps = 9/204 (4%)
Query: 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQL--SSKSKQGNREFVNEIGMISALQHPN 478
+ KIGEG +G VYK G A+K++ + + + EI ++ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+VKL+ +L+L++E+++ + L+ T + + G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 539 EESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAM 598
+ +++HRD+K N+L++++ KI+DFGLA+ + + +
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 599 RGYLTDKADVYSFGIVALEIVSGR 622
+ D++S G + E+V+G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 159 bits (404), Expect = 9e-45
Identities = 50/226 (22%), Positives = 94/226 (41%), Gaps = 17/226 (7%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLS---SKSKQGNREFVNEIGMISALQ 475
++ + +G GG V+ + VAVK L ++ F E +AL
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 476 HPNLVKLHGCCIE----GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIA 531
HP +V ++ G ++ EY++ +L + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADAC 121
Query: 532 RGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL--DEEDNTHISTRVAGTF 589
+ L + H+ I+HRD+K N+++ K+ DFG+A+ D ++ + V GT
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 590 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY 635
Y++PE A + ++DVYS G V E+++G + + Y
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 224
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 7e-44
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 15/218 (6%)
Query: 427 NKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQG-----NREFVNEIGMISALQHPNLV 480
+ +GEG F VYK +VA+K++ + NR + EI ++ L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
L + + L++++ME + + + L L + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE----VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 541 SRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMR- 599
I+HRD+K N+LLD++ K++DFGLAK N + +V T Y APE
Sbjct: 120 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 600 GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL 637
D+++ G + E++ D +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-43
Identities = 59/291 (20%), Positives = 109/291 (37%), Gaps = 24/291 (8%)
Query: 419 ATNNFAPDNKIGEGGFGPVYKG--HMADGTVVAVKQLSSKSKQGN--REFVNEIGMISAL 474
A + +IGEG +G V+K G VA+K++ ++ + + E+ ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 475 ---QHPNLVKLHGCCIEGNQLLLIYEYMENNSLAR--ALFGPEAHRLKLDWPTRHRICVG 529
+HPN+V+L C + + + + + + T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTF 589
+ RGL +LH ++VHRD+K N+L+ K++DFGLA++ T V T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 590 GYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLL----------DW 639
Y APE ++ D++S G + E+ + D + DW
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 640 ALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSV 690
+ + F + + ++ L C + R S S
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 20/219 (9%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNR------EFVNEIGMISALQHPNLV 480
++G G F V K + G A K + + + +R + E+ ++ +QHPN++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 481 KLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE 540
LH ++LI E + LF A + L I G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLKQILNGVYYLHS- 131
Query: 541 SRLKIVHRDIKATNVLLDKDLNP----KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 596
L+I H D+K N++L P KI DFGLA + N + GT ++APE
Sbjct: 132 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEI 187
Query: 597 AMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY 635
L +AD++S G++ ++SG S K++
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 226
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-42
Identities = 63/282 (22%), Positives = 103/282 (36%), Gaps = 22/282 (7%)
Query: 422 NFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLV 480
++ IG G FG VY+ G +VA+K++ + NRE + ++ L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 481 KLHGCCIEGNQ------LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGL 534
+L + L L+ +Y+ A A + L + R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYVKLYMYQLFRSL 135
Query: 535 AYLHEESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLDEEDNTHISTRVAGTFGYMA 593
AY+H I HRDIK N+LLD D K+ DFG AK + + +
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYRAP 191
Query: 594 PEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653
T DV+S G V E++ G+ D I+K G
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV-----EIIKVLGTPTREQ 246
Query: 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695
+ + N+ + + + T +++ +LE
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLE 288
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-41
Identities = 49/207 (23%), Positives = 79/207 (38%), Gaps = 20/207 (9%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE------FVNEIGMISALQ--HPN 478
+G GGFG VY G ++D VA+K + E E+ ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 479 LVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLH 538
+++L + +LI E E R L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCH 127
Query: 539 EESRLKIVHRDIKATNVLLDKD-LNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 597
++HRDIK N+L+D + K+ DFG L ++ T GT Y PE+
Sbjct: 128 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 181
Query: 598 M-RGYLTDKADVYSFGIVALEIVSGRS 623
Y A V+S GI+ ++V G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-40
Identities = 63/220 (28%), Positives = 90/220 (40%), Gaps = 12/220 (5%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQH 476
N+F +G+G FG V A G A+K L + +K V E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 477 PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
P L L ++L + EY L L + I L Y
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEY 120
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 596
LH +V+RDIK N++LDKD + KI+DFGL K D + T GT Y+APE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEV 176
Query: 597 AMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYL 636
D + G+V E++ GR + E +F L
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 61/261 (23%), Positives = 112/261 (42%), Gaps = 27/261 (10%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGN--REFVNEIGMISALQHP 477
+ + KIG+G FG V+K H G VA+K++ ++++ + EI ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 478 NLVKLHGCCIEG--------NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVG 529
N+V L C + L++++ E++ +K R+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQM 125
Query: 530 IARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK---LDEEDNTHISTRVA 586
+ GL Y+H KI+HRD+KA NVL+ +D K++DFGLA+ L + + T
Sbjct: 126 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 587 GTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA 645
T Y PE + D++ G + E+ + ++ ALI +
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL-----ALISQL 237
Query: 646 QGNLMELVDKRLGSNFDKEQV 666
G++ V + + E++
Sbjct: 238 CGSITPEVWPNVDNYELYEKL 258
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-39
Identities = 51/270 (18%), Positives = 88/270 (32%), Gaps = 28/270 (10%)
Query: 429 IGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC- 486
+G G G V + + A+K L + RE E+ A Q P++V++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYE 75
Query: 487 ---IEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRL 543
LL++ E ++ L + + I I + YLH +
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 544 KIVHRDIKATNVLLDKDLNP---KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRG 600
I HRD+K N+L K++DFG AK N+ + T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPE 188
Query: 601 YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSN 660
D++S G++ ++ G I + I Q +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPNPEWSEVSEE 247
Query: 661 FDKEQVMVMINVALLCTDVSSTSRPSMSSV 690
+ T R +++
Sbjct: 248 V--------KMLIRNLLKTEPTQRMTITEF 269
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 3e-39
Identities = 44/206 (21%), Positives = 89/206 (43%), Gaps = 10/206 (4%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQL--SSKSKQGNREFVNEIGMISALQHP 477
+ KIGEG +G V+K + +VA+K++ + + EI ++ L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 478 NLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYL 537
N+V+LH +L L++E+ + + ++ LD + +GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLK----KYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 538 HEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYA 597
H ++HRD+K N+L++++ K+++FGLA+ S V +
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 598 MRGYLTDKADVYSFGIVALEIVSGRS 623
+ D++S G + E+ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-38
Identities = 44/219 (20%), Positives = 88/219 (40%), Gaps = 13/219 (5%)
Query: 411 FTLRQIKAAT----NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQL--SSKSKQGNRE 463
F +++ + +G G +G V G VA+K+L +S+ +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 464 FVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTR 523
E+ ++ ++H N++ L L ++ G KL
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 524 HRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHIST 583
+ + +GL Y+H I+HRD+K N+ +++D KI DFGLA+ + ++ ++
Sbjct: 124 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTG 177
Query: 584 RVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR 622
V + T D++S G + E+++G+
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (358), Expect = 1e-37
Identities = 54/235 (22%), Positives = 92/235 (39%), Gaps = 15/235 (6%)
Query: 405 DLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNRE 463
D T Q A + F +G G FG V H G A+K L + ++
Sbjct: 25 DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ 84
Query: 464 ---FVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDW 520
+NE ++ A+ P LVKL + + L ++ EY+ + L +
Sbjct: 85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSE 140
Query: 521 PTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580
P I YLH L +++RD+K N+L+D+ +++DFG AK +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197
Query: 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY 635
+ GT +APE + D ++ G++ E+ +G I+
Sbjct: 198 LC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-35
Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 18/229 (7%)
Query: 405 DLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKG----HMADGTVVAVKQLS----SK 456
+L T + T K NF +G G +G V+ G + A+K L +
Sbjct: 8 ELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ 67
Query: 457 SKQGNREFVNEIGMISALQH-PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHR 515
+ E ++ ++ P LV LH +L LI +Y+ L L R
Sbjct: 68 KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QR 123
Query: 516 LKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575
+ I L +LH+ L I++RDIK N+LLD + + ++DFGL+K
Sbjct: 124 ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180
Query: 576 EDNTHISTRVAGTFGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGR 622
D T + GT YMAP+ G D +S G++ E+++G
Sbjct: 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 7e-35
Identities = 53/241 (21%), Positives = 97/241 (40%), Gaps = 27/241 (11%)
Query: 404 VDLHTGSFTLRQIKAATNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLS--SKSKQG 460
V++ +FT+ + IG G G V VA+K+LS +++
Sbjct: 6 VEVGDSTFTV------LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 59
Query: 461 NREFVNEIGMISALQHPNLVKLHGCCI------EGNQLLLIYEYMENNSLARALFGPEAH 514
+ E+ ++ + H N++ L E + L+ E M+ N +
Sbjct: 60 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-------QVI 112
Query: 515 RLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574
+++LD + + G+ +LH I+HRD+K +N+++ D KI DFGLA+
Sbjct: 113 QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169
Query: 575 EEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF 634
T T Y APE + + D++S G + E+V + + D +
Sbjct: 170 GTSFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227
Query: 635 Y 635
Sbjct: 228 N 228
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (327), Expect = 9e-34
Identities = 40/209 (19%), Positives = 84/209 (40%), Gaps = 21/209 (10%)
Query: 421 NNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-HPN 478
+++ K+G G + V++ ++ + V VK L K+ + EI ++ L+ PN
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 479 LVKLHGCCIE--GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
++ L + L++E++ N + L I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQ-------LYQTLTDYDIRFYMYEILKALDY 144
Query: 537 LHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPE 595
H + I+HRD+K NV++D + ++ D+GLA+ + + + PE
Sbjct: 145 CHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPE 199
Query: 596 YAMR-GYLTDKADVYSFGIVALEIVSGRS 623
+ D++S G + ++ +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 2e-33
Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 9/206 (4%)
Query: 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLS--SKSKQGNREFVNEIGMISALQH 476
+ + +G G +G V G VAVK+LS +S + E+ ++ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 477 PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
N++ L L + L A KL + I RGL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEY 596
+H I+HRD+K +N+ +++D KI DFGLA+ + ++ VA +
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM 190
Query: 597 AMRGYLTDKADVYSFGIVALEIVSGR 622
+ D++S G + E+++GR
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (288), Expect = 2e-28
Identities = 43/210 (20%), Positives = 72/210 (34%), Gaps = 18/210 (8%)
Query: 428 KIGEGGFGPVYKG-HMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCC 486
K+G G F V+ M + T VA+K + K +EI ++ + + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 487 IEGNQLLLIYEY------------MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGL 534
LL + E + + +I + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 535 AYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDFGLAKLDEEDNTHISTR-VAGTFGYM 592
Y+H R I+H DIK NVL++ D + +A L T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 593 APEYAMRGYLTDKADVYSFGIVALEIVSGR 622
+PE + AD++S + E+++G
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.8 bits (235), Expect = 6e-23
Identities = 28/156 (17%), Positives = 48/156 (30%), Gaps = 21/156 (13%)
Query: 427 NKIGEGGFGPVYKGHMADGTVVAVK----------QLSSKSKQGNREFVNEIGMISALQH 476
+GEG V+ + VK ++ K G+ F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 477 PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAY 536
L KL G + Y + N++ L + + I +A
Sbjct: 66 RALQKLQGLAVPKV-----YAWEG-NAVLMELIDAKELYRVRVENPD-EVLDMILEEVAK 118
Query: 537 LHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572
+ IVH D+ NVL+ + I DF +
Sbjct: 119 FYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.1 bits (152), Expect = 5e-11
Identities = 30/154 (19%), Positives = 64/154 (41%), Gaps = 10/154 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L L D +++N + P + T L +L + A+ + P + +L + L
Sbjct: 240 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL 297
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
P+ +K + L L N+S P + +T L+ L + NK++ S+
Sbjct: 298 E----DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLAN 349
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYN 155
L +++++ N ++ P L + ++ L+
Sbjct: 350 LTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 2e-06
Identities = 41/166 (24%), Positives = 74/166 (44%), Gaps = 10/166 (6%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
L L+ ++N + P I T L++L + + L +ASL+ LTDL +++
Sbjct: 196 LTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANN 251
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
+ PL + K+ L L + +S P L +T+L L+++ N+L S
Sbjct: 252 QISN--LAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE--DISPISN 305
Query: 122 LLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSETSCQ 167
L ++ Y+ L N ++ P L K R+ + N + SS +
Sbjct: 306 LKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSDVSSLANLT 351
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.3 bits (134), Expect = 5e-09
Identities = 24/69 (34%), Positives = 30/69 (43%), Gaps = 2/69 (2%)
Query: 74 MKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGN 133
K + L LR+ + G LP L + L L+VSFN L G IP L D N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANN 301
Query: 134 -LLTGTIPP 141
L G+ P
Sbjct: 302 KCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 48.6 bits (114), Expect = 1e-06
Identities = 19/70 (27%), Positives = 31/70 (44%), Gaps = 1/70 (1%)
Query: 98 MTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNS 156
+L LD+ N++ G +P L + + ++ N L G IP LQ+ D + N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 157 FTAGSSETSC 166
GS +C
Sbjct: 303 CLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 44.7 bits (104), Expect = 2e-05
Identities = 13/62 (20%), Positives = 24/62 (38%), Gaps = 2/62 (3%)
Query: 10 ISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNG-TEAPF 68
+ +N G +P + L L + + L G IP G +L + ++ +P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPL 309
Query: 69 PP 70
P
Sbjct: 310 PA 311
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 2e-06
Identities = 19/162 (11%), Positives = 43/162 (26%), Gaps = 13/162 (8%)
Query: 49 SLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGK----LPDYLGLMTSLKVL 104
+L+D R ++L L +++ + + L C ++ + L + +L L
Sbjct: 10 QCEELSDARWAEL---------LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 105 DVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSSET 164
++ N+L + L + L L +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 120
Query: 165 SCQYRSVNLFASSSKGNNSTGIVSCLRSFRCPKTYYSVHINC 206
L + + L+ C + S
Sbjct: 121 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 16/79 (20%), Positives = 29/79 (36%), Gaps = 9/79 (11%)
Query: 74 MKKMKTLILRSCNVSGK----LPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLD----- 124
++ L L C+VS L L SL+ LD+S N L A + +
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 125 VDYIYLTGNLLTGTIPPWM 143
++ + L + + +
Sbjct: 428 LEQLVLYDIYWSEEMEDRL 446
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 45.8 bits (107), Expect = 1e-05
Identities = 39/232 (16%), Positives = 74/232 (31%), Gaps = 33/232 (14%)
Query: 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL 61
LV L+ +S N + L + + + + +G+ + + +L + L
Sbjct: 78 LVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPL 136
Query: 62 NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMG 121
+ MKK+ + + N++ +P GL SL L + NK+ ++ G
Sbjct: 137 KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKG 193
Query: 122 L-----LDVDYIYLTG--------------------NLLTGTIPPWMLQKGDRVDLSYNS 156
L L + + ++ L+ + V L N+
Sbjct: 194 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 253
Query: 157 FTAGSSETSCQYRSVNLFASSSK----GNNSTGIVSCLRSFRCPKTYYSVHI 204
+A S C AS S N +FRC +V +
Sbjct: 254 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 27/148 (18%), Positives = 47/148 (31%), Gaps = 3/148 (2%)
Query: 43 IPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLK 102
+P + L + + TE +K + TLIL + +S P + L+
Sbjct: 25 VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 103 VLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGSS 162
L +S N+L L ++ + ++ L + V+L N +
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV-FNGLNQMIVVELGTNPLKSSGI 141
Query: 163 ETSCQYRSVNLFASSSKGNNSTGIVSCL 190
E L N T I L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQGL 169
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.003
Identities = 16/73 (21%), Positives = 31/73 (42%), Gaps = 9/73 (12%)
Query: 50 LSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFN 109
L +L +S+ E P +++ LI +++ ++P+ L +LK L V +N
Sbjct: 283 PPSLEELNVSNNKLIELP----ALPPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYN 334
Query: 110 KLNGAIPSTFMGL 122
L P +
Sbjct: 335 PLRE-FPDIPESV 346
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.2 bits (83), Expect = 0.003
Identities = 15/106 (14%), Positives = 38/106 (35%), Gaps = 8/106 (7%)
Query: 10 ISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPF- 68
++ T + + + L+ L + + L P+ L+ L L + +
Sbjct: 5 LAHKDLT-VLCHL-EQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNALENV 58
Query: 69 PPLDKMKKMKTLILRSCNV-SGKLPDYLGLMTSLKVLDVSFNKLNG 113
+ + +++ L+L + + L L +L++ N L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 771 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.85 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.83 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.8 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.79 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.66 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.65 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.62 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.62 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.6 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.59 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.59 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.57 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.52 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.51 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.5 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.49 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.45 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.38 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.37 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.35 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.24 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.13 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.11 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.97 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.96 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.81 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.58 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.54 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.52 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.44 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.35 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.98 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.56 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.51 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.39 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.04 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.7 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.59 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.5 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.38 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=424.94 Aligned_cols=254 Identities=25% Similarity=0.425 Sum_probs=200.3
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
++|++.+.||+|+||+||+|.+.+++.||||+++.. ....++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 467888999999999999999888899999999764 3446789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+|+|.+++... ...+++..++.|+.|||.||+|||+. +|+||||||+|||+++++.+||+|||+|+........
T Consensus 84 ~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999998543 34689999999999999999999998 8999999999999999999999999999877655444
Q ss_pred cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhC-CCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSG-RSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
......||+.|+|||++.+..++.++|||||||++|||+|+ ++|+......+.. .. +......
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~---~~-------------i~~~~~~ 221 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---ED-------------ISTGFRL 221 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH---HH-------------HHHTCCC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHH---HH-------------HHhcCCC
Confidence 44456799999999999999999999999999999999995 5555433222211 11 1111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
..+.....++.+++.+||+.||++||||+||++.|+++
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 22223345688999999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.5e-51 Score=428.42 Aligned_cols=259 Identities=24% Similarity=0.380 Sum_probs=216.2
Q ss_pred HhcCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
..++|++.++||+|+||+||+|.. .+|+.||||+++... ...++|.+|+.++++++|||||+++++|.+++..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 456788899999999999999965 468999999997643 346789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
||++|+|.+++.... ...+++..++.|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 94 ~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 94 FMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp CCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred cccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999995432 35789999999999999999999998 8999999999999999999999999999987665
Q ss_pred CcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhc
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRL 657 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 657 (771)
.........||+.|+|||++.+..++.++|||||||++|||++|..|+........ +.+.+....
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~---------------~~~~i~~~~ 233 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYELLEKDY 233 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---------------HHHHHHTTC
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH---------------HHHHHhcCC
Confidence 55444556789999999999999999999999999999999998777653322111 111222222
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 658 GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 658 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
....+......+.+++.+||+.||++||||+||++.|+.+.
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22333334556889999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=413.36 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=215.7
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
++|+..++||+|+||+||+|..++++.||||+++... ...++|.+|+.++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6889999999999999999998888899999998643 346789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+|+|.+++... ...+++..+++++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999998443 34789999999999999999999998 8999999999999999999999999999877655544
Q ss_pred cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+.... +......
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~----------------i~~~~~~ 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----------------IAQGLRL 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH----------------HHTTCCC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH----------------HHhCCCC
Confidence 4455679999999999999999999999999999999998 8999976543332111 1111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
..+......+.+++.+||+.||++|||++|+++.|.++
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 22223345688999999999999999999999998653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=420.70 Aligned_cols=255 Identities=30% Similarity=0.436 Sum_probs=209.0
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.++|++.++||+|+||.||+|.+.+++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 35788889999999999999998888999999997643 445789999999999999999999998854 5679999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++|+|.+++... ....+++..+++|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 90 ~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 90 ENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp TTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 999999988443 234699999999999999999999998 899999999999999999999999999998766554
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
.......||+.|+|||++.++.++.++|||||||++|||+||..|+....... ..... +......
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~~~-------------i~~~~~~ 229 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQN-------------LERGYRM 229 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHH-------------HHTTCCC
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHHHH-------------HHhcCCC
Confidence 44455679999999999999999999999999999999999765554322211 11111 1111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
..+......+.+++.+||+.||++||||+||+++|+.
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 2222334568899999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-50 Score=428.15 Aligned_cols=266 Identities=28% Similarity=0.462 Sum_probs=204.5
Q ss_pred CCHHHHHHHhcC---------CCCCCccccCCceeEEEEEcC-CC---cEEEEEEcccC-ChhcHHHHHHHHHHHHcCCC
Q 004155 411 FTLRQIKAATNN---------FAPDNKIGEGGFGPVYKGHMA-DG---TVVAVKQLSSK-SKQGNREFVNEIGMISALQH 476 (771)
Q Consensus 411 ~~~~~l~~~~~~---------f~~~~~lG~G~~g~Vy~~~~~-~g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h 476 (771)
++++++..++.+ |++.++||+|+||+||+|... +| ..||||++... .....++|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 556666666544 445679999999999999653 33 36999998754 34456789999999999999
Q ss_pred CcEEeEEEEEEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEE
Q 004155 477 PNLVKLHGCCIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVL 556 (771)
Q Consensus 477 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIl 556 (771)
||||+++|+|.+++..++|||||++|+|.+++... ...++|.++++|+.|||+||+|||++ +|+||||||+|||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNIL 160 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEE
Confidence 99999999999999999999999999999988543 34699999999999999999999998 8999999999999
Q ss_pred EcCCCCeEEEeecCccccCCCCccc----ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 004155 557 LDKDLNPKISDFGLAKLDEEDNTHI----STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKE 631 (771)
Q Consensus 557 l~~~~~~kl~DFGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~ 631 (771)
++.++++||+|||+|+......... .....||+.|+|||++.++.++.++|||||||++|||+| |++||......
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999998765433221 122457899999999999999999999999999999998 89999765433
Q ss_pred chhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 632 DIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
+... .+........+......+.+++.+||+.||++||||.||++.|+.+.
T Consensus 241 ~~~~----------------~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 241 DVIN----------------AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp HHHH----------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHH----------------HHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 2211 11111112233344566889999999999999999999999998753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=417.67 Aligned_cols=249 Identities=26% Similarity=0.450 Sum_probs=208.4
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
++|++.++||+|+||+||+|. ..+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 479999999999999999995 4679999999997665556678999999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++|+|.+++. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+.......
T Consensus 100 ~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 9999999883 34699999999999999999999998 899999999999999999999999999987654333
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGS 659 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 659 (771)
......||+.|+|||++.+..++.++|||||||++|||+||+.||......+.... ....+ ....
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------~~~~~--------~~~~ 236 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATNG--------TPEL 236 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHHHC--------SCCC
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH------HHhCC--------CCCC
Confidence 23446799999999999999999999999999999999999999975433221110 00110 0001
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 660 NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 660 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..+......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223356889999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=417.92 Aligned_cols=251 Identities=28% Similarity=0.359 Sum_probs=202.2
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
++|++.++||+|+||+||+|. ..+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 578999999999999999995 4679999999987543 23346789999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+++|+|.+++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999943 34699999999999999999999998 89999999999999999999999999998765433
Q ss_pred -cccccccccCCCccchhhhccCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 579 -THISTRVAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 579 -~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
........||+.|+|||++.+..+ +.++|||||||++|||+||++||.......... .. .....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~----~~~~~--------- 223 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SD----WKEKK--------- 223 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HH----HHTTC---------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-HH----HhcCC---------
Confidence 223345679999999999988765 678999999999999999999997644322211 00 00000
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
............+.+++.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000111122345778999999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=416.06 Aligned_cols=259 Identities=30% Similarity=0.460 Sum_probs=203.0
Q ss_pred hcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
.++|.+.++||+|+||+||+|... ..||||+++.. .....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467889999999999999999864 36999998754 34456789999999999999999999998754 56899999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
||++|+|.++++.. ...+++..++.|+.|||.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999543 24699999999999999999999998 8999999999999999999999999999876543
Q ss_pred Cc-ccccccccCCCccchhhhcc---CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 578 NT-HISTRVAGTFGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 578 ~~-~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
.. .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.......... . ....+..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~--~----~~~~~~~---- 227 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--F----MVGRGYL---- 227 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--H----HHHHTSC----
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH--H----HHhcCCC----
Confidence 22 23345679999999999864 458999999999999999999999997644332211 0 1111110
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
.+.+ .......+..+.+++.+||+.||++||||+||++.|+.+.
T Consensus 228 ~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 228 SPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp CCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 0000 0112223456889999999999999999999999998653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=417.44 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=196.2
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe--CCEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIE--GNQLLLI 495 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 495 (771)
++|++.+.||+|+||+||+|. ..+|+.||||++... .....+.+.+|++++++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 578999999999999999995 567999999998764 33445678999999999999999999999864 4568999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcC--CCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES--RLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
||||++|+|.+++.........+++..++.++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999554444567999999999999999999999872 12499999999999999999999999999997
Q ss_pred cCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 574 DEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 574 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
...... ......||+.|+|||++.+..++.++|||||||++|||+||++||......+... .+.
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~---------------~i~ 227 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---------------KIR 227 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---------------HHH
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHH---------------HHH
Confidence 654332 2344679999999999999999999999999999999999999997543322111 011
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.... ...+.....++.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 228 EGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111 1112223346889999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=411.56 Aligned_cols=245 Identities=24% Similarity=0.405 Sum_probs=205.5
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||+||+|.. .+|+.||+|++... .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4688999999999999999954 57899999998643 2234677899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
|||++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999993 335799999999999999999999998 899999999999999999999999999986554
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +....
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~---------------i~~~~ 220 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR---------------ISRVE 220 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---------------HHTTC
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHH---------------HHcCC
Confidence 32 2345799999999999999999999999999999999999999975443222111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..++......+.+++.+||+.||++|||++|+++
T Consensus 221 --~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 --FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1122223346788999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-49 Score=411.72 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=206.6
Q ss_pred cCCCCCC-ccccCCceeEEEEEcC---CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEE
Q 004155 421 NNFAPDN-KIGEGGFGPVYKGHMA---DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 421 ~~f~~~~-~lG~G~~g~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 495 (771)
++|.+.+ +||+|+||.||+|... ++..||||+++... ....++|.+|+++|++++|||||+++|+|.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455566 4999999999999543 45689999997653 4456789999999999999999999999865 568999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
||||++|+|.+++... +..+++..+.+++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 87 mE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998432 34799999999999999999999998 89999999999999999999999999999775
Q ss_pred CCCccc--ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 576 EDNTHI--STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 576 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
...... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||......+....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~---------------- 224 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---------------- 224 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH----------------
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH----------------
Confidence 543322 234568999999999999999999999999999999998 9999976543322111
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
+........+...+.++.+++.+||+.||++|||+.+|++.|+..
T Consensus 225 i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 225 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111111122333445688999999999999999999999998763
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=413.51 Aligned_cols=258 Identities=27% Similarity=0.443 Sum_probs=202.4
Q ss_pred cCCCCCCccccCCceeEEEEEcCCC-----cEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADG-----TVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
+.|+..++||+|+||.||+|.+.+. ..||||++... ......+|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677889999999999999965432 47999998754 33445679999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+.+|++.+++.. ....++|.++++++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999998843 235799999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCc--ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 575 EEDNT--HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 575 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
..... .......||+.|+|||++.++.++.++|||||||++|||++|..|+....... .. .+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~-------------~~~ 225 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EV-------------MKA 225 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH-------------HHH
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HH-------------HHH
Confidence 54332 22334568999999999999999999999999999999999766654332211 11 111
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
+........+...+..+.+++.+||+.||++||||.||+++|+.+..
T Consensus 226 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 22222223333455678999999999999999999999999987543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-49 Score=411.98 Aligned_cols=258 Identities=28% Similarity=0.418 Sum_probs=205.1
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEecc
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYME 500 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 500 (771)
++|++.+.||+|+||.||+|...+++.||||+++.. ....+.|.+|+.++++++|||||+++|+|.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 578899999999999999998888889999999754 3446789999999999999999999999854 56789999999
Q ss_pred CCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCcc
Q 004155 501 NNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTH 580 (771)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~ 580 (771)
+|+|..++... ....++|.+++.|+.||+.||+|||+. +|+||||||+|||++.++++||+|||+|+........
T Consensus 95 ~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 95 KGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 99999998543 234699999999999999999999998 8999999999999999999999999999876554444
Q ss_pred cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCC
Q 004155 581 ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSN 660 (771)
Q Consensus 581 ~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 660 (771)
......||+.|+|||++.++.++.++|||||||++|||+||..|+....... ....+ +.......
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~~~~-------------i~~~~~~~ 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQ-------------VERGYRMP 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHH-------------HHTTCCCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--HHHHH-------------HHhcCCCC
Confidence 4445679999999999999999999999999999999999766654432211 11111 11111122
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCCC
Q 004155 661 FDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRADV 700 (771)
Q Consensus 661 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 700 (771)
.+.....++.+++.+||+.||++||+|++|+++|+.....
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 3333445688999999999999999999999999986544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-49 Score=413.05 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=206.4
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
+.|++.+.||+|+||.||+|. ..+|+.||||++........+.+.+|++++++++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 468889999999999999995 4678999999998766666778999999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++|+|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 92 ~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 92 AGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 99999999743 234699999999999999999999998 899999999999999999999999999975533221
Q ss_pred ccccccccCCCccchhhhc-----cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh
Q 004155 580 HISTRVAGTFGYMAPEYAM-----RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD 654 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 654 (771)
......||+.|+|||++. +..++.++|||||||++|||+||+.||......+..... . .+..
T Consensus 166 -~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i------~-~~~~----- 232 (288)
T d2jfla1 166 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI------A-KSEP----- 232 (288)
T ss_dssp -HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH------H-HSCC-----
T ss_pred -cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH------H-cCCC-----
Confidence 223467999999999984 456899999999999999999999999765443322110 0 0000
Q ss_pred hhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 KRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+. ...+......+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~--~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 PT--LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CC--CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC--CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 1111223456889999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=408.25 Aligned_cols=246 Identities=27% Similarity=0.386 Sum_probs=199.0
Q ss_pred CccccCCceeEEEEEcC---CCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEeccC
Q 004155 427 NKIGEGGFGPVYKGHMA---DGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYMEN 501 (771)
Q Consensus 427 ~~lG~G~~g~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 501 (771)
++||+|+||+||+|.+. .++.||||+++... ....++|.+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999643 35689999997542 2335689999999999999999999999965 457899999999
Q ss_pred CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCccc
Q 004155 502 NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHI 581 (771)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 581 (771)
|+|.+++. ....+++..+++|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.........
T Consensus 92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999994 335699999999999999999999998 89999999999999999999999999998765443322
Q ss_pred --ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 582 --STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 582 --~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+... .+.....
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~----------------~i~~~~~ 228 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA----------------MLEKGER 228 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----------------HHHTTCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH----------------HHHcCCC
Confidence 234568999999999999999999999999999999998 899997644322211 1111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
...+...+.++.+++.+||+.||++|||+++|+++|+.
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 22233344568899999999999999999999998875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-49 Score=418.74 Aligned_cols=265 Identities=20% Similarity=0.346 Sum_probs=206.5
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
..++|++.++||+|+||+||+|. ..+|+.||+|+++... ......+.+|+.+|++++|||||+++++|.+.++.++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35789999999999999999995 5679999999997643 334568899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
|||++|+|.+++. ....+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++++||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~----~~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999994 2346999999999999999999999742 799999999999999999999999999986543
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHH-H--------------
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWA-L-------------- 641 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~-~-------------- 641 (771)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||............... .
T Consensus 158 ~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp H---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred C---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 2 223467999999999999999999999999999999999999999765432211000000 0
Q ss_pred --------HHHhhCChhHHhhhhcCC---CCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 642 --------ILKAQGNLMELVDKRLGS---NFD-KEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 642 --------~~~~~~~~~~~~d~~l~~---~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.........+..+..... ..+ .....++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000000111111111100 000 112346889999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=417.66 Aligned_cols=257 Identities=28% Similarity=0.415 Sum_probs=206.9
Q ss_pred cCCCCCCccccCCceeEEEEEcCC------CcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMAD------GTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 492 (771)
++|++.++||+|+||+||+|.... ...||||++.... ......+.+|+.++.++ +|||||+++++|.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578889999999999999996432 2379999986543 33456789999999998 899999999999999999
Q ss_pred EEEEEeccCCCHHHHhcCCCc-------------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCC
Q 004155 493 LLIYEYMENNSLARALFGPEA-------------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKAT 553 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~ 553 (771)
++|||||++|+|.++|+.... ....+++..++.|+.||+.||+|||++ +|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 999999999999999965432 124589999999999999999999998 8999999999
Q ss_pred cEEEcCCCCeEEEeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCcc
Q 004155 554 NVLLDKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKE 631 (771)
Q Consensus 554 NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~ 631 (771)
|||++.++.+||+|||+|+........ ......||+.|+|||++.++.++.++|||||||++|||+| |++||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999866544332 2334568999999999999999999999999999999998 89999765443
Q ss_pred chhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 004155 632 DIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLE 695 (771)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 695 (771)
... .+++........+......+.+|+.+||+.||++|||++||++.|.
T Consensus 274 ~~~---------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANF---------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHH---------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH---------------HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 221 1112222222233334456889999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=402.31 Aligned_cols=246 Identities=27% Similarity=0.410 Sum_probs=195.2
Q ss_pred CCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe----CCEEEEEE
Q 004155 424 APDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIE----GNQLLLIY 496 (771)
Q Consensus 424 ~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 496 (771)
+..++||+|+||+||+|. ..+++.||+|++... .....+.|.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 455689999999999995 457899999998654 34446679999999999999999999999875 35689999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc-CCCCeEEEeecCccccC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD-KDLNPKISDFGLAKLDE 575 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFGla~~~~ 575 (771)
||+++|+|.+++. ....+++..+..++.||+.||+|||++. ++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHh----ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999993 3357999999999999999999999982 2499999999999996 57899999999998654
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||........ +.. .. ..+....
T Consensus 167 ~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~---~i-~~~~~~~---- 232 (270)
T d1t4ha_ 167 ASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR---RV-TSGVKPA---- 232 (270)
T ss_dssp TTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH---HH-TTTCCCG----
T ss_pred CCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHH---HH-HcCCCCc----
Confidence 332 234679999999998865 589999999999999999999999965332211 111 00 1111000
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.. +.....++.+++.+||+.||++|||+.|+++
T Consensus 233 ~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11 1112235788999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=409.04 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=203.2
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||+||+|. ..+|+.||||++... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 568999999999999999995 467999999998653 2234567999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999983 345799999999999999999999998 899999999999999999999999999987654
Q ss_pred CC-cccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 577 DN-THISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 577 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.. ........||+.|+|||++.+..++.++|||||||++|||+||+.||......+... .+...
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~---------------~i~~~ 225 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ---------------KIIKL 225 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------HHHTT
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH---------------HHHcC
Confidence 33 223344679999999999999999999999999999999999999997643322111 01111
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. ..++......+.+++.+||+.||++|||++|+++
T Consensus 226 ~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 226 E--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp C--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred C--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1 1122223345789999999999999999998743
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-48 Score=410.14 Aligned_cols=245 Identities=27% Similarity=0.437 Sum_probs=201.3
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCCh---hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK---QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
+.|+..+.||+|+||.||+|. ..+|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 358889999999999999995 56789999999876432 33467899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
|||++|+|..++. ...++++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999987762 345799999999999999999999998 899999999999999999999999999986543
Q ss_pred CCcccccccccCCCccchhhhcc---CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMR---GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
. ....||+.|+|||++.+ +.++.++|||||||++|||++|+.||......+... .+.
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~---------------~i~ 227 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---------------HIA 227 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---------------HHH
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH---------------HHH
Confidence 2 23579999999999864 468999999999999999999999997543322111 111
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
........+......+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111111111122346889999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-48 Score=407.88 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=190.5
Q ss_pred HhcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCCh-hcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 419 ATNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK-QGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 419 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
..+.|++.+.||+|+||+||+|. ..+|+.||||++..... .....+.+|+.++++++|||||++++++.+++..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 34678999999999999999995 45789999999976432 33456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc---CCCCeEEEeecCccc
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAKL 573 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFGla~~ 573 (771)
|||++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+||++. +++.+||+|||+|+.
T Consensus 87 E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred eccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence 99999999999943 35799999999999999999999998 899999999999994 578999999999986
Q ss_pred cCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 574 DEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 574 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .. . .+.
T Consensus 160 ~~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~---~i--~--~~~----- 225 (307)
T d1a06a_ 160 EDPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE---QI--L--KAE----- 225 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HH--H--TTC-----
T ss_pred ccCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHH---HH--h--ccC-----
Confidence 644322 234579999999999999999999999999999999999999997543322111 00 0 000
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..............+.+++.+||+.||++|||+.|+++
T Consensus 226 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 226 -YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00111111223346889999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-47 Score=412.60 Aligned_cols=252 Identities=21% Similarity=0.321 Sum_probs=208.7
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
.++|++.+.||+|+||.||+|. ..+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4589999999999999999995 467999999999877666677899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc--CCCCeEEEeecCccccCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD--KDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFGla~~~~~ 576 (771)
|++|+|.+++... ...+++..+..|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+....
T Consensus 105 ~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 9999999999432 34699999999999999999999998 899999999999995 467899999999987654
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ .......
T Consensus 179 ~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i-----~~~~~~~------- 244 (350)
T d1koaa2 179 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-----KSCDWNM------- 244 (350)
T ss_dssp TSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HHTCCCS-------
T ss_pred ccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH-----HhCCCCC-------
Confidence 433 23457999999999999999999999999999999999999999754433221110 0000000
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...........+.+++.+||+.||++|||++|+++
T Consensus 245 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 245 -DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp -CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000112345789999999999999999999988
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-48 Score=409.86 Aligned_cols=266 Identities=29% Similarity=0.441 Sum_probs=213.7
Q ss_pred HHHHHHhcCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEE
Q 004155 414 RQIKAATNNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCC 486 (771)
Q Consensus 414 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 486 (771)
.+++...++|++.+.||+|+||+||+|... +++.||||+++... ....++|.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 344445678999999999999999999643 46789999997653 33467899999999999999999999999
Q ss_pred EeCCEEEEEEEeccCCCHHHHhcCCC--------------------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCcee
Q 004155 487 IEGNQLLLIYEYMENNSLARALFGPE--------------------AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIV 546 (771)
Q Consensus 487 ~~~~~~~lV~E~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~iv 546 (771)
.+.+..++||||+++|+|.++++... .....+++..++.|+.|++.||+|||++ +||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence 99999999999999999999995322 1233589999999999999999999998 899
Q ss_pred ccCCCCCcEEEcCCCCeEEEeecCccccCCCCc-ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCC-CC
Q 004155 547 HRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT-HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR-SN 624 (771)
Q Consensus 547 H~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~-~p 624 (771)
||||||+|||+|.++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999999999999999999999999986644332 2234467899999999999999999999999999999999996 56
Q ss_pred CCCCCccchhhHHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 625 SSCKPKEDIFYLLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
|......+.... ...+. ....+...+.++.+|+.+||+.||++||||.||+++|+++.
T Consensus 243 ~~~~~~~e~~~~-------v~~~~---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEEVIYY-------VRDGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHHHHHH-------HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHHHHHH-------HHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 665433322111 11111 11222233456889999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.7e-47 Score=410.98 Aligned_cols=256 Identities=23% Similarity=0.314 Sum_probs=210.7
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
.++|++.+.||+|+||.||+|. ..+|+.||||+++.........+.+|+.+|++++|||||++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3579999999999999999995 567999999999876666677889999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc--CCCCeEEEeecCccccCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD--KDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFGla~~~~~ 576 (771)
|++|+|.+++.. ...++++.+++.|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999998743 234699999999999999999999998 899999999999997 678999999999997765
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+....+ . .. +..
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i------~-~~------~~~ 246 (352)
T d1koba_ 182 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------K-RC------DWE 246 (352)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------H-HC------CCC
T ss_pred CCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------H-hC------CCC
Confidence 432 23457999999999999999999999999999999999999999754432221100 0 00 000
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcC
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEG 696 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 696 (771)
............+.+|+.+||+.||++|||+.|+++ .+++
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 111111123345789999999999999999999987 3544
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=398.32 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=197.4
Q ss_pred hcCCCCCCccccCCceeEEEEEcCC----CcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMAD----GTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
.++|++.+.||+|+||.||+|.... +..||||+++... ....+.|.+|+.++++++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578889999999999999996432 4579999987543 344577999999999999999999999985 467899
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999998743 234789999999999999999999998 8999999999999999999999999999877
Q ss_pred CCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHh
Q 004155 575 EEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELV 653 (771)
Q Consensus 575 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (771)
............||+.|+|||++.+..++.++|||||||++|||+| |++||......+....+ ..+
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i-------~~~------ 225 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENG------ 225 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------HTT------
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH-------HcC------
Confidence 6554444555678999999999999999999999999999999998 89999765544332111 011
Q ss_pred hhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 654 DKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 654 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.....+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 226 ---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 226 ---ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11122233445688999999999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=397.05 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=205.2
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC------hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS------KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 492 (771)
.++|++.+.||+|+||+||+|. ..+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4679999999999999999995 4679999999986432 12367899999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC----CeEEEee
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL----NPKISDF 568 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DF 568 (771)
|+|||||++|+|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~----~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhc----cccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999993 235799999999999999999999998 899999999999998776 4999999
Q ss_pred cCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 569 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 569 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
|+|+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ......
T Consensus 162 G~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i-----~~~~~~ 234 (293)
T d1jksa_ 162 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-----SAVNYE 234 (293)
T ss_dssp TTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----HTTCCC
T ss_pred hhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH-----HhcCCC
Confidence 99987654332 23457899999999999999999999999999999999999999765433221110 000000
Q ss_pred hhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 649 LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 649 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...... . .....+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~----~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 FEDEYF----S----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCHHHH----T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCchhc----C----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 1 12245789999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=395.92 Aligned_cols=249 Identities=30% Similarity=0.427 Sum_probs=198.1
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe-CCEEEEEEEec
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIE-GNQLLLIYEYM 499 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E~~ 499 (771)
++|++.++||+|+||.||+|.. .|+.||||+++.. ...+.|.+|++++++++||||++++|+|.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4567789999999999999987 4789999999754 345779999999999999999999999865 45689999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++|+|.++++.. ....++|..+++|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~- 157 (262)
T d1byga_ 84 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 157 (262)
T ss_dssp TTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC-
Confidence 999999999532 223589999999999999999999998 89999999999999999999999999998654322
Q ss_pred ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhhcC
Q 004155 580 HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKRLG 658 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 658 (771)
....+|..|+|||++.++.++.++|||||||++|||+| |++||......+... + +.....
T Consensus 158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~---~-------------i~~~~~ 218 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---R-------------VEKGYK 218 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH---H-------------HTTTCC
T ss_pred ---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH---H-------------HHcCCC
Confidence 23457899999999999999999999999999999998 688876554433221 1 111112
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 659 SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 659 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
...+.....++.+++.+||+.||++||||.|++++|+.+
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 223333445688999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=401.97 Aligned_cols=254 Identities=27% Similarity=0.458 Sum_probs=202.8
Q ss_pred cCCCCCCccccCCceeEEEEEc-CCCc----EEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM-ADGT----VVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~-~~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 494 (771)
.+|++.++||+|+||+||+|.. .+|+ +||+|+++.. .....++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 3588999999999999999954 3454 6899988653 344577899999999999999999999999865 5678
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCcccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLD 574 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 574 (771)
++||+.+|+|.+++.. ....+++..+++|+.|||.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 8999999999998843 345799999999999999999999998 8999999999999999999999999999977
Q ss_pred CCCCccc-ccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 575 EEDNTHI-STRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 575 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
....... .....||+.|+|||++.++.++.++|||||||++|||+| |++||......+....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~---------------- 225 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------------- 225 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH----------------
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHH----------------
Confidence 5543332 334568999999999999999999999999999999999 7888876544332211
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
+........+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 226 i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp HHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 111111222333445688999999999999999999999988764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=400.35 Aligned_cols=247 Identities=26% Similarity=0.332 Sum_probs=206.1
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||.||+|. ..+|+.||||++++. .....+.+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 578999999999999999995 567999999999753 2334677899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
|||++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 9999999999993 345789999999999999999999998 899999999999999999999999999986544
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
... .....+||+.|+|||++.+..++.++||||+||++|||++|++||......+.... +....
T Consensus 158 ~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~---------------i~~~~ 221 (337)
T d1o6la_ 158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL---------------ILMEE 221 (337)
T ss_dssp TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---------------HHHCC
T ss_pred CCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH---------------HhcCC
Confidence 332 23446799999999999999999999999999999999999999976543322110 01111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPS-----MSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 692 (771)
..++.....++.+++.+||+.||++||+ +.|+++
T Consensus 222 --~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1122223345788999999999999995 777765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=395.07 Aligned_cols=254 Identities=25% Similarity=0.397 Sum_probs=196.5
Q ss_pred cCCCCCCccccCCceeEEEEEc--CCC--cEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM--ADG--TVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~--~~g--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
++|++.+.||+|+||.||+|.. .++ ..||||+++.. .....++|.+|+.++++++||||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5688899999999999999954 223 47999998754 23345689999999999999999999999975 4678
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+||||+++|++.+++.. ....+++..+++++.|||.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999998843 234699999999999999999999998 899999999999999999999999999997
Q ss_pred cCCCCcc--cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhHHHHHHHHHhhCChh
Q 004155 574 DEEDNTH--ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYLLDWALILKAQGNLM 650 (771)
Q Consensus 574 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (771)
....... ......||..|+|||++.+..++.++|||||||++|||+| |+.||......+.. .+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~---~~----------- 226 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---HK----------- 226 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HH-----------
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH---HH-----------
Confidence 7554332 2234568889999999999999999999999999999998 89999755433221 11
Q ss_pred HHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcC
Q 004155 651 ELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEG 696 (771)
Q Consensus 651 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 696 (771)
+.........+...+..+.+++.+||+.||++||||.||++.|++
T Consensus 227 -i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 227 -IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111111112222334568899999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-46 Score=396.24 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=204.3
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||+||+|. ..+|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 568899999999999999995 467999999998653 2234578899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
|||+||+|..++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999983 345688999999999999999999998 899999999999999999999999999987654
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
.. ....||+.|+|||++.+..++.++|||||||++|||+||+.||......+... .+....
T Consensus 157 ~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---------------~i~~~~ 217 (316)
T d1fota_ 157 VT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE---------------KILNAE 217 (316)
T ss_dssp CB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---------------HHHHCC
T ss_pred cc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH---------------HHHcCC
Confidence 32 34679999999999999999999999999999999999999997644322211 111111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
..++......+.+++.+||+.||.+|| +++|+++
T Consensus 218 --~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 111222234578999999999999996 8899876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=398.86 Aligned_cols=258 Identities=27% Similarity=0.404 Sum_probs=205.5
Q ss_pred cCCCCCCccccCCceeEEEEEcC-CCc--EEEEEEcccC-ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA-DGT--VVAVKQLSSK-SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 495 (771)
++|++.++||+|+||.||+|... +|. .||||+++.. .....+.|.+|+++|+++ +|||||+++++|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57788899999999999999654 444 5788887644 334456899999999998 799999999999999999999
Q ss_pred EEeccCCCHHHHhcCCC------------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCe
Q 004155 496 YEYMENNSLARALFGPE------------AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNP 563 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 563 (771)
|||+++|+|.++|+... .....+++..+++++.|||.||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999996542 2346799999999999999999999998 89999999999999999999
Q ss_pred EEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCC-CCCCCCccchhhHHHHHHH
Q 004155 564 KISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRS-NSSCKPKEDIFYLLDWALI 642 (771)
Q Consensus 564 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~-p~~~~~~~~~~~~~~~~~~ 642 (771)
||+|||+|+....... .....||..|+|||.+.++.++.++|||||||++|||++|.. ||......+. .
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~---~----- 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---Y----- 236 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H-----
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH---H-----
Confidence 9999999986543322 223468999999999999999999999999999999999765 5654332221 1
Q ss_pred HHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 643 LKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 643 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
+.+........+.....++.+++.+||+.||++||||+||++.|+.+.+
T Consensus 237 --------~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 237 --------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp --------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111111122233344578899999999999999999999999887653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=396.92 Aligned_cols=260 Identities=25% Similarity=0.352 Sum_probs=198.7
Q ss_pred hcCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeC-C
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSK-SKQGNREFVNEIGMISAL-QHPNLVKLHGCCIEG-N 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 490 (771)
.++|++.++||+|+||.||+|... +++.||||+++.. .....+.+.+|..++.++ +|+||+.+++++.+. +
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 467889999999999999999542 3578999999754 334466788888888877 689999999998754 4
Q ss_pred EEEEEEEeccCCCHHHHhcCCCc------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc
Q 004155 491 QLLLIYEYMENNSLARALFGPEA------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD 558 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 558 (771)
..++|||||++|+|.++++.... ....+++.+++.++.||+.||+|||++ +|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 68999999999999999964322 134589999999999999999999998 899999999999999
Q ss_pred CCCCeEEEeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCC-CCCCCCCccchhhH
Q 004155 559 KDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR-SNSSCKPKEDIFYL 636 (771)
Q Consensus 559 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~-~p~~~~~~~~~~~~ 636 (771)
+++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||. +||......+..
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~-- 246 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-- 246 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence 9999999999999876544332 234567999999999999999999999999999999999975 567544332211
Q ss_pred HHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 637 LDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 637 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
. ..+........+.....++.+++.+||+.||++|||+.||++.|+.+
T Consensus 247 ~-------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 247 C-------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp H-------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-------------HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 11111111222223345688999999999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=397.26 Aligned_cols=260 Identities=28% Similarity=0.438 Sum_probs=212.0
Q ss_pred hcCCCCCCccccCCceeEEEEEc------CCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCCE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM------ADGTVVAVKQLSSKS-KQGNREFVNEIGMISAL-QHPNLVKLHGCCIEGNQ 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 491 (771)
.++|++.++||+|+||.||+|.+ .+++.||||+++... ......|.+|+.+++++ +|||||+++++|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 35778889999999999999964 356789999997643 34456799999999999 69999999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCc--------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEE
Q 004155 492 LLLIYEYMENNSLARALFGPEA--------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLL 557 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll 557 (771)
.++|||||++|+|.++++.... ....+++..+.+++.||+.||+|||++ +++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 9999999999999999964321 234689999999999999999999998 89999999999999
Q ss_pred cCCCCeEEEeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhh
Q 004155 558 DKDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFY 635 (771)
Q Consensus 558 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~ 635 (771)
+.++.+|++|||.++........ ......||+.|+|||++.++.++.++|||||||++|||+| |++|+......+..
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~- 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF- 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 99999999999999977654332 3345679999999999999999999999999999999999 55555443332221
Q ss_pred HHHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCC
Q 004155 636 LLDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGR 697 (771)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 697 (771)
.++++.......+......+.+|+.+||+.||++||||.||+++|++.
T Consensus 258 --------------~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 258 --------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp --------------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------------HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 122222222233333445688999999999999999999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=392.05 Aligned_cols=252 Identities=27% Similarity=0.379 Sum_probs=201.5
Q ss_pred CCccccCCceeEEEEEcCCC----cEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe-CCEEEEEEEec
Q 004155 426 DNKIGEGGFGPVYKGHMADG----TVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIE-GNQLLLIYEYM 499 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~g----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E~~ 499 (771)
.++||+|+||+||+|.+.++ ..||||+++.. .....++|.+|++++++++||||++++|++.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999965432 36999999753 44556789999999999999999999999876 46899999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
++|+|.++++.. ...+++..+++++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999998543 34678899999999999999999998 899999999999999999999999999987654332
Q ss_pred c---cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 580 H---ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 580 ~---~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
. ......||+.|+|||.+.++.++.++||||||+++|||+||+.||....... ....+ .. .+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~---i~-~g~-------- 251 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY---LL-QGR-------- 251 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH---HH-TTC--------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH---HH-cCC--------
Confidence 2 2234578999999999999999999999999999999999888875432111 11111 11 111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
....+......+.+++.+||+.||++||+|.||++.|+.+.
T Consensus 252 -~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 252 -RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11112223456889999999999999999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.1e-46 Score=386.04 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=203.8
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCCh---------hcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeC
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK---------QGNREFVNEIGMISALQ-HPNLVKLHGCCIEG 489 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 489 (771)
++|++.+.||+|+||+||+|. ..+|+.||||+++.... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 688999999999999999995 46799999999865421 12346889999999997 99999999999999
Q ss_pred CEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeec
Q 004155 490 NQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFG 569 (771)
Q Consensus 490 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 569 (771)
+..|+|||||++|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999994 345799999999999999999999998 89999999999999999999999999
Q ss_pred CccccCCCCcccccccccCCCccchhhhcc------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHH
Q 004155 570 LAKLDEEDNTHISTRVAGTFGYMAPEYAMR------GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALIL 643 (771)
Q Consensus 570 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~ 643 (771)
+++....... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.....
T Consensus 156 ~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i------ 227 (277)
T d1phka_ 156 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------ 227 (277)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------
T ss_pred heeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH------
Confidence 9987655332 244679999999999863 35788999999999999999999999865433221110
Q ss_pred HhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 644 KAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 644 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. .+.. ............++.+++.+||+.||++|||+.||++
T Consensus 228 ~-~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 M-SGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp H-HTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred H-hCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 1100 0011111123346889999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=398.58 Aligned_cols=261 Identities=28% Similarity=0.394 Sum_probs=198.9
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHH--HHHHHcCCCCcEEeEEEEEEeCC----EEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNE--IGMISALQHPNLVKLHGCCIEGN----QLLL 494 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E--~~~l~~l~h~niv~l~~~~~~~~----~~~l 494 (771)
++|...++||+|+||.||+|+. +|+.||||+++... .+++.+| +..+.+++||||++++++|.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4566778999999999999986 68999999986532 2344444 44556789999999999998654 6899
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhc-----CCCceeccCCCCCcEEEcCCCCeEEEeec
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEE-----SRLKIVHRDIKATNVLLDKDLNPKISDFG 569 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 569 (771)
|||||++|+|.++++ ...++|..+++++.|+|.||+|||+. +.++|+||||||+|||++.++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~-----~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 999999999999994 24689999999999999999999974 13589999999999999999999999999
Q ss_pred CccccCCCCcc---cccccccCCCccchhhhccCC------CCchHhHHHHHHHHHHHHhCCCCCCCCCccchhh-----
Q 004155 570 LAKLDEEDNTH---ISTRVAGTFGYMAPEYAMRGY------LTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFY----- 635 (771)
Q Consensus 570 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~----- 635 (771)
+++........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+..........
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 99876543322 223467999999999987642 6779999999999999999998875432211100
Q ss_pred ---HHHHHHHHHhhCChhHHhhhhcCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 636 ---LLDWALILKAQGNLMELVDKRLGSNF-----DKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 636 ---~~~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
....... ...+..+.... +.+....+.+++.+||+.||++|||+.||++.|+++.
T Consensus 234 ~~~~~~~~~~--------~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 234 SDPSVEEMRK--------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SSCCHHHHHH--------HHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchHHHHHH--------HHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 0011111 11122222221 2245667899999999999999999999999998653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-45 Score=386.58 Aligned_cols=258 Identities=20% Similarity=0.271 Sum_probs=200.5
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC----E
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMISALQHPNLVKLHGCCIEGN----Q 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 491 (771)
.++|++.+.||+|+||.||+|. ..+|+.||||+++... ......|.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4679999999999999999995 5679999999997543 233567999999999999999999999988643 4
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.|+||||+++|+|.+++. ....+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 899999999999999883 345799999999999999999999998 8999999999999999999999999998
Q ss_pred cccCCCCc--ccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCCh
Q 004155 572 KLDEEDNT--HISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL 649 (771)
Q Consensus 572 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (771)
+....... .......||+.|+|||++.+..++.++|||||||++|||+||++||......+.. ......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH------HHHHhcCCC
Confidence 76543322 2234467999999999999999999999999999999999999999754332211 111111100
Q ss_pred hHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhcCC
Q 004155 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRP-SMSSVVSMLEGR 697 (771)
Q Consensus 650 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~ 697 (771)
. ....... ....+.+++.+||+.||++|| ++++++..|.++
T Consensus 233 ~---~~~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 P---PSARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp C---GGGTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred C---CchhccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 0 0011112 234588999999999999999 899998877653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=394.96 Aligned_cols=259 Identities=28% Similarity=0.417 Sum_probs=206.2
Q ss_pred cCCCCCCccccCCceeEEEEEcC--------CCcEEEEEEcccCCh-hcHHHHHHHHHHHHcC-CCCcEEeEEEEEEeCC
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMA--------DGTVVAVKQLSSKSK-QGNREFVNEIGMISAL-QHPNLVKLHGCCIEGN 490 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 490 (771)
++|.+.+.||+|+||.||+|... ++..||||+++.... ....++.+|+..+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 57788899999999999999542 235799999976543 4457889999999888 8999999999999999
Q ss_pred EEEEEEEeccCCCHHHHhcCCCc------------cCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc
Q 004155 491 QLLLIYEYMENNSLARALFGPEA------------HRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD 558 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~ 558 (771)
..++||||+++|+|.+++..... ....+++.++++++.||+.||+|||+. +||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 99999999999999999965432 234689999999999999999999998 899999999999999
Q ss_pred CCCCeEEEeecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccchhhH
Q 004155 559 KDLNPKISDFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVS-GRSNSSCKPKEDIFYL 636 (771)
Q Consensus 559 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~ 636 (771)
.++.+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||++ |++||.........
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~-- 247 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF-- 247 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH--
Confidence 9999999999999876543322 2344678999999999999999999999999999999998 68888654432211
Q ss_pred HHHHHHHHhhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 637 LDWALILKAQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 637 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
. .+........+......+.+++.+||+.||++|||+.||+++|+++.
T Consensus 248 -~-------------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 248 -K-------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -H-------------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -H-------------HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 1 11111112222233456889999999999999999999999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-45 Score=398.10 Aligned_cols=248 Identities=25% Similarity=0.320 Sum_probs=199.0
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHH---HHHHHHcCCCCcEEeEEEEEEeCCEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVN---EIGMISALQHPNLVKLHGCCIEGNQLL 493 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~ 493 (771)
++|++.++||+|+||.||+|. ..+|+.||||++.... ......+.+ |+.+++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 579999999999999999995 4579999999986431 122333444 467777889999999999999999999
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
+|||||++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHH----hcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999993 345789999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 574 DEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 574 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
...... ....||+.|+|||++.. ..++.++|||||||++|||+||+.||......+...... . .
T Consensus 157 ~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----~--------~ 221 (364)
T d1omwa3 157 FSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----M--------T 221 (364)
T ss_dssp CSSSCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH----H--------S
T ss_pred cCCCcc---cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----h--------c
Confidence 654332 34579999999999975 568999999999999999999999998654433221111 0 0
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 004155 653 VDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPS-----MSSVVS 692 (771)
Q Consensus 653 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 692 (771)
... ....+......+.+++.+||+.||++||| ++|+++
T Consensus 222 ~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 222 LTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSC--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ccC--CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 000 01111223345889999999999999999 577765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-46 Score=393.80 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=211.0
Q ss_pred hcCCCCCCccccCCceeEEEEEcC------CCcEEEEEEcccC-ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHMA------DGTVVAVKQLSSK-SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 492 (771)
.++|...++||+|+||+||+|... +++.||||+++.. .......|.+|++++++++||||++++++|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367788899999999999999542 3578999999754 334456789999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHhcCCC------ccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEE
Q 004155 493 LLIYEYMENNSLARALFGPE------AHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKIS 566 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 566 (771)
++||||+++|+|.++++... .....+++..+.+++.|+|+||.|||++ +|+||||||+|||++.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 99999999999999985321 1223579999999999999999999998 89999999999999999999999
Q ss_pred eecCccccCCCCcc-cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCC-CCCCCCCccchhhHHHHHHHHH
Q 004155 567 DFGLAKLDEEDNTH-ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGR-SNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 567 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+||+ +||......+....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~-------- 247 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF-------- 247 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH--------
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH--------
Confidence 99999876543332 234456899999999999999999999999999999999985 66654433222111
Q ss_pred hhCChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCCC
Q 004155 645 AQGNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRAD 699 (771)
Q Consensus 645 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 699 (771)
+.+... ...+......+.+++.+||+.+|++||||.||+++|++..+
T Consensus 248 -------i~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 248 -------VMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -------HHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -------HHhCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111111 11222334568999999999999999999999999988643
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=390.04 Aligned_cols=255 Identities=18% Similarity=0.262 Sum_probs=206.5
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
.++|.+.+.||+|+||+||+|. ..+|+.||||+++... .....+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 4689999999999999999995 4578999999997654 3345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC--CCCeEEEeecCccccCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK--DLNPKISDFGLAKLDEE 576 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFGla~~~~~ 576 (771)
|++|+|.+++... ...+++.++..|+.||+.||+|||++ +|+||||||+|||++. ...+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 9999999999432 34699999999999999999999998 8999999999999985 45899999999987654
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
... .....||+.|+|||...+..++.++||||+||++|||++|+.||......+....+ ............
T Consensus 157 ~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i-----~~~~~~~~~~~~-- 227 (321)
T d1tkia_ 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-----MNAEYTFDEEAF-- 227 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-----HHTCCCCCHHHH--
T ss_pred CCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH-----HhCCCCCChhhc--
Confidence 332 23456899999999999999999999999999999999999999765433221110 000000100000
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcC
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEG 696 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 696 (771)
.. ...++.+++.+||+.||++|||+.|+++ .+++
T Consensus 228 --~~----~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 228 --KE----ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp --TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred --cC----CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 11 1235789999999999999999999987 3543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-45 Score=395.70 Aligned_cols=244 Identities=22% Similarity=0.330 Sum_probs=204.0
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC---ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK---SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 496 (771)
++|++.+.||+|+||.||+|. ..+|+.||||++... .....+.+.+|+.+|+.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 579999999999999999995 467999999998643 2233567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEE 576 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 576 (771)
||+.+|+|.+++. ....+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999993 334799999999999999999999998 899999999999999999999999999987654
Q ss_pred CCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhhh
Q 004155 577 DNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDKR 656 (771)
Q Consensus 577 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 656 (771)
.. ....||+.|||||++.+..++.++|||||||++|||+||+.||......... . .+....
T Consensus 194 ~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~------------~i~~~~ 254 (350)
T d1rdqe_ 194 RT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY---E------------KIVSGK 254 (350)
T ss_dssp CB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H------------HHHHCC
T ss_pred cc----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH---H------------HHhcCC
Confidence 32 3467999999999999999999999999999999999999999754322211 1 011111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 004155 657 LGSNFDKEQVMVMINVALLCTDVSSTSRP-----SMSSVVS 692 (771)
Q Consensus 657 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 692 (771)
. ..+......+.+++.+||+.||.+|+ +++|+++
T Consensus 255 ~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 V--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1 11222334588999999999999994 8999876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=392.03 Aligned_cols=247 Identities=24% Similarity=0.368 Sum_probs=202.5
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC---hhcHHHHHHHHHHHH-cCCCCcEEeEEEEEEeCCEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS---KQGNREFVNEIGMIS-ALQHPNLVKLHGCCIEGNQLLLI 495 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV 495 (771)
++|.+.++||+|+||+||+|. ..+|+.||||++++.. ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 578999999999999999994 4579999999997532 234556777777765 68999999999999999999999
Q ss_pred EEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccC
Q 004155 496 YEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDE 575 (771)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 575 (771)
||||++|+|.+++. ....+++.++..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+|+...
T Consensus 82 mEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999994 345789999999999999999999998 89999999999999999999999999998655
Q ss_pred CCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhhh
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVDK 655 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 655 (771)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...........+ ..+ .
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-------~~~------~- 219 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-------RMD------N- 219 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHC------C-
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH-------HcC------C-
Confidence 4332 234467999999999999999999999999999999999999999765433221111 001 0
Q ss_pred hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 004155 656 RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMS-SVVS 692 (771)
Q Consensus 656 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 692 (771)
..++......+.+++.+||+.||++||++. |+++
T Consensus 220 ---~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 ---PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 112222334588999999999999999995 6754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=387.22 Aligned_cols=260 Identities=22% Similarity=0.275 Sum_probs=196.9
Q ss_pred CCccccCCceeEEEEEc-CCCcEEEEEEcccCChhc-----HHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEec
Q 004155 426 DNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQG-----NREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEYM 499 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 499 (771)
.++||+|+||+||+|.. .+|+.||||+++...... .+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999964 569999999987543221 246889999999999999999999999999999999999
Q ss_pred cCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCCc
Q 004155 500 ENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNT 579 (771)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~ 579 (771)
.++++..+.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9887776652 345789999999999999999999998 899999999999999999999999999986654433
Q ss_pred ccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHHhh----
Q 004155 580 HISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMELVD---- 654 (771)
Q Consensus 580 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d---- 654 (771)
. .....||+.|+|||++.+. .++.++|||||||++|||+||++||......+....+ .............+
T Consensus 156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i---~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI---FETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCTTTSSSTTSS
T ss_pred c-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH---HHhcCCCChhhccchhcc
Confidence 2 2335799999999998754 6799999999999999999999999765433322111 11110000000000
Q ss_pred --hh-c--CCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcC
Q 004155 655 --KR-L--GSNFDK-----EQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEG 696 (771)
Q Consensus 655 --~~-l--~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 696 (771)
.. . ....+. .....+.+++.+||+.||++|||++|+++ .+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 00 0 000111 11246889999999999999999999987 4554
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=392.62 Aligned_cols=250 Identities=20% Similarity=0.218 Sum_probs=197.0
Q ss_pred hcCCCCCC-ccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHc-CCCCcEEeEEEEEEe----CCEE
Q 004155 420 TNNFAPDN-KIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISA-LQHPNLVKLHGCCIE----GNQL 492 (771)
Q Consensus 420 ~~~f~~~~-~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 492 (771)
.++|.+.+ +||+|+||+||+|. ..+|+.||||+++.. ..+.+|++++.+ .+|||||+++++|.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788765 59999999999994 567999999998642 456789988765 489999999999875 4578
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC---CCCeEEEeec
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK---DLNPKISDFG 569 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG 569 (771)
|+|||||+||+|.+++.... ...+++.++..|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence 99999999999999995432 24699999999999999999999998 8999999999999975 5679999999
Q ss_pred CccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCCh
Q 004155 570 LAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL 649 (771)
Q Consensus 570 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (771)
+|+....... .....||+.|+|||++.+..++.++|||||||++|||+||++||............ ..
T Consensus 160 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~------~~---- 227 (335)
T d2ozaa1 160 FAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------KT---- 227 (335)
T ss_dssp TCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH------HH----
Confidence 9987654433 23457999999999999999999999999999999999999999754332211100 00
Q ss_pred hHHhhhhc--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 650 MELVDKRL--GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 650 ~~~~d~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.+..... ..........++.+++.+||+.||++|||+.|+++
T Consensus 228 -~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 228 -RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000000 00001123456889999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=379.93 Aligned_cols=268 Identities=24% Similarity=0.359 Sum_probs=201.7
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
++|++.++||+|+||+||+|. ..+|+.||||+++... ......+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 589999999999999999995 5679999999996543 2235688999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
|+.++ +.+++... ....+++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~-~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCc-hhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99765 44444222 234699999999999999999999998 8999999999999999999999999999876543
Q ss_pred CcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC--ChhHHh-
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG--NLMELV- 653 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~- 653 (771)
... .....||+.|+|||.+... .++.++||||+||++|||++|+.||......+..... ........ ......
T Consensus 156 ~~~-~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 156 VRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp SBC-TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCCCCTTTSTTGGG
T ss_pred ccc-ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHH--HHhcCCCchhhcccccc
Confidence 332 3345799999999987765 4689999999999999999999999765433221111 00000000 000000
Q ss_pred hhhcCC------CCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCC
Q 004155 654 DKRLGS------NFDK-----EQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGR 697 (771)
Q Consensus 654 d~~l~~------~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 697 (771)
.+.... ..+. .....+.+++.+||+.||++|||+.|+++ .++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000000 0000 11246788999999999999999999987 35544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.7e-44 Score=375.39 Aligned_cols=262 Identities=24% Similarity=0.339 Sum_probs=200.9
Q ss_pred cCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYEY 498 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 498 (771)
++|++.++||+|+||+||+|...+|+.||||+++... ....+.+.+|+.+|++++||||+++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999988889999999997643 22357899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCCC
Q 004155 499 MENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDN 578 (771)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 578 (771)
+.++.+..+.. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.|.......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 98877776662 335799999999999999999999998 89999999999999999999999999998765433
Q ss_pred cccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHh--hCChhHHhh-
Q 004155 579 THISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKA--QGNLMELVD- 654 (771)
Q Consensus 579 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~d- 654 (771)
.. .....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+...... ..... .........
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 155 RK-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF--RILGTPNSKNWPNVTEL 231 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HHHCCCCTTTSTTGGGS
T ss_pred cc-cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHH--HhhCCCChhhccchhhh
Confidence 22 233468999999999875 467999999999999999999999997654332211111 11000 000000000
Q ss_pred ----hhcC--C-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 655 ----KRLG--S-----NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 655 ----~~l~--~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.... . .........+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0 000112346789999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-45 Score=378.41 Aligned_cols=240 Identities=22% Similarity=0.347 Sum_probs=195.1
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCCh------hcHHHHHHHHHHHHcCC--CCcEEeEEEEEEeCC
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSK------QGNREFVNEIGMISALQ--HPNLVKLHGCCIEGN 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 490 (771)
.++|++.++||+|+||+||+|. ..+|+.||||++..... ....++.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 3579999999999999999995 56799999999865321 11234678999999986 899999999999999
Q ss_pred EEEEEEEeccC-CCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC-CCCeEEEee
Q 004155 491 QLLLIYEYMEN-NSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK-DLNPKISDF 568 (771)
Q Consensus 491 ~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DF 568 (771)
..++||||+.+ +++.+++. ....+++.++..++.||+.||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence 99999999976 68888873 345799999999999999999999998 8999999999999985 479999999
Q ss_pred cCccccCCCCcccccccccCCCccchhhhccCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC
Q 004155 569 GLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYL-TDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG 647 (771)
Q Consensus 569 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 647 (771)
|+|+...... .+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||.... . . . .+
T Consensus 156 G~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~---i------~--~~ 219 (273)
T d1xwsa_ 156 GSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E---I------I--RG 219 (273)
T ss_dssp TTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H---H------H--HC
T ss_pred ccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H---H------h--hc
Confidence 9998654332 234679999999999987654 677999999999999999999996311 0 0 0 00
Q ss_pred ChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 648 NLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 648 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
. ..+....+ .++.+++.+||+.||++|||++|+++
T Consensus 220 ~------~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 Q------VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C------CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c------cCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 01112233 45789999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=373.92 Aligned_cols=262 Identities=23% Similarity=0.341 Sum_probs=196.3
Q ss_pred hcCCCCCCccccCCceeEEEEEc-CC-CcEEEEEEcccCC--hhcHHHHHHHHHHHHcC---CCCcEEeEEEEEEe----
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGHM-AD-GTVVAVKQLSSKS--KQGNREFVNEIGMISAL---QHPNLVKLHGCCIE---- 488 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~~-~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 488 (771)
.++|++.++||+|+||+||+|.. .+ ++.||||+++... ......+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999954 44 6789999986532 22233466777776655 79999999999863
Q ss_pred -CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEe
Q 004155 489 -GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISD 567 (771)
Q Consensus 489 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 567 (771)
....+++|||++++++...... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 2468999999998877655422 335789999999999999999999998 899999999999999999999999
Q ss_pred ecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC
Q 004155 568 FGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG 647 (771)
Q Consensus 568 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 647 (771)
||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|++||......+...... ......
T Consensus 160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~ 234 (305)
T d1blxa_ 160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL---DVIGLP 234 (305)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCCC
T ss_pred hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHH---HhhCCC
Confidence 99998654332 2345679999999999999999999999999999999999999997654333221111 110000
Q ss_pred ChhHH------hhhhcC-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 648 NLMEL------VDKRLG-------SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 648 ~~~~~------~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
..... ...... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 000000 0011112345778999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.1e-42 Score=361.31 Aligned_cols=261 Identities=19% Similarity=0.220 Sum_probs=207.5
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCC-CcEEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQH-PNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 497 (771)
.++|++.++||+|+||+||+|. ..+|+.||||++..... ...+.+|+++++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 4689999999999999999995 55789999999865432 2357788999999965 899999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcC-----CCCeEEEeecCcc
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDK-----DLNPKISDFGLAK 572 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFGla~ 572 (771)
|+ +++|.+++... ...+++.++..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 68999988432 34689999999999999999999998 8999999999999964 5789999999998
Q ss_pred ccCCCCcc------cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhh
Q 004155 573 LDEEDNTH------ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQ 646 (771)
Q Consensus 573 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 646 (771)
........ ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 76543211 223457999999999999999999999999999999999999999865544333222222211111
Q ss_pred CChhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 647 GNLMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 647 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
....+ +....+ .++.+++..|++.+|++||+++.+.+.|+++.
T Consensus 235 ~~~~~-----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 235 TPLRE-----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp SCHHH-----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CChHH-----hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11111 112233 45888999999999999999999988887654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=371.51 Aligned_cols=266 Identities=22% Similarity=0.298 Sum_probs=196.3
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe--------
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIE-------- 488 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 488 (771)
.++|++.++||+|+||+||+|. ..+|+.||||++... .....+.+.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 3689999999999999999995 468999999998654 23345678999999999999999999999864
Q ss_pred CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEee
Q 004155 489 GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDF 568 (771)
Q Consensus 489 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 568 (771)
.+..++||||+.++.+.... .....++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 34689999999887766554 2345789999999999999999999998 8999999999999999999999999
Q ss_pred cCccccCCCCcc---cccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHH
Q 004155 569 GLAKLDEEDNTH---ISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILK 644 (771)
Q Consensus 569 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~ 644 (771)
|+++........ ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...................
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999866533221 12235699999999998765 68999999999999999999999997644333222111110000
Q ss_pred hhCC--------hhHHhhhhcCCCCCH-H------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 645 AQGN--------LMELVDKRLGSNFDK-E------QVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 645 ~~~~--------~~~~~d~~l~~~~~~-~------~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
.... ....+.......... + ....+.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0000 000000000001111 1 1235678999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.2e-42 Score=362.14 Aligned_cols=261 Identities=22% Similarity=0.274 Sum_probs=199.2
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCc-EEeEEEEEEeCCEEEEEEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPN-LVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~E 497 (771)
.++|++.+.||+|+||.||+|. ..+|+.||||++..... ..++..|+++++.++|+| |+.+.+++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 3579999999999999999995 56789999999875433 245788999999998665 5555666678889999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEc---CCCCeEEEeecCcccc
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLD---KDLNPKISDFGLAKLD 574 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFGla~~~ 574 (771)
|+. ++|.+.+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+..
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LLG-PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CCC-CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EcC-Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 994 567666632 235799999999999999999999998 899999999999985 4567999999999976
Q ss_pred CCCCcc------cccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCC
Q 004155 575 EEDNTH------ISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGN 648 (771)
Q Consensus 575 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 648 (771)
...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......................
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 543321 22345799999999999999999999999999999999999999976544333222211111111111
Q ss_pred hhHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcCCC
Q 004155 649 LMELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVSMLEGRA 698 (771)
Q Consensus 649 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 698 (771)
.+.+....+ .++.+++..|++.+|++||+++++.+.|+...
T Consensus 237 -----~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 237 -----IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp -----HHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred -----hhHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 111112222 45888999999999999999999999888653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-42 Score=370.19 Aligned_cols=269 Identities=21% Similarity=0.297 Sum_probs=197.7
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC------
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIEGN------ 490 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 490 (771)
.++|++.++||+|+||+||+|. ..+|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4689999999999999999995 567999999999753 3344567899999999999999999999997654
Q ss_pred EEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecC
Q 004155 491 QLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGL 570 (771)
Q Consensus 491 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 570 (771)
+.|+||||+ +.+|..++ ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM-----KHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHH-----HhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 579999999 56888877 235799999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHH-----HH
Q 004155 571 AKLDEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALI-----LK 644 (771)
Q Consensus 571 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~-----~~ 644 (771)
|+...... +...||+.|+|||.+.+ ..++.++||||+||++|||++|++||................. ..
T Consensus 168 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 168 ARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 98765432 34579999999999876 4678999999999999999999999976543322211111000 00
Q ss_pred hhCC--hhHHhhhhcC---C----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCCCCCC
Q 004155 645 AQGN--LMELVDKRLG---S----NFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGRADVQ 701 (771)
Q Consensus 645 ~~~~--~~~~~d~~l~---~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~~ 701 (771)
.... ........+. . .........+.+|+.+||+.||++|||+.|+++ .++++....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence 0000 0000000000 0 000112235778999999999999999999998 466654443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-42 Score=370.32 Aligned_cols=269 Identities=22% Similarity=0.271 Sum_probs=199.7
Q ss_pred hcCCCCCCccccCCceeEEEE-EcCCCcEEEEEEcccCC-hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCC----EEE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKG-HMADGTVVAVKQLSSKS-KQGNREFVNEIGMISALQHPNLVKLHGCCIEGN----QLL 493 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~-~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 493 (771)
+++|++.++||+|+||+||+| +..+|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467999999999999999999 45789999999997543 344567899999999999999999999997543 234
Q ss_pred EEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 494 LIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 494 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
++++|+.+|+|.+++. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 87 ~l~~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 4556677999999993 24699999999999999999999998 899999999999999999999999999986
Q ss_pred cCCCCcc--cccccccCCCccchhhhc-cCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChh
Q 004155 574 DEEDNTH--ISTRVAGTFGYMAPEYAM-RGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLM 650 (771)
Q Consensus 574 ~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (771)
....... ......||+.|+|||++. ...++.++||||+||++|||++|+.||......+........ .......
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~---~~~~~~~ 235 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI---LGSPSQE 235 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH---HCSCCHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhh---ccCCChh
Confidence 6543222 234467999999999985 456789999999999999999999999765433322111110 0000000
Q ss_pred -----------HHhhhhc-CCCCCHH-----HHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcCCCC
Q 004155 651 -----------ELVDKRL-GSNFDKE-----QVMVMINVALLCTDVSSTSRPSMSSVVSM--LEGRAD 699 (771)
Q Consensus 651 -----------~~~d~~l-~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~ 699 (771)
....... ....+.. ...++.+++.+||+.||++|||++|+++- ++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 0000000 0011111 11357899999999999999999999973 554433
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=374.42 Aligned_cols=257 Identities=25% Similarity=0.308 Sum_probs=192.6
Q ss_pred CCCCCCccccCCceeEEEEEc-CCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC------CEEEE
Q 004155 422 NFAPDNKIGEGGFGPVYKGHM-ADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLHGCCIEG------NQLLL 494 (771)
Q Consensus 422 ~f~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 494 (771)
+|+..++||+|+||+||+|.. .+|+.||||++...... +.+|+++|++++||||++++++|... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 467788999999999999954 57999999999764322 34799999999999999999998643 35799
Q ss_pred EEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC-CeEEEeecCccc
Q 004155 495 IYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKL 573 (771)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFGla~~ 573 (771)
|||||+++.+..+. ........+++.++..|+.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~~~~l~-~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVAR-HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHH-HHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHH-hhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999876433332 2222345799999999999999999999998 899999999999999775 899999999987
Q ss_pred cCCCCcccccccccCCCccchhhhcc-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCChhHH
Q 004155 574 DEEDNTHISTRVAGTFGYMAPEYAMR-GYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNLMEL 652 (771)
Q Consensus 574 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (771)
....... ....||..|+|||.+.+ ..++.++||||+||++|||++|++||......+..... .... ... ..+.
T Consensus 173 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i--~~~~-g~~-~~~~ 246 (350)
T d1q5ka_ 173 LVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI--IKVL-GTP-TREQ 246 (350)
T ss_dssp CCTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH--HHHH-CCC-CHHH
T ss_pred ccCCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHH--HHHh-CCC-hHHh
Confidence 6543322 33579999999998875 57899999999999999999999999765433322111 1100 000 0000
Q ss_pred hhh--------hcC--------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 653 VDK--------RLG--------SNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 653 ~d~--------~l~--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
+.. ... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000 0001122345788999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=367.92 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=203.2
Q ss_pred cCCCCCCccccCCceeEEEEEc----CCCcEEEEEEcccCC----hhcHHHHHHHHHHHHcCCC-CcEEeEEEEEEeCCE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGHM----ADGTVVAVKQLSSKS----KQGNREFVNEIGMISALQH-PNLVKLHGCCIEGNQ 491 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 491 (771)
++|++.++||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999953 358999999986532 1234568899999999976 899999999999999
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.++||||+.+|+|.+++. ....++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999993 334678899999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCccchhhhccC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhCCh
Q 004155 572 KLDEEDNTHISTRVAGTFGYMAPEYAMRG--YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQGNL 649 (771)
Q Consensus 572 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (771)
+..............||+.|+|||.+.+. .++.++|||||||+||||++|+.||......+........
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~--------- 247 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--------- 247 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH---------
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh---------
Confidence 87765544444556799999999999754 5788999999999999999999999775544332211100
Q ss_pred hHHhhhhcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 004155 650 MELVDKRLGSNFDKEQVMVMINVALLCTDVSSTSRPS-----MSSVVS 692 (771)
Q Consensus 650 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 692 (771)
.... ....+.....++.+++.+||+.||++||+ ++|+++
T Consensus 248 --~~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 248 --ILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --HHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --cccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0011 11222234456889999999999999995 788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=357.47 Aligned_cols=262 Identities=20% Similarity=0.274 Sum_probs=203.5
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeCCEEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEGNQLLLIYE 497 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 497 (771)
++|++.++||+|+||+||+|. ..+|+.||||+++... ......+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 579999999999999999995 5678999999986542 3346789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCccccCCC
Q 004155 498 YMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEED 577 (771)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~ 577 (771)
++.+++|..++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988874 335789999999999999999999998 8999999999999999999999999999876543
Q ss_pred CcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHHHhhC---Ch---h
Q 004155 578 NTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALILKAQG---NL---M 650 (771)
Q Consensus 578 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~---~ 650 (771)
... .....++..|+|||.+... .++.++||||+||++|||++|+.||....... ............. .. .
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGG
T ss_pred Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhh
Confidence 332 2334578899999998765 47999999999999999999999975433221 1111111111110 00 0
Q ss_pred HHhhhhc---------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 651 ELVDKRL---------GSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 651 ~~~d~~l---------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
...+... ...........+.+|+.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 00011122345788999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.2e-41 Score=361.45 Aligned_cols=256 Identities=18% Similarity=0.236 Sum_probs=196.6
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeC--CEEEEEE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLHGCCIEG--NQLLLIY 496 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~ 496 (771)
++|++.++||+|+||+||+|. ..+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 579999999999999999995 467999999998753 3467889999999995 99999999999843 5699999
Q ss_pred EeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCC-CeEEEeecCccccC
Q 004155 497 EYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDL-NPKISDFGLAKLDE 575 (771)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFGla~~~~ 575 (771)
||+.+++|..+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 999999987764 3689999999999999999999998 899999999999998655 69999999998765
Q ss_pred CCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHHH--------Hh-
Q 004155 576 EDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALIL--------KA- 645 (771)
Q Consensus 576 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~--------~~- 645 (771)
.... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||.......... ....... ..
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~-~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL-VRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH-HHHHHHHCHHHHHHHHHH
T ss_pred CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHH-HHHHHHHCCchhhhhhhh
Confidence 4432 2345689999999998765 57999999999999999999999997644322110 0000000 00
Q ss_pred -hCChhHHhhhh------------cCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 646 -QGNLMELVDKR------------LGSNFDKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 646 -~~~~~~~~d~~------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
........... ...........++.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000 000011112345789999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=360.51 Aligned_cols=260 Identities=21% Similarity=0.242 Sum_probs=190.6
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccC--ChhcHHHHHHHHHHHHcCCCCcEEeEEEEEEe------CCE
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSK--SKQGNREFVNEIGMISALQHPNLVKLHGCCIE------GNQ 491 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 491 (771)
++|++.++||+|+||+||+|. ..+|+.||||++... ......++.+|+.++++++||||++++++|.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 679999999999999999995 457999999999754 33445678999999999999999999999963 368
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.|+||||+.++.+ +.++ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 9999999976544 4441 3589999999999999999999998 8999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHH------------
Q 004155 572 KLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDW------------ 639 (771)
Q Consensus 572 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~------------ 639 (771)
+...... ......||+.|+|||++.+..+++++||||+||++|||++|+.||..............
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 8654432 22445789999999999999999999999999999999999999975433221111000
Q ss_pred ----HHHHHhh------CChhHHhhhhcCCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 004155 640 ----ALILKAQ------GNLMELVDKRLGSNF---DKEQVMVMINVALLCTDVSSTSRPSMSSVVS 692 (771)
Q Consensus 640 ----~~~~~~~------~~~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 692 (771)
....... ............... .......+.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 001111111111111 1233557889999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=358.94 Aligned_cols=268 Identities=21% Similarity=0.285 Sum_probs=198.9
Q ss_pred hcCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCC--hhcHHHHHHHHHHHHcCCCCcEEeEEEEEEeC-----CE
Q 004155 420 TNNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKS--KQGNREFVNEIGMISALQHPNLVKLHGCCIEG-----NQ 491 (771)
Q Consensus 420 ~~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 491 (771)
+++|++.++||+|+||+||+|. ..+|+.||||+++... ....+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 5789999999999999999995 5689999999997542 33456788999999999999999999998633 34
Q ss_pred EEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEEEeecCc
Q 004155 492 LLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLA 571 (771)
Q Consensus 492 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 571 (771)
.+++++|+.+|+|.+++. ..++++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 566778888999999993 24699999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCccchhhhccC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCccchhhHHHHHHH-----HHh
Q 004155 572 KLDEEDNTHISTRVAGTFGYMAPEYAMRG-YLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIFYLLDWALI-----LKA 645 (771)
Q Consensus 572 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~-----~~~ 645 (771)
...... .....||+.|+|||...+. .++.++|||||||++|||++|++||................. ...
T Consensus 169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 754332 2345689999999987665 578999999999999999999999976543322211110000 000
Q ss_pred hCCh--hHHhhhhcC--CCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhcCCCC
Q 004155 646 QGNL--MELVDKRLG--SNFDK-----EQVMVMINVALLCTDVSSTSRPSMSSVVS--MLEGRAD 699 (771)
Q Consensus 646 ~~~~--~~~~d~~l~--~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~ 699 (771)
.... .......+. ..... .....+.+|+.+||+.||++|||++|+++ .+.+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 0000 000000000 00010 11245789999999999999999999997 5665443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7e-36 Score=324.24 Aligned_cols=269 Identities=19% Similarity=0.227 Sum_probs=193.0
Q ss_pred cCCCCCCccccCCceeEEEEE-cCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-----------CCcEEeEEEEEEe
Q 004155 421 NNFAPDNKIGEGGFGPVYKGH-MADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-----------HPNLVKLHGCCIE 488 (771)
Q Consensus 421 ~~f~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 488 (771)
++|++.++||+|+||+||+|. ..+|+.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 358899999999999999995 4679999999997643 33467788999888775 5789999998764
Q ss_pred --CCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCC----
Q 004155 489 --GNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLN---- 562 (771)
Q Consensus 489 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---- 562 (771)
....+++|+++..+........ ......+++..+..++.||+.||+|||+.. +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCccccc
Confidence 4567777777655432222211 123457899999999999999999999842 8999999999999986653
Q ss_pred --eEEEeecCccccCCCCcccccccccCCCccchhhhccCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccchh----hH
Q 004155 563 --PKISDFGLAKLDEEDNTHISTRVAGTFGYMAPEYAMRGYLTDKADVYSFGIVALEIVSGRSNSSCKPKEDIF----YL 636 (771)
Q Consensus 563 --~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDV~S~Gvil~elltG~~p~~~~~~~~~~----~~ 636 (771)
++++|||.++...... ....||+.|+|||++....++.++||||+||+++||++|+.||......... .+
T Consensus 169 ~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 9999999998554322 3456999999999999999999999999999999999999999754322111 11
Q ss_pred HHHHHHHHh-------h-CChhHHhhh-------------------hcCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 004155 637 LDWALILKA-------Q-GNLMELVDK-------------------RLGSNFDKEQVMVMINVALLCTDVSSTSRPSMSS 689 (771)
Q Consensus 637 ~~~~~~~~~-------~-~~~~~~~d~-------------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 689 (771)
......+.. . .......+. .............+.+|+.+|++.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 111111100 0 000000000 0012334566778999999999999999999999
Q ss_pred HHH--HhcCC
Q 004155 690 VVS--MLEGR 697 (771)
Q Consensus 690 vl~--~L~~~ 697 (771)
+++ .+++.
T Consensus 325 ~L~Hp~f~~~ 334 (362)
T d1q8ya_ 325 LVNHPWLKDT 334 (362)
T ss_dssp HHTCGGGTTC
T ss_pred HhcCcccCCC
Confidence 987 35543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.88 E-value=5.8e-23 Score=216.96 Aligned_cols=178 Identities=22% Similarity=0.263 Sum_probs=103.5
Q ss_pred CCCCcEEEccC-CcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEE
Q 004155 2 LVTLKDFRISD-NHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 2 L~~L~~L~Ls~-N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 80 (771)
|++|++|+|++ |+++|.+|..|++|++|++|+|++|+|.+..|..+..+.+|+.|++++|++....|..+.++++|+.+
T Consensus 75 L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l 154 (313)
T d1ogqa_ 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154 (313)
T ss_dssp CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred CccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCccccee
Confidence 44555555553 45555555555555555555555555555555555555555555555555555555555566666666
Q ss_pred EccCCcCcccCChhhhcCCCC-cEEEccCCCCCCC-----------------------CCccccCCCCCcEEEcCCCccc
Q 004155 81 ILRSCNVSGKLPDYLGLMTSL-KVLDVSFNKLNGA-----------------------IPSTFMGLLDVDYIYLTGNLLT 136 (771)
Q Consensus 81 ~Ls~N~l~g~~p~~~~~l~~L-~~L~Ls~N~l~g~-----------------------ip~~~~~l~~L~~L~Ls~N~l~ 136 (771)
++++|.+.|.+|..++.+.++ +.+++++|+++|. +|..+..+++|+.|++++|.++
T Consensus 155 ~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~ 234 (313)
T d1ogqa_ 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234 (313)
T ss_dssp ECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEEC
T ss_pred eccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 666666665565555554443 3444444433322 2223334556666666666666
Q ss_pred ccCchhh-hhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 137 GTIPPWM-LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 137 g~iP~~~-~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
+.+|... +++|+.|+|++|+++|.+|+.++++++|+.|++++|
T Consensus 235 ~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N 278 (313)
T d1ogqa_ 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278 (313)
T ss_dssp CBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCC
Confidence 5555322 677788888888888888888888888888887754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=6.2e-23 Score=200.57 Aligned_cols=163 Identities=20% Similarity=0.150 Sum_probs=121.3
Q ss_pred CCCCccccCCceeEEEEEcCCCcEEEEEEcccCCh------------------hcHHHHHHHHHHHHcCCCCcEEeEEEE
Q 004155 424 APDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSK------------------QGNREFVNEIGMISALQHPNLVKLHGC 485 (771)
Q Consensus 424 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 485 (771)
.+.++||+|+||+||+|...+|+.||||+++.... .......+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35689999999999999888899999998753210 112345678889999999999988765
Q ss_pred EEeCCEEEEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcCCCceeccCCCCCcEEEcCCCCeEE
Q 004155 486 CIEGNQLLLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEESRLKIVHRDIKATNVLLDKDLNPKI 565 (771)
Q Consensus 486 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 565 (771)
. . .++||||++++.+. .++......++.|++.+|+|||++ +|+||||||+|||++++ .++|
T Consensus 83 ~--~--~~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E--G--NAVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E--T--TEEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c--C--CEEEEEeecccccc-----------chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 2 37999999875432 345566778999999999999998 89999999999999865 4899
Q ss_pred EeecCccccCCCCcccccccccCCCccc------hhhhccCCCCchHhHHHHHHHH
Q 004155 566 SDFGLAKLDEEDNTHISTRVAGTFGYMA------PEYAMRGYLTDKADVYSFGIVA 615 (771)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~ksDV~S~Gvil 615 (771)
+|||+|+......... |.. .|. ....++.++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~~---------~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWRE---------ILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHHH---------HHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcHH---------HHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 9999998654332211 111 111 134567888999986544
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.85 E-value=5.7e-22 Score=209.28 Aligned_cols=175 Identities=26% Similarity=0.383 Sum_probs=156.0
Q ss_pred CCcEEEccCCcccc--cCCccccCCCcCCEEEccc-CCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEE
Q 004155 4 TLKDFRISDNHFTG--KIPNFIQNWTLLEKLVIQA-SGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 4 ~L~~L~Ls~N~l~~--~ip~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 80 (771)
+++.|+|++|+++| .+|..+++|++|++|+|++ |+++|.+|.+|++|++|++|+|++|++.+.++..+..+.+|+.|
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 58999999999998 5899999999999999997 89999999999999999999999999999998899999999999
Q ss_pred EccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCC-cEEEcCCCcccccCchhh----------------
Q 004155 81 ILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDV-DYIYLTGNLLTGTIPPWM---------------- 143 (771)
Q Consensus 81 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L-~~L~Ls~N~l~g~iP~~~---------------- 143 (771)
++++|++.+.+|..+.+++.|+.+++++|.++|.+|..+..+.++ +.+++++|+++|..|..+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~ 210 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLE 210 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999999999999999988876 888899888887665432
Q ss_pred ---------hhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 144 ---------LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 144 ---------~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
++.++.+++++|.+++.+| .+..+++|+.|+++.|
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N 254 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNN 254 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSS
T ss_pred cccccccccccccccccccccccccccc-ccccccccccccCccC
Confidence 3556777888888876554 5777788888888755
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=3e-20 Score=191.22 Aligned_cols=171 Identities=15% Similarity=0.048 Sum_probs=123.3
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|+.|+|++|+++.. +..+.++++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCSSC-CCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccccc-ccccccccccccccc
Confidence 46777788888777433356777777888888887777 454 356677778888877777765 356777777888888
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccccC
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~~ 160 (771)
++|++.+..+..+..+.+|+.|++++|.++...+..+..+++|+.|++++|+|++..|..+ +++|+.|+|++|+|+ .
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 8877775566667777778888888888775555566777788888888888875444444 677788888888877 5
Q ss_pred CCcccccccccceeccC
Q 004155 161 SSETSCQYRSVNLFASS 177 (771)
Q Consensus 161 ~p~~~~~l~~L~~l~~s 177 (771)
+|+.+..+++|+.++++
T Consensus 187 lp~~~~~~~~L~~L~L~ 203 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLH 203 (266)
T ss_dssp CCTTTTTTCCCSEEECC
T ss_pred cChhHCCCCCCCEEEec
Confidence 67777777777777765
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=1.4e-19 Score=188.00 Aligned_cols=177 Identities=16% Similarity=0.184 Sum_probs=116.8
Q ss_pred CCCCcEEEccCCcccccCC-ccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcC-CCCCCCCCCCCccCCCCCcE
Q 004155 2 LVTLKDFRISDNHFTGKIP-NFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRIS-DLNGTEAPFPPLDKMKKMKT 79 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-~n~l~~~~~~~~~~l~~L~~ 79 (771)
.+++++|+|++|+|+ .+| ..|.++++|++|++++|+|.+..+..+..+..+..|... .|.++...+..|.++++|++
T Consensus 31 p~~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~ 109 (284)
T d1ozna_ 31 PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHT 109 (284)
T ss_dssp CTTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCE
T ss_pred CCCCCEEECcCCcCC-CCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCE
Confidence 357899999999999 555 579999999999999999876666666666666666543 34455555556666666666
Q ss_pred EEccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCcc
Q 004155 80 LILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSF 157 (771)
Q Consensus 80 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l 157 (771)
|+|++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..|..+ +++|+.+++++|++
T Consensus 110 L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l 189 (284)
T d1ozna_ 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189 (284)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccc
Confidence 6666666664444555566666666666666664444556666666666666666664333333 55666666666666
Q ss_pred ccCCCcccccccccceeccCCC
Q 004155 158 TAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 158 ~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
++..|..+..+++|+.++++.|
T Consensus 190 ~~i~~~~f~~l~~L~~L~l~~N 211 (284)
T d1ozna_ 190 AHVHPHAFRDLGRLMTLYLFAN 211 (284)
T ss_dssp CEECTTTTTTCTTCCEEECCSS
T ss_pred cccChhHhhhhhhccccccccc
Confidence 6666666666666666666543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=2.9e-19 Score=183.67 Aligned_cols=172 Identities=21% Similarity=0.261 Sum_probs=152.9
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
.+++.+.+.++++|+ .+|+.+. ++|++|+|++|+|++..+..|.++++|++|+|++|+++.++ .++.+++|++|+
T Consensus 9 ~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L~ 83 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTLD 83 (266)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEEE
T ss_pred cCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--cccccccccccc
Confidence 356778899999999 8998875 68999999999999655678999999999999999998764 467899999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh---hhcCCeecccCCccc
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM---LQKGDRVDLSYNSFT 158 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~---~~~L~~l~ls~N~l~ 158 (771)
|++|+++ .+|..+..+++|+.|++++|.+.+..+..+..+.+|+.|++++|.++ .+|... ++.++.+++++|+++
T Consensus 84 Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~-~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCS
T ss_pred ccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccc-eeccccccccccchhccccccccc
Confidence 9999999 67888999999999999999999777788899999999999999999 455443 788999999999999
Q ss_pred cCCCcccccccccceeccCCCC
Q 004155 159 AGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 159 ~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
+..++.+..+++|+.|+++.|.
T Consensus 162 ~~~~~~~~~l~~L~~L~Ls~N~ 183 (266)
T d1p9ag_ 162 ELPAGLLNGLENLDTLLLQENS 183 (266)
T ss_dssp CCCTTTTTTCTTCCEEECCSSC
T ss_pred ccCccccccccccceeecccCC
Confidence 9999999999999999998653
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=2.3e-19 Score=175.01 Aligned_cols=168 Identities=14% Similarity=0.119 Sum_probs=145.0
Q ss_pred CcEEEccCCcccccCCccccCCCcCCEEEcccCCccccC-chhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEcc
Q 004155 5 LKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPI-PSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILR 83 (771)
Q Consensus 5 L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 83 (771)
.+.++.++|+|+ .||..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++...++..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 468999999999 9998875 78999999999998655 6678999999999999999999999999999999999999
Q ss_pred CCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCccccCCC
Q 004155 84 SCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTAGSS 162 (771)
Q Consensus 84 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~~~p 162 (771)
+|+|+...|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+... ...++.+.+..|.+++..|
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence 999997777789999999999999999997777889999999999999999986555333 5557778888999998888
Q ss_pred cccccccccceeccCC
Q 004155 163 ETSCQYRSVNLFASSS 178 (771)
Q Consensus 163 ~~~~~l~~L~~l~~s~ 178 (771)
..+ +.++.++++.
T Consensus 167 ~~l---~~~~l~~L~~ 179 (192)
T d1w8aa_ 167 SKV---RDVQIKDLPH 179 (192)
T ss_dssp TTT---TTSBGGGSCT
T ss_pred hhh---cCCEeeecCH
Confidence 654 4455555543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.74 E-value=1.4e-17 Score=174.46 Aligned_cols=173 Identities=18% Similarity=0.197 Sum_probs=145.2
Q ss_pred CCCCcEEEccCCcccccCCc-cccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCc---------
Q 004155 2 LVTLKDFRISDNHFTGKIPN-FIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPL--------- 71 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~--------- 71 (771)
.++|++|+|++|+|+ .+|+ .|.++++|++|++++|.+....|..|.++++|+.|++++|+++.++...+
T Consensus 30 ~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~~~~~l~~L~~~ 108 (305)
T d1xkua_ 30 PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVH 108 (305)
T ss_dssp CTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECC
T ss_pred CCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCccchhhhhhhhhcc
Confidence 367999999999999 6665 79999999999999999997778899999999999999998866543221
Q ss_pred --------------------------------------cCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccCCCCCC
Q 004155 72 --------------------------------------DKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNG 113 (771)
Q Consensus 72 --------------------------------------~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 113 (771)
..+++|+.+++++|+++ .+|..+ +++|+.|++++|.+++
T Consensus 109 ~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~ 185 (305)
T d1xkua_ 109 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK 185 (305)
T ss_dssp SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCE
T ss_pred ccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCC
Confidence 22356777888888777 566543 5789999999999998
Q ss_pred CCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccccCCCcccccccccceeccCCC
Q 004155 114 AIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 114 ~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~ 179 (771)
..+..|..++.++.|++++|++++..|.++ +++|+.|+|++|.|+. +|+.+..+++|+.|+++.|
T Consensus 186 ~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N 252 (305)
T d1xkua_ 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNN 252 (305)
T ss_dssp ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSS
T ss_pred CChhHhhccccccccccccccccccccccccccccceeeecccccccc-cccccccccCCCEEECCCC
Confidence 888899999999999999999997666666 7899999999999984 6788999999999999875
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=2.9e-18 Score=167.00 Aligned_cols=158 Identities=18% Similarity=0.199 Sum_probs=135.1
Q ss_pred CCCcEEEccCCcccccCC-ccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 3 VTLKDFRISDNHFTGKIP-NFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++++|+|++|+|++.++ ..|.++++|+.|+|++|.+.+..+..|..+++|++|+|++|+++.+++..|.++++|++|+
T Consensus 29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence 579999999999986564 4678999999999999999988999999999999999999999999999999999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhcCCeecccCCccccCC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGS 161 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~ 161 (771)
|++|+|++..|+.|..+++|++|+|++|.+....+.. .-...|+.+.+..|.++...|.. +..+..++|+.|.|++..
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~p~~-l~~~~l~~L~~n~l~C~~ 186 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSK-VRDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCSSTT-TTTSBGGGSCTTTCCCCC
T ss_pred cCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCCChh-hcCCEeeecCHhhCcCCC
Confidence 9999999777788999999999999999998543321 11234667778889988777765 466788899999998654
Q ss_pred C
Q 004155 162 S 162 (771)
Q Consensus 162 p 162 (771)
+
T Consensus 187 ~ 187 (192)
T d1w8aa_ 187 E 187 (192)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.1e-17 Score=173.30 Aligned_cols=160 Identities=19% Similarity=0.214 Sum_probs=139.6
Q ss_pred CCCCcEEEcc-CCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEE
Q 004155 2 LVTLKDFRIS-DNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 2 L~~L~~L~Ls-~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 80 (771)
+..+..|+.. .|.++...|..|.++++|++|+|++|.+....+..+..+.+|+.+++++|+++++++..|..+++|+.|
T Consensus 79 ~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L 158 (284)
T d1ozna_ 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL 158 (284)
T ss_dssp CTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhc
Confidence 4567777664 666775556789999999999999999987777788889999999999999999888889999999999
Q ss_pred EccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccc
Q 004155 81 ILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFT 158 (771)
Q Consensus 81 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~ 158 (771)
+|++|+|++..+..|.++++|+.|++++|++++..|..|..+++|++|++++|++++..|..+ +.+|+.|+|++|++.
T Consensus 159 ~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred ccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 999999997777889999999999999999998889999999999999999999997666666 788999999999998
Q ss_pred cCC
Q 004155 159 AGS 161 (771)
Q Consensus 159 ~~~ 161 (771)
+..
T Consensus 239 C~C 241 (284)
T d1ozna_ 239 CDC 241 (284)
T ss_dssp CSG
T ss_pred CCc
Confidence 754
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=3.5e-17 Score=160.17 Aligned_cols=160 Identities=20% Similarity=0.321 Sum_probs=130.8
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
|.+|+.|++++|+++ .++ .+..+++|++|+|++|+|++ ++. ++++++|+.|++++|.+...+ .+.++++|+.|+
T Consensus 39 l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred hcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccC-ccc-ccCCccccccccccccccccc--cccccccccccc
Confidence 467899999999998 665 48889999999999999985 443 889999999999999887764 488899999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCccccC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~~ 160 (771)
+++|.+.. + ..+..+++|+.|++++|++. .+| .+..+++|+.|++++|++++ ++..- +++|+.|++++|+++..
T Consensus 113 l~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~-l~~l~~l~~L~~L~ls~N~i~~i 187 (199)
T d2omxa2 113 LFNNQITD-I-DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTD-LKPLANLTTLERLDISSNKVSDI 187 (199)
T ss_dssp CCSSCCCC-C-GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCCC
T ss_pred cccccccc-c-cccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccC-CccccCCCCCCEEECCCCCCCCC
Confidence 99999873 3 35788999999999999998 454 58889999999999999984 55422 88999999999998863
Q ss_pred CCccccccccccee
Q 004155 161 SSETSCQYRSVNLF 174 (771)
Q Consensus 161 ~p~~~~~l~~L~~l 174 (771)
+ .++++++|+.|
T Consensus 188 -~-~l~~L~~L~~L 199 (199)
T d2omxa2 188 -S-VLAKLTNLESL 199 (199)
T ss_dssp -G-GGGGCTTCSEE
T ss_pred -c-cccCCCCCCcC
Confidence 3 46777777654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=4.8e-17 Score=160.61 Aligned_cols=163 Identities=21% Similarity=0.292 Sum_probs=138.4
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
|.+|+.|++++|+++ .++. +..+++|++|+|++|+|++ ++ .++.|++|++|++++|+++..+ .+.++++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~-~l~~-l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKDLS--SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCC-CCTT-GGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCC-Cchh-HhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccccc--cccccccccccc
Confidence 457899999999998 5554 8889999999999999995 55 3788999999999999998753 588999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCccccC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~~ 160 (771)
+++|.+. .++ .+..+++|+.++++.|.+++ + ..+..+++|+.+++++|++++ ++..- +++|+.|+|++|+++.
T Consensus 119 l~~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~-~-~~~~~l~~L~~l~l~~n~l~~-i~~l~~l~~L~~L~Ls~N~i~~- 192 (210)
T d1h6ta2 119 LEHNGIS-DIN-GLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHISD- 192 (210)
T ss_dssp CTTSCCC-CCG-GGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCB-
T ss_pred ccccccc-ccc-cccccccccccccccccccc-c-ccccccccccccccccccccc-cccccCCCCCCEEECCCCCCCC-
Confidence 9999987 444 68899999999999999984 3 357889999999999999995 55422 8899999999999985
Q ss_pred CCcccccccccceeccC
Q 004155 161 SSETSCQYRSVNLFASS 177 (771)
Q Consensus 161 ~p~~~~~l~~L~~l~~s 177 (771)
+| .+..+++|+.|+++
T Consensus 193 l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 193 LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp CG-GGTTCTTCSEEEEE
T ss_pred Ch-hhcCCCCCCEEEcc
Confidence 44 58889999999876
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.66 E-value=5.2e-16 Score=162.21 Aligned_cols=174 Identities=17% Similarity=0.209 Sum_probs=146.1
Q ss_pred CcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccC
Q 004155 5 LKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRS 84 (771)
Q Consensus 5 L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 84 (771)
++.+|=++++|+ .+|..+. ++|++|+|++|+|+...+.+|.++++|+.|++++|.+....|..|.++++|++|+|++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 567888999999 9999875 6899999999999954456899999999999999999999888999999999999999
Q ss_pred CcCcccCChh------------------------------------------------hhcCCCCcEEEccCCCCCCCCC
Q 004155 85 CNVSGKLPDY------------------------------------------------LGLMTSLKVLDVSFNKLNGAIP 116 (771)
Q Consensus 85 N~l~g~~p~~------------------------------------------------~~~l~~L~~L~Ls~N~l~g~ip 116 (771)
|+|+ .+|.. +..+++|+.+++++|.++ .+|
T Consensus 89 n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~ 166 (305)
T d1xkua_ 89 NQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIP 166 (305)
T ss_dssp SCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCC
T ss_pred CccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccC
Confidence 9886 34332 223566888888888887 666
Q ss_pred ccccCCCCCcEEEcCCCcccccCchhh--hhcCCeecccCCccccCCCcccccccccceeccCCCCCCCCCcc
Q 004155 117 STFMGLLDVDYIYLTGNLLTGTIPPWM--LQKGDRVDLSYNSFTAGSSETSCQYRSVNLFASSSKGNNSTGIV 187 (771)
Q Consensus 117 ~~~~~l~~L~~L~Ls~N~l~g~iP~~~--~~~L~~l~ls~N~l~~~~p~~~~~l~~L~~l~~s~~~~~~~~~~ 187 (771)
..+ +++|+.|++++|.+++..|..+ ++.++.|++++|.+++..+..+..+++|+.|+++.+ ....++
T Consensus 167 ~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N--~L~~lp 235 (305)
T d1xkua_ 167 QGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN--KLVKVP 235 (305)
T ss_dssp SSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSS--CCSSCC
T ss_pred ccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccc--cccccc
Confidence 544 6789999999999998877777 778999999999999999999999999999998865 344443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.65 E-value=4.9e-16 Score=155.20 Aligned_cols=166 Identities=18% Similarity=0.221 Sum_probs=113.4
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
|.+|+.|++++|+|+ .++ .+.++++|++|+|++|++++..| +..+++|++|++++|.++.. +.+.++++|+.|+
T Consensus 40 l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~ 113 (227)
T d1h6ua2 40 LDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLD 113 (227)
T ss_dssp HHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEE
T ss_pred cCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccccc--ccccccccccccc
Confidence 468999999999998 675 58999999999999999985433 88999999999999988764 3578899999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhcCCeecccCCccccCC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGS 161 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~ 161 (771)
+++|.+.+.. .+...+.++.++++++.+.... .+..+++|+.|++++|.+++..+-.-+++|+.|+|++|+++..
T Consensus 114 l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~l- 188 (227)
T d1h6ua2 114 LTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI- 188 (227)
T ss_dssp CTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC-
T ss_pred cccccccccc--hhccccchhhhhchhhhhchhh--hhccccccccccccccccccchhhcccccceecccCCCccCCC-
Confidence 9999877432 3445556666666666665322 2445556666666666655322211155666666666666542
Q ss_pred CcccccccccceeccCCC
Q 004155 162 SETSCQYRSVNLFASSSK 179 (771)
Q Consensus 162 p~~~~~l~~L~~l~~s~~ 179 (771)
+ .++.+++|+.|+++.+
T Consensus 189 ~-~l~~l~~L~~L~Ls~N 205 (227)
T d1h6ua2 189 S-PLASLPNLIEVHLKNN 205 (227)
T ss_dssp G-GGGGCTTCCEEECTTS
T ss_pred h-hhcCCCCCCEEECcCC
Confidence 2 2555566666665543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.62 E-value=1.3e-15 Score=150.09 Aligned_cols=143 Identities=20% Similarity=0.316 Sum_probs=124.0
Q ss_pred CCCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEE
Q 004155 1 MLVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTL 80 (771)
Q Consensus 1 ~L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 80 (771)
.|++|++|+|++|+|+ .++. ++++++|++|+|++|+|+ .+| .+..+++|+.|++++|.+... +.+..+++|+.+
T Consensus 66 ~l~~L~~L~L~~n~i~-~l~~-~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l 139 (210)
T d1h6ta2 66 YLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESL 139 (210)
T ss_dssp GCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEE
T ss_pred hCCCCCEEeCCCcccc-Cccc-cccCcccccccccccccc-ccc-ccccccccccccccccccccc--cccccccccccc
Confidence 3789999999999999 5654 789999999999999998 466 589999999999999998764 468899999999
Q ss_pred EccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccC
Q 004155 81 ILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSY 154 (771)
Q Consensus 81 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~ 154 (771)
++++|.+++ +..+..+++|+.+++++|++++ ++. +.++++|+.|+|++|+|+ .+|..- +++|+.|+|++
T Consensus 140 ~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~-~l~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 140 YLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFS 209 (210)
T ss_dssp ECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-BCGGGTTCTTCSEEEEEE
T ss_pred ccccccccc--cccccccccccccccccccccc-ccc-ccCCCCCCEEECCCCCCC-CChhhcCCCCCCEEEccC
Confidence 999999983 3467889999999999999995 543 899999999999999999 677422 88999999874
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.62 E-value=1.5e-15 Score=163.39 Aligned_cols=164 Identities=25% Similarity=0.342 Sum_probs=90.3
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
+++++.|++++|.+++..| +...++|+.|++++|+++ .+| .+..+++|+.|++++|.+++.+ .+..+++|+.|+
T Consensus 196 l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~-~~~-~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~ 269 (384)
T d2omza2 196 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK-DIG-TLASLTNLTDLDLANNQISNLA--PLSGLTKLTELK 269 (384)
T ss_dssp CTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC-CCG-GGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred ccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCC-Ccc-hhhcccccchhccccCccCCCC--cccccccCCEee
Confidence 4566677777777664333 344566677777777666 233 4566667777777776666543 356666677777
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhcCCeecccCCccccCC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFTAGS 161 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~~~~ 161 (771)
+++|++++. + .+..++.++.++++.|.+++ + ..+..+++++.|++++|++++..|-..+++|+.|++++|+++. +
T Consensus 270 l~~~~l~~~-~-~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~~-l 344 (384)
T d2omza2 270 LGANQISNI-S-PLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD-V 344 (384)
T ss_dssp CCSSCCCCC-G-GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC-C
T ss_pred ccCcccCCC-C-cccccccccccccccccccc-c-cccchhcccCeEECCCCCCCCCcccccCCCCCEEECCCCCCCC-C
Confidence 766666632 2 24445555555555555553 2 2244555555555555555532221224555555555555543 2
Q ss_pred CcccccccccceeccC
Q 004155 162 SETSCQYRSVNLFASS 177 (771)
Q Consensus 162 p~~~~~l~~L~~l~~s 177 (771)
+ .+..+++|+.|+++
T Consensus 345 ~-~l~~l~~L~~L~l~ 359 (384)
T d2omza2 345 S-SLANLTNINWLSAG 359 (384)
T ss_dssp G-GGGGCTTCCEEECC
T ss_pred h-hHcCCCCCCEEECC
Confidence 2 34555555555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.60 E-value=3.4e-15 Score=145.77 Aligned_cols=138 Identities=24% Similarity=0.374 Sum_probs=117.9
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
|++|++|+|++|+|+ .+++ ++++++|++|++++|.+. .+| .+.++++|+.|++++|.+... +.+..+++|+.|+
T Consensus 61 l~nL~~L~Ls~N~l~-~~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~ 134 (199)
T d2omxa2 61 LNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLE 134 (199)
T ss_dssp CTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred CCCcCcCcccccccc-Cccc-ccCCcccccccccccccc-ccc-ccccccccccccccccccccc--cccchhhhhHHhh
Confidence 789999999999999 4554 999999999999999998 565 489999999999999988875 3588899999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCee
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRV 150 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l 150 (771)
+++|++. .+| .+..+++|+.|++++|++++ ++ .++++++|+.|+|++|+++ .+|..- +++|+.|
T Consensus 135 l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~i~-~i~~l~~L~~L~~L 199 (199)
T d2omxa2 135 LSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNKVS-DISVLAKLTNLESL 199 (199)
T ss_dssp CCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CCGGGGGCTTCSEE
T ss_pred hhhhhhc-ccc-cccccccccccccccccccC-Cc-cccCCCCCCEEECCCCCCC-CCccccCCCCCCcC
Confidence 9999998 454 68899999999999999994 44 4899999999999999999 566422 5666554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=5.8e-16 Score=145.88 Aligned_cols=134 Identities=14% Similarity=0.163 Sum_probs=108.5
Q ss_pred cCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCccc
Q 004155 11 SDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGK 90 (771)
Q Consensus 11 s~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~ 90 (771)
+.|-+. ..|. +.+..+|++|+|++|+|+ .+|..+..+++|+.|+|++|+++.. +.|..+++|++|+|++|+++..
T Consensus 4 t~~~i~-~~~~-~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l 78 (162)
T d1a9na_ 4 TAELIE-QAAQ-YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRI 78 (162)
T ss_dssp CHHHHH-TSCE-EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEE
T ss_pred CHHHHh-hhHh-ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCC
Confidence 334443 4454 668889999999999998 6787778899999999999999876 3588999999999999999944
Q ss_pred CChhhhcCCCCcEEEccCCCCCCCCC--ccccCCCCCcEEEcCCCcccccCchh----h--hhcCCeec
Q 004155 91 LPDYLGLMTSLKVLDVSFNKLNGAIP--STFMGLLDVDYIYLTGNLLTGTIPPW----M--LQKGDRVD 151 (771)
Q Consensus 91 ~p~~~~~l~~L~~L~Ls~N~l~g~ip--~~~~~l~~L~~L~Ls~N~l~g~iP~~----~--~~~L~~l~ 151 (771)
.+..+..+++|+.|+|++|+|+ .++ ..+..+++|++|++++|.++ ..|.. + +++|+.||
T Consensus 79 ~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 79 GEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred Cccccccccccccceecccccc-ccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 4445678999999999999998 455 36888999999999999998 56641 2 78888887
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.59 E-value=2.3e-15 Score=134.93 Aligned_cols=101 Identities=18% Similarity=0.260 Sum_probs=75.7
Q ss_pred cEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCC
Q 004155 6 KDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSC 85 (771)
Q Consensus 6 ~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N 85 (771)
+.|+|++|+|+ .+|. +.++++|++|+|++|+|+ .+|..|+.+++|+.|++++|+++..+ .+.++++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~--~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD--GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCcc-cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccccC--ccccccccCeEECCCC
Confidence 46888888888 6664 788888888888888887 67777888888888888888777653 4777777777777777
Q ss_pred cCcccCC--hhhhcCCCCcEEEccCCCCC
Q 004155 86 NVSGKLP--DYLGLMTSLKVLDVSFNKLN 112 (771)
Q Consensus 86 ~l~g~~p--~~~~~l~~L~~L~Ls~N~l~ 112 (771)
+|+ .+| ..+..+++|+.|++++|.++
T Consensus 76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCC-SSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccC-CCCCchhhcCCCCCCEEECCCCcCC
Confidence 777 333 35677777777777777776
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=2.4e-15 Score=141.58 Aligned_cols=122 Identities=15% Similarity=0.161 Sum_probs=65.4
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
.+|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .++ .|..+++|+.|+|++|+++..++..+..+++|+.|+|
T Consensus 18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 34555566666555 44544455555566666666555 332 3555555666666665555554444455555666666
Q ss_pred cCCcCcccCC--hhhhcCCCCcEEEccCCCCCCCCCc----cccCCCCCcEEE
Q 004155 83 RSCNVSGKLP--DYLGLMTSLKVLDVSFNKLNGAIPS----TFMGLLDVDYIY 129 (771)
Q Consensus 83 s~N~l~g~~p--~~~~~l~~L~~L~Ls~N~l~g~ip~----~~~~l~~L~~L~ 129 (771)
++|+|+ .++ ..+..+++|++|++++|.++ ..|. .+..+++|++||
T Consensus 95 ~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 95 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred cccccc-ccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 666555 333 23555555666666665555 3332 244555555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.52 E-value=2.2e-14 Score=128.44 Aligned_cols=101 Identities=18% Similarity=0.220 Sum_probs=77.0
Q ss_pred CEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccCC
Q 004155 30 EKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFN 109 (771)
Q Consensus 30 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 109 (771)
++|+|++|+|+ .+| .+..+++|++|+|++|+++..+ +.|+.+++|+.|++++|+|+ .+| .++.+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp-~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALP-PALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCC-GGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcch-hhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 46888888887 555 4778888888888888887654 56778888888888888887 555 4778888888888888
Q ss_pred CCCCCCC--ccccCCCCCcEEEcCCCccc
Q 004155 110 KLNGAIP--STFMGLLDVDYIYLTGNLLT 136 (771)
Q Consensus 110 ~l~g~ip--~~~~~l~~L~~L~Ls~N~l~ 136 (771)
+|+ .+| ..+..+++|+.|++++|+++
T Consensus 76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCC-SSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccC-CCCCchhhcCCCCCCEEECCCCcCC
Confidence 887 333 35777888888888888877
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.51 E-value=3.9e-14 Score=141.13 Aligned_cols=163 Identities=19% Similarity=0.281 Sum_probs=138.9
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
|++|+.|+|++|+|++ +++ +..+++|++|++++|.++ .++ .+..+++|+.|++++|...... .+...+.++.++
T Consensus 62 l~~L~~L~ls~n~i~~-~~~-l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~ 135 (227)
T d1h6ua2 62 LNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLY 135 (227)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEE
T ss_pred CCCCcEeecCCceeec-ccc-cccccccccccccccccc-ccc-cccccccccccccccccccccc--hhccccchhhhh
Confidence 7899999999999994 443 899999999999999998 565 5889999999999999887653 467789999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCccccC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~~ 160 (771)
++++.+.... .+..+++|+.|++++|.+++. + .+.++++|+.|+|++|++++ +|..- +++|+.|+|++|+++..
T Consensus 136 ~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 136 LDLNQITNIS--PLAGLTNLQYLSIGNAQVSDL-T-PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp CCSSCCCCCG--GGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCCBC
T ss_pred chhhhhchhh--hhccccccccccccccccccc-h-hhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCCCC
Confidence 9999997433 477899999999999999843 3 38999999999999999994 66533 89999999999999975
Q ss_pred CCcccccccccceeccC
Q 004155 161 SSETSCQYRSVNLFASS 177 (771)
Q Consensus 161 ~p~~~~~l~~L~~l~~s 177 (771)
.| +.++++|+.|+++
T Consensus 211 ~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 211 SP--LANTSNLFIVTLT 225 (227)
T ss_dssp GG--GTTCTTCCEEEEE
T ss_pred cc--cccCCCCCEEEee
Confidence 44 7889999999876
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=2.8e-14 Score=143.50 Aligned_cols=177 Identities=13% Similarity=0.105 Sum_probs=130.1
Q ss_pred CCCCcEEEccCCcccccCCc-cccCCCcCCEEEcccCCccccC-chhhcCCcCCCEEEcCC-CCCCCCCCCCccCCCCCc
Q 004155 2 LVTLKDFRISDNHFTGKIPN-FIQNWTLLEKLVIQASGLVGPI-PSGIASLSKLTDLRISD-LNGTEAPFPPLDKMKKMK 78 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~-~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~ 78 (771)
.+++++|+|++|+|+ .+|. .|.++++|++|+|++|.+...+ +..|.++++++.|.+.. |++....+..|.++++|+
T Consensus 28 ~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~ 106 (242)
T d1xwdc1 28 PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQ 106 (242)
T ss_dssp CSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCC
T ss_pred CCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccc
Confidence 357889999999998 5654 6888999999999999887655 44678888999888754 677777777888899999
Q ss_pred EEEccCCcCcccCC-hhhhcCCCCcEEEccCCCCCCCCCccccCCC-CCcEEEcCCCcccccCchhh--hhcCC-eeccc
Q 004155 79 TLILRSCNVSGKLP-DYLGLMTSLKVLDVSFNKLNGAIPSTFMGLL-DVDYIYLTGNLLTGTIPPWM--LQKGD-RVDLS 153 (771)
Q Consensus 79 ~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~-~L~~L~Ls~N~l~g~iP~~~--~~~L~-~l~ls 153 (771)
.|++++|++....+ ..+..+..|..+..+++.+...-+..|..++ .++.|++++|+++ .++... ..++. .++++
T Consensus 107 ~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~ 185 (242)
T d1xwdc1 107 YLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSD 185 (242)
T ss_dssp EEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTT
T ss_pred ccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc-ccccccccchhhhcccccc
Confidence 99999998873322 2344566666777777787744445566664 6888899888888 455444 33443 34677
Q ss_pred CCccccCCCcccccccccceeccCCCC
Q 004155 154 YNSFTAGSSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~~s~~~ 180 (771)
+|+++...+..+..+++|+.|+++.+.
T Consensus 186 ~n~l~~l~~~~f~~l~~L~~L~Ls~N~ 212 (242)
T d1xwdc1 186 NNNLEELPNDVFHGASGPVILDISRTR 212 (242)
T ss_dssp CTTCCCCCTTTTTTSCCCSEEECTTSC
T ss_pred ccccccccHHHhcCCCCCCEEECCCCc
Confidence 888886666778888889998886553
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.49 E-value=1.2e-13 Score=148.23 Aligned_cols=165 Identities=15% Similarity=0.299 Sum_probs=140.3
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
.++|+.|++++|+++ .+| .+..+++|+.|++++|++++..| ++.+++|+.|++++|++++.. .+..++.++.++
T Consensus 218 ~~~L~~L~l~~n~l~-~~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~ 291 (384)
T d2omza2 218 LTNLDELSLNGNQLK-DIG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLE 291 (384)
T ss_dssp CTTCCEEECCSSCCC-CCG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred cCCCCEEECCCCCCC-Ccc-hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccc
Confidence 468999999999998 554 58889999999999999985433 788999999999999998764 477899999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhh-hhcCCeecccCCccccC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWM-LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~-~~~L~~l~ls~N~l~~~ 160 (771)
+++|++++ + ..+..+++++.|+|++|++++. + .+..+++|++|+|++|+|+ .+|..- +++|+.|++++|++++.
T Consensus 292 ~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~-~l~~l~~l~~L~~L~l~~N~l~~l 366 (384)
T d2omza2 292 LNENQLED-I-SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVS-DVSSLANLTNINWLSAGHNQISDL 366 (384)
T ss_dssp CCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCC-CCGGGGGCTTCCEEECCSSCCCBC
T ss_pred cccccccc-c-cccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCC-CChhHcCCCCCCEEECCCCcCCCC
Confidence 99999984 3 3588899999999999999964 3 3888999999999999998 566322 88999999999999987
Q ss_pred CCcccccccccceeccCCC
Q 004155 161 SSETSCQYRSVNLFASSSK 179 (771)
Q Consensus 161 ~p~~~~~l~~L~~l~~s~~ 179 (771)
.| +.++++|+.|+++.|
T Consensus 367 ~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 367 TP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GG--GTTCTTCSEEECCCE
T ss_pred hh--hccCCCCCEeeCCCC
Confidence 65 788899999988754
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=1.2e-13 Score=138.77 Aligned_cols=174 Identities=17% Similarity=0.130 Sum_probs=140.7
Q ss_pred CCCCcEEEccCCcccccCCc-cccCCCcCCEEEccc-CCccccCchhhcCCcCCCEEEcCCCCCCCCCCC-CccCCCCCc
Q 004155 2 LVTLKDFRISDNHFTGKIPN-FIQNWTLLEKLVIQA-SGLVGPIPSGIASLSKLTDLRISDLNGTEAPFP-PLDKMKKMK 78 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~-~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~ 78 (771)
+++|++|+|++|.+...+|. .|.+++++++|.+.. |.+....+..|.++++|+.|++++|++...++. .+..+..|.
T Consensus 52 l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~ 131 (242)
T d1xwdc1 52 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 131 (242)
T ss_dssp CTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEE
T ss_pred cchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccc
Confidence 68999999999999866654 688899999999864 788877788899999999999999999876543 355678888
Q ss_pred EEEccCCcCcccCChhhhcCC-CCcEEEccCCCCCCCCCccccCCCCCcEE-EcCCCcccccCchh-h--hhcCCeeccc
Q 004155 79 TLILRSCNVSGKLPDYLGLMT-SLKVLDVSFNKLNGAIPSTFMGLLDVDYI-YLTGNLLTGTIPPW-M--LQKGDRVDLS 153 (771)
Q Consensus 79 ~L~Ls~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L-~Ls~N~l~g~iP~~-~--~~~L~~l~ls 153 (771)
.+..+++++...-+..+..++ .++.|++++|+++ .++.......++..+ .+++|+|+ .+|.. + +++|+.|+|+
T Consensus 132 ~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls 209 (242)
T d1xwdc1 132 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDIS 209 (242)
T ss_dssp EEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECT
T ss_pred cccccccccccccccccccccccceeeeccccccc-ccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECC
Confidence 888899898855556666654 7999999999999 566655566676555 57888998 67764 3 7899999999
Q ss_pred CCccccCCCcccccccccceeccC
Q 004155 154 YNSFTAGSSETSCQYRSVNLFASS 177 (771)
Q Consensus 154 ~N~l~~~~p~~~~~l~~L~~l~~s 177 (771)
+|+++...+..+.+++.|+.+++.
T Consensus 210 ~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 210 RTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp TSCCCCCCSSSCTTCCEEESSSEE
T ss_pred CCcCCccCHHHHcCCcccccCcCC
Confidence 999997777788888888887653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=5.3e-13 Score=124.39 Aligned_cols=142 Identities=15% Similarity=0.183 Sum_probs=100.5
Q ss_pred cCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCC-CCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCc
Q 004155 24 QNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL-NGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLK 102 (771)
Q Consensus 24 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 102 (771)
+.....+.++++++++. .+|..+..+++|+.|+|++| .++.+.+.+|.++++|+.|+|++|+|+..-|..|..+++|+
T Consensus 5 C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~ 83 (156)
T d2ifga3 5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (156)
T ss_dssp SCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred CCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence 33445567888888887 67777888888888888765 47777777888888999999999999866677788899999
Q ss_pred EEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccC-chhh--hhcCCeecccCCccccCCCccccc
Q 004155 103 VLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTI-PPWM--LQKGDRVDLSYNSFTAGSSETSCQ 167 (771)
Q Consensus 103 ~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~i-P~~~--~~~L~~l~ls~N~l~~~~p~~~~~ 167 (771)
+|+|++|+|+ .+|.......+|+.|+|++|.|.-.- -.++ +.......+..+++++..|..+..
T Consensus 84 ~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l~~ 150 (156)
T d2ifga3 84 RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAH 150 (156)
T ss_dssp EEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCSSC
T ss_pred ceeccCCCCc-ccChhhhccccccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChHHCc
Confidence 9999999998 66655444557999999999886211 1122 122233344456677666655443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.38 E-value=4.8e-15 Score=144.40 Aligned_cols=112 Identities=15% Similarity=0.196 Sum_probs=52.9
Q ss_pred CCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcC
Q 004155 19 IPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLM 98 (771)
Q Consensus 19 ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l 98 (771)
+|..+..|++|++|+|++|+|+ .++ .|..|++|+.|+|++|+++.++ +.+..+++|++|++++|+|+ .++ .+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~-~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIE-NLDAVADTLEELWISYNQIA-SLS-GIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCS-SHHHHHHHCCEEECSEEECC-CHH-HHHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhccccccccc-cccccccccccccccccccc-ccc-ccccc
Confidence 3344555555555555555554 333 3445555555555555544432 22233344555555555554 222 34445
Q ss_pred CCCcEEEccCCCCCCCCC--ccccCCCCCcEEEcCCCccc
Q 004155 99 TSLKVLDVSFNKLNGAIP--STFMGLLDVDYIYLTGNLLT 136 (771)
Q Consensus 99 ~~L~~L~Ls~N~l~g~ip--~~~~~l~~L~~L~Ls~N~l~ 136 (771)
++|+.|+|++|+|+ .++ ..+..+++|+.|+|++|++.
T Consensus 115 ~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 115 VNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccchhc-cccccccccCCCccceeecCCCccc
Confidence 55555555555554 222 23445555555555555444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.37 E-value=8.6e-15 Score=142.60 Aligned_cols=142 Identities=18% Similarity=0.252 Sum_probs=116.6
Q ss_pred CcCCEEEcccC--CccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEE
Q 004155 27 TLLEKLVIQAS--GLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVL 104 (771)
Q Consensus 27 ~~L~~L~L~~N--~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 104 (771)
..++.+++.++ .+. .+|.++..|++|+.|+|++|+++.+. .+.+|++|+.|+|++|+|+ .+|..+..+++|+.|
T Consensus 23 ~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i~--~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L 98 (198)
T d1m9la_ 23 TEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKIS--SLSGMENLRILSLGRNLIK-KIENLDAVADTLEEL 98 (198)
T ss_dssp TTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCCC--CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEE
T ss_pred cccceeeeecccCchh-hhhhHHhcccccceeECcccCCCCcc--cccCCccccChhhcccccc-ccccccccccccccc
Confidence 34566677664 354 67889999999999999999999763 5899999999999999998 788777777899999
Q ss_pred EccCCCCCCCCCccccCCCCCcEEEcCCCcccccCch--hh--hhcCCeecccCCccccCCCcc----------cccccc
Q 004155 105 DVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPP--WM--LQKGDRVDLSYNSFTAGSSET----------SCQYRS 170 (771)
Q Consensus 105 ~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~--~~--~~~L~~l~ls~N~l~~~~p~~----------~~~l~~ 170 (771)
++++|+|+ .++ .+..+++|+.|+|++|+|+ .++. .+ +++|+.|+|++|+++...+.. +..+++
T Consensus 99 ~l~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~ 175 (198)
T d1m9la_ 99 WISYNQIA-SLS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPN 175 (198)
T ss_dssp ECSEEECC-CHH-HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSS
T ss_pred cccccccc-ccc-cccccccccccccccchhc-cccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCC
Confidence 99999999 454 4888999999999999998 4553 34 789999999999998765543 456777
Q ss_pred cceec
Q 004155 171 VNLFA 175 (771)
Q Consensus 171 L~~l~ 175 (771)
|+.||
T Consensus 176 L~~LD 180 (198)
T d1m9la_ 176 LKKLD 180 (198)
T ss_dssp CCEES
T ss_pred cCEeC
Confidence 77776
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.35 E-value=1.4e-12 Score=121.51 Aligned_cols=108 Identities=17% Similarity=0.039 Sum_probs=96.5
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccC-CccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQAS-GLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
...+.++.++++++ .+|..+..+++|++|+|++| .|+..-+.+|.+|++|+.|+|++|+++.+.+..|..+++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34677999999999 88999999999999999866 58866677899999999999999999999999999999999999
Q ss_pred ccCCcCcccCChhhhcCCCCcEEEccCCCCC
Q 004155 82 LRSCNVSGKLPDYLGLMTSLKVLDVSFNKLN 112 (771)
Q Consensus 82 Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 112 (771)
|++|+|+ .+|.......+|+.|+|++|.+.
T Consensus 87 Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred ccCCCCc-ccChhhhccccccccccCCCccc
Confidence 9999999 77776656668999999999986
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.24 E-value=6.8e-11 Score=124.43 Aligned_cols=75 Identities=20% Similarity=0.291 Sum_probs=42.1
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCC-cCCCEEEcCCCCCCCCCCCCccCCCCCcEEE
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASL-SKLTDLRISDLNGTEAPFPPLDKMKKMKTLI 81 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 81 (771)
++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++. + +.|++|+|++|.+...+ .++.+++|+.|+
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~----lp~~L~~L~L~~n~l~~lp--~~~~l~~L~~L~ 126 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD----LPPLLEYLGVSNNQLEKLP--ELQNSSFLKIID 126 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS----CCTTCCEEECCSSCCSSCC--CCTTCTTCCEEE
T ss_pred CCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh----hcccccccccccccccccc--chhhhccceeec
Confidence 34555555555555 445432 23444444444443 2221 1 34777778777777654 356777888888
Q ss_pred ccCCcCc
Q 004155 82 LRSCNVS 88 (771)
Q Consensus 82 Ls~N~l~ 88 (771)
+++|.+.
T Consensus 127 l~~~~~~ 133 (353)
T d1jl5a_ 127 VDNNSLK 133 (353)
T ss_dssp CCSSCCS
T ss_pred ccccccc
Confidence 8777765
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.13 E-value=4.1e-12 Score=130.76 Aligned_cols=175 Identities=14% Similarity=0.169 Sum_probs=112.3
Q ss_pred CCCcEEEccCCccccc-CCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCC-CCCCCCC-CCccCCCCCcE
Q 004155 3 VTLKDFRISDNHFTGK-IPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDL-NGTEAPF-PPLDKMKKMKT 79 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~-ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~~~-~~~~~l~~L~~ 79 (771)
.+|++|||++|.++.. ++.-+.++++|++|+|++|.++...+..++.+++|+.|+|+++ .++.... ..+.++++|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 4678888888877643 3344667788888888888877777777778888888888875 3432111 12345778888
Q ss_pred EEccCC-cCcc-cCChhhhc-CCCCcEEEccCC--CCCCC-CCccccCCCCCcEEEcCCC-cccccCchhh--hhcCCee
Q 004155 80 LILRSC-NVSG-KLPDYLGL-MTSLKVLDVSFN--KLNGA-IPSTFMGLLDVDYIYLTGN-LLTGTIPPWM--LQKGDRV 150 (771)
Q Consensus 80 L~Ls~N-~l~g-~~p~~~~~-l~~L~~L~Ls~N--~l~g~-ip~~~~~l~~L~~L~Ls~N-~l~g~iP~~~--~~~L~~l 150 (771)
|+|+++ .++. .+...+.. .++|+.|+++++ .++.. +...+.++++|++|+|++| .+++..+..+ +++|++|
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence 888775 3431 12222333 367888888764 34321 2223355778888888775 4665555444 6778888
Q ss_pred cccC-CccccCCCcccccccccceeccC
Q 004155 151 DLSY-NSFTAGSSETSCQYRSVNLFASS 177 (771)
Q Consensus 151 ~ls~-N~l~~~~p~~~~~l~~L~~l~~s 177 (771)
+|++ +.++......++++++|+.|+++
T Consensus 206 ~L~~C~~i~~~~l~~L~~~~~L~~L~l~ 233 (284)
T d2astb2 206 SLSRCYDIIPETLLELGEIPTLKTLQVF 233 (284)
T ss_dssp ECTTCTTCCGGGGGGGGGCTTCCEEECT
T ss_pred ECCCCCCCChHHHHHHhcCCCCCEEeee
Confidence 8887 45666666667777777777764
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.11 E-value=4.6e-10 Score=117.87 Aligned_cols=138 Identities=21% Similarity=0.247 Sum_probs=101.7
Q ss_pred CCCcEEEccCCcccccCCccccCCCcCCEEEcccCCccccCchhhcCCcCCCEEEcCCCCCCCCCCCCccCCCCCcEEEc
Q 004155 3 VTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQASGLVGPIPSGIASLSKLTDLRISDLNGTEAPFPPLDKMKKMKTLIL 82 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 82 (771)
.+|+.|||++|+|+ .+|+. +++|++|+|++|+|+ .+|.. +.+|+.|++++|+++.+. .+ .+.|++|+|
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l~--~l--p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKALS--DL--PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCC--SC--CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchhh--hh--ccccccccc
Confidence 36899999999999 89974 468999999999999 78865 468899999999988754 12 256999999
Q ss_pred cCCcCcccCChhhhcCCCCcEEEccCCCCCCCCCccccCCCCCcEEEcCCCcccccCchhhhhcCCeecccCCccc
Q 004155 83 RSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGAIPSTFMGLLDVDYIYLTGNLLTGTIPPWMLQKGDRVDLSYNSFT 158 (771)
Q Consensus 83 s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~L~~l~ls~N~l~ 158 (771)
++|.+. .+|. ++.+++|+.|++++|.+. ..|.. ...+..|.+.++.......-..+..++.+++++|.+.
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~-~~~~~---~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCS
T ss_pred cccccc-cccc-hhhhccceeecccccccc-ccccc---cccccchhhccccccccccccccccceeccccccccc
Confidence 999999 7775 688999999999999988 34332 2345556665555442221122455566666666554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.97 E-value=5.4e-11 Score=122.19 Aligned_cols=154 Identities=16% Similarity=0.125 Sum_probs=117.1
Q ss_pred CCCCcEEEccCCcccccCCccccCCCcCCEEEcccC-Cccc-cCchhhcCCcCCCEEEcCCCC-CCCC-CCCCcc-CCCC
Q 004155 2 LVTLKDFRISDNHFTGKIPNFIQNWTLLEKLVIQAS-GLVG-PIPSGIASLSKLTDLRISDLN-GTEA-PFPPLD-KMKK 76 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~ip~~~~~l~~L~~L~L~~N-~l~~-~~p~~~~~l~~L~~L~L~~n~-l~~~-~~~~~~-~l~~ 76 (771)
+++|++|+|++|.+++..+..++.+++|+.|+|+++ .++. .+..-+.++++|+.|+|+++. ++.. ....+. ..++
T Consensus 70 c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~ 149 (284)
T d2astb2 70 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET 149 (284)
T ss_dssp BCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred CCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccc
Confidence 578999999999999888888999999999999995 6652 123334678999999999863 4321 111233 3578
Q ss_pred CcEEEccCC--cCccc-CChhhhcCCCCcEEEccCC-CCCCCCCccccCCCCCcEEEcCC-CcccccCchhh--hhcCCe
Q 004155 77 MKTLILRSC--NVSGK-LPDYLGLMTSLKVLDVSFN-KLNGAIPSTFMGLLDVDYIYLTG-NLLTGTIPPWM--LQKGDR 149 (771)
Q Consensus 77 L~~L~Ls~N--~l~g~-~p~~~~~l~~L~~L~Ls~N-~l~g~ip~~~~~l~~L~~L~Ls~-N~l~g~iP~~~--~~~L~~ 149 (771)
|+.|+++++ .++.. +..-+.++++|+.|+|++| .+++.....+.++++|++|+|++ +.+++.....+ +++|+.
T Consensus 150 L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~ 229 (284)
T d2astb2 150 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 229 (284)
T ss_dssp CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred cchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCE
Confidence 999999975 34422 3334567899999999986 57877778899999999999999 46775544444 788999
Q ss_pred ecccCC
Q 004155 150 VDLSYN 155 (771)
Q Consensus 150 l~ls~N 155 (771)
|+++++
T Consensus 230 L~l~~~ 235 (284)
T d2astb2 230 LQVFGI 235 (284)
T ss_dssp EECTTS
T ss_pred EeeeCC
Confidence 999987
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.96 E-value=2.7e-11 Score=128.05 Aligned_cols=159 Identities=9% Similarity=0.034 Sum_probs=78.3
Q ss_pred CCCCcEEEccCCcccc---c-------CCccccCCCcCCEEEcccCCcccc----CchhhcCCcCCCEEEcCCCCCCCCC
Q 004155 2 LVTLKDFRISDNHFTG---K-------IPNFIQNWTLLEKLVIQASGLVGP----IPSGIASLSKLTDLRISDLNGTEAP 67 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~---~-------ip~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~ 67 (771)
+++|+.|+|+++.+.. . +...+...++|+.|+|++|.++.. +...+..+++|+.|+|++|.+....
T Consensus 58 ~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~ 137 (344)
T d2ca6a1 58 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQA 137 (344)
T ss_dssp CTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHH
T ss_pred CCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccc
Confidence 3566677776654431 1 112234456677777777766542 3334445666777777666543210
Q ss_pred CCC-------------ccCCCCCcEEEccCCcCccc----CChhhhcCCCCcEEEccCCCCCCC-----CCccccCCCCC
Q 004155 68 FPP-------------LDKMKKMKTLILRSCNVSGK----LPDYLGLMTSLKVLDVSFNKLNGA-----IPSTFMGLLDV 125 (771)
Q Consensus 68 ~~~-------------~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~-----ip~~~~~l~~L 125 (771)
... ....+.|+.|++++|+++.. +...+..++.|+.|+|++|.+... +...+..+++|
T Consensus 138 ~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L 217 (344)
T d2ca6a1 138 GAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 217 (344)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTC
T ss_pred cccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhh
Confidence 000 12344556666666655411 222344455566666666655421 22234455556
Q ss_pred cEEEcCCCccccc----Cchhh--hhcCCeecccCCccccC
Q 004155 126 DYIYLTGNLLTGT----IPPWM--LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 126 ~~L~Ls~N~l~g~----iP~~~--~~~L~~l~ls~N~l~~~ 160 (771)
+.|+|++|.++.. +...+ .++|+.|+|++|.++..
T Consensus 218 ~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~ 258 (344)
T d2ca6a1 218 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 258 (344)
T ss_dssp CEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred cccccccccccccccccccccccccccchhhhhhcCccCch
Confidence 6666666655421 11111 34555666666665543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.81 E-value=3.1e-10 Score=119.73 Aligned_cols=179 Identities=15% Similarity=0.066 Sum_probs=128.9
Q ss_pred CCCCcEEEccCCccccc----CCccccCCCcCCEEEcccCCcccc----------CchhhcCCcCCCEEEcCCCCCCCCC
Q 004155 2 LVTLKDFRISDNHFTGK----IPNFIQNWTLLEKLVIQASGLVGP----------IPSGIASLSKLTDLRISDLNGTEAP 67 (771)
Q Consensus 2 L~~L~~L~Ls~N~l~~~----ip~~~~~l~~L~~L~L~~N~l~~~----------~p~~~~~l~~L~~L~L~~n~l~~~~ 67 (771)
..+|+.|+|++|.|... +-..+...++|+.|+|+++.+... +...+..+++|+.|+|++|.+....
T Consensus 30 ~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 109 (344)
T d2ca6a1 30 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 109 (344)
T ss_dssp CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred CCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccccc
Confidence 46799999999998642 445577789999999998765421 2244566889999999999887643
Q ss_pred CC----CccCCCCCcEEEccCCcCcccCChh-------------hhcCCCCcEEEccCCCCCCC----CCccccCCCCCc
Q 004155 68 FP----PLDKMKKMKTLILRSCNVSGKLPDY-------------LGLMTSLKVLDVSFNKLNGA----IPSTFMGLLDVD 126 (771)
Q Consensus 68 ~~----~~~~l~~L~~L~Ls~N~l~g~~p~~-------------~~~l~~L~~L~Ls~N~l~g~----ip~~~~~l~~L~ 126 (771)
.. .+..+++|+.|+|++|.+...-... ....+.|+.|++++|+++.. +...+..++.|+
T Consensus 110 ~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~ 189 (344)
T d2ca6a1 110 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH 189 (344)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCC
T ss_pred ccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhc
Confidence 22 3456789999999999886221111 23467899999999998722 233456678999
Q ss_pred EEEcCCCccccc-----Cchhh--hhcCCeecccCCccccC----CCcccccccccceeccCCCC
Q 004155 127 YIYLTGNLLTGT-----IPPWM--LQKGDRVDLSYNSFTAG----SSETSCQYRSVNLFASSSKG 180 (771)
Q Consensus 127 ~L~Ls~N~l~g~-----iP~~~--~~~L~~l~ls~N~l~~~----~p~~~~~l~~L~~l~~s~~~ 180 (771)
.|+|++|+++.. +...+ .+.|+.|+|++|.++.. +...+..+++|+.|+++.+.
T Consensus 190 ~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~ 254 (344)
T d2ca6a1 190 TVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL 254 (344)
T ss_dssp EEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCC
T ss_pred ccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCc
Confidence 999999998732 11112 56799999999998754 34556778889999887653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.58 E-value=9.9e-08 Score=95.66 Aligned_cols=149 Identities=15% Similarity=0.098 Sum_probs=104.2
Q ss_pred HHHHHHhcCCCCCCccccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEE
Q 004155 414 RQIKAATNNFAPDNKIGEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQL 492 (771)
Q Consensus 414 ~~l~~~~~~f~~~~~lG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 492 (771)
.+++.....|+..+..+.++.+.||+... +++.+.||+...........+.+|..+++.+. +--+.++++++.+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45666667777666555455578999876 45667888876554444445778888887764 43467788888888999
Q ss_pred EEEEEeccCCCHHHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhhcC-------------------------------
Q 004155 493 LLIYEYMENNSLARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHEES------------------------------- 541 (771)
Q Consensus 493 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~~~------------------------------- 541 (771)
++||++++|.++.+... +......++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~---------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTT---------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEeccccccccccc---------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 99999999988866541 11123345556666666666421
Q ss_pred -------------------------CCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 542 -------------------------RLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 542 -------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
+..++|+|+.|.||++++++..-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987667799999876
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.54 E-value=2.5e-09 Score=99.60 Aligned_cols=64 Identities=20% Similarity=0.298 Sum_probs=28.2
Q ss_pred CCCCCcEEEccCCcCccc--CChhhhcCCCCcEEEccCCCCCCCCCc-cccCCCCCcEEEcCCCcccc
Q 004155 73 KMKKMKTLILRSCNVSGK--LPDYLGLMTSLKVLDVSFNKLNGAIPS-TFMGLLDVDYIYLTGNLLTG 137 (771)
Q Consensus 73 ~l~~L~~L~Ls~N~l~g~--~p~~~~~l~~L~~L~Ls~N~l~g~ip~-~~~~l~~L~~L~Ls~N~l~g 137 (771)
++++|++|+|++|+|+.. ++..+..+++|+.|+|++|.++ .+++ .+....+|+.|+|++|.+++
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCc
Confidence 344444444444444421 1223444555555555555555 2222 22222345555555555543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.52 E-value=2.2e-09 Score=116.60 Aligned_cols=158 Identities=16% Similarity=0.209 Sum_probs=91.9
Q ss_pred CCCcEEEccCCcccc-----cCCccccCCCcCCEEEcccCCcccc----CchhhcCCcCCCEEEcCCCCCCCCCCCC---
Q 004155 3 VTLKDFRISDNHFTG-----KIPNFIQNWTLLEKLVIQASGLVGP----IPSGIASLSKLTDLRISDLNGTEAPFPP--- 70 (771)
Q Consensus 3 ~~L~~L~Ls~N~l~~-----~ip~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~~~~--- 70 (771)
+.++.|++++|++.. .++........|+.|++++|.+... ....+..++.++.+++++|.+.......
T Consensus 226 ~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~ 305 (460)
T d1z7xw1 226 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 305 (460)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred ccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhc
Confidence 456777777776542 1223344456777777777777532 2334455677777777777665321111
Q ss_pred --ccCCCCCcEEEccCCcCcccCCh----hhhcCCCCcEEEccCCCCCCC----CCcccc-CCCCCcEEEcCCCccccc-
Q 004155 71 --LDKMKKMKTLILRSCNVSGKLPD----YLGLMTSLKVLDVSFNKLNGA----IPSTFM-GLLDVDYIYLTGNLLTGT- 138 (771)
Q Consensus 71 --~~~l~~L~~L~Ls~N~l~g~~p~----~~~~l~~L~~L~Ls~N~l~g~----ip~~~~-~l~~L~~L~Ls~N~l~g~- 138 (771)
......|+.+++++|.++..-.. .+...++|++|+|++|+|+.. ++..+. ..+.|++|+|++|+|+..
T Consensus 306 ~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~ 385 (460)
T d1z7xw1 306 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 385 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred cccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHH
Confidence 11235677777777777643222 233456777777777777532 233333 345677777777777632
Q ss_pred ---Cchhh--hhcCCeecccCCccccC
Q 004155 139 ---IPPWM--LQKGDRVDLSYNSFTAG 160 (771)
Q Consensus 139 ---iP~~~--~~~L~~l~ls~N~l~~~ 160 (771)
++..+ .++|++|+|++|+++..
T Consensus 386 ~~~l~~~l~~~~~L~~L~Ls~N~i~~~ 412 (460)
T d1z7xw1 386 CSSLAATLLANHSLRELDLSNNCLGDA 412 (460)
T ss_dssp HHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred HHHHHHHHhcCCCCCEEECCCCcCCHH
Confidence 22222 46677777777777643
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=1.1e-08 Score=111.00 Aligned_cols=133 Identities=17% Similarity=0.156 Sum_probs=55.2
Q ss_pred CCcEEEccCCccccc----CCccccCCCcCCEEEcccCCccccCchh----h-cCCcCCCEEEcCCCCCCCCCCCC----
Q 004155 4 TLKDFRISDNHFTGK----IPNFIQNWTLLEKLVIQASGLVGPIPSG----I-ASLSKLTDLRISDLNGTEAPFPP---- 70 (771)
Q Consensus 4 ~L~~L~Ls~N~l~~~----ip~~~~~l~~L~~L~L~~N~l~~~~p~~----~-~~l~~L~~L~L~~n~l~~~~~~~---- 70 (771)
.|+.|++++|.+... +...+...+.++.+++++|.++..-... + .....|+.+++++|.++......
T Consensus 256 ~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~ 335 (460)
T d1z7xw1 256 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV 335 (460)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccc
Confidence 455555555554421 1112333445555555555554211111 1 11234555555555444322111
Q ss_pred ccCCCCCcEEEccCCcCccc----CChhhh-cCCCCcEEEccCCCCCC----CCCccccCCCCCcEEEcCCCccc
Q 004155 71 LDKMKKMKTLILRSCNVSGK----LPDYLG-LMTSLKVLDVSFNKLNG----AIPSTFMGLLDVDYIYLTGNLLT 136 (771)
Q Consensus 71 ~~~l~~L~~L~Ls~N~l~g~----~p~~~~-~l~~L~~L~Ls~N~l~g----~ip~~~~~l~~L~~L~Ls~N~l~ 136 (771)
+...++|++|+|++|+|+.. ++..+. ..+.|+.|+|++|+|+. .++..+..+++|++|+|++|+|+
T Consensus 336 ~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 336 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410 (460)
T ss_dssp HHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred cccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 12234455555555555421 222222 23345555555555542 12233344455555555555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.35 E-value=2.3e-08 Score=92.83 Aligned_cols=118 Identities=19% Similarity=0.112 Sum_probs=83.6
Q ss_pred CCCEEEcCCCCCCCCCCCCccCCCCCcEEEccCCcCcccCChhhhcCCCCcEEEccCCCCCCC--CCccccCCCCCcEEE
Q 004155 52 KLTDLRISDLNGTEAPFPPLDKMKKMKTLILRSCNVSGKLPDYLGLMTSLKVLDVSFNKLNGA--IPSTFMGLLDVDYIY 129 (771)
Q Consensus 52 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~--ip~~~~~l~~L~~L~ 129 (771)
.++.|+++++... +.+..+..+..|++.+|... .++..+..+++|++|+|++|+|+.. ++..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3455666654422 23444555555666666554 5565667899999999999999943 234567899999999
Q ss_pred cCCCcccccCch-hh--hhcCCeecccCCccccCCCcc-------cccccccceec
Q 004155 130 LTGNLLTGTIPP-WM--LQKGDRVDLSYNSFTAGSSET-------SCQYRSVNLFA 175 (771)
Q Consensus 130 Ls~N~l~g~iP~-~~--~~~L~~l~ls~N~l~~~~p~~-------~~~l~~L~~l~ 175 (771)
|++|.++ .++. .. ...|+.|++++|+++...... +..+++|+.||
T Consensus 98 Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 98 LSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 9999999 5654 22 456899999999998765533 45678888887
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.98 E-value=1.9e-05 Score=77.97 Aligned_cols=130 Identities=18% Similarity=0.151 Sum_probs=85.2
Q ss_pred ccccCCc-eeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCC--CCcEEeEEEEEEeCCEEEEEEEeccCCCH
Q 004155 428 KIGEGGF-GPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQ--HPNLVKLHGCCIEGNQLLLIYEYMENNSL 504 (771)
Q Consensus 428 ~lG~G~~-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~E~~~~gsL 504 (771)
.+..|.. +.||+....++..+++|....... ..+..|+..++.+. .-.+.++++++.+++..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445554 679999888888899998655432 24567777777663 33467788888888889999999987654
Q ss_pred HHHhcCCCccCCCCChHHHHHHHHHHHHHHHHhhh---------------------------------------------
Q 004155 505 ARALFGPEAHRLKLDWPTRHRICVGIARGLAYLHE--------------------------------------------- 539 (771)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~~LH~--------------------------------------------- 539 (771)
.+.. .. ....+.++++.|+-||+
T Consensus 94 ~~~~---------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccc---------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 2210 00 11112222233333331
Q ss_pred ------c----CCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 540 ------E----SRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 540 ------~----~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
. .++.++|+|+.|.||+++++..+-|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 12348999999999999987667899999876
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.56 E-value=1.4e-05 Score=73.84 Aligned_cols=108 Identities=6% Similarity=-0.002 Sum_probs=49.9
Q ss_pred CCcCCEEEcccC-Ccccc----CchhhcCCcCCCEEEcCCCCCCCCCCC----CccCCCCCcEEEccCCcCccc----CC
Q 004155 26 WTLLEKLVIQAS-GLVGP----IPSGIASLSKLTDLRISDLNGTEAPFP----PLDKMKKMKTLILRSCNVSGK----LP 92 (771)
Q Consensus 26 l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~~~----~~~~l~~L~~L~Ls~N~l~g~----~p 92 (771)
.++|+.|+|+++ .++.. +-..+...++|+.|+|++|.+...... .+...+.|+.|+|++|.|+.. +-
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 355666666653 34311 222344445556666665555422111 223345566666666655522 11
Q ss_pred hhhhcCCCCcEEEccCCCCCCC-------CCccccCCCCCcEEEcCCC
Q 004155 93 DYLGLMTSLKVLDVSFNKLNGA-------IPSTFMGLLDVDYIYLTGN 133 (771)
Q Consensus 93 ~~~~~l~~L~~L~Ls~N~l~g~-------ip~~~~~l~~L~~L~Ls~N 133 (771)
..+...+.|++|+|++|.+... +...+...++|+.|+++.+
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 2233445566666665554411 1222333455555555544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.51 E-value=1.6e-05 Score=73.32 Aligned_cols=110 Identities=14% Similarity=0.065 Sum_probs=81.3
Q ss_pred CCCCcEEEccCC-ccccc----CCccccCCCcCCEEEcccCCccc----cCchhhcCCcCCCEEEcCCCCCCCCCC----
Q 004155 2 LVTLKDFRISDN-HFTGK----IPNFIQNWTLLEKLVIQASGLVG----PIPSGIASLSKLTDLRISDLNGTEAPF---- 68 (771)
Q Consensus 2 L~~L~~L~Ls~N-~l~~~----ip~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~~---- 68 (771)
.++|++|+|+++ .++.. +-..+...++|+.|+|++|.+.. .+...+...+.|+.|+|++|.+.....
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 478999999974 56532 33346677889999999999973 334556667899999999999875321
Q ss_pred CCccCCCCCcEEEccCCcCccc-------CChhhhcCCCCcEEEccCCCC
Q 004155 69 PPLDKMKKMKTLILRSCNVSGK-------LPDYLGLMTSLKVLDVSFNKL 111 (771)
Q Consensus 69 ~~~~~l~~L~~L~Ls~N~l~g~-------~p~~~~~l~~L~~L~Ls~N~l 111 (771)
..+...+.|++|+|++|++... +...+...+.|+.|+++.+..
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 2466678899999999987621 333455678999999987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.39 E-value=0.00017 Score=76.06 Aligned_cols=76 Identities=12% Similarity=0.079 Sum_probs=48.1
Q ss_pred CCccccCCceeEEEEEcCC-CcEEEEEEcccC-------ChhcHHHHHHHHHHHHcCC-C--CcEEeEEEEEEeCCEEEE
Q 004155 426 DNKIGEGGFGPVYKGHMAD-GTVVAVKQLSSK-------SKQGNREFVNEIGMISALQ-H--PNLVKLHGCCIEGNQLLL 494 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 494 (771)
.+.||.|....||+....+ ++.|+||.-... ......+...|.+.|+.+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3568999999999997654 678999975321 1112234556888777652 2 345566544 4555689
Q ss_pred EEEeccCCC
Q 004155 495 IYEYMENNS 503 (771)
Q Consensus 495 V~E~~~~gs 503 (771)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.04 E-value=0.00066 Score=69.37 Aligned_cols=136 Identities=13% Similarity=0.112 Sum_probs=78.7
Q ss_pred eeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCCCcE--EeEE-----EEEEeCCEEEEEEEeccCCCHH--
Q 004155 435 GPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQHPNL--VKLH-----GCCIEGNQLLLIYEYMENNSLA-- 505 (771)
Q Consensus 435 g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lV~E~~~~gsL~-- 505 (771)
-.||++..++|+.|++|+.+.. ....+++..|...+..|....+ +..+ ..+...+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 5899999999999999997653 2345667788888777642211 1111 1234567789999998764221
Q ss_pred ----------------HHhcCCC-ccCCCCChH-------------------HHHHHHHHHHHHHHHhhh----cCCCce
Q 004155 506 ----------------RALFGPE-AHRLKLDWP-------------------TRHRICVGIARGLAYLHE----ESRLKI 545 (771)
Q Consensus 506 ----------------~~l~~~~-~~~~~l~~~-------------------~~~~i~~~ia~aL~~LH~----~~~~~i 545 (771)
....... .....+++. .+..+...+.+.++.+.. ..+.++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 1111110 011112211 111222222233333322 234579
Q ss_pred eccCCCCCcEEEcCCCCeEEEeecCccc
Q 004155 546 VHRDIKATNVLLDKDLNPKISDFGLAKL 573 (771)
Q Consensus 546 vH~Dlkp~NIll~~~~~~kl~DFGla~~ 573 (771)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 46899998863
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.70 E-value=0.00015 Score=66.36 Aligned_cols=113 Identities=16% Similarity=0.082 Sum_probs=72.3
Q ss_pred cCCCcCCEEEccc-CCccc----cCchhhcCCcCCCEEEcCCCCCCCCCC----CCccCCCCCcEEEccCCcCccc----
Q 004155 24 QNWTLLEKLVIQA-SGLVG----PIPSGIASLSKLTDLRISDLNGTEAPF----PPLDKMKKMKTLILRSCNVSGK---- 90 (771)
Q Consensus 24 ~~l~~L~~L~L~~-N~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L~~L~Ls~N~l~g~---- 90 (771)
.+.++|++|+|++ |.++. .+-..+...++|+.|+|++|.+..... ..+...++|+.|++++|.+...
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4456777777776 44542 133445567777888888777654221 2345567888888888887633
Q ss_pred CChhhhcCCCCcEEEc--cCCCCCC----CCCccccCCCCCcEEEcCCCccc
Q 004155 91 LPDYLGLMTSLKVLDV--SFNKLNG----AIPSTFMGLLDVDYIYLTGNLLT 136 (771)
Q Consensus 91 ~p~~~~~l~~L~~L~L--s~N~l~g----~ip~~~~~l~~L~~L~Ls~N~l~ 136 (771)
+-..+...++|+.++| ++|.+.. .+...+...++|+.|+|+.|...
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 2245667788887655 4566652 24445667889999999877654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.59 E-value=0.00014 Score=66.74 Aligned_cols=115 Identities=12% Similarity=0.133 Sum_probs=69.7
Q ss_pred chhhcCCcCCCEEEcCC-CCCCCCC----CCCccCCCCCcEEEccCCcCccc----CChhhhcCCCCcEEEccCCCCCCC
Q 004155 44 PSGIASLSKLTDLRISD-LNGTEAP----FPPLDKMKKMKTLILRSCNVSGK----LPDYLGLMTSLKVLDVSFNKLNGA 114 (771)
Q Consensus 44 p~~~~~l~~L~~L~L~~-n~l~~~~----~~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~ 114 (771)
.....+.++|+.|+|++ +.++... ...+...++|+.|+|++|.++.. +-..+...++|+.|++++|.+...
T Consensus 10 ~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~ 89 (166)
T d1io0a_ 10 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS 89 (166)
T ss_dssp HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred HHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccch
Confidence 33345667888888886 3454321 12345677888888888887633 222355677888888888887622
Q ss_pred ----CCccccCCCCCcEEEc--CCCccccc----Cchhh--hhcCCeecccCCccc
Q 004155 115 ----IPSTFMGLLDVDYIYL--TGNLLTGT----IPPWM--LQKGDRVDLSYNSFT 158 (771)
Q Consensus 115 ----ip~~~~~l~~L~~L~L--s~N~l~g~----iP~~~--~~~L~~l~ls~N~l~ 158 (771)
+-..+...++|+.++| ++|.+... +...+ .+.|+.|+++.|...
T Consensus 90 g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 90 GILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred hHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 2235566777876555 45666421 22222 456778888776543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.50 E-value=0.0027 Score=66.45 Aligned_cols=72 Identities=15% Similarity=0.138 Sum_probs=48.7
Q ss_pred CCccccCCceeEEEEEcCC--------CcEEEEEEcccCChhcHHHHHHHHHHHHcCC-CCcEEeEEEEEEeCCEEEEEE
Q 004155 426 DNKIGEGGFGPVYKGHMAD--------GTVVAVKQLSSKSKQGNREFVNEIGMISALQ-HPNLVKLHGCCIEGNQLLLIY 496 (771)
Q Consensus 426 ~~~lG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 496 (771)
.+.|+.|-.-.+|++...+ .+.|.+++.... .......+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3578889999999997544 356777776532 22345567888888774 4334577777642 6899
Q ss_pred EeccCCC
Q 004155 497 EYMENNS 503 (771)
Q Consensus 497 E~~~~gs 503 (771)
||++|.+
T Consensus 121 efi~g~~ 127 (395)
T d1nw1a_ 121 EYIPSRP 127 (395)
T ss_dssp CCCCEEE
T ss_pred EEecccc
Confidence 9998743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.38 E-value=0.0094 Score=59.92 Aligned_cols=159 Identities=13% Similarity=0.077 Sum_probs=85.5
Q ss_pred CCHHHHHHHhcCCCCCCcc-----ccCCceeEEEEEcCCCcEEEEEEcccCChhcHHHHHHHHHHHHcCCC-----CcEE
Q 004155 411 FTLRQIKAATNNFAPDNKI-----GEGGFGPVYKGHMADGTVVAVKQLSSKSKQGNREFVNEIGMISALQH-----PNLV 480 (771)
Q Consensus 411 ~~~~~l~~~~~~f~~~~~l-----G~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-----~niv 480 (771)
.+-+|++....+|.+.+.. ..|---+.|+.+..+|+ +++|+...... ..++..|++++..+.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 5678888888899875543 35656888999876665 89998865322 2344456666665532 2222
Q ss_pred eEE---EEEEeCCEEEEEEEeccCCCHH--------------HHhc----CC--CccCCCC-----------------Ch
Q 004155 481 KLH---GCCIEGNQLLLIYEYMENNSLA--------------RALF----GP--EAHRLKL-----------------DW 520 (771)
Q Consensus 481 ~l~---~~~~~~~~~~lV~E~~~~gsL~--------------~~l~----~~--~~~~~~l-----------------~~ 520 (771)
... .+.........++.++.+.... ..++ .. ....... ..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110 0122345667777777654221 0000 00 0000000 01
Q ss_pred HHHHHHHHHHHHHHHHhhh-cCCCceeccCCCCCcEEEcCCCCeEEEeecCcc
Q 004155 521 PTRHRICVGIARGLAYLHE-ESRLKIVHRDIKATNVLLDKDLNPKISDFGLAK 572 (771)
Q Consensus 521 ~~~~~i~~~ia~aL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 572 (771)
......+..+...+.-.+. ..+.++||+|+.++||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1111222222222332222 124589999999999999998777899999885
|